Citrus Sinensis ID: 045449
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
ID ![]() | Alignment graph ![]() | Length ![]() |
Definition ![]() |
RBH(Q2H) ![]() |
RBH(H2Q) ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 823 | 2.2.26 [Sep-21-2011] | |||||||
| C0LGT6 | 1031 | LRR receptor-like serine/ | yes | no | 0.934 | 0.745 | 0.330 | 1e-111 | |
| C0LGP4 | 1010 | Probable LRR receptor-lik | no | no | 0.901 | 0.734 | 0.327 | 1e-103 | |
| Q9SD62 | 1025 | Putative receptor-like pr | no | no | 0.904 | 0.725 | 0.327 | 7e-91 | |
| Q42371 | 976 | LRR receptor-like serine/ | no | no | 0.893 | 0.753 | 0.310 | 7e-90 | |
| Q9M2Z1 | 1002 | Leucine-rich repeat recep | no | no | 0.882 | 0.724 | 0.299 | 3e-84 | |
| C0LGW6 | 966 | LRR receptor-like serine/ | no | no | 0.884 | 0.753 | 0.301 | 5e-84 | |
| O49545 | 1003 | Leucine-rich repeat recep | no | no | 0.889 | 0.729 | 0.307 | 8e-84 | |
| Q9ZUI0 | 980 | Putative leucine-rich rep | no | no | 0.919 | 0.772 | 0.315 | 1e-81 | |
| Q6XAT2 | 967 | LRR receptor-like serine/ | no | no | 0.897 | 0.764 | 0.299 | 1e-81 | |
| Q8VZG8 | 1045 | Probable LRR receptor-lik | no | no | 0.845 | 0.666 | 0.298 | 2e-81 |
| >sp|C0LGT6|EFR_ARATH LRR receptor-like serine/threonine-protein kinase EFR OS=Arabidopsis thaliana GN=EFR PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 402 bits (1032), Expect = e-111, Method: Compositional matrix adjust.
Identities = 309/934 (33%), Positives = 442/934 (47%), Gaps = 165/934 (17%)
Query: 12 QALLALKAHISYDHTNLFARNWTSSTSVCIWIGITCDVNSHRVIGLNISSFNLQGTITPQ 71
QALL K+ +S ++ +W S+ C WIG+TC RVI LN+ F L G I+P
Sbjct: 33 QALLEFKSQVSENNKREVLASWNHSSPFCNWIGVTCGRRRERVISLNLGGFKLTGVISPS 92
Query: 72 LGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLDFSDNQLFGSLSSFIFNMSSMTTIDL 131
+GNLS L+ L+L+ N IP + + L+ L+ S N L G + S + N S ++T+DL
Sbjct: 93 IGNLSFLRLLNLADNSFGSTIPQKVGRLFRLQYLNMSYNLLEGRIPSSLSNCSRLSTVDL 152
Query: 132 SINRLSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKEIGNLTKLKEIISTITNS 191
S N L +PS L +L L+L NNL+G P +GNLT L+++ N
Sbjct: 153 SSNHLGH-------GVPSELGSLSKLAILDLSKNNLTGNFPASLGNLTSLQKL-DFAYNQ 204
Query: 192 TVCEIPREIGNLPYLARLALATNNLVGVVPVTIFNMSALKEISLLNNSLSGSLPSRIDLS 251
EIP E+ L + +A N+ G P ++N+S+L+ +SL +NS SG+L +
Sbjct: 205 MRGEIPDEVARLTQMVFFQIALNSFSGGFPPALYNISSLESLSLADNSFSGNLRADFGYL 264
Query: 252 LPNVETLNLGINSFSGTIPSSITNSSKLSDLELGENLFSGFIPNTIGNLRNLEF-GNIAD 310
LPN+ L LG N F+G IP ++ N S L ++ N SG IP + G LRNL + G +
Sbjct: 265 LPNLRRLLLGTNQFTGAIPKTLANISSLERFDISSNYLSGSIPLSFGKLRNLWWLGIRNN 324
Query: 311 NYLTSSTPELSFLSSLTNCKKLKVLIVTGNPLDGILPKSIGNFSLSLETILMANCSISGN 370
+ +S+ L F+ ++ NC +L+ L V N L G LP SI N S +L ++ + ISG
Sbjct: 325 SLGNNSSSGLEFIGAVANCTQLEYLDVGYNRLGGELPASIANLSTTLTSLFLGQNLISGT 384
Query: 371 IPQVVGNLSNLLVLELGGNNLTGPIPVTFSQLQTLQAFDLTRNKLAGPITDELCHLARLH 430
IP +GNL +L L L N L+G +PV+F +L LQ DL N ++G I ++ RL
Sbjct: 385 IPHDIGNLVSLQELSLETNMLSGELPVSFGKLLNLQVVDLYSNAISGEIPSYFGNMTRLQ 444
Query: 431 SLVLQGNKFSGSIPSCLGNLTSVRVLYLGLNIFTSVLSSTIWNLKDILFIDVSSNFLDGP 490
L L N F G IP LG + L++ N + I + + +ID+S+NFL G
Sbjct: 445 KLHLNSNSFHGRIPQSLGRCRYLLDLWMDTNRLNGTIPQEILQIPSLAYIDLSNNFLTGH 504
Query: 491 LSLDIGNLKVVIGLDFSRNNLSGDIPITIG------------------------------ 520
++G L++++GL S N LSG +P IG
Sbjct: 505 FPEEVGKLELLVGLGASYNKLSGKMPQAIGGCLSMEFLFMQGNSFDGAIPDISRLVSLKN 564
Query: 521 --------EGEIPR------------------------GGPFANLTAKSFMGNELLC-GL 547
G IPR G F N TA S GN +C G+
Sbjct: 565 VDFSNNNLSGRIPRYLASLPSLRNLNLSMNKFEGRVPTTGVFRNATAVSVFGNTNICGGV 624
Query: 548 PDLQVSPCKPNKPNTHKKS---RKMLLLVIVLPLSTALIVVVTLTLKWKLIKCWKSRTGP 604
++Q+ PC +K RK ++ I + +++ L++++ +L W + + K+
Sbjct: 625 REMQLKPCIVQASPRKRKPLSVRKKVVSGICIGIASLLLIIIVASLCWFMKRKKKNNASD 684
Query: 605 SN--DGINSPQAIRRFSYHELLRATDRFSENNLIGIGN---------GME---VAVKVFH 650
N D + SY EL AT RFS NLIG GN G E VAVKV +
Sbjct: 685 GNPSDSTTLGMFHEKVSYEELHSATSRFSSTNLIGSGNFGNVFKGLLGPENKLVAVKVLN 744
Query: 651 QQYERALKSFEDECEVRKRIRHRNLVKIIS--SSL------------EYLHFG------- 689
A KSF ECE K IRHRNLVK+I+ SSL E++ G
Sbjct: 745 LLKHGATKSFMAECETFKGIRHRNLVKLITVCSSLDSEGNDFRALVYEFMPKGSLDMWLQ 804
Query: 690 ---------HSIPI--------------------IHC-------DLKPSNVLLDEDMVAH 713
HS + +HC D+KPSN+LLD+D+ AH
Sbjct: 805 LEDLERVNDHSRSLTPAEKLNIAIDVASALEYLHVHCHDPVAHCDIKPSNILLDDDLTAH 864
Query: 714 ISDFGIAKLLSGEDQLSKQTQ-----TLATIGYMAPEYGTKGRVSTRGDVCSFGII---- 764
+SDFG+A+LL D+ S Q TIGY APEYG G+ S +GDV SFGI+
Sbjct: 865 VSDFGLAQLLYKYDRESFLNQFSSAGVRGTIGYAAPEYGMGGQPSIQGDVYSFGILLLEM 924
Query: 765 -SGGKETRSMTVGETCTPVRESKYEVHPATTTIM 797
SG K T G+ Y +H T +I+
Sbjct: 925 FSGKKPTDESFAGD---------YNLHSYTKSIL 949
|
Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of elongation factor Tu (EF-Tu), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Reduces transformation by Rhizobium radiobacter probably by inducing plant defense during the interaction. Binding to the effector AvrPto1 from P.syringae blocks the downstream plant immune response. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|C0LGP4|Y3475_ARATH Probable LRR receptor-like serine/threonine-protein kinase At3g47570 OS=Arabidopsis thaliana GN=At3g47570 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 377 bits (968), Expect = e-103, Method: Compositional matrix adjust.
Identities = 294/897 (32%), Positives = 434/897 (48%), Gaps = 155/897 (17%)
Query: 11 QQALLALKAHISYDHTNLFARNWTSSTSVCIWIGITCDVNSHRVIGLNISSFNLQGTITP 70
+QALL K+ +S D + + +W S +C W G+TC + RV L + L G I+P
Sbjct: 26 RQALLQFKSQVSEDKRVVLS-SWNHSFPLCNWKGVTCGRKNKRVTHLELGRLQLGGVISP 84
Query: 71 QLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLDFSDNQLFGSLSSFIFNMSSMTTID 130
+GNLS L +LDL N G IP + + L+ LD N L G + ++N S + +
Sbjct: 85 SIGNLSFLVSLDLYENFFGGTIPQEVGQLSRLEYLDMGINYLRGPIPLGLYNCSRLLNLR 144
Query: 131 LSINRLSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKEIGNLTKLKEIISTITN 190
L NRL G +PS L L +LNL NN+ G +P +GNLT L+++ + N
Sbjct: 145 LDSNRLGG-------SVPSELGSLTNLVQLNLYGNNMRGKLPTSLGNLTLLEQLALS-HN 196
Query: 191 STVCEIPREIGNLPYLARLALATNNLVGVVPVTIFNMSALKEISLLNNSLSGSLPSRIDL 250
+ EIP ++ L + L L NN GV P ++N+S+LK + + N SG L + +
Sbjct: 197 NLEGEIPSDVAQLTQIWSLQLVANNFSGVFPPALYNLSSLKLLGIGYNHFSGRLRPDLGI 256
Query: 251 SLPNVETLNLGINSFSGTIPSSITNSSKLSDLELGENLFSGFIPNTIGNLRNLEFGNIAD 310
LPN+ + N+G N F+G+IP++++N S L L + EN +G IP T GN+ NL+ +
Sbjct: 257 LLPNLLSFNMGGNYFTGSIPTTLSNISTLERLGMNENNLTGSIP-TFGNVPNLKLLFLHT 315
Query: 311 NYLTS-STPELSFLSSLTNCKKLKVLIVTGNPLDGILPKSIGNFSLSLETILMANCSISG 369
N L S S+ +L FL+SLTNC +L+ L + N L G LP SI N S L T+ + ISG
Sbjct: 316 NSLGSDSSRDLEFLTSLTNCTQLETLGIGRNRLGGDLPISIANLSAKLVTLDLGGTLISG 375
Query: 370 NIPQVVGNLSNLLVLELGGNNLTGPIPVTFSQLQTLQAFDLTRNKLAGPITDELCHLARL 429
+IP +GNL NL L L N L+GP+P + +L L+ L N+L+G I + ++ L
Sbjct: 376 SIPYDIGNLINLQKLILDQNMLSGPLPTSLGKLLNLRYLSLFSNRLSGGIPAFIGNMTML 435
Query: 430 HSLVLQGNKFSGSIPSCLGNLTSVRVLYLGLNIFTSVLSSTIWNLKDILFIDVSSNFLDG 489
+L L N F G +P+ LGN + + L++G N + I ++ +L +D+S N L G
Sbjct: 436 ETLDLSNNGFEGIVPTSLGNCSHLLELWIGDNKLNGTIPLEIMKIQQLLRLDMSGNSLIG 495
Query: 490 PLSLDIGNLKVVIGLDFSRNNLSGDIPITIG----------EGEIPRGG----------- 528
L DIG L+ + L N LSG +P T+G EG + G
Sbjct: 496 SLPQDIGALQNLGTLSLGDNKLSGKLPQTLGNCLTMESLFLEGNLFYGDIPDLKGLVGVK 555
Query: 529 ----------------------------PFANLTAK-------------SFMGNELLC-G 546
F NL K S +GN LC G
Sbjct: 556 EVDLSNNDLSGSIPEYFASFSKLEYLNLSFNNLEGKVPVKGIFENATTVSIVGNNDLCGG 615
Query: 547 LPDLQVSPCKPNKPNTHKK-SRKMLLLVIVLPLSTALIVVV---TLTLKWKLIKCWKSRT 602
+ Q+ PC P+ KK S ++ +VI + + L++++ ++TL W ++ K
Sbjct: 616 IMGFQLKPCLSQAPSVVKKHSSRLKKVVIGVSVGITLLLLLFMASVTLIW--LRKRKKNK 673
Query: 603 GPSNDGINSPQAI-RRFSYHELLRATDRFSENNLIGIGN------------GMEVAVKVF 649
+N ++ + + + SY +L AT+ FS +N++G G+ VAVKV
Sbjct: 674 ETNNPTPSTLEVLHEKISYGDLRNATNGFSSSNMVGSGSFGTVYKALLLTEKKVVAVKVL 733
Query: 650 HQQYERALKSFEDECEVRKRIRHRNLVKIISSS--------------------------- 682
+ Q A+KSF ECE K IRHRNLVK++++
Sbjct: 734 NMQRRGAMKSFMAECESLKDIRHRNLVKLLTACSSIDFQGNEFRALIYEFMPNGSLDMWL 793
Query: 683 -----------------LEYLHFGHSIPII------HC-------DLKPSNVLLDEDMVA 712
LE L+ + + HC DLKPSNVLLD+D+ A
Sbjct: 794 HPEEVEEIHRPSRTLTLLERLNIAIDVASVLDYLHVHCHEPIAHCDLKPSNVLLDDDLTA 853
Query: 713 HISDFGIAKLLSGEDQLSKQTQ-----TLATIGYMAPEYGTKGRVSTRGDVCSFGII 764
H+SDFG+A+LL D+ S Q TIGY APEYG G+ S GDV SFGI+
Sbjct: 854 HVSDFGLARLLLKFDEESFFNQLSSAGVRGTIGYAAPEYGVGGQPSINGDVYSFGIL 910
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SD62|Y3471_ARATH Putative receptor-like protein kinase At3g47110 OS=Arabidopsis thaliana GN=At3g47110 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 335 bits (860), Expect = 7e-91, Method: Compositional matrix adjust.
Identities = 294/897 (32%), Positives = 428/897 (47%), Gaps = 153/897 (17%)
Query: 11 QQALLALKAHISYDHTNLFARNWTSSTSVCIWIGITCDVNSHRVIGLNISSFNLQGTITP 70
+QALL K+ +S + + + +W S +C W G+ C + RV G+++ L G ++P
Sbjct: 41 KQALLEFKSQVS-ETSRVVLGSWNDSLPLCSWTGVKCGLKHRRVTGVDLGGLKLTGVVSP 99
Query: 71 QLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLDFSDNQLFGSLSSFIFNMSSMTTID 130
+GNLS L++L+L+ N G IPS + N+ L+ L+ S+N G + + N SS++T+D
Sbjct: 100 FVGNLSFLRSLNLADNFFHGAIPSEVGNLFRLQYLNMSNNLFGGVIPVVLSNCSSLSTLD 159
Query: 131 LSINRLSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKEIGNLTKLKEIISTITN 190
LS N L +P +L L+LG NNL+G P +GNLT L +++ I N
Sbjct: 160 LSSNHLEQ-------GVPLEFGSLSKLVLLSLGRNNLTGKFPASLGNLTSL-QMLDFIYN 211
Query: 191 STVCEIPREIGNLPYLARLALATNNLVGVVPVTIFNMSALKEISLLNNSLSGSLPSRIDL 250
EIP +I L + +A N GV P I+N+S+L +S+ NS SG+L
Sbjct: 212 QIEGEIPGDIARLKQMIFFRIALNKFNGVFPPPIYNLSSLIFLSITGNSFSGTLRPDFGS 271
Query: 251 SLPNVETLNLGINSFSGTIPSSITNSSKLSDLELGENLFSGFIPNTIGNLRNLEFGNIAD 310
LPN++ L +GINSF+GTIP +++N S L L++ N +G IP + G L+NL + +
Sbjct: 272 LLPNLQILYMGINSFTGTIPETLSNISSLRQLDIPSNHLTGKIPLSFGRLQNLLLLGLNN 331
Query: 311 NYLTS-STPELSFLSSLTNCKKLKVLIVTGNPLDGILPKSIGNFSLSLETILMANCSISG 369
N L + S+ +L FL +LTNC +L+ L V N L G LP I N S L + + ISG
Sbjct: 332 NSLGNYSSGDLDFLGALTNCSQLQYLNVGFNKLGGQLPVFIANLSTQLTELSLGGNLISG 391
Query: 370 NIPQVVGNLSNLLVLELGGNNLTGPIPVTFSQLQTLQAFDLTRNKLAGPITDELCHLARL 429
+IP +GNL +L L+LG N LTG +P + +L L+ L N L+G I L +++ L
Sbjct: 392 SIPHGIGNLVSLQTLDLGENLLTGKLPPSLGELSELRKVLLYSNGLSGEIPSSLGNISGL 451
Query: 430 HSLVLQGNKFSGSIPSCLGNLTSVRVLYLGLNIFTSVLSSTIWNLKDILFIDVSSNFLDG 489
L L N F GSIPS LG+ + + L LG N + + L ++ ++VS N L G
Sbjct: 452 TYLYLLNNSFEGSIPSSLGSCSYLLDLNLGTNKLNGSIPHELMELPSLVVLNVSFNLLVG 511
Query: 490 PLSLDIGNLKVVIGLD-------------------------------------------- 505
PL DIG LK ++ LD
Sbjct: 512 PLRQDIGKLKFLLALDVSYNKLSGQIPQTLANCLSLEFLLLQGNSFVGPIPDIRGLTGLR 571
Query: 506 ---FSRNNLSGDIPITIG---------------EGEIPRGGPFANLTAKSFMGNELLCG- 546
S+NNLSG IP + +G +P G F N +A S GN LCG
Sbjct: 572 FLDLSKNNLSGTIPEYMANFSKLQNLNLSLNNFDGAVPTEGVFRNTSAMSVFGNINLCGG 631
Query: 547 LPDLQVSPCKPNKPNTHKKSRKMLLLVI-VLPLSTALIVVVTLTLKWKLIKCWKSRTGPS 605
+P LQ+ PC P H RK++ + + + + L+ + + L W ++ KS +
Sbjct: 632 IPSLQLQPCSVELPRRHSSVRKIITICVSAVMAALLLLCLCVVYLCWYKLRV-KSVRANN 690
Query: 606 NDGINSPQAIRRF----SYHELLRATDRFSENNLIGIGN------------GMEVAVKVF 649
N+ S ++ F SY EL + T FS +NLIG GN VA+KV
Sbjct: 691 NENDRSFSPVKSFYEKISYDELYKTTGGFSSSNLIGSGNFGAVFKGFLGSKNKAVAIKVL 750
Query: 650 HQQYERALKSFEDECEVRKRIRHRNLVKII---SSS-----------LEYLHFGHSIPII 695
+ A KSF ECE IRHRNLVK++ SSS E++ G+ +
Sbjct: 751 NLCKRGAAKSFIAECEALGGIRHRNLVKLVTICSSSDFEGNDFRALVYEFMPNGNLDMWL 810
Query: 696 HCDL-----KPS---------NVLLD------------EDMVAH---------------- 713
H D PS N+ +D + +AH
Sbjct: 811 HPDEIEETGNPSRTLGLFARLNIAIDVASALVYLHTYCHNPIAHCDIKPSNILLDKDLTA 870
Query: 714 -ISDFGIAKLLSGEDQLSKQTQ-----TLATIGYMAPEYGTKGRVSTRGDVCSFGII 764
+SDFG+A+LL D+ + Q TIGY APEYG G S GDV SFGI+
Sbjct: 871 HVSDFGLAQLLLKFDRDTFHIQFSSAGVRGTIGYAAPEYGMGGHPSIMGDVYSFGIV 927
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q42371|ERECT_ARATH LRR receptor-like serine/threonine-protein kinase ERECTA OS=Arabidopsis thaliana GN=ERECTA PE=1 SV=1 | Back alignment and function description |
|---|
Score = 332 bits (851), Expect = 7e-90, Method: Compositional matrix adjust.
Identities = 264/849 (31%), Positives = 408/849 (48%), Gaps = 114/849 (13%)
Query: 2 LLKSIISQHQQALLALKAHISYDHTNLFARNWTSSTS--VCIWIGITCDVNSHRVIGLNI 59
L+ ++ S+ LL +K S+ N +WT+S S C+W G++C+ + V+ LN+
Sbjct: 18 LVATVTSEEGATLLEIKK--SFKDVNNVLYDWTTSPSSDYCVWRGVSCENVTFNVVALNL 75
Query: 60 SSFNLQGTITPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLDFSDNQLFGSLSSF 119
S NL G I+P +G+L SL ++DL N+LSG IP I + +L+ LD S N+L G +
Sbjct: 76 SDLNLDGEISPAIGDLKSLLSIDLRGNRLSGQIPDEIGDCSSLQNLDLSFNELSGDIPFS 135
Query: 120 IFNMSSMTTIDLSINRLSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKEIGNLT 179
I + + + L N+L G IPSTLS+ L+ L+L N LSG IP+ I
Sbjct: 136 ISKLKQLEQLILKNNQLIG-------PIPSTLSQIPNLKILDLAQNKLSGEIPRLI-YWN 187
Query: 180 KLKEIISTITNSTVCEIPREIGNLPYLARLALATNNLVGVVPVTIFNMSALKEISLLNNS 239
++ + + N+ V I ++ L L + N+L G +P TI N +A + + L N
Sbjct: 188 EVLQYLGLRGNNLVGNISPDLCQLTGLWYFDVRNNSLTGSIPETIGNCTAFQVLDLSYNQ 247
Query: 240 LSGSLPSRIDLSLPNVETLNLGINSFSGTIPSSITNSSKLSDLELGENLFSGFIPNTIGN 299
L+G +P D+ V TL+L N SG IPS I L+ L+L NL SG IP +GN
Sbjct: 248 LTGEIP--FDIGFLQVATLSLQGNQLSGKIPSVIGLMQALAVLDLSGNLLSGSIPPILGN 305
Query: 300 LRNLEFGNIADNYLTSSTPELSFLSSLTNCKKLKVLIVTGNPLDGILPKSIGNFSLSLET 359
L E + N LT S P L N KL L + N L G +P +G + L
Sbjct: 306 LTFTEKLYLHSNKLTGSIPP-----ELGNMSKLHYLELNDNHLTGHIPPELGKLT-DLFD 359
Query: 360 ILMANCSISGNIPQVVGNLSNLLVLELGGNNLTGPIPVTFSQLQTLQAFDLTRNKLAGPI 419
+ +AN + G IP + + +NL L + GN +G IP F +L+++ +L+ N + GPI
Sbjct: 360 LNVANNDLEGPIPDHLSSCTNLNSLNVHGNKFSGTIPRAFQKLESMTYLNLSSNNIKGPI 419
Query: 420 TDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSVRVLYLGLNIFTSVLSSTIWNLKDILF 479
EL + L +L L NK +G IPS LG+L + + L N T V+ NL+ I+
Sbjct: 420 PVELSRIGNLDTLDLSNNKINGIIPSSLGDLEHLLKMNLSRNHITGVVPGDFGNLRSIME 479
Query: 480 IDVSSNFLDGPLSLDIGNLKVVIGLDFSRNNLSGDI-------PITIGE-------GEIP 525
ID+S+N + GP+ ++ L+ +I L NNL+G++ +T+ G+IP
Sbjct: 480 IDLSNNDISGPIPEELNQLQNIILLRLENNNLTGNVGSLANCLSLTVLNVSHNNLVGDIP 539
Query: 526 RGGPFANLTAKSFMGNELLCGLPDLQVSPCKPNKPNTHKKSRKMLLLVIVLPLSTALIVV 585
+ F+ + SF+GN LCG SPC ++ + R + +L ++ +V+
Sbjct: 540 KNNNFSRFSPDSFIGNPGLCG--SWLNSPCH----DSRRTVRVSISRAAILGIAIGGLVI 593
Query: 586 VTLTLKWKLIKCWKSRTGPSNDG-------INSPQAI------RRFSYHELLRATDRFSE 632
+ + L + C P DG ++P+ + Y +++R T+ SE
Sbjct: 594 LLMVL---IAACRPHNPPPFLDGSLDKPVTYSTPKLVILHMNMALHVYEDIMRMTENLSE 650
Query: 633 NNLIGIG-----------NGMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVKIISS 681
+IG G N VA+K + +++K FE E E+ I+HRNLV + +
Sbjct: 651 KYIIGHGASSTVYKCVLKNCKPVAIKRLYSHNPQSMKQFETELEMLSSIKHRNLVSLQAY 710
Query: 682 SLE----------------------------------------------YLHFGHSIPII 695
SL YLH S II
Sbjct: 711 SLSHLGSLLFYDYLENGSLWDLLHGPTKKKTLDWDTRLKIAYGAAQGLAYLHHDCSPRII 770
Query: 696 HCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTR 755
H D+K SN+LLD+D+ A ++DFGIAK L T + TIGY+ PEY R++ +
Sbjct: 771 HRDVKSSNILLDKDLEARLTDFGIAKSLCVSKS-HTSTYVMGTIGYIDPEYARTSRLTEK 829
Query: 756 GDVCSFGII 764
DV S+GI+
Sbjct: 830 SDVYSYGIV 838
|
Receptor kinase that, together with ERL1 and ERL2, regulates aerial architecture, including inflorescence (e.g. shoot apical meristem-originating organ shape, elongation of the internode and pedicels, and adaxial-abaxial polarity), and stomatal patterning (e.g. density and clustering), probably by tuning cell division and expansion. Modulates plant transpiration efficiency by controlling stomatal density, leaf photosynthetic capacity, epidermal cell expansion, mesophyll cell proliferation and cell-cell contact. Probable major trait regulating canalization (maintenance of phenotype despite varying environment) in many aspect of the plant physiology (e.g. plant morphology, light-dependent leaves number, branch number, flowering time, phytate and mineral concentrations) by transducing microenvironmental variation into phenotypic differentiation (ecological amplifier). May maintain development integrity in heat stress conditions. Regulates cell wall composition and structure. Confers resistance to the pathogenic bacteria Ralstonia solanacearum and to the necrotrophic fungi Plectosphaerella cucumerina and Pythium irregulare, and required for callose deposition upon infection. Resistance to P.cucumerina seems cell wall-mediated. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9M2Z1|BAME2_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase BAM2 OS=Arabidopsis thaliana GN=BAM2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 313 bits (803), Expect = 3e-84, Method: Compositional matrix adjust.
Identities = 264/881 (29%), Positives = 402/881 (45%), Gaps = 155/881 (17%)
Query: 12 QALLALKAHISYDHTNLFARNWTSSTSVCIWIGITCDVNSHRVIGLNISSFNLQGTITPQ 71
ALL+LK+ + D + +W ST+ C W G+TCDV+ V L++S NL GT++
Sbjct: 29 HALLSLKSSFTIDEHSPLLTSWNLSTTFCSWTGVTCDVSLRHVTSLDLSGLNLSGTLSSD 88
Query: 72 LGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLDFSDNQLFGS----LSSFIFNMSSMT 127
+ +L LQ L L+ N++SG IP I N++ L+ L+ S+N GS LSS + N+
Sbjct: 89 VAHLPLLQNLSLAANQISGPIPPQISNLYELRHLNLSNNVFNGSFPDELSSGLVNLR--- 145
Query: 128 TIDLSINRLSGELPANIC-----------------KIPSTLSKCKQLEELNLGFNNLSGA 170
+DL N L+G+LP ++ KIP+T LE L + N L+G
Sbjct: 146 VLDLYNNNLTGDLPVSLTNLTQLRHLHLGGNYFSGKIPATYGTWPVLEYLAVSGNELTGK 205
Query: 171 IPKEIGNLTKLKEIISTITNSTVCEIPREIGNLPYLARLALATNNLVGVVPVTIFNM--- 227
IP EIGNLT L+E+ N+ +P EIGNL L R A L G +P I +
Sbjct: 206 IPPEIGNLTTLRELYIGYYNAFENGLPPEIGNLSELVRFDAANCGLTGEIPPEIGKLQKL 265
Query: 228 ---------------------SALKEISLLNNSLSGSLPSRIDLSLPNVETLNLGINSFS 266
S+LK + L NN +G +P+ L N+ LNL N
Sbjct: 266 DTLFLQVNAFTGTITQELGLISSLKSMDLSNNMFTGEIPTSFS-QLKNLTLLNLFRNKLY 324
Query: 267 GTIPSSITNSSKLSDLELGENLFSGFIPNTIGNLRNLEFGNIADNYLTSSTPELSFLSSL 326
G IP I +L L+L EN F+G IP +G L +++ N LT + P ++
Sbjct: 325 GAIPEFIGEMPELEVLQLWENNFTGSIPQKLGENGRLVILDLSSNKLTGTLP-----PNM 379
Query: 327 TNCKKLKVLIVTGNPLDGILPKSIGNFSLSLETILMANCSISGNIPQVVGNLSNLLVLEL 386
+ +L LI GN L G +P S+G SL I M ++G+IP+ + L L +EL
Sbjct: 380 CSGNRLMTLITLGNFLFGSIPDSLGKCE-SLTRIRMGENFLNGSIPKELFGLPKLSQVEL 438
Query: 387 GGNNLTGPIPVTFSQLQ-TLQAFDLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPS 445
N LTG +P++ + L L+ N+L+G + + +L+ + L+L GNKFSGSIP
Sbjct: 439 QDNYLTGELPISGGGVSGDLGQISLSNNQLSGSLPAAIGNLSGVQKLLLDGNKFSGSIPP 498
Query: 446 CLGNLTSVRVLYLGLNIFTSVLSSTIWNLKDILFIDVSSNFLDGPLSLDIGNLKVVIGLD 505
+G L + L N+F+ ++ I K + F+D+S N L G + ++ +K++ L+
Sbjct: 499 EIGRLQQLSKLDFSHNLFSGRIAPEISRCKLLTFVDLSRNELSGDIPNELTGMKILNYLN 558
Query: 506 FSRNNLSGDIPITIG---------------EGEIPRGGPFANLTAKSFMGNELLCGLPDL 550
SRN+L G IP+TI G +P G F+ SF+GN LCG P L
Sbjct: 559 LSRNHLVGSIPVTIASMQSLTSVDFSYNNLSGLVPSTGQFSYFNYTSFVGNSHLCG-PYL 617
Query: 551 QVSPCKPNKPNTHKKSRKMLLLVIVLPLSTA-----LIVVVTLTLKWKLIKCWKSRTGPS 605
PC +H K PLS ++ ++ ++ + ++ K+R S
Sbjct: 618 --GPCGKGTHQSHVK-----------PLSATTKLLLVLGLLFCSMVFAIVAIIKAR---S 661
Query: 606 NDGINSPQAIRRFSYHEL----LRATDRFSENNLIGIG-----------NGMEVAVKVFH 650
+ +A R ++ L D E+N+IG G G VAVK
Sbjct: 662 LRNASEAKAWRLTAFQRLDFTCDDVLDSLKEDNIIGKGGAGIVYKGTMPKGDLVAVKRLA 721
Query: 651 QQYERALKS--FEDECEVRKRIRHRNLVKII----------------------------- 679
+ F E + RIRHR++V+++
Sbjct: 722 TMSHGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKK 781
Query: 680 ----------------SSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLL 723
+ L YLH S I+H D+K +N+LLD + AH++DFG+AK L
Sbjct: 782 GGHLHWNTRYKIALEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSNFEAHVADFGLAKFL 841
Query: 724 SGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGII 764
+ + GY+APEY +V + DV SFG++
Sbjct: 842 QDSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVV 882
|
Necessary for male gametophyte development, as well as ovule specification and function. Involved in cell-cell communication process required during early anther development, and regulating cell division and differentiation to organize cell layers. Required for the development of high-ordered vascular strands within the leaf and a correlated control of leaf shape, size and symmetry. May regulate the CLV1-dependent CLV3-mediated signaling in meristems maintenance. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGW6|ERL1_ARATH LRR receptor-like serine/threonine-protein kinase ERL1 OS=Arabidopsis thaliana GN=ERL1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 312 bits (800), Expect = 5e-84, Method: Compositional matrix adjust.
Identities = 257/851 (30%), Positives = 393/851 (46%), Gaps = 123/851 (14%)
Query: 3 LKSIISQHQQALLALKAHISYDHTNLFARNWTSSTSVCIWIGITCDVNSHRVIGLNISSF 62
+ S ++ +AL+A+K S L + ++ +C W G+ CD S+ V+ LN+SS
Sbjct: 22 VASAMNNEGKALMAIKGSFSNLVNMLLDWDDVHNSDLCSWRGVFCDNVSYSVVSLNLSSL 81
Query: 63 NLQGTITPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLDFSDNQLFGSLSSFIFN 122
NL G I+P +G+L +LQ++DL NKL+G IP I N +L LD S+N L+G + I
Sbjct: 82 NLGGEISPAIGDLRNLQSIDLQGNKLAGQIPDEIGNCASLVYLDLSENLLYGDIPFSISK 141
Query: 123 MSSMTTIDLSINRLSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKEIGNLTKLK 182
+ + T++L N+L+G +PA + +IP+ L+ L+L N+L+G EI L
Sbjct: 142 LKQLETLNLKNNQLTGPVPATLTQIPN-------LKRLDLAGNHLTG----EISRLLYWN 190
Query: 183 EIISTIT---NSTVCEIPREIGNLPYLARLALATNNLVGVVPVTIFNMSALKEISLLNNS 239
E++ + N + ++ L L + NNL G +P +I N ++ + + + N
Sbjct: 191 EVLQYLGLRGNMLTGTLSSDMCQLTGLWYFDVRGNNLTGTIPESIGNCTSFQILDISYNQ 250
Query: 240 LSGSLPSRIDLSLPNVETLNLGINSFSGTIPSSITNSSKLSDLELGENLFSGFIPNTIGN 299
++G +P I V TL+L N +G IP I L+ L+L +N G IP +GN
Sbjct: 251 ITGEIPYNI--GFLQVATLSLQGNRLTGRIPEVIGLMQALAVLDLSDNELVGPIPPILGN 308
Query: 300 LRNLEFGNIADNYLTSSTPELSFLSSLTNCKKLKVLIVTGNPLDGILPKSIGNFSLSLET 359
L + N LT P S L N +L L + N L G +P +G E
Sbjct: 309 LSFTGKLYLHGNMLTGPIP-----SELGNMSRLSYLQLNDNKLVGTIPPELGKLEQLFE- 362
Query: 360 ILMANCSISGNIPQVVGNLSNLLVLELGGNNLTGPIPVTFSQLQTLQAFDLTRNKLAGPI 419
+ +AN + G IP + + + L + GN L+G IP+ F L +L +L+ N G I
Sbjct: 363 LNLANNRLVGPIPSNISSCAALNQFNVHGNLLSGSIPLAFRNLGSLTYLNLSSNNFKGKI 422
Query: 420 TDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSVRVLYLGLNIFTSVLSSTIWNLKDILF 479
EL H+ L L L GN FSGSIP LG+L + +L L N + L + NL+ I
Sbjct: 423 PVELGHIINLDKLDLSGNNFSGSIPLTLGDLEHLLILNLSRNHLSGQLPAEFGNLRSIQM 482
Query: 480 IDVSSNFLDGPLSLDIG------------------------NLKVVIGLDFSRNNLSGDI 515
IDVS N L G + ++G N ++ L+ S NNLSG +
Sbjct: 483 IDVSFNLLSGVIPTELGQLQNLNSLILNNNKLHGKIPDQLTNCFTLVNLNVSFNNLSGIV 542
Query: 516 PITIGEGEIPRGGPFANLTAKSFMGNELLCGLPDLQVSPCKPNKPNTHKKSRKMLLLVI- 574
P P F+ SF+GN LCG + S C P P + SR L+ ++
Sbjct: 543 P--------PMKN-FSRFAPASFVGNPYLCG--NWVGSICGP-LPKSRVFSRGALICIVL 590
Query: 575 -VLPLSTALIVVVTLTLKWKLIKCWKSRTGPSNDG---INSPQAIRRFSYHELLRATDRF 630
V+ L + + V +++ K I S+ ++ AI F +++R T+
Sbjct: 591 GVITLLCMIFLAVYKSMQQKKILQGSSKQAEGLTKLVILHMDMAIHTFD--DIMRVTENL 648
Query: 631 SENNLIGIG-----------NGMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVKI- 678
+E +IG G + +A+K + QY L+ FE E E IRHRN+V +
Sbjct: 649 NEKFIIGYGASSTVYKCALKSSRPIAIKRLYNQYPHNLREFETELETIGSIRHRNIVSLH 708
Query: 679 ---------------------------------------------ISSSLEYLHFGHSIP 693
+ L YLH +
Sbjct: 709 GYALSPTGNLLFYDYMENGSLWDLLHGSLKKVKLDWETRLKIAVGAAQGLAYLHHDCTPR 768
Query: 694 IIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVS 753
IIH D+K SN+LLDE+ AH+SDFGIAK + + T L TIGY+ PEY R++
Sbjct: 769 IIHRDIKSSNILLDENFEAHLSDFGIAKSIPAS-KTHASTYVLGTIGYIDPEYARTSRIN 827
Query: 754 TRGDVCSFGII 764
+ D+ SFGI+
Sbjct: 828 EKSDIYSFGIV 838
|
Receptor kinase that regulates inflorescence architecture and organ shape as well as stomatal patterning, including density and clustering, together with ER and ERL2. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O49545|BAME1_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase BAM1 OS=Arabidopsis thaliana GN=BAM1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 312 bits (799), Expect = 8e-84, Method: Compositional matrix adjust.
Identities = 271/881 (30%), Positives = 407/881 (46%), Gaps = 149/881 (16%)
Query: 12 QALLALKAHI--SYDHTNLFARNWTSSTSVCIWIGITCDVNSHRVIGLNISSFNLQGTIT 69
+ALL+LK + + D N +W STS C WIG+TCDV+ V L++S NL GT++
Sbjct: 27 RALLSLKTSLTGAGDDKNSPLSSWKVSTSFCTWIGVTCDVSRRHVTSLDLSGLNLSGTLS 86
Query: 70 PQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLDFSDNQLFGSLSSFIFN-MSSMTT 128
P + +L LQ L L+ N +SG IP I ++ L+ L+ S+N GS I + + ++
Sbjct: 87 PDVSHLRLLQNLSLAENLISGPIPPEISSLSGLRHLNLSNNVFNGSFPDEISSGLVNLRV 146
Query: 129 IDLSINRLSGELPANIC-----------------KIPSTLSKCKQLEELNLGFNNLSGAI 171
+D+ N L+G+LP ++ KIP + +E L + N L G I
Sbjct: 147 LDVYNNNLTGDLPVSVTNLTQLRHLHLGGNYFAGKIPPSYGSWPVIEYLAVSGNELVGKI 206
Query: 172 PKEIGNLTKLKEIISTITNSTVCEIPREIGNLPYLARLALATNNLVGVVP---------- 221
P EIGNLT L+E+ N+ +P EIGNL L R A L G +P
Sbjct: 207 PPEIGNLTTLRELYIGYYNAFEDGLPPEIGNLSELVRFDGANCGLTGEIPPEIGKLQKLD 266
Query: 222 -----VTIFN---------MSALKEISLLNNSLSGSLPSRIDLSLPNVETLNLGINSFSG 267
V +F+ +S+LK + L NN +G +P+ L N+ LNL N G
Sbjct: 267 TLFLQVNVFSGPLTWELGTLSSLKSMDLSNNMFTGEIPASF-AELKNLTLLNLFRNKLHG 325
Query: 268 TIPSSITNSSKLSDLELGENLFSGFIPNTIGNLRNLEFGNIADNYLTSSTPELSFLSSLT 327
IP I + +L L+L EN F+G IP +G L +++ N LT + P ++
Sbjct: 326 EIPEFIGDLPELEVLQLWENNFTGSIPQKLGENGKLNLVDLSSNKLTGTLP-----PNMC 380
Query: 328 NCKKLKVLIVTGNPLDGILPKSIGNFSLSLETILMANCSISGNIPQVVGNLSNLLVLELG 387
+ KL+ LI GN L G +P S+G SL I M ++G+IP+ + L L +EL
Sbjct: 381 SGNKLETLITLGNFLFGSIPDSLGKCE-SLTRIRMGENFLNGSIPKGLFGLPKLTQVELQ 439
Query: 388 GNNLTGPIPVTFSQLQTLQAFDLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCL 447
N L+G +PV L L+ N+L+GP+ + + + L+L GNKF G IPS +
Sbjct: 440 DNYLSGELPVAGGVSVNLGQISLSNNQLSGPLPPAIGNFTGVQKLLLDGNKFQGPIPSEV 499
Query: 448 GNLTSVRVLYLGLNIFTSVLSSTIWNLKDILFIDVSSNFLDGPLSLDIGNLKVVIGLDFS 507
G L + + N+F+ ++ I K + F+D+S N L G + +I +K++ L+ S
Sbjct: 500 GKLQQLSKIDFSHNLFSGRIAPEISRCKLLTFVDLSRNELSGEIPNEITAMKILNYLNLS 559
Query: 508 RNNLSGDIPITIG---------------EGEIPRGGPFANLTAKSFMGNELLCGLPDLQV 552
RN+L G IP +I G +P G F+ SF+GN LCG P L
Sbjct: 560 RNHLVGSIPGSISSMQSLTSLDFSYNNLSGLVPGTGQFSYFNYTSFLGNPDLCG-PYL-- 616
Query: 553 SPCK----PNKPNTHKK-----SRKMLLLVIVLPLSTALIVVVTLTLKWKLIKCWKSRTG 603
PCK +H K S K+LL++ +L S A VV + + L K +SR
Sbjct: 617 GPCKDGVAKGGHQSHSKGPLSASMKLLLVLGLLVCSIAFAVVAIIKAR-SLKKASESRAW 675
Query: 604 PSNDGINSPQAIRR--FSYHELLRATDRFSENNLIGIG-----------NGMEVAVKVFH 650
A +R F+ ++L D E+N+IG G NG VAVK
Sbjct: 676 -------RLTAFQRLDFTCDDVL---DSLKEDNIIGKGGAGIVYKGVMPNGDLVAVKRLA 725
Query: 651 QQYERALKS--FEDECEVRKRIRHRNLVKII----------------------------- 679
+ F E + RIRHR++V+++
Sbjct: 726 AMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKK 785
Query: 680 ----------------SSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLL 723
+ L YLH S I+H D+K +N+LLD + AH++DFG+AK L
Sbjct: 786 GGHLHWDTRYKIALEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSNFEAHVADFGLAKFL 845
Query: 724 SGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGII 764
+ + GY+APEY +V + DV SFG++
Sbjct: 846 QDSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVV 886
|
Necessary for male gametophyte development, as well as ovule specification and function. Involved in cell-cell communication process required during early anther development, and regulating cell division and differentiation to organize cell layers. Required for the development of high-ordered vascular strands within the leaf and a correlated control of leaf shape, size and symmetry. May regulate the CLV1-dependent CLV3-mediated signaling in meristems maintenance. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZUI0|Y2241_ARATH Putative leucine-rich repeat receptor-like serine/threonine-protein kinase At2g24130 OS=Arabidopsis thaliana GN=At2g24130 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 305 bits (780), Expect = 1e-81, Method: Compositional matrix adjust.
Identities = 281/892 (31%), Positives = 422/892 (47%), Gaps = 135/892 (15%)
Query: 39 VCIWIGITCDVNSHRVIGLNISSFNLQGTITPQLGNLSSLQTLDLSHNKLSGNIPSSIFN 98
VC W G+ C+ S +VI L+IS +L G I+P + NL+ L LDLS N G IP I +
Sbjct: 53 VCNWSGVKCNKESTQVIELDISGRDLGGEISPSIANLTGLTVLDLSRNFFVGKIPPEIGS 112
Query: 99 MH-TLKLLDFSDNQLFGSLSSFIFNMSSMTTIDLSINRLSGELPANI-C----------- 145
+H TLK L S+N L G++ + ++ + +DL NRL+G +P + C
Sbjct: 113 LHETLKQLSLSENLLHGNIPQELGLLNRLVYLDLGSNRLNGSIPVQLFCNGSSSSLQYID 172
Query: 146 --------KIP-STLSKCKQLEELNLGFNNLSGAIPKEIGNLTKLKEIISTITNSTVCEI 196
+IP + K+L L L N L+G +P + N T LK + +N E+
Sbjct: 173 LSNNSLTGEIPLNYHCHLKELRFLLLWSNKLTGTVPSSLSNSTNLK-WMDLESNMLSGEL 231
Query: 197 PRE-IGNLPYLARLALATNNLVG------VVP--VTIFNMSALKEISLLNNSLSGSLPSR 247
P + I +P L L L+ N+ V + P ++ N S L+E+ L NSL G + S
Sbjct: 232 PSQVISKMPQLQFLYLSYNHFVSHNNNTNLEPFFASLANSSDLQELELAGNSLGGEITSS 291
Query: 248 IDLSLPNVETLNLGINSFSGTIPSSITNSSKLSDLELGENLFSGFIPNTIGNLRNLEFGN 307
+ N+ ++L N G+IP I+N L+ L L NL SG IP + L LE
Sbjct: 292 VRHLSVNLVQIHLDQNRIHGSIPPEISNLLNLTLLNLSSNLLSGPIPRELCKLSKLERVY 351
Query: 308 IADNYLTSSTPELSFLSSLTNCKKLKVLIVTGNPLDGILPKSIGNFSLSLETILMANCSI 367
+++N+LT P L + +L +L V+ N L G +P S GN S L +L+ +
Sbjct: 352 LSNNHLTGEIP-----MELGDIPRLGLLDVSRNNLSGSIPDSFGNLS-QLRRLLLYGNHL 405
Query: 368 SGNIPQVVGNLSNLLVLELGGNNLTGPIPV-TFSQLQTLQAF-DLTRNKLAGPITDELCH 425
SG +PQ +G NL +L+L NNLTG IPV S L+ L+ + +L+ N L+GPI EL
Sbjct: 406 SGTVPQSLGKCINLEILDLSHNNLTGTIPVEVVSNLRNLKLYLNLSSNHLSGPIPLELSK 465
Query: 426 LARLHSLVLQGNKFSGSIPSCLGNLTSVRVLYLGLNIFTSVLSSTIWNLKDILFIDVSSN 485
+ + S+ L N+ SG IP LG+ ++ L L N F+S L S++ L + +DVS N
Sbjct: 466 MDMVLSVDLSSNELSGKIPPQLGSCIALEHLNLSRNGFSSTLPSSLGQLPYLKELDVSFN 525
Query: 486 FLDGPLSLDIGNLKVVIGLDFSRNNLSGDIPITIGEGEIPRGGPFANLTAKSFMGNELLC 545
L G + + L+FS N LSG+ + G F+ LT +SF+G+ LLC
Sbjct: 526 RLTGAIPPSFQQSSTLKHLNFSFNLLSGN---------VSDKGSFSKLTIESFLGDSLLC 576
Query: 546 G-LPDLQVSPCKPNKPNTHKKSRKMLLLVIVLPLSTALIVVVTLTLKWKLIKCWKSRTGP 604
G + +Q K P+ L+ VL + +V + K + +
Sbjct: 577 GSIKGMQACKKKHKYPSVLLPVLLSLIATPVLCVFGYPLVQRSRFGKNLTVYAKEEVEDE 636
Query: 605 SNDGINSPQAIRRFSYHELLRATDRFSENNLIGIG-----------NGMEVAVKVFHQQY 653
N P+ R SY +L+ AT F+ ++LIG G N +VAVKV +
Sbjct: 637 EKQNQNDPK-YPRISYQQLIAATGGFNASSLIGSGRFGHVYKGVLRNNTKVAVKVLDPKT 695
Query: 654 ERALK-SFEDECEVRKRIRHRNLVKIISS-----------------SLE----------- 684
SF+ EC++ KR RHRNL++II++ SLE
Sbjct: 696 ALEFSGSFKRECQILKRTRHRNLIRIITTCSKPGFNALVLPLMPNGSLERHLYPGEYSSK 755
Query: 685 -------------------YLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSG 725
YLH + ++HCDLKPSN+LLD++M A ++DFGI++L+ G
Sbjct: 756 NLDLIQLVNICSDVAEGIAYLHHYSPVKVVHCDLKPSNILLDDEMTALVTDFGISRLVQG 815
Query: 726 EDQLSKQTQTLA----------TIGYMAPEYGTKGRVSTRGDVCSFGI----ISGGKETR 771
++ +++ ++GY+APEYG R ST GDV SFG+ I G+
Sbjct: 816 VEETVSTDDSVSFGSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVSGRRPT 875
Query: 772 SMTVGETCTPVRESKYEVHPATTTIMEHPLPRVGEVMDVDRGKARIQGKPIK 823
+ V E + K + I+E L R + QGKP K
Sbjct: 876 DVLVNEGSSLHEFMKSHYPDSLEGIIEQALSR-----------WKPQGKPEK 916
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q6XAT2|ERL2_ARATH LRR receptor-like serine/threonine-protein kinase ERL2 OS=Arabidopsis thaliana GN=ERL2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 305 bits (780), Expect = 1e-81, Method: Compositional matrix adjust.
Identities = 254/847 (29%), Positives = 387/847 (45%), Gaps = 108/847 (12%)
Query: 1 MLLKSI--ISQHQQALLALKAHISYDHTNLFARNWTSSTSVCIWIGITCDVNSHRVIGLN 58
MLL S+ ++ +AL+A+KA S L + + C W G+ CD S V+ LN
Sbjct: 20 MLLGSVSPMNNEGKALMAIKASFSNVANMLLDWDDVHNHDFCSWRGVFCDNVSLNVVSLN 79
Query: 59 ISSFNLQGTITPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLDFSDNQLFGSLSS 118
+S+ NL G I+ LG+L +LQ++DL NKL G IP I N +L +DFS N LFG +
Sbjct: 80 LSNLNLGGEISSALGDLMNLQSIDLQGNKLGGQIPDEIGNCVSLAYVDFSTNLLFGDIPF 139
Query: 119 FIFNMSSMTTIDLSINRLSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKEIGNL 178
I + + ++L N+L+G +PA + +IP+ L+ L+L N L+G IP+ L
Sbjct: 140 SISKLKQLEFLNLKNNQLTGPIPATLTQIPN-------LKTLDLARNQLTGEIPR----L 188
Query: 179 TKLKEIISTIT---NSTVCEIPREIGNLPYLARLALATNNLVGVVPVTIFNMSALKEISL 235
E++ + N + ++ L L + NNL G +P +I N ++ + + +
Sbjct: 189 LYWNEVLQYLGLRGNMLTGTLSPDMCQLTGLWYFDVRGNNLTGTIPESIGNCTSFEILDV 248
Query: 236 LNNSLSGSLPSRIDLSLPNVETLNLGINSFSGTIPSSITNSSKLSDLELGENLFSGFIPN 295
N ++G +P I V TL+L N +G IP I L+ L+L +N +G IP
Sbjct: 249 SYNQITGVIPYNI--GFLQVATLSLQGNKLTGRIPEVIGLMQALAVLDLSDNELTGPIPP 306
Query: 296 TIGNLRNLEFGNIADNYLTSSTPELSFLSSLTNCKKLKVLIVTGNPLDGILPKSIGNFSL 355
+GNL + N LT P L N +L L + N L G +P +G
Sbjct: 307 ILGNLSFTGKLYLHGNKLTGQIP-----PELGNMSRLSYLQLNDNELVGKIPPELGKLEQ 361
Query: 356 SLETILMANCSISGNIPQVVGNLSNLLVLELGGNNLTGPIPVTFSQLQTLQAFDLTRNKL 415
E + +AN ++ G IP + + + L + GN L+G +P+ F L +L +L+ N
Sbjct: 362 LFE-LNLANNNLVGLIPSNISSCAALNQFNVHGNFLSGAVPLEFRNLGSLTYLNLSSNSF 420
Query: 416 AGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSVRVLYLGLNIFTSVLSSTIWNLK 475
G I EL H+ L +L L GN FSGSIP LG+L + +L L N L + NL+
Sbjct: 421 KGKIPAELGHIINLDTLDLSGNNFSGSIPLTLGDLEHLLILNLSRNHLNGTLPAEFGNLR 480
Query: 476 DILFIDVSSNFLDGPLSLDIGNLKVVIGLDFSRNNLSGDIPITIG--------------- 520
I IDVS NFL G + ++G L+ + L + N + G IP +
Sbjct: 481 SIQIIDVSFNFLAGVIPTELGQLQNINSLILNNNKIHGKIPDQLTNCFSLANLNISFNNL 540
Query: 521 EGEIPRGGPFANLTAKSFMGNELLCGLPDLQVSPCKPNKPNTHKKSRKMLLLVIVLPLST 580
G IP F + SF GN LCG + S C P+ P + +R + ++ +VL T
Sbjct: 541 SGIIPPMKNFTRFSPASFFGNPFLCG--NWVGSICGPSLPKSQVFTR-VAVICMVLGFIT 597
Query: 581 ALIVVVTLTLKWKLIKCWKSRTGPSNDG------INSPQAIRRFSYHELLRATDRFSENN 634
+ ++ K K K + +G ++ AI F +++R T+ E
Sbjct: 598 LICMIFIAVYKSKQQKPVLKGSSKQPEGSTKLVILHMDMAIHTFD--DIMRVTENLDEKY 655
Query: 635 LIGIG-----------NGMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVKI----- 678
+IG G +A+K + QY + FE E E IRHRN+V +
Sbjct: 656 IIGYGASSTVYKCTSKTSRPIAIKRIYNQYPSNFREFETELETIGSIRHRNIVSLHGYAL 715
Query: 679 -----------------------------------------ISSSLEYLHFGHSIPIIHC 697
+ L YLH + IIH
Sbjct: 716 SPFGNLLFYDYMENGSLWDLLHGPGKKVKLDWETRLKIAVGAAQGLAYLHHDCTPRIIHR 775
Query: 698 DLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGD 757
D+K SN+LLD + A +SDFGIAK + + T L TIGY+ PEY R++ + D
Sbjct: 776 DIKSSNILLDGNFEARLSDFGIAKSIPATKTYAS-TYVLGTIGYIDPEYARTSRLNEKSD 834
Query: 758 VCSFGII 764
+ SFGI+
Sbjct: 835 IYSFGIV 841
|
Receptor kinase that regulates inflorescence architecture and organ shape as well as stomatal patterning, including density and clustering, together with ERL1 and ER. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8VZG8|Y4885_ARATH Probable LRR receptor-like serine/threonine-protein kinase At4g08850 OS=Arabidopsis thaliana GN=At4g08850 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 304 bits (778), Expect = 2e-81, Method: Compositional matrix adjust.
Identities = 250/837 (29%), Positives = 378/837 (45%), Gaps = 141/837 (16%)
Query: 57 LNISSFNLQGTITPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLDFSDNQLFGSL 116
++S L G I P+LG+LS+L TL L NKL+G+IPS I + + + DN L G +
Sbjct: 147 FDLSINQLVGEIPPELGDLSNLDTLHLVENKLNGSIPSEIGRLTKVTEIAIYDNLLTGPI 206
Query: 117 SSFIFNMSSMTTIDLSINRLSGELPANI---------C--------KIPSTLSKCKQLEE 159
S N++ + + L IN LSG +P+ I C KIPS+ K +
Sbjct: 207 PSSFGNLTKLVNLYLFINSLSGSIPSEIGNLPNLRELCLDRNNLTGKIPSSFGNLKNVTL 266
Query: 160 LNLGFNNLSGAIPKEIGNLTKLKEIISTITNSTVCEIPREIGNLPYLARLALATNNLVGV 219
LN+ N LSG IP EIGN+T L + +S TN IP +GN+ LA L L N L G
Sbjct: 267 LNMFENQLSGEIPPEIGNMTAL-DTLSLHTNKLTGPIPSTLGNIKTLAVLHLYLNQLNGS 325
Query: 220 VPVTIFNMSALKEISLLNNSLSGSLPSRIDLSLPNVETLNLGINSFSGTIPSSITNSSKL 279
+P + M ++ ++ + N L+G +P L +E L L N SG IP I NS++L
Sbjct: 326 IPPELGEMESMIDLEISENKLTGPVPDSFG-KLTALEWLFLRDNQLSGPIPPGIANSTEL 384
Query: 280 SDLELGENLFSGFIPNTIGNLRNLEFGNIADNYLTSSTPELSFLSSLTNCKKLKVLIVTG 339
+ L+L N F+GF+P+TI LE + DN+ P+ SL +CK L + G
Sbjct: 385 TVLQLDTNNFTGFLPDTICRGGKLENLTLDDNHFEGPVPK-----SLRDCKSLIRVRFKG 439
Query: 340 NPLDGILPKSIG-------------NF----------SLSLETILMANCSISGNIPQVVG 376
N G + ++ G NF S L +++N SI+G IP +
Sbjct: 440 NSFSGDISEAFGVYPTLNFIDLSNNNFHGQLSANWEQSQKLVAFILSNNSITGAIPPEIW 499
Query: 377 NLSNLLVLELGGNNLTGPIPVTFSQLQTLQAFDLTRNKLAGPITDELCHLARLHSLVLQG 436
N++ L L+L N +TG +P + S + + L N+L+G I + L L L L
Sbjct: 500 NMTQLSQLDLSSNRITGELPESISNINRISKLQLNGNRLSGKIPSGIRLLTNLEYLDLSS 559
Query: 437 NKFSGSIPSCLGNLTSVRVLYLGLNIFTSVLSSTIWNLKDILFIDVSSNFLDGPLSLDIG 496
N+FS IP L NL + + L N + + L + +D+S N LDG +S
Sbjct: 560 NRFSSEIPPTLNNLPRLYYMNLSRNDLDQTIPEGLTKLSQLQMLDLSYNQLDGEISSQFR 619
Query: 497 NLKVVIGLDFSRNNLSGDIPITIG---------------EGEIPRGGPFANLTAKSFMGN 541
+L+ + LD S NNLSG IP + +G IP F N +F GN
Sbjct: 620 SLQNLERLDLSHNNLSGQIPPSFKDMLALTHVDVSHNNLQGPIPDNAAFRNAPPDAFEGN 679
Query: 542 ELLCGLPDLQ--VSPCKPNKPNTHKKSRKMLLLVIVLPLSTALIVVVTLTLKWKLIKCWK 599
+ LCG + + PC K R +++ ++V P+ A+I+ L++ + C++
Sbjct: 680 KDLCGSVNTTQGLKPCSITSSKKSHKDRNLIIYILV-PIIGAIII---LSVCAGIFICFR 735
Query: 600 SRTGPSNDGINSPQAIRRFS---------YHELLRATDRFSENNLIGIGNGMEV------ 644
RT + +S S Y E+++AT F LIG G +V
Sbjct: 736 KRTKQIEEHTDSESGGETLSIFSFDGKVRYQEIIKATGEFDPKYLIGTGGHGKVYKAKLP 795
Query: 645 ----AVKVFHQQYERAL------KSFEDECEVRKRIRHRNLVKI---------------- 678
AVK ++ + ++ + F +E IRHRN+VK+
Sbjct: 796 NAIMAVKKLNETTDSSISNPSTKQEFLNEIRALTEIRHRNVVKLFGFCSHRRNTFLVYEY 855
Query: 679 ------------------------------ISSSLEYLHFGHSIPIIHCDLKPSNVLLDE 708
++ +L Y+H S I+H D+ N+LL E
Sbjct: 856 MERGSLRKVLENDDEAKKLDWGKRINVVKGVAHALSYMHHDRSPAIVHRDISSGNILLGE 915
Query: 709 DMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIIS 765
D A ISDFG AKLL + S + T GY+APE +V+ + DV SFG+++
Sbjct: 916 DYEAKISDFGTAKLLKPDS--SNWSAVAGTYGYVAPELAYAMKVTEKCDVYSFGVLT 970
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST 
Original result of BLAST against Nonredundant Database
GI ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 823 | ||||||
| 255572272 | 1089 | serine-threonine protein kinase, plant-t | 0.907 | 0.685 | 0.392 | 1e-164 | |
| 359483198 | 1087 | PREDICTED: probable LRR receptor-like se | 0.924 | 0.700 | 0.391 | 1e-159 | |
| 147853795 | 1420 | hypothetical protein VITISV_005816 [Viti | 0.886 | 0.514 | 0.404 | 1e-155 | |
| 147852480 | 1229 | hypothetical protein VITISV_039533 [Viti | 0.856 | 0.573 | 0.403 | 1e-155 | |
| 359483677 | 1229 | PREDICTED: LRR receptor-like serine/thre | 0.897 | 0.601 | 0.391 | 1e-154 | |
| 147776333 | 1205 | hypothetical protein VITISV_000078 [Viti | 0.840 | 0.574 | 0.403 | 1e-154 | |
| 147769371 | 1241 | hypothetical protein VITISV_010511 [Viti | 0.856 | 0.568 | 0.4 | 1e-153 | |
| 359485451 | 1454 | PREDICTED: LRR receptor-like serine/thre | 0.834 | 0.472 | 0.410 | 1e-152 | |
| 224116832 | 1061 | predicted protein [Populus trichocarpa] | 0.869 | 0.674 | 0.402 | 1e-152 | |
| 359497186 | 1140 | PREDICTED: LRR receptor-like serine/thre | 0.895 | 0.646 | 0.388 | 1e-152 |
| >gi|255572272|ref|XP_002527075.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223533580|gb|EEF35319.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 586 bits (1510), Expect = e-164, Method: Compositional matrix adjust.
Identities = 378/962 (39%), Positives = 509/962 (52%), Gaps = 215/962 (22%)
Query: 13 ALLALKAHISYDHTNLFARNWTSSTSVCIWIGITCDVNSHRVIGLNISSFNLQGTITPQL 72
ALL LK H ++D ++NW+S+TS C W G+TC +RV+ L +S+ ++G + P +
Sbjct: 34 ALLVLKEHSNFDP--FMSKNWSSATSFCHWYGVTCSERHNRVVALTLSNMGIKGIVPPHI 91
Query: 73 GNLSSLQTLDLSHNKLSGNIP--------------------------------------- 93
GNLS L +D+S+N SG++P
Sbjct: 92 GNLSFLVHIDMSNNSYSGHLPNELGNLHRLKFMNFSNNSFVGEIPSSLAMLPKLQHLLLA 151
Query: 94 --------SSIFNMHTLKLLDFSDN-------------------------QLFGSLSSFI 120
SSIFN+ TL LD +DN QL GS I
Sbjct: 152 NNSLTAGRSSIFNITTLNTLDLNDNLLGGNILDNIGGNLSNLQVLNMGLNQLSGSFPPKI 211
Query: 121 FNMSSMTTIDLSINRLSGELPANIC------------------KIPSTLSKCKQLEELNL 162
++ S+ I L +N LSG L +C +IPS L KCK+L L L
Sbjct: 212 LDLPSLKFIYLQVNNLSGNLKEILCNQNSKLQLLNLAGNQLYGQIPSDLYKCKELRSLAL 271
Query: 163 GFNNLSGAIPKEIGNLTKLKEIISTITNSTVCEIPREIGNLPYLARLALATNNLVGVVPV 222
N +G+IP+ IGNLTKLK +S N+ IP EIGNL L + L+ NNL G +P
Sbjct: 272 HANKFTGSIPRTIGNLTKLK-WLSLGRNNLTGRIPLEIGNLQNLQIVHLSFNNLNGSIPH 330
Query: 223 TIFNMSALKEISLLNNSLSGSLPSRIDLSLPNVETLNLGINSFSGTIPSSITNSSKLSDL 282
+FN+S +K I++ +N+L G+LP+ + L LPN+ L LGIN SG IPS I+N+SKL+ L
Sbjct: 331 ALFNISTMKWIAMTSNNLLGNLPTSLGLHLPNLIWLYLGINKLSGPIPSYISNASKLTIL 390
Query: 283 ELGENLFSGFIPNTIGNLRNLEFGNIADNYLTS--STPELSFLSSLTNCKKLKVLIVTGN 340
EL N F+GFIP+++G+LRNL+ + N L+S ++ EL+ SSL NC+ LK L ++ N
Sbjct: 391 ELPSNSFTGFIPDSLGDLRNLQTLKLGANLLSSKKTSQELTIFSSLKNCQNLKYLWLSYN 450
Query: 341 PLDGILPKSIGNFSLSLETILMANCSISGNIPQVVGNLSNLLVLELGGNNLTGPIPVTFS 400
PLDG LP S+GN S SLE+ L ++ I G++ + +GNLS+L L LG N+LTG IP T
Sbjct: 451 PLDGYLPHSVGNLSNSLESFLASDGLIKGSVHESIGNLSSLTRLNLGNNDLTGRIPTTIG 510
Query: 401 QLQTLQAFDLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSVRVLYLGL 460
L+ LQ L N L G I ELC L L++L L GNK SGSIP+C NLTS+R L+L
Sbjct: 511 TLKHLQGLYLHGNDLDGSIPSELCDLRTLYNLELTGNKLSGSIPTCFSNLTSLRNLFLAS 570
Query: 461 NIFTSVLSSTIWNLKDILFIDVSSNFLDGPLSLDIGNLKVV-----------------IG 503
N F S +SST+W LKDIL ++++SN+L G L +I NL+ V IG
Sbjct: 571 NRFVSTISSTLWTLKDILQVNLASNYLTGSLPSEIENLRAVYMINISKNQLSGEIPISIG 630
Query: 504 -------------------------------LDFSRNNLSGDIPITIG------------ 520
LD S NNLSG IP ++
Sbjct: 631 GLQDLAQLYLSGNKLQGPIPQSVGDIKSLEFLDLSSNNLSGMIPKSLDNLLYLKYFNVSF 690
Query: 521 ---EGEIPRGGPFANLTAKSFMGNELLCGLPDLQVSPCKPNKPNTHKKSRKMLLLVIVLP 577
+GEIP GG F+N +A+SF+GNE LCG LQVSPCK + + ++L VLP
Sbjct: 691 NYLQGEIPEGGSFSNFSAQSFIGNEALCGSARLQVSPCKDDNSRATETPGSKIVLRYVLP 750
Query: 578 LSTALIVVVTLTLKWKLIKCWKSRTGPSNDGINSPQAIRRFSYHELLRATDRFSENNLIG 637
+ V+ + K C + D + IRR SYHEL AT+ F E+N +G
Sbjct: 751 AIVFAVFVLAFVIMLKRY-CERKAKFSIEDDFLALTTIRRISYHELQLATNGFQESNFLG 809
Query: 638 IG-----------NGMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVKIISSS---- 682
+G +G +A KVF+ Q ERA KSF+ ECEV + +RHRNLVKII+S
Sbjct: 810 MGSFGSVYKGTLSDGTVIAAKVFNLQLERAFKSFDTECEVLRNLRHRNLVKIITSCSGPN 869
Query: 683 ----------------------------------------LEYLHFGHSIPIIHCDLKPS 702
LEYLH G++IP+ HCD+KPS
Sbjct: 870 FKALVLEFMPNWSLEKWLYSDDYFLNNLQRLNIMLDVASVLEYLHHGYTIPMAHCDIKPS 929
Query: 703 NVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFG 762
NVLL+EDMVA ++DFGI+KLL GE+ QT TLATIGYMAPEYG++G VS RGDV S+G
Sbjct: 930 NVLLNEDMVAFLADFGISKLL-GEEGSVMQTMTLATIGYMAPEYGSEGIVSVRGDVYSYG 988
Query: 763 II 764
++
Sbjct: 989 VL 990
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359483198|ref|XP_002271405.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 567 bits (1461), Expect = e-159, Method: Compositional matrix adjust.
Identities = 384/981 (39%), Positives = 504/981 (51%), Gaps = 220/981 (22%)
Query: 11 QQALLALKAHISYDHTNLFARNWTSSTSVCIWIGITCDVNSHRVIGLNISSFNLQGTITP 70
Q +LLALKAHI+ D ++ A NW++ TS C WIG++C+ RVI L++S+ L+GTI P
Sbjct: 33 QSSLLALKAHITLDPHHVLAGNWSTKTSFCEWIGVSCNAQQQRVIALDLSNLGLRGTIPP 92
Query: 71 QLGNLSSLQTLDLS---------------------------------------------- 84
LGNLS L +LDLS
Sbjct: 93 DLGNLSFLVSLDLSSNNFHGPVPVEVGQLTSLLSMNLQYNLLSGQIPPSFGNLNRLQSLF 152
Query: 85 --HNKLSGNIPSSIFNMHTLKLLDFSDNQLFG------------------------SLSS 118
+N +G IP SI NM L+ L N L G ++ S
Sbjct: 153 LGNNSFTGTIPPSIGNMSMLETLGLGGNHLQGNIPEEIGKLSTMKILDIQSNQLVGAIPS 212
Query: 119 FIFNMSSMTTIDLSINRLSGELPANICK-------------------IPSTLSKCKQLEE 159
IFN+SS+ I L+ N LSG+LP+++C IPS LSKC +L+
Sbjct: 213 AIFNISSLQEIALTYNSLSGDLPSSMCNHELSALRGIRLSANRFTGPIPSNLSKCGELQT 272
Query: 160 LNLGFNNLSGAIPKEIGNLTKLKEIISTITNSTVCEIPREIGNLPYLARLALATNNLVGV 219
L L FN +G IP+ I +LTKL ++S NS E+P EIG+L L L + N+L G
Sbjct: 273 LYLSFNKFTGGIPRSIDSLTKLT-MLSLAANSLSGEVPCEIGSLCTLNVLNIEDNSLTGH 331
Query: 220 VPVTIFNMSALKEISLLNNSLSGSLPSRIDLSLPNVETLNLGINSFSGTIPSSITNSSKL 279
+P IFN+S++ SL N+LSG+LP LPN+E L L IN SG IPSSI N+SKL
Sbjct: 332 IPFQIFNISSMVSGSLTRNNLSGNLPPNFGSYLPNLENLILEINWLSGIIPSSIGNASKL 391
Query: 280 SDLELGENLFSGFIPNTIGNLRNLEFGNIADNYLT--SSTPELSFLSSLTNCKKLKVLIV 337
L+ G N+ +G IP+ +G+LR LE N+ N L S ELSFL+SLTNCK+L++L +
Sbjct: 392 RSLDFGYNMLTGSIPHALGSLRFLERLNLGVNNLKGESYIQELSFLTSLTNCKRLRILYL 451
Query: 338 TGNPLDGILPKSIGNFSLSLETILMANCSISGNIPQVVGNLSNLLVLELGGNNLTGPIPV 397
+ NPL GILP SIGN S SL+ C + GNIP +GNLSNL +L L N+LTG IP
Sbjct: 452 SFNPLIGILPISIGNLSTSLQRFEANTCKLKGNIPTEIGNLSNLYLLSLNNNDLTGTIPP 511
Query: 398 TFSQLQTLQAFDLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSVRVLY 457
+ QLQ LQ L NKL G I +++C L L L L N+ SGSIP+CLG LT +R LY
Sbjct: 512 SIGQLQKLQGLYLPSNKLQGSIPNDICQLRNLGELFLTNNQLSGSIPACLGELTFLRHLY 571
Query: 458 LGLNIFTSVLSSTIWNLKDILFIDVSSNFLDGPLSLDIGNLKVVIGLDFSRNNLSGDIPI 517
LG N S + ST+W+L IL +D+SSNFL G L D+GNLKV++ +D SRN LSG+IP
Sbjct: 572 LGSNKLNSTIPSTLWSLIHILSLDMSSNFLVGYLPSDMGNLKVLVKIDLSRNQLSGEIPS 631
Query: 518 TIGE---------------------------------------GEIPRG----------- 527
IG GEIP+
Sbjct: 632 NIGGLQDLTSLSLAHNRFEGPILHSFSNLKSLEFMDLSDNALFGEIPKSLEGLVYLKYLD 691
Query: 528 -------------GPFANLTAKSFMGNELLCGLPDLQVSPCKPNKPNTHKKSRKMLLLVI 574
GPFAN +A+SFM N+ LCG P L++ PC+ + LLL
Sbjct: 692 VSFNGLYGEIPPEGPFANFSAESFMMNKALCGSPRLKLPPCRTG--TRWSTTISWLLLKY 749
Query: 575 VLPLSTALIVVVTLTLKWKLIKCWKSRTG-PSNDGINSPQAIRRFSYHELLRATDRFSEN 633
+LP + ++ + L W +C K P+ RR SY E+ +AT+ FS
Sbjct: 750 ILPAILSTLLFLALIFVWT--RCRKRNAVLPTQSESLLTATWRRISYQEIFQATNGFSAG 807
Query: 634 NLIGIG-----------NGMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVKIISS- 681
NL+G G +G A+KVF+ Q E A KSF+ ECEV IRHRNL+KI+SS
Sbjct: 808 NLLGRGSLGSVYRGTLSDGKNAAIKVFNLQEEAAFKSFDAECEVMHHIRHRNLIKIVSSC 867
Query: 682 ---------------------------------------------SLEYLHFGHSIPIIH 696
++EYLH G S P++H
Sbjct: 868 SNSYIDFKALVLEYVPNGSLERWLYSHNYCLDILQRLNIMIDVALAMEYLHHGCSTPVVH 927
Query: 697 CDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRG 756
CDLKPSN+LLDED H+ DFGIAKLL E+ + ++TQTLATIGYMAP+Y + G V+T G
Sbjct: 928 CDLKPSNILLDEDFGGHVGDFGIAKLLREEESI-RETQTLATIGYMAPKYVSNGIVTTSG 986
Query: 757 DVCSFGIISGGKETRSMTVGE 777
DV S+GI+ TR E
Sbjct: 987 DVYSYGIVLMETFTRRRPTDE 1007
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147853795|emb|CAN81714.1| hypothetical protein VITISV_005816 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 556 bits (1434), Expect = e-155, Method: Compositional matrix adjust.
Identities = 359/888 (40%), Positives = 473/888 (53%), Gaps = 158/888 (17%)
Query: 56 GLNISSFNLQGTITPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLDFSDNQLFGS 115
GL++S G I +G+LS+L+ + L++N L+G IP I N+ L L + G
Sbjct: 267 GLSLSLNQFTGGIPQAIGSLSNLEEVYLAYNNLAGGIPREIGNLSNLNSLQLGSCGISGP 326
Query: 116 LSSFIFNMSSMTTIDLSINRLSGELPANICK------------------IPSTLSKCKQL 157
+ IFN+SS+ IDL+ N L G LP +ICK +P+TLS C QL
Sbjct: 327 IPPEIFNISSLQMIDLTDNSLHGSLPMDICKHLHNLQGLYLSFNQLSGQLPTTLSLCGQL 386
Query: 158 EELNLGFNNLSGAIPKEIGNLTKLKEIISTITNSTVCEIPREIGNLPYLARLALATNNLV 217
L+L N +G IP GNLT L+++ N+ IP E+GNL L L L+ NNL
Sbjct: 387 LSLSLWGNRFTGNIPPSFGNLTVLQDL-ELXENNIQGNIPNELGNLINLQNLKLSVNNLT 445
Query: 218 GVVPVTIFNMSALKEISLLNNSLSGSLPSRIDLSLPNVETLNLGINSFSGTIPSSITNSS 277
G++P IFN+S L+ + L N SGSLPS I LP++E L +G N FSG IP SI+N S
Sbjct: 446 GIIPEAIFNISKLQTLXLAQNHFSGSLPSSIGTQLPDLEGLAIGXNEFSGIIPMSISNMS 505
Query: 278 KLSDLELGENLFSGFIPNTIGNLRNLEFGNIADNYLTS--STPELSFLSSLTNCKKLKVL 335
+L+ L++ N F+G +P +GNLR LEF N+ N LT ST E+ FL+SLTNCK L+ L
Sbjct: 506 ELTVLDIWANFFTGDVPKDLGNLRRLEFLNLGFNQLTDEHSTSEVGFLTSLTNCKFLRRL 565
Query: 336 IVTGNPLDGILPKSIGNFSLSLETILMANCSISGNIPQVVGNLSNLLVLELGGNNLTGPI 395
+ NPL GILP S+GN S+SLE+ + C G IP +GNL NL+ L L N+LTG I
Sbjct: 566 WIEDNPLKGILPNSLGNLSISLESFDASACQFKGTIPTGIGNLINLIDLRLNDNDLTGLI 625
Query: 396 PVTFSQLQTLQAFDLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSVRV 455
P++F LQ LQ F ++ N++ G I LCHL L L L NK SG+IP C GNLT++R
Sbjct: 626 PISFGHLQKLQWFAISGNRIHGSIPSVLCHLRNLGYLDLSSNKLSGTIPGCFGNLTALRN 685
Query: 456 LYLGLNIFTSVLSSTIWNLKDILFIDVSSNFLDGPLSLDIGNLKVVIGLDFSRN------ 509
+ L N S + S++W L+D+L +++SSNFL+ L L++GN+K ++ LD S+N
Sbjct: 686 ISLHSNGLASEIPSSLWTLRDLLVLNLSSNFLNCQLPLEVGNMKSLLVLDLSKNQFSGNI 745
Query: 510 ------------------------------------------NLSGDIPITIG------- 520
N SG IP ++
Sbjct: 746 PSTISLLQNLLQLYLSHNKLQGHMPPNFGALVSLEYLDLSGNNFSGTIPTSLEALKYLKY 805
Query: 521 --------EGEIPRGGPFANLTAKSFMGNELLCGLPDLQVSPCKPNKPNTHKKSRKMLLL 572
+GEIP GPFAN TA+SF+ N LCG P QV C+ + +++ K LLL
Sbjct: 806 LNVSFNKLQGEIPNRGPFANFTAESFISNLALCGAPRFQVMACEKDA----RRNTKSLLL 861
Query: 573 VIVLPLSTAL---IVVVTLTLKWKLIKCWKSRTGPSNDGINS----PQAIRRFSYHELLR 625
++PLS +L I+VV TL WK R S + P+ R S+ ELL
Sbjct: 862 KCIVPLSVSLSTMILVVLFTL-------WKRRQTESESPVQVDLLLPRMHRLISHQELLY 914
Query: 626 ATDRFSENNLIGIG-----------NGMEVAVKVFHQQYERALKSFEDECEVRKRIRHRN 674
AT F E NLIG G +G+ VAVKVF+ + A KSFE ECEV + IRHRN
Sbjct: 915 ATSYFGEENLIGKGSLGMVYKGVLSDGLIVAVKVFNLELHGAFKSFEVECEVMRNIRHRN 974
Query: 675 LVKIIS--------------------------------------------SSLEYLHFGH 690
L KIIS S LEYLH +
Sbjct: 975 LAKIISSCSNLDFKALVLEYMPNESLEKWLYSHNYCLDFIQRLKIMIDVASGLEYLHHDY 1034
Query: 691 SIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKG 750
S P++HCDLKPSNVLLD+DMVAHISDFGIAKLL G + K+T+TL TIGYMAPEYG++G
Sbjct: 1035 SNPVVHCDLKPSNVLLDDDMVAHISDFGIAKLLMGS-EFMKRTKTLGTIGYMAPEYGSEG 1093
Query: 751 RVSTRGDVCSFGIISGGKETRSMTVGETCTPVRESKYEVHPATTTIME 798
VST+ D S+GII R E K V + IME
Sbjct: 1094 IVSTKCDTYSYGIILMEIFVRKKPTDEMFVEELTLKSWVESSANNIME 1141
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147852480|emb|CAN78527.1| hypothetical protein VITISV_039533 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 555 bits (1430), Expect = e-155, Method: Compositional matrix adjust.
Identities = 343/850 (40%), Positives = 472/850 (55%), Gaps = 145/850 (17%)
Query: 53 RVIGLNISSFNLQGTITPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLDFSDNQL 112
RV+ L+I+ F G I +G+LS L+ L L +NKL+G IP I N+ L +L N +
Sbjct: 295 RVLSLSINRFT--GGIPQAIGSLSDLEELYLGYNKLTGGIPREIGNLSNLNILQLGSNGI 352
Query: 113 FGSLSSFIFNMSSMTTIDLSINRLSGELPANICK------------------IPSTLSKC 154
G + + IFN+SS+ I S N LSG LP +ICK +P+TLS C
Sbjct: 353 SGPIPAEIFNISSLQGIGFSNNSLSGSLPMDICKHLPNLQWLDLALNHLSGQLPTTLSLC 412
Query: 155 KQLEELNLGFNNLSGAIPKEIGNLTKLKEIISTITNSTVCEIPREIGNLPYLARLALATN 214
++L L+L FN G+IP+EIGNL+KL E I +NS V IP GNL L L L N
Sbjct: 413 RELLVLSLSFNKFRGSIPREIGNLSKL-EWIDLSSNSLVGSIPTSFGNLMALKFLNLGIN 471
Query: 215 NLVGVVPVTIFNMSALKEISLLNNSLSGSLPSRIDLSLPNVETLNLGINSFSGTIPSSIT 274
NL G VP IFN+S L+ +++ N LSGSLPS I LP++E L +G N FSG IP SI+
Sbjct: 472 NLTGTVPEAIFNISKLQSLAMAINHLSGSLPSSIGTWLPDLEGLFIGGNEFSGIIPVSIS 531
Query: 275 NSSKLSDLELGENLFSGFIPNTIGNLRNLEFGNIADNYLTSS--TPELSFLSSLTNCKKL 332
N SKL+ L++ N F G +P +GNL LE N+A N T+ E+SFL+SLTNCK L
Sbjct: 532 NMSKLTQLDVSRNSFIGNVPKDLGNLTKLEVLNLAGNQFTNEHLASEVSFLTSLTNCKFL 591
Query: 333 KVLIVTGNPLDGILPKSIGNFSLSLETILMANCSISGNIPQVVGNLSNLLVLELGGNNLT 392
K L + NP G LP S+GN ++LE+ + + C G IP +GNL+NL+ L+LG N+LT
Sbjct: 592 KNLWIGNNPFKGTLPNSLGNLPIALESFIASACQFRGTIPTGIGNLTNLIWLDLGANDLT 651
Query: 393 GPIPVTFSQLQTLQAFDLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTS 452
G IP +L+ LQ + N+L G I ++LCHL L L L NK SGSIPSC G+L +
Sbjct: 652 GSIPTILGRLKKLQRLHIAGNRLRGSIPNDLCHLKNLGYLHLSSNKLSGSIPSCFGDLPA 711
Query: 453 VRVLYLGLNIFTSVLSSTIWNLKDILFIDVSSNFLDGPLSLDIGNLKVVI---------- 502
++ L+L N+ + +++W+L+D+L +++SSNFL G L ++GN+K +
Sbjct: 712 LQELFLDSNVLAFNIPTSLWSLRDLLVLNLSSNFLTGNLPPEVGNMKSITTLDLSKNLVS 771
Query: 503 --------------------------------------GLDFSRNNLSGDIPITIG---- 520
LD S+NNLSG IP ++
Sbjct: 772 GYIPRRMGEQQNLAKLSLSQNRLQGPIPVEFGDLVSLESLDLSQNNLSGTIPKSLEALIY 831
Query: 521 -----------EGEIPRGGPFANLTAKSFMGNELLCGLPDLQVSPCKPNKPNTHKKSRKM 569
+GEIP GGPF N TA+SFM NE LCG P QV C N K++
Sbjct: 832 LKYLNVSSNKLQGEIPNGGPFVNFTAESFMFNEALCGAPHFQVMACDKNNRTQSWKTKSF 891
Query: 570 LLLVIVLPLSTALIVVVTLTLKWKLIKCWKSRTGPSNDGINSPQAIRRFSYHELLRATDR 629
+L I+LP+ + + +VV + L W I+ + P+ P + S+ LL AT+
Sbjct: 892 ILKYILLPVGSTITLVVFIVL-W--IRRRDNMEIPTPIDSWLPGTHEKISHQRLLYATND 948
Query: 630 FSENNLIGIG-----------NGMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVKI 678
F E+NLIG G NG+ VA+KVF+ +++ AL+SF+ ECEV + IRHRNLV+I
Sbjct: 949 FGEDNLIGKGSQGMVYKGVLSNGLIVAIKVFNLEFQGALRSFDSECEVMQGIRHRNLVRI 1008
Query: 679 I--------------------------------------------SSSLEYLHFGHSIPI 694
I +S+LEYLH S +
Sbjct: 1009 ITCCSNLDFKALVLKYMPNGSLEKWLYSHNYFLDLIQRLNIMIDVASALEYLHHDCSSLV 1068
Query: 695 IHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVST 754
+HCDLKPSNVLLD+DMVAH++DFGI KLL+ + + +QT+TL TIGYMAPE+G+ G VST
Sbjct: 1069 VHCDLKPSNVLLDDDMVAHVADFGITKLLTKTESM-QQTKTLGTIGYMAPEHGSDGIVST 1127
Query: 755 RGDVCSFGII 764
+ DV S+GI+
Sbjct: 1128 KSDVYSYGIL 1137
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359483677|ref|XP_003633000.1| PREDICTED: LRR receptor-like serine/threonine-protein kinase GSO2-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 553 bits (1425), Expect = e-154, Method: Compositional matrix adjust.
Identities = 346/884 (39%), Positives = 486/884 (54%), Gaps = 145/884 (16%)
Query: 53 RVIGLNISSFNLQGTITPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLDFSDNQL 112
RV+ L+ + F G I +G+LS+L+ L LSHNKL+G IP I N+ L +L S N +
Sbjct: 295 RVLSLSFNQFT--GGIPQAIGSLSNLEELYLSHNKLTGGIPREIGNLSNLNILQLSSNGI 352
Query: 113 FGSLSSFIFNMSSMTTIDLSINRLSGELPANICK------------------IPSTLSKC 154
G + + IFN+SS+ I + N LSG LP +ICK +P+TLS C
Sbjct: 353 SGPIPAEIFNVSSLQVIAFTDNSLSGSLPKDICKHLPNLQGLSLSQNHLSGQLPTTLSLC 412
Query: 155 KQLEELNLGFNNLSGAIPKEIGNLTKLKEIISTITNSTVCEIPREIGNLPYLARLALATN 214
+L L+L FN G+IPKEIGNL+KL++I TNS + IP GNL L L L N
Sbjct: 413 GELLFLSLSFNKFRGSIPKEIGNLSKLEKIYLG-TNSLIGSIPTSFGNLKALKFLNLGIN 471
Query: 215 NLVGVVPVTIFNMSALKEISLLNNSLSGSLPSRIDLSLPNVETLNLGINSFSGTIPSSIT 274
NL G VP IFN+S L+ ++++ N LSGSLPS I L ++E L + N FSG IP SI+
Sbjct: 472 NLTGTVPEAIFNISKLQSLAMVKNHLSGSLPSSIGTWLSDLEGLFIAGNEFSGIIPMSIS 531
Query: 275 NSSKLSDLELGENLFSGFIPNTIGNLRNLEFGNIADNYLTSS--TPELSFLSSLTNCKKL 332
N SKL+ L L N F+G +P +GNL L+ ++A N LT E+ FL+SLTNCK L
Sbjct: 532 NMSKLTVLGLSANSFTGNVPKDLGNLTKLKVLDLAGNQLTDEHVASEVGFLTSLTNCKFL 591
Query: 333 KVLIVTGNPLDGILPKSIGNFSLSLETILMANCSISGNIPQVVGNLSNLLVLELGGNNLT 392
K L + NP G LP S+GN ++LE+ + + C G IP +GNL+NL+ L+LG N+LT
Sbjct: 592 KNLWIGNNPFKGTLPNSLGNLPIALESFIASACQFRGTIPTRIGNLTNLIWLDLGANDLT 651
Query: 393 GPIPVTFSQLQTLQAFDLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTS 452
G IP T +L+ LQ + N+L G I ++LCHL L L L NK SGSIPSC G+L +
Sbjct: 652 GSIPTTLGRLKKLQKLHIVGNRLRGSIPNDLCHLKNLGYLHLSSNKLSGSIPSCFGDLPA 711
Query: 453 VRVLYLGLNIFTSVLSSTIWNLKDILFIDVSSNFLDGPLSLDIGNLKVVI---------- 502
++ L+L N+ + +++W+L+D+L +++SSNFL G L ++GN+K +
Sbjct: 712 LQELFLDSNVLAFNIPTSLWSLRDLLVLNLSSNFLTGNLPPEVGNMKSITTLDLSKNLVS 771
Query: 503 --------------------------------------GLDFSRNNLSGDIPITIG---- 520
LD S+NNLSG IP ++
Sbjct: 772 GHIPRKMGEQQNLAKLSLSQNKLQGPIPIEFGDLVSLESLDLSQNNLSGTIPKSLEALIY 831
Query: 521 -----------EGEIPRGGPFANLTAKSFMGNELLCGLPDLQVSPCKPNKPNTHKKSRKM 569
+GEIP GGPF N TA+SFM NE LCG P QV C N K++
Sbjct: 832 LKYLNVSLNKLQGEIPNGGPFINFTAESFMFNEALCGAPHFQVMACDKNNRTQSWKTKSF 891
Query: 570 LLLVIVLPLSTALIVVVTLTLKWKLIKCWKSRTGPSNDGINSPQAIRRFSYHELLRATDR 629
+L I+LP+ + + +VV + L W I+ + P+ P + S+ +LL AT+
Sbjct: 892 ILKYILLPVGSIVTLVVFIVL-W--IRRRDNMEIPTPIDSWLPGTHEKISHQQLLYATND 948
Query: 630 FSENNLIGIG-----------NGMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVKI 678
F E+NLIG G NG+ VA+KVF+ +++ AL+SF+ ECEV + IRHRNLV+I
Sbjct: 949 FGEDNLIGKGSQGMVYKGVLSNGLTVAIKVFNLEFQGALRSFDSECEVMQGIRHRNLVRI 1008
Query: 679 I--------------------------------------------SSSLEYLHFGHSIPI 694
I +S+LEYLH S +
Sbjct: 1009 ITCCSNLDFKALVLEYMPNGSLEKWLYSHNYFLDLIQRLNIMIDVASALEYLHHDCSSLV 1068
Query: 695 IHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVST 754
+HCDLKP+NVLLD+DMVAH++DFGI KLL+ + + +QT+TL TIGYMAPE+G+ G VST
Sbjct: 1069 VHCDLKPNNVLLDDDMVAHVADFGITKLLTKTESM-QQTKTLGTIGYMAPEHGSDGIVST 1127
Query: 755 RGDVCSFGIISGGKETRSMTVGETCTPVRESKYEVHPATTTIME 798
+ DV S+GI+ +R + E T K V + ++++
Sbjct: 1128 KSDVYSYGILLMEVFSRKKPMDEMFTGDLTLKTWVESLSNSVIQ 1171
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147776333|emb|CAN72034.1| hypothetical protein VITISV_000078 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 551 bits (1420), Expect = e-154, Method: Compositional matrix adjust.
Identities = 344/852 (40%), Positives = 465/852 (54%), Gaps = 160/852 (18%)
Query: 60 SSFN-LQGTITPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLDFSDNQLFGSLSS 118
SSFN G I +G+L +L+ L L+ NKL+G IP I N+ L +L N + G + +
Sbjct: 275 SSFNQFTGGIPQAIGSLCNLEELYLAFNKLTGGIPREIGNLSNLNILQLGSNGISGPIPA 334
Query: 119 FIFNMSSMTTIDLSINRLSGELPANICK------------------IPSTLSKCKQLEEL 160
IFN+SS+ ID + N LSG LP ICK +P+TLS C +L L
Sbjct: 335 EIFNISSLQVIDFTNNSLSGSLPMGICKHLPNLQGLYLAQNHLSGQLPTTLSLCGELLFL 394
Query: 161 NLGFNNLSGAIPKEIGNLTKLKEIISTITNSTVCEIPREIGNLPYLARLALATNNLVGVV 220
+L FN G+IP+EIGNL+KL E I +NS V IP GNL L L L N L G V
Sbjct: 395 SLSFNKFRGSIPREIGNLSKL-EHIDLRSNSLVGSIPTSFGNLKALKFLNLGINFLTGTV 453
Query: 221 PVTIFNMSALKEISLLNNSLSGSLPSRIDLSLPNVETLNLGINSFSGTIPSSITNSSKLS 280
P IFN+S L+ ++L+ N LSGSLPS I LP++E L +G N FSGTIP SI+N SKL+
Sbjct: 454 PEAIFNISELQNLALVQNHLSGSLPSSIGTWLPDLEGLYIGANEFSGTIPMSISNMSKLT 513
Query: 281 DLELGENLFSGFIPNTIGNLRNLEFGNIADNYLTSS--TPELSFLSSLTNCKKLKVLIVT 338
L L +N F+G +P + NL L+F N+A N LT + FL+SLTNCK L+ L +
Sbjct: 514 VLSLSDNSFTGNVPKDLCNLTKLKFLNLAHNQLTDEHLASGVGFLTSLTNCKFLRYLWIG 573
Query: 339 GNPLDGILPKSIGNFSLSLETILMANCSISGNIPQVVGNLSNLLVLELGGNNLTGPIPVT 398
NPL G LP S+GN ++LE+ C G IP +GNL+NL+ L+LG N+LTG IP T
Sbjct: 574 YNPLKGTLPNSLGNLPIALESFTAYACQFRGTIPTGIGNLTNLIWLDLGANDLTGSIPTT 633
Query: 399 FSQLQTLQAFDLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSVRVLYL 458
+LQ LQ + N++ G I ++LCHL L L L NK SGS PSC G+L ++R L+L
Sbjct: 634 LGRLQKLQRLHIAGNRIRGSIPNDLCHLKNLGYLGLSSNKLSGSTPSCFGDLLALRELFL 693
Query: 459 GLNIFTSVLSSTIWNLKDILFIDVSSNFLDGPLSLDIGNLKVVIGLDFSR---------- 508
N + +++W+L+D+L +++SSNFL G L ++GN+K + LD S+
Sbjct: 694 DSNALAFNIPTSLWSLRDLLVLNLSSNFLTGNLPPEVGNMKSITTLDLSKNLVSGYIPSR 753
Query: 509 --------------------------------------NNLSGDIPITIG---------- 520
NNLSG IP ++
Sbjct: 754 MGKLQYLITLSLSQNRLQGPIXVEFGDLVSLESLDLSHNNLSGTIPKSLEALIYLKYLNV 813
Query: 521 -----EGEIPRGGPFANLTAKSFMGNELLCGLPDLQVSPCKPNKPNTHKKSRKMLLLVIV 575
+GEIP GGPF TA+SFM NE LCG P QV C N K++ +L I+
Sbjct: 814 SFNKLQGEIPNGGPFVKFTAESFMFNEALCGAPHFQVMACDKNNRTQSWKTKSFILKYIL 873
Query: 576 LPLSTALIVVVTLTLKWKLIKCWKSRTGPSNDGINSPQAI--------RRFSYHELLRAT 627
LP+ + + +VV + L W R D + P I + S+ +LL AT
Sbjct: 874 LPVGSTVTLVVFIVL-------WIRR----RDNMEIPTPIDSWLLGTHEKISHQQLLYAT 922
Query: 628 DRFSENNLIGIG-----------NGMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLV 676
+ F E+NLIG G NG+ VA+KVF+ +++ AL+SF+ ECEV + IRHRNLV
Sbjct: 923 NDFGEDNLIGKGSQGMVYKGVLSNGLNVAIKVFNLEFQGALRSFDSECEVMQGIRHRNLV 982
Query: 677 KII--------------------------------------------SSSLEYLHFGHSI 692
+II +S+LEYLH S
Sbjct: 983 RIITCCSNLDFKALVLEYMPNGSLEKWLYSHNYFLDLIQRLNIMIDVASALEYLHHDCSS 1042
Query: 693 PIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRV 752
++HCDLKPSNVLLD+DMVAH++DFGIAKLL+ E + +QT+TL TIGYMAPE+G+ G V
Sbjct: 1043 LVVHCDLKPSNVLLDDDMVAHVADFGIAKLLT-ETESMQQTKTLGTIGYMAPEHGSAGIV 1101
Query: 753 STRGDVCSFGII 764
ST+ DV S+GI+
Sbjct: 1102 STKSDVYSYGIL 1113
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147769371|emb|CAN72496.1| hypothetical protein VITISV_010511 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 550 bits (1416), Expect = e-153, Method: Compositional matrix adjust.
Identities = 340/850 (40%), Positives = 473/850 (55%), Gaps = 145/850 (17%)
Query: 53 RVIGLNISSFNLQGTITPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLDFSDNQL 112
RV+ L+ + F G I +G+LS+L+ L LS+NKL+G IP I N+ L +L N +
Sbjct: 307 RVLSLSFNQFT--GGIPQAIGSLSNLEGLYLSYNKLTGGIPREIGNLSNLNILQLGSNGI 364
Query: 113 FGSLSSFIFNMSSMTTIDLSINRLSGELPANICK------------------IPSTLSKC 154
G + + IFN+SS+ ID S N LSG LP +ICK +P+TLS C
Sbjct: 365 SGPIPAEIFNISSLQIIDFSNNSLSGSLPMDICKHLPNLQGLYLLQNHLSGQLPTTLSLC 424
Query: 155 KQLEELNLGFNNLSGAIPKEIGNLTKLKEIISTITNSTVCEIPREIGNLPYLARLALATN 214
+L L+L N G+IP+EIGNL+KL++I S +NS V IP GNL L L L N
Sbjct: 425 GELLYLSLAVNKFRGSIPREIGNLSKLEDI-SLRSNSLVGSIPTSFGNLMALKYLDLGMN 483
Query: 215 NLVGVVPVTIFNMSALKEISLLNNSLSGSLPSRIDLSLPNVETLNLGINSFSGTIPSSIT 274
L G VP IFN+S L+ + L+ N LSGSLP I LP++E L +G N FSGTIP SI+
Sbjct: 484 FLTGTVPEAIFNISELQILVLVQNHLSGSLPPSIGTWLPDLEGLYIGSNKFSGTIPMSIS 543
Query: 275 NSSKLSDLELGENLFSGFIPNTIGNLRNLEFGNIADNYLTSS--TPELSFLSSLTNCKKL 332
N SKL L++ +N F+G +P +GNL LE N+A N LT+ + FL+SLTNCK L
Sbjct: 544 NMSKLIQLQVWDNSFTGNVPKDLGNLTKLEVLNLAANQLTNEHLASGVGFLTSLTNCKFL 603
Query: 333 KVLIVTGNPLDGILPKSIGNFSLSLETILMANCSISGNIPQVVGNLSNLLVLELGGNNLT 392
+ L + NP G LP S+GN ++LE+ + C G IP +GNL+NL+ L+LG N+LT
Sbjct: 604 RHLWIDDNPFKGTLPNSLGNLPIALESFTASACQFRGTIPTGIGNLTNLIELDLGANDLT 663
Query: 393 GPIPVTFSQLQTLQAFDLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTS 452
IP T +LQ LQ + N++ G I ++LCHL L L L NK SGSIPSC G+L +
Sbjct: 664 RSIPTTLGRLQKLQRLHIAGNRIRGSIPNDLCHLKNLGYLHLXSNKLSGSIPSCFGDLPA 723
Query: 453 VRVLYLGLNIFTSVLSSTIWNLKDILFIDVSSNFLDGPLSLDIGNLKVVI---------- 502
++ L+L N+ + +++W+L+D+L +++SSNFL G L ++GN+K +
Sbjct: 724 LQELFLDSNVLAFNIPTSLWSLRDLLVLNLSSNFLTGNLPPEVGNMKSITTLDLSKNLVS 783
Query: 503 --------------------------------------GLDFSRNNLSGDIPITIG---- 520
LD S+NNLSG IP ++
Sbjct: 784 GYIPRRMGEQQNLAKLSLSQNRLQGPIPXEFGDLVSLESLDLSQNNLSGTIPKSLEALIY 843
Query: 521 -----------EGEIPRGGPFANLTAKSFMGNELLCGLPDLQVSPCKPNKPNTHKKSRKM 569
+GEIP GGPF N TA+SFM NE LCG P QV C N K++
Sbjct: 844 LKYLNVSSNKLQGEIPNGGPFXNFTAESFMFNEALCGAPHFQVMACDKNNRTQSWKTKSF 903
Query: 570 LLLVIVLPLSTALIVVVTLTLKWKLIKCWKSRTGPSNDGINSPQAIRRFSYHELLRATDR 629
+L I+LP+ + + +VV + L W + P + + P + S+ +LL AT+
Sbjct: 904 ILKYILLPVGSTITLVVFIVL-WIRRRDNMEIXTPIDSWL--PGTHEKISHQQLLYATND 960
Query: 630 FSENNLIGIG-----------NGMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVKI 678
F E+NLIG G NG+ VA+KVF+ +++ AL+SF+ ECEV + IRHRNLV+I
Sbjct: 961 FGEDNLIGKGSQGMVYKGVLSNGLIVAIKVFNLEFQGALRSFDSECEVMQGIRHRNLVRI 1020
Query: 679 I--------------------------------------------SSSLEYLHFGHSIPI 694
I +S+LEYLH S +
Sbjct: 1021 ITCCSNLDFKALVLKYMPNGSLEKWLYSHNYFLDLIQRLNIMIDVASALEYLHHDCSSLV 1080
Query: 695 IHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVST 754
+HCDLKPSNVLLD+BMVAH++DFGIAKLL+ + + +QT+TL TIGYMAPE+G+ G VST
Sbjct: 1081 VHCDLKPSNVLLDDBMVAHVTDFGIAKLLTKTESM-QQTKTLGTIGYMAPEHGSDGIVST 1139
Query: 755 RGDVCSFGII 764
+ DV S+GI+
Sbjct: 1140 KSDVYSYGIL 1149
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359485451|ref|XP_002276944.2| PREDICTED: LRR receptor-like serine/threonine-protein kinase GSO2-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 546 bits (1407), Expect = e-152, Method: Compositional matrix adjust.
Identities = 339/826 (41%), Positives = 469/826 (56%), Gaps = 139/826 (16%)
Query: 63 NLQGTITPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLDFSDNQLFGSLSSFIF- 121
NL G I ++GNLS+L LD + +SG IP IFN+ +L++ D +DN L GSL I+
Sbjct: 552 NLVGGIPREIGNLSNLNILDFGSSGISGPIPPEIFNISSLQIFDLTDNSLLGSLPMDIYK 611
Query: 122 NMSSMTTIDLSINRLSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKEIGNLTKL 181
++ ++ + LS N+LSG+LP STLS C QL+ L+L N +G IP GNLT L
Sbjct: 612 HLPNLQELYLSWNKLSGQLP-------STLSLCGQLQSLSLWGNRFTGNIPPSFGNLTAL 664
Query: 182 KEIISTITNSTVCEIPREIGNLPYLARLALATNNLVGVVPVTIFNMSALKEISLLNNSLS 241
+++ N+ IP E+GNL L L L+ NNL G++P IFN+S L+ +SL N S
Sbjct: 665 QDL-ELGDNNIQGNIPNELGNLINLQNLKLSENNLTGIIPEAIFNISKLQSLSLAQNHFS 723
Query: 242 GSLPSRIDLSLPNVETLNLGINSFSGTIPSSITNSSKLSDLELGENLFSGFIPNTIGNLR 301
GSLPS + LP++E L +G N FSG IP SI+N S+L++L++ +N F+G +P +GNLR
Sbjct: 724 GSLPSSLGTQLPDLEGLAIGRNEFSGIIPMSISNMSELTELDIWDNFFTGDVPKDLGNLR 783
Query: 302 NLEFGNIADNYLTS--STPELSFLSSLTNCKKLKVLIVTGNPLDGILPKSIGNFSLSLET 359
LEF N+ N LT S E+ FL+SLTNC L+ L + NPL GILP S+GN S+SLE+
Sbjct: 784 RLEFLNLGSNQLTDEHSASEVGFLTSLTNCNFLRTLWIEDNPLKGILPNSLGNLSISLES 843
Query: 360 ILMANCSISGNIPQVVGNLSNLLVLELGGNNLTGPIPVTFSQLQTLQAFDLTRNKLAGPI 419
+ C G IP +GNL++L+ LELG N+LTG IP T QL+ LQ + N+L G I
Sbjct: 844 FDASACQFRGTIPTGIGNLTSLISLELGDNDLTGLIPTTLGQLKKLQELGIAGNRLRGSI 903
Query: 420 TDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSVRVLYLGLNIFTSVLSSTIWNLKDILF 479
++LC L L L L N+ +GSIPSCLG L +R LYL N S + ++W L+ +L
Sbjct: 904 PNDLCRLKNLGYLFLSSNQLTGSIPSCLGYLPPLRELYLHSNALASNIPPSLWTLRGLLV 963
Query: 480 IDVSSNFLDGPLSLDIGNLKVV-----------------IG------------------- 503
+++SSNFL G L ++GN+K + +G
Sbjct: 964 LNLSSNFLTGHLPPEVGNIKSIRTLDLSKNQVSGHIPRTLGELQNLEDLSLSQNRLQGPI 1023
Query: 504 ------------LDFSRNNLSGDIPITIG---------------EGEIPRGGPFANLTAK 536
LD S+NNLSG IP ++ +GEIP GGPF N TA+
Sbjct: 1024 PLEFGDLLSLKFLDLSQNNLSGVIPKSLKALTYLKYLNVSFNKLQGEIPDGGPFMNFTAE 1083
Query: 537 SFMGNELLCGLPDLQVSPCKPNKPNTHKKSR-KMLLLVIVLPLSTALIVVVTLTLKWKLI 595
SF+ NE LCG P QV C +K + R K+ +L +LP ++I +V + W I
Sbjct: 1084 SFIFNEALCGAPHFQVIAC--DKSTRSRSWRTKLFILKYILPPVISIITLVVFLVLW--I 1139
Query: 596 KCWKSRTGPSNDGINSPQAIRRFSYHELLRATDRFSENNLIGIG-----------NGMEV 644
+ K+ P+ P + + S+ +LL AT+ F E+NLIG G NG+ V
Sbjct: 1140 RRRKNLEVPTPIDSWLPGSHEKISHQQLLYATNYFGEDNLIGKGSLSMVYKGVLSNGLTV 1199
Query: 645 AVKVFHQQYERALKSFEDECEVRKRIRHRNLVKII------------------------- 679
AVKVF+ +++ A +SF+ ECEV + IRHRNLVKII
Sbjct: 1200 AVKVFNLEFQGAFRSFDSECEVMQSIRHRNLVKIITCCSNLDFKALVLEYMPKGSLDKWL 1259
Query: 680 -------------------SSSLEYLHFGHSIP--IIHCDLKPSNVLLDEDMVAHISDFG 718
+S+LEYLH H P ++HCDLKP+N+LLD+DMVAH+ DFG
Sbjct: 1260 YSHNYFLDLIQRLNIMIDVASALEYLH--HDCPSLVVHCDLKPNNILLDDDMVAHVGDFG 1317
Query: 719 IAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGII 764
IA+LL+ E + +QT+TL TIGYMAPEYG+ G VST+GDV S+GI+
Sbjct: 1318 IARLLT-ETESMQQTKTLGTIGYMAPEYGSDGIVSTKGDVFSYGIM 1362
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224116832|ref|XP_002317405.1| predicted protein [Populus trichocarpa] gi|222860470|gb|EEE98017.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 545 bits (1403), Expect = e-152, Method: Compositional matrix adjust.
Identities = 358/890 (40%), Positives = 467/890 (52%), Gaps = 174/890 (19%)
Query: 57 LNISSFNLQGTITPQLGNLSSLQTLDLSHNKLSGNIPSSIFNM----------------- 99
LN+ ++G I+ ++ NLS+L+ LDL HN SG I +FNM
Sbjct: 93 LNLEGNFIEGNISEEIRNLSNLKILDLGHNHFSGVISPILFNMPSLRLINLRANSLSGIL 152
Query: 100 ----------HTLKLLDFSDNQLFGSLSSFIFNMSSMTTIDLSINRLSGELPANIC---- 145
TL++L+ NQL G + S + + + +DL NR +G +P IC
Sbjct: 153 QVVMIMSNIPSTLEVLNLGYNQLHGRIPSNLHKCTELRVLDLESNRFTGSIPKEICTLTK 212
Query: 146 -------------KIPSTLSKCKQLEELNLGFNNLSGAIPKEIGNLTKLKEIISTITNST 192
+IP +++ LE+L L N L+G IP+EIGN T L EI N+
Sbjct: 213 LKELYLGKNNLTGQIPGEIARLVSLEKLGLEVNGLNGNIPREIGNCTYLMEI-HVENNNL 271
Query: 193 VCEIPREIGNLPYLARLALATNNLVGVVPVTIFNMSALKEISLLNNSLSGSLPSRIDLSL 252
IP E+GNL L L L NN+ G +P T FN S L+ +++ N LSG LPS L L
Sbjct: 272 TGVIPNEMGNLHTLQELDLGFNNITGSIPSTFFNFSILRRVNMAYNYLSGHLPSNTGLGL 331
Query: 253 PNVETLNLGINSFSGTIPSSITNSSKLSDLELGENLFSGFIPNTIGNLRNLEFGNIADNY 312
PN+E L L N SG IP SI N+SKL L+L N FSG IP+ +GNLRNL+ N+A+N
Sbjct: 332 PNLEELYLEKNELSGPIPDSIGNASKLIVLDLSYNSFSGRIPDLLGNLRNLQKLNLAENI 391
Query: 313 LTSSTPELSFLSSLT--NCKKLKVLIVTGNPLDGILPKSIGNFSLSLETILMANCSISGN 370
LTS + + NC+ L L GNPL G LP SIGN S SLE + +C I GN
Sbjct: 392 LTSKSLRSELSFLSSLSNCRSLAYLRFNGNPLRGRLPVSIGNLSASLEELYAFDCRIIGN 451
Query: 371 IPQVVGNLSNLLVLELGGNNLTGPIPVTFSQLQTLQAFDLTRNKLAGPITDELCHLARLH 430
IP+ +GNLSNL+ L L N LTG IP +L+ LQ F L NKL G I +E+CHL RL
Sbjct: 452 IPRGIGNLSNLIGLILQQNELTGAIPSEIGRLKHLQDFSLASNKLQGHIPNEICHLERLS 511
Query: 431 SLVLQGNKFSGSIPSCLGNLTSVRVLYLGLNIFTSVLSSTIWNLKDILFIDVSSNFLDGP 490
L L N FSGS+P+CL N+TS+R LYLG N FTS+ +T W+LKD+L I++S N L G
Sbjct: 512 YLYLLENGFSGSLPACLSNITSLRELYLGSNRFTSI-PTTFWSLKDLLQINLSFNSLTGT 570
Query: 491 LSLDIGNLKVVIGLDFS------------------------------------------- 507
L L+IGNLKVV +DFS
Sbjct: 571 LPLEIGNLKVVTVIDFSSNQLSGDIPTSIADLQNLAHFSLSDNRMQGPIPSSFGDLVSLE 630
Query: 508 -----RNNLSGDIPITIG---------------EGEIPRGGPFANLTAKSFMGNELLCGL 547
RN+LSG IP ++ +GEI GGPFAN + +SFM NE LCG
Sbjct: 631 FLDLSRNSLSGAIPKSLEKLVHLKTFNVSFNRLQGEILDGGPFANFSFRSFMDNEALCGP 690
Query: 548 PDLQVSPCKPNKPNTHKKSRKMLLLVIVLPLSTALIVVVTLTLKWKLIKCWKSRTGPSND 607
+QV PCK +TH++S++ VI + +++ L L + + R + +
Sbjct: 691 IRMQVPPCK--SISTHRQSKRPREFVIRYIVPAIAFIILVLALAVIIFRRSHKRKLSTQE 748
Query: 608 GINSPQAIRRFSYHELLRATDRFSENNLIGIG-----------NGMEVAVKVFHQQYERA 656
P R+ SYHEL RAT+ F+E NL+G G +G+ +AVKVFH Q E
Sbjct: 749 DPLPPATWRKISYHELYRATEGFNETNLLGTGSCGSVYKGTLSDGLCIAVKVFHLQLEGE 808
Query: 657 LKSFEDECEVRKRIRHRNLVKIIS------------------------------------ 680
L F+ ECEV + +RHRNLVKIIS
Sbjct: 809 LMRFDSECEVLRMLRHRNLVKIISSCCNLDFKALILEFIPHGSLEKWLYSHNYYLDILQR 868
Query: 681 --------SSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQ 732
S+LEYLH G + P++HCDLKPSNVL++EDMVAH+SDFGI++LL GE Q
Sbjct: 869 LNIMIDVASALEYLHHGCTRPVVHCDLKPSNVLINEDMVAHVSDFGISRLL-GEGDAVTQ 927
Query: 733 TQTLATIGYMAPEYGTKGRVSTRGDVCSFGI-----ISGGKETRSMTVGE 777
T TLATIGYMAPEYG +G VS +GDV S+GI + K T M GE
Sbjct: 928 TLTLATIGYMAPEYGLEGIVSVKGDVYSYGIFLMETFTRKKPTDDMFGGE 977
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359497186|ref|XP_003635448.1| PREDICTED: LRR receptor-like serine/threonine-protein kinase GSO1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 544 bits (1401), Expect = e-152, Method: Compositional matrix adjust.
Identities = 345/887 (38%), Positives = 480/887 (54%), Gaps = 150/887 (16%)
Query: 57 LNISSFNLQGTITPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLDFSDNQL--FG 114
LN+SS +L G I LG LQ + L++N +G+IPS I N+ L+ L +N F
Sbjct: 201 LNLSSNHLSGKIPTGLGQCIQLQVISLAYNDFTGSIPSGIDNLVELQRLSLQNNSFTAFK 260
Query: 115 SLS-----SFIFNMSSMTTIDLSINRLSGELPANICK------------------IPSTL 151
+S + IFN+SS+ I + N LSG LP +ICK +P+TL
Sbjct: 261 DISKALLFAEIFNVSSLQVIAFTDNSLSGSLPKDICKHLPNLQGLSLSQNHLSGQLPTTL 320
Query: 152 SKCKQLEELNLGFNNLSGAIPKEIGNLTKLKEIISTITNSTVCEIPREIGNLPYLARLAL 211
S C +L L+L FN G+IPKEIGNL+KL+EI TNS + IP GNL L L L
Sbjct: 321 SLCGELLFLSLSFNKFRGSIPKEIGNLSKLEEIYLG-TNSLIGSIPTSFGNLKALKFLNL 379
Query: 212 ATNNLVGVVPVTIFNMSALKEISLLNNSLSGSLPSRIDLSLPNVETLNLGINSFSGTIPS 271
NNL G VP IFN+S L+ ++++ N LSGSLPS I LP++E L + N FSG IP
Sbjct: 380 GINNLTGTVPEAIFNISKLQSLAMVKNHLSGSLPSSIGTWLPDLEGLFIAGNEFSGIIPM 439
Query: 272 SITNSSKLSDLELGENLFSGFIPNTIGNLRNLEFGNIADNYLTSS--TPELSFLSSLTNC 329
SI+N SKL+ L L N F+G +P +GNL L+ ++A N LT E+ FL+SLTNC
Sbjct: 440 SISNMSKLTVLGLSANSFTGNVPKDLGNLTKLKVLDLAGNQLTDEHVASEVGFLTSLTNC 499
Query: 330 KKLKVLIVTGNPLDGILPKSIGNFSLSLETILMANCSISGNIPQVVGNLSNLLVLELGGN 389
K LK L + P G LP S+GN ++LE+ + + C G IP +GNL+NL+ L+LG N
Sbjct: 500 KFLKNLWIGNIPFKGTLPNSLGNLPIALESFIASACQFRGTIPTGIGNLTNLIRLDLGAN 559
Query: 390 NLTGPIPVTFSQLQTLQAFDLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGN 449
+LTG IP T QLQ LQ + N++ G I ++LCHL L L L NK SGSIPSC G+
Sbjct: 560 DLTGSIPTTLGQLQKLQWLYIAGNRIRGSIPNDLCHLKDLGYLFLSSNKLSGSIPSCFGD 619
Query: 450 LTSVRVLYLGLNIFTSVLSSTIWNLKDILFIDVSSNFLDGPLSLDIGNLKVVIGLDFSRN 509
L +++ L+L N+ + +++W+L+D+L +++SSNFL G L ++GN+K + LD S+N
Sbjct: 620 LLALQELFLDSNVLAFNIPTSLWSLRDLLALNLSSNFLTGNLPPEVGNMKSITTLDLSKN 679
Query: 510 ------------------------NLSGDIPITIG------------------------- 520
L G IPI G
Sbjct: 680 LVSGYIPSKMGKLQSLITLSLSQNRLQGPIPIEFGDLVSLESLDLSQNNLSGTIPKSLEA 739
Query: 521 --------------EGEIPRGGPFANLTAKSFMGNELLCGLPDLQVSPCKPNKPNTHKKS 566
+GEIP GGPF N TA+SFM NE LCG P QV C N K+
Sbjct: 740 LIYLKYLNVSLNKLQGEIPNGGPFINFTAESFMFNEALCGAPHFQVMACDKNNRTQSWKT 799
Query: 567 RKMLLLVIVLPLSTALIVVVTLTLKWKLIKCWKSRTGPSNDGINSPQAIRRFSYHELLRA 626
+ +L I+LP+ + + +VV + L W I+ + P+ P + S+ +LL A
Sbjct: 800 KSFILKYILLPVGSIVTLVVFIVL-W--IRRRDNMEIPTPIDSWLPGTHEKISHQQLLYA 856
Query: 627 TDRFSENNLIGIG-----------NGMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNL 675
T+ F E+NLIG G NG+ VA+KVF+ +++ AL+SF+ ECEV + IRHRNL
Sbjct: 857 TNDFGEDNLIGKGSQGMVYKGVLSNGLTVAIKVFNLEFQGALRSFDSECEVMQGIRHRNL 916
Query: 676 VKII--------------------------------------------SSSLEYLHFGHS 691
V+II +S+LEYLH S
Sbjct: 917 VRIITCCSNLDFKALVLEYMPNGSLEKWLYSHNYFLDLIQRLNIMIDVASALEYLHHDCS 976
Query: 692 IPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGR 751
++HCDLKP+NVLLD+DMVAH++DFGI KLL+ + + +QT+TL TIGYMAPE+G+ G
Sbjct: 977 SLVVHCDLKPNNVLLDDDMVAHVADFGITKLLTKTESM-QQTKTLGTIGYMAPEHGSDGI 1035
Query: 752 VSTRGDVCSFGIISGGKETRSMTVGETCTPVRESKYEVHPATTTIME 798
VST+ DV S+GI+ +R + E T K V + ++++
Sbjct: 1036 VSTKSDVYSYGILLMEVFSRKKPMDEMFTGGLTLKTWVESLSNSVIQ 1082
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST 
Original result of BLAST against Gene Ontology (AMIGO)
ID ![]() |
Alignment graph ![]() |
Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 823 | ||||||
| TAIR|locus:2149922 | 1031 | EFR "EF-TU receptor" [Arabidop | 0.608 | 0.485 | 0.341 | 1.1e-97 | |
| TAIR|locus:2075661 | 1025 | AT3G47110 [Arabidopsis thalian | 0.606 | 0.486 | 0.358 | 2.3e-95 | |
| UNIPROTKB|Q40640 | 1025 | Xa21 "Receptor kinase-like pro | 0.614 | 0.493 | 0.352 | 4.8e-94 | |
| TAIR|locus:2079142 | 1010 | AT3G47570 [Arabidopsis thalian | 0.607 | 0.495 | 0.342 | 1.2e-93 | |
| TAIR|locus:2079157 | 1011 | AT3G47580 [Arabidopsis thalian | 0.608 | 0.495 | 0.318 | 1.9e-88 | |
| TAIR|locus:2005507 | 976 | ER "ERECTA" [Arabidopsis thali | 0.799 | 0.674 | 0.303 | 2.1e-88 | |
| TAIR|locus:2075631 | 1009 | AT3G47090 [Arabidopsis thalian | 0.609 | 0.497 | 0.328 | 9e-86 | |
| TAIR|locus:2167948 | 966 | ERL1 "ERECTA-like 1" [Arabidop | 0.787 | 0.670 | 0.298 | 1e-84 | |
| TAIR|locus:2182855 | 967 | ERL2 "ERECTA-like 2" [Arabidop | 0.795 | 0.677 | 0.295 | 1.2e-81 | |
| TAIR|locus:2047525 | 980 | AT2G24130 [Arabidopsis thalian | 0.719 | 0.604 | 0.319 | 2.1e-78 |
| TAIR|locus:2149922 EFR "EF-TU receptor" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 748 (268.4 bits), Expect = 1.1e-97, Sum P(2) = 1.1e-97
Identities = 174/510 (34%), Positives = 261/510 (51%)
Query: 12 QALLALKAHISYDHTNLFARNWTSSTSVCIWIGITCDVNSHRVIGLNISSFNLQGTITPQ 71
QALL K+ +S ++ +W S+ C WIG+TC RVI LN+ F L G I+P
Sbjct: 33 QALLEFKSQVSENNKREVLASWNHSSPFCNWIGVTCGRRRERVISLNLGGFKLTGVISPS 92
Query: 72 LGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLDFSDNQLFGSLSSFIFNMSSMTTIDL 131
+GNLS L+ L+L+ N IP + + L+ L+ S N L G + S + N S ++T+DL
Sbjct: 93 IGNLSFLRLLNLADNSFGSTIPQKVGRLFRLQYLNMSYNLLEGRIPSSLSNCSRLSTVDL 152
Query: 132 SINRLSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKEIGNLTKLKEIISTITNS 191
S N L +P+ + +LSK L L+L NNL+G P +GNLT L+++ N
Sbjct: 153 SSNHLGHGVPSEL----GSLSK---LAILDLSKNNLTGNFPASLGNLTSLQKL-DFAYNQ 204
Query: 192 TVCEIPREIGNLPYLARLALATNNLVGVVPVTIFNMSALKEIXXXXXXXXXXXPSRIDLS 251
EIP E+ L + +A N+ G P ++N+S+L+ + +
Sbjct: 205 MRGEIPDEVARLTQMVFFQIALNSFSGGFPPALYNISSLESLSLADNSFSGNLRADFGYL 264
Query: 252 LPNVETLNLGINSFSGTIPSSITNSSKLSDLELGENLFSGFIPNTIGNLRNLEFGNIADN 311
LPN+ L LG N F+G IP ++ N S L ++ N SG IP + G LRNL + I +N
Sbjct: 265 LPNLRRLLLGTNQFTGAIPKTLANISSLERFDISSNYLSGSIPLSFGKLRNLWWLGIRNN 324
Query: 312 YL-TSSTPELSFLSSLTNCKKLKVLIVTGNPLDGILPKSIGNFSLSLETILMANCSISGN 370
L +S+ L F+ ++ NC +L+ L V N L G LP SI N S +L ++ + ISG
Sbjct: 325 SLGNNSSSGLEFIGAVANCTQLEYLDVGYNRLGGELPASIANLSTTLTSLFLGQNLISGT 384
Query: 371 IPQXXXXXXXXXXXXXXXXXXTGPIPVTFSQLQTLQAFDLTRNKLAGPITDELCHLARLH 430
IP +G +PV+F +L LQ DL N ++G I ++ RL
Sbjct: 385 IPHDIGNLVSLQELSLETNMLSGELPVSFGKLLNLQVVDLYSNAISGEIPSYFGNMTRLQ 444
Query: 431 SLVLQGNKFSGSIPSCLGNLTSVRVLYLGLNIFTSVLSSTIWNLKDILFIDVSSNFLDGP 490
L L N F G IP LG + L++ N + I + + +ID+S+NFL G
Sbjct: 445 KLHLNSNSFHGRIPQSLGRCRYLLDLWMDTNRLNGTIPQEILQIPSLAYIDLSNNFLTGH 504
Query: 491 LSLDIGNLKVVIGLDFSRNNLSGDIPITIG 520
++G L++++GL S N LSG +P IG
Sbjct: 505 FPEEVGKLELLVGLGASYNKLSGKMPQAIG 534
|
|
| TAIR|locus:2075661 AT3G47110 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 741 (265.9 bits), Expect = 2.3e-95, Sum P(2) = 2.3e-95
Identities = 183/511 (35%), Positives = 271/511 (53%)
Query: 11 QQALLALKAHISYDHTNLFARNWTSSTSVCIWIGITCDVNSHRVIGLNISSFNLQGTITP 70
+QALL K+ +S + + + +W S +C W G+ C + RV G+++ L G ++P
Sbjct: 41 KQALLEFKSQVS-ETSRVVLGSWNDSLPLCSWTGVKCGLKHRRVTGVDLGGLKLTGVVSP 99
Query: 71 QLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLDFSDNQLFGSLSSFIF-NMSSMTTI 129
+GNLS L++L+L+ N G IPS + N+ L+ L+ S+N LFG + + N SS++T+
Sbjct: 100 FVGNLSFLRSLNLADNFFHGAIPSEVGNLFRLQYLNMSNN-LFGGVIPVVLSNCSSLSTL 158
Query: 130 DLSINRLSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKEIGNLTKLKEIISTIT 189
DLS N L +P +LSK L L+LG NNL+G P +GNLT L +++ I
Sbjct: 159 DLSSNHLEQGVPLEF----GSLSK---LVLLSLGRNNLTGKFPASLGNLTSL-QMLDFIY 210
Query: 190 NSTVCEIPREIGNLPYLARLALATNNLVGVVPVTIFNMSALKEIXXXXXXXXXXXPSRID 249
N EIP +I L + +A N GV P I+N+S+L +
Sbjct: 211 NQIEGEIPGDIARLKQMIFFRIALNKFNGVFPPPIYNLSSLIFLSITGNSFSGTLRPDFG 270
Query: 250 LSLPNVETLNLGINSFSGTIPSSITNSSKLSDLELGENLFSGFIPNTIGNLRNLEFGNIA 309
LPN++ L +GINSF+GTIP +++N S L L++ N +G IP + G L+NL +
Sbjct: 271 SLLPNLQILYMGINSFTGTIPETLSNISSLRQLDIPSNHLTGKIPLSFGRLQNLLLLGLN 330
Query: 310 DNYLTS-STPELSFLSSLTNCKKLKVLIVTGNPLDGILPKSIGNFSLSLETILMANCSIS 368
+N L + S+ +L FL +LTNC +L+ L V N L G LP I N S L + + IS
Sbjct: 331 NNSLGNYSSGDLDFLGALTNCSQLQYLNVGFNKLGGQLPVFIANLSTQLTELSLGGNLIS 390
Query: 369 GNIPQXXXXXXXXXXXXXXXXXXTGPIPVTFSQLQTLQAFDLTRNKLAGPITDELCHLAR 428
G+IP TG +P + +L L+ L N L+G I L +++
Sbjct: 391 GSIPHGIGNLVSLQTLDLGENLLTGKLPPSLGELSELRKVLLYSNGLSGEIPSSLGNISG 450
Query: 429 LHSLVLQGNKFSGSIPSCLGNLTSVRVLYLGLNIFTSVLSSTIWNLKDILFIDVSSNFLD 488
L L L N F GSIPS LG+ + + L LG N + + L ++ ++VS N L
Sbjct: 451 LTYLYLLNNSFEGSIPSSLGSCSYLLDLNLGTNKLNGSIPHELMELPSLVVLNVSFNLLV 510
Query: 489 GPLSLDIGNLKVVIGLDFSRNNLSGDIPITI 519
GPL DIG LK ++ LD S N LSG IP T+
Sbjct: 511 GPLRQDIGKLKFLLALDVSYNKLSGQIPQTL 541
|
|
| UNIPROTKB|Q40640 Xa21 "Receptor kinase-like protein" [Oryza sativa (taxid:4530)] | Back alignment and assigned GO terms |
|---|
Score = 726 (260.6 bits), Expect = 4.8e-94, Sum P(2) = 4.8e-94
Identities = 184/522 (35%), Positives = 280/522 (53%)
Query: 13 ALLALKAHISYDHTNLFARNWTSST--SVCIWIGITCDV----NSHRVIGLNISSFNLQG 66
ALL+ K+ + Y A +W +S C W+G+ C + HRV+ L + S NL G
Sbjct: 35 ALLSFKSSLLYQGGQSLA-SWNTSGHGQHCTWVGVVCGRRRRRHPHRVVKLLLRSSNLSG 93
Query: 67 TITPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLDFSDNQLFGSLSSFIFNMSSM 126
I+P LGNLS L+ LDL N LSG IP + + L+LL+ SDN + GS+ + I + +
Sbjct: 94 IISPSLGNLSFLRELDLGDNYLSGEIPPELSRLSRLQLLELSDNSIQGSIPAAIGACTKL 153
Query: 127 TTIDLSINRLSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKEIGNLTKLKEIIS 186
T++DLS N+L G +P +I ++L K L L L N LSG IP +GNLT L+E
Sbjct: 154 TSLDLSHNQLRGMIPR---EIGASL---KHLSNLYLYKNGLSGEIPSALGNLTSLQEFDL 207
Query: 187 TITNSTVCEIPREIGNLPYLARLALATNNLVGVVPVTIFNMSALKEIXXXXXXXXXXXPS 246
+ N IP +G L L + L NNL G++P +I+N+S+L+ P+
Sbjct: 208 SF-NRLSGAIPSSLGQLSSLLTMNLGQNNLSGMIPNSIWNLSSLRAFSVRENKLGGMIPT 266
Query: 247 RIDLSLPNVETLNLGINSFSGTIPSSITNSSKLSDLELGENLFSGFIPNTIGNLRNLEFG 306
+L +E +++G N F G IP+S+ N+S L+ +++ NLFSG I + G LRNL
Sbjct: 267 NAFKTLHLLEVIDMGTNRFHGKIPASVANASHLTVIQIYGNLFSGIITSGFGRLRNLTEL 326
Query: 307 NIADN-YLTSSTPELSFLSSLTNCKKLKVLIVTGNPLDGILPKSIGNFSLSLETILMANC 365
+ N + T + F+S LTNC KL+ L + N L G+LP S N S SL + +
Sbjct: 327 YLWRNLFQTREQDDWGFISDLTNCSKLQTLNLGENNLGGVLPNSFSNLSTSLSFLALELN 386
Query: 366 SISGNIPQXXXXXXXXXXXXXXXXXXTGPIPVTFSQLQTLQAFDLTRNKLAGPITDELCH 425
I+G+IP+ G +P + +L+ L N L+G I + +
Sbjct: 387 KITGSIPKDIGNLIGLQHLYLCNNNFRGSLPSSLGRLKNLGILLAYENNLSGSIPLAIGN 446
Query: 426 LARLHSLVLQGNKFSGSIPSCLGNLTSVRVLYLGLNIFTSVLSSTIWNLKDI-LFIDVSS 484
L L+ L+L NKFSG IP L NLT++ L L N + + S ++N++ + + I+VS
Sbjct: 447 LTELNILLLGTNKFSGWIPYTLSNLTNLLSLGLSTNNLSGPIPSELFNIQTLSIMINVSK 506
Query: 485 NFLDGPLSLDIGNLKVVIGLDFSRNNLSGDIPITIGEGEIPR 526
N L+G + +IG+LK ++ N LSG IP T+G+ ++ R
Sbjct: 507 NNLEGSIPQEIGHLKNLVEFHAESNRLSGKIPNTLGDCQLLR 548
|
|
| TAIR|locus:2079142 AT3G47570 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 716 (257.1 bits), Expect = 1.2e-93, Sum P(2) = 1.2e-93
Identities = 175/511 (34%), Positives = 266/511 (52%)
Query: 11 QQALLALKAHISYDHTNLFARNWTSSTSVCIWIGITCDVNSHRVIGLNISSFNLQGTITP 70
+QALL K+ +S D + + +W S +C W G+TC + RV L + L G I+P
Sbjct: 26 RQALLQFKSQVSEDKRVVLS-SWNHSFPLCNWKGVTCGRKNKRVTHLELGRLQLGGVISP 84
Query: 71 QLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLDFSDNQLFGSLSSFIFNMSSMTTID 130
+GNLS L +LDL N G IP + + L+ LD N L G + ++N S + +
Sbjct: 85 SIGNLSFLVSLDLYENFFGGTIPQEVGQLSRLEYLDMGINYLRGPIPLGLYNCSRLLNLR 144
Query: 131 LSINRLSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKEIGNLTKLKEIISTITN 190
L NRL G +PS L L +LNL NN+ G +P +GNLT L+++ + N
Sbjct: 145 LDSNRLGGS-------VPSELGSLTNLVQLNLYGNNMRGKLPTSLGNLTLLEQLALS-HN 196
Query: 191 STVCEIPREIGNLPYLARLALATNNLVGVVPVTIFNMSALKEIXXXXXXXXXXXPSRIDL 250
+ EIP ++ L + L L NN GV P ++N+S+LK + + +
Sbjct: 197 NLEGEIPSDVAQLTQIWSLQLVANNFSGVFPPALYNLSSLKLLGIGYNHFSGRLRPDLGI 256
Query: 251 SLPNVETLNLGINSFSGTIPSSITNSSKLSDLELGENLFSGFIPNTIGNLRNLEFGNIAD 310
LPN+ + N+G N F+G+IP++++N S L L + EN +G IP T GN+ NL+ +
Sbjct: 257 LLPNLLSFNMGGNYFTGSIPTTLSNISTLERLGMNENNLTGSIP-TFGNVPNLKLLFLHT 315
Query: 311 NYLTS-STPELSFLSSLTNCKKLKVLIVTGNPLDGILPKSIGNFSLSLETILMANCSISG 369
N L S S+ +L FL+SLTNC +L+ L + N L G LP SI N S L T+ + ISG
Sbjct: 316 NSLGSDSSRDLEFLTSLTNCTQLETLGIGRNRLGGDLPISIANLSAKLVTLDLGGTLISG 375
Query: 370 NIPQXXXXXXXXXXXXXXXXXXTGPIPVTFSQLQTLQAFDLTRNKLAGPITDELCHLARL 429
+IP +GP+P + +L L+ L N+L+G I + ++ L
Sbjct: 376 SIPYDIGNLINLQKLILDQNMLSGPLPTSLGKLLNLRYLSLFSNRLSGGIPAFIGNMTML 435
Query: 430 HSLVLQGNKFSGSIPSCLGNLTSVRVLYLGLNIFTSVLSSTIWNLKDILFIDVSSNFLDG 489
+L L N F G +P+ LGN + + L++G N + I ++ +L +D+S N L G
Sbjct: 436 ETLDLSNNGFEGIVPTSLGNCSHLLELWIGDNKLNGTIPLEIMKIQQLLRLDMSGNSLIG 495
Query: 490 PLSLDIGNLKVVIGLDFSRNNLSGDIPITIG 520
L DIG L+ + L N LSG +P T+G
Sbjct: 496 SLPQDIGALQNLGTLSLGDNKLSGKLPQTLG 526
|
|
| TAIR|locus:2079157 AT3G47580 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 676 (243.0 bits), Expect = 1.9e-88, Sum P(2) = 1.9e-88
Identities = 163/511 (31%), Positives = 255/511 (49%)
Query: 11 QQALLALKAHISYDHTNLFARNWTSSTSVCIWIGITCDVNSHRVIGLNISSFNLQGTITP 70
+QALL K+ +S ++ + +W +S +C W +TC RV LN+ L G ++P
Sbjct: 26 RQALLEFKSQVSEGKRDVLS-SWNNSFPLCNWKWVTCGRKHKRVTHLNLGGLQLGGIVSP 84
Query: 71 QLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLDFSDNQLFGSLSSFIFNMSSMTTID 130
+GN+S L +LDLS N G IP + N+ L+ L + N L G + + + N S + +D
Sbjct: 85 SIGNVSFLISLDLSDNAFGGIIPREVGNLFRLEHLYMAFNSLEGGIPATLSNCSRLLNLD 144
Query: 131 LSINRLSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKEIGNLTKLKEIISTITN 190
L N L +PS L +L L+LG NNL G +P+ +GNLT LK + T N
Sbjct: 145 LYSNPLRQG-------VPSELGSLTKLVILDLGRNNLKGKLPRSLGNLTSLKSLGFT-DN 196
Query: 191 STVCEIPREIGNLPYLARLALATNNLVGVVPVTIFNMSALKEIXXXXXXXXXXXPSRIDL 250
+ E+P E+ L + L L+ N GV P I+N+SAL+++
Sbjct: 197 NIEGEVPDELARLSQMVGLGLSMNKFFGVFPPAIYNLSALEDLFLFGSGFSGSLKPDFGN 256
Query: 251 SLPNVETLNLGINSFSGTIPSSITNSSKLSDLELGENLFSGFIPNTIGNLRNLEFGNIAD 310
LPN+ LNLG N G IP++++N S L + +N+ +G I G + +L++ ++++
Sbjct: 257 LLPNIRELNLGENDLVGAIPTTLSNISTLQKFGINKNMMTGGIYPNFGKVPSLQYLDLSE 316
Query: 311 NYLTSST-PELSFLSSLTNCKKLKVLIVTGNPLDGILPKSIGNFSLSLETILMANCSISG 369
N L S T +L F+ SLTNC L++L V L G LP SI N S L ++ + G
Sbjct: 317 NPLGSYTFGDLEFIDSLTNCTHLQLLSVGYTRLGGALPTSIANMSTELISLNLIGNHFFG 376
Query: 370 NIPQXXXXXXXXXXXXXXXXXXTGPIPVTFSQLQTLQAFDLTRNKLAGPITDELCHLARL 429
+IPQ TGP+P + +L L L N+++G I + +L +L
Sbjct: 377 SIPQDIGNLIGLQRLQLGKNMLTGPLPTSLGKLLRLGLLSLYSNRMSGEIPSFIGNLTQL 436
Query: 430 HSLVLQGNKFSGSIPSCLGNLTSVRVLYLGLNIFTSVLSSTIWNLKDILFIDVSSNFLDG 489
L L N F G +P LG + + L +G N + I + ++ + + N L G
Sbjct: 437 EILYLSNNSFEGIVPPSLGKCSHMLDLRIGYNKLNGTIPKEIMQIPTLVNLSMEGNSLSG 496
Query: 490 PLSLDIGNLKVVIGLDFSRNNLSGDIPITIG 520
L DIG+L+ ++ L N SG +P T+G
Sbjct: 497 SLPNDIGSLQNLVKLSLENNKFSGHLPQTLG 527
|
|
| TAIR|locus:2005507 ER "ERECTA" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 722 (259.2 bits), Expect = 2.1e-88, Sum P(2) = 2.1e-88
Identities = 220/725 (30%), Positives = 346/725 (47%)
Query: 2 LLKSIISQHQQALLALKAHISYDHTNLFARNWTSSTS--VCIWIGITCDVNSHRVIGLNI 59
L+ ++ S+ LL +K S+ N +WT+S S C+W G++C+ + V+ LN+
Sbjct: 18 LVATVTSEEGATLLEIKK--SFKDVNNVLYDWTTSPSSDYCVWRGVSCENVTFNVVALNL 75
Query: 60 SSFNLQGTITPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLDFSDNQLFGSLSSF 119
S NL G I+P +G+L SL ++DL N+LSG IP I + +L+ LD S N+L G +
Sbjct: 76 SDLNLDGEISPAIGDLKSLLSIDLRGNRLSGQIPDEIGDCSSLQNLDLSFNELSGDIPFS 135
Query: 120 IFNMSSMTTIDLSINRLSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKEIGNLT 179
I + + + L N+L G P IPSTLS+ L+ L+L N LSG IP+ I
Sbjct: 136 ISKLKQLEQLILKNNQLIG--P-----IPSTLSQIPNLKILDLAQNKLSGEIPRLI-YWN 187
Query: 180 KLKEIISTITNSTVCEIPREIGNLPYLARLALATNNLVGVVPVTIFNMSALKEIXXXXXX 239
++ + + N+ V I ++ L L + N+L G +P TI N +A + +
Sbjct: 188 EVLQYLGLRGNNLVGNISPDLCQLTGLWYFDVRNNSLTGSIPETIGNCTAFQVLDLSYNQ 247
Query: 240 XXXXXPSRIDLSLPNVETLNLGINSFSGTIPSSITNSSKLSDLELGENLFSGFIPNTIGN 299
P D+ V TL+L N SG IPS I L+ L+L NL SG IP +GN
Sbjct: 248 LTGEIP--FDIGFLQVATLSLQGNQLSGKIPSVIGLMQALAVLDLSGNLLSGSIPPILGN 305
Query: 300 LRNLEFGNIADNYLTSSTPELSFLSSLTNCKKLKVLIVTGNPLDGILPKSIGNFSLSLET 359
L E + N LT S P L N KL L + N L G +P +G + L
Sbjct: 306 LTFTEKLYLHSNKLTGSIPP-----ELGNMSKLHYLELNDNHLTGHIPPELGKLT-DLFD 359
Query: 360 ILMANCSISGNIPQXXXXXXXXXXXXXXXXXXTGPIPVTFSQLQTLQAFDLTRNKLAGPI 419
+ +AN + G IP +G IP F +L+++ +L+ N + GPI
Sbjct: 360 LNVANNDLEGPIPDHLSSCTNLNSLNVHGNKFSGTIPRAFQKLESMTYLNLSSNNIKGPI 419
Query: 420 TDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSVRVLYLGLNIFTSVLSSTIWNLKDILF 479
EL + L +L L NK +G IPS LG+L + + L N T V+ NL+ I+
Sbjct: 420 PVELSRIGNLDTLDLSNNKINGIIPSSLGDLEHLLKMNLSRNHITGVVPGDFGNLRSIME 479
Query: 480 IDVSSNFLDGPLSLDIGNLKVVIGLDFSRNNLSGDI-------PITIGE-------GEIP 525
ID+S+N + GP+ ++ L+ +I L NNL+G++ +T+ G+IP
Sbjct: 480 IDLSNNDISGPIPEELNQLQNIILLRLENNNLTGNVGSLANCLSLTVLNVSHNNLVGDIP 539
Query: 526 RGGPFANLTAKSFMGNELLCGLPDLQVSPCKPNKPNTHKKSRKMLLLVIVLPLSTALIVV 585
+ F+ + SF+GN LCG SPC ++ + R + +L ++ +V+
Sbjct: 540 KNNNFSRFSPDSFIGNPGLCG--SWLNSPCHDSR----RTVRVSISRAAILGIAIGGLVI 593
Query: 586 VTLTLKWKLIKCWKSRTGPSNDG-------INSPQAI------RRFSYHELLRATDRFSE 632
+ + L + C P DG ++P+ + Y +++R T+ SE
Sbjct: 594 LLMVL---IAACRPHNPPPFLDGSLDKPVTYSTPKLVILHMNMALHVYEDIMRMTENLSE 650
Query: 633 NNLIGIG-----------NGMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVKIISS 681
+IG G N VA+K + +++K FE E E+ I+HRNLV + +
Sbjct: 651 KYIIGHGASSTVYKCVLKNCKPVAIKRLYSHNPQSMKQFETELEMLSSIKHRNLVSLQAY 710
Query: 682 SLEYL 686
SL +L
Sbjct: 711 SLSHL 715
|
|
| TAIR|locus:2075631 AT3G47090 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 651 (234.2 bits), Expect = 9.0e-86, Sum P(2) = 9.0e-86
Identities = 168/512 (32%), Positives = 248/512 (48%)
Query: 11 QQALLALKAHISYDHTNLFARNWTSSTSVCIWIGITCDVNSHRVIGLNISSFNLQGTITP 70
+QALL +K+ +S + + W +S +C W + C RV L++ L G I+P
Sbjct: 26 RQALLEIKSQVSESKRDALSA-WNNSFPLCSWKWVRCGRKHKRVTRLDLGGLQLGGVISP 84
Query: 71 QLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLDFSDNQLFGSLSSFIFNMSSMTTID 130
+GNLS L LDLS+N G IP + N+ LK L N L G + + + N S + +D
Sbjct: 85 SIGNLSFLIYLDLSNNSFGGTIPQEMGNLFRLKYLAVGFNYLEGEIPASLSNCSRLLYLD 144
Query: 131 LSINRLSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKEIGNLTKLKEIISTITN 190
L N L G+ +PS L ++L L LG N+L G P I NLT L +++ N
Sbjct: 145 LFSNNL-GD------GVPSELGSLRKLLYLYLGLNDLKGKFPVFIRNLTSLI-VLNLGYN 196
Query: 191 STVCEIPREIGNLPYLARLALATNNLVGVVPVTIFNMSALKEIXXXXXXXXXXXPSRIDL 250
EIP +I L + L L NN GV P +N+S+L+ +
Sbjct: 197 HLEGEIPDDIAMLSQMVSLTLTMNNFSGVFPPAFYNLSSLENLYLLGNGFSGNLKPDFGN 256
Query: 251 SLPNVETLNLGINSFSGTIPSSITNSSKLSDLELGENLFSGFIPNTIGNLRNLEFGNIAD 310
LPN+ L+L N +G IP+++ N S L +G+N +G I G L NL + +A+
Sbjct: 257 LLPNIHELSLHGNFLTGAIPTTLANISTLEMFGIGKNRMTGSISPNFGKLENLHYLELAN 316
Query: 311 NYLTS-STPELSFLSSLTNCKKLKVLIVTGNPLDGILPKSIGNFSLSLETILMANCSISG 369
N L S S +L+FL +LTNC L L V+ N L G LP SI N S L + + I G
Sbjct: 317 NSLGSYSFGDLAFLDALTNCSHLHGLSVSYNRLGGALPTSIVNMSTELTVLNLKGNLIYG 376
Query: 370 NIPQXXXXXXXXXXXXXXXXXXTGPIPVTFSQLQTLQAFDLTRNKLAGPITDELCHLARL 429
+IP TGP+P + L L L N+ +G I + +L +L
Sbjct: 377 SIPHDIGNLIGLQSLLLADNLLTGPLPTSLGNLVGLGELILFSNRFSGEIPSFIGNLTQL 436
Query: 430 HSLVLQGNKFSGSIPSCLGNLTSVRVLYLGLNIFTSVLSSTIWNLKDILFIDVSSNFLDG 489
L L N F G +P LG+ + + L +G N + I + ++ +++ SN L G
Sbjct: 437 VKLYLSNNSFEGIVPPSLGDCSHMLDLQIGYNKLNGTIPKEIMQIPTLVHLNMESNSLSG 496
Query: 490 PLSLDIGNLKVVIGLDFSRNNLSGDIPITIGE 521
L DIG L+ ++ L NNLSG +P T+G+
Sbjct: 497 SLPNDIGRLQNLVELLLGNNNLSGHLPQTLGK 528
|
|
| TAIR|locus:2167948 ERL1 "ERECTA-like 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 677 (243.4 bits), Expect = 1.0e-84, Sum P(2) = 1.0e-84
Identities = 212/710 (29%), Positives = 329/710 (46%)
Query: 5 SIISQHQQALLALKAHISYDHTNLFARNWTS--STSVCIWIGITCDVNSHRVIGLNISSF 62
S ++ +AL+A+K S + N+ +W ++ +C W G+ CD S+ V+ LN+SS
Sbjct: 24 SAMNNEGKALMAIKGSFS-NLVNMLL-DWDDVHNSDLCSWRGVFCDNVSYSVVSLNLSSL 81
Query: 63 NLQGTITPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLDFSDNQLFGSLSSFIFN 122
NL G I+P +G+L +LQ++DL NKL+G IP I N +L LD S+N L+G + I
Sbjct: 82 NLGGEISPAIGDLRNLQSIDLQGNKLAGQIPDEIGNCASLVYLDLSENLLYGDIPFSISK 141
Query: 123 MSSMTTIDLSINRLSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKEIGNLTKLK 182
+ + T++L N+L+G +PA + +IP+ L+ L+L N+L+G EI L
Sbjct: 142 LKQLETLNLKNNQLTGPVPATLTQIPN-------LKRLDLAGNHLTG----EISRLLYWN 190
Query: 183 EIISTIT---NSTVCEIPREIGNLPYLARLALATNNLVGVVPVTIFNMSALKEIXXXXXX 239
E++ + N + ++ L L + NNL G +P +I N ++ + +
Sbjct: 191 EVLQYLGLRGNMLTGTLSSDMCQLTGLWYFDVRGNNLTGTIPESIGNCTSFQILDISYNQ 250
Query: 240 XXXXXPSRIDLSLPNVETLNLGINSFSGTIPSSITNSSKLSDLELGENLFSGFIPNTIGN 299
P I V TL+L N +G IP I L+ L+L +N G IP +GN
Sbjct: 251 ITGEIPYNIGFL--QVATLSLQGNRLTGRIPEVIGLMQALAVLDLSDNELVGPIPPILGN 308
Query: 300 LRNLEFGNIADNYLTSSTPELSFLSSLTNCKKLKVLIVTGNPLDGILPKSIGNFSLSLET 359
L + N LT P S L N +L L + N L G +P +G E
Sbjct: 309 LSFTGKLYLHGNMLTGPIP-----SELGNMSRLSYLQLNDNKLVGTIPPELGKLEQLFE- 362
Query: 360 ILMANCSISGNIPQXXXXXXXXXXXXXXXXXXTGPIPVTFSQLQTLQAFDLTRNKLAGPI 419
+ +AN + G IP +G IP+ F L +L +L+ N G I
Sbjct: 363 LNLANNRLVGPIPSNISSCAALNQFNVHGNLLSGSIPLAFRNLGSLTYLNLSSNNFKGKI 422
Query: 420 TDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSVRVLYLGLNIFTSVLSSTIWNLKDILF 479
EL H+ L L L GN FSGSIP LG+L + +L L N + L + NL+ I
Sbjct: 423 PVELGHIINLDKLDLSGNNFSGSIPLTLGDLEHLLILNLSRNHLSGQLPAEFGNLRSIQM 482
Query: 480 IDVSSNFLDGPLSLDIGNLKVVIGLDFSRNNLSGDIP---------ITIG------EGEI 524
IDVS N L G + ++G L+ + L + N L G IP + + G +
Sbjct: 483 IDVSFNLLSGVIPTELGQLQNLNSLILNNNKLHGKIPDQLTNCFTLVNLNVSFNNLSGIV 542
Query: 525 PRGGPFANLTAKSFMGNELLCGLPDLQVSPCKPNKPNTHKKSRKMLLLVI--VLPLSTAL 582
P F+ SF+GN LCG + S C P P + SR L+ ++ V+ L +
Sbjct: 543 PPMKNFSRFAPASFVGNPYLCG--NWVGSICGP-LPKSRVFSRGALICIVLGVITLLCMI 599
Query: 583 IVVVTLTLKWKLIKCWKSRTGPSNDGI---NSPQAIRRFSYHELLRATDRFSENNLIGIG 639
+ V +++ K I S+ + + AI F +++R T+ +E +IG G
Sbjct: 600 FLAVYKSMQQKKILQGSSKQAEGLTKLVILHMDMAIHTFD--DIMRVTENLNEKFIIGYG 657
Query: 640 -----------NGMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVKI 678
+ +A+K + QY L+ FE E E IRHRN+V +
Sbjct: 658 ASSTVYKCALKSSRPIAIKRLYNQYPHNLREFETELETIGSIRHRNIVSL 707
|
|
| TAIR|locus:2182855 ERL2 "ERECTA-like 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 668 (240.2 bits), Expect = 1.2e-81, Sum P(2) = 1.2e-81
Identities = 211/714 (29%), Positives = 326/714 (45%)
Query: 1 MLLKSI--ISQHQQALLALKAHISYDHTNLFARNWTS--STSVCIWIGITCDVNSHRVIG 56
MLL S+ ++ +AL+A+KA S + N+ +W + C W G+ CD S V+
Sbjct: 20 MLLGSVSPMNNEGKALMAIKASFS-NVANMLL-DWDDVHNHDFCSWRGVFCDNVSLNVVS 77
Query: 57 LNISSFNLQGTITPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLDFSDNQLFGSL 116
LN+S+ NL G I+ LG+L +LQ++DL NKL G IP I N +L +DFS N LFG +
Sbjct: 78 LNLSNLNLGGEISSALGDLMNLQSIDLQGNKLGGQIPDEIGNCVSLAYVDFSTNLLFGDI 137
Query: 117 SSFIFNMSSMTTIDLSINRLSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKEIG 176
I + + ++L N+L+G +PA + +IP+ L+ L+L N L+G IP+ +
Sbjct: 138 PFSISKLKQLEFLNLKNNQLTGPIPATLTQIPN-------LKTLDLARNQLTGEIPRLL- 189
Query: 177 NLTKLKEIISTITNSTVCEIPREIGNLPYLARLALATNNLVGVVPVTIFNMSALKEIXXX 236
++ + + N + ++ L L + NNL G +P +I N ++ + +
Sbjct: 190 YWNEVLQYLGLRGNMLTGTLSPDMCQLTGLWYFDVRGNNLTGTIPESIGNCTSFEILDVS 249
Query: 237 XXXXXXXXPSRIDLSLPNVETLNLGINSFSGTIPSSITNSSKLSDLELGENLFSGFIPNT 296
P I V TL+L N +G IP I L+ L+L +N +G IP
Sbjct: 250 YNQITGVIPYNIGFL--QVATLSLQGNKLTGRIPEVIGLMQALAVLDLSDNELTGPIPPI 307
Query: 297 IGNLRNLEFGNIADNYLTSSTPELSFLSSLTNCKKLKVLIVTGNPLDGILPKSIGNFSLS 356
+GNL + N LT P L N +L L + N L G +P +G
Sbjct: 308 LGNLSFTGKLYLHGNKLTGQIPP-----ELGNMSRLSYLQLNDNELVGKIPPELGKLEQL 362
Query: 357 LETILMANCSISGNIPQXXXXXXXXXXXXXXXXXXTGPIPVTFSQLQTLQAFDLTRNKLA 416
E + +AN ++ G IP +G +P+ F L +L +L+ N
Sbjct: 363 FE-LNLANNNLVGLIPSNISSCAALNQFNVHGNFLSGAVPLEFRNLGSLTYLNLSSNSFK 421
Query: 417 GPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSVRVLYLGLNIFTSVLSSTIWNLKD 476
G I EL H+ L +L L GN FSGSIP LG+L + +L L N L + NL+
Sbjct: 422 GKIPAELGHIINLDTLDLSGNNFSGSIPLTLGDLEHLLILNLSRNHLNGTLPAEFGNLRS 481
Query: 477 ILFIDVSSNFLDGPLSLDIGNLKVVIGLDFSRNNLSGDIP-----------ITIG----E 521
I IDVS NFL G + ++G L+ + L + N + G IP + I
Sbjct: 482 IQIIDVSFNFLAGVIPTELGQLQNINSLILNNNKIHGKIPDQLTNCFSLANLNISFNNLS 541
Query: 522 GEIPRGGPFANLTAKSFMGNELLCGLPDLQVSPCKPNKPNTHKKSRKMLLLVIVLPLSTA 581
G IP F + SF GN LCG + S C P+ P + +R + ++ +VL T
Sbjct: 542 GIIPPMKNFTRFSPASFFGNPFLCG--NWVGSICGPSLPKSQVFTR-VAVICMVLGFITL 598
Query: 582 LIVVVTLTLKWKLIKCWKSRTGPSNDG------INSPQAIRRFSYHELLRATDRFSENNL 635
+ ++ K K K + +G ++ AI F +++R T+ E +
Sbjct: 599 ICMIFIAVYKSKQQKPVLKGSSKQPEGSTKLVILHMDMAIHTFD--DIMRVTENLDEKYI 656
Query: 636 IGIG-----------NGMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVKI 678
IG G +A+K + QY + FE E E IRHRN+V +
Sbjct: 657 IGYGASSTVYKCTSKTSRPIAIKRIYNQYPSNFREFETELETIGSIRHRNIVSL 710
|
|
| TAIR|locus:2047525 AT2G24130 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 605 (218.0 bits), Expect = 2.1e-78, Sum P(2) = 2.1e-78
Identities = 212/663 (31%), Positives = 325/663 (49%)
Query: 57 LNISSFNLQGTITPQLGNL-SSLQTLDLSHNKLSGNIPSSIFNMHTLKLLDFSDNQLFGS 115
L++S G I P++G+L +L+ L LS N L GNIP + ++ L LD N+L GS
Sbjct: 95 LDLSRNFFVGKIPPEIGSLHETLKQLSLSENLLHGNIPQELGLLNRLVYLDLGSNRLNGS 154
Query: 116 LSSFIF---NMSSMTTIDLSINRLSGELPANI-CKIPSTLSKCKQLEELNLGFNNLSGAI 171
+ +F + SS+ IDLS N L+GE+P N C + K+L L L N L+G +
Sbjct: 155 IPVQLFCNGSSSSLQYIDLSNNSLTGEIPLNYHCHL-------KELRFLLLWSNKLTGTV 207
Query: 172 PKEIGNLTKLKEIISTITNSTVCEIPRE-IGNLPYLARLALATNNLVG------VVP--V 222
P + N T LK + +N E+P + I +P L L L+ N+ V + P
Sbjct: 208 PSSLSNSTNLKWM-DLESNMLSGELPSQVISKMPQLQFLYLSYNHFVSHNNNTNLEPFFA 266
Query: 223 TIFNMSALKEIXXXXXXXXXXXPSRI-DLSLPNVETLNLGINSFSGTIPSSITNSSKLSD 281
++ N S L+E+ S + LS+ N+ ++L N G+IP I+N L+
Sbjct: 267 SLANSSDLQELELAGNSLGGEITSSVRHLSV-NLVQIHLDQNRIHGSIPPEISNLLNLTL 325
Query: 282 LELGENLFSGFIPNTIGNLRNLEFGNIADNYLTSSTPELSFLSSLTNCKKLKVLIVTGNP 341
L L NL SG IP + L LE +++N+LT P L + +L +L V+ N
Sbjct: 326 LNLSSNLLSGPIPRELCKLSKLERVYLSNNHLTGEIP-----MELGDIPRLGLLDVSRNN 380
Query: 342 LDGILPKSIGNFSLSLETILMANCSISGNIPQXXXXXXXXXXXXXXXXXXTGPIPV-TFS 400
L G +P S GN S L +L+ +SG +PQ TG IPV S
Sbjct: 381 LSGSIPDSFGNLS-QLRRLLLYGNHLSGTVPQSLGKCINLEILDLSHNNLTGTIPVEVVS 439
Query: 401 QLQTLQAF-DLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSVRVLYLG 459
L+ L+ + +L+ N L+GPI EL + + S+ L N+ SG IP LG+ ++ L L
Sbjct: 440 NLRNLKLYLNLSSNHLSGPIPLELSKMDMVLSVDLSSNELSGKIPPQLGSCIALEHLNLS 499
Query: 460 LNIFTSVLSSTIWNLKDILFIDVSSNFLDGPLSLDIGNLKVVIGLDFSRNNLSGDIPITI 519
N F+S L S++ L + +DVS N L G + + L+FS N LSG++
Sbjct: 500 RNGFSSTLPSSLGQLPYLKELDVSFNRLTGAIPPSFQQSSTLKHLNFSFNLLSGNVSDK- 558
Query: 520 GEGEIPRGGPFANLTAKSFMGNELLCG-LPDLQVSPCKPNKPNTHKKSRKMLLLVIVLPL 578
G F+ LT +SF+G+ LLCG + +Q CK HK +LL V++ +
Sbjct: 559 --------GSFSKLTIESFLGDSLLCGSIKGMQA--CKKK----HKYP-SVLLPVLLSLI 603
Query: 579 STALIVVVTLTLKWKLIKCWKSRTGPSNDGI--------NSPQAIRRFSYHELLRATDRF 630
+T ++ V L + + K+ T + + + N P+ R SY +L+ AT F
Sbjct: 604 ATPVLCVFGYPLVQRS-RFGKNLTVYAKEEVEDEEKQNQNDPK-YPRISYQQLIAATGGF 661
Query: 631 SENNLIGIG-----------NGMEVAVKVFHQQYERALK-SFEDECEVRKRIRHRNLVKI 678
+ ++LIG G N +VAVKV + SF+ EC++ KR RHRNL++I
Sbjct: 662 NASSLIGSGRFGHVYKGVLRNNTKVAVKVLDPKTALEFSGSFKRECQILKRTRHRNLIRI 721
Query: 679 ISS 681
I++
Sbjct: 722 ITT 724
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries 
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server 
Original result from Ezypred Server
Fail to connect to Ezypred Server
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING 
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against CDD database part I
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 823 | |||
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 6e-77 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 3e-20 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 4e-19 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 8e-19 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 9e-19 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 4e-18 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-16 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-15 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 3e-15 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 3e-15 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-14 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-13 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-12 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 1e-12 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 4e-12 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 5e-12 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-11 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 3e-11 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 4e-11 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 7e-11 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 8e-11 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 1e-10 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 4e-10 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 4e-10 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 5e-10 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 5e-10 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 7e-10 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 7e-10 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 8e-10 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-09 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-09 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-09 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-09 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 3e-09 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 3e-09 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 3e-09 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 4e-09 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 4e-09 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 6e-09 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 7e-09 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 7e-09 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 9e-09 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-08 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-08 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-08 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-08 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-08 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-08 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 3e-08 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 3e-08 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 3e-08 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 4e-08 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 4e-08 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 5e-08 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 5e-08 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 6e-08 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 6e-08 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 6e-08 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 7e-08 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 7e-08 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 7e-08 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 8e-08 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 8e-08 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-07 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-07 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-07 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-07 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-07 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-07 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-07 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-07 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-07 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 3e-07 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 3e-07 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 3e-07 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 3e-07 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 3e-07 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 3e-07 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 3e-07 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 4e-07 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 4e-07 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 4e-07 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 5e-07 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 5e-07 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 5e-07 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 5e-07 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 5e-07 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 6e-07 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 7e-07 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 7e-07 | |
| pfam08263 | 42 | pfam08263, LRRNT_2, Leucine rich repeat N-terminal | 7e-07 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 8e-07 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 8e-07 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 8e-07 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 9e-07 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 9e-07 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-06 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 1e-06 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-06 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-06 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 1e-06 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-06 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-06 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-06 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-06 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-06 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-06 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-06 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-06 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-06 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-06 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-06 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-06 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-06 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-06 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 3e-06 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 3e-06 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 3e-06 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 3e-06 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 3e-06 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 3e-06 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 3e-06 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 4e-06 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 4e-06 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 5e-06 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 5e-06 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 5e-06 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 5e-06 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 5e-06 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 5e-06 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 5e-06 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 5e-06 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 6e-06 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 6e-06 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 6e-06 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 7e-06 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 7e-06 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 8e-06 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 8e-06 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 9e-06 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 9e-06 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 1e-05 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-05 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 1e-05 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-05 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-05 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 1e-05 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-05 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 1e-05 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 1e-05 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-05 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-05 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-05 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-05 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-05 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-05 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-05 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-05 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-05 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-05 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 3e-05 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 3e-05 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 3e-05 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 3e-05 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 3e-05 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 3e-05 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 3e-05 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 3e-05 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 4e-05 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 4e-05 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 5e-05 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 5e-05 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 5e-05 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 6e-05 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 7e-05 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 7e-05 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 8e-05 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 8e-05 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 8e-05 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 8e-05 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 8e-05 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 8e-05 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 8e-05 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 9e-05 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 9e-05 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-04 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 1e-04 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 1e-04 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 1e-04 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 1e-04 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 1e-04 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-04 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-04 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-04 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-04 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-04 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-04 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-04 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-04 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-04 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-04 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-04 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-04 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-04 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-04 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-04 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-04 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-04 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 3e-04 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 3e-04 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 3e-04 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 3e-04 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 4e-04 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 4e-04 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 4e-04 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 4e-04 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 4e-04 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 5e-04 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 5e-04 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 6e-04 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 6e-04 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 6e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 7e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 7e-04 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 7e-04 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 7e-04 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 7e-04 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 8e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.001 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 0.001 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 0.001 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 0.001 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 0.002 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 0.002 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 0.002 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 0.002 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 0.002 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 0.002 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 0.002 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 0.002 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 0.003 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 0.003 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 0.003 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 0.003 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 0.003 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 0.003 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 0.003 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 0.004 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 0.004 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 0.004 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 268 bits (687), Expect = 6e-77
Identities = 244/872 (27%), Positives = 381/872 (43%), Gaps = 159/872 (18%)
Query: 14 LLALKAHISYDHTNLFARNWTSSTSVCIWIGITCDVNSHRVIGL---------------- 57
LL+ K+ I+ L NW SS VC+W GITC+ NS RV+ +
Sbjct: 34 LLSFKSSINDPLKYLS--NWNSSADVCLWQGITCN-NSSRVVSIDLSGKNISGKISSAIF 90
Query: 58 --------NISSFNLQGTITPQL-----------------------GNLSSLQTLDLSHN 86
N+S+ L G I + G++ +L+TLDLS+N
Sbjct: 91 RLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPRGSIPNLETLDLSNN 150
Query: 87 KLSGNIPSSIFNMHTLKLLDFSDNQLFGSLSSFIFNMSSMTTIDLSINRLSGELPANICK 146
LSG IP+ I + +LK+LD N L G + + + N++S+ + L+ N+L G+
Sbjct: 151 MLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQ------- 203
Query: 147 IPSTLSKCKQLEELNLGFNNLSGAIPKEIGNLTKLKEIISTITNSTVCEIPREIGNLPYL 206
IP L + K L+ + LG+NNLSG IP EIG LT L + + N+ IP +GNL L
Sbjct: 204 IPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNH-LDLVYNNLTGPIPSSLGNLKNL 262
Query: 207 ARLALATNNLVGVVPVTIFNMSALKEISLLNNSLSGSLPSRIDLSLPNVETLNLGINSFS 266
L L N L G +P +IF++ L + L +NSLSG +P + + L N+E L+L N+F+
Sbjct: 263 QYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELV-IQLQNLEILHLFSNNFT 321
Query: 267 GTIPSSITNSSKLSDLELGENLFSGFIPNTIGNLRNLEFGNIADNYLTSSTPELSFLSSL 326
G IP ++T+ +L L+L N FSG IP +G NL +++ N LT PE L
Sbjct: 322 GKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPE-----GL 376
Query: 327 TNCKKLKVLIVTGNPLDGILPKSIGNFSLSLETILMANCSISGNIPQVVGNLSNLLVLEL 386
+ L LI+ N L+G +PKS+G SL + + + S SG +P L + L++
Sbjct: 377 CSSGNLFKLILFSNSLEGEIPKSLGACR-SLRRVRLQDNSFSGELPSEFTKLPLVYFLDI 435
Query: 387 GGNNLTGPIPVTFSQLQTLQAFDLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSC 446
NNL G I + +LQ L RNK G + D RL +L L N+FSG++P
Sbjct: 436 SNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPD-SFGSKRLENLDLSRNQFSGAVPRK 494
Query: 447 LGNLTSVRVLYLGLNIFTSVLSSTIWNLKDILFIDVSSNFLDGPLSLDIGNLKVVIGLDF 506
LG+L+ + L L N + + + + K ++ +D+S N L G + + V+ LD
Sbjct: 495 LGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDL 554
Query: 507 SRNNLSGDIPITIG---------------EGEIPRGGPFANLTAKSFMGNELLC------ 545
S+N LSG+IP +G G +P G F + A + GN LC
Sbjct: 555 SQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTS 614
Query: 546 GLPDLQVSPCKP-NKPNTHKKSRKMLLLVIVLPLSTALIVVVTLTLKWKLIKCWKSRTGP 604
GLP PCK K + L ++ A V +K ++ G
Sbjct: 615 GLP-----PCKRVRKTPSWWFYITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGT 669
Query: 605 SNDGINSPQAIRRFSYHELLRATDRFSENNLI------------GIGNGMEVAVKVFHQQ 652
+ + + +++L + E N+I I NGM+ VK +
Sbjct: 670 WELQFFDSKVSKSITINDILSSL---KEENVISRGKKGASYKGKSIKNGMQFVVKEINDV 726
Query: 653 YERALKSFEDECEVRKRIRHRNLVKI---------------------------------- 678
D +++H N+VK+
Sbjct: 727 NSIPSSEIAD----MGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRNLSWERR 782
Query: 679 ------ISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQ 732
I+ +L +LH S ++ +L P +++D H+ LS L
Sbjct: 783 RKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHL-------RLSLPGLLCTD 835
Query: 733 TQTLATIGYMAPEYGTKGRVSTRGDVCSFGII 764
T+ + Y+APE ++ + D+ FG+I
Sbjct: 836 TKCFISSAYVAPETRETKDITEKSDIYGFGLI 867
|
Length = 968 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 89.6 bits (223), Expect = 3e-20
Identities = 50/170 (29%), Positives = 72/170 (42%), Gaps = 46/170 (27%)
Query: 639 GNGMEVAVKVFHQQYE-RALKSFEDECEVRKRIRHRNLVKIISSS---------LEYLHF 688
G +VA+K+ ++ L+ E E+ K++ H N+VK+ +EY
Sbjct: 16 KTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEG 75
Query: 689 G--------------------------------HSIPIIHCDLKPSNVLLDED-MVAHIS 715
G HS IIH DLKP N+LLD D ++
Sbjct: 76 GSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLA 135
Query: 716 DFGIAKLLSGEDQLSKQTQTLATIGYMAPE-YGTKGRVSTRGDVCSFGII 764
DFG++KLL+ + L K T YMAPE KG S + D+ S G+I
Sbjct: 136 DFGLSKLLTSDKSLLKTIV--GTPAYMAPEVLLGKGYYSEKSDIWSLGVI 183
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 87.6 bits (218), Expect = 4e-19
Identities = 47/171 (27%), Positives = 73/171 (42%), Gaps = 50/171 (29%)
Query: 638 IGNGMEVAVKVFH-QQYERALKSFEDECEVRKRIRHRNLVKI------------------ 678
G VA+KV ++ ++ + E ++ K+++H N+V++
Sbjct: 21 KKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYDVFEDEDKLYLVMEYCE 80
Query: 679 -------------------------ISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAH 713
I S+LEYLH S I+H DLKP N+LLDED
Sbjct: 81 GGDLFDLLKKRGRLSEDEARFYLRQILSALEYLH---SKGIVHRDLKPENILLDEDGHVK 137
Query: 714 ISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGII 764
++DFG+A+ L ++L T + T YMAPE D+ S G+I
Sbjct: 138 LADFGLARQLDPGEKL---TTFVGTPEYMAPEVLLGKGYGKAVDIWSLGVI 185
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 86.8 bits (216), Expect = 8e-19
Identities = 44/181 (24%), Positives = 74/181 (40%), Gaps = 53/181 (29%)
Query: 639 GNGMEVAVKVFHQQY-ERALKSFEDECEVRKRIRHRNLVKI------------------- 678
G +VAVK + E + F +E + K++ H N+V++
Sbjct: 26 GTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRLLGVCTQGEPLYIVTEYMPG 85
Query: 679 -------------------------ISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAH 713
I+ +EYL S +H DL N L+ E++V
Sbjct: 86 GDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLE---SKNFVHRDLAARNCLVTENLVVK 142
Query: 714 ISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFG-----IISGGK 768
ISDFG+++ + +D K+ I +MAPE G+ +++ DV SFG I + G+
Sbjct: 143 ISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGE 202
Query: 769 E 769
+
Sbjct: 203 Q 203
|
Length = 258 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 86.5 bits (215), Expect = 9e-19
Identities = 50/170 (29%), Positives = 70/170 (41%), Gaps = 45/170 (26%)
Query: 638 IGNGMEVAVKVF--HQQYERALKSFEDECEVRKRIRHRNLVKIISSS---------LEY- 685
G G VAVK+ + + ++ E + +R+ H N+V++I + +EY
Sbjct: 21 KGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDAFEDKDHLYLVMEYC 80
Query: 686 ------------------------------LHFGHSIPIIHCDLKPSNVLLDEDMVAHIS 715
L + HS IIH DLKP N+LLDE+ V I+
Sbjct: 81 EGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNGIIHRDLKPENILLDENGVVKIA 140
Query: 716 DFGIAKLLSGEDQLSKQTQTLATIGYMAPE-YGTKGRVSTRGDVCSFGII 764
DFG+AK L S T T YMAPE + DV S G+I
Sbjct: 141 DFGLAKKLLKSSS-SLTTFV-GTPWYMAPEVLLGGNGYGPKVDVWSLGVI 188
|
Length = 260 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 84.5 bits (210), Expect = 4e-18
Identities = 41/167 (24%), Positives = 60/167 (35%), Gaps = 44/167 (26%)
Query: 640 NGMEVAVKV--FHQQYERALKSFEDECEVRKRIRHRNLVKIISSS-----------LEYL 686
G +AVK E L++ E E + ++H N+V+ S LEY+
Sbjct: 24 TGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYV 83
Query: 687 HFG-------------------------------HSIPIIHCDLKPSNVLLDEDMVAHIS 715
G HS I+H D+K +N+L+D D V ++
Sbjct: 84 SGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLA 143
Query: 716 DFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFG 762
DFG AK L + T +MAPE D+ S G
Sbjct: 144 DFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLG 190
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 79.5 bits (197), Expect = 2e-16
Identities = 43/169 (25%), Positives = 72/169 (42%), Gaps = 49/169 (28%)
Query: 640 NGMEVAVKVFHQQY-ERALKSFEDECEVRKRIRHRNLVKI-------------------- 678
+EVAVK + E+ ++ F E + +++ H N+VK+
Sbjct: 27 KKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKLLGVCTEEEPLYIVMEYMEGG 86
Query: 679 ------------------------ISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHI 714
I+ +EYL S IH DL N L+ E++V I
Sbjct: 87 DLLSYLRKNRPKLSLSDLLSFALQIARGMEYL---ESKNFIHRDLAARNCLVGENLVVKI 143
Query: 715 SDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGI 763
SDFG+++ L +D ++ I +MAPE +G+ +++ DV SFG+
Sbjct: 144 SDFGLSRDLY-DDDYYRKRGGKLPIRWMAPESLKEGKFTSKSDVWSFGV 191
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 77.2 bits (191), Expect = 2e-15
Identities = 45/177 (25%), Positives = 68/177 (38%), Gaps = 50/177 (28%)
Query: 637 GIGNGMEVAVKVFHQQYERALKS-FEDECEVRKRIRHRNLVKIISSS---------LEYL 686
G EVAVK + + F E V K++ H N+V+++ LEY+
Sbjct: 19 KDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYM 78
Query: 687 HFG----------------------------------------HSIPIIHCDLKPSNVLL 706
G S +H DL N L+
Sbjct: 79 EGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLV 138
Query: 707 DEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGI 763
ED+V ISDFG+++ + +D K+T I +MAPE G +++ DV SFG+
Sbjct: 139 GEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGV 195
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 76.0 bits (188), Expect = 3e-15
Identities = 46/176 (26%), Positives = 73/176 (41%), Gaps = 50/176 (28%)
Query: 634 NLIGIGNGMEVAVKVFHQQY-ERALKSFEDECEVRKRIRHRNLVKI-------------- 678
G G +EVAVK + E+ ++ F E + +++ H N+VK+
Sbjct: 21 KGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80
Query: 679 -------------------------------ISSSLEYLHFGHSIPIIHCDLKPSNVLLD 707
I+ +EYL S IH DL N L+
Sbjct: 81 EYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE---SKNFIHRDLAARNCLVG 137
Query: 708 EDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGI 763
E++V ISDFG+++ L +D K I +MAPE +G+ +++ DV SFG+
Sbjct: 138 ENLVVKISDFGLSRDLY-DDDYYKVKGGKLPIRWMAPESLKEGKFTSKSDVWSFGV 192
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 76.2 bits (188), Expect = 3e-15
Identities = 37/86 (43%), Positives = 46/86 (53%), Gaps = 6/86 (6%)
Query: 679 ISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLAT 738
I +LEYLH S IIH D+KP N+LLDE HI+DF IA ++ + T T T
Sbjct: 109 IVLALEYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLT---TSTSGT 162
Query: 739 IGYMAPEYGTKGRVSTRGDVCSFGII 764
GYMAPE + S D S G+
Sbjct: 163 PGYMAPEVLCRQGYSVAVDWWSLGVT 188
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.3 bits (181), Expect = 2e-14
Identities = 36/87 (41%), Positives = 47/87 (54%), Gaps = 7/87 (8%)
Query: 679 ISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLA- 737
I +LEYLH S+ II+ DLKP N+LLD D ++DFG+AK LS E +T T
Sbjct: 102 IVLALEYLH---SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS---RTNTFCG 155
Query: 738 TIGYMAPEYGTKGRVSTRGDVCSFGII 764
T Y+APE D S G++
Sbjct: 156 TPEYLAPEVLLGKGYGKAVDWWSLGVL 182
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 2e-13
Identities = 52/193 (26%), Positives = 81/193 (41%), Gaps = 38/193 (19%)
Query: 42 WIGITC---DVNSHRVI-GLNISSFNLQGTITPQLGNLSSLQTLDLSHNKLSGNIPSSIF 97
W G C I GL + + L+G I + L LQ+++LS N + GNIP S
Sbjct: 404 WSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPS-- 461
Query: 98 NMHTLKLLDFSDNQLFGSLSSFIFNMSSMTTIDLSINRLSGELPANICKIPSTLSKCKQL 157
G +++S+ +DLS N +G IP +L + L
Sbjct: 462 ---------------LG-------SITSLEVLDLSYNSFNGS-------IPESLGQLTSL 492
Query: 158 EELNLGFNNLSGAIPKEIGNLTKLKEIISTITNSTVCEIP--REIG-NLPYLARLALATN 214
LNL N+LSG +P +G + + N+ +C IP R G +L A++ +A
Sbjct: 493 RILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPGLRACGPHLSVGAKIGIAFG 552
Query: 215 NLVGVVPVTIFNM 227
V + + I M
Sbjct: 553 VSVAFLFLVICAM 565
|
Length = 623 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 68.3 bits (168), Expect = 1e-12
Identities = 30/93 (32%), Positives = 47/93 (50%), Gaps = 19/93 (20%)
Query: 679 ISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLA- 737
+ +L+YLH S I+H D+KP N+ L + + + DFGI+K+LS L +T+
Sbjct: 112 LCLALKYLH---SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDL---AKTVVG 165
Query: 738 TIGYMAPE------YGTKGRVSTRGDVCSFGII 764
T Y++PE Y K D+ S G +
Sbjct: 166 TPYYLSPELCQNKPYNYK------SDIWSLGCV 192
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 1e-12
Identities = 48/172 (27%), Positives = 73/172 (42%), Gaps = 48/172 (27%)
Query: 635 LIGIGNGMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVKIISSSL---------EY 685
++G G +VAVK + A ++F E V +RH NLV+++ L EY
Sbjct: 23 MLGDYRGQKVAVKCL-KDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEY 81
Query: 686 LHFGHSI---------------------------------PIIHCDLKPSNVLLDEDMVA 712
+ G + +H DL NVL+ ED+VA
Sbjct: 82 MAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVA 141
Query: 713 HISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGII 764
+SDFG+AK E + + L + + APE + + ST+ DV SFGI+
Sbjct: 142 KVSDFGLAK----EASQGQDSGKLP-VKWTAPEALREKKFSTKSDVWSFGIL 188
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 68.6 bits (166), Expect = 4e-12
Identities = 38/116 (32%), Positives = 54/116 (46%), Gaps = 8/116 (6%)
Query: 657 LKSFEDECEVRKRIRHRNLVKIISSSLEYLHFGHSIPIIHCDLKPSNVLLDED-MVAHIS 715
L+ + + + + I++ L L + HS IIH D+KP N+LLD D V +
Sbjct: 85 LEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLI 144
Query: 716 DFGIAKLLSGEDQLSKQTQTLA----TIGYMAPEY---GTKGRVSTRGDVCSFGII 764
DFG+AKLL S + T GYMAPE + S+ D+ S GI
Sbjct: 145 DFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGIT 200
|
Length = 384 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 66.5 bits (163), Expect = 5e-12
Identities = 30/82 (36%), Positives = 41/82 (50%), Gaps = 8/82 (9%)
Query: 683 LEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLA-TIGY 741
LEYLH IIH D+K +N+LL D + DFG++ LS +K T+ T +
Sbjct: 111 LEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLS----DTKARNTMVGTPYW 163
Query: 742 MAPEYGTKGRVSTRGDVCSFGI 763
MAPE + D+ S GI
Sbjct: 164 MAPEVINGKPYDYKADIWSLGI 185
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 2e-11
Identities = 59/218 (27%), Positives = 82/218 (37%), Gaps = 69/218 (31%)
Query: 384 LELGGNNLTGPIPVTFSQLQTLQAFDLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSI 443
L L L G IP S+L+ LQ+ +L+ N + G I L + L L L N F+GSI
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 444 PSCLGNLTSVRVLYLGLNIFTSVLSSTIWNLKDILFIDVSSNFLDGPLSLDIGNLKVVIG 503
P LG LTS+R+L NL
Sbjct: 483 PESLGQLTSLRIL----------------NLNG--------------------------- 499
Query: 504 LDFSRNNLSGDIPITIGEGEIPRGGPFANLTAKSFMGNELLCGLPDLQVSPCKPNKPNTH 563
N+LSG +P +G G + F +F N LCG+P L+ C P+
Sbjct: 500 -----NSLSGRVPAALG-GRLLHRASF------NFTDNAGLCGIPGLR--ACGPHLSVGA 545
Query: 564 KKSRKMLLLVIVLPLSTALIVVVTLTLKWKLIKCWKSR 601
K + I +S A + +V + W WK R
Sbjct: 546 K-------IGIAFGVSVAFLFLVICAMCW-----WKRR 571
|
Length = 623 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 3e-11
Identities = 50/187 (26%), Positives = 76/187 (40%), Gaps = 50/187 (26%)
Query: 640 NGMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNL------------VKIISSSLE--- 684
N + VA+K+ + F+ E + KR+RH++L V II+ +E
Sbjct: 29 NRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKGS 88
Query: 685 YLHF-----GHSIP----------------------IIHCDLKPSNVLLDEDMVAHISDF 717
L F G +P IH DL N+L+ ED+V ++DF
Sbjct: 89 LLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADF 148
Query: 718 GIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGII------SGGKETR 771
G+A+L+ + LS + + APE + G ST+ DV SFGI+ G
Sbjct: 149 GLARLIKEDVYLSSDKKI--PYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYP 206
Query: 772 SMTVGET 778
M E
Sbjct: 207 GMNNHEV 213
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 4e-11
Identities = 40/102 (39%), Positives = 50/102 (49%), Gaps = 7/102 (6%)
Query: 665 EVRK---RIRHRNLVKIISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAK 721
+V+K RI + L KI S L+ L + HS IIH D+KPSN+LL + DFG+
Sbjct: 94 KVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGV-- 151
Query: 722 LLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGI 763
SGE S T YMAPE S DV S G+
Sbjct: 152 --SGELVNSLAGTFTGTSFYMAPERIQGKPYSITSDVWSLGL 191
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 63.4 bits (155), Expect = 7e-11
Identities = 31/88 (35%), Positives = 45/88 (51%), Gaps = 18/88 (20%)
Query: 683 LEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQT-LATIGY 741
L+YLH I IH D+KPSN+L++ I+DFGI+K+L + Q T + T+ Y
Sbjct: 112 LDYLHTKRHI--IHRDIKPSNLLINSKGEVKIADFGISKVL---ENTLDQCNTFVGTVTY 166
Query: 742 MAPE------YGTKGRVSTRGDVCSFGI 763
M+PE Y D+ S G+
Sbjct: 167 MSPERIQGESYSYA------ADIWSLGL 188
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 63.4 bits (155), Expect = 8e-11
Identities = 35/105 (33%), Positives = 48/105 (45%), Gaps = 23/105 (21%)
Query: 679 ISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLAT 738
I +LEYLH S IIH DLKP N+LLD+DM I+DFG AK+L + + + AT
Sbjct: 111 ILLALEYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVL-DPNSSPESNKGDAT 166
Query: 739 IG-------------------YMAPEYGTKGRVSTRGDVCSFGII 764
Y++PE + D+ + G I
Sbjct: 167 NIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCI 211
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 1e-10
Identities = 89/366 (24%), Positives = 155/366 (42%), Gaps = 53/366 (14%)
Query: 51 SHRVIGLNISSFNLQGTITPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLDFSDN 110
S V L ++ + + P + L S + ++ N+ L LD + N
Sbjct: 44 SVAVNRLALNLSSNTLLLLPSSLSRLLSLDLLSPSGISSLDGSENLLNLLPLPSLDLNLN 103
Query: 111 QLFGSLSSFIFNMSSMTTIDLSINRLSGELPANICKIPSTLSK-CKQLEELNLGFNNLSG 169
+L ++S + ++++T++DL N NI IP + L+EL+L N +
Sbjct: 104 RLRSNIS-ELLELTNLTSLDLDNN--------NITDIPPLIGLLKSNLKELDLSDNKIE- 153
Query: 170 AIPKEIGNLTKLKEIISTITNSTVCEIPREIGNLPYLARLALATNNLVGVVPVTIFNMSA 229
++P + NL LK + ++ + + ++P+ + NL L L L+ N + +P I +SA
Sbjct: 154 SLPSPLRNLPNLKNL--DLSFNDLSDLPKLLSNLSNLNNLDLSGNKI-SDLPPEIELLSA 210
Query: 230 LKEISLLNNSLSGSLPSRIDLSLPNVETLNLGINSFSGTIPSSITNSSKLSDLELGENLF 289
L+E+ L NNS+ + SS++N LS LEL N
Sbjct: 211 LEELDLSNNSII--------------------------ELLSSLSNLKNLSGLELSNNKL 244
Query: 290 SGFIPNTIGNLRNLEFGNIADNYLTSSTPELSFLSSLTNCKKLKVLIVTGNPLDGILPKS 349
+P +IGNL NLE ++++N ++S +SSL + L+ L ++GN L LP
Sbjct: 245 E-DLPESIGNLSNLETLDLSNNQISS-------ISSLGSLTNLRELDLSGNSLSNALPLI 296
Query: 350 IGNFSLSLETILMANCSISGNIPQVVGNLSNLLVLELGGNNLTGPIPVTFSQLQTLQAFD 409
L + + + + S LL + N T P S L++L
Sbjct: 297 ALLLLLLELLLNLLLTLKALE----LKLNSILLNNNILSNGETS-SPEALSILESLNNLW 351
Query: 410 LTRNKL 415
N L
Sbjct: 352 TLDNAL 357
|
Length = 394 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 60.8 bits (148), Expect = 4e-10
Identities = 46/171 (26%), Positives = 78/171 (45%), Gaps = 45/171 (26%)
Query: 637 GIGNG-MEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVK------------IIS--- 680
G NG +VAVK + + ++F E ++ K++RH LV+ I++
Sbjct: 25 GTWNGTTKVAVKTL-KPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYM 83
Query: 681 ---SSLEYLHF--GHSIPI----------------------IHCDLKPSNVLLDEDMVAH 713
S L++L G + + IH DL N+L+ E++V
Sbjct: 84 SKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCK 143
Query: 714 ISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGII 764
I+DFG+A+L+ +D+ + + I + APE GR + + DV SFGI+
Sbjct: 144 IADFGLARLIE-DDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGIL 193
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 61.1 bits (149), Expect = 4e-10
Identities = 45/184 (24%), Positives = 69/184 (37%), Gaps = 61/184 (33%)
Query: 641 GMEVAVKVFH--QQYERALKSFEDECEVRKRIRHRNLVKIISSSL---------EY---- 685
G EVA+K +Q + + +E + K +H N+V S L EY
Sbjct: 44 GKEVAIKKMRLRKQNKELII---NEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGG 100
Query: 686 ----------------------------LHFGHSIPIIHCDLKPSNVLLDEDMVAHISDF 717
L + HS +IH D+K N+LL +D ++DF
Sbjct: 101 SLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADF 160
Query: 718 GIAKLLSGEDQLSKQTQTLATI-G---YMAPEYGTKGRVSTRGDVCSFGIISGGKETRSM 773
G A QL+K+ ++ G +MAPE + + D+ S GI+ M
Sbjct: 161 GFAA------QLTKEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIM-----CIEM 209
Query: 774 TVGE 777
GE
Sbjct: 210 AEGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 60.8 bits (148), Expect = 5e-10
Identities = 48/165 (29%), Positives = 67/165 (40%), Gaps = 47/165 (28%)
Query: 645 AVKV--FHQQYERALKSFEDECEVRKRIRHRNLVK-----------II------SSSLE- 684
AVK + +K DE +V + ++H NLVK I +LE
Sbjct: 29 AVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCSGGTLEE 88
Query: 685 YLHFG----------------------HSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKL 722
L G HS I+H D+KP+N+ LD + V + DFG A
Sbjct: 89 LLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVK 148
Query: 723 LS-GEDQLSKQTQTLA-TIGYMAPEYGTKGRVSTRG---DVCSFG 762
L + ++ Q+LA T YMAPE T G+ G D+ S G
Sbjct: 149 LKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLG 193
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 61.6 bits (150), Expect = 5e-10
Identities = 29/65 (44%), Positives = 40/65 (61%), Gaps = 5/65 (7%)
Query: 683 LEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLL--SGEDQLSKQTQTLATIG 740
L+Y+H S +IH DLKPSN+L++ED I DFG+A+ L S + T+ +AT
Sbjct: 120 LKYIH---SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRW 176
Query: 741 YMAPE 745
Y APE
Sbjct: 177 YRAPE 181
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 7e-10
Identities = 30/85 (35%), Positives = 44/85 (51%)
Query: 364 NCSISGNIPQVVGNLSNLLVLELGGNNLTGPIPVTFSQLQTLQAFDLTRNKLAGPITDEL 423
N + G IP + L +L + L GN++ G IP + + +L+ DL+ N G I + L
Sbjct: 427 NQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESL 486
Query: 424 CHLARLHSLVLQGNKFSGSIPSCLG 448
L L L L GN SG +P+ LG
Sbjct: 487 GQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 60.0 bits (146), Expect = 7e-10
Identities = 29/86 (33%), Positives = 50/86 (58%), Gaps = 2/86 (2%)
Query: 678 IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLA 737
I+ +L+ L + HS IH D+K N+LL+E+ A ++DFG++ L D ++K+ +
Sbjct: 104 ILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQL--TDTMAKRNTVIG 161
Query: 738 TIGYMAPEYGTKGRVSTRGDVCSFGI 763
T +MAPE + + + D+ S GI
Sbjct: 162 TPFWMAPEVIQEIGYNNKADIWSLGI 187
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 8e-10
Identities = 33/114 (28%), Positives = 60/114 (52%), Gaps = 5/114 (4%)
Query: 668 KRIRHRNLVKIISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGED 727
K ++ LV + + + + + + IH DL+ +N+L+ +++V I+DFG+A+L+ +
Sbjct: 97 KYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNE 156
Query: 728 QLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGETCTP 781
++Q I + APE GR + + DV SFGI+ T +T G P
Sbjct: 157 YTARQGAKFP-IKWTAPEAALYGRFTIKSDVWSFGIL----LTELVTKGRVPYP 205
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 1e-09
Identities = 32/85 (37%), Positives = 38/85 (44%), Gaps = 6/85 (7%)
Query: 679 ISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLAT 738
I LE+LH I++ DLKP NVLLD+ ISD G+A L G K T
Sbjct: 104 IICGLEHLH---QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG---KKIKGRAGT 157
Query: 739 IGYMAPEYGTKGRVSTRGDVCSFGI 763
GYMAPE D + G
Sbjct: 158 PGYMAPEVLQGEVYDFSVDWFALGC 182
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 59.6 bits (145), Expect = 1e-09
Identities = 38/102 (37%), Positives = 51/102 (50%), Gaps = 9/102 (8%)
Query: 665 EVRKRIRHRNLVKI---ISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAK 721
EV+ RI R L KI + L YLH H I IH D+KPSN+L++ + DFG+
Sbjct: 92 EVQGRIPERILGKIAVAVLKGLTYLHEKHKI--IHRDVKPSNILVNSRGQIKLCDFGV-- 147
Query: 722 LLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGI 763
SG+ S + T YMAPE S + D+ S G+
Sbjct: 148 --SGQLVNSLAKTFVGTSSYMAPERIQGNDYSVKSDIWSLGL 187
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 59.6 bits (145), Expect = 2e-09
Identities = 29/67 (43%), Positives = 42/67 (62%), Gaps = 3/67 (4%)
Query: 683 LEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYM 742
L+ + + H+ I+H DLKP+N+L+ D V I+DFG+A+L S E+ Q +AT Y
Sbjct: 109 LKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQ-VATRWYR 167
Query: 743 APE--YG 747
APE YG
Sbjct: 168 APELLYG 174
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 2e-09
Identities = 30/107 (28%), Positives = 55/107 (51%), Gaps = 6/107 (5%)
Query: 661 EDECEVRKRIRHRNLVKI---ISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDF 717
+ V+ + + + I I++ +EYL H +H DL N L+ E + ISDF
Sbjct: 112 SGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGLTVKISDF 168
Query: 718 GIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGII 764
G+++ + D Q+++L + +M PE G+ +T D+ SFG++
Sbjct: 169 GLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVV 215
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 58.9 bits (143), Expect = 3e-09
Identities = 39/111 (35%), Positives = 53/111 (47%), Gaps = 16/111 (14%)
Query: 664 CEVRKRIRH----RNLVKI---ISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISD 716
++ KRI+ L K+ I +L YL H + IH D+KPSN+LLD + D
Sbjct: 101 DKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGV--IHRDVKPSNILLDASGNVKLCD 158
Query: 717 FGIAKLLSGEDQLSKQTQTLATIGYMAPEY----GTKGRVSTRGDVCSFGI 763
FGI+ L D +K T++ YMAPE + R DV S GI
Sbjct: 159 FGISGRLV--DSKAK-TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGI 206
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 3e-09
Identities = 33/111 (29%), Positives = 59/111 (53%), Gaps = 10/111 (9%)
Query: 659 SFEDECEVRKRIRHRNLVKI---ISSSLEYL--HFGHSIPIIHCDLKPSNVLLDEDMVAH 713
S +++ V+ + H + + I I++ +EYL HF +H DL N+L+ E +
Sbjct: 110 SSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF-----FVHKDLAARNILIGEQLHVK 164
Query: 714 ISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGII 764
ISD G+++ + D Q ++L I +M PE G+ S+ D+ SFG++
Sbjct: 165 ISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVV 215
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 3e-09
Identities = 30/100 (30%), Positives = 56/100 (56%), Gaps = 1/100 (1%)
Query: 665 EVRKRIRHRNLVKIISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLS 724
E+ K +R LV + + + + + +H DL+ +N+L+ E++V ++DFG+A+L+
Sbjct: 94 EMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE 153
Query: 725 GEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGII 764
+ ++Q I + APE GR + + DV SFGI+
Sbjct: 154 DNEYTARQGAKFP-IKWTAPEAALYGRFTIKSDVWSFGIL 192
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 4e-09
Identities = 29/75 (38%), Positives = 42/75 (56%), Gaps = 2/75 (2%)
Query: 690 HSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTK 749
HS+ II+ DLKP N+LLDE+ ++DFG++K D K T+ YMAPE +
Sbjct: 115 HSLGIIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAYSFCGTVEYMAPEVVNR 172
Query: 750 GRVSTRGDVCSFGII 764
+ D SFG++
Sbjct: 173 RGHTQSADWWSFGVL 187
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 58.1 bits (141), Expect = 4e-09
Identities = 29/115 (25%), Positives = 50/115 (43%), Gaps = 6/115 (5%)
Query: 653 YERALKSFEDECEVR---KRIRHRNLVKIISSSLEYLHFGHSIPIIHCDLKPSNVLLDED 709
Y R+ + + + + I+ + YL +H DL N ++ ED
Sbjct: 99 YLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAED 155
Query: 710 MVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGII 764
+ I DFG+ + + D K + L + +MAPE G +T+ DV SFG++
Sbjct: 156 LTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVV 210
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 6e-09
Identities = 37/91 (40%), Positives = 45/91 (49%), Gaps = 20/91 (21%)
Query: 683 LEYLH-FGHSIPIIHCDLKPSNVLLDEDMVAHISDFGI-AKLLSGEDQLSKQTQTLA-TI 739
LEYLH G IH D+K N+LL ED I+DFG+ A L G D+ K +T T
Sbjct: 115 LEYLHSNGQ----IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTP 170
Query: 740 GYMAPE-------YGTKGRVSTRGDVCSFGI 763
+MAPE Y K D+ SFGI
Sbjct: 171 CWMAPEVMEQVHGYDFK------ADIWSFGI 195
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 7e-09
Identities = 45/171 (26%), Positives = 64/171 (37%), Gaps = 47/171 (27%)
Query: 639 GNGMEVAVKVF-HQQYERALKSFEDECEVRKRIRHRNLVKIISSS-----------LEYL 686
G +VAVK H E+ FE E E+ + + H N+VK +EYL
Sbjct: 31 NTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYL 90
Query: 687 HFG--------------------------------HSIPIIHCDLKPSNVLLDEDMVAHI 714
G S IH DL N+L++ + + I
Sbjct: 91 PSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKI 150
Query: 715 SDFGIAKLLSGEDQL--SKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGI 763
SDFG+AK+L + K+ Y APE + S+ DV SFG+
Sbjct: 151 SDFGLAKVLPEDKDYYYVKEPGESPIFWY-APECLRTSKFSSASDVWSFGV 200
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 7e-09
Identities = 46/171 (26%), Positives = 79/171 (46%), Gaps = 44/171 (25%)
Query: 636 IGIGNG-MEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVKIIS-------------- 680
+G NG +VAVK + + +SF +E ++ K++RH LV++ +
Sbjct: 24 MGTWNGNTKVAVKTL-KPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVSEEPIYIVTEYM 82
Query: 681 ---SSLEYLHFGH----SIP--------------------IIHCDLKPSNVLLDEDMVAH 713
S L++L G +P IH DL+ +N+L+ + +V
Sbjct: 83 SKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCK 142
Query: 714 ISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGII 764
I+DFG+A+L+ + ++Q I + APE GR + + DV SFGI+
Sbjct: 143 IADFGLARLIEDNEYTARQGAKFP-IKWTAPEAALYGRFTIKSDVWSFGIL 192
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 9e-09
Identities = 30/86 (34%), Positives = 48/86 (55%), Gaps = 1/86 (1%)
Query: 233 ISLLNNSLSGSLPSRIDLSLPNVETLNLGINSFSGTIPSSITNSSKLSDLELGENLFSGF 292
+ L N L G +P+ I L +++++NL NS G IP S+ + + L L+L N F+G
Sbjct: 423 LGLDNQGLRGFIPNDIS-KLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGS 481
Query: 293 IPNTIGNLRNLEFGNIADNYLTSSTP 318
IP ++G L +L N+ N L+ P
Sbjct: 482 IPESLGQLTSLRILNLNGNSLSGRVP 507
|
Length = 623 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 2e-08
Identities = 37/103 (35%), Positives = 50/103 (48%), Gaps = 12/103 (11%)
Query: 668 KRIRHRNLVKI---ISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLS 724
I L KI I +LEYLH + +IH D+KPSNVL++ + + DFGI+ L
Sbjct: 98 LTIPEDILGKIAVSIVKALEYLH--SKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLV 155
Query: 725 GEDQLSKQTQTLATIGYMAPEY----GTKGRVSTRGDVCSFGI 763
D ++K T YMAPE + + DV S GI
Sbjct: 156 --DSVAK-TIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGI 195
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.7 bits (135), Expect = 2e-08
Identities = 45/165 (27%), Positives = 66/165 (40%), Gaps = 44/165 (26%)
Query: 640 NGMEVAVK--VFHQQYERALKSFEDECEVRKRIRHRNLVKIISSS---------LEY--- 685
G VA+K + E ALKS E ++ K ++H N+VK I S LEY
Sbjct: 24 TGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAEN 83
Query: 686 ----------------------------LHFGHSIPIIHCDLKPSNVLLDEDMVAHISDF 717
L + H +IH D+K +N+L +D V ++DF
Sbjct: 84 GSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADF 143
Query: 718 GIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFG 762
G+A L+ + + T +MAPE ST D+ S G
Sbjct: 144 GVATKLNDVSKDD--ASVVGTPYWMAPEVIEMSGASTASDIWSLG 186
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 2e-08
Identities = 48/173 (27%), Positives = 71/173 (41%), Gaps = 50/173 (28%)
Query: 635 LIGIGNGMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVKII------SSSL----E 684
++G G +VAVK + + ++F E V ++RH NLV+++ L E
Sbjct: 23 MLGDYRGNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 80
Query: 685 Y-----------------------LHFGHSI----------PIIHCDLKPSNVLLDEDMV 711
Y L F + +H DL NVL+ ED V
Sbjct: 81 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNV 140
Query: 712 AHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGII 764
A +SDFG+ K S S Q + + APE + + ST+ DV SFGI+
Sbjct: 141 AKVSDFGLTKEAS-----STQDTGKLPVKWTAPEALREKKFSTKSDVWSFGIL 188
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 2e-08
Identities = 43/176 (24%), Positives = 66/176 (37%), Gaps = 52/176 (29%)
Query: 641 GMEVAVKVF---HQQYERALKSFEDECEVRKRIRHRNLVKIISSS--------------- 682
G EVA+K+ + E F E + R+ H N+V ++ S
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62
Query: 683 --------------------------LEYLHFGHSIPIIHCDLKPSNVLL---DEDMVAH 713
L+ L H+ I+H DLKP N+++ A
Sbjct: 63 GRTLREVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHAK 122
Query: 714 ISDFGIAKLLSG-----EDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGII 764
+ DFGI LL G L++ T+ L T Y APE V+ D+ ++G+I
Sbjct: 123 VLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLI 178
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.0 bits (136), Expect = 2e-08
Identities = 47/158 (29%), Positives = 70/158 (44%), Gaps = 31/158 (19%)
Query: 599 KSRTGPSNDGINSPQAIRRFSYHELLRATDRFSENNLIGIGNGMEVAVK------VFHQQ 652
K R +GI S A+R S LL+ N++ + ++V VF +
Sbjct: 31 KIRLDNEEEGIPS-TALREIS---LLK---ELKHPNIVKL---LDVIHTERKLYLVF--E 78
Query: 653 Y-ERALKSFEDECEVRKRIRHRNLVKIIS----SSLEYLHFGHSIPIIHCDLKPSNVLLD 707
Y + LK + + R NL+K I L Y H S I+H DLKP N+L++
Sbjct: 79 YCDMDLKKY---LDKRPGPLSPNLIKSIMYQLLRGLAYCH---SHRILHRDLKPQNILIN 132
Query: 708 EDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPE 745
D V ++DFG+A+ L T + T+ Y APE
Sbjct: 133 RDGVLKLADFGLARAFGIP--LRTYTHEVVTLWYRAPE 168
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 3e-08
Identities = 37/105 (35%), Positives = 55/105 (52%), Gaps = 4/105 (3%)
Query: 209 LALATNNLVGVVPVTIFNMSALKEISLLNNSLSGSLPSRIDLSLPNVETLNLGINSFSGT 268
L L L G +P I + L+ I+L NS+ G++P + S+ ++E L+L NSF+G+
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLG-SITSLEVLDLSYNSFNGS 481
Query: 269 IPSSITNSSKLSDLELGENLFSGFIPNTIGN--LRNLEFGNIADN 311
IP S+ + L L L N SG +P +G L F N DN
Sbjct: 482 IPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASF-NFTDN 525
|
Length = 623 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 3e-08
Identities = 40/149 (26%), Positives = 64/149 (42%), Gaps = 43/149 (28%)
Query: 658 KSFEDECEVRKRIRHRNLVK------------IIS------SSLEYLHF--GHSIPI--- 694
K F E ++ K++RH L++ I++ S LEYL G ++ +
Sbjct: 46 KDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQL 105
Query: 695 -------------------IHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQT 735
IH DL NVL+ E+ + ++DFG+A+++ ED +
Sbjct: 106 IDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVI-KEDIYEAREGA 164
Query: 736 LATIGYMAPEYGTKGRVSTRGDVCSFGII 764
I + APE R S + DV SFGI+
Sbjct: 165 KFPIKWTAPEAALYNRFSIKSDVWSFGIL 193
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.4 bits (134), Expect = 3e-08
Identities = 41/147 (27%), Positives = 58/147 (39%), Gaps = 43/147 (29%)
Query: 641 GMEVAVKVFHQQY--ERALKSFEDECEVRKRIRHRNLVKII-----------------SS 681
G VA+K F + E K+ E +V +++RH N+V + +
Sbjct: 26 GEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVERT 85
Query: 682 SLEYL-----------------------HFGHSIPIIHCDLKPSNVLLDEDMVAHISDFG 718
LE L + HS IIH D+KP N+L+ E V + DFG
Sbjct: 86 LLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFG 145
Query: 719 IAKLLSGEDQLSKQTQTLATIGYMAPE 745
A+ L S T +AT Y APE
Sbjct: 146 FARALRARPA-SPLTDYVATRWYRAPE 171
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 3e-08
Identities = 41/169 (24%), Positives = 72/169 (42%), Gaps = 56/169 (33%)
Query: 641 GMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVKI---------------------- 678
G +VAVK + + ++F +E V ++ H+NLV++
Sbjct: 29 GQKVAVKNI--KCDVTAQAFLEETAVMTKLHHKNLVRLLGVILHNGLYIVMELMSKGNLV 86
Query: 679 ----------------------ISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISD 716
++ +EYL S ++H DL N+L+ ED VA +SD
Sbjct: 87 NFLRTRGRALVSVIQLLQFSLDVAEGMEYLE---SKKLVHRDLAARNILVSEDGVAKVSD 143
Query: 717 FGIAKLLS-GEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGII 764
FG+A++ S G D + + + APE + S++ DV S+G++
Sbjct: 144 FGLARVGSMGVD------NSKLPVKWTAPEALKHKKFSSKSDVWSYGVL 186
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 54.9 bits (133), Expect = 4e-08
Identities = 25/87 (28%), Positives = 41/87 (47%), Gaps = 6/87 (6%)
Query: 679 ISSSLEYLHFGH--SIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQT- 735
+ +L H ++H DLKP+N+ LD + + DFG+AK+L + +T
Sbjct: 114 LLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSF---AKTY 170
Query: 736 LATIGYMAPEYGTKGRVSTRGDVCSFG 762
+ T YM+PE + D+ S G
Sbjct: 171 VGTPYYMSPEQLNHMSYDEKSDIWSLG 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 55.7 bits (135), Expect = 4e-08
Identities = 29/67 (43%), Positives = 42/67 (62%), Gaps = 6/67 (8%)
Query: 682 SLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLS-GEDQLSKQTQT--LAT 738
+L+Y+H G+ +IH DLKPSN+LL+ D ++DFG+A+ LS E+ T +AT
Sbjct: 119 ALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVAT 175
Query: 739 IGYMAPE 745
Y APE
Sbjct: 176 RWYRAPE 182
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 5e-08
Identities = 44/168 (26%), Positives = 65/168 (38%), Gaps = 53/168 (31%)
Query: 643 EVAVKVFHQQYERALKS-FEDECEVRKRIRHRNLVKII---------------------- 679
EVAVK Q++ A K F E V ++ H +V++I
Sbjct: 25 EVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKGEPLMLVMELAPLGPLLK 84
Query: 680 --------------------SSSLEYL---HFGHSIPIIHCDLKPSNVLLDEDMVAHISD 716
+ + YL HF +H DL NVLL A ISD
Sbjct: 85 YLKKRREIPVSDLKELAHQVAMGMAYLESKHF------VHRDLAARNVLLVNRHQAKISD 138
Query: 717 FGIAKLL-SGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGI 763
FG+++ L +G D T + + APE G+ S++ DV S+G+
Sbjct: 139 FGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGV 186
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 5e-08
Identities = 32/88 (36%), Positives = 47/88 (53%), Gaps = 5/88 (5%)
Query: 678 IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLA 737
II L L + H + +IH D+K +N+L+ + DFG+A LL+ Q S + T
Sbjct: 106 IIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLN---QNSSKRSTFV 162
Query: 738 TIGY-MAPEYGTKGRV-STRGDVCSFGI 763
Y MAPE T+G+ T+ D+ S GI
Sbjct: 163 GTPYWMAPEVITEGKYYDTKADIWSLGI 190
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 6e-08
Identities = 25/78 (32%), Positives = 49/78 (62%), Gaps = 1/78 (1%)
Query: 196 IPREIGNLPYLARLALATNNLVGVVPVTIFNMSALKEISLLNNSLSGSLPSRIDLSLPNV 255
IP +I L +L + L+ N++ G +P ++ ++++L+ + L NS +GS+P + L ++
Sbjct: 434 IPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQ-LTSL 492
Query: 256 ETLNLGINSFSGTIPSSI 273
LNL NS SG +P+++
Sbjct: 493 RILNLNGNSLSGRVPAAL 510
|
Length = 623 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.6 bits (132), Expect = 6e-08
Identities = 49/172 (28%), Positives = 77/172 (44%), Gaps = 34/172 (19%)
Query: 606 NDGINSPQAIRRFSYHELLRATDRFSENNLIGIGNGMEVAVKVFHQQYERALKSFE---- 661
++GI A+R ++ + N+I + + VF + + L FE
Sbjct: 38 SEGIPK-TALRE------IKLLKELNHPNIIKLLD-------VFRHKGDLYL-VFEFMDT 82
Query: 662 DECEVRKRIRHRNLV---KIISS----SLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHI 714
D ++ I+ R +I S L+ L F HS I+H DLKP N+L++ + V +
Sbjct: 83 DLYKL---IKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKL 139
Query: 715 SDFGIAKLLSGEDQLSKQTQTLATIGYMAPE--YGTKGRVSTRGDVCSFGII 764
+DFG+A+ + T + T Y APE G KG ST D+ S G I
Sbjct: 140 ADFGLARSFGSPVRP--YTHYVVTRWYRAPELLLGDKG-YSTPVDIWSVGCI 188
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 6e-08
Identities = 44/169 (26%), Positives = 70/169 (41%), Gaps = 41/169 (24%)
Query: 636 IGIGNGMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVKIISSSL---------EYL 686
I + G EVA+K + Q + + +E V + +H N+V + S L EYL
Sbjct: 39 IDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98
Query: 687 ------------------------------HFGHSIPIIHCDLKPSNVLLDEDMVAHISD 716
F HS +IH D+K N+LL D ++D
Sbjct: 99 AGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTD 158
Query: 717 FGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIIS 765
FG ++ E SK++ + T +MAPE T+ + D+ S GI++
Sbjct: 159 FGFCAQITPEQ--SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMA 205
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 7e-08
Identities = 69/284 (24%), Positives = 103/284 (36%), Gaps = 96/284 (33%)
Query: 548 PDLQVSPCKPNKPNTHKKSRKMLLLVIVLPLSTALIVVVTLTLKWKLIKCWKSRTGPSND 607
P V + T + R+ L + LP +L + L S + S+
Sbjct: 6 PPPGVPLPSTARHTTKSRPRRRPDLTLPLPQRD-----PSLAVPLPLPPPSSSSSSSSSS 60
Query: 608 GINSPQAIRRFSYHELLRATDRFSENNLIGIGNGMEVAVKVFHQQYER--ALK----SFE 661
+ S EL R N IG G G V KV H+ R ALK + E
Sbjct: 61 SASGSAPSAAKSLSELERV-------NRIGSGAGGTV-YKVIHRPTGRLYALKVIYGNHE 112
Query: 662 D--------ECEVRKRIRHRNLVKI----------------------------------- 678
D E E+ + + H N+VK
Sbjct: 113 DTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLAD 172
Query: 679 ----ISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQT- 733
I S + YLH H I+H D+KPSN+L++ I+DFG++++L+ QT
Sbjct: 173 VARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILA-------QTM 222
Query: 734 ----QTLATIGYMAPEYGTKGRVST----------RGDVCSFGI 763
++ TI YM+PE R++T GD+ S G+
Sbjct: 223 DPCNSSVGTIAYMSPE-----RINTDLNHGAYDGYAGDIWSLGV 261
|
Length = 353 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 7e-08
Identities = 26/69 (37%), Positives = 39/69 (56%), Gaps = 2/69 (2%)
Query: 677 KIISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTL 736
KII +L+ ++F H IH D+KP N+L+ + + DFG A++L+G T +
Sbjct: 104 KIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPG--DDYTDYV 161
Query: 737 ATIGYMAPE 745
AT Y APE
Sbjct: 162 ATRWYRAPE 170
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 54.8 bits (133), Expect = 7e-08
Identities = 23/61 (37%), Positives = 36/61 (59%), Gaps = 1/61 (1%)
Query: 686 LHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQ-TQTLATIGYMAP 744
L + HS +IH DLKPSN+L++ + I DFG+A+ + ++ T+ + T Y AP
Sbjct: 116 LKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAP 175
Query: 745 E 745
E
Sbjct: 176 E 176
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 8e-08
Identities = 41/169 (24%), Positives = 68/169 (40%), Gaps = 50/169 (29%)
Query: 641 GMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVKI---------------------- 678
+ VAVK + ++ F E V K I+H NLV++
Sbjct: 31 SLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNL 89
Query: 679 -----------------------ISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHIS 715
ISS++EYL + IH DL N L+ E+ + ++
Sbjct: 90 LDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVA 146
Query: 716 DFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGII 764
DFG+++L++G D + I + APE + S + DV +FG++
Sbjct: 147 DFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVL 194
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 54.2 bits (131), Expect = 8e-08
Identities = 28/79 (35%), Positives = 43/79 (54%), Gaps = 9/79 (11%)
Query: 673 RNLVKIISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQL--- 729
R + I +LEYLH S IIH DLKP N+L+D + ++DFG++K+ Q+
Sbjct: 96 RIYIAEIVLALEYLH---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLN 152
Query: 730 ---SKQTQTLATIGYMAPE 745
+ + + T Y+APE
Sbjct: 153 DDEKEDKRIVGTPDYIAPE 171
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 54.1 bits (131), Expect = 1e-07
Identities = 45/155 (29%), Positives = 62/155 (40%), Gaps = 56/155 (36%)
Query: 638 IGNGMEVAVKVFHQQYERALKSFE---DECEVRKRIRHRNLVKIISS------------- 681
G+G A+K+ + LK E +E + + IRH LV + S
Sbjct: 23 KGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEY 82
Query: 682 ------------------------------SLEYLHFGHSIPIIHCDLKPSNVLLDEDMV 711
+LEYLH S+ I++ DLKP N+LLD D
Sbjct: 83 VPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLH---SLDIVYRDLKPENLLLDSDGY 139
Query: 712 AHISDFGIAKLLSGEDQLSKQTQTL-ATIGYMAPE 745
I+DFG AK + G +T TL T Y+APE
Sbjct: 140 IKITDFGFAKRVKG------RTYTLCGTPEYLAPE 168
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 1e-07
Identities = 44/173 (25%), Positives = 70/173 (40%), Gaps = 56/173 (32%)
Query: 640 NGMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVKIISSS----------------- 682
+ +A+K ++ R ++ +E + ++HRN+V+ + S
Sbjct: 32 TQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGS 91
Query: 683 --------------------------LEYLHFGHSIPIIHCDLKPSNVLLDE-DMVAHIS 715
LE L + H I+H D+K NVL++ V IS
Sbjct: 92 LSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKIS 151
Query: 716 DFGIAKLLSGEDQLSKQTQTL-ATIGYMAPEYGTKGRVSTRG-----DVCSFG 762
DFG +K L+G ++ T+T T+ YMAPE KG RG D+ S G
Sbjct: 152 DFGTSKRLAG---INPCTETFTGTLQYMAPEVIDKG---PRGYGAPADIWSLG 198
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 1e-07
Identities = 32/74 (43%), Positives = 44/74 (59%), Gaps = 11/74 (14%)
Query: 679 ISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTL-A 737
I +LEYLH S I++ DLKP N+LLD++ ++DFG AK +L +T TL
Sbjct: 110 IVCALEYLH---SKEIVYRDLKPENILLDKEGHIKLTDFGFAK------KLRDRTWTLCG 160
Query: 738 TIGYMAPE-YGTKG 750
T Y+APE +KG
Sbjct: 161 TPEYLAPEVIQSKG 174
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 53.8 bits (130), Expect = 2e-07
Identities = 27/63 (42%), Positives = 36/63 (57%), Gaps = 8/63 (12%)
Query: 683 LEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYM 742
L+Y+H S IIH DLKPSN+ ++ED I DFG+A+ + T +AT Y
Sbjct: 131 LKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLARHTD-----DEMTGYVATRWYR 182
Query: 743 APE 745
APE
Sbjct: 183 APE 185
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 2e-07
Identities = 44/108 (40%), Positives = 55/108 (50%), Gaps = 22/108 (20%)
Query: 640 NGMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVKIISSSLEYLHFGHSIPIIHCDL 699
NG E+ FH Q ER SF E R R I+S+L YLH S+ II+ DL
Sbjct: 79 NGGEL---FFHLQRER---SFP---EPRARFYAAE----IASALGYLH---SLNIIYRDL 122
Query: 700 KPSNVLLDEDMVAHISDFGIAKLLSGED-QLSKQTQTL-ATIGYMAPE 745
KP N+LLD ++DFG+ K E + SK T T T Y+APE
Sbjct: 123 KPENILLDSQGHVVLTDFGLCK----EGIEHSKTTSTFCGTPEYLAPE 166
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.3 bits (129), Expect = 2e-07
Identities = 25/74 (33%), Positives = 40/74 (54%), Gaps = 8/74 (10%)
Query: 683 LEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYM 742
LE L + HS I+H D+K SN+L++ D V ++DFG+A+ + + T + T+ Y
Sbjct: 110 LEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKR-NSADYTNRVITLWYR 168
Query: 743 APE-------YGTK 749
PE YG +
Sbjct: 169 PPELLLGATRYGPE 182
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 2e-07
Identities = 33/95 (34%), Positives = 49/95 (51%), Gaps = 9/95 (9%)
Query: 679 ISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLAT 738
+ ++EYL S IH DL N L+ ED V +SDFG+A+ + +DQ + T
Sbjct: 109 VCEAMEYLE---SNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVL-DDQYTSSQGTKFP 164
Query: 739 IGYMAPEYGTKGRVSTRGDVCSFGII-----SGGK 768
+ + PE R S++ DV SFG++ S GK
Sbjct: 165 VKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGK 199
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 3e-07
Identities = 28/76 (36%), Positives = 45/76 (59%), Gaps = 1/76 (1%)
Query: 342 LDGILPKSIGNFSLSLETILMANCSISGNIPQVVGNLSNLLVLELGGNNLTGPIPVTFSQ 401
L G +P I L++I ++ SI GNIP +G++++L VL+L N+ G IP + Q
Sbjct: 430 LRGFIPNDISKLR-HLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQ 488
Query: 402 LQTLQAFDLTRNKLAG 417
L +L+ +L N L+G
Sbjct: 489 LTSLRILNLNGNSLSG 504
|
Length = 623 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 3e-07
Identities = 30/87 (34%), Positives = 50/87 (57%), Gaps = 3/87 (3%)
Query: 162 LGFNN--LSGAIPKEIGNLTKLKEIISTITNSTVCEIPREIGNLPYLARLALATNNLVGV 219
LG +N L G IP +I L L+ I + NS IP +G++ L L L+ N+ G
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSI-NLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGS 481
Query: 220 VPVTIFNMSALKEISLLNNSLSGSLPS 246
+P ++ +++L+ ++L NSLSG +P+
Sbjct: 482 IPESLGQLTSLRILNLNGNSLSGRVPA 508
|
Length = 623 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 3e-07
Identities = 37/114 (32%), Positives = 55/114 (48%), Gaps = 10/114 (8%)
Query: 654 ERALKSFEDECEV-RKRIRHRNLVKIISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVA 712
E L S D EV +K ++ + I +L+ L + HS IH D+K N+LL E
Sbjct: 95 EYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTV 154
Query: 713 HISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEY---GTKGRVSTRGDVCSFGI 763
++DFG A L+S + + T +MAPE +G+ + DV S GI
Sbjct: 155 KLADFGSASLVSPANSF------VGTPYWMAPEVILAMDEGQYDGKVDVWSLGI 202
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 3e-07
Identities = 44/168 (26%), Positives = 70/168 (41%), Gaps = 44/168 (26%)
Query: 641 GMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVKI--ISSS---------LEYLHFG 689
G VAVK L+ FE E E+ K ++H N+VK + S +EYL +G
Sbjct: 33 GEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYG 92
Query: 690 --------------------HSIPI------------IHCDLKPSNVLLDEDMVAHISDF 717
++ I +H DL N+L++ + I DF
Sbjct: 93 SLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDF 152
Query: 718 GIAKLLSGEDQLSKQTQT-LATIGYMAPEYGTKGRVSTRGDVCSFGII 764
G+ K+L + + K + + I + APE T+ + S DV SFG++
Sbjct: 153 GLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVV 200
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 3e-07
Identities = 33/68 (48%), Positives = 39/68 (57%), Gaps = 7/68 (10%)
Query: 679 ISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIA-KLLSGEDQLSKQTQTLA 737
I S LE+LH II+ DLKP NVLLD D ISD G+A +L G+ SK
Sbjct: 106 IISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQ---SKTKGYAG 159
Query: 738 TIGYMAPE 745
T G+MAPE
Sbjct: 160 TPGFMAPE 167
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 52.2 bits (126), Expect = 3e-07
Identities = 27/64 (42%), Positives = 35/64 (54%), Gaps = 8/64 (12%)
Query: 683 LEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTL-ATIGY 741
EYLH + II+ DLKP N+LLD + + DFG AK L ++T T T Y
Sbjct: 106 FEYLH---NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKS----GQKTWTFCGTPEY 158
Query: 742 MAPE 745
+APE
Sbjct: 159 VAPE 162
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 3e-07
Identities = 34/125 (27%), Positives = 57/125 (45%), Gaps = 9/125 (7%)
Query: 659 SFEDECEVRKRIRHRNLVKIISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFG 718
+F E + + L++ S + + IH DL NVL+ E++ + I+DFG
Sbjct: 105 AFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFG 164
Query: 719 IAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGII------SGGKETRS 772
+++ GE+ K+T + +MA E +T+ DV SFG++ GG
Sbjct: 165 LSR---GEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCG 221
Query: 773 MTVGE 777
MT E
Sbjct: 222 MTCAE 226
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 3e-07
Identities = 27/86 (31%), Positives = 47/86 (54%), Gaps = 4/86 (4%)
Query: 679 ISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLAT 738
+ + YL S +IH DL N L+ E+ V +SDFG+ + + +DQ + T T
Sbjct: 109 VCEGMAYLE---SSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVL-DDQYTSSTGTKFP 164
Query: 739 IGYMAPEYGTKGRVSTRGDVCSFGII 764
+ + +PE + + S++ DV SFG++
Sbjct: 165 VKWSSPEVFSFSKYSSKSDVWSFGVL 190
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.3 bits (126), Expect = 3e-07
Identities = 26/73 (35%), Positives = 43/73 (58%), Gaps = 6/73 (8%)
Query: 673 RNLVKIISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQ 732
++L++ + +++LH S I+H DLKP N+L+ D I+DFG+A++ S E
Sbjct: 110 KDLMRQLLRGVDFLH---SHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFE---MAL 163
Query: 733 TQTLATIGYMAPE 745
T + T+ Y APE
Sbjct: 164 TSVVVTLWYRAPE 176
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 4e-07
Identities = 25/79 (31%), Positives = 38/79 (48%), Gaps = 2/79 (2%)
Query: 686 LHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPE 745
L HS I+H D+K N+ LD I D G+AKLLS + + T Y++PE
Sbjct: 114 LAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFAN--TIVGTPYYLSPE 171
Query: 746 YGTKGRVSTRGDVCSFGII 764
+ + DV + G++
Sbjct: 172 LCEDKPYNEKSDVWALGVV 190
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 4e-07
Identities = 34/109 (31%), Positives = 54/109 (49%), Gaps = 6/109 (5%)
Query: 659 SFEDECEVRKRIRHRNLVKI---ISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHIS 715
S +D + + ++LV ++ +E+L S IH DL NVL+ ED V I+
Sbjct: 118 SPDDPRPPEETLTQKDLVSFAYQVARGMEFLA---SKKCIHRDLAARNVLVTEDHVMKIA 174
Query: 716 DFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGII 764
DFG+A+ + D K T + +MAPE + + DV SFG++
Sbjct: 175 DFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVL 223
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 4e-07
Identities = 32/87 (36%), Positives = 46/87 (52%), Gaps = 11/87 (12%)
Query: 683 LEYLHFGHSIPIIHCDLKPSNVLLDE-----DMVAHISDFGIAKLLSGEDQLSKQTQTLA 737
LE +HF IH DL N L+ E D V I DFG+A+ + D K+ + L
Sbjct: 122 LEQMHF------IHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLL 175
Query: 738 TIGYMAPEYGTKGRVSTRGDVCSFGII 764
+ +MAPE G+ +T+ DV SFG++
Sbjct: 176 PVRWMAPESLLDGKFTTQSDVWSFGVL 202
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 5e-07
Identities = 35/101 (34%), Positives = 54/101 (53%), Gaps = 10/101 (9%)
Query: 669 RIRHRNLVKII---SSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSG 725
R++ + L++++ ++ +EYL H I H DL N L+ E V ISDFG+++
Sbjct: 90 RLKVKELIQMVENAAAGMEYLESKHCI---HRDLAARNCLVTEKNVLKISDFGMSR--EE 144
Query: 726 EDQLSKQTQTLATI--GYMAPEYGTKGRVSTRGDVCSFGII 764
ED + T + I + APE GR S+ DV SFGI+
Sbjct: 145 EDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGIL 185
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 5e-07
Identities = 39/158 (24%), Positives = 64/158 (40%), Gaps = 46/158 (29%)
Query: 650 HQQYERALKSFEDECEVRKRIRHRNLVKIISSSLE------------------------- 684
Q + + ++EC+V K + H N+++ + LE
Sbjct: 36 EQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCN 95
Query: 685 -----------------YLHFGHSIPIIHCDLKPSNVLLDE-DMVAHISDFGIAKLLSGE 726
LH H+ I+H DLK N+LLD+ MV I DFGI+K+LS +
Sbjct: 96 SLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK 155
Query: 727 DQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGII 764
SK + T Y++PE + + D+ + G +
Sbjct: 156 ---SKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCV 190
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 5e-07
Identities = 54/171 (31%), Positives = 81/171 (47%), Gaps = 22/171 (12%)
Query: 642 MEVAVKVFHQQYERALK------SFEDECEV-RKRIRHRNLVKI---ISSSLEYLHFGHS 691
+E A K ++Y RA + SF D C++ +++ ++LV ++ +EYL S
Sbjct: 97 VEYASKGNLREYLRARRPPGMDYSF-DTCKLPEEQLTFKDLVSCAYQVARGMEYLA---S 152
Query: 692 IPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGR 751
IH DL NVL+ ED V I+DFG+A+ + D K T + +MAPE R
Sbjct: 153 QKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPE-ALFDR 211
Query: 752 VST-RGDVCSFGII------SGGKETRSMTVGETCTPVRESKYEVHPATTT 795
V T + DV SFG++ GG + V E ++E PA T
Sbjct: 212 VYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCT 262
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 5e-07
Identities = 29/91 (31%), Positives = 48/91 (52%), Gaps = 2/91 (2%)
Query: 675 LVKIISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQ 734
+ + L+ L F HS +IH D+K N+LL D ++DFG ++ E SK++
Sbjct: 118 IAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--SKRST 175
Query: 735 TLATIGYMAPEYGTKGRVSTRGDVCSFGIIS 765
+ T +MAPE T+ + D+ S GI++
Sbjct: 176 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMA 206
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 5e-07
Identities = 34/156 (21%), Positives = 72/156 (46%), Gaps = 2/156 (1%)
Query: 609 INSPQAIRRFSYHELLRATDRFSENNLIGIGNGMEVAVKVFHQQYERALKSFEDECEVRK 668
+N ++ F+ H ++R S+ + ME+ + + Y R+L+ + V+
Sbjct: 57 LNEASVMKEFNCHHVVRLLGVVSQGQPTLVI--MELMTRGDLKSYLRSLRPEMENNPVQA 114
Query: 669 RIRHRNLVKIISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQ 728
+ ++++ + + + ++ +H DL N ++ ED I DFG+ + + D
Sbjct: 115 PPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY 174
Query: 729 LSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGII 764
K + L + +M+PE G +T DV SFG++
Sbjct: 175 YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVV 210
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 6e-07
Identities = 37/97 (38%), Positives = 48/97 (49%), Gaps = 17/97 (17%)
Query: 674 NLVKIISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQT 733
N+ + +L YLH I+H DL P+N++L ED I+DFG+AK E SK T
Sbjct: 117 NIFVQMVLALRYLH--KEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPE---SKLT 171
Query: 734 QTLATIGYMAPE------YGTKGRVSTRGDVCSFGII 764
+ TI Y PE YG K DV +FG I
Sbjct: 172 SVVGTILYSCPEIVKNEPYGEK------ADVWAFGCI 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 7e-07
Identities = 28/86 (32%), Positives = 47/86 (54%), Gaps = 3/86 (3%)
Query: 679 ISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLAT 738
IS ++YL + ++H DL NVL+ E ISDFG+++ + ED K+++
Sbjct: 136 ISRGMQYLA---EMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIP 192
Query: 739 IGYMAPEYGTKGRVSTRGDVCSFGII 764
+ +MA E +T+ DV SFG++
Sbjct: 193 VKWMAIESLFDHIYTTQSDVWSFGVL 218
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 51.2 bits (123), Expect = 7e-07
Identities = 26/86 (30%), Positives = 35/86 (40%), Gaps = 4/86 (4%)
Query: 679 ISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAK-LLSGEDQLSKQTQTLA 737
I++ + YL IH DL N+LL D I DFG+ + L ED +
Sbjct: 106 IANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV 162
Query: 738 TIGYMAPEYGTKGRVSTRGDVCSFGI 763
+ APE S DV FG+
Sbjct: 163 PFAWCAPESLRTRTFSHASDVWMFGV 188
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|219766 pfam08263, LRRNT_2, Leucine rich repeat N-terminal domain | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 7e-07
Identities = 15/38 (39%), Positives = 23/38 (60%), Gaps = 2/38 (5%)
Query: 12 QALLALKAHISYDHTNLFARNWTSSTSV-CIWIGITCD 48
ALLA K+ ++ D + + +W S+S C W G+TCD
Sbjct: 6 DALLAFKSSLNGDPSGALS-SWNPSSSDPCSWTGVTCD 42
|
Leucine Rich Repeats pfam00560 are short sequence motifs present in a number of proteins with diverse functions and cellular locations. Leucine Rich Repeats are often flanked by cysteine rich domains. This domain is often found at the N-terminus of tandem leucine rich repeats. Length = 42 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 8e-07
Identities = 29/97 (29%), Positives = 48/97 (49%), Gaps = 5/97 (5%)
Query: 255 VETLNLGINSFSGTIPSSITNSSKLSDLELGENLFSGFIPNTIGNLRNLEFGNIADNYLT 314
++ L L G IP+ I+ L + L N G IP ++G++ +LE +++ N
Sbjct: 420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFN 479
Query: 315 SSTPELSFLSSLTNCKKLKVLIVTGNPLDGILPKSIG 351
S PE SL L++L + GN L G +P ++G
Sbjct: 480 GSIPE-----SLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 8e-07
Identities = 27/60 (45%), Positives = 35/60 (58%), Gaps = 4/60 (6%)
Query: 686 LHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPE 745
LH HS+ I++ D+KP NVLLD+ +SD G+A L + TQ T GYMAPE
Sbjct: 109 LHL-HSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTI---TQRAGTNGYMAPE 164
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 8e-07
Identities = 32/98 (32%), Positives = 50/98 (51%), Gaps = 13/98 (13%)
Query: 673 RNLVKIISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAK----LLSGEDQ 728
R + + L YLH S I+H DLK N+L+D D + ISDFGI+K + +
Sbjct: 111 RFFTEQVLEGLAYLH---SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQN 167
Query: 729 LSKQTQTLATIGYMAPEY-GTKGR-VSTRGDVCSFGII 764
+S Q ++ +MAPE + + S + D+ S G +
Sbjct: 168 MSMQ----GSVFWMAPEVIHSYSQGYSAKVDIWSLGCV 201
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 51.2 bits (123), Expect = 9e-07
Identities = 36/106 (33%), Positives = 52/106 (49%), Gaps = 17/106 (16%)
Query: 667 RKRIRHRNLVKIISSSLEYL-HFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSG 725
+ I L KI ++++ L + + IIH D+KPSN+LLD + + DFGI+ L
Sbjct: 101 KSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQL-- 158
Query: 726 EDQLSKQTQTLATIGYMAPEYGTKGRVST--------RGDVCSFGI 763
D ++K T+ YMAPE R+ R DV S GI
Sbjct: 159 VDSIAK-TRDAGCRPYMAPE-----RIDPSARDGYDVRSDVWSLGI 198
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 9e-07
Identities = 32/90 (35%), Positives = 47/90 (52%), Gaps = 9/90 (10%)
Query: 677 KIISSSLE---YLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQT 733
KI + +E YL+ H I +H D+KPSN+L++ + DFG+ SGE S
Sbjct: 107 KIAVAVVEGLTYLYNVHRI--MHRDIKPSNILVNSRGQIKLCDFGV----SGELINSIAD 160
Query: 734 QTLATIGYMAPEYGTKGRVSTRGDVCSFGI 763
+ T YM+PE G+ + + DV S GI
Sbjct: 161 TFVGTSTYMSPERIQGGKYTVKSDVWSLGI 190
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 50.5 bits (120), Expect = 1e-06
Identities = 31/125 (24%), Positives = 54/125 (43%), Gaps = 9/125 (7%)
Query: 659 SFEDECEVRKRIRHRNLVKIISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFG 718
+F + + L+ + + + IH DL N+L+ E+ VA I+DFG
Sbjct: 98 AFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFG 157
Query: 719 IAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGII------SGGKETRS 772
+++ G++ K+T + +MA E +T DV S+G++ GG
Sbjct: 158 LSR---GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG 214
Query: 773 MTVGE 777
MT E
Sbjct: 215 MTCAE 219
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 1e-06
Identities = 31/96 (32%), Positives = 48/96 (50%), Gaps = 12/96 (12%)
Query: 675 LVKI---ISSSLEYL---HFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQ 728
L++I I+S + YL HF +H DL N L+ D+V I DFG+++ + D
Sbjct: 124 LLQIAVQIASGMVYLASQHF------VHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDY 177
Query: 729 LSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGII 764
T+ I +M PE + +T DV SFG++
Sbjct: 178 YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVV 213
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 1e-06
Identities = 36/109 (33%), Positives = 50/109 (45%), Gaps = 18/109 (16%)
Query: 674 NLVKIISSS--LEYLHFG-------------HSIPIIHCDLKPSNVLLDEDMVAHISDFG 718
+L +II S L HF HS ++H DLKP N+L++ D I DFG
Sbjct: 91 DLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFG 150
Query: 719 IAKLLSG--EDQLSKQTQTLATIGYMAPEYGTKGRVSTRG-DVCSFGII 764
+A+ S + T+ +AT Y APE + T+ DV S G I
Sbjct: 151 LARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCI 199
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 1e-06
Identities = 29/84 (34%), Positives = 45/84 (53%), Gaps = 5/84 (5%)
Query: 679 ISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLAT 738
I+ +L+YLH H I+H DLK NV L + + D GIA++L E+Q + + T
Sbjct: 111 IAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVL--ENQCDMASTLIGT 165
Query: 739 IGYMAPEYGTKGRVSTRGDVCSFG 762
YM+PE + + + DV + G
Sbjct: 166 PYYMSPELFSNKPYNYKSDVWALG 189
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 1e-06
Identities = 34/87 (39%), Positives = 47/87 (54%), Gaps = 5/87 (5%)
Query: 679 ISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLAT 738
++ +EYL S IH DL NVL+ ED V I+DFG+A+ + D K +
Sbjct: 143 VARGMEYLE---SRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLP 199
Query: 739 IGYMAPEYGTKGRVST-RGDVCSFGII 764
+ +MAPE RV T + DV SFGI+
Sbjct: 200 VKWMAPE-ALFDRVYTHQSDVWSFGIL 225
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 1e-06
Identities = 41/124 (33%), Positives = 59/124 (47%), Gaps = 11/124 (8%)
Query: 679 ISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLAT 738
++ +EYL S IH DL NVL+ E+ V I+DFG+A+ ++ D K T
Sbjct: 146 VARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLP 202
Query: 739 IGYMAPEYGTKGRVST-RGDVCSFGIIS------GGKETRSMTVGETCTPVRESKYEVHP 791
+ +MAPE RV T + DV SFG++ GG + V E ++E P
Sbjct: 203 VKWMAPE-ALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKP 261
Query: 792 ATTT 795
A T
Sbjct: 262 ANCT 265
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 2e-06
Identities = 33/96 (34%), Positives = 50/96 (52%), Gaps = 11/96 (11%)
Query: 673 RNLVKIISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAK-----LLSGED 727
RN V+ I L YLH + IIH D+K +N+L+D ISDFGI+K LS
Sbjct: 109 RNFVRQILKGLNYLH---NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLST-- 163
Query: 728 QLSKQTQTL-ATIGYMAPEYGTKGRVSTRGDVCSFG 762
+ + +L ++ +MAPE + + + D+ S G
Sbjct: 164 KTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLG 199
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 50.5 bits (120), Expect = 2e-06
Identities = 29/91 (31%), Positives = 48/91 (52%), Gaps = 2/91 (2%)
Query: 675 LVKIISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQ 734
+ + L+ L F HS +IH D+K N+LL D ++DFG ++ E SK++
Sbjct: 117 IAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--SKRST 174
Query: 735 TLATIGYMAPEYGTKGRVSTRGDVCSFGIIS 765
+ T +MAPE T+ + D+ S GI++
Sbjct: 175 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMA 205
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-06
Identities = 39/132 (29%), Positives = 63/132 (47%), Gaps = 12/132 (9%)
Query: 642 MEVAVKVFHQQYERALK------SFEDECEVRKRIRHRNLVKI---ISSSLEYLHFGHSI 692
+E A K ++Y RA + + +++ ++LV ++ +EYL S
Sbjct: 103 VEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLA---SK 159
Query: 693 PIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRV 752
IH DL NVL+ ED V I+DFG+A+ + D K T + +MAPE
Sbjct: 160 KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIY 219
Query: 753 STRGDVCSFGII 764
+ + DV SFG++
Sbjct: 220 THQSDVWSFGVL 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 2e-06
Identities = 28/65 (43%), Positives = 37/65 (56%), Gaps = 10/65 (15%)
Query: 682 SLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTL-ATIG 740
+ EYLH S II+ DLKP N+LLD ++DFG AK ++ +T TL T
Sbjct: 130 AFEYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAK------KVPDRTFTLCGTPE 180
Query: 741 YMAPE 745
Y+APE
Sbjct: 181 YLAPE 185
|
Length = 329 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 2e-06
Identities = 30/68 (44%), Positives = 38/68 (55%), Gaps = 7/68 (10%)
Query: 679 ISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTL-A 737
IS +LE+LH II+ DLKP N+LLD ++DFG+ K E + T T
Sbjct: 109 ISLALEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTV---THTFCG 162
Query: 738 TIGYMAPE 745
TI YMAPE
Sbjct: 163 TIEYMAPE 170
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 2e-06
Identities = 37/120 (30%), Positives = 57/120 (47%), Gaps = 13/120 (10%)
Query: 668 KRIRHRN---LVKIISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLS 724
K + +N LV +S ++YL + +H DL NVLL A ISDFG++K L
Sbjct: 90 KHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALG 146
Query: 725 GEDQLSK-QTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIIS------GGKETRSMTVGE 777
++ K +T + + APE + S++ DV SFG++ G K + M E
Sbjct: 147 ADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNE 206
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 2e-06
Identities = 38/168 (22%), Positives = 64/168 (38%), Gaps = 41/168 (24%)
Query: 637 GIGNGMEVAVKVFHQQYER-ALKSFEDECEVRKRIRHRNLVKIIS--------------- 680
G + VA+KV ++ A K DE V + H ++V+++
Sbjct: 32 GEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLSSQVQLITQLMP 91
Query: 681 --SSLEY-------------LHFGHSIP----------IIHCDLKPSNVLLDEDMVAHIS 715
L+Y L++ I ++H DL NVL+ I+
Sbjct: 92 LGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKIT 151
Query: 716 DFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGI 763
DFG+AKLL +++ I +MA E + + DV S+G+
Sbjct: 152 DFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGV 199
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 2e-06
Identities = 32/91 (35%), Positives = 49/91 (53%), Gaps = 5/91 (5%)
Query: 675 LVKIISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQ 734
++K I L+YLH S IH D+K +NVLL E ++DFG+A L+ D K+
Sbjct: 106 MLKEILKGLDYLH---SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLT--DTQIKRNT 160
Query: 735 TLATIGYMAPEYGTKGRVSTRGDVCSFGIIS 765
+ T +MAPE + ++ D+ S GI +
Sbjct: 161 FVGTPFWMAPEVIQQSAYDSKADIWSLGITA 191
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 2e-06
Identities = 31/83 (37%), Positives = 44/83 (53%), Gaps = 5/83 (6%)
Query: 683 LEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYM 742
L+YLH I+H D+KP N+L++ + V I DFG+A+ + D+ TQ + T Y
Sbjct: 116 LKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLAR-VEEPDESKHMTQEVVTQYYR 171
Query: 743 APEYGTKGRVSTRG-DVCSFGII 764
APE R T D+ S G I
Sbjct: 172 APEILMGSRHYTSAVDIWSVGCI 194
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 2e-06
Identities = 24/70 (34%), Positives = 43/70 (61%), Gaps = 1/70 (1%)
Query: 695 IHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVST 754
IH DL+ +NVL+ E ++ I+DFG+A+++ +++ + + I + APE G +
Sbjct: 125 IHRDLRAANVLVSESLMCKIADFGLARVIE-DNEYTAREGAKFPIKWTAPEAINFGSFTI 183
Query: 755 RGDVCSFGII 764
+ DV SFGI+
Sbjct: 184 KSDVWSFGIL 193
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 2e-06
Identities = 22/71 (30%), Positives = 42/71 (59%), Gaps = 2/71 (2%)
Query: 677 KIISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAK--LLSGEDQLSKQTQ 734
K++ L L++ H I+H D+K +N+L+ +D + ++DFG+A+ LS + ++ T
Sbjct: 123 KVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTN 182
Query: 735 TLATIGYMAPE 745
+ T+ Y PE
Sbjct: 183 RVVTLWYRPPE 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.6 bits (119), Expect = 2e-06
Identities = 28/84 (33%), Positives = 44/84 (52%), Gaps = 8/84 (9%)
Query: 683 LEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYM 742
L YLH IH D+K +N+LL ED ++DFG++ L+ ++K+ + T +M
Sbjct: 114 LAYLH---ETGKIHRDIKGANILLTEDGDVKLADFGVSAQLT--ATIAKRKSFIGTPYWM 168
Query: 743 APEYG---TKGRVSTRGDVCSFGI 763
APE KG + D+ + GI
Sbjct: 169 APEVAAVERKGGYDGKCDIWALGI 192
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 2e-06
Identities = 26/86 (30%), Positives = 45/86 (52%), Gaps = 3/86 (3%)
Query: 679 ISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLAT 738
I+S + YL S+ +H DL N L+ + +V I DFG+++ + D +T+
Sbjct: 131 IASGMVYLA---SLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLP 187
Query: 739 IGYMAPEYGTKGRVSTRGDVCSFGII 764
I +M PE + +T D+ SFG++
Sbjct: 188 IRWMPPESILYRKFTTESDIWSFGVV 213
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 3e-06
Identities = 82/301 (27%), Positives = 139/301 (46%), Gaps = 18/301 (5%)
Query: 171 IPKEIGNLTKLKEIISTITNSTVCEIPREI---GNLPYLARLALATNNLVGVVPVTIFNM 227
+ K + L+E++S+ T T + NL +A LA N + + ++
Sbjct: 7 LLKSALSSNTLREVLSSNTYHTTPQSINLNFPDSNLESVAVNRLALNLSSNTLLLLPSSL 66
Query: 228 SALKEISLLNNSLSGSLP-SRIDLSLPNVETLNLGINSFSGTIPSSITNSSKLSDLELGE 286
S L + LL+ S SL S L+L + +L+L +N I S + + L+ L+L
Sbjct: 67 SRLLSLDLLSPSGISSLDGSENLLNLLPLPSLDLNLNRLRSNI-SELLELTNLTSLDLDN 125
Query: 287 NLFSGFIPNTIGNLRNLEFGNIADNYLTSSTPELSFLSSLTNCKKLKVLIVTGNPLDGIL 346
N + P NL+ +++DN + S S L N LK L ++ N L L
Sbjct: 126 NNITDIPPLIGLLKSNLKELDLSDNKIES------LPSPLRNLPNLKNLDLSFNDLS-DL 178
Query: 347 PKSIGNFSLSLETILMANCSISGNIPQVVGNLSNLLVLELGGNNLTGPIPVTFSQLQTLQ 406
PK + N +L + ++ IS ++P + LS L L+L N++ + + S L+ L
Sbjct: 179 PKLLSN-LSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLS 235
Query: 407 AFDLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSVRVLYLGLNIFTSV 466
+L+ NKL + +L+ L +L L N+ S S LG+LT++R L L N ++
Sbjct: 236 GLELSNNKLEDLPES-IGNLSNLETLDLSNNQ--ISSISSLGSLTNLRELDLSGNSLSNA 292
Query: 467 L 467
L
Sbjct: 293 L 293
|
Length = 394 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 3e-06
Identities = 41/106 (38%), Positives = 52/106 (49%), Gaps = 18/106 (16%)
Query: 640 NGMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVKIISSSLEYLHFGHSIPIIHCDL 699
NG E+ FH Q ER SF + R R I+S+L YLH SI I++ DL
Sbjct: 79 NGGEL---FFHLQRER---SFPEP-------RARFYAAEIASALGYLH---SINIVYRDL 122
Query: 700 KPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPE 745
KP N+LLD ++DFG+ K G Q T T Y+APE
Sbjct: 123 KPENILLDSQGHVVLTDFGLCK--EGIAQSDTTTTFCGTPEYLAPE 166
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 3e-06
Identities = 24/70 (34%), Positives = 41/70 (58%), Gaps = 1/70 (1%)
Query: 695 IHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVST 754
IH DL+ +N+L+ E + I+DFG+A+L+ + +++ I + APE G +
Sbjct: 124 IHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFP-IKWTAPEAINYGTFTI 182
Query: 755 RGDVCSFGII 764
+ DV SFGI+
Sbjct: 183 KSDVWSFGIL 192
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.0 bits (120), Expect = 3e-06
Identities = 24/57 (42%), Positives = 34/57 (59%), Gaps = 1/57 (1%)
Query: 690 HSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKL-LSGEDQLSKQTQTLATIGYMAPE 745
HS ++H DLKPSN+LL+ + I DFG+A++ D T+ +AT Y APE
Sbjct: 123 HSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPE 179
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 3e-06
Identities = 26/87 (29%), Positives = 45/87 (51%), Gaps = 5/87 (5%)
Query: 695 IHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVST 754
IH DL+ +N+L+ +V I+DFG+A+++ + +++ I + APE G +
Sbjct: 124 IHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFP-IKWTAPEAINFGSFTI 182
Query: 755 RGDVCSFGIISGGKETRSMTVGETCTP 781
+ DV SFGI+ +T G P
Sbjct: 183 KSDVWSFGILL----MEIVTYGRIPYP 205
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 3e-06
Identities = 26/91 (28%), Positives = 48/91 (52%), Gaps = 3/91 (3%)
Query: 674 NLVKIISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQT 733
++V I++ +E+L H ++H DL NVL+ + + ISD G+ + + D
Sbjct: 128 HIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMG 184
Query: 734 QTLATIGYMAPEYGTKGRVSTRGDVCSFGII 764
+L I +M+PE G+ S D+ S+G++
Sbjct: 185 NSLLPIRWMSPEAIMYGKFSIDSDIWSYGVV 215
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 3e-06
Identities = 27/96 (28%), Positives = 49/96 (51%), Gaps = 2/96 (2%)
Query: 669 RIRHRNLVKIISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQ 728
R+ + + + L+ L F H+ +IH D+K ++LL D +SDFG +S +
Sbjct: 111 RMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVS--KE 168
Query: 729 LSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGII 764
+ ++ + T +MAPE ++ T D+ S GI+
Sbjct: 169 VPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIM 204
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 4e-06
Identities = 24/60 (40%), Positives = 37/60 (61%), Gaps = 5/60 (8%)
Query: 686 LHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPE 745
L + HS ++H DLKPSN+L++E+ I DFG+A++ Q + T ++T Y APE
Sbjct: 121 LKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARI-----QDPQMTGYVSTRYYRAPE 175
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 4e-06
Identities = 24/86 (27%), Positives = 46/86 (53%), Gaps = 5/86 (5%)
Query: 679 ISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLAT 738
I S++ Y+H I+H D+K N+ L + + + DFGI+K+L E +++ + T
Sbjct: 110 IVSAVSYIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAE--TVVGT 164
Query: 739 IGYMAPEYGTKGRVSTRGDVCSFGII 764
YM+PE + + + D+ + G +
Sbjct: 165 PYYMSPELCQGVKYNFKSDIWALGCV 190
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 5e-06
Identities = 33/106 (31%), Positives = 55/106 (51%), Gaps = 30/106 (28%)
Query: 291 GFIPNTIGNLRNLEFGNIADNYLTSSTPELSFLSSLTNCKKLKVLIVTGNPLDGILPKSI 350
GFIPN I LR+L+ N+ +GN + G +P S+
Sbjct: 432 GFIPNDISKLRHLQSINL-----------------------------SGNSIRGNIPPSL 462
Query: 351 GNFSLSLETILMANCSISGNIPQVVGNLSNLLVLELGGNNLTGPIP 396
G+ + SLE + ++ S +G+IP+ +G L++L +L L GN+L+G +P
Sbjct: 463 GSIT-SLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVP 507
|
Length = 623 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 5e-06
Identities = 29/92 (31%), Positives = 49/92 (53%), Gaps = 6/92 (6%)
Query: 673 RNLVKIISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQ 732
++L++ L++LH I+H DLKP N+L+ ++DFG+A++ S + L
Sbjct: 111 KDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQMAL--- 164
Query: 733 TQTLATIGYMAPEYGTKGRVSTRGDVCSFGII 764
T + T+ Y APE + +T D+ S G I
Sbjct: 165 TPVVVTLWYRAPEVLLQSTYATPVDMWSVGCI 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 5e-06
Identities = 29/67 (43%), Positives = 37/67 (55%), Gaps = 6/67 (8%)
Query: 679 ISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLAT 738
I LE LH I++ DLKP N+LLD+ ISD G+A + E Q K + T
Sbjct: 111 ICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVP-EGQTIK--GRVGT 164
Query: 739 IGYMAPE 745
+GYMAPE
Sbjct: 165 VGYMAPE 171
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 5e-06
Identities = 30/86 (34%), Positives = 42/86 (48%), Gaps = 4/86 (4%)
Query: 679 ISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLL-SGEDQLSKQTQTLA 737
I + YLH H IH DL NVLLD D + I DFG+AK + G + + +
Sbjct: 116 ICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDS 172
Query: 738 TIGYMAPEYGTKGRVSTRGDVCSFGI 763
+ + A E + + S DV SFG+
Sbjct: 173 PVFWYAVECLKENKFSYASDVWSFGV 198
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 5e-06
Identities = 33/93 (35%), Positives = 47/93 (50%), Gaps = 14/93 (15%)
Query: 683 LEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYM 742
L+Y+H S ++H DLKPSN+LL+ + I DFG+A+ S + T+ + T Y
Sbjct: 121 LKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDF--MTEYVVTRWYR 175
Query: 743 APE-------YGTKGRVSTRGDVCSFGIISGGK 768
APE Y T V + G C F + G K
Sbjct: 176 APELLLNCSEYTTAIDVWSVG--CIFAELLGRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 5e-06
Identities = 40/136 (29%), Positives = 63/136 (46%), Gaps = 13/136 (9%)
Query: 667 RKRIRHRNLVKI---ISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLL 723
+ I N+V++ +S ++YL + +H DL NVLL A ISDFG++K L
Sbjct: 89 KDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKAL 145
Query: 724 SGEDQLSK-QTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIIS------GGKETRSMTVG 776
+D K ++ + + APE + S+R DV S+GI G K + M
Sbjct: 146 GADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP 205
Query: 777 ETCTPVRESKYEVHPA 792
E + + + K PA
Sbjct: 206 EVMSFIEQGKRLDCPA 221
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 5e-06
Identities = 50/184 (27%), Positives = 69/184 (37%), Gaps = 55/184 (29%)
Query: 635 LIGIGN-----------GMEVAVKVFHQQYERALK-SFEDECEVRKRIRHRNLVKIIS-- 680
IG GN EVAVK LK F E E+ K+ H N+VK+I
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61
Query: 681 ----------------SSLEYLH-----------------------FGHSIPIIHCDLKP 701
S L +L + S IH DL
Sbjct: 62 VQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAA 121
Query: 702 SNVLLDEDMVAHISDFGIAKL-LSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCS 760
N L+ E+ V ISDFG+++ G +S + + I + APE GR ++ DV S
Sbjct: 122 RNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIP-IKWTAPEALNYGRYTSESDVWS 180
Query: 761 FGII 764
+GI+
Sbjct: 181 YGIL 184
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.8 bits (117), Expect = 5e-06
Identities = 28/86 (32%), Positives = 43/86 (50%), Gaps = 18/86 (20%)
Query: 672 HRNLVK-IISSSLEYLHFGHSIPIIHCDLKPSNVLL----DEDMVAHISDFGIA------ 720
++VK ++ L +H+ HS ++H DLKP+N+L+ E V I D G+A
Sbjct: 106 PPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAP 165
Query: 721 -KLLSGEDQLSKQTQTLATIGYMAPE 745
K L+ D + + TI Y APE
Sbjct: 166 LKPLADLDPV------VVTIWYRAPE 185
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 6e-06
Identities = 29/96 (30%), Positives = 49/96 (51%), Gaps = 2/96 (2%)
Query: 669 RIRHRNLVKIISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQ 728
R+ + + S L+ L + HS +IH D+K ++LL D +SDFG +S +
Sbjct: 113 RLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKD-- 170
Query: 729 LSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGII 764
+ K+ + T +MAPE ++ T D+ S GI+
Sbjct: 171 VPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIM 206
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 6e-06
Identities = 30/68 (44%), Positives = 40/68 (58%), Gaps = 5/68 (7%)
Query: 678 IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLA 737
+I L L + HS IIH DLKPSNV ++ED I DFG+A+ +D++ T +A
Sbjct: 123 LIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLAR--QADDEM---TGYVA 177
Query: 738 TIGYMAPE 745
T Y APE
Sbjct: 178 TRWYRAPE 185
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 6e-06
Identities = 30/91 (32%), Positives = 48/91 (52%), Gaps = 2/91 (2%)
Query: 675 LVKIISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQ 734
+ I+ L+ L + HS IH D+K +NVLL E ++DFG+A L+ D K+
Sbjct: 103 IATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLT--DTQIKRNT 160
Query: 735 TLATIGYMAPEYGTKGRVSTRGDVCSFGIIS 765
+ T +MAPE + ++ D+ S GI +
Sbjct: 161 FVGTPFWMAPEVIKQSAYDSKADIWSLGITA 191
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 7e-06
Identities = 28/68 (41%), Positives = 40/68 (58%), Gaps = 7/68 (10%)
Query: 683 LEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYM 742
LE++H + +++ DLKP+N+LLDE ISD G+A S + K ++ T GYM
Sbjct: 110 LEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK----KPHASVGTHGYM 162
Query: 743 APEYGTKG 750
APE KG
Sbjct: 163 APEVLQKG 170
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 48.2 bits (114), Expect = 7e-06
Identities = 29/91 (31%), Positives = 48/91 (52%), Gaps = 2/91 (2%)
Query: 675 LVKIISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQ 734
+ + L+ L F H+ +IH D+K NVLL D ++DFG ++ E SK++
Sbjct: 117 IAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQ--SKRST 174
Query: 735 TLATIGYMAPEYGTKGRVSTRGDVCSFGIIS 765
+ T +MAPE T+ + D+ S GI++
Sbjct: 175 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMA 205
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 8e-06
Identities = 32/91 (35%), Positives = 47/91 (51%), Gaps = 5/91 (5%)
Query: 683 LEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYM 742
L+ L F HS ++H DLKP N+L++ + ++DFG+A+ + T + T+ Y
Sbjct: 110 LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP--VRTYTHEVVTLWYR 167
Query: 743 APE--YGTKGRVSTRGDVCSFGIISGGKETR 771
APE G K ST D+ S G I TR
Sbjct: 168 APEILLGCK-YYSTAVDIWSLGCIFAEMVTR 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 8e-06
Identities = 25/76 (32%), Positives = 41/76 (53%), Gaps = 12/76 (15%)
Query: 673 RNLVKIISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQ 732
R + I LEYLH + +H D+K +N+L+D + V ++DFG+AK Q+ +
Sbjct: 105 RLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAK------QVVEF 155
Query: 733 TQTLATIG---YMAPE 745
+ + G +MAPE
Sbjct: 156 SFAKSFKGSPYWMAPE 171
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 9e-06
Identities = 28/75 (37%), Positives = 40/75 (53%), Gaps = 4/75 (5%)
Query: 690 HSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTK 749
H I+H DLK +N+LL + + I D GI+K+L ++K TQ T YMAPE
Sbjct: 120 HEQKILHRDLKSANILLVANDLVKIGDLGISKVLKK--NMAK-TQI-GTPHYMAPEVWKG 175
Query: 750 GRVSTRGDVCSFGII 764
S + D+ S G +
Sbjct: 176 RPYSYKSDIWSLGCL 190
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 9e-06
Identities = 23/65 (35%), Positives = 37/65 (56%), Gaps = 2/65 (3%)
Query: 683 LEYLHFGHSIPIIHCDLKPSNVLLD-EDMVAHISDFGIAKLLSGEDQLSKQ-TQTLATIG 740
L L + HS ++H DLKP+NV ++ ED+V I DFG+A+++ ++ L T
Sbjct: 124 LRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKW 183
Query: 741 YMAPE 745
Y +P
Sbjct: 184 YRSPR 188
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 1e-05
Identities = 24/70 (34%), Positives = 40/70 (57%)
Query: 694 IIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVS 753
++H +L N+LL D + I+DFG+A LL +D+ ++ I +MA E GR +
Sbjct: 130 MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYT 189
Query: 754 TRGDVCSFGI 763
+ DV S+G+
Sbjct: 190 HQSDVWSYGV 199
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 48.0 bits (115), Expect = 1e-05
Identities = 33/84 (39%), Positives = 45/84 (53%), Gaps = 8/84 (9%)
Query: 683 LEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYM 742
LEYLH S I+H DLKP+N+L+ D V ++DFG+A+ S K T + T Y
Sbjct: 115 LEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLAR--SFGSPNRKMTHQVVTRWYR 169
Query: 743 APE--YGTKGRVSTRGDVCSFGII 764
APE +G + D+ S G I
Sbjct: 170 APELLFGAR-HYGVGVDMWSVGCI 192
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 1e-05
Identities = 33/106 (31%), Positives = 53/106 (50%), Gaps = 17/106 (16%)
Query: 640 NGMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVKIISSSLEYLHFGHSIPIIHCDL 699
NG E+ ++ +++ F E EVR I I +L++LH + II+ D+
Sbjct: 88 NGGELFTHLYQREH------F-TESEVRVYIAE------IVLALDHLH---QLGIIYRDI 131
Query: 700 KPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPE 745
K N+LLD + ++DFG++K E + + TI YMAPE
Sbjct: 132 KLENILLDSEGHVVLTDFGLSKEFLAE-EEERAYSFCGTIEYMAPE 176
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 1e-05
Identities = 26/68 (38%), Positives = 36/68 (52%), Gaps = 2/68 (2%)
Query: 678 IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLA 737
I LE L + HS+ IIH DLK NVLL D ++DFG++ L ++ +
Sbjct: 115 ICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSA--KNVKTLQRRDSFIG 172
Query: 738 TIGYMAPE 745
T +MAPE
Sbjct: 173 TPYWMAPE 180
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 1e-05
Identities = 28/68 (41%), Positives = 38/68 (55%), Gaps = 8/68 (11%)
Query: 679 ISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIA-KLLSGEDQLSKQTQTLA 737
I LE LH + ++ DLKP N+LLD+ ISD G+A K+ GE + +
Sbjct: 111 ILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGR----VG 163
Query: 738 TIGYMAPE 745
T+GYMAPE
Sbjct: 164 TVGYMAPE 171
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 1e-05
Identities = 24/86 (27%), Positives = 42/86 (48%), Gaps = 3/86 (3%)
Query: 679 ISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLAT 738
+++ + YL +H DL N L+ E+MV I+DFG+++ + D
Sbjct: 139 VAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIP 195
Query: 739 IGYMAPEYGTKGRVSTRGDVCSFGII 764
I +M PE R +T DV ++G++
Sbjct: 196 IRWMPPESIFYNRYTTESDVWAYGVV 221
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 1e-05
Identities = 26/61 (42%), Positives = 36/61 (59%), Gaps = 4/61 (6%)
Query: 690 HSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTK 749
H+ +++ DLKP+N+LLDE ISD G+A S + K ++ T GYMAPE K
Sbjct: 114 HNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK----KPHASVGTHGYMAPEVLQK 169
Query: 750 G 750
G
Sbjct: 170 G 170
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 1e-05
Identities = 34/118 (28%), Positives = 54/118 (45%), Gaps = 13/118 (11%)
Query: 657 LKSFEDECEVRK----RIRHRNLVKI---ISSSLEYLHFGHSIPIIHCDLKPSNVLLD-- 707
LKSF E R + ++L+ ++ +YL H IH D+ N LL
Sbjct: 96 LKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCK 152
Query: 708 -EDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGII 764
VA I+DFG+A+ + K + + I +M PE G +++ DV SFG++
Sbjct: 153 GPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVL 210
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 1e-05
Identities = 27/86 (31%), Positives = 43/86 (50%), Gaps = 3/86 (3%)
Query: 679 ISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLAT 738
I+S + YL H +H DL N L+ +++ I DFG+++ + D T+
Sbjct: 132 IASGMVYLASQH---FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLP 188
Query: 739 IGYMAPEYGTKGRVSTRGDVCSFGII 764
I +M PE + +T DV SFG+I
Sbjct: 189 IRWMPPESIMYRKFTTESDVWSFGVI 214
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 1e-05
Identities = 26/67 (38%), Positives = 38/67 (56%), Gaps = 6/67 (8%)
Query: 679 ISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLAT 738
I+ LE LH I++ DLKP N+LLD+ ISD G+A + + + + + T
Sbjct: 111 ITCGLEDLH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGR---VGT 164
Query: 739 IGYMAPE 745
+GYMAPE
Sbjct: 165 VGYMAPE 171
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 2e-05
Identities = 29/68 (42%), Positives = 37/68 (54%), Gaps = 5/68 (7%)
Query: 678 IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLA 737
+I L L + HS IIH DLKPSN+ ++ED I DFG+A+ E T +A
Sbjct: 125 LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVA 179
Query: 738 TIGYMAPE 745
T Y APE
Sbjct: 180 TRWYRAPE 187
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-05
Identities = 36/159 (22%), Positives = 71/159 (44%), Gaps = 8/159 (5%)
Query: 609 INSPQAIRRFSYHELLRATDRFSENNLIGIGNGMEVAVKVFHQQYERALKSFEDECEVRK 668
+N ++ F+ H ++R S+ + ME+ + Y R+L+ + R
Sbjct: 57 LNEASVMKGFTCHHVVRLLGVVSKGQPTLVV--MELMAHGDLKSYLRSLRPEAENNPGRP 114
Query: 669 RIRHRNLVKI---ISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSG 725
+ ++++ I+ + YL+ + +H DL N ++ D I DFG+ + +
Sbjct: 115 PPTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYE 171
Query: 726 EDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGII 764
D K + L + +MAPE G +T D+ SFG++
Sbjct: 172 TDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVV 210
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-05
Identities = 27/85 (31%), Positives = 44/85 (51%), Gaps = 3/85 (3%)
Query: 679 ISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLAT 738
I+S ++YL S+ +H DL N L+ I+DFG+++ L D Q + +
Sbjct: 138 IASGMKYLA---SLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLP 194
Query: 739 IGYMAPEYGTKGRVSTRGDVCSFGI 763
I +MA E G+ +T DV +FG+
Sbjct: 195 IRWMAWESILLGKFTTASDVWAFGV 219
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 47.2 bits (113), Expect = 2e-05
Identities = 32/86 (37%), Positives = 42/86 (48%), Gaps = 5/86 (5%)
Query: 683 LEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYM 742
L + H I+H DLK SN+LL+ + I DFG+A+ L TQ + T+ Y
Sbjct: 116 LSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYG--SPLKPYTQLVVTLWYR 173
Query: 743 APE--YGTKGRVSTRGDVCSFGIISG 766
APE G K ST D+ S G I
Sbjct: 174 APELLLGAK-EYSTAIDMWSVGCIFA 198
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 2e-05
Identities = 30/91 (32%), Positives = 47/91 (51%), Gaps = 2/91 (2%)
Query: 675 LVKIISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQ 734
+ I+ L+ L + HS IH D+K +NVLL E ++DFG+A L+ D K+
Sbjct: 103 IATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLT--DTQIKRNT 160
Query: 735 TLATIGYMAPEYGTKGRVSTRGDVCSFGIIS 765
+ T +MAPE + + D+ S GI +
Sbjct: 161 FVGTPFWMAPEVIKQSAYDFKADIWSLGITA 191
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 2e-05
Identities = 44/148 (29%), Positives = 64/148 (43%), Gaps = 28/148 (18%)
Query: 681 SSLEYLHFGHSIP----------IIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLS 730
SS + LHF + IH DL N+L+ E+ VA I+DFG+++ G++
Sbjct: 122 SSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYV 178
Query: 731 KQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGII------SGGKETRSMTVGETCTPVRE 784
K+T + +MA E +T DV S+G++ GG MT E
Sbjct: 179 KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL------ 232
Query: 785 SKYEVHPATTTIMEHPLPRVGEVMDVDR 812
YE P +E PL EV D+ R
Sbjct: 233 --YEKLPQGYR-LEKPLNCDDEVYDLMR 257
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 2e-05
Identities = 31/92 (33%), Positives = 42/92 (45%), Gaps = 19/92 (20%)
Query: 683 LEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYM 742
LE L+F HS +IH DLK N+LL D ++DFG++ Q K+ + T +M
Sbjct: 113 LEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ--KRDTFIGTPYWM 170
Query: 743 APE-----------YGTKGRVSTRGDVCSFGI 763
APE Y K D+ S GI
Sbjct: 171 APEVVACETFKDNPYDYK------ADIWSLGI 196
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 2e-05
Identities = 29/96 (30%), Positives = 48/96 (50%), Gaps = 2/96 (2%)
Query: 669 RIRHRNLVKIISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQ 728
R+ + + S L L + H+ +IH D+K ++LL D +SDFG +S E
Sbjct: 114 RMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKE-- 171
Query: 729 LSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGII 764
+ K+ + T +MAPE ++ T D+ S GI+
Sbjct: 172 VPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIM 207
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 2e-05
Identities = 29/82 (35%), Positives = 44/82 (53%), Gaps = 3/82 (3%)
Query: 683 LEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYM 742
L L F HS ++H DLKP N+L+ ++DFG+A++ S + L T + T+ Y
Sbjct: 120 LRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL---TSVVVTLWYR 176
Query: 743 APEYGTKGRVSTRGDVCSFGII 764
APE + +T D+ S G I
Sbjct: 177 APEVLLQSSYATPVDLWSVGCI 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 3e-05
Identities = 26/81 (32%), Positives = 40/81 (49%), Gaps = 6/81 (7%)
Query: 683 LEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYM 742
L YL H I +H D+KPSN+L++ + DFG+ SG+ S + T YM
Sbjct: 112 LTYLREKHKI--MHRDVKPSNILVNSRGEIKLCDFGV----SGQLIDSMANSFVGTRSYM 165
Query: 743 APEYGTKGRVSTRGDVCSFGI 763
+PE + + D+ S G+
Sbjct: 166 SPERLQGTHYTVQSDIWSLGL 186
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 3e-05
Identities = 33/81 (40%), Positives = 44/81 (54%), Gaps = 6/81 (7%)
Query: 686 LHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKL-LSGEDQLSKQTQTLATIGYMAP 744
L F H II+ DLK NVLLD+D I+DFG+ K ++GE K + T Y+AP
Sbjct: 109 LQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE---GKASTFCGTPDYIAP 165
Query: 745 EYGTKGRVSTRG-DVCSFGII 764
E KG+ D SFG++
Sbjct: 166 EI-LKGQKYNESVDWWSFGVL 185
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 3e-05
Identities = 34/116 (29%), Positives = 56/116 (48%), Gaps = 10/116 (8%)
Query: 654 ERALKSFEDECEVRKR-IRHRNLVKIISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVA 712
E L S D EV K+ ++ + + +L+ L + HS +IH D+K N+LL E +
Sbjct: 95 EYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLV 154
Query: 713 HISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEY---GTKGRVSTRGDVCSFGIIS 765
+ DFG A +++ + + T +MAPE +G+ + DV S GI
Sbjct: 155 KLGDFGSASIMAPANXF------VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITC 204
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.5 bits (111), Expect = 3e-05
Identities = 33/111 (29%), Positives = 56/111 (50%), Gaps = 8/111 (7%)
Query: 657 LKSFEDECEVRKRIRHRNLVK-IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHIS 715
LK + D + L+K + L+ + + HS ++H DLKP N+L+D + ++
Sbjct: 84 LKKYMDSSPLTGL--DPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLA 141
Query: 716 DFGIAKLLSGEDQLSKQTQTLATIGYMAPE--YGTKGRVSTRGDVCSFGII 764
DFG+A+ + T + T+ Y APE G++ + ST D+ S G I
Sbjct: 142 DFGLARAFG--VPVRTYTHEVVTLWYRAPEILLGSR-QYSTPVDIWSIGCI 189
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 3e-05
Identities = 25/100 (25%), Positives = 50/100 (50%), Gaps = 1/100 (1%)
Query: 665 EVRKRIRHRNLVKIISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLS 724
E KR + L+++ E + + S IH DL N L+D+ +SDFG+++ +
Sbjct: 92 EHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVL 151
Query: 725 GEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGII 764
+D+ + + + + PE + S++ DV +FG++
Sbjct: 152 -DDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVL 190
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 3e-05
Identities = 26/69 (37%), Positives = 38/69 (55%), Gaps = 2/69 (2%)
Query: 677 KIISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTL 736
K + L + F HS IIH D+KP N+L+ + V + DFG A+ L+ ++ T +
Sbjct: 104 KYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVY--TDYV 161
Query: 737 ATIGYMAPE 745
AT Y APE
Sbjct: 162 ATRWYRAPE 170
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 3e-05
Identities = 36/114 (31%), Positives = 55/114 (48%), Gaps = 10/114 (8%)
Query: 654 ERALKSFEDECEVRKR-IRHRNLVKIISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVA 712
E L S D EV K+ ++ + I +L+ L + HS +IH D+K N+LL E
Sbjct: 105 EYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQV 164
Query: 713 HISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEY---GTKGRVSTRGDVCSFGI 763
++DFG A + S + + T +MAPE +G+ + DV S GI
Sbjct: 165 KLADFGSASIASPANSF------VGTPYWMAPEVILAMDEGQYDGKVDVWSLGI 212
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.1 bits (110), Expect = 3e-05
Identities = 28/81 (34%), Positives = 44/81 (54%), Gaps = 5/81 (6%)
Query: 683 LEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYM 742
LEYLH IH D+K +N+LL E+ ++DFG++ L+ +SK+ + T +M
Sbjct: 111 LEYLH---EEGKIHRDIKAANILLSEEGDVKLADFGVSGQLT--STMSKRNTFVGTPFWM 165
Query: 743 APEYGTKGRVSTRGDVCSFGI 763
APE + + D+ S GI
Sbjct: 166 APEVIKQSGYDEKADIWSLGI 186
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 4e-05
Identities = 49/151 (32%), Positives = 68/151 (45%), Gaps = 36/151 (23%)
Query: 634 NLIGIGNGMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVKIISSSLE-----YL-- 686
N+IG+ N VF Q ++L+ F+D V + + NL ++I L+ YL
Sbjct: 76 NIIGLLN-------VFTPQ--KSLEEFQDVYLVMELMDA-NLCQVIQMDLDHERMSYLLY 125
Query: 687 -------HFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATI 739
H HS IIH DLKPSN+++ D I DFG+A+ + T + T
Sbjct: 126 QMLCGIKHL-HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM---TPYVVTR 181
Query: 740 GYMAPE----YGTKGRVSTRGDVCSFGIISG 766
Y APE G K V D+ S G I G
Sbjct: 182 YYRAPEVILGMGYKENV----DIWSVGCIMG 208
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 4e-05
Identities = 29/96 (30%), Positives = 47/96 (48%), Gaps = 3/96 (3%)
Query: 679 ISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLAT 738
I+S +EYL S IH DL N +L+E+M ++DFG++K + D + +
Sbjct: 122 IASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLP 178
Query: 739 IGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMT 774
+ ++A E +T DV +FG+ TR T
Sbjct: 179 VKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQT 214
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 5e-05
Identities = 28/85 (32%), Positives = 47/85 (55%), Gaps = 3/85 (3%)
Query: 679 ISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLAT 738
I+S ++YL S+ +H DL N L+ E++ I+DFG+++ L D Q + +
Sbjct: 147 IASGMKYLS---SLNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLP 203
Query: 739 IGYMAPEYGTKGRVSTRGDVCSFGI 763
I +MA E G+ +T DV +FG+
Sbjct: 204 IRWMAWECILMGKFTTASDVWAFGV 228
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 5e-05
Identities = 25/77 (32%), Positives = 38/77 (49%), Gaps = 4/77 (5%)
Query: 690 HSIPIIHCDLKPSNVLLDED-MVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGT 748
H ++H DLKP N+L+D+ + I+D G+ + S + T + T+ Y APE
Sbjct: 127 HKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFS--IPVKSYTHEIVTLWYRAPEVLL 184
Query: 749 KGR-VSTRGDVCSFGII 764
ST D+ S G I
Sbjct: 185 GSTHYSTPVDIWSVGCI 201
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 5e-05
Identities = 27/79 (34%), Positives = 42/79 (53%), Gaps = 3/79 (3%)
Query: 686 LHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPE 745
+H+ H I+H DLK N+ L +++ I DFG+++LL G L+ T T YM+PE
Sbjct: 119 VHYMHQRRILHRDLKAKNIFLKNNLL-KIGDFGVSRLLMGSCDLA--TTFTGTPYYMSPE 175
Query: 746 YGTKGRVSTRGDVCSFGII 764
++ D+ S G I
Sbjct: 176 ALKHQGYDSKSDIWSLGCI 194
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 6e-05
Identities = 25/75 (33%), Positives = 38/75 (50%)
Query: 690 HSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTK 749
HS ++H DLK +N+ L + + DFG +K S L + T Y+APE +
Sbjct: 186 HSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWER 245
Query: 750 GRVSTRGDVCSFGII 764
R S + D+ S G+I
Sbjct: 246 KRYSKKADMWSLGVI 260
|
Length = 478 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 7e-05
Identities = 26/79 (32%), Positives = 41/79 (51%)
Query: 686 LHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPE 745
+ F S IH DL N+LL E+ V I DFG+A+ + + ++ + +MAPE
Sbjct: 187 MEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPE 246
Query: 746 YGTKGRVSTRGDVCSFGII 764
+T+ DV SFG++
Sbjct: 247 SIFDKVYTTQSDVWSFGVL 265
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 7e-05
Identities = 36/114 (31%), Positives = 54/114 (47%), Gaps = 10/114 (8%)
Query: 654 ERALKSFEDECEVRKR-IRHRNLVKIISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVA 712
E L S D EV K+ ++ + I +L+ L + HS +IH D+K N+LL E
Sbjct: 101 EYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQV 160
Query: 713 HISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEY---GTKGRVSTRGDVCSFGI 763
++DFG A S + + T +MAPE +G+ + DV S GI
Sbjct: 161 KLADFGSASKSSPANSF------VGTPYWMAPEVILAMDEGQYDGKVDVWSLGI 208
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 45.1 bits (106), Expect = 8e-05
Identities = 25/91 (27%), Positives = 46/91 (50%), Gaps = 3/91 (3%)
Query: 674 NLVKIISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQT 733
++ + I++ + YL H +H DL N L+ E+++ I DFG+++ + D
Sbjct: 124 HIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGG 180
Query: 734 QTLATIGYMAPEYGTKGRVSTRGDVCSFGII 764
T+ I +M PE + +T DV S G++
Sbjct: 181 HTMLPIRWMPPESIMYRKFTTESDVWSLGVV 211
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 8e-05
Identities = 28/84 (33%), Positives = 44/84 (52%), Gaps = 1/84 (1%)
Query: 683 LEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYM 742
++ +H+ H I+H D+KP N+L+ + V + DFG A+ LS E + T+ +AT Y
Sbjct: 110 IKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLS-EGSNANYTEYVATRWYR 168
Query: 743 APEYGTKGRVSTRGDVCSFGIISG 766
+PE D+ S G I G
Sbjct: 169 SPELLLGAPYGKAVDMWSVGCILG 192
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 8e-05
Identities = 28/91 (30%), Positives = 50/91 (54%), Gaps = 10/91 (10%)
Query: 679 ISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLA- 737
I++ ++YL + +H DL N+L++ ++V +SDFG+++ L ED S T T +
Sbjct: 115 IAAGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRFL--EDDTSDPTYTSSL 169
Query: 738 ----TIGYMAPEYGTKGRVSTRGDVCSFGII 764
I + APE + ++ DV S+GI+
Sbjct: 170 GGKIPIRWTAPEAIAYRKFTSASDVWSYGIV 200
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 8e-05
Identities = 41/134 (30%), Positives = 60/134 (44%), Gaps = 19/134 (14%)
Query: 646 VKVFHQQYERALKSFEDECEVRKRIRHRNLVKIISSSLE-----YLHFG--------HSI 692
+ VF Q ++L+ F+D V + + NL ++I L+ YL + HS
Sbjct: 86 LNVFTPQ--KSLEEFQDVYLVME-LMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHSA 142
Query: 693 PIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRV 752
IIH DLKPSN+++ D I DFG+A+ + T + T Y APE
Sbjct: 143 GIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMM---TPYVVTRYYRAPEVILGMGY 199
Query: 753 STRGDVCSFGIISG 766
D+ S G I G
Sbjct: 200 KENVDIWSVGCIMG 213
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 8e-05
Identities = 27/96 (28%), Positives = 45/96 (46%), Gaps = 3/96 (3%)
Query: 679 ISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLAT 738
I+ +EYL + IH DL N +L EDM ++DFG++K + D +
Sbjct: 122 IALGMEYLS---NRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMP 178
Query: 739 IGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMT 774
+ ++A E +++ DV +FG+ TR T
Sbjct: 179 VKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQT 214
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 8e-05
Identities = 35/106 (33%), Positives = 49/106 (46%), Gaps = 18/106 (16%)
Query: 640 NGMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVKIISSSLEYLHFGHSIPIIHCDL 699
NG E+ FH Q ER R R ++S++ YLH S+ II+ DL
Sbjct: 79 NGGEL---FFHLQRERCFL----------EPRARFYAAEVASAIGYLH---SLNIIYRDL 122
Query: 700 KPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPE 745
KP N+LLD ++DFG+ K G + + T Y+APE
Sbjct: 123 KPENILLDSQGHVVLTDFGLCK--EGVEPEETTSTFCGTPEYLAPE 166
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 8e-05
Identities = 36/113 (31%), Positives = 60/113 (53%), Gaps = 8/113 (7%)
Query: 658 KSFEDECEVRKRIRHRN--LVKIISSSLEY-LHFGHSIPIIHCDLKPSNVLLDEDMVAHI 714
K E+ E+ KRI+ +N L+K I + L + H I H D+KP N+++D + +I
Sbjct: 108 KLVENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYI 167
Query: 715 SDFGIAK--LLSGED-QLSKQTQTL--ATIGYMAPEYGTKGRVSTRGDVCSFG 762
D+GIA ++ G+ + SK+ + L T+ Y + V+ RGD+ S G
Sbjct: 168 IDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLG 220
|
Length = 294 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 9e-05
Identities = 30/99 (30%), Positives = 50/99 (50%), Gaps = 4/99 (4%)
Query: 665 EVRKRIRHRNLVKIISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLS 724
+V ++I L +I + ++ L + S+ I+H D+KPSN+L++ + DFG++ L
Sbjct: 87 DVYRKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLV 146
Query: 725 GEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGI 763
S + T YMAPE + + DV S GI
Sbjct: 147 N----SIAKTYVGTNAYMAPERISGEQYGIHSDVWSLGI 181
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 9e-05
Identities = 30/93 (32%), Positives = 47/93 (50%), Gaps = 3/93 (3%)
Query: 675 LVKIISSSLEY---LHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSK 731
L +IS S + + F S IH DL N+LL E+ V I DFG+A+ + + +
Sbjct: 172 LEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVR 231
Query: 732 QTQTLATIGYMAPEYGTKGRVSTRGDVCSFGII 764
+ + +MAPE +T+ DV SFG++
Sbjct: 232 KGDARLPLKWMAPESIFDKVYTTQSDVWSFGVL 264
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 1e-04
Identities = 32/100 (32%), Positives = 49/100 (49%), Gaps = 5/100 (5%)
Query: 667 RKRIRHRNLVKIISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGE 726
+ ++ + LVK + + + S IH DL N L+ E+ V ISDFG+++ E
Sbjct: 87 KDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSR---QE 143
Query: 727 DQLSKQTQTLAT--IGYMAPEYGTKGRVSTRGDVCSFGII 764
D + L I + APE GR S+ DV S+GI+
Sbjct: 144 DDGIYSSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGIL 183
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 1e-04
Identities = 31/84 (36%), Positives = 47/84 (55%), Gaps = 5/84 (5%)
Query: 683 LEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYM 742
L+ + F HS ++H DLKP N+L+D V ++DFG+A+ ++ T + T+ Y
Sbjct: 111 LQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRV--YTHEVVTLWYR 168
Query: 743 APE--YGTKGRVSTRGDVCSFGII 764
APE G+ R ST D+ S G I
Sbjct: 169 APEVLLGSP-RYSTPVDIWSIGTI 191
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 1e-04
Identities = 31/115 (26%), Positives = 54/115 (46%), Gaps = 13/115 (11%)
Query: 673 RNLVKIISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQ 732
+ I+S ++YL S+ +H DL N L+ ++ I+DFG+++ L D Q
Sbjct: 133 IFMATQIASGMKYLS---SLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQ 189
Query: 733 TQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGETCTPVRESKY 787
+ + I +M+ E G+ +T DV +FG+ T+ E T +E Y
Sbjct: 190 GRAVLPIRWMSWESILLGKFTTASDVWAFGV----------TLWEILTLCKEQPY 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 1e-04
Identities = 33/103 (32%), Positives = 50/103 (48%), Gaps = 6/103 (5%)
Query: 675 LVKI---ISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSK 731
LVK I+S +EYL S IH DL N +L+E+M ++DFG++K + D +
Sbjct: 114 LVKFMTDIASGMEYLS---SKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQ 170
Query: 732 QTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMT 774
+ ++A E +T+ DV SFG+ TR T
Sbjct: 171 GRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQT 213
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 1e-04
Identities = 25/79 (31%), Positives = 39/79 (49%)
Query: 686 LHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPE 745
+ F S +H DL NVLL + + I DFG+A+ + + + T + +MAPE
Sbjct: 250 MEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPE 309
Query: 746 YGTKGRVSTRGDVCSFGII 764
+T DV S+GI+
Sbjct: 310 SIFDNLYTTLSDVWSYGIL 328
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 1e-04
Identities = 25/79 (31%), Positives = 40/79 (50%)
Query: 686 LHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPE 745
+ F S IH DL N+LL E+ V I DFG+A+ + + ++ + +MAPE
Sbjct: 192 MEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPE 251
Query: 746 YGTKGRVSTRGDVCSFGII 764
+ + DV SFG++
Sbjct: 252 TIFDRVYTIQSDVWSFGVL 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 1e-04
Identities = 24/71 (33%), Positives = 37/71 (52%), Gaps = 2/71 (2%)
Query: 695 IHCDLKPSNVLLDEDMVAHISDFGIAK-LLSGEDQLSKQTQTLATIGYMAPEYGTKGRVS 753
IH DL NVLL + I DFG+A+ +++ + + K L + +MAPE +
Sbjct: 163 IHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLP-VKWMAPESIFNCVYT 221
Query: 754 TRGDVCSFGII 764
DV S+GI+
Sbjct: 222 FESDVWSYGIL 232
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 1e-04
Identities = 25/74 (33%), Positives = 39/74 (52%), Gaps = 8/74 (10%)
Query: 695 IHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLA----TIGYMAPEYGTKG 750
+H DL N+L++ ++V +SDFG LS + S+ T T I + APE
Sbjct: 128 VHRDLAARNILVNSNLVCKVSDFG----LSRRLEDSEATYTTKGGKIPIRWTAPEAIAYR 183
Query: 751 RVSTRGDVCSFGII 764
+ ++ DV SFGI+
Sbjct: 184 KFTSASDVWSFGIV 197
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 1e-04
Identities = 29/80 (36%), Positives = 43/80 (53%), Gaps = 4/80 (5%)
Query: 686 LHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKL-LSGEDQLSKQTQTLATIGYMAP 744
L F HS II+ DLK NV+LD D I+DFG+ K + G+ ++ + T Y+AP
Sbjct: 109 LQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD---NRASTFCGTPDYIAP 165
Query: 745 EYGTKGRVSTRGDVCSFGII 764
E + + D SFG++
Sbjct: 166 EILQGLKYTFSVDWWSFGVL 185
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 2e-04
Identities = 31/81 (38%), Positives = 43/81 (53%), Gaps = 6/81 (7%)
Query: 686 LHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQL--SKQTQTLATIGYMA 743
L F HS I++ DLK N+LLD D I+DFG+ K E+ L +K T Y+A
Sbjct: 109 LQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCK----ENMLGDAKTCTFCGTPDYIA 164
Query: 744 PEYGTKGRVSTRGDVCSFGII 764
PE + +T D SFG++
Sbjct: 165 PEILLGQKYNTSVDWWSFGVL 185
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 2e-04
Identities = 31/116 (26%), Positives = 58/116 (50%), Gaps = 17/116 (14%)
Query: 655 RALKSFEDECEVRKRIRHRNLVKI---ISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMV 711
R +K F+ + ++ I + + K + S+LE++H S ++H D+KP+NV + V
Sbjct: 91 RMIKHFKKQ---KRLIPEKTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGV 144
Query: 712 AHISDFGIAKLLSGEDQLSKQTQTLATIG---YMAPEYGTKGRVSTRGDVCSFGII 764
+ D G+ + S SK T + +G YM+PE + + + D+ S G +
Sbjct: 145 VKLGDLGLGRFFS-----SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCL 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 2e-04
Identities = 26/79 (32%), Positives = 38/79 (48%), Gaps = 11/79 (13%)
Query: 683 LEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIG-- 740
LE + + HS I+H D+K +N+L D + DFG +K L + S T + G
Sbjct: 114 LEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRL--QTICSSGTGMKSVTGTP 171
Query: 741 -YMAPE------YGTKGRV 752
+M+PE YG K V
Sbjct: 172 YWMSPEVISGEGYGRKADV 190
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 2e-04
Identities = 26/96 (27%), Positives = 47/96 (48%), Gaps = 2/96 (2%)
Query: 669 RIRHRNLVKIISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQ 728
R+ + + + L+ L H+ +IH D+K ++LL D +SDFG +S E
Sbjct: 112 RMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE-- 169
Query: 729 LSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGII 764
+ ++ + T +MAPE ++ D+ S GI+
Sbjct: 170 VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIM 205
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 2e-04
Identities = 27/69 (39%), Positives = 35/69 (50%), Gaps = 9/69 (13%)
Query: 679 ISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTL-- 736
I L++LH II+ DLK NVLLD + I+DFG+ K E L T +
Sbjct: 105 IVLGLQFLH---ERGIIYRDLKLDNVLLDSEGHIKIADFGMCK----EGILGGVTTSTFC 157
Query: 737 ATIGYMAPE 745
T Y+APE
Sbjct: 158 GTPDYIAPE 166
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.2 bits (105), Expect = 2e-04
Identities = 27/93 (29%), Positives = 38/93 (40%), Gaps = 36/93 (38%)
Query: 683 LEYLH-FGHSIPIIHCDLKPSNVLLDEDMVAHI--SDFGIAK----------LLSGEDQL 729
L+ +H G IH D+KP N+L+D D HI +DFG+ K L+ L
Sbjct: 114 LDSVHKLGF----IHRDIKPDNILIDAD--GHIKLADFGLCKKMNKAKDREYYLNDSHNL 167
Query: 730 SKQTQTLA--------------TIG---YMAPE 745
+ L T+G Y+APE
Sbjct: 168 LFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPE 200
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 2e-04
Identities = 25/67 (37%), Positives = 40/67 (59%), Gaps = 4/67 (5%)
Query: 679 ISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLAT 738
I +LE+LH + II+ D+K N+LLD + ++DFG++K ED++ + T
Sbjct: 114 IVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFH-EDEVERAYSFCGT 169
Query: 739 IGYMAPE 745
I YMAP+
Sbjct: 170 IEYMAPD 176
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 2e-04
Identities = 25/63 (39%), Positives = 35/63 (55%), Gaps = 5/63 (7%)
Query: 683 LEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYM 742
L+ L + H+ IIH DLKP N+ ++ED I DFG+A+ S+ T + T Y
Sbjct: 128 LKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTD-----SEMTGYVVTRWYR 182
Query: 743 APE 745
APE
Sbjct: 183 APE 185
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 2e-04
Identities = 38/164 (23%), Positives = 79/164 (48%), Gaps = 22/164 (13%)
Query: 607 DGINSPQAIRRFSYHELLRATDRFSENNLIGIGNGMEVAVKVFHQQYERALKSFEDECEV 666
D + +++ ++ +++ D F E+N + I +E+A + +K F+ +
Sbjct: 48 DCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIV--LELADA---GDLSQMIKYFKKQ--- 99
Query: 667 RKRIRHRNLVKI---ISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLL 723
++ I R + K + S++E++H S ++H D+KP+NV + V + D G+ +
Sbjct: 100 KRLIPERTVWKYFVQLCSAVEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFF 156
Query: 724 SGEDQLSKQTQTLATIG---YMAPEYGTKGRVSTRGDVCSFGII 764
S SK T + +G YM+PE + + + D+ S G +
Sbjct: 157 S-----SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCL 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 2e-04
Identities = 25/87 (28%), Positives = 50/87 (57%), Gaps = 4/87 (4%)
Query: 679 ISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQ-TLA 737
I+S ++YL + +H DL N+L++ ++V +SDFG++++L + + + T+
Sbjct: 115 IASGMKYLS---DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI 171
Query: 738 TIGYMAPEYGTKGRVSTRGDVCSFGII 764
I + APE + ++ DV S+GI+
Sbjct: 172 PIRWTAPEAIAYRKFTSASDVWSYGIV 198
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 2e-04
Identities = 26/68 (38%), Positives = 35/68 (51%), Gaps = 5/68 (7%)
Query: 678 IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLA 737
++ L L + HS IIH DLKP N+ ++ED I DFG+A+ E T +
Sbjct: 122 LVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAE-----MTGYVV 176
Query: 738 TIGYMAPE 745
T Y APE
Sbjct: 177 TRWYRAPE 184
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 2e-04
Identities = 24/70 (34%), Positives = 38/70 (54%), Gaps = 11/70 (15%)
Query: 679 ISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLAT 738
+ S+LE++H S I+H D+KP+NV + V + D G+ + S SK T +
Sbjct: 115 LCSALEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFS-----SKTTAAHSL 166
Query: 739 IG---YMAPE 745
+G YM+PE
Sbjct: 167 VGTPYYMSPE 176
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 2e-04
Identities = 27/64 (42%), Positives = 38/64 (59%), Gaps = 10/64 (15%)
Query: 683 LEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTL-ATIGY 741
EYL S+ I++ DLKP N+LLD+D ++DFG AK+ + +T TL T Y
Sbjct: 144 FEYLQ---SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKV------VDTRTYTLCGTPEY 194
Query: 742 MAPE 745
+APE
Sbjct: 195 IAPE 198
|
Length = 340 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 2e-04
Identities = 23/53 (43%), Positives = 33/53 (62%), Gaps = 5/53 (9%)
Query: 694 IIHCDLKPSNVLLDEDMVAHISDFGIA-KLLSGEDQLSKQTQTLATIGYMAPE 745
I++ DLKP N+LLD+ ISD G+A ++ GE + + T+GYMAPE
Sbjct: 123 IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGR----VGTVGYMAPE 171
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 3e-04
Identities = 34/126 (26%), Positives = 61/126 (48%), Gaps = 11/126 (8%)
Query: 679 ISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQ-TLA 737
I++ ++YL + +H DL N+L++ ++ +SDFG++++L + + + T
Sbjct: 116 IAAGMKYLS---DMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKI 172
Query: 738 TIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGETCTPVRE-SKYEVHPATTTI 796
I + APE + ++ DV SFGI+ M+ GE P + S +EV A
Sbjct: 173 PIRWTAPEAIAYRKFTSASDVWSFGIVM----WEVMSFGE--RPYWDMSNHEVMKAINDG 226
Query: 797 MEHPLP 802
P P
Sbjct: 227 FRLPAP 232
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 3e-04
Identities = 51/174 (29%), Positives = 75/174 (43%), Gaps = 37/174 (21%)
Query: 610 NSPQAIRRFSYHELLRATDRFSENNLIGIGNGMEVAVKVFHQQYERALKSFEDECEVRKR 669
N A R + L++ + N+IG+ N VF Q ++L+ F+D +
Sbjct: 63 NQTHAKRAYRELVLMKCVN---HKNIIGLLN-------VFTPQ--KSLEEFQD-VYIVME 109
Query: 670 IRHRNLVKIISSSLE-----YLHFG--------HSIPIIHCDLKPSNVLLDEDMVAHISD 716
+ NL ++I L+ YL + HS IIH DLKPSN+++ D I D
Sbjct: 110 LMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILD 169
Query: 717 FGIAKLLSGEDQLSKQTQTLATIGYMAPE----YGTKGRVSTRGDVCSFGIISG 766
FG+A+ + T + T Y APE G K V D+ S G I G
Sbjct: 170 FGLARTAGTSFMM---TPYVVTRYYRAPEVILGMGYKENV----DIWSVGCIMG 216
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 3e-04
Identities = 26/69 (37%), Positives = 37/69 (53%), Gaps = 9/69 (13%)
Query: 679 ISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGED-QLSKQTQTL- 736
I S+L YLH S +++ DLK N++LD+D I+DFG+ K E +T
Sbjct: 104 IVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCK----EGISDGATMKTFC 156
Query: 737 ATIGYMAPE 745
T Y+APE
Sbjct: 157 GTPEYLAPE 165
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 3e-04
Identities = 30/104 (28%), Positives = 47/104 (45%), Gaps = 23/104 (22%)
Query: 679 ISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQ---------- 728
I +++EY+H S ++H DLKP N+LL I D+G A E++
Sbjct: 122 ICATIEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDER 178
Query: 729 ------LSKQTQTLATIGYMAPE--YGTKGRVSTRGDVCSFGII 764
++ + + T YMAPE G ST D+ + G+I
Sbjct: 179 NICYSSMTIPGKIVGTPDYMAPERLLGVPASEST--DIYALGVI 220
|
Length = 932 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 4e-04
Identities = 27/88 (30%), Positives = 46/88 (52%), Gaps = 5/88 (5%)
Query: 679 ISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLAT 738
++ +EYL S +H DL N +LDE ++DFG+A+ + ++ S T A
Sbjct: 107 VAKGMEYLA---SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAK 163
Query: 739 --IGYMAPEYGTKGRVSTRGDVCSFGII 764
+ +MA E + +T+ DV SFG++
Sbjct: 164 LPVKWMALESLQTQKFTTKSDVWSFGVL 191
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 4e-04
Identities = 27/110 (24%), Positives = 56/110 (50%), Gaps = 5/110 (4%)
Query: 659 SFEDECEVRKRIRHRNLVKIISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFG 718
S +D V + + + +L+ L++ HS +H D+K +N+LL ++ ++DFG
Sbjct: 92 SLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFG 151
Query: 719 IAKLLSGEDQLSKQTQTLATIGYMAPEYGT---KGRVSTRGDVCSFGIIS 765
++ ++ ++K+ + T +MAPE KG + D+ + GI +
Sbjct: 152 VSAQITA--TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITA 199
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 4e-04
Identities = 26/100 (26%), Positives = 48/100 (48%), Gaps = 7/100 (7%)
Query: 667 RKRIRHRNLVKI---ISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLL 723
+ + +L+ +S++L YL S +H D+ NVL+ + DFG+++ L
Sbjct: 101 KYSLDLASLILYSYQLSTALAYLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYL 157
Query: 724 SGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGI 763
++ K ++ I +MAPE R ++ DV FG+
Sbjct: 158 E-DESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGV 196
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 4e-04
Identities = 26/79 (32%), Positives = 39/79 (49%)
Query: 686 LHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPE 745
+ F S +H DL NVL+ E + I DFG+A+ + + + T + +MAPE
Sbjct: 252 MEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPE 311
Query: 746 YGTKGRVSTRGDVCSFGII 764
+T DV SFGI+
Sbjct: 312 SIFNNLYTTLSDVWSFGIL 330
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 4e-04
Identities = 36/106 (33%), Positives = 49/106 (46%), Gaps = 18/106 (16%)
Query: 640 NGMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVKIISSSLEYLHFGHSIPIIHCDL 699
NG E+ FH ER E R R +V S+L+YLH G I++ DL
Sbjct: 78 NGGEL---FFHLSRERVFS------EDRTRFYGAEIV----SALDYLHSGK---IVYRDL 121
Query: 700 KPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPE 745
K N++LD+D I+DFG+ K G + T Y+APE
Sbjct: 122 KLENLMLDKDGHIKITDFGLCK--EGITDAATMKTFCGTPEYLAPE 165
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 5e-04
Identities = 23/64 (35%), Positives = 38/64 (59%), Gaps = 4/64 (6%)
Query: 682 SLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGY 741
+LE+LH + I++ D+K N+LLD + ++DFG++K E++ + TI Y
Sbjct: 117 ALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEK-ERTYSFCGTIEY 172
Query: 742 MAPE 745
MAPE
Sbjct: 173 MAPE 176
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 5e-04
Identities = 23/86 (26%), Positives = 41/86 (47%), Gaps = 4/86 (4%)
Query: 679 ISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLAT 738
+ +EYL IH DL N L+ V +SDFG+ + + +D+ + +
Sbjct: 109 VCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVL-DDEYTSSSGAKFP 164
Query: 739 IGYMAPEYGTKGRVSTRGDVCSFGII 764
+ + PE + S++ DV SFG++
Sbjct: 165 VKWSPPEVFNFSKYSSKSDVWSFGVL 190
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 6e-04
Identities = 28/68 (41%), Positives = 36/68 (52%), Gaps = 10/68 (14%)
Query: 683 LEYLHFGHSIPIIHCDLKPSNVLLDED-MVAHISDFGIAKLL----SGEDQLSKQTQTLA 737
L YLH IIH D+K +N+L+D I+DFG A L +G + Q Q L
Sbjct: 116 LSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEF--QGQLLG 170
Query: 738 TIGYMAPE 745
TI +MAPE
Sbjct: 171 TIAFMAPE 178
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 6e-04
Identities = 24/63 (38%), Positives = 33/63 (52%), Gaps = 2/63 (3%)
Query: 683 LEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYM 742
L L + H IIH DLK SN+LL + I+DFG+A+ + T + T+ Y
Sbjct: 118 LRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAK--PMTPKVVTLWYR 175
Query: 743 APE 745
APE
Sbjct: 176 APE 178
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 42.4 bits (99), Expect = 6e-04
Identities = 38/126 (30%), Positives = 57/126 (45%), Gaps = 17/126 (13%)
Query: 654 ERALKSFEDECEVRKRIRHRNLVKIISSSLE-----YLHFG--------HSIPIIHCDLK 700
+++L+ F+D V + + NL ++I L+ YL + HS IIH DLK
Sbjct: 88 QKSLEEFQDVYLVME-LMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLK 146
Query: 701 PSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCS 760
PSN+++ D I DFG+A+ + T + T Y APE D+ S
Sbjct: 147 PSNIVVKSDCTLKILDFGLARTAGTSFMM---TPYVVTRYYRAPEVILGMGYKENVDIWS 203
Query: 761 FGIISG 766
G I G
Sbjct: 204 VGCIMG 209
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 38.3 bits (90), Expect = 7e-04
Identities = 22/60 (36%), Positives = 35/60 (58%)
Query: 356 SLETILMANCSISGNIPQVVGNLSNLLVLELGGNNLTGPIPVTFSQLQTLQAFDLTRNKL 415
+L+++ ++N ++ L NL VL+L GNNLT P FS L +L++ DL+ N L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 37.9 bits (89), Expect = 7e-04
Identities = 23/61 (37%), Positives = 37/61 (60%), Gaps = 2/61 (3%)
Query: 77 SLQTLDLSHNKLSGNIPSSIFNMHTLKLLDFSDNQLFGSLSSFIF-NMSSMTTIDLSINR 135
+L++LDLS+N+L+ + + LK+LD S N L S+S F + S+ ++DLS N
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNL-TSISPEAFSGLPSLRSLDLSGNN 59
Query: 136 L 136
L
Sbjct: 60 L 60
|
Length = 60 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 7e-04
Identities = 35/106 (33%), Positives = 49/106 (46%), Gaps = 18/106 (16%)
Query: 640 NGMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVKIISSSLEYLHFGHSIPIIHCDL 699
NG E+ FH ER E R R +V S+LEYLH S +++ D+
Sbjct: 78 NGGEL---FFHLSRERVFT------EERARFYGAEIV----SALEYLH---SRDVVYRDI 121
Query: 700 KPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPE 745
K N++LD+D I+DFG+ K G + T Y+APE
Sbjct: 122 KLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPE 165
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 42.3 bits (100), Expect = 7e-04
Identities = 28/126 (22%), Positives = 49/126 (38%), Gaps = 14/126 (11%)
Query: 50 NSH-RVIGLNISSFNLQGT--ITPQLGNLSSLQTLDLSHNKLSGNI-----PSSIFNMHT 101
N + V+ LN + +G + L +L SL+ L+L N L+ + + +
Sbjct: 192 NCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNIS 251
Query: 102 LKLLDFSDNQL----FGSLSSFIFNMSSMTTIDLSINRLSGELPANICKIPSTLSKCKQL 157
L L S N + L+ + S+ +DL N+ E + S L +L
Sbjct: 252 LLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEEGAQLLA--ESLLEPGNEL 309
Query: 158 EELNLG 163
E L +
Sbjct: 310 ESLWVK 315
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 7e-04
Identities = 32/99 (32%), Positives = 47/99 (47%), Gaps = 9/99 (9%)
Query: 668 KRIRHRNLVKI---ISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLS 724
KRI L K+ + L YL H I +H D+KPSN+L++ + DFG+ S
Sbjct: 98 KRIPEEILGKVSIAVLRGLAYLREKHQI--MHRDVKPSNILVNSRGEIKLCDFGV----S 151
Query: 725 GEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGI 763
G+ S + T YM+PE S + D+ S G+
Sbjct: 152 GQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGL 190
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 8e-04
Identities = 22/64 (34%), Positives = 31/64 (48%), Gaps = 11/64 (17%)
Query: 690 HSIPIIHCDLKPSNVLLDEDMVAHI--SDFGIAKLLSGEDQLSKQTQTLATIGYMAPE-- 745
H + IH DLKP N L+D HI +DFG++K ++ + + YMAPE
Sbjct: 118 HELGYIHRDLKPENFLIDAS--GHIKLTDFGLSK-----GIVTYANSVVGSPDYMAPEVL 170
Query: 746 YGTK 749
G
Sbjct: 171 RGKG 174
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 37.5 bits (88), Expect = 0.001
Identities = 18/56 (32%), Positives = 28/56 (50%)
Query: 57 LNISSFNLQGTITPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLDFSDNQL 112
L++S+ L L +L+ LDLS N L+ P + + +L+ LD S N L
Sbjct: 5 LDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 0.001
Identities = 26/61 (42%), Positives = 33/61 (54%), Gaps = 4/61 (6%)
Query: 686 LHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTL-ATIGYMAP 744
L F HS II+ DLK NV+LD + I+DFG+ K K T+T T Y+AP
Sbjct: 114 LFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG---KTTRTFCGTPDYIAP 170
Query: 745 E 745
E
Sbjct: 171 E 171
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 0.001
Identities = 35/106 (33%), Positives = 50/106 (47%), Gaps = 18/106 (16%)
Query: 640 NGMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVKIISSSLEYLHFGHSIPIIHCDL 699
NG E+ +H Q ER C + R R I+S+L YLH S+ I++ DL
Sbjct: 79 NGGEL---FYHLQRER--------CFLEPRARF--YAAEIASALGYLH---SLNIVYRDL 122
Query: 700 KPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPE 745
KP N+LLD ++DFG+ K + + T Y+APE
Sbjct: 123 KPENILLDSQGHIVLTDFGLCK--ENIEHNGTTSTFCGTPEYLAPE 166
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 0.001
Identities = 25/85 (29%), Positives = 40/85 (47%), Gaps = 3/85 (3%)
Query: 679 ISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLAT 738
I+ + YL ++H DL NVL+ I+DFG+AKLL +++
Sbjct: 118 IAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVP 174
Query: 739 IGYMAPEYGTKGRVSTRGDVCSFGI 763
I +MA E + + DV S+G+
Sbjct: 175 IKWMALESILHRIYTHQSDVWSYGV 199
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.002
Identities = 29/102 (28%), Positives = 49/102 (48%), Gaps = 6/102 (5%)
Query: 665 EVRKRIRHRNLVKI---ISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAK 721
E + RI ++L+ I+ + YL + ++H DL NVL+ I+DFG+A+
Sbjct: 101 ENKDRIGSQDLLNWCVQIAKGMSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLAR 157
Query: 722 LLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGI 763
LL ++ I +MA E R + + DV S+G+
Sbjct: 158 LLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGV 199
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 0.002
Identities = 30/79 (37%), Positives = 42/79 (53%), Gaps = 20/79 (25%)
Query: 682 SLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHI--SDFGIAK--LLS-----GEDQLSKQ 732
+LEYLH + I+H DLKP N+L+ + HI +DFG++K L+S E + K
Sbjct: 113 ALEYLH---NYGIVHRDLKPDNLLITS--MGHIKLTDFGLSKIGLMSLTTNLYEGHIEKD 167
Query: 733 T------QTLATIGYMAPE 745
T Q T Y+APE
Sbjct: 168 TREFLDKQVCGTPEYIAPE 186
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 0.002
Identities = 24/76 (31%), Positives = 41/76 (53%), Gaps = 3/76 (3%)
Query: 690 HSIPIIHCDLKPSNVLLDED-MVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGT 748
H I+H D+K N+ L ++ MVA + DFGIA+ L+ +L+ + T Y++PE
Sbjct: 118 HDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAY--TCVGTPYYLSPEICQ 175
Query: 749 KGRVSTRGDVCSFGII 764
+ + D+ S G +
Sbjct: 176 NRPYNNKTDIWSLGCV 191
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.002
Identities = 24/97 (24%), Positives = 43/97 (44%), Gaps = 3/97 (3%)
Query: 668 KRIRHRNLVKIISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGED 727
+ + + I LE L + H+ IIH D+K N+ +++ I D G A+
Sbjct: 152 RPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP 211
Query: 728 QLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGII 764
T+ T APE + + +++ D+ S GI+
Sbjct: 212 AFLGLAGTVET---NAPEVLARDKYNSKADIWSAGIV 245
|
Length = 357 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.7 bits (96), Expect = 0.002
Identities = 21/49 (42%), Positives = 27/49 (55%), Gaps = 7/49 (14%)
Query: 683 LEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHI--SDFGIAKLLSGEDQL 729
LEYLH + I++ DLKP N+LL E HI SDF ++K E
Sbjct: 116 LEYLH---LLGIVYRDLKPENILLHES--GHIMLSDFDLSKQSDVEPPP 159
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.002
Identities = 24/81 (29%), Positives = 43/81 (53%), Gaps = 4/81 (4%)
Query: 686 LHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSG--EDQLSKQTQTLATIGYMA 743
+H HS +IH D+K +N+LL + + + DFG +K+ + D + + T Y+A
Sbjct: 156 VHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGR--TFCGTPYYVA 213
Query: 744 PEYGTKGRVSTRGDVCSFGII 764
PE + S + D+ S G++
Sbjct: 214 PEIWRRKPYSKKADMFSLGVL 234
|
Length = 496 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.002
Identities = 21/75 (28%), Positives = 40/75 (53%), Gaps = 2/75 (2%)
Query: 690 HSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTK 749
H I+H D+K N+ L +D + DFGIA++L+ +L++ + T Y++PE
Sbjct: 118 HDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELAR--TCIGTPYYLSPEICEN 175
Query: 750 GRVSTRGDVCSFGII 764
+ + D+ + G +
Sbjct: 176 RPYNNKSDIWALGCV 190
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.002
Identities = 30/99 (30%), Positives = 51/99 (51%), Gaps = 7/99 (7%)
Query: 673 RNLVK-IISSSLEYLHFGHSIPIIHCDLKPSNVLL----DEDMVAHISDFGIAKLLSGE- 726
R++VK ++ L+ +H+ H+ ++H DLKP+N+L+ E I+D G A+L +
Sbjct: 107 RSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPL 166
Query: 727 DQLSKQTQTLATIGYMAPEYGTKGRVSTRG-DVCSFGII 764
L+ + T Y APE R T+ D+ + G I
Sbjct: 167 KPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCI 205
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.003
Identities = 29/104 (27%), Positives = 49/104 (47%), Gaps = 7/104 (6%)
Query: 665 EVRKRIRHRNLVKIISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLS 724
E+ + + + + +LE L++ H IIH DLK N+L D ++DFG++
Sbjct: 95 ELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSA--K 152
Query: 725 GEDQLSKQTQTLATIGYMAPEY----GTKGR-VSTRGDVCSFGI 763
+ ++ + T +MAPE +K R + DV S GI
Sbjct: 153 NTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGI 196
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.003
Identities = 33/111 (29%), Positives = 52/111 (46%), Gaps = 7/111 (6%)
Query: 657 LKSFEDECEVRKRIRHRNLVKIISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVA-HIS 715
LK D + R + + L + + HS ++H DLKP N+L+D A ++
Sbjct: 87 LKKHMDSSPDFAK-NPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLA 145
Query: 716 DFGIAKLLSGEDQLSKQTQTLATIGYMAPE--YGTKGRVSTRGDVCSFGII 764
DFG+A+ + T + T+ Y APE G++ ST D+ S G I
Sbjct: 146 DFGLARAFG--IPVRTFTHEVVTLWYRAPEILLGSR-HYSTPVDIWSVGCI 193
|
Length = 294 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.003
Identities = 24/65 (36%), Positives = 36/65 (55%), Gaps = 7/65 (10%)
Query: 682 SLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTL-ATIG 740
+LE+LH I++ DLKP N+LLD + DFG++K +++ T T T
Sbjct: 108 ALEHLH---KYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKT---TNTFCGTTE 161
Query: 741 YMAPE 745
Y+APE
Sbjct: 162 YLAPE 166
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 0.003
Identities = 29/115 (25%), Positives = 50/115 (43%), Gaps = 11/115 (9%)
Query: 657 LKSFEDEC-----EVRKRIRHRNLVKI---ISSSLEYLHFGHSIPIIHCDLKPSNVLLDE 708
LK F +C + + + LV + I+ + YLH +IH D+ N ++DE
Sbjct: 96 LKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH---KRGVIHKDIAARNCVIDE 152
Query: 709 DMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGI 763
++ I+D +++ L D + +MA E S+ DV SFG+
Sbjct: 153 ELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGV 207
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.003
Identities = 30/99 (30%), Positives = 50/99 (50%), Gaps = 7/99 (7%)
Query: 673 RNLVK-IISSSLEYLHFGHSIPIIHCDLKPSNVLL----DEDMVAHISDFGIAKLLSGE- 726
R +VK ++ L+ +H+ H+ ++H DLKP+N+L+ E I+D G A+L +
Sbjct: 107 RGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPL 166
Query: 727 DQLSKQTQTLATIGYMAPEYGTKGRVSTRG-DVCSFGII 764
L+ + T Y APE R T+ D+ + G I
Sbjct: 167 KPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCI 205
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.003
Identities = 27/81 (33%), Positives = 40/81 (49%), Gaps = 6/81 (7%)
Query: 683 LEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYM 742
L YL H I +H D+KPSN+L++ + DFG+ SG+ S + T YM
Sbjct: 116 LTYLREKHKI--MHRDVKPSNILVNSRGEIKLCDFGV----SGQLIDSMANSFVGTRSYM 169
Query: 743 APEYGTKGRVSTRGDVCSFGI 763
+PE S + D+ S G+
Sbjct: 170 SPERLQGTHYSVQSDIWSMGL 190
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 0.003
Identities = 23/64 (35%), Positives = 34/64 (53%), Gaps = 1/64 (1%)
Query: 683 LEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSK-QTQTLATIGY 741
L L + H+ + H DLKP N+L + D I DFG+A++ + + T +AT Y
Sbjct: 113 LRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWY 172
Query: 742 MAPE 745
APE
Sbjct: 173 RAPE 176
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.004
Identities = 31/102 (30%), Positives = 50/102 (49%), Gaps = 4/102 (3%)
Query: 672 HRNLVKIISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSK 731
++ + LE L++ H +H D+K SN+LL+ ++DFG+A+L + E+
Sbjct: 115 EDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEES-RP 173
Query: 732 QTQTLATIGYMAPE--YGTKGRVSTRGDVCSFGIISGGKETR 771
T + T+ Y PE G + R DV S G I G T+
Sbjct: 174 YTNKVITLWYRPPELLLGEE-RYGPAIDVWSCGCILGELFTK 214
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 39.6 bits (93), Expect = 0.004
Identities = 34/110 (30%), Positives = 53/110 (48%), Gaps = 13/110 (11%)
Query: 679 ISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLAT 738
I+S + YL S+ +H DL N L+ ++ I+DFG+++ L D Q +
Sbjct: 139 IASGMRYLE---SLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLP 195
Query: 739 IGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGETCTPVRESKYE 788
I +MA E G+ +T+ DV +FG+ T+ E T RE YE
Sbjct: 196 IRWMAWESVLLGKFTTKSDVWAFGV----------TLWEILTLCREQPYE 235
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.004
Identities = 23/63 (36%), Positives = 34/63 (53%), Gaps = 9/63 (14%)
Query: 683 LEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYM 742
+E LH IIH D+KP N+L+D+ ++DFG LS +K + + T Y+
Sbjct: 110 VEDLH---QRGIIHRDIKPENLLIDQTGHLKLTDFG----LSRNGLENK--KFVGTPDYL 160
Query: 743 APE 745
APE
Sbjct: 161 APE 163
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
Conserved Domains Detected by HHsearch 
Original result of HHsearch against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 823 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 100.0 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 100.0 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 100.0 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 100.0 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 99.96 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 99.96 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 99.96 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 99.96 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 99.95 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 99.95 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 99.95 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 99.95 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 99.94 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 99.94 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 99.94 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 99.94 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 99.94 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 99.94 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 99.94 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 99.93 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 99.93 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 99.93 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 99.93 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 99.93 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 99.93 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.92 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 99.92 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 99.92 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 99.92 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 99.92 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 99.91 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 99.91 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 99.91 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 99.91 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.91 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.91 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 99.91 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 99.91 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 99.91 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.91 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.91 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 99.91 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 99.91 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.9 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 99.9 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.9 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.9 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 99.9 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.9 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 99.89 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.89 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 99.89 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 99.89 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 99.89 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.89 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 99.89 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 99.89 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 99.89 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 99.89 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 99.89 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 99.89 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 99.89 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 99.88 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 99.88 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 99.88 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 99.88 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 99.88 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.88 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 99.88 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 99.88 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 99.88 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 99.88 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 99.88 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.88 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 99.88 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 99.88 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.88 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 99.88 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.88 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 99.88 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 99.88 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 99.88 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 99.88 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 99.88 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 99.88 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 99.87 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 99.87 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 99.87 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.87 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 99.87 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.87 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.87 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 99.87 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 99.87 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 99.87 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 99.87 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 99.87 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 99.87 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 99.87 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 99.87 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.87 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 99.87 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 99.87 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.87 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 99.87 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 99.87 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 99.87 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 99.87 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.86 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 99.86 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 99.86 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 99.86 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 99.86 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 99.86 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 99.86 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 99.86 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 99.86 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 99.86 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 99.86 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 99.86 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 99.86 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.86 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 99.86 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 99.86 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 99.86 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 99.86 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 99.86 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 99.86 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 99.86 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 99.86 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 99.86 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 99.86 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 99.86 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 99.85 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 99.85 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 99.85 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 99.85 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 99.85 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 99.85 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 99.85 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 99.85 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 99.85 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 99.85 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 99.85 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.85 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 99.85 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 99.85 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 99.85 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.85 | |
| PTZ00284 | 467 | protein kinase; Provisional | 99.85 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.84 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 99.84 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 99.84 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 99.84 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.84 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 99.84 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 99.84 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.84 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 99.84 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 99.84 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 99.84 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 99.84 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.84 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 99.84 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.84 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 99.84 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 99.84 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 99.84 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 99.83 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 99.83 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 99.83 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 99.83 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 99.83 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.83 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 99.83 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 99.83 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.83 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 99.83 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 99.83 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.83 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 99.83 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 99.83 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 99.83 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.83 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 99.83 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 99.83 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.83 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 99.83 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.83 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 99.83 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.83 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 99.83 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.83 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 99.83 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 99.82 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 99.82 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.82 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 99.82 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 99.82 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 99.82 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 99.82 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 99.82 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 99.82 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 99.82 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.82 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 99.82 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 99.82 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.82 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 99.82 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 99.82 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 99.82 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 99.82 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 99.82 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 99.82 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 99.82 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.82 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.82 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 99.82 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 99.82 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 99.82 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 99.82 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 99.82 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 99.82 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 99.82 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 99.82 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 99.82 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 99.82 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 99.82 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 99.81 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 99.81 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.81 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 99.81 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 99.81 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 99.81 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 99.81 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.81 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 99.81 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.81 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 99.81 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 99.81 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 99.81 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.81 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 99.81 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.81 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.81 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 99.81 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.81 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 99.81 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 99.81 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.81 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.81 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.81 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 99.81 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 99.81 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 99.81 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 99.81 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 99.81 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 99.81 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 99.81 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 99.81 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.81 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.81 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 99.81 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.81 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 99.81 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.81 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.81 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.81 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.81 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 99.8 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.8 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 99.8 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 99.8 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.8 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 99.8 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.8 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 99.8 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 99.8 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.8 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.8 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.8 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 99.8 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 99.8 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 99.8 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 99.8 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 99.8 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 99.8 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 99.8 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.8 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 99.8 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 99.8 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 99.8 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.8 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.8 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.8 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 99.8 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 99.8 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 99.8 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 99.8 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.8 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 99.8 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 99.8 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 99.8 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.8 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.79 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 99.79 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 99.79 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 99.79 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 99.79 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.79 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.79 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.79 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 99.79 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.79 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.79 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.79 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 99.79 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.79 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 99.79 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.79 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.79 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 99.79 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.79 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 99.79 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.79 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.79 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.79 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 99.78 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 99.78 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 99.78 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.78 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.78 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.78 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.78 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.78 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.78 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.78 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.78 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.78 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.78 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.78 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.78 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.78 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.78 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.78 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.78 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.77 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.77 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.77 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.77 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.77 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.77 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 99.77 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.77 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.77 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.77 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.77 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.77 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.77 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.77 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.77 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.77 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.77 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.77 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.77 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.77 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.76 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.76 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 99.76 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.76 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.76 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.76 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.76 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.76 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.76 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.76 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.76 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.76 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.75 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.75 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.75 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.75 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.75 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.75 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.75 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.74 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.74 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.74 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.74 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.74 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.74 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.74 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.73 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.73 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.73 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.73 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.73 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.73 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.72 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.72 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.72 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.71 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.71 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.7 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.7 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.7 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.7 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.68 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.68 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.67 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.67 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.64 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.64 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.62 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.62 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.61 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.59 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.55 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.54 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.52 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.5 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.48 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.45 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.4 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.4 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.39 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.39 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.38 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.37 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.34 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.29 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.28 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.27 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.24 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.21 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.19 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.16 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.13 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.13 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.09 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.07 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.05 | |
| PF08263 | 43 | LRRNT_2: Leucine rich repeat N-terminal domain; In | 99.04 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.04 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.01 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 98.99 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 98.98 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 98.97 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 98.96 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 98.96 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 98.95 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 98.92 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 98.91 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 98.9 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 98.84 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 98.83 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 98.83 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 98.82 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.82 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.76 | |
| smart00090 | 237 | RIO RIO-like kinase. | 98.75 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.72 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 98.67 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 98.64 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 98.61 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.6 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 98.58 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 98.57 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 98.56 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.55 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.52 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 98.38 | |
| KOG2982 | 418 | consensus Uncharacterized conserved protein [Funct | 98.33 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.22 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.19 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 98.11 | |
| KOG2982 | 418 | consensus Uncharacterized conserved protein [Funct | 98.02 | |
| COG5238 | 388 | RNA1 Ran GTPase-activating protein (RanGAP) involv | 98.01 | |
| COG5238 | 388 | RNA1 Ran GTPase-activating protein (RanGAP) involv | 97.97 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 97.96 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 97.9 | |
| KOG2120 | 419 | consensus SCF ubiquitin ligase, Skp2 component [Po | 97.9 | |
| PF12799 | 44 | LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_ | 97.84 | |
| KOG2120 | 419 | consensus SCF ubiquitin ligase, Skp2 component [Po | 97.82 | |
| PF12799 | 44 | LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_ | 97.75 | |
| PRK15386 | 426 | type III secretion protein GogB; Provisional | 97.74 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 97.66 | |
| PRK15386 | 426 | type III secretion protein GogB; Provisional | 97.64 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 97.64 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 97.59 | |
| KOG1644 | 233 | consensus U2-associated snRNP A' protein [RNA proc | 97.55 | |
| KOG1644 | 233 | consensus U2-associated snRNP A' protein [RNA proc | 97.42 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 97.28 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-93 Score=888.10 Aligned_cols=736 Identities=31% Similarity=0.508 Sum_probs=507.6
Q ss_pred hHHHHHHHHHHHHhccCCCccccccccCCCCCCccceeeeeCCCCCcEEEEEcCCCCCccccCcccCCCCCCcEEEccCC
Q 045449 7 ISQHQQALLALKAHISYDHTNLFARNWTSSTSVCIWIGITCDVNSHRVIGLNISSFNLQGTITPQLGNLSSLQTLDLSHN 86 (823)
Q Consensus 7 ~~~~~~aLl~~k~~~~~~~~~~~~~~W~~~~~~c~w~gv~c~~~~~~v~~L~L~~~~l~g~~~~~l~~l~~L~~L~Ls~N 86 (823)
.++|++||++||+++. ||.+.+. +|+.+.|||.|.||+|++ +++|+.|||++++++|.+++.+..+++|++|||++|
T Consensus 27 ~~~~~~~l~~~~~~~~-~~~~~~~-~w~~~~~~c~w~gv~c~~-~~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~Ls~n 103 (968)
T PLN00113 27 HAEELELLLSFKSSIN-DPLKYLS-NWNSSADVCLWQGITCNN-SSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNN 103 (968)
T ss_pred CHHHHHHHHHHHHhCC-CCcccCC-CCCCCCCCCcCcceecCC-CCcEEEEEecCCCccccCChHHhCCCCCCEEECCCC
Confidence 4588999999999984 6777766 998888999999999985 569999999999999999999999999999999999
Q ss_pred CCCCCCCCCCC-CCCCCCEEECCCCcCcCCCchhhhcCCCCcEEecccccccCccCccccCCCCCCccccccceeeeccc
Q 045449 87 KLSGNIPSSIF-NMHTLKLLDFSDNQLFGSLSSFIFNMSSMTTIDLSINRLSGELPANICKIPSTLSKCKQLEELNLGFN 165 (823)
Q Consensus 87 ~l~g~~p~~~~-~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~p~~~~~l~~L~~L~Ls~N 165 (823)
+++|.+|..+. .+++|++|+|++|++++.+|. +.+++|++|+|++|.+++.+|..+ +++++|++|+|++|
T Consensus 104 ~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~--~~l~~L~~L~Ls~n~~~~~~p~~~-------~~l~~L~~L~L~~n 174 (968)
T PLN00113 104 QLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDI-------GSFSSLKVLDLGGN 174 (968)
T ss_pred ccCCcCChHHhccCCCCCEEECcCCccccccCc--cccCCCCEEECcCCcccccCChHH-------hcCCCCCEEECccC
Confidence 99999998765 888999999999988877775 457778888888887777666555 55566666666666
Q ss_pred eeeccCccccccchhhHHHHHhhcCCCcccCCcccCCcchhhhhccccccccCCccccccCCCCCcEEEccCCcccccCC
Q 045449 166 NLSGAIPKEIGNLTKLKEIISTITNSTVCEIPREIGNLPYLARLALATNNLVGVVPVTIFNMSALKEISLLNNSLSGSLP 245 (823)
Q Consensus 166 ~l~~~~p~~l~~l~~L~~L~~l~~n~~~~~ip~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~lp 245 (823)
.+++.+|..++++++|++|. +..|.+.+.+|..++++++|++|+|++|++++.+|..+.++++|++|++++|.+++.+|
T Consensus 175 ~l~~~~p~~~~~l~~L~~L~-L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p 253 (968)
T PLN00113 175 VLVGKIPNSLTNLTSLEFLT-LASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIP 253 (968)
T ss_pred cccccCChhhhhCcCCCeee-ccCCCCcCcCChHHcCcCCccEEECcCCccCCcCChhHhcCCCCCEEECcCceeccccC
Confidence 66666666666666666664 55555666666666666666666666666666566666666666666666666655555
Q ss_pred cccccCCCCccEEEeeccccccccCccccCCCCCCeEEeecccccccCCCccCCCcccCcccccCccccCCCCcc-----
Q 045449 246 SRIDLSLPNVETLNLGINSFSGTIPSSITNSSKLSDLELGENLFSGFIPNTIGNLRNLEFGNIADNYLTSSTPEL----- 320 (823)
Q Consensus 246 ~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~----- 320 (823)
..+.. +++|++|+|++|++++.+|..+.++++|++|+|++|.+++.+|..+.++++|++|++++|.+++..+..
T Consensus 254 ~~l~~-l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~ 332 (968)
T PLN00113 254 SSLGN-LKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLP 332 (968)
T ss_pred hhHhC-CCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCChhHcCCCCCcEEECCCCccCCcCChhHhcCC
Confidence 55443 555566666655555555555555555555555555555555555555555555555555555441100
Q ss_pred --------------cccccccCCCCceEEEeecCCCCccCCccccccccccceEEecCCcceeccCccccCcccccEEEc
Q 045449 321 --------------SFLSSLTNCKKLKVLIVTGNPLDGILPKSIGNFSLSLETILMANCSISGNIPQVVGNLSNLLVLEL 386 (823)
Q Consensus 321 --------------~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 386 (823)
..+..+..+++|+.|++++|.+++.+|.++..+ .+|+.|++++|.+.+.+|..+..+++|+.|++
T Consensus 333 ~L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~-~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L 411 (968)
T PLN00113 333 RLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSS-GNLFKLILFSNSLEGEIPKSLGACRSLRRVRL 411 (968)
T ss_pred CCCEEECcCCCCcCcCChHHhCCCCCcEEECCCCeeEeeCChhHhCc-CCCCEEECcCCEecccCCHHHhCCCCCCEEEC
Confidence 023344445555555555555555555555544 45555555566666666666666777777777
Q ss_pred ccCcCCCCchhcccccCCCCEEEccCCCCCCcchHhhhcCCC-----------------------CCEEEcccCcCcccc
Q 045449 387 GGNNLTGPIPVTFSQLQTLQAFDLTRNKLAGPITDELCHLAR-----------------------LHSLVLQGNKFSGSI 443 (823)
Q Consensus 387 s~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~-----------------------L~~L~Ls~N~l~g~~ 443 (823)
++|+++|.+|..|..++.|+.|++++|++++.+|..+..+++ |+.|+|++|++++.+
T Consensus 412 ~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~~~~~L~~L~ls~n~l~~~~ 491 (968)
T PLN00113 412 QDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGSKRLENLDLSRNQFSGAV 491 (968)
T ss_pred cCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCcccccccceEEECcCCccCCcc
Confidence 777777777777777777777777777777766665544444 445555566666667
Q ss_pred cccccCCCCCCeEeccCCccccccchhhhccCCCcEEeccccccccccCccccCCCCCcEEEcccCCCCCCCCCccc---
Q 045449 444 PSCLGNLTSVRVLYLGLNIFTSVLSSTIWNLKDILFIDVSSNFLDGPLSLDIGNLKVVIGLDFSRNNLSGDIPITIG--- 520 (823)
Q Consensus 444 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~~--- 520 (823)
|..+.++++|+.|+|++|++++.+|..+..+++|++|+|++|.++|.+|..+..++.|+.|||++|+++|.+|..+.
T Consensus 492 ~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~ 571 (968)
T PLN00113 492 PRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVE 571 (968)
T ss_pred ChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCc
Confidence 77777888889999999999999999999999999999999999999999999999999999999999999997653
Q ss_pred ------------CccCCCCCCCCCCCcccccCCcccCCCCCC-CCCCCCCCCCCCCCccccceeeeeehhHHHHHH--HH
Q 045449 521 ------------EGEIPRGGPFANLTAKSFMGNELLCGLPDL-QVSPCKPNKPNTHKKSRKMLLLVIVLPLSTALI--VV 585 (823)
Q Consensus 521 ------------~g~ip~~~~~~~~~~~~~~~n~~~c~~~~~-~~~~c~~~~~~~~~~~~~~~~~~iv~~~~~~l~--~~ 585 (823)
.|.+|..+++.++...++.||+.+|+.+.. ..++|... .+ ....+++++++++++++ ++
T Consensus 572 ~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~~~~c~~~----~~--~~~~~~~~~~~~~~~~~~~~~ 645 (968)
T PLN00113 572 SLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRV----RK--TPSWWFYITCTLGAFLVLALV 645 (968)
T ss_pred ccCEEeccCCcceeeCCCcchhcccChhhhcCCccccCCccccCCCCCccc----cc--cceeeeehhHHHHHHHHHHHH
Confidence 578999899999999999999999986532 33455321 11 11122222222111111 22
Q ss_pred HHHHHhhhhhhhcccCCCCCCCCCCC-----cccccccCHHHHHHHhccCCccceeeccC------------CeEEEEEE
Q 045449 586 VTLTLKWKLIKCWKSRTGPSNDGINS-----PQAIRRFSYHELLRATDRFSENNLIGIGN------------GMEVAVKV 648 (823)
Q Consensus 586 ~~~~~~~~~~r~~k~~~~~~~~~~~~-----~~~~~~~~~~~l~~at~~f~~~~~lg~g~------------~~~vavK~ 648 (823)
+++++++++++..+.+..+...+... ....+.++++++.. .|...+++|+|+ +..||||+
T Consensus 646 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~ 722 (968)
T PLN00113 646 AFGFVFIRGRNNLELKRVENEDGTWELQFFDSKVSKSITINDILS---SLKEENVISRGKKGASYKGKSIKNGMQFVVKE 722 (968)
T ss_pred HHHHHHHHhhhcccccccccccccccccccccccchhhhHHHHHh---hCCcccEEccCCCeeEEEEEECCCCcEEEEEE
Confidence 22222222222111111111111100 11123455555544 466778899875 56799998
Q ss_pred ehHhhHHHHHHHHHHHHHHhhcchhhHHH-------------------------------------HHHHHHHHhhhcC-
Q 045449 649 FHQQYERALKSFEDECEVRKRIRHRNLVK-------------------------------------IISSSLEYLHFGH- 690 (823)
Q Consensus 649 ~~~~~~~~~~~~~~E~~~l~~l~h~niv~-------------------------------------~~~~~l~~L~~~h- 690 (823)
+..... ....|++++++++|||||+ ++.+++++|+|+|
T Consensus 723 ~~~~~~----~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~l~~~~~~~i~~~ia~~L~yLH~ 798 (968)
T PLN00113 723 INDVNS----IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRNLSWERRRKIAIGIAKALRFLHC 798 (968)
T ss_pred ccCCcc----ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHhcCCHHHHHHHHHHHHHHHHHhcc
Confidence 864322 2235688999999999998 2345555566666
Q ss_pred --CCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCcccccCCCccccccceehhhhhhccc
Q 045449 691 --SIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGK 768 (823)
Q Consensus 691 --~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~ 768 (823)
+++|+|||+||+||+++.++.+++. ||.+...... ....||+.|+|||++.+..|+.++|||||||++||+
T Consensus 799 ~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el 871 (968)
T PLN00113 799 RCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD------TKCFISSAYVAPETRETKDITEKSDIYGFGLILIEL 871 (968)
T ss_pred CCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC------CCccccccccCcccccCCCCCcccchhhHHHHHHHH
Confidence 7899999999999999999888876 6665543211 224689999999999999999999999999999999
Q ss_pred cCCCCCcCC
Q 045449 769 ETRSMTVGE 777 (823)
Q Consensus 769 ~~~~~~~~~ 777 (823)
++|+.|++.
T Consensus 872 ~tg~~p~~~ 880 (968)
T PLN00113 872 LTGKSPADA 880 (968)
T ss_pred HhCCCCCCc
Confidence 999999854
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-58 Score=572.36 Aligned_cols=450 Identities=31% Similarity=0.503 Sum_probs=361.9
Q ss_pred cEEEEEcCCCCCccccCcccCCCCCCcEEEccCCCCCCCCCCCCCCCCCCCEEECCCCcCcCCCchhhhcCCCCcEEecc
Q 045449 53 RVIGLNISSFNLQGTITPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLDFSDNQLFGSLSSFIFNMSSMTTIDLS 132 (823)
Q Consensus 53 ~v~~L~L~~~~l~g~~~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 132 (823)
+++.|+|++|.+.+.+|..++++++|++|||++|.+.+.+|..|+++++|++|+|++|.+++.+|..++++++|++|+|+
T Consensus 141 ~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~ 220 (968)
T PLN00113 141 NLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLG 220 (968)
T ss_pred CCCEEECcCCcccccCChHHhcCCCCCEEECccCcccccCChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECc
Confidence 45556666666666666666666666666666666666666666666666666666666666666666666666666666
Q ss_pred cccccCccCccccCCCCCCccccccceeeeccceeeccCccccccchhhHHHHHhhcCCCcccCCcccCCcchhhhhccc
Q 045449 133 INRLSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKEIGNLTKLKEIISTITNSTVCEIPREIGNLPYLARLALA 212 (823)
Q Consensus 133 ~N~l~~~~p~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~~l~~n~~~~~ip~~l~~l~~L~~L~Ls 212 (823)
+|++++.+|..+ +++++|++|+|++|++++.+|..++++++|++|. +..|.+.+.+|..+.++++|++|+|+
T Consensus 221 ~n~l~~~~p~~l-------~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~-L~~n~l~~~~p~~l~~l~~L~~L~Ls 292 (968)
T PLN00113 221 YNNLSGEIPYEI-------GGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLF-LYQNKLSGPIPPSIFSLQKLISLDLS 292 (968)
T ss_pred CCccCCcCChhH-------hcCCCCCEEECcCceeccccChhHhCCCCCCEEE-CcCCeeeccCchhHhhccCcCEEECc
Confidence 666665555444 6677777777777777777777777777777775 66677777777777777777777777
Q ss_pred cccccCCccccccCCCCCcEEEccCCcccccCCcccccCCCCccEEEeeccccccccCccccCCCCCCeEEeeccccccc
Q 045449 213 TNNLVGVVPVTIFNMSALKEISLLNNSLSGSLPSRIDLSLPNVETLNLGINSFSGTIPSSITNSSKLSDLELGENLFSGF 292 (823)
Q Consensus 213 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 292 (823)
+|++.+.+|..+.++++|++|++++|.+++.+|..+.. +++|++|+|++|.+++.+|..++.+++|+.|++++|++++.
T Consensus 293 ~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~-l~~L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~ 371 (968)
T PLN00113 293 DNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTS-LPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGE 371 (968)
T ss_pred CCeeccCCChhHcCCCCCcEEECCCCccCCcCChhHhc-CCCCCEEECcCCCCcCcCChHHhCCCCCcEEECCCCeeEee
Confidence 77777777777777777777777777777777766554 77777777777777777777777777777777777777777
Q ss_pred CCCccCCCcccCcccccCccccCCCCcccccccccCCCCceEEEeecCCCCccCCccccccccccceEEecCCcceeccC
Q 045449 293 IPNTIGNLRNLEFGNIADNYLTSSTPELSFLSSLTNCKKLKVLIVTGNPLDGILPKSIGNFSLSLETILMANCSISGNIP 372 (823)
Q Consensus 293 ~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~p 372 (823)
+|..+..+++|+.|++++|++.+. .+..+..+++|+.|++++|++++.+|..+..+ +.|+.|++++|.+++.+|
T Consensus 372 ~p~~~~~~~~L~~L~l~~n~l~~~-----~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l-~~L~~L~Ls~N~l~~~~~ 445 (968)
T PLN00113 372 IPEGLCSSGNLFKLILFSNSLEGE-----IPKSLGACRSLRRVRLQDNSFSGELPSEFTKL-PLVYFLDISNNNLQGRIN 445 (968)
T ss_pred CChhHhCcCCCCEEECcCCEeccc-----CCHHHhCCCCCCEEECcCCEeeeECChhHhcC-CCCCEEECcCCcccCccC
Confidence 777777777777777777777766 55677888889999999999998888888888 689999999999999888
Q ss_pred ccccCcccccEEEcccCcCCCCchhcccccCCCCEEEccCCCCCCcchHhhhcCCCCCEEEcccCcCcccccccccCCCC
Q 045449 373 QVVGNLSNLLVLELGGNNLTGPIPVTFSQLQTLQAFDLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTS 452 (823)
Q Consensus 373 ~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~ 452 (823)
..+..+++|+.|+|++|++.|.+|..+ ..++|+.|+|++|++++.+|..|.++++|+.|+|++|++++.+|..+.++++
T Consensus 446 ~~~~~l~~L~~L~L~~n~~~~~~p~~~-~~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 524 (968)
T PLN00113 446 SRKWDMPSLQMLSLARNKFFGGLPDSF-GSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKK 524 (968)
T ss_pred hhhccCCCCcEEECcCceeeeecCccc-ccccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccC
Confidence 888889999999999999998888765 4588999999999999999999999999999999999999999999999999
Q ss_pred CCeEeccCCccccccchhhhccCCCcEEeccccccccccCccccCCCCCcEEEcccCCCCCCCCCc
Q 045449 453 VRVLYLGLNIFTSVLSSTIWNLKDILFIDVSSNFLDGPLSLDIGNLKVVIGLDFSRNNLSGDIPIT 518 (823)
Q Consensus 453 L~~L~Ls~N~l~~~~p~~~~~l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~ip~~ 518 (823)
|++|+|++|.+++.+|..+..+++|+.|||++|+++|.+|..+..++.|+.|++++|+++|.||..
T Consensus 525 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~ 590 (968)
T PLN00113 525 LVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPST 590 (968)
T ss_pred CCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCcceeeCCCc
Confidence 999999999999999999999999999999999999999999999999999999999999999975
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-44 Score=363.98 Aligned_cols=433 Identities=27% Similarity=0.421 Sum_probs=342.1
Q ss_pred EEEEEcCCCCCccccCcccCCCCCCcEEEccCCCCCCCCCCCCCCCCCCCEEECCCCcCcCCCchhhhcCCCCcEEeccc
Q 045449 54 VIGLNISSFNLQGTITPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLDFSDNQLFGSLSSFIFNMSSMTTIDLSI 133 (823)
Q Consensus 54 v~~L~L~~~~l~g~~~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 133 (823)
++.|++++|++. ++|++++.+..++.|+.++|+++ .+|..++++.+|+.|+.++|.+. ..|+.++.+..|+.||..+
T Consensus 70 l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~~s~n~~~-el~~~i~~~~~l~dl~~~~ 146 (565)
T KOG0472|consen 70 LTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISLVKLDCSSNELK-ELPDSIGRLLDLEDLDATN 146 (565)
T ss_pred eeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhhhhhhcccccee-ecCchHHHHhhhhhhhccc
Confidence 456666666666 55666666666666666666666 66666666666777777777665 4555666666677777777
Q ss_pred ccccCccCccccCCCCCCccccccceeeeccceeeccCccccccchhhHHHHHhhcCCCcccCCcccCCcchhhhhcccc
Q 045449 134 NRLSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKEIGNLTKLKEIISTITNSTVCEIPREIGNLPYLARLALAT 213 (823)
Q Consensus 134 N~l~~~~p~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~~l~~n~~~~~ip~~l~~l~~L~~L~Ls~ 213 (823)
|+++ . +|.++.++.+|..|++.+|++.. .|...-+++.|+++ ....+..+.+|..++.+.+|+.|+|..
T Consensus 147 N~i~-s-------lp~~~~~~~~l~~l~~~~n~l~~-l~~~~i~m~~L~~l--d~~~N~L~tlP~~lg~l~~L~~LyL~~ 215 (565)
T KOG0472|consen 147 NQIS-S-------LPEDMVNLSKLSKLDLEGNKLKA-LPENHIAMKRLKHL--DCNSNLLETLPPELGGLESLELLYLRR 215 (565)
T ss_pred cccc-c-------CchHHHHHHHHHHhhccccchhh-CCHHHHHHHHHHhc--ccchhhhhcCChhhcchhhhHHHHhhh
Confidence 7665 2 34445888899999999999984 44444458888888 456677889999999999999999999
Q ss_pred ccccCCccccccCCCCCcEEEccCCcccccCCcccccCCCCccEEEeeccccccccCccccCCCCCCeEEeecccccccC
Q 045449 214 NNLVGVVPVTIFNMSALKEISLLNNSLSGSLPSRIDLSLPNVETLNLGINSFSGTIPSSITNSSKLSDLELGENLFSGFI 293 (823)
Q Consensus 214 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 293 (823)
|+|. ..| .|..++.|++|+++.|+|. .+|......+++|.+|||..|+++ ..|+.++-+.+|+.||+|+|.+++ .
T Consensus 216 Nki~-~lP-ef~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN~is~-L 290 (565)
T KOG0472|consen 216 NKIR-FLP-EFPGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLRSLERLDLSNNDISS-L 290 (565)
T ss_pred cccc-cCC-CCCccHHHHHHHhcccHHH-hhHHHHhcccccceeeeccccccc-cCchHHHHhhhhhhhcccCCcccc-C
Confidence 9998 456 8999999999999999998 899999878999999999999998 789999999999999999999995 5
Q ss_pred CCccCCCcccCcccccCccccCCCCcc------------------------------------cccccccCCCCceEEEe
Q 045449 294 PNTIGNLRNLEFGNIADNYLTSSTPEL------------------------------------SFLSSLTNCKKLKVLIV 337 (823)
Q Consensus 294 p~~~~~l~~L~~L~L~~N~l~~~~~~~------------------------------------~~~~~l~~l~~L~~L~L 337 (823)
|.+++++ .|++|-+.+|.++.+..++ ........+-+.+.|++
T Consensus 291 p~sLgnl-hL~~L~leGNPlrTiRr~ii~~gT~~vLKyLrs~~~~dglS~se~~~e~~~t~~~~~~~~~~~~i~tkiL~~ 369 (565)
T KOG0472|consen 291 PYSLGNL-HLKFLALEGNPLRTIRREIISKGTQEVLKYLRSKIKDDGLSQSEGGTETAMTLPSESFPDIYAIITTKILDV 369 (565)
T ss_pred Ccccccc-eeeehhhcCCchHHHHHHHHcccHHHHHHHHHHhhccCCCCCCcccccccCCCCCCcccchhhhhhhhhhcc
Confidence 7789999 9999999999876431110 00111223456788888
Q ss_pred ecCCCCccCCccccccc--cccceEEecCCcceeccCccccCcccccE-EEcccCcCCCCchhcccccCCCCEEEccCCC
Q 045449 338 TGNPLDGILPKSIGNFS--LSLETILMANCSISGNIPQVVGNLSNLLV-LELGGNNLTGPIPVTFSQLQTLQAFDLTRNK 414 (823)
Q Consensus 338 s~N~l~~~~p~~~~~~~--~~L~~L~L~~N~l~~~~p~~~~~l~~L~~-L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~ 414 (823)
++-+++. +|...+... .-....+++.|++. .+|..+..++.+.+ +++++|.++ -+|..++.+++|..|+|++|-
T Consensus 370 s~~qlt~-VPdEVfea~~~~~Vt~VnfskNqL~-elPk~L~~lkelvT~l~lsnn~is-fv~~~l~~l~kLt~L~L~NN~ 446 (565)
T KOG0472|consen 370 SDKQLTL-VPDEVFEAAKSEIVTSVNFSKNQLC-ELPKRLVELKELVTDLVLSNNKIS-FVPLELSQLQKLTFLDLSNNL 446 (565)
T ss_pred ccccccc-CCHHHHHHhhhcceEEEecccchHh-hhhhhhHHHHHHHHHHHhhcCccc-cchHHHHhhhcceeeecccch
Confidence 8888884 566554431 12678899999998 67887777776654 556666654 888889999999999999998
Q ss_pred CCCcchHhhhcCCCCCEEEcccCcCcccccccccCCCCCCeEeccCCccccccchhhhccCCCcEEeccccccccccCcc
Q 045449 415 LAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSVRVLYLGLNIFTSVLSSTIWNLKDILFIDVSSNFLDGPLSLD 494 (823)
Q Consensus 415 l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~LdLs~N~l~g~~p~~ 494 (823)
+. .+|..++.+..|+.||+|.|+|. .+|.+...+..++.+-.++|++..+.|+.+.+|.+|..|||.+|.+. .||+.
T Consensus 447 Ln-~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~tLDL~nNdlq-~IPp~ 523 (565)
T KOG0472|consen 447 LN-DLPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQTLETLLASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQ-QIPPI 523 (565)
T ss_pred hh-hcchhhhhhhhhheecccccccc-cchHHHhhHHHHHHHHhccccccccChHHhhhhhhcceeccCCCchh-hCChh
Confidence 87 77888999999999999999998 78988888877887777789998888888999999999999999997 78999
Q ss_pred ccCCCCCcEEEcccCCCC
Q 045449 495 IGNLKVVIGLDFSRNNLS 512 (823)
Q Consensus 495 ~~~l~~L~~L~ls~N~l~ 512 (823)
+++|++|++|++++|+|.
T Consensus 524 LgnmtnL~hLeL~gNpfr 541 (565)
T KOG0472|consen 524 LGNMTNLRHLELDGNPFR 541 (565)
T ss_pred hccccceeEEEecCCccC
Confidence 999999999999999998
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-43 Score=355.74 Aligned_cols=451 Identities=27% Similarity=0.386 Sum_probs=380.3
Q ss_pred EEEEEcCCCCCccccCcccCCCCCCcEEEccCCCCCCCCCCCCCCCCCCCEEECCCCcCcCCCchhhhcCCCCcEEeccc
Q 045449 54 VIGLNISSFNLQGTITPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLDFSDNQLFGSLSSFIFNMSSMTTIDLSI 133 (823)
Q Consensus 54 v~~L~L~~~~l~g~~~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 133 (823)
+..|++++|.+. .+.+.+.+|..|.+|++++|+++ ..|++++.+..++.|+.|+|+++ .+|.+++++.+|+.|+.++
T Consensus 47 l~~lils~N~l~-~l~~dl~nL~~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~~s~ 123 (565)
T KOG0472|consen 47 LQKLILSHNDLE-VLREDLKNLACLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISLVKLDCSS 123 (565)
T ss_pred hhhhhhccCchh-hccHhhhcccceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhhhhhhccc
Confidence 567899999998 56677899999999999999998 88999999999999999999997 7899999999999999999
Q ss_pred ccccCccCccccCCCCCCccccccceeeeccceeeccCccccccchhhHHHHHhhcCCCcccCCcccCCcchhhhhcccc
Q 045449 134 NRLSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKEIGNLTKLKEIISTITNSTVCEIPREIGNLPYLARLALAT 213 (823)
Q Consensus 134 N~l~~~~p~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~~l~~n~~~~~ip~~l~~l~~L~~L~Ls~ 213 (823)
|.+. .+|++ ++.+..|+.|+..+|+++ ..|..+.++.+|..+. +.+|.+....|..+. ++.|++||...
T Consensus 124 n~~~-el~~~-------i~~~~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~-~~~n~l~~l~~~~i~-m~~L~~ld~~~ 192 (565)
T KOG0472|consen 124 NELK-ELPDS-------IGRLLDLEDLDATNNQIS-SLPEDMVNLSKLSKLD-LEGNKLKALPENHIA-MKRLKHLDCNS 192 (565)
T ss_pred ccee-ecCch-------HHHHhhhhhhhccccccc-cCchHHHHHHHHHHhh-ccccchhhCCHHHHH-HHHHHhcccch
Confidence 9998 44444 489999999999999998 7899999999999886 777777665555555 99999999999
Q ss_pred ccccCCccccccCCCCCcEEEccCCcccccCCcccccCCCCccEEEeeccccccccCcccc-CCCCCCeEEeeccccccc
Q 045449 214 NNLVGVVPVTIFNMSALKEISLLNNSLSGSLPSRIDLSLPNVETLNLGINSFSGTIPSSIT-NSSKLSDLELGENLFSGF 292 (823)
Q Consensus 214 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~~ 292 (823)
|-++ .+|..++.|.+|.-|||.+|++. .+| .+. ++..|.+|+++.|+|+ .+|.+.+ ++++|.+|||.+|+++ .
T Consensus 193 N~L~-tlP~~lg~l~~L~~LyL~~Nki~-~lP-ef~-gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLRdNklk-e 266 (565)
T KOG0472|consen 193 NLLE-TLPPELGGLESLELLYLRRNKIR-FLP-EFP-GCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDLRDNKLK-E 266 (565)
T ss_pred hhhh-cCChhhcchhhhHHHHhhhcccc-cCC-CCC-ccHHHHHHHhcccHHH-hhHHHHhcccccceeeeccccccc-c
Confidence 9988 67889999999999999999998 888 444 4889999999999998 6676665 8999999999999999 6
Q ss_pred CCCccCCCcccCcccccCccccCCCCcccccccccCCCCceEEEeecCCCCcc---------------------------
Q 045449 293 IPNTIGNLRNLEFGNIADNYLTSSTPELSFLSSLTNCKKLKVLIVTGNPLDGI--------------------------- 345 (823)
Q Consensus 293 ~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~--------------------------- 345 (823)
.|+.++-+.+|++||+|+|.+++. |.+++++ .|+.|.+.+|.+..+
T Consensus 267 ~Pde~clLrsL~rLDlSNN~is~L------p~sLgnl-hL~~L~leGNPlrTiRr~ii~~gT~~vLKyLrs~~~~dglS~ 339 (565)
T KOG0472|consen 267 VPDEICLLRSLERLDLSNNDISSL------PYSLGNL-HLKFLALEGNPLRTIRREIISKGTQEVLKYLRSKIKDDGLSQ 339 (565)
T ss_pred CchHHHHhhhhhhhcccCCccccC------Ccccccc-eeeehhhcCCchHHHHHHHHcccHHHHHHHHHHhhccCCCCC
Confidence 799999999999999999999996 5578999 999999999998642
Q ss_pred ----------CCc-cccc--cccccceEEecCCcceeccCccccCc--ccccEEEcccCcCCCCchhcccccCCCCEE-E
Q 045449 346 ----------LPK-SIGN--FSLSLETILMANCSISGNIPQVVGNL--SNLLVLELGGNNLTGPIPVTFSQLQTLQAF-D 409 (823)
Q Consensus 346 ----------~p~-~~~~--~~~~L~~L~L~~N~l~~~~p~~~~~l--~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L-~ 409 (823)
.|. .+.+ ...+.+.|+++.-+++.+....|..- .-.+.++++.|++. ++|..+..++.+.+. +
T Consensus 340 se~~~e~~~t~~~~~~~~~~~~i~tkiL~~s~~qlt~VPdEVfea~~~~~Vt~VnfskNqL~-elPk~L~~lkelvT~l~ 418 (565)
T KOG0472|consen 340 SEGGTETAMTLPSESFPDIYAIITTKILDVSDKQLTLVPDEVFEAAKSEIVTSVNFSKNQLC-ELPKRLVELKELVTDLV 418 (565)
T ss_pred CcccccccCCCCCCcccchhhhhhhhhhcccccccccCCHHHHHHhhhcceEEEecccchHh-hhhhhhHHHHHHHHHHH
Confidence 000 0100 01357788888888885444444332 23788999999998 889888887777554 4
Q ss_pred ccCCCCCCcchHhhhcCCCCCEEEcccCcCcccccccccCCCCCCeEeccCCccccccchhhhccCCCcEEecccccccc
Q 045449 410 LTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSVRVLYLGLNIFTSVLSSTIWNLKDILFIDVSSNFLDG 489 (823)
Q Consensus 410 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~LdLs~N~l~g 489 (823)
+++|.+ +.+|..++.+++|..|+|++|-+. .+|..++.+..|+.||+|.|+|.- +|..+..+..++.+-.++|++..
T Consensus 419 lsnn~i-sfv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr~-lP~~~y~lq~lEtllas~nqi~~ 495 (565)
T KOG0472|consen 419 LSNNKI-SFVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFRM-LPECLYELQTLETLLASNNQIGS 495 (565)
T ss_pred hhcCcc-ccchHHHHhhhcceeeecccchhh-hcchhhhhhhhhheeccccccccc-chHHHhhHHHHHHHHhccccccc
Confidence 555555 588999999999999999999998 789999999999999999999976 89999999999999999999987
Q ss_pred ccCccccCCCCCcEEEcccCCCCCCCCCcccCccCCCCCCCCCCCcccccCCccc
Q 045449 490 PLSLDIGNLKVVIGLDFSRNNLSGDIPITIGEGEIPRGGPFANLTAKSFMGNELL 544 (823)
Q Consensus 490 ~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~~~g~ip~~~~~~~~~~~~~~~n~~~ 544 (823)
.-|..+.+|..|..|||.+|.+. .||..+ +.+.++....+.|||+-
T Consensus 496 vd~~~l~nm~nL~tLDL~nNdlq-~IPp~L--------gnmtnL~hLeL~gNpfr 541 (565)
T KOG0472|consen 496 VDPSGLKNMRNLTTLDLQNNDLQ-QIPPIL--------GNMTNLRHLELDGNPFR 541 (565)
T ss_pred cChHHhhhhhhcceeccCCCchh-hCChhh--------ccccceeEEEecCCccC
Confidence 66667999999999999999998 333333 56788888999999864
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=343.50 Aligned_cols=372 Identities=22% Similarity=0.253 Sum_probs=259.1
Q ss_pred CCEEECCCCcCcCCCchhhhcCCCCcEEecccccccCccCccccCCCCCCccccccceeeeccceeeccCccccccchhh
Q 045449 102 LKLLDFSDNQLFGSLSSFIFNMSSMTTIDLSINRLSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKEIGNLTKL 181 (823)
Q Consensus 102 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L 181 (823)
-+.||||+|.|+...+..|.++++|+.+.|..|.++ .||. ..+...+|+.|+|.+|.++..-..++
T Consensus 80 t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~-------f~~~sghl~~L~L~~N~I~sv~se~L------ 145 (873)
T KOG4194|consen 80 TQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPR-------FGHESGHLEKLDLRHNLISSVTSEEL------ 145 (873)
T ss_pred eeeeeccccccccCcHHHHhcCCcceeeeeccchhh-hccc-------ccccccceeEEeeeccccccccHHHH------
Confidence 345777777777777777777777777777777766 3333 22444557777777777663322222
Q ss_pred HHHHHhhcCCCcccCCcccCCcchhhhhccccccccCCccccccCCCCCcEEEccCCcccccCCcccccCCCCccEEEee
Q 045449 182 KEIISTITNSTVCEIPREIGNLPYLARLALATNNLVGVVPVTIFNMSALKEISLLNNSLSGSLPSRIDLSLPNVETLNLG 261 (823)
Q Consensus 182 ~~L~~l~~n~~~~~ip~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~Ls 261 (823)
..++.|+.||||.|.|+.+.-.+|..-.++++|+|++|.|+ .+-..-|.++.+|.+|.|+
T Consensus 146 -------------------~~l~alrslDLSrN~is~i~~~sfp~~~ni~~L~La~N~It-~l~~~~F~~lnsL~tlkLs 205 (873)
T KOG4194|consen 146 -------------------SALPALRSLDLSRNLISEIPKPSFPAKVNIKKLNLASNRIT-TLETGHFDSLNSLLTLKLS 205 (873)
T ss_pred -------------------HhHhhhhhhhhhhchhhcccCCCCCCCCCceEEeecccccc-ccccccccccchheeeecc
Confidence 23344555566666665444445555555666666666665 4444444445566666666
Q ss_pred ccccccccCccccCCCCCCeEEeecccccccCCCccCCCcccCcccccCccccCCCCcccccccccCCCCceEEEeecCC
Q 045449 262 INSFSGTIPSSITNSSKLSDLELGENLFSGFIPNTIGNLRNLEFGNIADNYLTSSTPELSFLSSLTNCKKLKVLIVTGNP 341 (823)
Q Consensus 262 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~ 341 (823)
.|+++...+..|.++++|+.|+|..|+|.-..--.|.+|++|+.|.|..|.++... ...|..|.+++.|+|+.|+
T Consensus 206 rNrittLp~r~Fk~L~~L~~LdLnrN~irive~ltFqgL~Sl~nlklqrN~I~kL~-----DG~Fy~l~kme~l~L~~N~ 280 (873)
T KOG4194|consen 206 RNRITTLPQRSFKRLPKLESLDLNRNRIRIVEGLTFQGLPSLQNLKLQRNDISKLD-----DGAFYGLEKMEHLNLETNR 280 (873)
T ss_pred cCcccccCHHHhhhcchhhhhhccccceeeehhhhhcCchhhhhhhhhhcCccccc-----Ccceeeecccceeecccch
Confidence 66666444455555666666666666665444455666666666666666666552 2356677777777777777
Q ss_pred CCccCCccccccccccceEEecCCcceeccCccccCcccccEEEcccCcCCCCchhcccccCCCCEEEccCCCCCCcchH
Q 045449 342 LDGILPKSIGNFSLSLETILMANCSISGNIPQVVGNLSNLLVLELGGNNLTGPIPVTFSQLQTLQAFDLTRNKLAGPITD 421 (823)
Q Consensus 342 l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 421 (823)
++.....|+.++ .+|+.|+||+|.|..+.++...-+++|.+||||+|+++...+..|..+..|+.|+|++|+++..-..
T Consensus 281 l~~vn~g~lfgL-t~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~ 359 (873)
T KOG4194|consen 281 LQAVNEGWLFGL-TSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEG 359 (873)
T ss_pred hhhhhccccccc-chhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhh
Confidence 777777777777 6788888888888877788888888888888888888877777888888888888888888877677
Q ss_pred hhhcCCCCCEEEcccCcCcccccc---cccCCCCCCeEeccCCccccccchhhhccCCCcEEeccccccccccCccccCC
Q 045449 422 ELCHLARLHSLVLQGNKFSGSIPS---CLGNLTSVRVLYLGLNIFTSVLSSTIWNLKDILFIDVSSNFLDGPLSLDIGNL 498 (823)
Q Consensus 422 ~~~~l~~L~~L~Ls~N~l~g~~p~---~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~LdLs~N~l~g~~p~~~~~l 498 (823)
.|..+++|+.|||++|.+++.|-+ .|..+++|+.|+|.+|++..+.-..|.++..|+.|||.+|.|...-|..|..|
T Consensus 360 af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m 439 (873)
T KOG4194|consen 360 AFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPM 439 (873)
T ss_pred HHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceeeecchhhhccCcccceecCCCCcceeecccccccc
Confidence 788888888888888888877754 47778888888888888888777888888888999999888888888888888
Q ss_pred CCCcEEEcccCCCCCC
Q 045449 499 KVVIGLDFSRNNLSGD 514 (823)
Q Consensus 499 ~~L~~L~ls~N~l~g~ 514 (823)
.|+.|-+..-.|-++
T Consensus 440 -~Lk~Lv~nSssflCD 454 (873)
T KOG4194|consen 440 -ELKELVMNSSSFLCD 454 (873)
T ss_pred -hhhhhhhcccceEEe
Confidence 788777765554433
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-40 Score=346.25 Aligned_cols=370 Identities=24% Similarity=0.272 Sum_probs=248.4
Q ss_pred CCcEEEccCCCCCCCCCCCCCCCCCCCEEECCCCcCcCCCchhhhcCCCCcEEecccccccCccCccccCCCCCCccccc
Q 045449 77 SLQTLDLSHNKLSGNIPSSIFNMHTLKLLDFSDNQLFGSLSSFIFNMSSMTTIDLSINRLSGELPANICKIPSTLSKCKQ 156 (823)
Q Consensus 77 ~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~p~~~~~l~~ 156 (823)
.-+.||+++|.++-+.+..|.++++|+.++|.+|.++ .+|...+...+|+.|+|.+|.|+..-.+.+ ..++.
T Consensus 79 ~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L~~N~I~sv~se~L-------~~l~a 150 (873)
T KOG4194|consen 79 QTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDLRHNLISSVTSEEL-------SALPA 150 (873)
T ss_pred ceeeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEeeeccccccccHHHH-------HhHhh
Confidence 3466888888887777777778888888888888776 566666666668888888887775444444 66677
Q ss_pred cceeeeccceeeccCccccccchhhHHHHHhhcCCCcccCCcccCCcchhhhhccccccccCCccccccCCCCCcEEEcc
Q 045449 157 LEELNLGFNNLSGAIPKEIGNLTKLKEIISTITNSTVCEIPREIGNLPYLARLALATNNLVGVVPVTIFNMSALKEISLL 236 (823)
Q Consensus 157 L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~~l~~n~~~~~ip~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 236 (823)
|+.||||.|.++ .+|. ..|..-.++++|+|++|.|+....+.|.++.+|..|.|+
T Consensus 151 lrslDLSrN~is-~i~~------------------------~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLs 205 (873)
T KOG4194|consen 151 LRSLDLSRNLIS-EIPK------------------------PSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLS 205 (873)
T ss_pred hhhhhhhhchhh-cccC------------------------CCCCCCCCceEEeeccccccccccccccccchheeeecc
Confidence 888888888776 3331 122333456666777777776666666666677777777
Q ss_pred CCcccccCCcccccCCCCccEEEeeccccccccCccccCCCCCCeEEeecccccccCCCccCCCcccCcccccCccccCC
Q 045449 237 NNSLSGSLPSRIDLSLPNVETLNLGINSFSGTIPSSITNSSKLSDLELGENLFSGFIPNTIGNLRNLEFGNIADNYLTSS 316 (823)
Q Consensus 237 ~N~l~g~lp~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 316 (823)
+|.++ .+|...|..+++|+.|+|..|+|.-.--..|.++++|+.|.|..|.++..-...|..+.++++|+|+.|+++..
T Consensus 206 rNrit-tLp~r~Fk~L~~L~~LdLnrN~irive~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~v 284 (873)
T KOG4194|consen 206 RNRIT-TLPQRSFKRLPKLESLDLNRNRIRIVEGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAV 284 (873)
T ss_pred cCccc-ccCHHHhhhcchhhhhhccccceeeehhhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhh
Confidence 77776 66666666677777777777776644455666677777777777777666666677777777777777776665
Q ss_pred CCcccccccccCCCCceEEEeecCCCCccCCccccccccccceEEecCCcceeccCccccCcccccEEEcccCcCCCCch
Q 045449 317 TPELSFLSSLTNCKKLKVLIVTGNPLDGILPKSIGNFSLSLETILMANCSISGNIPQVVGNLSNLLVLELGGNNLTGPIP 396 (823)
Q Consensus 317 ~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p 396 (823)
. -.++.++++|+.|+||+|.|..+-++.+.-. ++|++|+|++|+|+...+..|..+..|++|+|++|+++..-.
T Consensus 285 n-----~g~lfgLt~L~~L~lS~NaI~rih~d~Wsft-qkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e 358 (873)
T KOG4194|consen 285 N-----EGWLFGLTSLEQLDLSYNAIQRIHIDSWSFT-QKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAE 358 (873)
T ss_pred h-----cccccccchhhhhccchhhhheeecchhhhc-ccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHh
Confidence 3 2356666777777777777766666555544 567777777777776666777777777777777777765555
Q ss_pred hcccccCCCCEEEccCCCCCCcchH---hhhcCCCCCEEEcccCcCcccccccccCCCCCCeEeccCCccccccchhhhc
Q 045449 397 VTFSQLQTLQAFDLTRNKLAGPITD---ELCHLARLHSLVLQGNKFSGSIPSCLGNLTSVRVLYLGLNIFTSVLSSTIWN 473 (823)
Q Consensus 397 ~~~~~l~~L~~L~Ls~N~l~~~~p~---~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 473 (823)
..|..+++|+.|||++|.|++.+-+ .|..|+.|+.|+|.+|++....-.+|.++..|+.|||.+|.+..+-|..|..
T Consensus 359 ~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~ 438 (873)
T KOG4194|consen 359 GAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEP 438 (873)
T ss_pred hHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceeeecchhhhccCcccceecCCCCcceeeccccccc
Confidence 5666777777777777777665543 3566777777777777777444456777777777777777777777777766
Q ss_pred cCCCcEEecccccc
Q 045449 474 LKDILFIDVSSNFL 487 (823)
Q Consensus 474 l~~L~~LdLs~N~l 487 (823)
+ .|+.|-++.-.+
T Consensus 439 m-~Lk~Lv~nSssf 451 (873)
T KOG4194|consen 439 M-ELKELVMNSSSF 451 (873)
T ss_pred c-hhhhhhhcccce
Confidence 6 666665544433
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-37 Score=324.24 Aligned_cols=364 Identities=24% Similarity=0.356 Sum_probs=271.8
Q ss_pred CCCCEEECCCCcCc-CCCchhhhcCCCCcEEecccccccCccCccccCCCCCCccccccceeeeccceeeccCccccccc
Q 045449 100 HTLKLLDFSDNQLF-GSLSSFIFNMSSMTTIDLSINRLSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKEIGNL 178 (823)
Q Consensus 100 ~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l 178 (823)
+-.+-.|+|+|.++ +.+|.....+++++.|.|.+.++. .+|+ .++.+.+|++|.+++|++. .+..++..|
T Consensus 7 pFVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPe-------EL~~lqkLEHLs~~HN~L~-~vhGELs~L 77 (1255)
T KOG0444|consen 7 PFVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPE-------ELSRLQKLEHLSMAHNQLI-SVHGELSDL 77 (1255)
T ss_pred ceeecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChH-------HHHHHhhhhhhhhhhhhhH-hhhhhhccc
Confidence 34455666666666 356666666777777777666654 3333 3366777777777777776 455666666
Q ss_pred hhhHHHHHhhcCCC-cccCCcccCCcchhhhhccccccccCCccccccCCCCCcEEEccCCcccccCCcccccCCCCccE
Q 045449 179 TKLKEIISTITNST-VCEIPREIGNLPYLARLALATNNLVGVVPVTIFNMSALKEISLLNNSLSGSLPSRIDLSLPNVET 257 (823)
Q Consensus 179 ~~L~~L~~l~~n~~-~~~ip~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~lp~~~~~~l~~L~~ 257 (823)
+.|+.++ ...|++ ..-||..+..+..|+.||||+|+++ ..|..+..-+++-.|+||+|+|. +||..++..+..|-+
T Consensus 78 p~LRsv~-~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~Ie-tIPn~lfinLtDLLf 154 (1255)
T KOG0444|consen 78 PRLRSVI-VRDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIE-TIPNSLFINLTDLLF 154 (1255)
T ss_pred hhhHHHh-hhccccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccc-cCCchHHHhhHhHhh
Confidence 6666665 334433 3457788888888888999999988 56778888888888999999987 888888888888888
Q ss_pred EEeeccccccccCccccCCCCCCeEEeecccccccCCCccCCCcccCcccccCccccCCCCcccccccccCCCCceEEEe
Q 045449 258 LNLGINSFSGTIPSSITNSSKLSDLELGENLFSGFIPNTIGNLRNLEFGNIADNYLTSSTPELSFLSSLTNCKKLKVLIV 337 (823)
Q Consensus 258 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~L 337 (823)
||||+|++. .+|+.+..+..|++|+||+|.+.-.--..+-.+++|+.|.+++.+-+-. .+|.++..+.+|..+|+
T Consensus 155 LDLS~NrLe-~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~----N~Ptsld~l~NL~dvDl 229 (1255)
T KOG0444|consen 155 LDLSNNRLE-MLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLD----NIPTSLDDLHNLRDVDL 229 (1255)
T ss_pred hccccchhh-hcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhh----cCCCchhhhhhhhhccc
Confidence 999999887 6777888888889999999887765555566677888888887765543 26777888888888888
Q ss_pred ecCCCCccCCccccccccccceEEecCCcceeccCccccCcccccEEEcccCcCCCCchhcccccCCCCEEEccCCCCCC
Q 045449 338 TGNPLDGILPKSIGNFSLSLETILMANCSISGNIPQVVGNLSNLLVLELGGNNLTGPIPVTFSQLQTLQAFDLTRNKLAG 417 (823)
Q Consensus 338 s~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~ 417 (823)
|.|.+. .+|..+.++ .+|+.|+||+|+|+. +....+...+|++|+||.|+++ .+|+.+.+++.|+.|.+.+|+++-
T Consensus 230 S~N~Lp-~vPecly~l-~~LrrLNLS~N~ite-L~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~F 305 (1255)
T KOG0444|consen 230 SENNLP-IVPECLYKL-RNLRRLNLSGNKITE-LNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTF 305 (1255)
T ss_pred cccCCC-cchHHHhhh-hhhheeccCcCceee-eeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCcccc
Confidence 888887 567777777 678888888888873 3444556677888888888887 678888888888888888887763
Q ss_pred -cchHhhhcCCCCCEEEcccCcCcccccccccCCCCCCeEeccCCccccccchhhhccCCCcEEeccccc
Q 045449 418 -PITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSVRVLYLGLNIFTSVLSSTIWNLKDILFIDVSSNF 486 (823)
Q Consensus 418 -~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~LdLs~N~ 486 (823)
-+|..++.+.+|+.+..++|.+. .+|..+..+..|+.|.|+.|++-. .|..+.-++.|.+|||..|.
T Consensus 306 eGiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLiT-LPeaIHlL~~l~vLDlreNp 373 (1255)
T KOG0444|consen 306 EGIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLIT-LPEAIHLLPDLKVLDLRENP 373 (1255)
T ss_pred cCCccchhhhhhhHHHHhhccccc-cCchhhhhhHHHHHhcccccceee-chhhhhhcCCcceeeccCCc
Confidence 36777788888888888888876 778888888888888888888765 67777778888888888775
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=334.00 Aligned_cols=422 Identities=25% Similarity=0.287 Sum_probs=280.1
Q ss_pred EEEEEcCCCCCccccCcccCCCCCCcEEEccCCCCCCCCCCCCCCCCCCCEEECCCCcCcCCCchhhhcCCCCcEEeccc
Q 045449 54 VIGLNISSFNLQGTITPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLDFSDNQLFGSLSSFIFNMSSMTTIDLSI 133 (823)
Q Consensus 54 v~~L~L~~~~l~g~~~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 133 (823)
+.+||+++|.+. ..|..+..+.+|+.|+++.|.|. ..|.+..++++|++|+|.+|.+. ..|..+..+.+|++||+|.
T Consensus 47 L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~i~-~vp~s~~~~~~l~~lnL~~n~l~-~lP~~~~~lknl~~LdlS~ 123 (1081)
T KOG0618|consen 47 LKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNYIR-SVPSSCSNMRNLQYLNLKNNRLQ-SLPASISELKNLQYLDLSF 123 (1081)
T ss_pred eEEeeccccccc-cCCchhhhHHHHhhcccchhhHh-hCchhhhhhhcchhheeccchhh-cCchhHHhhhcccccccch
Confidence 566666666654 55666666666777777777666 55666666667777777766664 5666666667777777777
Q ss_pred ccccCccCccccCCCCCCccccccceeeeccc-------------------eeeccCccccccchhhHHHHHhhcCCCcc
Q 045449 134 NRLSGELPANICKIPSTLSKCKQLEELNLGFN-------------------NLSGAIPKEIGNLTKLKEIISTITNSTVC 194 (823)
Q Consensus 134 N~l~~~~p~~~~~~p~~~~~l~~L~~L~Ls~N-------------------~l~~~~p~~l~~l~~L~~L~~l~~n~~~~ 194 (823)
|++. .+|.-+ ..++.++.+..++| .+.+.++.++..++. .|+ +.+|...
T Consensus 124 N~f~-~~Pl~i-------~~lt~~~~~~~s~N~~~~~lg~~~ik~~~l~~n~l~~~~~~~i~~l~~--~ld-Lr~N~~~- 191 (1081)
T KOG0618|consen 124 NHFG-PIPLVI-------EVLTAEEELAASNNEKIQRLGQTSIKKLDLRLNVLGGSFLIDIYNLTH--QLD-LRYNEME- 191 (1081)
T ss_pred hccC-CCchhH-------HhhhHHHHHhhhcchhhhhhccccchhhhhhhhhcccchhcchhhhhe--eee-cccchhh-
Confidence 7664 444333 33333333333333 333333333333332 111 2222222
Q ss_pred cCCcccCCcchhhhhccccccccCCccccccCCCCCcEEEccCCcccccCCcccccCCCCccEEEeeccccccccCcccc
Q 045449 195 EIPREIGNLPYLARLALATNNLVGVVPVTIFNMSALKEISLLNNSLSGSLPSRIDLSLPNVETLNLGINSFSGTIPSSIT 274 (823)
Q Consensus 195 ~ip~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 274 (823)
-..+.++.+|+.|....|++... --..++|+.|+.++|.++...+.. ...+|+++|+++|+++ .+|++++
T Consensus 192 --~~dls~~~~l~~l~c~rn~ls~l----~~~g~~l~~L~a~~n~l~~~~~~p---~p~nl~~~dis~n~l~-~lp~wi~ 261 (1081)
T KOG0618|consen 192 --VLDLSNLANLEVLHCERNQLSEL----EISGPSLTALYADHNPLTTLDVHP---VPLNLQYLDISHNNLS-NLPEWIG 261 (1081)
T ss_pred --hhhhhhccchhhhhhhhcccceE----EecCcchheeeeccCcceeecccc---ccccceeeecchhhhh-cchHHHH
Confidence 11233333444444444443311 112346667777777776222221 1457899999999998 4679999
Q ss_pred CCCCCCeEEeecccccccCCCccCCCcccCcccccCccccCCCCcccccccccCCCCceEEEeecCCCCccCCccccccc
Q 045449 275 NSSKLSDLELGENLFSGFIPNTIGNLRNLEFGNIADNYLTSSTPELSFLSSLTNCKKLKVLIVTGNPLDGILPKSIGNFS 354 (823)
Q Consensus 275 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~ 354 (823)
.+.+|+.|+..+|+|+ .+|..+...++|++|....|.+...+ ..+..++.|+.|+|..|+|....+..+.-..
T Consensus 262 ~~~nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~~~nel~yip------~~le~~~sL~tLdL~~N~L~~lp~~~l~v~~ 334 (1081)
T KOG0618|consen 262 ACANLEALNANHNRLV-ALPLRISRITSLVSLSAAYNELEYIP------PFLEGLKSLRTLDLQSNNLPSLPDNFLAVLN 334 (1081)
T ss_pred hcccceEecccchhHH-hhHHHHhhhhhHHHHHhhhhhhhhCC------CcccccceeeeeeehhccccccchHHHhhhh
Confidence 9999999999999996 67888888999999999999998863 4566788999999999999854333333333
Q ss_pred cccceEEecCCcceeccCccccCcccccEEEcccCcCCCCchhcccccCCCCEEEccCCCCCCcchHhhhcCCCCCEEEc
Q 045449 355 LSLETILMANCSISGNIPQVVGNLSNLLVLELGGNNLTGPIPVTFSQLQTLQAFDLTRNKLAGPITDELCHLARLHSLVL 434 (823)
Q Consensus 355 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 434 (823)
.+|..|..+.|.+....-..=...+.|+.|++.+|.|+...-..+.+.++|++|+|++|+|.......+.++..|+.|+|
T Consensus 335 ~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~L 414 (1081)
T KOG0618|consen 335 ASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNL 414 (1081)
T ss_pred HHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeecccccccCCHHHHhchHHhHHHhc
Confidence 34777777777777443222224567888888888888766556788888888888888888555555778888888888
Q ss_pred ccCcCcccccccccCCCCCCeEeccCCccccccchhhhccCCCcEEeccccccccccCccccCCCCCcEEEcccCC
Q 045449 435 QGNKFSGSIPSCLGNLTSVRVLYLGLNIFTSVLSSTIWNLKDILFIDVSSNFLDGPLSLDIGNLKVVIGLDFSRNN 510 (823)
Q Consensus 435 s~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~ls~N~ 510 (823)
|+|+|+ .+|.++.++..|++|...+|++.. .| .+..++.|+.+|+|.|+|+...-..-...+.|++|||++|.
T Consensus 415 SGNkL~-~Lp~tva~~~~L~tL~ahsN~l~~-fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~ 487 (1081)
T KOG0618|consen 415 SGNKLT-TLPDTVANLGRLHTLRAHSNQLLS-FP-ELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNT 487 (1081)
T ss_pred ccchhh-hhhHHHHhhhhhHHHhhcCCceee-ch-hhhhcCcceEEecccchhhhhhhhhhCCCcccceeeccCCc
Confidence 888888 778888888888888888888876 34 78888888888888888886543333334788888888886
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=319.16 Aligned_cols=369 Identities=25% Similarity=0.376 Sum_probs=311.9
Q ss_pred cEEEEEcCCCCCc-cccCcccCCCCCCcEEEccCCCCCCCCCCCCCCCCCCCEEECCCCcCcCCCchhhhcCCCCcEEec
Q 045449 53 RVIGLNISSFNLQ-GTITPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLDFSDNQLFGSLSSFIFNMSSMTTIDL 131 (823)
Q Consensus 53 ~v~~L~L~~~~l~-g~~~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 131 (823)
-|...|+++|.++ +..|.....++.++.|-|...++. .+|..++.+.+|++|.+++|++. .+-..++.++.|+.+++
T Consensus 8 FVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LRsv~~ 85 (1255)
T KOG0444|consen 8 FVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI-SVHGELSDLPRLRSVIV 85 (1255)
T ss_pred eeecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH-hhhhhhccchhhHHHhh
Confidence 4788999999998 468888999999999999999887 88999999999999999999986 45667788899999999
Q ss_pred ccccccCccCccccCCCCCCccccccceeeeccceeeccCccccccchhhHHHHHhhcCCCcccCCcccCCcchhhhhcc
Q 045449 132 SINRLSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKEIGNLTKLKEIISTITNSTVCEIPREIGNLPYLARLAL 211 (823)
Q Consensus 132 s~N~l~~~~p~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~~l~~n~~~~~ip~~l~~l~~L~~L~L 211 (823)
..|++... .+|..+.++..|..||||+|+++ ..|. .+.+-+++-.|+|
T Consensus 86 R~N~LKns------GiP~diF~l~dLt~lDLShNqL~-EvP~-------------------------~LE~AKn~iVLNL 133 (1255)
T KOG0444|consen 86 RDNNLKNS------GIPTDIFRLKDLTILDLSHNQLR-EVPT-------------------------NLEYAKNSIVLNL 133 (1255)
T ss_pred hccccccC------CCCchhcccccceeeecchhhhh-hcch-------------------------hhhhhcCcEEEEc
Confidence 99998632 24444488899999999999987 4554 3344456778899
Q ss_pred ccccccCCccccccCCCCCcEEEccCCcccccCCcccccCCCCccEEEeeccccccccCccccCCCCCCeEEeeccccc-
Q 045449 212 ATNNLVGVVPVTIFNMSALKEISLLNNSLSGSLPSRIDLSLPNVETLNLGINSFSGTIPSSITNSSKLSDLELGENLFS- 290 (823)
Q Consensus 212 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~- 290 (823)
|+|+|..+.-..|.+++.|-.||||+|.+. .+|+.+.. +..|++|+|++|.+....-..+..+++|++|.+|+.+=+
T Consensus 134 S~N~IetIPn~lfinLtDLLfLDLS~NrLe-~LPPQ~RR-L~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl 211 (1255)
T KOG0444|consen 134 SYNNIETIPNSLFINLTDLLFLDLSNNRLE-MLPPQIRR-LSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTL 211 (1255)
T ss_pred ccCccccCCchHHHhhHhHhhhccccchhh-hcCHHHHH-HhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchh
Confidence 999998665566779999999999999998 88888875 889999999999887655556677889999999987543
Q ss_pred ccCCCccCCCcccCcccccCccccCCCCcccccccccCCCCceEEEeecCCCCccCCccccccccccceEEecCCcceec
Q 045449 291 GFIPNTIGNLRNLEFGNIADNYLTSSTPELSFLSSLTNCKKLKVLIVTGNPLDGILPKSIGNFSLSLETILMANCSISGN 370 (823)
Q Consensus 291 ~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~ 370 (823)
..+|.++..+.+|..+|||.|.+... |..+.++.+|+.|+||+|.|+. +....+.. .+|++|+||+|+++ .
T Consensus 212 ~N~Ptsld~l~NL~dvDlS~N~Lp~v------Pecly~l~~LrrLNLS~N~ite-L~~~~~~W-~~lEtLNlSrNQLt-~ 282 (1255)
T KOG0444|consen 212 DNIPTSLDDLHNLRDVDLSENNLPIV------PECLYKLRNLRRLNLSGNKITE-LNMTEGEW-ENLETLNLSRNQLT-V 282 (1255)
T ss_pred hcCCCchhhhhhhhhccccccCCCcc------hHHHhhhhhhheeccCcCceee-eeccHHHH-hhhhhhccccchhc-c
Confidence 46889999999999999999999874 5678889999999999999984 34444555 68999999999999 7
Q ss_pred cCccccCcccccEEEcccCcCCC-CchhcccccCCCCEEEccCCCCCCcchHhhhcCCCCCEEEcccCcCcccccccccC
Q 045449 371 IPQVVGNLSNLLVLELGGNNLTG-PIPVTFSQLQTLQAFDLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGN 449 (823)
Q Consensus 371 ~p~~~~~l~~L~~L~Ls~N~l~g-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~ 449 (823)
+|++++.++.|+.|.+.+|+++- -||+.++++.+|+++..++|.+. .+|..+|.+..|+.|.|+.|++. ..|+.+.-
T Consensus 283 LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLi-TLPeaIHl 360 (1255)
T KOG0444|consen 283 LPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHL 360 (1255)
T ss_pred chHHHhhhHHHHHHHhccCcccccCCccchhhhhhhHHHHhhccccc-cCchhhhhhHHHHHhccccccee-echhhhhh
Confidence 89999999999999999999873 38999999999999999999998 88999999999999999999998 78999999
Q ss_pred CCCCCeEeccCCccccccc
Q 045449 450 LTSVRVLYLGLNIFTSVLS 468 (823)
Q Consensus 450 l~~L~~L~Ls~N~l~~~~p 468 (823)
++.|+.|||..|.=--..|
T Consensus 361 L~~l~vLDlreNpnLVMPP 379 (1255)
T KOG0444|consen 361 LPDLKVLDLRENPNLVMPP 379 (1255)
T ss_pred cCCcceeeccCCcCccCCC
Confidence 9999999999995333344
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=328.52 Aligned_cols=442 Identities=29% Similarity=0.361 Sum_probs=315.6
Q ss_pred cEEEEEcCCCCCccccCcccCCCCCCcEEEccCCCCCCCCCCCCCCCCCCCEEECCCCcCcCCCchhhhcCCCCcEEecc
Q 045449 53 RVIGLNISSFNLQGTITPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLDFSDNQLFGSLSSFIFNMSSMTTIDLS 132 (823)
Q Consensus 53 ~v~~L~L~~~~l~g~~~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 132 (823)
+++.|+++.|-+-...-+.+...-+|+.|||++|+++ ..|..+..+.+|+.|+++.|.|. ..|.+..++.+|++|.|.
T Consensus 22 ~~~~ln~~~N~~l~~pl~~~~~~v~L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~i~-~vp~s~~~~~~l~~lnL~ 99 (1081)
T KOG0618|consen 22 ALQILNLRRNSLLSRPLEFVEKRVKLKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNYIR-SVPSSCSNMRNLQYLNLK 99 (1081)
T ss_pred HHHhhhccccccccCchHHhhheeeeEEeeccccccc-cCCchhhhHHHHhhcccchhhHh-hCchhhhhhhcchhheec
Confidence 4788899888776433333444445999999999997 88999999999999999999997 677999999999999999
Q ss_pred cccccCccCccccCCCCCCccccccceeeeccceeeccCccccccchhhHHHHHhhcCCCcccCCcccCCcchhhhhccc
Q 045449 133 INRLSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKEIGNLTKLKEIISTITNSTVCEIPREIGNLPYLARLALA 212 (823)
Q Consensus 133 ~N~l~~~~p~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~~l~~n~~~~~ip~~l~~l~~L~~L~Ls 212 (823)
.|++. .+|.++ ..+++|++|++++|+|. .+|..+..++.+..+. .++|..+..++.. . ++.++|.
T Consensus 100 ~n~l~-~lP~~~-------~~lknl~~LdlS~N~f~-~~Pl~i~~lt~~~~~~-~s~N~~~~~lg~~----~-ik~~~l~ 164 (1081)
T KOG0618|consen 100 NNRLQ-SLPASI-------SELKNLQYLDLSFNHFG-PIPLVIEVLTAEEELA-ASNNEKIQRLGQT----S-IKKLDLR 164 (1081)
T ss_pred cchhh-cCchhH-------HhhhcccccccchhccC-CCchhHHhhhHHHHHh-hhcchhhhhhccc----c-chhhhhh
Confidence 99987 555555 89999999999999997 8999999999888874 5555333222222 1 7778888
Q ss_pred cccccCCccccccCCCCCcEEEccCCcccccCCcccccCCCCccEEEeeccccccccCccccCCCCCCeEEeeccccccc
Q 045449 213 TNNLVGVVPVTIFNMSALKEISLLNNSLSGSLPSRIDLSLPNVETLNLGINSFSGTIPSSITNSSKLSDLELGENLFSGF 292 (823)
Q Consensus 213 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 292 (823)
.|.+.+.++..+.+++. .|+|.+|.+. ... + ..+++|+.|....|+++... -..++|+.|+.++|.++..
T Consensus 165 ~n~l~~~~~~~i~~l~~--~ldLr~N~~~-~~d--l-s~~~~l~~l~c~rn~ls~l~----~~g~~l~~L~a~~n~l~~~ 234 (1081)
T KOG0618|consen 165 LNVLGGSFLIDIYNLTH--QLDLRYNEME-VLD--L-SNLANLEVLHCERNQLSELE----ISGPSLTALYADHNPLTTL 234 (1081)
T ss_pred hhhcccchhcchhhhhe--eeecccchhh-hhh--h-hhccchhhhhhhhcccceEE----ecCcchheeeeccCcceee
Confidence 88888888877777766 6888888776 221 1 12556666666666655221 1234555555555555521
Q ss_pred CCCccCCCcccCcccccCccccCCCCcccccccccCCCCceEEEeecCCCCccCCccccccccccceEEecCCcceeccC
Q 045449 293 IPNTIGNLRNLEFGNIADNYLTSSTPELSFLSSLTNCKKLKVLIVTGNPLDGILPKSIGNFSLSLETILMANCSISGNIP 372 (823)
Q Consensus 293 ~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~p 372 (823)
.+ -..-.+|+++++++|++++. |.+++.|.+|+.++...|+|. .+|..+... .+|++|.+.+|.++ -+|
T Consensus 235 ~~--~p~p~nl~~~dis~n~l~~l------p~wi~~~~nle~l~~n~N~l~-~lp~ri~~~-~~L~~l~~~~nel~-yip 303 (1081)
T KOG0618|consen 235 DV--HPVPLNLQYLDISHNNLSNL------PEWIGACANLEALNANHNRLV-ALPLRISRI-TSLVSLSAAYNELE-YIP 303 (1081)
T ss_pred cc--ccccccceeeecchhhhhcc------hHHHHhcccceEecccchhHH-hhHHHHhhh-hhHHHHHhhhhhhh-hCC
Confidence 11 11123455555555555553 344555555555555555553 344444444 45555555555555 344
Q ss_pred ccccCcccccEEEcccCcCCCCchhc------------------------c--cccCCCCEEEccCCCCCCcchHhhhcC
Q 045449 373 QVVGNLSNLLVLELGGNNLTGPIPVT------------------------F--SQLQTLQAFDLTRNKLAGPITDELCHL 426 (823)
Q Consensus 373 ~~~~~l~~L~~L~Ls~N~l~g~~p~~------------------------~--~~l~~L~~L~Ls~N~l~~~~p~~~~~l 426 (823)
.....++.|++|||..|+|. ..|+. + ...+.|+.|+|.+|.|+...-..+.+.
T Consensus 304 ~~le~~~sL~tLdL~~N~L~-~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~ 382 (1081)
T KOG0618|consen 304 PFLEGLKSLRTLDLQSNNLP-SLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNF 382 (1081)
T ss_pred Ccccccceeeeeeehhcccc-ccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhhhccc
Confidence 44455555555555555554 22211 1 224568889999999998877788899
Q ss_pred CCCCEEEcccCcCcccccccccCCCCCCeEeccCCccccccchhhhccCCCcEEeccccccccccCccccCCCCCcEEEc
Q 045449 427 ARLHSLVLQGNKFSGSIPSCLGNLTSVRVLYLGLNIFTSVLSSTIWNLKDILFIDVSSNFLDGPLSLDIGNLKVVIGLDF 506 (823)
Q Consensus 427 ~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~l 506 (823)
..|+.|+|++|+|.......+.++..|+.|+||+|.++. +|.++..+..|++|-.-+|++. ..| ++.++++|+.+|+
T Consensus 383 ~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~~-Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDl 459 (1081)
T KOG0618|consen 383 KHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLTT-LPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDL 459 (1081)
T ss_pred cceeeeeecccccccCCHHHHhchHHhHHHhcccchhhh-hhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEec
Confidence 999999999999985555668899999999999999998 6799999999999999999998 456 8999999999999
Q ss_pred ccCCCCCCCCCcccCccCCCCCCCCCCCcccccCCccc
Q 045449 507 SRNNLSGDIPITIGEGEIPRGGPFANLTAKSFMGNELL 544 (823)
Q Consensus 507 s~N~l~g~ip~~~~~g~ip~~~~~~~~~~~~~~~n~~~ 544 (823)
|.|+|+ .+.+|...+..++..+++.||.++
T Consensus 460 S~N~L~--------~~~l~~~~p~p~LkyLdlSGN~~l 489 (1081)
T KOG0618|consen 460 SCNNLS--------EVTLPEALPSPNLKYLDLSGNTRL 489 (1081)
T ss_pred ccchhh--------hhhhhhhCCCcccceeeccCCccc
Confidence 999998 355666666678888999999864
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.2e-31 Score=268.36 Aligned_cols=183 Identities=27% Similarity=0.412 Sum_probs=141.2
Q ss_pred ccCCccceeeccC------------CeEEEEEEehHhhHH-------HHHHHHHHHHHHhhcchhhHHH-----------
Q 045449 628 DRFSENNLIGIGN------------GMEVAVKVFHQQYER-------ALKSFEDECEVRKRIRHRNLVK----------- 677 (823)
Q Consensus 628 ~~f~~~~~lg~g~------------~~~vavK~~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~----------- 677 (823)
+.|...+.+|.|+ |+.||||++..+.-. ......+|+++|++++|||||+
T Consensus 172 d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~ 251 (475)
T KOG0615|consen 172 DYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSS 251 (475)
T ss_pred ceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCce
Confidence 4556667788875 778999999765411 1123469999999999999998
Q ss_pred -----------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCC---CcEEEeecccccccCC
Q 045449 678 -----------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDED---MVAHISDFGIAKLLSG 725 (823)
Q Consensus 678 -----------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~---~~~kl~DfGla~~~~~ 725 (823)
++.|++.++.|+|++||+||||||+|||+..+ ..+||+|||+|+....
T Consensus 252 YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~g~ 331 (475)
T KOG0615|consen 252 YMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKVSGE 331 (475)
T ss_pred EEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhcccc
Confidence 46799999999999999999999999999755 7899999999998753
Q ss_pred CCccccccccccCCCcCcccccCCCcc---ccccceehhhhhhccccCCCCCcCCCc------ccccccccccCC-cccc
Q 045449 726 EDQLSKQTQTLATIGYMAPEYGTKGRV---STRGDVCSFGIISGGKETRSMTVGETC------TPVRESKYEVHP-ATTT 795 (823)
Q Consensus 726 ~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~Dv~S~Gvv~~~~~~~~~~~~~~~------~~~~~~~~~~~~-~~~~ 795 (823)
. ..+.+.+|||.|.|||++....+ ..++|+||+|||+|.+++|..||.+.. +++..++|.+.| .+.+
T Consensus 332 ~---sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~w~~ 408 (475)
T KOG0615|consen 332 G---SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQWDR 408 (475)
T ss_pred c---eehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChhhhh
Confidence 2 34667899999999999876553 458899999999999999999997753 445667776664 3344
Q ss_pred cccCCCcccccccccccc
Q 045449 796 IMEHPLPRVGEVMDVDRG 813 (823)
Q Consensus 796 ~~~~~~~~~~~~~~~~~~ 813 (823)
+.++....+..++.+++.
T Consensus 409 Iseea~dlI~~mL~VdP~ 426 (475)
T KOG0615|consen 409 ISEEALDLINWMLVVDPE 426 (475)
T ss_pred hhHHHHHHHHHhhEeCcc
Confidence 444444445555555444
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.7e-30 Score=260.43 Aligned_cols=151 Identities=28% Similarity=0.329 Sum_probs=131.7
Q ss_pred hccCCccceeeccC------------CeEEEEEEehHhh---HHHHHHHHHHHHHHhhcchhhHHH--------------
Q 045449 627 TDRFSENNLIGIGN------------GMEVAVKVFHQQY---ERALKSFEDECEVRKRIRHRNLVK-------------- 677 (823)
Q Consensus 627 t~~f~~~~~lg~g~------------~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~-------------- 677 (823)
.++|+..++||+|+ ++.+|+|++++.. ....+...+|..++.+++||.||+
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 46788899999997 5558888887654 334578899999999999999998
Q ss_pred --------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCcccc
Q 045449 678 --------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSK 731 (823)
Q Consensus 678 --------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~ 731 (823)
++|.++.||.|+|+.||||||+||+|||+|.+|+++|+|||+|+....... .
T Consensus 104 ld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~~--~ 181 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDGD--A 181 (357)
T ss_pred EeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcccCCC--c
Confidence 478999999999999999999999999999999999999999996443322 2
Q ss_pred ccccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCCCc
Q 045449 732 QTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGETC 779 (823)
Q Consensus 732 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~~ 779 (823)
..+++||+.|||||++.+..|+..+|+||+||++|+|++|..||....
T Consensus 182 t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~ 229 (357)
T KOG0598|consen 182 TRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAED 229 (357)
T ss_pred cccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCcc
Confidence 345799999999999999999999999999999999999999997653
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-29 Score=247.57 Aligned_cols=148 Identities=28% Similarity=0.374 Sum_probs=126.1
Q ss_pred cCCccceeeccC------------CeEEEEEEehHhh--HHHHHHHHHHHHHHhhcchhhHHH-----------------
Q 045449 629 RFSENNLIGIGN------------GMEVAVKVFHQQY--ERALKSFEDECEVRKRIRHRNLVK----------------- 677 (823)
Q Consensus 629 ~f~~~~~lg~g~------------~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~----------------- 677 (823)
.|+.-..+|+|+ |+.||||++.+.. ....+-..||++++++++|+|+|.
T Consensus 3 kYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~ 82 (396)
T KOG0593|consen 3 KYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEY 82 (396)
T ss_pred HHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeee
Confidence 344455677775 7889999997543 344567889999999999999998
Q ss_pred -----------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccc
Q 045449 678 -----------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQ 734 (823)
Q Consensus 678 -----------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 734 (823)
++.|++.+++|+|+++++||||||+|||++.++.+||||||+||.+.... ...+.
T Consensus 83 ~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pg--d~YTD 160 (396)
T KOG0593|consen 83 CDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPG--DNYTD 160 (396)
T ss_pred cchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCCc--chhhh
Confidence 36799999999999999999999999999999999999999999987322 23466
Q ss_pred cccCCCcCcccccCC-CccccccceehhhhhhccccCCCCCcCCC
Q 045449 735 TLATIGYMAPEYGTK-GRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 735 ~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
.+.|.+|+|||.+.+ ..|+..+||||.||+++||.+|...|.+.
T Consensus 161 YVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~ 205 (396)
T KOG0593|consen 161 YVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGR 205 (396)
T ss_pred hhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCc
Confidence 789999999998887 78999999999999999999999877653
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.1e-30 Score=248.76 Aligned_cols=158 Identities=24% Similarity=0.356 Sum_probs=132.3
Q ss_pred cCCccceeeccC------------CeEEEEEEehHh--hHHHHHHHHHHHHHHhhcchhhHHH-----------------
Q 045449 629 RFSENNLIGIGN------------GMEVAVKVFHQQ--YERALKSFEDECEVRKRIRHRNLVK----------------- 677 (823)
Q Consensus 629 ~f~~~~~lg~g~------------~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~----------------- 677 (823)
+|.+.+.||+|. |..||.|.++-+ ..+..++...|+.++++++|||||+
T Consensus 20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivm 99 (375)
T KOG0591|consen 20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVM 99 (375)
T ss_pred HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHH
Confidence 345556777775 566888877632 2566788999999999999999999
Q ss_pred -----------------------------HHHHHHHHhhhcCC--CC--EEeccCCCCCEEeCCCCcEEEeecccccccC
Q 045449 678 -----------------------------IISSSLEYLHFGHS--IP--IIHCDLKPSNVLLDEDMVAHISDFGIAKLLS 724 (823)
Q Consensus 678 -----------------------------~~~~~l~~L~~~h~--~~--ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~ 724 (823)
+++|++.||.++|. ++ |+||||||.||.++..|.+||.|||++|.+.
T Consensus 100 E~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~ 179 (375)
T KOG0591|consen 100 ELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLS 179 (375)
T ss_pred HhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhc
Confidence 36799999999999 66 9999999999999999999999999999986
Q ss_pred CCCccccccccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCCC-----cccccccccc
Q 045449 725 GEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGET-----CTPVRESKYE 788 (823)
Q Consensus 725 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~-----~~~~~~~~~~ 788 (823)
.... .....+|||.||+||.+...+|+.|+||||+||++|||+.-..||.+. +.++.++.+.
T Consensus 180 s~~t--fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~ 246 (375)
T KOG0591|consen 180 SKTT--FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYP 246 (375)
T ss_pred chhH--HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCC
Confidence 5433 345689999999999999999999999999999999999999999774 4555566554
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-29 Score=271.65 Aligned_cols=163 Identities=45% Similarity=0.721 Sum_probs=138.8
Q ss_pred cccccCHHHHHHHhccCCccceeeccC-----------CeEEEEEEehHhhHHHHHHHHHHHHHHhhcchhhHHHH----
Q 045449 614 AIRRFSYHELLRATDRFSENNLIGIGN-----------GMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVKI---- 678 (823)
Q Consensus 614 ~~~~~~~~~l~~at~~f~~~~~lg~g~-----------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~---- 678 (823)
..+.|+|.|+.+||++|+..++||+|+ |..||||++........++|..|++++++++|||+|++
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 577899999999999999999999996 46799998876543214569999999999999999981
Q ss_pred ------------------------------------------HHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEee
Q 045449 679 ------------------------------------------ISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISD 716 (823)
Q Consensus 679 ------------------------------------------~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~D 716 (823)
+|++++|||+.+.+.|+||||||+|||+|+++.+||+|
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsD 220 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSD 220 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccC
Confidence 57888888888888999999999999999999999999
Q ss_pred cccccccCCCCcccccccc-ccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCCC
Q 045449 717 FGIAKLLSGEDQLSKQTQT-LATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 717 fGla~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
||+|+....... ..... .||.+|+|||+...+..+.|+||||||||+.|+++|+.+.+..
T Consensus 221 FGLa~~~~~~~~--~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~ 281 (361)
T KOG1187|consen 221 FGLAKLGPEGDT--SVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQS 281 (361)
T ss_pred ccCcccCCcccc--ceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCC
Confidence 999976543111 11112 7999999999999999999999999999999999999776643
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.4e-29 Score=258.28 Aligned_cols=149 Identities=29% Similarity=0.415 Sum_probs=129.8
Q ss_pred hccCCccceeeccC------------CeEEEEEEehHh--hHHHHHHHHHHHHHHhhcchhhHHH---------------
Q 045449 627 TDRFSENNLIGIGN------------GMEVAVKVFHQQ--YERALKSFEDECEVRKRIRHRNLVK--------------- 677 (823)
Q Consensus 627 t~~f~~~~~lg~g~------------~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~--------------- 677 (823)
.++|...+.||.|. +..||||.+... ..+.++....|+++++.++|||||+
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 45666677788875 677999999876 4667788999999999999999998
Q ss_pred -------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCC------CcEEEeecccccccCCC
Q 045449 678 -------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDED------MVAHISDFGIAKLLSGE 726 (823)
Q Consensus 678 -------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~------~~~kl~DfGla~~~~~~ 726 (823)
++.|+..+|+++|+.+||||||||+|||++.. -.+||+|||+||.+...
T Consensus 89 EyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~~ 168 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQPG 168 (429)
T ss_pred EeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCCch
Confidence 46789999999999999999999999999754 46899999999998644
Q ss_pred CccccccccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCCC
Q 045449 727 DQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 727 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
.. ..+.+|++-|||||++..+.|+.|+|+||.|+|+|++++|+.||+..
T Consensus 169 ~~---a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~ 217 (429)
T KOG0595|consen 169 SM---AETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAE 217 (429)
T ss_pred hH---HHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCcccc
Confidence 32 34678999999999999999999999999999999999999999843
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.9e-29 Score=270.16 Aligned_cols=162 Identities=28% Similarity=0.439 Sum_probs=140.5
Q ss_pred ccCCccceeeccC------------CeEEEEEEehHhh---HHHHHHHHHHHHHHhhcchhhHHH---------------
Q 045449 628 DRFSENNLIGIGN------------GMEVAVKVFHQQY---ERALKSFEDECEVRKRIRHRNLVK--------------- 677 (823)
Q Consensus 628 ~~f~~~~~lg~g~------------~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~--------------- 677 (823)
.+|...+++|+|+ |..||+|++.+.. ....+...+||++.+.|+|||||+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5688889999997 7889999998643 455678999999999999999999
Q ss_pred -------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccc
Q 045449 678 -------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQ 732 (823)
Q Consensus 678 -------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~ 732 (823)
++.|++++|.|+|+.+|+|||||..|++++++.++||+|||+|..+..++. ..
T Consensus 98 ELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~E--rk 175 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGE--RK 175 (592)
T ss_pred EecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCccc--cc
Confidence 467999999999999999999999999999999999999999998864432 23
Q ss_pred cccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCCC-----cccccccccccCC
Q 045449 733 TQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGET-----CTPVRESKYEVHP 791 (823)
Q Consensus 733 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~-----~~~~~~~~~~~~~ 791 (823)
.+.+|||.|.|||++.+...+..+||||+|||+|-+++|+.||+.. +..+....|.++.
T Consensus 176 ~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P~ 239 (592)
T KOG0575|consen 176 KTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMPS 239 (592)
T ss_pred ceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCccccc
Confidence 4679999999999999999999999999999999999999999764 4556666665543
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-29 Score=267.03 Aligned_cols=169 Identities=29% Similarity=0.440 Sum_probs=139.5
Q ss_pred HHhccCCccceeeccC------------CeEEEEEEehHhh---HHHHHHHHHHHHHHhhc-chhhHHH-----------
Q 045449 625 RATDRFSENNLIGIGN------------GMEVAVKVFHQQY---ERALKSFEDECEVRKRI-RHRNLVK----------- 677 (823)
Q Consensus 625 ~at~~f~~~~~lg~g~------------~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~----------- 677 (823)
+...+|...+++|+|. ++.||||++.+.. ++.++...+|-++|.+| .||.|++
T Consensus 70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sL 149 (604)
T KOG0592|consen 70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESL 149 (604)
T ss_pred CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccce
Confidence 3345666677777775 6789999998765 34456677899999999 8999998
Q ss_pred -----------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCc
Q 045449 678 -----------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQ 728 (823)
Q Consensus 678 -----------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~ 728 (823)
++|+++.+|+|+|++|||||||||+|||+|+|+++||+|||-|+.+.+...
T Consensus 150 YFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~ 229 (604)
T KOG0592|consen 150 YFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQK 229 (604)
T ss_pred EEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChhhc
Confidence 478999999999999999999999999999999999999999998764322
Q ss_pred c---------ccc--cccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCCCc-----ccccccccccCCc
Q 045449 729 L---------SKQ--TQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGETC-----TPVRESKYEVHPA 792 (823)
Q Consensus 729 ~---------~~~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~ 792 (823)
. ... ..++||..|.+||++.....+..+|+|+|||++|+|+.|..||.+.. ..++.-.|++++.
T Consensus 230 ~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y~fp~~ 309 (604)
T KOG0592|consen 230 SQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDYEFPEG 309 (604)
T ss_pred cccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhcccCCCC
Confidence 1 112 56899999999999999999999999999999999999999998753 4455555665554
Q ss_pred c
Q 045449 793 T 793 (823)
Q Consensus 793 ~ 793 (823)
.
T Consensus 310 f 310 (604)
T KOG0592|consen 310 F 310 (604)
T ss_pred C
Confidence 3
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-28 Score=257.44 Aligned_cols=137 Identities=28% Similarity=0.346 Sum_probs=121.3
Q ss_pred CeEEEEEEehHhh--HHHHHHHHHHHHHHhhcchhhHHH-----------------------------------------
Q 045449 641 GMEVAVKVFHQQY--ERALKSFEDECEVRKRIRHRNLVK----------------------------------------- 677 (823)
Q Consensus 641 ~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~----------------------------------------- 677 (823)
|..||+|+++.+. +....-..+||.||+++.||||++
T Consensus 142 gkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFeYMdhDL~GLl~~p~vkft~~qIK 221 (560)
T KOG0600|consen 142 GKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFEYMDHDLSGLLSSPGVKFTEPQIK 221 (560)
T ss_pred CcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEecccchhhhhhcCCCcccChHHHH
Confidence 6789999997654 455567789999999999999999
Q ss_pred -HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCcccccCCC-ccccc
Q 045449 678 -IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKG-RVSTR 755 (823)
Q Consensus 678 -~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~ 755 (823)
++.|++++|+|||.+||+|||||.+|||+|.+|.+||+|||+|+++..... ...+..+-|.+|+|||++.+. .|+..
T Consensus 222 c~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~-~~~T~rVvTLWYRpPELLLG~t~Yg~a 300 (560)
T KOG0600|consen 222 CYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGS-APYTSRVVTLWYRPPELLLGATSYGTA 300 (560)
T ss_pred HHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccCCCC-cccccceEEeeccChHHhcCCcccccc
Confidence 467999999999999999999999999999999999999999998765543 235677899999999988775 59999
Q ss_pred cceehhhhhhccccCCCCCcCCC
Q 045449 756 GDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 756 ~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
+|+||.|||++||..|+..+++-
T Consensus 301 VDlWS~GCIl~El~~gkPI~~G~ 323 (560)
T KOG0600|consen 301 VDLWSVGCILAELFLGKPILQGR 323 (560)
T ss_pred eeehhhhHHHHHHHcCCCCcCCc
Confidence 99999999999999999988764
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.3e-29 Score=239.23 Aligned_cols=184 Identities=25% Similarity=0.394 Sum_probs=150.0
Q ss_pred ccCCccceeeccC------------CeEEEEEEehHhh--HHHHHHHHHHHHHHhhcchhhHHH----------------
Q 045449 628 DRFSENNLIGIGN------------GMEVAVKVFHQQY--ERALKSFEDECEVRKRIRHRNLVK---------------- 677 (823)
Q Consensus 628 ~~f~~~~~lg~g~------------~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~---------------- 677 (823)
+.|+..+.||+|. |+.+|+|++.... ....++..+|+++-+.++|||||+
T Consensus 11 d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe 90 (355)
T KOG0033|consen 11 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD 90 (355)
T ss_pred hhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEe
Confidence 4445556666664 6778888886443 345678999999999999999998
Q ss_pred ------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeC---CCCcEEEeecccccccCCCCccc
Q 045449 678 ------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLD---EDMVAHISDFGIAKLLSGEDQLS 730 (823)
Q Consensus 678 ------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~---~~~~~kl~DfGla~~~~~~~~~~ 730 (823)
++.|++++|.|+|.++|||||+||+|+++. ....+|++|||+|..+... .
T Consensus 91 ~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g---~ 167 (355)
T KOG0033|consen 91 LVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDG---E 167 (355)
T ss_pred cccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeCCc---c
Confidence 257999999999999999999999999995 3457899999999988632 2
Q ss_pred cccccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCC-----CcccccccccccCC-cccccccCCCccc
Q 045449 731 KQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGE-----TCTPVRESKYEVHP-ATTTIMEHPLPRV 804 (823)
Q Consensus 731 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~-----~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 804 (823)
.....+|||+|||||++...+|+..+|||+.|||+|-++.|..||.+ .++++..+.|++++ .+..+.+.....+
T Consensus 168 ~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~Ak~Lv 247 (355)
T KOG0033|consen 168 AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPEAKSLI 247 (355)
T ss_pred ccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHHHHHHH
Confidence 34568899999999999999999999999999999999999999876 36778888898886 5566666666677
Q ss_pred cccccccccc
Q 045449 805 GEVMDVDRGK 814 (823)
Q Consensus 805 ~~~~~~~~~~ 814 (823)
+.++.+++.+
T Consensus 248 rrML~~dP~k 257 (355)
T KOG0033|consen 248 RRMLTVNPKK 257 (355)
T ss_pred HHHhccChhh
Confidence 7777776655
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.9e-28 Score=259.39 Aligned_cols=138 Identities=31% Similarity=0.431 Sum_probs=116.9
Q ss_pred CeE-EEEEEehHhh--HHHHHHHHHHHHHHhhcchhhHHH----------------------------------------
Q 045449 641 GME-VAVKVFHQQY--ERALKSFEDECEVRKRIRHRNLVK---------------------------------------- 677 (823)
Q Consensus 641 ~~~-vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~---------------------------------------- 677 (823)
|.. ||||++.... ....++|.+|+.++.+++|||||+
T Consensus 64 g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~ 143 (362)
T KOG0192|consen 64 GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKV 143 (362)
T ss_pred CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCCcHHHHHhhcccCCCCHHH
Confidence 455 9999997554 222679999999999999999999
Q ss_pred ---HHHHHHHHhhhcCCCC-EEeccCCCCCEEeCCCC-cEEEeecccccccCCCCccccccccccCCCcCcccccC--CC
Q 045449 678 ---IISSSLEYLHFGHSIP-IIHCDLKPSNVLLDEDM-VAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGT--KG 750 (823)
Q Consensus 678 ---~~~~~l~~L~~~h~~~-ivHrdlk~~NiLl~~~~-~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~ 750 (823)
++.+++.+|.|+|+.+ |||||+||+|||++.++ ++||+|||+++...... ...+...||+.|||||++. ..
T Consensus 144 ~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~--~~~~~~~GT~~wMAPEv~~~~~~ 221 (362)
T KOG0192|consen 144 RLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK--TSMTSVAGTYRWMAPEVLRGEKS 221 (362)
T ss_pred HHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceeecccc--ccccCCCCCccccChhhhcCCCC
Confidence 2446777888889999 99999999999999997 99999999998765322 2234468999999999999 56
Q ss_pred ccccccceehhhhhhccccCCCCCcCCCcc
Q 045449 751 RVSTRGDVCSFGIISGGKETRSMTVGETCT 780 (823)
Q Consensus 751 ~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~~~ 780 (823)
.|+.|+|||||||++||+.+++.||.+...
T Consensus 222 ~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~ 251 (362)
T KOG0192|consen 222 PYTEKSDVYSFGIVLWELLTGEIPFEDLAP 251 (362)
T ss_pred cCCccchhhhHHHHHHHHHHCCCCCCCCCH
Confidence 899999999999999999999999988754
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.6e-28 Score=240.04 Aligned_cols=160 Identities=28% Similarity=0.335 Sum_probs=135.5
Q ss_pred ccCCccceeeccC------------CeEEEEEEehHhh---HHHHHHHHHHHHHHhhcchhhHHH---------------
Q 045449 628 DRFSENNLIGIGN------------GMEVAVKVFHQQY---ERALKSFEDECEVRKRIRHRNLVK--------------- 677 (823)
Q Consensus 628 ~~f~~~~~lg~g~------------~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~--------------- 677 (823)
++|+..+.+|.|+ |..+|+|++..+. .+.++....|..+++.+.||.+++
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 3455556777775 5669999997664 344567889999999999999998
Q ss_pred -------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccc
Q 045449 678 -------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQ 732 (823)
Q Consensus 678 -------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~ 732 (823)
++||++.||+|+|+.+|++||+||+|||+|.+|++||+|||+|+.+... .
T Consensus 124 eyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r-----T 198 (355)
T KOG0616|consen 124 EYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR-----T 198 (355)
T ss_pred eccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecCc-----E
Confidence 4789999999999999999999999999999999999999999987543 3
Q ss_pred cccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCCC-----cccccccccccCCc
Q 045449 733 TQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGET-----CTPVRESKYEVHPA 792 (823)
Q Consensus 733 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~ 792 (823)
.+.+|||.|+|||++...+|+..+|.|||||+.|||+.|..||... ++++..+++.+++.
T Consensus 199 ~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP~~ 263 (355)
T KOG0616|consen 199 WTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFPSY 263 (355)
T ss_pred EEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCCcc
Confidence 4578999999999999999999999999999999999999999764 45566666655543
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-27 Score=243.95 Aligned_cols=151 Identities=27% Similarity=0.357 Sum_probs=127.4
Q ss_pred ccCHHHHHHHhccCCccceeeccC------------CeEEEEEEehHhh-HHHHHHHHHHHHHHhhcchhhHHH------
Q 045449 617 RFSYHELLRATDRFSENNLIGIGN------------GMEVAVKVFHQQY-ERALKSFEDECEVRKRIRHRNLVK------ 677 (823)
Q Consensus 617 ~~~~~~l~~at~~f~~~~~lg~g~------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~------ 677 (823)
.++..|+.+. +.||.|. ++.+|+|++.... ....++..+|++++++.+||+||+
T Consensus 75 ~i~~~dle~~-------~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~ 147 (364)
T KOG0581|consen 75 GISLSDLERL-------GVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFY 147 (364)
T ss_pred ccCHHHhhhh-------hhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEE
Confidence 3566666654 6788875 4558999995443 455678999999999999999998
Q ss_pred -----------------------------------HHHHHHHHhhhcC-CCCEEeccCCCCCEEeCCCCcEEEeeccccc
Q 045449 678 -----------------------------------IISSSLEYLHFGH-SIPIIHCDLKPSNVLLDEDMVAHISDFGIAK 721 (823)
Q Consensus 678 -----------------------------------~~~~~l~~L~~~h-~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~ 721 (823)
++.+++.+|.|+| +++||||||||+|||+...|.+||||||+++
T Consensus 148 ~~~~~isI~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~ 227 (364)
T KOG0581|consen 148 SNGEEISICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSG 227 (364)
T ss_pred eCCceEEeehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccH
Confidence 2346777788888 4999999999999999999999999999999
Q ss_pred ccCCCCccccccccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCCC
Q 045449 722 LLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 722 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
.+... ...+++||..|||||.+.+..|+.++||||||+.+.|+.+|+.|+...
T Consensus 228 ~lvnS----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~ 280 (364)
T KOG0581|consen 228 ILVNS----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPP 280 (364)
T ss_pred Hhhhh----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCc
Confidence 87644 345689999999999999999999999999999999999999998664
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1e-27 Score=232.40 Aligned_cols=183 Identities=25% Similarity=0.329 Sum_probs=138.5
Q ss_pred ccCCccceeeccC------------CeEEEEEEehHhhH--HHHHHHHHHHHHHhhcchhhHHHH---------------
Q 045449 628 DRFSENNLIGIGN------------GMEVAVKVFHQQYE--RALKSFEDECEVRKRIRHRNLVKI--------------- 678 (823)
Q Consensus 628 ~~f~~~~~lg~g~------------~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~--------------- 678 (823)
++|...+++|+|. |+.||||.++.... .......||+..++.++|+||+.+
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 3556667778775 77899999975532 223578899999999999999993
Q ss_pred -------------------------HHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCcccccc
Q 045449 679 -------------------------ISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQT 733 (823)
Q Consensus 679 -------------------------~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~ 733 (823)
+.+.+.+++|+|+..|+|||+||.|+|++.+|.+||+|||+|+.+...... .+
T Consensus 82 fm~tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~--~~ 159 (318)
T KOG0659|consen 82 FMPTDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRI--QT 159 (318)
T ss_pred eccccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCcc--cc
Confidence 457889999999999999999999999999999999999999998755442 33
Q ss_pred ccccCCCcCcccccCCC-ccccccceehhhhhhccccCCCCCcCCCcccccccccccCCcccccccCCCccccccccccc
Q 045449 734 QTLATIGYMAPEYGTKG-RVSTRGDVCSFGIISGGKETRSMTVGETCTPVRESKYEVHPATTTIMEHPLPRVGEVMDVDR 812 (823)
Q Consensus 734 ~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 812 (823)
..+-|.+|+|||.+.+. .|+..+|+||.|||++|++-+...|.+..+- .+-.. .........+..||.+.++.++..
T Consensus 160 ~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDi-dQL~~-If~~LGTP~~~~WP~~~~lpdY~~ 237 (318)
T KOG0659|consen 160 HQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDI-DQLSK-IFRALGTPTPDQWPEMTSLPDYVK 237 (318)
T ss_pred cceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchH-HHHHH-HHHHcCCCCcccCccccccccHHH
Confidence 44789999999988775 5999999999999999999998777654222 11111 111223334566677666666554
Q ss_pred cc
Q 045449 813 GK 814 (823)
Q Consensus 813 ~~ 814 (823)
-+
T Consensus 238 ~~ 239 (318)
T KOG0659|consen 238 IQ 239 (318)
T ss_pred Hh
Confidence 43
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-27 Score=242.70 Aligned_cols=168 Identities=21% Similarity=0.324 Sum_probs=142.8
Q ss_pred ccccccCHHHHHHHhccCCccceeeccCCeEEEEEEehHhh---HHHHHHHHHHHHHHhhcchhhHHH------------
Q 045449 613 QAIRRFSYHELLRATDRFSENNLIGIGNGMEVAVKVFHQQY---ERALKSFEDECEVRKRIRHRNLVK------------ 677 (823)
Q Consensus 613 ~~~~~~~~~~l~~at~~f~~~~~lg~g~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~------------ 677 (823)
+.+...||..+..|++++. |+.||||.++++. ++..-.+++|++||+.++||||+.
T Consensus 59 etLGkGTYGKVk~A~e~~s---------gR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIv 129 (668)
T KOG0611|consen 59 ETLGKGTYGKVKLAYEHKS---------GREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIV 129 (668)
T ss_pred HHhcCCcccceeehhhccC---------CcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEE
Confidence 3456678888888887776 7899999998765 445567889999999999999998
Q ss_pred ----------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCcc
Q 045449 678 ----------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQL 729 (823)
Q Consensus 678 ----------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~ 729 (823)
++.|++.++||||..+|||||+|.+|||+|+++.+||+|||++..+....
T Consensus 130 ivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~k-- 207 (668)
T KOG0611|consen 130 IVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADKK-- 207 (668)
T ss_pred EEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhcccc--
Confidence 47899999999999999999999999999999999999999998875443
Q ss_pred ccccccccCCCcCcccccCCCcc-ccccceehhhhhhccccCCCCCcCCCc-----ccccccccccCCc
Q 045449 730 SKQTQTLATIGYMAPEYGTKGRV-STRGDVCSFGIISGGKETRSMTVGETC-----TPVRESKYEVHPA 792 (823)
Q Consensus 730 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~S~Gvv~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~ 792 (823)
...+++|+|-|++||++.+.+| ++.+|-||+||++|-+.+|.+||++.. .++..+.|..++.
T Consensus 208 -fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP~~ 275 (668)
T KOG0611|consen 208 -FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREPET 275 (668)
T ss_pred -HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCCCC
Confidence 2456899999999999999998 788999999999999999999998853 4455566655544
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-27 Score=258.15 Aligned_cols=168 Identities=26% Similarity=0.345 Sum_probs=138.9
Q ss_pred CeEEEEEEehHhh---HHHHHHHHHHHHHHhhcchhhHHH----------------------------------------
Q 045449 641 GMEVAVKVFHQQY---ERALKSFEDECEVRKRIRHRNLVK---------------------------------------- 677 (823)
Q Consensus 641 ~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~---------------------------------------- 677 (823)
|+.+|||++.... ......+.+|+.+|+-+.|||+++
T Consensus 37 GqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEyv~gGELFdylv~kG~l~e~eaa~ 116 (786)
T KOG0588|consen 37 GQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEYVPGGELFDYLVRKGPLPEREAAH 116 (786)
T ss_pred cceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEecCCchhHHHHHhhCCCCCHHHHH
Confidence 7889999997653 233467899999999999999998
Q ss_pred HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCcccccCCCcc-cccc
Q 045449 678 IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRV-STRG 756 (823)
Q Consensus 678 ~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~ 756 (823)
++.|++.++.|||..+|+|||+||+|+|+|..+.+||+|||+|....++. ...+.||+|.|+|||++.+.+| +.++
T Consensus 117 ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gk---lLeTSCGSPHYA~PEIV~G~pYdG~~s 193 (786)
T KOG0588|consen 117 FFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGK---LLETSCGSPHYAAPEIVSGRPYDGRPS 193 (786)
T ss_pred HHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccCCc---cccccCCCcccCCchhhcCCCCCCCcc
Confidence 47899999999999999999999999999999999999999998765443 2456789999999999999998 7889
Q ss_pred ceehhhhhhccccCCCCCcCCC-----cccccccccccCCcccccccCCCccccccccccccc
Q 045449 757 DVCSFGIISGGKETRSMTVGET-----CTPVRESKYEVHPATTTIMEHPLPRVGEVMDVDRGK 814 (823)
Q Consensus 757 Dv~S~Gvv~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 814 (823)
||||+|||++.+++|+.||++. ..+++.+.++++-. +..+....++.++++|+.+
T Consensus 194 DVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MPs~---Is~eaQdLLr~ml~VDp~~ 253 (786)
T KOG0588|consen 194 DVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMPSN---ISSEAQDLLRRMLDVDPST 253 (786)
T ss_pred ccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCCCc---CCHHHHHHHHHHhccCccc
Confidence 9999999999999999999875 35567777777633 2334445566666676655
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.5e-27 Score=255.99 Aligned_cols=167 Identities=23% Similarity=0.393 Sum_probs=135.7
Q ss_pred HHhccCCccceeeccC------------CeEEEEEEehHh----hH-HHHHHHHHHHHHHhhcc-hhhHHH---------
Q 045449 625 RATDRFSENNLIGIGN------------GMEVAVKVFHQQ----YE-RALKSFEDECEVRKRIR-HRNLVK--------- 677 (823)
Q Consensus 625 ~at~~f~~~~~lg~g~------------~~~vavK~~~~~----~~-~~~~~~~~E~~~l~~l~-h~niv~--------- 677 (823)
...++|...+.+|.|. +..||||++.+. .. ...+...+|+.++++++ ||||++
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 3456777788888875 577999987664 12 33456778999999999 999998
Q ss_pred -------------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCC-CcEEEeecccccccCC
Q 045449 678 -------------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDED-MVAHISDFGIAKLLSG 725 (823)
Q Consensus 678 -------------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~-~~~kl~DfGla~~~~~ 725 (823)
++.|++.+++|+|++||+||||||+|||+|.+ +.+||+|||+++....
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~~ 173 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISPG 173 (370)
T ss_pred eEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccCC
Confidence 47899999999999999999999999999998 9999999999998741
Q ss_pred CCccccccccccCCCcCcccccCCCc-c-ccccceehhhhhhccccCCCCCcCCCc-----ccccccccccCCcc
Q 045449 726 EDQLSKQTQTLATIGYMAPEYGTKGR-V-STRGDVCSFGIISGGKETRSMTVGETC-----TPVRESKYEVHPAT 793 (823)
Q Consensus 726 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~-~~~~Dv~S~Gvv~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~ 793 (823)
......+.+||+.|+|||++.+.. | +.++||||+||++|.|++|..||++.. ..+..+.+..+...
T Consensus 174 --~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~p~~~ 246 (370)
T KOG0583|consen 174 --EDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKIPSYL 246 (370)
T ss_pred --CCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccCCCCc
Confidence 123356789999999999999877 8 478999999999999999999998742 23455555555443
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.2e-27 Score=247.02 Aligned_cols=135 Identities=28% Similarity=0.368 Sum_probs=120.1
Q ss_pred CeEEEEEEehHhh--HHHHHHHHHHHHHHhhcchhhHHHH---------------------------------------H
Q 045449 641 GMEVAVKVFHQQY--ERALKSFEDECEVRKRIRHRNLVKI---------------------------------------I 679 (823)
Q Consensus 641 ~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~---------------------------------------~ 679 (823)
.+.||+|.+.+.. ++..+...+|++++++++|||||.+ .
T Consensus 27 ~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~a~g~L~~il~~d~~lpEe~v~~~a 106 (808)
T KOG0597|consen 27 IQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEYAVGDLFTILEQDGKLPEEQVRAIA 106 (808)
T ss_pred eeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehhhhhhHHHHHHhccCCCHHHHHHHH
Confidence 4679999997554 5566789999999999999999993 4
Q ss_pred HHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCcccccCCCcccccccee
Q 045449 680 SSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVC 759 (823)
Q Consensus 680 ~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~ 759 (823)
++.+.+|+|+|+.+|+|||+||.|||++..+++|+||||+||.+.... ...+...|||.|||||++.+++|+..+|.|
T Consensus 107 ~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t--~vltsikGtPlYmAPElv~e~pyd~~sDlW 184 (808)
T KOG0597|consen 107 YDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT--SVLTSIKGTPLYMAPELVEEQPYDHTSDLW 184 (808)
T ss_pred HHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccCc--eeeeeccCcccccCHHHHcCCCccchhhHH
Confidence 578889999999999999999999999999999999999999876532 344567899999999999999999999999
Q ss_pred hhhhhhccccCCCCCcCC
Q 045449 760 SFGIISGGKETRSMTVGE 777 (823)
Q Consensus 760 S~Gvv~~~~~~~~~~~~~ 777 (823)
|+|||+||+..|+.||..
T Consensus 185 slGcilYE~~~G~PPF~a 202 (808)
T KOG0597|consen 185 SLGCILYELYVGQPPFYA 202 (808)
T ss_pred HHHHHHHHHhcCCCCchH
Confidence 999999999999999864
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=9.7e-27 Score=248.78 Aligned_cols=134 Identities=28% Similarity=0.357 Sum_probs=120.2
Q ss_pred CeEEEEEEehHhhHHHHHHHHHHHHHHhhcchhhHHHH---------------------------------------HHH
Q 045449 641 GMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVKI---------------------------------------ISS 681 (823)
Q Consensus 641 ~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~---------------------------------------~~~ 681 (823)
+..||||++........+-...|+.+|+..+|+|||++ ...
T Consensus 298 ~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ggsLTDvVt~~~~~E~qIA~Icre 377 (550)
T KOG0578|consen 298 KQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGGSLTDVVTKTRMTEGQIAAICRE 377 (550)
T ss_pred CceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCCCchhhhhhcccccHHHHHHHHHH
Confidence 56799999987766666778899999999999999993 246
Q ss_pred HHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCcccccCCCccccccceehh
Q 045449 682 SLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSF 761 (823)
Q Consensus 682 ~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~ 761 (823)
++++|+|+|.+||+|||||.+|||++.++.+||+|||++..+..... ...+.+|||+|||||++....|++|+||||+
T Consensus 378 ~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~--KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSL 455 (550)
T KOG0578|consen 378 ILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS--KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSL 455 (550)
T ss_pred HHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccccC--ccccccCCCCccchhhhhhcccCccccchhh
Confidence 78899999999999999999999999999999999999998765543 4567899999999999999999999999999
Q ss_pred hhhhccccCCCCCcC
Q 045449 762 GIISGGKETRSMTVG 776 (823)
Q Consensus 762 Gvv~~~~~~~~~~~~ 776 (823)
|+++.||..|+.||-
T Consensus 456 GIMaIEMveGEPPYl 470 (550)
T KOG0578|consen 456 GIMAIEMVEGEPPYL 470 (550)
T ss_pred hhHHHHHhcCCCCcc
Confidence 999999999999985
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.3e-26 Score=241.19 Aligned_cols=153 Identities=25% Similarity=0.360 Sum_probs=122.9
Q ss_pred HhccCCccceeeccC------------CeEEEEEEehHhhH--------------HHHHHHHHHHHHHhhcchhhHHH--
Q 045449 626 ATDRFSENNLIGIGN------------GMEVAVKVFHQQYE--------------RALKSFEDECEVRKRIRHRNLVK-- 677 (823)
Q Consensus 626 at~~f~~~~~lg~g~------------~~~vavK~~~~~~~--------------~~~~~~~~E~~~l~~l~h~niv~-- 677 (823)
..+.|.....||.|. ++.||||++.+... ...+...+||++|++++|||||+
T Consensus 95 ~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~Li 174 (576)
T KOG0585|consen 95 QLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLI 174 (576)
T ss_pred ehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEE
Confidence 345677777778774 67799999975431 12357889999999999999999
Q ss_pred ----------------------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeec
Q 045449 678 ----------------------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDF 717 (823)
Q Consensus 678 ----------------------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~Df 717 (823)
++..++.+|.|+|.+||+||||||+|+|++.+|++||+||
T Consensus 175 EvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VKIsDF 254 (576)
T KOG0585|consen 175 EVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVKISDF 254 (576)
T ss_pred EeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEEeecc
Confidence 3556777888889999999999999999999999999999
Q ss_pred ccccccCCC---CccccccccccCCCcCcccccCCCc----cccccceehhhhhhccccCCCCCcCCC
Q 045449 718 GIAKLLSGE---DQLSKQTQTLATIGYMAPEYGTKGR----VSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 718 Gla~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
|.+...... .........+|||.|+|||...++. .+.+.||||+||.+|-+++|+.||-+.
T Consensus 255 GVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~ 322 (576)
T KOG0585|consen 255 GVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDD 322 (576)
T ss_pred ceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccc
Confidence 999866322 1112234578999999999887633 367889999999999999999999765
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.2e-26 Score=236.05 Aligned_cols=143 Identities=29% Similarity=0.348 Sum_probs=119.2
Q ss_pred cCCccceeeccC------------CeEEEEEEehHhhHHHHHHHHHHHHHHhhcchhhHHH-------------------
Q 045449 629 RFSENNLIGIGN------------GMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVK------------------- 677 (823)
Q Consensus 629 ~f~~~~~lg~g~------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------------- 677 (823)
.|...+++|.|. +..||||++..+.+ ---+|.++|+++.|||||+
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 455566777775 56799998866532 1236899999999999998
Q ss_pred -----------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCC-CcEEEeecccccccCCCC
Q 045449 678 -----------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDED-MVAHISDFGIAKLLSGED 727 (823)
Q Consensus 678 -----------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~-~~~kl~DfGla~~~~~~~ 727 (823)
+..|+.++|.|+|+.+|+||||||+|+|+|.+ |.+||||||.|+.+...+
T Consensus 101 leymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~e 180 (364)
T KOG0658|consen 101 LEYMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGE 180 (364)
T ss_pred HHhchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceeeccCC
Confidence 24688999999999999999999999999965 999999999999987654
Q ss_pred ccccccccccCCCcCcccccCCC-ccccccceehhhhhhccccCCCCCcCCC
Q 045449 728 QLSKQTQTLATIGYMAPEYGTKG-RVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 728 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
. ..+...|..|+|||.+.+. .|+.+.||||.|||++||+-|+..|.+.
T Consensus 181 p---niSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~ 229 (364)
T KOG0658|consen 181 P---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGD 229 (364)
T ss_pred C---ceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCC
Confidence 4 2456789999999988764 5999999999999999999999888764
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.3e-26 Score=238.07 Aligned_cols=152 Identities=25% Similarity=0.387 Sum_probs=127.5
Q ss_pred ccCCccceeeccC------------CeEEEEEEehHhh-HHHHHHHHHHHHHHhhcchhhHHH-----------------
Q 045449 628 DRFSENNLIGIGN------------GMEVAVKVFHQQY-ERALKSFEDECEVRKRIRHRNLVK----------------- 677 (823)
Q Consensus 628 ~~f~~~~~lg~g~------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~----------------- 677 (823)
+.|.....||.|. +..||||++..+. ....+.+.+|+..|+.++||||++
T Consensus 26 ~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpf 105 (516)
T KOG0582|consen 26 KDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPF 105 (516)
T ss_pred cceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehh
Confidence 5677778888884 6779999998554 444688999999999999999998
Q ss_pred -------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCc-ccc
Q 045449 678 -------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQ-LSK 731 (823)
Q Consensus 678 -------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~-~~~ 731 (823)
++.+++.+|.|+|.+|.+|||||+.|||++.+|.+||+|||.+..+..... ...
T Consensus 106 Ma~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R~~~ 185 (516)
T KOG0582|consen 106 MAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDRQVT 185 (516)
T ss_pred hcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeecccCceeeE
Confidence 346889999999999999999999999999999999999998876644322 111
Q ss_pred c-cccccCCCcCcccccCC--CccccccceehhhhhhccccCCCCCcCCCc
Q 045449 732 Q-TQTLATIGYMAPEYGTK--GRVSTRGDVCSFGIISGGKETRSMTVGETC 779 (823)
Q Consensus 732 ~-~~~~gt~~y~aPE~~~~--~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~~ 779 (823)
. .+.+||+.|||||++.. ..|+.|+||||||+...|+..|..||....
T Consensus 186 rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~p 236 (516)
T KOG0582|consen 186 RFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYP 236 (516)
T ss_pred eeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCC
Confidence 2 56789999999999543 469999999999999999999999998764
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.2e-27 Score=241.60 Aligned_cols=411 Identities=18% Similarity=0.208 Sum_probs=244.3
Q ss_pred cEEEEEcCCCCCccccCcccCCCCCCcEEEccCCCCCCCCCCCCCCCCCCCEEECCC-CcCcCCCchhhhcCCCCcEEec
Q 045449 53 RVIGLNISSFNLQGTITPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLDFSD-NQLFGSLSSFIFNMSSMTTIDL 131 (823)
Q Consensus 53 ~v~~L~L~~~~l~g~~~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~L 131 (823)
..+.++|..|+|+...+.+|..+++|+.||||+|+|+.+-|++|.++++|..|-+.+ |+|+...-..|++|.+|+.|.+
T Consensus 68 ~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrLll 147 (498)
T KOG4237|consen 68 ETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFGGLSSLQRLLL 147 (498)
T ss_pred cceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhHHHHHHHhc
Confidence 456777777777766666777777888888888887777777777777766665544 7777666677777777777777
Q ss_pred ccccccCccCccccCCCCCCccccccceeeeccceeeccCcc-ccccchhhHHHHHhhcCCCcc------------cCCc
Q 045449 132 SINRLSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAIPK-EIGNLTKLKEIISTITNSTVC------------EIPR 198 (823)
Q Consensus 132 s~N~l~~~~p~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~-~l~~l~~L~~L~~l~~n~~~~------------~ip~ 198 (823)
.-|++.-...+ +|..+++|..|.|..|.+. .++. .|..+..++.+. +..|.+.+ ..|.
T Consensus 148 Nan~i~Cir~~-------al~dL~~l~lLslyDn~~q-~i~~~tf~~l~~i~tlh-lA~np~icdCnL~wla~~~a~~~i 218 (498)
T KOG4237|consen 148 NANHINCIRQD-------ALRDLPSLSLLSLYDNKIQ-SICKGTFQGLAAIKTLH-LAQNPFICDCNLPWLADDLAMNPI 218 (498)
T ss_pred ChhhhcchhHH-------HHHHhhhcchhcccchhhh-hhccccccchhccchHh-hhcCccccccccchhhhHHhhchh
Confidence 77777633333 3467777777777777776 4443 677777777765 55554221 1233
Q ss_pred ccCCcchhhhhccccccccCCccccccC-CCCCcEEEccCCcccccCCcccccCCCCccEEEeeccccccccCccccCCC
Q 045449 199 EIGNLPYLARLALATNNLVGVVPVTIFN-MSALKEISLLNNSLSGSLPSRIDLSLPNVETLNLGINSFSGTIPSSITNSS 277 (823)
Q Consensus 199 ~l~~l~~L~~L~Ls~N~l~~~~p~~~~~-l~~L~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 277 (823)
+++...-..-..+.++++..+-+..|.. +..+.+-..+.....+.-|...+..+++|+.|+|++|+++++-+.+|.++.
T Consensus 219 etsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a 298 (498)
T KOG4237|consen 219 ETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAA 298 (498)
T ss_pred hcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhhhcchh
Confidence 3444444444444444444443333322 112222222233333456666666778888888888888877777888888
Q ss_pred CCCeEEeecccccccCCCccCCCcccCcccccCccccCCCCcccccccccCCCCceEEEeecCCCCccC-Cccccccccc
Q 045449 278 KLSDLELGENLFSGFIPNTIGNLRNLEFGNIADNYLTSSTPELSFLSSLTNCKKLKVLIVTGNPLDGIL-PKSIGNFSLS 356 (823)
Q Consensus 278 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~-p~~~~~~~~~ 356 (823)
+++.|.|..|++..+....|.++..|+.|+|.+|+|+.. .+.+|..+..|..|.|-.|.+.--- -.|++..
T Consensus 299 ~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~-----~~~aF~~~~~l~~l~l~~Np~~CnC~l~wl~~W--- 370 (498)
T KOG4237|consen 299 ELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTV-----APGAFQTLFSLSTLNLLSNPFNCNCRLAWLGEW--- 370 (498)
T ss_pred hhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEE-----ecccccccceeeeeehccCcccCccchHHHHHH---
Confidence 888888888887777777777777777788888877776 4556777777777777777664210 0112211
Q ss_pred cceEEecCCcceeccCccccCcccccEEEcccCcCCC---CchhcccccCCCCEEEccCCCCCCcchHhhhcCCCCC-EE
Q 045449 357 LETILMANCSISGNIPQVVGNLSNLLVLELGGNNLTG---PIPVTFSQLQTLQAFDLTRNKLAGPITDELCHLARLH-SL 432 (823)
Q Consensus 357 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g---~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~-~L 432 (823)
|..+.-.|..|- +.-..++.++++.+.+.. ..|++.+..+ ++.-|. .++-+. +.
T Consensus 371 -----lr~~~~~~~~~C--q~p~~~~~~~~~dv~~~~~~c~~~ee~~~~~------------s~~cP~---~c~c~~tVv 428 (498)
T KOG4237|consen 371 -----LRKKSVVGNPRC--QSPGFVRQIPISDVAFGDFRCGGPEELGCLT------------SSPCPP---PCTCLDTVV 428 (498)
T ss_pred -----HhhCCCCCCCCC--CCCchhccccchhccccccccCCccccCCCC------------CCCCCC---CcchhhhhH
Confidence 222222222211 112234455555544431 1111111100 001111 112222 22
Q ss_pred EcccCcCcccccccccCCCCCCeEeccCCccccccchhhhccCCCcEEeccccccccccCccccCCCCCcEEEcccC
Q 045449 433 VLQGNKFSGSIPSCLGNLTSVRVLYLGLNIFTSVLSSTIWNLKDILFIDVSSNFLDGPLSLDIGNLKVVIGLDFSRN 509 (823)
Q Consensus 433 ~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~ls~N 509 (823)
..|++.+. .+|..+. ..-.+||+.+|.++. +|.. .+.+| .+|+|+|+++-.--..|.+|+.|.+|-+|+|
T Consensus 429 RcSnk~lk-~lp~~iP--~d~telyl~gn~~~~-vp~~--~~~~l-~~dls~n~i~~Lsn~tf~n~tql~tlilsyn 498 (498)
T KOG4237|consen 429 RCSNKLLK-LLPRGIP--VDVTELYLDGNAITS-VPDE--LLRSL-LLDLSNNRISSLSNYTFSNMTQLSTLILSYN 498 (498)
T ss_pred hhcccchh-hcCCCCC--chhHHHhcccchhcc-cCHH--HHhhh-hcccccCceehhhcccccchhhhheeEEecC
Confidence 33444443 4444332 234577888888876 4544 56667 8888888888766677888888888888876
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.5e-26 Score=229.30 Aligned_cols=136 Identities=29% Similarity=0.283 Sum_probs=117.2
Q ss_pred CeEEEEEEehHhhHH--HHHHHHHHHHHHhhcchhhHHH-----------------------------------------
Q 045449 641 GMEVAVKVFHQQYER--ALKSFEDECEVRKRIRHRNLVK----------------------------------------- 677 (823)
Q Consensus 641 ~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~----------------------------------------- 677 (823)
+..||+|+++.+.++ .--.-.|||.++.+++|||||.
T Consensus 101 ~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~~EhDLksl~d~m~q~F~~~evK 180 (419)
T KOG0663|consen 101 DEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVMEYVEHDLKSLMETMKQPFLPGEVK 180 (419)
T ss_pred ceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHHHHHhhHHHHHHhccCCCchHHHH
Confidence 577999999866422 1124579999999999999998
Q ss_pred -HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCcccccCCCc-cccc
Q 045449 678 -IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGR-VSTR 755 (823)
Q Consensus 678 -~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~ 755 (823)
++.|++.++.|+|...|+|||+|++|+|+...|.+||+|||+||.+.... ...+..+-|.+|+|||.+.+.+ |++.
T Consensus 181 ~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~--k~~T~lVVTLWYRaPELLLG~~tyst~ 258 (419)
T KOG0663|consen 181 TLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPL--KPYTPLVVTLWYRAPELLLGAKTYSTA 258 (419)
T ss_pred HHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCCc--ccCcceEEEeeecCHHHhcCCcccCcc
Confidence 35799999999999999999999999999999999999999999886542 3456778899999999988765 8999
Q ss_pred cceehhhhhhccccCCCCCcCCC
Q 045449 756 GDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 756 ~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
.|+||+|||++|++.++..|.+.
T Consensus 259 iDMWSvGCI~aE~l~~kPlf~G~ 281 (419)
T KOG0663|consen 259 VDMWSVGCIFAELLTQKPLFPGK 281 (419)
T ss_pred hhhhhHHHHHHHHHhcCCCCCCC
Confidence 99999999999999999888664
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=4e-26 Score=231.94 Aligned_cols=155 Identities=29% Similarity=0.339 Sum_probs=129.3
Q ss_pred HHHhccCCccceeeccC------------CeEEEEEEehHhh--HHHHHHHHHHHHHHhhcchhhHHH------------
Q 045449 624 LRATDRFSENNLIGIGN------------GMEVAVKVFHQQY--ERALKSFEDECEVRKRIRHRNLVK------------ 677 (823)
Q Consensus 624 ~~at~~f~~~~~lg~g~------------~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~------------ 677 (823)
......|...+.+|.|+ |..||||.+.... ....++..+|+.++++++|+||+.
T Consensus 18 ~~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~ 97 (359)
T KOG0660|consen 18 FEIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDK 97 (359)
T ss_pred EeccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccc
Confidence 34445555556777775 6779999987443 344578889999999999999998
Q ss_pred --------------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCC
Q 045449 678 --------------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSG 725 (823)
Q Consensus 678 --------------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~ 725 (823)
++.|++.+|.|+|+.+|+|||+||+|++++.+...||+|||+||....
T Consensus 98 f~DvYiV~elMetDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~ 177 (359)
T KOG0660|consen 98 FNDVYLVFELMETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDK 177 (359)
T ss_pred cceeEEehhHHhhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeeccc
Confidence 367999999999999999999999999999999999999999998764
Q ss_pred CCccccccccccCCCcCcccccC-CCccccccceehhhhhhccccCCCCCcCCC
Q 045449 726 EDQLSKQTQTLATIGYMAPEYGT-KGRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 726 ~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
.......+..+.|.+|+|||++. ...|+...||||.|||++||++|+..|.+.
T Consensus 178 ~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~ 231 (359)
T KOG0660|consen 178 FFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGK 231 (359)
T ss_pred cCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCC
Confidence 32333457788999999999765 467999999999999999999999888664
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=8e-26 Score=242.26 Aligned_cols=192 Identities=25% Similarity=0.317 Sum_probs=135.6
Q ss_pred cCCccceeeccC-Ce--------EEEEEEehHhh--HHHHHHHHHHHHHHhhcchhhHHH--------------------
Q 045449 629 RFSENNLIGIGN-GM--------EVAVKVFHQQY--ERALKSFEDECEVRKRIRHRNLVK-------------------- 677 (823)
Q Consensus 629 ~f~~~~~lg~g~-~~--------~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~-------------------- 677 (823)
.+.....||.|. |+ .||||++.... ....+.|+.|+.++++-+|.||+=
T Consensus 393 ev~l~~rIGsGsFGtV~Rg~whGdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~AIiTqwCeGs 472 (678)
T KOG0193|consen 393 EVLLGERIGSGSFGTVYRGRWHGDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPLAIITQWCEGS 472 (678)
T ss_pred HhhccceeccccccceeecccccceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCceeeeehhccCc
Confidence 334457899886 22 39999997654 446689999999999999999996
Q ss_pred --------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCcccccccccc
Q 045449 678 --------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLA 737 (823)
Q Consensus 678 --------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~g 737 (823)
++.|+++++.|+|.++|||||+|..||++.+++.|||+|||++..-..-..........|
T Consensus 473 SLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~~q~~qp~g 552 (678)
T KOG0193|consen 473 SLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGEQQLEQPHG 552 (678)
T ss_pred hhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeeeeeccccccCCCcc
Confidence 345788888899999999999999999999999999999999864321111111223457
Q ss_pred CCCcCcccccCCC---ccccccceehhhhhhccccCCCCCcCCCcc-cc--cccccccCCcccccccCCCcccccccccc
Q 045449 738 TIGYMAPEYGTKG---RVSTRGDVCSFGIISGGKETRSMTVGETCT-PV--RESKYEVHPATTTIMEHPLPRVGEVMDVD 811 (823)
Q Consensus 738 t~~y~aPE~~~~~---~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~~~-~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 811 (823)
...|||||++..+ +|++.+||||||||.||+++|..||..... ++ +.++=...|...........++.+++..+
T Consensus 553 silwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~~~s~~pk~mk~Ll~~C 632 (678)
T KOG0193|consen 553 SLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSKIRSNCPKAMKRLLSDC 632 (678)
T ss_pred chhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccchhhhccCHHHHHHHHHHH
Confidence 8899999998753 589999999999999999999999973221 11 11111222333333333434555555555
Q ss_pred cccccccCC
Q 045449 812 RGKARIQGK 820 (823)
Q Consensus 812 ~~~~~~~~~ 820 (823)
..+.+-+||
T Consensus 633 ~~~~~~eRP 641 (678)
T KOG0193|consen 633 WKFDREERP 641 (678)
T ss_pred HhcCcccCc
Confidence 444444443
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.3e-26 Score=240.83 Aligned_cols=147 Identities=28% Similarity=0.403 Sum_probs=122.1
Q ss_pred ccCHHHHHHHhccCCccceeeccC----------CeEEEEEEehHhhHHHHHHHHHHHHHHhhcchhhHHHH--------
Q 045449 617 RFSYHELLRATDRFSENNLIGIGN----------GMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVKI-------- 678 (823)
Q Consensus 617 ~~~~~~l~~at~~f~~~~~lg~g~----------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~-------- 678 (823)
+++|+++.+. +.+|.|+ +..||||.++... ..+|.-+++++|+||+.+
T Consensus 120 eiPFe~IsEL-------eWlGSGaQGAVF~Grl~netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsP 185 (904)
T KOG4721|consen 120 EIPFEEISEL-------EWLGSGAQGAVFLGRLHNETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSP 185 (904)
T ss_pred cCCHHHhhhh-------hhhccCcccceeeeeccCceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCc
Confidence 4667776553 5667664 6679999876443 346778999999999982
Q ss_pred --------------------------------HHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCC
Q 045449 679 --------------------------------ISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGE 726 (823)
Q Consensus 679 --------------------------------~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~ 726 (823)
..+++.++||+|.+.|||||+|..|||+..+..+||+|||-++.....
T Consensus 186 cyCIiMEfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~ 265 (904)
T KOG4721|consen 186 CYCIIMEFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK 265 (904)
T ss_pred eeEEeeeccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhhh
Confidence 246677889999999999999999999999999999999999876543
Q ss_pred CccccccccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCCCcc
Q 045449 727 DQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGETCT 780 (823)
Q Consensus 727 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~~~ 780 (823)
.....++||..|||||++...+.++|+||||||||+|||+|+..|+.++..
T Consensus 266 ---STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVds 316 (904)
T KOG4721|consen 266 ---STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDS 316 (904)
T ss_pred ---hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccch
Confidence 223468999999999999999999999999999999999999999988643
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.9e-26 Score=220.73 Aligned_cols=184 Identities=26% Similarity=0.369 Sum_probs=146.4
Q ss_pred ccCCccceeeccC------------CeEEEEEEehHh--------hHHHHHHHHHHHHHHhhc-chhhHHH---------
Q 045449 628 DRFSENNLIGIGN------------GMEVAVKVFHQQ--------YERALKSFEDECEVRKRI-RHRNLVK--------- 677 (823)
Q Consensus 628 ~~f~~~~~lg~g~------------~~~vavK~~~~~--------~~~~~~~~~~E~~~l~~l-~h~niv~--------- 677 (823)
..|...+++|+|. |...|+|++... .....+.-.+|+++++++ .||+|++
T Consensus 17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s 96 (411)
T KOG0599|consen 17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA 96 (411)
T ss_pred hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc
Confidence 3455666777664 677899988532 234456778999999998 7999998
Q ss_pred -------------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCC
Q 045449 678 -------------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGE 726 (823)
Q Consensus 678 -------------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~ 726 (823)
++.|+++++.|+|...|||||+||+|||+|++..+||+|||+|+.+.++
T Consensus 97 F~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l~~G 176 (411)
T KOG0599|consen 97 FVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQLEPG 176 (411)
T ss_pred hhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeeccCCc
Confidence 4678999999999999999999999999999999999999999998766
Q ss_pred CccccccccccCCCcCcccccCC------CccccccceehhhhhhccccCCCCCcCCC-----cccccccccccC-Cccc
Q 045449 727 DQLSKQTQTLATIGYMAPEYGTK------GRVSTRGDVCSFGIISGGKETRSMTVGET-----CTPVRESKYEVH-PATT 794 (823)
Q Consensus 727 ~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~-----~~~~~~~~~~~~-~~~~ 794 (823)
+. ....+|||+|.|||.+.. ..|+..+|.||+||++|-++.|..||-.- .+.+++++|++. |.+.
T Consensus 177 ek---LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~speWa 253 (411)
T KOG0599|consen 177 EK---LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSPEWA 253 (411)
T ss_pred hh---HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCcchh
Confidence 54 345789999999998753 35888999999999999999999998553 344667777776 4555
Q ss_pred ccccCCCccccccccccccc
Q 045449 795 TIMEHPLPRVGEVMDVDRGK 814 (823)
Q Consensus 795 ~~~~~~~~~~~~~~~~~~~~ 814 (823)
...+.+...+..++.+++.+
T Consensus 254 dis~~~KdLIsrlLqVdp~~ 273 (411)
T KOG0599|consen 254 DISATVKDLISRLLQVDPTK 273 (411)
T ss_pred hccccHHHHHHHHHeeCchh
Confidence 56666666777777776654
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.7e-25 Score=237.28 Aligned_cols=153 Identities=24% Similarity=0.290 Sum_probs=129.8
Q ss_pred HhccCCccceeeccC------------CeEEEEEEehHhh---HHHHHHHHHHHHHHhhcchhhHHH-------------
Q 045449 626 ATDRFSENNLIGIGN------------GMEVAVKVFHQQY---ERALKSFEDECEVRKRIRHRNLVK------------- 677 (823)
Q Consensus 626 at~~f~~~~~lg~g~------------~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~------------- 677 (823)
..++|+.-..||+|+ |..+|+|++++.. ...++..+.|-++|....+|.||+
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 457899999999997 6779999998664 345577889999999999999999
Q ss_pred ---------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCC----
Q 045449 678 ---------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGE---- 726 (823)
Q Consensus 678 ---------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~---- 726 (823)
++|+.+-|++.+|..|++||||||+|+|+|..|++||+|||++..+...
T Consensus 219 iMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~ 298 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIE 298 (550)
T ss_pred EEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhhhhhh
Confidence 4789999999999999999999999999999999999999998643210
Q ss_pred ------------------Ccc-----c------------------cccccccCCCcCcccccCCCccccccceehhhhhh
Q 045449 727 ------------------DQL-----S------------------KQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIIS 765 (823)
Q Consensus 727 ------------------~~~-----~------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~ 765 (823)
+.. . .....+|||.|||||++.+..|+..+|+||+|||+
T Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~Im 378 (550)
T KOG0605|consen 299 SYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCIM 378 (550)
T ss_pred hhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHHHH
Confidence 000 0 01135899999999999999999999999999999
Q ss_pred ccccCCCCCcCCC
Q 045449 766 GGKETRSMTVGET 778 (823)
Q Consensus 766 ~~~~~~~~~~~~~ 778 (823)
|||+.|-.||...
T Consensus 379 yEmLvGyPPF~s~ 391 (550)
T KOG0605|consen 379 YEMLVGYPPFCSE 391 (550)
T ss_pred HHHHhCCCCCCCC
Confidence 9999999999653
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.4e-25 Score=244.53 Aligned_cols=150 Identities=25% Similarity=0.273 Sum_probs=130.4
Q ss_pred hccCCccceeeccC------------CeEEEEEEehHhh---HHHHHHHHHHHHHHhhc-chhhHHH-------------
Q 045449 627 TDRFSENNLIGIGN------------GMEVAVKVFHQQY---ERALKSFEDECEVRKRI-RHRNLVK------------- 677 (823)
Q Consensus 627 t~~f~~~~~lg~g~------------~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~------------- 677 (823)
.++|...+++|+|. ++.+|||+++++. ...++..+.|.+|+... +||.++.
T Consensus 367 l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~f 446 (694)
T KOG0694|consen 367 LDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFF 446 (694)
T ss_pred ccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEE
Confidence 46788888999886 5669999998765 44567888899988877 5999998
Q ss_pred --------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCcccc
Q 045449 678 --------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSK 731 (823)
Q Consensus 678 --------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~ 731 (823)
++|.++-+|+|+|+.|||+||+|.+|||+|.+|++||+|||+++.-.... ..
T Consensus 447 vmey~~Ggdm~~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~g--~~ 524 (694)
T KOG0694|consen 447 VMEYVAGGDLMHHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQG--DR 524 (694)
T ss_pred EEEecCCCcEEEEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccCCCC--Cc
Confidence 46889999999999999999999999999999999999999999754222 24
Q ss_pred ccccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCCC
Q 045449 732 QTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 732 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
..+++|||.|||||++.+..|+..+|+|||||++|||+.|..||.+.
T Consensus 525 TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gd 571 (694)
T KOG0694|consen 525 TSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGD 571 (694)
T ss_pred cccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCC
Confidence 56789999999999999999999999999999999999999999754
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=3e-25 Score=231.10 Aligned_cols=150 Identities=32% Similarity=0.461 Sum_probs=121.7
Q ss_pred cCCccceeeccC------------CeEEEEEEehHhhHHHHHHHHHHHHHHhhcchhhHHH-------------------
Q 045449 629 RFSENNLIGIGN------------GMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVK------------------- 677 (823)
Q Consensus 629 ~f~~~~~lg~g~------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------------- 677 (823)
++...+.+|+|. |...|||.+........+.+.+|+.++++++|||||+
T Consensus 18 ~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy 97 (313)
T KOG0198|consen 18 NWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEY 97 (313)
T ss_pred hhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeec
Confidence 344556777764 4678999887653333677999999999999999998
Q ss_pred ------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCC-CCcEEEeecccccccCCC-Ccccc
Q 045449 678 ------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDE-DMVAHISDFGIAKLLSGE-DQLSK 731 (823)
Q Consensus 678 ------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~-~~~~kl~DfGla~~~~~~-~~~~~ 731 (823)
+..|++++|.|+|++|||||||||+|||++. ++.+||+|||+++..... .....
T Consensus 98 ~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~~~ 177 (313)
T KOG0198|consen 98 APGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTKSDS 177 (313)
T ss_pred cCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCccccccccccccccc
Confidence 3568899999999999999999999999999 699999999999876531 11122
Q ss_pred ccccccCCCcCcccccCCCc-cccccceehhhhhhccccCCCCCcCCC
Q 045449 732 QTQTLATIGYMAPEYGTKGR-VSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 732 ~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
.....||+.|||||++..+. .+.++||||+||++.||.||..||.+.
T Consensus 178 ~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~ 225 (313)
T KOG0198|consen 178 ELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF 225 (313)
T ss_pred cccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh
Confidence 34578999999999998643 345999999999999999999999873
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.4e-24 Score=264.60 Aligned_cols=343 Identities=19% Similarity=0.240 Sum_probs=246.1
Q ss_pred cccCCCCCCcEEEccCCC------CCCCCCCCCCCCC-CCCEEECCCCcCcCCCchhhhcCCCCcEEecccccccCccCc
Q 045449 70 PQLGNLSSLQTLDLSHNK------LSGNIPSSIFNMH-TLKLLDFSDNQLFGSLSSFIFNMSSMTTIDLSINRLSGELPA 142 (823)
Q Consensus 70 ~~l~~l~~L~~L~Ls~N~------l~g~~p~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 142 (823)
.+|..+.+|+.|.+..+. +...+|..|..++ +|+.|++.+|.+. .+|..| ...+|++|+|++|++. .+|.
T Consensus 552 ~aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~-~L~~ 628 (1153)
T PLN03210 552 NAFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLE-KLWD 628 (1153)
T ss_pred HHHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC-CCCCcC-CccCCcEEECcCcccc-cccc
Confidence 457788889999887653 3345777777764 5888888888875 556666 4678888888888876 3333
Q ss_pred cccCCCCCCccccccceeeeccceeeccCccccccchhhHHHHHhhcCCCcccCCcccCCcchhhhhccccccccCCccc
Q 045449 143 NICKIPSTLSKCKQLEELNLGFNNLSGAIPKEIGNLTKLKEIISTITNSTVCEIPREIGNLPYLARLALATNNLVGVVPV 222 (823)
Q Consensus 143 ~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~~l~~n~~~~~ip~~l~~l~~L~~L~Ls~N~l~~~~p~ 222 (823)
.+..+++|++|+|++|...+.+|. +..+++|+.|+|++|.....+|.
T Consensus 629 -------~~~~l~~Lk~L~Ls~~~~l~~ip~--------------------------ls~l~~Le~L~L~~c~~L~~lp~ 675 (1153)
T PLN03210 629 -------GVHSLTGLRNIDLRGSKNLKEIPD--------------------------LSMATNLETLKLSDCSSLVELPS 675 (1153)
T ss_pred -------ccccCCCCCEEECCCCCCcCcCCc--------------------------cccCCcccEEEecCCCCccccch
Confidence 347788888888887754434442 33456677777777766666777
Q ss_pred cccCCCCCcEEEccCCcccccCCcccccCCCCccEEEeeccccccccCccccCCCCCCeEEeecccccccCCCccCCCcc
Q 045449 223 TIFNMSALKEISLLNNSLSGSLPSRIDLSLPNVETLNLGINSFSGTIPSSITNSSKLSDLELGENLFSGFIPNTIGNLRN 302 (823)
Q Consensus 223 ~~~~l~~L~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 302 (823)
.+.++++|+.|++++|..-+.+|..+ .+++|++|+|++|...+.+|.. .++|+.|+|++|.++ .+|..+ .+++
T Consensus 676 si~~L~~L~~L~L~~c~~L~~Lp~~i--~l~sL~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~-~lP~~~-~l~~ 748 (1153)
T PLN03210 676 SIQYLNKLEDLDMSRCENLEILPTGI--NLKSLYRLNLSGCSRLKSFPDI---STNISWLDLDETAIE-EFPSNL-RLEN 748 (1153)
T ss_pred hhhccCCCCEEeCCCCCCcCccCCcC--CCCCCCEEeCCCCCCccccccc---cCCcCeeecCCCccc-cccccc-cccc
Confidence 77777788888887764444677655 3777888888777655555543 346778888888776 345444 5677
Q ss_pred cCcccccCccccCCCCccc--ccccccCCCCceEEEeecCCCCccCCccccccccccceEEecCCcceeccCccccCccc
Q 045449 303 LEFGNIADNYLTSSTPELS--FLSSLTNCKKLKVLIVTGNPLDGILPKSIGNFSLSLETILMANCSISGNIPQVVGNLSN 380 (823)
Q Consensus 303 L~~L~L~~N~l~~~~~~~~--~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~ 380 (823)
|++|++.++.......... .+......++|+.|+|++|...+.+|.+++++ ++|+.|++++|..-+.+|..+ ++++
T Consensus 749 L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L-~~L~~L~Ls~C~~L~~LP~~~-~L~s 826 (1153)
T PLN03210 749 LDELILCEMKSEKLWERVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNL-HKLEHLEIENCINLETLPTGI-NLES 826 (1153)
T ss_pred cccccccccchhhccccccccchhhhhccccchheeCCCCCCccccChhhhCC-CCCCEEECCCCCCcCeeCCCC-Cccc
Confidence 7777776643221100000 01112335689999999998888899999998 799999999986555777766 7899
Q ss_pred ccEEEcccCcCCCCchhcccccCCCCEEEccCCCCCCcchHhhhcCCCCCEEEccc-CcCcccccccccCCCCCCeEecc
Q 045449 381 LLVLELGGNNLTGPIPVTFSQLQTLQAFDLTRNKLAGPITDELCHLARLHSLVLQG-NKFSGSIPSCLGNLTSVRVLYLG 459 (823)
Q Consensus 381 L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~-N~l~g~~p~~~~~l~~L~~L~Ls 459 (823)
|+.|+|++|..-..+|.. ..+|+.|+|++|.++ .+|.++..+++|+.|+|++ |++. .+|..+..+++|+.++++
T Consensus 827 L~~L~Ls~c~~L~~~p~~---~~nL~~L~Ls~n~i~-~iP~si~~l~~L~~L~L~~C~~L~-~l~~~~~~L~~L~~L~l~ 901 (1153)
T PLN03210 827 LESLDLSGCSRLRTFPDI---STNISDLNLSRTGIE-EVPWWIEKFSNLSFLDMNGCNNLQ-RVSLNISKLKHLETVDFS 901 (1153)
T ss_pred cCEEECCCCCcccccccc---ccccCEeECCCCCCc-cChHHHhcCCCCCEEECCCCCCcC-ccCcccccccCCCeeecC
Confidence 999999997655566653 367999999999998 6788999999999999998 4565 578888899999999998
Q ss_pred CCc
Q 045449 460 LNI 462 (823)
Q Consensus 460 ~N~ 462 (823)
++.
T Consensus 902 ~C~ 904 (1153)
T PLN03210 902 DCG 904 (1153)
T ss_pred CCc
Confidence 874
|
syringae 6; Provisional |
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.9e-24 Score=263.29 Aligned_cols=340 Identities=19% Similarity=0.237 Sum_probs=254.5
Q ss_pred CCCCCCCCCCCEEECCCCc------CcCCCchhhhcCC-CCcEEecccccccCccCccccCCCCCCccccccceeeeccc
Q 045449 93 PSSIFNMHTLKLLDFSDNQ------LFGSLSSFIFNMS-SMTTIDLSINRLSGELPANICKIPSTLSKCKQLEELNLGFN 165 (823)
Q Consensus 93 p~~~~~l~~L~~L~Ls~N~------l~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~~p~~~~~l~~L~~L~Ls~N 165 (823)
+.+|.++++|++|.+..+. +...+|..|..++ +|+.|++.+|.++ .+|..+ ...+|++|+|++|
T Consensus 551 ~~aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f--------~~~~L~~L~L~~s 621 (1153)
T PLN03210 551 ENAFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNF--------RPENLVKLQMQGS 621 (1153)
T ss_pred HHHHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC-CCCCcC--------CccCCcEEECcCc
Confidence 3456667777777775543 2234455555543 4677777666654 333322 3456667777666
Q ss_pred eeeccCccccccchhhHHHHHhhcCCCcccCCcccCCcchhhhhccccccccCCccccccCCCCCcEEEccCCcccccCC
Q 045449 166 NLSGAIPKEIGNLTKLKEIISTITNSTVCEIPREIGNLPYLARLALATNNLVGVVPVTIFNMSALKEISLLNNSLSGSLP 245 (823)
Q Consensus 166 ~l~~~~p~~l~~l~~L~~L~~l~~n~~~~~ip~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~lp 245 (823)
++. . +|..+..+++|+.|+|++++....+| .+..+++|++|+|++|..-..+|
T Consensus 622 ~l~-~-------------------------L~~~~~~l~~Lk~L~Ls~~~~l~~ip-~ls~l~~Le~L~L~~c~~L~~lp 674 (1153)
T PLN03210 622 KLE-K-------------------------LWDGVHSLTGLRNIDLRGSKNLKEIP-DLSMATNLETLKLSDCSSLVELP 674 (1153)
T ss_pred ccc-c-------------------------cccccccCCCCCEEECCCCCCcCcCC-ccccCCcccEEEecCCCCccccc
Confidence 654 2 33445567788899999887656677 48889999999999987666899
Q ss_pred cccccCCCCccEEEeeccccccccCccccCCCCCCeEEeecccccccCCCccCCCcccCcccccCccccCCCCccccccc
Q 045449 246 SRIDLSLPNVETLNLGINSFSGTIPSSITNSSKLSDLELGENLFSGFIPNTIGNLRNLEFGNIADNYLTSSTPELSFLSS 325 (823)
Q Consensus 246 ~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~ 325 (823)
..+.. +++|+.|++++|..-+.+|..+ ++++|+.|++++|.....+|.. .++|+.|++++|.++..+ ..
T Consensus 675 ~si~~-L~~L~~L~L~~c~~L~~Lp~~i-~l~sL~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~~lP------~~ 743 (1153)
T PLN03210 675 SSIQY-LNKLEDLDMSRCENLEILPTGI-NLKSLYRLNLSGCSRLKSFPDI---STNISWLDLDETAIEEFP------SN 743 (1153)
T ss_pred hhhhc-cCCCCEEeCCCCCCcCccCCcC-CCCCCCEEeCCCCCCccccccc---cCCcCeeecCCCcccccc------cc
Confidence 88775 9999999999976556788766 7899999999999766666653 467899999999987643 22
Q ss_pred ccCCCCceEEEeecCCCC---c---cCCccccccccccceEEecCCcceeccCccccCcccccEEEcccCcCCCCchhcc
Q 045449 326 LTNCKKLKVLIVTGNPLD---G---ILPKSIGNFSLSLETILMANCSISGNIPQVVGNLSNLLVLELGGNNLTGPIPVTF 399 (823)
Q Consensus 326 l~~l~~L~~L~Ls~N~l~---~---~~p~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~ 399 (823)
+ .+++|+.|.+.++... + .++......+++|++|++++|...+.+|..++++++|+.|++++|..-+.+|..+
T Consensus 744 ~-~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~ 822 (1153)
T PLN03210 744 L-RLENLDELILCEMKSEKLWERVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI 822 (1153)
T ss_pred c-cccccccccccccchhhccccccccchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC
Confidence 2 5677888888764321 1 1111222233689999999999888999999999999999999986555788766
Q ss_pred cccCCCCEEEccCCCCCCcchHhhhcCCCCCEEEcccCcCcccccccccCCCCCCeEeccC-CccccccchhhhccCCCc
Q 045449 400 SQLQTLQAFDLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSVRVLYLGL-NIFTSVLSSTIWNLKDIL 478 (823)
Q Consensus 400 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~ 478 (823)
++++|+.|+|++|..-..+|.. .++|+.|+|++|.++ .+|.++..+++|+.|+|++ |++++ +|..+..++.|+
T Consensus 823 -~L~sL~~L~Ls~c~~L~~~p~~---~~nL~~L~Ls~n~i~-~iP~si~~l~~L~~L~L~~C~~L~~-l~~~~~~L~~L~ 896 (1153)
T PLN03210 823 -NLESLESLDLSGCSRLRTFPDI---STNISDLNLSRTGIE-EVPWWIEKFSNLSFLDMNGCNNLQR-VSLNISKLKHLE 896 (1153)
T ss_pred -CccccCEEECCCCCcccccccc---ccccCEeECCCCCCc-cChHHHhcCCCCCEEECCCCCCcCc-cCcccccccCCC
Confidence 7899999999998765555543 468999999999998 6899999999999999998 45665 777888999999
Q ss_pred EEeccccc
Q 045449 479 FIDVSSNF 486 (823)
Q Consensus 479 ~LdLs~N~ 486 (823)
.++++++.
T Consensus 897 ~L~l~~C~ 904 (1153)
T PLN03210 897 TVDFSDCG 904 (1153)
T ss_pred eeecCCCc
Confidence 99999884
|
syringae 6; Provisional |
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.1e-25 Score=234.79 Aligned_cols=135 Identities=27% Similarity=0.333 Sum_probs=114.7
Q ss_pred CeEEEEEEehHhhHHHHH-HHHHHHHHHhhcc-hhhHHH-----------------------------------------
Q 045449 641 GMEVAVKVFHQQYERALK-SFEDECEVRKRIR-HRNLVK----------------------------------------- 677 (823)
Q Consensus 641 ~~~vavK~~~~~~~~~~~-~~~~E~~~l~~l~-h~niv~----------------------------------------- 677 (823)
|..||||+++.......+ -=.||+..++++. |||||+
T Consensus 35 ~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fVfE~Md~NLYqLmK~R~r~fse~~irn 114 (538)
T KOG0661|consen 35 GELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVFEFMDCNLYQLMKDRNRLFSESDIRN 114 (538)
T ss_pred CceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeeeHHhhhhhHHHHHhhcCCcCCHHHHHH
Confidence 566999999877644322 2358999999998 999998
Q ss_pred HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCcccccCC-Ccccccc
Q 045449 678 IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTK-GRVSTRG 756 (823)
Q Consensus 678 ~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~ 756 (823)
++.|++++|.|+|++|+.|||+||||||+.....+||+|||+||.+..... .+..+.|.+|+|||++.. +-|+.+.
T Consensus 115 im~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~SkpP---YTeYVSTRWYRAPEvLLrs~~Ys~pv 191 (538)
T KOG0661|consen 115 IMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRSKPP---YTEYVSTRWYRAPEVLLRSGYYSSPV 191 (538)
T ss_pred HHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccccccCCC---cchhhhcccccchHHhhhccccCCch
Confidence 367999999999999999999999999999889999999999998876554 356789999999998654 5689999
Q ss_pred ceehhhhhhccccCCCCCcCCC
Q 045449 757 DVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 757 Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
|+||+|||++|+.+-+..|.+.
T Consensus 192 D~wA~GcI~aEl~sLrPLFPG~ 213 (538)
T KOG0661|consen 192 DMWAVGCIMAELYSLRPLFPGA 213 (538)
T ss_pred HHHHHHHHHHHHHHhcccCCCC
Confidence 9999999999988777766554
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.3e-25 Score=248.12 Aligned_cols=181 Identities=24% Similarity=0.267 Sum_probs=146.2
Q ss_pred CeEEEEEEehHhhHH-HHHHHHHHHHHHhhcchhhHHH------------------------------------------
Q 045449 641 GMEVAVKVFHQQYER-ALKSFEDECEVRKRIRHRNLVK------------------------------------------ 677 (823)
Q Consensus 641 ~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~------------------------------------------ 677 (823)
.+.||||.+++..+. ..++|++|+++++.++|||||+
T Consensus 516 ~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~ 595 (774)
T KOG1026|consen 516 EQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQD 595 (774)
T ss_pred ceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCC
Confidence 345999999877654 7899999999999999999999
Q ss_pred ------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCccc
Q 045449 678 ------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPE 745 (823)
Q Consensus 678 ------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE 745 (823)
+++|++++|.|+.++.+|||||-..|+|+.+...+||+|||++|.+...+.+.......-..+|||||
T Consensus 596 ~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppE 675 (774)
T KOG1026|consen 596 TPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPE 675 (774)
T ss_pred CCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccceEEEecccccchhhhhhhhhcccCCceeeeecCCHH
Confidence 35688888999999999999999999999999999999999999887777665544455678999999
Q ss_pred ccCCCccccccceehhhhhhccccC-CCCCcCCCcccccccccccCCcccccccCCCcccccccccccccccccCCCC
Q 045449 746 YGTKGRVSTRGDVCSFGIISGGKET-RSMTVGETCTPVRESKYEVHPATTTIMEHPLPRVGEVMDVDRGKARIQGKPI 822 (823)
Q Consensus 746 ~~~~~~~~~~~Dv~S~Gvv~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~ 822 (823)
.+..++|+++|||||||||+||+.+ |..|+.+...+......... ..-..++.++..+.++|.-+..+.+-+||-.
T Consensus 676 sIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~g-~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF 752 (774)
T KOG1026|consen 676 SILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRAG-QLLSCPENCPTEVYSLMLECWNENPKRRPSF 752 (774)
T ss_pred HhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHHcC-CcccCCCCCCHHHHHHHHHHhhcCcccCCCH
Confidence 9999999999999999999999875 77888776443222221111 1133456777888888888888877777654
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.3e-25 Score=229.23 Aligned_cols=138 Identities=32% Similarity=0.373 Sum_probs=118.8
Q ss_pred CeEEEEEEehHhhH--HHHHHHHHHHHHHhhcchhh-HHH----------------------------------------
Q 045449 641 GMEVAVKVFHQQYE--RALKSFEDECEVRKRIRHRN-LVK---------------------------------------- 677 (823)
Q Consensus 641 ~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~n-iv~---------------------------------------- 677 (823)
|..||+|.++...+ .......+|+.++++++|+| ||+
T Consensus 36 g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l~lvfe~~d~DL~~ymd~~~~~~~ 115 (323)
T KOG0594|consen 36 GKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKLYLVFEFLDRDLKKYMDSLPKKPQ 115 (323)
T ss_pred CCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceEEEEEEeecccHHHHHHhcccccc
Confidence 67899999976543 24456789999999999999 876
Q ss_pred ---------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCcccccC
Q 045449 678 ---------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGT 748 (823)
Q Consensus 678 ---------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 748 (823)
++.|++.+|+|+|+++|+|||+||+|||++.+|.+||+|||+|+...-.. ...++.++|.+|+|||++.
T Consensus 116 g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAra~~ip~--~~yt~evvTlWYRaPEvLl 193 (323)
T KOG0594|consen 116 GLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLARAFSIPM--RTYTPEVVTLWYRAPEVLL 193 (323)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchHHHhcCCc--ccccccEEEeeccCHHHhc
Confidence 46799999999999999999999999999999999999999999665332 2356678999999999988
Q ss_pred CC-ccccccceehhhhhhccccCCCCCcCCCcc
Q 045449 749 KG-RVSTRGDVCSFGIISGGKETRSMTVGETCT 780 (823)
Q Consensus 749 ~~-~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~~~ 780 (823)
+. .|+...||||+||+++||.+++..|.+..+
T Consensus 194 Gs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se 226 (323)
T KOG0594|consen 194 GSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSE 226 (323)
T ss_pred CCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcH
Confidence 86 699999999999999999999988877644
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.7e-24 Score=247.66 Aligned_cols=263 Identities=23% Similarity=0.296 Sum_probs=212.7
Q ss_pred hhhhccccccccCCccccccCCCCCcEEEccCCcccccCCcccccCCCCccEEEeeccccccccCccccCCCCCCeEEee
Q 045449 206 LARLALATNNLVGVVPVTIFNMSALKEISLLNNSLSGSLPSRIDLSLPNVETLNLGINSFSGTIPSSITNSSKLSDLELG 285 (823)
Q Consensus 206 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 285 (823)
-..|+|+.|+|+ .+|..+. ++|+.|++++|+|+ .+|.. +++|++|+|++|+|+. +|.. .++|+.|+++
T Consensus 203 ~~~LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt-~LP~l----p~~Lk~LdLs~N~Lts-LP~l---p~sL~~L~Ls 270 (788)
T PRK15387 203 NAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPAL----PPELRTLEVSGNQLTS-LPVL---PPGLLELSIF 270 (788)
T ss_pred CcEEEcCCCCCC-cCCcchh--cCCCEEEccCCcCC-CCCCC----CCCCcEEEecCCccCc-ccCc---ccccceeecc
Confidence 457899999999 5677665 48999999999998 67752 6899999999999994 5653 4689999999
Q ss_pred cccccccCCCccCCCcccCcccccCccccCCCCcccccccccCCCCceEEEeecCCCCccCCccccccccccceEEecCC
Q 045449 286 ENLFSGFIPNTIGNLRNLEFGNIADNYLTSSTPELSFLSSLTNCKKLKVLIVTGNPLDGILPKSIGNFSLSLETILMANC 365 (823)
Q Consensus 286 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N 365 (823)
+|.++. +|..+ ++|+.|++++|+++..+. ..++|+.|++++|+|++. |. ++.+|+.|++++|
T Consensus 271 ~N~L~~-Lp~lp---~~L~~L~Ls~N~Lt~LP~---------~p~~L~~LdLS~N~L~~L-p~----lp~~L~~L~Ls~N 332 (788)
T PRK15387 271 SNPLTH-LPALP---SGLCKLWIFGNQLTSLPV---------LPPGLQELSVSDNQLASL-PA----LPSELCKLWAYNN 332 (788)
T ss_pred CCchhh-hhhch---hhcCEEECcCCccccccc---------cccccceeECCCCccccC-CC----CcccccccccccC
Confidence 999985 44433 568889999999987632 236799999999999964 43 2357889999999
Q ss_pred cceeccCccccCcccccEEEcccCcCCCCchhcccccCCCCEEEccCCCCCCcchHhhhcCCCCCEEEcccCcCcccccc
Q 045449 366 SISGNIPQVVGNLSNLLVLELGGNNLTGPIPVTFSQLQTLQAFDLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPS 445 (823)
Q Consensus 366 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~ 445 (823)
+|++ +|.. ..+|++|+|++|+|++ +|.. ..+|+.|++++|+|++ +|.. ..+|+.|+|++|+|++ +|.
T Consensus 333 ~L~~-LP~l---p~~Lq~LdLS~N~Ls~-LP~l---p~~L~~L~Ls~N~L~~-LP~l---~~~L~~LdLs~N~Lt~-LP~ 399 (788)
T PRK15387 333 QLTS-LPTL---PSGLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRLTS-LPAL---PSGLKELIVSGNRLTS-LPV 399 (788)
T ss_pred cccc-cccc---ccccceEecCCCccCC-CCCC---Ccccceehhhcccccc-Cccc---ccccceEEecCCcccC-CCC
Confidence 9985 5542 2589999999999995 5643 3578899999999995 5653 3579999999999995 665
Q ss_pred cccCCCCCCeEeccCCccccccchhhhccCCCcEEeccccccccccCccccCCCCCcEEEcccCCCCCCCCCcc
Q 045449 446 CLGNLTSVRVLYLGLNIFTSVLSSTIWNLKDILFIDVSSNFLDGPLSLDIGNLKVVIGLDFSRNNLSGDIPITI 519 (823)
Q Consensus 446 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~ 519 (823)
.. ++|+.|++++|+|++ +|... ..|+.|++++|+|+ .+|..+.+++.|+.|+|++|+|+|.+|..+
T Consensus 400 l~---s~L~~LdLS~N~Lss-IP~l~---~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~~L 465 (788)
T PRK15387 400 LP---SELKELMVSGNRLTS-LPMLP---SGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQAL 465 (788)
T ss_pred cc---cCCCEEEccCCcCCC-CCcch---hhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCchHHHHH
Confidence 43 579999999999997 56543 46889999999998 789999999999999999999999888876
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.2e-24 Score=223.72 Aligned_cols=132 Identities=32% Similarity=0.462 Sum_probs=107.9
Q ss_pred CeEEEEEEehHhhHHHHHHHHHHHHHHhh--cchhhHHHH----------------------------------------
Q 045449 641 GMEVAVKVFHQQYERALKSFEDECEVRKR--IRHRNLVKI---------------------------------------- 678 (823)
Q Consensus 641 ~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~~---------------------------------------- 678 (823)
++.||||++..... +.|..|-+|.+- ++|+||+++
T Consensus 233 ~~~VAVKifp~~~k---qs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh~kGsL~dyL~~ntisw~~~ 309 (534)
T KOG3653|consen 233 NRLVAVKIFPEQEK---QSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFHPKGSLCDYLKANTISWNSL 309 (534)
T ss_pred CceeEEEecCHHHH---HHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeeeccCCcHHHHHHhccccHHHH
Confidence 67899999976543 678888888764 589999993
Q ss_pred ------HHHHHHHhhhc------CCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCcccc
Q 045449 679 ------ISSSLEYLHFG------HSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEY 746 (823)
Q Consensus 679 ------~~~~l~~L~~~------h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~ 746 (823)
++++++|||.. |+++|+|||||+.|||+..|+++.|+|||+|..+............+||.+|||||+
T Consensus 310 cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEv 389 (534)
T KOG3653|consen 310 CRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEV 389 (534)
T ss_pred HHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHH
Confidence 47888888854 567899999999999999999999999999998876655555566899999999999
Q ss_pred cCCCc-c-----ccccceehhhhhhccccCCCCCc
Q 045449 747 GTKGR-V-----STRGDVCSFGIISGGKETRSMTV 775 (823)
Q Consensus 747 ~~~~~-~-----~~~~Dv~S~Gvv~~~~~~~~~~~ 775 (823)
+.+.. . -.+.||||+|.|+||+..+-...
T Consensus 390 LEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~ 424 (534)
T KOG3653|consen 390 LEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDA 424 (534)
T ss_pred HhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccc
Confidence 87643 1 23589999999999987765433
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.4e-24 Score=224.91 Aligned_cols=176 Identities=22% Similarity=0.269 Sum_probs=137.9
Q ss_pred CeEEEEEEehHhh-HHHHHHHHHHHHHHhhcchhhHHHH----------------------------------------H
Q 045449 641 GMEVAVKVFHQQY-ERALKSFEDECEVRKRIRHRNLVKI----------------------------------------I 679 (823)
Q Consensus 641 ~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~----------------------------------------~ 679 (823)
++.||+|++..+. +..+++..+|+.++..++++||.++ +
T Consensus 38 ~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~gGsv~~lL~~~~~~~E~~i~~il 117 (467)
T KOG0201|consen 38 KKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCGGGSVLDLLKSGNILDEFEIAVIL 117 (467)
T ss_pred cceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhcCcchhhhhccCCCCccceeeeeh
Confidence 5789999998665 4556889999999999999999882 4
Q ss_pred HHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCcccccCCCcccccccee
Q 045449 680 SSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVC 759 (823)
Q Consensus 680 ~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~ 759 (823)
.+.+.+|.|+|.++.+|||||+.||++..+|.+|++|||++..+..... ...+++|||.|||||++....|+.|+|||
T Consensus 118 re~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~--rr~tfvGTPfwMAPEVI~~~~Y~~KADIW 195 (467)
T KOG0201|consen 118 REVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK--RRKTFVGTPFWMAPEVIKQSGYDTKADIW 195 (467)
T ss_pred HHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechhh--ccccccccccccchhhhccccccchhhhh
Confidence 5778899999999999999999999999999999999999988754332 23678999999999999988999999999
Q ss_pred hhhhhhccccCCCCCcCCCcccccccccccCCcc-cccccCCCcccccccccccccccccCC
Q 045449 760 SFGIISGGKETRSMTVGETCTPVRESKYEVHPAT-TTIMEHPLPRVGEVMDVDRGKARIQGK 820 (823)
Q Consensus 760 S~Gvv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 820 (823)
|+|+.++||.+|..|+.+... ++ -.+..+... +....+.-+.++|.+..+-.+.+-.||
T Consensus 196 SLGITaiEla~GePP~s~~hP-mr-vlflIpk~~PP~L~~~~S~~~kEFV~~CL~k~P~~Rp 255 (467)
T KOG0201|consen 196 SLGITAIELAKGEPPHSKLHP-MR-VLFLIPKSAPPRLDGDFSPPFKEFVEACLDKNPEFRP 255 (467)
T ss_pred hhhHHHHHHhcCCCCCcccCc-ce-EEEeccCCCCCccccccCHHHHHHHHHHhhcCcccCc
Confidence 999999999999999977543 21 111111111 222234455677777776666554444
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.2e-25 Score=213.36 Aligned_cols=148 Identities=24% Similarity=0.341 Sum_probs=128.8
Q ss_pred hccCCccceeeccC------------CeEEEEEEehHhh---HHHHHHHHHHHHHHhhcchhhHHH--------------
Q 045449 627 TDRFSENNLIGIGN------------GMEVAVKVFHQQY---ERALKSFEDECEVRKRIRHRNLVK-------------- 677 (823)
Q Consensus 627 t~~f~~~~~lg~g~------------~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~-------------- 677 (823)
.++|+.++.+|+|. +..||+|++.+.. .+..+++.+|++|-+.++||||.+
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 46778888888875 4569999997554 334578999999999999999999
Q ss_pred ----------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCcc
Q 045449 678 ----------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQL 729 (823)
Q Consensus 678 ----------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~ 729 (823)
++.|++.||.|+|.++|+||||||+|+|++.++..|++|||-+.....
T Consensus 101 lEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~---- 176 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS---- 176 (281)
T ss_pred EEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecCC----
Confidence 468999999999999999999999999999999999999998876432
Q ss_pred ccccccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCCC
Q 045449 730 SKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 730 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
....+.+||..|.|||.+.+..++..+|+|++||++||++.|..||...
T Consensus 177 ~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~ 225 (281)
T KOG0580|consen 177 NKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQ 225 (281)
T ss_pred CCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhh
Confidence 2345678999999999999999999999999999999999999999654
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.1e-25 Score=229.58 Aligned_cols=159 Identities=25% Similarity=0.441 Sum_probs=133.7
Q ss_pred cceeeccC------------CeEEEEEEehHhh--HHHHHHHHHHHHHHhhcchhhHHH---------------------
Q 045449 633 NNLIGIGN------------GMEVAVKVFHQQY--ERALKSFEDECEVRKRIRHRNLVK--------------------- 677 (823)
Q Consensus 633 ~~~lg~g~------------~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~--------------------- 677 (823)
++++|.|. |+.||||++.+.. .+...+.+.|++|+..++||.||.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD 648 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence 46777663 7889999997654 344478999999999999999997
Q ss_pred --------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCC---CcEEEeecccccccCCCCccccccc
Q 045449 678 --------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDED---MVAHISDFGIAKLLSGEDQLSKQTQ 734 (823)
Q Consensus 678 --------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~---~~~kl~DfGla~~~~~~~~~~~~~~ 734 (823)
+++|++.+|.|+|-.+|||+|+||+|||+... -.+||||||+||.+.+.. ....
T Consensus 649 MLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks---FRrs 725 (888)
T KOG4236|consen 649 MLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS---FRRS 725 (888)
T ss_pred HHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhh---hhhh
Confidence 47899999999999999999999999999633 378999999999986543 2346
Q ss_pred cccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCCC---cccccccccccCCccc
Q 045449 735 TLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGET---CTPVRESKYEVHPATT 794 (823)
Q Consensus 735 ~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~ 794 (823)
.+|||.|.|||++....|...-|+||.|||+|.-+.|..||.+. .++++...+.++|...
T Consensus 726 VVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNAaFMyPp~PW 788 (888)
T KOG4236|consen 726 VVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNAAFMYPPNPW 788 (888)
T ss_pred hcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHHhhccccccCCCch
Confidence 78999999999999999999999999999999999999999664 4667777766666543
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.8e-25 Score=236.40 Aligned_cols=172 Identities=28% Similarity=0.340 Sum_probs=134.4
Q ss_pred eEEEEEEehHhhHHHHHHHHHHHHHHhhcchhhHHH------------------------------------------HH
Q 045449 642 MEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVK------------------------------------------II 679 (823)
Q Consensus 642 ~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------------------------------------~~ 679 (823)
..||||.++... ...++|.+|+++|++++|++||+ +.
T Consensus 231 ~~vavk~ik~~~-m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a 309 (468)
T KOG0197|consen 231 TKVAVKTIKEGS-MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFA 309 (468)
T ss_pred CcccceEEeccc-cChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCcHHHHhhhcCCCccchHHHHHHH
Confidence 369999997653 33478999999999999999999 36
Q ss_pred HHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCcccccCCCcccccccee
Q 045449 680 SSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVC 759 (823)
Q Consensus 680 ~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~ 759 (823)
+|++++|+|+.++++|||||-+.|||++++..+||+|||+||... ++.+.......-...|.|||.+..+.++.|||||
T Consensus 310 ~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~-d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVW 388 (468)
T KOG0197|consen 310 AQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIG-DDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVW 388 (468)
T ss_pred HHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccC-CCceeecCCCCCCceecCHHHHhhCCccccccee
Confidence 899999999999999999999999999999999999999999543 3333333333446789999999999999999999
Q ss_pred hhhhhhccccC-CCCCcCCCc-----ccccccccccCCcccccccCCCcccccccccccccccccCCC
Q 045449 760 SFGIISGGKET-RSMTVGETC-----TPVRESKYEVHPATTTIMEHPLPRVGEVMDVDRGKARIQGKP 821 (823)
Q Consensus 760 S~Gvv~~~~~~-~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p 821 (823)
||||+++|+.| |+.|+.+.. +.+..+... +.++.+.+.+-++|..+....+-+||.
T Consensus 389 SFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRl------p~P~~CP~~vY~lM~~CW~~~P~~RPt 450 (468)
T KOG0197|consen 389 SFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRL------PRPEGCPDEVYELMKSCWHEDPEDRPT 450 (468)
T ss_pred ehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcC------CCCCCCCHHHHHHHHHHhhCCcccCCC
Confidence 99999999987 566665543 223333222 223456677777777777776666664
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.7e-25 Score=240.92 Aligned_cols=206 Identities=20% Similarity=0.289 Sum_probs=148.6
Q ss_pred ccccccCHHHHHHHhccCC---------ccceeeccC---------------CeEEEEEEehHhh-HHHHHHHHHHHHHH
Q 045449 613 QAIRRFSYHELLRATDRFS---------ENNLIGIGN---------------GMEVAVKVFHQQY-ERALKSFEDECEVR 667 (823)
Q Consensus 613 ~~~~~~~~~~l~~at~~f~---------~~~~lg~g~---------------~~~vavK~~~~~~-~~~~~~~~~E~~~l 667 (823)
..+..++|+|=-+|...|. ++++||.|. ...||||.++..+ ++...+|..|+.||
T Consensus 605 ~YiDP~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIM 684 (996)
T KOG0196|consen 605 TYIDPHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIM 684 (996)
T ss_pred eecCCccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhc
Confidence 3456788888877777665 357888874 2349999998776 56678999999999
Q ss_pred hhcchhhHHH-----------------------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEe
Q 045449 668 KRIRHRNLVK-----------------------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLL 706 (823)
Q Consensus 668 ~~l~h~niv~-----------------------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl 706 (823)
.++.||||++ ++..+.+++.|+.+.++|||||-..|||+
T Consensus 685 GQFdHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILV 764 (996)
T KOG0196|consen 685 GQFDHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILV 764 (996)
T ss_pred ccCCCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheee
Confidence 9999999998 12345567778889999999999999999
Q ss_pred CCCCcEEEeecccccccCCCCcccccccccc--CCCcCcccccCCCccccccceehhhhhhcccc-CCCCCcCCCccccc
Q 045449 707 DEDMVAHISDFGIAKLLSGEDQLSKQTQTLA--TIGYMAPEYGTKGRVSTRGDVCSFGIISGGKE-TRSMTVGETCTPVR 783 (823)
Q Consensus 707 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~-~~~~~~~~~~~~~~ 783 (823)
+.+..+||+|||++|.+..+.. ...++.-| ..+|.|||.+...+++..+||||||||+||.+ +|+.|+-+...+..
T Consensus 765 NsnLvCKVsDFGLSRvledd~~-~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdV 843 (996)
T KOG0196|consen 765 NSNLVCKVSDFGLSRVLEDDPE-AAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDV 843 (996)
T ss_pred ccceEEEeccccceeecccCCC-ccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHH
Confidence 9999999999999998754432 22222223 57899999999999999999999999999965 57778766544422
Q ss_pred ccccccCCcccccccCCCcccccccccccccccccCC
Q 045449 784 ESKYEVHPATTTIMEHPLPRVGEVMDVDRGKARIQGK 820 (823)
Q Consensus 784 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 820 (823)
....+.-...+ .+.++...+-++|.-...+.|-.||
T Consensus 844 IkaIe~gyRLP-pPmDCP~aL~qLMldCWqkdR~~RP 879 (996)
T KOG0196|consen 844 IKAIEQGYRLP-PPMDCPAALYQLMLDCWQKDRNRRP 879 (996)
T ss_pred HHHHHhccCCC-CCCCCcHHHHHHHHHHHHHHhhcCC
Confidence 22111111111 1234444555555555555555444
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.5e-25 Score=226.69 Aligned_cols=367 Identities=19% Similarity=0.216 Sum_probs=231.5
Q ss_pred CCCEEECCCCcCcCCCchhhhcCCCCcEEecccccccCccCccccCCCCCCccccccceeeecc-ceeeccCccccccch
Q 045449 101 TLKLLDFSDNQLFGSLSSFIFNMSSMTTIDLSINRLSGELPANICKIPSTLSKCKQLEELNLGF-NNLSGAIPKEIGNLT 179 (823)
Q Consensus 101 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~l~~l~ 179 (823)
.-..++|..|.|+.+.|.+|+.+.+|+.||||+|.|+..-|+.| .++++|-.|-+.+ |+|+ .+|
T Consensus 68 ~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF-------~GL~~l~~Lvlyg~NkI~-~l~------- 132 (498)
T KOG4237|consen 68 ETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAF-------KGLASLLSLVLYGNNKIT-DLP------- 132 (498)
T ss_pred cceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhh-------hhhHhhhHHHhhcCCchh-hhh-------
Confidence 34677888888877777777777777777777776664333333 5555555554444 5555 222
Q ss_pred hhHHHHHhhcCCCcccCCcccCCcchhhhhccccccccCCccccccCCCCCcEEEccCCcccccCCcccccCCCCccEEE
Q 045449 180 KLKEIISTITNSTVCEIPREIGNLPYLARLALATNNLVGVVPVTIFNMSALKEISLLNNSLSGSLPSRIDLSLPNVETLN 259 (823)
Q Consensus 180 ~L~~L~~l~~n~~~~~ip~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~ 259 (823)
-+.|++|.+|+.|.+.-|++.....+.|..+++|..|.+.+|.+. .++...+..+..++.+.
T Consensus 133 -----------------k~~F~gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q-~i~~~tf~~l~~i~tlh 194 (498)
T KOG4237|consen 133 -----------------KGAFGGLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQ-SICKGTFQGLAAIKTLH 194 (498)
T ss_pred -----------------hhHhhhHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhh-hhccccccchhccchHh
Confidence 234556666666667777777666667777777777777777766 66665555566666666
Q ss_pred eecccc------------ccccCccccCCCCCCeEEeecccccccCCCccCCC-cccCcccccCccccCCCCcccccccc
Q 045449 260 LGINSF------------SGTIPSSITNSSKLSDLELGENLFSGFIPNTIGNL-RNLEFGNIADNYLTSSTPELSFLSSL 326 (823)
Q Consensus 260 Ls~N~l------------~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~~L~~L~L~~N~l~~~~~~~~~~~~l 326 (823)
+..|.+ ....|..++.+.......+.++++.-+.+..|..- ..+..=..+.....++.| ...|
T Consensus 195 lA~np~icdCnL~wla~~~a~~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP----~~cf 270 (498)
T KOG4237|consen 195 LAQNPFICDCNLPWLADDLAMNPIETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICP----AKCF 270 (498)
T ss_pred hhcCccccccccchhhhHHhhchhhcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcCh----HHHH
Confidence 666652 22344455555555555566666654444444321 112111112222233322 2348
Q ss_pred cCCCCceEEEeecCCCCccCCccccccccccceEEecCCcceeccCccccCcccccEEEcccCcCCCCchhcccccCCCC
Q 045449 327 TNCKKLKVLIVTGNPLDGILPKSIGNFSLSLETILMANCSISGNIPQVVGNLSNLLVLELGGNNLTGPIPVTFSQLQTLQ 406 (823)
Q Consensus 327 ~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~ 406 (823)
..+++|+.|+|++|+++++-+.+|.+. ..+++|+|..|+|...-...|.++.+|++|+|.+|+|+-..|..|..+.+|.
T Consensus 271 ~~L~~L~~lnlsnN~i~~i~~~aFe~~-a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~ 349 (498)
T KOG4237|consen 271 KKLPNLRKLNLSNNKITRIEDGAFEGA-AELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLS 349 (498)
T ss_pred hhcccceEeccCCCccchhhhhhhcch-hhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceee
Confidence 889999999999999999999999988 7899999999999988888899999999999999999988888999999999
Q ss_pred EEEccCCCCCCc-----chHhh-----------hcCCCCCEEEcccCcCc---cccccccc---------CCCCCCe-Ee
Q 045449 407 AFDLTRNKLAGP-----ITDEL-----------CHLARLHSLVLQGNKFS---GSIPSCLG---------NLTSVRV-LY 457 (823)
Q Consensus 407 ~L~Ls~N~l~~~-----~p~~~-----------~~l~~L~~L~Ls~N~l~---g~~p~~~~---------~l~~L~~-L~ 457 (823)
.|+|-.|.+--. .-+|+ .+...++.++++.+.+. -..|++.+ .++-+.+ ..
T Consensus 350 ~l~l~~Np~~CnC~l~wl~~Wlr~~~~~~~~~Cq~p~~~~~~~~~dv~~~~~~c~~~ee~~~~~s~~cP~~c~c~~tVvR 429 (498)
T KOG4237|consen 350 TLNLLSNPFNCNCRLAWLGEWLRKKSVVGNPRCQSPGFVRQIPISDVAFGDFRCGGPEELGCLTSSPCPPPCTCLDTVVR 429 (498)
T ss_pred eeehccCcccCccchHHHHHHHhhCCCCCCCCCCCCchhccccchhccccccccCCccccCCCCCCCCCCCcchhhhhHh
Confidence 999988887411 11111 12234556666666543 12232222 1222322 22
Q ss_pred ccCCccccccchhhhccCCCcEEeccccccccccCccccCCCCCcEEEcccCCCC
Q 045449 458 LGLNIFTSVLSSTIWNLKDILFIDVSSNFLDGPLSLDIGNLKVVIGLDFSRNNLS 512 (823)
Q Consensus 458 Ls~N~l~~~~p~~~~~l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~ls~N~l~ 512 (823)
-|++.+. .+|..+. ..-+.|.+.+|.++ .+|.+ .+..| .+|+|+|+++
T Consensus 430 cSnk~lk-~lp~~iP--~d~telyl~gn~~~-~vp~~--~~~~l-~~dls~n~i~ 477 (498)
T KOG4237|consen 430 CSNKLLK-LLPRGIP--VDVTELYLDGNAIT-SVPDE--LLRSL-LLDLSNNRIS 477 (498)
T ss_pred hcccchh-hcCCCCC--chhHHHhcccchhc-ccCHH--HHhhh-hcccccCcee
Confidence 3333333 2333221 23456888999988 56665 66777 8999999987
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.4e-24 Score=235.66 Aligned_cols=151 Identities=24% Similarity=0.296 Sum_probs=124.9
Q ss_pred ccCCccceeeccC------------CeEEEEEEehHhh---HHHHHHHHHHHHHHhhcchhhHHH---------------
Q 045449 628 DRFSENNLIGIGN------------GMEVAVKVFHQQY---ERALKSFEDECEVRKRIRHRNLVK--------------- 677 (823)
Q Consensus 628 ~~f~~~~~lg~g~------------~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~--------------- 677 (823)
++|+..+.||.|+ ++.||||++.... ......+.+|++++.+++|++|++
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 3567777888775 5679999997543 234467889999999999999998
Q ss_pred -------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCcc---
Q 045449 678 -------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQL--- 729 (823)
Q Consensus 678 -------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~--- 729 (823)
+++|++.+|+|+|+.+|+||||||+|||++.++.+||+|||+++........
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~ 160 (363)
T cd05628 81 EFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFY 160 (363)
T ss_pred cCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCccccccccccccc
Confidence 3678999999999999999999999999999999999999999764321100
Q ss_pred ------------------------------ccccccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCCC
Q 045449 730 ------------------------------SKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 730 ------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~~ 239 (363)
T cd05628 161 RNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSE 239 (363)
T ss_pred ccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCCC
Confidence 0012357999999999999999999999999999999999999999653
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.4e-23 Score=238.70 Aligned_cols=267 Identities=26% Similarity=0.385 Sum_probs=143.7
Q ss_pred CCcEEEccCCCCCCCCCCCCCCCCCCCEEECCCCcCcCCCchhhhcCCCCcEEecccccccCccCccccCCCCCCccccc
Q 045449 77 SLQTLDLSHNKLSGNIPSSIFNMHTLKLLDFSDNQLFGSLSSFIFNMSSMTTIDLSINRLSGELPANICKIPSTLSKCKQ 156 (823)
Q Consensus 77 ~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~p~~~~~l~~ 156 (823)
.-..|||+.|.|+ .+|..+. ++|+.|+|++|+|+. +|. .+++|++|+|++|+|+ .+|.. .++
T Consensus 202 ~~~~LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt~-LP~---lp~~Lk~LdLs~N~Lt-sLP~l----------p~s 263 (788)
T PRK15387 202 GNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLTS-LPA---LPPELRTLEVSGNQLT-SLPVL----------PPG 263 (788)
T ss_pred CCcEEEcCCCCCC-cCCcchh--cCCCEEEccCCcCCC-CCC---CCCCCcEEEecCCccC-cccCc----------ccc
Confidence 3456677777666 5565554 356667777776663 333 2356666666666666 23321 235
Q ss_pred cceeeeccceeeccCccccccchhhHHHHHhhcCCCcccCCcccCCcchhhhhccccccccCCccccccCCCCCcEEEcc
Q 045449 157 LEELNLGFNNLSGAIPKEIGNLTKLKEIISTITNSTVCEIPREIGNLPYLARLALATNNLVGVVPVTIFNMSALKEISLL 236 (823)
Q Consensus 157 L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~~l~~n~~~~~ip~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 236 (823)
|+.|+|++|.++ .+|..+ ++|+.|++++|+++. +|. ..++|+.|+|+
T Consensus 264 L~~L~Ls~N~L~-~Lp~lp----------------------------~~L~~L~Ls~N~Lt~-LP~---~p~~L~~LdLS 310 (788)
T PRK15387 264 LLELSIFSNPLT-HLPALP----------------------------SGLCKLWIFGNQLTS-LPV---LPPGLQELSVS 310 (788)
T ss_pred cceeeccCCchh-hhhhch----------------------------hhcCEEECcCCcccc-ccc---cccccceeECC
Confidence 666666666655 222110 123445555555553 232 12455555555
Q ss_pred CCcccccCCcccccCCCCccEEEeeccccccccCccccCCCCCCeEEeecccccccCCCccCCCcccCcccccCccccCC
Q 045449 237 NNSLSGSLPSRIDLSLPNVETLNLGINSFSGTIPSSITNSSKLSDLELGENLFSGFIPNTIGNLRNLEFGNIADNYLTSS 316 (823)
Q Consensus 237 ~N~l~g~lp~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 316 (823)
+|+|+ .+|.. ..+|+.|++++|+|++ +|.. ..+|++|+|++|+|++ +|... .+|+
T Consensus 311 ~N~L~-~Lp~l----p~~L~~L~Ls~N~L~~-LP~l---p~~Lq~LdLS~N~Ls~-LP~lp---~~L~------------ 365 (788)
T PRK15387 311 DNQLA-SLPAL----PSELCKLWAYNNQLTS-LPTL---PSGLQELSVSDNQLAS-LPTLP---SELY------------ 365 (788)
T ss_pred CCccc-cCCCC----cccccccccccCcccc-cccc---ccccceEecCCCccCC-CCCCC---cccc------------
Confidence 55555 34431 2245555555555542 3321 1245555555555553 22211 2333
Q ss_pred CCcccccccccCCCCceEEEeecCCCCccCCccccccccccceEEecCCcceeccCccccCcccccEEEcccCcCCCCch
Q 045449 317 TPELSFLSSLTNCKKLKVLIVTGNPLDGILPKSIGNFSLSLETILMANCSISGNIPQVVGNLSNLLVLELGGNNLTGPIP 396 (823)
Q Consensus 317 ~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p 396 (823)
.|++++|.|++ +|.. +.+|+.|++++|+|++ +|.. .++|+.|++++|+|++ +|
T Consensus 366 -----------------~L~Ls~N~L~~-LP~l----~~~L~~LdLs~N~Lt~-LP~l---~s~L~~LdLS~N~Lss-IP 418 (788)
T PRK15387 366 -----------------KLWAYNNRLTS-LPAL----PSGLKELIVSGNRLTS-LPVL---PSELKELMVSGNRLTS-LP 418 (788)
T ss_pred -----------------eehhhcccccc-Cccc----ccccceEEecCCcccC-CCCc---ccCCCEEEccCCcCCC-CC
Confidence 44444444442 2321 1345566666666653 3332 2457777777777763 55
Q ss_pred hcccccCCCCEEEccCCCCCCcchHhhhcCCCCCEEEcccCcCcccccccccCC
Q 045449 397 VTFSQLQTLQAFDLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNL 450 (823)
Q Consensus 397 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l 450 (823)
..+ .+|+.|+|++|+|+ .+|..++++++|+.|+|++|.|++.+|..+..+
T Consensus 419 ~l~---~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~~L~~l 468 (788)
T PRK15387 419 MLP---SGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREI 468 (788)
T ss_pred cch---hhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCchHHHHHHHH
Confidence 432 35677777777777 567777777778888888888887777666443
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.8e-24 Score=224.66 Aligned_cols=147 Identities=24% Similarity=0.354 Sum_probs=124.3
Q ss_pred CeEEEEEEehHhh--HHHHHHHHHHHHHHhhcchhhHHH-----------------------------------------
Q 045449 641 GMEVAVKVFHQQY--ERALKSFEDECEVRKRIRHRNLVK----------------------------------------- 677 (823)
Q Consensus 641 ~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~----------------------------------------- 677 (823)
|..||||++.+.. ......+.+|++-|+-++|||||+
T Consensus 43 GekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLELGD~GDl~DyImKHe~Gl~E~La~k 122 (864)
T KOG4717|consen 43 GEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILELGDGGDLFDYIMKHEEGLNEDLAKK 122 (864)
T ss_pred cceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEecCCchHHHHHHhhhccccHHHHHH
Confidence 7889999998654 344567889999999999999999
Q ss_pred HHHHHHHHhhhcCCCCEEeccCCCCCEEeC-CCCcEEEeecccccccCCCCccccccccccCCCcCcccccCCCcccc-c
Q 045449 678 IISSSLEYLHFGHSIPIIHCDLKPSNVLLD-EDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVST-R 755 (823)
Q Consensus 678 ~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~-~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~ 755 (823)
+++|++.++.|||..-|||||+||+||.+- .-|.+||+|||++-.+.+.+. .++.+|+..|-|||++.+..|+. .
T Consensus 123 YF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~k---L~TsCGSLAYSAPEILLGDsYDAPA 199 (864)
T KOG4717|consen 123 YFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKK---LTTSCGSLAYSAPEILLGDSYDAPA 199 (864)
T ss_pred HHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCCcch---hhcccchhhccCchhhhcCccCCcc
Confidence 478999999999999999999999999875 558999999999987765543 45679999999999999999964 5
Q ss_pred cceehhhhhhccccCCCCCcCCCc-----ccccccccccC
Q 045449 756 GDVCSFGIISGGKETRSMTVGETC-----TPVRESKYEVH 790 (823)
Q Consensus 756 ~Dv~S~Gvv~~~~~~~~~~~~~~~-----~~~~~~~~~~~ 790 (823)
+||||+|||+|-+..|+.||++.. ..++..+|..+
T Consensus 200 VDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtvP 239 (864)
T KOG4717|consen 200 VDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTVP 239 (864)
T ss_pred hhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccCc
Confidence 799999999999999999998753 33455555544
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.1e-24 Score=212.71 Aligned_cols=172 Identities=24% Similarity=0.349 Sum_probs=137.2
Q ss_pred ccCHHHHHHHhccCCccceeeccC------------CeEEEEEEehHhhHHHHHHHHHHHHHHhhc-chhhHHHH-----
Q 045449 617 RFSYHELLRATDRFSENNLIGIGN------------GMEVAVKVFHQQYERALKSFEDECEVRKRI-RHRNLVKI----- 678 (823)
Q Consensus 617 ~~~~~~l~~at~~f~~~~~lg~g~------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~----- 678 (823)
..+|.|+.+.|+ +.+|+|+ |.++|||++.+.......+..+|++++.+. .|+||+++
T Consensus 72 ~g~F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFE 146 (463)
T KOG0607|consen 72 SGKFEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFE 146 (463)
T ss_pred cchHHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhc
Confidence 456899999884 6888886 677999999988777778999999999999 59999993
Q ss_pred -----------------------------------HHHHHHHhhhcCCCCEEeccCCCCCEEeCCC---CcEEEeecccc
Q 045449 679 -----------------------------------ISSSLEYLHFGHSIPIIHCDLKPSNVLLDED---MVAHISDFGIA 720 (823)
Q Consensus 679 -----------------------------------~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~---~~~kl~DfGla 720 (823)
+..+..+|.++|..||.|||+||+|||-... ..+|||||.++
T Consensus 147 dd~~FYLVfEKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLg 226 (463)
T KOG0607|consen 147 DDTRFYLVFEKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLG 226 (463)
T ss_pred ccceEEEEEecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccc
Confidence 3466778999999999999999999998643 36899999987
Q ss_pred cccCCCCc-----cccccccccCCCcCcccccC-----CCccccccceehhhhhhccccCCCCCcCCCc-----------
Q 045449 721 KLLSGEDQ-----LSKQTQTLATIGYMAPEYGT-----KGRVSTRGDVCSFGIISGGKETRSMTVGETC----------- 779 (823)
Q Consensus 721 ~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~~----------- 779 (823)
..+..... .....+.+|+..|||||++. ...|+.++|.||+|||+|-|+.|..||.+.+
T Consensus 227 Sg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~ 306 (463)
T KOG0607|consen 227 SGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEV 306 (463)
T ss_pred cccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCc
Confidence 65432221 12234678999999999753 2358999999999999999999999997652
Q ss_pred ---------ccccccccccCCcc
Q 045449 780 ---------TPVRESKYEVHPAT 793 (823)
Q Consensus 780 ---------~~~~~~~~~~~~~~ 793 (823)
+.++++.|+++...
T Consensus 307 Cr~CQ~~LFesIQEGkYeFPdkd 329 (463)
T KOG0607|consen 307 CRVCQNKLFESIQEGKYEFPDKD 329 (463)
T ss_pred cHHHHHHHHHHHhccCCcCChhh
Confidence 45667777776543
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.6e-23 Score=232.51 Aligned_cols=150 Identities=23% Similarity=0.262 Sum_probs=121.7
Q ss_pred cCCccceeeccC------------CeEEEEEEehHhh---HHHHHHHHHHHHHHhhcchhhHHH----------------
Q 045449 629 RFSENNLIGIGN------------GMEVAVKVFHQQY---ERALKSFEDECEVRKRIRHRNLVK---------------- 677 (823)
Q Consensus 629 ~f~~~~~lg~g~------------~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~---------------- 677 (823)
+|...+.||.|+ +..||||++.... ....+.+.+|++++++++||||++
T Consensus 2 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E 81 (377)
T cd05629 2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIME 81 (377)
T ss_pred CceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEe
Confidence 466667777765 5679999986542 334567889999999999999998
Q ss_pred ------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCcc----
Q 045449 678 ------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQL---- 729 (823)
Q Consensus 678 ------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~---- 729 (823)
++.|++.+|+|+|+.+|+||||||+|||++.++.+||+|||+++........
T Consensus 82 ~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~ 161 (377)
T cd05629 82 FLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQ 161 (377)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeeccccccccccccccccc
Confidence 3578999999999999999999999999999999999999999643211000
Q ss_pred --------c---------------------------------cccccccCCCcCcccccCCCccccccceehhhhhhccc
Q 045449 730 --------S---------------------------------KQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGK 768 (823)
Q Consensus 730 --------~---------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~ 768 (823)
. .....+||+.|+|||++.+..++.++||||+||++|++
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~el 241 (377)
T cd05629 162 KLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFEC 241 (377)
T ss_pred ccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhhhhh
Confidence 0 00124699999999999988999999999999999999
Q ss_pred cCCCCCcCCC
Q 045449 769 ETRSMTVGET 778 (823)
Q Consensus 769 ~~~~~~~~~~ 778 (823)
++|..||...
T Consensus 242 ltG~~Pf~~~ 251 (377)
T cd05629 242 LIGWPPFCSE 251 (377)
T ss_pred hcCCCCCCCC
Confidence 9999999653
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.7e-23 Score=227.14 Aligned_cols=136 Identities=22% Similarity=0.251 Sum_probs=116.0
Q ss_pred CeEEEEEEehHhh---HHHHHHHHHHHHHHhhcchhhHHH----------------------------------------
Q 045449 641 GMEVAVKVFHQQY---ERALKSFEDECEVRKRIRHRNLVK---------------------------------------- 677 (823)
Q Consensus 641 ~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~---------------------------------------- 677 (823)
|..||||++.... ......+.+|++++++++||||++
T Consensus 20 ~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~ 99 (323)
T cd05571 20 GKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF 99 (323)
T ss_pred CCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHH
Confidence 6789999997543 234467889999999999999998
Q ss_pred HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCcccccCCCccccccc
Q 045449 678 IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGD 757 (823)
Q Consensus 678 ~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D 757 (823)
++.|++.+|+|+|+.+|+||||||+||+++.++.+||+|||+++....... .....+||+.|+|||++.+..++.++|
T Consensus 100 ~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~D 177 (323)
T cd05571 100 YGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVD 177 (323)
T ss_pred HHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCC--cccceecCccccChhhhcCCCCCcccc
Confidence 357899999999999999999999999999999999999999985432211 223457999999999999999999999
Q ss_pred eehhhhhhccccCCCCCcCCC
Q 045449 758 VCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 758 v~S~Gvv~~~~~~~~~~~~~~ 778 (823)
|||+||++|++++|..||...
T Consensus 178 iwSlG~il~elltg~~Pf~~~ 198 (323)
T cd05571 178 WWGLGVVMYEMMCGRLPFYNQ 198 (323)
T ss_pred CcccchhhhhhhcCCCCCCCC
Confidence 999999999999999998653
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.6e-23 Score=231.49 Aligned_cols=150 Identities=24% Similarity=0.292 Sum_probs=124.2
Q ss_pred cCCccceeeccC------------CeEEEEEEehHhh---HHHHHHHHHHHHHHhhcchhhHHH----------------
Q 045449 629 RFSENNLIGIGN------------GMEVAVKVFHQQY---ERALKSFEDECEVRKRIRHRNLVK---------------- 677 (823)
Q Consensus 629 ~f~~~~~lg~g~------------~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~---------------- 677 (823)
+|...+.||.|+ ++.||||++.... ......+.+|++++.+++||||++
T Consensus 2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (364)
T cd05599 2 DFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIME 81 (364)
T ss_pred CceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEEC
Confidence 567777888875 5679999997543 334467889999999999999998
Q ss_pred ------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccc---
Q 045449 678 ------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLS--- 730 (823)
Q Consensus 678 ------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~--- 730 (823)
+++|++.+|+|+|+.+|+||||||+|||++.++.+||+|||+++.+.......
T Consensus 82 ~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 161 (364)
T cd05599 82 YLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYR 161 (364)
T ss_pred CCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceeccccccccccc
Confidence 35789999999999999999999999999999999999999987643211000
Q ss_pred ---------------------------------cccccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCC
Q 045449 731 ---------------------------------KQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGE 777 (823)
Q Consensus 731 ---------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~ 777 (823)
.....+||+.|+|||++....++.++||||+||++|++.+|..||..
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~Pf~~ 241 (364)
T cd05599 162 ILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFCS 241 (364)
T ss_pred cccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCCCCC
Confidence 01124699999999999988999999999999999999999999865
Q ss_pred C
Q 045449 778 T 778 (823)
Q Consensus 778 ~ 778 (823)
.
T Consensus 242 ~ 242 (364)
T cd05599 242 D 242 (364)
T ss_pred C
Confidence 4
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.5e-24 Score=224.43 Aligned_cols=153 Identities=23% Similarity=0.279 Sum_probs=127.6
Q ss_pred ccCCccceeeccC-CeE-----------EEEEEehHhh---HHHHHHHHHHHHHHhhcchhhHHH---------------
Q 045449 628 DRFSENNLIGIGN-GME-----------VAVKVFHQQY---ERALKSFEDECEVRKRIRHRNLVK--------------- 677 (823)
Q Consensus 628 ~~f~~~~~lg~g~-~~~-----------vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~--------------- 677 (823)
+.|+.-+++|+|+ |.+ +|.|.+.+.. +++..-...|..++.++..+.||.
T Consensus 185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVL 264 (591)
T KOG0986|consen 185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVL 264 (591)
T ss_pred cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEE
Confidence 4677788999997 333 4445554333 234456778999999999999987
Q ss_pred ---------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccc
Q 045449 678 ---------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLS 730 (823)
Q Consensus 678 ---------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~ 730 (823)
++|+++.+|.|+|..+||.||+||+|||+|+.|+++|+|.|+|..+...+.
T Consensus 265 tlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~-- 342 (591)
T KOG0986|consen 265 TLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKP-- 342 (591)
T ss_pred EeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecCCCCc--
Confidence 478999999999999999999999999999999999999999998876544
Q ss_pred cccccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCCCccccc
Q 045449 731 KQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGETCTPVR 783 (823)
Q Consensus 731 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~~~~~~ 783 (823)
....+||.+|||||++..+.|+...|+||+||++|||+.|+.||..-.+++.
T Consensus 343 -~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk 394 (591)
T KOG0986|consen 343 -IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVK 394 (591)
T ss_pred -cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhh
Confidence 2345899999999999999999999999999999999999999976544443
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.5e-23 Score=233.13 Aligned_cols=150 Identities=21% Similarity=0.253 Sum_probs=122.9
Q ss_pred cCCccceeeccC------------CeEEEEEEehHhh---HHHHHHHHHHHHHHhhcchhhHHH----------------
Q 045449 629 RFSENNLIGIGN------------GMEVAVKVFHQQY---ERALKSFEDECEVRKRIRHRNLVK---------------- 677 (823)
Q Consensus 629 ~f~~~~~lg~g~------------~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~---------------- 677 (823)
+|...+.||+|+ +..||||++.... ....+.+.+|++++++++|+|||+
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 466677788775 5679999997543 344567899999999999999998
Q ss_pred ------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCc-----
Q 045449 678 ------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQ----- 728 (823)
Q Consensus 678 ------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~----- 728 (823)
+++|++.+|+|+|+.+|+||||||+|||++.++.+||+|||+|+.......
T Consensus 82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~~ 161 (382)
T cd05625 82 YIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQ 161 (382)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCccccccccccccc
Confidence 357899999999999999999999999999999999999999753210000
Q ss_pred ----------------------------------------cccccccccCCCcCcccccCCCccccccceehhhhhhccc
Q 045449 729 ----------------------------------------LSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGK 768 (823)
Q Consensus 729 ----------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~ 768 (823)
.......+||+.|+|||++.+..|+.++||||+||++|+|
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~el 241 (382)
T cd05625 162 SGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEM 241 (382)
T ss_pred cccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHHHHH
Confidence 0001234799999999999999999999999999999999
Q ss_pred cCCCCCcCCC
Q 045449 769 ETRSMTVGET 778 (823)
Q Consensus 769 ~~~~~~~~~~ 778 (823)
++|..||...
T Consensus 242 ltG~~Pf~~~ 251 (382)
T cd05625 242 LVGQPPFLAQ 251 (382)
T ss_pred HhCCCCCCCC
Confidence 9999999754
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.1e-23 Score=232.43 Aligned_cols=152 Identities=20% Similarity=0.225 Sum_probs=124.5
Q ss_pred HhccCCccceeeccC------------CeEEEEEEehHhh---HHHHHHHHHHHHHHhhcchhhHHH-------------
Q 045449 626 ATDRFSENNLIGIGN------------GMEVAVKVFHQQY---ERALKSFEDECEVRKRIRHRNLVK------------- 677 (823)
Q Consensus 626 at~~f~~~~~lg~g~------------~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~------------- 677 (823)
..++|...+.||.|+ +..||+|++.... ....+.+.+|+++++.++||||++
T Consensus 41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l 120 (370)
T cd05621 41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYM 120 (370)
T ss_pred CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence 346777778888875 5679999986432 233456889999999999999998
Q ss_pred --------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCcccc
Q 045449 678 --------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSK 731 (823)
Q Consensus 678 --------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~ 731 (823)
++.|++.+|+|+|+.+|+||||||+|||++.++.+||+|||+|+....... ..
T Consensus 121 v~Ey~~gg~L~~~l~~~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~-~~ 199 (370)
T cd05621 121 VMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGM-VR 199 (370)
T ss_pred EEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecccCCc-ee
Confidence 356889999999999999999999999999999999999999987643222 12
Q ss_pred ccccccCCCcCcccccCCC----ccccccceehhhhhhccccCCCCCcCCC
Q 045449 732 QTQTLATIGYMAPEYGTKG----RVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 732 ~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
....+||+.|+|||++.+. .++.++||||+||++|++++|..||...
T Consensus 200 ~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~ 250 (370)
T cd05621 200 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYAD 250 (370)
T ss_pred cccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCC
Confidence 2346799999999998654 3789999999999999999999998654
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=99.89 E-value=9.4e-24 Score=225.00 Aligned_cols=146 Identities=23% Similarity=0.278 Sum_probs=121.8
Q ss_pred CCccceeeccC------------CeEEEEEEehHhh---HHHHHHHHHHHHHHhhcchhhHHH-----------------
Q 045449 630 FSENNLIGIGN------------GMEVAVKVFHQQY---ERALKSFEDECEVRKRIRHRNLVK----------------- 677 (823)
Q Consensus 630 f~~~~~lg~g~------------~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~----------------- 677 (823)
|...+.||.|+ +..||||.+.... ......+.+|++++++++|++|++
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 44556677664 5679999986543 233356889999999999999987
Q ss_pred -------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccc
Q 045449 678 -------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQ 732 (823)
Q Consensus 678 -------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~ 732 (823)
++.|++.+|+|+|+.+|+||||||+||+++.++.+||+|||+++....... .
T Consensus 82 ~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~---~ 158 (285)
T cd05631 82 MNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET---V 158 (285)
T ss_pred cCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCe---e
Confidence 356889999999999999999999999999999999999999987543221 2
Q ss_pred cccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCCC
Q 045449 733 TQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 733 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
....||+.|+|||++.+..++.++||||+||++|++.+|+.||...
T Consensus 159 ~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~ 204 (285)
T cd05631 159 RGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKR 204 (285)
T ss_pred cCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCC
Confidence 3457999999999999999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.89 E-value=6e-24 Score=232.41 Aligned_cols=98 Identities=27% Similarity=0.326 Sum_probs=83.4
Q ss_pred HHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCcccccCCCccccccceeh
Q 045449 681 SSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCS 760 (823)
Q Consensus 681 ~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S 760 (823)
|++++|+|+|+.+|+||||||+||+++.++.+||+|||+++...............+++.|+|||++.+..++.++||||
T Consensus 182 qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiws 261 (338)
T cd05102 182 QVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWS 261 (338)
T ss_pred HHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccCcHHhhcCCCCcccCHHH
Confidence 78889999999999999999999999999999999999998764333222223345678999999998889999999999
Q ss_pred hhhhhccccC-CCCCcCCC
Q 045449 761 FGIISGGKET-RSMTVGET 778 (823)
Q Consensus 761 ~Gvv~~~~~~-~~~~~~~~ 778 (823)
|||++|++++ |..||.+.
T Consensus 262 lG~il~el~~~g~~pf~~~ 280 (338)
T cd05102 262 FGVLLWEIFSLGASPYPGV 280 (338)
T ss_pred HHHHHHHHHhCCCCCCCCC
Confidence 9999999986 88888764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.9e-23 Score=223.25 Aligned_cols=145 Identities=25% Similarity=0.274 Sum_probs=122.6
Q ss_pred cCCccceeeccC------------CeEEEEEEehHhh---HHHHHHHHHHHHHHhhcchhhHHH----------------
Q 045449 629 RFSENNLIGIGN------------GMEVAVKVFHQQY---ERALKSFEDECEVRKRIRHRNLVK---------------- 677 (823)
Q Consensus 629 ~f~~~~~lg~g~------------~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~---------------- 677 (823)
+|...+.||.|+ +..||||++.... ....+.+.+|++++++++||||++
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 81 (291)
T cd05612 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLME 81 (291)
T ss_pred CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEe
Confidence 456667777764 5679999986432 234567899999999999999998
Q ss_pred ------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCcccccc
Q 045449 678 ------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQT 733 (823)
Q Consensus 678 ------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~ 733 (823)
++.|++.+|+|+|+.+|+||||||+||+++.++.+||+|||+++..... ..
T Consensus 82 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~-----~~ 156 (291)
T cd05612 82 YVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR-----TW 156 (291)
T ss_pred CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC-----cc
Confidence 2568889999999999999999999999999999999999999875432 12
Q ss_pred ccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCCC
Q 045449 734 QTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 734 ~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
...||+.|+|||++.+..++.++||||+||++|++++|..||.+.
T Consensus 157 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~ 201 (291)
T cd05612 157 TLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDD 201 (291)
T ss_pred cccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 356999999999999888999999999999999999999998664
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.9e-23 Score=232.10 Aligned_cols=150 Identities=21% Similarity=0.246 Sum_probs=122.6
Q ss_pred cCCccceeeccC------------CeEEEEEEehHhh---HHHHHHHHHHHHHHhhcchhhHHH----------------
Q 045449 629 RFSENNLIGIGN------------GMEVAVKVFHQQY---ERALKSFEDECEVRKRIRHRNLVK---------------- 677 (823)
Q Consensus 629 ~f~~~~~lg~g~------------~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~---------------- 677 (823)
.|...+.||+|+ +..||||++.... ....+.+.+|++++++++|+||++
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 456667777775 5679999997543 344567999999999999999998
Q ss_pred ------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCc-----
Q 045449 678 ------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQ----- 728 (823)
Q Consensus 678 ------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~----- 728 (823)
+++|++.+|+|+|+.+|+||||||+|||++.++++||+|||+++.......
T Consensus 82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~~ 161 (381)
T cd05626 82 YIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQ 161 (381)
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCccccccccccccc
Confidence 367899999999999999999999999999999999999999864311000
Q ss_pred ----------------------------------------cccccccccCCCcCcccccCCCccccccceehhhhhhccc
Q 045449 729 ----------------------------------------LSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGK 768 (823)
Q Consensus 729 ----------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~ 768 (823)
.......+||+.|+|||++.+..++.++||||+||++|++
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~el 241 (381)
T cd05626 162 KGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEM 241 (381)
T ss_pred ccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHHHHH
Confidence 0001235799999999999888899999999999999999
Q ss_pred cCCCCCcCCC
Q 045449 769 ETRSMTVGET 778 (823)
Q Consensus 769 ~~~~~~~~~~ 778 (823)
++|..||...
T Consensus 242 ltG~~Pf~~~ 251 (381)
T cd05626 242 LVGQPPFLAP 251 (381)
T ss_pred HhCCCCCcCC
Confidence 9999999653
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.1e-23 Score=224.82 Aligned_cols=160 Identities=30% Similarity=0.462 Sum_probs=133.6
Q ss_pred cceeeccC------------CeEEEEEEehHhhHHHHHHHHHHHHHHhhcchhhHHHH----------------------
Q 045449 633 NNLIGIGN------------GMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVKI---------------------- 678 (823)
Q Consensus 633 ~~~lg~g~------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~---------------------- 678 (823)
.-++|+|. ...+|||-+.....+..+-.-.|+.+-++++|.|||++
T Consensus 580 rvVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSL 659 (1226)
T KOG4279|consen 580 RVVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSL 659 (1226)
T ss_pred eEEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcH
Confidence 34678875 23378998887777777889999999999999999993
Q ss_pred ---------------------HHHHHHHhhhcCCCCEEeccCCCCCEEeC-CCCcEEEeecccccccCCCCccccccccc
Q 045449 679 ---------------------ISSSLEYLHFGHSIPIIHCDLKPSNVLLD-EDMVAHISDFGIAKLLSGEDQLSKQTQTL 736 (823)
Q Consensus 679 ---------------------~~~~l~~L~~~h~~~ivHrdlk~~NiLl~-~~~~~kl~DfGla~~~~~~~~~~~~~~~~ 736 (823)
-.|++++|.|+|+..|||||||-+|||+. -.|.+||+|||-++.+..-.. ...++.
T Consensus 660 SsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP--~TETFT 737 (1226)
T KOG4279|consen 660 SSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINP--CTETFT 737 (1226)
T ss_pred HHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCc--cccccc
Confidence 36999999999999999999999999996 679999999999998765443 345678
Q ss_pred cCCCcCcccccCCCc--cccccceehhhhhhccccCCCCCcCCCccc----ccccccccCCccc
Q 045449 737 ATIGYMAPEYGTKGR--VSTRGDVCSFGIISGGKETRSMTVGETCTP----VRESKYEVHPATT 794 (823)
Q Consensus 737 gt~~y~aPE~~~~~~--~~~~~Dv~S~Gvv~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~ 794 (823)
||..|||||++..++ |+..+|||||||.+-||.||+.||-+...+ .+.+.|..+|.++
T Consensus 738 GTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iP 801 (1226)
T KOG4279|consen 738 GTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIP 801 (1226)
T ss_pred cchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCc
Confidence 999999999998764 899999999999999999999999776433 3456677777654
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.4e-23 Score=228.22 Aligned_cols=137 Identities=23% Similarity=0.251 Sum_probs=116.5
Q ss_pred CCeEEEEEEehHhh---HHHHHHHHHHHHHHhhcchhhHHH---------------------------------------
Q 045449 640 NGMEVAVKVFHQQY---ERALKSFEDECEVRKRIRHRNLVK--------------------------------------- 677 (823)
Q Consensus 640 ~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~--------------------------------------- 677 (823)
.+..||||++.... ......+.+|++++++++||||++
T Consensus 19 ~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~l~~~~~~ 98 (328)
T cd05593 19 SGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTR 98 (328)
T ss_pred CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCCCHHHHHHhcCCCCHHHHH
Confidence 36789999997543 234567889999999999999998
Q ss_pred -HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCcccccCCCcccccc
Q 045449 678 -IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRG 756 (823)
Q Consensus 678 -~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 756 (823)
++.|++.+|+|+|+.+|+||||||+|||++.++.+||+|||+++....... .....+||+.|+|||++.+..++.++
T Consensus 99 ~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~ 176 (328)
T cd05593 99 FYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA--TMKTFCGTPEYLAPEVLEDNDYGRAV 176 (328)
T ss_pred HHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCccc--ccccccCCcCccChhhhcCCCCCccC
Confidence 357889999999999999999999999999999999999999986432211 22345799999999999988999999
Q ss_pred ceehhhhhhccccCCCCCcCCC
Q 045449 757 DVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 757 Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
||||+||++|++++|..||...
T Consensus 177 DiwslGvil~elltG~~Pf~~~ 198 (328)
T cd05593 177 DWWGLGVVMYEMMCGRLPFYNQ 198 (328)
T ss_pred CccccchHHHHHhhCCCCCCCC
Confidence 9999999999999999999653
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.7e-23 Score=227.79 Aligned_cols=146 Identities=23% Similarity=0.284 Sum_probs=124.4
Q ss_pred ccCCccceeeccC------------CeEEEEEEehHhh---HHHHHHHHHHHHHHhhcchhhHHH---------------
Q 045449 628 DRFSENNLIGIGN------------GMEVAVKVFHQQY---ERALKSFEDECEVRKRIRHRNLVK--------------- 677 (823)
Q Consensus 628 ~~f~~~~~lg~g~------------~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~--------------- 677 (823)
++|...+.||.|+ ++.||||++.... ....+.+.+|++++++++||||++
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 4566677888775 5679999997543 234567899999999999999998
Q ss_pred -------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccc
Q 045449 678 -------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQ 732 (823)
Q Consensus 678 -------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~ 732 (823)
++.|++.+|+|+|+.+|+||||||+|||++.++.+||+|||+++......
T Consensus 98 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~----- 172 (329)
T PTZ00263 98 EFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT----- 172 (329)
T ss_pred cCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCCc-----
Confidence 24688899999999999999999999999999999999999998764321
Q ss_pred cccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCCC
Q 045449 733 TQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 733 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
....||+.|+|||++.+..++.++|||||||++|++++|..||.+.
T Consensus 173 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~ 218 (329)
T PTZ00263 173 FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDD 218 (329)
T ss_pred ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCC
Confidence 2357999999999999988999999999999999999999998653
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.3e-23 Score=231.29 Aligned_cols=150 Identities=23% Similarity=0.256 Sum_probs=122.0
Q ss_pred cCCccceeeccC------------CeEEEEEEehHhh---HHHHHHHHHHHHHHhhcchhhHHH----------------
Q 045449 629 RFSENNLIGIGN------------GMEVAVKVFHQQY---ERALKSFEDECEVRKRIRHRNLVK---------------- 677 (823)
Q Consensus 629 ~f~~~~~lg~g~------------~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~---------------- 677 (823)
.|...+.||.|+ +..||||++.... ....+.+.+|++++++++|+||++
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence 466667777775 5679999996543 233467889999999999999998
Q ss_pred ------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCC------
Q 045449 678 ------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGED------ 727 (823)
Q Consensus 678 ------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~------ 727 (823)
+++|++.+|+|+|+.+|+||||||+|||++.++.+||+|||+|+.+....
T Consensus 82 ~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~~ 161 (376)
T cd05598 82 YIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQ 161 (376)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccccccccc
Confidence 35788999999999999999999999999999999999999985321000
Q ss_pred -----------------------------------ccccccccccCCCcCcccccCCCccccccceehhhhhhccccCCC
Q 045449 728 -----------------------------------QLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRS 772 (823)
Q Consensus 728 -----------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~ 772 (823)
........+||+.|+|||++.+..++.++||||+||++|++++|.
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell~G~ 241 (376)
T cd05598 162 KGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQ 241 (376)
T ss_pred cccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehhhCC
Confidence 000012357999999999999999999999999999999999999
Q ss_pred CCcCCC
Q 045449 773 MTVGET 778 (823)
Q Consensus 773 ~~~~~~ 778 (823)
.||.+.
T Consensus 242 ~Pf~~~ 247 (376)
T cd05598 242 PPFLAD 247 (376)
T ss_pred CCCCCC
Confidence 999764
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.7e-23 Score=231.08 Aligned_cols=158 Identities=20% Similarity=0.229 Sum_probs=129.4
Q ss_pred HHHHHHHhccCCccceeeccC------------CeEEEEEEehHhh---HHHHHHHHHHHHHHhhcchhhHHH-------
Q 045449 620 YHELLRATDRFSENNLIGIGN------------GMEVAVKVFHQQY---ERALKSFEDECEVRKRIRHRNLVK------- 677 (823)
Q Consensus 620 ~~~l~~at~~f~~~~~lg~g~------------~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~------- 677 (823)
..++....++|...+.||.|+ +..||+|++.... ....+.+.+|+.+++.++||||++
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 114 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 344555668899999999986 5668999986432 233456889999999999999998
Q ss_pred --------------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCC
Q 045449 678 --------------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSG 725 (823)
Q Consensus 678 --------------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~ 725 (823)
+++|++.+|+|+|+.+|+||||||+||+++.++.+||+|||+++....
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~ 194 (371)
T cd05622 115 DRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNK 194 (371)
T ss_pred CCEEEEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCc
Confidence 357889999999999999999999999999999999999999987643
Q ss_pred CCccccccccccCCCcCcccccCCC----ccccccceehhhhhhccccCCCCCcCCC
Q 045449 726 EDQLSKQTQTLATIGYMAPEYGTKG----RVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 726 ~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
... ......+||+.|+|||++.+. .++.++||||+||++|+|++|..||...
T Consensus 195 ~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~ 250 (371)
T cd05622 195 EGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD 250 (371)
T ss_pred CCc-ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCC
Confidence 322 122346799999999998653 3789999999999999999999999754
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.7e-23 Score=229.22 Aligned_cols=150 Identities=24% Similarity=0.294 Sum_probs=123.6
Q ss_pred cCCccceeeccC------------CeEEEEEEehHhh---HHHHHHHHHHHHHHhhcchhhHHH----------------
Q 045449 629 RFSENNLIGIGN------------GMEVAVKVFHQQY---ERALKSFEDECEVRKRIRHRNLVK---------------- 677 (823)
Q Consensus 629 ~f~~~~~lg~g~------------~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~---------------- 677 (823)
+|...+.||.|+ +..||||+++... ....+.+.+|+.++.+++|++|++
T Consensus 2 ~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E 81 (360)
T cd05627 2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIME 81 (360)
T ss_pred CceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEe
Confidence 566677788775 5679999997543 334567889999999999999998
Q ss_pred ------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCcc----
Q 045449 678 ------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQL---- 729 (823)
Q Consensus 678 ------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~---- 729 (823)
+++|++.+|+|+|+.+|+||||||+|||++.++.+||+|||+++........
T Consensus 82 ~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~~ 161 (360)
T cd05627 82 FLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYR 161 (360)
T ss_pred CCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCccccccccccccc
Confidence 3678999999999999999999999999999999999999998754321100
Q ss_pred -----------------------------ccccccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCCC
Q 045449 730 -----------------------------SKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 730 -----------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
......+||+.|+|||++.+..++.++||||+||++|++++|..||.+.
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~~ 239 (360)
T cd05627 162 NLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSE 239 (360)
T ss_pred ccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCCC
Confidence 0012357999999999999999999999999999999999999999654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=9.6e-24 Score=230.79 Aligned_cols=135 Identities=30% Similarity=0.420 Sum_probs=115.8
Q ss_pred CeEEEEEEehHhh-HHHHHHHHHHHHHHhhcchhhHHH------------------------------------------
Q 045449 641 GMEVAVKVFHQQY-ERALKSFEDECEVRKRIRHRNLVK------------------------------------------ 677 (823)
Q Consensus 641 ~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~------------------------------------------ 677 (823)
|..||||.++... ....+...+|++++++++|+|||+
T Consensus 38 G~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmEyC~gGsL~~~L~~PEN~~GL 117 (732)
T KOG4250|consen 38 GRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVMEYCSGGSLRKVLNSPENAYGL 117 (732)
T ss_pred ccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEEeecCCCcHHHHhcCcccccCC
Confidence 6789999998644 345578999999999999999999
Q ss_pred -------HHHHHHHHhhhcCCCCEEeccCCCCCEEeC--C--CCcEEEeecccccccCCCCccccccccccCCCcCcccc
Q 045449 678 -------IISSSLEYLHFGHSIPIIHCDLKPSNVLLD--E--DMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEY 746 (823)
Q Consensus 678 -------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~--~--~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~ 746 (823)
++..+..+|+|+|++|||||||||.||++- . ....||+|||.||.+.... .....+||+.|.+||+
T Consensus 118 pE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel~d~s---~~~S~vGT~~YLhPel 194 (732)
T KOG4250|consen 118 PESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARELDDNS---LFTSLVGTEEYLHPEL 194 (732)
T ss_pred CHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccccccCCCCC---eeeeecCchhhcChHH
Confidence 245677889999999999999999999983 3 3367999999999886554 4567899999999999
Q ss_pred cCC-CccccccceehhhhhhccccCCCCCcCCC
Q 045449 747 GTK-GRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 747 ~~~-~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
... +.|+..+|.|||||++|+..||..||-..
T Consensus 195 ~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~ 227 (732)
T KOG4250|consen 195 YERQKKYTATVDLWSFGVTLYECATGELPFIPF 227 (732)
T ss_pred HhhccCcCceeehhhhhhHHHHHhccCCCCCcC
Confidence 885 78899999999999999999999998554
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.6e-23 Score=228.57 Aligned_cols=150 Identities=25% Similarity=0.309 Sum_probs=125.7
Q ss_pred cCCccceeeccC------------CeEEEEEEehHhh---HHHHHHHHHHHHHHhhcchhhHHH----------------
Q 045449 629 RFSENNLIGIGN------------GMEVAVKVFHQQY---ERALKSFEDECEVRKRIRHRNLVK---------------- 677 (823)
Q Consensus 629 ~f~~~~~lg~g~------------~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~---------------- 677 (823)
+|...+.||.|+ +..||||++.... ....+.+.+|++++..++|+||++
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (350)
T cd05573 2 DFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVME 81 (350)
T ss_pred CceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEc
Confidence 566677788775 5679999997543 234567899999999999999998
Q ss_pred ------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCC------
Q 045449 678 ------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGED------ 727 (823)
Q Consensus 678 ------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~------ 727 (823)
++.|++.+|+|+|+.||+||||||+||+++.++.+||+|||+++......
T Consensus 82 ~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~ 161 (350)
T cd05573 82 YMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYL 161 (350)
T ss_pred CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCcccccc
Confidence 35688999999999999999999999999999999999999998764332
Q ss_pred ---------------------ccccccccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCCC
Q 045449 728 ---------------------QLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 728 ---------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
.........||+.|+|||++.+..++.++|||||||++|++++|..||...
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~ 233 (350)
T cd05573 162 NDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSD 233 (350)
T ss_pred cccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCC
Confidence 001123457999999999999999999999999999999999999999764
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.4e-23 Score=227.10 Aligned_cols=146 Identities=24% Similarity=0.293 Sum_probs=123.4
Q ss_pred ccCCccceeeccC-------------CeEEEEEEehHhh---HHHHHHHHHHHHHHhhcchhhHHH--------------
Q 045449 628 DRFSENNLIGIGN-------------GMEVAVKVFHQQY---ERALKSFEDECEVRKRIRHRNLVK-------------- 677 (823)
Q Consensus 628 ~~f~~~~~lg~g~-------------~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~-------------- 677 (823)
++|...+.||.|+ +..||||++.... ....+.+.+|++++++++||||++
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 109 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV 109 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence 3566667777775 2469999986542 334567889999999999999998
Q ss_pred --------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCcccc
Q 045449 678 --------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSK 731 (823)
Q Consensus 678 --------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~ 731 (823)
++.|++.+|+|+|+.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 110 ~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~----- 184 (340)
T PTZ00426 110 LEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR----- 184 (340)
T ss_pred EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCCC-----
Confidence 3568899999999999999999999999999999999999999875422
Q ss_pred ccccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCCC
Q 045449 732 QTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 732 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
.....||+.|+|||++.+..++.++||||+||++|++++|..||...
T Consensus 185 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~ 231 (340)
T PTZ00426 185 TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYAN 231 (340)
T ss_pred cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCC
Confidence 23457999999999998888999999999999999999999999764
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.2e-23 Score=225.10 Aligned_cols=137 Identities=23% Similarity=0.212 Sum_probs=116.8
Q ss_pred CCeEEEEEEehHhh---HHHHHHHHHHHHHHhhcchhhHHH---------------------------------------
Q 045449 640 NGMEVAVKVFHQQY---ERALKSFEDECEVRKRIRHRNLVK--------------------------------------- 677 (823)
Q Consensus 640 ~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~--------------------------------------- 677 (823)
.+..||+|++.... ......+.+|++++.+++||||++
T Consensus 17 ~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~ 96 (312)
T cd05585 17 TQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRAR 96 (312)
T ss_pred CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcHHHHHHhcCCCCHHHHH
Confidence 35789999997543 344567889999999999999998
Q ss_pred -HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCcccccCCCcccccc
Q 045449 678 -IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRG 756 (823)
Q Consensus 678 -~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 756 (823)
++.|++++|+|+|+.+|+||||||+||+++.++.+||+|||+++....... .....+||+.|+|||++.+..++.++
T Consensus 97 ~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~ 174 (312)
T cd05585 97 FYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD--KTNTFCGTPEYLAPELLLGHGYTKAV 174 (312)
T ss_pred HHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCC--ccccccCCcccCCHHHHcCCCCCCcc
Confidence 356889999999999999999999999999999999999999986432221 22345799999999999998999999
Q ss_pred ceehhhhhhccccCCCCCcCCC
Q 045449 757 DVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 757 Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
||||+||++|++++|..||.+.
T Consensus 175 DvwslGvil~el~tg~~pf~~~ 196 (312)
T cd05585 175 DWWTLGVLLYEMLTGLPPFYDE 196 (312)
T ss_pred ceechhHHHHHHHhCCCCcCCC
Confidence 9999999999999999998653
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=4e-23 Score=225.38 Aligned_cols=145 Identities=23% Similarity=0.278 Sum_probs=124.0
Q ss_pred cCCccceeeccC------------CeEEEEEEehHhh---HHHHHHHHHHHHHHhhcchhhHHH----------------
Q 045449 629 RFSENNLIGIGN------------GMEVAVKVFHQQY---ERALKSFEDECEVRKRIRHRNLVK---------------- 677 (823)
Q Consensus 629 ~f~~~~~lg~g~------------~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~---------------- 677 (823)
+|...+.||.|+ +..||||++.... ....+.+.+|++++.+++||||++
T Consensus 2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e 81 (333)
T cd05600 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAME 81 (333)
T ss_pred CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEe
Confidence 566667777774 5679999997553 234567889999999999999998
Q ss_pred ------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCcccccc
Q 045449 678 ------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQT 733 (823)
Q Consensus 678 ------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~ 733 (823)
++.|++.+|.|+|+.+|+||||||+||+++.++.+||+|||+++.... ...
T Consensus 82 ~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-----~~~ 156 (333)
T cd05600 82 YVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-----YAN 156 (333)
T ss_pred CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc-----ccC
Confidence 356889999999999999999999999999999999999999986543 223
Q ss_pred ccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCCC
Q 045449 734 QTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 734 ~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
...||+.|+|||++.+..++.++||||+||++|++++|..||...
T Consensus 157 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~ 201 (333)
T cd05600 157 SVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGS 201 (333)
T ss_pred CcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCC
Confidence 457999999999999889999999999999999999999998654
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=1e-23 Score=240.66 Aligned_cols=155 Identities=23% Similarity=0.277 Sum_probs=128.9
Q ss_pred HHHhccCCccceeeccC------------CeEEEEEEehHh--hHHHHHHHHHHHHHHhhcchhhHHH------------
Q 045449 624 LRATDRFSENNLIGIGN------------GMEVAVKVFHQQ--YERALKSFEDECEVRKRIRHRNLVK------------ 677 (823)
Q Consensus 624 ~~at~~f~~~~~lg~g~------------~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~------------ 677 (823)
....++|...+.||.|+ +..||||++... .......+.+|+..+..++|+|+++
T Consensus 28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~ 107 (496)
T PTZ00283 28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN 107 (496)
T ss_pred cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence 33456888889999886 567999998643 2344567889999999998888774
Q ss_pred ----------------------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeec
Q 045449 678 ----------------------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDF 717 (823)
Q Consensus 678 ----------------------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~Df 717 (823)
++.|++.+|+|+|+.+|+||||||+|||++.++.+||+||
T Consensus 108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DF 187 (496)
T PTZ00283 108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDF 187 (496)
T ss_pred cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEec
Confidence 2468899999999999999999999999999999999999
Q ss_pred ccccccCCCCccccccccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCCC
Q 045449 718 GIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 718 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
|+++.+............+||+.|+|||++.+..++.++|||||||++|++++|..||...
T Consensus 188 Gls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~ 248 (496)
T PTZ00283 188 GFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGE 248 (496)
T ss_pred ccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 9998764332222234567999999999999989999999999999999999999999754
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.8e-23 Score=223.29 Aligned_cols=149 Identities=27% Similarity=0.390 Sum_probs=128.9
Q ss_pred hccCCccceeeccC------------CeEEEEEEehHhh--HHHHHHHHHHHHHHhhcchhhHHH---------------
Q 045449 627 TDRFSENNLIGIGN------------GMEVAVKVFHQQY--ERALKSFEDECEVRKRIRHRNLVK--------------- 677 (823)
Q Consensus 627 t~~f~~~~~lg~g~------------~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~--------------- 677 (823)
+..|.....||.|. +..||||.+++.. ....+.+.+|+++|..+.|||||+
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~ 134 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM 134 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence 45566667777764 6789999998765 344466999999999999999998
Q ss_pred -------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccc
Q 045449 678 -------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQ 732 (823)
Q Consensus 678 -------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~ 732 (823)
.+.|++.+++|+|+..|||||||++|||++.+..+||+|||++..+..... .
T Consensus 135 eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~~---l 211 (596)
T KOG0586|consen 135 EYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYGLM---L 211 (596)
T ss_pred EeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeeccccc---c
Confidence 256899999999999999999999999999999999999999998864433 3
Q ss_pred cccccCCCcCcccccCCCcc-ccccceehhhhhhccccCCCCCcCCC
Q 045449 733 TQTLATIGYMAPEYGTKGRV-STRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 733 ~~~~gt~~y~aPE~~~~~~~-~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
.+.+|++.|+|||++.+..| ++++|+||+|||+|-+..|..||++.
T Consensus 212 qt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~ 258 (596)
T KOG0586|consen 212 QTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQ 258 (596)
T ss_pred cccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCc
Confidence 46789999999999998887 78899999999999999999999864
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.8e-23 Score=201.08 Aligned_cols=153 Identities=21% Similarity=0.261 Sum_probs=122.1
Q ss_pred ccCCccceeeccC------------CeEEEEEEehHhhHHHHHHHHHHHHHHhhcchhhHHHH-----------------
Q 045449 628 DRFSENNLIGIGN------------GMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVKI----------------- 678 (823)
Q Consensus 628 ~~f~~~~~lg~g~------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~----------------- 678 (823)
++|...+.+|+|+ +..+|+|++.-...+..+...+|++..++++|||+++.
T Consensus 21 ~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yl 100 (302)
T KOG2345|consen 21 KRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYL 100 (302)
T ss_pred ceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEE
Confidence 4666667777776 45589999877767777899999999999999999992
Q ss_pred --------------------------------HHHHHHHhhhcCCCC--EEeccCCCCCEEeCCCCcEEEeecccccccC
Q 045449 679 --------------------------------ISSSLEYLHFGHSIP--IIHCDLKPSNVLLDEDMVAHISDFGIAKLLS 724 (823)
Q Consensus 679 --------------------------------~~~~l~~L~~~h~~~--ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~ 724 (823)
+.+++++|.++|+.. .+||||||.|||+.+++.+++.|||.++...
T Consensus 101 l~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~a~ 180 (302)
T KOG2345|consen 101 LLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLGSATQAP 180 (302)
T ss_pred EeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEeccCccccc
Confidence 345677788888877 9999999999999999999999999987643
Q ss_pred CCCc-------cccccccccCCCcCcccccCC---CccccccceehhhhhhccccCCCCCcCCCcc
Q 045449 725 GEDQ-------LSKQTQTLATIGYMAPEYGTK---GRVSTRGDVCSFGIISGGKETRSMTVGETCT 780 (823)
Q Consensus 725 ~~~~-------~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~~~ 780 (823)
-.-. .........|..|+|||.+.- ...++++||||+||++|.++++..||+....
T Consensus 181 i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~ 246 (302)
T KOG2345|consen 181 IQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ 246 (302)
T ss_pred eEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh
Confidence 2110 111223457999999998754 3468999999999999999999999977654
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=2e-23 Score=238.12 Aligned_cols=149 Identities=25% Similarity=0.266 Sum_probs=125.2
Q ss_pred CCccceeeccC-------------CeEEEEEEehHhhHHHHHHHHHHHHHHhhcchhhHHH-------------------
Q 045449 630 FSENNLIGIGN-------------GMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVK------------------- 677 (823)
Q Consensus 630 f~~~~~lg~g~-------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------------- 677 (823)
|...+.+|+|+ +..||+|.+..........+.+|++++++++|||||+
T Consensus 69 y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~ 148 (478)
T PTZ00267 69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGS 148 (478)
T ss_pred EEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCC
Confidence 66677888775 3457888775555555567889999999999999998
Q ss_pred -------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccc
Q 045449 678 -------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQ 732 (823)
Q Consensus 678 -------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~ 732 (823)
+++|++.+|+|+|+++|+||||||+|||++.++.+||+|||+++...........
T Consensus 149 gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~~~ 228 (478)
T PTZ00267 149 GGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVA 228 (478)
T ss_pred CCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCccccccc
Confidence 3568899999999999999999999999999999999999999876543322223
Q ss_pred cccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCCC
Q 045449 733 TQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 733 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
...+||+.|+|||++.+..++.++|||||||+++++++|..||...
T Consensus 229 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~ 274 (478)
T PTZ00267 229 SSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGP 274 (478)
T ss_pred cccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCC
Confidence 4567999999999999989999999999999999999999998654
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.4e-23 Score=205.51 Aligned_cols=149 Identities=23% Similarity=0.254 Sum_probs=127.3
Q ss_pred ccCCccceeeccC------------CeEEEEEEehHhh---HHHHHHHHHHHHHHhhcchhhHHH---------------
Q 045449 628 DRFSENNLIGIGN------------GMEVAVKVFHQQY---ERALKSFEDECEVRKRIRHRNLVK--------------- 677 (823)
Q Consensus 628 ~~f~~~~~lg~g~------------~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~--------------- 677 (823)
++|+.-+++|+|. ++.+|+|+++++. +..+..-..|-+++...+||.+..
T Consensus 168 ~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVM 247 (516)
T KOG0690|consen 168 EDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVM 247 (516)
T ss_pred chhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEE
Confidence 5677778888885 5679999998765 334456678999999999999887
Q ss_pred -------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccc
Q 045449 678 -------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQ 732 (823)
Q Consensus 678 -------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~ 732 (823)
+-|.++.+|.|+|+++||.||+|.+|.|+|.||++||+|||+++.--. .....
T Consensus 248 eyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~--~g~t~ 325 (516)
T KOG0690|consen 248 EYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIK--YGDTT 325 (516)
T ss_pred EEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhccc--cccee
Confidence 236889999999999999999999999999999999999999986322 22345
Q ss_pred cccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCCC
Q 045449 733 TQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 733 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
.+++|||.|.|||++....|+..+|+|.+|||+|||+.|+.||..-
T Consensus 326 kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~ 371 (516)
T KOG0690|consen 326 KTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNK 371 (516)
T ss_pred ccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCccccc
Confidence 6789999999999999999999999999999999999999999653
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=8.8e-23 Score=221.57 Aligned_cols=138 Identities=26% Similarity=0.286 Sum_probs=116.2
Q ss_pred cCCeEEEEEEehHhh----HHHHHHHHHHHHHHhhcchhhHHH-------------------------------------
Q 045449 639 GNGMEVAVKVFHQQY----ERALKSFEDECEVRKRIRHRNLVK------------------------------------- 677 (823)
Q Consensus 639 g~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~------------------------------------- 677 (823)
..+..||||++.... ......+..|++++++++||||++
T Consensus 22 ~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~ 101 (323)
T cd05584 22 DTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDT 101 (323)
T ss_pred CCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeCCCCchHHHHHHHcCCCCHHH
Confidence 346789999997542 233456789999999999999998
Q ss_pred ---HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCcccccCCCcccc
Q 045449 678 ---IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVST 754 (823)
Q Consensus 678 ---~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 754 (823)
++.|++.+|+|+|+.+|+||||||+||+++.++.+||+|||+++....... ......||+.|+|||++.+..++.
T Consensus 102 ~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~ 179 (323)
T cd05584 102 ACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT--VTHTFCGTIEYMAPEILMRSGHGK 179 (323)
T ss_pred HHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC--cccccCCCccccChhhccCCCCCC
Confidence 256889999999999999999999999999999999999999975432222 223457999999999999888999
Q ss_pred ccceehhhhhhccccCCCCCcCCC
Q 045449 755 RGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 755 ~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
++||||+||++|++++|..||...
T Consensus 180 ~~DiwslG~il~ell~G~~pf~~~ 203 (323)
T cd05584 180 AVDWWSLGALMYDMLTGAPPFTAE 203 (323)
T ss_pred cceecccHHHHHHHhcCCCCCCCC
Confidence 999999999999999999998664
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.4e-24 Score=209.85 Aligned_cols=143 Identities=27% Similarity=0.321 Sum_probs=115.8
Q ss_pred EEEEEEehHhh--HHHHHHHHHHHHHHhhcchhhHHH-------------------------------------------
Q 045449 643 EVAVKVFHQQY--ERALKSFEDECEVRKRIRHRNLVK------------------------------------------- 677 (823)
Q Consensus 643 ~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~------------------------------------------- 677 (823)
.+|+|.++.+. ........+|+.+++.++|||++.
T Consensus 55 ~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~l~fdYAEhDL~~II~fHr~~~~~~lp~~mv 134 (438)
T KOG0666|consen 55 EYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVWLLFDYAEHDLWHIIKFHRASKAKQLPRSMV 134 (438)
T ss_pred hhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEEEEehhhhhhHHHHHHHhccchhccCCHHHH
Confidence 45666654332 122356789999999999999998
Q ss_pred --HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCC----CcEEEeecccccccCCCCcc-ccccccccCCCcCcccccCCC
Q 045449 678 --IISSSLEYLHFGHSIPIIHCDLKPSNVLLDED----MVAHISDFGIAKLLSGEDQL-SKQTQTLATIGYMAPEYGTKG 750 (823)
Q Consensus 678 --~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~----~~~kl~DfGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~ 750 (823)
++.|++.++||+|+.=|+|||+||.|||+..+ |++||+|||+||.+...-.. .....++-|.+|+|||.+.+.
T Consensus 135 KsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa 214 (438)
T KOG0666|consen 135 KSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGA 214 (438)
T ss_pred HHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhccc
Confidence 35699999999999999999999999999877 89999999999987654332 233456789999999998876
Q ss_pred c-cccccceehhhhhhccccCCCCCcCCCccccccc
Q 045449 751 R-VSTRGDVCSFGIISGGKETRSMTVGETCTPVRES 785 (823)
Q Consensus 751 ~-~~~~~Dv~S~Gvv~~~~~~~~~~~~~~~~~~~~~ 785 (823)
+ |+.+.||||.|||++|+++-+..|.+...++...
T Consensus 215 ~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~ 250 (438)
T KOG0666|consen 215 RHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTK 250 (438)
T ss_pred ccccchhhhHHHHHHHHHHHccCccccchhhhcccC
Confidence 5 8999999999999999999998888766555544
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.1e-23 Score=229.13 Aligned_cols=152 Identities=20% Similarity=0.246 Sum_probs=124.7
Q ss_pred HhccCCccceeeccC------------CeEEEEEEehHhh---HHHHHHHHHHHHHHhhcchhhHHH-------------
Q 045449 626 ATDRFSENNLIGIGN------------GMEVAVKVFHQQY---ERALKSFEDECEVRKRIRHRNLVK------------- 677 (823)
Q Consensus 626 at~~f~~~~~lg~g~------------~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~------------- 677 (823)
..++|...+.||.|+ +..||||++.... ....+.+.+|+.++++++||||++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 356777788888875 5679999996532 233456889999999999999998
Q ss_pred --------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCcccc
Q 045449 678 --------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSK 731 (823)
Q Consensus 678 --------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~ 731 (823)
+++|++.+|+|+|+.+|+||||||+|||++.++.+||+|||+++....... ..
T Consensus 121 v~Ey~~gg~L~~~l~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~-~~ 199 (370)
T cd05596 121 VMEYMPGGDLVNLMSNYDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGM-VR 199 (370)
T ss_pred EEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCCc-cc
Confidence 356889999999999999999999999999999999999999987643222 12
Q ss_pred ccccccCCCcCcccccCCC----ccccccceehhhhhhccccCCCCCcCCC
Q 045449 732 QTQTLATIGYMAPEYGTKG----RVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 732 ~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
....+||+.|+|||++.+. .++.++||||+||++|++++|..||...
T Consensus 200 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~ 250 (370)
T cd05596 200 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD 250 (370)
T ss_pred CCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCC
Confidence 2345799999999987653 4789999999999999999999998754
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=7.6e-23 Score=222.89 Aligned_cols=149 Identities=26% Similarity=0.372 Sum_probs=123.4
Q ss_pred cCCccceeeccC------------CeEEEEEEehHhh---HHHHHHHHHHHHHHhhcchhhHHH----------------
Q 045449 629 RFSENNLIGIGN------------GMEVAVKVFHQQY---ERALKSFEDECEVRKRIRHRNLVK---------------- 677 (823)
Q Consensus 629 ~f~~~~~lg~g~------------~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~---------------- 677 (823)
+|...+.||.|+ +..||||+++... ....+.+.+|+.+++.++|+||++
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (330)
T cd05601 2 DFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVME 81 (330)
T ss_pred CceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEEC
Confidence 566677777775 5679999997653 234567889999999999999998
Q ss_pred -------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccc
Q 045449 678 -------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQ 732 (823)
Q Consensus 678 -------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~ 732 (823)
++.|++++|+|+|+.+|+||||||+||+++.++.+||+|||+++........ ..
T Consensus 82 ~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~-~~ 160 (330)
T cd05601 82 YQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMV-NS 160 (330)
T ss_pred CCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCce-ee
Confidence 3568999999999999999999999999999999999999999876543321 22
Q ss_pred cccccCCCcCcccccC------CCccccccceehhhhhhccccCCCCCcCCC
Q 045449 733 TQTLATIGYMAPEYGT------KGRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 733 ~~~~gt~~y~aPE~~~------~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
....||+.|+|||++. ...++.++|||||||++|++++|..||.+.
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~ 212 (330)
T cd05601 161 KLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEG 212 (330)
T ss_pred ecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCC
Confidence 3357999999999876 456789999999999999999999999653
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.7e-23 Score=222.96 Aligned_cols=137 Identities=21% Similarity=0.250 Sum_probs=116.2
Q ss_pred CCeEEEEEEehHhh---HHHHHHHHHHHHHHhhcchhhHHH---------------------------------------
Q 045449 640 NGMEVAVKVFHQQY---ERALKSFEDECEVRKRIRHRNLVK--------------------------------------- 677 (823)
Q Consensus 640 ~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~--------------------------------------- 677 (823)
.|..||+|++.... ......+.+|++++++++||||++
T Consensus 19 ~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~~~~~ 98 (323)
T cd05595 19 TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERAR 98 (323)
T ss_pred CCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHH
Confidence 36789999997653 234467889999999999999998
Q ss_pred -HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCcccccCCCcccccc
Q 045449 678 -IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRG 756 (823)
Q Consensus 678 -~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 756 (823)
++.|++.+|+|+|+.+|+||||||+|||++.++.+||+|||+++....... ......||+.|+|||++.+..++.++
T Consensus 99 ~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~ 176 (323)
T cd05595 99 FYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKTFCGTPEYLAPEVLEDNDYGRAV 176 (323)
T ss_pred HHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCC--ccccccCCcCcCCcccccCCCCCchh
Confidence 357889999999999999999999999999999999999999875422211 12345799999999999989999999
Q ss_pred ceehhhhhhccccCCCCCcCCC
Q 045449 757 DVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 757 Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
|||||||++|++++|..||...
T Consensus 177 DiwSlGvil~ell~g~~Pf~~~ 198 (323)
T cd05595 177 DWWGLGVVMYEMMCGRLPFYNQ 198 (323)
T ss_pred chhhhHHHHHHHHhCCCCCCCC
Confidence 9999999999999999998654
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.8e-23 Score=225.80 Aligned_cols=144 Identities=29% Similarity=0.372 Sum_probs=120.4
Q ss_pred cCCccceeeccC------------CeEEEEEEehHhhHHHHHHHHHHHHHHhhcc-hh-----hHHH-------------
Q 045449 629 RFSENNLIGIGN------------GMEVAVKVFHQQYERALKSFEDECEVRKRIR-HR-----NLVK------------- 677 (823)
Q Consensus 629 ~f~~~~~lg~g~------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~------------- 677 (823)
+|.+.++||+|. ++.||||+++... ...++...|+.+|.+++ |. |+|+
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 788889999886 6679999997663 44467788999999986 43 5555
Q ss_pred ----------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCC--CCcEEEeecccccccCCCC
Q 045449 678 ----------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDE--DMVAHISDFGIAKLLSGED 727 (823)
Q Consensus 678 ----------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~--~~~~kl~DfGla~~~~~~~ 727 (823)
+..|++.+|.++|+.+|||+||||||||+.+ ...+||+|||.|......
T Consensus 266 VfELL~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q~- 344 (586)
T KOG0667|consen 266 VFELLSTNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQR- 344 (586)
T ss_pred eehhhhhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecccccccCCc-
Confidence 3568999999999999999999999999964 348999999999875422
Q ss_pred ccccccccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCCC
Q 045449 728 QLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 728 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
....+.+..|+|||++.+.+|+.+.||||||||++||.+|...|.+.
T Consensus 345 ----vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ 391 (586)
T KOG0667|consen 345 ----VYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGD 391 (586)
T ss_pred ----ceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCC
Confidence 12567899999999999999999999999999999999998777664
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.8e-23 Score=230.57 Aligned_cols=142 Identities=23% Similarity=0.233 Sum_probs=118.7
Q ss_pred ccCCccceeeccC------------CeEEEEEEehHhhHHHHHHHHHHHHHHhhcchhhHHH------------------
Q 045449 628 DRFSENNLIGIGN------------GMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVK------------------ 677 (823)
Q Consensus 628 ~~f~~~~~lg~g~------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------------ 677 (823)
.+|...+.||.|+ +..||+|... .+.+.+|++++++++|||||+
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~ 165 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY 165 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecC
Confidence 4688888888886 4557888643 245789999999999999998
Q ss_pred ---------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccc
Q 045449 678 ---------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTL 736 (823)
Q Consensus 678 ---------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~ 736 (823)
++.|++++|.|+|+.+|+||||||+||+++.++.+||+|||+|+....... ......+
T Consensus 166 ~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~-~~~~~~~ 244 (391)
T PHA03212 166 KTDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA-NKYYGWA 244 (391)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCcccccccccc-ccccccc
Confidence 356889999999999999999999999999999999999999975432211 1223457
Q ss_pred cCCCcCcccccCCCccccccceehhhhhhccccCCCCCcC
Q 045449 737 ATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVG 776 (823)
Q Consensus 737 gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~ 776 (823)
||+.|+|||++.+..++.++||||+||++|++++|..|+.
T Consensus 245 gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~ 284 (391)
T PHA03212 245 GTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLF 284 (391)
T ss_pred CccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcC
Confidence 9999999999999899999999999999999999987754
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.4e-23 Score=223.86 Aligned_cols=148 Identities=24% Similarity=0.313 Sum_probs=126.7
Q ss_pred cCCccceeeccC------------CeEEEEEEehHhh--HHHHHHHHHHHHHHhhcchhhHHH-----------------
Q 045449 629 RFSENNLIGIGN------------GMEVAVKVFHQQY--ERALKSFEDECEVRKRIRHRNLVK----------------- 677 (823)
Q Consensus 629 ~f~~~~~lg~g~------------~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~----------------- 677 (823)
+|...+.+|+|+ +..||+|.+.... +...+....|+.++++++|||||.
T Consensus 5 ~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~ 84 (426)
T KOG0589|consen 5 NYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVME 84 (426)
T ss_pred hhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEe
Confidence 444555666664 4568999886433 455568899999999999999998
Q ss_pred --------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCcccc
Q 045449 678 --------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSK 731 (823)
Q Consensus 678 --------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~ 731 (823)
++.|++.++.|+|+..|+|||+|+.||+++.+..+||.|||+|+.+..+.. .
T Consensus 85 Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~--~ 162 (426)
T KOG0589|consen 85 YCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDS--L 162 (426)
T ss_pred ecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCchh--h
Confidence 367899999999999999999999999999999999999999999876542 3
Q ss_pred ccccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCCC
Q 045449 732 QTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 732 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
..+.+||+.||+||.+.+.+|+.|+|+||+||++|||.+-+.+|...
T Consensus 163 a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~ 209 (426)
T KOG0589|consen 163 ASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKAS 209 (426)
T ss_pred hheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCcc
Confidence 45678999999999999999999999999999999999999988765
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.87 E-value=5.3e-23 Score=211.69 Aligned_cols=150 Identities=24% Similarity=0.275 Sum_probs=123.0
Q ss_pred CCccceeeccC------------CeEEEEEEehHhh---HHHHHHHHHHHHHHhhcchhhHHH-----------------
Q 045449 630 FSENNLIGIGN------------GMEVAVKVFHQQY---ERALKSFEDECEVRKRIRHRNLVK----------------- 677 (823)
Q Consensus 630 f~~~~~lg~g~------------~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~----------------- 677 (823)
|..-+.+|.|+ +...|+|++.+.. .+...+...|-+||+.++||.++.
T Consensus 79 f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~mey 158 (459)
T KOG0610|consen 79 FRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVMEY 158 (459)
T ss_pred HHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEec
Confidence 33445667664 4668999998765 344467888999999999999998
Q ss_pred -------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCC-------
Q 045449 678 -------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSG------- 725 (823)
Q Consensus 678 -------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~------- 725 (823)
++|+++.||+|+|..|||.||+||+|||+.++|++.|+||-++.....
T Consensus 159 CpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~~~s 238 (459)
T KOG0610|consen 159 CPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPTLVKS 238 (459)
T ss_pred CCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCCCCCeeecc
Confidence 478999999999999999999999999999999999999998754211
Q ss_pred --------------------------CCc---------------------cccccccccCCCcCcccccCCCccccccce
Q 045449 726 --------------------------EDQ---------------------LSKQTQTLATIGYMAPEYGTKGRVSTRGDV 758 (823)
Q Consensus 726 --------------------------~~~---------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv 758 (823)
... ......++||..|.|||++.+...+.++|+
T Consensus 239 ~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgsAVDW 318 (459)
T KOG0610|consen 239 SSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGSAVDW 318 (459)
T ss_pred CCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCchhhH
Confidence 000 011224689999999999999999999999
Q ss_pred ehhhhhhccccCCCCCcCCCc
Q 045449 759 CSFGIISGGKETRSMTVGETC 779 (823)
Q Consensus 759 ~S~Gvv~~~~~~~~~~~~~~~ 779 (823)
|+|||++|||++|..||.+..
T Consensus 319 WtfGIflYEmLyG~TPFKG~~ 339 (459)
T KOG0610|consen 319 WTFGIFLYEMLYGTTPFKGSN 339 (459)
T ss_pred HHHHHHHHHHHhCCCCcCCCC
Confidence 999999999999999997753
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.87 E-value=4.1e-23 Score=225.86 Aligned_cols=148 Identities=26% Similarity=0.374 Sum_probs=119.9
Q ss_pred CCccceeeccC------------CeEEEEEEehHhh--HHHHHHHHHHHHHHhhcchhhHHH------------------
Q 045449 630 FSENNLIGIGN------------GMEVAVKVFHQQY--ERALKSFEDECEVRKRIRHRNLVK------------------ 677 (823)
Q Consensus 630 f~~~~~lg~g~------------~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~------------------ 677 (823)
|...+.||.|+ +..||||++.... .....++.+|++++++++||||++
T Consensus 2 y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~l 81 (338)
T cd07859 2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYV 81 (338)
T ss_pred eEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEE
Confidence 55556666664 5779999987432 233457889999999999999986
Q ss_pred --------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCcc-c
Q 045449 678 --------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQL-S 730 (823)
Q Consensus 678 --------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~-~ 730 (823)
++.|++++|+|+|+.+|+||||||+|||++.++.+||+|||+++........ .
T Consensus 82 v~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~ 161 (338)
T cd07859 82 VFELMESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAI 161 (338)
T ss_pred EEecCCCCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccccCccc
Confidence 3568899999999999999999999999999999999999999865322211 1
Q ss_pred cccccccCCCcCcccccCC--CccccccceehhhhhhccccCCCCCcCC
Q 045449 731 KQTQTLATIGYMAPEYGTK--GRVSTRGDVCSFGIISGGKETRSMTVGE 777 (823)
Q Consensus 731 ~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~ 777 (823)
......||+.|+|||++.+ ..++.++|||||||++|++.+|+.||.+
T Consensus 162 ~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~ 210 (338)
T cd07859 162 FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPG 210 (338)
T ss_pred cccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCC
Confidence 1234579999999999865 6789999999999999999999999865
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.1e-23 Score=226.19 Aligned_cols=149 Identities=28% Similarity=0.382 Sum_probs=125.8
Q ss_pred ccCCccceeeccC------------CeEEEEEEehHhhH---HHHHHHHHHHHHHhhcc-hhhHHH--------------
Q 045449 628 DRFSENNLIGIGN------------GMEVAVKVFHQQYE---RALKSFEDECEVRKRIR-HRNLVK-------------- 677 (823)
Q Consensus 628 ~~f~~~~~lg~g~------------~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~-h~niv~-------------- 677 (823)
+.|...+.+|+|. |..+|+|++.+... ...+.+.+|+++|+++. |||||.
T Consensus 35 ~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lv 114 (382)
T KOG0032|consen 35 EKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLV 114 (382)
T ss_pred ccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEE
Confidence 4455556777774 67799999976653 24468999999999998 999998
Q ss_pred -------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCC----CCcEEEeecccccccCCCCc
Q 045449 678 -------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDE----DMVAHISDFGIAKLLSGEDQ 728 (823)
Q Consensus 678 -------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~----~~~~kl~DfGla~~~~~~~~ 728 (823)
++.|++++++|+|+.||+|||+||+|+|+.. ++.+|++|||+|+.....
T Consensus 115 mEL~~GGeLfd~i~~~~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~~-- 192 (382)
T KOG0032|consen 115 MELCEGGELFDRIVKKHYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKPG-- 192 (382)
T ss_pred EEecCCchHHHHHHHccCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEccCC--
Confidence 2568899999999999999999999999963 258999999999987652
Q ss_pred cccccccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCCCc
Q 045449 729 LSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGETC 779 (823)
Q Consensus 729 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~~ 779 (823)
......+||+.|+|||++....|+..+||||.||++|.++.|..||.+..
T Consensus 193 -~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~ 242 (382)
T KOG0032|consen 193 -ERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGET 242 (382)
T ss_pred -ceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCC
Confidence 23456799999999999999999999999999999999999999997643
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.6e-22 Score=209.51 Aligned_cols=182 Identities=27% Similarity=0.396 Sum_probs=127.6
Q ss_pred ccCCccceeeccC----------CeEEEEEEehHhhHHHHHHHHHHHHHHhhc--chhhHHHHH----------------
Q 045449 628 DRFSENNLIGIGN----------GMEVAVKVFHQQYERALKSFEDECEVRKRI--RHRNLVKII---------------- 679 (823)
Q Consensus 628 ~~f~~~~~lg~g~----------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~~~---------------- 679 (823)
+.....+.||+|. |..||||+|....+ +.+.+|.++...+ +|+||..++
T Consensus 211 rqI~L~e~IGkGRyGEVwrG~wrGe~VAVKiF~srdE---~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLv 287 (513)
T KOG2052|consen 211 RQIVLQEIIGKGRFGEVWRGRWRGEDVAVKIFSSRDE---RSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLV 287 (513)
T ss_pred heeEEEEEecCccccceeeccccCCceEEEEecccch---hhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEe
Confidence 3445557788875 67799999975544 5788999998864 999999942
Q ss_pred ---------------------------HHHHHHhhhcC--------CCCEEeccCCCCCEEeCCCCcEEEeecccccccC
Q 045449 680 ---------------------------SSSLEYLHFGH--------SIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLS 724 (823)
Q Consensus 680 ---------------------------~~~l~~L~~~h--------~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~ 724 (823)
..++.+|.|+| ++.|.|||||+.|||+..++...|+|+|+|-...
T Consensus 288 TdYHe~GSL~DyL~r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h~ 367 (513)
T KOG2052|consen 288 TDYHEHGSLYDYLNRNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD 367 (513)
T ss_pred eecccCCcHHHHHhhccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEEec
Confidence 23344555555 4789999999999999999999999999997654
Q ss_pred CCCc--cccccccccCCCcCcccccCCCc----c--ccccceehhhhhhccccCCCCCcCCCcccccccccccCCccccc
Q 045449 725 GEDQ--LSKQTQTLATIGYMAPEYGTKGR----V--STRGDVCSFGIISGGKETRSMTVGETCTPVRESKYEVHPATTTI 796 (823)
Q Consensus 725 ~~~~--~~~~~~~~gt~~y~aPE~~~~~~----~--~~~~Dv~S~Gvv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 796 (823)
.... .......+||.+|||||++.... + -..+||||||.|+||+.-+-. .+++.+..+...|+..|.
T Consensus 368 ~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~-~ggi~eey~~Pyyd~Vp~---- 442 (513)
T KOG2052|consen 368 SDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCE-SGGIVEEYQLPYYDVVPS---- 442 (513)
T ss_pred ccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhh-cCCEehhhcCCcccCCCC----
Confidence 4321 22345678999999999986542 1 235899999999999865443 234444444444444443
Q ss_pred ccCCCccccccccccccccccc
Q 045449 797 MEHPLPRVGEVMDVDRGKARIQ 818 (823)
Q Consensus 797 ~~~~~~~~~~~~~~~~~~~~~~ 818 (823)
+.....|++++++++.+..++
T Consensus 443 -DPs~eeMrkVVCv~~~RP~ip 463 (513)
T KOG2052|consen 443 -DPSFEEMRKVVCVQKLRPNIP 463 (513)
T ss_pred -CCCHHHHhcceeecccCCCCC
Confidence 333456667777766665443
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.3e-22 Score=220.43 Aligned_cols=137 Identities=22% Similarity=0.240 Sum_probs=115.4
Q ss_pred CCeEEEEEEehHhh---HHHHHHHHHHHHHHhhcchhhHHH---------------------------------------
Q 045449 640 NGMEVAVKVFHQQY---ERALKSFEDECEVRKRIRHRNLVK--------------------------------------- 677 (823)
Q Consensus 640 ~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~--------------------------------------- 677 (823)
.+..||+|++.... ......+..|++++.+++||||++
T Consensus 19 ~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~l~~~~~~ 98 (325)
T cd05594 19 TGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRAR 98 (325)
T ss_pred CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHH
Confidence 36789999997643 234467889999999999999998
Q ss_pred -HHHHHHHHhhhcCC-CCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCcccccCCCccccc
Q 045449 678 -IISSSLEYLHFGHS-IPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTR 755 (823)
Q Consensus 678 -~~~~~l~~L~~~h~-~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 755 (823)
++.|++.+|+|+|+ .+|+||||||+|||++.++.+||+|||+++....... ......||+.|+|||++.+..++.+
T Consensus 99 ~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~ 176 (325)
T cd05594 99 FYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA--TMKTFCGTPEYLAPEVLEDNDYGRA 176 (325)
T ss_pred HHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc--ccccccCCcccCCHHHHccCCCCCc
Confidence 35688999999997 7999999999999999999999999999875432221 1234579999999999998899999
Q ss_pred cceehhhhhhccccCCCCCcCCC
Q 045449 756 GDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 756 ~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
+||||+||++|++++|..||...
T Consensus 177 ~DiwslG~il~el~tG~~Pf~~~ 199 (325)
T cd05594 177 VDWWGLGVVMYEMMCGRLPFYNQ 199 (325)
T ss_pred cccccccceeeeeccCCCCCCCC
Confidence 99999999999999999998653
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.3e-23 Score=222.49 Aligned_cols=152 Identities=24% Similarity=0.325 Sum_probs=122.5
Q ss_pred cCCccceeeccC-----------CeEEEEEEehHh--hHHHHHHHHHHHHHHhhc-chhhHHH-----------------
Q 045449 629 RFSENNLIGIGN-----------GMEVAVKVFHQQ--YERALKSFEDECEVRKRI-RHRNLVK----------------- 677 (823)
Q Consensus 629 ~f~~~~~lg~g~-----------~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~----------------- 677 (823)
.|+..+.||.|| ...||+|++... ..+....|..|++.|.++ .|.+||+
T Consensus 362 ~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE~ 441 (677)
T KOG0596|consen 362 EYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVMEC 441 (677)
T ss_pred hhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEeec
Confidence 345556777776 244666655432 356678999999999999 5888887
Q ss_pred -----------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccc
Q 045449 678 -----------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQ 734 (823)
Q Consensus 678 -----------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 734 (823)
+-.|+|.++++.|..||||.|+||.|.|+- +|.+||+|||+|..+..+........
T Consensus 442 Gd~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~DTTsI~kds 520 (677)
T KOG0596|consen 442 GDIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV-KGRLKLIDFGIANAIQPDTTSIVKDS 520 (677)
T ss_pred ccccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE-eeeEEeeeechhcccCccccceeecc
Confidence 236899999999999999999999999985 57899999999998876655555566
Q ss_pred cccCCCcCcccccCCCc-----------cccccceehhhhhhccccCCCCCcCCCccc
Q 045449 735 TLATIGYMAPEYGTKGR-----------VSTRGDVCSFGIISGGKETRSMTVGETCTP 781 (823)
Q Consensus 735 ~~gt~~y~aPE~~~~~~-----------~~~~~Dv~S~Gvv~~~~~~~~~~~~~~~~~ 781 (823)
.+||+.||+||.+.... .++++||||+|||+|+|.+|+.||++....
T Consensus 521 QvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~ 578 (677)
T KOG0596|consen 521 QVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQ 578 (677)
T ss_pred ccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHH
Confidence 79999999999875432 568999999999999999999999987533
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=9.9e-23 Score=198.12 Aligned_cols=135 Identities=27% Similarity=0.330 Sum_probs=104.6
Q ss_pred CeEEEEEEehHhh-HHHHHHHHHHHHHHhhcc-hhhHHH----------------------------------------H
Q 045449 641 GMEVAVKVFHQQY-ERALKSFEDECEVRKRIR-HRNLVK----------------------------------------I 678 (823)
Q Consensus 641 ~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~----------------------------------------~ 678 (823)
|...|||.+.+.. ....+++...++++.+-+ .|.||+ +
T Consensus 117 ~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs~C~ekLlkrik~piPE~ilGk~ 196 (391)
T KOG0983|consen 117 GHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMSTCAEKLLKRIKGPIPERILGKM 196 (391)
T ss_pred ceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHHHHHHHHHHHhcCCchHHhhhhh
Confidence 5778999887554 334466777777766654 688887 1
Q ss_pred HHHHHHHhhhcC-CCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCcccccCC---Ccccc
Q 045449 679 ISSSLEYLHFGH-SIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTK---GRVST 754 (823)
Q Consensus 679 ~~~~l~~L~~~h-~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~ 754 (823)
...++.+|+|+. +++|+|||+||+|||+|+.|.+|+||||++..+..... .+..+|-+.|||||.+.- ..|+.
T Consensus 197 tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkA---htrsAGC~~YMaPERidp~~~~kYDi 273 (391)
T KOG0983|consen 197 TVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKA---HTRSAGCAAYMAPERIDPPDKPKYDI 273 (391)
T ss_pred HHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeecccc---cccccCCccccCccccCCCCCCccch
Confidence 123444555553 35899999999999999999999999999988765433 344578899999998753 46999
Q ss_pred ccceehhhhhhccccCCCCCcCCC
Q 045449 755 RGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 755 ~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
++|||||||.++|+.||..||...
T Consensus 274 RaDVWSlGITlveLaTg~yPy~~c 297 (391)
T KOG0983|consen 274 RADVWSLGITLVELATGQYPYKGC 297 (391)
T ss_pred hhhhhhhccchhhhhcccCCCCCC
Confidence 999999999999999999999873
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=99.87 E-value=8e-23 Score=222.64 Aligned_cols=150 Identities=22% Similarity=0.289 Sum_probs=122.3
Q ss_pred ccCCccceeeccC------------CeEEEEEEehHhh---HHHHHHHHHHHHHHhhcchhhHHH---------------
Q 045449 628 DRFSENNLIGIGN------------GMEVAVKVFHQQY---ERALKSFEDECEVRKRIRHRNLVK--------------- 677 (823)
Q Consensus 628 ~~f~~~~~lg~g~------------~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~--------------- 677 (823)
++|...+.||+|+ +..||||++.... ....+.+.+|+.++..++|++|++
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 3566677788775 4569999986532 233456889999999999999987
Q ss_pred --------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCcccc
Q 045449 678 --------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSK 731 (823)
Q Consensus 678 --------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~ 731 (823)
+++|++.+|+|+|+.+|+||||||+||+++.++.+||+|||+++........ .
T Consensus 81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~-~ 159 (331)
T cd05624 81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTV-Q 159 (331)
T ss_pred eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCce-e
Confidence 3578999999999999999999999999999999999999999876443221 1
Q ss_pred ccccccCCCcCcccccCC-----CccccccceehhhhhhccccCCCCCcCCC
Q 045449 732 QTQTLATIGYMAPEYGTK-----GRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 732 ~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
.....||+.|+|||++.+ +.++.++||||+||++|++++|..||...
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~ 211 (331)
T cd05624 160 SSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAE 211 (331)
T ss_pred eccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCC
Confidence 233569999999998865 46789999999999999999999999654
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=9.5e-23 Score=222.04 Aligned_cols=149 Identities=23% Similarity=0.312 Sum_probs=121.5
Q ss_pred cCCccceeeccC------------CeEEEEEEehHhh---HHHHHHHHHHHHHHhhcchhhHHH----------------
Q 045449 629 RFSENNLIGIGN------------GMEVAVKVFHQQY---ERALKSFEDECEVRKRIRHRNLVK---------------- 677 (823)
Q Consensus 629 ~f~~~~~lg~g~------------~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~---------------- 677 (823)
+|...+.||.|+ +..||||++.... ....+.|.+|+.++.+++|+||++
T Consensus 2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (331)
T cd05597 2 DFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMD 81 (331)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEe
Confidence 566677788775 5679999997532 234467889999999999999987
Q ss_pred -------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccc
Q 045449 678 -------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQ 732 (823)
Q Consensus 678 -------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~ 732 (823)
++.|++.+|+|+|+.+|+||||||+|||++.++.+||+|||+++........ ..
T Consensus 82 ~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~ 160 (331)
T cd05597 82 YYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTV-QS 160 (331)
T ss_pred cCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCc-cc
Confidence 3578899999999999999999999999999999999999999765433221 12
Q ss_pred cccccCCCcCcccccCC-----CccccccceehhhhhhccccCCCCCcCCC
Q 045449 733 TQTLATIGYMAPEYGTK-----GRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 733 ~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
....||+.|+|||++.. ..++.++||||+||++|++++|..||...
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~ 211 (331)
T cd05597 161 NVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAE 211 (331)
T ss_pred cceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCC
Confidence 23469999999999863 45788999999999999999999998653
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=99.87 E-value=9e-23 Score=224.66 Aligned_cols=151 Identities=27% Similarity=0.332 Sum_probs=127.0
Q ss_pred HHhccCCccceeeccC------------CeEEEEEEehHhh--HHHHHHHHHHHHHHhhcchhhHHH-------------
Q 045449 625 RATDRFSENNLIGIGN------------GMEVAVKVFHQQY--ERALKSFEDECEVRKRIRHRNLVK------------- 677 (823)
Q Consensus 625 ~at~~f~~~~~lg~g~------------~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~------------- 677 (823)
...++|...+.||.|+ +..||||++.... ....+.+.+|+.+++.++||||++
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 3457888888899885 5668999986432 334467889999999999999987
Q ss_pred ------------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCC
Q 045449 678 ------------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGED 727 (823)
Q Consensus 678 ------------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~ 727 (823)
++.|++++|+|+|+.||+||||||+||+++.++.+||+|||+++......
T Consensus 94 ~~~~~lv~e~~~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 173 (355)
T cd07874 94 FQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 173 (355)
T ss_pred cceeEEEhhhhcccHHHHHhhcCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccCCCcc
Confidence 24688999999999999999999999999999999999999998653321
Q ss_pred ccccccccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCCC
Q 045449 728 QLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 728 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
......||+.|+|||++.+..++.++|||||||++|++++|..||.+.
T Consensus 174 ---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 221 (355)
T cd07874 174 ---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR 221 (355)
T ss_pred ---ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 223457899999999999889999999999999999999999998653
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=99.87 E-value=7.3e-23 Score=218.39 Aligned_cols=149 Identities=26% Similarity=0.369 Sum_probs=123.2
Q ss_pred cCCccceeeccC------------CeEEEEEEehHhh--HHHHHHHHHHHHHHhhcchhhHHH-----------------
Q 045449 629 RFSENNLIGIGN------------GMEVAVKVFHQQY--ERALKSFEDECEVRKRIRHRNLVK----------------- 677 (823)
Q Consensus 629 ~f~~~~~lg~g~------------~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~----------------- 677 (823)
+|...+.+|.|+ +..||||++.... ....+.+.+|++++++++||||++
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (287)
T cd07848 2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEY 81 (287)
T ss_pred CceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEec
Confidence 455666677664 5679999986432 334567889999999999999998
Q ss_pred -----------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccc
Q 045449 678 -----------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQ 734 (823)
Q Consensus 678 -----------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 734 (823)
++.|++.+|+|+|+.+|+||||||+||+++.++.+||+|||+++....... .....
T Consensus 82 ~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~~ 160 (287)
T cd07848 82 VEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN-ANYTE 160 (287)
T ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCccccccccc-ccccc
Confidence 356889999999999999999999999999999999999999987643222 12234
Q ss_pred cccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCCC
Q 045449 735 TLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 735 ~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
..||+.|+|||++.+..++.++||||+||++|++.+|+.||...
T Consensus 161 ~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~ 204 (287)
T cd07848 161 YVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGE 204 (287)
T ss_pred cccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCC
Confidence 57899999999998888999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=4.3e-23 Score=222.03 Aligned_cols=150 Identities=26% Similarity=0.301 Sum_probs=123.0
Q ss_pred hccCCccceeeccC------------CeEEEEEEehHhhH-HHHHHHHHHHHHHhhcchhhHHH----------------
Q 045449 627 TDRFSENNLIGIGN------------GMEVAVKVFHQQYE-RALKSFEDECEVRKRIRHRNLVK---------------- 677 (823)
Q Consensus 627 t~~f~~~~~lg~g~------------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~---------------- 677 (823)
.++|...+.||.|+ +..||||++..... .....+.+|++++++++||||++
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 46777778888875 56799999864432 22346788999999999999998
Q ss_pred ------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCcccccc
Q 045449 678 ------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQT 733 (823)
Q Consensus 678 ------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~ 733 (823)
++.|++.+|+|+|+.+|+||||||+||+++.++.+||+|||+++...... ....
T Consensus 84 ~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~~~~ 161 (303)
T cd07869 84 YVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPS--HTYS 161 (303)
T ss_pred CCCcCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCC--ccCC
Confidence 35688999999999999999999999999999999999999997643221 1223
Q ss_pred ccccCCCcCcccccCC-CccccccceehhhhhhccccCCCCCcCCC
Q 045449 734 QTLATIGYMAPEYGTK-GRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 734 ~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
...||+.|+|||++.+ ..++.++||||+||+++++.+|..||.+.
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 207 (303)
T cd07869 162 NEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGM 207 (303)
T ss_pred CCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 4568999999998765 45889999999999999999999999764
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.87 E-value=8.6e-23 Score=222.66 Aligned_cols=136 Identities=25% Similarity=0.279 Sum_probs=112.3
Q ss_pred CeEEEEEEehHhh----HHHHHHHHHHHHHHhhc-chhhHHH--------------------------------------
Q 045449 641 GMEVAVKVFHQQY----ERALKSFEDECEVRKRI-RHRNLVK-------------------------------------- 677 (823)
Q Consensus 641 ~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~-------------------------------------- 677 (823)
+..||+|++.... ....+.+..|++++.++ +|++|++
T Consensus 28 ~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~ 107 (332)
T cd05614 28 GKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEV 107 (332)
T ss_pred CCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHH
Confidence 4668999986532 23346788999999999 5899997
Q ss_pred --HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCcccccCCC-cccc
Q 045449 678 --IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKG-RVST 754 (823)
Q Consensus 678 --~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ 754 (823)
++.|++.+|+|+|+.+|+||||||+|||++.++.+||+|||+++....... .......||+.|+|||++.+. .++.
T Consensus 108 ~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~ 186 (332)
T cd05614 108 RFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEK-ERTYSFCGTIEYMAPEIIRGKGGHGK 186 (332)
T ss_pred HHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccccccCC-CccccccCCccccCHHHhcCCCCCCC
Confidence 346899999999999999999999999999999999999999986533222 122345799999999998765 4789
Q ss_pred ccceehhhhhhccccCCCCCcCC
Q 045449 755 RGDVCSFGIISGGKETRSMTVGE 777 (823)
Q Consensus 755 ~~Dv~S~Gvv~~~~~~~~~~~~~ 777 (823)
++|||||||++|++++|..||..
T Consensus 187 ~~DiwslG~il~elltg~~pf~~ 209 (332)
T cd05614 187 AVDWWSLGILIFELLTGASPFTL 209 (332)
T ss_pred ccccccchhhhhhhhcCCCCCCC
Confidence 99999999999999999999864
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=5.3e-23 Score=218.80 Aligned_cols=156 Identities=17% Similarity=0.184 Sum_probs=123.6
Q ss_pred cccccCHHHHHHHhccCCccceeeccC----------CeEEEEEEehHhh---HHHHHHHHHHHHHHhhcchhhHHH---
Q 045449 614 AIRRFSYHELLRATDRFSENNLIGIGN----------GMEVAVKVFHQQY---ERALKSFEDECEVRKRIRHRNLVK--- 677 (823)
Q Consensus 614 ~~~~~~~~~l~~at~~f~~~~~lg~g~----------~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~--- 677 (823)
.++.++.+++... ....+|+|+ |..||||++.... ....+.|.+|++++++++||||++
T Consensus 11 ~~~~i~~~~i~~~-----~~~~i~~g~~~~v~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g 85 (283)
T PHA02988 11 DIKCIESDDIDKY-----TSVLIKENDQNSIYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYG 85 (283)
T ss_pred cceecCHHHcCCC-----CCeEEeeCCceEEEEEEECCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEee
Confidence 3455666666322 124455553 6789999997543 233578899999999999999998
Q ss_pred -----------------------------------------HHHHHHHHhhhcCC-CCEEeccCCCCCEEeCCCCcEEEe
Q 045449 678 -----------------------------------------IISSSLEYLHFGHS-IPIIHCDLKPSNVLLDEDMVAHIS 715 (823)
Q Consensus 678 -----------------------------------------~~~~~l~~L~~~h~-~~ivHrdlk~~NiLl~~~~~~kl~ 715 (823)
++.+++.+|+++|+ .+++||||||+||++++++.+||+
T Consensus 86 ~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~ 165 (283)
T PHA02988 86 FIIDIVDDLPRLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKII 165 (283)
T ss_pred eEEecccCCCceEEEEEeCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEc
Confidence 24577788888897 489999999999999999999999
Q ss_pred ecccccccCCCCccccccccccCCCcCcccccCC--CccccccceehhhhhhccccCCCCCcCCCc
Q 045449 716 DFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTK--GRVSTRGDVCSFGIISGGKETRSMTVGETC 779 (823)
Q Consensus 716 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~~ 779 (823)
|||+++...... ....|+..|+|||++.+ ..++.++|||||||++|++.+|..||.+..
T Consensus 166 dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~ 226 (283)
T PHA02988 166 CHGLEKILSSPP-----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLT 226 (283)
T ss_pred ccchHhhhcccc-----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCC
Confidence 999998654321 23468999999999876 679999999999999999999999997653
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.7e-22 Score=221.36 Aligned_cols=149 Identities=30% Similarity=0.365 Sum_probs=124.2
Q ss_pred HHHhccCCccceeeccC------------CeEEEEEEehHhh--HHHHHHHHHHHHHHhhcchhhHHH------------
Q 045449 624 LRATDRFSENNLIGIGN------------GMEVAVKVFHQQY--ERALKSFEDECEVRKRIRHRNLVK------------ 677 (823)
Q Consensus 624 ~~at~~f~~~~~lg~g~------------~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~------------ 677 (823)
.+..++|...+.||.|+ +..||||++.... ....+.+.+|++++++++||||++
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07878 11 WEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIE 90 (343)
T ss_pred hhhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccc
Confidence 34556777778888775 5669999986543 233456889999999999999997
Q ss_pred --------------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCC
Q 045449 678 --------------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSG 725 (823)
Q Consensus 678 --------------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~ 725 (823)
++.|++++|+|+|+.+|+||||||+||+++.++.+||+|||+++....
T Consensus 91 ~~~~~~~~~~~~~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~ 170 (343)
T cd07878 91 NFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADD 170 (343)
T ss_pred ccCcEEEEeecCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceecCC
Confidence 246889999999999999999999999999999999999999987543
Q ss_pred CCccccccccccCCCcCcccccCC-CccccccceehhhhhhccccCCCCCcCC
Q 045449 726 EDQLSKQTQTLATIGYMAPEYGTK-GRVSTRGDVCSFGIISGGKETRSMTVGE 777 (823)
Q Consensus 726 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~ 777 (823)
. .....||+.|+|||++.+ ..++.++||||+||++|++.+|..||.+
T Consensus 171 ~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 218 (343)
T cd07878 171 E-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPG 218 (343)
T ss_pred C-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence 2 234578999999999876 5689999999999999999999999864
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=4.3e-22 Score=232.23 Aligned_cols=224 Identities=21% Similarity=0.354 Sum_probs=128.2
Q ss_pred hhhhccccccccCCccccccCCCCCcEEEccCCcccccCCcccccCCCCccEEEeeccccccccCccccCCCCCCeEEee
Q 045449 206 LARLALATNNLVGVVPVTIFNMSALKEISLLNNSLSGSLPSRIDLSLPNVETLNLGINSFSGTIPSSITNSSKLSDLELG 285 (823)
Q Consensus 206 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 285 (823)
|+.|+|++|++. .+|..+. ++|+.|+|++|+|+ .+|..+. ++|++|+|++|+|++ +|..+. ++|+.|+++
T Consensus 243 L~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~---~sL~~L~Ls~N~Lt~-LP~~lp--~sL~~L~Ls 312 (754)
T PRK15370 243 IQEMELSINRIT-ELPERLP--SALQSLDLFHNKIS-CLPENLP---EELRYLSVYDNSIRT-LPAHLP--SGITHLNVQ 312 (754)
T ss_pred ccEEECcCCccC-cCChhHh--CCCCEEECcCCccC-ccccccC---CCCcEEECCCCcccc-Ccccch--hhHHHHHhc
Confidence 444555555555 3343332 35666666666665 4555432 356666666666663 444332 356666666
Q ss_pred cccccccCCCccCCCcccCcccccCccccCCCCcccccccccCCCCceEEEeecCCCCccCCccccccccccceEEecCC
Q 045449 286 ENLFSGFIPNTIGNLRNLEFGNIADNYLTSSTPELSFLSSLTNCKKLKVLIVTGNPLDGILPKSIGNFSLSLETILMANC 365 (823)
Q Consensus 286 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N 365 (823)
+|+++. +|..+. ++|+.|++++|.+++.+. .+ .++|+.|++++|+|+. +|..+. .+|++|++++|
T Consensus 313 ~N~Lt~-LP~~l~--~sL~~L~Ls~N~Lt~LP~------~l--~~sL~~L~Ls~N~L~~-LP~~lp---~~L~~LdLs~N 377 (754)
T PRK15370 313 SNSLTA-LPETLP--PGLKTLEAGENALTSLPA------SL--PPELQVLDVSKNQITV-LPETLP---PTITTLDVSRN 377 (754)
T ss_pred CCcccc-CCcccc--ccceeccccCCccccCCh------hh--cCcccEEECCCCCCCc-CChhhc---CCcCEEECCCC
Confidence 666664 333322 466677777777665432 22 2567777777777763 555442 57888888888
Q ss_pred cceeccCccccCcccccEEEcccCcCCCCchh----cccccCCCCEEEccCCCCCCcchHhhhcCCCCCEEEcccCcCcc
Q 045449 366 SISGNIPQVVGNLSNLLVLELGGNNLTGPIPV----TFSQLQTLQAFDLTRNKLAGPITDELCHLARLHSLVLQGNKFSG 441 (823)
Q Consensus 366 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~----~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g 441 (823)
+|+. +|..+. .+|+.|++++|+|+ .+|. .++.++.+..|+|.+|.|+. . .+.+|+.| ++.+.+.|
T Consensus 378 ~Lt~-LP~~l~--~sL~~LdLs~N~L~-~LP~sl~~~~~~~~~l~~L~L~~Npls~---~---tl~~L~~L-l~s~~~~g 446 (754)
T PRK15370 378 ALTN-LPENLP--AALQIMQASRNNLV-RLPESLPHFRGEGPQPTRIIVEYNPFSE---R---TIQNMQRL-MSSVGYQG 446 (754)
T ss_pred cCCC-CCHhHH--HHHHHHhhccCCcc-cCchhHHHHhhcCCCccEEEeeCCCccH---H---HHHHHHHh-hhcccccC
Confidence 8874 454443 36888888888887 4444 34455788889999998872 2 33344444 44555544
Q ss_pred -cccccccCCCCCCeEeccCCcccc
Q 045449 442 -SIPSCLGNLTSVRVLYLGLNIFTS 465 (823)
Q Consensus 442 -~~p~~~~~l~~L~~L~Ls~N~l~~ 465 (823)
.++...+....++....-.+.+++
T Consensus 447 p~i~~~~~~~~~l~~~~~l~~a~~~ 471 (754)
T PRK15370 447 PRVLFAMGDFSIVRVTRPLHQAVQG 471 (754)
T ss_pred CcccccccccccccccchHHHHHhc
Confidence 334444445555544433444433
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=99.87 E-value=9.6e-23 Score=224.75 Aligned_cols=150 Identities=30% Similarity=0.367 Sum_probs=126.2
Q ss_pred HhccCCccceeeccC------------CeEEEEEEehHhh--HHHHHHHHHHHHHHhhcchhhHHH--------------
Q 045449 626 ATDRFSENNLIGIGN------------GMEVAVKVFHQQY--ERALKSFEDECEVRKRIRHRNLVK-------------- 677 (823)
Q Consensus 626 at~~f~~~~~lg~g~------------~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~-------------- 677 (823)
..++|...+.||.|+ |..||||++.... ....+.+.+|+.++++++||||++
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 346788888888875 5679999986432 334567889999999999999987
Q ss_pred -----------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCc
Q 045449 678 -----------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQ 728 (823)
Q Consensus 678 -----------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~ 728 (823)
++.|++.+|+|+|+.+|+||||||+||+++.++.+||+|||+++......
T Consensus 99 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~- 177 (359)
T cd07876 99 QDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNF- 177 (359)
T ss_pred ceeEEEEeCCCcCHHHHHhccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCccccccCc-
Confidence 24688999999999999999999999999999999999999998643221
Q ss_pred cccccccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCCC
Q 045449 729 LSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 729 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
......||+.|+|||++.+..++.++||||+||++|++++|..||.+.
T Consensus 178 --~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~ 225 (359)
T cd07876 178 --MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGT 225 (359)
T ss_pred --cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence 123457899999999999999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.2e-22 Score=221.41 Aligned_cols=149 Identities=20% Similarity=0.281 Sum_probs=120.7
Q ss_pred cCCccceeeccC------------CeEEEEEEehHhh---HHHHHHHHHHHHHHhhcchhhHHH----------------
Q 045449 629 RFSENNLIGIGN------------GMEVAVKVFHQQY---ERALKSFEDECEVRKRIRHRNLVK---------------- 677 (823)
Q Consensus 629 ~f~~~~~lg~g~------------~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~---------------- 677 (823)
+|...+.||+|+ +..||+|++.... ....+.|..|+.++..++|++|++
T Consensus 2 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (332)
T cd05623 2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMD 81 (332)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEe
Confidence 566677788775 4568999986432 233456889999999999999987
Q ss_pred -------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccc
Q 045449 678 -------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQ 732 (823)
Q Consensus 678 -------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~ 732 (823)
+++|++.+|+|+|+.+|+||||||+||+++.++.+||+|||+++....... ...
T Consensus 82 y~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~-~~~ 160 (332)
T cd05623 82 YYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT-VQS 160 (332)
T ss_pred ccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCCc-cee
Confidence 356889999999999999999999999999999999999999976543222 122
Q ss_pred cccccCCCcCcccccC-----CCccccccceehhhhhhccccCCCCCcCCC
Q 045449 733 TQTLATIGYMAPEYGT-----KGRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 733 ~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
...+||+.|+|||++. ...++.++|||||||++|++++|+.||...
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~ 211 (332)
T cd05623 161 SVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAE 211 (332)
T ss_pred cccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCC
Confidence 3357999999999875 346889999999999999999999999654
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=6.9e-23 Score=217.78 Aligned_cols=149 Identities=27% Similarity=0.385 Sum_probs=127.8
Q ss_pred CccceeeccC-----------CeEEEEEEehHhh-HHHHHHHHHHHHHHhhcchhhHHH---------------------
Q 045449 631 SENNLIGIGN-----------GMEVAVKVFHQQY-ERALKSFEDECEVRKRIRHRNLVK--------------------- 677 (823)
Q Consensus 631 ~~~~~lg~g~-----------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~--------------------- 677 (823)
...+.||+|. +..||||.++... .....+|.+|+++|.+++|||||+
T Consensus 541 ~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYmEnG 620 (807)
T KOG1094|consen 541 RFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYMENG 620 (807)
T ss_pred ehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHHhcC
Confidence 3456788875 3679999998765 445689999999999999999998
Q ss_pred ---------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccc
Q 045449 678 ---------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTL 736 (823)
Q Consensus 678 ---------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~ 736 (823)
+.+|+..+|.|+.+.++||||+.+.|+|+|+++++||+|||++|-+...+.+......+
T Consensus 621 DLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~vqgr~v 700 (807)
T KOG1094|consen 621 DLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRVQGRAV 700 (807)
T ss_pred cHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccCCceeeeccee
Confidence 24688888899999999999999999999999999999999999877777766666677
Q ss_pred cCCCcCcccccCCCccccccceehhhhhhcccc--CCCCCcCCCc
Q 045449 737 ATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKE--TRSMTVGETC 779 (823)
Q Consensus 737 gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~--~~~~~~~~~~ 779 (823)
-..+|||+|.+.-++++.++|||+|||.+||+. ..+.||.+..
T Consensus 701 lpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt 745 (807)
T KOG1094|consen 701 LPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLT 745 (807)
T ss_pred eeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhh
Confidence 789999999999999999999999999999974 4677876653
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=5.6e-23 Score=219.41 Aligned_cols=149 Identities=26% Similarity=0.312 Sum_probs=121.2
Q ss_pred ccCCccceeeccC------------CeEEEEEEehHhh-HHHHHHHHHHHHHHhhcchhhHHH-----------------
Q 045449 628 DRFSENNLIGIGN------------GMEVAVKVFHQQY-ERALKSFEDECEVRKRIRHRNLVK----------------- 677 (823)
Q Consensus 628 ~~f~~~~~lg~g~------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~----------------- 677 (823)
++|...+.||.|+ +..||+|+++... ......+.+|++++++++||||++
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 4566667777764 5679999986433 223356789999999999999998
Q ss_pred -----------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccc
Q 045449 678 -----------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQ 734 (823)
Q Consensus 678 -----------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 734 (823)
++.|++++|+|+|+.+|+||||||+||+++.++.+||+|||+++....... ....
T Consensus 85 ~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~--~~~~ 162 (288)
T cd07871 85 LDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK--TYSN 162 (288)
T ss_pred CCcCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc--cccC
Confidence 356889999999999999999999999999999999999999986532221 1234
Q ss_pred cccCCCcCcccccCC-CccccccceehhhhhhccccCCCCCcCCC
Q 045449 735 TLATIGYMAPEYGTK-GRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 735 ~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
..||+.|+|||++.+ ..++.++||||+||++|++.+|..||...
T Consensus 163 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~ 207 (288)
T cd07871 163 EVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGS 207 (288)
T ss_pred ceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 568999999998765 56899999999999999999999998653
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.3e-22 Score=224.03 Aligned_cols=150 Identities=28% Similarity=0.330 Sum_probs=126.3
Q ss_pred HhccCCccceeeccC------------CeEEEEEEehHhh--HHHHHHHHHHHHHHhhcchhhHHH--------------
Q 045449 626 ATDRFSENNLIGIGN------------GMEVAVKVFHQQY--ERALKSFEDECEVRKRIRHRNLVK-------------- 677 (823)
Q Consensus 626 at~~f~~~~~lg~g~------------~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~-------------- 677 (823)
..++|...+.||.|+ +..||||++.... ....+.+.+|+.+++.++||||++
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 457788888899886 4568999986432 334467889999999999999986
Q ss_pred -----------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCc
Q 045449 678 -----------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQ 728 (823)
Q Consensus 678 -----------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~ 728 (823)
++.|++.+|+|+|+.+|+||||||+||+++.++.+||+|||+++......
T Consensus 102 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~- 180 (364)
T cd07875 102 QDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF- 180 (364)
T ss_pred CeEEEEEeCCCCCHHHHHHhcCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccCCCC-
Confidence 25688899999999999999999999999999999999999998654321
Q ss_pred cccccccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCCC
Q 045449 729 LSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 729 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
......||+.|+|||++.+..++.++||||+||++|++++|..||...
T Consensus 181 --~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 228 (364)
T cd07875 181 --MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGT 228 (364)
T ss_pred --cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCC
Confidence 123457899999999999999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=4.9e-23 Score=232.05 Aligned_cols=152 Identities=26% Similarity=0.303 Sum_probs=122.3
Q ss_pred CeEEEEEEehHhhHHHHHHHHHHHHHHhhcc-hhhHHH------------------------------------------
Q 045449 641 GMEVAVKVFHQQYERALKSFEDECEVRKRIR-HRNLVK------------------------------------------ 677 (823)
Q Consensus 641 ~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~------------------------------------------ 677 (823)
|..||+|++-...+.+.+...+||++|++|+ |+|||.
T Consensus 62 ~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~l 141 (738)
T KOG1989|consen 62 GKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRL 141 (738)
T ss_pred CceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEEEeehhhccCCcHHHHHHHHHhccC
Confidence 4889999998778888899999999999997 999998
Q ss_pred -------HHHHHHHHhhhcCC--CCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccc-------cccccccCCCc
Q 045449 678 -------IISSSLEYLHFGHS--IPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLS-------KQTQTLATIGY 741 (823)
Q Consensus 678 -------~~~~~l~~L~~~h~--~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~-------~~~~~~gt~~y 741 (823)
++.++++++.++|. ++|+|||||-||||+..++..||||||-|.......... ..-...-|+.|
T Consensus 142 te~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~Y 221 (738)
T KOG1989|consen 142 TEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQY 221 (738)
T ss_pred ChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccc
Confidence 23444455544444 569999999999999999999999999886532221100 00122358999
Q ss_pred Cccccc---CCCccccccceehhhhhhccccCCCCCcCCC-cccccccccccCCc
Q 045449 742 MAPEYG---TKGRVSTRGDVCSFGIISGGKETRSMTVGET-CTPVRESKYEVHPA 792 (823)
Q Consensus 742 ~aPE~~---~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 792 (823)
+|||.+ .+.+.++|+|||++||++|++++...||++. ...+..+.|.+++.
T Consensus 222 RsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~laIlng~Y~~P~~ 276 (738)
T KOG1989|consen 222 RSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLAILNGNYSFPPF 276 (738)
T ss_pred cChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcceeEEeccccCCCC
Confidence 999975 4567899999999999999999999999998 78889999988875
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.4e-22 Score=218.32 Aligned_cols=136 Identities=24% Similarity=0.246 Sum_probs=112.3
Q ss_pred CeEEEEEEehHhh---HHHHHHHHHHHHHH---hhcchhhHHH-------------------------------------
Q 045449 641 GMEVAVKVFHQQY---ERALKSFEDECEVR---KRIRHRNLVK------------------------------------- 677 (823)
Q Consensus 641 ~~~vavK~~~~~~---~~~~~~~~~E~~~l---~~l~h~niv~------------------------------------- 677 (823)
+..||||++.... ....+.+.+|++++ ++++||||++
T Consensus 24 ~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~~~~~~l~~~~~ 103 (324)
T cd05589 24 GELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRA 103 (324)
T ss_pred CCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEEEcCCCCCcHHHHhhcCCCCHHHH
Confidence 5779999997543 23345677776655 5678999998
Q ss_pred --HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCcccccCCCccccc
Q 045449 678 --IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTR 755 (823)
Q Consensus 678 --~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 755 (823)
++.|++.+|+|+|+.+|+||||||+||+++.++.+||+|||+++....... .....+||+.|+|||++.+..++.+
T Consensus 104 ~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~ 181 (324)
T cd05589 104 VFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGD--RTSTFCGTPEFLAPEVLTETSYTRA 181 (324)
T ss_pred HHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCCC--cccccccCccccCHhHhcCCCCCcc
Confidence 357889999999999999999999999999999999999999875432221 2234679999999999998899999
Q ss_pred cceehhhhhhccccCCCCCcCCC
Q 045449 756 GDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 756 ~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
+|||||||++|++++|..||...
T Consensus 182 ~DiwslG~il~el~~G~~pf~~~ 204 (324)
T cd05589 182 VDWWGLGVLIYEMLVGESPFPGD 204 (324)
T ss_pred cchhhHHHHHHHHHhCCCCCCCC
Confidence 99999999999999999998653
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=6.5e-23 Score=233.45 Aligned_cols=156 Identities=22% Similarity=0.280 Sum_probs=128.9
Q ss_pred HHHHHHhccCCccceeeccC------------CeEEEEEEehHhh---HHHHHHHHHHHHHHhhcchhhHHH--------
Q 045449 621 HELLRATDRFSENNLIGIGN------------GMEVAVKVFHQQY---ERALKSFEDECEVRKRIRHRNLVK-------- 677 (823)
Q Consensus 621 ~~l~~at~~f~~~~~lg~g~------------~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~-------- 677 (823)
.++....++|...++||+|+ ++.||+|++.+.. .....-|..|-++|..-..+.||.
T Consensus 68 ~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~ 147 (1317)
T KOG0612|consen 68 KELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDE 147 (1317)
T ss_pred HHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCc
Confidence 34444557899999999997 4446777776532 223356888999999889999998
Q ss_pred --------------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCC
Q 045449 678 --------------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSG 725 (823)
Q Consensus 678 --------------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~ 725 (823)
++|.++.||+.+|+.|+|||||||+|||+|..|++||+|||-+-.+..
T Consensus 148 ~~LYlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~ 227 (1317)
T KOG0612|consen 148 RYLYLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDA 227 (1317)
T ss_pred cceEEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCC
Confidence 468899999999999999999999999999999999999999887765
Q ss_pred CCccccccccccCCCcCcccccC----C-CccccccceehhhhhhccccCCCCCcCC
Q 045449 726 EDQLSKQTQTLATIGYMAPEYGT----K-GRVSTRGDVCSFGIISGGKETRSMTVGE 777 (823)
Q Consensus 726 ~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~ 777 (823)
+... .....+|||.|++||++. + +.|+..+|+||+||++|||++|..||..
T Consensus 228 dG~V-~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa 283 (1317)
T KOG0612|consen 228 DGTV-RSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYA 283 (1317)
T ss_pred CCcE-EeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchH
Confidence 4442 345678999999999874 3 6799999999999999999999999965
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.4e-22 Score=219.35 Aligned_cols=150 Identities=23% Similarity=0.303 Sum_probs=120.9
Q ss_pred cCCccceeeccC----------------CeEEEEEEehHhh-HHHHHHHHHHHHHHhhcchhhHHH--------------
Q 045449 629 RFSENNLIGIGN----------------GMEVAVKVFHQQY-ERALKSFEDECEVRKRIRHRNLVK-------------- 677 (823)
Q Consensus 629 ~f~~~~~lg~g~----------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~-------------- 677 (823)
+|+..+.||+|+ +..||||++.... ....++|.+|+.+++.++||||++
T Consensus 8 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~~~~~v~ 87 (316)
T cd05108 8 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIT 87 (316)
T ss_pred hceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCCCceeee
Confidence 466666677664 1238999986432 445578999999999999999998
Q ss_pred --------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCcccc
Q 045449 678 --------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSK 731 (823)
Q Consensus 678 --------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~ 731 (823)
++.|++.+|+|+|+.+|+||||||+||+++.++.+||+|||+++..........
T Consensus 88 e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 167 (316)
T cd05108 88 QLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYH 167 (316)
T ss_pred ecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccccCCCccee
Confidence 246888899999999999999999999999999999999999997654332222
Q ss_pred ccccccCCCcCcccccCCCccccccceehhhhhhccccC-CCCCcCCC
Q 045449 732 QTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKET-RSMTVGET 778 (823)
Q Consensus 732 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~-~~~~~~~~ 778 (823)
.....++..|+|||++.+..++.++|||||||++|++++ |..||.+.
T Consensus 168 ~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~ 215 (316)
T cd05108 168 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 215 (316)
T ss_pred ccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCC
Confidence 222345678999999999999999999999999999886 88888664
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=99.86 E-value=3e-22 Score=217.67 Aligned_cols=136 Identities=27% Similarity=0.275 Sum_probs=112.1
Q ss_pred CeEEEEEEehHhh---HHHHHHHHHHHH-HHhhcchhhHHH---------------------------------------
Q 045449 641 GMEVAVKVFHQQY---ERALKSFEDECE-VRKRIRHRNLVK--------------------------------------- 677 (823)
Q Consensus 641 ~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~--------------------------------------- 677 (823)
|..||||++.... ....+.+..|.. +++.++||||++
T Consensus 20 ~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~ 99 (325)
T cd05604 20 GKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRAR 99 (325)
T ss_pred CCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCCCCHHHHHHHcCCCCHHHHH
Confidence 6789999997543 233355666665 467789999998
Q ss_pred -HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCcccccCCCcccccc
Q 045449 678 -IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRG 756 (823)
Q Consensus 678 -~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 756 (823)
++.|++.+|+|+|+.||+||||||+|||++.++.+||+|||+++....... .....+||+.|+|||++.+..++.++
T Consensus 100 ~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~ 177 (325)
T cd05604 100 FYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD--TTTTFCGTPEYLAPEVIRKQPYDNTV 177 (325)
T ss_pred HHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC--CcccccCChhhCCHHHHcCCCCCCcC
Confidence 357899999999999999999999999999999999999999875422211 22345799999999999999999999
Q ss_pred ceehhhhhhccccCCCCCcCCC
Q 045449 757 DVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 757 Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
||||+||++|++++|..||...
T Consensus 178 DvwslG~il~el~~G~~pf~~~ 199 (325)
T cd05604 178 DWWCLGAVLYEMLYGLPPFYCR 199 (325)
T ss_pred ccccccceehhhhcCCCCCCCC
Confidence 9999999999999999998653
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.8e-22 Score=218.28 Aligned_cols=137 Identities=26% Similarity=0.243 Sum_probs=112.9
Q ss_pred CCeEEEEEEehHhh---HHHHHHHHHHHHHHhhc-chhhHHH--------------------------------------
Q 045449 640 NGMEVAVKVFHQQY---ERALKSFEDECEVRKRI-RHRNLVK-------------------------------------- 677 (823)
Q Consensus 640 ~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~-------------------------------------- 677 (823)
.+..||||+++... ....+.+..|.+++... +||||++
T Consensus 19 ~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~gg~L~~~~~~~~~~~~~~~ 98 (316)
T cd05592 19 TNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARA 98 (316)
T ss_pred CCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCCcHHHHHHHcCCCCHHHH
Confidence 35779999997543 23345566777777654 8999998
Q ss_pred --HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCcccccCCCccccc
Q 045449 678 --IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTR 755 (823)
Q Consensus 678 --~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 755 (823)
++.|++.+|.|+|+.+|+||||||+||+++.++.+||+|||+++...... ......+||+.|+|||++.+..++.+
T Consensus 99 ~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~ 176 (316)
T cd05592 99 RFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GKASTFCGTPDYIAPEILKGQKYNES 176 (316)
T ss_pred HHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--CccccccCCccccCHHHHcCCCCCCc
Confidence 35688999999999999999999999999999999999999998643222 12234579999999999998899999
Q ss_pred cceehhhhhhccccCCCCCcCCC
Q 045449 756 GDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 756 ~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
+||||+||++|++++|..||.+.
T Consensus 177 ~DvwslG~il~ell~G~~Pf~~~ 199 (316)
T cd05592 177 VDWWSFGVLLYEMLIGQSPFHGE 199 (316)
T ss_pred ccchhHHHHHHHHHhCCCCCCCC
Confidence 99999999999999999998654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.1e-22 Score=226.62 Aligned_cols=145 Identities=26% Similarity=0.294 Sum_probs=119.5
Q ss_pred cCCccceeeccC--------------CeEEEEEEehHhhHHHHHHHHHHHHHHhhcchhhHHH-----------------
Q 045449 629 RFSENNLIGIGN--------------GMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVK----------------- 677 (823)
Q Consensus 629 ~f~~~~~lg~g~--------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~----------------- 677 (823)
+|...+.||.|+ +..||||.+... +.+.+|++++++++|||||+
T Consensus 93 ~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~ 167 (392)
T PHA03207 93 QYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPK 167 (392)
T ss_pred ceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehh
Confidence 455555666553 355788877543 34578999999999999998
Q ss_pred ----------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCcccccccc
Q 045449 678 ----------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQT 735 (823)
Q Consensus 678 ----------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 735 (823)
++.|++.+|+|+|+.+|+||||||+|||++.++.+||+|||+++..............
T Consensus 168 ~~~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~~~~~~ 247 (392)
T PHA03207 168 YKCDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGW 247 (392)
T ss_pred cCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCccccccccccc
Confidence 3568899999999999999999999999999999999999999876543332223356
Q ss_pred ccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCCC
Q 045449 736 LATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 736 ~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
.||+.|+|||++.+..|+.++||||+||++|++++|..||.+.
T Consensus 248 ~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~ 290 (392)
T PHA03207 248 SGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGK 290 (392)
T ss_pred ccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence 7999999999999999999999999999999999999998653
|
|
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.9e-22 Score=216.39 Aligned_cols=136 Identities=25% Similarity=0.269 Sum_probs=111.9
Q ss_pred CeEEEEEEehHhh---HHHHHHHHHHHH-HHhhcchhhHHH---------------------------------------
Q 045449 641 GMEVAVKVFHQQY---ERALKSFEDECE-VRKRIRHRNLVK--------------------------------------- 677 (823)
Q Consensus 641 ~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~--------------------------------------- 677 (823)
+..||+|++.... ......+.+|.. +++.++||||++
T Consensus 20 ~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~ 99 (321)
T cd05603 20 GSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRAR 99 (321)
T ss_pred CCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCCCCHHHHHHHcCCCCHHHHH
Confidence 5789999986543 223345666654 578899999998
Q ss_pred -HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCcccccCCCcccccc
Q 045449 678 -IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRG 756 (823)
Q Consensus 678 -~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 756 (823)
++.|++++|+|+|+.+|+||||||+||+++.++.+||+|||+++....... ......||+.|+|||++.+..++.++
T Consensus 100 ~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~ 177 (321)
T cd05603 100 FYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE--TTSTFCGTPEYLAPEVLRKEPYDRTV 177 (321)
T ss_pred HHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCC--ccccccCCcccCCHHHhcCCCCCCcC
Confidence 356889999999999999999999999999999999999999875322221 22345799999999999888899999
Q ss_pred ceehhhhhhccccCCCCCcCCC
Q 045449 757 DVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 757 Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
||||+||++|++++|..||...
T Consensus 178 DiwslG~il~el~~g~~pf~~~ 199 (321)
T cd05603 178 DWWCLGAVLYEMLYGLPPFYSR 199 (321)
T ss_pred cccccchhhhhhhcCCCCCCCC
Confidence 9999999999999999998654
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.3e-22 Score=224.37 Aligned_cols=99 Identities=26% Similarity=0.304 Sum_probs=82.8
Q ss_pred HHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCcccccCCCcccccccee
Q 045449 680 SSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVC 759 (823)
Q Consensus 680 ~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~ 759 (823)
.|++++|.|+|+.+|+||||||+|||+++++.+||+|||+++...............++..|+|||++....++.++|||
T Consensus 219 ~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvw 298 (374)
T cd05106 219 SQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVW 298 (374)
T ss_pred HHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCCCCccceeCHHHhcCCCCCccccHH
Confidence 56788999999999999999999999999999999999999875433222222223456789999999888999999999
Q ss_pred hhhhhhccccC-CCCCcCCC
Q 045449 760 SFGIISGGKET-RSMTVGET 778 (823)
Q Consensus 760 S~Gvv~~~~~~-~~~~~~~~ 778 (823)
||||++|++++ |..||...
T Consensus 299 SlGvil~ellt~G~~Pf~~~ 318 (374)
T cd05106 299 SYGILLWEIFSLGKSPYPGI 318 (374)
T ss_pred HHHHHHHHHHhCCCCCCccc
Confidence 99999999996 99998654
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.4e-22 Score=222.88 Aligned_cols=134 Identities=27% Similarity=0.405 Sum_probs=111.7
Q ss_pred CeEEEEEEehHhh-HHHHHHHHHHHHHHhhcchhhHHH------------------------------------HHHHHH
Q 045449 641 GMEVAVKVFHQQY-ERALKSFEDECEVRKRIRHRNLVK------------------------------------IISSSL 683 (823)
Q Consensus 641 ~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~------------------------------------~~~~~l 683 (823)
++.||||++.... ....+.+.+|++++++++|+||++ ++.|++
T Consensus 99 ~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~i~~qi~ 178 (353)
T PLN00034 99 GRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVARQIL 178 (353)
T ss_pred CCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCCCCcccccccCCHHHHHHHHHHHH
Confidence 5779999986443 344568999999999999999998 356889
Q ss_pred HHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCcccccCC-----Cccccccce
Q 045449 684 EYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTK-----GRVSTRGDV 758 (823)
Q Consensus 684 ~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv 758 (823)
.+|.|+|+.+|+||||||+|||++.++.+||+|||+++....... .....+||..|+|||++.. ..++.++||
T Consensus 179 ~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~Dv 256 (353)
T PLN00034 179 SGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD--PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDI 256 (353)
T ss_pred HHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceecccccc--cccccccCccccCccccccccccCcCCCcchhH
Confidence 999999999999999999999999999999999999987643221 1234579999999998743 234568999
Q ss_pred ehhhhhhccccCCCCCcC
Q 045449 759 CSFGIISGGKETRSMTVG 776 (823)
Q Consensus 759 ~S~Gvv~~~~~~~~~~~~ 776 (823)
|||||++|++.+|+.||.
T Consensus 257 wslGvil~el~~g~~pf~ 274 (353)
T PLN00034 257 WSLGVSILEFYLGRFPFG 274 (353)
T ss_pred HHHHHHHHHHHhCCCCCC
Confidence 999999999999999986
|
|
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.8e-22 Score=216.40 Aligned_cols=137 Identities=21% Similarity=0.194 Sum_probs=114.8
Q ss_pred CCeEEEEEEehHhh---HHHHHHHHHHHHHHhhc-chhhHHH--------------------------------------
Q 045449 640 NGMEVAVKVFHQQY---ERALKSFEDECEVRKRI-RHRNLVK-------------------------------------- 677 (823)
Q Consensus 640 ~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~-------------------------------------- 677 (823)
.+..||||++.... ....+.+..|.+++..+ +||||++
T Consensus 19 ~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~~~~ 98 (321)
T cd05591 19 TDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRS 98 (321)
T ss_pred CCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCCCcHHHHHHHcCCCCHHHH
Confidence 35789999997643 33446688899998876 7999998
Q ss_pred --HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCcccccCCCccccc
Q 045449 678 --IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTR 755 (823)
Q Consensus 678 --~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 755 (823)
++.|++.+|+|+|+.+|+||||||+||+++.++.+||+|||+++....... ......||+.|+|||++.+..++.+
T Consensus 99 ~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~ 176 (321)
T cd05591 99 RFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV--TTTTFCGTPDYIAPEILQELEYGPS 176 (321)
T ss_pred HHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCCc--cccccccCccccCHHHHcCCCCCCc
Confidence 356888999999999999999999999999999999999999976432221 2234579999999999998899999
Q ss_pred cceehhhhhhccccCCCCCcCCC
Q 045449 756 GDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 756 ~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
+||||+||++|++++|..||...
T Consensus 177 ~DvwslG~il~el~tg~~Pf~~~ 199 (321)
T cd05591 177 VDWWALGVLMYEMMAGQPPFEAD 199 (321)
T ss_pred cceechhHHHHHHhcCCCCCCCC
Confidence 99999999999999999999654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.3e-22 Score=217.12 Aligned_cols=147 Identities=23% Similarity=0.209 Sum_probs=118.7
Q ss_pred CCccceeeccC------------CeEEEEEEehHhh---HHHHHHHHHHHHHHhhc-chhhHHH----------------
Q 045449 630 FSENNLIGIGN------------GMEVAVKVFHQQY---ERALKSFEDECEVRKRI-RHRNLVK---------------- 677 (823)
Q Consensus 630 f~~~~~lg~g~------------~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~---------------- 677 (823)
|...+.||.|+ +..||||++.... ....+.+..|.+++..+ +|++|++
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (323)
T cd05616 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVME 81 (323)
T ss_pred ceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEc
Confidence 45556677664 5679999987543 23345677888888877 5777775
Q ss_pred ------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCcccccc
Q 045449 678 ------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQT 733 (823)
Q Consensus 678 ------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~ 733 (823)
++.|++.+|+|+|+.+|+||||||+|||++.++.+||+|||+++....... ...
T Consensus 82 ~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~--~~~ 159 (323)
T cd05616 82 YVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGV--TTK 159 (323)
T ss_pred CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCCC--ccc
Confidence 357889999999999999999999999999999999999999986432221 123
Q ss_pred ccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCCC
Q 045449 734 QTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 734 ~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
...||+.|+|||++.+..++.++|||||||++|++++|..||...
T Consensus 160 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~ 204 (323)
T cd05616 160 TFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE 204 (323)
T ss_pred cCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCC
Confidence 457999999999999999999999999999999999999999764
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.6e-22 Score=216.89 Aligned_cols=147 Identities=23% Similarity=0.200 Sum_probs=119.1
Q ss_pred CCccceeeccC------------CeEEEEEEehHhh---HHHHHHHHHHHHHHhhcchhh-HHH----------------
Q 045449 630 FSENNLIGIGN------------GMEVAVKVFHQQY---ERALKSFEDECEVRKRIRHRN-LVK---------------- 677 (823)
Q Consensus 630 f~~~~~lg~g~------------~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~n-iv~---------------- 677 (823)
|...+.||.|+ +..||||++.... ....+.+..|++++..+.|++ |++
T Consensus 2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (324)
T cd05587 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVME 81 (324)
T ss_pred ceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEc
Confidence 45556677664 5679999997543 334567889999999997765 554
Q ss_pred ------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCcccccc
Q 045449 678 ------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQT 733 (823)
Q Consensus 678 ------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~ 733 (823)
++.|++.+|+|+|+.+|+||||||+|||++.++.+||+|||+++....... ...
T Consensus 82 ~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~--~~~ 159 (324)
T cd05587 82 YVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK--TTR 159 (324)
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCC--cee
Confidence 357889999999999999999999999999999999999999875322211 123
Q ss_pred ccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCCC
Q 045449 734 QTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 734 ~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
...||+.|+|||++.+..++.++||||+||++|++++|..||...
T Consensus 160 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~ 204 (324)
T cd05587 160 TFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGE 204 (324)
T ss_pred eecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCC
Confidence 457999999999999999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.8e-22 Score=217.00 Aligned_cols=134 Identities=22% Similarity=0.210 Sum_probs=113.3
Q ss_pred CeEEEEEEehHhh---HHHHHHHHHHHHHHhhc-chhhHHH---------------------------------------
Q 045449 641 GMEVAVKVFHQQY---ERALKSFEDECEVRKRI-RHRNLVK--------------------------------------- 677 (823)
Q Consensus 641 ~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~--------------------------------------- 677 (823)
+..||+|++.... ....+.+.+|+.++.++ +||||++
T Consensus 20 ~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~~~L~~~~~~~~~l~~~~~~ 99 (329)
T cd05618 20 ERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHAR 99 (329)
T ss_pred CCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCCCCHHHHHHHcCCCCHHHHH
Confidence 5779999997643 23446688899988877 8999998
Q ss_pred -HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCcccccCCCcccccc
Q 045449 678 -IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRG 756 (823)
Q Consensus 678 -~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 756 (823)
+++|++.+|+|+|+.+|+||||||+||+++.++.+||+|||+++....... ......||+.|+|||++.+..++.++
T Consensus 100 ~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~ 177 (329)
T cd05618 100 FYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--TTSTFCGTPNYIAPEILRGEDYGFSV 177 (329)
T ss_pred HHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC--ccccccCCccccCHHHHcCCCCCCcc
Confidence 356889999999999999999999999999999999999999975432211 12345799999999999999999999
Q ss_pred ceehhhhhhccccCCCCCcC
Q 045449 757 DVCSFGIISGGKETRSMTVG 776 (823)
Q Consensus 757 Dv~S~Gvv~~~~~~~~~~~~ 776 (823)
|||||||++|++++|..||.
T Consensus 178 DiwslG~il~el~~g~~Pf~ 197 (329)
T cd05618 178 DWWALGVLMFEMMAGRSPFD 197 (329)
T ss_pred ceecccHHHHHHhhCCCCCc
Confidence 99999999999999999985
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.4e-22 Score=235.44 Aligned_cols=150 Identities=27% Similarity=0.332 Sum_probs=123.8
Q ss_pred ccCCccceeeccC------------CeEEEEEEehHhh---HHHHHHHHHHHHHHhhcchhhHHHH--------------
Q 045449 628 DRFSENNLIGIGN------------GMEVAVKVFHQQY---ERALKSFEDECEVRKRIRHRNLVKI-------------- 678 (823)
Q Consensus 628 ~~f~~~~~lg~g~------------~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~-------------- 678 (823)
++|...+.||.|+ +..||||++.... ....++|.+|++++++++||||+++
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 5677788888875 5679999987532 3445789999999999999999971
Q ss_pred -------------------------------------HHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeeccccc
Q 045449 679 -------------------------------------ISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAK 721 (823)
Q Consensus 679 -------------------------------------~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~ 721 (823)
+.|++++|.|+|+.+|+||||||+||+++.++.+||+|||+++
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLAk 161 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAI 161 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCcce
Confidence 2367788999999999999999999999999999999999998
Q ss_pred ccCCCCc----------------cccccccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCC
Q 045449 722 LLSGEDQ----------------LSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGE 777 (823)
Q Consensus 722 ~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~ 777 (823)
....... .......+||+.|+|||++.+..++.++||||+||+++++++|..||..
T Consensus 162 ~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~ 233 (932)
T PRK13184 162 FKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRR 233 (932)
T ss_pred ecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCC
Confidence 7621110 0111235799999999999999999999999999999999999999865
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.1e-23 Score=205.43 Aligned_cols=152 Identities=22% Similarity=0.258 Sum_probs=117.4
Q ss_pred HHHHHHHHHHhhc-chhhHHH----------------------------------------------HHHHHHHHhhhcC
Q 045449 658 KSFEDECEVRKRI-RHRNLVK----------------------------------------------IISSSLEYLHFGH 690 (823)
Q Consensus 658 ~~~~~E~~~l~~l-~h~niv~----------------------------------------------~~~~~l~~L~~~h 690 (823)
...++|+++--+. .|||||. ++.|+..++.|+|
T Consensus 99 ~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH 178 (400)
T KOG0604|consen 99 PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLH 178 (400)
T ss_pred HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHH
Confidence 4577888876555 7999998 3567888999999
Q ss_pred CCCEEeccCCCCCEEeCC---CCcEEEeecccccccCCCCccccccccccCCCcCcccccCCCccccccceehhhhhhcc
Q 045449 691 SIPIIHCDLKPSNVLLDE---DMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGG 767 (823)
Q Consensus 691 ~~~ivHrdlk~~NiLl~~---~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~ 767 (823)
+..|.|||+||+|+|... +..+||+|||+|+.-... ....+.+-||.|.|||++...+|+..+|+||+||++|-
T Consensus 179 ~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~---~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYI 255 (400)
T KOG0604|consen 179 SMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEP---GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYI 255 (400)
T ss_pred hcchhhccCChhheeeecCCCCcceEecccccccccCCC---ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHH
Confidence 999999999999999963 458999999999975432 22445788999999999999999999999999999999
Q ss_pred ccCCCCCcCCC---------cccccccccccC-CcccccccCCCccccccccccc
Q 045449 768 KETRSMTVGET---------CTPVRESKYEVH-PATTTIMEHPLPRVGEVMDVDR 812 (823)
Q Consensus 768 ~~~~~~~~~~~---------~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 812 (823)
++.|-.||... ...++.+.|+++ |++..+.+.....++.++..++
T Consensus 256 lLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~P 310 (400)
T KOG0604|consen 256 LLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEP 310 (400)
T ss_pred hhcCCCcccccCCccCChhHHhHhhccCccCCChhHhHHHHHHHHHHHHHhcCCc
Confidence 99999999654 345666677665 3444444444444454444443
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.3e-22 Score=214.82 Aligned_cols=135 Identities=30% Similarity=0.342 Sum_probs=110.8
Q ss_pred CeEEEEEEehHhh--HHHHHHHHHHHHHHhhc---chhhHHH--------------------------------------
Q 045449 641 GMEVAVKVFHQQY--ERALKSFEDECEVRKRI---RHRNLVK-------------------------------------- 677 (823)
Q Consensus 641 ~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~-------------------------------------- 677 (823)
+..||||+++... ......+.+|+++++++ +||||++
T Consensus 27 ~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~ 106 (290)
T cd07862 27 GRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPG 106 (290)
T ss_pred CeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCCcEEEEEccCCCCHHHHHHhCCCCC
Confidence 4679999886432 22234566788777766 6999986
Q ss_pred --------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCcccccCC
Q 045449 678 --------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTK 749 (823)
Q Consensus 678 --------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 749 (823)
++.|++++|+|+|+.+|+||||||+||+++.++.+||+|||+++...... ......||+.|+|||++.+
T Consensus 107 ~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~ 183 (290)
T cd07862 107 VPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQ 183 (290)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceEeccCCc---ccccccccccccChHHHhC
Confidence 35688899999999999999999999999999999999999998754331 2234578999999999988
Q ss_pred CccccccceehhhhhhccccCCCCCcCCC
Q 045449 750 GRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 750 ~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
..++.++|||||||++|++++|..||.+.
T Consensus 184 ~~~~~~~DiwslG~il~el~~g~~~f~~~ 212 (290)
T cd07862 184 SSYATPVDLWSVGCIFAEMFRRKPLFRGS 212 (290)
T ss_pred CCCCCccchHHHHHHHHHHHcCCCCcCCC
Confidence 88999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.8e-22 Score=217.36 Aligned_cols=138 Identities=25% Similarity=0.387 Sum_probs=112.3
Q ss_pred CeEEEEEEehHhh-HHHHHHHHHHHHHHhhcchhhHHH------------------------------------------
Q 045449 641 GMEVAVKVFHQQY-ERALKSFEDECEVRKRIRHRNLVK------------------------------------------ 677 (823)
Q Consensus 641 ~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~------------------------------------------ 677 (823)
+..||||++.... .....+|.+|++++.+++||||++
T Consensus 46 ~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 125 (304)
T cd05096 46 PLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDA 125 (304)
T ss_pred ceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccc
Confidence 3579999987543 344578999999999999999887
Q ss_pred -----------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCC
Q 045449 678 -----------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIG 740 (823)
Q Consensus 678 -----------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~ 740 (823)
++.|++.+|.|+|+.+|+||||||+||+++.++.+||+|||+++...............++..
T Consensus 126 ~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~ 205 (304)
T cd05096 126 VPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIR 205 (304)
T ss_pred cccccccccccHHHHHHHHHHHHHHHHHHHHCCccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCcc
Confidence 134677889999999999999999999999999999999999987644333222333456889
Q ss_pred cCcccccCCCccccccceehhhhhhccccC--CCCCcCCC
Q 045449 741 YMAPEYGTKGRVSTRGDVCSFGIISGGKET--RSMTVGET 778 (823)
Q Consensus 741 y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~--~~~~~~~~ 778 (823)
|+|||++..+.++.++|||||||++|++++ +..|+.+.
T Consensus 206 y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~ 245 (304)
T cd05096 206 WMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGEL 245 (304)
T ss_pred ccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCCCCcC
Confidence 999999988889999999999999999875 55677654
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.4e-22 Score=216.58 Aligned_cols=134 Identities=23% Similarity=0.212 Sum_probs=113.9
Q ss_pred CeEEEEEEehHhh---HHHHHHHHHHHHHHhhc-chhhHHH---------------------------------------
Q 045449 641 GMEVAVKVFHQQY---ERALKSFEDECEVRKRI-RHRNLVK--------------------------------------- 677 (823)
Q Consensus 641 ~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~--------------------------------------- 677 (823)
+..||||+++... ....+.+.+|+.++.++ +||||++
T Consensus 20 ~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~l~~~~~~ 99 (329)
T cd05588 20 RRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHAR 99 (329)
T ss_pred CCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCCCCHHHHHHHcCCCCHHHHH
Confidence 6789999997643 23446788999999998 7999998
Q ss_pred -HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCcccccCCCcccccc
Q 045449 678 -IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRG 756 (823)
Q Consensus 678 -~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 756 (823)
++.|++.+|+|+|+.+|+||||||+||+++.++.+||+|||+++....... ......||+.|+|||++.+..++.++
T Consensus 100 ~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~ 177 (329)
T cd05588 100 FYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD--TTSTFCGTPNYIAPEILRGEDYGFSV 177 (329)
T ss_pred HHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCCC--ccccccCCccccCHHHHcCCCCCCcc
Confidence 356889999999999999999999999999999999999999975322111 22345799999999999999999999
Q ss_pred ceehhhhhhccccCCCCCcC
Q 045449 757 DVCSFGIISGGKETRSMTVG 776 (823)
Q Consensus 757 Dv~S~Gvv~~~~~~~~~~~~ 776 (823)
||||+||++|++++|..||.
T Consensus 178 DiwslG~~l~el~~g~~Pf~ 197 (329)
T cd05588 178 DWWALGVLMFEMMAGRSPFD 197 (329)
T ss_pred ceechHHHHHHHHHCCCCcc
Confidence 99999999999999999985
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=9.2e-23 Score=216.64 Aligned_cols=131 Identities=27% Similarity=0.349 Sum_probs=111.2
Q ss_pred CeEEEEEEehHh---hHHHHHHHHHHHHHHhhcchhhHHHH---------------------------------------
Q 045449 641 GMEVAVKVFHQQ---YERALKSFEDECEVRKRIRHRNLVKI--------------------------------------- 678 (823)
Q Consensus 641 ~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~--------------------------------------- 678 (823)
...||||.+.-. .....+++..||..+.+++|||+|.+
T Consensus 51 ~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYClGSAsDlleVhkKplqEvEIAA 130 (948)
T KOG0577|consen 51 SEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAA 130 (948)
T ss_pred cceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHHhccHHHHHHHHhccchHHHHHH
Confidence 467999998532 33445788999999999999999982
Q ss_pred -HHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCcccccC---CCcccc
Q 045449 679 -ISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGT---KGRVST 754 (823)
Q Consensus 679 -~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~ 754 (823)
..+++.+|.|+|+.+.||||||..|||+++.|.+||+|||.|....+. ..++|||.|||||++. .+.|+-
T Consensus 131 i~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA------nsFvGTPywMAPEVILAMDEGqYdg 204 (948)
T KOG0577|consen 131 ITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA------NSFVGTPYWMAPEVILAMDEGQYDG 204 (948)
T ss_pred HHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcCch------hcccCCccccchhHheeccccccCC
Confidence 236788899999999999999999999999999999999999876432 3589999999999875 467999
Q ss_pred ccceehhhhhhccccCCCCCcCC
Q 045449 755 RGDVCSFGIISGGKETRSMTVGE 777 (823)
Q Consensus 755 ~~Dv~S~Gvv~~~~~~~~~~~~~ 777 (823)
|+||||+|+..-|+..++.|...
T Consensus 205 kvDvWSLGITCIELAERkPPlFn 227 (948)
T KOG0577|consen 205 KVDVWSLGITCIELAERKPPLFN 227 (948)
T ss_pred ccceeeccchhhhhhhcCCCccC
Confidence 99999999999999888888654
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=99.86 E-value=5.2e-22 Score=215.12 Aligned_cols=136 Identities=24% Similarity=0.217 Sum_probs=114.3
Q ss_pred CeEEEEEEehHhh---HHHHHHHHHHHHHHhhc-chhhHHH---------------------------------------
Q 045449 641 GMEVAVKVFHQQY---ERALKSFEDECEVRKRI-RHRNLVK--------------------------------------- 677 (823)
Q Consensus 641 ~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~--------------------------------------- 677 (823)
+..||||++.... ....+.+..|.+++..+ +||||++
T Consensus 20 ~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~g~L~~~i~~~~~l~~~~~~ 99 (320)
T cd05590 20 GRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARAR 99 (320)
T ss_pred CCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCCchHHHHHHHcCCCCHHHHH
Confidence 5789999997543 23456778899888876 6999998
Q ss_pred -HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCcccccCCCcccccc
Q 045449 678 -IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRG 756 (823)
Q Consensus 678 -~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 756 (823)
++.|++.+|+|+|+.+|+||||||+||+++.++.+||+|||+++....... ......||+.|+|||++.+..++.++
T Consensus 100 ~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~ 177 (320)
T cd05590 100 FYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK--TTSTFCGTPDYIAPEILQEMLYGPSV 177 (320)
T ss_pred HHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC--cccccccCccccCHHHHcCCCCCCcc
Confidence 356889999999999999999999999999999999999999876432211 22345799999999999988999999
Q ss_pred ceehhhhhhccccCCCCCcCCC
Q 045449 757 DVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 757 Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
||||+||++|++++|..||...
T Consensus 178 DiwslG~il~el~~g~~Pf~~~ 199 (320)
T cd05590 178 DWWAMGVLLYEMLCGHAPFEAE 199 (320)
T ss_pred chhhhHHHHHHHhhCCCCCCCC
Confidence 9999999999999999998654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.1e-22 Score=227.17 Aligned_cols=145 Identities=27% Similarity=0.298 Sum_probs=118.5
Q ss_pred hccCCccceeeccC------------CeEEEEEEehHhhHHHHHHHHHHHHHHhhcchhhHHH-----------------
Q 045449 627 TDRFSENNLIGIGN------------GMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVK----------------- 677 (823)
Q Consensus 627 t~~f~~~~~lg~g~------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~----------------- 677 (823)
.++|...+.||.|+ +..||||++.... ....+|+.++++++|||||+
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 140 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI 140 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence 45688888899885 5669999885432 23457999999999999985
Q ss_pred ----------------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCC-CcEEEeecccccc
Q 045449 678 ----------------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDED-MVAHISDFGIAKL 722 (823)
Q Consensus 678 ----------------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~-~~~kl~DfGla~~ 722 (823)
++.|++.+|+|+|+.+|+||||||+|||++.+ +.+||+|||+|+.
T Consensus 141 ~l~lvmE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFGla~~ 220 (440)
T PTZ00036 141 FLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKN 220 (440)
T ss_pred EEEEEEecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeeccccchh
Confidence 13478889999999999999999999999965 4799999999987
Q ss_pred cCCCCccccccccccCCCcCcccccCCC-ccccccceehhhhhhccccCCCCCcCCC
Q 045449 723 LSGEDQLSKQTQTLATIGYMAPEYGTKG-RVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 723 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
+..... .....||+.|+|||++.+. .|+.++||||+||++|++++|..||.+.
T Consensus 221 ~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~ 274 (440)
T PTZ00036 221 LLAGQR---SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQ 274 (440)
T ss_pred ccCCCC---cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 643322 2345789999999987654 6899999999999999999999998653
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.4e-22 Score=219.14 Aligned_cols=99 Identities=26% Similarity=0.316 Sum_probs=83.8
Q ss_pred HHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCcccccCCCcccccccee
Q 045449 680 SSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVC 759 (823)
Q Consensus 680 ~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~ 759 (823)
.|++.+|.|+|+.+|+||||||+||+++.++.+||+|||+++.+.............++..|+|||++.+..++.++|||
T Consensus 180 ~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~ 259 (337)
T cd05054 180 FQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDKVYTTQSDVW 259 (337)
T ss_pred HHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCcHHhcCCCCCccccHH
Confidence 46888999999999999999999999999999999999999876433322222334567889999999999999999999
Q ss_pred hhhhhhccccC-CCCCcCCC
Q 045449 760 SFGIISGGKET-RSMTVGET 778 (823)
Q Consensus 760 S~Gvv~~~~~~-~~~~~~~~ 778 (823)
||||+++++++ |..||.+.
T Consensus 260 SlGv~l~el~t~g~~p~~~~ 279 (337)
T cd05054 260 SFGVLLWEIFSLGASPYPGV 279 (337)
T ss_pred HHHHHHHHHHHcCCCCCCCC
Confidence 99999999997 88888653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=4e-22 Score=220.93 Aligned_cols=148 Identities=27% Similarity=0.373 Sum_probs=120.6
Q ss_pred CCccceeeccC------------CeEEEEEEehHhh--HHHHHHHHHHHHHHhhcchhhHHH------------------
Q 045449 630 FSENNLIGIGN------------GMEVAVKVFHQQY--ERALKSFEDECEVRKRIRHRNLVK------------------ 677 (823)
Q Consensus 630 f~~~~~lg~g~------------~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~------------------ 677 (823)
|+..+.||.|+ +..||||++.... ....+++.+|+++++.++|+||++
T Consensus 2 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 81 (372)
T cd07853 2 VEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYV 81 (372)
T ss_pred CcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEE
Confidence 55566777664 5679999886432 234467899999999999999986
Q ss_pred --------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCcccc
Q 045449 678 --------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSK 731 (823)
Q Consensus 678 --------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~ 731 (823)
++.|++.+|+|+|+.+|+||||||+||+++.++.+||+|||+++....... ..
T Consensus 82 v~e~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~-~~ 160 (372)
T cd07853 82 VTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDES-KH 160 (372)
T ss_pred EeeccccCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccCcc-cc
Confidence 256889999999999999999999999999999999999999986543222 12
Q ss_pred ccccccCCCcCcccccCCC-ccccccceehhhhhhccccCCCCCcCCC
Q 045449 732 QTQTLATIGYMAPEYGTKG-RVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 732 ~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
.....+|+.|+|||++.+. .++.++||||+||+++++++|+.||.+.
T Consensus 161 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 208 (372)
T cd07853 161 MTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQ 208 (372)
T ss_pred CCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCC
Confidence 2345689999999998764 4799999999999999999999998653
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=99.86 E-value=5.6e-22 Score=215.48 Aligned_cols=137 Identities=25% Similarity=0.248 Sum_probs=111.3
Q ss_pred CCeEEEEEEehHhh---HHHHHHHHHHHH-HHhhcchhhHHH--------------------------------------
Q 045449 640 NGMEVAVKVFHQQY---ERALKSFEDECE-VRKRIRHRNLVK-------------------------------------- 677 (823)
Q Consensus 640 ~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~-------------------------------------- 677 (823)
.+..||+|++.... ......+..|.. +++.++||||++
T Consensus 19 ~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~ 98 (325)
T cd05602 19 EEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRA 98 (325)
T ss_pred CCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCCCcHHHHHHhcCCCCHHHH
Confidence 35779999997543 222334555544 567789999998
Q ss_pred --HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCcccccCCCccccc
Q 045449 678 --IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTR 755 (823)
Q Consensus 678 --~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 755 (823)
++.|++++|+|+|+.||+||||||+||+++.++.+||+|||+++....... .....+||+.|+|||++.+..++.+
T Consensus 99 ~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~ 176 (325)
T cd05602 99 RFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG--TTSTFCGTPEYLAPEVLHKQPYDRT 176 (325)
T ss_pred HHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC--CcccccCCccccCHHHHcCCCCCCc
Confidence 357899999999999999999999999999999999999999976432221 2234579999999999999999999
Q ss_pred cceehhhhhhccccCCCCCcCCC
Q 045449 756 GDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 756 ~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
+||||+||++|++++|..||...
T Consensus 177 ~DiwslG~il~el~~g~~pf~~~ 199 (325)
T cd05602 177 VDWWCLGAVLYEMLYGLPPFYSR 199 (325)
T ss_pred cccccccHHHHHHhcCCCCCCCC
Confidence 99999999999999999998653
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=5.8e-22 Score=215.21 Aligned_cols=136 Identities=26% Similarity=0.270 Sum_probs=111.3
Q ss_pred CeEEEEEEehHhh---HHHHHHHHHHHH-HHhhcchhhHHH---------------------------------------
Q 045449 641 GMEVAVKVFHQQY---ERALKSFEDECE-VRKRIRHRNLVK--------------------------------------- 677 (823)
Q Consensus 641 ~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~--------------------------------------- 677 (823)
|+.||||++.... ....+++..|.. +++.++||||++
T Consensus 20 ~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~ 99 (323)
T cd05575 20 GKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRAR 99 (323)
T ss_pred CCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCCCCHHHHHHhcCCCCHHHHH
Confidence 6789999997543 222345555655 567899999998
Q ss_pred -HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCcccccCCCcccccc
Q 045449 678 -IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRG 756 (823)
Q Consensus 678 -~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 756 (823)
++.|++.+|+|+|+.+|+||||||+|||++.++.+||+|||+++....... ......||+.|+|||++.+..++.++
T Consensus 100 ~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~ 177 (323)
T cd05575 100 FYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK--TTSTFCGTPEYLAPEVLRKQPYDRTV 177 (323)
T ss_pred HHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCC--ccccccCChhhcChhhhcCCCCCccc
Confidence 356889999999999999999999999999999999999999875432221 22345799999999999998999999
Q ss_pred ceehhhhhhccccCCCCCcCCC
Q 045449 757 DVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 757 Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
|||||||++|++++|..||...
T Consensus 178 DvwslG~il~ell~g~~pf~~~ 199 (323)
T cd05575 178 DWWCLGAVLYEMLYGLPPFYSR 199 (323)
T ss_pred cccccchhhhhhhcCCCCCCCC
Confidence 9999999999999999998653
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.4e-22 Score=225.82 Aligned_cols=140 Identities=22% Similarity=0.252 Sum_probs=115.6
Q ss_pred cCCccceeeccC------------CeEEEEEEehHhhHHHHHHHHHHHHHHhhcchhhHHH-------------------
Q 045449 629 RFSENNLIGIGN------------GMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVK------------------- 677 (823)
Q Consensus 629 ~f~~~~~lg~g~------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------------- 677 (823)
+|...+.||.|+ +..||||... ...+.+|++++++++|+|||+
T Consensus 170 gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~ 243 (461)
T PHA03211 170 GFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYR 243 (461)
T ss_pred CeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEccC
Confidence 577778888876 4558888532 234678999999999999998
Q ss_pred ---------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccc
Q 045449 678 ---------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTL 736 (823)
Q Consensus 678 ---------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~ 736 (823)
++.|++.+|+|+|+.+|+||||||+|||++.++.+||+|||+++...............
T Consensus 244 ~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~ 323 (461)
T PHA03211 244 SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIA 323 (461)
T ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceecccccccccccccC
Confidence 35688899999999999999999999999999999999999998764332222223457
Q ss_pred cCCCcCcccccCCCccccccceehhhhhhccccCCCCC
Q 045449 737 ATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMT 774 (823)
Q Consensus 737 gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~ 774 (823)
||+.|+|||++.+..++.++|||||||++||+.++..+
T Consensus 324 GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~ 361 (461)
T PHA03211 324 GTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTAS 361 (461)
T ss_pred CCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCC
Confidence 99999999999999999999999999999999877654
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.5e-22 Score=215.66 Aligned_cols=135 Identities=24% Similarity=0.226 Sum_probs=114.3
Q ss_pred CeEEEEEEehHhh---HHHHHHHHHHHHHHhhc-chhhHHH---------------------------------------
Q 045449 641 GMEVAVKVFHQQY---ERALKSFEDECEVRKRI-RHRNLVK--------------------------------------- 677 (823)
Q Consensus 641 ~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~--------------------------------------- 677 (823)
+..||||++.... ....+.+.+|+.++.++ +||+|++
T Consensus 20 ~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~ 99 (327)
T cd05617 20 DQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHAR 99 (327)
T ss_pred CCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHH
Confidence 5789999997653 23456788999999888 6999987
Q ss_pred -HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCcccccCCCcccccc
Q 045449 678 -IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRG 756 (823)
Q Consensus 678 -~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 756 (823)
++.|++.+|+|+|+.+|+||||||+||+++.++.+||+|||+++....... .....+||+.|+|||++.+..++.++
T Consensus 100 ~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~ 177 (327)
T cd05617 100 FYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD--TTSTFCGTPNYIAPEILRGEEYGFSV 177 (327)
T ss_pred HHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCC--ceecccCCcccCCHHHHCCCCCCchh
Confidence 357889999999999999999999999999999999999999975322211 12346799999999999999999999
Q ss_pred ceehhhhhhccccCCCCCcCC
Q 045449 757 DVCSFGIISGGKETRSMTVGE 777 (823)
Q Consensus 757 Dv~S~Gvv~~~~~~~~~~~~~ 777 (823)
||||+||++|++++|..||..
T Consensus 178 DiwslGvil~ell~g~~pf~~ 198 (327)
T cd05617 178 DWWALGVLMFEMMAGRSPFDI 198 (327)
T ss_pred eeehhHHHHHHHHhCCCCCCc
Confidence 999999999999999999954
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.4e-22 Score=214.59 Aligned_cols=136 Identities=26% Similarity=0.227 Sum_probs=113.1
Q ss_pred CeEEEEEEehHhh---HHHHHHHHHHHHHHhhc-chhhHHH---------------------------------------
Q 045449 641 GMEVAVKVFHQQY---ERALKSFEDECEVRKRI-RHRNLVK--------------------------------------- 677 (823)
Q Consensus 641 ~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~--------------------------------------- 677 (823)
|..||||+++... ....+.+..|.+++.+. +||+|++
T Consensus 20 ~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~i~~~~~~~~~~~~ 99 (316)
T cd05620 20 GEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRAT 99 (316)
T ss_pred CCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCCCcHHHHHHHcCCCCHHHHH
Confidence 6789999997653 23345677788888754 8999998
Q ss_pred -HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCcccccCCCcccccc
Q 045449 678 -IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRG 756 (823)
Q Consensus 678 -~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 756 (823)
++.|++.+|+|+|+.+|+||||||+||+++.++.+||+|||+++....... ......||+.|+|||++.+..++.++
T Consensus 100 ~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~ 177 (316)
T cd05620 100 FYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDN--RASTFCGTPDYIAPEILQGLKYTFSV 177 (316)
T ss_pred HHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCC--ceeccCCCcCccCHHHHcCCCCCccc
Confidence 356899999999999999999999999999999999999999875322211 22346799999999999999999999
Q ss_pred ceehhhhhhccccCCCCCcCCC
Q 045449 757 DVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 757 Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
||||+||++|++++|..||...
T Consensus 178 DiwslGvil~el~~g~~Pf~~~ 199 (316)
T cd05620 178 DWWSFGVLLYEMLIGQSPFHGD 199 (316)
T ss_pred chhhhHHHHHHHHhCCCCCCCC
Confidence 9999999999999999998654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.85 E-value=6.8e-22 Score=214.17 Aligned_cols=141 Identities=29% Similarity=0.351 Sum_probs=118.3
Q ss_pred eeccCCeEEEEEEehHhhH--HHHHHHHHHHHHHhhcchhhHHH------------------------------------
Q 045449 636 IGIGNGMEVAVKVFHQQYE--RALKSFEDECEVRKRIRHRNLVK------------------------------------ 677 (823)
Q Consensus 636 lg~g~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~------------------------------------ 677 (823)
.+...|..||||++..... .....+..|++++++++||||++
T Consensus 19 ~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~ 98 (318)
T cd05582 19 TGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEE 98 (318)
T ss_pred ccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCCCCcHHHHHHHcCCCCHH
Confidence 3444568899999976432 23456788999999999999998
Q ss_pred ----HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCcccccCCCccc
Q 045449 678 ----IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVS 753 (823)
Q Consensus 678 ----~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 753 (823)
++.|++++|+|+|+.+|+||||||+||+++.++.+||+|||+++....... ......||+.|+|||++.+..++
T Consensus 99 ~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~ 176 (318)
T cd05582 99 DVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK--KAYSFCGTVEYMAPEVVNRRGHT 176 (318)
T ss_pred HHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC--ceecccCChhhcCHHHHcCCCCC
Confidence 357889999999999999999999999999999999999999986543221 22345799999999999888899
Q ss_pred cccceehhhhhhccccCCCCCcCCC
Q 045449 754 TRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 754 ~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
.++|||||||++|++.+|+.||...
T Consensus 177 ~~~DiwslG~il~el~tg~~p~~~~ 201 (318)
T cd05582 177 QSADWWSFGVLMFEMLTGSLPFQGK 201 (318)
T ss_pred CccceeccceEeeeeccCCCCCCCC
Confidence 9999999999999999999998654
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=99.85 E-value=7.9e-22 Score=214.00 Aligned_cols=147 Identities=22% Similarity=0.197 Sum_probs=119.2
Q ss_pred CCccceeeccC------------CeEEEEEEehHhh---HHHHHHHHHHHHHHhhcch-hhHHH----------------
Q 045449 630 FSENNLIGIGN------------GMEVAVKVFHQQY---ERALKSFEDECEVRKRIRH-RNLVK---------------- 677 (823)
Q Consensus 630 f~~~~~lg~g~------------~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h-~niv~---------------- 677 (823)
|...+.||.|+ +..||||++.... ....+.+..|++++..+.| ++|++
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (323)
T cd05615 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVME 81 (323)
T ss_pred ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEc
Confidence 45556777764 5679999997543 2344678889999988864 66665
Q ss_pred ------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCcccccc
Q 045449 678 ------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQT 733 (823)
Q Consensus 678 ------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~ 733 (823)
++.|++.+|+|+|+.+|+||||||+||+++.++.+||+|||+++....... ...
T Consensus 82 y~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~--~~~ 159 (323)
T cd05615 82 YVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGV--TTR 159 (323)
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCCc--ccc
Confidence 356889999999999999999999999999999999999999986432221 123
Q ss_pred ccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCCC
Q 045449 734 QTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 734 ~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
...||+.|+|||++.+..++.++||||+||+++++++|..||...
T Consensus 160 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~ 204 (323)
T cd05615 160 TFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGE 204 (323)
T ss_pred CccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCC
Confidence 456999999999999889999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.85 E-value=6.1e-22 Score=208.24 Aligned_cols=151 Identities=26% Similarity=0.312 Sum_probs=122.5
Q ss_pred ccCCccceeeccC------------CeEEEEEEehHhh-----HHHHHHHHHHHHHHhhcchhhHHH-------------
Q 045449 628 DRFSENNLIGIGN------------GMEVAVKVFHQQY-----ERALKSFEDECEVRKRIRHRNLVK------------- 677 (823)
Q Consensus 628 ~~f~~~~~lg~g~------------~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~------------- 677 (823)
++|...+.+|.|+ +..||+|.+.... ....+.+.+|++++++++||||++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 4566677777764 5678999875332 223467899999999999999998
Q ss_pred ---------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccc
Q 045449 678 ---------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLS 730 (823)
Q Consensus 678 ---------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~ 730 (823)
++.|++.+|+++|+.+++||||||+||+++.++.++|+|||+++.........
T Consensus 82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~~ 161 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSG 161 (263)
T ss_pred EEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecccccccc
Confidence 34678889999999999999999999999999999999999998654322111
Q ss_pred c-ccccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCCC
Q 045449 731 K-QTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 731 ~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
. .....|+..|+|||+..+..++.++||||+||++|++++|+.||.+.
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 210 (263)
T cd06625 162 TGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEF 210 (263)
T ss_pred ccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCcccc
Confidence 1 12346788999999999888999999999999999999999998654
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=99.85 E-value=4.9e-22 Score=211.52 Aligned_cols=137 Identities=25% Similarity=0.368 Sum_probs=113.6
Q ss_pred eEEEEEEehHhh-HHHHHHHHHHHHHHhhcchhhHHH-------------------------------------------
Q 045449 642 MEVAVKVFHQQY-ERALKSFEDECEVRKRIRHRNLVK------------------------------------------- 677 (823)
Q Consensus 642 ~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~------------------------------------------- 677 (823)
..||+|.+.... ....++|.+|++++++++||||++
T Consensus 36 ~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 115 (283)
T cd05048 36 TSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDE 115 (283)
T ss_pred eeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEEEEecCCCCcHHHHHHhcCCCcccccccccc
Confidence 568999886443 344567999999999999999987
Q ss_pred -------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCcc
Q 045449 678 -------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAP 744 (823)
Q Consensus 678 -------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aP 744 (823)
++.|++++|+|+|+.+++||||||+||++++++.+||+|||+++...............+++.|+||
T Consensus 116 ~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 195 (283)
T cd05048 116 TVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPP 195 (283)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCCCcEEECCCcceeeccccccccccCCCcccccccCH
Confidence 2356788999999999999999999999999999999999999865443332233345678899999
Q ss_pred cccCCCccccccceehhhhhhccccC-CCCCcCCC
Q 045449 745 EYGTKGRVSTRGDVCSFGIISGGKET-RSMTVGET 778 (823)
Q Consensus 745 E~~~~~~~~~~~Dv~S~Gvv~~~~~~-~~~~~~~~ 778 (823)
|++....++.++|||||||++|++++ |..||.+.
T Consensus 196 E~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~ 230 (283)
T cd05048 196 EAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGF 230 (283)
T ss_pred HHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCC
Confidence 99988899999999999999999987 88888654
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.9e-22 Score=220.78 Aligned_cols=99 Identities=24% Similarity=0.279 Sum_probs=82.5
Q ss_pred HHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCcccccCCCcccccccee
Q 045449 680 SSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVC 759 (823)
Q Consensus 680 ~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~ 759 (823)
.|++.+|+|+|+.+|+||||||+||+++.++.+||+|||+++...............++..|+|||++.+..++.++|||
T Consensus 221 ~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~ 300 (375)
T cd05104 221 YQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVW 300 (375)
T ss_pred HHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCcccccccCCCCCCcceeChhHhcCCCCCCCCCHH
Confidence 37888999999999999999999999999999999999999876443322222223456789999999999999999999
Q ss_pred hhhhhhccccC-CCCCcCCC
Q 045449 760 SFGIISGGKET-RSMTVGET 778 (823)
Q Consensus 760 S~Gvv~~~~~~-~~~~~~~~ 778 (823)
||||+++++++ |..||...
T Consensus 301 slG~~l~ellt~g~~p~~~~ 320 (375)
T cd05104 301 SYGILLWEIFSLGSSPYPGM 320 (375)
T ss_pred HHHHHHHHHHhcCCCCCCCC
Confidence 99999999987 78887654
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.6e-22 Score=214.84 Aligned_cols=136 Identities=24% Similarity=0.300 Sum_probs=110.4
Q ss_pred CeEEEEEEehHhhHHHHHHHHHHHHHHhhcchhhHHH-------------------------------------------
Q 045449 641 GMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVK------------------------------------------- 677 (823)
Q Consensus 641 ~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------------------------------------- 677 (823)
+..||+|.+.... ....+.+|++++++++||||++
T Consensus 28 ~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l 105 (317)
T cd07868 28 DRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQL 105 (317)
T ss_pred CceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccCCCHHHHHHhcccccccCCcccC
Confidence 4678999886432 1245788999999999999987
Q ss_pred -------HHHHHHHHhhhcCCCCEEeccCCCCCEEe----CCCCcEEEeecccccccCCCCc-cccccccccCCCcCccc
Q 045449 678 -------IISSSLEYLHFGHSIPIIHCDLKPSNVLL----DEDMVAHISDFGIAKLLSGEDQ-LSKQTQTLATIGYMAPE 745 (823)
Q Consensus 678 -------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl----~~~~~~kl~DfGla~~~~~~~~-~~~~~~~~gt~~y~aPE 745 (823)
++.|++++|+|+|+.+|+||||||+|||+ +.++.+||+|||+|+....... ........||+.|+|||
T Consensus 106 ~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE 185 (317)
T cd07868 106 PRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPE 185 (317)
T ss_pred CHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceeccCCCCccccccCCccccccccCCH
Confidence 24688899999999999999999999999 4567999999999987643321 11223467899999999
Q ss_pred ccCCC-ccccccceehhhhhhccccCCCCCcCCC
Q 045449 746 YGTKG-RVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 746 ~~~~~-~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
++.+. .++.++||||+||+++++++|..||...
T Consensus 186 ~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 186 LLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred HHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 98764 5899999999999999999999998643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=99.85 E-value=4.4e-22 Score=211.52 Aligned_cols=137 Identities=26% Similarity=0.266 Sum_probs=116.1
Q ss_pred CCeEEEEEEehHhh---HHHHHHHHHHHHHHhhcchhhHHH---------------------------------------
Q 045449 640 NGMEVAVKVFHQQY---ERALKSFEDECEVRKRIRHRNLVK--------------------------------------- 677 (823)
Q Consensus 640 ~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~--------------------------------------- 677 (823)
.+..||||.+.... ....+.+..|++++++++|+||++
T Consensus 17 ~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~l~~ 96 (280)
T cd05608 17 TGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPE 96 (280)
T ss_pred CCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCHHHHHHhccccCCCCCH
Confidence 46789999986543 223467789999999999999997
Q ss_pred -----HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCcccccCCCcc
Q 045449 678 -----IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRV 752 (823)
Q Consensus 678 -----~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 752 (823)
++.|++.+|+|+|+.+|+||||||+||+++.++.+||+|||+++....... ......||+.|+|||++.+..+
T Consensus 97 ~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~ 174 (280)
T cd05608 97 PRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KTKGYAGTPGFMAPELLQGEEY 174 (280)
T ss_pred HHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc--cccccCCCcCccCHHHhcCCCC
Confidence 356889999999999999999999999999999999999999987643322 1234578999999999999999
Q ss_pred ccccceehhhhhhccccCCCCCcCCC
Q 045449 753 STRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 753 ~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
+.++|||||||++|++.+|+.||...
T Consensus 175 ~~~~DvwslG~il~el~~g~~pf~~~ 200 (280)
T cd05608 175 DFSVDYFALGVTLYEMIAARGPFRAR 200 (280)
T ss_pred CccccHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999999999999999998653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=99.85 E-value=9.1e-22 Score=212.77 Aligned_cols=136 Identities=26% Similarity=0.235 Sum_probs=113.3
Q ss_pred CeEEEEEEehHhh---HHHHHHHHHHHHHHhhc-chhhHHH---------------------------------------
Q 045449 641 GMEVAVKVFHQQY---ERALKSFEDECEVRKRI-RHRNLVK--------------------------------------- 677 (823)
Q Consensus 641 ~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~--------------------------------------- 677 (823)
+..||||+++... ....+.+..|..++... +||||++
T Consensus 20 ~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~ 99 (316)
T cd05619 20 NQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRAT 99 (316)
T ss_pred CCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHH
Confidence 5789999997653 23345677788888764 9999998
Q ss_pred -HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCcccccCCCcccccc
Q 045449 678 -IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRG 756 (823)
Q Consensus 678 -~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 756 (823)
++.|++.+|+|+|+.+|+||||||+||+++.++.+||+|||+++....... ......||+.|+|||++.+..++.++
T Consensus 100 ~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~ 177 (316)
T cd05619 100 FYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA--KTCTFCGTPDYIAPEILLGQKYNTSV 177 (316)
T ss_pred HHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC--ceeeecCCccccCHHHHcCCCCCchh
Confidence 357889999999999999999999999999999999999999875322211 22345799999999999988999999
Q ss_pred ceehhhhhhccccCCCCCcCCC
Q 045449 757 DVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 757 Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
||||+||++|++++|..||...
T Consensus 178 DvwslG~il~el~~G~~pf~~~ 199 (316)
T cd05619 178 DWWSFGVLLYEMLIGQSPFHGH 199 (316)
T ss_pred hhhhHHHHHHHHHhCCCCCCCC
Confidence 9999999999999999998654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=99.85 E-value=1e-21 Score=213.97 Aligned_cols=146 Identities=24% Similarity=0.327 Sum_probs=122.1
Q ss_pred ccCCccceeeccC------------CeEEEEEEehHhh-HHHHHHHHHHHHHHhhcchhhHHH-----------------
Q 045449 628 DRFSENNLIGIGN------------GMEVAVKVFHQQY-ERALKSFEDECEVRKRIRHRNLVK----------------- 677 (823)
Q Consensus 628 ~~f~~~~~lg~g~------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~----------------- 677 (823)
++|+..+.||.|+ +..||+|++.... ....++|.+|++++++++||||++
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 84 (331)
T cd06649 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 84 (331)
T ss_pred ccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeec
Confidence 5677777788775 5668999887543 344578999999999999999998
Q ss_pred -----------------------HHHHHHHHhhhcCCC-CEEeccCCCCCEEeCCCCcEEEeecccccccCCCCcccccc
Q 045449 678 -----------------------IISSSLEYLHFGHSI-PIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQT 733 (823)
Q Consensus 678 -----------------------~~~~~l~~L~~~h~~-~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~ 733 (823)
++.|++.+|.|+|+. +|+||||||+||+++.++.+||+|||+++...... ..
T Consensus 85 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~----~~ 160 (331)
T cd06649 85 MDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM----AN 160 (331)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCcccccccccc----cc
Confidence 245778888889975 69999999999999999999999999998653321 23
Q ss_pred ccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCC
Q 045449 734 QTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGE 777 (823)
Q Consensus 734 ~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~ 777 (823)
...||+.|+|||++.+..++.++|||||||++|++++|+.||..
T Consensus 161 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~ 204 (331)
T cd06649 161 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPP 204 (331)
T ss_pred cCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 45799999999999988999999999999999999999999864
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.2e-22 Score=194.01 Aligned_cols=133 Identities=32% Similarity=0.366 Sum_probs=106.5
Q ss_pred CeEEEEEEehHhh-HHHHHHHHHHHHHHhhc-chhhHHHHH---------------------------------------
Q 045449 641 GMEVAVKVFHQQY-ERALKSFEDECEVRKRI-RHRNLVKII--------------------------------------- 679 (823)
Q Consensus 641 ~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~--------------------------------------- 679 (823)
|+..|||+++... ++..+++..|.++..+- ..||||++.
T Consensus 89 g~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd~SlDklYk~vy~vq~~~ipE~I 168 (361)
T KOG1006|consen 89 GKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMDISLDKLYKRVYSVQKSRIPENI 168 (361)
T ss_pred CcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHhhhHHHHHHHHHHHHhccCcHhh
Confidence 7889999998554 45667899998876555 789999931
Q ss_pred --------HHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCcccccCC--
Q 045449 680 --------SSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTK-- 749 (823)
Q Consensus 680 --------~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-- 749 (823)
..+++||..- ..|+|||+||+|||+|..|.+||||||.+..+...- ..+.-+|-..|||||.+..
T Consensus 169 lg~ItvatV~AL~yLK~~--lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~Si---AkT~daGCrpYmAPERi~p~~ 243 (361)
T KOG1006|consen 169 LGHITVATVDALDYLKEE--LKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSI---AKTVDAGCRPYMAPERIDPSD 243 (361)
T ss_pred hhheeeeehhHHHHHHHH--hhhhhccCChhheEEecCCCEeeecccchHhHHHHH---HhhhccCCccccChhccCCcc
Confidence 2456666543 469999999999999999999999999998764332 2344578899999998753
Q ss_pred CccccccceehhhhhhccccCCCCCcCCC
Q 045449 750 GRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 750 ~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
..|+.++||||+|+.++|..||..|+...
T Consensus 244 ~gyDiRSDvWSLGITL~EvAtG~fPyr~w 272 (361)
T KOG1006|consen 244 KGYDIRSDVWSLGITLYEVATGNFPYRKW 272 (361)
T ss_pred CCcchhhhhhhhcceEeeeecCCCCcchH
Confidence 35999999999999999999999998764
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=99.85 E-value=6.7e-22 Score=211.09 Aligned_cols=139 Identities=26% Similarity=0.348 Sum_probs=116.2
Q ss_pred CeEEEEEEehHhhHHHHHHHHHHHHHHhhcchhhHHH-------------------------------------------
Q 045449 641 GMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVK------------------------------------------- 677 (823)
Q Consensus 641 ~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------------------------------------- 677 (823)
+..||+|.+........+.|.+|++++++++||||++
T Consensus 35 ~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~ 114 (288)
T cd05093 35 KILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRP 114 (288)
T ss_pred ceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEcCCCCCHHHHHHHcCCccccccccCCC
Confidence 3558999987666666678999999999999999998
Q ss_pred ----------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCccccc
Q 045449 678 ----------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYG 747 (823)
Q Consensus 678 ----------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~ 747 (823)
++.|++.+|.|+|+.+++||||||+||++++++.+||+|||+++...............++..|+|||++
T Consensus 115 ~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 194 (288)
T cd05093 115 AELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESI 194 (288)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEEeccCCccccccCCceeecCCCCCccccccCHHHh
Confidence 2357888899999999999999999999999999999999999876443322223334567899999999
Q ss_pred CCCccccccceehhhhhhccccC-CCCCcCCCc
Q 045449 748 TKGRVSTRGDVCSFGIISGGKET-RSMTVGETC 779 (823)
Q Consensus 748 ~~~~~~~~~Dv~S~Gvv~~~~~~-~~~~~~~~~ 779 (823)
.+..++.++|||||||+++++.+ |..||....
T Consensus 195 ~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~ 227 (288)
T cd05093 195 MYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLS 227 (288)
T ss_pred ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 88889999999999999999998 888886643
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.3e-21 Score=208.47 Aligned_cols=146 Identities=24% Similarity=0.290 Sum_probs=120.8
Q ss_pred CCccceeeccC------------CeEEEEEEehHhh---HHHHHHHHHHHHHHhhcchhhHHH-----------------
Q 045449 630 FSENNLIGIGN------------GMEVAVKVFHQQY---ERALKSFEDECEVRKRIRHRNLVK----------------- 677 (823)
Q Consensus 630 f~~~~~lg~g~------------~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~----------------- 677 (823)
|+..+.||.|+ +..||||++.... ......+.+|++++++++||||++
T Consensus 2 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05605 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEec
Confidence 44556666664 5679999986543 223456789999999999999997
Q ss_pred -------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccc
Q 045449 678 -------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQ 732 (823)
Q Consensus 678 -------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~ 732 (823)
++.|++.+|.|+|+.+++||||||+||++++++.++|+|||+++....... .
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~---~ 158 (285)
T cd05605 82 MNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET---I 158 (285)
T ss_pred cCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCc---c
Confidence 356888999999999999999999999999999999999999987543221 2
Q ss_pred cccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCCC
Q 045449 733 TQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 733 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
....|++.|+|||++.+..++.++||||+||++|++++|..||.+.
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~ 204 (285)
T cd05605 159 RGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQR 204 (285)
T ss_pred ccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCC
Confidence 2357899999999998888999999999999999999999999764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.5e-21 Score=212.66 Aligned_cols=147 Identities=23% Similarity=0.327 Sum_probs=121.0
Q ss_pred ccCCccceeeccC------------CeEEEEEEehHhh-HHHHHHHHHHHHHHhhcchhhHHH-----------------
Q 045449 628 DRFSENNLIGIGN------------GMEVAVKVFHQQY-ERALKSFEDECEVRKRIRHRNLVK----------------- 677 (823)
Q Consensus 628 ~~f~~~~~lg~g~------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~----------------- 677 (823)
++|+..+.||.|+ +..||+|++.... ....+.+.+|++++++++|+||++
T Consensus 5 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 84 (333)
T cd06650 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 84 (333)
T ss_pred hhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEec
Confidence 4666667777764 5668999886542 344567999999999999999999
Q ss_pred -----------------------HHHHHHHHhhhcCC-CCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCcccccc
Q 045449 678 -----------------------IISSSLEYLHFGHS-IPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQT 733 (823)
Q Consensus 678 -----------------------~~~~~l~~L~~~h~-~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~ 733 (823)
++.+++.+|.|+|+ .+|+||||||+||+++.++.+||+|||+++...... ..
T Consensus 85 ~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~----~~ 160 (333)
T cd06650 85 MDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM----AN 160 (333)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc----cc
Confidence 24577888888886 479999999999999999999999999997653221 22
Q ss_pred ccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCCC
Q 045449 734 QTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 734 ~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
...||..|+|||++.+..++.++|||||||++|++.+|..||...
T Consensus 161 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~ 205 (333)
T cd06650 161 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP 205 (333)
T ss_pred cCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 356899999999999888999999999999999999999998653
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.3e-22 Score=229.57 Aligned_cols=94 Identities=32% Similarity=0.396 Sum_probs=79.3
Q ss_pred HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCC----------------CCccccccccccCCCc
Q 045449 678 IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSG----------------EDQLSKQTQTLATIGY 741 (823)
Q Consensus 678 ~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~----------------~~~~~~~~~~~gt~~y 741 (823)
++++++++|.|+|++|||||||||.||++|.+..+||.|||+|+.... .......+..+||.-|
T Consensus 702 LFreIlEGLaYIH~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalY 781 (1351)
T KOG1035|consen 702 LFREILEGLAYIHDQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALY 781 (1351)
T ss_pred HHHHHHHHHHHHHhCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeee
Confidence 368999999999999999999999999999999999999999987210 0111234567999999
Q ss_pred CcccccCCCc---cccccceehhhhhhccccCC
Q 045449 742 MAPEYGTKGR---VSTRGDVCSFGIISGGKETR 771 (823)
Q Consensus 742 ~aPE~~~~~~---~~~~~Dv~S~Gvv~~~~~~~ 771 (823)
+|||++.+.. |+.|+|+||+|||++||+.-
T Consensus 782 vAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~yP 814 (1351)
T KOG1035|consen 782 VAPELLSDTSSNKYNSKIDMYSLGIVLFEMLYP 814 (1351)
T ss_pred ecHHHhcccccccccchhhhHHHHHHHHHHhcc
Confidence 9999987654 99999999999999998643
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.6e-22 Score=226.18 Aligned_cols=152 Identities=24% Similarity=0.277 Sum_probs=119.3
Q ss_pred HHHHHHhccCCccceeeccC------------CeEEEEEEehHhhHHHHHHHHHHHHHHhhcchhh------HHH-----
Q 045449 621 HELLRATDRFSENNLIGIGN------------GMEVAVKVFHQQYERALKSFEDECEVRKRIRHRN------LVK----- 677 (823)
Q Consensus 621 ~~l~~at~~f~~~~~lg~g~------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~----- 677 (823)
+++...+++|...+.||+|+ +..||||+++... ...+.+..|++++.+++|.+ +++
T Consensus 122 ~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~ 200 (467)
T PTZ00284 122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYF 200 (467)
T ss_pred CccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEE
Confidence 34445678899999999986 5569999986432 23345666777777765544 222
Q ss_pred -----------------------------------HHHHHHHHhhhcCC-CCEEeccCCCCCEEeCCCC-----------
Q 045449 678 -----------------------------------IISSSLEYLHFGHS-IPIIHCDLKPSNVLLDEDM----------- 710 (823)
Q Consensus 678 -----------------------------------~~~~~l~~L~~~h~-~~ivHrdlk~~NiLl~~~~----------- 710 (823)
++.|++.+|+|+|+ .+||||||||+|||++.++
T Consensus 201 ~~~~~~~~iv~~~~g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~ 280 (467)
T PTZ00284 201 QNETGHMCIVMPKYGPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRAL 280 (467)
T ss_pred EcCCceEEEEEeccCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCccccccccccc
Confidence 46788999999997 6999999999999998655
Q ss_pred -----cEEEeecccccccCCCCccccccccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCCC
Q 045449 711 -----VAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 711 -----~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
.+||+|||.+..... .....+||+.|+|||++.+..|+.++|||||||++||+++|+.||...
T Consensus 281 ~~~~~~vkl~DfG~~~~~~~-----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~ 348 (467)
T PTZ00284 281 PPDPCRVRICDLGGCCDERH-----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTH 348 (467)
T ss_pred CCCCceEEECCCCccccCcc-----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 499999998864321 123467999999999999999999999999999999999999999653
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.7e-22 Score=232.93 Aligned_cols=155 Identities=31% Similarity=0.380 Sum_probs=125.5
Q ss_pred HhccCCccceeeccC------------CeEEEEEEehHhh--HHHHHHHHHHHHHHhhcchhhHHH--------------
Q 045449 626 ATDRFSENNLIGIGN------------GMEVAVKVFHQQY--ERALKSFEDECEVRKRIRHRNLVK-------------- 677 (823)
Q Consensus 626 at~~f~~~~~lg~g~------------~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~-------------- 677 (823)
.+-++....+||.|. |...|||-+.-+. .+..+...+|..++..+.|||+|+
T Consensus 1233 V~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IF 1312 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIF 1312 (1509)
T ss_pred ceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHH
Confidence 344666677888774 5557888665332 445567889999999999999998
Q ss_pred --------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCc--c
Q 045449 678 --------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQ--L 729 (823)
Q Consensus 678 --------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~--~ 729 (823)
+.+|.++++.|+|+.|||||||||+||+++.+|.+|++|||.|..+....+ .
T Consensus 1313 MEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~ 1392 (1509)
T KOG4645|consen 1313 MEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMP 1392 (1509)
T ss_pred HHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhcCC
Confidence 246889999999999999999999999999999999999999988755421 1
Q ss_pred ccccccccCCCcCcccccCCCc---cccccceehhhhhhccccCCCCCcCCCcc
Q 045449 730 SKQTQTLATIGYMAPEYGTKGR---VSTRGDVCSFGIISGGKETRSMTVGETCT 780 (823)
Q Consensus 730 ~~~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~S~Gvv~~~~~~~~~~~~~~~~ 780 (823)
......+||+.|||||++.+.. -..++||||+|||..||.||+.||.+...
T Consensus 1393 ~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn 1446 (1509)
T KOG4645|consen 1393 GELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN 1446 (1509)
T ss_pred HHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc
Confidence 1223568999999999987654 46779999999999999999999987643
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.84 E-value=2e-21 Score=211.75 Aligned_cols=136 Identities=22% Similarity=0.225 Sum_probs=110.1
Q ss_pred CeEEEEEEehHhh---HHHHHHHHHHHHHHhhc---chhhHHH-------------------------------------
Q 045449 641 GMEVAVKVFHQQY---ERALKSFEDECEVRKRI---RHRNLVK------------------------------------- 677 (823)
Q Consensus 641 ~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l---~h~niv~------------------------------------- 677 (823)
+..||||++.... ......+..|..++.+. +||+|++
T Consensus 18 ~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~ 97 (330)
T cd05586 18 RRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDR 97 (330)
T ss_pred CCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCCChHHHHHHhcCCCCHHH
Confidence 6789999996543 22334566677777665 6999987
Q ss_pred ---HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCcccccCCC-ccc
Q 045449 678 ---IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKG-RVS 753 (823)
Q Consensus 678 ---~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~ 753 (823)
++.|++++|+|+|+.+|+||||||+|||++.++.+||+|||+++....... .....+||+.|+|||++.+. .++
T Consensus 98 ~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~ 175 (330)
T cd05586 98 AKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK--TTNTFCGTTEYLAPEVLLDEKGYT 175 (330)
T ss_pred HHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC--CccCccCCccccCHHHHcCCCCCC
Confidence 357899999999999999999999999999999999999999976432221 12345799999999998754 479
Q ss_pred cccceehhhhhhccccCCCCCcCCC
Q 045449 754 TRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 754 ~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
.++||||+||++|+|++|..||...
T Consensus 176 ~~~DvwslGvil~elltG~~Pf~~~ 200 (330)
T cd05586 176 KHVDFWSLGVLVFEMCCGWSPFYAE 200 (330)
T ss_pred CccceeccccEEEEeccCCCCCCCC
Confidence 9999999999999999999998654
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.8e-22 Score=198.21 Aligned_cols=135 Identities=26% Similarity=0.398 Sum_probs=116.1
Q ss_pred CeEEEEEEehHhhHHHHHHHHHHHHHHhhcchhhHHHH-----------------------------------------H
Q 045449 641 GMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVKI-----------------------------------------I 679 (823)
Q Consensus 641 ~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~-----------------------------------------~ 679 (823)
|+.||||.+..+ ...+++..|+.++.+++.|++|++ +
T Consensus 58 G~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAGSiSDI~R~R~K~L~E~EIs~iL 135 (502)
T KOG0574|consen 58 GHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAGSISDIMRARRKPLSEQEISAVL 135 (502)
T ss_pred CcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCCcHHHHHHHhcCCccHHHHHHHH
Confidence 789999998655 345789999999999999999993 2
Q ss_pred HHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCcccccCCCcccccccee
Q 045449 680 SSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVC 759 (823)
Q Consensus 680 ~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~ 759 (823)
...+.+|+|+|...-+|||||..|||+..+|++|++|||+|..+.. +.....+++|||.|||||++..-.|+.++|||
T Consensus 136 ~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTD--TMAKRNTVIGTPFWMAPEVI~EIGY~~~ADIW 213 (502)
T KOG0574|consen 136 RDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTD--TMAKRNTVIGTPFWMAPEVIEEIGYDTKADIW 213 (502)
T ss_pred HHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhh--hHHhhCccccCcccccHHHHHHhccchhhhHh
Confidence 3445667777777889999999999999999999999999987642 33445678999999999999999999999999
Q ss_pred hhhhhhccccCCCCCcCCCc
Q 045449 760 SFGIISGGKETRSMTVGETC 779 (823)
Q Consensus 760 S~Gvv~~~~~~~~~~~~~~~ 779 (823)
|+|+..-||..|+.|+.++.
T Consensus 214 SLGITaIEMAEG~PPYsDIH 233 (502)
T KOG0574|consen 214 SLGITAIEMAEGRPPYSDIH 233 (502)
T ss_pred hhcchhhhhhcCCCCccccc
Confidence 99999999999999998763
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.1e-21 Score=208.47 Aligned_cols=138 Identities=28% Similarity=0.331 Sum_probs=114.4
Q ss_pred CeEEEEEEehHhhH-HHHHHHHHHHHHHhhcchhhHHHH-----------------------------------------
Q 045449 641 GMEVAVKVFHQQYE-RALKSFEDECEVRKRIRHRNLVKI----------------------------------------- 678 (823)
Q Consensus 641 ~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~----------------------------------------- 678 (823)
+..||||++..... ...+.|.+|++++++++|+||+++
T Consensus 35 ~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~ 114 (280)
T cd05049 35 KELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDS 114 (280)
T ss_pred cceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeEEEEecCCCCCHHHHHHhcCCchhhhccccc
Confidence 36799999875443 355789999999999999998871
Q ss_pred -------------HHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCccc
Q 045449 679 -------------ISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPE 745 (823)
Q Consensus 679 -------------~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE 745 (823)
+.|++.++.++|+.+++||||||+||+++.++.+||+|||+++...............+++.|+|||
T Consensus 115 ~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE 194 (280)
T cd05049 115 PMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPE 194 (280)
T ss_pred ccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCeEEECCcccceecccCcceecCCCCcccceecChh
Confidence 4577888999999999999999999999999999999999998654333222223445678999999
Q ss_pred ccCCCccccccceehhhhhhccccC-CCCCcCCC
Q 045449 746 YGTKGRVSTRGDVCSFGIISGGKET-RSMTVGET 778 (823)
Q Consensus 746 ~~~~~~~~~~~Dv~S~Gvv~~~~~~-~~~~~~~~ 778 (823)
++.++.++.++||||+||+++++++ |..||.+.
T Consensus 195 ~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~ 228 (280)
T cd05049 195 SIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGL 228 (280)
T ss_pred hhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCC
Confidence 9999999999999999999999997 99887653
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.6e-21 Score=224.52 Aligned_cols=223 Identities=25% Similarity=0.458 Sum_probs=117.4
Q ss_pred EEEEEcCCCCCccccCcccCCCCCCcEEEccCCCCCCCCCCCCCCCCCCCEEECCCCcCcCCCchhhhcCCCCcEEeccc
Q 045449 54 VIGLNISSFNLQGTITPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLDFSDNQLFGSLSSFIFNMSSMTTIDLSI 133 (823)
Q Consensus 54 v~~L~L~~~~l~g~~~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 133 (823)
.+.|++++++++ .+|..+. ++|+.|+|++|+|+ .+|..+. ++|++|+|++|+|+ .+|..+. .+|+.|+|++
T Consensus 180 ~~~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls~ 250 (754)
T PRK15370 180 KTELRLKILGLT-TIPACIP--EQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMELSI 250 (754)
T ss_pred ceEEEeCCCCcC-cCCcccc--cCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEECcC
Confidence 467778777777 3555443 46788888888887 4555544 47888888888877 3455443 4678888888
Q ss_pred ccccCccCccccCCCCCCccccccceeeeccceeeccCccccccchhhHHHHHhhcCCCcccCCcccCCcchhhhhcccc
Q 045449 134 NRLSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKEIGNLTKLKEIISTITNSTVCEIPREIGNLPYLARLALAT 213 (823)
Q Consensus 134 N~l~~~~p~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~~l~~n~~~~~ip~~l~~l~~L~~L~Ls~ 213 (823)
|+++ .+|..+ .++|+.|+|++|+|+ .+|..+. ++|+.|. +++|++. .+|..+. ++|+.|++++
T Consensus 251 N~L~-~LP~~l---------~s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~-Ls~N~Lt-~LP~~lp--~sL~~L~Ls~ 313 (754)
T PRK15370 251 NRIT-ELPERL---------PSALQSLDLFHNKIS-CLPENLP--EELRYLS-VYDNSIR-TLPAHLP--SGITHLNVQS 313 (754)
T ss_pred CccC-cCChhH---------hCCCCEEECcCCccC-ccccccC--CCCcEEE-CCCCccc-cCcccch--hhHHHHHhcC
Confidence 8876 455543 136788888888777 4565442 2333332 3344333 2333322 2445555555
Q ss_pred ccccCCccccccCCCCCcEEEccCCcccccCCcccccCCCCccEEEeeccccccccCccccCCCCCCeEEeecccccccC
Q 045449 214 NNLVGVVPVTIFNMSALKEISLLNNSLSGSLPSRIDLSLPNVETLNLGINSFSGTIPSSITNSSKLSDLELGENLFSGFI 293 (823)
Q Consensus 214 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 293 (823)
|+++. +|..+. ++|+.|++++|.++ .+|..+ .++|+.|+|++|+|+ .+|..+. ++|++|+|++|+|+. +
T Consensus 314 N~Lt~-LP~~l~--~sL~~L~Ls~N~Lt-~LP~~l---~~sL~~L~Ls~N~L~-~LP~~lp--~~L~~LdLs~N~Lt~-L 382 (754)
T PRK15370 314 NSLTA-LPETLP--PGLKTLEAGENALT-SLPASL---PPELQVLDVSKNQIT-VLPETLP--PTITTLDVSRNALTN-L 382 (754)
T ss_pred Ccccc-CCcccc--ccceeccccCCccc-cCChhh---cCcccEEECCCCCCC-cCChhhc--CCcCEEECCCCcCCC-C
Confidence 55543 222221 34455555555554 244332 234455555555444 2333332 344455555554442 2
Q ss_pred CCccCCCcccCcccccCccccC
Q 045449 294 PNTIGNLRNLEFGNIADNYLTS 315 (823)
Q Consensus 294 p~~~~~l~~L~~L~L~~N~l~~ 315 (823)
|..+. ..|+.|++++|+++.
T Consensus 383 P~~l~--~sL~~LdLs~N~L~~ 402 (754)
T PRK15370 383 PENLP--AALQIMQASRNNLVR 402 (754)
T ss_pred CHhHH--HHHHHHhhccCCccc
Confidence 22221 134444444444443
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.5e-21 Score=207.97 Aligned_cols=135 Identities=23% Similarity=0.255 Sum_probs=114.4
Q ss_pred CeEEEEEEehHhh---HHHHHHHHHHHHHHhhcchhhHHH----------------------------------------
Q 045449 641 GMEVAVKVFHQQY---ERALKSFEDECEVRKRIRHRNLVK---------------------------------------- 677 (823)
Q Consensus 641 ~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~---------------------------------------- 677 (823)
++.||+|.+.... ....+.+.+|++++++++|++|+.
T Consensus 25 ~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~ 104 (285)
T cd05632 25 GKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERA 104 (285)
T ss_pred CcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEeccCccHHHHHHHhcCCCCCHHHH
Confidence 5679999986543 223456788999999999999997
Q ss_pred --HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCcccccCCCccccc
Q 045449 678 --IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTR 755 (823)
Q Consensus 678 --~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 755 (823)
++.|++.+|+|+|+.+|+||||||+||+++.++.+||+|||+++....... .....|+..|+|||++.+..++.+
T Consensus 105 ~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~---~~~~~g~~~~~aPE~~~~~~~~~~ 181 (285)
T cd05632 105 LFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES---IRGRVGTVGYMAPEVLNNQRYTLS 181 (285)
T ss_pred HHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCCc---ccCCCCCcCccChHHhcCCCCCcc
Confidence 356889999999999999999999999999999999999999976543221 234578999999999988899999
Q ss_pred cceehhhhhhccccCCCCCcCCC
Q 045449 756 GDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 756 ~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
+|+||+||+++++.+|..||...
T Consensus 182 ~Di~slG~~l~~l~~g~~P~~~~ 204 (285)
T cd05632 182 PDYWGLGCLIYEMIEGQSPFRGR 204 (285)
T ss_pred cchHHHHHHHHHHHhCCCCCCCC
Confidence 99999999999999999999764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.4e-21 Score=207.48 Aligned_cols=137 Identities=22% Similarity=0.307 Sum_probs=113.0
Q ss_pred EEEEEEehHhh-HHHHHHHHHHHHHHhhcchhhHHH----------------------------------------HHHH
Q 045449 643 EVAVKVFHQQY-ERALKSFEDECEVRKRIRHRNLVK----------------------------------------IISS 681 (823)
Q Consensus 643 ~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~----------------------------------------~~~~ 681 (823)
.||+|.+.... ....+++..|+..++++.||||++ ++.|
T Consensus 38 ~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~~~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~q 117 (279)
T cd05111 38 PVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQ 117 (279)
T ss_pred EEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECCCccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHH
Confidence 47888875433 234467888999999999999998 3568
Q ss_pred HHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCcccccCCCccccccceehh
Q 045449 682 SLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSF 761 (823)
Q Consensus 682 ~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~ 761 (823)
++.+|.|+|+.+++||||||+||++++++.+||+|||+++...............++..|+|||+..++.++.++|||||
T Consensus 118 i~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~sl 197 (279)
T cd05111 118 IAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSY 197 (279)
T ss_pred HHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHH
Confidence 88999999999999999999999999999999999999987644332222334557789999999988899999999999
Q ss_pred hhhhccccC-CCCCcCCCc
Q 045449 762 GIISGGKET-RSMTVGETC 779 (823)
Q Consensus 762 Gvv~~~~~~-~~~~~~~~~ 779 (823)
||++|++++ |..||.+..
T Consensus 198 G~il~el~t~g~~p~~~~~ 216 (279)
T cd05111 198 GVTVWEMMSYGAEPYAGMR 216 (279)
T ss_pred HHHHHHHHcCCCCCCCCCC
Confidence 999999997 888887653
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=5.3e-22 Score=192.64 Aligned_cols=136 Identities=27% Similarity=0.403 Sum_probs=114.6
Q ss_pred CeEEEEEEehHhhH--HHHHHHHHHHHHHhhcchhhHHH-----------------------------------------
Q 045449 641 GMEVAVKVFHQQYE--RALKSFEDECEVRKRIRHRNLVK----------------------------------------- 677 (823)
Q Consensus 641 ~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~----------------------------------------- 677 (823)
|+.||.|.+..... ...+++.+|.+++.-.+|.|+..
T Consensus 78 grrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TELmQSDLHKIIVSPQ~Ls~DH 157 (449)
T KOG0664|consen 78 GKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTELMQSDLHKIIVSPQALTPDH 157 (449)
T ss_pred ccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHHHHHhhhhheeccCCCCCcch
Confidence 56678887754432 34478899999999999999987
Q ss_pred ---HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCcccccCCCc-cc
Q 045449 678 ---IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGR-VS 753 (823)
Q Consensus 678 ---~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~ 753 (823)
++.|++.+|.|+|+.+|+||||||.|.|++.+-..||||||+||....++. ..++..+-|-.|+|||++.+.+ |+
T Consensus 158 vKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~-~hMTqEVVTQYYRAPEiLMGaRhYs 236 (449)
T KOG0664|consen 158 VKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDR-LNMTHEVVTQYYRAPELLMGARRYT 236 (449)
T ss_pred hhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhhh-hhhHHHHHHHHhccHHHhhcchhhc
Confidence 357999999999999999999999999999999999999999998654433 3456677899999999988764 89
Q ss_pred cccceehhhhhhccccCCCCCcCC
Q 045449 754 TRGDVCSFGIISGGKETRSMTVGE 777 (823)
Q Consensus 754 ~~~Dv~S~Gvv~~~~~~~~~~~~~ 777 (823)
...||||.||+++|++-++..|+.
T Consensus 237 ~AvDiWSVGCIFaELLgRrILFQA 260 (449)
T KOG0664|consen 237 GAVDIWSVGCIFAELLQRKILFQA 260 (449)
T ss_pred CccceehhhHHHHHHHhhhhhhhc
Confidence 999999999999999888877754
|
|
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.84 E-value=7.7e-22 Score=209.32 Aligned_cols=137 Identities=24% Similarity=0.355 Sum_probs=111.3
Q ss_pred eEEEEEEehHhh-HHHHHHHHHHHHHHhhcchhhHHH-------------------------------------------
Q 045449 642 MEVAVKVFHQQY-ERALKSFEDECEVRKRIRHRNLVK------------------------------------------- 677 (823)
Q Consensus 642 ~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~------------------------------------------- 677 (823)
..||||++.... .....+|.+|+.++++++||||++
T Consensus 37 ~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ 116 (277)
T cd05062 37 TRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPP 116 (277)
T ss_pred eEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCC
Confidence 458999886432 334467999999999999999997
Q ss_pred -------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCcccccCCC
Q 045449 678 -------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKG 750 (823)
Q Consensus 678 -------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 750 (823)
++.|++++|+|+|+.+++||||||+||++++++.+||+|||+++...............+++.|+|||++.++
T Consensus 117 ~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 196 (277)
T cd05062 117 SLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG 196 (277)
T ss_pred CHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcC
Confidence 1336788899999999999999999999999999999999999865433322222234567889999999888
Q ss_pred ccccccceehhhhhhccccC-CCCCcCCC
Q 045449 751 RVSTRGDVCSFGIISGGKET-RSMTVGET 778 (823)
Q Consensus 751 ~~~~~~Dv~S~Gvv~~~~~~-~~~~~~~~ 778 (823)
.++.++|||||||+++++++ +..||.+.
T Consensus 197 ~~~~~~Di~slG~~l~el~~~~~~p~~~~ 225 (277)
T cd05062 197 VFTTYSDVWSFGVVLWEIATLAEQPYQGM 225 (277)
T ss_pred CcCchhHHHHHHHHHHHHHcCCCCCCCCC
Confidence 89999999999999999998 67787654
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.2e-21 Score=210.07 Aligned_cols=137 Identities=24% Similarity=0.201 Sum_probs=114.8
Q ss_pred CCeEEEEEEehHhh---HHHHHHHHHHHHHHhhc-chhhHHH--------------------------------------
Q 045449 640 NGMEVAVKVFHQQY---ERALKSFEDECEVRKRI-RHRNLVK-------------------------------------- 677 (823)
Q Consensus 640 ~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~-------------------------------------- 677 (823)
.+..||||+++... ....+.+.+|++++..+ +||||++
T Consensus 19 ~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~ 98 (318)
T cd05570 19 TDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRA 98 (318)
T ss_pred CCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCCCHHHHHHHcCCCCHHHH
Confidence 35789999997653 23446778899999888 7999998
Q ss_pred --HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCcccccCCCccccc
Q 045449 678 --IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTR 755 (823)
Q Consensus 678 --~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 755 (823)
++.|++++|.|+|+.+|+||||||+||+++.++.+||+|||+++....... .....+||+.|+|||++.+..++.+
T Consensus 99 ~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~ 176 (318)
T cd05570 99 RFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV--TTSTFCGTPDYIAPEILSYQPYGPA 176 (318)
T ss_pred HHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC--cccceecCccccCHHHhcCCCCCcc
Confidence 356889999999999999999999999999999999999999875322221 1234579999999999999999999
Q ss_pred cceehhhhhhccccCCCCCcCCC
Q 045449 756 GDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 756 ~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
+||||+||++|++++|..||...
T Consensus 177 ~DiwslGvil~~l~~G~~pf~~~ 199 (318)
T cd05570 177 VDWWALGVLLYEMLAGQSPFEGD 199 (318)
T ss_pred hhhhhHHHHHHHHhhCCCCCCCC
Confidence 99999999999999999998653
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.1e-21 Score=208.18 Aligned_cols=136 Identities=26% Similarity=0.230 Sum_probs=114.4
Q ss_pred CCeEEEEEEehHhhH---HHHHHHHHHHHHHhhcchhhHHH---------------------------------------
Q 045449 640 NGMEVAVKVFHQQYE---RALKSFEDECEVRKRIRHRNLVK--------------------------------------- 677 (823)
Q Consensus 640 ~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~--------------------------------------- 677 (823)
.|..||+|++..... ...+.+..|++++++++||||++
T Consensus 17 ~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~ 96 (277)
T cd05607 17 TGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMER 96 (277)
T ss_pred CCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCHHHHHHhccccCCCHHH
Confidence 368899999865431 23345677999999999999998
Q ss_pred ---HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCcccccCCCcccc
Q 045449 678 ---IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVST 754 (823)
Q Consensus 678 ---~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 754 (823)
++.|++.+|.|+|+.+|+||||||+||+++.++.+||+|||++........ .....|++.|+|||++.+..++.
T Consensus 97 ~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~ 173 (277)
T cd05607 97 VIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT---ITQRAGTNGYMAPEILKEEPYSY 173 (277)
T ss_pred HHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCce---eeccCCCCCccCHHHHccCCCCC
Confidence 245888999999999999999999999999999999999999987643221 23356899999999998888999
Q ss_pred ccceehhhhhhccccCCCCCcCCC
Q 045449 755 RGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 755 ~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
++||||+||++|++++|..||...
T Consensus 174 ~~DvwslGv~l~el~~g~~p~~~~ 197 (277)
T cd05607 174 PVDWFAMGCSIYEMVAGRTPFKDH 197 (277)
T ss_pred chhHHHHHHHHHHHHhCCCCCCCC
Confidence 999999999999999999998654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=99.84 E-value=7.9e-22 Score=209.93 Aligned_cols=138 Identities=25% Similarity=0.340 Sum_probs=113.4
Q ss_pred CeEEEEEEehHhh-HHHHHHHHHHHHHHhhcchhhHHH------------------------------------------
Q 045449 641 GMEVAVKVFHQQY-ERALKSFEDECEVRKRIRHRNLVK------------------------------------------ 677 (823)
Q Consensus 641 ~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~------------------------------------------ 677 (823)
+..||||++.... ....+.|.+|+.++.+++||||++
T Consensus 35 ~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~ 114 (283)
T cd05091 35 TQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDD 114 (283)
T ss_pred eeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEEEEEcCCCCcHHHHHHhcCCCccccccccc
Confidence 3679999997543 334567999999999999999985
Q ss_pred --------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCc
Q 045449 678 --------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMA 743 (823)
Q Consensus 678 --------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a 743 (823)
++.|++.+|.|+|+.+|+||||||+||++++++.+||+|||+++...............+++.|+|
T Consensus 115 ~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~a 194 (283)
T cd05091 115 KTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMS 194 (283)
T ss_pred cccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCCCceEecccccccccccchheeeccCccCCccccC
Confidence 234788899999999999999999999999999999999999987644332222233456789999
Q ss_pred ccccCCCccccccceehhhhhhccccC-CCCCcCCC
Q 045449 744 PEYGTKGRVSTRGDVCSFGIISGGKET-RSMTVGET 778 (823)
Q Consensus 744 PE~~~~~~~~~~~Dv~S~Gvv~~~~~~-~~~~~~~~ 778 (823)
||++.++.++.++||||+||+++++++ |..||.+.
T Consensus 195 PE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~ 230 (283)
T cd05091 195 PEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGY 230 (283)
T ss_pred HHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCC
Confidence 999988889999999999999999997 77777654
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.1e-21 Score=200.39 Aligned_cols=114 Identities=24% Similarity=0.187 Sum_probs=98.8
Q ss_pred HHHHHhhcchhhHHHHHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcC
Q 045449 663 ECEVRKRIRHRNLVKIISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYM 742 (823)
Q Consensus 663 E~~~l~~l~h~niv~~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~ 742 (823)
.++...+.+.|..|-++|.++.+|-++|++||+.||+|.+|||+|.+|++||+|||+++.-..+.. ...+++|||.|+
T Consensus 440 hiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~~~--TTkTFCGTPdYi 517 (683)
T KOG0696|consen 440 HIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFDGV--TTKTFCGTPDYI 517 (683)
T ss_pred HHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccccccCCc--ceeeecCCCccc
Confidence 445555556666666789999999999999999999999999999999999999999986433322 245689999999
Q ss_pred cccccCCCccccccceehhhhhhccccCCCCCcCCC
Q 045449 743 APEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 743 aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
|||++...+|+..+|+|||||++|||+.|+.||++.
T Consensus 518 APEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGe 553 (683)
T KOG0696|consen 518 APEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGE 553 (683)
T ss_pred ccceEEecccccchhHHHHHHHHHHHHcCCCCCCCC
Confidence 999999999999999999999999999999999775
|
|
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.6e-21 Score=207.59 Aligned_cols=138 Identities=24% Similarity=0.326 Sum_probs=112.9
Q ss_pred CeEEEEEEehHhh-HHHHHHHHHHHHHHhhcchhhHHH------------------------------------------
Q 045449 641 GMEVAVKVFHQQY-ERALKSFEDECEVRKRIRHRNLVK------------------------------------------ 677 (823)
Q Consensus 641 ~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~------------------------------------------ 677 (823)
+..||+|.+.... ....+.|.+|++++++++||||++
T Consensus 34 ~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 113 (283)
T cd05090 34 AQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDE 113 (283)
T ss_pred cceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEEEEEcCCCCcHHHHHHhcCCCCcccccccc
Confidence 4678999986432 344578999999999999999987
Q ss_pred ---------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcC
Q 045449 678 ---------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYM 742 (823)
Q Consensus 678 ---------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~ 742 (823)
++.|++.+|.|+|+.+++||||||+||+++.++.+||+|||+++...............++..|+
T Consensus 114 ~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~ 193 (283)
T cd05090 114 DGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWM 193 (283)
T ss_pred ccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCCCcEEeccccccccccCCcceecccCCCccceec
Confidence 12367888999999999999999999999999999999999998764433222223345677899
Q ss_pred cccccCCCccccccceehhhhhhccccC-CCCCcCCC
Q 045449 743 APEYGTKGRVSTRGDVCSFGIISGGKET-RSMTVGET 778 (823)
Q Consensus 743 aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~-~~~~~~~~ 778 (823)
|||+..+..++.++|||||||+++++++ |..||.+.
T Consensus 194 aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~ 230 (283)
T cd05090 194 PPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGF 230 (283)
T ss_pred ChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCC
Confidence 9999988889999999999999999998 88888654
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1e-21 Score=183.89 Aligned_cols=138 Identities=30% Similarity=0.332 Sum_probs=106.4
Q ss_pred CeEEEEEEehHhh-HHHHHHHHHHHHHHhhc-chhhHHH-----------------------------------------
Q 045449 641 GMEVAVKVFHQQY-ERALKSFEDECEVRKRI-RHRNLVK----------------------------------------- 677 (823)
Q Consensus 641 ~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~----------------------------------------- 677 (823)
|+..|||+++... .+..++..+|+++..+. ..|.+|.
T Consensus 71 g~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M~tSldkfy~~v~~~g~~ipE~vl 150 (282)
T KOG0984|consen 71 GTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELMDTSLDKFYRKVLKKGGTIPEDVL 150 (282)
T ss_pred CeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHhhhhHHHHHHHHHhcCCcCchHHh
Confidence 6789999997543 33445677777765554 5666665
Q ss_pred --HHHHHHHHhhhcCCC-CEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCcccccCC----C
Q 045449 678 --IISSSLEYLHFGHSI-PIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTK----G 750 (823)
Q Consensus 678 --~~~~~l~~L~~~h~~-~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~ 750 (823)
++..++.+|+|+|++ .|+|||+||+|||++.+|++|+||||.+..+...-. -+.-.|-..|||||.+.. .
T Consensus 151 GkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiA---kt~daGCkpYmaPEri~~e~n~~ 227 (282)
T KOG0984|consen 151 GKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIA---KTMDAGCKPYMAPERINPELNQK 227 (282)
T ss_pred hHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceeehhhhH---HHHhcCCCccCChhhcCcccCcc
Confidence 345677888888875 899999999999999999999999999987653321 122357789999998754 3
Q ss_pred ccccccceehhhhhhccccCCCCCcCCCccc
Q 045449 751 RVSTRGDVCSFGIISGGKETRSMTVGETCTP 781 (823)
Q Consensus 751 ~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~~~~ 781 (823)
.|+.|+||||+|+.+.|+.+++.|+......
T Consensus 228 gY~vksDvWSLGItmiElA~lr~PY~~w~tp 258 (282)
T KOG0984|consen 228 GYSVKSDVWSLGITMIEMAILRFPYESWGTP 258 (282)
T ss_pred cceeehhhhhhhhhhhhhhhccccccccCCH
Confidence 6999999999999999999999998765443
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=8.2e-22 Score=214.50 Aligned_cols=136 Identities=28% Similarity=0.322 Sum_probs=112.5
Q ss_pred EEEEEehH---hhHHHHHHHHHHHHHHhhcchhhHHH-----------------------------------------HH
Q 045449 644 VAVKVFHQ---QYERALKSFEDECEVRKRIRHRNLVK-----------------------------------------II 679 (823)
Q Consensus 644 vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~-----------------------------------------~~ 679 (823)
||||.... .....+.+|.+|+++|+.++|||||+ ++
T Consensus 189 VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~ 268 (474)
T KOG0194|consen 189 VAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFC 268 (474)
T ss_pred eEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHH
Confidence 89999885 23667789999999999999999998 34
Q ss_pred HHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCcccccCCCcccccccee
Q 045449 680 SSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVC 759 (823)
Q Consensus 680 ~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~ 759 (823)
.+++.+|.|+|+.+++||||-.+|+|++.++.+||+|||+++.-.. .........-...|+|||.+..+.|+.++|||
T Consensus 269 ~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~--~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~ 346 (474)
T KOG0194|consen 269 YDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQ--YVMKKFLKKLPIRWLAPETLNTGIFSFKTDVW 346 (474)
T ss_pred HHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccccCCcc--eeeccccccCcceecChhhhccCccccccchh
Confidence 6777888888999999999999999999999999999999886431 11111112346789999999999999999999
Q ss_pred hhhhhhccccC-CCCCcCCCccc
Q 045449 760 SFGIISGGKET-RSMTVGETCTP 781 (823)
Q Consensus 760 S~Gvv~~~~~~-~~~~~~~~~~~ 781 (823)
||||++||..+ |..|+.+....
T Consensus 347 sfGV~~~Eif~~g~~Py~g~~~~ 369 (474)
T KOG0194|consen 347 SFGVLLWEIFENGAEPYPGMKNY 369 (474)
T ss_pred heeeeEEeeeccCCCCCCCCCHH
Confidence 99999999988 67788776433
|
|
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.8e-21 Score=203.76 Aligned_cols=150 Identities=25% Similarity=0.306 Sum_probs=121.4
Q ss_pred cCCccceeeccC------------CeEEEEEEehHh-----hHHHHHHHHHHHHHHhhcchhhHHH--------------
Q 045449 629 RFSENNLIGIGN------------GMEVAVKVFHQQ-----YERALKSFEDECEVRKRIRHRNLVK-------------- 677 (823)
Q Consensus 629 ~f~~~~~lg~g~------------~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~-------------- 677 (823)
+|...+.+|.|+ +..||+|++... ..+..+.+.+|+.++++++||||++
T Consensus 3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (266)
T cd06651 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLT 82 (266)
T ss_pred CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEE
Confidence 456666677664 567999987532 2334567899999999999999998
Q ss_pred ----------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCc-
Q 045449 678 ----------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQ- 728 (823)
Q Consensus 678 ----------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~- 728 (823)
++.|++++|.++|+.+|+|||+||+||+++.++.+||+|||+++.......
T Consensus 83 l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 162 (266)
T cd06651 83 IFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMS 162 (266)
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCcccccccccc
Confidence 356788899999999999999999999999999999999999986532211
Q ss_pred cccccccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCCC
Q 045449 729 LSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 729 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
........++..|+|||++.+..++.++||||+||+++++.+|..||.+.
T Consensus 163 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~ 212 (266)
T cd06651 163 GTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEY 212 (266)
T ss_pred CCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCcccc
Confidence 11122345889999999998888999999999999999999999999765
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=99.84 E-value=2e-21 Score=206.44 Aligned_cols=136 Identities=24% Similarity=0.286 Sum_probs=111.9
Q ss_pred EEEEEEehHh-hHHHHHHHHHHHHHHhhcchhhHHH----------------------------------------HHHH
Q 045449 643 EVAVKVFHQQ-YERALKSFEDECEVRKRIRHRNLVK----------------------------------------IISS 681 (823)
Q Consensus 643 ~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~----------------------------------------~~~~ 681 (823)
.||||++... .....+.+.+|+.++.+++|+||++ ++.|
T Consensus 38 ~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~q 117 (279)
T cd05109 38 PVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQ 117 (279)
T ss_pred EEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCCCcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHH
Confidence 4799998643 2444578999999999999999986 3578
Q ss_pred HHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCcccccCCCccccccceehh
Q 045449 682 SLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSF 761 (823)
Q Consensus 682 ~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~ 761 (823)
++.+|.|+|+.+|+||||||+||++++++.+||+|||+++...............+++.|+|||...+..++.++|||||
T Consensus 118 i~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~sl 197 (279)
T cd05109 118 IAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSY 197 (279)
T ss_pred HHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHH
Confidence 89999999999999999999999999999999999999987653322211222345678999999988899999999999
Q ss_pred hhhhccccC-CCCCcCCC
Q 045449 762 GIISGGKET-RSMTVGET 778 (823)
Q Consensus 762 Gvv~~~~~~-~~~~~~~~ 778 (823)
||++|++.+ |..||...
T Consensus 198 G~~l~el~t~g~~p~~~~ 215 (279)
T cd05109 198 GVTVWELMTFGAKPYDGI 215 (279)
T ss_pred HHHHHHHHcCCCCCCCCC
Confidence 999999887 88888654
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.8e-21 Score=206.92 Aligned_cols=138 Identities=27% Similarity=0.376 Sum_probs=115.2
Q ss_pred CeEEEEEEehHhhHHHHHHHHHHHHHHhhcchhhHHH-------------------------------------------
Q 045449 641 GMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVK------------------------------------------- 677 (823)
Q Consensus 641 ~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------------------------------------- 677 (823)
+..||+|.+........+.|.+|++++++++|+||++
T Consensus 35 ~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~ 114 (280)
T cd05092 35 KMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDV 114 (280)
T ss_pred ceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEEEEecCCCCCHHHHHHhcCcchhhhcccccC
Confidence 4678999887666666788999999999999999988
Q ss_pred ------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCccc
Q 045449 678 ------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPE 745 (823)
Q Consensus 678 ------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE 745 (823)
++.|++.++.|+|+.+++||||||+||++++++.+||+|||+++...............+++.|+|||
T Consensus 115 ~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE 194 (280)
T cd05092 115 APGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPE 194 (280)
T ss_pred CccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCCCEEECCCCceeEcCCCceeecCCCccccccccCHH
Confidence 13477888999999999999999999999999999999999998654333222223344678899999
Q ss_pred ccCCCccccccceehhhhhhccccC-CCCCcCCC
Q 045449 746 YGTKGRVSTRGDVCSFGIISGGKET-RSMTVGET 778 (823)
Q Consensus 746 ~~~~~~~~~~~Dv~S~Gvv~~~~~~-~~~~~~~~ 778 (823)
+..+..++.++|||||||+++++.+ |..||.+.
T Consensus 195 ~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~ 228 (280)
T cd05092 195 SILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQL 228 (280)
T ss_pred HhccCCcCchhhHHHHHHHHHHHHcCCCCCCccC
Confidence 9998899999999999999999997 88888654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.4e-21 Score=210.81 Aligned_cols=149 Identities=24% Similarity=0.304 Sum_probs=119.5
Q ss_pred ccCCccceeeccC------------CeEEEEEEehHhh-HHHHHHHHHHHHHHhhcchhhHHH-----------------
Q 045449 628 DRFSENNLIGIGN------------GMEVAVKVFHQQY-ERALKSFEDECEVRKRIRHRNLVK----------------- 677 (823)
Q Consensus 628 ~~f~~~~~lg~g~------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~----------------- 677 (823)
++|...+.+|.|+ +..||+|+++... ......+.+|++++++++||||++
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 3455666677664 4569999986443 223346788999999999999998
Q ss_pred -----------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccc
Q 045449 678 -----------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQ 734 (823)
Q Consensus 678 -----------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 734 (823)
++.|++.+|+|+|+.+|+||||||+||+++.++.+||+|||+++....... ....
T Consensus 86 ~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--~~~~ 163 (309)
T cd07872 86 LDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK--TYSN 163 (309)
T ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCcc--cccc
Confidence 245889999999999999999999999999999999999999976433221 1233
Q ss_pred cccCCCcCcccccCC-CccccccceehhhhhhccccCCCCCcCCC
Q 045449 735 TLATIGYMAPEYGTK-GRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 735 ~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
..+|+.|+|||++.+ ..++.++||||+||+++++++|..||...
T Consensus 164 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~ 208 (309)
T cd07872 164 EVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGS 208 (309)
T ss_pred ccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 468999999998765 45899999999999999999999998653
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.9e-21 Score=207.56 Aligned_cols=146 Identities=30% Similarity=0.372 Sum_probs=116.3
Q ss_pred CCccceeeccC------------CeEEEEEEehHhh--HHHHHHHHHHHHHHhhc---chhhHHH---------------
Q 045449 630 FSENNLIGIGN------------GMEVAVKVFHQQY--ERALKSFEDECEVRKRI---RHRNLVK--------------- 677 (823)
Q Consensus 630 f~~~~~lg~g~------------~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~--------------- 677 (823)
|...+.||.|+ ++.||+|.+.... ......+.+|+++++++ .||||++
T Consensus 2 y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~ 81 (288)
T cd07863 2 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETK 81 (288)
T ss_pred ceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCce
Confidence 55556677664 5679999886432 11223566777777765 6999886
Q ss_pred -------------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCC
Q 045449 678 -------------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGE 726 (823)
Q Consensus 678 -------------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~ 726 (823)
++.|++.+|.|+|+.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 82 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~~~ 161 (288)
T cd07863 82 VTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQ 161 (288)
T ss_pred EEEEEcccccCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccccccCc
Confidence 3568889999999999999999999999999999999999999876432
Q ss_pred CccccccccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCCC
Q 045449 727 DQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 727 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
.. .....||..|+|||++.+..++.++||||+||++|++.+|..+|...
T Consensus 162 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~ 210 (288)
T cd07863 162 MA---LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGN 210 (288)
T ss_pred cc---CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCC
Confidence 21 23456899999999998888999999999999999999999888553
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.2e-21 Score=204.85 Aligned_cols=133 Identities=25% Similarity=0.288 Sum_probs=115.0
Q ss_pred CeEEEEEEehHh-hHHHHHHHHHHHHHHhhcchhhHHH------------------------------------HHHHHH
Q 045449 641 GMEVAVKVFHQQ-YERALKSFEDECEVRKRIRHRNLVK------------------------------------IISSSL 683 (823)
Q Consensus 641 ~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~------------------------------------~~~~~l 683 (823)
+..||+|++... .....++|.+|++++.+++||||++ ++.|++
T Consensus 26 ~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~qi~ 105 (279)
T cd06619 26 RRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDGGSLDVYRKIPEHVLGRIAVAVV 105 (279)
T ss_pred CcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCCCCChHHhhcCCHHHHHHHHHHHH
Confidence 577999998644 2344567999999999999999998 357889
Q ss_pred HHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCcccccCCCccccccceehhhh
Q 045449 684 EYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGI 763 (823)
Q Consensus 684 ~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gv 763 (823)
.+|+|+|+.+|+|+||||+||+++.++.+||+|||++....... .....||..|+|||++.+..++.++|||||||
T Consensus 106 ~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~ 181 (279)
T cd06619 106 KGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI----AKTYVGTNAYMAPERISGEQYGIHSDVWSLGI 181 (279)
T ss_pred HHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc----ccCCCCChhhcCceeecCCCCCCcchHHHHHH
Confidence 99999999999999999999999999999999999998654321 23457899999999999889999999999999
Q ss_pred hhccccCCCCCcCC
Q 045449 764 ISGGKETRSMTVGE 777 (823)
Q Consensus 764 v~~~~~~~~~~~~~ 777 (823)
++|++.+|..||..
T Consensus 182 ~l~~l~~g~~pf~~ 195 (279)
T cd06619 182 SFMELALGRFPYPQ 195 (279)
T ss_pred HHHHHHhCCCCchh
Confidence 99999999999865
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.5e-21 Score=203.60 Aligned_cols=138 Identities=22% Similarity=0.308 Sum_probs=113.5
Q ss_pred CeEEEEEEehHhh--HHHHHHHHHHHHHHhhcchhhHHH-----------------------------------------
Q 045449 641 GMEVAVKVFHQQY--ERALKSFEDECEVRKRIRHRNLVK----------------------------------------- 677 (823)
Q Consensus 641 ~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~----------------------------------------- 677 (823)
+..||||++.... ....+.|.+|++.+++++|+||++
T Consensus 27 ~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~ 106 (273)
T cd05035 27 QLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGL 106 (273)
T ss_pred cceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcccEEEEeccCCCCHHHHHHHhhccCC
Confidence 3669999987432 344578999999999999999986
Q ss_pred -----------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCcccc
Q 045449 678 -----------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEY 746 (823)
Q Consensus 678 -----------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~ 746 (823)
++.|++.+|.|+|+.+++||||||+||++++++.+||+|||+++...............++..|+|||+
T Consensus 107 ~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~ 186 (273)
T cd05035 107 PEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIES 186 (273)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccceeeccccccccccccccCCccccCHhh
Confidence 246788899999999999999999999999999999999999987654433222222345678999999
Q ss_pred cCCCccccccceehhhhhhccccC-CCCCcCCC
Q 045449 747 GTKGRVSTRGDVCSFGIISGGKET-RSMTVGET 778 (823)
Q Consensus 747 ~~~~~~~~~~Dv~S~Gvv~~~~~~-~~~~~~~~ 778 (823)
+.+..++.++|||||||+++++.+ |..||.+.
T Consensus 187 ~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~ 219 (273)
T cd05035 187 LADRVYTSKSDVWAFGVTMWEIATRGQTPYPGV 219 (273)
T ss_pred cccCCCCcccchHHHHHHHHHHHhCCCCCCCCC
Confidence 988889999999999999999998 77887654
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.5e-21 Score=223.68 Aligned_cols=117 Identities=24% Similarity=0.296 Sum_probs=101.5
Q ss_pred HHHHHHHHHHHhhcchhhHHH--------------------------------------------HHHHHHHHhhhcCCC
Q 045449 657 LKSFEDECEVRKRIRHRNLVK--------------------------------------------IISSSLEYLHFGHSI 692 (823)
Q Consensus 657 ~~~~~~E~~~l~~l~h~niv~--------------------------------------------~~~~~l~~L~~~h~~ 692 (823)
...+.+|++++++++|||||+ ++.|++.+|+|+|+.
T Consensus 207 ~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~ 286 (501)
T PHA03210 207 AIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK 286 (501)
T ss_pred HHHHHHHHHHHHhCCCCCcCcEeEEEEECCeeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC
Confidence 456889999999999999987 345788899999999
Q ss_pred CEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCcccccCCCccccccceehhhhhhccccCCC
Q 045449 693 PIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRS 772 (823)
Q Consensus 693 ~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~ 772 (823)
+|+||||||+|||++.++.+||+|||+++.+..... ......+||+.|+|||++.+..++.++|||||||++|+++++.
T Consensus 287 gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~ 365 (501)
T PHA03210 287 KLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKERE-AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHD 365 (501)
T ss_pred CeecCCCCHHHEEECCCCCEEEEeCCCceecCcccc-cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCC
Confidence 999999999999999999999999999987643322 1223467999999999999999999999999999999999887
Q ss_pred CC
Q 045449 773 MT 774 (823)
Q Consensus 773 ~~ 774 (823)
.+
T Consensus 366 ~~ 367 (501)
T PHA03210 366 FC 367 (501)
T ss_pred CC
Confidence 54
|
|
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.5e-21 Score=207.04 Aligned_cols=137 Identities=28% Similarity=0.356 Sum_probs=114.7
Q ss_pred eEEEEEEehHhhHHHHHHHHHHHHHHhhcchhhHHH--------------------------------------------
Q 045449 642 MEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVK-------------------------------------------- 677 (823)
Q Consensus 642 ~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-------------------------------------------- 677 (823)
..||+|.+........+.|.+|++++++++|+||++
T Consensus 36 ~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~ 115 (291)
T cd05094 36 MLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQ 115 (291)
T ss_pred eeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEEEecCCCCcHHHHHHhcCccccccccccccc
Confidence 458889887666666678999999999999999988
Q ss_pred ------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCccc
Q 045449 678 ------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPE 745 (823)
Q Consensus 678 ------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE 745 (823)
++.|++.++.|+|+.+|+||||||+||+++.++.+||+|||+++...............++..|+|||
T Consensus 116 ~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE 195 (291)
T cd05094 116 AKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPE 195 (291)
T ss_pred CcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEEECCCCcccccCCCceeecCCCCCcceeecChH
Confidence 12467888999999999999999999999999999999999998654433222233456788999999
Q ss_pred ccCCCccccccceehhhhhhccccC-CCCCcCCC
Q 045449 746 YGTKGRVSTRGDVCSFGIISGGKET-RSMTVGET 778 (823)
Q Consensus 746 ~~~~~~~~~~~Dv~S~Gvv~~~~~~-~~~~~~~~ 778 (823)
++.+..++.++|||||||+++++++ |..||...
T Consensus 196 ~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 229 (291)
T cd05094 196 SIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQL 229 (291)
T ss_pred HhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 9988889999999999999999998 89887654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.2e-21 Score=208.55 Aligned_cols=152 Identities=24% Similarity=0.300 Sum_probs=121.2
Q ss_pred ccCCccceeeccC-----------------CeEEEEEEehHhh-HHHHHHHHHHHHHHhhc-chhhHHH-----------
Q 045449 628 DRFSENNLIGIGN-----------------GMEVAVKVFHQQY-ERALKSFEDECEVRKRI-RHRNLVK----------- 677 (823)
Q Consensus 628 ~~f~~~~~lg~g~-----------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~----------- 677 (823)
++|...+.||.|+ +..||||+++... ....+.+.+|+++++++ +|+||++
T Consensus 35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 114 (302)
T cd05055 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPI 114 (302)
T ss_pred HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCce
Confidence 3566666777664 2358999886542 34456899999999999 7999998
Q ss_pred -------------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCC
Q 045449 678 -------------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGE 726 (823)
Q Consensus 678 -------------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~ 726 (823)
++.+++.+|.|+|+.+|+||||||+||+++.++.+|++|||+++.....
T Consensus 115 ~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~ 194 (302)
T cd05055 115 LVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMND 194 (302)
T ss_pred EEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCcccccccCC
Confidence 2457888899999999999999999999999999999999999866433
Q ss_pred CccccccccccCCCcCcccccCCCccccccceehhhhhhccccC-CCCCcCCCc
Q 045449 727 DQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKET-RSMTVGETC 779 (823)
Q Consensus 727 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~-~~~~~~~~~ 779 (823)
..........++..|+|||++.++.++.++||||+||+++++++ |..||....
T Consensus 195 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~ 248 (302)
T cd05055 195 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMP 248 (302)
T ss_pred CceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCC
Confidence 22111223346788999999988889999999999999999997 888876543
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=9.6e-22 Score=205.91 Aligned_cols=132 Identities=26% Similarity=0.293 Sum_probs=115.0
Q ss_pred EEEEEehHhh---HHHHHHHHHHHHHHhhcchhhHHH----------------------------------------HHH
Q 045449 644 VAVKVFHQQY---ERALKSFEDECEVRKRIRHRNLVK----------------------------------------IIS 680 (823)
Q Consensus 644 vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~----------------------------------------~~~ 680 (823)
+|+|++++.. .+..+....|-.+|...+.|.||+ ++|
T Consensus 448 fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaClGGElWTiLrdRg~Fdd~tarF~~a 527 (732)
T KOG0614|consen 448 FALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEACLGGELWTILRDRGSFDDYTARFYVA 527 (732)
T ss_pred HHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhhcCchhhhhhhhcCCcccchhhhhHH
Confidence 3455554332 344567889999999999999999 357
Q ss_pred HHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCcccccCCCccccccceeh
Q 045449 681 SSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCS 760 (823)
Q Consensus 681 ~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S 760 (823)
-+++++.|+|+.+||.||+||+|.++|.+|.+||.|||+|+.+.... ...+++|||.|.|||++.....+..+|.||
T Consensus 528 cv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~---KTwTFcGTpEYVAPEIILnKGHD~avDyWa 604 (732)
T KOG0614|consen 528 CVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGR---KTWTFCGTPEYVAPEIILNKGHDRAVDYWA 604 (732)
T ss_pred HHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhccCC---ceeeecCCcccccchhhhccCcchhhHHHH
Confidence 78899999999999999999999999999999999999999986554 346789999999999999999999999999
Q ss_pred hhhhhccccCCCCCcCCC
Q 045449 761 FGIISGGKETRSMTVGET 778 (823)
Q Consensus 761 ~Gvv~~~~~~~~~~~~~~ 778 (823)
+|+++||+++|..||.+.
T Consensus 605 LGIli~ELL~G~pPFs~~ 622 (732)
T KOG0614|consen 605 LGILIYELLTGSPPFSGV 622 (732)
T ss_pred HHHHHHHHHcCCCCCCCC
Confidence 999999999999999875
|
|
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.2e-21 Score=210.16 Aligned_cols=136 Identities=24% Similarity=0.300 Sum_probs=110.3
Q ss_pred CeEEEEEEehHhhHHHHHHHHHHHHHHhhcchhhHHH-------------------------------------------
Q 045449 641 GMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVK------------------------------------------- 677 (823)
Q Consensus 641 ~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------------------------------------- 677 (823)
+..||+|.+.... ....+.+|++++++++||||++
T Consensus 28 ~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l 105 (317)
T cd07867 28 EKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQL 105 (317)
T ss_pred cceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCCcHHHHHHhhhccccCCCCccC
Confidence 4678999886442 2246789999999999999986
Q ss_pred -------HHHHHHHHhhhcCCCCEEeccCCCCCEEe----CCCCcEEEeecccccccCCCCc-cccccccccCCCcCccc
Q 045449 678 -------IISSSLEYLHFGHSIPIIHCDLKPSNVLL----DEDMVAHISDFGIAKLLSGEDQ-LSKQTQTLATIGYMAPE 745 (823)
Q Consensus 678 -------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl----~~~~~~kl~DfGla~~~~~~~~-~~~~~~~~gt~~y~aPE 745 (823)
++.|++++|+|+|+.+|+||||||+||++ +.++.+||+|||+++....... ........||+.|+|||
T Consensus 106 ~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE 185 (317)
T cd07867 106 PRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPE 185 (317)
T ss_pred CHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceeccCCCcccccccCcceecccccCcH
Confidence 24588899999999999999999999999 4567999999999987643322 11223457899999999
Q ss_pred ccCCC-ccccccceehhhhhhccccCCCCCcCCC
Q 045449 746 YGTKG-RVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 746 ~~~~~-~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
++.+. .++.++||||+||+++++++|..||...
T Consensus 186 ~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 186 LLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred HhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 88764 5799999999999999999999998653
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=99.83 E-value=8.8e-22 Score=208.19 Aligned_cols=151 Identities=26% Similarity=0.351 Sum_probs=120.8
Q ss_pred HHhccCCccceeeccC------------CeEEEEEEehHhhHHHHHHHHHHHHHHhhc-chhhHHH--------------
Q 045449 625 RATDRFSENNLIGIGN------------GMEVAVKVFHQQYERALKSFEDECEVRKRI-RHRNLVK-------------- 677 (823)
Q Consensus 625 ~at~~f~~~~~lg~g~------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~-------------- 677 (823)
.+++.|+..+.+|.|+ ++.||+|++.... .....+.+|++++.++ +|+||++
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 3455666666666664 5678999986443 2335788999999998 7999997
Q ss_pred ----------------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeeccccccc
Q 045449 678 ----------------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLL 723 (823)
Q Consensus 678 ----------------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~ 723 (823)
++.|++.+++|+|+.+|+|||+||+||++++++.+||+|||+++..
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~ 161 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 161 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCceec
Confidence 2468888999999999999999999999999999999999999865
Q ss_pred CCCCccccccccccCCCcCcccccC-----CCccccccceehhhhhhccccCCCCCcCCC
Q 045449 724 SGEDQLSKQTQTLATIGYMAPEYGT-----KGRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 724 ~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
.... .......|++.|+|||++. ...++.++||||+||++|++++|..||.+.
T Consensus 162 ~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~ 219 (272)
T cd06637 162 DRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDM 219 (272)
T ss_pred cccc--ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCcccc
Confidence 3321 1233457899999999876 345888999999999999999999998654
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.83 E-value=8.5e-22 Score=189.39 Aligned_cols=157 Identities=24% Similarity=0.329 Sum_probs=123.5
Q ss_pred cccCHHHHHHHhccCCccceeeccCCeEEEEEEehHhh--HHHHHHHHHHHHHHhhcchhhHHHH---------------
Q 045449 616 RRFSYHELLRATDRFSENNLIGIGNGMEVAVKVFHQQY--ERALKSFEDECEVRKRIRHRNLVKI--------------- 678 (823)
Q Consensus 616 ~~~~~~~l~~at~~f~~~~~lg~g~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~--------------- 678 (823)
...++.|+.+|...-. |+.||+|++-.+. +.......+|++++..++|+|++.+
T Consensus 26 gqGtfgeVFkAr~~n~---------~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 26 GQGTFGEVFKARSKNT---------GKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred CCchHHHHHHHhhcCc---------cchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 4566778887753221 4568888765432 2233567899999999999999983
Q ss_pred ---------------------------------HHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCC
Q 045449 679 ---------------------------------ISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSG 725 (823)
Q Consensus 679 ---------------------------------~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~ 725 (823)
+.+.+++|.|+|+..|+|||+|++|+|++.++.+||+|||+||.+..
T Consensus 97 ~t~ylVf~~cehDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGlar~fs~ 176 (376)
T KOG0669|consen 97 ATFYLVFDFCEHDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLARAFST 176 (376)
T ss_pred ceeeeeHHHhhhhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeeccccccceec
Confidence 34678899999999999999999999999999999999999987654
Q ss_pred CCccc--cccccccCCCcCcccccCCC-ccccccceehhhhhhccccCCCCCcCCCccc
Q 045449 726 EDQLS--KQTQTLATIGYMAPEYGTKG-RVSTRGDVCSFGIISGGKETRSMTVGETCTP 781 (823)
Q Consensus 726 ~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~~~~ 781 (823)
.+... ..+..+.|.+|++||.+.+. .|+++.|||..|||+++|.++...+++..++
T Consensus 177 ~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteq 235 (376)
T KOG0669|consen 177 SKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQ 235 (376)
T ss_pred ccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHH
Confidence 43322 23456679999999988765 5999999999999999999999988775433
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=99.83 E-value=5.2e-21 Score=203.83 Aligned_cols=146 Identities=24% Similarity=0.301 Sum_probs=120.3
Q ss_pred CCccceeeccC------------CeEEEEEEehHhh---HHHHHHHHHHHHHHhhcchhhHHH-----------------
Q 045449 630 FSENNLIGIGN------------GMEVAVKVFHQQY---ERALKSFEDECEVRKRIRHRNLVK----------------- 677 (823)
Q Consensus 630 f~~~~~lg~g~------------~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~----------------- 677 (823)
|+..+.||.|+ ++.||||.+.... ....+.+.+|+.++++++|++++.
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 44456666664 5679999886542 233456788999999999999997
Q ss_pred -------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccc
Q 045449 678 -------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQ 732 (823)
Q Consensus 678 -------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~ 732 (823)
++.|++.+|.|+|+.+|+||||||+||+++.++.++|+|||++........ .
T Consensus 82 ~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~---~ 158 (285)
T cd05630 82 MNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT---I 158 (285)
T ss_pred cCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc---c
Confidence 356788999999999999999999999999999999999999976543221 2
Q ss_pred cccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCCC
Q 045449 733 TQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 733 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
....||..|+|||++.+..++.++||||+||+++++++|..||...
T Consensus 159 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~ 204 (285)
T cd05630 159 KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQR 204 (285)
T ss_pred cCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCC
Confidence 2347899999999999889999999999999999999999999764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.1e-21 Score=204.01 Aligned_cols=136 Identities=24% Similarity=0.326 Sum_probs=111.7
Q ss_pred EEEEEEehHh--hHHHHHHHHHHHHHHhhcchhhHHH-------------------------------------------
Q 045449 643 EVAVKVFHQQ--YERALKSFEDECEVRKRIRHRNLVK------------------------------------------- 677 (823)
Q Consensus 643 ~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~------------------------------------------- 677 (823)
.||||.+... .....+.|.+|++++++++|+||++
T Consensus 28 ~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~ 107 (272)
T cd05075 28 KVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQ 107 (272)
T ss_pred eEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcEEEEEeCCCCcHHHHHHHhcccCCcc
Confidence 5899988643 2444578999999999999999997
Q ss_pred ---------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCcccccC
Q 045449 678 ---------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGT 748 (823)
Q Consensus 678 ---------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 748 (823)
++.|++++|.|+|+.+|+||||||+||+++.++.+||+|||+++...............+++.|+|||+..
T Consensus 108 ~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~ 187 (272)
T cd05075 108 YLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLA 187 (272)
T ss_pred cCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCcccccCcccceecCCcccCCcccCCHHHcc
Confidence 23577888999999999999999999999999999999999998764332211122234677899999999
Q ss_pred CCccccccceehhhhhhccccC-CCCCcCCC
Q 045449 749 KGRVSTRGDVCSFGIISGGKET-RSMTVGET 778 (823)
Q Consensus 749 ~~~~~~~~Dv~S~Gvv~~~~~~-~~~~~~~~ 778 (823)
+..++.++|||||||+++++.+ |..||...
T Consensus 188 ~~~~~~~~Di~slG~il~el~~~g~~p~~~~ 218 (272)
T cd05075 188 DRVYTTKSDVWSFGVTMWEIATRGQTPYPGV 218 (272)
T ss_pred CCCcChHHHHHHHHHHHHHHHcCCCCCCCCC
Confidence 8889999999999999999998 78888654
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.2e-21 Score=202.66 Aligned_cols=150 Identities=26% Similarity=0.374 Sum_probs=119.9
Q ss_pred ccCCccceeeccC-----------CeEEEEEEehHhhHHHHHHHHHHHHHHhhcchhhHHH-------------------
Q 045449 628 DRFSENNLIGIGN-----------GMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVK------------------- 677 (823)
Q Consensus 628 ~~f~~~~~lg~g~-----------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------------- 677 (823)
++|...+.+|.|+ +..||||.++... ...++|.+|++++++++|+||++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 84 (261)
T cd05068 6 TSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMK 84 (261)
T ss_pred hheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeeccc
Confidence 4466666777664 3569999987543 23467999999999999999998
Q ss_pred -----------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccc
Q 045449 678 -----------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQ 734 (823)
Q Consensus 678 -----------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 734 (823)
++.+++.+++++|+.+++||||||+||+++.++.+||+|||+++....... .....
T Consensus 85 ~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~-~~~~~ 163 (261)
T cd05068 85 YGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIY-EAREG 163 (261)
T ss_pred CCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcc-cccCC
Confidence 346788899999999999999999999999999999999999987653211 11112
Q ss_pred cccCCCcCcccccCCCccccccceehhhhhhccccC-CCCCcCCCc
Q 045449 735 TLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKET-RSMTVGETC 779 (823)
Q Consensus 735 ~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~-~~~~~~~~~ 779 (823)
...+..|+|||+..+..++.++|||||||+++++.+ |+.||.+..
T Consensus 164 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~ 209 (261)
T cd05068 164 AKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMT 209 (261)
T ss_pred CcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCC
Confidence 223468999999998899999999999999999998 888886643
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=9.6e-22 Score=179.59 Aligned_cols=135 Identities=26% Similarity=0.299 Sum_probs=111.9
Q ss_pred CeEEEEEEehHhh--HHHHHHHHHHHHHHhhcchhhHHH----------------------------------------H
Q 045449 641 GMEVAVKVFHQQY--ERALKSFEDECEVRKRIRHRNLVK----------------------------------------I 678 (823)
Q Consensus 641 ~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~----------------------------------------~ 678 (823)
++.||+|+++.+. +.......+|+-+++.++|+|||+ +
T Consensus 27 ~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~cdqdlkkyfdslng~~d~~~~rsf 106 (292)
T KOG0662|consen 27 HEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSLNGDLDPEIVRSF 106 (292)
T ss_pred cceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHhhHHHHHHHHhcCCcCCHHHHHHH
Confidence 4679999987443 344467889999999999999998 3
Q ss_pred HHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCcccccCCCc-cccccc
Q 045449 679 ISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGR-VSTRGD 757 (823)
Q Consensus 679 ~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~D 757 (823)
+.|.+.+|.++|++.+.|||+||+|.|+..+|+.|++|||+||.+.-. ....+..+-|.+|++|.++.+.. |++..|
T Consensus 107 mlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgip--vrcysaevvtlwyrppdvlfgakly~tsid 184 (292)
T KOG0662|consen 107 MLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIP--VRCYSAEVVTLWYRPPDVLFGAKLYSTSID 184 (292)
T ss_pred HHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCc--eEeeeceeeeeeccCcceeeeeehhccchH
Confidence 568999999999999999999999999999999999999999976433 23445567899999999988765 899999
Q ss_pred eehhhhhhccccC-CCCCcCC
Q 045449 758 VCSFGIISGGKET-RSMTVGE 777 (823)
Q Consensus 758 v~S~Gvv~~~~~~-~~~~~~~ 777 (823)
+||.||++.|+.- |+..|.+
T Consensus 185 mwsagcifaelanagrplfpg 205 (292)
T KOG0662|consen 185 MWSAGCIFAELANAGRPLFPG 205 (292)
T ss_pred hhhcchHHHHHhhcCCCCCCC
Confidence 9999999988865 4443443
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=99.83 E-value=4.2e-21 Score=201.99 Aligned_cols=136 Identities=26% Similarity=0.414 Sum_probs=112.7
Q ss_pred CeEEEEEEehHhhHHHHHHHHHHHHHHhhcchhhHHH------------------------------------------H
Q 045449 641 GMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVK------------------------------------------I 678 (823)
Q Consensus 641 ~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------------------------------------~ 678 (823)
+..||+|++.... ...+++.+|++++++++|+||++ +
T Consensus 31 ~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~ 109 (263)
T cd05052 31 SLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYM 109 (263)
T ss_pred CceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHH
Confidence 5679999987543 33567999999999999999999 2
Q ss_pred HHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCcccccCCCccccccce
Q 045449 679 ISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDV 758 (823)
Q Consensus 679 ~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv 758 (823)
+.|++++|.|+|+.+++||||||+||++++++.+||+|||+++....... .......++..|+|||++.+..++.++||
T Consensus 110 ~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv 188 (263)
T cd05052 110 ATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDV 188 (263)
T ss_pred HHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCcccccccccee-eccCCCCCccccCCHHHhccCCCCchhHH
Confidence 56888999999999999999999999999999999999999987643321 11122234678999999988899999999
Q ss_pred ehhhhhhccccC-CCCCcCCC
Q 045449 759 CSFGIISGGKET-RSMTVGET 778 (823)
Q Consensus 759 ~S~Gvv~~~~~~-~~~~~~~~ 778 (823)
|||||++|++.+ |..|+...
T Consensus 189 ~slG~il~el~t~g~~p~~~~ 209 (263)
T cd05052 189 WAFGVLLWEIATYGMSPYPGI 209 (263)
T ss_pred HHHHHHHHHHHcCCCCCCCCC
Confidence 999999999997 88887653
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.6e-21 Score=204.04 Aligned_cols=138 Identities=20% Similarity=0.248 Sum_probs=111.8
Q ss_pred CeEEEEEEehHhh-HHHHHHHHHHHHHHhhcchhhHHH-----------------------------------------H
Q 045449 641 GMEVAVKVFHQQY-ERALKSFEDECEVRKRIRHRNLVK-----------------------------------------I 678 (823)
Q Consensus 641 ~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~-----------------------------------------~ 678 (823)
+..||+|+++... ....+.|.+|+.++++++||||++ +
T Consensus 33 ~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~ 112 (266)
T cd05064 33 ELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGM 112 (266)
T ss_pred eeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHH
Confidence 4579999987543 344568999999999999999998 3
Q ss_pred HHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCcccccCCCccccccce
Q 045449 679 ISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDV 758 (823)
Q Consensus 679 ~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv 758 (823)
+.|++.+|.|+|+.+++||||||+||+++.++.+|++|||.+........ .......++..|+|||++.+..++.++||
T Consensus 113 ~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di 191 (266)
T cd05064 113 LPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAI-YTTMSGKSPVLWAAPEAIQYHHFSSASDV 191 (266)
T ss_pred HHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccccccccch-hcccCCCCceeecCHHHHhhCCccchhHH
Confidence 56788899999999999999999999999999999999998765422211 11112345678999999998999999999
Q ss_pred ehhhhhhcccc-CCCCCcCCCc
Q 045449 759 CSFGIISGGKE-TRSMTVGETC 779 (823)
Q Consensus 759 ~S~Gvv~~~~~-~~~~~~~~~~ 779 (823)
|||||++++++ +|..||.+..
T Consensus 192 ~slG~~l~ell~~g~~p~~~~~ 213 (266)
T cd05064 192 WSFGIVMWEVMSYGERPYWDMS 213 (266)
T ss_pred HHHHHHHHHHhcCCCCCcCcCC
Confidence 99999999965 5999987643
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=2e-21 Score=207.98 Aligned_cols=101 Identities=24% Similarity=0.280 Sum_probs=86.6
Q ss_pred HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCcc-----ccccccccCCCcCcccccCCCcc
Q 045449 678 IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQL-----SKQTQTLATIGYMAPEYGTKGRV 752 (823)
Q Consensus 678 ~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~ 752 (823)
++.|++.+|+|+|+.+|+||||||+|||++.++.+||+|||+|+........ .......||+.|+|||+..+..+
T Consensus 131 i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~ 210 (294)
T PHA02882 131 IMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACV 210 (294)
T ss_pred HHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCC
Confidence 4678899999999999999999999999999999999999999876432211 11123469999999999999999
Q ss_pred ccccceehhhhhhccccCCCCCcCCC
Q 045449 753 STRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 753 ~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
+.++||||+||+++++.+|..||.+.
T Consensus 211 ~~~~DiwSlG~~l~el~~g~~P~~~~ 236 (294)
T PHA02882 211 TRRGDLESLGYCMLKWAGIKLPWKGF 236 (294)
T ss_pred CcHHHHHHHHHHHHHHHhCCCCCCcc
Confidence 99999999999999999999999765
|
|
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.83 E-value=5.6e-21 Score=203.40 Aligned_cols=138 Identities=28% Similarity=0.359 Sum_probs=113.8
Q ss_pred CeEEEEEEehHhh-HHHHHHHHHHHHHHhhcchhhHHH-----------------------------------------H
Q 045449 641 GMEVAVKVFHQQY-ERALKSFEDECEVRKRIRHRNLVK-----------------------------------------I 678 (823)
Q Consensus 641 ~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~-----------------------------------------~ 678 (823)
+..||+|++.... ....+.|.+|++++++++||||++ +
T Consensus 33 ~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~l~~~~~~~i 112 (283)
T cd05080 33 GEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLF 112 (283)
T ss_pred CceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEEecCCCCCCHHHHHHHcCCCHHHHHHH
Confidence 4679999987543 334578899999999999999998 3
Q ss_pred HHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccc-cccccccCCCcCcccccCCCccccccc
Q 045449 679 ISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLS-KQTQTLATIGYMAPEYGTKGRVSTRGD 757 (823)
Q Consensus 679 ~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~D 757 (823)
+.|++.+|+|+|+.+|+||||||+||+++.++.+||+|||+++......... ......++..|+|||......++.++|
T Consensus 113 ~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~D 192 (283)
T cd05080 113 AQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASD 192 (283)
T ss_pred HHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccc
Confidence 5688889999999999999999999999999999999999998765332211 112234567799999998888999999
Q ss_pred eehhhhhhccccCCCCCcCCC
Q 045449 758 VCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 758 v~S~Gvv~~~~~~~~~~~~~~ 778 (823)
||||||+++++.+|..|+...
T Consensus 193 i~slG~~l~el~tg~~p~~~~ 213 (283)
T cd05080 193 VWSFGVTLYELLTHCDSKQSP 213 (283)
T ss_pred cHHHHHHHHHHHhCCCCCCCC
Confidence 999999999999999887654
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=6.6e-22 Score=214.94 Aligned_cols=132 Identities=23% Similarity=0.281 Sum_probs=108.2
Q ss_pred CeEEEEEEehHhhHHHHHHHHHHHHHHhhc-chhhHHH---------------------------------------HHH
Q 045449 641 GMEVAVKVFHQQYERALKSFEDECEVRKRI-RHRNLVK---------------------------------------IIS 680 (823)
Q Consensus 641 ~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~---------------------------------------~~~ 680 (823)
++..|||++.+. ..+-.+|+.++.+. .||||++ +++
T Consensus 347 ~~~~~vkii~~~----~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~g~ell~ri~~~~~~~~e~~~w~~ 422 (612)
T KOG0603|consen 347 DQEPAVKIISKR----ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLDGGELLRRIRSKPEFCSEASQWAA 422 (612)
T ss_pred ccchhheecccc----ccccccccchhhhhcCCCcceeecceecCCceeeeeehhccccHHHHHHHhcchhHHHHHHHHH
Confidence 455777777554 12344566555555 6888887 467
Q ss_pred HHHHHhhhcCCCCEEeccCCCCCEEe-CCCCcEEEeecccccccCCCCccccccccccCCCcCcccccCCCcccccccee
Q 045449 681 SSLEYLHFGHSIPIIHCDLKPSNVLL-DEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVC 759 (823)
Q Consensus 681 ~~l~~L~~~h~~~ivHrdlk~~NiLl-~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~ 759 (823)
+++.+++|+|++||||||+||+|||+ +..++++|+|||.++..... ..+.+-|..|.|||+.....|++.||+|
T Consensus 423 ~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~-----~~tp~~t~~y~APEvl~~~~yt~acD~W 497 (612)
T KOG0603|consen 423 ELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS-----CDTPALTLQYVAPEVLAIQEYTEACDWW 497 (612)
T ss_pred HHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh-----hcccchhhcccChhhhccCCCCcchhhH
Confidence 89999999999999999999999999 58899999999999987544 2345678999999999999999999999
Q ss_pred hhhhhhccccCCCCCcCCCccc
Q 045449 760 SFGIISGGKETRSMTVGETCTP 781 (823)
Q Consensus 760 S~Gvv~~~~~~~~~~~~~~~~~ 781 (823)
|+||++|+|++|..||..-...
T Consensus 498 SLGvlLy~ML~G~tp~~~~P~~ 519 (612)
T KOG0603|consen 498 SLGVLLYEMLTGRTLFAAHPAG 519 (612)
T ss_pred HHHHHHHHHHhCCCccccCCch
Confidence 9999999999999999766544
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.83 E-value=5.5e-21 Score=201.45 Aligned_cols=151 Identities=21% Similarity=0.363 Sum_probs=120.4
Q ss_pred ccCCccceeeccC---------------CeEEEEEEehHhh-HHHHHHHHHHHHHHhhcchhhHHH--------------
Q 045449 628 DRFSENNLIGIGN---------------GMEVAVKVFHQQY-ERALKSFEDECEVRKRIRHRNLVK-------------- 677 (823)
Q Consensus 628 ~~f~~~~~lg~g~---------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~-------------- 677 (823)
++|...+.+|.|+ ...||||+++... ....++|.+|+.++++++||||++
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 3455666666664 2458999886543 445578999999999999999998
Q ss_pred ---------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccc
Q 045449 678 ---------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLS 730 (823)
Q Consensus 678 ---------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~ 730 (823)
++.|++.+|+|+|+.+|+||||||+||+++.++.+|++|||+++.........
T Consensus 84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~ 163 (266)
T cd05033 84 TEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATY 163 (266)
T ss_pred EEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhcccccccce
Confidence 24678889999999999999999999999999999999999999875222211
Q ss_pred cccccccCCCcCcccccCCCccccccceehhhhhhccccC-CCCCcCCC
Q 045449 731 KQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKET-RSMTVGET 778 (823)
Q Consensus 731 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~-~~~~~~~~ 778 (823)
......++..|+|||...+..++.++|||||||+++++++ |..||.+.
T Consensus 164 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~ 212 (266)
T cd05033 164 TTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDM 212 (266)
T ss_pred eccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCC
Confidence 1222345678999999988889999999999999999886 88888654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.83 E-value=5e-21 Score=209.59 Aligned_cols=98 Identities=26% Similarity=0.321 Sum_probs=81.3
Q ss_pred HHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCcccccCCCccccccceeh
Q 045449 681 SSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCS 760 (823)
Q Consensus 681 ~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S 760 (823)
|++++|+|+|+.+|+||||||+||+++.++.+||+|||+++...............++..|+|||++.+..++.++||||
T Consensus 187 qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s 266 (343)
T cd05103 187 QVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWS 266 (343)
T ss_pred HHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCCCcceECcHHhcCCCCCchhhHHH
Confidence 67788999999999999999999999999999999999998754332222222334567899999998888999999999
Q ss_pred hhhhhccccC-CCCCcCCC
Q 045449 761 FGIISGGKET-RSMTVGET 778 (823)
Q Consensus 761 ~Gvv~~~~~~-~~~~~~~~ 778 (823)
|||+++++++ |..|+...
T Consensus 267 lG~~l~el~~~g~~p~~~~ 285 (343)
T cd05103 267 FGVLLWEIFSLGASPYPGV 285 (343)
T ss_pred HHHHHHHHHHCCCCCCCCc
Confidence 9999999985 88887653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.5e-21 Score=209.51 Aligned_cols=139 Identities=27% Similarity=0.419 Sum_probs=114.6
Q ss_pred ceeeccCCeEEEEEEehHh-----------------hHHHHHHHHHHHHHHhhcchhhHHHH------------------
Q 045449 634 NLIGIGNGMEVAVKVFHQQ-----------------YERALKSFEDECEVRKRIRHRNLVKI------------------ 678 (823)
Q Consensus 634 ~~lg~g~~~~vavK~~~~~-----------------~~~~~~~~~~E~~~l~~l~h~niv~~------------------ 678 (823)
.++|+|. ..++-|.++.. .....++|..|+++++.|+|||||++
T Consensus 46 evLGrGa-fKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL 124 (632)
T KOG0584|consen 46 EVLGRGA-FKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL 124 (632)
T ss_pred hhccccc-ceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence 5778887 45555555321 12345789999999999999999992
Q ss_pred ------------------------HHHHHHHhhhcCC--CCEEeccCCCCCEEeCCC-CcEEEeecccccccCCCCcccc
Q 045449 679 ------------------------ISSSLEYLHFGHS--IPIIHCDLKPSNVLLDED-MVAHISDFGIAKLLSGEDQLSK 731 (823)
Q Consensus 679 ------------------------~~~~l~~L~~~h~--~~ivHrdlk~~NiLl~~~-~~~kl~DfGla~~~~~~~~~~~ 731 (823)
..|++.+|+|+|+ ++|+|||||.+||++++. |.+||.|.|+|+..... .
T Consensus 125 ~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s----~ 200 (632)
T KOG0584|consen 125 FTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS----H 200 (632)
T ss_pred ccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhcc----c
Confidence 4688888888876 689999999999999855 89999999999987543 2
Q ss_pred ccccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCCC
Q 045449 732 QTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 732 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
....+|||.|||||+.. ..|++.+||||||+.+.||.|+.+|+.+.
T Consensus 201 aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC 246 (632)
T KOG0584|consen 201 AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSEC 246 (632)
T ss_pred cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhh
Confidence 34579999999999876 78999999999999999999999999875
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.83 E-value=8e-21 Score=208.17 Aligned_cols=157 Identities=31% Similarity=0.379 Sum_probs=131.0
Q ss_pred cccCHHHHHHHhccCCccceeeccC------------CeEEEEEEehHhh--HHHHHHHHHHHHHHhhcchhhHHH----
Q 045449 616 RRFSYHELLRATDRFSENNLIGIGN------------GMEVAVKVFHQQY--ERALKSFEDECEVRKRIRHRNLVK---- 677 (823)
Q Consensus 616 ~~~~~~~l~~at~~f~~~~~lg~g~------------~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~---- 677 (823)
+.....++..++++|...+.||.|+ +..||||++.... ....+.+.+|++++++++||||++
T Consensus 5 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~ 84 (345)
T cd07877 5 RQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 84 (345)
T ss_pred hhhHHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeee
Confidence 4456678888999999999999885 5679999986432 233467889999999999999987
Q ss_pred ----------------------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeec
Q 045449 678 ----------------------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDF 717 (823)
Q Consensus 678 ----------------------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~Df 717 (823)
++.|++.+|+|+|+.+|+||||||+||++++++.+||+||
T Consensus 85 ~~~~~~~~~~~~~~lv~~~~~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~df 164 (345)
T cd07877 85 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDF 164 (345)
T ss_pred eeecccccccccEEEEehhcccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEecc
Confidence 3468889999999999999999999999999999999999
Q ss_pred ccccccCCCCccccccccccCCCcCcccccCC-CccccccceehhhhhhccccCCCCCcCC
Q 045449 718 GIAKLLSGEDQLSKQTQTLATIGYMAPEYGTK-GRVSTRGDVCSFGIISGGKETRSMTVGE 777 (823)
Q Consensus 718 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~ 777 (823)
|+++..... .....|+..|+|||+..+ ..++.++||||+||+++++.+|..||..
T Consensus 165 g~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~ 220 (345)
T cd07877 165 GLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 220 (345)
T ss_pred ccccccccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 998864321 233568899999998765 4688999999999999999999998854
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=99.83 E-value=4e-21 Score=201.88 Aligned_cols=149 Identities=26% Similarity=0.406 Sum_probs=119.7
Q ss_pred ccCCccceeeccC-----------CeEEEEEEehHhhHHHHHHHHHHHHHHhhcchhhHHH-------------------
Q 045449 628 DRFSENNLIGIGN-----------GMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVK------------------- 677 (823)
Q Consensus 628 ~~f~~~~~lg~g~-----------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------------- 677 (823)
++|+..+.+|+|+ +..||+|.+..... ..+.+.+|+.++++++|+||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 84 (261)
T cd05072 6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTM-SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMA 84 (261)
T ss_pred HHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCch-hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCC
Confidence 3455556666664 35689998765432 3478999999999999999998
Q ss_pred -----------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccc
Q 045449 678 -----------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQ 734 (823)
Q Consensus 678 -----------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 734 (823)
++.|++++|+|+|+.+++||||||+||+++.++.+||+|||+++....... .....
T Consensus 85 ~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-~~~~~ 163 (261)
T cd05072 85 KGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY-TAREG 163 (261)
T ss_pred CCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCCce-eccCC
Confidence 246788899999999999999999999999999999999999987643221 11223
Q ss_pred cccCCCcCcccccCCCccccccceehhhhhhccccC-CCCCcCCC
Q 045449 735 TLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKET-RSMTVGET 778 (823)
Q Consensus 735 ~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~-~~~~~~~~ 778 (823)
..++..|+|||+...+.++.++|||||||++|++++ |..||.+.
T Consensus 164 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~ 208 (261)
T cd05072 164 AKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGM 208 (261)
T ss_pred CccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCC
Confidence 346778999999988889999999999999999998 88888653
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=99.82 E-value=3.9e-21 Score=213.53 Aligned_cols=98 Identities=26% Similarity=0.313 Sum_probs=82.2
Q ss_pred HHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCcccccCCCccccccceeh
Q 045449 681 SSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCS 760 (823)
Q Consensus 681 ~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S 760 (823)
|++++|.|+|+.+|+||||||+||+++.++.+||+|||+++...............++..|+|||++.+..++.++||||
T Consensus 245 qi~~aL~~LH~~~ivH~dikp~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwS 324 (400)
T cd05105 245 QVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWS 324 (400)
T ss_pred HHHHHHHHHHhCCeeCCCCChHhEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHH
Confidence 46788999999999999999999999999999999999998764333222223345778999999998888999999999
Q ss_pred hhhhhccccC-CCCCcCCC
Q 045449 761 FGIISGGKET-RSMTVGET 778 (823)
Q Consensus 761 ~Gvv~~~~~~-~~~~~~~~ 778 (823)
|||+++++++ |..||...
T Consensus 325 lGvil~ellt~g~~P~~~~ 343 (400)
T cd05105 325 YGILLWEIFSLGGTPYPGM 343 (400)
T ss_pred HHHHHHHHHHCCCCCCccc
Confidence 9999999985 88887653
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=99.82 E-value=6e-21 Score=201.43 Aligned_cols=155 Identities=30% Similarity=0.403 Sum_probs=125.9
Q ss_pred HHHHHhccCCccceeeccC------------CeEEEEEEehHhhHHHHHHHHHHHHHHhhcchhhHHH------------
Q 045449 622 ELLRATDRFSENNLIGIGN------------GMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVK------------ 677 (823)
Q Consensus 622 ~l~~at~~f~~~~~lg~g~------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------ 677 (823)
|+..+++.+.....+|+|+ +..||+|.+........+.+.+|++++++++|+||++
T Consensus 2 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 81 (268)
T cd06624 2 EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFK 81 (268)
T ss_pred CcccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEE
Confidence 3455677777777888875 4568999887666666678999999999999999998
Q ss_pred -------------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCC-CCcEEEeecccccccCC
Q 045449 678 -------------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDE-DMVAHISDFGIAKLLSG 725 (823)
Q Consensus 678 -------------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~-~~~~kl~DfGla~~~~~ 725 (823)
++.|++.+|.|+|+.+|+||||||+||+++. ++.+||+|||.+.....
T Consensus 82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~ 161 (268)
T cd06624 82 IFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG 161 (268)
T ss_pred EEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheeccc
Confidence 2357888999999999999999999999986 67999999999876543
Q ss_pred CCccccccccccCCCcCcccccCCCc--cccccceehhhhhhccccCCCCCcCCC
Q 045449 726 EDQLSKQTQTLATIGYMAPEYGTKGR--VSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 726 ~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
... ......|++.|+|||+..... ++.++|||||||+++++.+|..|+.+.
T Consensus 162 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~ 214 (268)
T cd06624 162 INP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIEL 214 (268)
T ss_pred CCC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccc
Confidence 221 122345889999999986644 789999999999999999999998654
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.82 E-value=6.2e-21 Score=200.87 Aligned_cols=150 Identities=25% Similarity=0.281 Sum_probs=121.8
Q ss_pred cCCccceeeccC------------CeEEEEEEehHh-----hHHHHHHHHHHHHHHhhcchhhHHH--------------
Q 045449 629 RFSENNLIGIGN------------GMEVAVKVFHQQ-----YERALKSFEDECEVRKRIRHRNLVK-------------- 677 (823)
Q Consensus 629 ~f~~~~~lg~g~------------~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~-------------- 677 (823)
+|...+.+|.|+ +..||+|++... .....+.|.+|++++++++|+||++
T Consensus 3 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (264)
T cd06653 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLS 82 (264)
T ss_pred ceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEE
Confidence 456666777664 567999987422 2344568999999999999999998
Q ss_pred ----------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCc-
Q 045449 678 ----------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQ- 728 (823)
Q Consensus 678 ----------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~- 728 (823)
++.|++++|.|+|+.+++|||+||+||+++.++.++|+|||+++.......
T Consensus 83 ~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~ 162 (264)
T cd06653 83 IFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMS 162 (264)
T ss_pred EEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcccccccccccccc
Confidence 346888999999999999999999999999999999999999986532111
Q ss_pred cccccccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCCC
Q 045449 729 LSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 729 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
........|+..|+|||+..+..++.++|||||||+++++.+|..||.+.
T Consensus 163 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 212 (264)
T cd06653 163 GTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEY 212 (264)
T ss_pred CccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCcc
Confidence 01112346899999999998888999999999999999999999999765
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.82 E-value=4.9e-21 Score=203.05 Aligned_cols=137 Identities=25% Similarity=0.373 Sum_probs=113.3
Q ss_pred eEEEEEEehHhh-HHHHHHHHHHHHHHhhcchhhHHH-------------------------------------------
Q 045449 642 MEVAVKVFHQQY-ERALKSFEDECEVRKRIRHRNLVK------------------------------------------- 677 (823)
Q Consensus 642 ~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~------------------------------------------- 677 (823)
..||+|.+.... ......|.+|+.++.+++|+||++
T Consensus 37 ~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 116 (277)
T cd05032 37 TRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPP 116 (277)
T ss_pred eeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCC
Confidence 569999986443 344567899999999999999997
Q ss_pred -------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCcccccCCC
Q 045449 678 -------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKG 750 (823)
Q Consensus 678 -------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 750 (823)
++.|++.+|.|+|+.+++||||||+||+++.++.+||+|||+++...............++..|+|||.+..+
T Consensus 117 ~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 196 (277)
T cd05032 117 TLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDG 196 (277)
T ss_pred CHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEECCcccchhhccCcccccCCCCCccccccCHHHHhcC
Confidence 1357788999999999999999999999999999999999999876544332233344578899999999888
Q ss_pred ccccccceehhhhhhccccC-CCCCcCCC
Q 045449 751 RVSTRGDVCSFGIISGGKET-RSMTVGET 778 (823)
Q Consensus 751 ~~~~~~Dv~S~Gvv~~~~~~-~~~~~~~~ 778 (823)
.++.++|||||||+++++.+ |..||.+.
T Consensus 197 ~~~~~~Di~slG~il~el~t~g~~p~~~~ 225 (277)
T cd05032 197 VFTTKSDVWSFGVVLWEMATLAEQPYQGL 225 (277)
T ss_pred CCCcccchHHHHHHHHHhhccCCCCCccC
Confidence 89999999999999999997 88887653
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=99.82 E-value=5.8e-21 Score=200.22 Aligned_cols=139 Identities=23% Similarity=0.321 Sum_probs=114.8
Q ss_pred CCeEEEEEEehHhh--HHHHHHHHHHHHHHhhcchhhHHH---------------------------------------H
Q 045449 640 NGMEVAVKVFHQQY--ERALKSFEDECEVRKRIRHRNLVK---------------------------------------I 678 (823)
Q Consensus 640 ~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~---------------------------------------~ 678 (823)
.+..||||++.... ....++|.+|+.++++++|+||++ +
T Consensus 21 ~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i 100 (257)
T cd05116 21 SEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEAESWMLVMELAELGPLNKFLQKNKHVTEKNITEL 100 (257)
T ss_pred CceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCcEEEEecCCCCcHHHHHHhcCCCCHHHHHHH
Confidence 35789999986432 345678999999999999999997 3
Q ss_pred HHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccc-cccccccCCCcCcccccCCCccccccc
Q 045449 679 ISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLS-KQTQTLATIGYMAPEYGTKGRVSTRGD 757 (823)
Q Consensus 679 ~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~D 757 (823)
+.|++.+|+++|+++|+||||||+||+++.++.+||+|||+++......... ......++..|+|||.+....++.++|
T Consensus 101 ~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D 180 (257)
T cd05116 101 VHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSD 180 (257)
T ss_pred HHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCCCCCccccCHhHhccCCcCchhH
Confidence 5688899999999999999999999999999999999999998764433211 112234467999999988888999999
Q ss_pred eehhhhhhccccC-CCCCcCCC
Q 045449 758 VCSFGIISGGKET-RSMTVGET 778 (823)
Q Consensus 758 v~S~Gvv~~~~~~-~~~~~~~~ 778 (823)
||||||++|++.+ |..||...
T Consensus 181 i~slG~~l~el~t~g~~p~~~~ 202 (257)
T cd05116 181 VWSFGVLMWEAFSYGQKPYKGM 202 (257)
T ss_pred HHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999999997 88898764
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=99.82 E-value=7.5e-21 Score=199.03 Aligned_cols=137 Identities=24% Similarity=0.277 Sum_probs=116.0
Q ss_pred CeEEEEEEehHh--hHHHHHHHHHHHHHHhhcchhhHHH-----------------------------------------
Q 045449 641 GMEVAVKVFHQQ--YERALKSFEDECEVRKRIRHRNLVK----------------------------------------- 677 (823)
Q Consensus 641 ~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~----------------------------------------- 677 (823)
+..||+|.+... .....+.+.+|++++++++|||+++
T Consensus 25 ~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 104 (256)
T cd08529 25 KRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVW 104 (256)
T ss_pred CcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeCCCCcHHHHHHHhcCCCCCHHHHH
Confidence 577999988643 2445678999999999999999998
Q ss_pred -HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCcccccCCCcccccc
Q 045449 678 -IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRG 756 (823)
Q Consensus 678 -~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 756 (823)
++.+++.+|.|+|+.+++|||+||+||+++.++.+||+|||+++....... ......|++.|+|||+..+..++.++
T Consensus 105 ~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~ 182 (256)
T cd08529 105 RFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN--FANTIVGTPYYLSPELCEDKPYNEKS 182 (256)
T ss_pred HHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCccc--hhhccccCccccCHHHhcCCCCCCcc
Confidence 245788889999999999999999999999999999999999987654322 12334688999999999988899999
Q ss_pred ceehhhhhhccccCCCCCcCCCc
Q 045449 757 DVCSFGIISGGKETRSMTVGETC 779 (823)
Q Consensus 757 Dv~S~Gvv~~~~~~~~~~~~~~~ 779 (823)
|||||||+++++.+|..||....
T Consensus 183 Di~slG~il~~l~~g~~p~~~~~ 205 (256)
T cd08529 183 DVWALGVVLYECCTGKHPFDANN 205 (256)
T ss_pred chHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999986543
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.6e-21 Score=224.97 Aligned_cols=136 Identities=26% Similarity=0.400 Sum_probs=112.6
Q ss_pred EEEEEEehHhh-HHHHHHHHHHHHHHhhcchhhHHH--------------------------------------------
Q 045449 643 EVAVKVFHQQY-ERALKSFEDECEVRKRIRHRNLVK-------------------------------------------- 677 (823)
Q Consensus 643 ~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~-------------------------------------------- 677 (823)
.||||.+.+.. .+.+.+|.+|+.+|++++|||||+
T Consensus 724 ~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~d 803 (1025)
T KOG1095|consen 724 QVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRD 803 (1025)
T ss_pred EEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHH
Confidence 38999997654 566789999999999999999999
Q ss_pred ---HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCcccccCCCcccc
Q 045449 678 ---IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVST 754 (823)
Q Consensus 678 ---~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 754 (823)
+..+++.+++|+++..+|||||-.+|+|++.+..+||+|||+||.+...+.+.......-...|||||.+..+.++.
T Consensus 804 Ll~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFts 883 (1025)
T KOG1095|consen 804 LLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTS 883 (1025)
T ss_pred HHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEcccchhHhhhhchheeccCccccceecCCHHHHhhccccc
Confidence 12355566666678889999999999999999999999999999666555554443333457899999999999999
Q ss_pred ccceehhhhhhccccC-CCCCcCCC
Q 045449 755 RGDVCSFGIISGGKET-RSMTVGET 778 (823)
Q Consensus 755 ~~Dv~S~Gvv~~~~~~-~~~~~~~~ 778 (823)
|+|||||||++||+++ |..||.+.
T Consensus 884 kSDvWsFGVllWEifslG~~PY~~~ 908 (1025)
T KOG1095|consen 884 KSDVWSFGVLLWEIFSLGATPYPSR 908 (1025)
T ss_pred ccchhhhHHHHHHHHhCCCCCCCCc
Confidence 9999999999999987 66777664
|
|
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=99.82 E-value=5.2e-21 Score=201.51 Aligned_cols=150 Identities=25% Similarity=0.293 Sum_probs=120.9
Q ss_pred cCCccceeeccC------------CeEEEEEEehHh-----hHHHHHHHHHHHHHHhhcchhhHHH--------------
Q 045449 629 RFSENNLIGIGN------------GMEVAVKVFHQQ-----YERALKSFEDECEVRKRIRHRNLVK-------------- 677 (823)
Q Consensus 629 ~f~~~~~lg~g~------------~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~-------------- 677 (823)
+|...+.+|.|+ +..||||.+... .....+.+.+|++++++++||||++
T Consensus 3 ~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (265)
T cd06652 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLS 82 (265)
T ss_pred cceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEE
Confidence 455566666664 567999987532 1234578899999999999999997
Q ss_pred ----------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCcc
Q 045449 678 ----------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQL 729 (823)
Q Consensus 678 ----------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~ 729 (823)
++.|++.+|+++|+.+++||||||+||+++.++.+||+|||+++........
T Consensus 83 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~ 162 (265)
T cd06652 83 IFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLS 162 (265)
T ss_pred EEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCcccccccccccc
Confidence 3567888999999999999999999999999999999999999865322111
Q ss_pred -ccccccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCCC
Q 045449 730 -SKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 730 -~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
.......|+..|+|||+..+..++.++|||||||++|++.+|..||.+.
T Consensus 163 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~ 212 (265)
T cd06652 163 GTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEF 212 (265)
T ss_pred ccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCcc
Confidence 1122346889999999998888999999999999999999999998764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=99.82 E-value=5.8e-21 Score=200.12 Aligned_cols=137 Identities=23% Similarity=0.304 Sum_probs=115.8
Q ss_pred eEEEEEEehHhhH-HHHHHHHHHHHHHhhcchhhHHH-----------------------------------------HH
Q 045449 642 MEVAVKVFHQQYE-RALKSFEDECEVRKRIRHRNLVK-----------------------------------------II 679 (823)
Q Consensus 642 ~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~-----------------------------------------~~ 679 (823)
..||||++..... ...++|.+|++++++++||||++ ++
T Consensus 24 ~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 103 (257)
T cd05040 24 IPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLTHPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYA 103 (257)
T ss_pred eEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcCCeEEEEEEecCCCcHHHHHHhcccccCcHHHHHHHH
Confidence 4699999986655 56688999999999999999997 24
Q ss_pred HHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCcc-ccccccccCCCcCcccccCCCccccccce
Q 045449 680 SSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQL-SKQTQTLATIGYMAPEYGTKGRVSTRGDV 758 (823)
Q Consensus 680 ~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv 758 (823)
.|++++|+++|+.+++||||||+||+++.++.+||+|||+++........ .......++..|+|||++.+..++.++||
T Consensus 104 ~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di 183 (257)
T cd05040 104 VQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDV 183 (257)
T ss_pred HHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccceecccCCCCCceecCHHHhcccCcCchhhh
Confidence 58889999999999999999999999999999999999999876543221 11223457889999999988889999999
Q ss_pred ehhhhhhccccC-CCCCcCCC
Q 045449 759 CSFGIISGGKET-RSMTVGET 778 (823)
Q Consensus 759 ~S~Gvv~~~~~~-~~~~~~~~ 778 (823)
|||||+++++.+ |..||...
T Consensus 184 ~slG~~l~el~t~g~~p~~~~ 204 (257)
T cd05040 184 WMFGVTLWEMFTYGEEPWAGL 204 (257)
T ss_pred HHHHHHHHHHHhCCCCCCCCC
Confidence 999999999997 99988653
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=99.82 E-value=4e-21 Score=201.82 Aligned_cols=136 Identities=28% Similarity=0.439 Sum_probs=114.9
Q ss_pred CeEEEEEEehHhhHHHHHHHHHHHHHHhhcchhhHHH------------------------------------------H
Q 045449 641 GMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVK------------------------------------------I 678 (823)
Q Consensus 641 ~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------------------------------------~ 678 (823)
+..||+|++..........+.+|++++++++|+||++ +
T Consensus 30 ~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ 109 (261)
T cd05148 30 RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDM 109 (261)
T ss_pred CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeecccCCHHHHHhcCCCCCCCHHHHHHH
Confidence 4668999998766656678999999999999999998 2
Q ss_pred HHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCcccccCCCccccccce
Q 045449 679 ISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDV 758 (823)
Q Consensus 679 ~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv 758 (823)
+.|++.+|+|+|+.+++||||||+||++++++.+||+|||.+........ ......++..|+|||+.....++.++||
T Consensus 110 ~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~Di 187 (261)
T cd05148 110 ACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY--LSSDKKIPYKWTAPEAASHGTFSTKSDV 187 (261)
T ss_pred HHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCccc--cccCCCCceEecCHHHHccCCCCchhhH
Confidence 46788899999999999999999999999999999999999987643221 1223446778999999988889999999
Q ss_pred ehhhhhhccccC-CCCCcCCC
Q 045449 759 CSFGIISGGKET-RSMTVGET 778 (823)
Q Consensus 759 ~S~Gvv~~~~~~-~~~~~~~~ 778 (823)
|||||+++++.+ |..||...
T Consensus 188 wslG~~l~~l~~~g~~p~~~~ 208 (261)
T cd05148 188 WSFGILLYEMFTYGQVPYPGM 208 (261)
T ss_pred HHHHHHHHHHHcCCCCCCCcC
Confidence 999999999998 78888654
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.82 E-value=6.4e-21 Score=205.11 Aligned_cols=136 Identities=24% Similarity=0.329 Sum_probs=111.3
Q ss_pred EEEEEEehHhh-HHHHHHHHHHHHHHhhcchhhHHH----------------------------------------HHHH
Q 045449 643 EVAVKVFHQQY-ERALKSFEDECEVRKRIRHRNLVK----------------------------------------IISS 681 (823)
Q Consensus 643 ~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~----------------------------------------~~~~ 681 (823)
.||+|++.... .....++.+|+.++++++||||++ ++.|
T Consensus 38 ~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~q 117 (303)
T cd05110 38 PVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQ 117 (303)
T ss_pred eEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCCCceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHH
Confidence 47889886543 344457899999999999999998 2458
Q ss_pred HHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCcccccCCCccccccceehh
Q 045449 682 SLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSF 761 (823)
Q Consensus 682 ~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~ 761 (823)
++.+|.|+|+.+|+||||||+||+++.++.+||+|||+++...............++..|+|||++.+..++.++|||||
T Consensus 118 i~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Diwsl 197 (303)
T cd05110 118 IAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSY 197 (303)
T ss_pred HHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHH
Confidence 88899999999999999999999999999999999999987653332212223446788999999988889999999999
Q ss_pred hhhhccccC-CCCCcCCC
Q 045449 762 GIISGGKET-RSMTVGET 778 (823)
Q Consensus 762 Gvv~~~~~~-~~~~~~~~ 778 (823)
||++|++++ |..||.+.
T Consensus 198 G~~l~el~t~g~~p~~~~ 215 (303)
T cd05110 198 GVTIWELMTFGGKPYDGI 215 (303)
T ss_pred HHHHHHHHhCCCCCCCCC
Confidence 999999886 88888654
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=5.2e-21 Score=210.52 Aligned_cols=141 Identities=21% Similarity=0.250 Sum_probs=115.1
Q ss_pred HhccCCccceeeccC------------CeEEEEEEehHhhHHHHHHHHHHHHHHhhcchhhHHH----------------
Q 045449 626 ATDRFSENNLIGIGN------------GMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVK---------------- 677 (823)
Q Consensus 626 at~~f~~~~~lg~g~------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~---------------- 677 (823)
...+|...+.||.|+ +..||+|+.... ....|+.++++++|+||++
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 137 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP 137 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence 345688888888875 346888875332 3456999999999999998
Q ss_pred ------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCcccccc
Q 045449 678 ------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQT 733 (823)
Q Consensus 678 ------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~ 733 (823)
++.|++.+|.|+|+.+|+||||||+|||++.++.+||+|||+++...... ...
T Consensus 138 ~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~---~~~ 214 (357)
T PHA03209 138 HYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP---AFL 214 (357)
T ss_pred ccCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccCc---ccc
Confidence 35688999999999999999999999999999999999999997543221 123
Q ss_pred ccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCc
Q 045449 734 QTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTV 775 (823)
Q Consensus 734 ~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~ 775 (823)
...||+.|+|||++.+..++.++|||||||++|+++++..++
T Consensus 215 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 215 GLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred cccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 456999999999999999999999999999999998755443
|
|
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=99.82 E-value=6.3e-21 Score=199.24 Aligned_cols=139 Identities=27% Similarity=0.336 Sum_probs=111.7
Q ss_pred CCeEEEEEEehHhh-HHHHHHHHHHHHHHhhcchhhHHH-----------------------------------------
Q 045449 640 NGMEVAVKVFHQQY-ERALKSFEDECEVRKRIRHRNLVK----------------------------------------- 677 (823)
Q Consensus 640 ~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~----------------------------------------- 677 (823)
.++.||+|.+.... ......|.+|++++++++||||++
T Consensus 19 ~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~ 98 (252)
T cd05084 19 DNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQ 98 (252)
T ss_pred CCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcHHHHHHhCCCCCCHHHHHH
Confidence 35789999876433 344578999999999999999998
Q ss_pred HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCcccccCCCccccccc
Q 045449 678 IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGD 757 (823)
Q Consensus 678 ~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D 757 (823)
++.|++++|.|+|+.+++||||||+||+++.++.+||+|||+++...............++..|+|||.+.++.++.++|
T Consensus 99 ~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D 178 (252)
T cd05084 99 MVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESD 178 (252)
T ss_pred HHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCCCceeecCchhhcCCCCChHHH
Confidence 35688889999999999999999999999999999999999998654221111111112345799999998889999999
Q ss_pred eehhhhhhccccC-CCCCcCCC
Q 045449 758 VCSFGIISGGKET-RSMTVGET 778 (823)
Q Consensus 758 v~S~Gvv~~~~~~-~~~~~~~~ 778 (823)
|||+||++|++.+ |..|+...
T Consensus 179 v~slG~il~e~~~~~~~p~~~~ 200 (252)
T cd05084 179 VWSFGILLWEAFSLGAVPYANL 200 (252)
T ss_pred HHHHHHHHHHHHhCCCCCcccc
Confidence 9999999999997 77777543
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=2e-21 Score=207.62 Aligned_cols=134 Identities=28% Similarity=0.316 Sum_probs=114.1
Q ss_pred EEEEEEehHhhHHHHHHHHHHHHHHhhcchhhHHHH-----------------------------------------HHH
Q 045449 643 EVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVKI-----------------------------------------ISS 681 (823)
Q Consensus 643 ~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~-----------------------------------------~~~ 681 (823)
..|.|++.-..+...++|.-||+|++.+.||+||++ ..|
T Consensus 59 lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q 138 (1187)
T KOG0579|consen 59 LAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQ 138 (1187)
T ss_pred hhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCCchHhHHHHHhccccchHHHHHHHHH
Confidence 357788877777778999999999999999999993 357
Q ss_pred HHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCcccccC-----CCcccccc
Q 045449 682 SLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGT-----KGRVSTRG 756 (823)
Q Consensus 682 ~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~ 756 (823)
.+++|.|+|+..|+|||+|..|||++.+|.++|+|||++...... ......++|||+|||||++. ..+|+.++
T Consensus 139 ~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t--~qkRDsFIGTPYWMAPEVvmCET~KD~PYDyka 216 (1187)
T KOG0579|consen 139 VLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKST--RQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKA 216 (1187)
T ss_pred HHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchhH--HhhhccccCCcccccchheeeccccCCCchhhh
Confidence 899999999999999999999999999999999999987653221 22345689999999999864 46799999
Q ss_pred ceehhhhhhccccCCCCCcCCC
Q 045449 757 DVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 757 Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
||||||+.+-+|..+..|-.+.
T Consensus 217 DiWSlGITLIEMAqiEPPHhel 238 (1187)
T KOG0579|consen 217 DIWSLGITLIEMAQIEPPHHEL 238 (1187)
T ss_pred hHHhhhhHHHHHhccCCCcccc
Confidence 9999999999999988876654
|
|
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.82 E-value=4.9e-21 Score=205.26 Aligned_cols=136 Identities=27% Similarity=0.369 Sum_probs=115.7
Q ss_pred CeEEEEEEehHhhHHHHHHHHHHHHHHhhcchhhHHH---------------------------------------HHHH
Q 045449 641 GMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVK---------------------------------------IISS 681 (823)
Q Consensus 641 ~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~---------------------------------------~~~~ 681 (823)
+..||+|.+........+.+.+|+.++++++|+|+++ ++.|
T Consensus 45 ~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~i~~q 124 (296)
T cd06654 45 GQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRE 124 (296)
T ss_pred CcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecccCCCCHHHHHHhcCCCHHHHHHHHHH
Confidence 5679999887655445578999999999999999998 2457
Q ss_pred HHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCcccccCCCccccccceehh
Q 045449 682 SLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSF 761 (823)
Q Consensus 682 ~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~ 761 (823)
++.+|.|+|+.+|+||||||+||+++.++.+||+|||+++....... ......|++.|+|||...+..++.++|||||
T Consensus 125 l~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~ 202 (296)
T cd06654 125 CLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSL 202 (296)
T ss_pred HHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhcccccc--ccCcccCCccccCHHHHcCCCCCccchHHHH
Confidence 88899999999999999999999999999999999999886543321 1233468999999999988889999999999
Q ss_pred hhhhccccCCCCCcCCC
Q 045449 762 GIISGGKETRSMTVGET 778 (823)
Q Consensus 762 Gvv~~~~~~~~~~~~~~ 778 (823)
||++|++++|..||...
T Consensus 203 Gvil~~l~~g~~pf~~~ 219 (296)
T cd06654 203 GIMAIEMIEGEPPYLNE 219 (296)
T ss_pred HHHHHHHHhCCCCCCCC
Confidence 99999999999998654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=99.82 E-value=1e-20 Score=199.40 Aligned_cols=136 Identities=23% Similarity=0.321 Sum_probs=114.0
Q ss_pred CeEEEEEEehHh---hHHHHHHHHHHHHHHhhcchhhHHH----------------------------------------
Q 045449 641 GMEVAVKVFHQQ---YERALKSFEDECEVRKRIRHRNLVK---------------------------------------- 677 (823)
Q Consensus 641 ~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~---------------------------------------- 677 (823)
+..||||.+... .....++|.+|++++++++|+||++
T Consensus 27 ~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~ 106 (267)
T cd08229 27 GVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEK 106 (267)
T ss_pred CceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEEecCCCCHHHHHHHhhccCCCCCHH
Confidence 577999987542 2344568999999999999999998
Q ss_pred ----HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCcccccCCCccc
Q 045449 678 ----IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVS 753 (823)
Q Consensus 678 ----~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 753 (823)
++.|++++|.|+|+.+++|+||||+||+++.++.++++|||+++....... ......|+..|+|||+..+..++
T Consensus 107 ~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~~ape~~~~~~~~ 184 (267)
T cd08229 107 TVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT--AAHSLVGTPYYMSPERIHENGYN 184 (267)
T ss_pred HHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccCCc--ccccccCCcCccCHHHhcCCCcc
Confidence 245788899999999999999999999999999999999999887643322 12234689999999999888899
Q ss_pred cccceehhhhhhccccCCCCCcCCC
Q 045449 754 TRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 754 ~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
.++|||||||+++++.+|..||...
T Consensus 185 ~~~Dv~slG~il~~l~~g~~p~~~~ 209 (267)
T cd08229 185 FKSDIWSLGCLLYEMAALQSPFYGD 209 (267)
T ss_pred chhhHHHHHHHHHHHHhCCCCcccc
Confidence 9999999999999999999998653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.2e-20 Score=197.63 Aligned_cols=136 Identities=21% Similarity=0.258 Sum_probs=115.3
Q ss_pred CeEEEEEEehHh-hHHHHHHHHHHHHHHhhcchhhHHH------------------------------------------
Q 045449 641 GMEVAVKVFHQQ-YERALKSFEDECEVRKRIRHRNLVK------------------------------------------ 677 (823)
Q Consensus 641 ~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~------------------------------------------ 677 (823)
+..||+|.++.. .....+.+.+|+.++++++|+||++
T Consensus 25 ~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~ 104 (255)
T cd08219 25 DQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQ 104 (255)
T ss_pred CceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCCCCcHHHHHHhccCCCCCHHHHHH
Confidence 567899988532 2445578899999999999999988
Q ss_pred HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCcccccCCCccccccc
Q 045449 678 IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGD 757 (823)
Q Consensus 678 ~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D 757 (823)
++.|++.+|.++|+.+|+|+||||+||+++.++.++++|||.++....... ......|++.|+|||+..+..++.++|
T Consensus 105 ~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~D 182 (255)
T cd08219 105 WFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA--YACTYVGTPYYVPPEIWENMPYNNKSD 182 (255)
T ss_pred HHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeeccccc--ccccccCCccccCHHHHccCCcCchhh
Confidence 357888999999999999999999999999999999999999987643322 123356899999999998888999999
Q ss_pred eehhhhhhccccCCCCCcCCC
Q 045449 758 VCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 758 v~S~Gvv~~~~~~~~~~~~~~ 778 (823)
|||||++++++.+|..||...
T Consensus 183 v~slG~i~~~l~~g~~p~~~~ 203 (255)
T cd08219 183 IWSLGCILYELCTLKHPFQAN 203 (255)
T ss_pred hhhhchhheehhhccCCCCCC
Confidence 999999999999999998754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=99.82 E-value=6.9e-21 Score=199.98 Aligned_cols=148 Identities=26% Similarity=0.408 Sum_probs=120.0
Q ss_pred cCCccceeeccC-----------CeEEEEEEehHhhHHHHHHHHHHHHHHhhcchhhHHH--------------------
Q 045449 629 RFSENNLIGIGN-----------GMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVK-------------------- 677 (823)
Q Consensus 629 ~f~~~~~lg~g~-----------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-------------------- 677 (823)
+|...++||.|+ +..||+|.+..... ..++|.+|+.++++++|+||++
T Consensus 7 ~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v~e~~~~~ 85 (260)
T cd05067 7 TLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVTQEPIYIITEYMENG 85 (260)
T ss_pred HceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEccCCcEEEEEcCCCC
Confidence 445556666654 46799999875432 3367999999999999999988
Q ss_pred ---------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccc
Q 045449 678 ---------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTL 736 (823)
Q Consensus 678 ---------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~ 736 (823)
++.|++.+|+|+|+.+++||||||+||+++.++.++++|||+++....... .......
T Consensus 86 ~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~ 164 (260)
T cd05067 86 SLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEY-TAREGAK 164 (260)
T ss_pred CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCc-ccccCCc
Confidence 246888999999999999999999999999999999999999987643221 1122334
Q ss_pred cCCCcCcccccCCCccccccceehhhhhhccccC-CCCCcCCC
Q 045449 737 ATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKET-RSMTVGET 778 (823)
Q Consensus 737 gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~-~~~~~~~~ 778 (823)
++..|+|||++....++.++|||||||+++++++ |..||.+.
T Consensus 165 ~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~ 207 (260)
T cd05067 165 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGM 207 (260)
T ss_pred ccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCC
Confidence 6778999999988889999999999999999998 89998654
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.82 E-value=7.3e-21 Score=203.86 Aligned_cols=136 Identities=24% Similarity=0.347 Sum_probs=110.4
Q ss_pred eEEEEEEehHhh-HHHHHHHHHHHHHHhhcchhhHHH-------------------------------------------
Q 045449 642 MEVAVKVFHQQY-ERALKSFEDECEVRKRIRHRNLVK------------------------------------------- 677 (823)
Q Consensus 642 ~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~------------------------------------------- 677 (823)
..||||.++... ....+.|.+|++++++++|+|+++
T Consensus 45 ~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 124 (295)
T cd05097 45 VLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIP 124 (295)
T ss_pred eEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCC
Confidence 358999987542 344568999999999999999987
Q ss_pred ---------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCcccccC
Q 045449 678 ---------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGT 748 (823)
Q Consensus 678 ---------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 748 (823)
++.+++.+|.|+|+.+++||||||+||+++.++.+||+|||+++...............++..|+|||+..
T Consensus 125 ~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 204 (295)
T cd05097 125 SVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESIL 204 (295)
T ss_pred cccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhc
Confidence 23567888999999999999999999999999999999999998654332222223344577899999998
Q ss_pred CCccccccceehhhhhhccccC--CCCCcCC
Q 045449 749 KGRVSTRGDVCSFGIISGGKET--RSMTVGE 777 (823)
Q Consensus 749 ~~~~~~~~Dv~S~Gvv~~~~~~--~~~~~~~ 777 (823)
++.++.++|||||||+++++.+ +..||..
T Consensus 205 ~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~ 235 (295)
T cd05097 205 LGKFTTASDVWAFGVTLWEMFTLCKEQPYSL 235 (295)
T ss_pred cCCcCchhhHHHHHHHHHHHHHcCCCCCCcc
Confidence 8889999999999999999977 5566654
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.2e-20 Score=202.32 Aligned_cols=148 Identities=26% Similarity=0.358 Sum_probs=114.5
Q ss_pred ccCCccceeeccC--------------CeEEEEEEehHh-hHHHHHHHHHHHHHHhhc-chhhHHHH-------------
Q 045449 628 DRFSENNLIGIGN--------------GMEVAVKVFHQQ-YERALKSFEDECEVRKRI-RHRNLVKI------------- 678 (823)
Q Consensus 628 ~~f~~~~~lg~g~--------------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~------------- 678 (823)
++|...+.||.|+ ...+|+|.++.. .....+.|.+|++++.++ +||||+++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 3456666677664 123688877642 234457899999999999 79999872
Q ss_pred -------------------------------------------HHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEe
Q 045449 679 -------------------------------------------ISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHIS 715 (823)
Q Consensus 679 -------------------------------------------~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~ 715 (823)
+.|++.+|+|+|+.+|+||||||+||++++++.+||+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~ 161 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIA 161 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEEEC
Confidence 2456788999999999999999999999999999999
Q ss_pred ecccccccCCCCccccccccccCCCcCcccccCCCccccccceehhhhhhccccC-CCCCcCCC
Q 045449 716 DFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKET-RSMTVGET 778 (823)
Q Consensus 716 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~-~~~~~~~~ 778 (823)
|||++...... ........+..|+|||+..+..++.++|||||||+++++++ |..||...
T Consensus 162 dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~ 222 (297)
T cd05089 162 DFGLSRGEEVY---VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGM 222 (297)
T ss_pred CcCCCccccce---eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Confidence 99998743211 11111233567999999988889999999999999999997 88888654
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=99.82 E-value=8.3e-21 Score=200.14 Aligned_cols=149 Identities=22% Similarity=0.315 Sum_probs=121.1
Q ss_pred ccCCccceeeccC------------CeEEEEEEehHh---hHHHHHHHHHHHHHHhhcchhhHHH---------------
Q 045449 628 DRFSENNLIGIGN------------GMEVAVKVFHQQ---YERALKSFEDECEVRKRIRHRNLVK--------------- 677 (823)
Q Consensus 628 ~~f~~~~~lg~g~------------~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~--------------- 677 (823)
++|...+.+|.|+ +..||||.+... .......|.+|++++++++||||++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 3555666666664 577999987532 2344567999999999999999998
Q ss_pred -----------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCc
Q 045449 678 -----------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQ 728 (823)
Q Consensus 678 -----------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~ 728 (823)
++.|++.+|.|+|+.+++||||||+||+++.++.++++|||+++.......
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~ 161 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 161 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccchhH
Confidence 245788889999999999999999999999999999999999987643221
Q ss_pred cccccccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCCC
Q 045449 729 LSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 729 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
......|++.|+|||+..+..++.++||||+||+++++.+|..||...
T Consensus 162 --~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~ 209 (267)
T cd08228 162 --AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209 (267)
T ss_pred --HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccc
Confidence 122346889999999998888999999999999999999999998543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.82 E-value=8e-21 Score=199.65 Aligned_cols=137 Identities=23% Similarity=0.327 Sum_probs=110.1
Q ss_pred CeEEEEEEehHh-hHHHHHHHHHHHHHHhhcchhhHHH------------------------------------------
Q 045449 641 GMEVAVKVFHQQ-YERALKSFEDECEVRKRIRHRNLVK------------------------------------------ 677 (823)
Q Consensus 641 ~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~------------------------------------------ 677 (823)
+..||+|++... .....+.|.+|+.++++++||||++
T Consensus 23 ~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~ 102 (262)
T cd05058 23 KIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIG 102 (262)
T ss_pred eEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCCCCCHHHHHHhcCCCCCHHHHHH
Confidence 467999998543 2345578999999999999999998
Q ss_pred HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCcc--ccccccccCCCcCcccccCCCccccc
Q 045449 678 IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQL--SKQTQTLATIGYMAPEYGTKGRVSTR 755 (823)
Q Consensus 678 ~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~ 755 (823)
++.|++.+|+|+|+.+++||||||+||+++.++.+||+|||+++........ .......++..|+|||+..+..++.+
T Consensus 103 ~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 182 (262)
T cd05058 103 FGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTK 182 (262)
T ss_pred HHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceeecccccCcCCccccChhHhccCccchH
Confidence 2458888999999999999999999999999999999999999865432111 11123346778999999988889999
Q ss_pred cceehhhhhhccccCCCC-CcCC
Q 045449 756 GDVCSFGIISGGKETRSM-TVGE 777 (823)
Q Consensus 756 ~Dv~S~Gvv~~~~~~~~~-~~~~ 777 (823)
+|||||||+++++.++.. |+..
T Consensus 183 ~Di~slG~~l~el~~~~~~~~~~ 205 (262)
T cd05058 183 SDVWSFGVLLWELMTRGAPPYPD 205 (262)
T ss_pred HHHHHHHHHHHHHHcCCCCCCCC
Confidence 999999999999999644 4543
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.82 E-value=6.8e-21 Score=202.62 Aligned_cols=158 Identities=25% Similarity=0.336 Sum_probs=128.1
Q ss_pred cCHHHHHHHhccCCccceeeccC------------CeEEEEEEehHhhHHHHHHHHHHHHHHhhc-chhhHHH-------
Q 045449 618 FSYHELLRATDRFSENNLIGIGN------------GMEVAVKVFHQQYERALKSFEDECEVRKRI-RHRNLVK------- 677 (823)
Q Consensus 618 ~~~~~l~~at~~f~~~~~lg~g~------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~------- 677 (823)
.++.++..+.+.|+..+.+|.|+ +..||+|++.... ....++..|+.++.++ +|+||++
T Consensus 6 ~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 84 (282)
T cd06636 6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIK 84 (282)
T ss_pred hhhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhc
Confidence 46677777788888888888885 4568999886543 2336788999999998 6999886
Q ss_pred -----------------------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEee
Q 045449 678 -----------------------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISD 716 (823)
Q Consensus 678 -----------------------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~D 716 (823)
++.|++++|.|+|+.+++|||+||+||++++++.++|+|
T Consensus 85 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~d 164 (282)
T cd06636 85 KSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVD 164 (282)
T ss_pred ccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEee
Confidence 245788999999999999999999999999999999999
Q ss_pred cccccccCCCCccccccccccCCCcCcccccC-----CCccccccceehhhhhhccccCCCCCcCCC
Q 045449 717 FGIAKLLSGEDQLSKQTQTLATIGYMAPEYGT-----KGRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 717 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
||+++....... ......|++.|+|||++. ...++.++|||||||+++++.+|..||.+.
T Consensus 165 fg~~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~ 229 (282)
T cd06636 165 FGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDM 229 (282)
T ss_pred Ccchhhhhcccc--CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCcccc
Confidence 999886532211 223456899999999875 346788999999999999999999998654
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=99.82 E-value=1e-20 Score=201.22 Aligned_cols=136 Identities=28% Similarity=0.346 Sum_probs=113.9
Q ss_pred CeEEEEEEehHhhHHHHHHHHHHHHHHhhcchhhHHH-----------------------------------------HH
Q 045449 641 GMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVK-----------------------------------------II 679 (823)
Q Consensus 641 ~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-----------------------------------------~~ 679 (823)
+..||+|.+........+.|.+|++++++++|||+++ ++
T Consensus 30 ~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~ 109 (282)
T cd06643 30 GVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVC 109 (282)
T ss_pred CeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHH
Confidence 5678999987665566678999999999999999998 24
Q ss_pred HHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCcccccC-----CCcccc
Q 045449 680 SSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGT-----KGRVST 754 (823)
Q Consensus 680 ~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ 754 (823)
.|++++|.|+|+.+++||||||+||+++.++.+|++|||+++...... .......|+..|+|||++. +..++.
T Consensus 110 ~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~ 187 (282)
T cd06643 110 KQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--QRRDSFIGTPYWMAPEVVMCETSKDRPYDY 187 (282)
T ss_pred HHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEccccccccccccc--cccccccccccccCHhhccccCCCCCCCCc
Confidence 578889999999999999999999999999999999999987653221 1223456899999999873 345788
Q ss_pred ccceehhhhhhccccCCCCCcCCC
Q 045449 755 RGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 755 ~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
++|||||||+++++.+|..||...
T Consensus 188 ~~Dv~slGvil~el~~g~~p~~~~ 211 (282)
T cd06643 188 KADVWSLGITLIEMAQIEPPHHEL 211 (282)
T ss_pred cchhhhHHHHHHHHccCCCCcccc
Confidence 999999999999999999998654
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=99.82 E-value=7.4e-21 Score=202.13 Aligned_cols=138 Identities=22% Similarity=0.220 Sum_probs=113.8
Q ss_pred CeEEEEEEehHhh-HHHHHHHHHHHHHHhhcchhhHHH------------------------------------------
Q 045449 641 GMEVAVKVFHQQY-ERALKSFEDECEVRKRIRHRNLVK------------------------------------------ 677 (823)
Q Consensus 641 ~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~------------------------------------------ 677 (823)
+..||+|++.... ....+.+.+|+.++++++|+||++
T Consensus 35 ~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l 114 (280)
T cd05043 35 EEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQAL 114 (280)
T ss_pred eeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCCEEEEEcCCCCcHHHHHHhccccccccccCC
Confidence 3668899886442 344578999999999999999998
Q ss_pred -------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCcccccCCC
Q 045449 678 -------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKG 750 (823)
Q Consensus 678 -------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 750 (823)
++.+++.+|+|+|+.+++||||||+||++++++.+|++|||+++.+.............++..|+|||+..+.
T Consensus 115 ~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~ 194 (280)
T cd05043 115 STQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNK 194 (280)
T ss_pred CHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcC
Confidence 2347888999999999999999999999999999999999999876443322122233467789999999888
Q ss_pred ccccccceehhhhhhccccC-CCCCcCCC
Q 045449 751 RVSTRGDVCSFGIISGGKET-RSMTVGET 778 (823)
Q Consensus 751 ~~~~~~Dv~S~Gvv~~~~~~-~~~~~~~~ 778 (823)
.++.++|||||||+++++.+ |..||.+.
T Consensus 195 ~~~~~~Di~slG~~l~el~~~g~~p~~~~ 223 (280)
T cd05043 195 EYSSASDVWSFGVLLWELMTLGQTPYVEI 223 (280)
T ss_pred CCCchhhHHHhHHHHHHHhcCCCCCcCcC
Confidence 89999999999999999998 89998764
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.82 E-value=5.9e-21 Score=201.35 Aligned_cols=136 Identities=24% Similarity=0.334 Sum_probs=113.4
Q ss_pred CeEEEEEEehHhhHHHHHHHHHHHHHHhhcchhhHHH----------------------------------------HHH
Q 045449 641 GMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVK----------------------------------------IIS 680 (823)
Q Consensus 641 ~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~----------------------------------------~~~ 680 (823)
+..||+|+++.........+.+|+.+++.++||||++ ++.
T Consensus 34 ~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ 113 (267)
T cd06645 34 GELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSR 113 (267)
T ss_pred CcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHH
Confidence 6789999987654444567889999999999999988 356
Q ss_pred HHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCcccccC---CCccccccc
Q 045449 681 SSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGT---KGRVSTRGD 757 (823)
Q Consensus 681 ~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~D 757 (823)
|++.+++|+|+.+++||||||+||+++.++.+||+|||++....... .......|+..|+|||++. ...++.++|
T Consensus 114 ~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~D 191 (267)
T cd06645 114 ETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATI--AKRKSFIGTPYWMAPEVAAVERKGGYNQLCD 191 (267)
T ss_pred HHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCcc--cccccccCcccccChhhhccccCCCCCchhh
Confidence 88899999999999999999999999999999999999987654221 1223457899999999874 456889999
Q ss_pred eehhhhhhccccCCCCCcCCC
Q 045449 758 VCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 758 v~S~Gvv~~~~~~~~~~~~~~ 778 (823)
|||+||+++++.++..|+...
T Consensus 192 vwSlG~il~~l~~~~~p~~~~ 212 (267)
T cd06645 192 IWAVGITAIELAELQPPMFDL 212 (267)
T ss_pred hHHHHHHHHHHhcCCCCcccc
Confidence 999999999999999988543
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.82 E-value=1e-20 Score=199.57 Aligned_cols=136 Identities=24% Similarity=0.322 Sum_probs=112.0
Q ss_pred CeEEEEEEehHhhHHHHHHHHHHHHHHhhcchhhHHH----------------------------------------HHH
Q 045449 641 GMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVK----------------------------------------IIS 680 (823)
Q Consensus 641 ~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~----------------------------------------~~~ 680 (823)
+..||+|++........+.+.+|+.++.+++||||++ ++.
T Consensus 34 ~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ 113 (267)
T cd06646 34 GELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCR 113 (267)
T ss_pred CeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHH
Confidence 5679999987554444467889999999999999998 246
Q ss_pred HHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCcccccC---CCccccccc
Q 045449 681 SSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGT---KGRVSTRGD 757 (823)
Q Consensus 681 ~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~D 757 (823)
|++++|.|+|+.+|+|||+||+||+++.++.+||+|||+++....... ......|++.|+|||.+. ...++.++|
T Consensus 114 qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~D 191 (267)
T cd06646 114 ETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA--KRKSFIGTPYWMAPEVAAVEKNGGYNQLCD 191 (267)
T ss_pred HHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeeccccc--ccCccccCccccCHhHcccccCCCCcchhh
Confidence 788899999999999999999999999999999999999986542211 123356889999999874 345788999
Q ss_pred eehhhhhhccccCCCCCcCCC
Q 045449 758 VCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 758 v~S~Gvv~~~~~~~~~~~~~~ 778 (823)
|||+||+++++.+|..|+...
T Consensus 192 vws~G~il~el~~g~~p~~~~ 212 (267)
T cd06646 192 IWAVGITAIELAELQPPMFDL 212 (267)
T ss_pred HHHHHHHHHHHHhCCCCcccc
Confidence 999999999999999988543
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=99.82 E-value=6.9e-21 Score=200.30 Aligned_cols=148 Identities=26% Similarity=0.436 Sum_probs=117.9
Q ss_pred cCCccceeeccC-----------CeEEEEEEehHhhHHHHHHHHHHHHHHhhcchhhHHH--------------------
Q 045449 629 RFSENNLIGIGN-----------GMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVK-------------------- 677 (823)
Q Consensus 629 ~f~~~~~lg~g~-----------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-------------------- 677 (823)
+|...+.+|.|+ ...||+|++..... ..++|.+|++++++++|+||++
T Consensus 7 ~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~lv~e~~~~~ 85 (262)
T cd05071 7 SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKG 85 (262)
T ss_pred HeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEECCCCcEEEEEcCCCC
Confidence 445555565553 24589999875332 2357999999999999999997
Q ss_pred ---------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccc
Q 045449 678 ---------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTL 736 (823)
Q Consensus 678 ---------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~ 736 (823)
++.+++++|+++|+.+++||||||+||++++++.+||+|||.++........ ......
T Consensus 86 ~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~-~~~~~~ 164 (262)
T cd05071 86 SLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAK 164 (262)
T ss_pred cHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeeccccccc-cccCCc
Confidence 2467888999999999999999999999999999999999999876433221 122334
Q ss_pred cCCCcCcccccCCCccccccceehhhhhhccccC-CCCCcCCC
Q 045449 737 ATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKET-RSMTVGET 778 (823)
Q Consensus 737 gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~-~~~~~~~~ 778 (823)
++..|+|||+..+..++.++|||||||++|++++ |..||.+.
T Consensus 165 ~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~ 207 (262)
T cd05071 165 FPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM 207 (262)
T ss_pred ccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Confidence 6778999999988889999999999999999999 77787654
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.82 E-value=9.9e-21 Score=198.86 Aligned_cols=149 Identities=26% Similarity=0.357 Sum_probs=122.8
Q ss_pred ccCCccceeeccC------------CeEEEEEEehHhhHHHHHHHHHHHHHHhhcchhhHHH------------------
Q 045449 628 DRFSENNLIGIGN------------GMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVK------------------ 677 (823)
Q Consensus 628 ~~f~~~~~lg~g~------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------------ 677 (823)
++|...+.+|.|+ +..+|+|++........+.+.+|++++++++||||++
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~ 82 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC 82 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence 3455555666553 4668999987665556688999999999999999998
Q ss_pred -----------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccc
Q 045449 678 -----------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQ 734 (823)
Q Consensus 678 -----------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 734 (823)
++.|++.+|.|+|+.+++||||||+||+++.++.+||+|||.+........ ....
T Consensus 83 ~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~--~~~~ 160 (262)
T cd06613 83 GGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA--KRKS 160 (262)
T ss_pred CCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhhh--cccc
Confidence 356788899999999999999999999999999999999999986543211 1234
Q ss_pred cccCCCcCcccccCCC---ccccccceehhhhhhccccCCCCCcCCC
Q 045449 735 TLATIGYMAPEYGTKG---RVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 735 ~~gt~~y~aPE~~~~~---~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
..++..|+|||.+... .++.++|||||||++++|.+|..|+.+.
T Consensus 161 ~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~ 207 (262)
T cd06613 161 FIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDL 207 (262)
T ss_pred ccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence 5688999999998776 7899999999999999999999998764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.4e-20 Score=198.40 Aligned_cols=138 Identities=27% Similarity=0.370 Sum_probs=114.1
Q ss_pred CeEEEEEEehHhh---------HHHHHHHHHHHHHHhhcchhhHHH----------------------------------
Q 045449 641 GMEVAVKVFHQQY---------ERALKSFEDECEVRKRIRHRNLVK---------------------------------- 677 (823)
Q Consensus 641 ~~~vavK~~~~~~---------~~~~~~~~~E~~~l~~l~h~niv~---------------------------------- 677 (823)
+..||+|.+.... ....+.+.+|++++++++||||++
T Consensus 25 ~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~ 104 (267)
T cd06628 25 GELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFE 104 (267)
T ss_pred CcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCccEEEEEecCCCCHHHHHHhccCcc
Confidence 5679999885321 233467899999999999999998
Q ss_pred ------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCcc----ccccccccCCCcCccccc
Q 045449 678 ------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQL----SKQTQTLATIGYMAPEYG 747 (823)
Q Consensus 678 ------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~----~~~~~~~gt~~y~aPE~~ 747 (823)
++.|++.+|.++|+.+++||||||+||+++.++.+||+|||.++........ .......|+..|+|||++
T Consensus 105 ~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~ 184 (267)
T cd06628 105 ETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVV 184 (267)
T ss_pred HHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCcccccccccCCccccccccCCCcCccChhHh
Confidence 3568888999999999999999999999999999999999999876532111 111234588999999999
Q ss_pred CCCccccccceehhhhhhccccCCCCCcCCC
Q 045449 748 TKGRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 748 ~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
.+..++.++||||+||+++++.+|..||.+.
T Consensus 185 ~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 215 (267)
T cd06628 185 KQTSYTRKADIWSLGCLVVEMLTGKHPFPDC 215 (267)
T ss_pred ccCCCCchhhhHHHHHHHHHHhhCCCCCCCc
Confidence 8888999999999999999999999999764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.1e-20 Score=202.54 Aligned_cols=138 Identities=23% Similarity=0.357 Sum_probs=111.9
Q ss_pred CeEEEEEEehHhh-HHHHHHHHHHHHHHhhcchhhHHH------------------------------------------
Q 045449 641 GMEVAVKVFHQQY-ERALKSFEDECEVRKRIRHRNLVK------------------------------------------ 677 (823)
Q Consensus 641 ~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~------------------------------------------ 677 (823)
...||+|++.... ....++|.+|++++++++|+||++
T Consensus 46 ~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 125 (296)
T cd05095 46 PVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVV 125 (296)
T ss_pred eeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCccccccccccc
Confidence 4569999997543 445678999999999999999987
Q ss_pred ---------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCcccccC
Q 045449 678 ---------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGT 748 (823)
Q Consensus 678 ---------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 748 (823)
++.|++.+|.|+|+.+++||||||+||+++.++.+||+|||+++.+.............+++.|+|||+..
T Consensus 126 ~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~ 205 (296)
T cd05095 126 TISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESIL 205 (296)
T ss_pred ccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHh
Confidence 13577888999999999999999999999999999999999998654332222222234567899999988
Q ss_pred CCccccccceehhhhhhccccC--CCCCcCCC
Q 045449 749 KGRVSTRGDVCSFGIISGGKET--RSMTVGET 778 (823)
Q Consensus 749 ~~~~~~~~Dv~S~Gvv~~~~~~--~~~~~~~~ 778 (823)
++.++.++|||||||++|++.+ +..||...
T Consensus 206 ~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~ 237 (296)
T cd05095 206 LGKFTTASDVWAFGVTLWEILTLCKEQPYSQL 237 (296)
T ss_pred cCCccchhhhhHHHHHHHHHHHhCCCCCcccc
Confidence 8889999999999999999987 66777543
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.82 E-value=8.7e-21 Score=200.90 Aligned_cols=136 Identities=26% Similarity=0.349 Sum_probs=116.5
Q ss_pred CeEEEEEEehHhh-HHHHHHHHHHHHHHhhcchhhHHH---------------------------------------HHH
Q 045449 641 GMEVAVKVFHQQY-ERALKSFEDECEVRKRIRHRNLVK---------------------------------------IIS 680 (823)
Q Consensus 641 ~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~---------------------------------------~~~ 680 (823)
+..||+|++.... ......+.+|++++++++|+|+++ ++.
T Consensus 26 ~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~ 105 (274)
T cd06609 26 NQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPGKLDETYIAFILR 105 (274)
T ss_pred CeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEeeCCCcHHHHHhhcCCCHHHHHHHHH
Confidence 6789999986543 344567899999999999999998 357
Q ss_pred HHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCcccccCCCccccccceeh
Q 045449 681 SSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCS 760 (823)
Q Consensus 681 ~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S 760 (823)
|++.++.|+|+.+++||||+|+||++++++.++++|||+++...... .......|++.|+|||+..+..++.++||||
T Consensus 106 ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~s 183 (274)
T cd06609 106 EVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM--SKRNTFVGTPFWMAPEVIKQSGYDEKADIWS 183 (274)
T ss_pred HHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeecccc--cccccccCCccccChhhhccCCCCchhhHHH
Confidence 88899999999999999999999999999999999999998765432 1223456889999999998888999999999
Q ss_pred hhhhhccccCCCCCcCCC
Q 045449 761 FGIISGGKETRSMTVGET 778 (823)
Q Consensus 761 ~Gvv~~~~~~~~~~~~~~ 778 (823)
|||+++++++|..||...
T Consensus 184 lG~il~~l~tg~~p~~~~ 201 (274)
T cd06609 184 LGITAIELAKGEPPLSDL 201 (274)
T ss_pred HHHHHHHHHhCCCCcccC
Confidence 999999999999998653
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.3e-20 Score=202.89 Aligned_cols=137 Identities=29% Similarity=0.380 Sum_probs=111.5
Q ss_pred eEEEEEEehHhh-HHHHHHHHHHHHHHhhc-chhhHHHH-----------------------------------------
Q 045449 642 MEVAVKVFHQQY-ERALKSFEDECEVRKRI-RHRNLVKI----------------------------------------- 678 (823)
Q Consensus 642 ~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~----------------------------------------- 678 (823)
..||+|.+.... ....+++.+|+.+++++ +||||+++
T Consensus 48 ~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 127 (304)
T cd05101 48 VTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIA 127 (304)
T ss_pred eeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccc
Confidence 358889886443 34457899999999999 89999981
Q ss_pred ---------------HHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCc
Q 045449 679 ---------------ISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMA 743 (823)
Q Consensus 679 ---------------~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a 743 (823)
+.|++++|.|+|+.+++||||||+||++++++.+||+|||+++...............+++.|+|
T Consensus 128 ~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~a 207 (304)
T cd05101 128 RVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMA 207 (304)
T ss_pred cCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeC
Confidence 23788999999999999999999999999999999999999987644332222233456788999
Q ss_pred ccccCCCccccccceehhhhhhccccC-CCCCcCCC
Q 045449 744 PEYGTKGRVSTRGDVCSFGIISGGKET-RSMTVGET 778 (823)
Q Consensus 744 PE~~~~~~~~~~~Dv~S~Gvv~~~~~~-~~~~~~~~ 778 (823)
||++.+..++.++|||||||+++++.+ |..|+...
T Consensus 208 PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~ 243 (304)
T cd05101 208 PEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI 243 (304)
T ss_pred chhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccC
Confidence 999988889999999999999999987 66776543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.82 E-value=5.9e-21 Score=204.57 Aligned_cols=148 Identities=28% Similarity=0.402 Sum_probs=122.4
Q ss_pred cCCccceeeccC------------CeEEEEEEehHhhHHHHHHHHHHHHHHhhcchhhHHH-------------------
Q 045449 629 RFSENNLIGIGN------------GMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVK------------------- 677 (823)
Q Consensus 629 ~f~~~~~lg~g~------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------------- 677 (823)
+|+..+.+|.|+ +..||+|.+........+.+.+|++++++++|||+++
T Consensus 20 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 99 (296)
T cd06655 20 KYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLA 99 (296)
T ss_pred eEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecC
Confidence 455555666553 5779999887554445578899999999999999998
Q ss_pred --------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCcccccccccc
Q 045449 678 --------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLA 737 (823)
Q Consensus 678 --------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~g 737 (823)
++.+++.+++++|+.+++||||||+||+++.++.+||+|||+++....... ......|
T Consensus 100 ~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~ 177 (296)
T cd06655 100 GGSLTDVVTETCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS--KRSTMVG 177 (296)
T ss_pred CCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcccccc--cCCCcCC
Confidence 346788899999999999999999999999999999999999886543322 1223468
Q ss_pred CCCcCcccccCCCccccccceehhhhhhccccCCCCCcCCC
Q 045449 738 TIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 738 t~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
+..|+|||.+.+..++.++|||||||++|++++|..||...
T Consensus 178 ~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~ 218 (296)
T cd06655 178 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNE 218 (296)
T ss_pred CccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 89999999998888999999999999999999999998654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=99.81 E-value=8.8e-21 Score=203.26 Aligned_cols=138 Identities=25% Similarity=0.356 Sum_probs=112.7
Q ss_pred CeEEEEEEehHhh-HHHHHHHHHHHHHHhhcchhhHHH------------------------------------------
Q 045449 641 GMEVAVKVFHQQY-ERALKSFEDECEVRKRIRHRNLVK------------------------------------------ 677 (823)
Q Consensus 641 ~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~------------------------------------------ 677 (823)
+..||+|++.... ....++|.+|++++++++||||++
T Consensus 46 ~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 125 (296)
T cd05051 46 PVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSK 125 (296)
T ss_pred ceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCC
Confidence 3568999987543 345678999999999999999877
Q ss_pred ---------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCcccccC
Q 045449 678 ---------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGT 748 (823)
Q Consensus 678 ---------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 748 (823)
++.|++++|.|+|+.+|+||||||+||+++.++.++|+|||+++...............+++.|+|||+..
T Consensus 126 ~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 205 (296)
T cd05051 126 SLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVL 205 (296)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHcCccccccchhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhh
Confidence 23577888999999999999999999999999999999999998754433222233455778999999998
Q ss_pred CCccccccceehhhhhhccccC--CCCCcCCC
Q 045449 749 KGRVSTRGDVCSFGIISGGKET--RSMTVGET 778 (823)
Q Consensus 749 ~~~~~~~~Dv~S~Gvv~~~~~~--~~~~~~~~ 778 (823)
++.++.++|||||||++|++.+ +..|+...
T Consensus 206 ~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~ 237 (296)
T cd05051 206 LGKFTTKSDVWAFGVTLWEILTLCREQPYEHL 237 (296)
T ss_pred cCCCCccchhhhhHHHHHHHHhcCCCCCCCCc
Confidence 8889999999999999999876 56666543
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.2e-20 Score=199.36 Aligned_cols=137 Identities=22% Similarity=0.394 Sum_probs=110.3
Q ss_pred eEEEEEEehHhh-HHHHHHHHHHHHHHhhcchhhHHH-----------------------------------------HH
Q 045449 642 MEVAVKVFHQQY-ERALKSFEDECEVRKRIRHRNLVK-----------------------------------------II 679 (823)
Q Consensus 642 ~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~-----------------------------------------~~ 679 (823)
..||||++.... ....++|..|++++++++||||++ ++
T Consensus 33 ~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~ 112 (269)
T cd05065 33 IFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGML 112 (269)
T ss_pred eeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHH
Confidence 359999987542 445578999999999999999998 24
Q ss_pred HHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccc-c--ccCCCcCcccccCCCcccccc
Q 045449 680 SSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQ-T--LATIGYMAPEYGTKGRVSTRG 756 (823)
Q Consensus 680 ~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~-~--~gt~~y~aPE~~~~~~~~~~~ 756 (823)
.|++.+|.|+|+.+++||||||+||+++.++.+|++|||+++............. . ..+..|+|||+..+..++.++
T Consensus 113 ~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~ 192 (269)
T cd05065 113 RGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSAS 192 (269)
T ss_pred HHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccCccccccccccCCCcceeecCHhHhccCcccchh
Confidence 5788899999999999999999999999999999999999986543222111111 1 124579999999988999999
Q ss_pred ceehhhhhhccccC-CCCCcCCC
Q 045449 757 DVCSFGIISGGKET-RSMTVGET 778 (823)
Q Consensus 757 Dv~S~Gvv~~~~~~-~~~~~~~~ 778 (823)
|||||||+++++++ |..||.+.
T Consensus 193 DvwslG~~l~e~l~~g~~p~~~~ 215 (269)
T cd05065 193 DVWSYGIVMWEVMSYGERPYWDM 215 (269)
T ss_pred hhhhhHHHHHHHhcCCCCCCCCC
Confidence 99999999999775 88888654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.81 E-value=9.3e-21 Score=203.15 Aligned_cols=135 Identities=27% Similarity=0.351 Sum_probs=115.4
Q ss_pred CeEEEEEEehHhhHHHHHHHHHHHHHHhhcchhhHHH---------------------------------------HHHH
Q 045449 641 GMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVK---------------------------------------IISS 681 (823)
Q Consensus 641 ~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~---------------------------------------~~~~ 681 (823)
+..||||++........+.+.+|+.++.+++||||++ ++.|
T Consensus 46 ~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~q 125 (297)
T cd06659 46 GRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQTRLNEEQIATVCES 125 (297)
T ss_pred CCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCHHHHHhhcCCCHHHHHHHHHH
Confidence 6789999986554445567899999999999999998 2468
Q ss_pred HHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCcccccCCCccccccceehh
Q 045449 682 SLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSF 761 (823)
Q Consensus 682 ~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~ 761 (823)
++++|.|+|+.+++||||||+||+++.++.+||+|||+++....... ......|+..|+|||++.+..++.++|||||
T Consensus 126 i~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~sl 203 (297)
T cd06659 126 VLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP--KRKSLVGTPYWMAPEVISRTPYGTEVDIWSL 203 (297)
T ss_pred HHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhcccccc--cccceecCccccCHHHHccCCCCchhhHHHH
Confidence 88999999999999999999999999999999999999876543221 2234568999999999988889999999999
Q ss_pred hhhhccccCCCCCcCC
Q 045449 762 GIISGGKETRSMTVGE 777 (823)
Q Consensus 762 Gvv~~~~~~~~~~~~~ 777 (823)
||+++++.+|..||..
T Consensus 204 G~il~el~~g~~p~~~ 219 (297)
T cd06659 204 GIMVIEMVDGEPPYFS 219 (297)
T ss_pred HHHHHHHHhCCCCCCC
Confidence 9999999999999854
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.7e-20 Score=200.58 Aligned_cols=136 Identities=30% Similarity=0.342 Sum_probs=114.1
Q ss_pred CeEEEEEEehHhhHHHHHHHHHHHHHHhhcchhhHHH-----------------------------------------HH
Q 045449 641 GMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVK-----------------------------------------II 679 (823)
Q Consensus 641 ~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-----------------------------------------~~ 679 (823)
+..||+|++........+.+.+|++++++++|+||++ ++
T Consensus 37 ~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~ 116 (292)
T cd06644 37 GALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVIC 116 (292)
T ss_pred CceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecCCCCcHHHHHHhhcCCCCHHHHHHHH
Confidence 5779999987666666788999999999999999998 35
Q ss_pred HHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCcccccC-----CCcccc
Q 045449 680 SSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGT-----KGRVST 754 (823)
Q Consensus 680 ~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ 754 (823)
.|++.+++|+|+.+++|||+||+||+++.++.+||+|||+++...... .......+++.|+|||++. ...++.
T Consensus 117 ~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~ 194 (292)
T cd06644 117 RQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL--QRRDSFIGTPYWMAPEVVMCETMKDTPYDY 194 (292)
T ss_pred HHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceeccccc--cccceecCCccccCceeeccccccCCCCCc
Confidence 678899999999999999999999999999999999999987643221 1123456889999999874 345788
Q ss_pred ccceehhhhhhccccCCCCCcCCC
Q 045449 755 RGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 755 ~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
++|||||||++|++.+|..||...
T Consensus 195 ~~Dv~slG~il~el~~g~~p~~~~ 218 (292)
T cd06644 195 KADIWSLGITLIEMAQIEPPHHEL 218 (292)
T ss_pred hhhhHhHHHHHHHHhcCCCCCccc
Confidence 999999999999999999998653
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.3e-20 Score=199.46 Aligned_cols=145 Identities=28% Similarity=0.342 Sum_probs=121.5
Q ss_pred cCCccceeeccC------------CeEEEEEEehHhh---HHHHHHHHHHHHHHhhcchhhHHH----------------
Q 045449 629 RFSENNLIGIGN------------GMEVAVKVFHQQY---ERALKSFEDECEVRKRIRHRNLVK---------------- 677 (823)
Q Consensus 629 ~f~~~~~lg~g~------------~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~---------------- 677 (823)
+|...+.||.|+ ++.||+|++.... ....+.+.+|++++++++||||++
T Consensus 2 ~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 81 (290)
T cd05580 2 DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVME 81 (290)
T ss_pred ceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEe
Confidence 455556666654 5779999986543 234567899999999999999998
Q ss_pred ------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCcccccc
Q 045449 678 ------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQT 733 (823)
Q Consensus 678 ------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~ 733 (823)
++.|++++|.++|+.+++||||+|+||+++.++.+||+|||+++..... ..
T Consensus 82 ~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~-----~~ 156 (290)
T cd05580 82 YVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-----TY 156 (290)
T ss_pred cCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC-----CC
Confidence 3568899999999999999999999999999999999999999876433 22
Q ss_pred ccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCCC
Q 045449 734 QTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 734 ~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
...|++.|+|||.+.+..++.++||||+|++++++.+|..||...
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 201 (290)
T cd05580 157 TLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDD 201 (290)
T ss_pred CCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence 346899999999998888899999999999999999999998654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=99.81 E-value=7.6e-21 Score=199.21 Aligned_cols=136 Identities=22% Similarity=0.364 Sum_probs=112.1
Q ss_pred eEEEEEEehHhhHHHHHHHHHHHHHHhhcchhhHHH-----------------------------------------HHH
Q 045449 642 MEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVK-----------------------------------------IIS 680 (823)
Q Consensus 642 ~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-----------------------------------------~~~ 680 (823)
..||||.+.... ...++|.+|++++.+++||||++ ++.
T Consensus 29 ~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~ 107 (256)
T cd05113 29 YDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCK 107 (256)
T ss_pred CcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHH
Confidence 459999887443 23467999999999999999998 356
Q ss_pred HHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCcccccCCCccccccceeh
Q 045449 681 SSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCS 760 (823)
Q Consensus 681 ~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S 760 (823)
|++.+|+|+|+.+++||||||+||+++.++.+||+|||.++....... .......++..|+|||+..+..++.++||||
T Consensus 108 ~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~-~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~s 186 (256)
T cd05113 108 DVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY-TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWA 186 (256)
T ss_pred HHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCce-eecCCCccChhhCCHHHHhcCcccchhHHHH
Confidence 888999999999999999999999999999999999999986543321 1122234567899999998888999999999
Q ss_pred hhhhhccccC-CCCCcCCCc
Q 045449 761 FGIISGGKET-RSMTVGETC 779 (823)
Q Consensus 761 ~Gvv~~~~~~-~~~~~~~~~ 779 (823)
|||++|++.+ |..||....
T Consensus 187 lG~~l~~l~~~g~~p~~~~~ 206 (256)
T cd05113 187 FGVLMWEVYSLGKMPYERFN 206 (256)
T ss_pred HHHHHHHHhcCCCCCcCcCC
Confidence 9999999998 888886543
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=99.81 E-value=8.9e-21 Score=198.66 Aligned_cols=148 Identities=22% Similarity=0.349 Sum_probs=118.1
Q ss_pred cCCccceeeccC-----------CeEEEEEEehHhhHHHHHHHHHHHHHHhhcchhhHHH--------------------
Q 045449 629 RFSENNLIGIGN-----------GMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVK-------------------- 677 (823)
Q Consensus 629 ~f~~~~~lg~g~-----------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-------------------- 677 (823)
+|...+.+|+|+ +..||+|.+.... ...++|.+|++++++++||||++
T Consensus 5 ~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~ 83 (256)
T cd05114 5 ELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMEN 83 (256)
T ss_pred HcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCC
Confidence 355556667664 3468999876432 23467899999999999999998
Q ss_pred ---------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccc
Q 045449 678 ---------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTL 736 (823)
Q Consensus 678 ---------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~ 736 (823)
++.|++.+|.|+|+.+++||||||+||++++++.+|++|||.++........ ......
T Consensus 84 ~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~-~~~~~~ 162 (256)
T cd05114 84 GCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT-SSSGAK 162 (256)
T ss_pred CcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCcee-ccCCCC
Confidence 2467888999999999999999999999999999999999999865432221 112234
Q ss_pred cCCCcCcccccCCCccccccceehhhhhhccccC-CCCCcCCC
Q 045449 737 ATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKET-RSMTVGET 778 (823)
Q Consensus 737 gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~-~~~~~~~~ 778 (823)
++..|+|||++.+..++.++|||||||+++++.+ |..||...
T Consensus 163 ~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~ 205 (256)
T cd05114 163 FPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKK 205 (256)
T ss_pred CchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCC
Confidence 5678999999988889999999999999999999 88888654
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.1e-20 Score=206.51 Aligned_cols=151 Identities=28% Similarity=0.368 Sum_probs=122.2
Q ss_pred hccCCccceeeccC------------CeEEEEEEehHh-hHHHHHHHHHHHHHHhhcchhhHHH----------------
Q 045449 627 TDRFSENNLIGIGN------------GMEVAVKVFHQQ-YERALKSFEDECEVRKRIRHRNLVK---------------- 677 (823)
Q Consensus 627 t~~f~~~~~lg~g~------------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~---------------- 677 (823)
+++|...+.+|.|+ |..||||++... ......++.+|++++++++|+||++
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 46777778888775 567999998642 2334567889999999999999987
Q ss_pred ---------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCcc-
Q 045449 678 ---------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQL- 729 (823)
Q Consensus 678 ---------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~- 729 (823)
++.|++++|.++|+.+|+||||||+||+++.++.+||+|||+++........
T Consensus 84 ~lv~e~~~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 163 (336)
T cd07849 84 YIVQELMETDLYKLIKTQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHT 163 (336)
T ss_pred EEEehhcccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeecccccccc
Confidence 2457889999999999999999999999999999999999999875432221
Q ss_pred ccccccccCCCcCcccccCC-CccccccceehhhhhhccccCCCCCcCC
Q 045449 730 SKQTQTLATIGYMAPEYGTK-GRVSTRGDVCSFGIISGGKETRSMTVGE 777 (823)
Q Consensus 730 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~ 777 (823)
.......||+.|+|||++.+ ..++.++||||+||+++++.+|+.||.+
T Consensus 164 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~ 212 (336)
T cd07849 164 GFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPG 212 (336)
T ss_pred CCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 11233568999999998654 4689999999999999999999998854
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=99.81 E-value=9.8e-21 Score=202.31 Aligned_cols=137 Identities=25% Similarity=0.330 Sum_probs=112.2
Q ss_pred eEEEEEEehHhh-HHHHHHHHHHHHHHhhcchhhHHHH------------------------------------------
Q 045449 642 MEVAVKVFHQQY-ERALKSFEDECEVRKRIRHRNLVKI------------------------------------------ 678 (823)
Q Consensus 642 ~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~------------------------------------------ 678 (823)
..||+|.+.... ....+++.+|++++++++||||+++
T Consensus 31 ~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 110 (290)
T cd05045 31 TTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGN 110 (290)
T ss_pred eeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEEEEecCCCCHHHHHHhcCCccccccccccc
Confidence 568899886443 3345789999999999999999871
Q ss_pred ----------------------HHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccc
Q 045449 679 ----------------------ISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTL 736 (823)
Q Consensus 679 ----------------------~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~ 736 (823)
+.|++.+|+|+|+.+++||||||+||++++++.+||+|||+++...............
T Consensus 111 ~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 190 (290)
T cd05045 111 RNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGR 190 (290)
T ss_pred cccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheEEEcCCCcEEeccccccccccCccchhcccCCC
Confidence 3477889999999999999999999999999999999999998654333222223344
Q ss_pred cCCCcCcccccCCCccccccceehhhhhhccccC-CCCCcCCC
Q 045449 737 ATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKET-RSMTVGET 778 (823)
Q Consensus 737 gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~-~~~~~~~~ 778 (823)
++..|+|||+..+..++.++|||||||+++++++ |..||.+.
T Consensus 191 ~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~ 233 (290)
T cd05045 191 IPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI 233 (290)
T ss_pred CCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCC
Confidence 6778999999888889999999999999999998 88888654
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.2e-20 Score=206.63 Aligned_cols=156 Identities=29% Similarity=0.379 Sum_probs=125.8
Q ss_pred cCHHHHHHHh----ccCCccceeeccC------------CeEEEEEEehHhh--HHHHHHHHHHHHHHhhcchhhHHH--
Q 045449 618 FSYHELLRAT----DRFSENNLIGIGN------------GMEVAVKVFHQQY--ERALKSFEDECEVRKRIRHRNLVK-- 677 (823)
Q Consensus 618 ~~~~~l~~at----~~f~~~~~lg~g~------------~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~-- 677 (823)
|+.+|+.+++ ++|...+.||.|+ +..||||++.... ....+.+.+|++++++++||||++
T Consensus 1 ~~~~~~~~~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~ 80 (342)
T cd07879 1 FYREEVNKTVWELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLL 80 (342)
T ss_pred CchhhhhhhhhccccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchh
Confidence 3455565554 6787778888774 5679999886432 233457889999999999999986
Q ss_pred -----------------------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEee
Q 045449 678 -----------------------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISD 716 (823)
Q Consensus 678 -----------------------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~D 716 (823)
++.|++.+|.|+|+.+++||||||+||+++.++.+||+|
T Consensus 81 ~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~d 160 (342)
T cd07879 81 DVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILD 160 (342)
T ss_pred heecccccCCCCceEEEEecccccCHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEee
Confidence 245788899999999999999999999999999999999
Q ss_pred cccccccCCCCccccccccccCCCcCcccccCC-CccccccceehhhhhhccccCCCCCcCCC
Q 045449 717 FGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTK-GRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 717 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
||+++..... .....++..|+|||++.+ ..++.++|||||||+++++++|+.||...
T Consensus 161 fg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~ 218 (342)
T cd07879 161 FGLARHADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGK 218 (342)
T ss_pred CCCCcCCCCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCC
Confidence 9999864321 223467899999998866 45899999999999999999999998653
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.7e-20 Score=196.53 Aligned_cols=136 Identities=24% Similarity=0.354 Sum_probs=114.8
Q ss_pred CeEEEEEEehHhh--HHHHHHHHHHHHHHhhcchhhHHH-----------------------------------------
Q 045449 641 GMEVAVKVFHQQY--ERALKSFEDECEVRKRIRHRNLVK----------------------------------------- 677 (823)
Q Consensus 641 ~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~----------------------------------------- 677 (823)
++.||+|.+.... ....+.+.+|++++++++|+|+++
T Consensus 25 ~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~l~~~~~ 104 (257)
T cd08223 25 GKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQV 104 (257)
T ss_pred CcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecccCCCcHHHHHHHhcCCCCCHHHH
Confidence 5679999986432 344567899999999999999997
Q ss_pred --HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCcccccCCCccccc
Q 045449 678 --IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTR 755 (823)
Q Consensus 678 --~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 755 (823)
++.+++.+++++|+.+++||||||+||+++.++.++|+|||+++....... ......|++.|+|||+..+..++.+
T Consensus 105 ~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~ 182 (257)
T cd08223 105 VEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD--MASTLIGTPYYMSPELFSNKPYNYK 182 (257)
T ss_pred HHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccCC--ccccccCCcCccChhHhcCCCCCch
Confidence 245788889999999999999999999999999999999999987643221 2234568999999999998889999
Q ss_pred cceehhhhhhccccCCCCCcCCC
Q 045449 756 GDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 756 ~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
+||||+||+++++++|..||...
T Consensus 183 ~Dv~slG~il~~l~~g~~~~~~~ 205 (257)
T cd08223 183 SDVWALGCCVYEMATLKHAFNAK 205 (257)
T ss_pred hhhHHHHHHHHHHHcCCCCCCCC
Confidence 99999999999999999988653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.1e-20 Score=198.11 Aligned_cols=143 Identities=31% Similarity=0.413 Sum_probs=116.4
Q ss_pred cCCccceeeccC----------CeEEEEEEehHhhHHHHHHHHHHHHHHhhcchhhHHH---------------------
Q 045449 629 RFSENNLIGIGN----------GMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVK--------------------- 677 (823)
Q Consensus 629 ~f~~~~~lg~g~----------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~--------------------- 677 (823)
+|...+.+|+|+ +..||+|...... ..+.|.+|+.++++++|+|+++
T Consensus 7 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~ 84 (256)
T cd05082 7 ELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAK 84 (256)
T ss_pred hCeeeeeecccCCCeEEEEEEcCCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCCC
Confidence 444555666654 4668999886443 3467999999999999999998
Q ss_pred ----------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCcccccccc
Q 045449 678 ----------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQT 735 (823)
Q Consensus 678 ----------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 735 (823)
++.|++.+|+|+|+.+++||||||+||++++++.+|++|||+++...... ...
T Consensus 85 ~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-----~~~ 159 (256)
T cd05082 85 GSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-----DTG 159 (256)
T ss_pred CcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceeccccC-----CCC
Confidence 24678889999999999999999999999999999999999988653221 123
Q ss_pred ccCCCcCcccccCCCccccccceehhhhhhccccC-CCCCcCCC
Q 045449 736 LATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKET-RSMTVGET 778 (823)
Q Consensus 736 ~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~-~~~~~~~~ 778 (823)
.++..|+|||+..+..++.++|||||||++|++.+ |..|+...
T Consensus 160 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~ 203 (256)
T cd05082 160 KLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI 203 (256)
T ss_pred ccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence 45678999999988889999999999999999996 88887653
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=99.81 E-value=1e-20 Score=202.91 Aligned_cols=149 Identities=28% Similarity=0.387 Sum_probs=123.7
Q ss_pred ccCCccceeeccC------------CeEEEEEEehHhhHHHHHHHHHHHHHHhhcchhhHHH------------------
Q 045449 628 DRFSENNLIGIGN------------GMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVK------------------ 677 (823)
Q Consensus 628 ~~f~~~~~lg~g~------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------------ 677 (823)
++|...+.+|.|+ +..||+|.+........+.+.+|+.++++++|+||++
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 98 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 98 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence 4566666777664 5779999987655455577899999999999999998
Q ss_pred ---------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccc
Q 045449 678 ---------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTL 736 (823)
Q Consensus 678 ---------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~ 736 (823)
++.|++.+|.|+|+.+++||||||+||+++.++.+||+|||++........ ......
T Consensus 99 ~~~~L~~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~--~~~~~~ 176 (297)
T cd06656 99 AGGSLTDVVTETCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KRSTMV 176 (297)
T ss_pred CCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCcc--CcCccc
Confidence 245788899999999999999999999999999999999999986543322 123356
Q ss_pred cCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCCC
Q 045449 737 ATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 737 gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
+++.|+|||...+..++.++|||||||++|++.+|..||...
T Consensus 177 ~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~ 218 (297)
T cd06656 177 GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNE 218 (297)
T ss_pred CCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 889999999998888999999999999999999999998653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.81 E-value=5.1e-21 Score=204.92 Aligned_cols=160 Identities=23% Similarity=0.280 Sum_probs=123.7
Q ss_pred cCHHHHHHHh---ccCCccceeeccC-CeE-----------EEEEEehHhh---HHHHHHHHHHHHHHhhcchhhHHH--
Q 045449 618 FSYHELLRAT---DRFSENNLIGIGN-GME-----------VAVKVFHQQY---ERALKSFEDECEVRKRIRHRNLVK-- 677 (823)
Q Consensus 618 ~~~~~l~~at---~~f~~~~~lg~g~-~~~-----------vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~-- 677 (823)
-.|-.+.+|. .-|...+-||.|+ |++ +|+|.+++.. +..+...+.|-+||.....+.||+
T Consensus 616 SnYiRLkRaKMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLy 695 (1034)
T KOG0608|consen 616 SNYIRLKRAKMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLY 695 (1034)
T ss_pred hhHHHHHHhhccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEE
Confidence 3455555554 3466677889887 333 5556555443 233456778999999999999998
Q ss_pred --------------------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeeccc
Q 045449 678 --------------------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGI 719 (823)
Q Consensus 678 --------------------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGl 719 (823)
+||++..++++.|..|.|||||||+|||+|.+|++||+|||+
T Consensus 696 ySFQDkdnLYFVMdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGL 775 (1034)
T KOG0608|consen 696 YSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGL 775 (1034)
T ss_pred EEeccCCceEEEEeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccc
Confidence 468888899999999999999999999999999999999999
Q ss_pred ccccCCCCc----------------------------------------cccccccccCCCcCcccccCCCcccccccee
Q 045449 720 AKLLSGEDQ----------------------------------------LSKQTQTLATIGYMAPEYGTKGRVSTRGDVC 759 (823)
Q Consensus 720 a~~~~~~~~----------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~ 759 (823)
+.-+.-... .......+||+.|+|||++....|+.-||+|
T Consensus 776 CTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdww 855 (1034)
T KOG0608|consen 776 CTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWW 855 (1034)
T ss_pred cccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhh
Confidence 864311000 0011235799999999999999999999999
Q ss_pred hhhhhhccccCCCCCcCC
Q 045449 760 SFGIISGGKETRSMTVGE 777 (823)
Q Consensus 760 S~Gvv~~~~~~~~~~~~~ 777 (823)
|.|||+|||++|+.||-.
T Consensus 856 s~gvil~em~~g~~pf~~ 873 (1034)
T KOG0608|consen 856 SVGVILYEMLVGQPPFLA 873 (1034)
T ss_pred HhhHHHHHHhhCCCCccC
Confidence 999999999999999854
|
|
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.3e-20 Score=197.49 Aligned_cols=138 Identities=24% Similarity=0.347 Sum_probs=113.1
Q ss_pred CeEEEEEEehHhh-HHHHHHHHHHHHHHhhcchhhHHH----------------------------------------HH
Q 045449 641 GMEVAVKVFHQQY-ERALKSFEDECEVRKRIRHRNLVK----------------------------------------II 679 (823)
Q Consensus 641 ~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~----------------------------------------~~ 679 (823)
+..||||++.... ....+.|.+|++++++++|+||++ ++
T Consensus 22 ~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 101 (257)
T cd05115 22 QIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELM 101 (257)
T ss_pred ceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcCCCeEEEEEeCCCCCHHHHHHhCCCCCCHHHHHHHH
Confidence 4679999997554 344567999999999999999997 35
Q ss_pred HHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccc-cccccccCCCcCcccccCCCccccccce
Q 045449 680 SSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLS-KQTQTLATIGYMAPEYGTKGRVSTRGDV 758 (823)
Q Consensus 680 ~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv 758 (823)
.|++.+|.|+|+.+++||||||+||+++.++.+||+|||+++......... ......++..|+|||+.....++.++||
T Consensus 102 ~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di 181 (257)
T cd05115 102 HQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDV 181 (257)
T ss_pred HHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCCCCCcccCCHHHHccCCCCchhhH
Confidence 688889999999999999999999999999999999999998654332211 1122234678999999988889999999
Q ss_pred ehhhhhhccccC-CCCCcCCC
Q 045449 759 CSFGIISGGKET-RSMTVGET 778 (823)
Q Consensus 759 ~S~Gvv~~~~~~-~~~~~~~~ 778 (823)
|||||++|++++ |..||.+.
T Consensus 182 ~slG~~l~el~~~g~~p~~~~ 202 (257)
T cd05115 182 WSYGITMWEAFSYGQKPYKKM 202 (257)
T ss_pred HHHHHHHHHHhcCCCCCcCcC
Confidence 999999999885 88888764
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=3.9e-21 Score=213.35 Aligned_cols=149 Identities=32% Similarity=0.475 Sum_probs=120.6
Q ss_pred CCccceeeccC-----------CeEEEEEEehHhhHHHHHHHHHHHHHHhhc-chhhHHH--------------------
Q 045449 630 FSENNLIGIGN-----------GMEVAVKVFHQQYERALKSFEDECEVRKRI-RHRNLVK-------------------- 677 (823)
Q Consensus 630 f~~~~~lg~g~-----------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~-------------------- 677 (823)
|...+++|.|. |+.||||++-.+.. +-..+||..+..- .|||||+
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye~R~VAVKrll~e~~---~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~~ 587 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYEGREVAVKRLLEEFF---DFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCAC 587 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeCCceehHHHHhhHhH---HHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhhh
Confidence 44456666664 67899998865543 4567899988877 7999999
Q ss_pred -----------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCC---C--CcEEEeecccccccCCCCc-
Q 045449 678 -----------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDE---D--MVAHISDFGIAKLLSGEDQ- 728 (823)
Q Consensus 678 -----------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~---~--~~~kl~DfGla~~~~~~~~- 728 (823)
.+.|+..+|.|+|+.+|||||+||+|||++. + .+++|+|||+++.+.....
T Consensus 588 sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS 667 (903)
T KOG1027|consen 588 SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSS 667 (903)
T ss_pred hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCCcch
Confidence 2468889999999999999999999999975 2 5899999999998876543
Q ss_pred cccccccccCCCcCcccccCCCccccccceehhhhhhccccCC-CCCcCCCccc
Q 045449 729 LSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETR-SMTVGETCTP 781 (823)
Q Consensus 729 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~-~~~~~~~~~~ 781 (823)
........||-+|+|||.+....-+..+|++|+|||+|+.++| ..||++....
T Consensus 668 ~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R 721 (903)
T KOG1027|consen 668 FSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLER 721 (903)
T ss_pred hhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHh
Confidence 2334567899999999999988888899999999998888876 7899876433
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.3e-20 Score=207.68 Aligned_cols=147 Identities=24% Similarity=0.309 Sum_probs=121.6
Q ss_pred cceeeccC----------------CeEEEEEEehHhh-HHHHHHHHHHHHHHhhcchhhHHHH-----------------
Q 045449 633 NNLIGIGN----------------GMEVAVKVFHQQY-ERALKSFEDECEVRKRIRHRNLVKI----------------- 678 (823)
Q Consensus 633 ~~~lg~g~----------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~----------------- 678 (823)
.++||.|+ +-+||+|++.... .+...+|.+|+-+|.+++|||++++
T Consensus 701 ~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~~qlvtq~mP 780 (1177)
T KOG1025|consen 701 DKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLSTLQLVTQLMP 780 (1177)
T ss_pred hceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccchHHHHHHhcc
Confidence 46788775 2359999986543 4556899999999999999999993
Q ss_pred -----------------------HHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCcccccccc
Q 045449 679 -----------------------ISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQT 735 (823)
Q Consensus 679 -----------------------~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 735 (823)
..|++.+|.|+|++++|||||-..|||+..-.++|++|||+|+....++........
T Consensus 781 ~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey~~~~g 860 (1177)
T KOG1025|consen 781 LGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEYSAPGG 860 (1177)
T ss_pred cchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCccccccccccc
Confidence 247777888889999999999999999999999999999999998766554333334
Q ss_pred ccCCCcCcccccCCCccccccceehhhhhhccccC-CCCCcCCCc
Q 045449 736 LATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKET-RSMTVGETC 779 (823)
Q Consensus 736 ~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~-~~~~~~~~~ 779 (823)
.-.+.|||-|.+....|+.++|||||||..||++| |..|+++..
T Consensus 861 K~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~ 905 (1177)
T KOG1025|consen 861 KVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIP 905 (1177)
T ss_pred ccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCC
Confidence 44678999999999999999999999999999865 778887754
|
|
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.8e-20 Score=199.50 Aligned_cols=136 Identities=31% Similarity=0.402 Sum_probs=112.2
Q ss_pred CeEEEEEEehHhhHHHHHHHHHHHHHHhhcchhhHHH-------------------------------------------
Q 045449 641 GMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVK------------------------------------------- 677 (823)
Q Consensus 641 ~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------------------------------------- 677 (823)
+..||||++........+.|.+|++++++++||||++
T Consensus 33 ~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~ 112 (284)
T cd05081 33 GEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLL 112 (284)
T ss_pred CcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEEEEEecCCCCHHHHHHhcCcCCCHHHHHH
Confidence 5679999997666666688999999999999999997
Q ss_pred HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCcccc-ccccccCCCcCcccccCCCcccccc
Q 045449 678 IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSK-QTQTLATIGYMAPEYGTKGRVSTRG 756 (823)
Q Consensus 678 ~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~ 756 (823)
++.|++.+|+|+|+.+|+||||||+||+++.++.+||+|||+++.......... .....++..|+|||+..+..++.++
T Consensus 113 ~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 192 (284)
T cd05081 113 YASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVAS 192 (284)
T ss_pred HHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccccCCCcceeecCCCCCceEeeCHHHhccCCcChHH
Confidence 246788899999999999999999999999999999999999987654322111 1112344569999999888899999
Q ss_pred ceehhhhhhccccCCCCCcC
Q 045449 757 DVCSFGIISGGKETRSMTVG 776 (823)
Q Consensus 757 Dv~S~Gvv~~~~~~~~~~~~ 776 (823)
|||||||+++++.++..++.
T Consensus 193 Di~slG~~l~el~~~~~~~~ 212 (284)
T cd05081 193 DVWSFGVVLYELFTYSDKSC 212 (284)
T ss_pred HHHHHHHHHHHHhhcCCcCC
Confidence 99999999999998766543
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.8e-20 Score=198.30 Aligned_cols=139 Identities=23% Similarity=0.322 Sum_probs=113.3
Q ss_pred CCeEEEEEEehHhh--HHHHHHHHHHHHHHhhcchhhHHH----------------------------------------
Q 045449 640 NGMEVAVKVFHQQY--ERALKSFEDECEVRKRIRHRNLVK---------------------------------------- 677 (823)
Q Consensus 640 ~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~---------------------------------------- 677 (823)
.+..||||++.... ....+++.+|++++++++||||++
T Consensus 26 ~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 105 (273)
T cd05074 26 SFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGE 105 (273)
T ss_pred CceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccceEEEEecCCCCcHHHHHHHhcccC
Confidence 35789999986542 344578999999999999999876
Q ss_pred ------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCccc
Q 045449 678 ------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPE 745 (823)
Q Consensus 678 ------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE 745 (823)
++.|++.+|.|+|+.+|+||||||+||+++.++.+|++|||+++...............+++.|++||
T Consensus 106 ~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe 185 (273)
T cd05074 106 EPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALE 185 (273)
T ss_pred CCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECcccccccccCCcceecCCCccCchhhcCHh
Confidence 24577788999999999999999999999999999999999998764333222223344667899999
Q ss_pred ccCCCccccccceehhhhhhccccC-CCCCcCCC
Q 045449 746 YGTKGRVSTRGDVCSFGIISGGKET-RSMTVGET 778 (823)
Q Consensus 746 ~~~~~~~~~~~Dv~S~Gvv~~~~~~-~~~~~~~~ 778 (823)
......++.++|||||||+++++.+ |..||.+.
T Consensus 186 ~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~ 219 (273)
T cd05074 186 SLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGV 219 (273)
T ss_pred HHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCC
Confidence 9988889999999999999999998 77777654
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.5e-20 Score=203.53 Aligned_cols=150 Identities=25% Similarity=0.303 Sum_probs=120.9
Q ss_pred cCCccceeeccC------------CeEEEEEEehHhh---HHHHHHHHHHHHHHhhcchhhHHH----------------
Q 045449 629 RFSENNLIGIGN------------GMEVAVKVFHQQY---ERALKSFEDECEVRKRIRHRNLVK---------------- 677 (823)
Q Consensus 629 ~f~~~~~lg~g~------------~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~---------------- 677 (823)
+|...+.+|.|+ +..||+|.+.... ....+.+..|++++++++|+||++
T Consensus 2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (316)
T cd05574 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMD 81 (316)
T ss_pred ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEE
Confidence 455556666653 5779999986543 235567999999999999999998
Q ss_pred --------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCcc--
Q 045449 678 --------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQL-- 729 (823)
Q Consensus 678 --------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~-- 729 (823)
++.|++++|.|+|+.+++||||||+||+++.++.++|+|||++.........
T Consensus 82 ~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~ 161 (316)
T cd05574 82 YCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVS 161 (316)
T ss_pred ecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhcccccccccc
Confidence 2468888999999999999999999999999999999999998764322110
Q ss_pred -------------------------ccccccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCCC
Q 045449 730 -------------------------SKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 730 -------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
.......||..|+|||+..+..++.++|||||||++|++++|..||...
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~ 235 (316)
T cd05574 162 KALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGS 235 (316)
T ss_pred cccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCC
Confidence 0011346899999999998888999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=8e-21 Score=223.52 Aligned_cols=152 Identities=24% Similarity=0.343 Sum_probs=120.7
Q ss_pred HHHhccCCccceeeccC------------CeEEEEEEehHh--hHHHHHHHHHHHHHHhhcchhhHHH------------
Q 045449 624 LRATDRFSENNLIGIGN------------GMEVAVKVFHQQ--YERALKSFEDECEVRKRIRHRNLVK------------ 677 (823)
Q Consensus 624 ~~at~~f~~~~~lg~g~------------~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~------------ 677 (823)
....++|...+.||.|+ +..||+|++... .......|..|+.++.+++|||||+
T Consensus 9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ 88 (1021)
T PTZ00266 9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK 88 (1021)
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence 34456788888899885 456889988643 2344578999999999999999998
Q ss_pred ----------------------------------HHHHHHHHhhhcCCC-------CEEeccCCCCCEEeCC--------
Q 045449 678 ----------------------------------IISSSLEYLHFGHSI-------PIIHCDLKPSNVLLDE-------- 708 (823)
Q Consensus 678 ----------------------------------~~~~~l~~L~~~h~~-------~ivHrdlk~~NiLl~~-------- 708 (823)
++.|++.+|.|+|.. +||||||||+|||++.
T Consensus 89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i 168 (1021)
T PTZ00266 89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI 168 (1021)
T ss_pred EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence 246788888888874 5999999999999964
Q ss_pred ---------CCcEEEeecccccccCCCCccccccccccCCCcCcccccCC--CccccccceehhhhhhccccCCCCCcCC
Q 045449 709 ---------DMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTK--GRVSTRGDVCSFGIISGGKETRSMTVGE 777 (823)
Q Consensus 709 ---------~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~ 777 (823)
...+||+|||+++.+.... ......||+.|+|||++.+ ..++.++|||||||++|++++|..||..
T Consensus 169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~ 245 (1021)
T PTZ00266 169 TAQANNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK 245 (1021)
T ss_pred cccccccCCCCceEEccCCccccccccc---cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence 3458999999998754322 1234579999999998854 4589999999999999999999999965
Q ss_pred C
Q 045449 778 T 778 (823)
Q Consensus 778 ~ 778 (823)
.
T Consensus 246 ~ 246 (1021)
T PTZ00266 246 A 246 (1021)
T ss_pred C
Confidence 3
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.1e-20 Score=205.70 Aligned_cols=149 Identities=28% Similarity=0.324 Sum_probs=123.7
Q ss_pred HhccCCccceeeccC------------CeEEEEEEehHh--hHHHHHHHHHHHHHHhhcchhhHHH--------------
Q 045449 626 ATDRFSENNLIGIGN------------GMEVAVKVFHQQ--YERALKSFEDECEVRKRIRHRNLVK-------------- 677 (823)
Q Consensus 626 at~~f~~~~~lg~g~------------~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~-------------- 677 (823)
..++|...+.+|.|+ +..||||++... .....+.+.+|++++++++|+||++
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 446777778888775 567999998643 2334467888999999999999985
Q ss_pred -----------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCc
Q 045449 678 -----------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQ 728 (823)
Q Consensus 678 -----------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~ 728 (823)
++.|++.+|+|+|+.+|+||||||+||+++.++.+||+|||+++......
T Consensus 94 ~~~~lv~e~~~~~l~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~- 172 (353)
T cd07850 94 QDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF- 172 (353)
T ss_pred CcEEEEEeccCCCHHHHHhhcCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCCCCC-
Confidence 25678899999999999999999999999999999999999998754322
Q ss_pred cccccccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCC
Q 045449 729 LSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGE 777 (823)
Q Consensus 729 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~ 777 (823)
......+++.|+|||++.+..++.++||||+||+++++++|+.||..
T Consensus 173 --~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~ 219 (353)
T cd07850 173 --MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPG 219 (353)
T ss_pred --CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCC
Confidence 12334688999999999998999999999999999999999998864
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.81 E-value=9.4e-21 Score=202.54 Aligned_cols=158 Identities=27% Similarity=0.337 Sum_probs=127.8
Q ss_pred cCHHHHHHHhccCCccceeeccC------------CeEEEEEEehHhhHHHHHHHHHHHHHHhhc-chhhHHH-------
Q 045449 618 FSYHELLRATDRFSENNLIGIGN------------GMEVAVKVFHQQYERALKSFEDECEVRKRI-RHRNLVK------- 677 (823)
Q Consensus 618 ~~~~~l~~at~~f~~~~~lg~g~------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~------- 677 (823)
+++.++.+++++|...+.+|.|+ +..||+|++.... .....+.+|+.++.++ +|||+++
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~ 90 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYK 90 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence 55677777889999988898875 5678999886432 2235678899999998 7998887
Q ss_pred ------------------------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEe
Q 045449 678 ------------------------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHIS 715 (823)
Q Consensus 678 ------------------------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~ 715 (823)
++.|++.+|+++|+.+++||||||+||+++.++.+||+
T Consensus 91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~ 170 (291)
T cd06639 91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLV 170 (291)
T ss_pred ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEe
Confidence 24577889999999999999999999999999999999
Q ss_pred ecccccccCCCCccccccccccCCCcCcccccCCC-----ccccccceehhhhhhccccCCCCCcCCC
Q 045449 716 DFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKG-----RVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 716 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
|||+++....... ......|+..|+|||++... .++.++|||||||+++++.+|+.||...
T Consensus 171 dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~ 236 (291)
T cd06639 171 DFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDM 236 (291)
T ss_pred ecccchhcccccc--cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCC
Confidence 9999987543221 12234688999999987543 3688999999999999999999998764
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.81 E-value=9.6e-21 Score=179.78 Aligned_cols=131 Identities=22% Similarity=0.351 Sum_probs=111.4
Q ss_pred CeEEEEEEehHhhHHHHHHHHHHHHHHhhcc-hhhHHHH---------------------------------------HH
Q 045449 641 GMEVAVKVFHQQYERALKSFEDECEVRKRIR-HRNLVKI---------------------------------------IS 680 (823)
Q Consensus 641 ~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~---------------------------------------~~ 680 (823)
+..++||++++... +...+|+.++..++ ||||+++ +.
T Consensus 63 ~eK~ViKiLKPVkk---kKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~v~n~Dfk~ly~tl~d~dIryY~~ 139 (338)
T KOG0668|consen 63 NEKCVIKILKPVKK---KKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEYVNNTDFKQLYPTLTDYDIRYYIY 139 (338)
T ss_pred CceEEEeeechHHH---HHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhhhhccccHHHHhhhhchhhHHHHHH
Confidence 46789999987644 57889999999997 9999982 46
Q ss_pred HHHHHhhhcCCCCEEeccCCCCCEEeCCC-CcEEEeecccccccCCCCccccccccccCCCcCcccccCC-Cccccccce
Q 045449 681 SSLEYLHFGHSIPIIHCDLKPSNVLLDED-MVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTK-GRVSTRGDV 758 (823)
Q Consensus 681 ~~l~~L~~~h~~~ivHrdlk~~NiLl~~~-~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv 758 (823)
+++.+|.|||++||+|||+||.|+++|.. -..+++|+|+|.++.+...+ ...+.+..|--||.+.. ..|+-.-|+
T Consensus 140 elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~eY---nVRVASRyfKGPELLVdy~~YDYSLD~ 216 (338)
T KOG0668|consen 140 ELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDYQMYDYSLDM 216 (338)
T ss_pred HHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCCCcee---eeeeehhhcCCchheeechhccccHHH
Confidence 88999999999999999999999999954 57999999999998766543 34567888999997654 558889999
Q ss_pred ehhhhhhccccCCCCCcCC
Q 045449 759 CSFGIISGGKETRSMTVGE 777 (823)
Q Consensus 759 ~S~Gvv~~~~~~~~~~~~~ 777 (823)
|||||+++.|.|.+.||-.
T Consensus 217 WS~GcmlA~miFrkepFFh 235 (338)
T KOG0668|consen 217 WSLGCMLASMIFRKEPFFH 235 (338)
T ss_pred HHHHHHHHHHHhccCcccC
Confidence 9999999999999999843
|
|
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.9e-20 Score=200.44 Aligned_cols=137 Identities=31% Similarity=0.373 Sum_probs=111.6
Q ss_pred eEEEEEEehHhh-HHHHHHHHHHHHHHhhc-chhhHHH------------------------------------------
Q 045449 642 MEVAVKVFHQQY-ERALKSFEDECEVRKRI-RHRNLVK------------------------------------------ 677 (823)
Q Consensus 642 ~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~------------------------------------------ 677 (823)
..||+|++.... .+...++.+|++++.++ +|+||++
T Consensus 43 ~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 122 (293)
T cd05053 43 STVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDP 122 (293)
T ss_pred eeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccc
Confidence 568999887532 34456799999999999 7999986
Q ss_pred --------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCc
Q 045449 678 --------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMA 743 (823)
Q Consensus 678 --------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a 743 (823)
++.|++.+|.|+|+.+|+||||||+||++++++.+||+|||+++.+.............++..|+|
T Consensus 123 ~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~a 202 (293)
T cd05053 123 RPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMA 202 (293)
T ss_pred cccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEcCCCeEEeCccccccccccccceeccCCCCCCccccC
Confidence 245788889999999999999999999999999999999999987654333222233345678999
Q ss_pred ccccCCCccccccceehhhhhhccccC-CCCCcCCC
Q 045449 744 PEYGTKGRVSTRGDVCSFGIISGGKET-RSMTVGET 778 (823)
Q Consensus 744 PE~~~~~~~~~~~Dv~S~Gvv~~~~~~-~~~~~~~~ 778 (823)
||+..+..++.++|||||||++|++++ |..||...
T Consensus 203 PE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~ 238 (293)
T cd05053 203 PEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI 238 (293)
T ss_pred HHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCC
Confidence 999988889999999999999999886 88887654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.3e-20 Score=199.55 Aligned_cols=136 Identities=27% Similarity=0.322 Sum_probs=116.2
Q ss_pred CeEEEEEEehHhhHHHHHHHHHHHHHHhhcchhhHHH---------------------------------------HHHH
Q 045449 641 GMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVK---------------------------------------IISS 681 (823)
Q Consensus 641 ~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~---------------------------------------~~~~ 681 (823)
+..||||.+........+.+.+|+.++++++|+||++ ++.|
T Consensus 47 ~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~l~~~~~~~~~~q 126 (292)
T cd06658 47 GKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLS 126 (292)
T ss_pred CCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcHHHHHhcCCCCHHHHHHHHHH
Confidence 5779999987655556678999999999999999999 2467
Q ss_pred HHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCcccccCCCccccccceehh
Q 045449 682 SLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSF 761 (823)
Q Consensus 682 ~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~ 761 (823)
++.+|.|+|+.+|+||||||+||+++.++.+||+|||++........ ......|+..|+|||+..+..++.++|||||
T Consensus 127 i~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~sl 204 (292)
T cd06658 127 VLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP--KRKSLVGTPYWMAPEVISRLPYGTEVDIWSL 204 (292)
T ss_pred HHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc--cCceeecCccccCHHHHccCCCCchhhHHHH
Confidence 88899999999999999999999999999999999999876543221 2234568999999999988889999999999
Q ss_pred hhhhccccCCCCCcCCC
Q 045449 762 GIISGGKETRSMTVGET 778 (823)
Q Consensus 762 Gvv~~~~~~~~~~~~~~ 778 (823)
||+++++.+|..||...
T Consensus 205 Gvil~el~~g~~p~~~~ 221 (292)
T cd06658 205 GIMVIEMIDGEPPYFNE 221 (292)
T ss_pred HHHHHHHHhCCCCCCCC
Confidence 99999999999998653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.81 E-value=3.9e-21 Score=201.72 Aligned_cols=179 Identities=25% Similarity=0.352 Sum_probs=128.3
Q ss_pred CeEEEEEEehHhh-HHHHHHHHHHHHHHhhcchhhHHH------------------------------------------
Q 045449 641 GMEVAVKVFHQQY-ERALKSFEDECEVRKRIRHRNLVK------------------------------------------ 677 (823)
Q Consensus 641 ~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~------------------------------------------ 677 (823)
+..||||++.... ....+.|.+|++.+++++||||++
T Consensus 28 ~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~ 107 (259)
T PF07714_consen 28 NQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYCPGGSLDDYLKSKNKEPLSEQQRLS 107 (259)
T ss_dssp EEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--TTEBHHHHHHHTCTTTSBHHHHHH
T ss_pred CEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 5679999996533 445789999999999999999999
Q ss_pred HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCcccccCCCccccccc
Q 045449 678 IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGD 757 (823)
Q Consensus 678 ~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D 757 (823)
++.|++++|+|+|+.+++|+||+++||+++.++.+||+|||+++...............+...|+|||.+....++.++|
T Consensus 108 i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksD 187 (259)
T PF07714_consen 108 IAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSD 187 (259)
T ss_dssp HHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSEEESTTSESGGGGS-HHHHHHSEESHHHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 35688889999999999999999999999999999999999998763333322233445778999999998888999999
Q ss_pred eehhhhhhccccC-CCCCcCCCcccccccccccCCcccccccCCCcccccccccccccccccCC
Q 045449 758 VCSFGIISGGKET-RSMTVGETCTPVRESKYEVHPATTTIMEHPLPRVGEVMDVDRGKARIQGK 820 (823)
Q Consensus 758 v~S~Gvv~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 820 (823)
|||||++++|+.+ +..|+.+.......... ...............+.+++..+....+-+||
T Consensus 188 VysfG~~l~ei~~~~~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~C~~~~p~~RP 250 (259)
T PF07714_consen 188 VYSFGMLLYEILTLGKFPFSDYDNEEIIEKL-KQGQRLPIPDNCPKDIYSLIQQCWSHDPEKRP 250 (259)
T ss_dssp HHHHHHHHHHHHTTSSGTTTTSCHHHHHHHH-HTTEETTSBTTSBHHHHHHHHHHT-SSGGGS-
T ss_pred ccccccccccccccccccccccccccccccc-cccccceeccchhHHHHHHHHHHcCCChhhCc
Confidence 9999999999999 67888765332211111 11111222333445555666555555444444
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.3e-20 Score=199.92 Aligned_cols=137 Identities=26% Similarity=0.335 Sum_probs=109.4
Q ss_pred eEEEEEEehHhh-HHHHHHHHHHHHHHhhcchhhHHH-------------------------------------------
Q 045449 642 MEVAVKVFHQQY-ERALKSFEDECEVRKRIRHRNLVK------------------------------------------- 677 (823)
Q Consensus 642 ~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~------------------------------------------- 677 (823)
..||+|.+.... ......|.+|+.++++++|+||++
T Consensus 37 ~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~ 116 (277)
T cd05036 37 LQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMK 116 (277)
T ss_pred eeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHH
Confidence 568899886433 344567999999999999999998
Q ss_pred ----HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCC---cEEEeecccccccCCCCccccccccccCCCcCcccccCCC
Q 045449 678 ----IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDM---VAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKG 750 (823)
Q Consensus 678 ----~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~---~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 750 (823)
++.|++.+|+|+|+.+++||||||+||+++.++ .+||+|||+++................+..|+|||++.+.
T Consensus 117 ~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 196 (277)
T cd05036 117 DLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDG 196 (277)
T ss_pred HHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEeccCccccccCCccceecCCCCCccHhhCCHHHHhcC
Confidence 245778889999999999999999999998654 6999999999876432221112223345689999999888
Q ss_pred ccccccceehhhhhhccccC-CCCCcCCC
Q 045449 751 RVSTRGDVCSFGIISGGKET-RSMTVGET 778 (823)
Q Consensus 751 ~~~~~~Dv~S~Gvv~~~~~~-~~~~~~~~ 778 (823)
.++.++|||||||+++++++ |..||...
T Consensus 197 ~~~~~~DiwslG~il~el~~~g~~pf~~~ 225 (277)
T cd05036 197 IFTSKTDVWSFGVLLWEIFSLGYMPYPGR 225 (277)
T ss_pred CcCchhHHHHHHHHHHHHHcCCCCCCCCC
Confidence 89999999999999999986 88888654
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.2e-20 Score=198.07 Aligned_cols=135 Identities=27% Similarity=0.460 Sum_probs=111.4
Q ss_pred eEEEEEEehHhhHHHHHHHHHHHHHHhhcchhhHHH-----------------------------------------HHH
Q 045449 642 MEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVK-----------------------------------------IIS 680 (823)
Q Consensus 642 ~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-----------------------------------------~~~ 680 (823)
..||+|++.... ...+.|.+|++++++++|+|+++ ++.
T Consensus 31 ~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ 109 (260)
T cd05069 31 TKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVSEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAA 109 (260)
T ss_pred ceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCcEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHH
Confidence 458999886543 23467899999999999999997 246
Q ss_pred HHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCcccccCCCccccccceeh
Q 045449 681 SSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCS 760 (823)
Q Consensus 681 ~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S 760 (823)
|++++|.|+|+.+++||||||+||++++++.+||+|||+++....... .......++..|+|||+..+..++.++||||
T Consensus 110 ~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~s 188 (260)
T cd05069 110 QIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWS 188 (260)
T ss_pred HHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCcc-cccCCCccchhhCCHHHhccCCcChHHHHHH
Confidence 888999999999999999999999999999999999999987543221 1112234677899999998888999999999
Q ss_pred hhhhhccccC-CCCCcCCC
Q 045449 761 FGIISGGKET-RSMTVGET 778 (823)
Q Consensus 761 ~Gvv~~~~~~-~~~~~~~~ 778 (823)
|||++|++.+ |..||.+.
T Consensus 189 lG~~l~el~t~g~~p~~~~ 207 (260)
T cd05069 189 FGILLTELVTKGRVPYPGM 207 (260)
T ss_pred HHHHHHHHHhCCCCCCCCC
Confidence 9999999998 88888664
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.3e-20 Score=201.06 Aligned_cols=152 Identities=22% Similarity=0.340 Sum_probs=119.1
Q ss_pred hccCCccceeeccC-----------------CeEEEEEEehHhh-HHHHHHHHHHHHHHhhcchhhHHH-----------
Q 045449 627 TDRFSENNLIGIGN-----------------GMEVAVKVFHQQY-ERALKSFEDECEVRKRIRHRNLVK----------- 677 (823)
Q Consensus 627 t~~f~~~~~lg~g~-----------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~----------- 677 (823)
+++|...+.+|.|+ +..||+|.+.... ......+.+|+.++++++||||++
T Consensus 5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (288)
T cd05061 5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPT 84 (288)
T ss_pred HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCc
Confidence 45566666666664 2368999876443 233457889999999999999998
Q ss_pred ---------------------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecc
Q 045449 678 ---------------------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFG 718 (823)
Q Consensus 678 ---------------------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfG 718 (823)
++.|++.+|.|+|+++|+||||||+||+++.++.+|++|||
T Consensus 85 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~L~Dfg 164 (288)
T cd05061 85 LVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFG 164 (288)
T ss_pred EEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEEECcCC
Confidence 13467788999999999999999999999999999999999
Q ss_pred cccccCCCCccccccccccCCCcCcccccCCCccccccceehhhhhhccccC-CCCCcCCC
Q 045449 719 IAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKET-RSMTVGET 778 (823)
Q Consensus 719 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~-~~~~~~~~ 778 (823)
+++...............++..|+|||...++.++.++|||||||+++++.+ +..||...
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~ 225 (288)
T cd05061 165 MTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGL 225 (288)
T ss_pred ccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 9986543332222223345778999999988889999999999999999987 67777653
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=99.81 E-value=8.5e-21 Score=199.30 Aligned_cols=148 Identities=27% Similarity=0.441 Sum_probs=117.9
Q ss_pred cCCccceeeccC-----------CeEEEEEEehHhhHHHHHHHHHHHHHHhhcchhhHHH--------------------
Q 045449 629 RFSENNLIGIGN-----------GMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVK-------------------- 677 (823)
Q Consensus 629 ~f~~~~~lg~g~-----------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-------------------- 677 (823)
+|+..+.+|.|+ +..||+|.+..... ..++|.+|++++++++|+++++
T Consensus 7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~lv~e~~~~~ 85 (260)
T cd05070 7 SLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVSEEPIYIVTEYMSKG 85 (260)
T ss_pred HhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEECCCCcEEEEEecCCC
Confidence 445556666664 35689998865432 2357999999999999999987
Q ss_pred ---------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccc
Q 045449 678 ---------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTL 736 (823)
Q Consensus 678 ---------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~ 736 (823)
++.+++.+|+|+|+.+++||||||+||++++++.+||+|||+++........ ......
T Consensus 86 ~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~ 164 (260)
T cd05070 86 SLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT-ARQGAK 164 (260)
T ss_pred cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCcccc-cccCCC
Confidence 3568888999999999999999999999999999999999999876433211 112234
Q ss_pred cCCCcCcccccCCCccccccceehhhhhhccccC-CCCCcCCC
Q 045449 737 ATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKET-RSMTVGET 778 (823)
Q Consensus 737 gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~-~~~~~~~~ 778 (823)
++..|+|||+..+..++.++|||||||+++++.+ |..||.+.
T Consensus 165 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~ 207 (260)
T cd05070 165 FPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGM 207 (260)
T ss_pred CCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCC
Confidence 5678999999988889999999999999999998 78888653
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.81 E-value=2e-20 Score=195.99 Aligned_cols=136 Identities=25% Similarity=0.280 Sum_probs=114.3
Q ss_pred CeEEEEEEehHhh-----HHHHHHHHHHHHHHhhcchhhHHH--------------------------------------
Q 045449 641 GMEVAVKVFHQQY-----ERALKSFEDECEVRKRIRHRNLVK-------------------------------------- 677 (823)
Q Consensus 641 ~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~-------------------------------------- 677 (823)
+..||+|.+.... ....+.+.+|++++++++|+||++
T Consensus 25 ~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~ 104 (258)
T cd06632 25 GDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVI 104 (258)
T ss_pred CcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEEEecCCCcHHHHHHhcCCCCHHHH
Confidence 5679999875432 345578999999999999999998
Q ss_pred --HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCcccccCCCc-ccc
Q 045449 678 --IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGR-VST 754 (823)
Q Consensus 678 --~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~ 754 (823)
++.|+++++.|+|+.+++|+||||+||+++.++.+||+|||+++...... ......|+..|+|||.+.... ++.
T Consensus 105 ~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~---~~~~~~~~~~y~~pe~~~~~~~~~~ 181 (258)
T cd06632 105 RLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS---FAKSFKGSPYWMAPEVIAQQGGYGL 181 (258)
T ss_pred HHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccccc---cccccCCCcceeCHHHhcCCCCCCc
Confidence 24578889999999999999999999999999999999999988754332 123456889999999887766 899
Q ss_pred ccceehhhhhhccccCCCCCcCCCc
Q 045449 755 RGDVCSFGIISGGKETRSMTVGETC 779 (823)
Q Consensus 755 ~~Dv~S~Gvv~~~~~~~~~~~~~~~ 779 (823)
++|+|||||+++++.+|..||.+..
T Consensus 182 ~~D~~slG~~l~~l~~g~~pf~~~~ 206 (258)
T cd06632 182 AADIWSLGCTVLEMATGKPPWSQLE 206 (258)
T ss_pred hhhhHHHHHHHHHHHhCCCCcccCc
Confidence 9999999999999999999987654
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.3e-20 Score=187.76 Aligned_cols=149 Identities=23% Similarity=0.244 Sum_probs=119.5
Q ss_pred ccCCccceeeccC------------CeEEEEEEehHhh---HHHHHHHHHHHHHHhhc-chhhHHH--------------
Q 045449 628 DRFSENNLIGIGN------------GMEVAVKVFHQQY---ERALKSFEDECEVRKRI-RHRNLVK-------------- 677 (823)
Q Consensus 628 ~~f~~~~~lg~g~------------~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~-------------- 677 (823)
++|+.-.+||+|+ .+.+|+|+++++. .+.++=...|..+..+. +||.+|.
T Consensus 250 ~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffv 329 (593)
T KOG0695|consen 250 QDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFV 329 (593)
T ss_pred ccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEE
Confidence 4677777888875 4668999987654 22233344555555554 5777775
Q ss_pred --------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCcccc
Q 045449 678 --------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSK 731 (823)
Q Consensus 678 --------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~ 731 (823)
+-+.+.-+|||+|++||+.||+|.+|||+|..|++|++|+|+++.--.... .
T Consensus 330 ieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~l~~gd--~ 407 (593)
T KOG0695|consen 330 IEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGPGD--T 407 (593)
T ss_pred EEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcCCCCCc--c
Confidence 346788899999999999999999999999999999999999986433222 3
Q ss_pred ccccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCCC
Q 045449 732 QTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 732 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
.++++|||.|+|||++.+..|+..+|+|++||+++||+.|+.||+-.
T Consensus 408 tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdiv 454 (593)
T KOG0695|consen 408 TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIV 454 (593)
T ss_pred cccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCccee
Confidence 45789999999999999999999999999999999999999999643
|
|
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.2e-20 Score=201.68 Aligned_cols=152 Identities=25% Similarity=0.270 Sum_probs=122.2
Q ss_pred HhccCCccceeeccC------------CeEEEEEEehHhh-HHHHHHHHHHHHHHhhcchhhHHH---------------
Q 045449 626 ATDRFSENNLIGIGN------------GMEVAVKVFHQQY-ERALKSFEDECEVRKRIRHRNLVK--------------- 677 (823)
Q Consensus 626 at~~f~~~~~lg~g~------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~--------------- 677 (823)
|+++|...+.||.|+ +..||+|++.... ......+.+|++++++++|+||++
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 456777778888774 5679999986443 222346788999999999999987
Q ss_pred -------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccc
Q 045449 678 -------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQ 732 (823)
Q Consensus 678 -------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~ 732 (823)
++.|++.+|+|+|+.+|+||||||+||+++.++.+||+|||+++....... ..
T Consensus 83 e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~--~~ 160 (291)
T cd07870 83 EYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ--TY 160 (291)
T ss_pred ecccCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCC--CC
Confidence 346888999999999999999999999999999999999999986432221 12
Q ss_pred cccccCCCcCcccccCCC-ccccccceehhhhhhccccCCCCCcCCCc
Q 045449 733 TQTLATIGYMAPEYGTKG-RVSTRGDVCSFGIISGGKETRSMTVGETC 779 (823)
Q Consensus 733 ~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~~ 779 (823)
....+++.|+|||++.+. .++.++||||+||+++++.+|..||....
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~ 208 (291)
T cd07870 161 SSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVS 208 (291)
T ss_pred CCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCch
Confidence 234578999999998754 47889999999999999999999987543
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.3e-20 Score=202.49 Aligned_cols=149 Identities=25% Similarity=0.313 Sum_probs=118.6
Q ss_pred ccCCccceeeccC------------CeEEEEEEehHhh-HHHHHHHHHHHHHHhhcchhhHHH-----------------
Q 045449 628 DRFSENNLIGIGN------------GMEVAVKVFHQQY-ERALKSFEDECEVRKRIRHRNLVK----------------- 677 (823)
Q Consensus 628 ~~f~~~~~lg~g~------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~----------------- 677 (823)
++|...+.||.|+ +..||+|.+.... ......+.+|++++++++||||++
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 3455556666654 5679999986433 223356788999999999999998
Q ss_pred -----------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccc
Q 045449 678 -----------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQ 734 (823)
Q Consensus 678 -----------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 734 (823)
++.|++.+|.|+|+.+|+||||||+||+++.++.+||+|||+++....... ....
T Consensus 86 ~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~ 163 (301)
T cd07873 86 LDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK--TYSN 163 (301)
T ss_pred cccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC--cccc
Confidence 246888999999999999999999999999999999999999976432221 1223
Q ss_pred cccCCCcCcccccCCC-ccccccceehhhhhhccccCCCCCcCCC
Q 045449 735 TLATIGYMAPEYGTKG-RVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 735 ~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
..+++.|+|||++.+. .++.++||||+||+++++.+|..||...
T Consensus 164 ~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~ 208 (301)
T cd07873 164 EVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGS 208 (301)
T ss_pred cceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 4678999999987654 4788999999999999999999998653
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.7e-20 Score=197.66 Aligned_cols=138 Identities=25% Similarity=0.294 Sum_probs=113.0
Q ss_pred eEEEEEEehHhh-HHHHHHHHHHHHHHhhcchhhHHH----------------------------------------HHH
Q 045449 642 MEVAVKVFHQQY-ERALKSFEDECEVRKRIRHRNLVK----------------------------------------IIS 680 (823)
Q Consensus 642 ~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~----------------------------------------~~~ 680 (823)
..||+|+..... .....++.+|+.++++++||||++ ++.
T Consensus 37 ~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~ 116 (279)
T cd05057 37 IPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLSSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCV 116 (279)
T ss_pred eEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHH
Confidence 358999886543 345578999999999999999997 356
Q ss_pred HHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCcccccCCCccccccceeh
Q 045449 681 SSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCS 760 (823)
Q Consensus 681 ~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S 760 (823)
|++.+|+|+|+.+++||||||+||+++.++.+||+|||+++...............++..|+|||......++.++||||
T Consensus 117 qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s 196 (279)
T cd05057 117 QIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWS 196 (279)
T ss_pred HHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHH
Confidence 88889999999999999999999999999999999999998765433221112223467899999998888999999999
Q ss_pred hhhhhccccC-CCCCcCCCc
Q 045449 761 FGIISGGKET-RSMTVGETC 779 (823)
Q Consensus 761 ~Gvv~~~~~~-~~~~~~~~~ 779 (823)
|||+++++++ |..||....
T Consensus 197 lG~~l~el~~~g~~p~~~~~ 216 (279)
T cd05057 197 YGVTVWELMTFGAKPYEGIP 216 (279)
T ss_pred HHHHHHHHhcCCCCCCCCCC
Confidence 9999999997 898887643
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.9e-20 Score=197.79 Aligned_cols=138 Identities=20% Similarity=0.250 Sum_probs=109.0
Q ss_pred CeEEEEEEehHhh-HHHHHHHHHHHHHHhhcchhhHHH------------------------------------------
Q 045449 641 GMEVAVKVFHQQY-ERALKSFEDECEVRKRIRHRNLVK------------------------------------------ 677 (823)
Q Consensus 641 ~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~------------------------------------------ 677 (823)
...||+|.+.... ......|.+|+++++.++|+||++
T Consensus 22 ~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~ 101 (269)
T cd05042 22 KARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDV 101 (269)
T ss_pred CeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCcHHHHHHhccccccccccHHH
Confidence 3568999876433 344567899999999999999998
Q ss_pred ---HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCcccccCC-----
Q 045449 678 ---IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTK----- 749 (823)
Q Consensus 678 ---~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----- 749 (823)
++.|++.+|.|+|+.+|+||||||+||+++.++.+||+|||+++...............++..|+|||+...
T Consensus 102 ~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 181 (269)
T cd05042 102 LQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDL 181 (269)
T ss_pred HHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchheeccCCCCCcccccCHHHHhhccccc
Confidence 235788889999999999999999999999999999999999876543322212233456778999998642
Q ss_pred --CccccccceehhhhhhccccC-CCCCcCCC
Q 045449 750 --GRVSTRGDVCSFGIISGGKET-RSMTVGET 778 (823)
Q Consensus 750 --~~~~~~~Dv~S~Gvv~~~~~~-~~~~~~~~ 778 (823)
..++.++||||+||+++++++ +..||...
T Consensus 182 ~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~ 213 (269)
T cd05042 182 LPKDQTKKSNIWSLGVTMWELFTAADQPYPDL 213 (269)
T ss_pred cccccchhhHHHHHHHHHHHHHhCCCCCCCcC
Confidence 356889999999999999998 67777654
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.81 E-value=3.1e-20 Score=194.72 Aligned_cols=136 Identities=30% Similarity=0.355 Sum_probs=116.0
Q ss_pred CeEEEEEEehHhh---HHHHHHHHHHHHHHhhcchhhHHH----------------------------------------
Q 045449 641 GMEVAVKVFHQQY---ERALKSFEDECEVRKRIRHRNLVK---------------------------------------- 677 (823)
Q Consensus 641 ~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~---------------------------------------- 677 (823)
+..||+|++.... ....+.+.+|++++++++||||++
T Consensus 25 ~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~ 104 (258)
T cd05578 25 KKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKF 104 (258)
T ss_pred CcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeCCCCCCHHHHHHhcCCcCHHHHHH
Confidence 5779999997543 245678999999999999999998
Q ss_pred HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCcccccCCCccccccc
Q 045449 678 IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGD 757 (823)
Q Consensus 678 ~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D 757 (823)
++.|++++|.|+|+.+++|+||||+||++++++.++|+|||.+....... ......|+..|+|||+.....++.++|
T Consensus 105 ~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~D 181 (258)
T cd05578 105 WICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT---LTTSTSGTPGYMAPEVLCRQGYSVAVD 181 (258)
T ss_pred HHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc---cccccCCChhhcCHHHHcccCCCCccc
Confidence 24678888999999999999999999999999999999999988754332 123356889999999998888999999
Q ss_pred eehhhhhhccccCCCCCcCCCc
Q 045449 758 VCSFGIISGGKETRSMTVGETC 779 (823)
Q Consensus 758 v~S~Gvv~~~~~~~~~~~~~~~ 779 (823)
|||+|+++|++.+|..||....
T Consensus 182 i~slG~~l~~l~~g~~p~~~~~ 203 (258)
T cd05578 182 WWSLGVTAYECLRGKRPYRGHS 203 (258)
T ss_pred chhhHHHHHHHHhCCCCCCCCC
Confidence 9999999999999999987643
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.81 E-value=4.5e-20 Score=196.53 Aligned_cols=135 Identities=24% Similarity=0.338 Sum_probs=111.6
Q ss_pred CeEEEEEEehHhh-HHHHHHHHHHHHHHhhcchhhHHH------------------------------------------
Q 045449 641 GMEVAVKVFHQQY-ERALKSFEDECEVRKRIRHRNLVK------------------------------------------ 677 (823)
Q Consensus 641 ~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~------------------------------------------ 677 (823)
+..||+|.+.... ....+.|.+|++++++++|||+++
T Consensus 33 ~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~ 112 (284)
T cd05079 33 GEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQL 112 (284)
T ss_pred cceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceEEEEEccCCCCHHHHHHhccCCCCHHHHH
Confidence 5679999987443 344568999999999999999987
Q ss_pred -HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCcc-ccccccccCCCcCcccccCCCccccc
Q 045449 678 -IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQL-SKQTQTLATIGYMAPEYGTKGRVSTR 755 (823)
Q Consensus 678 -~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~ 755 (823)
++.|++.+|+|+|+.|++||||||+||+++.++.+||+|||+++........ .......++..|+|||+..+..++.+
T Consensus 113 ~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~ 192 (284)
T cd05079 113 KYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIA 192 (284)
T ss_pred HHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccccccccCccceeecCCCCCCccccCHHHhccCCCCcc
Confidence 3568888999999999999999999999999999999999999876433221 11223456778999999988889999
Q ss_pred cceehhhhhhccccCCCCCc
Q 045449 756 GDVCSFGIISGGKETRSMTV 775 (823)
Q Consensus 756 ~Dv~S~Gvv~~~~~~~~~~~ 775 (823)
+|||||||++++++++..+.
T Consensus 193 ~Di~slG~il~ellt~~~~~ 212 (284)
T cd05079 193 SDVWSFGVTLYELLTYCDSE 212 (284)
T ss_pred ccchhhhhhhhhhhcCCCCC
Confidence 99999999999999876554
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=8.8e-21 Score=202.38 Aligned_cols=175 Identities=23% Similarity=0.285 Sum_probs=134.5
Q ss_pred EEEEEEehHhhHHHHHHHHHHHHHHhhcchhhHHHH------------------------------------------HH
Q 045449 643 EVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVKI------------------------------------------IS 680 (823)
Q Consensus 643 ~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~------------------------------------------~~ 680 (823)
.||||.++.+. ..+++|..|+++|+.++|||+|++ +.
T Consensus 294 TvAVKtLKEDt-MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAt 372 (1157)
T KOG4278|consen 294 TVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMAT 372 (1157)
T ss_pred eeehhhhhhcc-hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHH
Confidence 48999997664 456899999999999999999992 34
Q ss_pred HHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCcccccCCCccccccceeh
Q 045449 681 SSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCS 760 (823)
Q Consensus 681 ~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S 760 (823)
|+..++.|+.....||||+-..|.|+.++..+||+|||++|.+..+. ++......-.+.|.|||.+....++.|+|||+
T Consensus 373 QIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDT-YTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWA 451 (1157)
T KOG4278|consen 373 QISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDT-YTAHAGAKFPIKWTAPESLAYNTFSIKSDVWA 451 (1157)
T ss_pred HHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhcCCc-eecccCccCcccccCcccccccccccchhhHH
Confidence 77777888888999999999999999999999999999999987543 33333333367899999999999999999999
Q ss_pred hhhhhccccCC-CCCcCCCcccccccccccCCcccccccCCCcccccccccccccccccCC
Q 045449 761 FGIISGGKETR-SMTVGETCTPVRESKYEVHPATTTIMEHPLPRVGEVMDVDRGKARIQGK 820 (823)
Q Consensus 761 ~Gvv~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 820 (823)
|||++||+.|. ..|+.++......+..+. ......++.+.|.+-++|..+..-.+-+||
T Consensus 452 FGVLLWEIATYGMsPYPGidlSqVY~LLEk-gyRM~~PeGCPpkVYeLMraCW~WsPsDRP 511 (1157)
T KOG4278|consen 452 FGVLLWEIATYGMSPYPGIDLSQVYGLLEK-GYRMDGPEGCPPKVYELMRACWNWSPSDRP 511 (1157)
T ss_pred HHHHHHHHHhcCCCCCCCccHHHHHHHHhc-cccccCCCCCCHHHHHHHHHHhcCCcccCc
Confidence 99999999874 456766644322222211 122334567778888888877766655555
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.5e-20 Score=198.39 Aligned_cols=146 Identities=22% Similarity=0.329 Sum_probs=121.4
Q ss_pred ccCCccceeeccC------------CeEEEEEEehHhhH--------HHHHHHHHHHHHHhhcc---hhhHHH-------
Q 045449 628 DRFSENNLIGIGN------------GMEVAVKVFHQQYE--------RALKSFEDECEVRKRIR---HRNLVK------- 677 (823)
Q Consensus 628 ~~f~~~~~lg~g~------------~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~---h~niv~------- 677 (823)
..|..-+.+|+|+ ...|+||.+.+++- +.....-.|++||.+++ |+||++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 4577778889886 45699998876541 11123457999999997 999999
Q ss_pred ----------------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeeccccccc
Q 045449 678 ----------------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLL 723 (823)
Q Consensus 678 ----------------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~ 723 (823)
++.|++.++.|+|+.||||||||-+||.++.+|.+||+|||.|...
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgsaa~~ 720 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGSAAYT 720 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccchhhh
Confidence 3679999999999999999999999999999999999999998765
Q ss_pred CCCCccccccccccCCCcCcccccCCCcc-ccccceehhhhhhccccCCCCCcCC
Q 045449 724 SGEDQLSKQTQTLATIGYMAPEYGTKGRV-STRGDVCSFGIISGGKETRSMTVGE 777 (823)
Q Consensus 724 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~S~Gvv~~~~~~~~~~~~~ 777 (823)
.... ...++||.+|+|||++.+.+| +..-|||++||++|-..+.+-||..
T Consensus 721 ksgp----fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 721 KSGP----FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred cCCC----cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 4332 345789999999999999998 5668999999999999999888753
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.80 E-value=2e-20 Score=196.15 Aligned_cols=146 Identities=32% Similarity=0.421 Sum_probs=120.5
Q ss_pred CccceeeccC------------CeEEEEEEehHhhHHH--HHHHHHHHHHHhhcchhhHHH-------------------
Q 045449 631 SENNLIGIGN------------GMEVAVKVFHQQYERA--LKSFEDECEVRKRIRHRNLVK------------------- 677 (823)
Q Consensus 631 ~~~~~lg~g~------------~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~------------------- 677 (823)
+..+.||.|+ +..||+|++....... .....+|+.++++++||||++
T Consensus 2 ~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~~ 81 (260)
T PF00069_consen 2 RLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYCP 81 (260)
T ss_dssp EEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEET
T ss_pred EEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccccccccccccccc
Confidence 3456777775 5679999997654322 234566999999999999998
Q ss_pred ---------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccc
Q 045449 678 ---------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTL 736 (823)
Q Consensus 678 ---------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~ 736 (823)
++.|++++|+++|+.+++||||||+||+++.++.++|+|||.+...... ........
T Consensus 82 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~--~~~~~~~~ 159 (260)
T PF00069_consen 82 GGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSEN--NENFNPFV 159 (260)
T ss_dssp TEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTST--TSEBSSSS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc--cccccccc
Confidence 3678899999999999999999999999999999999999999764111 12234567
Q ss_pred cCCCcCcccccC-CCccccccceehhhhhhccccCCCCCcCCC
Q 045449 737 ATIGYMAPEYGT-KGRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 737 gt~~y~aPE~~~-~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
++..|+|||+.. +..++.++||||+|++++++++|..|+.+.
T Consensus 160 ~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~ 202 (260)
T PF00069_consen 160 GTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEES 202 (260)
T ss_dssp SSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTS
T ss_pred ccccccccccccccccccccccccccccccccccccccccccc
Confidence 899999999988 788999999999999999999999999875
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=8.5e-21 Score=189.34 Aligned_cols=134 Identities=29% Similarity=0.348 Sum_probs=111.4
Q ss_pred CeEEEEEEehHhh--HHHHHHHHHHHHHHhhcchhhHHH-----------------------------------------
Q 045449 641 GMEVAVKVFHQQY--ERALKSFEDECEVRKRIRHRNLVK----------------------------------------- 677 (823)
Q Consensus 641 ~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~----------------------------------------- 677 (823)
+..||+|.+.... ....++..+|..++..+.|+||++
T Consensus 41 ~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e~m~~nl~~vi~~elDH~ti 120 (369)
T KOG0665|consen 41 GRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVMELMDANLCQVILMELDHETI 120 (369)
T ss_pred cCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHHhhhhHHHHHHHHhcchHHH
Confidence 4567777664332 122356677888888888888887
Q ss_pred --HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCcccccCCCccccc
Q 045449 678 --IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTR 755 (823)
Q Consensus 678 --~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 755 (823)
++.|.+.+++|+|+.||+|||+||+||++..+..+||.|||+|+..... ...+..+.|..|+|||++.+..|.+.
T Consensus 121 s~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~---~~mtpyVvtRyyrapevil~~~~ke~ 197 (369)
T KOG0665|consen 121 SYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD---FMMTPYVVTRYYRAPEVILGMGYKEN 197 (369)
T ss_pred HHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcccCcc---cccCchhheeeccCchheeccCCccc
Confidence 4568899999999999999999999999999999999999999864322 34567889999999999999899999
Q ss_pred cceehhhhhhccccCCCCCcCC
Q 045449 756 GDVCSFGIISGGKETRSMTVGE 777 (823)
Q Consensus 756 ~Dv~S~Gvv~~~~~~~~~~~~~ 777 (823)
+||||.||++|||..|...|.+
T Consensus 198 vdiwSvGci~gEli~~~Vlf~g 219 (369)
T KOG0665|consen 198 VDIWSVGCIMGELILGTVLFPG 219 (369)
T ss_pred chhhhhhhHHHHHhhceEEecC
Confidence 9999999999999999987764
|
|
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.3e-20 Score=195.46 Aligned_cols=136 Identities=22% Similarity=0.296 Sum_probs=114.7
Q ss_pred CeEEEEEEehHhh--HHHHHHHHHHHHHHhhcchhhHHH-----------------------------------------
Q 045449 641 GMEVAVKVFHQQY--ERALKSFEDECEVRKRIRHRNLVK----------------------------------------- 677 (823)
Q Consensus 641 ~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~----------------------------------------- 677 (823)
+..||+|.+.... ....+++.+|++++++++|+||++
T Consensus 25 ~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~~~~~~~~~~~~~~~~ 104 (256)
T cd08221 25 DSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVL 104 (256)
T ss_pred CcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEecCCCcHHHHHHhccccCCCHHHHH
Confidence 5678999876432 445578999999999999999998
Q ss_pred -HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCcccccCCCcccccc
Q 045449 678 -IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRG 756 (823)
Q Consensus 678 -~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 756 (823)
++.|++.+|.|+|+.+++||||||+||++++++.+||+|||+++....... ......|++.|+|||+..+..++.++
T Consensus 105 ~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~--~~~~~~~~~~y~ape~~~~~~~~~~~ 182 (256)
T cd08221 105 WYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS--MAETVVGTPYYMSPELCQGVKYNFKS 182 (256)
T ss_pred HHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEcccccc--cccccCCCccccCHhhcCCCCCCCcc
Confidence 245788889999999999999999999999999999999999987644332 22345689999999999888889999
Q ss_pred ceehhhhhhccccCCCCCcCCC
Q 045449 757 DVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 757 Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
|||||||+++++.+|..||...
T Consensus 183 Dv~slG~i~~~l~~g~~~~~~~ 204 (256)
T cd08221 183 DIWALGCVLYELLTLKRTFDAT 204 (256)
T ss_pred hhHHHHHHHHHHHHCCCCCCCC
Confidence 9999999999999999988653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.5e-20 Score=195.67 Aligned_cols=138 Identities=22% Similarity=0.264 Sum_probs=110.4
Q ss_pred CeEEEEEEehHhh-HHHHHHHHHHHHHHhhcchhhHHH------------------------------------------
Q 045449 641 GMEVAVKVFHQQY-ERALKSFEDECEVRKRIRHRNLVK------------------------------------------ 677 (823)
Q Consensus 641 ~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~------------------------------------------ 677 (823)
+..+|+|.++... ......|.+|+.++++++||||++
T Consensus 22 ~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~ 101 (269)
T cd05087 22 PAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTT 101 (269)
T ss_pred ceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCcHHHHHHHhhhcccccccHHH
Confidence 4568999886543 234457899999999999999998
Q ss_pred ---HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCcccccCCC----
Q 045449 678 ---IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKG---- 750 (823)
Q Consensus 678 ---~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---- 750 (823)
++.|++.+++|+|+.+++||||||+||+++.++.+||+|||+++...............|+..|+|||++.+.
T Consensus 102 ~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 181 (269)
T cd05087 102 LQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNL 181 (269)
T ss_pred HHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcceeecCCCcCCcccccCHhHhccccccc
Confidence 2357888999999999999999999999999999999999999765433222222334578899999987542
Q ss_pred ---ccccccceehhhhhhccccC-CCCCcCCC
Q 045449 751 ---RVSTRGDVCSFGIISGGKET-RSMTVGET 778 (823)
Q Consensus 751 ---~~~~~~Dv~S~Gvv~~~~~~-~~~~~~~~ 778 (823)
.++.++|||||||+++++++ |..||...
T Consensus 182 ~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~ 213 (269)
T cd05087 182 LVVDQTKESNVWSLGVTIWELFELGSQPYRHL 213 (269)
T ss_pred cccCCCccchhHHHHHHHHHHHhCCCCCCCCC
Confidence 35789999999999999985 99888654
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.3e-20 Score=199.15 Aligned_cols=138 Identities=24% Similarity=0.320 Sum_probs=111.1
Q ss_pred CeEEEEEEehHhh-HHHHHHHHHHHHHHhhcchhhHHH------------------------------------------
Q 045449 641 GMEVAVKVFHQQY-ERALKSFEDECEVRKRIRHRNLVK------------------------------------------ 677 (823)
Q Consensus 641 ~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~------------------------------------------ 677 (823)
+..||+|++.... ....++|.+|+++++++.||||++
T Consensus 35 ~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 114 (288)
T cd05050 35 FTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHST 114 (288)
T ss_pred ceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccEEEEecCCCCCHHHHHHHcCccccccccccc
Confidence 4678999987543 344578999999999999999986
Q ss_pred --------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCcccccccccc
Q 045449 678 --------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLA 737 (823)
Q Consensus 678 --------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~g 737 (823)
++.|++.+|.|+|+.+++||||||+||++++++.+||+|||+++...............+
T Consensus 115 ~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~ 194 (288)
T cd05050 115 SSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAI 194 (288)
T ss_pred cccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhheEecCCCceEECccccceecccCccccccCCCcc
Confidence 234667789999999999999999999999999999999999886543322212223345
Q ss_pred CCCcCcccccCCCccccccceehhhhhhccccC-CCCCcCCC
Q 045449 738 TIGYMAPEYGTKGRVSTRGDVCSFGIISGGKET-RSMTVGET 778 (823)
Q Consensus 738 t~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~-~~~~~~~~ 778 (823)
+..|+|||++.+..++.++|||||||++|++.+ +..||.+.
T Consensus 195 ~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~ 236 (288)
T cd05050 195 PIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGM 236 (288)
T ss_pred ChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 678999999988899999999999999999986 77777543
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.5e-20 Score=193.31 Aligned_cols=137 Identities=28% Similarity=0.308 Sum_probs=111.5
Q ss_pred CeEEEEEEehHhh-HHHHHHHHHHHHHHhhcchhhHHH-----------------------------------------H
Q 045449 641 GMEVAVKVFHQQY-ERALKSFEDECEVRKRIRHRNLVK-----------------------------------------I 678 (823)
Q Consensus 641 ~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~-----------------------------------------~ 678 (823)
+..||+|++.... ......|.+|++++++++||||++ +
T Consensus 19 ~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~ 98 (250)
T cd05085 19 KTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKF 98 (250)
T ss_pred CcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHHHHHHhcCCCCCHHHHHHH
Confidence 4679999987543 334457999999999999999998 2
Q ss_pred HHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCcccccCCCccccccce
Q 045449 679 ISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDV 758 (823)
Q Consensus 679 ~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv 758 (823)
+.+++.+|.|+|+.+++|||+||+||+++.++.+||+|||+++....... .......++..|+|||+...+.++.++||
T Consensus 99 ~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di 177 (250)
T cd05085 99 ALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIY-SSSGLKQIPIKWTAPEALNYGRYSSESDV 177 (250)
T ss_pred HHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceecccccc-ccCCCCCCcccccCHHHhccCCCCchhHH
Confidence 46778889999999999999999999999999999999999976432211 11112234678999999988889999999
Q ss_pred ehhhhhhccccC-CCCCcCCC
Q 045449 759 CSFGIISGGKET-RSMTVGET 778 (823)
Q Consensus 759 ~S~Gvv~~~~~~-~~~~~~~~ 778 (823)
|||||+++++.+ |..||.+.
T Consensus 178 ~slG~ll~~~~~~g~~p~~~~ 198 (250)
T cd05085 178 WSYGILLWETFSLGVCPYPGM 198 (250)
T ss_pred HHHHHHHHHHhcCCCCCCCCC
Confidence 999999999988 88888654
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.7e-20 Score=195.62 Aligned_cols=137 Identities=23% Similarity=0.279 Sum_probs=113.0
Q ss_pred eEEEEEEehHhh-HHHHHHHHHHHHHHhhcchhhHHH----------------------------------------HHH
Q 045449 642 MEVAVKVFHQQY-ERALKSFEDECEVRKRIRHRNLVK----------------------------------------IIS 680 (823)
Q Consensus 642 ~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~----------------------------------------~~~ 680 (823)
..||||...... ....+.|.+|+.++++++||||++ ++.
T Consensus 35 ~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 114 (270)
T cd05056 35 IAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSY 114 (270)
T ss_pred cceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcCCCcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHH
Confidence 358999887554 455678999999999999999998 246
Q ss_pred HHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCcccccCCCccccccceeh
Q 045449 681 SSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCS 760 (823)
Q Consensus 681 ~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S 760 (823)
+++.+|.|+|+.+++||||||+||+++.++.+|++|||+++......... .....++..|+|||++....++.++||||
T Consensus 115 ~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~s 193 (270)
T cd05056 115 QLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYK-ASKGKLPIKWMAPESINFRRFTSASDVWM 193 (270)
T ss_pred HHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeeccccccee-cCCCCccccccChhhhccCCCCchhhhHH
Confidence 88889999999999999999999999999999999999998765432211 12234557899999998888999999999
Q ss_pred hhhhhccccC-CCCCcCCCc
Q 045449 761 FGIISGGKET-RSMTVGETC 779 (823)
Q Consensus 761 ~Gvv~~~~~~-~~~~~~~~~ 779 (823)
|||+++++++ |..||....
T Consensus 194 lG~il~el~~~g~~pf~~~~ 213 (270)
T cd05056 194 FGVCMWEILMLGVKPFQGVK 213 (270)
T ss_pred HHHHHHHHHHcCCCCCCCCC
Confidence 9999999885 888886653
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.4e-20 Score=196.73 Aligned_cols=151 Identities=21% Similarity=0.413 Sum_probs=118.8
Q ss_pred ccCCccceeeccC---------------CeEEEEEEehHhh-HHHHHHHHHHHHHHhhcchhhHHH--------------
Q 045449 628 DRFSENNLIGIGN---------------GMEVAVKVFHQQY-ERALKSFEDECEVRKRIRHRNLVK-------------- 677 (823)
Q Consensus 628 ~~f~~~~~lg~g~---------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~-------------- 677 (823)
++|...+.+|+|+ ...||||.+.... ....++|..|++++++++|+|+++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII 84 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence 3556666777664 1258999886543 344578999999999999999988
Q ss_pred ---------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccc
Q 045449 678 ---------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLS 730 (823)
Q Consensus 678 ---------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~ 730 (823)
++.+++.+++|+|+.+++|||+||+||+++.++.+|++|||+++.........
T Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~ 164 (268)
T cd05063 85 TEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGT 164 (268)
T ss_pred EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceecccccccc
Confidence 35678889999999999999999999999999999999999998764332211
Q ss_pred c-ccccccCCCcCcccccCCCccccccceehhhhhhccccC-CCCCcCCC
Q 045449 731 K-QTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKET-RSMTVGET 778 (823)
Q Consensus 731 ~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~-~~~~~~~~ 778 (823)
. ......+..|+|||++....++.++|||||||++|++++ |..||...
T Consensus 165 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~ 214 (268)
T cd05063 165 YTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDM 214 (268)
T ss_pred eeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcC
Confidence 1 111223567999999988889999999999999999886 89898553
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.9e-20 Score=197.18 Aligned_cols=137 Identities=26% Similarity=0.330 Sum_probs=115.6
Q ss_pred CCeEEEEEEehHhh-HHHHHHHHHHHHHHhhcchhhHHH---------------------------------------HH
Q 045449 640 NGMEVAVKVFHQQY-ERALKSFEDECEVRKRIRHRNLVK---------------------------------------II 679 (823)
Q Consensus 640 ~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~---------------------------------------~~ 679 (823)
.+..||+|.+.... ....+.+.+|++++++++||||++ ++
T Consensus 28 ~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~ 107 (277)
T cd06642 28 TKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIATIL 107 (277)
T ss_pred CCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccCCCcHHHHhhcCCCCHHHHHHHH
Confidence 35789999987433 344578999999999999999999 24
Q ss_pred HHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCcccccCCCcccccccee
Q 045449 680 SSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVC 759 (823)
Q Consensus 680 ~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~ 759 (823)
.++++++.|+|+.+++|+||+|+||+++.++.+|++|||+++....... ......|+..|+|||++.+..++.++|||
T Consensus 108 ~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~ 185 (277)
T cd06642 108 REILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI--KRNTFVGTPFWMAPEVIKQSAYDFKADIW 185 (277)
T ss_pred HHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcch--hhhcccCcccccCHHHhCcCCCchhhhHH
Confidence 6788899999999999999999999999999999999999987643221 12234688999999999988899999999
Q ss_pred hhhhhhccccCCCCCcCCC
Q 045449 760 SFGIISGGKETRSMTVGET 778 (823)
Q Consensus 760 S~Gvv~~~~~~~~~~~~~~ 778 (823)
||||+++++.+|..|+.+.
T Consensus 186 slG~il~el~tg~~p~~~~ 204 (277)
T cd06642 186 SLGITAIELAKGEPPNSDL 204 (277)
T ss_pred HHHHHHHHHHhCCCCCccc
Confidence 9999999999999998654
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.80 E-value=4e-20 Score=194.44 Aligned_cols=138 Identities=33% Similarity=0.414 Sum_probs=115.5
Q ss_pred CeEEEEEEehHhhH--HHHHHHHHHHHHHhhcchhhHHH----------------------------------------H
Q 045449 641 GMEVAVKVFHQQYE--RALKSFEDECEVRKRIRHRNLVK----------------------------------------I 678 (823)
Q Consensus 641 ~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~----------------------------------------~ 678 (823)
+..||+|++..... ...+.+.+|++++++++|+||++ +
T Consensus 25 ~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i 104 (264)
T cd06626 25 GELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVY 104 (264)
T ss_pred CcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecCCCCcHHHHHhhcCCCChHHHHHH
Confidence 56799999875443 46688999999999999999998 3
Q ss_pred HHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCcccc--ccccccCCCcCcccccCCCc---cc
Q 045449 679 ISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSK--QTQTLATIGYMAPEYGTKGR---VS 753 (823)
Q Consensus 679 ~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~---~~ 753 (823)
+.+++.+|.|+|+.+|+||||||+||++++++.+||+|||++........... .....+++.|+|||++.+.. ++
T Consensus 105 ~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~ 184 (264)
T cd06626 105 TLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHG 184 (264)
T ss_pred HHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcccccccCCcCCcCccChhhccCCCCCCCC
Confidence 56888899999999999999999999999999999999999987654332111 11346789999999988766 88
Q ss_pred cccceehhhhhhccccCCCCCcCCC
Q 045449 754 TRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 754 ~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
.++|||||||+++++++|..||.+.
T Consensus 185 ~~~Dv~s~G~il~~l~~g~~pf~~~ 209 (264)
T cd06626 185 RAADIWSLGCVVLEMATGKRPWSEL 209 (264)
T ss_pred cccchHHHHHHHHHHHhCCCCccCC
Confidence 9999999999999999999999754
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.3e-20 Score=204.08 Aligned_cols=137 Identities=21% Similarity=0.286 Sum_probs=116.7
Q ss_pred EEEEEEehHhhHH-HHHHHHHHHHHHhhcchhhHHH-----------------------------------------HHH
Q 045449 643 EVAVKVFHQQYER-ALKSFEDECEVRKRIRHRNLVK-----------------------------------------IIS 680 (823)
Q Consensus 643 ~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~-----------------------------------------~~~ 680 (823)
.||||+++..... ...+|.+|+.+|.+|+|||+++ ++.
T Consensus 140 ~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~ 219 (1039)
T KOG0199|consen 140 NVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLDQPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAM 219 (1039)
T ss_pred eEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeeccchhhHHhhhcccchHHHHHhhccccceeHHHHHHHHH
Confidence 4999999876643 5689999999999999999998 346
Q ss_pred HHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCcccccc-ccccCCCcCcccccCCCcccccccee
Q 045449 681 SSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQT-QTLATIGYMAPEYGTKGRVSTRGDVC 759 (823)
Q Consensus 681 ~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~Dv~ 759 (823)
|++.+|.|+..++.||||+-..|+|+...-.+||+|||+.|-+...+.+..+. ...-...|.|||.+....++.++|||
T Consensus 220 QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvW 299 (1039)
T KOG0199|consen 220 QIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVW 299 (1039)
T ss_pred HHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccCCCCcceEecCCCcCcccccCHhHhccccccccchhh
Confidence 88888999999999999999999999988899999999999887665543332 23346789999999999999999999
Q ss_pred hhhhhhccccC-CCCCcCCCc
Q 045449 760 SFGIISGGKET-RSMTVGETC 779 (823)
Q Consensus 760 S~Gvv~~~~~~-~~~~~~~~~ 779 (823)
+|||.+|||++ |++||.+..
T Consensus 300 myGVTiWEMFtyGEePW~G~~ 320 (1039)
T KOG0199|consen 300 MYGVTIWEMFTYGEEPWVGCR 320 (1039)
T ss_pred hhhhhHHhhhccCCCCCCCCC
Confidence 99999999976 678887754
|
|
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.9e-20 Score=194.25 Aligned_cols=149 Identities=27% Similarity=0.409 Sum_probs=120.3
Q ss_pred ccCCccceeeccC-----------CeEEEEEEehHhhHHHHHHHHHHHHHHhhcchhhHHH-------------------
Q 045449 628 DRFSENNLIGIGN-----------GMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVK------------------- 677 (823)
Q Consensus 628 ~~f~~~~~lg~g~-----------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------------- 677 (823)
++|...+.+|+|+ +..||+|.+.... ...+.|.+|++++++++|+||++
T Consensus 6 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~v~e~~~~ 84 (260)
T cd05073 6 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTKEPIYIITEFMAK 84 (260)
T ss_pred cceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcCCCeEEEEEeCCC
Confidence 4556666777664 3458899886543 34578999999999999999998
Q ss_pred ----------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCcccccccc
Q 045449 678 ----------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQT 735 (823)
Q Consensus 678 ----------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 735 (823)
++.|++.+|+++|+.+++||||||+||+++.++.+||+|||.++....... ......
T Consensus 85 ~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~~~~~~ 163 (260)
T cd05073 85 GSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY-TAREGA 163 (260)
T ss_pred CcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCCCc-ccccCC
Confidence 246888999999999999999999999999999999999999986543222 112233
Q ss_pred ccCCCcCcccccCCCccccccceehhhhhhccccC-CCCCcCCC
Q 045449 736 LATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKET-RSMTVGET 778 (823)
Q Consensus 736 ~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~-~~~~~~~~ 778 (823)
.++..|+|||++..+.++.++|||||||+++++++ |..||.+.
T Consensus 164 ~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~ 207 (260)
T cd05073 164 KFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGM 207 (260)
T ss_pred cccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCC
Confidence 46678999999988889999999999999999998 88888654
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.2e-20 Score=194.37 Aligned_cols=144 Identities=32% Similarity=0.431 Sum_probs=118.9
Q ss_pred cCCccceeeccC----------CeEEEEEEehHhhHHHHHHHHHHHHHHhhcchhhHHH---------------------
Q 045449 629 RFSENNLIGIGN----------GMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVK--------------------- 677 (823)
Q Consensus 629 ~f~~~~~lg~g~----------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~--------------------- 677 (823)
+|...+.+|.|+ ++.||||.+..... ..+++.+|+.++++++|+||++
T Consensus 7 ~~~~~~~ig~g~~g~v~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~ 85 (256)
T cd05039 7 ELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKG 85 (256)
T ss_pred hccceeeeecCCCceEEEEEecCcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCCC
Confidence 444555666553 67799999976654 5678999999999999999998
Q ss_pred ---------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccc
Q 045449 678 ---------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTL 736 (823)
Q Consensus 678 ---------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~ 736 (823)
++.|++.+|.|+|+.+++||||||+||+++.++.+||+|||.++....... ...
T Consensus 86 ~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~-----~~~ 160 (256)
T cd05039 86 SLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD-----SGK 160 (256)
T ss_pred cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEcccccccccccccc-----cCC
Confidence 246788889999999999999999999999999999999999987632221 233
Q ss_pred cCCCcCcccccCCCccccccceehhhhhhccccC-CCCCcCCC
Q 045449 737 ATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKET-RSMTVGET 778 (823)
Q Consensus 737 gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~-~~~~~~~~ 778 (823)
++..|+|||++..+.++.++|||||||+++++.+ |..||...
T Consensus 161 ~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~ 203 (256)
T cd05039 161 LPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI 203 (256)
T ss_pred CcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCC
Confidence 5678999999988889999999999999999986 88887654
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.4e-20 Score=197.30 Aligned_cols=135 Identities=28% Similarity=0.409 Sum_probs=109.3
Q ss_pred eEEEEEEehHhhHHHHHHHHHHHHHHhhcchhhHHH-----------------------------------------HHH
Q 045449 642 MEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVK-----------------------------------------IIS 680 (823)
Q Consensus 642 ~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-----------------------------------------~~~ 680 (823)
..+|+|++..... ...+|.+|++++++++|+||++ ++.
T Consensus 29 ~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ 107 (256)
T cd05059 29 IDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCS 107 (256)
T ss_pred ccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCCCCHHHHHHhcccCCCHHHHHHHHH
Confidence 4689998864322 2357889999999999999997 356
Q ss_pred HHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCcccccCCCccccccceeh
Q 045449 681 SSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCS 760 (823)
Q Consensus 681 ~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S 760 (823)
|++.+|+|+|+.+++||||||+||+++.++.+|++|||+++....... .......++..|+|||+..+..++.++||||
T Consensus 108 qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~s 186 (256)
T cd05059 108 DVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY-TSSQGTKFPVKWAPPEVFDYSRFSSKSDVWS 186 (256)
T ss_pred HHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceecccccc-cccCCCCCCccccCHHHhccCCCCchhhHHH
Confidence 788899999999999999999999999999999999999986543221 1111223456899999999889999999999
Q ss_pred hhhhhccccC-CCCCcCCC
Q 045449 761 FGIISGGKET-RSMTVGET 778 (823)
Q Consensus 761 ~Gvv~~~~~~-~~~~~~~~ 778 (823)
|||++|++++ |..||...
T Consensus 187 lG~il~~l~~~g~~p~~~~ 205 (256)
T cd05059 187 FGVLMWEVFSEGKMPYERF 205 (256)
T ss_pred HHHHHHHHhccCCCCCCCC
Confidence 9999999998 78888653
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=99.80 E-value=5e-20 Score=198.59 Aligned_cols=145 Identities=23% Similarity=0.320 Sum_probs=119.1
Q ss_pred cCCccceeeccC------------CeEEEEEEehHhh-HHHHHHHHHHHHHHhhcchhhHHH------------------
Q 045449 629 RFSENNLIGIGN------------GMEVAVKVFHQQY-ERALKSFEDECEVRKRIRHRNLVK------------------ 677 (823)
Q Consensus 629 ~f~~~~~lg~g~------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~------------------ 677 (823)
+|...+.+|.|+ +..||+|.+.... ....+++.+|++++.+++||||++
T Consensus 2 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~ 81 (308)
T cd06615 2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHM 81 (308)
T ss_pred CceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeecc
Confidence 456666666664 5668999886442 344567899999999999999998
Q ss_pred ----------------------HHHHHHHHhhhcCC-CCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccc
Q 045449 678 ----------------------IISSSLEYLHFGHS-IPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQ 734 (823)
Q Consensus 678 ----------------------~~~~~l~~L~~~h~-~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 734 (823)
++.|++++|.|+|+ .+++||||||+||+++.++.+||+|||+++...... ...
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~----~~~ 157 (308)
T cd06615 82 DGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM----ANS 157 (308)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCcccccccc----ccc
Confidence 35678888999997 699999999999999999999999999987653221 234
Q ss_pred cccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCC
Q 045449 735 TLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGE 777 (823)
Q Consensus 735 ~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~ 777 (823)
..|++.|+|||+..+..++.++|||||||+++++++|..||..
T Consensus 158 ~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~ 200 (308)
T cd06615 158 FVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPP 200 (308)
T ss_pred CCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCC
Confidence 5789999999998888899999999999999999999998753
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.7e-20 Score=199.67 Aligned_cols=134 Identities=26% Similarity=0.303 Sum_probs=109.9
Q ss_pred CeEEEEEEehHhh--HHHHHHHHHHHHHHhhcchhhHHH----------------------------------------H
Q 045449 641 GMEVAVKVFHQQY--ERALKSFEDECEVRKRIRHRNLVK----------------------------------------I 678 (823)
Q Consensus 641 ~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~----------------------------------------~ 678 (823)
|..||+|++.... ......+.+|++++++++|+||++ +
T Consensus 25 g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~ 104 (284)
T cd07839 25 HEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSF 104 (284)
T ss_pred CcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecCCCCHHHHHHhcCCCCCHHHHHHH
Confidence 5679999886432 223356788999999999999997 3
Q ss_pred HHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCcccccCCCc-cccccc
Q 045449 679 ISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGR-VSTRGD 757 (823)
Q Consensus 679 ~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~D 757 (823)
+.|++++|.|+|+.+++||||||+||+++.++.+||+|||+++....... ......+++.|+|||++.+.. ++.++|
T Consensus 105 ~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~D 182 (284)
T cd07839 105 MFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR--CYSAEVVTLWYRPPDVLFGAKLYSTSID 182 (284)
T ss_pred HHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC--CcCCCccccCCcChHHHhCCcccCcHHH
Confidence 56889999999999999999999999999999999999999986543221 123346789999999876644 789999
Q ss_pred eehhhhhhccccCCCCCcC
Q 045449 758 VCSFGIISGGKETRSMTVG 776 (823)
Q Consensus 758 v~S~Gvv~~~~~~~~~~~~ 776 (823)
|||+||+++++++|..|+.
T Consensus 183 iwslG~il~~l~tg~~p~~ 201 (284)
T cd07839 183 MWSAGCIFAELANAGRPLF 201 (284)
T ss_pred HHHHHHHHHHHHhcCCCCc
Confidence 9999999999999988864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.1e-20 Score=199.73 Aligned_cols=148 Identities=25% Similarity=0.356 Sum_probs=115.0
Q ss_pred ccCCccceeeccC------------C--eEEEEEEehHhh-HHHHHHHHHHHHHHhhc-chhhHHHH-------------
Q 045449 628 DRFSENNLIGIGN------------G--MEVAVKVFHQQY-ERALKSFEDECEVRKRI-RHRNLVKI------------- 678 (823)
Q Consensus 628 ~~f~~~~~lg~g~------------~--~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~------------- 678 (823)
++|+..+.+|.|+ + ..+|+|.+.... ....+.|.+|++++.++ +|+||+++
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 3455566677664 1 246777776432 34557899999999999 89999871
Q ss_pred -------------------------------------------HHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEe
Q 045449 679 -------------------------------------------ISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHIS 715 (823)
Q Consensus 679 -------------------------------------------~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~ 715 (823)
+.|+++++.|+|+.+++||||||+|||++.++.+||+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~~~kl~ 166 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIA 166 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCCcEEeC
Confidence 2467888999999999999999999999999999999
Q ss_pred ecccccccCCCCccccccccccCCCcCcccccCCCccccccceehhhhhhccccC-CCCCcCCC
Q 045449 716 DFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKET-RSMTVGET 778 (823)
Q Consensus 716 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~-~~~~~~~~ 778 (823)
|||+++..... .......++..|+|||++.+..++.++|||||||+++++++ |..||...
T Consensus 167 dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~ 227 (303)
T cd05088 167 DFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM 227 (303)
T ss_pred ccccCcccchh---hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccC
Confidence 99998743211 11112234678999999988889999999999999999997 88888643
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.6e-20 Score=195.40 Aligned_cols=137 Identities=22% Similarity=0.408 Sum_probs=111.2
Q ss_pred eEEEEEEehHhh-HHHHHHHHHHHHHHhhcchhhHHH-----------------------------------------HH
Q 045449 642 MEVAVKVFHQQY-ERALKSFEDECEVRKRIRHRNLVK-----------------------------------------II 679 (823)
Q Consensus 642 ~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~-----------------------------------------~~ 679 (823)
..||+|.++... ....+.|.+|+.++.+++||||++ ++
T Consensus 33 ~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~ 112 (267)
T cd05066 33 IPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGML 112 (267)
T ss_pred eEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHH
Confidence 368999886543 344578999999999999999998 24
Q ss_pred HHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccc-cccccccCCCcCcccccCCCccccccce
Q 045449 680 SSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLS-KQTQTLATIGYMAPEYGTKGRVSTRGDV 758 (823)
Q Consensus 680 ~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv 758 (823)
.|++.++.++|+.+++||||||+||+++.++.+|++|||+++......... ......++..|+|||++.+..++.++||
T Consensus 113 ~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv 192 (267)
T cd05066 113 RGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDV 192 (267)
T ss_pred HHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCcccccccccceeeecCCCccceeecCHhHhccCccCchhhh
Confidence 678889999999999999999999999999999999999998764332211 1112234568999999998889999999
Q ss_pred ehhhhhhccccC-CCCCcCCC
Q 045449 759 CSFGIISGGKET-RSMTVGET 778 (823)
Q Consensus 759 ~S~Gvv~~~~~~-~~~~~~~~ 778 (823)
|||||+++++++ |..||.+.
T Consensus 193 ~slG~~l~ell~~g~~p~~~~ 213 (267)
T cd05066 193 WSYGIVMWEVMSYGERPYWEM 213 (267)
T ss_pred HHHHHHHHHHhcCCCCCcccC
Confidence 999999999775 99888654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.5e-20 Score=198.71 Aligned_cols=158 Identities=26% Similarity=0.352 Sum_probs=127.0
Q ss_pred cCHHHHHHHhccCCccceeeccC------------CeEEEEEEehHhhHHHHHHHHHHHHHHhhc-chhhHHH-------
Q 045449 618 FSYHELLRATDRFSENNLIGIGN------------GMEVAVKVFHQQYERALKSFEDECEVRKRI-RHRNLVK------- 677 (823)
Q Consensus 618 ~~~~~l~~at~~f~~~~~lg~g~------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~------- 677 (823)
+.++.+..++++|...+.||.|+ +..||+|++.... .....+.+|+.+++++ +||||++
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 86 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYK 86 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence 45567777888888888888875 4668999876432 2235788899999999 6999997
Q ss_pred ------------------------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEe
Q 045449 678 ------------------------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHIS 715 (823)
Q Consensus 678 ------------------------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~ 715 (823)
++.|++++|.|+|+.+++|||+||+||+++.++.+||+
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~ 166 (286)
T cd06638 87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLV 166 (286)
T ss_pred cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEc
Confidence 23567888999999999999999999999999999999
Q ss_pred ecccccccCCCCccccccccccCCCcCcccccCC-----CccccccceehhhhhhccccCCCCCcCCC
Q 045449 716 DFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTK-----GRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 716 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
|||+++....... ......|++.|+|||++.. ..++.++||||+||++|++.+|..|+.+.
T Consensus 167 dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~ 232 (286)
T cd06638 167 DFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADL 232 (286)
T ss_pred cCCceeecccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCC
Confidence 9999987643221 1233468999999998753 45789999999999999999999998654
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.5e-20 Score=196.15 Aligned_cols=134 Identities=27% Similarity=0.334 Sum_probs=114.4
Q ss_pred CeEEEEEEehHhh-HHHHHHHHHHHHHHhhcchhhHHH-----------------------------------------H
Q 045449 641 GMEVAVKVFHQQY-ERALKSFEDECEVRKRIRHRNLVK-----------------------------------------I 678 (823)
Q Consensus 641 ~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~-----------------------------------------~ 678 (823)
+..||+|++.... ....+++.+|++++++++||||++ +
T Consensus 26 ~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~ 105 (265)
T cd06605 26 GKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKI 105 (265)
T ss_pred CcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecCCCcHHHHHHHccCCCCHHHHHHH
Confidence 5779999887553 345578999999999999999998 2
Q ss_pred HHHHHHHhhhcCC-CCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCcccccCCCccccccc
Q 045449 679 ISSSLEYLHFGHS-IPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGD 757 (823)
Q Consensus 679 ~~~~l~~L~~~h~-~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D 757 (823)
+.|++++++++|+ .+++||||||+||+++.++.+||+|||.+........ ....++..|+|||+..+..++.++|
T Consensus 106 ~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~----~~~~~~~~y~~PE~~~~~~~~~~~D 181 (265)
T cd06605 106 AVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA----KTFVGTSSYMAPERIQGNDYSVKSD 181 (265)
T ss_pred HHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh----hcccCChhccCHHHHcCCCCCchhh
Confidence 4678889999999 9999999999999999999999999999876532211 1256889999999998889999999
Q ss_pred eehhhhhhccccCCCCCcCCC
Q 045449 758 VCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 758 v~S~Gvv~~~~~~~~~~~~~~ 778 (823)
|||+||+++++.+|..|+...
T Consensus 182 v~slG~~l~~l~~g~~p~~~~ 202 (265)
T cd06605 182 IWSLGLSLIELATGRFPYPPE 202 (265)
T ss_pred HHHHHHHHHHHHhCCCCCCcc
Confidence 999999999999999998654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.5e-20 Score=200.41 Aligned_cols=137 Identities=29% Similarity=0.375 Sum_probs=110.1
Q ss_pred eEEEEEEehHhh-HHHHHHHHHHHHHHhhc-chhhHHHH-----------------------------------------
Q 045449 642 MEVAVKVFHQQY-ERALKSFEDECEVRKRI-RHRNLVKI----------------------------------------- 678 (823)
Q Consensus 642 ~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~----------------------------------------- 678 (823)
..||+|++.... .....++.+|+++++++ +||||+++
T Consensus 45 ~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~ 124 (314)
T cd05099 45 VTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDIT 124 (314)
T ss_pred eEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCCceEEEEecCCCCcHHHHHHhcCCCccccccccc
Confidence 358999887432 34456789999999999 69999881
Q ss_pred ---------------HHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCc
Q 045449 679 ---------------ISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMA 743 (823)
Q Consensus 679 ---------------~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a 743 (823)
+.|++.+|.|+|+.|++||||||+||+++.++.+||+|||+++...............++..|+|
T Consensus 125 ~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~a 204 (314)
T cd05099 125 KVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMA 204 (314)
T ss_pred CCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEEcCCCcEEEccccccccccccccccccccCCCCccccC
Confidence 23788899999999999999999999999999999999999987643322211222334568999
Q ss_pred ccccCCCccccccceehhhhhhccccC-CCCCcCCC
Q 045449 744 PEYGTKGRVSTRGDVCSFGIISGGKET-RSMTVGET 778 (823)
Q Consensus 744 PE~~~~~~~~~~~Dv~S~Gvv~~~~~~-~~~~~~~~ 778 (823)
||++.++.++.++|||||||++|++++ |..||...
T Consensus 205 PE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~ 240 (314)
T cd05099 205 PEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGI 240 (314)
T ss_pred HHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCC
Confidence 999988889999999999999999988 77777654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.6e-20 Score=199.44 Aligned_cols=150 Identities=22% Similarity=0.220 Sum_probs=118.9
Q ss_pred cCCccceeeccC------------CeEEEEEEehHhh---HHHHHHHHHHHHHHhhcchhhHHH----------------
Q 045449 629 RFSENNLIGIGN------------GMEVAVKVFHQQY---ERALKSFEDECEVRKRIRHRNLVK---------------- 677 (823)
Q Consensus 629 ~f~~~~~lg~g~------------~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~---------------- 677 (823)
+|...+.+|.|+ +..||+|.+.... ....+.+.+|++++++++||||++
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (305)
T cd05609 2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVME 81 (305)
T ss_pred CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEe
Confidence 455556666653 4679999987553 234567889999999999999998
Q ss_pred ------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCc-----
Q 045449 678 ------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQ----- 728 (823)
Q Consensus 678 ------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~----- 728 (823)
++.|++.+|+|+|+.+++||||||+||+++.++.+|++|||+++.......
T Consensus 82 ~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~~ 161 (305)
T cd05609 82 YVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYE 161 (305)
T ss_pred cCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCccccccc
Confidence 256788899999999999999999999999999999999999874211000
Q ss_pred --------cccccccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCCC
Q 045449 729 --------LSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 729 --------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
........|+..|+|||++....++.++|+|||||+++++.+|..||.+.
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~ 219 (305)
T cd05609 162 GHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGD 219 (305)
T ss_pred cccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 00111245788999999998888999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.80 E-value=5.1e-20 Score=194.19 Aligned_cols=137 Identities=28% Similarity=0.337 Sum_probs=113.3
Q ss_pred CeEEEEEEehHhh------HHHHHHHHHHHHHHhhcchhhHHH-------------------------------------
Q 045449 641 GMEVAVKVFHQQY------ERALKSFEDECEVRKRIRHRNLVK------------------------------------- 677 (823)
Q Consensus 641 ~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~------------------------------------- 677 (823)
+..||+|++.... ....+.+.+|++++++++|+||++
T Consensus 25 ~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~ 104 (268)
T cd06630 25 GTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAV 104 (268)
T ss_pred CcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEEEeccCCCcHHHHHHHhCCCCHHH
Confidence 5779999886432 234578999999999999999998
Q ss_pred ---HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCC-cEEEeecccccccCCCCcc--ccccccccCCCcCcccccCCCc
Q 045449 678 ---IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDM-VAHISDFGIAKLLSGEDQL--SKQTQTLATIGYMAPEYGTKGR 751 (823)
Q Consensus 678 ---~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~-~~kl~DfGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~ 751 (823)
++.|++.+|.++|+.+++||||||+||+++.++ .+||+|||.++........ .......|+..|+|||+..+..
T Consensus 105 ~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~ 184 (268)
T cd06630 105 IINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQ 184 (268)
T ss_pred HHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEcccccccccccccccCCccccccccccceeCHhHhccCC
Confidence 357889999999999999999999999998765 6999999999876533211 1112346889999999998888
Q ss_pred cccccceehhhhhhccccCCCCCcCC
Q 045449 752 VSTRGDVCSFGIISGGKETRSMTVGE 777 (823)
Q Consensus 752 ~~~~~Dv~S~Gvv~~~~~~~~~~~~~ 777 (823)
++.++||||+||+++++++|..||..
T Consensus 185 ~~~~~Dv~slG~~l~~l~~g~~p~~~ 210 (268)
T cd06630 185 YGRSCDVWSVGCVIIEMATAKPPWNA 210 (268)
T ss_pred CCcccchHHHHHHHHHHHhCCCCCCC
Confidence 99999999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.9e-20 Score=194.46 Aligned_cols=143 Identities=28% Similarity=0.419 Sum_probs=116.2
Q ss_pred cCCccceeeccC----------CeEEEEEEehHhhHHHHHHHHHHHHHHhhcchhhHHH---------------------
Q 045449 629 RFSENNLIGIGN----------GMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVK--------------------- 677 (823)
Q Consensus 629 ~f~~~~~lg~g~----------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~--------------------- 677 (823)
+|...+.+|.|+ +..||+|...... ..+.|.+|+.++++++|||+++
T Consensus 7 ~~~~~~~lg~g~~g~v~~~~~~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~v~e~~~~~~ 84 (254)
T cd05083 7 KLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHNGLYIVMELMSKGN 84 (254)
T ss_pred HceeeeeeccCCCCceEecccCCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCCCcEEEEECCCCCC
Confidence 344555666553 5679999986543 2367899999999999999998
Q ss_pred --------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCcccccccccc
Q 045449 678 --------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLA 737 (823)
Q Consensus 678 --------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~g 737 (823)
++.|++.++.|+|+.+++|||+||+||+++.++.+||+|||+++...... .....
T Consensus 85 L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~-----~~~~~ 159 (254)
T cd05083 85 LVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV-----DNSKL 159 (254)
T ss_pred HHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceeccccC-----CCCCC
Confidence 25688899999999999999999999999999999999999987643211 12234
Q ss_pred CCCcCcccccCCCccccccceehhhhhhccccC-CCCCcCCC
Q 045449 738 TIGYMAPEYGTKGRVSTRGDVCSFGIISGGKET-RSMTVGET 778 (823)
Q Consensus 738 t~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~-~~~~~~~~ 778 (823)
+..|+|||++.++.++.++|||||||+++++++ |..||...
T Consensus 160 ~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~ 201 (254)
T cd05083 160 PVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKM 201 (254)
T ss_pred CceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccC
Confidence 578999999988899999999999999999987 88888654
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.80 E-value=4.5e-20 Score=196.63 Aligned_cols=135 Identities=27% Similarity=0.334 Sum_probs=114.7
Q ss_pred CeEEEEEEehHhhHHHHHHHHHHHHHHhhcchhhHHH---------------------------------------HHHH
Q 045449 641 GMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVK---------------------------------------IISS 681 (823)
Q Consensus 641 ~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~---------------------------------------~~~~ 681 (823)
+..||+|++........+.+.+|+.++++++|+||++ ++.|
T Consensus 44 ~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~q 123 (285)
T cd06648 44 GRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLA 123 (285)
T ss_pred CCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCCHHHHHHhCCCCHHHHHHHHHH
Confidence 5679999887555555567899999999999999998 3567
Q ss_pred HHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCcccccCCCccccccceehh
Q 045449 682 SLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSF 761 (823)
Q Consensus 682 ~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~ 761 (823)
++.+|.++|+.+++||||||+||+++.++.++++|||.+........ ......|++.|+|||+..+..++.++|||||
T Consensus 124 l~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~sl 201 (285)
T cd06648 124 VLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP--RRKSLVGTPYWMAPEVISRLPYGTEVDIWSL 201 (285)
T ss_pred HHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCc--ccccccCCccccCHHHhcCCCCCCcccHHHH
Confidence 88899999999999999999999999999999999998876543221 1223568999999999988889999999999
Q ss_pred hhhhccccCCCCCcCC
Q 045449 762 GIISGGKETRSMTVGE 777 (823)
Q Consensus 762 Gvv~~~~~~~~~~~~~ 777 (823)
||+++++++|..||..
T Consensus 202 Gv~l~ell~g~~p~~~ 217 (285)
T cd06648 202 GIMVIEMVDGEPPYFN 217 (285)
T ss_pred HHHHHHHHhCCCCCcC
Confidence 9999999999999854
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.80 E-value=4.3e-20 Score=199.05 Aligned_cols=144 Identities=29% Similarity=0.362 Sum_probs=117.0
Q ss_pred cCCccceeeccC------------CeEEEEEEehHhh---HHHHHHHHHHHHHHhhcchhhHHH----------------
Q 045449 629 RFSENNLIGIGN------------GMEVAVKVFHQQY---ERALKSFEDECEVRKRIRHRNLVK---------------- 677 (823)
Q Consensus 629 ~f~~~~~lg~g~------------~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~---------------- 677 (823)
+|...+.+|.|+ +..||+|++.... ....+++.+|++++++++||||++
T Consensus 16 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e 95 (307)
T cd06607 16 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVME 95 (307)
T ss_pred hhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHH
Confidence 355555566653 6779999885322 334467899999999999999987
Q ss_pred ------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCcccccc
Q 045449 678 ------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQT 733 (823)
Q Consensus 678 ------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~ 733 (823)
++.|++.+|.|+|+.+|+||||+|+||+++.++.+||+|||+++..... .
T Consensus 96 ~~~g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~------~ 169 (307)
T cd06607 96 YCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA------N 169 (307)
T ss_pred hhCCCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCCC------C
Confidence 3567889999999999999999999999999999999999998765322 2
Q ss_pred ccccCCCcCcccccC---CCccccccceehhhhhhccccCCCCCcCCC
Q 045449 734 QTLATIGYMAPEYGT---KGRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 734 ~~~gt~~y~aPE~~~---~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
...|++.|+|||++. .+.++.++|||||||++|++.+|..|+...
T Consensus 170 ~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~ 217 (307)
T cd06607 170 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 217 (307)
T ss_pred CccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCc
Confidence 346888999999874 456889999999999999999999988653
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.8e-20 Score=199.13 Aligned_cols=136 Identities=29% Similarity=0.368 Sum_probs=114.8
Q ss_pred CeEEEEEEehHhhHHHHHHHHHHHHHHhhcchhhHHH-----------------------------------------HH
Q 045449 641 GMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVK-----------------------------------------II 679 (823)
Q Consensus 641 ~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-----------------------------------------~~ 679 (823)
+..||+|++........+.|.+|++++++++|+||++ ++
T Consensus 30 ~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~l~~~~~~~~~ 109 (280)
T cd06611 30 GLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVC 109 (280)
T ss_pred CcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeeccCCCcHHHHHHHhcCCCCHHHHHHHH
Confidence 6789999997666666678999999999999999998 35
Q ss_pred HHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCcccccC-----CCcccc
Q 045449 680 SSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGT-----KGRVST 754 (823)
Q Consensus 680 ~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ 754 (823)
.|++++|+|+|+.+|+|||+||+||+++.++.++|+|||++........ ......|++.|+|||++. ...++.
T Consensus 110 ~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~ 187 (280)
T cd06611 110 RQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ--KRDTFIGTPYWMAPEVVACETFKDNPYDY 187 (280)
T ss_pred HHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhccccc--ccceeecchhhcCHHHHhhcccCCCCCCc
Confidence 7888999999999999999999999999999999999999876533221 223456899999999874 345688
Q ss_pred ccceehhhhhhccccCCCCCcCCC
Q 045449 755 RGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 755 ~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
++|||||||++|++.+|..||...
T Consensus 188 ~sDi~slG~il~~l~~g~~p~~~~ 211 (280)
T cd06611 188 KADIWSLGITLIELAQMEPPHHEL 211 (280)
T ss_pred cccHHHHHHHHHHHHhCCCCcccC
Confidence 999999999999999999998664
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.9e-20 Score=195.49 Aligned_cols=131 Identities=18% Similarity=0.292 Sum_probs=109.3
Q ss_pred CeEEEEEEehHhhHHHHHHHHHHHHHHhhcchhhHHH-----------------------------------------HH
Q 045449 641 GMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVK-----------------------------------------II 679 (823)
Q Consensus 641 ~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-----------------------------------------~~ 679 (823)
...||+|.+..........|.+|+.++++++||||++ ++
T Consensus 32 ~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~ 111 (262)
T cd05077 32 EIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVA 111 (262)
T ss_pred ceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHH
Confidence 4679999987766666678999999999999999998 35
Q ss_pred HHHHHHhhhcCCCCEEeccCCCCCEEeCCCCc-------EEEeecccccccCCCCccccccccccCCCcCcccccC-CCc
Q 045449 680 SSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMV-------AHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGT-KGR 751 (823)
Q Consensus 680 ~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~-------~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~ 751 (823)
.|++++|+|+|+.+|+||||||+|||++.++. +|++|||++...... ....++..|+|||++. +..
T Consensus 112 ~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~ 185 (262)
T cd05077 112 KQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSR------QECVERIPWIAPECVEDSKN 185 (262)
T ss_pred HHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCCCCccccCc------ccccccccccChhhhcCCCC
Confidence 78999999999999999999999999986653 899999998765322 2345788999999876 456
Q ss_pred cccccceehhhhhhcccc-CCCCCcCC
Q 045449 752 VSTRGDVCSFGIISGGKE-TRSMTVGE 777 (823)
Q Consensus 752 ~~~~~Dv~S~Gvv~~~~~-~~~~~~~~ 777 (823)
++.++|||||||++|+++ .+..|+..
T Consensus 186 ~~~~~DiwslG~~l~el~~~~~~p~~~ 212 (262)
T cd05077 186 LSIAADKWSFGTTLWEICYNGEIPLKD 212 (262)
T ss_pred CCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence 899999999999999997 47777654
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.80 E-value=5.2e-20 Score=193.03 Aligned_cols=138 Identities=30% Similarity=0.409 Sum_probs=115.9
Q ss_pred CeEEEEEEehHhhHH-HHHHHHHHHHHHhhcchhhHHH------------------------------------------
Q 045449 641 GMEVAVKVFHQQYER-ALKSFEDECEVRKRIRHRNLVK------------------------------------------ 677 (823)
Q Consensus 641 ~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~------------------------------------------ 677 (823)
+..||||++...... ..+.+.+|++.+.+++|+|+++
T Consensus 23 ~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 102 (262)
T cd00192 23 TTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTL 102 (262)
T ss_pred CceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccCCcHHHHHhhccccccccccccC
Confidence 578999999765433 3678999999999999999998
Q ss_pred -------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCcccccCCC
Q 045449 678 -------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKG 750 (823)
Q Consensus 678 -------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 750 (823)
++.|++.+|+++|+.+++||||||+||+++.++.+||+|||.++...............++..|+|||.....
T Consensus 103 ~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 182 (262)
T cd00192 103 SLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDG 182 (262)
T ss_pred CHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccccccccccccccCCCcCccccCHHHhccC
Confidence 2346778899999999999999999999999999999999999877554322223345678999999999888
Q ss_pred ccccccceehhhhhhccccC-CCCCcCCC
Q 045449 751 RVSTRGDVCSFGIISGGKET-RSMTVGET 778 (823)
Q Consensus 751 ~~~~~~Dv~S~Gvv~~~~~~-~~~~~~~~ 778 (823)
.++.++||||+||+++++++ |..||...
T Consensus 183 ~~~~~~Di~slG~il~~l~~~g~~p~~~~ 211 (262)
T cd00192 183 IFTSKSDVWSFGVLLWEIFTLGATPYPGL 211 (262)
T ss_pred CcchhhccHHHHHHHHHHHhcCCCCCCCC
Confidence 89999999999999999998 58888665
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.80 E-value=4.3e-20 Score=193.58 Aligned_cols=138 Identities=28% Similarity=0.362 Sum_probs=113.7
Q ss_pred CeEEEEEEehHhhH-HHHHHHHHHHHHHhhcchhhHHH---------------------------------------HHH
Q 045449 641 GMEVAVKVFHQQYE-RALKSFEDECEVRKRIRHRNLVK---------------------------------------IIS 680 (823)
Q Consensus 641 ~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~---------------------------------------~~~ 680 (823)
+..||+|.+..... ...+++.+|+++++++.|+||++ ++.
T Consensus 23 ~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 102 (257)
T cd05060 23 EVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAH 102 (257)
T ss_pred cceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcCCceEEEEEeCCCCcHHHHHHhCCCCCHHHHHHHHH
Confidence 36799999875543 35578999999999999999998 357
Q ss_pred HHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccc-cccccccCCCcCcccccCCCcccccccee
Q 045449 681 SSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLS-KQTQTLATIGYMAPEYGTKGRVSTRGDVC 759 (823)
Q Consensus 681 ~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~ 759 (823)
|++++|.++|..+++||||||+||+++.++.+||+|||+++......... ......++..|+|||...+..++.++|||
T Consensus 103 qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~ 182 (257)
T cd05060 103 QVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVW 182 (257)
T ss_pred HHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccccCccccccccCHHHhcCCCCCccchHH
Confidence 88899999999999999999999999999999999999998764333211 11122345689999999888899999999
Q ss_pred hhhhhhccccC-CCCCcCCC
Q 045449 760 SFGIISGGKET-RSMTVGET 778 (823)
Q Consensus 760 S~Gvv~~~~~~-~~~~~~~~ 778 (823)
||||+++++++ |..||.+.
T Consensus 183 slG~~l~~~~~~g~~p~~~~ 202 (257)
T cd05060 183 SYGVTLWEAFSYGAKPYGEM 202 (257)
T ss_pred HHHHHHHHHHcCCCCCcccC
Confidence 99999999997 88888654
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.9e-20 Score=198.41 Aligned_cols=135 Identities=30% Similarity=0.366 Sum_probs=111.0
Q ss_pred CeEEEEEEehHhh-HHHHHHHHHHHHHHhhcc-hhhHHH-----------------------------------------
Q 045449 641 GMEVAVKVFHQQY-ERALKSFEDECEVRKRIR-HRNLVK----------------------------------------- 677 (823)
Q Consensus 641 ~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~----------------------------------------- 677 (823)
+..||||.+.... ......+.+|+.++.++. |+||++
T Consensus 29 ~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~~~l~~l~~~~~~~~~~~l~~~~ 108 (288)
T cd06616 29 GTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEI 108 (288)
T ss_pred CCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEecccCCHHHHHHHHHHhhcCCCCHHH
Confidence 5779999987543 344568899999999996 999997
Q ss_pred ---HHHHHHHHhhhcCC-CCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCcccccCCC---
Q 045449 678 ---IISSSLEYLHFGHS-IPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKG--- 750 (823)
Q Consensus 678 ---~~~~~l~~L~~~h~-~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--- 750 (823)
++.+++.+|+|+|+ .+++||||||+||+++.++.+||+|||+++....... .....|++.|+|||++...
T Consensus 109 ~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~ 185 (288)
T cd06616 109 LGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIA---KTRDAGCRPYMAPERIDPSARD 185 (288)
T ss_pred HHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhccCCc---cccccCccCccCHHHhcccccc
Confidence 23567778888886 5999999999999999999999999999986543221 1234688999999998766
Q ss_pred ccccccceehhhhhhccccCCCCCcCCC
Q 045449 751 RVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 751 ~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
.++.++||||+||+++++.+|..||...
T Consensus 186 ~~~~~~Di~slG~il~el~~g~~p~~~~ 213 (288)
T cd06616 186 GYDVRSDVWSLGITLYEVATGKFPYPKW 213 (288)
T ss_pred CCcchhhhhHHHHHHHHHHhCCCCchhc
Confidence 6899999999999999999999998654
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.1e-20 Score=199.16 Aligned_cols=136 Identities=30% Similarity=0.363 Sum_probs=111.9
Q ss_pred CeEEEEEEehHhh--HHHHHHHHHHHHHHhhcchhhHHH-----------------------------------------
Q 045449 641 GMEVAVKVFHQQY--ERALKSFEDECEVRKRIRHRNLVK----------------------------------------- 677 (823)
Q Consensus 641 ~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~----------------------------------------- 677 (823)
+..||||++.... ....+.+.+|+.++++++||||++
T Consensus 25 ~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~l~~~~~~~~~~~~~~~~~~~ 104 (285)
T cd07861 25 GQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVK 104 (285)
T ss_pred CcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecCCCCHHHHHhcCCCCCcCCHHHHH
Confidence 5779999886432 223467889999999999999998
Q ss_pred -HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCcccccCCC-ccccc
Q 045449 678 -IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKG-RVSTR 755 (823)
Q Consensus 678 -~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~ 755 (823)
++.|++++|.|+|+.+++||||||+||+++.++.+||+|||+++...... .......+++.|+|||++.+. .++.+
T Consensus 105 ~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~ 182 (285)
T cd07861 105 SYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV--RVYTHEVVTLWYRAPEVLLGSPRYSTP 182 (285)
T ss_pred HHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCc--ccccCCcccccccChHHhcCCCCcCcH
Confidence 35788999999999999999999999999999999999999997653321 112334678999999987654 47899
Q ss_pred cceehhhhhhccccCCCCCcCCC
Q 045449 756 GDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 756 ~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
+||||+||+++++.+|..||.+.
T Consensus 183 ~Dv~slG~il~~l~tg~~~~~~~ 205 (285)
T cd07861 183 VDIWSIGTIFAEMATKKPLFHGD 205 (285)
T ss_pred HHHHHHHHHHHHHHHCCCCCCCC
Confidence 99999999999999999988654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.80 E-value=5.2e-20 Score=193.87 Aligned_cols=138 Identities=23% Similarity=0.305 Sum_probs=113.4
Q ss_pred CeEEEEEEehHh------hHHHHHHHHHHHHHHhhcchhhHHH-------------------------------------
Q 045449 641 GMEVAVKVFHQQ------YERALKSFEDECEVRKRIRHRNLVK------------------------------------- 677 (823)
Q Consensus 641 ~~~vavK~~~~~------~~~~~~~~~~E~~~l~~l~h~niv~------------------------------------- 677 (823)
+..||||.+... .....+.+.+|++++++++|+||++
T Consensus 24 ~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~ 103 (265)
T cd06631 24 GQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPV 103 (265)
T ss_pred CCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEEecCCCCcHHHHHHhcCCCCHHH
Confidence 467899987532 1334467999999999999999988
Q ss_pred ---HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCc----cccccccccCCCcCcccccCCC
Q 045449 678 ---IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQ----LSKQTQTLATIGYMAPEYGTKG 750 (823)
Q Consensus 678 ---~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~ 750 (823)
++.|++.+|.++|+.+++|+||||+||+++.++.+||+|||+++....... ........|+..|+|||+..+.
T Consensus 104 ~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~ 183 (265)
T cd06631 104 FCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINES 183 (265)
T ss_pred HHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhccccccccccccccCCCccccChhhhcCC
Confidence 356888899999999999999999999999999999999999886532111 1112234689999999999888
Q ss_pred ccccccceehhhhhhccccCCCCCcCCC
Q 045449 751 RVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 751 ~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
.++.++||||+||+++++.+|..||...
T Consensus 184 ~~~~~~Dv~slG~~~~~l~~g~~p~~~~ 211 (265)
T cd06631 184 GYGRKSDIWSIGCTVFEMATGKPPLASM 211 (265)
T ss_pred CCcchhhHHHHHHHHHHHHhCCCccccC
Confidence 8999999999999999999999999653
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=99.80 E-value=4.2e-20 Score=193.37 Aligned_cols=134 Identities=28% Similarity=0.377 Sum_probs=114.9
Q ss_pred CeEEEEEEehHhhHHHHHHHHHHHHHHhhcchhhHHH-----------------------------------------HH
Q 045449 641 GMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVK-----------------------------------------II 679 (823)
Q Consensus 641 ~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-----------------------------------------~~ 679 (823)
+..||+|.+..... .+++.+|++++++++|+||++ ++
T Consensus 28 ~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~ 105 (256)
T cd06612 28 GQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAIL 105 (256)
T ss_pred CcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCCCCcHHHHHHhCccCCCHHHHHHHH
Confidence 57799999875533 578999999999999999998 35
Q ss_pred HHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCcccccCCCcccccccee
Q 045449 680 SSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVC 759 (823)
Q Consensus 680 ~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~ 759 (823)
.|++++|.|+|..+++|||++|+||+++.++.+||+|||++........ ......|+..|+|||++.+..++.++|||
T Consensus 106 ~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~ 183 (256)
T cd06612 106 YQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA--KRNTVIGTPFWMAPEVIQEIGYNNKADIW 183 (256)
T ss_pred HHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCcc--ccccccCCccccCHHHHhcCCCCchhhHH
Confidence 6788899999999999999999999999999999999999987643321 12334588999999999888899999999
Q ss_pred hhhhhhccccCCCCCcCCC
Q 045449 760 SFGIISGGKETRSMTVGET 778 (823)
Q Consensus 760 S~Gvv~~~~~~~~~~~~~~ 778 (823)
||||+++++++|..|+...
T Consensus 184 s~G~il~~l~~g~~p~~~~ 202 (256)
T cd06612 184 SLGITAIEMAEGKPPYSDI 202 (256)
T ss_pred HHHHHHHHHHhCCCCCCCc
Confidence 9999999999999998653
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.5e-20 Score=193.43 Aligned_cols=138 Identities=28% Similarity=0.336 Sum_probs=111.5
Q ss_pred CeEEEEEEehHhh-HHHHHHHHHHHHHHhhcchhhHHH-----------------------------------------H
Q 045449 641 GMEVAVKVFHQQY-ERALKSFEDECEVRKRIRHRNLVK-----------------------------------------I 678 (823)
Q Consensus 641 ~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~-----------------------------------------~ 678 (823)
++.||+|.+.... ....+.|.+|+++++++.|+||++ +
T Consensus 19 ~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~ 98 (251)
T cd05041 19 NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQM 98 (251)
T ss_pred CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHHHHHHhcCCCCCHHHHHHH
Confidence 5789999886543 235578999999999999999997 2
Q ss_pred HHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCcccccCCCccccccce
Q 045449 679 ISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDV 758 (823)
Q Consensus 679 ~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv 758 (823)
+.+++++++++|+.+++||||||+||+++.++.+||+|||+++...............++..|+|||++.++.++.++||
T Consensus 99 ~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di 178 (251)
T cd05041 99 SLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDV 178 (251)
T ss_pred HHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcceeccCChHhhccCCCCcchhH
Confidence 45778889999999999999999999999999999999999986542211111112234567999999988889999999
Q ss_pred ehhhhhhccccC-CCCCcCCC
Q 045449 759 CSFGIISGGKET-RSMTVGET 778 (823)
Q Consensus 759 ~S~Gvv~~~~~~-~~~~~~~~ 778 (823)
||+||+++++.+ +..||...
T Consensus 179 ~slG~i~~~l~t~~~~p~~~~ 199 (251)
T cd05041 179 WSYGILLWETFSLGDTPYPGM 199 (251)
T ss_pred HHHHHHHHHHHhccCCCCccC
Confidence 999999999998 77777554
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.79 E-value=8.8e-20 Score=192.94 Aligned_cols=138 Identities=29% Similarity=0.339 Sum_probs=111.6
Q ss_pred CeEEEEEEehHhh----------HHHHHHHHHHHHHHhhcchhhHHH---------------------------------
Q 045449 641 GMEVAVKVFHQQY----------ERALKSFEDECEVRKRIRHRNLVK--------------------------------- 677 (823)
Q Consensus 641 ~~~vavK~~~~~~----------~~~~~~~~~E~~~l~~l~h~niv~--------------------------------- 677 (823)
+..||||.++... ....+.+.+|++++++++|+|+++
T Consensus 26 ~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l 105 (272)
T cd06629 26 GEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRF 105 (272)
T ss_pred CceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCceEEEEecCCCCcHHHHHhhccCC
Confidence 5679999875321 223457889999999999999988
Q ss_pred -------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCcccccCCC
Q 045449 678 -------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKG 750 (823)
Q Consensus 678 -------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 750 (823)
++.|++.+|.++|+.+++||||||+||+++.++.++++|||+++...............|+..|+|||+....
T Consensus 106 ~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~ 185 (272)
T cd06629 106 EEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSY 185 (272)
T ss_pred CHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeeccccccccccccccccccccCCccccCHHHhccc
Confidence 2467888999999999999999999999999999999999999865432211122345688999999988765
Q ss_pred c--cccccceehhhhhhccccCCCCCcCCC
Q 045449 751 R--VSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 751 ~--~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
. ++.++||||+||+++++.+|..|+...
T Consensus 186 ~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~ 215 (272)
T cd06629 186 SQGYSAKVDIWSLGCVVLEMFAGRRPWSDE 215 (272)
T ss_pred cCCCCccchhHHHHHHHHHHHhCCCCCcCc
Confidence 4 789999999999999999999998643
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=99.79 E-value=5.4e-20 Score=193.81 Aligned_cols=149 Identities=24% Similarity=0.334 Sum_probs=121.6
Q ss_pred ccCCccceeeccC------------CeEEEEEEehHh---hHHHHHHHHHHHHHHhhcchhhHHH---------------
Q 045449 628 DRFSENNLIGIGN------------GMEVAVKVFHQQ---YERALKSFEDECEVRKRIRHRNLVK--------------- 677 (823)
Q Consensus 628 ~~f~~~~~lg~g~------------~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~--------------- 677 (823)
++|...+.+|.|+ |..||+|.++.. .....+.+.+|++++++++|+|+++
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 4566666777664 677999988532 2334578999999999999999987
Q ss_pred -----------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCc
Q 045449 678 -----------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQ 728 (823)
Q Consensus 678 -----------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~ 728 (823)
++.+++.+|.++|+.|++||||||+||+++.++.++++|||+++.......
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~ 161 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 161 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCCCc
Confidence 245778889999999999999999999999999999999999886543221
Q ss_pred cccccccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCCC
Q 045449 729 LSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 729 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
......|++.|+|||+..+..++.++|||||||+++++.+|..||...
T Consensus 162 --~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 209 (267)
T cd08224 162 --AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209 (267)
T ss_pred --ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccC
Confidence 122346889999999998888999999999999999999999998553
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=99.79 E-value=2.8e-20 Score=200.56 Aligned_cols=151 Identities=30% Similarity=0.363 Sum_probs=118.1
Q ss_pred ccCCccceeeccC-------------------CeEEEEEEehHhh-HHHHHHHHHHHHHHhhc-chhhHHH---------
Q 045449 628 DRFSENNLIGIGN-------------------GMEVAVKVFHQQY-ERALKSFEDECEVRKRI-RHRNLVK--------- 677 (823)
Q Consensus 628 ~~f~~~~~lg~g~-------------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~--------- 677 (823)
++|...+.||+|+ ...||+|++.... ....+++.+|++++.++ +|+||++
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 97 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 97 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence 4566667777765 1248889887542 34456788999999999 7999887
Q ss_pred -----------------------------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCC
Q 045449 678 -----------------------------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDM 710 (823)
Q Consensus 678 -----------------------------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~ 710 (823)
++.|++.+|+|+|+.+++||||||+||+++.++
T Consensus 98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~~~ 177 (307)
T cd05098 98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDN 177 (307)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEEcCCC
Confidence 134677889999999999999999999999999
Q ss_pred cEEEeecccccccCCCCccccccccccCCCcCcccccCCCccccccceehhhhhhccccC-CCCCcCCC
Q 045449 711 VAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKET-RSMTVGET 778 (823)
Q Consensus 711 ~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~-~~~~~~~~ 778 (823)
.+||+|||.++...............+++.|+|||++.+..++.++||||+||++|++.+ |..||...
T Consensus 178 ~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~ 246 (307)
T cd05098 178 VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV 246 (307)
T ss_pred cEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcC
Confidence 999999999986543222111222334578999999988889999999999999999998 77787654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.79 E-value=5.3e-20 Score=200.84 Aligned_cols=136 Identities=29% Similarity=0.378 Sum_probs=110.1
Q ss_pred EEEEEEehHhh-HHHHHHHHHHHHHHhhc-chhhHHHH------------------------------------------
Q 045449 643 EVAVKVFHQQY-ERALKSFEDECEVRKRI-RHRNLVKI------------------------------------------ 678 (823)
Q Consensus 643 ~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~------------------------------------------ 678 (823)
.||+|.+.... ....+++.+|+++++++ +||||+++
T Consensus 46 ~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~ 125 (334)
T cd05100 46 TVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCK 125 (334)
T ss_pred eEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCCceEEEEecCCCCcHHHHHHhcCCccccccccccc
Confidence 58999887432 34557899999999999 89999971
Q ss_pred --------------HHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCcc
Q 045449 679 --------------ISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAP 744 (823)
Q Consensus 679 --------------~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aP 744 (823)
+.|++++|.|+|+.+++||||||+||+++.++.+||+|||+++...............++..|+||
T Consensus 126 ~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 205 (334)
T cd05100 126 LPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAP 205 (334)
T ss_pred CccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCH
Confidence 237788899999999999999999999999999999999999876433222112223446789999
Q ss_pred cccCCCccccccceehhhhhhccccC-CCCCcCCC
Q 045449 745 EYGTKGRVSTRGDVCSFGIISGGKET-RSMTVGET 778 (823)
Q Consensus 745 E~~~~~~~~~~~Dv~S~Gvv~~~~~~-~~~~~~~~ 778 (823)
|++.+..++.++|||||||+++++.+ |..||.+.
T Consensus 206 E~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~ 240 (334)
T cd05100 206 EALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI 240 (334)
T ss_pred HHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCC
Confidence 99998899999999999999999987 77777654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=99.79 E-value=3.4e-20 Score=205.93 Aligned_cols=98 Identities=29% Similarity=0.324 Sum_probs=81.9
Q ss_pred HHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCcccccCCCccccccceeh
Q 045449 681 SSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCS 760 (823)
Q Consensus 681 ~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S 760 (823)
|++.+|.|+|+.+++||||||+|||+++++.+||+|||+++...............+++.|+|||++.+..++.++||||
T Consensus 247 qi~~aL~~LH~~~ivHrdlkp~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws 326 (401)
T cd05107 247 QVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWS 326 (401)
T ss_pred HHHHHHHHHhcCCcCcccCCcceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHH
Confidence 67788999999999999999999999999999999999998654322211222345788999999998888999999999
Q ss_pred hhhhhccccC-CCCCcCCC
Q 045449 761 FGIISGGKET-RSMTVGET 778 (823)
Q Consensus 761 ~Gvv~~~~~~-~~~~~~~~ 778 (823)
|||+++++++ |..||...
T Consensus 327 lGvil~e~l~~g~~P~~~~ 345 (401)
T cd05107 327 FGILLWEIFTLGGTPYPEL 345 (401)
T ss_pred HHHHHHHHHHcCCCCCCCC
Confidence 9999999997 78887654
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.79 E-value=7.4e-20 Score=195.78 Aligned_cols=136 Identities=29% Similarity=0.384 Sum_probs=115.2
Q ss_pred CeEEEEEEehHhhHHHHHHHHHHHHHHhhcchhhHHH---------------------------------------HHHH
Q 045449 641 GMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVK---------------------------------------IISS 681 (823)
Q Consensus 641 ~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~---------------------------------------~~~~ 681 (823)
+..||+|.+........+.+.+|+.++++++|||+++ ++.+
T Consensus 44 ~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~l~~~~~~~i~~~ 123 (293)
T cd06647 44 GQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRE 123 (293)
T ss_pred CCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecCCCCcHHHHHhhcCCCHHHHHHHHHH
Confidence 5679999987555455578999999999999999998 2457
Q ss_pred HHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCcccccCCCccccccceehh
Q 045449 682 SLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSF 761 (823)
Q Consensus 682 ~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~ 761 (823)
++.+|.|+|+.+++|||+||+||+++.++.+||+|||++........ ......|++.|+|||+.....++.++|||||
T Consensus 124 l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~sl 201 (293)
T cd06647 124 CLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSL 201 (293)
T ss_pred HHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceeccccccc--ccccccCChhhcCchhhccCCCCchhhHHHH
Confidence 88899999999999999999999999999999999999876543322 1233468899999999988889999999999
Q ss_pred hhhhccccCCCCCcCCC
Q 045449 762 GIISGGKETRSMTVGET 778 (823)
Q Consensus 762 Gvv~~~~~~~~~~~~~~ 778 (823)
||+++++.+|..||...
T Consensus 202 G~ll~~ll~g~~pf~~~ 218 (293)
T cd06647 202 GIMAIEMVEGEPPYLNE 218 (293)
T ss_pred HHHHHHHHhCCCCCCCC
Confidence 99999999999998653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.79 E-value=5e-20 Score=199.36 Aligned_cols=139 Identities=27% Similarity=0.339 Sum_probs=114.2
Q ss_pred CeEEEEEEehHhh---HHHHHHHHHHHHHHhhcchhhHHH----------------------------------------
Q 045449 641 GMEVAVKVFHQQY---ERALKSFEDECEVRKRIRHRNLVK---------------------------------------- 677 (823)
Q Consensus 641 ~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~---------------------------------------- 677 (823)
+..||+|++.... ....+.+.+|++++++++||||++
T Consensus 27 ~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~ 106 (316)
T cd07842 27 GKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIP 106 (316)
T ss_pred CCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEEEEeCCCcCHHHHHHhhccCCCcCcC
Confidence 5789999997632 333467889999999999999998
Q ss_pred ------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCC----CCcEEEeecccccccCCCCc-cccccccccCCCcCcccc
Q 045449 678 ------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDE----DMVAHISDFGIAKLLSGEDQ-LSKQTQTLATIGYMAPEY 746 (823)
Q Consensus 678 ------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~----~~~~kl~DfGla~~~~~~~~-~~~~~~~~gt~~y~aPE~ 746 (823)
++.|++.+|+|+|+.+|+||||||+||+++. ++.+||+|||+++....... ........+++.|+|||+
T Consensus 107 ~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~ 186 (316)
T cd07842 107 PSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPEL 186 (316)
T ss_pred HHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccccccCCCcccccccCCccccccccCHHH
Confidence 2468899999999999999999999999999 89999999999987643322 112234568899999998
Q ss_pred cCCC-ccccccceehhhhhhccccCCCCCcCCCc
Q 045449 747 GTKG-RVSTRGDVCSFGIISGGKETRSMTVGETC 779 (823)
Q Consensus 747 ~~~~-~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~~ 779 (823)
+.+. .++.++|||||||+++++.+|..||.+..
T Consensus 187 ~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~ 220 (316)
T cd07842 187 LLGARHYTKAIDIWAIGCIFAELLTLEPIFKGRE 220 (316)
T ss_pred HhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCc
Confidence 7664 57899999999999999999999987543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.79 E-value=6.6e-20 Score=195.54 Aligned_cols=148 Identities=31% Similarity=0.404 Sum_probs=121.1
Q ss_pred cCCccceeeccC------------CeEEEEEEehHhh--HHHHHHHHHHHHHHhhcchhhHHH-----------------
Q 045449 629 RFSENNLIGIGN------------GMEVAVKVFHQQY--ERALKSFEDECEVRKRIRHRNLVK----------------- 677 (823)
Q Consensus 629 ~f~~~~~lg~g~------------~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~----------------- 677 (823)
+|+..+.||.|+ +..||||+++... ....+.+.+|++++++++|+||++
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 81 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEY 81 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEec
Confidence 455555566553 5679999886542 334578999999999999999998
Q ss_pred -----------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccc
Q 045449 678 -----------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQ 734 (823)
Q Consensus 678 -----------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 734 (823)
++.|++.+|+|+|..+++|||++|+||++++++.+||+|||+++....... .....
T Consensus 82 ~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~-~~~~~ 160 (288)
T cd07833 82 VERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA-SPLTD 160 (288)
T ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc-ccccC
Confidence 356788899999999999999999999999999999999999987654332 12234
Q ss_pred cccCCCcCcccccCCC-ccccccceehhhhhhccccCCCCCcCC
Q 045449 735 TLATIGYMAPEYGTKG-RVSTRGDVCSFGIISGGKETRSMTVGE 777 (823)
Q Consensus 735 ~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvv~~~~~~~~~~~~~ 777 (823)
..++..|+|||++.+. .++.++|||||||+++++.+|..||..
T Consensus 161 ~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~ 204 (288)
T cd07833 161 YVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPG 204 (288)
T ss_pred cccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 5688999999998887 789999999999999999999988864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.1e-19 Score=193.63 Aligned_cols=133 Identities=23% Similarity=0.319 Sum_probs=109.2
Q ss_pred CeEEEEEEehHh-hHHHHHHHHHHHHHHhhcchhhHHHH-----------------------------------------
Q 045449 641 GMEVAVKVFHQQ-YERALKSFEDECEVRKRIRHRNLVKI----------------------------------------- 678 (823)
Q Consensus 641 ~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~----------------------------------------- 678 (823)
+..||+|.+... .....+.+.+|++++.+++|+||+++
T Consensus 26 ~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~ 105 (286)
T cd06622 26 GVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLR 105 (286)
T ss_pred CcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeecCCCCHHHHHHhccccCCCCHHHHH
Confidence 678999988653 23445789999999999999999982
Q ss_pred --HHHHHHHhhhcCC-CCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCcccccCCC-----
Q 045449 679 --ISSSLEYLHFGHS-IPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKG----- 750 (823)
Q Consensus 679 --~~~~l~~L~~~h~-~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----- 750 (823)
+.+++.+|.|+|+ .+|+||||||+||+++.++.+||+|||+++...... .....|++.|+|||++.+.
T Consensus 106 ~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~ 181 (286)
T cd06622 106 RITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL----AKTNIGCQSYMAPERIKSGGPNQN 181 (286)
T ss_pred HHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc----cccCCCccCccCcchhcCCCCCcc
Confidence 4567778888885 699999999999999999999999999997653221 2234688899999987544
Q ss_pred -ccccccceehhhhhhccccCCCCCcCC
Q 045449 751 -RVSTRGDVCSFGIISGGKETRSMTVGE 777 (823)
Q Consensus 751 -~~~~~~Dv~S~Gvv~~~~~~~~~~~~~ 777 (823)
.++.++||||+||+++++.+|..||..
T Consensus 182 ~~~~~~~DiwslG~il~~l~~g~~pf~~ 209 (286)
T cd06622 182 PTYTVQSDVWSLGLSILEMALGRYPYPP 209 (286)
T ss_pred CCCCcccchHhHHHHHHHHHhCCCCCCC
Confidence 358899999999999999999999865
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.79 E-value=8e-21 Score=205.94 Aligned_cols=281 Identities=20% Similarity=0.233 Sum_probs=151.0
Q ss_pred hhcccccccc-CCccccccCCCCCcEEEccCCccccc----CCcccccCCCCccEEEeecccccc------ccCccccCC
Q 045449 208 RLALATNNLV-GVVPVTIFNMSALKEISLLNNSLSGS----LPSRIDLSLPNVETLNLGINSFSG------TIPSSITNS 276 (823)
Q Consensus 208 ~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~g~----lp~~~~~~l~~L~~L~Ls~N~l~~------~~p~~~~~l 276 (823)
.|+|..+.++ ...+..+..+.+|+.|+++++.++.. ++..+. ..++|++|+++.+.+.+ .++..+..+
T Consensus 2 ~l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~-~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~ 80 (319)
T cd00116 2 QLSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALR-PQPSLKELCLSLNETGRIPRGLQSLLQGLTKG 80 (319)
T ss_pred ccccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHh-hCCCceEEeccccccCCcchHHHHHHHHHHhc
Confidence 3556666665 23344445566677777777766422 232322 25556677776666552 233445556
Q ss_pred CCCCeEEeecccccccCCCccCCCcc---cCcccccCccccCCCCcccccccccCC-CCceEEEeecCCCCccCCccccc
Q 045449 277 SKLSDLELGENLFSGFIPNTIGNLRN---LEFGNIADNYLTSSTPELSFLSSLTNC-KKLKVLIVTGNPLDGILPKSIGN 352 (823)
Q Consensus 277 ~~L~~L~Ls~N~l~~~~p~~~~~l~~---L~~L~L~~N~l~~~~~~~~~~~~l~~l-~~L~~L~Ls~N~l~~~~p~~~~~ 352 (823)
++|+.|++++|.+.+..+..+..+.. |++|++++|++++.... .+...+..+ ++|+.|++++|.+++....
T Consensus 81 ~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~-~l~~~l~~~~~~L~~L~L~~n~l~~~~~~---- 155 (319)
T cd00116 81 CGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLR-LLAKGLKDLPPALEKLVLGRNRLEGASCE---- 155 (319)
T ss_pred CceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHH-HHHHHHHhCCCCceEEEcCCCcCCchHHH----
Confidence 66666666666665544444444333 55555555555432110 012223333 4455555555554432111
Q ss_pred cccccceEEecCCcceeccCccccCcccccEEEcccCcCCCC----chhcccccCCCCEEEccCCCCCCcc----hHhhh
Q 045449 353 FSLSLETILMANCSISGNIPQVVGNLSNLLVLELGGNNLTGP----IPVTFSQLQTLQAFDLTRNKLAGPI----TDELC 424 (823)
Q Consensus 353 ~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~----~p~~~~~l~~L~~L~Ls~N~l~~~~----p~~~~ 424 (823)
.++..+..+++|++|++++|.+++. ++..+..+++|++|+|++|.+++.. ...+.
T Consensus 156 -----------------~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~ 218 (319)
T cd00116 156 -----------------ALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLA 218 (319)
T ss_pred -----------------HHHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhc
Confidence 1223344455666666666666632 2233444456777777777665432 22344
Q ss_pred cCCCCCEEEcccCcCccccccccc-----CCCCCCeEeccCCcccc----ccchhhhccCCCcEEeccccccccc----c
Q 045449 425 HLARLHSLVLQGNKFSGSIPSCLG-----NLTSVRVLYLGLNIFTS----VLSSTIWNLKDILFIDVSSNFLDGP----L 491 (823)
Q Consensus 425 ~l~~L~~L~Ls~N~l~g~~p~~~~-----~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~LdLs~N~l~g~----~ 491 (823)
.+++|++|++++|.+++.....+. ..+.|+.|++++|.++. .+...+..+++|+++|+++|.++.. +
T Consensus 219 ~~~~L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~~~~~~ 298 (319)
T cd00116 219 SLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEEGAQLL 298 (319)
T ss_pred ccCCCCEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcHHHHHHH
Confidence 556677777777776643222221 23567777777777762 2334455567777777777777744 4
Q ss_pred CccccCC-CCCcEEEcccCCC
Q 045449 492 SLDIGNL-KVVIGLDFSRNNL 511 (823)
Q Consensus 492 p~~~~~l-~~L~~L~ls~N~l 511 (823)
...+... ..|++||+.+|.+
T Consensus 299 ~~~~~~~~~~~~~~~~~~~~~ 319 (319)
T cd00116 299 AESLLEPGNELESLWVKDDSF 319 (319)
T ss_pred HHHHhhcCCchhhcccCCCCC
Confidence 4444444 6777777777754
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.79 E-value=6.6e-20 Score=200.11 Aligned_cols=150 Identities=31% Similarity=0.383 Sum_probs=120.6
Q ss_pred ccCCccceeeccC------------CeEEEEEEehHhh--HHHHHHHHHHHHHHhhcchhhHHH----------------
Q 045449 628 DRFSENNLIGIGN------------GMEVAVKVFHQQY--ERALKSFEDECEVRKRIRHRNLVK---------------- 677 (823)
Q Consensus 628 ~~f~~~~~lg~g~------------~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~---------------- 677 (823)
++|...+.||.|+ +..||+|++.... ....+.+.+|+.++++++||||++
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 84 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY 84 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence 5666666777664 5679999987543 234467888999999999999986
Q ss_pred ---------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCcc-
Q 045449 678 ---------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQL- 729 (823)
Q Consensus 678 ---------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~- 729 (823)
++.|++.+|.|+|+.+|+||||||+||+++.++.+||+|||+++........
T Consensus 85 lv~e~~~~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~ 164 (334)
T cd07855 85 VVMDLMESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEH 164 (334)
T ss_pred EEEehhhhhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecccCcCC
Confidence 2457888999999999999999999999999999999999999875432211
Q ss_pred -ccccccccCCCcCcccccCC-CccccccceehhhhhhccccCCCCCcCC
Q 045449 730 -SKQTQTLATIGYMAPEYGTK-GRVSTRGDVCSFGIISGGKETRSMTVGE 777 (823)
Q Consensus 730 -~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~ 777 (823)
.......|+..|+|||++.. ..++.++|||||||++|++.+|..||.+
T Consensus 165 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~ 214 (334)
T cd07855 165 KYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPG 214 (334)
T ss_pred CcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCC
Confidence 11123578999999998765 4589999999999999999999999865
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.79 E-value=4.9e-20 Score=196.99 Aligned_cols=149 Identities=26% Similarity=0.324 Sum_probs=119.1
Q ss_pred ccCCccceeeccC------------CeEEEEEEehHhhH-HHHHHHHHHHHHHhhcchhhHHH-----------------
Q 045449 628 DRFSENNLIGIGN------------GMEVAVKVFHQQYE-RALKSFEDECEVRKRIRHRNLVK----------------- 677 (823)
Q Consensus 628 ~~f~~~~~lg~g~------------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~----------------- 677 (823)
++|...+.+|.|+ +..||||.+..... .....+.+|++++++++|+||++
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 4566667777764 57799999865432 22345778999999999999998
Q ss_pred -----------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccc
Q 045449 678 -----------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQ 734 (823)
Q Consensus 678 -----------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 734 (823)
++.|++++|.|+|+.+|+||||||+||+++.++.+||+|||+++....... ....
T Consensus 85 ~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~ 162 (291)
T cd07844 85 LDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK--TYSN 162 (291)
T ss_pred CCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCCc--cccc
Confidence 356889999999999999999999999999999999999999875432211 1122
Q ss_pred cccCCCcCcccccCC-CccccccceehhhhhhccccCCCCCcCCC
Q 045449 735 TLATIGYMAPEYGTK-GRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 735 ~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
..++..|+|||+..+ ..++.++||||+||+++++.+|..||.+.
T Consensus 163 ~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~ 207 (291)
T cd07844 163 EVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGS 207 (291)
T ss_pred cccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 357889999998765 45789999999999999999999998654
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=99.79 E-value=8.3e-20 Score=198.66 Aligned_cols=139 Identities=19% Similarity=0.277 Sum_probs=110.6
Q ss_pred CCeEEEEEEehHhh--HHHHHHHHHHHHHHhhcchhhHHH----------------------------------------
Q 045449 640 NGMEVAVKVFHQQY--ERALKSFEDECEVRKRIRHRNLVK---------------------------------------- 677 (823)
Q Consensus 640 ~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~---------------------------------------- 677 (823)
.|..||||++.... ....+.+.+|+++++.++||||++
T Consensus 24 ~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~l~~~~~ 103 (327)
T cd08227 24 TGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAI 103 (327)
T ss_pred cCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccCCCcHHHHHHhhccCCCCHHHH
Confidence 36779999997543 334467788999999999999998
Q ss_pred --HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCcc-----ccccccccCCCcCcccccCC-
Q 045449 678 --IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQL-----SKQTQTLATIGYMAPEYGTK- 749 (823)
Q Consensus 678 --~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~- 749 (823)
++.|++.+|.|+|+.+|+||||||+||+++.++.++++|||.+......... .......++..|+|||++.+
T Consensus 104 ~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 183 (327)
T cd08227 104 AYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQN 183 (327)
T ss_pred HHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhccccccccccccccccccccceecccChHHhhcc
Confidence 3467888999999999999999999999999999999999865443211110 01122356788999999876
Q ss_pred -CccccccceehhhhhhccccCCCCCcCCC
Q 045449 750 -GRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 750 -~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
..++.++|||||||+++++.+|..||.+.
T Consensus 184 ~~~~~~~~DiwslG~il~el~~g~~pf~~~ 213 (327)
T cd08227 184 LQGYDAKSDIYSVGITACELANGHVPFKDM 213 (327)
T ss_pred cCCCCchhhHHHHHHHHHHHHHCCCCCCCc
Confidence 45899999999999999999999999753
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.1e-20 Score=204.80 Aligned_cols=260 Identities=22% Similarity=0.268 Sum_probs=174.5
Q ss_pred EEEccCCcccccCCcccccCCCCccEEEeeccccccc----cCccccCCCCCCeEEeecccccccCCCccCCCcccCccc
Q 045449 232 EISLLNNSLSGSLPSRIDLSLPNVETLNLGINSFSGT----IPSSITNSSKLSDLELGENLFSGFIPNTIGNLRNLEFGN 307 (823)
Q Consensus 232 ~L~Ls~N~l~g~lp~~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 307 (823)
.|+|..+.+++.--..++..+.+|++|+++++.++.. ++..+...++|+.|+++++.+.+. +..
T Consensus 2 ~l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~-~~~----------- 69 (319)
T cd00116 2 QLSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRI-PRG----------- 69 (319)
T ss_pred ccccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCc-chH-----------
Confidence 3566666665322222222355566666666665321 334444455555565555554420 000
Q ss_pred ccCccccCCCCcccccccccCCCCceEEEeecCCCCccCCcccccccc--ccceEEecCCccee----ccCccccCc-cc
Q 045449 308 IADNYLTSSTPELSFLSSLTNCKKLKVLIVTGNPLDGILPKSIGNFSL--SLETILMANCSISG----NIPQVVGNL-SN 380 (823)
Q Consensus 308 L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~--~L~~L~L~~N~l~~----~~p~~~~~l-~~ 380 (823)
....+..+..+++|+.|++++|.+.+..+..+..+.. +|++|++++|++++ .+...+..+ ++
T Consensus 70 -----------~~~~~~~l~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~ 138 (319)
T cd00116 70 -----------LQSLLQGLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPA 138 (319)
T ss_pred -----------HHHHHHHHHhcCceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCC
Confidence 0012334555677777777777776655555555421 27888888887763 233445566 89
Q ss_pred ccEEEcccCcCCCC----chhcccccCCCCEEEccCCCCCCc----chHhhhcCCCCCEEEcccCcCccc----cccccc
Q 045449 381 LLVLELGGNNLTGP----IPVTFSQLQTLQAFDLTRNKLAGP----ITDELCHLARLHSLVLQGNKFSGS----IPSCLG 448 (823)
Q Consensus 381 L~~L~Ls~N~l~g~----~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~g~----~p~~~~ 448 (823)
|+.|++++|.+++. ++..+..+.+|++|++++|.+++. ++..+..+++|+.|+|++|.+++. ++..+.
T Consensus 139 L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~ 218 (319)
T cd00116 139 LEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLA 218 (319)
T ss_pred ceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhc
Confidence 99999999999954 344567778999999999999953 344456667999999999999754 345567
Q ss_pred CCCCCCeEeccCCccccccchhhhc-----cCCCcEEeccccccc----cccCccccCCCCCcEEEcccCCCCCC
Q 045449 449 NLTSVRVLYLGLNIFTSVLSSTIWN-----LKDILFIDVSSNFLD----GPLSLDIGNLKVVIGLDFSRNNLSGD 514 (823)
Q Consensus 449 ~l~~L~~L~Ls~N~l~~~~p~~~~~-----l~~L~~LdLs~N~l~----g~~p~~~~~l~~L~~L~ls~N~l~g~ 514 (823)
.+++|++|++++|.+++.....+.. .+.|+.|++++|.++ ..+...+..++.|+++|+++|.++..
T Consensus 219 ~~~~L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~ 293 (319)
T cd00116 219 SLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEE 293 (319)
T ss_pred ccCCCCEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcHH
Confidence 7899999999999999754544433 379999999999997 23455677779999999999999843
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=99.79 E-value=6.3e-20 Score=195.51 Aligned_cols=136 Identities=30% Similarity=0.367 Sum_probs=112.6
Q ss_pred CeEEEEEEehHhh--HHHHHHHHHHHHHHhhcchhhHHH----------------------------------------H
Q 045449 641 GMEVAVKVFHQQY--ERALKSFEDECEVRKRIRHRNLVK----------------------------------------I 678 (823)
Q Consensus 641 ~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~----------------------------------------~ 678 (823)
+..||+|++.... ....+.+.+|++++++++|+|+++ +
T Consensus 26 ~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~ 105 (286)
T cd07847 26 GQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKI 105 (286)
T ss_pred CcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEeccCccHHHHHHhCCCCCCHHHHHHH
Confidence 5779999886432 223356889999999999999998 3
Q ss_pred HHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCcccccCC-Cccccccc
Q 045449 679 ISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTK-GRVSTRGD 757 (823)
Q Consensus 679 ~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~D 757 (823)
+.|++++|.|+|+.+++||||||+||+++.++.+||+|||++........ ......++..|+|||++.+ ..++.++|
T Consensus 106 ~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~D 183 (286)
T cd07847 106 IWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD--DYTDYVATRWYRAPELLVGDTQYGPPVD 183 (286)
T ss_pred HHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcc--cccCcccccccCCHHHHhCCCCcCchhh
Confidence 56888999999999999999999999999999999999999987654321 1223457889999998866 45789999
Q ss_pred eehhhhhhccccCCCCCcCCC
Q 045449 758 VCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 758 v~S~Gvv~~~~~~~~~~~~~~ 778 (823)
||||||+++++.+|..||.+.
T Consensus 184 i~slG~i~~~l~~g~~p~~~~ 204 (286)
T cd07847 184 VWAIGCVFAELLTGQPLWPGK 204 (286)
T ss_pred hHHHHHHHHHHHhCCCCCCCC
Confidence 999999999999999998654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.3e-19 Score=192.89 Aligned_cols=138 Identities=30% Similarity=0.380 Sum_probs=114.5
Q ss_pred CeEEEEEEehHhhHH-HHHHHHHHHHHHhhcchhhHHH------------------------------------------
Q 045449 641 GMEVAVKVFHQQYER-ALKSFEDECEVRKRIRHRNLVK------------------------------------------ 677 (823)
Q Consensus 641 ~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~------------------------------------------ 677 (823)
+..||||++...... ..+.|.+|+++++++.|+||++
T Consensus 33 ~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~ 112 (284)
T cd05038 33 GEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLL 112 (284)
T ss_pred ceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceEEEEecCCCCCHHHHHHhCccccCHHHHH
Confidence 578999999755432 5678999999999999999998
Q ss_pred -HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCcc-ccccccccCCCcCcccccCCCccccc
Q 045449 678 -IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQL-SKQTQTLATIGYMAPEYGTKGRVSTR 755 (823)
Q Consensus 678 -~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~ 755 (823)
++.|++.+|+|+|+.+++||||||+||+++.++.+|++|||.++........ .......++..|+|||......++.+
T Consensus 113 ~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~ 192 (284)
T cd05038 113 LFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSA 192 (284)
T ss_pred HHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccccccccccCCcceeccCCCCCcccccCcHHHccCCCCcc
Confidence 3567888999999999999999999999999999999999999876533221 11112345667999999988889999
Q ss_pred cceehhhhhhccccCCCCCcCCC
Q 045449 756 GDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 756 ~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
+|||||||+++++.+|..|+...
T Consensus 193 ~Di~slG~~l~el~tg~~p~~~~ 215 (284)
T cd05038 193 SDVWSFGVTLYELFTYGDPSQSP 215 (284)
T ss_pred cchHHHhhhhheeeccCCCcccc
Confidence 99999999999999999887653
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.79 E-value=6.4e-20 Score=198.66 Aligned_cols=132 Identities=29% Similarity=0.356 Sum_probs=110.8
Q ss_pred CeEEEEEEehHh---hHHHHHHHHHHHHHHhhcchhhHHH----------------------------------------
Q 045449 641 GMEVAVKVFHQQ---YERALKSFEDECEVRKRIRHRNLVK---------------------------------------- 677 (823)
Q Consensus 641 ~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~---------------------------------------- 677 (823)
+..||+|++... .....+++.+|++++++++|+|+++
T Consensus 50 ~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~l~~~~~~~~~~l~~~~~~~ 129 (317)
T cd06635 50 NEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAA 129 (317)
T ss_pred CcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeCCCCCHHHHHHHhcCCCCHHHHHH
Confidence 577999998632 2344567899999999999999988
Q ss_pred HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCcccccC---CCcccc
Q 045449 678 IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGT---KGRVST 754 (823)
Q Consensus 678 ~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~ 754 (823)
++.++++++.|+|+.+|+||||||+||+++.++.+||+|||++...... ....|++.|+|||++. .+.++.
T Consensus 130 i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~ 203 (317)
T cd06635 130 ITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA------NSFVGTPYWMAPEVILAMDEGQYDG 203 (317)
T ss_pred HHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCCc------ccccCCccccChhhhhcCCCCCCCc
Confidence 3567888999999999999999999999999999999999998764322 2346889999999873 456899
Q ss_pred ccceehhhhhhccccCCCCCcCCC
Q 045449 755 RGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 755 ~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
++|||||||+++++.+|..||.+.
T Consensus 204 ~~Dv~slGvil~el~~g~~p~~~~ 227 (317)
T cd06635 204 KVDVWSLGITCIELAERKPPLFNM 227 (317)
T ss_pred cccHHHHHHHHHHHHhCCCCCCCc
Confidence 999999999999999999998653
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=99.79 E-value=8.5e-20 Score=194.54 Aligned_cols=147 Identities=30% Similarity=0.397 Sum_probs=117.5
Q ss_pred cCCccceeeccC------------CeEEEEEEehHhh--HHHHHHHHHHHHHHhhcchhhHHH-----------------
Q 045449 629 RFSENNLIGIGN------------GMEVAVKVFHQQY--ERALKSFEDECEVRKRIRHRNLVK----------------- 677 (823)
Q Consensus 629 ~f~~~~~lg~g~------------~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~----------------- 677 (823)
+|+..+.+|.|+ ++.||+|++.... ....+.+.+|++++++++||||++
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 81 (286)
T cd07846 2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEF 81 (286)
T ss_pred ceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEec
Confidence 344555666553 5779999886433 223467889999999999999998
Q ss_pred -----------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccc
Q 045449 678 -----------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQ 734 (823)
Q Consensus 678 -----------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 734 (823)
++.|++.+|.|+|+.+++|||++|+||+++.++.+||+|||+++....... ....
T Consensus 82 ~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~--~~~~ 159 (286)
T cd07846 82 VDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE--VYTD 159 (286)
T ss_pred CCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcc--ccCc
Confidence 245788889999999999999999999999999999999999987543321 2234
Q ss_pred cccCCCcCcccccCC-CccccccceehhhhhhccccCCCCCcCC
Q 045449 735 TLATIGYMAPEYGTK-GRVSTRGDVCSFGIISGGKETRSMTVGE 777 (823)
Q Consensus 735 ~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~ 777 (823)
..++..|+|||+..+ ..++.++|||||||+++++.+|..+|..
T Consensus 160 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~ 203 (286)
T cd07846 160 YVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPG 203 (286)
T ss_pred ccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCC
Confidence 568899999998865 3478899999999999999999888754
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.79 E-value=1e-19 Score=191.31 Aligned_cols=136 Identities=25% Similarity=0.355 Sum_probs=114.3
Q ss_pred CeEEEEEEehHh--hHHHHHHHHHHHHHHhhcchhhHHH-----------------------------------------
Q 045449 641 GMEVAVKVFHQQ--YERALKSFEDECEVRKRIRHRNLVK----------------------------------------- 677 (823)
Q Consensus 641 ~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~----------------------------------------- 677 (823)
+..||+|++... .....+++..|++++++++|+||++
T Consensus 25 ~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~ 104 (265)
T cd08217 25 GKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEE 104 (265)
T ss_pred CCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEehhccCCCHHHHHHHHhhcccCCCH
Confidence 567999988643 2344567899999999999999998
Q ss_pred -----HHHHHHHHhhhcC-----CCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCccccc
Q 045449 678 -----IISSSLEYLHFGH-----SIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYG 747 (823)
Q Consensus 678 -----~~~~~l~~L~~~h-----~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~ 747 (823)
++.+++++|+++| +.+++||||||+||+++.++.+|++|||+++....... ......|++.|+|||++
T Consensus 105 ~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~--~~~~~~~~~~~~~pE~~ 182 (265)
T cd08217 105 EFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSS--FAKTYVGTPYYMSPEQL 182 (265)
T ss_pred HHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccccCCcc--cccccccCCCccChhhh
Confidence 2457788888888 99999999999999999999999999999987654332 12335689999999999
Q ss_pred CCCccccccceehhhhhhccccCCCCCcCCC
Q 045449 748 TKGRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 748 ~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
.+..++.++|||||||+++++.+|..|+...
T Consensus 183 ~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 213 (265)
T cd08217 183 NHMSYDEKSDIWSLGCLIYELCALSPPFTAR 213 (265)
T ss_pred cCCCCCchhHHHHHHHHHHHHHHCCCcccCc
Confidence 8888999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.79 E-value=4.7e-20 Score=193.71 Aligned_cols=149 Identities=28% Similarity=0.457 Sum_probs=118.6
Q ss_pred ccCCccceeeccC-----------CeEEEEEEehHhhHHHHHHHHHHHHHHhhcchhhHHH-------------------
Q 045449 628 DRFSENNLIGIGN-----------GMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVK------------------- 677 (823)
Q Consensus 628 ~~f~~~~~lg~g~-----------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------------- 677 (823)
++|...+.+|.|+ +..||||.+..... ..+++.+|+.++++++|+||++
T Consensus 6 ~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 84 (261)
T cd05034 6 ESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM-SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMS 84 (261)
T ss_pred hheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc-CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEeccC
Confidence 3455556666554 35689998875432 3467999999999999999998
Q ss_pred -----------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccc
Q 045449 678 -----------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQ 734 (823)
Q Consensus 678 -----------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 734 (823)
++.+++.++.|+|+.+++||||||+||+++.++.+|++|||.++....... .....
T Consensus 85 ~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~-~~~~~ 163 (261)
T cd05034 85 KGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEY-TAREG 163 (261)
T ss_pred CCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccchhh-hhhhc
Confidence 346788899999999999999999999999999999999999987643211 11122
Q ss_pred cccCCCcCcccccCCCccccccceehhhhhhccccC-CCCCcCCC
Q 045449 735 TLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKET-RSMTVGET 778 (823)
Q Consensus 735 ~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~-~~~~~~~~ 778 (823)
..++..|+|||.+.+..++.++||||+||+++++.+ |..||.+.
T Consensus 164 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~ 208 (261)
T cd05034 164 AKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGM 208 (261)
T ss_pred cCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 335678999999988889999999999999999998 88888654
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=6.2e-20 Score=196.49 Aligned_cols=177 Identities=18% Similarity=0.216 Sum_probs=138.5
Q ss_pred eEEEEEEehHhh-HHHHHHHHHHHHHHhhcchhhHHHH----------------------------------------HH
Q 045449 642 MEVAVKVFHQQY-ERALKSFEDECEVRKRIRHRNLVKI----------------------------------------IS 680 (823)
Q Consensus 642 ~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~----------------------------------------~~ 680 (823)
--||||..+.+. ....+.|..|+.+|+.++|||||++ ..
T Consensus 419 iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~ 498 (974)
T KOG4257|consen 419 IAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQPMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCY 498 (974)
T ss_pred eeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeeccceeEEEecccchhHHHHHHhccccchHHHHHHHHH
Confidence 449999998644 3446889999999999999999992 45
Q ss_pred HHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCcccccCCCccccccceeh
Q 045449 681 SSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCS 760 (823)
Q Consensus 681 ~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S 760 (823)
|+..+|.|+|+...|||||-..|||+.....+|++|||++|.+..+..+.. +...-...|||||.+...+++.++|||=
T Consensus 499 Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~yYka-S~~kLPIKWmaPESINfRrFTtASDVWM 577 (974)
T KOG4257|consen 499 QICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAYYKA-SRGKLPIKWMAPESINFRRFTTASDVWM 577 (974)
T ss_pred HHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhccccchhhc-cccccceeecCccccchhcccchhhHHH
Confidence 888899999999999999999999999999999999999999876655433 3444578899999999999999999999
Q ss_pred hhhhhccc-cCCCCCcCCCcccccccccccCCcccccccCCCcccccccccccccccccCC
Q 045449 761 FGIISGGK-ETRSMTVGETCTPVRESKYEVHPATTTIMEHPLPRVGEVMDVDRGKARIQGK 820 (823)
Q Consensus 761 ~Gvv~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 820 (823)
|||.+||+ ..|.-||++.......+..+.- ...+.++.+.|..--+|..+....+..||
T Consensus 578 FgVCmWEIl~lGvkPfqgvkNsDVI~~iEnG-eRlP~P~nCPp~LYslmskcWayeP~kRP 637 (974)
T KOG4257|consen 578 FGVCMWEILSLGVKPFQGVKNSDVIGHIENG-ERLPCPPNCPPALYSLMSKCWAYEPSKRP 637 (974)
T ss_pred HHHHHHHHHHhcCCccccccccceEEEecCC-CCCCCCCCCChHHHHHHHHHhccCcccCC
Confidence 99999997 4688999987665444443322 11233455566666666666665555554
|
|
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.3e-19 Score=189.59 Aligned_cols=135 Identities=27% Similarity=0.415 Sum_probs=112.6
Q ss_pred CeEEEEEEehHhh--HHHHHHHHHHHHHHhhcchhhHHH-----------------------------------------
Q 045449 641 GMEVAVKVFHQQY--ERALKSFEDECEVRKRIRHRNLVK----------------------------------------- 677 (823)
Q Consensus 641 ~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~----------------------------------------- 677 (823)
+..||||++.... ....+.+.+|++++++++|||+++
T Consensus 25 ~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~ 104 (256)
T cd08220 25 QKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTIL 104 (256)
T ss_pred CcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecCCCCCHHHHHHHhcccCCCHHHHH
Confidence 5679999886432 334578999999999999999998
Q ss_pred -HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCC-CcEEEeecccccccCCCCccccccccccCCCcCcccccCCCccccc
Q 045449 678 -IISSSLEYLHFGHSIPIIHCDLKPSNVLLDED-MVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTR 755 (823)
Q Consensus 678 -~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~-~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 755 (823)
++.+++++|+++|+.+++||||||+||+++.+ +.+|++|||+++....... .....|+..|+|||...+..++.+
T Consensus 105 ~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~ 181 (256)
T cd08220 105 HFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK---AYTVVGTPCYISPELCEGKPYNQK 181 (256)
T ss_pred HHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc---ccccccCCcccCchhccCCCCCcc
Confidence 24678889999999999999999999999854 5689999999987643321 223568999999999988889999
Q ss_pred cceehhhhhhccccCCCCCcCCC
Q 045449 756 GDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 756 ~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
+|||||||+++++.++..||...
T Consensus 182 ~Dv~slG~~l~~l~~~~~~~~~~ 204 (256)
T cd08220 182 SDIWALGCVLYELASLKRAFEAA 204 (256)
T ss_pred cchHHHHHHHHHHHhCCCCcccC
Confidence 99999999999999999998664
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.79 E-value=7.4e-20 Score=193.85 Aligned_cols=137 Identities=20% Similarity=0.284 Sum_probs=111.9
Q ss_pred CeEEEEEEehHhhHH-HHHHHHHHHHHHhhcchhhHHH------------------------------------------
Q 045449 641 GMEVAVKVFHQQYER-ALKSFEDECEVRKRIRHRNLVK------------------------------------------ 677 (823)
Q Consensus 641 ~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~------------------------------------------ 677 (823)
...||+|.+...... ..+.|.+|++++++++|+||++
T Consensus 35 ~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l 114 (275)
T cd05046 35 ETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPL 114 (275)
T ss_pred cceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcceEEEEecCCCcHHHHHHhcccccccccccCC
Confidence 356899988654433 5578999999999999999998
Q ss_pred -------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCcccccCCC
Q 045449 678 -------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKG 750 (823)
Q Consensus 678 -------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 750 (823)
++.|++++|+|+|+.+|+||||||+||+++.++.++++|||+++....... .......++..|+|||.+.+.
T Consensus 115 ~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~ 193 (275)
T cd05046 115 STKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEY-YKLRNALIPLRWLAPEAVQED 193 (275)
T ss_pred CHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEcccccccccCcccc-cccCCceeEEeecChhhhccC
Confidence 245788899999999999999999999999999999999999875432221 122334567889999998888
Q ss_pred ccccccceehhhhhhccccC-CCCCcCCC
Q 045449 751 RVSTRGDVCSFGIISGGKET-RSMTVGET 778 (823)
Q Consensus 751 ~~~~~~Dv~S~Gvv~~~~~~-~~~~~~~~ 778 (823)
.++.++|||||||+++++.+ |..||.+.
T Consensus 194 ~~~~~~Di~slG~~l~~l~~~~~~p~~~~ 222 (275)
T cd05046 194 DFSTKSDVWSFGVLMWEVFTQGELPFYGL 222 (275)
T ss_pred CCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence 89999999999999999987 67777553
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=99.78 E-value=6.4e-20 Score=194.61 Aligned_cols=137 Identities=26% Similarity=0.339 Sum_probs=115.9
Q ss_pred CCeEEEEEEehHhh-HHHHHHHHHHHHHHhhcchhhHHH---------------------------------------HH
Q 045449 640 NGMEVAVKVFHQQY-ERALKSFEDECEVRKRIRHRNLVK---------------------------------------II 679 (823)
Q Consensus 640 ~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~---------------------------------------~~ 679 (823)
.+..||+|++.... ....+.+.+|+++++++.|+||++ ++
T Consensus 28 ~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~l~~~~~~~~~ 107 (277)
T cd06640 28 TQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATML 107 (277)
T ss_pred CCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecCCCCcHHHHHhcCCCCHHHHHHHH
Confidence 36789999987443 445578999999999999999998 35
Q ss_pred HHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCcccccCCCcccccccee
Q 045449 680 SSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVC 759 (823)
Q Consensus 680 ~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~ 759 (823)
.|++.+|.++|+.+++|+||+|+||+++.++.++++|||++........ ......++..|+|||++.+..++.++|||
T Consensus 108 ~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Dv~ 185 (277)
T cd06640 108 KEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI--KRNTFVGTPFWMAPEVIQQSAYDSKADIW 185 (277)
T ss_pred HHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCcc--ccccccCcccccCHhHhccCCCccHHHHH
Confidence 6788889999999999999999999999999999999999987643321 12234688899999999888899999999
Q ss_pred hhhhhhccccCCCCCcCCC
Q 045449 760 SFGIISGGKETRSMTVGET 778 (823)
Q Consensus 760 S~Gvv~~~~~~~~~~~~~~ 778 (823)
||||+++++.+|..|+.+.
T Consensus 186 slG~il~el~tg~~p~~~~ 204 (277)
T cd06640 186 SLGITAIELAKGEPPNSDM 204 (277)
T ss_pred HHHHHHHHHHHCCCCCCCc
Confidence 9999999999999998654
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=99.78 E-value=9.3e-20 Score=191.98 Aligned_cols=150 Identities=27% Similarity=0.392 Sum_probs=121.2
Q ss_pred cCCccceeeccC------------CeEEEEEEehHhh-HHHHHHHHHHHHHHhhcchhhHHH------------------
Q 045449 629 RFSENNLIGIGN------------GMEVAVKVFHQQY-ERALKSFEDECEVRKRIRHRNLVK------------------ 677 (823)
Q Consensus 629 ~f~~~~~lg~g~------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~------------------ 677 (823)
+|...+.+|.|+ +..||+|++.... ....+.+.+|++++++++|+|+++
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~ 81 (267)
T cd06610 2 DYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYL 81 (267)
T ss_pred cceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEecc
Confidence 455555566553 5679999986432 335678999999999999999987
Q ss_pred -------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccc--
Q 045449 678 -------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLS-- 730 (823)
Q Consensus 678 -------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~-- 730 (823)
++.|++++|.++|+.+++|||+||+||++++++.+||+|||++..+.......
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~ 161 (267)
T cd06610 82 SGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRK 161 (267)
T ss_pred CCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcccccc
Confidence 24678889999999999999999999999999999999999998765433221
Q ss_pred cccccccCCCcCcccccCCC-ccccccceehhhhhhccccCCCCCcCCC
Q 045449 731 KQTQTLATIGYMAPEYGTKG-RVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 731 ~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
......|+..|+|||++... .++.++|||||||+++++.+|..||...
T Consensus 162 ~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~ 210 (267)
T cd06610 162 VRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKY 210 (267)
T ss_pred ccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCcccc
Confidence 12334689999999998776 7899999999999999999999998654
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.1e-19 Score=190.25 Aligned_cols=135 Identities=21% Similarity=0.318 Sum_probs=113.7
Q ss_pred CeEEEEEEehHhh--HHHHHHHHHHHHHHhhcchhhHHH-----------------------------------------
Q 045449 641 GMEVAVKVFHQQY--ERALKSFEDECEVRKRIRHRNLVK----------------------------------------- 677 (823)
Q Consensus 641 ~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~----------------------------------------- 677 (823)
+..||+|++.... ....+++.+|++++++++||||++
T Consensus 25 ~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~ 104 (256)
T cd08218 25 GKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQIL 104 (256)
T ss_pred CCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecCCCCcHHHHHHhccCCCCCHHHHH
Confidence 5779999886432 344568999999999999999998
Q ss_pred -HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCcccccCCCcccccc
Q 045449 678 -IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRG 756 (823)
Q Consensus 678 -~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 756 (823)
++.|++.++.++|+.+++|+||+|+||+++.++.++++|||++........ ......|++.|+|||+..+..++.++
T Consensus 105 ~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~ 182 (256)
T cd08218 105 DWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE--LARTCIGTPYYLSPEICENRPYNNKS 182 (256)
T ss_pred HHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh--hhhhccCCccccCHHHhCCCCCCCcc
Confidence 245788889999999999999999999999999999999999986543222 12234688999999999888899999
Q ss_pred ceehhhhhhccccCCCCCcCC
Q 045449 757 DVCSFGIISGGKETRSMTVGE 777 (823)
Q Consensus 757 Dv~S~Gvv~~~~~~~~~~~~~ 777 (823)
|||||||+++++.+|..|+..
T Consensus 183 Dv~slG~i~~~l~~g~~~~~~ 203 (256)
T cd08218 183 DIWALGCVLYEMCTLKHAFEA 203 (256)
T ss_pred chhHHHHHHHHHHcCCCCccC
Confidence 999999999999999998854
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.2e-19 Score=190.77 Aligned_cols=136 Identities=28% Similarity=0.284 Sum_probs=116.0
Q ss_pred CeEEEEEEehHhh---HHHHHHHHHHHHHHhhcchhhHHH----------------------------------------
Q 045449 641 GMEVAVKVFHQQY---ERALKSFEDECEVRKRIRHRNLVK---------------------------------------- 677 (823)
Q Consensus 641 ~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~---------------------------------------- 677 (823)
+..||+|++.... ....+.+.+|++++++++||||++
T Consensus 18 ~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~ 97 (262)
T cd05572 18 NRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARF 97 (262)
T ss_pred CcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcHHHHHhhcCCCCHHHHHH
Confidence 6789999986543 234468999999999999999998
Q ss_pred HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCcccccCCCccccccc
Q 045449 678 IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGD 757 (823)
Q Consensus 678 ~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D 757 (823)
++.|++.+|+|+|+.+++|+||||+||+++.++.+||+|||+++...... ......|++.|+|||++.+..++.++|
T Consensus 98 ~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~D 174 (262)
T cd05572 98 YIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFCGTPEYVAPEIILNKGYDFSVD 174 (262)
T ss_pred HHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---ccccccCCcCccChhHhcCCCCCChhh
Confidence 24678899999999999999999999999999999999999998765432 122346889999999988888999999
Q ss_pred eehhhhhhccccCCCCCcCCCc
Q 045449 758 VCSFGIISGGKETRSMTVGETC 779 (823)
Q Consensus 758 v~S~Gvv~~~~~~~~~~~~~~~ 779 (823)
+||+||++|++.+|..||....
T Consensus 175 i~slG~il~~l~~g~~p~~~~~ 196 (262)
T cd05572 175 YWSLGILLYELLTGRPPFGEDD 196 (262)
T ss_pred hhhhHHHHHHHHhCCCCcCCCC
Confidence 9999999999999999987654
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.78 E-value=1e-19 Score=198.97 Aligned_cols=137 Identities=31% Similarity=0.348 Sum_probs=111.8
Q ss_pred CeEEEEEEehHhh--HHHHHHHHHHHHHHhhc-chhhHHH----------------------------------------
Q 045449 641 GMEVAVKVFHQQY--ERALKSFEDECEVRKRI-RHRNLVK---------------------------------------- 677 (823)
Q Consensus 641 ~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~---------------------------------------- 677 (823)
+..||||++.... ......+.+|+++++++ +||||++
T Consensus 32 ~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~ 111 (337)
T cd07852 32 KEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYMETDLHAVIRANILEDVHKRY 111 (337)
T ss_pred CeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEEEecccccCHHHHHhcCCCCHHHHHH
Confidence 5779999885422 23345678899999999 9999988
Q ss_pred HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCcc---ccccccccCCCcCcccccCC-Cccc
Q 045449 678 IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQL---SKQTQTLATIGYMAPEYGTK-GRVS 753 (823)
Q Consensus 678 ~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~ 753 (823)
++.|++.+|.|+|+.+|+||||||+||+++.++.+||+|||+++........ .......||..|+|||++.+ ..++
T Consensus 112 i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 191 (337)
T cd07852 112 IMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYT 191 (337)
T ss_pred HHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhccccccccccCcchhcccccccccCceeeecccccc
Confidence 2567788999999999999999999999999999999999999876433221 12234568999999998755 4578
Q ss_pred cccceehhhhhhccccCCCCCcCC
Q 045449 754 TRGDVCSFGIISGGKETRSMTVGE 777 (823)
Q Consensus 754 ~~~Dv~S~Gvv~~~~~~~~~~~~~ 777 (823)
.++|||||||+++++++|+.||..
T Consensus 192 ~~sDi~slG~~l~el~tg~~pf~~ 215 (337)
T cd07852 192 KGVDMWSVGCILGEMLLGKPLFPG 215 (337)
T ss_pred ccchHHHHHHHHHHHHhCCCCCCC
Confidence 999999999999999999998854
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.78 E-value=9.5e-20 Score=194.79 Aligned_cols=137 Identities=25% Similarity=0.303 Sum_probs=116.2
Q ss_pred CCeEEEEEEehHhhHHHHHHHHHHHHHHhhcchhhHHH---------------------------------------HHH
Q 045449 640 NGMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVK---------------------------------------IIS 680 (823)
Q Consensus 640 ~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~---------------------------------------~~~ 680 (823)
.+..||||.+........+.+.+|+.++++++|+|+++ ++.
T Consensus 44 ~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~ 123 (292)
T cd06657 44 SGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCL 123 (292)
T ss_pred CCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHHHHHhcCCCCHHHHHHHHH
Confidence 36789999986554555678999999999999999998 357
Q ss_pred HHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCcccccCCCccccccceeh
Q 045449 681 SSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCS 760 (823)
Q Consensus 681 ~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S 760 (823)
|++.+|.|+|+.|++||||||+||+++.++.++|+|||++........ ......|++.|+|||+..+..++.++||||
T Consensus 124 ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~s 201 (292)
T cd06657 124 AVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RRKSLVGTPYWMAPELISRLPYGPEVDIWS 201 (292)
T ss_pred HHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceecccccc--cccccccCccccCHHHhcCCCCCchhhHHH
Confidence 889999999999999999999999999999999999999876543221 123356899999999998888999999999
Q ss_pred hhhhhccccCCCCCcCCC
Q 045449 761 FGIISGGKETRSMTVGET 778 (823)
Q Consensus 761 ~Gvv~~~~~~~~~~~~~~ 778 (823)
+||+++++.+|..||...
T Consensus 202 lGvil~el~tg~~p~~~~ 219 (292)
T cd06657 202 LGIMVIEMVDGEPPYFNE 219 (292)
T ss_pred HHHHHHHHHhCCCCCCCC
Confidence 999999999999998653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.3e-19 Score=192.72 Aligned_cols=146 Identities=27% Similarity=0.335 Sum_probs=112.7
Q ss_pred cCCccceeeccC------------CeEEEEEEehHhh-HHHHHHHHHHHHH-HhhcchhhHHH-----------------
Q 045449 629 RFSENNLIGIGN------------GMEVAVKVFHQQY-ERALKSFEDECEV-RKRIRHRNLVK----------------- 677 (823)
Q Consensus 629 ~f~~~~~lg~g~------------~~~vavK~~~~~~-~~~~~~~~~E~~~-l~~l~h~niv~----------------- 677 (823)
+|+..+.||.|+ |..||+|++.... .....++..|+++ ++..+||||++
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~ 81 (283)
T cd06617 2 DLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEV 81 (283)
T ss_pred CceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhh
Confidence 445555566553 6789999986543 2233456666665 55668999987
Q ss_pred --------------------------HHHHHHHHhhhcCCC-CEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccc
Q 045449 678 --------------------------IISSSLEYLHFGHSI-PIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLS 730 (823)
Q Consensus 678 --------------------------~~~~~l~~L~~~h~~-~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~ 730 (823)
++.|++.+|+|+|+. +++||||||+||+++.++.+||+|||+++......
T Consensus 82 ~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~--- 158 (283)
T cd06617 82 MDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSV--- 158 (283)
T ss_pred hcccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeeccccccccccc---
Confidence 346788899999987 99999999999999999999999999998653221
Q ss_pred cccccccCCCcCcccccCC----CccccccceehhhhhhccccCCCCCcCC
Q 045449 731 KQTQTLATIGYMAPEYGTK----GRVSTRGDVCSFGIISGGKETRSMTVGE 777 (823)
Q Consensus 731 ~~~~~~gt~~y~aPE~~~~----~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~ 777 (823)
......|+..|+|||++.+ ..++.++|+||+||+++++.+|..||..
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~ 209 (283)
T cd06617 159 AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDS 209 (283)
T ss_pred ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCc
Confidence 1123468899999998764 4568899999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=9.3e-20 Score=186.21 Aligned_cols=146 Identities=28% Similarity=0.321 Sum_probs=117.4
Q ss_pred hccCCccceeeccC------------CeEEEEEEehHhhHHHHHHHHHHHHHHhhcchh--h----HHH-----------
Q 045449 627 TDRFSENNLIGIGN------------GMEVAVKVFHQQYERALKSFEDECEVRKRIRHR--N----LVK----------- 677 (823)
Q Consensus 627 t~~f~~~~~lg~g~------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--n----iv~----------- 677 (823)
+.+|.....+|+|. +..||||+++.. .+..+..+-|++++.++.+. + +|.
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V-~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghi 166 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV-DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHI 166 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH-HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCce
Confidence 67788788888885 456888888644 45667788899999998322 1 111
Q ss_pred ------------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCC-------------------
Q 045449 678 ------------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDE------------------- 708 (823)
Q Consensus 678 ------------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~------------------- 708 (823)
+..|+++++.++|+.+++|.|+||+|||+..
T Consensus 167 CivfellG~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r~~ 246 (415)
T KOG0671|consen 167 CIVFELLGLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCFIRPL 246 (415)
T ss_pred EEEEeccChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCccceeccC
Confidence 3469999999999999999999999999821
Q ss_pred -CCcEEEeecccccccCCCCccccccccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCCC
Q 045449 709 -DMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 709 -~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
+..+||+|||-|+...... ...+.|..|+|||++.+-+++.++||||+|||+.|+.+|...|+.-
T Consensus 247 ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtH 312 (415)
T KOG0671|consen 247 KSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTH 312 (415)
T ss_pred CCcceEEEecCCcceeccCc-----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccC
Confidence 3358999999998754332 4567899999999999999999999999999999999999888654
|
|
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.78 E-value=1e-19 Score=194.21 Aligned_cols=146 Identities=30% Similarity=0.337 Sum_probs=120.6
Q ss_pred cCCccceeeccC------------CeEEEEEEehHhh-HHHHHHHHHHHHHHhhcchhhHHH------------------
Q 045449 629 RFSENNLIGIGN------------GMEVAVKVFHQQY-ERALKSFEDECEVRKRIRHRNLVK------------------ 677 (823)
Q Consensus 629 ~f~~~~~lg~g~------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~------------------ 677 (823)
+|...+.+|.|. ++.||+|++.... ....+++.+|++++++++||||++
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e 81 (287)
T cd06621 2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAME 81 (287)
T ss_pred ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEE
Confidence 455666677664 5779999987443 244578999999999999999988
Q ss_pred ----------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCcc
Q 045449 678 ----------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQL 729 (823)
Q Consensus 678 ----------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~ 729 (823)
++.|++++|.|+|+.+++|||++|+||+++.++.++|+|||++........
T Consensus 82 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~- 160 (287)
T cd06621 82 YCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLA- 160 (287)
T ss_pred ecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeecccccccccccc-
Confidence 245678889999999999999999999999999999999999876542221
Q ss_pred ccccccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCCC
Q 045449 730 SKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 730 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
....++..|+|||.+.+..++.++||||+||++|++.+|..||...
T Consensus 161 ---~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 206 (287)
T cd06621 161 ---GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPE 206 (287)
T ss_pred ---ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence 2345788999999998889999999999999999999999998754
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.78 E-value=1e-19 Score=193.74 Aligned_cols=136 Identities=30% Similarity=0.371 Sum_probs=111.2
Q ss_pred CeEEEEEEehHhh--HHHHHHHHHHHHHHhhcchhhHHH-----------------------------------------
Q 045449 641 GMEVAVKVFHQQY--ERALKSFEDECEVRKRIRHRNLVK----------------------------------------- 677 (823)
Q Consensus 641 ~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~----------------------------------------- 677 (823)
+..||||++.... ....+.+.+|++++++++||||++
T Consensus 25 ~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~l~~~~~~~~~~~l~~~~~~~ 104 (284)
T cd07860 25 GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKS 104 (284)
T ss_pred CCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeeccccCHHHHHHhCCCCCCCHHHHHH
Confidence 5679999886433 223357889999999999999998
Q ss_pred HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCcccccCCCc-ccccc
Q 045449 678 IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGR-VSTRG 756 (823)
Q Consensus 678 ~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~ 756 (823)
++.|++.+|+|+|+.+++||||+|+||+++.++.+||+|||+++....... ......+++.|+|||+..+.. ++.++
T Consensus 105 ~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~ 182 (284)
T cd07860 105 YLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYRAPEILLGCKYYSTAV 182 (284)
T ss_pred HHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc--ccccccccccccCCeEEecCCCCCcHH
Confidence 245788899999999999999999999999999999999999886543221 123345788999999876644 58899
Q ss_pred ceehhhhhhccccCCCCCcCCC
Q 045449 757 DVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 757 Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
|||||||+++++++|..||.+.
T Consensus 183 Dv~slG~il~~l~tg~~p~~~~ 204 (284)
T cd07860 183 DIWSLGCIFAEMVTRRALFPGD 204 (284)
T ss_pred HHHHHHHHHHHHHHCCCCCCCC
Confidence 9999999999999999988653
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.1e-19 Score=195.99 Aligned_cols=151 Identities=25% Similarity=0.323 Sum_probs=119.8
Q ss_pred ccCCccceeeccC------------CeEEEEEEehHhh--HHHHHHHHHHHHHHhhcchhhHHH----------------
Q 045449 628 DRFSENNLIGIGN------------GMEVAVKVFHQQY--ERALKSFEDECEVRKRIRHRNLVK---------------- 677 (823)
Q Consensus 628 ~~f~~~~~lg~g~------------~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~---------------- 677 (823)
++|...+.+|.|+ +..||||++.... ......+.+|++++++++||||++
T Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 91 (310)
T cd07865 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK 91 (310)
T ss_pred hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCC
Confidence 4577777788774 6779999886432 222345678999999999999987
Q ss_pred --------------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCC
Q 045449 678 --------------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSG 725 (823)
Q Consensus 678 --------------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~ 725 (823)
++.|++++|+|+|+.+++||||||+||+++.++.+||+|||+++....
T Consensus 92 ~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 171 (310)
T cd07865 92 GSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSL 171 (310)
T ss_pred ceEEEEEcCCCcCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCcccccC
Confidence 246789999999999999999999999999999999999999987643
Q ss_pred CCcc--ccccccccCCCcCcccccCCCc-cccccceehhhhhhccccCCCCCcCCC
Q 045449 726 EDQL--SKQTQTLATIGYMAPEYGTKGR-VSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 726 ~~~~--~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
.... .......++..|+|||++.+.. ++.++|||||||+++++.+|..||...
T Consensus 172 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~ 227 (310)
T cd07865 172 SKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGN 227 (310)
T ss_pred CcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence 2221 1123346788999999876644 788999999999999999999888654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.6e-19 Score=192.84 Aligned_cols=137 Identities=25% Similarity=0.288 Sum_probs=111.8
Q ss_pred CCeEEEEEEehHhh----HHHHHHHHHHHHHHhhc-chhhHHH-------------------------------------
Q 045449 640 NGMEVAVKVFHQQY----ERALKSFEDECEVRKRI-RHRNLVK------------------------------------- 677 (823)
Q Consensus 640 ~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~------------------------------------- 677 (823)
.|..||+|++.... ....+.+.+|++++.++ +|++|++
T Consensus 27 ~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~ 106 (290)
T cd05613 27 SGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQE 106 (290)
T ss_pred CCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEEEEEecCCCCcHHHHHHHcCCCCHHH
Confidence 35779999987543 23346788999999999 5899998
Q ss_pred ---HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCcccccCCC--cc
Q 045449 678 ---IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKG--RV 752 (823)
Q Consensus 678 ---~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~ 752 (823)
++.|++++|+|+|+.+++||||||+||+++.++.+||+|||+++....... .......|+..|+|||+.... .+
T Consensus 107 ~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~ 185 (290)
T cd05613 107 VQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEV-ERAYSFCGTIEYMAPDIVRGGDGGH 185 (290)
T ss_pred HHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceecccccc-cccccccCCcccCChhhccCCCCCC
Confidence 234889999999999999999999999999999999999999987543222 122345689999999998653 46
Q ss_pred ccccceehhhhhhccccCCCCCcCC
Q 045449 753 STRGDVCSFGIISGGKETRSMTVGE 777 (823)
Q Consensus 753 ~~~~Dv~S~Gvv~~~~~~~~~~~~~ 777 (823)
+.++|||||||+++++++|..|+..
T Consensus 186 ~~~~Dv~slG~~l~~ll~g~~p~~~ 210 (290)
T cd05613 186 DKAVDWWSMGVLMYELLTGASPFTV 210 (290)
T ss_pred CccccHHHHHHHHHHHhcCCCCCCc
Confidence 8899999999999999999999853
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.5e-19 Score=197.87 Aligned_cols=150 Identities=29% Similarity=0.386 Sum_probs=123.1
Q ss_pred HHHhccCCccceeeccC------------CeEEEEEEehHhh--HHHHHHHHHHHHHHhhcchhhHHH------------
Q 045449 624 LRATDRFSENNLIGIGN------------GMEVAVKVFHQQY--ERALKSFEDECEVRKRIRHRNLVK------------ 677 (823)
Q Consensus 624 ~~at~~f~~~~~lg~g~------------~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~------------ 677 (823)
....++|...+.||.|+ +..||||++.... ....+.+.+|++++++++||||++
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07880 11 WEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLD 90 (343)
T ss_pred hccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccc
Confidence 34566788888888875 5679999985432 334467889999999999999876
Q ss_pred --------------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCC
Q 045449 678 --------------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSG 725 (823)
Q Consensus 678 --------------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~ 725 (823)
++.|++++|+|+|+.+|+||||||+||+++.++.+|++|||+++....
T Consensus 91 ~~~~~~lv~e~~~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~ 170 (343)
T cd07880 91 RFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDS 170 (343)
T ss_pred ccceEEEEEecCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeccccccccc
Confidence 246888999999999999999999999999999999999999986532
Q ss_pred CCccccccccccCCCcCcccccCC-CccccccceehhhhhhccccCCCCCcCCC
Q 045449 726 EDQLSKQTQTLATIGYMAPEYGTK-GRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 726 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
. .....+++.|+|||++.+ ..++.++||||+||+++++.+|..||...
T Consensus 171 ~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~ 219 (343)
T cd07880 171 E-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGH 219 (343)
T ss_pred C-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 2 223467899999998765 45889999999999999999999998653
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.2e-19 Score=190.84 Aligned_cols=149 Identities=26% Similarity=0.326 Sum_probs=123.7
Q ss_pred cCCccceeeccC------------CeEEEEEEehHhhH-HHHHHHHHHHHHHhhcchhhHHH------------------
Q 045449 629 RFSENNLIGIGN------------GMEVAVKVFHQQYE-RALKSFEDECEVRKRIRHRNLVK------------------ 677 (823)
Q Consensus 629 ~f~~~~~lg~g~------------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~------------------ 677 (823)
+|...+.+|.|+ +..||||++..... ...+.+.+|++.+.+++|+|+++
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYM 81 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEec
Confidence 455556666553 57799999876543 44578999999999999999998
Q ss_pred ----------------------HHHHHHHHhhhcCC-CCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccc
Q 045449 678 ----------------------IISSSLEYLHFGHS-IPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQ 734 (823)
Q Consensus 678 ----------------------~~~~~l~~L~~~h~-~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 734 (823)
++.|+++++.++|+ .+++|||++|+||+++.++.++|+|||.++........ ...
T Consensus 82 ~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~--~~~ 159 (264)
T cd06623 82 DGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ--CNT 159 (264)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCc--ccc
Confidence 35688899999999 99999999999999999999999999999876543321 123
Q ss_pred cccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCCCc
Q 045449 735 TLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGETC 779 (823)
Q Consensus 735 ~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~~ 779 (823)
..++..|+|||......++.++||||||++++++.+|..|+....
T Consensus 160 ~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~ 204 (264)
T cd06623 160 FVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPG 204 (264)
T ss_pred eeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence 568899999999988889999999999999999999999986653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.78 E-value=2e-19 Score=188.27 Aligned_cols=136 Identities=29% Similarity=0.438 Sum_probs=113.4
Q ss_pred CeEEEEEEehHhhHH-HHHHHHHHHHHHhhcchhhHHH------------------------------------------
Q 045449 641 GMEVAVKVFHQQYER-ALKSFEDECEVRKRIRHRNLVK------------------------------------------ 677 (823)
Q Consensus 641 ~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~------------------------------------------ 677 (823)
+..||+|++...... ..+.+..|++++.+++|+||++
T Consensus 28 ~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~ 107 (258)
T smart00219 28 EVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEYMEGGDLLDYLRKNRPKELSLSDLLS 107 (258)
T ss_pred CceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEeccCCCCHHHHHHhhhhccCCHHHHHH
Confidence 377999999755432 5678999999999999999998
Q ss_pred HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCcccccCCCccccccc
Q 045449 678 IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGD 757 (823)
Q Consensus 678 ~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D 757 (823)
++.|++.+|+++|+.+++||||||+||+++.++.++++|||+++.......... ....+++.|+|||......++.++|
T Consensus 108 ~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~-~~~~~~~~y~~Pe~~~~~~~~~~~D 186 (258)
T smart00219 108 FALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKK-KGGKLPIRWMAPESLKDGKFTSKSD 186 (258)
T ss_pred HHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceeccccccccc-ccCCCcccccChHHhccCCCCcchh
Confidence 245788899999999999999999999999999999999999987654422211 1233778999999998888999999
Q ss_pred eehhhhhhccccC-CCCCcCC
Q 045449 758 VCSFGIISGGKET-RSMTVGE 777 (823)
Q Consensus 758 v~S~Gvv~~~~~~-~~~~~~~ 777 (823)
|||+||+++++.+ |..|+..
T Consensus 187 i~slG~i~~~l~~~g~~p~~~ 207 (258)
T smart00219 187 VWSFGVLLWEIFTLGESPYPG 207 (258)
T ss_pred HHHHHHHHHHHHhCCCCCCCC
Confidence 9999999999987 6777754
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.3e-19 Score=192.29 Aligned_cols=136 Identities=29% Similarity=0.437 Sum_probs=113.1
Q ss_pred CeEEEEEEehHhh-HHHHHHHHHHHHHHhhcc---hhhHHH---------------------------------------
Q 045449 641 GMEVAVKVFHQQY-ERALKSFEDECEVRKRIR---HRNLVK--------------------------------------- 677 (823)
Q Consensus 641 ~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~---h~niv~--------------------------------------- 677 (823)
+..||||++.... ....+++.+|++++++++ |||+++
T Consensus 26 ~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~l~~~~~~~ 105 (277)
T cd06917 26 GRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISV 105 (277)
T ss_pred CcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEecCCCCcHHHHHHccCCCHHHHHH
Confidence 5779999986432 344567889999999997 999997
Q ss_pred HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCcccccCCC-cccccc
Q 045449 678 IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKG-RVSTRG 756 (823)
Q Consensus 678 ~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~ 756 (823)
++.+++++|.|+|+.+++||||+|+||+++.++.++++|||++........ ......|+..|+|||+...+ .++.++
T Consensus 106 i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~ 183 (277)
T cd06917 106 IIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS--KRSTFVGTPYWMAPEVITEGKYYDTKA 183 (277)
T ss_pred HHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCcc--ccccccCCcceeCHHHhccCCccccch
Confidence 356888899999999999999999999999999999999999987654332 22345689999999987654 468999
Q ss_pred ceehhhhhhccccCCCCCcCCC
Q 045449 757 DVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 757 Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
|||||||++|++++|..||...
T Consensus 184 Dv~slG~~l~~ll~g~~p~~~~ 205 (277)
T cd06917 184 DIWSLGITIYEMATGNPPYSDV 205 (277)
T ss_pred hHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999999999999998764
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.78 E-value=2e-19 Score=188.64 Aligned_cols=130 Identities=20% Similarity=0.287 Sum_probs=107.8
Q ss_pred eEEEEEEehHhhHHHHHHHHHHHHHHhhcchhhHHH----------------------------------------HHHH
Q 045449 642 MEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVK----------------------------------------IISS 681 (823)
Q Consensus 642 ~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~----------------------------------------~~~~ 681 (823)
..||+|++...... ...|.+|++++++++||||++ ++.|
T Consensus 31 ~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ 109 (259)
T cd05037 31 VSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVRDENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQ 109 (259)
T ss_pred eeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEecCCcEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHH
Confidence 45788887655433 678999999999999999998 2458
Q ss_pred HHHHhhhcCCCCEEeccCCCCCEEeCCCC-------cEEEeecccccccCCCCccccccccccCCCcCcccccCCC--cc
Q 045449 682 SLEYLHFGHSIPIIHCDLKPSNVLLDEDM-------VAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKG--RV 752 (823)
Q Consensus 682 ~l~~L~~~h~~~ivHrdlk~~NiLl~~~~-------~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~ 752 (823)
++.+|.|+|+.+|+||||||+||+++.++ .+||+|||+++..... ....++..|+|||++.+. .+
T Consensus 110 i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~~~~~------~~~~~~~~y~aPE~~~~~~~~~ 183 (259)
T cd05037 110 LASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSR------EERVERIPWIAPECIRNGQASL 183 (259)
T ss_pred HHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCcccccccc------cccccCCCccChhhhcCCCCCc
Confidence 88899999999999999999999999887 7999999999875431 224567889999998776 78
Q ss_pred ccccceehhhhhhccccC-CCCCcCCC
Q 045449 753 STRGDVCSFGIISGGKET-RSMTVGET 778 (823)
Q Consensus 753 ~~~~Dv~S~Gvv~~~~~~-~~~~~~~~ 778 (823)
+.++|||||||+++++.+ +..|+...
T Consensus 184 ~~~~Di~slG~~~~~l~~~~~~p~~~~ 210 (259)
T cd05037 184 TIAADKWSFGTTLLEICSNGEEPLSTL 210 (259)
T ss_pred chhhHHHHHHHHHHHHHhCCCCCcccC
Confidence 999999999999999988 46666554
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.78 E-value=3.3e-19 Score=188.14 Aligned_cols=136 Identities=17% Similarity=0.285 Sum_probs=106.1
Q ss_pred eEEEEEEehHhh-HHHHHHHHHHHHHHhhcchhhHHH-------------------------------------------
Q 045449 642 MEVAVKVFHQQY-ERALKSFEDECEVRKRIRHRNLVK------------------------------------------- 677 (823)
Q Consensus 642 ~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~------------------------------------------- 677 (823)
..+++|.+.... ....+.|.+|+.++++++||||++
T Consensus 23 ~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 102 (268)
T cd05086 23 ARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQ 102 (268)
T ss_pred ceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCcHHHHHHhhhcccccccHHHHH
Confidence 456777765433 345578999999999999999998
Q ss_pred -HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCcccccCC-------
Q 045449 678 -IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTK------- 749 (823)
Q Consensus 678 -~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------- 749 (823)
++.|++.+|+|+|+.+++||||||+||+++.++.+||+|||+++...............|+..|+|||+...
T Consensus 103 ~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 182 (268)
T cd05086 103 RMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLIT 182 (268)
T ss_pred HHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhhhcccCCcCcccccCchhcccccCcccc
Confidence 235788899999999999999999999999999999999999865332222122234568899999998743
Q ss_pred CccccccceehhhhhhccccCC-CCCcCC
Q 045449 750 GRVSTRGDVCSFGIISGGKETR-SMTVGE 777 (823)
Q Consensus 750 ~~~~~~~Dv~S~Gvv~~~~~~~-~~~~~~ 777 (823)
..++.++|||||||+++++.++ ..||..
T Consensus 183 ~~~~~~~DiwslG~~l~el~~~~~~p~~~ 211 (268)
T cd05086 183 AEQTKPSNVWALGVTLWELFENAAQPYSH 211 (268)
T ss_pred CCCCCcchhHHHHHHHHHHHhCCCCCCCC
Confidence 2457899999999999999864 556654
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.78 E-value=9.3e-20 Score=198.18 Aligned_cols=152 Identities=28% Similarity=0.405 Sum_probs=125.6
Q ss_pred HHHHHHhccCCccceeeccC------------CeEEEEEEehHhh--HHHHHHHHHHHHHHhhcchhhHHH---------
Q 045449 621 HELLRATDRFSENNLIGIGN------------GMEVAVKVFHQQY--ERALKSFEDECEVRKRIRHRNLVK--------- 677 (823)
Q Consensus 621 ~~l~~at~~f~~~~~lg~g~------------~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~--------- 677 (823)
.++..++++|+..+.||.|+ +..||||++.... ....+.+.+|++++++++||||++
T Consensus 3 ~~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 82 (328)
T cd07856 3 GTVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPL 82 (328)
T ss_pred cceeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCC
Confidence 45566788898888898874 5679999875422 233467889999999999999998
Q ss_pred ------------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCC
Q 045449 678 ------------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGED 727 (823)
Q Consensus 678 ------------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~ 727 (823)
++.|++++|.|+|+.+|+||||||+||+++.++.+||+|||.++.....
T Consensus 83 ~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~- 161 (328)
T cd07856 83 EDIYFVTELLGTDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQ- 161 (328)
T ss_pred CcEEEEeehhccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCCC-
Confidence 3578889999999999999999999999999999999999998864321
Q ss_pred ccccccccccCCCcCcccccCC-CccccccceehhhhhhccccCCCCCcCC
Q 045449 728 QLSKQTQTLATIGYMAPEYGTK-GRVSTRGDVCSFGIISGGKETRSMTVGE 777 (823)
Q Consensus 728 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~ 777 (823)
.....++..|+|||++.+ ..++.++|||||||+++++.+|..||..
T Consensus 162 ----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~ 208 (328)
T cd07856 162 ----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPG 208 (328)
T ss_pred ----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 123467889999998765 5689999999999999999999988854
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.77 E-value=9.7e-20 Score=196.51 Aligned_cols=150 Identities=29% Similarity=0.311 Sum_probs=119.6
Q ss_pred hccCCccceeeccC------------CeEEEEEEehHhh--HHHHHHHHHHHHHHhhcchhhHHH---------------
Q 045449 627 TDRFSENNLIGIGN------------GMEVAVKVFHQQY--ERALKSFEDECEVRKRIRHRNLVK--------------- 677 (823)
Q Consensus 627 t~~f~~~~~lg~g~------------~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~--------------- 677 (823)
.++|...+.||.|+ |..||+|+++... ......+.+|++++++++|+||++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 35666667777764 6779999986432 122235678999999999999987
Q ss_pred ---------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccc
Q 045449 678 ---------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLS 730 (823)
Q Consensus 678 ---------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~ 730 (823)
++.|++++|+|+|+.+++||||||+||+++.++.+||+|||+++.......
T Consensus 86 v~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~-- 163 (309)
T cd07845 86 VMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAK-- 163 (309)
T ss_pred EEecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCccC--
Confidence 356888999999999999999999999999999999999999987653321
Q ss_pred cccccccCCCcCcccccCC-CccccccceehhhhhhccccCCCCCcCCC
Q 045449 731 KQTQTLATIGYMAPEYGTK-GRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 731 ~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
......+++.|+|||++.+ ..++.++||||+||++|++.+|..||...
T Consensus 164 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~ 212 (309)
T cd07845 164 PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGK 212 (309)
T ss_pred CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCC
Confidence 1223456888999998765 45789999999999999999999888643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.8e-19 Score=196.86 Aligned_cols=149 Identities=28% Similarity=0.352 Sum_probs=120.5
Q ss_pred hccCCccceeeccC------------CeEEEEEEehHhh--HHHHHHHHHHHHHHhhcchhhHHH---------------
Q 045449 627 TDRFSENNLIGIGN------------GMEVAVKVFHQQY--ERALKSFEDECEVRKRIRHRNLVK--------------- 677 (823)
Q Consensus 627 t~~f~~~~~lg~g~------------~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~--------------- 677 (823)
.++|...+.+|.|+ +..||||.+.... ......+.+|+.++++++|+||++
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 34667777777774 5679999886432 233456788999999999999986
Q ss_pred -----------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCc
Q 045449 678 -----------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQ 728 (823)
Q Consensus 678 -----------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~ 728 (823)
++.|++.+|+|+|+.+++||||||+||+++.++.+||+|||+++.......
T Consensus 84 ~~lv~e~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~ 163 (337)
T cd07858 84 VYIVYELMDTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGD 163 (337)
T ss_pred EEEEEeCCCCCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCCCcc
Confidence 246888999999999999999999999999999999999999987643321
Q ss_pred cccccccccCCCcCcccccCC-CccccccceehhhhhhccccCCCCCcCC
Q 045449 729 LSKQTQTLATIGYMAPEYGTK-GRVSTRGDVCSFGIISGGKETRSMTVGE 777 (823)
Q Consensus 729 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~ 777 (823)
......++..|+|||++.. ..++.++|||||||+++++.+|..||..
T Consensus 164 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~ 211 (337)
T cd07858 164 --FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPG 211 (337)
T ss_pred --cccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCC
Confidence 1234568899999998765 4589999999999999999999998854
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.3e-19 Score=195.26 Aligned_cols=132 Identities=27% Similarity=0.363 Sum_probs=110.3
Q ss_pred CeEEEEEEehHh---hHHHHHHHHHHHHHHhhcchhhHHH----------------------------------------
Q 045449 641 GMEVAVKVFHQQ---YERALKSFEDECEVRKRIRHRNLVK---------------------------------------- 677 (823)
Q Consensus 641 ~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~---------------------------------------- 677 (823)
+..||+|.+... .....+++.+|++++++++|+|+++
T Consensus 40 ~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~ 119 (308)
T cd06634 40 SEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAA 119 (308)
T ss_pred CcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEccCCCHHHHHHHcCCCCCHHHHHH
Confidence 567999988532 2344567889999999999999988
Q ss_pred HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCcccccC---CCcccc
Q 045449 678 IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGT---KGRVST 754 (823)
Q Consensus 678 ~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~ 754 (823)
++.++++++.|+|+.+++||||||+||+++.++.+||+|||++...... ....|++.|+|||++. .+.++.
T Consensus 120 ~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~ 193 (308)
T cd06634 120 VTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA------NXFVGTPYWMAPEVILAMDEGQYDG 193 (308)
T ss_pred HHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecCc------ccccCCccccCHHHHhhcccCCCCc
Confidence 2567888999999999999999999999999999999999998765422 2346889999999874 356788
Q ss_pred ccceehhhhhhccccCCCCCcCCC
Q 045449 755 RGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 755 ~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
++|||||||+++++.+|..|+...
T Consensus 194 ~~Di~slG~il~el~~g~~p~~~~ 217 (308)
T cd06634 194 KVDVWSLGITCIELAERKPPLFNM 217 (308)
T ss_pred ccchHHHHHHHHHHHcCCCCCccc
Confidence 999999999999999999998653
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.8e-19 Score=196.45 Aligned_cols=137 Identities=28% Similarity=0.303 Sum_probs=111.4
Q ss_pred CeEEEEEEehHhh--HHHHHHHHHHHHHHhhc-chhhHHH----------------------------------------
Q 045449 641 GMEVAVKVFHQQY--ERALKSFEDECEVRKRI-RHRNLVK---------------------------------------- 677 (823)
Q Consensus 641 ~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~---------------------------------------- 677 (823)
+..||||++.... ....+.+.+|++++.++ .||||++
T Consensus 27 ~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~e~~~~~L~~~l~~~~~~~~~~ 106 (332)
T cd07857 27 EETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQPLTDAH 106 (332)
T ss_pred CceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcEEEEEecccCCHHHHHhcCCCCCHHH
Confidence 4679999886432 22346788999999999 5999998
Q ss_pred ---HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCcc--ccccccccCCCcCcccccCC-Cc
Q 045449 678 ---IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQL--SKQTQTLATIGYMAPEYGTK-GR 751 (823)
Q Consensus 678 ---~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~ 751 (823)
++.|++.+|.|+|+.||+||||||+||+++.++.+||+|||+++........ .......||..|+|||+..+ ..
T Consensus 107 ~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~ 186 (332)
T cd07857 107 FQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQS 186 (332)
T ss_pred HHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceecccccccccccccCcccCccccCcHHHhCCCC
Confidence 2468889999999999999999999999999999999999999865432211 11233578999999998765 46
Q ss_pred cccccceehhhhhhccccCCCCCcCC
Q 045449 752 VSTRGDVCSFGIISGGKETRSMTVGE 777 (823)
Q Consensus 752 ~~~~~Dv~S~Gvv~~~~~~~~~~~~~ 777 (823)
++.++||||+||+++++++|..||..
T Consensus 187 ~~~~~Di~slGv~l~~l~~g~~pf~~ 212 (332)
T cd07857 187 YTKAIDVWSVGCILAELLGRKPVFKG 212 (332)
T ss_pred CCcHHHHHHHHHHHHHHHhCCcCCCC
Confidence 89999999999999999999988865
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.9e-19 Score=190.48 Aligned_cols=150 Identities=25% Similarity=0.384 Sum_probs=120.8
Q ss_pred HhccCCccceeeccC------------CeEEEEEEehHhhHHHHHHHHHHHHHHhhc-chhhHHH---------------
Q 045449 626 ATDRFSENNLIGIGN------------GMEVAVKVFHQQYERALKSFEDECEVRKRI-RHRNLVK--------------- 677 (823)
Q Consensus 626 at~~f~~~~~lg~g~------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~--------------- 677 (823)
++++|...+.+|.|+ +..||+|++..... ..++|.+|+++++++ .|+||++
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 456777777777764 56799998875543 346799999999999 6999876
Q ss_pred -----------------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccc
Q 045449 678 -----------------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKL 722 (823)
Q Consensus 678 -----------------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~ 722 (823)
++.|++++|.|+|+.+++||||+|+||++++++.+||+|||++..
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~ 162 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQ 162 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCcccee
Confidence 245788899999999999999999999999999999999999876
Q ss_pred cCCCCccccccccccCCCcCcccccCC-----CccccccceehhhhhhccccCCCCCcCCC
Q 045449 723 LSGEDQLSKQTQTLATIGYMAPEYGTK-----GRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 723 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
..... .......|+..|+|||++.. ..++.++||||+||+++++.+|..||...
T Consensus 163 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 221 (275)
T cd06608 163 LDSTL--GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDM 221 (275)
T ss_pred cccch--hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCcccc
Confidence 54322 12234568999999998753 34688999999999999999999998653
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.2e-19 Score=191.34 Aligned_cols=136 Identities=29% Similarity=0.319 Sum_probs=112.6
Q ss_pred CeEEEEEEehHhh--HHHHHHHHHHHHHHhhcchhhHHH----------------------------------------H
Q 045449 641 GMEVAVKVFHQQY--ERALKSFEDECEVRKRIRHRNLVK----------------------------------------I 678 (823)
Q Consensus 641 ~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~----------------------------------------~ 678 (823)
|..||||++.... ....+.+.+|+.++++++||||++ +
T Consensus 25 ~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~L~~~~~~~~~~~~~~~~~~~ 104 (286)
T cd07832 25 GETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYMPSDLSEVLRDEERPLPEAQVKSY 104 (286)
T ss_pred CceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecccCCCHHHHHHhcCCCCCHHHHHHH
Confidence 5789999987543 334578999999999999999998 2
Q ss_pred HHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCcccccCCCc-cccccc
Q 045449 679 ISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGR-VSTRGD 757 (823)
Q Consensus 679 ~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~D 757 (823)
+.|++++|.|+|+.+++|+||||+||+++.++.++++|||+++....... .......|+..|+|||++.+.. ++.++|
T Consensus 105 ~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~D 183 (286)
T cd07832 105 MRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP-RLYSHQVATRWYRAPELLYGARKYDPGVD 183 (286)
T ss_pred HHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC-CccccccCcccccCceeeeccccCCchhH
Confidence 46788899999999999999999999999999999999999987654322 1223456899999999876544 689999
Q ss_pred eehhhhhhccccCCCCCcCC
Q 045449 758 VCSFGIISGGKETRSMTVGE 777 (823)
Q Consensus 758 v~S~Gvv~~~~~~~~~~~~~ 777 (823)
|||+||+++++.+|..+|..
T Consensus 184 i~slG~~l~~l~tg~~~~~~ 203 (286)
T cd07832 184 LWAVGCIFAELLNGSPLFPG 203 (286)
T ss_pred HHHHHHHHHHHHcCCcCcCC
Confidence 99999999999999777754
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.77 E-value=2e-19 Score=190.06 Aligned_cols=134 Identities=24% Similarity=0.318 Sum_probs=107.0
Q ss_pred eEEEEEEehHhh-HHHHHHHHHHHHHHhhc-chhhHHH------------------------------------------
Q 045449 642 MEVAVKVFHQQY-ERALKSFEDECEVRKRI-RHRNLVK------------------------------------------ 677 (823)
Q Consensus 642 ~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~------------------------------------------ 677 (823)
..+|+|.+.... ....+.|.+|++++.++ +||||++
T Consensus 23 ~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~ 102 (270)
T cd05047 23 MDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIA 102 (270)
T ss_pred eEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCCCcHHHHHHhccccccccccccc
Confidence 457889887432 44556899999999999 7999876
Q ss_pred --------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCc
Q 045449 678 --------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMA 743 (823)
Q Consensus 678 --------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a 743 (823)
++.|++.++.|+|+.+++||||||+||++++++.+|++|||+++..... ........+..|+|
T Consensus 103 ~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl~~~~~~~---~~~~~~~~~~~y~a 179 (270)
T cd05047 103 NSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVY---VKKTMGRLPVRWMA 179 (270)
T ss_pred cCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCCccccchh---hhccCCCCccccCC
Confidence 2346777899999999999999999999999999999999998643211 11112234667999
Q ss_pred ccccCCCccccccceehhhhhhccccC-CCCCcCCC
Q 045449 744 PEYGTKGRVSTRGDVCSFGIISGGKET-RSMTVGET 778 (823)
Q Consensus 744 PE~~~~~~~~~~~Dv~S~Gvv~~~~~~-~~~~~~~~ 778 (823)
||+.....++.++|||||||+++++.+ |..||.+.
T Consensus 180 pE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~ 215 (270)
T cd05047 180 IESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM 215 (270)
T ss_pred hHHHccCCCCchhhHHHHHHHHHHHHcCCCCCcccc
Confidence 999988889999999999999999996 88888653
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.1e-19 Score=189.77 Aligned_cols=135 Identities=30% Similarity=0.401 Sum_probs=111.3
Q ss_pred CeEEEEEEehHh----------hHHHHHHHHHHHHHHhh-cchhhHHH--------------------------------
Q 045449 641 GMEVAVKVFHQQ----------YERALKSFEDECEVRKR-IRHRNLVK-------------------------------- 677 (823)
Q Consensus 641 ~~~vavK~~~~~----------~~~~~~~~~~E~~~l~~-l~h~niv~-------------------------------- 677 (823)
+..||||.+... ......++.+|+.++.+ ++||||++
T Consensus 26 ~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~ 105 (269)
T cd08528 26 QNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKE 105 (269)
T ss_pred CceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccCCeEEEEEecCCCCcHHHHHHHHHh
Confidence 467999987532 23445678889988875 79999998
Q ss_pred ------------HHHHHHHHhhhcCC-CCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCcc
Q 045449 678 ------------IISSSLEYLHFGHS-IPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAP 744 (823)
Q Consensus 678 ------------~~~~~l~~L~~~h~-~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aP 744 (823)
++.|++.+|.|+|. .+++||||||+||+++.++.+||+|||.+....... ......|+..|+||
T Consensus 106 ~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~~P 182 (269)
T cd08528 106 KKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPES---KLTSVVGTILYSCP 182 (269)
T ss_pred ccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccceeeccccc---ccccccCcccCcCh
Confidence 24578888999995 789999999999999999999999999998754332 22345689999999
Q ss_pred cccCCCccccccceehhhhhhccccCCCCCcCCC
Q 045449 745 EYGTKGRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 745 E~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
|+..++.++.++|||||||++|++.+|..||...
T Consensus 183 e~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~ 216 (269)
T cd08528 183 EIVKNEPYGEKADVWAFGCILYQMCTLQPPFYST 216 (269)
T ss_pred hhhcCCCCchHHHHHHHHHHHHHHHhCCCccccc
Confidence 9999888999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.77 E-value=1e-19 Score=192.12 Aligned_cols=137 Identities=29% Similarity=0.395 Sum_probs=111.5
Q ss_pred eEEEEEEehHhh-HHHHHHHHHHHHHHhhcchhhHHH-------------------------------------------
Q 045449 642 MEVAVKVFHQQY-ERALKSFEDECEVRKRIRHRNLVK------------------------------------------- 677 (823)
Q Consensus 642 ~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~------------------------------------------- 677 (823)
..||||.+.... ......|.+|++++++++||||++
T Consensus 27 ~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 106 (269)
T cd05044 27 IRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLK 106 (269)
T ss_pred eeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEeccCCCcHHHHHHHhhhcccCCccccHH
Confidence 678999876443 234568999999999999999997
Q ss_pred ----HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCC-----cEEEeecccccccCCCCccccccccccCCCcCcccccC
Q 045449 678 ----IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDM-----VAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGT 748 (823)
Q Consensus 678 ----~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~-----~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 748 (823)
++.|++.+|+|+|+.+++|+|+||+||+++.+. .+|++|||+++...............++..|+|||++.
T Consensus 107 ~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 186 (269)
T cd05044 107 ELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLL 186 (269)
T ss_pred HHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccccccccccccccCcccCCCccccCHHHHc
Confidence 134677888999999999999999999999877 89999999998664333222222345678999999999
Q ss_pred CCccccccceehhhhhhccccC-CCCCcCCC
Q 045449 749 KGRVSTRGDVCSFGIISGGKET-RSMTVGET 778 (823)
Q Consensus 749 ~~~~~~~~Dv~S~Gvv~~~~~~-~~~~~~~~ 778 (823)
++.++.++|||||||++|++++ |..||...
T Consensus 187 ~~~~~~~~Dv~slG~il~ellt~g~~p~~~~ 217 (269)
T cd05044 187 DGKFTTQSDVWSFGVLMWEILTLGQQPYPAL 217 (269)
T ss_pred cCCcccchhHHHHHHHHHHHHHcCCCCCccc
Confidence 8999999999999999999997 88888653
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.9e-19 Score=192.78 Aligned_cols=135 Identities=26% Similarity=0.330 Sum_probs=109.6
Q ss_pred CeEEEEEEehHhh--HHHHHHHHHHHHHHhhcchhhHHH-----------------------------------------
Q 045449 641 GMEVAVKVFHQQY--ERALKSFEDECEVRKRIRHRNLVK----------------------------------------- 677 (823)
Q Consensus 641 ~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~----------------------------------------- 677 (823)
++.||+|.+.... ....+.+.+|++++++++|+||++
T Consensus 27 ~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~ 106 (294)
T PLN00009 27 NETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKT 106 (294)
T ss_pred CcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEecccccHHHHHHhCCCCCcCHHHHHH
Confidence 5679999886432 233467889999999999999988
Q ss_pred HHHHHHHHhhhcCCCCEEeccCCCCCEEeCC-CCcEEEeecccccccCCCCccccccccccCCCcCcccccCCC-ccccc
Q 045449 678 IISSSLEYLHFGHSIPIIHCDLKPSNVLLDE-DMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKG-RVSTR 755 (823)
Q Consensus 678 ~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~-~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~ 755 (823)
++.|++++|+|+|+.+++||||||+||+++. ++.+||+|||+++...... .......+++.|+|||++.+. .++.+
T Consensus 107 ~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~ 184 (294)
T PLN00009 107 YLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV--RTFTHEVVTLWYRAPEILLGSRHYSTP 184 (294)
T ss_pred HHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCc--cccccCceeecccCHHHHhCCCCCCcH
Confidence 2458899999999999999999999999985 5679999999997653221 112334678999999987664 57899
Q ss_pred cceehhhhhhccccCCCCCcCC
Q 045449 756 GDVCSFGIISGGKETRSMTVGE 777 (823)
Q Consensus 756 ~Dv~S~Gvv~~~~~~~~~~~~~ 777 (823)
+||||+||+++++++|..||..
T Consensus 185 ~Dv~slG~i~~~l~tg~~pf~~ 206 (294)
T PLN00009 185 VDIWSVGCIFAEMVNQKPLFPG 206 (294)
T ss_pred HHHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999998854
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.4e-19 Score=195.42 Aligned_cols=152 Identities=26% Similarity=0.338 Sum_probs=120.0
Q ss_pred hccCCccceeeccC------------CeEEEEEEehHhh--HHHHHHHHHHHHHHhhcchhhHHHH--------------
Q 045449 627 TDRFSENNLIGIGN------------GMEVAVKVFHQQY--ERALKSFEDECEVRKRIRHRNLVKI-------------- 678 (823)
Q Consensus 627 t~~f~~~~~lg~g~------------~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~-------------- 678 (823)
.++|...+.||.|+ +..||||++.... ......+.+|++++++++|+||+++
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 46777777888775 5679999885432 1223467889999999999999972
Q ss_pred ----------------------------------HHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccC
Q 045449 679 ----------------------------------ISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLS 724 (823)
Q Consensus 679 ----------------------------------~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~ 724 (823)
+.|++++|.|+|+.+++|||+||+||+++.++.+||+|||+++...
T Consensus 87 ~~~~~lv~~~~~~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 166 (311)
T cd07866 87 RGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYD 166 (311)
T ss_pred CceEEEEEecCCcCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccchhcc
Confidence 3577889999999999999999999999999999999999998654
Q ss_pred CCCcc---------ccccccccCCCcCcccccCCC-ccccccceehhhhhhccccCCCCCcCCC
Q 045449 725 GEDQL---------SKQTQTLATIGYMAPEYGTKG-RVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 725 ~~~~~---------~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
..... ...+...|++.|+|||++.+. .++.++|||||||+++++.+|..||.+.
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~ 230 (311)
T cd07866 167 GPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGK 230 (311)
T ss_pred CCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCC
Confidence 32211 111234678899999987654 5799999999999999999999888643
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.77 E-value=4.7e-19 Score=191.63 Aligned_cols=140 Identities=20% Similarity=0.291 Sum_probs=114.6
Q ss_pred cCCeEEEEEEehHh--hHHHHHHHHHHHHHHhhcchhhHHH---------------------------------------
Q 045449 639 GNGMEVAVKVFHQQ--YERALKSFEDECEVRKRIRHRNLVK--------------------------------------- 677 (823)
Q Consensus 639 g~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~--------------------------------------- 677 (823)
..++.||||++... .....+.+.+|++++++++|+||++
T Consensus 23 ~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~ 102 (314)
T cd08216 23 PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELA 102 (314)
T ss_pred CCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHHHhcccCCCHHH
Confidence 34788999998654 3445678999999999999999998
Q ss_pred ---HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCc-----cccccccccCCCcCcccccCC
Q 045449 678 ---IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQ-----LSKQTQTLATIGYMAPEYGTK 749 (823)
Q Consensus 678 ---~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~ 749 (823)
++.|++.+|.|+|+.+|+||||||+||+++.++.+|++|||.+........ ........++..|+|||++..
T Consensus 103 ~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 182 (314)
T cd08216 103 IAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQ 182 (314)
T ss_pred HHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeeccccccccccccccccccccccccCHHHhcC
Confidence 246788899999999999999999999999999999999998876532211 011123457889999999865
Q ss_pred --CccccccceehhhhhhccccCCCCCcCCC
Q 045449 750 --GRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 750 --~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
..++.++|||||||+++++.+|..||...
T Consensus 183 ~~~~~~~~~Diws~G~il~el~~g~~pf~~~ 213 (314)
T cd08216 183 NLQGYNEKSDIYSVGITACELANGHVPFKDM 213 (314)
T ss_pred CCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Confidence 35889999999999999999999999754
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.3e-19 Score=190.08 Aligned_cols=131 Identities=23% Similarity=0.246 Sum_probs=107.9
Q ss_pred CeEEEEEEehHhhHHHHHHHHHHHHHHhhcchhhHHH-----------------------------------------HH
Q 045449 641 GMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVK-----------------------------------------II 679 (823)
Q Consensus 641 ~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-----------------------------------------~~ 679 (823)
...||+|.+........+.|..|+.++++++||||++ ++
T Consensus 27 ~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~ 106 (258)
T cd05078 27 KTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVA 106 (258)
T ss_pred cchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEecCCCCcHHHHHhcCCCCCCHHHHHHHH
Confidence 3568889887666666678999999999999999999 24
Q ss_pred HHHHHHhhhcCCCCEEeccCCCCCEEeCCCCc--------EEEeecccccccCCCCccccccccccCCCcCcccccCCC-
Q 045449 680 SSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMV--------AHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKG- 750 (823)
Q Consensus 680 ~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~--------~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~- 750 (823)
.|++.+|.|+|+.+|+||||||+||+++.++. +|++|||++...... ....+++.|+|||++.+.
T Consensus 107 ~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~ 180 (258)
T cd05078 107 KQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPK------EILLERIPWVPPECIENPQ 180 (258)
T ss_pred HHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccccCCc------hhccccCCccCchhccCCC
Confidence 68888999999999999999999999987654 699999988754322 224578899999998764
Q ss_pred ccccccceehhhhhhccccCCC-CCcCC
Q 045449 751 RVSTRGDVCSFGIISGGKETRS-MTVGE 777 (823)
Q Consensus 751 ~~~~~~Dv~S~Gvv~~~~~~~~-~~~~~ 777 (823)
.++.++|||||||++|++.+|. .|+..
T Consensus 181 ~~~~~~DiwslG~~l~~l~~g~~~~~~~ 208 (258)
T cd05078 181 NLSLAADKWSFGTTLWEIFSGGDKPLSA 208 (258)
T ss_pred CCCchhhHHHHHHHHHHHHcCCCCChhh
Confidence 5799999999999999999985 45443
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.77 E-value=3.6e-19 Score=187.09 Aligned_cols=138 Identities=26% Similarity=0.269 Sum_probs=115.5
Q ss_pred CeEEEEEEehHhhH---HHHHHHHHHHHHHhhcchhhHHH----------------------------------------
Q 045449 641 GMEVAVKVFHQQYE---RALKSFEDECEVRKRIRHRNLVK---------------------------------------- 677 (823)
Q Consensus 641 ~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~---------------------------------------- 677 (823)
+..||+|++..... ...+.+.+|++++.+++|+||++
T Consensus 18 ~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~ 97 (265)
T cd05579 18 GDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARI 97 (265)
T ss_pred CCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcHHHHHHHcCCCCHHHHHH
Confidence 67899999865432 45678999999999999999998
Q ss_pred HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCc------cccccccccCCCcCcccccCCCc
Q 045449 678 IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQ------LSKQTQTLATIGYMAPEYGTKGR 751 (823)
Q Consensus 678 ~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~~~ 751 (823)
++.|++++|.++|+.+++||||+|+||+++.++.+||+|||++........ ........++..|+|||+.....
T Consensus 98 i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~ 177 (265)
T cd05579 98 YIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQG 177 (265)
T ss_pred HHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccccccCcccCccccCHHHhcCCC
Confidence 256888899999999999999999999999999999999999886543211 01223356888999999998888
Q ss_pred cccccceehhhhhhccccCCCCCcCCC
Q 045449 752 VSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 752 ~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
++.++||||||++++++.+|..||...
T Consensus 178 ~~~~~Dv~slG~~~~~l~~g~~p~~~~ 204 (265)
T cd05579 178 HSKTVDWWSLGCILYEFLVGIPPFHGE 204 (265)
T ss_pred CCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence 999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.7e-19 Score=186.34 Aligned_cols=135 Identities=30% Similarity=0.396 Sum_probs=116.9
Q ss_pred CeEEEEEEehHhhHHHHHHHHHHHHHHhhcchhhHHH-----------------------------------------HH
Q 045449 641 GMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVK-----------------------------------------II 679 (823)
Q Consensus 641 ~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-----------------------------------------~~ 679 (823)
+..||+|++........+.+.+|++.+++++|+++++ ++
T Consensus 25 ~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~~~~~~~~~~~~i~ 104 (253)
T cd05122 25 GKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVC 104 (253)
T ss_pred CcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCCCcHHHHHhhcCCCCCHHHHHHHH
Confidence 5779999997765556678999999999999999987 35
Q ss_pred HHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCcccccCCCcccccccee
Q 045449 680 SSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVC 759 (823)
Q Consensus 680 ~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~ 759 (823)
.|++++|.++|..+++|||++|+||+++.++.++|+|||.+........ .....|+..|+|||++.+..++.++|||
T Consensus 105 ~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Dv~ 181 (253)
T cd05122 105 KELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA---RNTMVGTPYWMAPEVINGKPYDYKADIW 181 (253)
T ss_pred HHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccccc---ccceecCCcccCHHHHcCCCCCccccHH
Confidence 6788899999999999999999999999999999999999987654321 2345688999999999888899999999
Q ss_pred hhhhhhccccCCCCCcCCC
Q 045449 760 SFGIISGGKETRSMTVGET 778 (823)
Q Consensus 760 S~Gvv~~~~~~~~~~~~~~ 778 (823)
|||++++++++|..|+...
T Consensus 182 slG~il~~l~~g~~p~~~~ 200 (253)
T cd05122 182 SLGITAIELAEGKPPYSEL 200 (253)
T ss_pred HHHHHHHHHHhCCCCCCCC
Confidence 9999999999999998654
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.77 E-value=4.2e-19 Score=190.28 Aligned_cols=146 Identities=28% Similarity=0.353 Sum_probs=114.4
Q ss_pred cCCccceeeccC------------CeEEEEEEehHhh-HHHHHHHHHHHHHHhhcc-hhhHHH-----------------
Q 045449 629 RFSENNLIGIGN------------GMEVAVKVFHQQY-ERALKSFEDECEVRKRIR-HRNLVK----------------- 677 (823)
Q Consensus 629 ~f~~~~~lg~g~------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~----------------- 677 (823)
+|...+.+|.|+ +..||||++.... .....++.+|++++.+.. |+||++
T Consensus 16 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~ 95 (296)
T cd06618 16 DLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMEL 95 (296)
T ss_pred hheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEeec
Confidence 344555666653 6789999987532 233456777887777775 999998
Q ss_pred -----------------------HHHHHHHHhhhcCC-CCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCcccccc
Q 045449 678 -----------------------IISSSLEYLHFGHS-IPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQT 733 (823)
Q Consensus 678 -----------------------~~~~~l~~L~~~h~-~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~ 733 (823)
++.|++.+++|+|+ .+|+||||+|+||++++++.+||+|||++..+..... ..
T Consensus 96 ~~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~---~~ 172 (296)
T cd06618 96 MSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKA---KT 172 (296)
T ss_pred cCcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhccCCCc---cc
Confidence 24577888999996 6999999999999999999999999999986543222 12
Q ss_pred ccccCCCcCcccccCCCc----cccccceehhhhhhccccCCCCCcCC
Q 045449 734 QTLATIGYMAPEYGTKGR----VSTRGDVCSFGIISGGKETRSMTVGE 777 (823)
Q Consensus 734 ~~~gt~~y~aPE~~~~~~----~~~~~Dv~S~Gvv~~~~~~~~~~~~~ 777 (823)
...++..|+|||++.+.. ++.++|||||||+++++.+|..||..
T Consensus 173 ~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 220 (296)
T cd06618 173 RSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKN 220 (296)
T ss_pred CCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCc
Confidence 345788999999987553 78999999999999999999999865
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.77 E-value=4.5e-19 Score=193.23 Aligned_cols=138 Identities=29% Similarity=0.378 Sum_probs=115.2
Q ss_pred CeEEEEEEehHhh--HHHHHHHHHHHHHHhhcchhhHHH-----------------------------------------
Q 045449 641 GMEVAVKVFHQQY--ERALKSFEDECEVRKRIRHRNLVK----------------------------------------- 677 (823)
Q Consensus 641 ~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~----------------------------------------- 677 (823)
+..||||++.... ....+.+.+|++++++++|+||++
T Consensus 25 ~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~l~~~~ 104 (330)
T cd07834 25 GRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVTELMETDLHKVIKSPQPLTDDH 104 (330)
T ss_pred CcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEEEecchhhhHHHHHhCCCCCCHHH
Confidence 5779999987543 344568999999999999999987
Q ss_pred ---HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCc-cccccccccCCCcCcccccCCC-cc
Q 045449 678 ---IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQ-LSKQTQTLATIGYMAPEYGTKG-RV 752 (823)
Q Consensus 678 ---~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~ 752 (823)
++.+++++|.++|+.||+||||||+||+++.++.++|+|||++........ ........++..|+|||++.+. .+
T Consensus 105 ~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 184 (330)
T cd07834 105 IQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRY 184 (330)
T ss_pred HHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeecccccccccccccccccCcCCceeeecccCC
Confidence 245788899999999999999999999999999999999999987654321 0112345688999999998887 78
Q ss_pred ccccceehhhhhhccccCCCCCcCCC
Q 045449 753 STRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 753 ~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
+.++||||+||+++++.+|..||.+.
T Consensus 185 ~~~sDi~slG~il~~l~~g~~pf~~~ 210 (330)
T cd07834 185 TKAIDIWSVGCIFAELLTRKPLFPGR 210 (330)
T ss_pred CcchhHHHHHHHHHHHHcCCCCcCCC
Confidence 99999999999999999999998654
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.7e-19 Score=186.81 Aligned_cols=136 Identities=30% Similarity=0.355 Sum_probs=116.0
Q ss_pred CeEEEEEEehHhhH--HHHHHHHHHHHHHhhcchhhHHH----------------------------------------H
Q 045449 641 GMEVAVKVFHQQYE--RALKSFEDECEVRKRIRHRNLVK----------------------------------------I 678 (823)
Q Consensus 641 ~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~----------------------------------------~ 678 (823)
+..||+|.+..... ...+.+.+|++++++++|+|+++ +
T Consensus 25 ~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~ 104 (254)
T cd06627 25 GDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVY 104 (254)
T ss_pred CcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecCCCCcHHHHHHhccCCCHHHHHHH
Confidence 56799999875543 45678999999999999999998 3
Q ss_pred HHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCcccccCCCccccccce
Q 045449 679 ISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDV 758 (823)
Q Consensus 679 ~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv 758 (823)
+.|++++|.++|+.|++||||||+||+++.++.++|+|||.++........ .....++..|+|||...+..++.++||
T Consensus 105 ~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv 182 (254)
T cd06627 105 VYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD--DASVVGTPYWMAPEVIEMSGASTASDI 182 (254)
T ss_pred HHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCccc--ccccccchhhcCHhhhcCCCCCcchhH
Confidence 568889999999999999999999999999999999999999876543321 233568899999999888888999999
Q ss_pred ehhhhhhccccCCCCCcCCC
Q 045449 759 CSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 759 ~S~Gvv~~~~~~~~~~~~~~ 778 (823)
||+|++++++.+|..|+...
T Consensus 183 ~~lG~~l~~l~~g~~p~~~~ 202 (254)
T cd06627 183 WSLGCTVIELLTGNPPYYDL 202 (254)
T ss_pred HHHHHHHHHHHhCCCCCCCc
Confidence 99999999999999998654
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.77 E-value=3.4e-19 Score=189.06 Aligned_cols=136 Identities=27% Similarity=0.345 Sum_probs=114.2
Q ss_pred CeEEEEEEehHhh-HHHHHHHHHHHHHHhhcchhhHHH---------------------------------------HHH
Q 045449 641 GMEVAVKVFHQQY-ERALKSFEDECEVRKRIRHRNLVK---------------------------------------IIS 680 (823)
Q Consensus 641 ~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~---------------------------------------~~~ 680 (823)
+..||||++.... ....+.|.+|+.++++++||||++ ++.
T Consensus 29 ~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~i~~~~~~~~~~~~~~~ 108 (277)
T cd06641 29 QKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILR 108 (277)
T ss_pred CcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCCCCcHHHHHhcCCCCHHHHHHHHH
Confidence 5679999886432 344568999999999999999997 356
Q ss_pred HHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCcccccCCCccccccceeh
Q 045449 681 SSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCS 760 (823)
Q Consensus 681 ~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S 760 (823)
+++.++.++|+.+++|+||||+||+++.++.++++|||+++....... ......|+..|+|||+..+..++.++||||
T Consensus 109 ~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~s 186 (277)
T cd06641 109 EILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI--KRNTFVGTPFWMAPEVIKQSAYDSKADIWS 186 (277)
T ss_pred HHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccchh--hhccccCCccccChhhhccCCCCchhhHHH
Confidence 788899999999999999999999999999999999999876543221 122346889999999998888899999999
Q ss_pred hhhhhccccCCCCCcCCC
Q 045449 761 FGIISGGKETRSMTVGET 778 (823)
Q Consensus 761 ~Gvv~~~~~~~~~~~~~~ 778 (823)
|||+++++.+|..|+...
T Consensus 187 lG~~l~~l~~g~~p~~~~ 204 (277)
T cd06641 187 LGITAIELAKGEPPHSEL 204 (277)
T ss_pred HHHHHHHHHcCCCCCCcc
Confidence 999999999999998654
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.3e-19 Score=191.24 Aligned_cols=135 Identities=28% Similarity=0.382 Sum_probs=114.1
Q ss_pred CeEEEEEEehHhhHHHHHHHHHHHHHHhhcchhhHHH-----------------------------------------HH
Q 045449 641 GMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVK-----------------------------------------II 679 (823)
Q Consensus 641 ~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-----------------------------------------~~ 679 (823)
+..||+|++..... ..+.+.+|++++++++|+|+++ ++
T Consensus 44 ~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~ 122 (286)
T cd06614 44 GKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVC 122 (286)
T ss_pred CcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccCCCcHHHHHHHhccCCCHHHHHHHH
Confidence 56799999976544 4578899999999999999987 35
Q ss_pred HHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCcccccCCCcccccccee
Q 045449 680 SSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVC 759 (823)
Q Consensus 680 ~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~ 759 (823)
.+++.+|.++|+.|++|+|+||+||+++.++.++|+|||++........ ......++..|+|||++.+..++.++|||
T Consensus 123 ~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~ 200 (286)
T cd06614 123 REVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS--KRNSVVGTPYWMAPEVIKRKDYGPKVDIW 200 (286)
T ss_pred HHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchh--hhccccCCcccCCHhHhcCCCCCCccccH
Confidence 6788889999999999999999999999999999999999876543221 12234578899999999888899999999
Q ss_pred hhhhhhccccCCCCCcCCC
Q 045449 760 SFGIISGGKETRSMTVGET 778 (823)
Q Consensus 760 S~Gvv~~~~~~~~~~~~~~ 778 (823)
||||+++++.+|..|+...
T Consensus 201 slGvil~~l~~g~~p~~~~ 219 (286)
T cd06614 201 SLGIMCIEMAEGEPPYLRE 219 (286)
T ss_pred HHHHHHHHHHhCCCCCCCC
Confidence 9999999999999998654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.76 E-value=2.7e-19 Score=189.88 Aligned_cols=136 Identities=26% Similarity=0.262 Sum_probs=114.2
Q ss_pred CCeEEEEEEehHhh---HHHHHHHHHHHHHHhhcchhhHHH---------------------------------------
Q 045449 640 NGMEVAVKVFHQQY---ERALKSFEDECEVRKRIRHRNLVK--------------------------------------- 677 (823)
Q Consensus 640 ~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~--------------------------------------- 677 (823)
.|..||+|.+.... ....+.+..|++++++++||||++
T Consensus 17 ~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~ 96 (277)
T cd05577 17 TGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEAR 96 (277)
T ss_pred CCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcHHHHHHHcCcCCCCHHH
Confidence 46789999986543 223456788999999999999998
Q ss_pred ---HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCcccccCCCcccc
Q 045449 678 ---IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVST 754 (823)
Q Consensus 678 ---~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 754 (823)
++.|++.+|.|+|+.+++||||||+||+++.++.+||+|||.++...... ......++..|+|||+..+..++.
T Consensus 97 ~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~ 173 (277)
T cd05577 97 AIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK---KIKGRAGTPGYMAPEVLQGEVYDF 173 (277)
T ss_pred HHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCC---ccccccCCCCcCCHHHhcCCCCCc
Confidence 24688889999999999999999999999999999999999998654321 123346788999999998888999
Q ss_pred ccceehhhhhhccccCCCCCcCCC
Q 045449 755 RGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 755 ~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
++||||+||+++++.+|..||...
T Consensus 174 ~~Di~slG~il~~l~~g~~p~~~~ 197 (277)
T cd05577 174 SVDWFALGCTLYEMIAGRSPFRQR 197 (277)
T ss_pred hhhhHHHHHHHHHHhhCCCCCCCC
Confidence 999999999999999999998654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.76 E-value=4.2e-19 Score=191.85 Aligned_cols=132 Identities=28% Similarity=0.332 Sum_probs=110.0
Q ss_pred CeEEEEEEehHh---hHHHHHHHHHHHHHHhhcchhhHHH----------------------------------------
Q 045449 641 GMEVAVKVFHQQ---YERALKSFEDECEVRKRIRHRNLVK---------------------------------------- 677 (823)
Q Consensus 641 ~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~---------------------------------------- 677 (823)
+..||+|++... .....+.+.+|++++++++|||+++
T Consensus 46 ~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~l~~~~~~~ 125 (313)
T cd06633 46 NEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAA 125 (313)
T ss_pred CcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEecCCCCHHHHHHhcCCCCCHHHHHH
Confidence 577999988632 2344467889999999999999998
Q ss_pred HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCcccccC---CCcccc
Q 045449 678 IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGT---KGRVST 754 (823)
Q Consensus 678 ~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~ 754 (823)
++.|++.++.|+|+.+++||||||+||+++.++.+||+|||++..... .....|+..|+|||++. .+.++.
T Consensus 126 ~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~ 199 (313)
T cd06633 126 ITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP------ANSFVGTPYWMAPEVILAMDEGQYDG 199 (313)
T ss_pred HHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccCC------CCCccccccccChhhccccCCCCCCc
Confidence 356788899999999999999999999999999999999999865322 12356889999999874 456889
Q ss_pred ccceehhhhhhccccCCCCCcCCC
Q 045449 755 RGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 755 ~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
++|||||||+++++.+|..|+...
T Consensus 200 ~sDv~slGvil~el~~g~~p~~~~ 223 (313)
T cd06633 200 KVDVWSLGITCIELAERKPPLFNM 223 (313)
T ss_pred hhhHHHHHHHHHHHHhCCCCCCCC
Confidence 999999999999999999988653
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.76 E-value=2.4e-19 Score=190.98 Aligned_cols=134 Identities=26% Similarity=0.323 Sum_probs=111.6
Q ss_pred CeEEEEEEehHhh-HHHHHHHHHHHHHHhhcchhhHHH----------------------------------------HH
Q 045449 641 GMEVAVKVFHQQY-ERALKSFEDECEVRKRIRHRNLVK----------------------------------------II 679 (823)
Q Consensus 641 ~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~----------------------------------------~~ 679 (823)
+..||+|++.... ....+.|.+|++++++++||||++ ++
T Consensus 30 ~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~ 109 (284)
T cd06620 30 GTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIA 109 (284)
T ss_pred CcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEecCCCCCHHHHHHhccCCCHHHHHHHH
Confidence 5679999876443 345578999999999999999998 24
Q ss_pred HHHHHHhhhcCC-CCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCcccccCCCccccccce
Q 045449 680 SSSLEYLHFGHS-IPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDV 758 (823)
Q Consensus 680 ~~~l~~L~~~h~-~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv 758 (823)
.+++.+|.|+|+ .+++||||||+||++++++.++|+|||+++...... .....|+..|+|||++.++.++.++||
T Consensus 110 ~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~Di 185 (284)
T cd06620 110 VAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI----ADTFVGTSTYMSPERIQGGKYTVKSDV 185 (284)
T ss_pred HHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc----cCccccCcccCCHHHHccCCCCccchH
Confidence 566777888885 689999999999999999999999999987543221 123568999999999988889999999
Q ss_pred ehhhhhhccccCCCCCcCCC
Q 045449 759 CSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 759 ~S~Gvv~~~~~~~~~~~~~~ 778 (823)
|||||+++++.+|..||...
T Consensus 186 ~slG~~l~~l~tg~~p~~~~ 205 (284)
T cd06620 186 WSLGISIIELALGKFPFAFS 205 (284)
T ss_pred HHHHHHHHHHHhCCCCCccc
Confidence 99999999999999998754
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.76 E-value=4.6e-19 Score=190.19 Aligned_cols=135 Identities=27% Similarity=0.317 Sum_probs=110.3
Q ss_pred CeEEEEEEehHhh-----HHHHHHHHHHHHHHhhcchhhHHH--------------------------------------
Q 045449 641 GMEVAVKVFHQQY-----ERALKSFEDECEVRKRIRHRNLVK-------------------------------------- 677 (823)
Q Consensus 641 ~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~-------------------------------------- 677 (823)
+..||||.+.... ......+..|++++++++|+||++
T Consensus 25 ~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~L~~~i~~~~~~~~~~~~ 104 (298)
T cd07841 25 GRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVFEFMETDLEKVIKDKSIVLTPADI 104 (298)
T ss_pred CcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEEcccCCCHHHHHhccCCCCCHHHH
Confidence 5789999987543 223456788999999999999997
Q ss_pred --HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCcccccCC-Ccccc
Q 045449 678 --IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTK-GRVST 754 (823)
Q Consensus 678 --~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ 754 (823)
++.|++++|.|+|+.+++||||||+||+++.++.+||+|||+++....... ......+++.|+|||.+.+ ..++.
T Consensus 105 ~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~ 182 (298)
T cd07841 105 KSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNR--KMTHQVVTRWYRAPELLFGARHYGV 182 (298)
T ss_pred HHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCCc--cccccccceeeeCHHHHhCCCCCCc
Confidence 356889999999999999999999999999999999999999987644321 1223457889999998754 45789
Q ss_pred ccceehhhhhhccccCCCCCcCC
Q 045449 755 RGDVCSFGIISGGKETRSMTVGE 777 (823)
Q Consensus 755 ~~Dv~S~Gvv~~~~~~~~~~~~~ 777 (823)
++|||||||+++++++|..+|..
T Consensus 183 ~~Dv~slG~il~e~~~g~~~~~~ 205 (298)
T cd07841 183 GVDMWSVGCIFAELLLRVPFLPG 205 (298)
T ss_pred HHHHHHHHHHHHHHHcCCccccC
Confidence 99999999999999999766643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.3e-18 Score=179.36 Aligned_cols=139 Identities=31% Similarity=0.387 Sum_probs=111.9
Q ss_pred CeEEEEEEehHh-------hHHHHHHHHHHHHHHhhcchhhHHH------------------------------------
Q 045449 641 GMEVAVKVFHQQ-------YERALKSFEDECEVRKRIRHRNLVK------------------------------------ 677 (823)
Q Consensus 641 ~~~vavK~~~~~-------~~~~~~~~~~E~~~l~~l~h~niv~------------------------------------ 677 (823)
.+.||||+-... .+...+...+|.+|-+.+.||.||+
T Consensus 488 qRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsFCTVLEYceGNDLDFYLKQhklmSE 567 (775)
T KOG1151|consen 488 QRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSFCTVLEYCEGNDLDFYLKQHKLMSE 567 (775)
T ss_pred hheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccceeeeeecCCCchhHHHHhhhhhhH
Confidence 467999986422 1345677899999999999999999
Q ss_pred -----HHHHHHHHhhhcC--CCCEEeccCCCCCEEeC---CCCcEEEeecccccccCCCCcc-----ccccccccCCCcC
Q 045449 678 -----IISSSLEYLHFGH--SIPIIHCDLKPSNVLLD---EDMVAHISDFGIAKLLSGEDQL-----SKQTQTLATIGYM 742 (823)
Q Consensus 678 -----~~~~~l~~L~~~h--~~~ivHrdlk~~NiLl~---~~~~~kl~DfGla~~~~~~~~~-----~~~~~~~gt~~y~ 742 (823)
++.|++.+|.|+. +++|+|-|+||.|||+- ..|.+||+|||+++.+..+... ......+||.+|.
T Consensus 568 KEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYL 647 (775)
T KOG1151|consen 568 KEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYL 647 (775)
T ss_pred HHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchhhhccCCccCcccceeeecccCceeeec
Confidence 4667888888775 46899999999999994 4589999999999998755432 2234568999999
Q ss_pred cccccCCC----ccccccceehhhhhhccccCCCCCcCCCc
Q 045449 743 APEYGTKG----RVSTRGDVCSFGIISGGKETRSMTVGETC 779 (823)
Q Consensus 743 aPE~~~~~----~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~~ 779 (823)
+||.+.-+ ..+.|+||||.|||+|..++|+-||+...
T Consensus 648 PPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnq 688 (775)
T KOG1151|consen 648 PPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQ 688 (775)
T ss_pred CcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCch
Confidence 99976544 36899999999999999999999997653
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.76 E-value=3.5e-19 Score=195.00 Aligned_cols=150 Identities=27% Similarity=0.385 Sum_probs=119.0
Q ss_pred ccCCccceeeccC------------CeEEEEEEehHhhHHHHHHHHHHHHHHhhcchhhHHHH-----------------
Q 045449 628 DRFSENNLIGIGN------------GMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVKI----------------- 678 (823)
Q Consensus 628 ~~f~~~~~lg~g~------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~----------------- 678 (823)
++|...+.||.|+ +..||+|.+........+.+.+|++++++++||||+++
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS 84 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence 5666667777764 56799998866554556778899999999999999862
Q ss_pred -----------------------------------HHHHHHHhhhcCCCCEEeccCCCCCEEeC-CCCcEEEeecccccc
Q 045449 679 -----------------------------------ISSSLEYLHFGHSIPIIHCDLKPSNVLLD-EDMVAHISDFGIAKL 722 (823)
Q Consensus 679 -----------------------------------~~~~l~~L~~~h~~~ivHrdlk~~NiLl~-~~~~~kl~DfGla~~ 722 (823)
+.|++++|.|+|+.+|+||||||+||+++ .++.+|++|||.++.
T Consensus 85 ~~~~~~~~lv~e~~~~~L~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~dfg~~~~ 164 (342)
T cd07854 85 LTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARI 164 (342)
T ss_pred ccccceEEEEeecccccHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECCccccee
Confidence 35788999999999999999999999998 456789999999986
Q ss_pred cCCCCccc-cccccccCCCcCcccccCC-CccccccceehhhhhhccccCCCCCcCC
Q 045449 723 LSGEDQLS-KQTQTLATIGYMAPEYGTK-GRVSTRGDVCSFGIISGGKETRSMTVGE 777 (823)
Q Consensus 723 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~ 777 (823)
........ ......|+..|+|||++.. ..++.++|||||||+++++.+|+.||..
T Consensus 165 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~ 221 (342)
T cd07854 165 VDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAG 221 (342)
T ss_pred cCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 54321111 1122457889999997654 4578999999999999999999999864
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.76 E-value=4.8e-19 Score=187.58 Aligned_cols=132 Identities=19% Similarity=0.237 Sum_probs=108.2
Q ss_pred CeEEEEEEehHhhHHHHHHHHHHHHHHhhcchhhHHH-----------------------------------------HH
Q 045449 641 GMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVK-----------------------------------------II 679 (823)
Q Consensus 641 ~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-----------------------------------------~~ 679 (823)
...||+|++.........+|.+|++++++++||||++ ++
T Consensus 44 ~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~ 123 (274)
T cd05076 44 ELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVA 123 (274)
T ss_pred eeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHH
Confidence 4679999998766656678999999999999999998 35
Q ss_pred HHHHHHhhhcCCCCEEeccCCCCCEEeCCCC-------cEEEeecccccccCCCCccccccccccCCCcCcccccCC-Cc
Q 045449 680 SSSLEYLHFGHSIPIIHCDLKPSNVLLDEDM-------VAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTK-GR 751 (823)
Q Consensus 680 ~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~-------~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~ 751 (823)
.|++.+|+|+|+.+|+||||||+||+++..+ .+|++|||+++..... ....++..|+|||++.+ ..
T Consensus 124 ~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~ 197 (274)
T cd05076 124 QQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNS 197 (274)
T ss_pred HHHHHHHHHHHcCCccCCCCCcccEEEeccCcccCccceeeecCCccccccccc------cccccCCcccCchhhcCCCC
Confidence 6888899999999999999999999997543 4799999988654221 12357888999998865 56
Q ss_pred cccccceehhhhhhcccc-CCCCCcCCC
Q 045449 752 VSTRGDVCSFGIISGGKE-TRSMTVGET 778 (823)
Q Consensus 752 ~~~~~Dv~S~Gvv~~~~~-~~~~~~~~~ 778 (823)
++.++|||||||+++++. +|..|+...
T Consensus 198 ~~~~~Dv~slG~~l~el~~~g~~p~~~~ 225 (274)
T cd05076 198 LSTAADKWSFGTTLLEICFDGEVPLKER 225 (274)
T ss_pred CCcHHHHHHHHHHHHHHHhCCCCCcccc
Confidence 899999999999999984 678887654
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.76 E-value=7.6e-19 Score=183.78 Aligned_cols=135 Identities=24% Similarity=0.285 Sum_probs=114.4
Q ss_pred CeEEEEEEehHhh--HHHHHHHHHHHHHHhhcchhhHHHH----------------------------------------
Q 045449 641 GMEVAVKVFHQQY--ERALKSFEDECEVRKRIRHRNLVKI---------------------------------------- 678 (823)
Q Consensus 641 ~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~---------------------------------------- 678 (823)
+..+|+|.+.... .....++.+|++++++++|+||+++
T Consensus 25 ~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~ 104 (256)
T cd08530 25 NQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQE 104 (256)
T ss_pred CCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhcCCCCHHHHHHHHHhhcCCCCHHH
Confidence 5779999987542 3445678899999999999999982
Q ss_pred ----HHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCcccccCCCcccc
Q 045449 679 ----ISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVST 754 (823)
Q Consensus 679 ----~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 754 (823)
+.+++++|.++|+.+++||||+|+||+++.++.+|++|||+++...... .....+++.|+|||...+..++.
T Consensus 105 ~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~----~~~~~~~~~~~~Pe~~~~~~~~~ 180 (256)
T cd08530 105 IWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNM----AKTQIGTPHYMAPEVWKGRPYSY 180 (256)
T ss_pred HHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccCC----cccccCCccccCHHHHCCCCCCc
Confidence 3477888999999999999999999999999999999999998765431 12345889999999998888999
Q ss_pred ccceehhhhhhccccCCCCCcCCCc
Q 045449 755 RGDVCSFGIISGGKETRSMTVGETC 779 (823)
Q Consensus 755 ~~Dv~S~Gvv~~~~~~~~~~~~~~~ 779 (823)
++|+||+|++++++.+|..||....
T Consensus 181 ~~D~~slG~~~~~l~~g~~p~~~~~ 205 (256)
T cd08530 181 KSDIWSLGCLLYEMATFAPPFEARS 205 (256)
T ss_pred hhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999999999999999986643
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.76 E-value=4.8e-19 Score=185.44 Aligned_cols=136 Identities=21% Similarity=0.278 Sum_probs=112.3
Q ss_pred CeEEEEEEehHhh--HHHHHHHHHHHHHHhhcchhhHHHH----------------------------------------
Q 045449 641 GMEVAVKVFHQQY--ERALKSFEDECEVRKRIRHRNLVKI---------------------------------------- 678 (823)
Q Consensus 641 ~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~---------------------------------------- 678 (823)
|..||+|.+.... ....+.+.+|++++++++|+||+++
T Consensus 25 ~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~ 104 (257)
T cd08225 25 SEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQIL 104 (257)
T ss_pred CceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecCCCCcHHHHHHhccCCCCCHHHHH
Confidence 5678999986542 2334678899999999999999982
Q ss_pred --HHHHHHHhhhcCCCCEEeccCCCCCEEeCCCC-cEEEeecccccccCCCCccccccccccCCCcCcccccCCCccccc
Q 045449 679 --ISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDM-VAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTR 755 (823)
Q Consensus 679 --~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~-~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 755 (823)
+.+++++|.|+|+.+++|+|+||+||++++++ .+|++|||.+........ ......|++.|+|||+.....++.+
T Consensus 105 ~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~ape~~~~~~~~~~ 182 (257)
T cd08225 105 SWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME--LAYTCVGTPYYLSPEICQNRPYNNK 182 (257)
T ss_pred HHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCcc--cccccCCCccccCHHHHcCCCCCch
Confidence 45778889999999999999999999999775 579999999987643322 1223468999999999888889999
Q ss_pred cceehhhhhhccccCCCCCcCCC
Q 045449 756 GDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 756 ~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
+|||||||+++++.+|..|+...
T Consensus 183 ~Dv~slG~il~~l~~g~~p~~~~ 205 (257)
T cd08225 183 TDIWSLGCVLYELCTLKHPFEGN 205 (257)
T ss_pred hhHHHHHHHHHHHHhCCCCCCCc
Confidence 99999999999999999998653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.76 E-value=5.1e-19 Score=193.79 Aligned_cols=147 Identities=31% Similarity=0.395 Sum_probs=120.1
Q ss_pred HhccCCccceeeccC------------CeEEEEEEehHhh--HHHHHHHHHHHHHHhhcchhhHHHH-------------
Q 045449 626 ATDRFSENNLIGIGN------------GMEVAVKVFHQQY--ERALKSFEDECEVRKRIRHRNLVKI------------- 678 (823)
Q Consensus 626 at~~f~~~~~lg~g~------------~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~------------- 678 (823)
..++|.....||.|+ +..||||++.... ....+.+.+|++++++++|+|++++
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 456677777787764 5679999986432 2334667889999999999999872
Q ss_pred -------------------------------HHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCC
Q 045449 679 -------------------------------ISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGED 727 (823)
Q Consensus 679 -------------------------------~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~ 727 (823)
+.|++++|+++|+.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 93 ~~~~lv~e~~~~~L~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~~- 171 (343)
T cd07851 93 QDVYLVTHLMGADLNNIVKCQKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE- 171 (343)
T ss_pred ccEEEEEecCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEcccccccccccc-
Confidence 357888999999999999999999999999999999999999865432
Q ss_pred ccccccccccCCCcCcccccCC-CccccccceehhhhhhccccCCCCCcCC
Q 045449 728 QLSKQTQTLATIGYMAPEYGTK-GRVSTRGDVCSFGIISGGKETRSMTVGE 777 (823)
Q Consensus 728 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~ 777 (823)
.....++..|+|||+..+ ..++.++||||+||+++++++|..||..
T Consensus 172 ----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~ 218 (343)
T cd07851 172 ----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPG 218 (343)
T ss_pred ----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 233467889999998765 3678999999999999999999998854
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.76 E-value=3.5e-19 Score=190.62 Aligned_cols=136 Identities=29% Similarity=0.291 Sum_probs=110.9
Q ss_pred CeEEEEEEehHhh--HHHHHHHHHHHHHHhhcchhhHHH-----------------------------------------
Q 045449 641 GMEVAVKVFHQQY--ERALKSFEDECEVRKRIRHRNLVK----------------------------------------- 677 (823)
Q Consensus 641 ~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~----------------------------------------- 677 (823)
++.||+|.++... ......+.+|++++++++||||++
T Consensus 30 ~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~l~~~~~~ 109 (293)
T cd07843 30 GEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVK 109 (293)
T ss_pred CcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEehhcCcCHHHHHHhccCCCCHHHHH
Confidence 5779999886433 222346788999999999999987
Q ss_pred -HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCcccccCCCc-cccc
Q 045449 678 -IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGR-VSTR 755 (823)
Q Consensus 678 -~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~ 755 (823)
++.|++.+|.|+|+.+++||||||+||+++.++.+||+|||+++....... ......+++.|+|||++.+.. ++.+
T Consensus 110 ~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~ 187 (293)
T cd07843 110 CLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLK--PYTQLVVTLWYRAPELLLGAKEYSTA 187 (293)
T ss_pred HHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCcc--ccccccccccccCchhhcCCccccch
Confidence 346788899999999999999999999999999999999999987654321 123345789999999886544 6899
Q ss_pred cceehhhhhhccccCCCCCcCCC
Q 045449 756 GDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 756 ~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
+|+||+||+++++.+|..||...
T Consensus 188 ~Di~slG~~l~~l~~g~~~f~~~ 210 (293)
T cd07843 188 IDMWSVGCIFAELLTKKPLFPGK 210 (293)
T ss_pred hhHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999999999999888643
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.76 E-value=4.5e-19 Score=185.68 Aligned_cols=136 Identities=24% Similarity=0.363 Sum_probs=110.3
Q ss_pred CeEEEEEEehHhhHHHHHHHHHHHHHHhhcchhhHHH-----------------------------------------HH
Q 045449 641 GMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVK-----------------------------------------II 679 (823)
Q Consensus 641 ~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-----------------------------------------~~ 679 (823)
+..+|+|++..... ...+|.+|+++++++.|||+++ ++
T Consensus 28 ~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ 106 (256)
T cd05112 28 KRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMC 106 (256)
T ss_pred CCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHH
Confidence 45689998864422 2357899999999999999998 24
Q ss_pred HHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCcccccCCCcccccccee
Q 045449 680 SSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVC 759 (823)
Q Consensus 680 ~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~ 759 (823)
.+++.++.++|+.+++||||||+||+++.++.+||+|||+++....... .......++.+|+|||+..++.++.++|||
T Consensus 107 ~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~ 185 (256)
T cd05112 107 LDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY-TSSTGTKFPVKWSSPEVFSFSKYSSKSDVW 185 (256)
T ss_pred HHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCcc-cccCCCccchhhcCHhHhccCCcChHHHHH
Confidence 5778889999999999999999999999999999999999886533211 112223456789999999888899999999
Q ss_pred hhhhhhccccC-CCCCcCCC
Q 045449 760 SFGIISGGKET-RSMTVGET 778 (823)
Q Consensus 760 S~Gvv~~~~~~-~~~~~~~~ 778 (823)
|+||++|++.+ |..||...
T Consensus 186 slG~~l~el~~~g~~p~~~~ 205 (256)
T cd05112 186 SFGVLMWEVFSEGKTPYENR 205 (256)
T ss_pred HHHHHHHHHHcCCCCCCCcC
Confidence 99999999998 88888654
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.75 E-value=7.9e-19 Score=183.61 Aligned_cols=136 Identities=24% Similarity=0.345 Sum_probs=115.2
Q ss_pred CeEEEEEEehHhh--HHHHHHHHHHHHHHhhcchhhHHH-----------------------------------------
Q 045449 641 GMEVAVKVFHQQY--ERALKSFEDECEVRKRIRHRNLVK----------------------------------------- 677 (823)
Q Consensus 641 ~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~----------------------------------------- 677 (823)
+..||+|++.... ....+.+.+|++++++++|+|+++
T Consensus 25 ~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 104 (258)
T cd08215 25 GKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQ 104 (258)
T ss_pred CcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEecCCCcHHHHHHHhhccCCCcCHHH
Confidence 5779999987543 355678899999999999999998
Q ss_pred ---HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCcccccCCCcccc
Q 045449 678 ---IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVST 754 (823)
Q Consensus 678 ---~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 754 (823)
++.+++.+|+++|+.+++|+|++|+||+++.++.++|+|||++........ ......|++.|+|||...+..++.
T Consensus 105 ~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~y~~pe~~~~~~~~~ 182 (258)
T cd08215 105 ILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVD--LAKTVVGTPYYLSPELCQNKPYNY 182 (258)
T ss_pred HHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCcc--eecceeeeecccChhHhccCCCCc
Confidence 245788899999999999999999999999999999999999987644321 223356889999999988888999
Q ss_pred ccceehhhhhhccccCCCCCcCCC
Q 045449 755 RGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 755 ~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
++||||+|++++++.+|..|+...
T Consensus 183 ~~Dv~slG~~~~~l~~g~~p~~~~ 206 (258)
T cd08215 183 KSDIWSLGCVLYELCTLKHPFEGE 206 (258)
T ss_pred cccHHHHHHHHHHHHcCCCCCCCC
Confidence 999999999999999999998654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.75 E-value=5.6e-19 Score=187.96 Aligned_cols=136 Identities=28% Similarity=0.362 Sum_probs=110.8
Q ss_pred CeEEEEEEehHhh--HHHHHHHHHHHHHHhhcchhhHHH-----------------------------------------
Q 045449 641 GMEVAVKVFHQQY--ERALKSFEDECEVRKRIRHRNLVK----------------------------------------- 677 (823)
Q Consensus 641 ~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~----------------------------------------- 677 (823)
|..||||++.... ....+.+.+|++++++++|||+++
T Consensus 24 ~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~~~~~~~ 103 (283)
T cd07835 24 GEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKS 103 (283)
T ss_pred CCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEeccCcCHHHHHhhCCCCCCCHHHHHH
Confidence 6779999986443 223357889999999999999997
Q ss_pred HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCcccccCCC-cccccc
Q 045449 678 IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKG-RVSTRG 756 (823)
Q Consensus 678 ~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~ 756 (823)
++.|++++|.|+|+.+++|||++|+||+++.++.++|+|||+++....... ......++..|+|||++.+. .++.++
T Consensus 104 ~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~ 181 (283)
T cd07835 104 YLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR--TYTHEVVTLWYRAPEILLGSRQYSTPV 181 (283)
T ss_pred HHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc--ccCccccccCCCCCceeecCcccCcHH
Confidence 245788889999999999999999999999999999999999976532211 12234578899999987654 478999
Q ss_pred ceehhhhhhccccCCCCCcCCC
Q 045449 757 DVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 757 Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
|||||||+++++.+|..||...
T Consensus 182 Di~slG~~l~~l~~g~~pf~~~ 203 (283)
T cd07835 182 DIWSIGCIFAEMVNRRPLFPGD 203 (283)
T ss_pred HHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999999999999988643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.75 E-value=8.2e-19 Score=186.14 Aligned_cols=139 Identities=31% Similarity=0.418 Sum_probs=115.5
Q ss_pred CeEEEEEEehHhh---HHHHHHHHHHHHHHhhcc-hhhHHH---------------------------------------
Q 045449 641 GMEVAVKVFHQQY---ERALKSFEDECEVRKRIR-HRNLVK--------------------------------------- 677 (823)
Q Consensus 641 ~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h~niv~--------------------------------------- 677 (823)
+..||+|++.... ....+.+.+|++++.+++ |+||++
T Consensus 26 ~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~ 105 (280)
T cd05581 26 NKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTR 105 (280)
T ss_pred CCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEcCCCCCcHHHHHHHcCCCCHHHHH
Confidence 6779999987532 334467899999999998 999998
Q ss_pred -HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCcc------------------ccccccccC
Q 045449 678 -IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQL------------------SKQTQTLAT 738 (823)
Q Consensus 678 -~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~------------------~~~~~~~gt 738 (823)
++.|++.+|.++|+.+++|+|+||+||+++.++.++++|||++......... .......|+
T Consensus 106 ~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 185 (280)
T cd05581 106 FYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGT 185 (280)
T ss_pred HHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCccccccCCCCCccccccccccccccccccCC
Confidence 2467888899999999999999999999999999999999999876433211 122335678
Q ss_pred CCcCcccccCCCccccccceehhhhhhccccCCCCCcCCCc
Q 045449 739 IGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGETC 779 (823)
Q Consensus 739 ~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~~ 779 (823)
..|+|||+.....++.++||||+|++++++.+|..|+....
T Consensus 186 ~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 226 (280)
T cd05581 186 AEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSN 226 (280)
T ss_pred ccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCcc
Confidence 99999999888889999999999999999999999987653
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.75 E-value=7.8e-19 Score=188.04 Aligned_cols=147 Identities=24% Similarity=0.287 Sum_probs=115.9
Q ss_pred cCCccceeeccC------------CeEEEEEEehHhhH--HHHHHHHHHHHHHhhcc-hhhHHH----------------
Q 045449 629 RFSENNLIGIGN------------GMEVAVKVFHQQYE--RALKSFEDECEVRKRIR-HRNLVK---------------- 677 (823)
Q Consensus 629 ~f~~~~~lg~g~------------~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~-h~niv~---------------- 677 (823)
+|+..+.+|.|+ +..||||.++.... .....+.+|++++++++ |+||++
T Consensus 2 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~ 81 (295)
T cd07837 2 AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSL 81 (295)
T ss_pred CceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceE
Confidence 456666676653 67799998865432 22357889999999995 699987
Q ss_pred ---------------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCC-CCcEEEeeccccccc
Q 045449 678 ---------------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDE-DMVAHISDFGIAKLL 723 (823)
Q Consensus 678 ---------------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~-~~~~kl~DfGla~~~ 723 (823)
++.|++++|.|+|+.+|+||||||+||+++. ++.+||+|||+++..
T Consensus 82 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~~ 161 (295)
T cd07837 82 YLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAF 161 (295)
T ss_pred EEEeeccCcCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccceec
Confidence 2457788899999999999999999999998 889999999999865
Q ss_pred CCCCccccccccccCCCcCcccccCC-CccccccceehhhhhhccccCCCCCcCC
Q 045449 724 SGEDQLSKQTQTLATIGYMAPEYGTK-GRVSTRGDVCSFGIISGGKETRSMTVGE 777 (823)
Q Consensus 724 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~ 777 (823)
..... ......+++.|+|||++.+ ..++.++|||||||++|++.+|..||..
T Consensus 162 ~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~ 214 (295)
T cd07837 162 SIPVK--SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPG 214 (295)
T ss_pred CCCcc--ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCC
Confidence 33211 1223457889999998765 4579999999999999999999988865
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.75 E-value=6e-19 Score=184.56 Aligned_cols=139 Identities=29% Similarity=0.329 Sum_probs=117.8
Q ss_pred CeEEEEEEehHhh--HHHHHHHHHHHHHHhhcchhhHHH-----------------------------------------
Q 045449 641 GMEVAVKVFHQQY--ERALKSFEDECEVRKRIRHRNLVK----------------------------------------- 677 (823)
Q Consensus 641 ~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~----------------------------------------- 677 (823)
+..|++|++.... ....+.+.+|++++++++|+||++
T Consensus 25 ~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 104 (260)
T cd06606 25 GELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIR 104 (260)
T ss_pred CcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEEecCCCcHHHHHHHcCCCCHHHHH
Confidence 5779999987554 245678999999999999999998
Q ss_pred -HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCcccccCCCcccccc
Q 045449 678 -IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRG 756 (823)
Q Consensus 678 -~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 756 (823)
++.+++.+|+|+|+.+++|+|++|+||+++.++.++|+|||.+................++..|+|||...+..++.++
T Consensus 105 ~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~ 184 (260)
T cd06606 105 KYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAA 184 (260)
T ss_pred HHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEecccccccccccCCCCCccccCHhhhcCCCCCchh
Confidence 3567888999999999999999999999999999999999999876544321112345688999999999888899999
Q ss_pred ceehhhhhhccccCCCCCcCCCc
Q 045449 757 DVCSFGIISGGKETRSMTVGETC 779 (823)
Q Consensus 757 Dv~S~Gvv~~~~~~~~~~~~~~~ 779 (823)
||||+|++++++++|..||....
T Consensus 185 Dv~slG~il~~l~~g~~p~~~~~ 207 (260)
T cd06606 185 DIWSLGCTVIEMATGKPPWSELG 207 (260)
T ss_pred hHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999987654
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.75 E-value=5.4e-19 Score=188.13 Aligned_cols=136 Identities=27% Similarity=0.337 Sum_probs=111.5
Q ss_pred CeEEEEEEehHhh-HHHHHHHHHHHHHHhhcchhhHHH------------------------------------------
Q 045449 641 GMEVAVKVFHQQY-ERALKSFEDECEVRKRIRHRNLVK------------------------------------------ 677 (823)
Q Consensus 641 ~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~------------------------------------------ 677 (823)
|..||||++.... ....+.+.+|++++++++|+||++
T Consensus 25 ~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~ 104 (284)
T cd07836 25 GEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKS 104 (284)
T ss_pred CeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCCccHHHHHHhcCCCCCcCHHHHHH
Confidence 5779999987543 223456788999999999999998
Q ss_pred HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCcccccCCC-cccccc
Q 045449 678 IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKG-RVSTRG 756 (823)
Q Consensus 678 ~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~ 756 (823)
++.|++++|.|+|+.+++||||||+||++++++.+|++|||+++....... ......++..|+|||++.+. .++.++
T Consensus 105 ~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~ 182 (284)
T cd07836 105 FTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN--TFSNEVVTLWYRAPDVLLGSRTYSTSI 182 (284)
T ss_pred HHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc--ccccccccccccChHHhcCCCCCCcHH
Confidence 356788999999999999999999999999999999999999976533211 12234578999999987654 468899
Q ss_pred ceehhhhhhccccCCCCCcCCC
Q 045449 757 DVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 757 Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
||||+||+++++.+|..||.+.
T Consensus 183 Dv~slG~~l~~l~~g~~~~~~~ 204 (284)
T cd07836 183 DIWSVGCIMAEMITGRPLFPGT 204 (284)
T ss_pred HHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999999999999988654
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.75 E-value=6.4e-19 Score=189.41 Aligned_cols=153 Identities=30% Similarity=0.399 Sum_probs=121.2
Q ss_pred HHhccCCccceeeccC------------CeEEEEEEehHhh--HHHHHHHHHHHHHHhhcchhhHHH-------------
Q 045449 625 RATDRFSENNLIGIGN------------GMEVAVKVFHQQY--ERALKSFEDECEVRKRIRHRNLVK------------- 677 (823)
Q Consensus 625 ~at~~f~~~~~lg~g~------------~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~------------- 677 (823)
.+.++|+..+.+|.|+ +..||||+++... ......+.+|++++++++||||++
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 3456777777888774 5679999986432 223356788999999999999986
Q ss_pred -------------------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccc
Q 045449 678 -------------------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIA 720 (823)
Q Consensus 678 -------------------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla 720 (823)
++.|++.+|+|+|+.+|+|||+||+||++++++.+||+|||++
T Consensus 84 ~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg~~ 163 (302)
T cd07864 84 FKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLA 163 (302)
T ss_pred ccccCCcEEEEEcccCccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCccccc
Confidence 2457888999999999999999999999999999999999999
Q ss_pred cccCCCCccccccccccCCCcCcccccCC-CccccccceehhhhhhccccCCCCCcCCC
Q 045449 721 KLLSGEDQLSKQTQTLATIGYMAPEYGTK-GRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 721 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
+....... .......++..|+|||.+.+ ..++.++||||+||+++++.+|..||...
T Consensus 164 ~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~ 221 (302)
T cd07864 164 RLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQAN 221 (302)
T ss_pred ccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence 87643322 11223356888999998764 35789999999999999999999888653
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.6e-18 Score=184.30 Aligned_cols=135 Identities=31% Similarity=0.376 Sum_probs=113.0
Q ss_pred CeEEEEEEehHhhH--HHHHHHHHHHHHHhhcchhhHHH----------------------------------------H
Q 045449 641 GMEVAVKVFHQQYE--RALKSFEDECEVRKRIRHRNLVK----------------------------------------I 678 (823)
Q Consensus 641 ~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~----------------------------------------~ 678 (823)
+..||+|++..... .....+.+|++++++++|+||++ +
T Consensus 24 ~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~l~~~l~~~~~~~~~~~~~~~ 103 (283)
T cd05118 24 GEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMDTDLYKLIKDRQRGLPESLIKSY 103 (283)
T ss_pred CcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccCCCHHHHHHhhcccCCHHHHHHH
Confidence 57799999865432 34568889999999999999998 2
Q ss_pred HHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCcccccCCC-ccccccc
Q 045449 679 ISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKG-RVSTRGD 757 (823)
Q Consensus 679 ~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~D 757 (823)
+.|++++|.++|+.+|+|+||||+||+++.++.+||+|||.+....... .......++..|+|||...+. .++.++|
T Consensus 104 ~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~~D 181 (283)
T cd05118 104 LYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV--RPYTHYVVTRWYRAPELLLGDKGYSTPVD 181 (283)
T ss_pred HHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc--ccccCccCcccccCcHHHhcCCCCCchhH
Confidence 4678889999999999999999999999999999999999998765432 112334688899999988776 6899999
Q ss_pred eehhhhhhccccCCCCCcCC
Q 045449 758 VCSFGIISGGKETRSMTVGE 777 (823)
Q Consensus 758 v~S~Gvv~~~~~~~~~~~~~ 777 (823)
|||+||+++++.+|..+|..
T Consensus 182 i~slG~~l~~l~tg~~~~~~ 201 (283)
T cd05118 182 IWSVGCIFAELLSRRPLFPG 201 (283)
T ss_pred HHHHHHHHHHHHhCCCCCCC
Confidence 99999999999999988754
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.74 E-value=2.6e-18 Score=183.32 Aligned_cols=136 Identities=27% Similarity=0.312 Sum_probs=111.1
Q ss_pred CeEEEEEEehHhh----HHHHHHHHHHHHHHhhc-chhhHHH--------------------------------------
Q 045449 641 GMEVAVKVFHQQY----ERALKSFEDECEVRKRI-RHRNLVK-------------------------------------- 677 (823)
Q Consensus 641 ~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~-------------------------------------- 677 (823)
+..||||+++... ....+.+.+|++++.++ +||||++
T Consensus 28 ~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~ 107 (288)
T cd05583 28 GKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEV 107 (288)
T ss_pred CcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEEEEEecCCCCcHHHHHhhcCCcCHHHH
Confidence 4669999886432 23446788999999999 5999998
Q ss_pred --HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCcccccCCCc--cc
Q 045449 678 --IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGR--VS 753 (823)
Q Consensus 678 --~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~ 753 (823)
++.|++++|.|+|+.+++||||||+||+++.++.++++|||+++........ ......|+..|+|||...+.. .+
T Consensus 108 ~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~ 186 (288)
T cd05583 108 RVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEE-RAYSFCGTIEYMAPEVIRGGSGGHD 186 (288)
T ss_pred HHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECcccccccccccc-ccccccCCccccCHHHhcCCCCCCc
Confidence 2458888999999999999999999999999999999999998875433221 122346899999999987655 78
Q ss_pred cccceehhhhhhccccCCCCCcCC
Q 045449 754 TRGDVCSFGIISGGKETRSMTVGE 777 (823)
Q Consensus 754 ~~~Dv~S~Gvv~~~~~~~~~~~~~ 777 (823)
.++||||||++++++.+|..||..
T Consensus 187 ~~~Dv~slG~il~el~tg~~p~~~ 210 (288)
T cd05583 187 KAVDWWSLGVLTFELLTGASPFTV 210 (288)
T ss_pred chhhhHHHHHHHHHHHhCCCCccc
Confidence 899999999999999999999853
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.1e-18 Score=185.85 Aligned_cols=137 Identities=28% Similarity=0.349 Sum_probs=112.9
Q ss_pred CeEEEEEEehHhh--HHHHHHHHHHHHHHhhcchhhHHH-----------------------------------------
Q 045449 641 GMEVAVKVFHQQY--ERALKSFEDECEVRKRIRHRNLVK----------------------------------------- 677 (823)
Q Consensus 641 ~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~----------------------------------------- 677 (823)
+..||||++.... ....+.+.+|++++++++|+|+++
T Consensus 24 ~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~ 103 (287)
T cd07840 24 GELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIK 103 (287)
T ss_pred CeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEeccccccHHHHHhccCCCCCHHHHH
Confidence 5789999997653 334467889999999999999887
Q ss_pred -HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCcccccCC-Cccccc
Q 045449 678 -IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTK-GRVSTR 755 (823)
Q Consensus 678 -~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~ 755 (823)
++.|++++|.++|+.+++|+||||+||++++++.+|++|||+++....... .......++..|+|||.+.+ ..++.+
T Consensus 104 ~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~ 182 (287)
T cd07840 104 CYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS-ADYTNRVITLWYRPPELLLGATRYGPE 182 (287)
T ss_pred HHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCc-ccccccccccccCCceeeEccccCChH
Confidence 246788889999999999999999999999999999999999987654332 11233457889999997664 457899
Q ss_pred cceehhhhhhccccCCCCCcCCC
Q 045449 756 GDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 756 ~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
+|||||||+++++.+|..||...
T Consensus 183 ~Dv~slG~~l~el~t~~~p~~~~ 205 (287)
T cd07840 183 VDMWSVGCILAELFLGKPIFQGS 205 (287)
T ss_pred HHHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999999999999998654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.2e-18 Score=185.14 Aligned_cols=135 Identities=24% Similarity=0.221 Sum_probs=104.4
Q ss_pred CCeEEEEEEehHhh---HHHHHHHHHHHHHHhh---cchhhHHH------------------------------------
Q 045449 640 NGMEVAVKVFHQQY---ERALKSFEDECEVRKR---IRHRNLVK------------------------------------ 677 (823)
Q Consensus 640 ~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~---l~h~niv~------------------------------------ 677 (823)
.+..||||.+.... ......+.+|..++.. .+||+|+.
T Consensus 18 ~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~l~~~ 97 (279)
T cd05633 18 TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEK 97 (279)
T ss_pred CCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCCCCCHHHHHHhcCCCCHH
Confidence 36789999886432 1222334455444333 36888876
Q ss_pred ----HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCcccccCC-Ccc
Q 045449 678 ----IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTK-GRV 752 (823)
Q Consensus 678 ----~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~ 752 (823)
++.|++.+|.|+|+.+|+||||||+||+++.++.+|++|||+++...... .....||..|+|||.... ..+
T Consensus 98 ~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~ 173 (279)
T cd05633 98 EMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASVGTHGYMAPEVLQKGTAY 173 (279)
T ss_pred HHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC----ccCcCCCcCccCHHHhcCCCCC
Confidence 35688889999999999999999999999999999999999987653221 123468999999998864 558
Q ss_pred ccccceehhhhhhccccCCCCCcCCC
Q 045449 753 STRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 753 ~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
+.++||||+||+++++.+|..||.+.
T Consensus 174 ~~~~Di~slG~~l~~l~~g~~pf~~~ 199 (279)
T cd05633 174 DSSADWFSLGCMLFKLLRGHSPFRQH 199 (279)
T ss_pred CchhhhHHHHHHHHHHHhCCCCcCCC
Confidence 99999999999999999999998654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.74 E-value=1e-18 Score=190.86 Aligned_cols=138 Identities=24% Similarity=0.270 Sum_probs=109.8
Q ss_pred CeEEEEEEehHhhHHH--------------HHHHHHHHHHHhhcchhhHHH-----------------------------
Q 045449 641 GMEVAVKVFHQQYERA--------------LKSFEDECEVRKRIRHRNLVK----------------------------- 677 (823)
Q Consensus 641 ~~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~l~h~niv~----------------------------- 677 (823)
+..||||.+....... ...+.+|++++++++|+||++
T Consensus 34 ~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~ 113 (335)
T PTZ00024 34 GKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMASDLKKVVDRK 113 (335)
T ss_pred CCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecCCcEEEEEeccccCHHHHHHhc
Confidence 5779999886432111 125789999999999999987
Q ss_pred ----------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCC------------cccccccc
Q 045449 678 ----------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGED------------QLSKQTQT 735 (823)
Q Consensus 678 ----------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~------------~~~~~~~~ 735 (823)
++.|++.+|+++|+.+++||||||+||+++.++.+|++|||+++...... ........
T Consensus 114 ~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (335)
T PTZ00024 114 IRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSK 193 (335)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCccceeeccccccccccccccccccccccccc
Confidence 35788999999999999999999999999999999999999998654111 00111234
Q ss_pred ccCCCcCcccccCCC-ccccccceehhhhhhccccCCCCCcCCC
Q 045449 736 LATIGYMAPEYGTKG-RVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 736 ~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
.+++.|+|||++.+. .++.++||||+||+++++++|..||...
T Consensus 194 ~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~ 237 (335)
T PTZ00024 194 VVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGE 237 (335)
T ss_pred ccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 578899999988764 4689999999999999999999888653
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.74 E-value=2.2e-18 Score=182.86 Aligned_cols=136 Identities=25% Similarity=0.244 Sum_probs=105.4
Q ss_pred cCCeEEEEEEehHhh---HHHHHHHHHHHH---HHhhcchhhHHH-----------------------------------
Q 045449 639 GNGMEVAVKVFHQQY---ERALKSFEDECE---VRKRIRHRNLVK----------------------------------- 677 (823)
Q Consensus 639 g~~~~vavK~~~~~~---~~~~~~~~~E~~---~l~~l~h~niv~----------------------------------- 677 (823)
..++.||+|++.... ......+..|.. .++...||+|++
T Consensus 17 ~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~g~~L~~~l~~~~~l~~ 96 (278)
T cd05606 17 DTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSE 96 (278)
T ss_pred cCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCCCCcHHHHHHhcCCCCH
Confidence 346789999886532 112223444443 344457888886
Q ss_pred -----HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCcccccCCC-c
Q 045449 678 -----IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKG-R 751 (823)
Q Consensus 678 -----~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~ 751 (823)
++.|++.+|+|+|+.+|+||||||+||+++.++.+||+|||+++...... .....|+..|+|||++.++ .
T Consensus 97 ~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~ 172 (278)
T cd05606 97 AEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASVGTHGYMAPEVLQKGVA 172 (278)
T ss_pred HHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC----CcCcCCCcCCcCcHHhcCCCC
Confidence 35688889999999999999999999999999999999999987653322 1234689999999998754 5
Q ss_pred cccccceehhhhhhccccCCCCCcCCC
Q 045449 752 VSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 752 ~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
++.++||||+||+++++++|..||.+.
T Consensus 173 ~~~~~Di~s~G~~l~~l~~g~~p~~~~ 199 (278)
T cd05606 173 YDSSADWFSLGCMLFKLLRGHSPFRQH 199 (278)
T ss_pred CCcccchHhHHHHHHHHHhCCCCCCCC
Confidence 899999999999999999999998764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.74 E-value=2.2e-18 Score=183.24 Aligned_cols=133 Identities=22% Similarity=0.294 Sum_probs=107.6
Q ss_pred CeEEEEEEehHhh-HHHHHHHHHHHHHHhhcc-hhhHHH-----------------------------------------
Q 045449 641 GMEVAVKVFHQQY-ERALKSFEDECEVRKRIR-HRNLVK----------------------------------------- 677 (823)
Q Consensus 641 ~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~----------------------------------------- 677 (823)
+..||+|++.... ........+|+.++.++. |+|+++
T Consensus 24 ~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~ 103 (282)
T cd07831 24 GKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELMDMNLYELIKGRKRPLPEKRVK 103 (282)
T ss_pred CcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEecCCccHHHHHHhccCCCCHHHHH
Confidence 5779999987543 122234557888999885 999998
Q ss_pred -HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCcccccCC-Cccccc
Q 045449 678 -IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTK-GRVSTR 755 (823)
Q Consensus 678 -~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~ 755 (823)
++.|++.+|+|+|+.+++||||||+||+++. +.+||+|||+++....... .....++..|+|||+... +.++.+
T Consensus 104 ~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~ 179 (282)
T cd07831 104 SYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP---YTEYISTRWYRAPECLLTDGYYGPK 179 (282)
T ss_pred HHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccCCC---cCCCCCCcccCChhHhhcCCCCCcc
Confidence 3578889999999999999999999999999 9999999999987643322 123467899999997644 457889
Q ss_pred cceehhhhhhccccCCCCCcCC
Q 045449 756 GDVCSFGIISGGKETRSMTVGE 777 (823)
Q Consensus 756 ~Dv~S~Gvv~~~~~~~~~~~~~ 777 (823)
+||||+||+++++.+|..||..
T Consensus 180 ~Di~slGv~l~el~~~~~p~~~ 201 (282)
T cd07831 180 MDIWAVGCVFFEILSLFPLFPG 201 (282)
T ss_pred hhHHHHHHHHHHHHcCCcCCCC
Confidence 9999999999999999988864
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.7e-18 Score=188.39 Aligned_cols=139 Identities=22% Similarity=0.326 Sum_probs=109.6
Q ss_pred CCeEEEEEEehHhh--HHHHHHHHHHHHHHhhcchhhHHH----------------------------------------
Q 045449 640 NGMEVAVKVFHQQY--ERALKSFEDECEVRKRIRHRNLVK---------------------------------------- 677 (823)
Q Consensus 640 ~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~---------------------------------------- 677 (823)
.|+.||||++.... ....+.+.+|+.+++.++||||++
T Consensus 24 ~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~ 103 (328)
T cd08226 24 TGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALI 103 (328)
T ss_pred CCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCCCHHHHHHhhcccCCCHHHH
Confidence 36889999986432 344578999999999999999997
Q ss_pred --HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccc-----cccccccCCCcCcccccCCC
Q 045449 678 --IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLS-----KQTQTLATIGYMAPEYGTKG 750 (823)
Q Consensus 678 --~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~ 750 (823)
++.|++++|.|+|+.+|+||||||+||+++.++.+|++|||.+.......... ......++..|+|||++.+.
T Consensus 104 ~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 183 (328)
T cd08226 104 GNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQD 183 (328)
T ss_pred HHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccccccccccccCccCccChhhhcCC
Confidence 24678889999999999999999999999999999999998654332211100 01112356779999998764
Q ss_pred --ccccccceehhhhhhccccCCCCCcCCC
Q 045449 751 --RVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 751 --~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
.++.++||||+||+++++.+|..||.+.
T Consensus 184 ~~~~~~~~DiwslG~~l~el~~g~~p~~~~ 213 (328)
T cd08226 184 LYGYNVKSDIYSVGITACELATGRVPFQDM 213 (328)
T ss_pred CCCCCchhhHHHHHHHHHHHHhCCCCCCCc
Confidence 4789999999999999999999999764
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.73 E-value=3e-18 Score=182.60 Aligned_cols=135 Identities=33% Similarity=0.363 Sum_probs=109.9
Q ss_pred CeEEEEEEehHhh--HHHHHHHHHHHHHHhhc---chhhHHH--------------------------------------
Q 045449 641 GMEVAVKVFHQQY--ERALKSFEDECEVRKRI---RHRNLVK-------------------------------------- 677 (823)
Q Consensus 641 ~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~-------------------------------------- 677 (823)
+..||||++.... ......+.+|++++.++ .|+|+++
T Consensus 24 ~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~l~~e~~~~~l~~~l~~~~~~~ 103 (287)
T cd07838 24 GRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPG 103 (287)
T ss_pred CCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCceeEEEehhcccCHHHHHHHccCCC
Confidence 5789999996432 22235677788877766 5999887
Q ss_pred --------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCcccccCC
Q 045449 678 --------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTK 749 (823)
Q Consensus 678 --------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 749 (823)
++.|++++|.++|+.+++|+|+||+||+++.++.+||+|||.++....... .....++..|+|||++.+
T Consensus 104 l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~~PE~~~~ 180 (287)
T cd07838 104 LPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMA---LTSVVVTLWYRAPEVLLQ 180 (287)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceeccCCcc---cccccccccccChHHhcc
Confidence 346788889999999999999999999999999999999999987643322 123457889999999998
Q ss_pred CccccccceehhhhhhccccCCCCCcCCC
Q 045449 750 GRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 750 ~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
..++.++|||||||+++++.+|..||...
T Consensus 181 ~~~~~~~Di~s~G~~l~~l~~~~~~~~~~ 209 (287)
T cd07838 181 SSYATPVDMWSVGCIFAELFRRRPLFRGT 209 (287)
T ss_pred CCCCCcchhhhHHHHHHHHHhCCCcccCC
Confidence 88999999999999999999998887653
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.73 E-value=3.3e-18 Score=181.80 Aligned_cols=136 Identities=32% Similarity=0.369 Sum_probs=112.8
Q ss_pred CeEEEEEEehHhh--HHHHHHHHHHHHHHhhcchhhHHH----------------------------------------H
Q 045449 641 GMEVAVKVFHQQY--ERALKSFEDECEVRKRIRHRNLVK----------------------------------------I 678 (823)
Q Consensus 641 ~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~----------------------------------------~ 678 (823)
+..||+|++.... ....+.+..|++++++++|+|+++ +
T Consensus 24 ~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~l~~~i~~~~~~~~~~~~~~~ 103 (282)
T cd07829 24 GEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCDMDLKKYLDKRPGPLSPNLIKSI 103 (282)
T ss_pred CcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcCcCHHHHHHhhccCCCHHHHHHH
Confidence 5789999987653 333467889999999999999998 2
Q ss_pred HHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCcccccCCC-ccccccc
Q 045449 679 ISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKG-RVSTRGD 757 (823)
Q Consensus 679 ~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~D 757 (823)
+.+++.+|+++|+.+|+||||+|+||++++++.+||+|||.++....... ......++..|+|||++... .++.++|
T Consensus 104 ~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~D 181 (282)
T cd07829 104 MYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR--TYTHEVVTLWYRAPEILLGSKHYSTAVD 181 (282)
T ss_pred HHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc--ccCccccCcCcCChHHhcCCcCCCcccc
Confidence 46778899999999999999999999999999999999999987643321 12234567889999988766 7899999
Q ss_pred eehhhhhhccccCCCCCcCCC
Q 045449 758 VCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 758 v~S~Gvv~~~~~~~~~~~~~~ 778 (823)
||||||++++++++..||...
T Consensus 182 v~slG~~l~~l~~~~~~~~~~ 202 (282)
T cd07829 182 IWSVGCIFAEMITGKPLFPGD 202 (282)
T ss_pred HHHHHHHHHHHHhCCCCCCCc
Confidence 999999999999998888653
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.73 E-value=6.4e-18 Score=194.81 Aligned_cols=100 Identities=27% Similarity=0.248 Sum_probs=79.5
Q ss_pred HHHHHHHHHhhhcCCCCEEeccCCCCCEEeCC-CCcEEEeecccccccCCCCccccccccccCCCcCcccccCCC-----
Q 045449 677 KIISSSLEYLHFGHSIPIIHCDLKPSNVLLDE-DMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKG----- 750 (823)
Q Consensus 677 ~~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~-~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----- 750 (823)
.++.|++.+|+|+|+++|+||||||+|||++. ++.+||+|||+|+.+...... ......||+.|+|||.+...
T Consensus 259 ~i~~qll~aL~yLH~~gIiHRDLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~-~~~~~~~t~~Y~APE~~~~~~~~~~ 337 (566)
T PLN03225 259 TIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIMSTQTPS 337 (566)
T ss_pred HHHHHHHHHHHHHHHCCEEeCcCCHHHEEEeCCCCcEEEEeCCCcccccccccc-CCcccccCCCccChHHhhccCCCCC
Confidence 46788999999999999999999999999985 579999999999865433221 23456789999999964322
Q ss_pred -----------------ccccccceehhhhhhccccCCCCCcCC
Q 045449 751 -----------------RVSTRGDVCSFGIISGGKETRSMTVGE 777 (823)
Q Consensus 751 -----------------~~~~~~Dv~S~Gvv~~~~~~~~~~~~~ 777 (823)
.++.++||||+||++|+|+++..++..
T Consensus 338 ~~~~~~~~~~sp~l~~~~~~~k~DVwSlGviL~el~~~~~~~~~ 381 (566)
T PLN03225 338 APSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMAFPNLRSDS 381 (566)
T ss_pred CccccccccccchhccccCCCCcccHHHHHHHHHHHhCcCCCch
Confidence 234567999999999999987766543
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.73 E-value=4.1e-18 Score=177.58 Aligned_cols=138 Identities=30% Similarity=0.327 Sum_probs=116.1
Q ss_pred CCeEEEEEEehHhhH---HHHHHHHHHHHHHhhcchhhHHH---------------------------------------
Q 045449 640 NGMEVAVKVFHQQYE---RALKSFEDECEVRKRIRHRNLVK--------------------------------------- 677 (823)
Q Consensus 640 ~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~--------------------------------------- 677 (823)
.+..||+|++..... ...+.+..|++++++++|+||++
T Consensus 17 ~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~ 96 (250)
T cd05123 17 TGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERAR 96 (250)
T ss_pred CCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcHHHHHHhcCCCCHHHHH
Confidence 367899999875532 24568999999999999999998
Q ss_pred -HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCcccccCCCcccccc
Q 045449 678 -IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRG 756 (823)
Q Consensus 678 -~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 756 (823)
++.|++++++++|+.+++|+||||+||+++.++.++|+|||++........ ......++..|+|||...+..++.++
T Consensus 97 ~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~ 174 (250)
T cd05123 97 FYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS--RTNTFCGTPEYLAPEVLLGKGYGKAV 174 (250)
T ss_pred HHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCCC--cccCCcCCccccChHHhCCCCCCchh
Confidence 256788999999999999999999999999999999999999987643321 12345688999999999888889999
Q ss_pred ceehhhhhhccccCCCCCcCCCc
Q 045449 757 DVCSFGIISGGKETRSMTVGETC 779 (823)
Q Consensus 757 Dv~S~Gvv~~~~~~~~~~~~~~~ 779 (823)
|+||||++++++.+|..||....
T Consensus 175 D~~slG~~~~~l~~g~~p~~~~~ 197 (250)
T cd05123 175 DWWSLGVLLYEMLTGKPPFYAED 197 (250)
T ss_pred hHHHHHHHHHHHHHCCCCCCCCC
Confidence 99999999999999999986543
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.4e-19 Score=163.00 Aligned_cols=165 Identities=30% Similarity=0.519 Sum_probs=118.3
Q ss_pred cCCCCCCcEEEccCCCCCCCCCCCCCCCCCCCEEECCCCcCcCCCchhhhcCCCCcEEecccccccCccCccccCCCCCC
Q 045449 72 LGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLDFSDNQLFGSLSSFIFNMSSMTTIDLSINRLSGELPANICKIPSTL 151 (823)
Q Consensus 72 l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~p~~~ 151 (823)
+.++++++.|-||+|+++ .+|+.+..+.+|++|++++|+|. ..|.+++.+++|+.|+++.|++. .+|..|
T Consensus 29 Lf~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~--------~lprgf 98 (264)
T KOG0617|consen 29 LFNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN--------ILPRGF 98 (264)
T ss_pred ccchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh--------cCcccc
Confidence 567778888888999888 77778888888888888888886 67788888888888888888876 345555
Q ss_pred ccccccceeeeccceeec-cCccccccchhhHHHHHhhcCCCcccCCcccCCcchhhhhccccccccCCccccccCCCCC
Q 045449 152 SKCKQLEELNLGFNNLSG-AIPKEIGNLTKLKEIISTITNSTVCEIPREIGNLPYLARLALATNNLVGVVPVTIFNMSAL 230 (823)
Q Consensus 152 ~~l~~L~~L~Ls~N~l~~-~~p~~l~~l~~L~~L~~l~~n~~~~~ip~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 230 (823)
+.++.|++|||.+|+++. .+ |+.|..++.|.-|+|++|.+. .+|..++++++|
T Consensus 99 gs~p~levldltynnl~e~~l-------------------------pgnff~m~tlralyl~dndfe-~lp~dvg~lt~l 152 (264)
T KOG0617|consen 99 GSFPALEVLDLTYNNLNENSL-------------------------PGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNL 152 (264)
T ss_pred CCCchhhhhhccccccccccC-------------------------CcchhHHHHHHHHHhcCCCcc-cCChhhhhhcce
Confidence 888888888888888762 23 344444445555666777666 566667777777
Q ss_pred cEEEccCCcccccCCcccccCCCCccEEEeeccccccccCccccC
Q 045449 231 KEISLLNNSLSGSLPSRIDLSLPNVETLNLGINSFSGTIPSSITN 275 (823)
Q Consensus 231 ~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 275 (823)
+.|.+..|.+- ++|..++. +..|++|.+.+|+++ .+|+.+++
T Consensus 153 qil~lrdndll-~lpkeig~-lt~lrelhiqgnrl~-vlppel~~ 194 (264)
T KOG0617|consen 153 QILSLRDNDLL-SLPKEIGD-LTRLRELHIQGNRLT-VLPPELAN 194 (264)
T ss_pred eEEeeccCchh-hCcHHHHH-HHHHHHHhcccceee-ecChhhhh
Confidence 77777777766 66666664 666666666666665 44554444
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.72 E-value=4.8e-18 Score=179.18 Aligned_cols=95 Identities=26% Similarity=0.299 Sum_probs=83.9
Q ss_pred HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCC-cEEEeecccccccCCCCccccccccccCCCcCcccccCCCcccccc
Q 045449 678 IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDM-VAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRG 756 (823)
Q Consensus 678 ~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~-~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 756 (823)
++.|++.+|.++|+.+++||||||+||+++.++ .++|+|||+++..... ....|+..|+|||++.+..++.++
T Consensus 114 ~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~ 187 (267)
T PHA03390 114 IIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP------SCYDGTLDYFSPEKIKGHNYDVSF 187 (267)
T ss_pred HHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC------ccCCCCCcccChhhhcCCCCCchh
Confidence 467889999999999999999999999999888 9999999998865422 224688999999999988999999
Q ss_pred ceehhhhhhccccCCCCCcCCC
Q 045449 757 DVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 757 Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
||||+||+++++.+|..||...
T Consensus 188 DvwslG~il~~l~~g~~p~~~~ 209 (267)
T PHA03390 188 DWWAVGVLTYELLTGKHPFKED 209 (267)
T ss_pred hHHHHHHHHHHHHHCCCCCCCC
Confidence 9999999999999999998743
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.72 E-value=5.8e-18 Score=177.73 Aligned_cols=132 Identities=21% Similarity=0.198 Sum_probs=107.3
Q ss_pred CeEEEEEEehHhh---HHHHHHHHHHHHHH-hhcchhhHHH---------------------------------------
Q 045449 641 GMEVAVKVFHQQY---ERALKSFEDECEVR-KRIRHRNLVK--------------------------------------- 677 (823)
Q Consensus 641 ~~~vavK~~~~~~---~~~~~~~~~E~~~l-~~l~h~niv~--------------------------------------- 677 (823)
+..||||++.... ......+..|..++ ...+|+|+++
T Consensus 21 ~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~ 100 (260)
T cd05611 21 GDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAK 100 (260)
T ss_pred CCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCCCCHHHHHHHcCCCCHHHHH
Confidence 5789999986532 22234455565544 4458999988
Q ss_pred -HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCcccccCCCcccccc
Q 045449 678 -IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRG 756 (823)
Q Consensus 678 -~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 756 (823)
++.|++++|.|+|+.+++||||+|+||+++.++.+||+|||+++.... .....|+..|+|||...+..++.++
T Consensus 101 ~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------~~~~~~~~~y~~pe~~~~~~~~~~~ 174 (260)
T cd05611 101 QYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------NKKFVGTPDYLAPETILGVGDDKMS 174 (260)
T ss_pred HHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc------cccCCCCcCccChhhhcCCCCcchh
Confidence 356889999999999999999999999999999999999999876432 1234688999999999888899999
Q ss_pred ceehhhhhhccccCCCCCcCCC
Q 045449 757 DVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 757 Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
||||+|++++++.+|..||...
T Consensus 175 Dv~slG~il~~l~~g~~p~~~~ 196 (260)
T cd05611 175 DWWSLGCVIFEFLFGYPPFHAE 196 (260)
T ss_pred hhHHHHHHHHHHHHCCCCCCCC
Confidence 9999999999999999998654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.72 E-value=7.8e-18 Score=188.27 Aligned_cols=156 Identities=26% Similarity=0.361 Sum_probs=124.8
Q ss_pred HHHHHHHhccCCccceeeccC------------CeEEEEEEehHhhHHHHHHHHHHHHHHhhc-chhhHHH---------
Q 045449 620 YHELLRATDRFSENNLIGIGN------------GMEVAVKVFHQQYERALKSFEDECEVRKRI-RHRNLVK--------- 677 (823)
Q Consensus 620 ~~~l~~at~~f~~~~~lg~g~------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~--------- 677 (823)
++.+-..++-|...+.+|.|. ++.+|||+.....+. .++.+.|.++++.. .|||++.
T Consensus 11 ~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~-deEiE~eynil~~~~~hpnv~~fyg~~~k~~ 89 (953)
T KOG0587|consen 11 LSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDE-EEEIELEYNMLKKYSHHPNVATFYGAFIKKD 89 (953)
T ss_pred hhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccc-cHHHHHHHHHHHhccCCCCcceEEEEEEEec
Confidence 344444567777778888875 556899988766432 35677888888877 7999998
Q ss_pred --------------------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeeccc
Q 045449 678 --------------------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGI 719 (823)
Q Consensus 678 --------------------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGl 719 (823)
++..++.++.|+|...++|||||-.|||++.++.+|++|||+
T Consensus 90 ~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGv 169 (953)
T KOG0587|consen 90 PGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGV 169 (953)
T ss_pred CCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeee
Confidence 234667789999999999999999999999999999999999
Q ss_pred ccccCCCCccccccccccCCCcCcccccCCC-----ccccccceehhhhhhccccCCCCCcCCC
Q 045449 720 AKLLSGEDQLSKQTQTLATIGYMAPEYGTKG-----RVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 720 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
+..+... .....+.+|||.|||||++... .|+.++|+||+|++.-||.-|..|+.+.
T Consensus 170 SaQldsT--~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~Dm 231 (953)
T KOG0587|consen 170 SAQLDST--VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDM 231 (953)
T ss_pred eeeeecc--cccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCc
Confidence 9876432 2234467899999999998754 3788999999999999999999888764
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.71 E-value=1.7e-17 Score=176.43 Aligned_cols=134 Identities=28% Similarity=0.321 Sum_probs=108.8
Q ss_pred CeEEEEEEehHhhH-HHHHHHHHHHHHHhhcc-hhhHHH-----------------------------------------
Q 045449 641 GMEVAVKVFHQQYE-RALKSFEDECEVRKRIR-HRNLVK----------------------------------------- 677 (823)
Q Consensus 641 ~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~----------------------------------------- 677 (823)
+..||||++..... .......+|++.+++++ |+|+++
T Consensus 24 ~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~ 103 (283)
T cd07830 24 GELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYMEGNLYQLMKDRKGKPFSESVIRS 103 (283)
T ss_pred CcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecCCCCHHHHHHhcccccCCHHHHHH
Confidence 56799999875432 22234567999999999 999998
Q ss_pred HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCcccccCC-Ccccccc
Q 045449 678 IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTK-GRVSTRG 756 (823)
Q Consensus 678 ~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~ 756 (823)
++.|++.+|+|+|+.+++|+||||+||+++.++.++|+|||.++....... .....++..|+|||++.. ..++.++
T Consensus 104 ~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~ 180 (283)
T cd07830 104 IIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP---YTDYVSTRWYRAPEILLRSTSYSSPV 180 (283)
T ss_pred HHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCC---cCCCCCcccccCceeeecCcCcCCcc
Confidence 245788899999999999999999999999999999999999987643222 233568899999998754 4578999
Q ss_pred ceehhhhhhccccCCCCCcCC
Q 045449 757 DVCSFGIISGGKETRSMTVGE 777 (823)
Q Consensus 757 Dv~S~Gvv~~~~~~~~~~~~~ 777 (823)
||||||++++++.+|..||..
T Consensus 181 Di~s~G~~l~el~~g~~~~~~ 201 (283)
T cd07830 181 DIWALGCIMAELYTLRPLFPG 201 (283)
T ss_pred chhhHHHHHHHHHhCCCccCC
Confidence 999999999999999988754
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.71 E-value=3.5e-18 Score=176.76 Aligned_cols=96 Identities=23% Similarity=0.161 Sum_probs=82.2
Q ss_pred HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCcccccCCCccccccc
Q 045449 678 IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGD 757 (823)
Q Consensus 678 ~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D 757 (823)
++.|++++|+|+|+.+|+||||||+||+++.++.++++|||.+...... .....++..|+|||...+..++.++|
T Consensus 90 ~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~D 164 (237)
T cd05576 90 WAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-----CDGEAVENMYCAPEVGGISEETEACD 164 (237)
T ss_pred HHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccc-----cccCCcCccccCCcccCCCCCCchhh
Confidence 4578899999999999999999999999999999999999988765322 12345678899999998888999999
Q ss_pred eehhhhhhccccCCCCCcCCC
Q 045449 758 VCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 758 v~S~Gvv~~~~~~~~~~~~~~ 778 (823)
|||+||+++++.+|..++...
T Consensus 165 vwslG~il~el~~g~~~~~~~ 185 (237)
T cd05576 165 WWSLGAILFELLTGKTLVECH 185 (237)
T ss_pred HHHHHHHHHHHHHCcchhhcC
Confidence 999999999999999776543
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.70 E-value=8.1e-18 Score=176.61 Aligned_cols=118 Identities=26% Similarity=0.355 Sum_probs=99.2
Q ss_pred HHHHHHHHHHHhhcchhhHHHH--------------------------------------------HHHHHHHhhhcCCC
Q 045449 657 LKSFEDECEVRKRIRHRNLVKI--------------------------------------------ISSSLEYLHFGHSI 692 (823)
Q Consensus 657 ~~~~~~E~~~l~~l~h~niv~~--------------------------------------------~~~~l~~L~~~h~~ 692 (823)
..++.+|+.++++++||||+++ +.|++++|.|+|+.
T Consensus 46 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~ 125 (260)
T cd08222 46 TVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR 125 (260)
T ss_pred HHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc
Confidence 3467789999999999999982 35778889999999
Q ss_pred CEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCcccccCCCccccccceehhhhhhccccCCC
Q 045449 693 PIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRS 772 (823)
Q Consensus 693 ~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~ 772 (823)
+++|+|+||+||+++. +.+|++|||+++....... ......|++.|+|||...+..++.++||||||++++++.++.
T Consensus 126 ~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~ 202 (260)
T cd08222 126 RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLA 202 (260)
T ss_pred CccccCCChhheEeec-CCEeecccCceeecCCCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCC
Confidence 9999999999999975 5699999999987643322 122346889999999988888899999999999999999999
Q ss_pred CCcCC
Q 045449 773 MTVGE 777 (823)
Q Consensus 773 ~~~~~ 777 (823)
.|+..
T Consensus 203 ~~~~~ 207 (260)
T cd08222 203 HAFEG 207 (260)
T ss_pred CCCCC
Confidence 98864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.70 E-value=3.9e-19 Score=161.66 Aligned_cols=163 Identities=31% Similarity=0.527 Sum_probs=100.8
Q ss_pred CCCCCCeEEeecccccccCCCccCCCcccCcccccCccccCCCCcccccccccCCCCceEEEeecCCCCccCCccccccc
Q 045449 275 NSSKLSDLELGENLFSGFIPNTIGNLRNLEFGNIADNYLTSSTPELSFLSSLTNCKKLKVLIVTGNPLDGILPKSIGNFS 354 (823)
Q Consensus 275 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~ 354 (823)
++...+.|.||+|+++ .+|+.+..+.+|+.|++++|+++.. |.+++.+++|+.|+++-|++. .+|..|+.+
T Consensus 31 ~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie~l------p~~issl~klr~lnvgmnrl~-~lprgfgs~- 101 (264)
T KOG0617|consen 31 NMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIEEL------PTSISSLPKLRILNVGMNRLN-ILPRGFGSF- 101 (264)
T ss_pred chhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhhhc------Chhhhhchhhhheecchhhhh-cCccccCCC-
Confidence 3445555566666665 4455566666666666666666553 345566666666666666665 456666666
Q ss_pred cccceEEecCCccee-ccCccccCcccccEEEcccCcCCCCchhcccccCCCCEEEccCCCCCCcchHhhhcCCCCCEEE
Q 045449 355 LSLETILMANCSISG-NIPQVVGNLSNLLVLELGGNNLTGPIPVTFSQLQTLQAFDLTRNKLAGPITDELCHLARLHSLV 433 (823)
Q Consensus 355 ~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 433 (823)
+.|+.|+|.+|++.. ..|..|..++.|+.|+|+.|.|. .+|..++++++|+.|.+..|.+- ..|..++.+++|++|.
T Consensus 102 p~levldltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelh 179 (264)
T KOG0617|consen 102 PALEVLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELH 179 (264)
T ss_pred chhhhhhccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHh
Confidence 456666666665542 45666666777777777777776 56666777777777777776665 5566666666666666
Q ss_pred cccCcCcccccccccC
Q 045449 434 LQGNKFSGSIPSCLGN 449 (823)
Q Consensus 434 Ls~N~l~g~~p~~~~~ 449 (823)
+++|+++ .+|..+++
T Consensus 180 iqgnrl~-vlppel~~ 194 (264)
T KOG0617|consen 180 IQGNRLT-VLPPELAN 194 (264)
T ss_pred cccceee-ecChhhhh
Confidence 6666666 44444443
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.4e-17 Score=193.89 Aligned_cols=179 Identities=22% Similarity=0.266 Sum_probs=129.7
Q ss_pred eEEEEEEehHhh-HHHHHHHHHHHHHHhhc-chhhHHHH-----------------------------------------
Q 045449 642 MEVAVKVFHQQY-ERALKSFEDECEVRKRI-RHRNLVKI----------------------------------------- 678 (823)
Q Consensus 642 ~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~----------------------------------------- 678 (823)
..||||.++... ....+.+..|+++|..+ +|+||+.+
T Consensus 329 ~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~ 408 (609)
T KOG0200|consen 329 VTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVF 408 (609)
T ss_pred EEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCC
Confidence 569999997554 34567899999999999 69999982
Q ss_pred ---------------HHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccc--cCCCc
Q 045449 679 ---------------ISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTL--ATIGY 741 (823)
Q Consensus 679 ---------------~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~--gt~~y 741 (823)
..|++.++.|+++.++||||+-..|||+.++..+||+|||+||.....+.+.. .... -...|
T Consensus 409 ~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~-~~~~~~LP~kW 487 (609)
T KOG0200|consen 409 PNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLITKNKVIKIADFGLARDHYNKDYYRT-KSSAGTLPVKW 487 (609)
T ss_pred ccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEecCCCEEEEccccceeccCCCCceEe-cCCCCccceee
Confidence 24677788888999999999999999999999999999999997655444321 1122 23459
Q ss_pred CcccccCCCccccccceehhhhhhccccC-CCCCcCCCcccccccccccCCcccccccCCCcccccccccccccccccCC
Q 045449 742 MAPEYGTKGRVSTRGDVCSFGIISGGKET-RSMTVGETCTPVRESKYEVHPATTTIMEHPLPRVGEVMDVDRGKARIQGK 820 (823)
Q Consensus 742 ~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 820 (823)
||||.+....|+.|+|||||||++||+.+ |..|+.+......-..+.........+.++.+.+-++|..+....+.+||
T Consensus 488 mApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP 567 (609)
T KOG0200|consen 488 MAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRP 567 (609)
T ss_pred cCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCC
Confidence 99999999999999999999999999876 66777663211111112222222333455556666666666655555555
Q ss_pred C
Q 045449 821 P 821 (823)
Q Consensus 821 p 821 (823)
.
T Consensus 568 ~ 568 (609)
T KOG0200|consen 568 T 568 (609)
T ss_pred C
Confidence 3
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.70 E-value=5.6e-17 Score=189.12 Aligned_cols=156 Identities=28% Similarity=0.458 Sum_probs=131.4
Q ss_pred chHHHHHHHHHHHHhccCCCccccccccCCCCCCc----cceeeeeCC--CC--CcEEEEEcCCCCCccccCcccCCCCC
Q 045449 6 IISQHQQALLALKAHISYDHTNLFARNWTSSTSVC----IWIGITCDV--NS--HRVIGLNISSFNLQGTITPQLGNLSS 77 (823)
Q Consensus 6 ~~~~~~~aLl~~k~~~~~~~~~~~~~~W~~~~~~c----~w~gv~c~~--~~--~~v~~L~L~~~~l~g~~~~~l~~l~~ 77 (823)
..++|.+||++||+++. ++.. . +|.. ..|| .|.||.|+. .+ ..|+.|+|++|++.|.+|+.++++++
T Consensus 369 t~~~~~~aL~~~k~~~~-~~~~--~-~W~g-~~C~p~~~~w~Gv~C~~~~~~~~~~v~~L~L~~n~L~g~ip~~i~~L~~ 443 (623)
T PLN03150 369 TLLEEVSALQTLKSSLG-LPLR--F-GWNG-DPCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLRH 443 (623)
T ss_pred cCchHHHHHHHHHHhcC-Cccc--C-CCCC-CCCCCcccccccceeeccCCCCceEEEEEECCCCCccccCCHHHhCCCC
Confidence 35678999999999974 3322 3 7963 3343 799999953 22 25999999999999999999999999
Q ss_pred CcEEEccCCCCCCCCCCCCCCCCCCCEEECCCCcCcCCCchhhhcCCCCcEEecccccccCccCccccCCCCCCcccccc
Q 045449 78 LQTLDLSHNKLSGNIPSSIFNMHTLKLLDFSDNQLFGSLSSFIFNMSSMTTIDLSINRLSGELPANICKIPSTLSKCKQL 157 (823)
Q Consensus 78 L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~p~~~~~l~~L 157 (823)
|++|+|++|+|+|.+|..++.+++|++|||++|+|+|.+|+.++++++|++|+|++|+++|.+|..+. ..+.++
T Consensus 444 L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~------~~~~~~ 517 (623)
T PLN03150 444 LQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALG------GRLLHR 517 (623)
T ss_pred CCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChHHh------hccccC
Confidence 99999999999999999999999999999999999999999999999999999999999999998772 123467
Q ss_pred ceeeeccceeeccCc
Q 045449 158 EELNLGFNNLSGAIP 172 (823)
Q Consensus 158 ~~L~Ls~N~l~~~~p 172 (823)
..+++.+|......|
T Consensus 518 ~~l~~~~N~~lc~~p 532 (623)
T PLN03150 518 ASFNFTDNAGLCGIP 532 (623)
T ss_pred ceEEecCCccccCCC
Confidence 788999887544333
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.68 E-value=4.2e-17 Score=171.87 Aligned_cols=159 Identities=25% Similarity=0.281 Sum_probs=122.5
Q ss_pred ccccccCHHHHHHHhccCCccceeeccC------------CeEEEEEEehHhhHHHHHHHHHHHHHHhhcc------hhh
Q 045449 613 QAIRRFSYHELLRATDRFSENNLIGIGN------------GMEVAVKVFHQQYERALKSFEDECEVRKRIR------HRN 674 (823)
Q Consensus 613 ~~~~~~~~~~l~~at~~f~~~~~lg~g~------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------h~n 674 (823)
++..++.+.|++. .+|.+....|.|- |..||||+++... ...+.=.+|+++|++|. .-|
T Consensus 419 EGYYrv~igE~LD--~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE-~M~KtGl~EleiLkKL~~AD~Edk~H 495 (752)
T KOG0670|consen 419 EGYYRVRIGELLD--SRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE-VMHKTGLKELEILKKLNDADPEDKFH 495 (752)
T ss_pred cceEEEehhhhhc--ceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch-HHhhhhhHHHHHHHHhhccCchhhhH
Confidence 4556677777764 4666666666662 6789999997653 23344567888887773 224
Q ss_pred HHH------------------------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCC-Cc
Q 045449 675 LVK------------------------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDED-MV 711 (823)
Q Consensus 675 iv~------------------------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~-~~ 711 (823)
+++ +..|+.-+|.++-..+|+|.||||.|||+.+. ..
T Consensus 496 clrl~r~F~hknHLClVFE~LslNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~i 575 (752)
T KOG0670|consen 496 CLRLFRHFKHKNHLCLVFEPLSLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNI 575 (752)
T ss_pred HHHHHHHhhhcceeEEEehhhhchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcce
Confidence 444 24578888999999999999999999999854 68
Q ss_pred EEEeecccccccCCCCccccccccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCCC
Q 045449 712 AHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 712 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
.||||||.|......+ .+....+..|.|||++.+-+|+...|+||.||.+||+-||+..|.+-
T Consensus 576 LKLCDfGSA~~~~ene----itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~ 638 (752)
T KOG0670|consen 576 LKLCDFGSASFASENE----ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGR 638 (752)
T ss_pred eeeccCcccccccccc----ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCC
Confidence 9999999998765432 23455678899999999999999999999999999999999887664
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.3e-17 Score=160.82 Aligned_cols=132 Identities=21% Similarity=0.298 Sum_probs=103.6
Q ss_pred CCeEEEEEEehHhhHHHHHHHHHHHHHHhhc-chhhHHH----------------------------------------H
Q 045449 640 NGMEVAVKVFHQQYERALKSFEDECEVRKRI-RHRNLVK----------------------------------------I 678 (823)
Q Consensus 640 ~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~----------------------------------------~ 678 (823)
..+.+|+|.+..... ..++|.+|...--.+ .|.||+. +
T Consensus 48 s~t~ivlKavp~p~t-t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~aP~gdL~snv~~~GigE~~~K~v 126 (378)
T KOG1345|consen 48 SKTRIVLKAVPRPQT-TQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQEFAPRGDLRSNVEAAGIGEANTKKV 126 (378)
T ss_pred CceEEEeeccCcchh-hHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeeccCccchhhhhcCcccccHHHHHHH
Confidence 367799999876643 347899999876666 6899997 4
Q ss_pred HHHHHHHhhhcCCCCEEeccCCCCCEEeC--CCCcEEEeecccccccCCCCccccccccccCCCcCcccccCC---Cc--
Q 045449 679 ISSSLEYLHFGHSIPIIHCDLKPSNVLLD--EDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTK---GR-- 751 (823)
Q Consensus 679 ~~~~l~~L~~~h~~~ivHrdlk~~NiLl~--~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~-- 751 (823)
++|++.++.|+|+..+||||||.+|||+- +..++||||||..+..... ....--+..|-|||+... +.
T Consensus 127 ~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~t-----V~~~~~~~~y~~pe~~~~~~ne~~~ 201 (378)
T KOG1345|consen 127 FAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTT-----VKYLEYVNNYHAPELCDTVVNEKLV 201 (378)
T ss_pred HHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCce-----ehhhhhhcccCCcHHHhhccccceE
Confidence 68999999999999999999999999993 3459999999998764321 111223567899996532 33
Q ss_pred cccccceehhhhhhccccCCCCCcCC
Q 045449 752 VSTRGDVCSFGIISGGKETRSMTVGE 777 (823)
Q Consensus 752 ~~~~~Dv~S~Gvv~~~~~~~~~~~~~ 777 (823)
..+.+|||.||++++..++|..||+.
T Consensus 202 ~~ps~D~WqfGIi~f~cltG~~PWQk 227 (378)
T KOG1345|consen 202 VNPSTDIWQFGIIFFYCLTGKFPWQK 227 (378)
T ss_pred ecccccchheeeeeeeeecCCCcchh
Confidence 46778999999999999999999984
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.67 E-value=5.3e-17 Score=167.80 Aligned_cols=136 Identities=33% Similarity=0.405 Sum_probs=116.0
Q ss_pred cCCeEEEEEEehHhhHHH-HHHHHHHHHHHhhcchhhHHHH---------------------------------------
Q 045449 639 GNGMEVAVKVFHQQYERA-LKSFEDECEVRKRIRHRNLVKI--------------------------------------- 678 (823)
Q Consensus 639 g~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~~--------------------------------------- 678 (823)
+.+..||+|++....... .+.+.+|++.+++++|+|++++
T Consensus 12 ~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~~~~~~~~~~~ 91 (244)
T smart00220 12 KTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKKRGRLSEDEARF 91 (244)
T ss_pred CCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHhccCCCHHHHHH
Confidence 346889999997654433 6889999999999999999982
Q ss_pred -HHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCcccccCCCccccccc
Q 045449 679 -ISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGD 757 (823)
Q Consensus 679 -~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D 757 (823)
+.+++.+++++|+.+++|+|++|+||+++.++.++++|||.+....... ......++..|+|||...+..++.++|
T Consensus 92 ~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~~pE~~~~~~~~~~~D 168 (244)
T smart00220 92 YARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPEYMAPEVLLGKGYGKAVD 168 (244)
T ss_pred HHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcCCCCHHHHccCCCCchhh
Confidence 4567788899999999999999999999999999999999998765432 223456889999999998888899999
Q ss_pred eehhhhhhccccCCCCCcCC
Q 045449 758 VCSFGIISGGKETRSMTVGE 777 (823)
Q Consensus 758 v~S~Gvv~~~~~~~~~~~~~ 777 (823)
|||+|++++++.++..|+..
T Consensus 169 i~slG~~l~~l~~~~~p~~~ 188 (244)
T smart00220 169 VWSLGVILYELLTGKPPFPG 188 (244)
T ss_pred HHHHHHHHHHHHhCCCCCCC
Confidence 99999999999999988865
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.67 E-value=1.3e-16 Score=179.35 Aligned_cols=97 Identities=24% Similarity=0.235 Sum_probs=75.1
Q ss_pred HHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCcccccCCCc-------
Q 045449 679 ISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGR------- 751 (823)
Q Consensus 679 ~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------- 751 (823)
+.|++++|+|+|+.+|+||||||+||+++.++.+||+|||+++........ ......+|+.|+|||.+....
T Consensus 315 ~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~g~~tp~Y~aPE~l~~~~~~~~~~~ 393 (507)
T PLN03224 315 MRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF-NPLYGMLDPRYSPPEELVMPQSCPRAPA 393 (507)
T ss_pred HHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCcc-CccccCCCcceeChhhhcCCCCCCccch
Confidence 457788999999999999999999999999999999999999765432221 112234589999999875322
Q ss_pred -------------cc--cccceehhhhhhccccCCCC-CcC
Q 045449 752 -------------VS--TRGDVCSFGIISGGKETRSM-TVG 776 (823)
Q Consensus 752 -------------~~--~~~Dv~S~Gvv~~~~~~~~~-~~~ 776 (823)
|+ .+.||||+||++++|.++.. |+.
T Consensus 394 ~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~ 434 (507)
T PLN03224 394 PAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVA 434 (507)
T ss_pred hhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCcc
Confidence 22 34799999999999999875 554
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.64 E-value=3e-16 Score=160.42 Aligned_cols=136 Identities=30% Similarity=0.413 Sum_probs=114.1
Q ss_pred CeEEEEEEehHhhHH-HHHHHHHHHHHHhhcchhhHHHH-----------------------------------------
Q 045449 641 GMEVAVKVFHQQYER-ALKSFEDECEVRKRIRHRNLVKI----------------------------------------- 678 (823)
Q Consensus 641 ~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~----------------------------------------- 678 (823)
+..+|+|.+...... ..+.+.+|++.+.+++|+|++++
T Consensus 24 ~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~ 103 (225)
T smart00221 24 GELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEGGDLFDYLRKKGGKLSEEEARFY 103 (225)
T ss_pred CcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCCCCHHHHHHhcccCCCHHHHHHH
Confidence 578999999866544 56789999999999999999982
Q ss_pred HHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCccccc-CCCccccccc
Q 045449 679 ISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYG-TKGRVSTRGD 757 (823)
Q Consensus 679 ~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~D 757 (823)
+.+++.+++++|+.+++|+|++|+||+++.++.++++|||.+........ .......++..|++||.. ....++.++|
T Consensus 104 ~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~~D 182 (225)
T smart00221 104 LRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA-ALLKTVKGTPFYLAPEVLLGGKGYGEAVD 182 (225)
T ss_pred HHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc-ccccceeccCCcCCHhHhcCCCCCCchhh
Confidence 35677888999999999999999999999999999999999987654321 012335678899999998 6667788999
Q ss_pred eehhhhhhccccCCCCCcCC
Q 045449 758 VCSFGIISGGKETRSMTVGE 777 (823)
Q Consensus 758 v~S~Gvv~~~~~~~~~~~~~ 777 (823)
||+||++++++.+|+.||..
T Consensus 183 v~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 183 IWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred HHHHHHHHHHHHHCCCCccc
Confidence 99999999999999999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.64 E-value=6.2e-17 Score=165.20 Aligned_cols=164 Identities=16% Similarity=0.114 Sum_probs=120.9
Q ss_pred HHHHHHHHHHHHhhcchhhHHH-------------------------------------------------HHHHHHHHh
Q 045449 656 ALKSFEDECEVRKRIRHRNLVK-------------------------------------------------IISSSLEYL 686 (823)
Q Consensus 656 ~~~~~~~E~~~l~~l~h~niv~-------------------------------------------------~~~~~l~~L 686 (823)
....|..|...+..+.|||+.. +..|+..++
T Consensus 330 Qv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am 409 (563)
T KOG1024|consen 330 QVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAM 409 (563)
T ss_pred HHHHHHHHHHHHhcCcCCCccceeEEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHH
Confidence 3456888999999999999998 245778899
Q ss_pred hhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCcccccCCCccccccceehhhhhhc
Q 045449 687 HFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISG 766 (823)
Q Consensus 687 ~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~ 766 (823)
.|+|+.+|||.||-..|.++|+...+|++|=.++|.+.+.+........-....||+||.+....|+..+|||||||++|
T Consensus 410 ~hlh~~~ViHkDiAaRNCvIdd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllW 489 (563)
T KOG1024|consen 410 EHLHNHGVIHKDIAARNCVIDDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLW 489 (563)
T ss_pred HHHHhcCcccchhhhhcceehhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHH
Confidence 99999999999999999999999999999999999887766543333334567899999999999999999999999999
Q ss_pred cccC-CCCCcCCCcccccccccccCCcccccccCCCcccccccccccccccccCC
Q 045449 767 GKET-RSMTVGETCTPVRESKYEVHPATTTIMEHPLPRVGEVMDVDRGKARIQGK 820 (823)
Q Consensus 767 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 820 (823)
|+++ |+.|+.++.-... .-|-.+...-.-+-.++.+.-++|..+....+-+||
T Consensus 490 ELmtlg~~PyaeIDPfEm-~~ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRP 543 (563)
T KOG1024|consen 490 ELMTLGKLPYAEIDPFEM-EHYLKDGYRLAQPFNCPDELFTVMACCWALLPEERP 543 (563)
T ss_pred HHHhcCCCCccccCHHHH-HHHHhccceecCCCCCcHHHHHHHHHHHhcCcccCC
Confidence 9987 7788877532211 112122221222233444555555555555544444
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.62 E-value=6.5e-16 Score=160.54 Aligned_cols=154 Identities=27% Similarity=0.297 Sum_probs=111.8
Q ss_pred ccCHHHHHHHhccCCccceeeccCCeEEEEEEehHhhHHHHHHHHHHHHHHhhc-chhhHHH------------------
Q 045449 617 RFSYHELLRATDRFSENNLIGIGNGMEVAVKVFHQQYERALKSFEDECEVRKRI-RHRNLVK------------------ 677 (823)
Q Consensus 617 ~~~~~~l~~at~~f~~~~~lg~g~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~------------------ 677 (823)
..++.-+..|+..=+ .+....||+|.+..... ..+...|++.+.++ .+.||++
T Consensus 46 eGsFssv~~a~~~~~------~~~~~~valk~i~~ts~--p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp~~ 117 (418)
T KOG1167|consen 46 EGSFSSVYKATDIEQ------DTKRRYVALKAIYRTSS--PSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLPYF 117 (418)
T ss_pred ccchhhhhhhhHhhh------ccccceEeeeecccccC--chHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEeccc
Confidence 444555555543221 22357799998865532 24688899999988 5778887
Q ss_pred -------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCC-CcEEEeecccccccCCCC----------
Q 045449 678 -------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDED-MVAHISDFGIAKLLSGED---------- 727 (823)
Q Consensus 678 -------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~-~~~kl~DfGla~~~~~~~---------- 727 (823)
++...+.+|.++|..|||||||||+|+|.+.. +.-.|+|||+|.......
T Consensus 118 ~H~~f~~l~~~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~~~~s~~~~~ 197 (418)
T KOG1167|consen 118 EHDRFRDLYRSLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQTEHSRSYSG 197 (418)
T ss_pred CccCHHHHHhcCCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHHhhhhhhhhhhhhc
Confidence 34567788889999999999999999999854 678899999998311000
Q ss_pred --------------------------------ccccccccccCCCcCcccccCCC-ccccccceehhhhhhccccCCCCC
Q 045449 728 --------------------------------QLSKQTQTLATIGYMAPEYGTKG-RVSTRGDVCSFGIISGGKETRSMT 774 (823)
Q Consensus 728 --------------------------------~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvv~~~~~~~~~~ 774 (823)
........+||+||+|||++.+. ..++++||||.|||+.-++++..|
T Consensus 198 ~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~Lslls~~~P 277 (418)
T KOG1167|consen 198 RHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILLSLLSRRYP 277 (418)
T ss_pred ccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccceeehhhccccc
Confidence 00011235799999999988764 468899999999998888888888
Q ss_pred cCCC
Q 045449 775 VGET 778 (823)
Q Consensus 775 ~~~~ 778 (823)
|...
T Consensus 278 Ff~a 281 (418)
T KOG1167|consen 278 FFKA 281 (418)
T ss_pred cccC
Confidence 7543
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.62 E-value=1.9e-16 Score=191.97 Aligned_cols=108 Identities=16% Similarity=0.188 Sum_probs=84.3
Q ss_pred cchhhHHHHHHHHHHHhhhcCCCCEEeccCCCCCEEeCC-------------------CCcEEEeecccccccCCCCc--
Q 045449 670 IRHRNLVKIISSSLEYLHFGHSIPIIHCDLKPSNVLLDE-------------------DMVAHISDFGIAKLLSGEDQ-- 728 (823)
Q Consensus 670 l~h~niv~~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~-------------------~~~~kl~DfGla~~~~~~~~-- 728 (823)
+....+..++.|++++|+|+|++||+||||||+|||++. ++.+|++|||+++.......
T Consensus 77 ~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~ 156 (793)
T PLN00181 77 VDAFECFHVFRQIVEIVNAAHSQGIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERR 156 (793)
T ss_pred ccHHHHHHHHHHHHHHHHHHHhCCeeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccc
Confidence 455667788999999999999999999999999999954 45567777777764321000
Q ss_pred ------------cccccccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCC
Q 045449 729 ------------LSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGE 777 (823)
Q Consensus 729 ------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~ 777 (823)
.......+||+.|||||++.+..|+.++|||||||++||++++..|+..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~ 217 (793)
T PLN00181 157 IEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREE 217 (793)
T ss_pred hhhhhccccCCCcccccccCCCcceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhh
Confidence 0001124689999999999999999999999999999999998877653
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.61 E-value=1.5e-15 Score=177.28 Aligned_cols=120 Identities=24% Similarity=0.467 Sum_probs=101.2
Q ss_pred CCCEEEcccCcCcccccccccCCCCCCeEeccCCccccccchhhhccCCCcEEeccccccccccCccccCCCCCcEEEcc
Q 045449 428 RLHSLVLQGNKFSGSIPSCLGNLTSVRVLYLGLNIFTSVLSSTIWNLKDILFIDVSSNFLDGPLSLDIGNLKVVIGLDFS 507 (823)
Q Consensus 428 ~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~ls 507 (823)
.++.|+|++|.++|.+|..+..+++|+.|+|++|.++|.+|..++.+++|+.|||++|+++|.+|..+++++.|+.|+|+
T Consensus 419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls 498 (623)
T PLN03150 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN 498 (623)
T ss_pred EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence 36788999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cCCCCCCCCCcccCccCCCCCCCCCCCcccccCCcccCCCCCCCCCCCC
Q 045449 508 RNNLSGDIPITIGEGEIPRGGPFANLTAKSFMGNELLCGLPDLQVSPCK 556 (823)
Q Consensus 508 ~N~l~g~ip~~~~~g~ip~~~~~~~~~~~~~~~n~~~c~~~~~~~~~c~ 556 (823)
+|+|+|.+|..++.. +......++.+|+.+|+.|.. .+|.
T Consensus 499 ~N~l~g~iP~~l~~~-------~~~~~~l~~~~N~~lc~~p~l--~~C~ 538 (623)
T PLN03150 499 GNSLSGRVPAALGGR-------LLHRASFNFTDNAGLCGIPGL--RACG 538 (623)
T ss_pred CCcccccCChHHhhc-------cccCceEEecCCccccCCCCC--CCCc
Confidence 999998888877421 123345678999999997753 3564
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.59 E-value=2.1e-15 Score=162.44 Aligned_cols=126 Identities=25% Similarity=0.229 Sum_probs=99.0
Q ss_pred HHhccCCccceeeccC-------------CeEEEEEEehHh-----hHHHHHHHHHHHHHHhhcchhhHHH---------
Q 045449 625 RATDRFSENNLIGIGN-------------GMEVAVKVFHQQ-----YERALKSFEDECEVRKRIRHRNLVK--------- 677 (823)
Q Consensus 625 ~at~~f~~~~~lg~g~-------------~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~--------- 677 (823)
...++|...+.||+|+ ++.||||++... .....+.|.+|++++++++|+|++.
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~~~~~ 94 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLATGKDG 94 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEcCCcE
Confidence 3456788888899886 455799986532 2334567999999999999999984
Q ss_pred ---------------------HHHHHHHHhhhcCCCCEEeccC-CCCCEEeCCCCcEEEeecccccccCCCCcccc----
Q 045449 678 ---------------------IISSSLEYLHFGHSIPIIHCDL-KPSNVLLDEDMVAHISDFGIAKLLSGEDQLSK---- 731 (823)
Q Consensus 678 ---------------------~~~~~l~~L~~~h~~~ivHrdl-k~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~---- 731 (823)
++.+++++|.|+|+.||+|||| ||+|||++.++.+||+|||+|+..........
T Consensus 95 LVmE~~~G~~L~~~~~~~~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~~~~~~~~~~~ 174 (365)
T PRK09188 95 LVRGWTEGVPLHLARPHGDPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRRRGALYRIAAY 174 (365)
T ss_pred EEEEccCCCCHHHhCccchHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccceecccCcchhhhhhh
Confidence 3567889999999999999999 99999999999999999999997654332111
Q ss_pred --ccccccCCCcCcccccCCC
Q 045449 732 --QTQTLATIGYMAPEYGTKG 750 (823)
Q Consensus 732 --~~~~~gt~~y~aPE~~~~~ 750 (823)
.+...+++.|+|||++...
T Consensus 175 ~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 175 EDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred hhhhhhhccCccCCcccCChh
Confidence 1356788999999987654
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.55 E-value=7.1e-16 Score=167.52 Aligned_cols=145 Identities=28% Similarity=0.413 Sum_probs=116.1
Q ss_pred ccccccCHHHHHHHhccCCccceeeccCCeEEEEEEehHhhHHHHHHHHHHHHHHhhcchhhHHHHH-------------
Q 045449 613 QAIRRFSYHELLRATDRFSENNLIGIGNGMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVKII------------- 679 (823)
Q Consensus 613 ~~~~~~~~~~l~~at~~f~~~~~lg~g~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~------------- 679 (823)
+-....||.|+.+|-+.-+ +..+|||+++........-..+|+-+++..+|||||.++
T Consensus 21 qrvgsgTygdvyKaRd~~s---------~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicM 91 (829)
T KOG0576|consen 21 QRVGSGTYGDVYKARDKRS---------GELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICM 91 (829)
T ss_pred eeecCCcccchhhhccccc---------CchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEE
Confidence 3345577888888754322 577899999877655556778899999999999999842
Q ss_pred ---------------------------HHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccc
Q 045449 680 ---------------------------SSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQ 732 (823)
Q Consensus 680 ---------------------------~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~ 732 (823)
...+..|+|+|+.|-+|||||-.||++++.+.+|++|||.+..+.. ...+.
T Consensus 92 EycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqita--ti~Kr 169 (829)
T KOG0576|consen 92 EYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITA--TIAKR 169 (829)
T ss_pred EecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhh--hhhhh
Confidence 3456789999999999999999999999999999999999877643 23345
Q ss_pred cccccCCCcCccccc---CCCccccccceehhhhhhccc
Q 045449 733 TQTLATIGYMAPEYG---TKGRVSTRGDVCSFGIISGGK 768 (823)
Q Consensus 733 ~~~~gt~~y~aPE~~---~~~~~~~~~Dv~S~Gvv~~~~ 768 (823)
..++||+.|||||+. ..+.|..++|||+.|+..-|+
T Consensus 170 ksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel 208 (829)
T KOG0576|consen 170 KSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIEL 208 (829)
T ss_pred hcccCCccccchhHHHHHhcccccccccccccccchhhh
Confidence 678999999999975 456799999999999874443
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.54 E-value=4.2e-15 Score=146.06 Aligned_cols=94 Identities=21% Similarity=0.216 Sum_probs=82.5
Q ss_pred cchhhHHHHHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCcccccCC
Q 045449 670 IRHRNLVKIISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTK 749 (823)
Q Consensus 670 l~h~niv~~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 749 (823)
+.-+.+..++.|++.+|+|+|+.+ ||+||+++.++.+|+ ||+++..... ...||+.|||||++.+
T Consensus 14 l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~-------~~~g~~~y~aPE~~~~ 78 (176)
T smart00750 14 LNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPE-------QSRVDPYFMAPEVIQG 78 (176)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeeccc-------cCCCcccccChHHhcC
Confidence 566677888999999999999887 999999999999999 9999875432 1258999999999999
Q ss_pred CccccccceehhhhhhccccCCCCCcCCC
Q 045449 750 GRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 750 ~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
..|+.++|||||||++|++++|+.||...
T Consensus 79 ~~~~~~~DiwSlG~il~elltg~~p~~~~ 107 (176)
T smart00750 79 QSYTEKADIYSLGITLYEALDYELPYNEE 107 (176)
T ss_pred CCCcchhhHHHHHHHHHHHHhCCCCcccc
Confidence 99999999999999999999999998653
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.52 E-value=1.8e-14 Score=170.58 Aligned_cols=135 Identities=23% Similarity=0.284 Sum_probs=106.8
Q ss_pred ccCCccceeeccC------------CeEEEEEEehHhh---HHHHHHHHHHHHHHhhcchhhHHH---------------
Q 045449 628 DRFSENNLIGIGN------------GMEVAVKVFHQQY---ERALKSFEDECEVRKRIRHRNLVK--------------- 677 (823)
Q Consensus 628 ~~f~~~~~lg~g~------------~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~--------------- 677 (823)
++|...+.||.|+ +..||||+++... ....+.+.+|+.++..++|+||++
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 4666677788775 5679999997542 344577899999999999999998
Q ss_pred -------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccc
Q 045449 678 -------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQ 732 (823)
Q Consensus 678 -------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~ 732 (823)
++.|++.+|+|+|..+|+||||||+|||++.++.+||+|||+++....... ..
T Consensus 84 Ey~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~~~~~~~~--~~ 161 (669)
T cd05610 84 EYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSKVTLNREL--NM 161 (669)
T ss_pred eCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCccccCCcc--cc
Confidence 356888999999999999999999999999999999999999997643322 23
Q ss_pred cccccCCCcCcccccCCCc-cccccceehhhhh
Q 045449 733 TQTLATIGYMAPEYGTKGR-VSTRGDVCSFGII 764 (823)
Q Consensus 733 ~~~~gt~~y~aPE~~~~~~-~~~~~Dv~S~Gvv 764 (823)
....+|+.|+|||...... ....+++|++|+-
T Consensus 162 ~~~~~t~~~~~pe~~~~~~~~~~~s~~~s~g~~ 194 (669)
T cd05610 162 MDILTTPSMAKPKNDYSRTPGQVLSLISSLGFN 194 (669)
T ss_pred cccccCccccCccccccCCCCceeeeeeecCcC
Confidence 3467899999999654332 3456788999864
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.50 E-value=1.5e-14 Score=152.30 Aligned_cols=43 Identities=23% Similarity=0.140 Sum_probs=39.3
Q ss_pred cccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCC
Q 045449 735 TLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGE 777 (823)
Q Consensus 735 ~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~ 777 (823)
-+.|..|+|||++.+..|++.+|+||++|+++|+.||.+.|+.
T Consensus 411 DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFeP 453 (590)
T KOG1290|consen 411 DIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEP 453 (590)
T ss_pred hhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecC
Confidence 3568899999999999999999999999999999999988753
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.48 E-value=1.9e-14 Score=138.42 Aligned_cols=192 Identities=20% Similarity=0.232 Sum_probs=132.1
Q ss_pred ccCCccceeeccC------------CeEEEEEEehHhhHHHHHHHHHHHHHHhhcch----hhHHH--------------
Q 045449 628 DRFSENNLIGIGN------------GMEVAVKVFHQQYERALKSFEDECEVRKRIRH----RNLVK-------------- 677 (823)
Q Consensus 628 ~~f~~~~~lg~g~------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h----~niv~-------------- 677 (823)
+.|...+.||.|+ |..||||+-...... .+...|..+.+.++| |+|-.
T Consensus 15 gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h--pqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdL 92 (341)
T KOG1163|consen 15 GKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH--PQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDL 92 (341)
T ss_pred cceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC--cchhHHHHHHHHhccCCCCchhhhhccccccceeeeec
Confidence 3455555666554 788999986543221 345667777666643 33333
Q ss_pred -----------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCC---CcEEEeecccccccCCCCc---
Q 045449 678 -----------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDED---MVAHISDFGIAKLLSGEDQ--- 728 (823)
Q Consensus 678 -----------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~---~~~kl~DfGla~~~~~~~~--- 728 (823)
++.|.+.-++|+|.++.+||||||+|.|+.-. ..+.++|||+|+.+....+
T Consensus 93 LGPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~~H 172 (341)
T KOG1163|consen 93 LGPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTRQH 172 (341)
T ss_pred cCccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhcccccccc
Confidence 35688999999999999999999999999643 4678999999998754322
Q ss_pred --cccccccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCCCcccccccccccCC------cccccccCC
Q 045449 729 --LSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGETCTPVRESKYEVHP------ATTTIMEHP 800 (823)
Q Consensus 729 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~ 800 (823)
+.......||..|++--...+...+.+.|+=|+|.|+..+--|..||++........+|+... .+...+...
T Consensus 173 Ipyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~ie~LC~G~ 252 (341)
T KOG1163|consen 173 IPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTPIEVLCKGF 252 (341)
T ss_pred CccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCCHHHHhCCC
Confidence 223345679999999888877788999999999999988899999999987665555553322 122333444
Q ss_pred CcccccccccccccccccCCCC
Q 045449 801 LPRVGEVMDVDRGKARIQGKPI 822 (823)
Q Consensus 801 ~~~~~~~~~~~~~~~~~~~~p~ 822 (823)
+.++.--+...+.. ++..+|+
T Consensus 253 P~EF~myl~Y~R~L-~F~E~Pd 273 (341)
T KOG1163|consen 253 PAEFAMYLNYCRGL-GFEEKPD 273 (341)
T ss_pred cHHHHHHHHHHhhc-CCCCCCc
Confidence 44444444555544 4555554
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.45 E-value=4.2e-14 Score=142.29 Aligned_cols=126 Identities=37% Similarity=0.533 Sum_probs=105.0
Q ss_pred CeEEEEEEehHhhHH-HHHHHHHHHHHHhhcchhhHHH-----------------------------------------H
Q 045449 641 GMEVAVKVFHQQYER-ALKSFEDECEVRKRIRHRNLVK-----------------------------------------I 678 (823)
Q Consensus 641 ~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~-----------------------------------------~ 678 (823)
+..++||++...... ..+.+.+|++.+++++|+++++ +
T Consensus 18 ~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~~~~~~~~~~ 97 (215)
T cd00180 18 GKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRI 97 (215)
T ss_pred CcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHHHHHhccCCCCHHHHHHH
Confidence 688999999766432 4578999999999999998887 2
Q ss_pred HHHHHHHhhhcCCCCEEeccCCCCCEEeCC-CCcEEEeecccccccCCCCccccccccccCCCcCcccccCCC-cccccc
Q 045449 679 ISSSLEYLHFGHSIPIIHCDLKPSNVLLDE-DMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKG-RVSTRG 756 (823)
Q Consensus 679 ~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~-~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~ 756 (823)
+.+++.+++++|+.+++|+|++|.||+++. ++.++++|||.+........ ......+...|++||..... .++.+.
T Consensus 98 ~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~ 175 (215)
T cd00180 98 LLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTIVGTPAYMAPEVLLGKGYYSEKS 175 (215)
T ss_pred HHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcccCCCCccChhHhcccCCCCchh
Confidence 457788899999999999999999999998 89999999999987643321 12335578899999998777 788999
Q ss_pred ceehhhhhhccc
Q 045449 757 DVCSFGIISGGK 768 (823)
Q Consensus 757 Dv~S~Gvv~~~~ 768 (823)
|+|++|++++++
T Consensus 176 D~~~lg~~~~~l 187 (215)
T cd00180 176 DIWSLGVILYEL 187 (215)
T ss_pred hhHHHHHHHHHH
Confidence 999999999988
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.40 E-value=1.1e-14 Score=155.83 Aligned_cols=172 Identities=28% Similarity=0.425 Sum_probs=126.6
Q ss_pred ceEEEeecCCCCccCCccccccccccceEEecCCcceeccCccccCcccccEEEcccCcCCCCchhcccccCCCCEEEcc
Q 045449 332 LKVLIVTGNPLDGILPKSIGNFSLSLETILMANCSISGNIPQVVGNLSNLLVLELGGNNLTGPIPVTFSQLQTLQAFDLT 411 (823)
Q Consensus 332 L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls 411 (823)
-...||+.|++. .+|..+..+ ..|+.+.|..|.+. .+|..++++..|+.|||+.|+++ ..|..+..++ |+.|-++
T Consensus 77 t~~aDlsrNR~~-elp~~~~~f-~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvli~s 151 (722)
T KOG0532|consen 77 TVFADLSRNRFS-ELPEEACAF-VSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVLIVS 151 (722)
T ss_pred hhhhhccccccc-cCchHHHHH-HHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeEEEe
Confidence 344566666666 456666666 57777777777776 66777778888888888888887 5666666554 7778888
Q ss_pred CCCCCCcchHhhhcCCCCCEEEcccCcCcccccccccCCCCCCeEeccCCccccccchhhhccCCCcEEecccccccccc
Q 045449 412 RNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSVRVLYLGLNIFTSVLSSTIWNLKDILFIDVSSNFLDGPL 491 (823)
Q Consensus 412 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~LdLs~N~l~g~~ 491 (823)
+|+++ .+|..++.+..|..||.+.|.+. .+|..++++++|+.|++..|++.. .|..++ .-.|..||+|.|+++ .|
T Consensus 152 NNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~~-lp~El~-~LpLi~lDfScNkis-~i 226 (722)
T KOG0532|consen 152 NNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLED-LPEELC-SLPLIRLDFSCNKIS-YL 226 (722)
T ss_pred cCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhhh-CCHHHh-CCceeeeecccCcee-ec
Confidence 88887 66777777777788888888877 667777788888888888888776 455555 345777888888887 67
Q ss_pred CccccCCCCCcEEEcccCCCCC
Q 045449 492 SLDIGNLKVVIGLDFSRNNLSG 513 (823)
Q Consensus 492 p~~~~~l~~L~~L~ls~N~l~g 513 (823)
|.+|..|+.|++|-|.+|.|..
T Consensus 227 Pv~fr~m~~Lq~l~LenNPLqS 248 (722)
T KOG0532|consen 227 PVDFRKMRHLQVLQLENNPLQS 248 (722)
T ss_pred chhhhhhhhheeeeeccCCCCC
Confidence 8888888888888888888874
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.40 E-value=2.7e-13 Score=136.49 Aligned_cols=111 Identities=23% Similarity=0.271 Sum_probs=92.5
Q ss_pred HHHHHHHhhhcCCCCEEeccCCCCCEEeCCC-----CcEEEeecccccccCCCCc-----cccccccccCCCcCcccccC
Q 045449 679 ISSSLEYLHFGHSIPIIHCDLKPSNVLLDED-----MVAHISDFGIAKLLSGEDQ-----LSKQTQTLATIGYMAPEYGT 748 (823)
Q Consensus 679 ~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~-----~~~kl~DfGla~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~ 748 (823)
+.|++.-++++|++..|.|||||+|.|+... ..+.++|||+|+.+....+ +.......||.+||+--...
T Consensus 130 A~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHl 209 (449)
T KOG1165|consen 130 AKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHL 209 (449)
T ss_pred HHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcCccccccCccccccccccceeeeEeeccc
Confidence 5688889999999999999999999999643 4689999999998865543 22334567999999999999
Q ss_pred CCccccccceehhhhhhccccCCCCCcCCCccccccccccc
Q 045449 749 KGRVSTRGDVCSFGIISGGKETRSMTVGETCTPVRESKYEV 789 (823)
Q Consensus 749 ~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~~~~~~~~~~~~ 789 (823)
+.+.+.+.|.=|+|-|+..++-|..||++........+|+.
T Consensus 210 GrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeK 250 (449)
T KOG1165|consen 210 GREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEK 250 (449)
T ss_pred cchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHH
Confidence 99999999999999999999999999999866555555543
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.39 E-value=1.3e-13 Score=138.00 Aligned_cols=131 Identities=15% Similarity=0.185 Sum_probs=96.3
Q ss_pred HHHHHH--HhccCCccceeeccC----------CeEEEEEEehHhhH---HHHHH------HHHHHHHHhhcchhhHHH-
Q 045449 620 YHELLR--ATDRFSENNLIGIGN----------GMEVAVKVFHQQYE---RALKS------FEDECEVRKRIRHRNLVK- 677 (823)
Q Consensus 620 ~~~l~~--at~~f~~~~~lg~g~----------~~~vavK~~~~~~~---~~~~~------~~~E~~~l~~l~h~niv~- 677 (823)
|.++.. ..++|...+++|.|+ +..+|||+++.... ..... |.+|+..+.++.|++|..
T Consensus 21 ~~~~~~~~l~~~y~~~~~l~~~~f~~v~l~~~~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~ 100 (232)
T PRK10359 21 YKEIFDDFLSYNIKTIKVFRNIDDTKVSLIDTDYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASL 100 (232)
T ss_pred HHHHHHHHhhCceEEEEEecCCCceEEEEEecCCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcc
Confidence 444433 346788888888665 34599999975542 22223 689999999999998775
Q ss_pred ---------------------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecc
Q 045449 678 ---------------------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFG 718 (823)
Q Consensus 678 ---------------------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfG 718 (823)
...++++++..+|+.|++|||+||+||+++.++ ++++|||
T Consensus 101 ~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~~~~~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~liDfg 179 (232)
T PRK10359 101 NDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMPEISEDVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRIIDLS 179 (232)
T ss_pred eEeeeecccccccccCCeEEEEEEECCccHHHhhhccHHHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEEECC
Confidence 135778889999999999999999999999888 9999999
Q ss_pred cccccCCCCccccccccccCCCcCcccccCCCccccccceehhhhhh
Q 045449 719 IAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIIS 765 (823)
Q Consensus 719 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~ 765 (823)
..+........ ..+.....|+.++|+||+||.+
T Consensus 180 ~~~~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~ 212 (232)
T PRK10359 180 GKRCTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYL 212 (232)
T ss_pred CcccccchhhH--------------HHHHHHhHhcccccccceeEee
Confidence 88754321110 1134445577899999999974
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.39 E-value=9.6e-15 Score=159.59 Aligned_cols=134 Identities=26% Similarity=0.238 Sum_probs=105.8
Q ss_pred eeccCCeEEEEEEehHhhH--HHHHHHHHHHHHHhhcc-hhhHHH-----------------------------------
Q 045449 636 IGIGNGMEVAVKVFHQQYE--RALKSFEDECEVRKRIR-HRNLVK----------------------------------- 677 (823)
Q Consensus 636 lg~g~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~-h~niv~----------------------------------- 677 (823)
-|.-.|..+|+|+.++... +.......|..++..++ ||.+|+
T Consensus 17 ~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rgg~lft~l~~~~~f~~ 96 (612)
T KOG0603|consen 17 GGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRGGDLFTRLSKEVMFDE 96 (612)
T ss_pred ccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcccchhhhccccCCchHH
Confidence 3444466677777754331 11124556667777775 777776
Q ss_pred -----HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCcccccCCCcc
Q 045449 678 -----IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRV 752 (823)
Q Consensus 678 -----~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 752 (823)
+.+..+-++.++|+.+|+|||+|++||+++.+|++|+.|||+++....... .+||..|||||++. ..
T Consensus 97 ~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~------~cgt~eymApEI~~--gh 168 (612)
T KOG0603|consen 97 LDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI------ACGTYEYRAPEIIN--GH 168 (612)
T ss_pred HHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhhh------cccchhhhhhHhhh--cc
Confidence 356777889999999999999999999999999999999999997654322 28999999999987 56
Q ss_pred ccccceehhhhhhccccCCCCCcCC
Q 045449 753 STRGDVCSFGIISGGKETRSMTVGE 777 (823)
Q Consensus 753 ~~~~Dv~S~Gvv~~~~~~~~~~~~~ 777 (823)
...+|.|||||+++++++|..||+.
T Consensus 169 ~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 169 LSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred CCcccchhhhhhHHHHhhCCCCCch
Confidence 7889999999999999999999987
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.38 E-value=2.1e-14 Score=153.73 Aligned_cols=175 Identities=28% Similarity=0.475 Sum_probs=106.5
Q ss_pred CCCccEEEeeccccccccCccccCCCCCCeEEeecccccccCCCccCCCcccCcccccCccccCCCCcccccccccCCCC
Q 045449 252 LPNVETLNLGINSFSGTIPSSITNSSKLSDLELGENLFSGFIPNTIGNLRNLEFGNIADNYLTSSTPELSFLSSLTNCKK 331 (823)
Q Consensus 252 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~ 331 (823)
+..-...||+.|++. .+|..++.+..|+.+.|.+|.+. .+|..++++..|.+|||+.|+++-.
T Consensus 74 ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS~l--------------- 136 (722)
T KOG0532|consen 74 LTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLSHL--------------- 136 (722)
T ss_pred ccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhhcC---------------
Confidence 444456677777776 56666666666777777777666 5566666666666666666666553
Q ss_pred ceEEEeecCCCCccCCccccccccccceEEecCCcceeccCccccCcccccEEEcccCcCCCCchhcccccCCCCEEEcc
Q 045449 332 LKVLIVTGNPLDGILPKSIGNFSLSLETILMANCSISGNIPQVVGNLSNLLVLELGGNNLTGPIPVTFSQLQTLQAFDLT 411 (823)
Q Consensus 332 L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls 411 (823)
|..++.+ -|+.|.+++|+++ .+|..++.+..|..||.+.|++. .+|..++.+.+|+.|.+.
T Consensus 137 ---------------p~~lC~l--pLkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vr 197 (722)
T KOG0532|consen 137 ---------------PDGLCDL--PLKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVR 197 (722)
T ss_pred ---------------ChhhhcC--cceeEEEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHh
Confidence 3334433 2555555555554 44555555566666666666665 455566666666666666
Q ss_pred CCCCCCcchHhhhcCCCCCEEEcccCcCcccccccccCCCCCCeEeccCCcccc
Q 045449 412 RNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSVRVLYLGLNIFTS 465 (823)
Q Consensus 412 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~ 465 (823)
.|++. .+|..++.|+ |..||+|.|+++ .||-+|.+++.|++|-|.+|.|+.
T Consensus 198 Rn~l~-~lp~El~~Lp-Li~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPLqS 248 (722)
T KOG0532|consen 198 RNHLE-DLPEELCSLP-LIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQS 248 (722)
T ss_pred hhhhh-hCCHHHhCCc-eeeeecccCcee-ecchhhhhhhhheeeeeccCCCCC
Confidence 66665 4455555443 666666666666 566666666666666666666655
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.37 E-value=2.3e-13 Score=156.52 Aligned_cols=110 Identities=25% Similarity=0.245 Sum_probs=93.1
Q ss_pred cchhhHHHHHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCc--cccccccccCCCcCccccc
Q 045449 670 IRHRNLVKIISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQ--LSKQTQTLATIGYMAPEYG 747 (823)
Q Consensus 670 l~h~niv~~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~--~~~~~~~~gt~~y~aPE~~ 747 (823)
+.-.-+-.++.|++.++.|+|..||.|||+|++|++++.++.+||+|||.+....-... .......+|+..|+|||++
T Consensus 417 ~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~ 496 (601)
T KOG0590|consen 417 LTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVL 496 (601)
T ss_pred cchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCcchhhhhhcCcccCCcCcCcccc
Confidence 34444555788999999999999999999999999999999999999999876543322 2455678999999999999
Q ss_pred CCCccccc-cceehhhhhhccccCCCCCcCCCc
Q 045449 748 TKGRVSTR-GDVCSFGIISGGKETRSMTVGETC 779 (823)
Q Consensus 748 ~~~~~~~~-~Dv~S~Gvv~~~~~~~~~~~~~~~ 779 (823)
.+..|+++ .||||.|||+..|.+++.||....
T Consensus 497 ~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~ 529 (601)
T KOG0590|consen 497 TGKEYDPRAVDVWSCGIIYICMILGRFPWKVAK 529 (601)
T ss_pred cccccCcchhhhhhccceEEEEecCCCcccccc
Confidence 99999776 799999999999999999986543
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.34 E-value=3.3e-13 Score=145.96 Aligned_cols=103 Identities=21% Similarity=0.180 Sum_probs=84.6
Q ss_pred HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCC-----CcEEEeeccccc--ccCCCCc-----ccc-ccccccCCCcCcc
Q 045449 678 IISSSLEYLHFGHSIPIIHCDLKPSNVLLDED-----MVAHISDFGIAK--LLSGEDQ-----LSK-QTQTLATIGYMAP 744 (823)
Q Consensus 678 ~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~-----~~~kl~DfGla~--~~~~~~~-----~~~-~~~~~gt~~y~aP 744 (823)
+..|++.+|+++|+.|++||||||+|+++... ..+.+.|||+|+ .+..... ... .....||..|+++
T Consensus 127 ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~ 206 (322)
T KOG1164|consen 127 IAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASI 206 (322)
T ss_pred HHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCccccccCCCCcccccCCCCccCCCCccccccH
Confidence 46799999999999999999999999999854 468999999999 4322211 111 2345699999999
Q ss_pred cccCCCccccccceehhhhhhccccCCCCCcCCCcc
Q 045449 745 EYGTKGRVSTRGDVCSFGIISGGKETRSMTVGETCT 780 (823)
Q Consensus 745 E~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~~~ 780 (823)
....+...+++.|+||++.++.++..|..||.....
T Consensus 207 ~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~ 242 (322)
T KOG1164|consen 207 NVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEM 242 (322)
T ss_pred HHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccc
Confidence 999999999999999999999999999999866543
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.29 E-value=4.1e-13 Score=153.89 Aligned_cols=97 Identities=25% Similarity=0.220 Sum_probs=81.5
Q ss_pred HHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCc-------------cccccccccCCCcCcccccC
Q 045449 682 SLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQ-------------LSKQTQTLATIGYMAPEYGT 748 (823)
Q Consensus 682 ~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~ 748 (823)
++.+++|+|+-||||||+||+|.+++.-|++|++|||+++..-.... .-.....+||+.|+|||++.
T Consensus 152 mvla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVil 231 (1205)
T KOG0606|consen 152 MVLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVIL 231 (1205)
T ss_pred hhHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhh
Confidence 35678888999999999999999999999999999999876311100 01123468999999999999
Q ss_pred CCccccccceehhhhhhccccCCCCCcCCC
Q 045449 749 KGRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 749 ~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
...|+..+|+|++|+|+||++.|..||.+.
T Consensus 232 rqgygkpvdwwamGiIlyeFLVgcvpffGd 261 (1205)
T KOG0606|consen 232 RQGYGKPVDWWAMGIILYEFLVGCVPFFGD 261 (1205)
T ss_pred hhccCCCccHHHHHHHHHHHheeeeeccCC
Confidence 999999999999999999999999998665
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.28 E-value=5.4e-12 Score=140.95 Aligned_cols=200 Identities=36% Similarity=0.524 Sum_probs=118.2
Q ss_pred EEEcCCCCCccccCcccCCCCCCcEEEccCCCCCCCCCCCCCCCC-CCCEEECCCCcCcCCCchhhhcCCCCcEEecccc
Q 045449 56 GLNISSFNLQGTITPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMH-TLKLLDFSDNQLFGSLSSFIFNMSSMTTIDLSIN 134 (823)
Q Consensus 56 ~L~L~~~~l~g~~~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 134 (823)
.|++..+.+...+ ..+..++.++.|++.+|.++ .+|.....++ +|+.|++++|.+. .+|..++.+++|+.|++++|
T Consensus 97 ~l~~~~~~~~~~~-~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N 173 (394)
T COG4886 97 SLDLNLNRLRSNI-SELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFN 173 (394)
T ss_pred eeeccccccccCc-hhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCc
Confidence 3555555554322 23445566777777777776 5666666664 7777777777765 44456667777777777777
Q ss_pred cccCccCccccCCCCCCccccccceeeeccceeeccCccccccchhhHHHHHhhcCCCcccCCcccCCcchhhhhccccc
Q 045449 135 RLSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKEIGNLTKLKEIISTITNSTVCEIPREIGNLPYLARLALATN 214 (823)
Q Consensus 135 ~l~~~~p~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~~l~~n~~~~~ip~~l~~l~~L~~L~Ls~N 214 (823)
+++ .+|... +.+++|+.|++++|+++ .+|..+. ....|++|++++|
T Consensus 174 ~l~-~l~~~~-------~~~~~L~~L~ls~N~i~-~l~~~~~-------------------------~~~~L~~l~~~~N 219 (394)
T COG4886 174 DLS-DLPKLL-------SNLSNLNNLDLSGNKIS-DLPPEIE-------------------------LLSALEELDLSNN 219 (394)
T ss_pred hhh-hhhhhh-------hhhhhhhheeccCCccc-cCchhhh-------------------------hhhhhhhhhhcCC
Confidence 766 223221 35667777777777776 4554433 3334555566666
Q ss_pred cccCCccccccCCCCCcEEEccCCcccccCCcccccCCCCccEEEeeccccccccCccccCCCCCCeEEeecccccccCC
Q 045449 215 NLVGVVPVTIFNMSALKEISLLNNSLSGSLPSRIDLSLPNVETLNLGINSFSGTIPSSITNSSKLSDLELGENLFSGFIP 294 (823)
Q Consensus 215 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 294 (823)
.+. ..+..+.++.++..+.+.+|++. .++..+.. ++++++|++++|+++. ++. ++.+.+++.|++++|.+....|
T Consensus 220 ~~~-~~~~~~~~~~~l~~l~l~~n~~~-~~~~~~~~-l~~l~~L~~s~n~i~~-i~~-~~~~~~l~~L~~s~n~~~~~~~ 294 (394)
T COG4886 220 SII-ELLSSLSNLKNLSGLELSNNKLE-DLPESIGN-LSNLETLDLSNNQISS-ISS-LGSLTNLRELDLSGNSLSNALP 294 (394)
T ss_pred cce-ecchhhhhcccccccccCCceee-eccchhcc-ccccceeccccccccc-ccc-ccccCccCEEeccCccccccch
Confidence 432 23445566666666666666665 33333333 5667777777777663 333 6666777777777777765555
Q ss_pred Ccc
Q 045449 295 NTI 297 (823)
Q Consensus 295 ~~~ 297 (823)
...
T Consensus 295 ~~~ 297 (394)
T COG4886 295 LIA 297 (394)
T ss_pred hhh
Confidence 443
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.27 E-value=4.9e-12 Score=141.28 Aligned_cols=183 Identities=30% Similarity=0.435 Sum_probs=127.9
Q ss_pred CCCCceEEEeecCCCCccCCcccccccc-ccceEEecCCcceeccCccccCcccccEEEcccCcCCCCchhcccccCCCC
Q 045449 328 NCKKLKVLIVTGNPLDGILPKSIGNFSL-SLETILMANCSISGNIPQVVGNLSNLLVLELGGNNLTGPIPVTFSQLQTLQ 406 (823)
Q Consensus 328 ~l~~L~~L~Ls~N~l~~~~p~~~~~~~~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~ 406 (823)
.++.++.|++.+|.++.. |...... . +|+.|++++|++. .+|..+..+++|+.|++++|+++ .+|...+.++.|+
T Consensus 114 ~~~~l~~L~l~~n~i~~i-~~~~~~~-~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L~ 189 (394)
T COG4886 114 ELTNLTSLDLDNNNITDI-PPLIGLL-KSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLN 189 (394)
T ss_pred cccceeEEecCCcccccC-ccccccc-hhhcccccccccchh-hhhhhhhccccccccccCCchhh-hhhhhhhhhhhhh
Confidence 335566666666666533 3323322 2 6777777777776 44456777888888888888887 5665555777888
Q ss_pred EEEccCCCCCCcchHhhhcCCCCCEEEcccCcCcccccccccCCCCCCeEeccCCccccccchhhhccCCCcEEeccccc
Q 045449 407 AFDLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSVRVLYLGLNIFTSVLSSTIWNLKDILFIDVSSNF 486 (823)
Q Consensus 407 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~LdLs~N~ 486 (823)
.|++++|+++ .+|.....+..|++|++++|.+. .++..+.+++++..+.+++|++... +..++.++.++.|++++|.
T Consensus 190 ~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~~~-~~~~~~l~~l~~L~~s~n~ 266 (394)
T COG4886 190 NLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLEDL-PESIGNLSNLETLDLSNNQ 266 (394)
T ss_pred heeccCCccc-cCchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceeeec-cchhccccccceecccccc
Confidence 8888888887 55665555566888888888644 4566777788888888888877653 6677778888888888888
Q ss_pred cccccCccccCCCCCcEEEcccCCCCCCCCCcc
Q 045449 487 LDGPLSLDIGNLKVVIGLDFSRNNLSGDIPITI 519 (823)
Q Consensus 487 l~g~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~ 519 (823)
++...+ ++.+..++.||+++|.++...|...
T Consensus 267 i~~i~~--~~~~~~l~~L~~s~n~~~~~~~~~~ 297 (394)
T COG4886 267 ISSISS--LGSLTNLRELDLSGNSLSNALPLIA 297 (394)
T ss_pred cccccc--ccccCccCEEeccCccccccchhhh
Confidence 875444 7788888888888888886655544
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.24 E-value=6.6e-12 Score=135.80 Aligned_cols=138 Identities=36% Similarity=0.466 Sum_probs=107.8
Q ss_pred eEEEEEEehHhhHH---HHHHHHHHHHHHhhcchh-hHHH----------------------------------------
Q 045449 642 MEVAVKVFHQQYER---ALKSFEDECEVRKRIRHR-NLVK---------------------------------------- 677 (823)
Q Consensus 642 ~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~-niv~---------------------------------------- 677 (823)
..+|+|.+...... ....|.+|+.+++.+.|+ ++++
T Consensus 23 ~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 102 (384)
T COG0515 23 KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESE 102 (384)
T ss_pred cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecCCCCcHHHHHHhcccccCCCHHH
Confidence 34677777654422 356788888888888777 5666
Q ss_pred ---HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCC-cEEEeecccccccCCCCccc----cccccccCCCcCcccccCC
Q 045449 678 ---IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDM-VAHISDFGIAKLLSGEDQLS----KQTQTLATIGYMAPEYGTK 749 (823)
Q Consensus 678 ---~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~-~~kl~DfGla~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~ 749 (823)
++.|++.++.++|+.+++|||+||+||+++... .++++|||.++......... ......||..|+|||...+
T Consensus 103 ~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~ 182 (384)
T COG0515 103 ALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLG 182 (384)
T ss_pred HHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCccccccccccccccccccCCHHHhcC
Confidence 346777788899999999999999999999888 79999999998654433221 2356789999999999887
Q ss_pred ---CccccccceehhhhhhccccCCCCCcCCCc
Q 045449 750 ---GRVSTRGDVCSFGIISGGKETRSMTVGETC 779 (823)
Q Consensus 750 ---~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~~ 779 (823)
..+....|+||+|++++++.++..|+....
T Consensus 183 ~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~ 215 (384)
T COG0515 183 LSLAYASSSSDIWSLGITLYELLTGLPPFEGEK 215 (384)
T ss_pred CCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 578899999999999999999998865543
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.21 E-value=8.2e-12 Score=122.31 Aligned_cols=149 Identities=18% Similarity=0.088 Sum_probs=101.6
Q ss_pred ccCCccceeeccCCeEEEEEEehHhhH----HHHHHHHHHHHHHhhcch-hhHHH-------------------------
Q 045449 628 DRFSENNLIGIGNGMEVAVKVFHQQYE----RALKSFEDECEVRKRIRH-RNLVK------------------------- 677 (823)
Q Consensus 628 ~~f~~~~~lg~g~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~h-~niv~------------------------- 677 (823)
+.|......+.+ +..++.+.+..... -....|.+|+++++++.| +++.+
T Consensus 13 ~~f~~v~~~~~~-~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~~~~~lvmeyI~G~~L~~~~~~ 91 (218)
T PRK12274 13 DTFGRILLVRGG-ERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHWDGRHLDRSYLAGAAMYQRPPR 91 (218)
T ss_pred CCcceEEEeecC-CceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEEcCEEEEEeeecCccHHhhhhh
Confidence 445544444553 46677666643321 122368899999999954 44443
Q ss_pred ----HHHHHHHHhhhcCCCCEEeccC-CCCCEEeCCCCcEEEeecccccccCCCCcc----c--c-----ccccccCCCc
Q 045449 678 ----IISSSLEYLHFGHSIPIIHCDL-KPSNVLLDEDMVAHISDFGIAKLLSGEDQL----S--K-----QTQTLATIGY 741 (823)
Q Consensus 678 ----~~~~~l~~L~~~h~~~ivHrdl-k~~NiLl~~~~~~kl~DfGla~~~~~~~~~----~--~-----~~~~~gt~~y 741 (823)
++.|++++|+++|+.||+|||| ||+|||++.++.++|+|||+|......... . . ......++.|
T Consensus 92 ~~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~ 171 (218)
T PRK12274 92 GDLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAA 171 (218)
T ss_pred hhHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCC
Confidence 3567788899999999999999 799999999999999999999865432210 0 0 0112367888
Q ss_pred CcccccCCC-ccc-cccceehhhhhhccccCCCCCcCC
Q 045449 742 MAPEYGTKG-RVS-TRGDVCSFGIISGGKETRSMTVGE 777 (823)
Q Consensus 742 ~aPE~~~~~-~~~-~~~Dv~S~Gvv~~~~~~~~~~~~~ 777 (823)
++|+...-- ..+ ...+.++-|.-+|++.|+..+.-+
T Consensus 172 l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 172 LTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred CCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence 888743221 222 456889999999999999987533
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.19 E-value=2.7e-11 Score=124.79 Aligned_cols=167 Identities=19% Similarity=0.151 Sum_probs=103.0
Q ss_pred eeeccCCeEEEEEEehHhhHHHHHHHHHHHHHHhhcchhhHHHHHHHHHHHhhhcCCCCEEeccCCCCCEEe--CCCC--
Q 045449 635 LIGIGNGMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVKIISSSLEYLHFGHSIPIIHCDLKPSNVLL--DEDM-- 710 (823)
Q Consensus 635 ~lg~g~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~l~~L~~~h~~~ivHrdlk~~NiLl--~~~~-- 710 (823)
..|++....+++|+.+....+ .-.-....-++-.-+++|.++++.|+|++||.|||+|++|||+ |+|.
T Consensus 311 g~g~~~tlylvMkrY~~tLr~--------yl~~~~~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P 382 (598)
T KOG4158|consen 311 GAGEPKTLYLVMKRYRQTLRE--------YLWTRHRSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIP 382 (598)
T ss_pred ccCCCceEEEehhcchhhHHH--------HHhcCCCchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCc
Confidence 345554455677776544322 1112222233444578999999999999999999999999998 4555
Q ss_pred cEEEeecccccccCCC----CccccccccccCCCcCcccccCCCc------cccccceehhhhhhccccCCCCCcCCCcc
Q 045449 711 VAHISDFGIAKLLSGE----DQLSKQTQTLATIGYMAPEYGTKGR------VSTRGDVCSFGIISGGKETRSMTVGETCT 780 (823)
Q Consensus 711 ~~kl~DfGla~~~~~~----~~~~~~~~~~gt~~y~aPE~~~~~~------~~~~~Dv~S~Gvv~~~~~~~~~~~~~~~~ 780 (823)
...|+|||.+---... ...+......|...-||||+....+ --.|+|.|+.|.+.||++...-||..--+
T Consensus 383 ~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGe 462 (598)
T KOG4158|consen 383 QLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGE 462 (598)
T ss_pred EEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccch
Confidence 4578999986421110 0111122345677889999875432 14689999999999999999999876322
Q ss_pred cccccccccCCcccccccCCCcccccccc
Q 045449 781 PVRESKYEVHPATTTIMEHPLPRVGEVMD 809 (823)
Q Consensus 781 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 809 (823)
.....+-......+.+++.+.|..++++.
T Consensus 463 m~L~~r~Yqe~qLPalp~~vpp~~rqlV~ 491 (598)
T KOG4158|consen 463 MLLDTRTYQESQLPALPSRVPPVARQLVF 491 (598)
T ss_pred heechhhhhhhhCCCCcccCChHHHHHHH
Confidence 22111111112233445555555555443
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.16 E-value=1.8e-11 Score=126.41 Aligned_cols=94 Identities=20% Similarity=0.252 Sum_probs=68.0
Q ss_pred HHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCcccccCC--------Cc
Q 045449 680 SSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTK--------GR 751 (823)
Q Consensus 680 ~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~ 751 (823)
.|++..++++|+.|+||+||||+|++++.+|.++|+||+....... .... ...+..|.+||.... ..
T Consensus 152 ~Q~I~lvA~Lh~~GlVHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~--~~~~---~~~~~~~~PPe~~~~~~~~~~~~~~ 226 (288)
T PF14531_consen 152 VQMIRLVANLHSYGLVHGDIKPENFLLDQDGGVFLGDFSSLVRAGT--RYRC---SEFPVAFTPPELESCAGQFGQNNAP 226 (288)
T ss_dssp HHHHHHHHHHHHTTEEEST-SGGGEEE-TTS-EEE--GGGEEETTE--EEEG---GGS-TTTS-HHHHHHHTSCHHSEEE
T ss_pred HHHHHHHHHHhhcceEecccceeeEEEcCCCCEEEcChHHHeecCc--eeec---cCCCcccCChhhhhhhcccCcccce
Confidence 5677778888999999999999999999999999999987765432 1111 234578999997543 24
Q ss_pred cccccceehhhhhhccccCCCCCcCCC
Q 045449 752 VSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 752 ~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
++.+.|.|++|+++|.+.+++.||+..
T Consensus 227 ~t~~~DaW~LG~~ly~lWC~~lPf~~~ 253 (288)
T PF14531_consen 227 YTFATDAWQLGITLYSLWCGRLPFGLS 253 (288)
T ss_dssp E-HHHHHHHHHHHHHHHHHSS-STCCC
T ss_pred eeeccCHHHHHHHHHHHHHccCCCCCC
Confidence 788999999999999999999999764
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.13 E-value=1.1e-11 Score=123.02 Aligned_cols=136 Identities=26% Similarity=0.339 Sum_probs=112.3
Q ss_pred ccccCcccccEEEcccCcCCCCchhcccccCCCCEEEccCCCCCCcchHhhhcCCCCCEEEcccCcCcccccccccCCCC
Q 045449 373 QVVGNLSNLLVLELGGNNLTGPIPVTFSQLQTLQAFDLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTS 452 (823)
Q Consensus 373 ~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~ 452 (823)
..+...+.|+++|||+|.++ .+..+..-++.++.|++|+|.+... ..+..+.+|+.||||+|.++ .+-.+-..+-+
T Consensus 278 ~~~dTWq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v--~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGN 353 (490)
T KOG1259|consen 278 VSADTWQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTV--QNLAELPQLQLLDLSGNLLA-ECVGWHLKLGN 353 (490)
T ss_pred EecchHhhhhhccccccchh-hhhhhhhhccceeEEeccccceeee--hhhhhcccceEeecccchhH-hhhhhHhhhcC
Confidence 33445677899999999998 7777888889999999999999833 33888999999999999998 55566677788
Q ss_pred CCeEeccCCccccccchhhhccCCCcEEeccccccccccC-ccccCCCCCcEEEcccCCCCCC
Q 045449 453 VRVLYLGLNIFTSVLSSTIWNLKDILFIDVSSNFLDGPLS-LDIGNLKVVIGLDFSRNNLSGD 514 (823)
Q Consensus 453 L~~L~Ls~N~l~~~~p~~~~~l~~L~~LdLs~N~l~g~~p-~~~~~l~~L~~L~ls~N~l~g~ 514 (823)
.+.|.|+.|.+... +.++.+-+|..||+++|++...-. ..+++++-|+.+.|.+|.+.+.
T Consensus 354 IKtL~La~N~iE~L--SGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~ 414 (490)
T KOG1259|consen 354 IKTLKLAQNKIETL--SGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGS 414 (490)
T ss_pred EeeeehhhhhHhhh--hhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCcccc
Confidence 89999999988754 567888899999999999985432 5789999999999999999853
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.13 E-value=2e-11 Score=127.63 Aligned_cols=210 Identities=24% Similarity=0.337 Sum_probs=113.9
Q ss_pred CCCCCcEEEccCCCCCCCCC--CCCCCCCCCCEEECCCCcCcCCCc--hhhhcCCCCcEEecccccccCccCccccCCCC
Q 045449 74 NLSSLQTLDLSHNKLSGNIP--SSIFNMHTLKLLDFSDNQLFGSLS--SFIFNMSSMTTIDLSINRLSGELPANICKIPS 149 (823)
Q Consensus 74 ~l~~L~~L~Ls~N~l~g~~p--~~~~~l~~L~~L~Ls~N~l~~~~p--~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~p~ 149 (823)
++.+|+...|.+.... ..+ .....+++++.||||.|-|....| .....+++|+.|+||.|++.-.......
T Consensus 119 n~kkL~~IsLdn~~V~-~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~---- 193 (505)
T KOG3207|consen 119 NLKKLREISLDNYRVE-DAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTT---- 193 (505)
T ss_pred hHHhhhheeecCcccc-ccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccch----
Confidence 4556777777666654 222 244566777777777776654322 3345677777777777777644333221
Q ss_pred CCccccccceeeeccceeeccCccccccchhhHHHHHhhcCCCcccCCcccCCcchhhhhccccccccCCccccccCCCC
Q 045449 150 TLSKCKQLEELNLGFNNLSGAIPKEIGNLTKLKEIISTITNSTVCEIPREIGNLPYLARLALATNNLVGVVPVTIFNMSA 229 (823)
Q Consensus 150 ~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~~l~~n~~~~~ip~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 229 (823)
..++.|+.|.|++|.|+-. .+ . .....+++|+.|+|..|............++.
T Consensus 194 --~~l~~lK~L~l~~CGls~k---~V------~---------------~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~ 247 (505)
T KOG3207|consen 194 --LLLSHLKQLVLNSCGLSWK---DV------Q---------------WILLTFPSLEVLYLEANEIILIKATSTKILQT 247 (505)
T ss_pred --hhhhhhheEEeccCCCCHH---HH------H---------------HHHHhCCcHHHhhhhcccccceecchhhhhhH
Confidence 2456677777777766511 11 0 11234566777777777533333334445666
Q ss_pred CcEEEccCCcccccCC--cccccCCCCccEEEeecccccccc-Ccc-----ccCCCCCCeEEeecccccccC-CCccCCC
Q 045449 230 LKEISLLNNSLSGSLP--SRIDLSLPNVETLNLGINSFSGTI-PSS-----ITNSSKLSDLELGENLFSGFI-PNTIGNL 300 (823)
Q Consensus 230 L~~L~Ls~N~l~g~lp--~~~~~~l~~L~~L~Ls~N~l~~~~-p~~-----~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l 300 (823)
|++|||++|++- ..+ ...+ .++.|..|+++.+.+...- |+. ...+++|++|+++.|++...- -..+..+
T Consensus 248 L~~LdLs~N~li-~~~~~~~~~-~l~~L~~Lnls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~~w~sl~~l~~l 325 (505)
T KOG3207|consen 248 LQELDLSNNNLI-DFDQGYKVG-TLPGLNQLNLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIRDWRSLNHLRTL 325 (505)
T ss_pred HhhccccCCccc-ccccccccc-cccchhhhhccccCcchhcCCCccchhhhcccccceeeecccCccccccccchhhcc
Confidence 777777777665 333 1222 2666666666666665322 222 234556666666666664321 1223334
Q ss_pred cccCcccccCccccCC
Q 045449 301 RNLEFGNIADNYLTSS 316 (823)
Q Consensus 301 ~~L~~L~L~~N~l~~~ 316 (823)
++|+.|....|+++..
T Consensus 326 ~nlk~l~~~~n~ln~e 341 (505)
T KOG3207|consen 326 ENLKHLRITLNYLNKE 341 (505)
T ss_pred chhhhhhccccccccc
Confidence 4555555555555543
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.09 E-value=4.2e-11 Score=118.63 Aligned_cols=44 Identities=18% Similarity=0.191 Sum_probs=38.8
Q ss_pred HHHHHHHhhhc-CCCCEEeccCCCCCEEeCCCCcEEEeeccccccc
Q 045449 679 ISSSLEYLHFG-HSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLL 723 (823)
Q Consensus 679 ~~~~l~~L~~~-h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~ 723 (823)
+.|++++|.++ |+.||+|||+||+||+++ ++.++|+|||+|...
T Consensus 123 ~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~v~LiDFG~a~~~ 167 (190)
T cd05147 123 YLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGKLYIIDVSQSVEH 167 (190)
T ss_pred HHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCcEEEEEccccccC
Confidence 56778888888 799999999999999998 478999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.07 E-value=1.4e-11 Score=137.83 Aligned_cols=107 Identities=21% Similarity=0.382 Sum_probs=45.6
Q ss_pred CcchhhhhccccccccCCccccccCCCCCcEEEccCCcccccCCcccccCCCCccEEEeeccccccccCccccCCCCCCe
Q 045449 202 NLPYLARLALATNNLVGVVPVTIFNMSALKEISLLNNSLSGSLPSRIDLSLPNVETLNLGINSFSGTIPSSITNSSKLSD 281 (823)
Q Consensus 202 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 281 (823)
.+..++.+++..|.+.. +-..+..+++|+.|++.+|+|. .+...+. .+++|++|+|++|.|+... .+..++.|+.
T Consensus 70 ~l~~l~~l~l~~n~i~~-~~~~l~~~~~l~~l~l~~n~i~-~i~~~l~-~~~~L~~L~ls~N~I~~i~--~l~~l~~L~~ 144 (414)
T KOG0531|consen 70 SLTSLKELNLRQNLIAK-ILNHLSKLKSLEALDLYDNKIE-KIENLLS-SLVNLQVLDLSFNKITKLE--GLSTLTLLKE 144 (414)
T ss_pred HhHhHHhhccchhhhhh-hhcccccccceeeeeccccchh-hcccchh-hhhcchheecccccccccc--chhhccchhh
Confidence 34455555555555553 1222344455555555555554 2222111 1444555555555444222 1233333444
Q ss_pred EEeecccccccCCCccCCCcccCcccccCccccC
Q 045449 282 LELGENLFSGFIPNTIGNLRNLEFGNIADNYLTS 315 (823)
Q Consensus 282 L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 315 (823)
|++++|.++.+ ..+..++.|+.+++++|.++.
T Consensus 145 L~l~~N~i~~~--~~~~~l~~L~~l~l~~n~i~~ 176 (414)
T KOG0531|consen 145 LNLSGNLISDI--SGLESLKSLKLLDLSYNRIVD 176 (414)
T ss_pred heeccCcchhc--cCCccchhhhcccCCcchhhh
Confidence 44444444422 223334444444444444443
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.05 E-value=2.2e-10 Score=113.88 Aligned_cols=47 Identities=23% Similarity=0.202 Sum_probs=41.8
Q ss_pred HHHHHHHHhhhcCC-CCEEeccCCCCCEEeCCCCcEEEeecccccccCC
Q 045449 678 IISSSLEYLHFGHS-IPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSG 725 (823)
Q Consensus 678 ~~~~~l~~L~~~h~-~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~ 725 (823)
++.|+++++.++|. .||+||||||+||+++ ++.++|+|||+|+....
T Consensus 122 i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 122 LYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGKPYIIDVSQAVELDH 169 (190)
T ss_pred HHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCCEEEEEcccceecCC
Confidence 45688888999999 9999999999999999 78999999999987643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PF08263 LRRNT_2: Leucine rich repeat N-terminal domain; InterPro: IPR013210 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape [] | Back alignment and domain information |
|---|
Probab=99.04 E-value=1.5e-10 Score=83.78 Aligned_cols=40 Identities=40% Similarity=0.893 Sum_probs=30.9
Q ss_pred HHHHHHHHHHHHhccCCCccccccccCCC--CCCccceeeeeC
Q 045449 8 SQHQQALLALKAHISYDHTNLFARNWTSS--TSVCIWIGITCD 48 (823)
Q Consensus 8 ~~~~~aLl~~k~~~~~~~~~~~~~~W~~~--~~~c~w~gv~c~ 48 (823)
++|++|||+||+++..||.+.+. +|+.+ .+||+|.||+||
T Consensus 2 ~~d~~aLl~~k~~l~~~~~~~l~-~W~~~~~~~~C~W~GV~Cd 43 (43)
T PF08263_consen 2 NQDRQALLAFKKSLNNDPSGVLS-SWNPSSDSDPCSWSGVTCD 43 (43)
T ss_dssp HHHHHHHHHHHHCTT-SC-CCCT-T--TT--S-CCCSTTEEE-
T ss_pred cHHHHHHHHHHHhcccccCcccc-cCCCcCCCCCeeeccEEeC
Confidence 68999999999999877777777 99987 799999999996
|
LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. This domain is often found at the N terminus of tandem leucine rich repeats.; PDB: 3RGZ_A 3RJ0_A 3RIZ_A 3RGX_A 1OGQ_A. |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.04 E-value=6.7e-11 Score=136.13 Aligned_cols=97 Identities=22% Similarity=0.199 Sum_probs=71.5
Q ss_pred HHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccC-CCCcccccc----ccccCCCcCcccccCCC---
Q 045449 679 ISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLS-GEDQLSKQT----QTLATIGYMAPEYGTKG--- 750 (823)
Q Consensus 679 ~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~-~~~~~~~~~----~~~gt~~y~aPE~~~~~--- 750 (823)
+-|++.+|..+|+.||+|+|||.+|||++.-..+.|+||.--+... +++.....+ +...-..|.|||.+...
T Consensus 126 aFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~ 205 (1431)
T KOG1240|consen 126 AFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGK 205 (1431)
T ss_pred HHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCCcccceEEEecCCceeeecChHhhhccccc
Confidence 5689999999999999999999999999999999999998665421 222211111 11223479999965431
Q ss_pred -------c-cccccceehhhhhhccccCCCCCc
Q 045449 751 -------R-VSTRGDVCSFGIISGGKETRSMTV 775 (823)
Q Consensus 751 -------~-~~~~~Dv~S~Gvv~~~~~~~~~~~ 775 (823)
. .+++-||||+|||++|+.+...|.
T Consensus 206 ~~~~q~~~~L~paMDIFS~GCViaELf~Eg~Pl 238 (1431)
T KOG1240|consen 206 TSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPL 238 (1431)
T ss_pred cccCCcccccChhhhhhhhhHHHHHHHhcCCCc
Confidence 1 467889999999999998764443
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.01 E-value=6.2e-10 Score=106.99 Aligned_cols=105 Identities=29% Similarity=0.343 Sum_probs=27.2
Q ss_pred ccceEEecCCcceeccCcccc-CcccccEEEcccCcCCCCchhcccccCCCCEEEccCCCCCCcchHhhhcCCCCCEEEc
Q 045449 356 SLETILMANCSISGNIPQVVG-NLSNLLVLELGGNNLTGPIPVTFSQLQTLQAFDLTRNKLAGPITDELCHLARLHSLVL 434 (823)
Q Consensus 356 ~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 434 (823)
.+++|+|++|.|+.+ ..++ .+.+|+.|||++|.++. ++ .+..++.|+.|++++|+|+...+.....+++|++|+|
T Consensus 20 ~~~~L~L~~n~I~~I--e~L~~~l~~L~~L~Ls~N~I~~-l~-~l~~L~~L~~L~L~~N~I~~i~~~l~~~lp~L~~L~L 95 (175)
T PF14580_consen 20 KLRELNLRGNQISTI--ENLGATLDKLEVLDLSNNQITK-LE-GLPGLPRLKTLDLSNNRISSISEGLDKNLPNLQELYL 95 (175)
T ss_dssp ------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS---S-CHHHHHH-TT--EEE-
T ss_pred ccccccccccccccc--cchhhhhcCCCEEECCCCCCcc-cc-CccChhhhhhcccCCCCCCccccchHHhCCcCCEEEC
Confidence 344444444444422 1232 35566666666666663 32 3555666666666666666332222234566666666
Q ss_pred ccCcCcccc-cccccCCCCCCeEeccCCccc
Q 045449 435 QGNKFSGSI-PSCLGNLTSVRVLYLGLNIFT 464 (823)
Q Consensus 435 s~N~l~g~~-p~~~~~l~~L~~L~Ls~N~l~ 464 (823)
++|+|...- -..+..+++|+.|+|.+|.++
T Consensus 96 ~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~ 126 (175)
T PF14580_consen 96 SNNKISDLNELEPLSSLPKLRVLSLEGNPVC 126 (175)
T ss_dssp TTS---SCCCCGGGGG-TT--EEE-TT-GGG
T ss_pred cCCcCCChHHhHHHHcCCCcceeeccCCccc
Confidence 666665321 123344455555555555444
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.99 E-value=7.1e-11 Score=120.45 Aligned_cols=238 Identities=20% Similarity=0.337 Sum_probs=157.8
Q ss_pred CCCccEEEeeccccccc----cCccccCCCCCCeEEeecccccc----cCCCccCCCcccCcccccCccccCCCCccccc
Q 045449 252 LPNVETLNLGINSFSGT----IPSSITNSSKLSDLELGENLFSG----FIPNTIGNLRNLEFGNIADNYLTSSTPELSFL 323 (823)
Q Consensus 252 l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~ 323 (823)
+..++.++||+|.|... +-..+.+.++|+..++|+- ++| .+|+.+. .+.
T Consensus 29 ~~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~-ftGR~~~Ei~e~L~----------------------~l~ 85 (382)
T KOG1909|consen 29 MDSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDM-FTGRLKDEIPEALK----------------------MLS 85 (382)
T ss_pred cCceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhh-hcCCcHHHHHHHHH----------------------HHH
Confidence 55677777777776422 2233444556666666542 222 2222211 022
Q ss_pred ccccCCCCceEEEeecCCCCccCCcccccc---ccccceEEecCCcceecc-------------CccccCcccccEEEcc
Q 045449 324 SSLTNCKKLKVLIVTGNPLDGILPKSIGNF---SLSLETILMANCSISGNI-------------PQVVGNLSNLLVLELG 387 (823)
Q Consensus 324 ~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~---~~~L~~L~L~~N~l~~~~-------------p~~~~~l~~L~~L~Ls 387 (823)
..+..+++|++|+||.|.|.-.-+..|..+ ..+|++|+|.+|.+.-.- ....+.-+.|+++...
T Consensus 86 ~aL~~~~~L~~ldLSDNA~G~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~al~~l~~~kk~~~~~~Lrv~i~~ 165 (382)
T KOG1909|consen 86 KALLGCPKLQKLDLSDNAFGPKGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGRALFELAVNKKAASKPKLRVFICG 165 (382)
T ss_pred HHHhcCCceeEeeccccccCccchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHHHHHHHHHHhccCCCcceEEEEee
Confidence 345566677777777777764444433322 146777777777665211 1223445789999999
Q ss_pred cCcCCCC----chhcccccCCCCEEEccCCCCCCc----chHhhhcCCCCCEEEcccCcCccc----ccccccCCCCCCe
Q 045449 388 GNNLTGP----IPVTFSQLQTLQAFDLTRNKLAGP----ITDELCHLARLHSLVLQGNKFSGS----IPSCLGNLTSVRV 455 (823)
Q Consensus 388 ~N~l~g~----~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~g~----~p~~~~~l~~L~~ 455 (823)
+|++... +...|...+.|+.+.++.|.|... +...|..++.|+.|||..|.|+-. +...+..++.|+.
T Consensus 166 rNrlen~ga~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~E 245 (382)
T KOG1909|consen 166 RNRLENGGATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRE 245 (382)
T ss_pred ccccccccHHHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchhee
Confidence 9999743 334567778999999999998632 234567899999999999999743 3345677889999
Q ss_pred EeccCCccccccchhh-----hccCCCcEEecccccccc----ccCccccCCCCCcEEEcccCCCC
Q 045449 456 LYLGLNIFTSVLSSTI-----WNLKDILFIDVSSNFLDG----PLSLDIGNLKVVIGLDFSRNNLS 512 (823)
Q Consensus 456 L~Ls~N~l~~~~p~~~-----~~l~~L~~LdLs~N~l~g----~~p~~~~~l~~L~~L~ls~N~l~ 512 (823)
|+++.+.+...-...+ ...+.|++|++.+|.++- .+..++...+.|..|+|++|.|.
T Consensus 246 l~l~dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l~ 311 (382)
T KOG1909|consen 246 LNLGDCLLENEGAIAFVDALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRLG 311 (382)
T ss_pred ecccccccccccHHHHHHHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCccccc
Confidence 9999999876544433 236899999999999985 34456777899999999999884
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.98 E-value=9.7e-11 Score=116.43 Aligned_cols=132 Identities=26% Similarity=0.257 Sum_probs=104.7
Q ss_pred cccceEEecCCcceeccCccccCcccccEEEcccCcCCCCchhcccccCCCCEEEccCCCCCCcchHhhhcCCCCCEEEc
Q 045449 355 LSLETILMANCSISGNIPQVVGNLSNLLVLELGGNNLTGPIPVTFSQLQTLQAFDLTRNKLAGPITDELCHLARLHSLVL 434 (823)
Q Consensus 355 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 434 (823)
..|++++||+|.|+ .+..++.-.+.++.|++|+|.+. .+. .+..+++|+.||||+|.++ .+..+-..+.+++.|.|
T Consensus 284 q~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~-~v~-nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~L 359 (490)
T KOG1259|consen 284 QELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIR-TVQ-NLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLKL 359 (490)
T ss_pred hhhhhccccccchh-hhhhhhhhccceeEEecccccee-eeh-hhhhcccceEeecccchhH-hhhhhHhhhcCEeeeeh
Confidence 56888888888887 45666777888999999999987 343 3778889999999999988 55566677888999999
Q ss_pred ccCcCcccccccccCCCCCCeEeccCCcccccc-chhhhccCCCcEEeccccccccccC
Q 045449 435 QGNKFSGSIPSCLGNLTSVRVLYLGLNIFTSVL-SSTIWNLKDILFIDVSSNFLDGPLS 492 (823)
Q Consensus 435 s~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~LdLs~N~l~g~~p 492 (823)
+.|.+... +.+..+-+|..||+++|++.... -..+++++-|+.+.|-+|.+.+...
T Consensus 360 a~N~iE~L--SGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~vd 416 (490)
T KOG1259|consen 360 AQNKIETL--SGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGSVD 416 (490)
T ss_pred hhhhHhhh--hhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccccch
Confidence 99987633 44677888999999999887642 3578899999999999999986543
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.97 E-value=4.4e-11 Score=133.92 Aligned_cols=108 Identities=24% Similarity=0.317 Sum_probs=62.5
Q ss_pred CCCCCcEEEccCCcccccCCcccccCCCCccEEEeeccccccccCccccCCCCCCeEEeecccccccCCCccCCCcccCc
Q 045449 226 NMSALKEISLLNNSLSGSLPSRIDLSLPNVETLNLGINSFSGTIPSSITNSSKLSDLELGENLFSGFIPNTIGNLRNLEF 305 (823)
Q Consensus 226 ~l~~L~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 305 (823)
.+..++.+++..|.++ .+-..+. .+.+|+.|++..|+|..+ ...+..+++|++|+|++|+|+.+. .+..++.|+.
T Consensus 70 ~l~~l~~l~l~~n~i~-~~~~~l~-~~~~l~~l~l~~n~i~~i-~~~l~~~~~L~~L~ls~N~I~~i~--~l~~l~~L~~ 144 (414)
T KOG0531|consen 70 SLTSLKELNLRQNLIA-KILNHLS-KLKSLEALDLYDNKIEKI-ENLLSSLVNLQVLDLSFNKITKLE--GLSTLTLLKE 144 (414)
T ss_pred HhHhHHhhccchhhhh-hhhcccc-cccceeeeeccccchhhc-ccchhhhhcchheecccccccccc--chhhccchhh
Confidence 4456666667777776 2222222 266777777777777633 222556666777777777776553 2445555666
Q ss_pred ccccCccccCCCCcccccccccCCCCceEEEeecCCCCcc
Q 045449 306 GNIADNYLTSSTPELSFLSSLTNCKKLKVLIVTGNPLDGI 345 (823)
Q Consensus 306 L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~ 345 (823)
|++++|.++.. ..+..++.|+.+++++|.+...
T Consensus 145 L~l~~N~i~~~-------~~~~~l~~L~~l~l~~n~i~~i 177 (414)
T KOG0531|consen 145 LNLSGNLISDI-------SGLESLKSLKLLDLSYNRIVDI 177 (414)
T ss_pred heeccCcchhc-------cCCccchhhhcccCCcchhhhh
Confidence 66666666654 2344455555556666655543
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.96 E-value=6.8e-10 Score=111.07 Aligned_cols=91 Identities=18% Similarity=0.265 Sum_probs=67.3
Q ss_pred CccceeeccCCe---------EEEEEEehHhhHHHHHHHHHHHHHHhhc-----chhhHHHH------------------
Q 045449 631 SENNLIGIGNGM---------EVAVKVFHQQYERALKSFEDECEVRKRI-----RHRNLVKI------------------ 678 (823)
Q Consensus 631 ~~~~~lg~g~~~---------~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~~------------------ 678 (823)
.....||.|+.. ..+||++........+.+.+|+++++++ .||||+++
T Consensus 5 ~~~~~LG~G~~~~Vy~hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~ 84 (210)
T PRK10345 5 SEQSPLGTGRHRKCYAHPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIA 84 (210)
T ss_pred CCcceecCCCceEEEECCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEe
Confidence 345677777611 1368877654334457899999999999 57999981
Q ss_pred -------------------------HHHHHHHh-hhcCCCCEEeccCCCCCEEeCC----CCcEEEeeccccc
Q 045449 679 -------------------------ISSSLEYL-HFGHSIPIIHCDLKPSNVLLDE----DMVAHISDFGIAK 721 (823)
Q Consensus 679 -------------------------~~~~l~~L-~~~h~~~ivHrdlk~~NiLl~~----~~~~kl~DfGla~ 721 (823)
+.+++..+ +|+|+.+|+||||||+|||++. +..++|+||+-++
T Consensus 85 e~~G~~~~tL~~~l~~~~~~e~~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~~ 157 (210)
T PRK10345 85 DFDGKPSITLTEFAEQCRYEEDVAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGES 157 (210)
T ss_pred cCCCCcchhHHHHHHcccccHhHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCCc
Confidence 34666566 8999999999999999999974 3489999954343
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=98.96 E-value=5.1e-10 Score=107.60 Aligned_cols=127 Identities=27% Similarity=0.343 Sum_probs=50.7
Q ss_pred ccCcccccEEEcccCcCCCCchhccc-ccCCCCEEEccCCCCCCcchHhhhcCCCCCEEEcccCcCcccccccc-cCCCC
Q 045449 375 VGNLSNLLVLELGGNNLTGPIPVTFS-QLQTLQAFDLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCL-GNLTS 452 (823)
Q Consensus 375 ~~~l~~L~~L~Ls~N~l~g~~p~~~~-~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~-~~l~~ 452 (823)
+.+..++++|+|++|+++ .|. .++ .+.+|+.||||+|.|+.. . .+..++.|++|++++|+++. ++..+ ..+++
T Consensus 15 ~~n~~~~~~L~L~~n~I~-~Ie-~L~~~l~~L~~L~Ls~N~I~~l-~-~l~~L~~L~~L~L~~N~I~~-i~~~l~~~lp~ 89 (175)
T PF14580_consen 15 YNNPVKLRELNLRGNQIS-TIE-NLGATLDKLEVLDLSNNQITKL-E-GLPGLPRLKTLDLSNNRISS-ISEGLDKNLPN 89 (175)
T ss_dssp -----------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS---S--CHHHHHH-TT
T ss_pred cccccccccccccccccc-ccc-chhhhhcCCCEEECCCCCCccc-c-CccChhhhhhcccCCCCCCc-cccchHHhCCc
Confidence 345567899999999998 343 455 578899999999999843 3 47778999999999999984 44444 46889
Q ss_pred CCeEeccCCccccccc-hhhhccCCCcEEeccccccccccC---ccccCCCCCcEEEc
Q 045449 453 VRVLYLGLNIFTSVLS-STIWNLKDILFIDVSSNFLDGPLS---LDIGNLKVVIGLDF 506 (823)
Q Consensus 453 L~~L~Ls~N~l~~~~p-~~~~~l~~L~~LdLs~N~l~g~~p---~~~~~l~~L~~L~l 506 (823)
|+.|+|++|++...-- ..+..+++|+.|+|.+|.++..-- ..+..+++|+.||-
T Consensus 90 L~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~~~YR~~vi~~lP~Lk~LD~ 147 (175)
T PF14580_consen 90 LQELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCEKKNYRLFVIYKLPSLKVLDG 147 (175)
T ss_dssp --EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGGGSTTHHHHHHHH-TT-SEETT
T ss_pred CCEEECcCCcCCChHHhHHHHcCCCcceeeccCCcccchhhHHHHHHHHcChhheeCC
Confidence 9999999999876422 566788899999999998875421 23567788888873
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=98.95 E-value=7.7e-11 Score=123.31 Aligned_cols=65 Identities=23% Similarity=0.328 Sum_probs=40.2
Q ss_pred CCCCccEEEeeccccccccC--ccccCCCCCCeEEeecccccccCC--CccCCCcccCcccccCccccCC
Q 045449 251 SLPNVETLNLGINSFSGTIP--SSITNSSKLSDLELGENLFSGFIP--NTIGNLRNLEFGNIADNYLTSS 316 (823)
Q Consensus 251 ~l~~L~~L~Ls~N~l~~~~p--~~~~~l~~L~~L~Ls~N~l~~~~p--~~~~~l~~L~~L~L~~N~l~~~ 316 (823)
++.+|+...|.+.... ..+ .-...+++++.||||+|-|....| .....+++|+.|+|+.|++...
T Consensus 119 n~kkL~~IsLdn~~V~-~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~ 187 (505)
T KOG3207|consen 119 NLKKLREISLDNYRVE-DAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNF 187 (505)
T ss_pred hHHhhhheeecCcccc-ccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCC
Confidence 3667777778776654 222 245567778888888887765422 2234566666666666666543
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.92 E-value=1.4e-10 Score=125.04 Aligned_cols=90 Identities=28% Similarity=0.442 Sum_probs=75.5
Q ss_pred HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCC----ccccccccccCCCcCcccccCCCccc
Q 045449 678 IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGED----QLSKQTQTLATIGYMAPEYGTKGRVS 753 (823)
Q Consensus 678 ~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~ 753 (823)
.+.|...++.| ++.+|||+||.||....+..+||.|||+...+.... .....+..+||..||+||.+.+..|+
T Consensus 364 ~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~ 440 (516)
T KOG1033|consen 364 IFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYS 440 (516)
T ss_pred HHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhh
Confidence 45555555555 899999999999999999899999999988765444 12334567899999999999999999
Q ss_pred cccceehhhhhhccccC
Q 045449 754 TRGDVCSFGIISGGKET 770 (823)
Q Consensus 754 ~~~Dv~S~Gvv~~~~~~ 770 (823)
.|+||||+|++++|+..
T Consensus 441 ~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 441 EKVDIYALGLILAELLI 457 (516)
T ss_pred hhcchhhHHHHHHHHHH
Confidence 99999999999999876
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.91 E-value=4.6e-11 Score=121.84 Aligned_cols=229 Identities=24% Similarity=0.302 Sum_probs=116.9
Q ss_pred cccCCCCCCcEEEccCCCCCC----CCCCCCCCCCCCCEEECCCCc---CcCCCchh-------hhcCCCCcEEeccccc
Q 045449 70 PQLGNLSSLQTLDLSHNKLSG----NIPSSIFNMHTLKLLDFSDNQ---LFGSLSSF-------IFNMSSMTTIDLSINR 135 (823)
Q Consensus 70 ~~l~~l~~L~~L~Ls~N~l~g----~~p~~~~~l~~L~~L~Ls~N~---l~~~~p~~-------~~~l~~L~~L~Ls~N~ 135 (823)
+.+..+..++.|+||+|.|.. .+-..+.+.++|+.-++|+=. +...+|+. +...+.|++||||.|.
T Consensus 24 ~~~~~~~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSDNA 103 (382)
T KOG1909|consen 24 EELEPMDSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDMFTGRLKDEIPEALKMLSKALLGCPKLQKLDLSDNA 103 (382)
T ss_pred HHhcccCceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhhhcCCcHHHHHHHHHHHHHHHhcCCceeEeeccccc
Confidence 455667888899999998862 355566777788888888642 22234433 3445578888888887
Q ss_pred ccCccCccccCCCCCCccccccceeeeccceeeccCccccccch-hhHHHHHhhcCCCcccCCcccCCcchhhhhccccc
Q 045449 136 LSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKEIGNLT-KLKEIISTITNSTVCEIPREIGNLPYLARLALATN 214 (823)
Q Consensus 136 l~~~~p~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~-~L~~L~~l~~n~~~~~ip~~l~~l~~L~~L~Ls~N 214 (823)
|.-.-+..+. .-+.++..|++|+|.+|.+. |..=+.+. .|..| ..+. -.++-+.|+++..++|
T Consensus 104 ~G~~g~~~l~---~ll~s~~~L~eL~L~N~Glg---~~ag~~l~~al~~l---~~~k-------k~~~~~~Lrv~i~~rN 167 (382)
T KOG1909|consen 104 FGPKGIRGLE---ELLSSCTDLEELYLNNCGLG---PEAGGRLGRALFEL---AVNK-------KAASKPKLRVFICGRN 167 (382)
T ss_pred cCccchHHHH---HHHHhccCHHHHhhhcCCCC---hhHHHHHHHHHHHH---HHHh-------ccCCCcceEEEEeecc
Confidence 7633333221 22355777888888887664 21111111 12222 1111 1233345666666666
Q ss_pred cccCCc----cccccCCCCCcEEEccCCcccccC---CcccccCCCCccEEEeecccccc----ccCccccCCCCCCeEE
Q 045449 215 NLVGVV----PVTIFNMSALKEISLLNNSLSGSL---PSRIDLSLPNVETLNLGINSFSG----TIPSSITNSSKLSDLE 283 (823)
Q Consensus 215 ~l~~~~----p~~~~~l~~L~~L~Ls~N~l~g~l---p~~~~~~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~ 283 (823)
++.... ...|...+.|+.+.++.|.|...- -...+..+++|++|||..|-|+. .+...++.+++|+.|+
T Consensus 168 rlen~ga~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~ 247 (382)
T KOG1909|consen 168 RLENGGATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELN 247 (382)
T ss_pred ccccccHHHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeec
Confidence 654321 122334455666666666553100 00011225556666666555542 1223344455555555
Q ss_pred eecccccccCCCcc-----CCCcccCcccccCcccc
Q 045449 284 LGENLFSGFIPNTI-----GNLRNLEFGNIADNYLT 314 (823)
Q Consensus 284 Ls~N~l~~~~p~~~-----~~l~~L~~L~L~~N~l~ 314 (823)
++++.+...-..+| ...+.|+.|.|.+|.++
T Consensus 248 l~dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt 283 (382)
T KOG1909|consen 248 LGDCLLENEGAIAFVDALKESAPSLEVLELAGNEIT 283 (382)
T ss_pred ccccccccccHHHHHHHHhccCCCCceeccCcchhH
Confidence 55555543222221 12344555555555554
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.90 E-value=5.8e-10 Score=131.16 Aligned_cols=97 Identities=19% Similarity=0.083 Sum_probs=81.2
Q ss_pred HHHHHHHHhhhcCCCCEEeccCCCCCEEeCC-------CCcEEEeecccccccCCCCccccccccccCCCcCcccccCCC
Q 045449 678 IISSSLEYLHFGHSIPIIHCDLKPSNVLLDE-------DMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKG 750 (823)
Q Consensus 678 ~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~-------~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 750 (823)
+..|++.-+.++|+.+|||+||||+|.|+.. ...++|+|||.+--+.--.........++|-.+-.+|...+.
T Consensus 799 ~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~gr 878 (974)
T KOG1166|consen 799 FSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGR 878 (974)
T ss_pred HHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCC
Confidence 4678888899999999999999999999932 346899999998765432233445667899999999999999
Q ss_pred ccccccceehhhhhhccccCCCCC
Q 045449 751 RVSTRGDVCSFGIISGGKETRSMT 774 (823)
Q Consensus 751 ~~~~~~Dv~S~Gvv~~~~~~~~~~ 774 (823)
.++..+|-|.++.+++.|+||+.-
T Consensus 879 pWtYq~DyfGlAa~~h~mLFG~y~ 902 (974)
T KOG1166|consen 879 PWTYQIDYFGLAATVHVMLFGKYM 902 (974)
T ss_pred CCchhhhhHHHHHHHHHHHHHHHH
Confidence 999999999999999999999853
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.84 E-value=1.4e-09 Score=106.68 Aligned_cols=131 Identities=22% Similarity=0.329 Sum_probs=95.3
Q ss_pred CeEEEEEEehHhh--HHHHHHHHHHHHHHhhcchhhHHHH----------------------------------------
Q 045449 641 GMEVAVKVFHQQY--ERALKSFEDECEVRKRIRHRNLVKI---------------------------------------- 678 (823)
Q Consensus 641 ~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~---------------------------------------- 678 (823)
|..+++|++.... ....++|..|.-.++-..||||..+
T Consensus 213 gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gslynvlhe~t~vvvd~sqav 292 (448)
T KOG0195|consen 213 GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSLYNVLHEQTSVVVDHSQAV 292 (448)
T ss_pred CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchHHHHHHhcCccEEEecchHH
Confidence 5667888886443 3444789999999999999999982
Q ss_pred -----HHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEe--ecccccccCCCCccccccccccCCCcCcccccCCCc
Q 045449 679 -----ISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHIS--DFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGR 751 (823)
Q Consensus 679 -----~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~--DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 751 (823)
+|++++|||.+. +-|..-.+.+..+++|++.+++|+ |--++.. .....-.|.||+||.+...+
T Consensus 293 ~faldiargmaflhsle-p~ipr~~lns~hvmidedltarismad~kfsfq---------e~gr~y~pawmspealqrkp 362 (448)
T KOG0195|consen 293 RFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARISMADTKFSFQ---------EVGRAYSPAWMSPEALQRKP 362 (448)
T ss_pred HHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhheecccceeeee---------ccccccCcccCCHHHHhcCc
Confidence 456666666543 345555788899999999988874 3222211 12234578999999988765
Q ss_pred c---ccccceehhhhhhccccCCCCCcCCCccc
Q 045449 752 V---STRGDVCSFGIISGGKETRSMTVGETCTP 781 (823)
Q Consensus 752 ~---~~~~Dv~S~Gvv~~~~~~~~~~~~~~~~~ 781 (823)
- -..+|+|||.+++||+-|++.||.+....
T Consensus 363 ed~n~raadmwsfaillwel~trevpfadlspm 395 (448)
T KOG0195|consen 363 EDLNIRAADMWSFAILLWELNTREVPFADLSPM 395 (448)
T ss_pred hhcchhhhhHHHHHHHHHHhhccccccccCCch
Confidence 4 34689999999999999999999886433
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.83 E-value=1.2e-09 Score=120.20 Aligned_cols=105 Identities=29% Similarity=0.368 Sum_probs=76.5
Q ss_pred HHHHHHHHHHhhhcCCCCE-EeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCcccccCCCc---
Q 045449 676 VKIISSSLEYLHFGHSIPI-IHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGR--- 751 (823)
Q Consensus 676 v~~~~~~l~~L~~~h~~~i-vHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--- 751 (823)
..++..++.+|.|+|...| .|+.+++.|.++|....+|++|||+.................-..-|.|||.+....
T Consensus 51 ~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~ 130 (484)
T KOG1023|consen 51 LSFIRDISKGLAYLHNSPIGYHGALKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQS 130 (484)
T ss_pred HHHHHHHHHHHHHHhcCcceeeeeeccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhccccccc
Confidence 3344555555566666655 999999999999999999999999988764311111111222346789999887642
Q ss_pred ----cccccceehhhhhhccccCCCCCcCCCcc
Q 045449 752 ----VSTRGDVCSFGIISGGKETRSMTVGETCT 780 (823)
Q Consensus 752 ----~~~~~Dv~S~Gvv~~~~~~~~~~~~~~~~ 780 (823)
.+.++||||||++++|+.+++.||.....
T Consensus 131 ~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~~~~ 163 (484)
T KOG1023|consen 131 LESALTQKGDIYSFGIIMYEILFRSGPFDLRNL 163 (484)
T ss_pred ccccccccCCeehHHHHHHHHHhccCccccccc
Confidence 36679999999999999999999977443
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=98.83 E-value=5.9e-09 Score=104.45 Aligned_cols=47 Identities=28% Similarity=0.279 Sum_probs=42.2
Q ss_pred HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccC
Q 045449 678 IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLS 724 (823)
Q Consensus 678 ~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~ 724 (823)
++.++++++.++|..+|+|||+||+||++++++.++|+|||++....
T Consensus 130 ~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 130 VLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred HHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCcEEEEECCccccCC
Confidence 45678888889999999999999999999999999999999997654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.82 E-value=1.1e-09 Score=126.31 Aligned_cols=138 Identities=25% Similarity=0.296 Sum_probs=106.9
Q ss_pred eEEEEEEehHhh--HHHHHHHHHHHHHHhhcc-hhhHHH-----------------------------------------
Q 045449 642 MEVAVKVFHQQY--ERALKSFEDECEVRKRIR-HRNLVK----------------------------------------- 677 (823)
Q Consensus 642 ~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~----------------------------------------- 677 (823)
..+|+|.+.... ....+....|..+-..+. |+|+++
T Consensus 47 ~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~ 126 (601)
T KOG0590|consen 47 SSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLSYSDGGSLFSKISHPDSTGTSSSSAS 126 (601)
T ss_pred ceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccccCcccccccccccccCCccCCCCcchh
Confidence 446666554332 233344555777777776 888887
Q ss_pred -HHHHHHHHhhhcC-CCCEEeccCCCCCEEeCCCC-cEEEeecccccccCC-CCcccccccccc-CCCcCcccccCCCc-
Q 045449 678 -IISSSLEYLHFGH-SIPIIHCDLKPSNVLLDEDM-VAHISDFGIAKLLSG-EDQLSKQTQTLA-TIGYMAPEYGTKGR- 751 (823)
Q Consensus 678 -~~~~~l~~L~~~h-~~~ivHrdlk~~NiLl~~~~-~~kl~DfGla~~~~~-~~~~~~~~~~~g-t~~y~aPE~~~~~~- 751 (823)
++.|...++.|.| ..++.|||+||+|.+++..+ ..|++|||+|..+.. ..........+| ++.|+|||...+..
T Consensus 127 ~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~ 206 (601)
T KOG0590|consen 127 RYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAY 206 (601)
T ss_pred hhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhccccccCCcceeeecccCCCCCCCCcccccchhh
Confidence 3568888899999 99999999999999999998 999999999988765 333333445678 99999999988744
Q ss_pred cccccceehhhhhhccccCCCCCcCCCc
Q 045449 752 VSTRGDVCSFGIISGGKETRSMTVGETC 779 (823)
Q Consensus 752 ~~~~~Dv~S~Gvv~~~~~~~~~~~~~~~ 779 (823)
.++..|+||.|+++..+.+|..|++...
T Consensus 207 ~~~~~d~~S~g~~l~~~~~g~~p~~~~~ 234 (601)
T KOG0590|consen 207 RGPSVDVWSLGIVLSAMLTGELPWDFPS 234 (601)
T ss_pred cCCCcccccccccccccccCCCCccccc
Confidence 4777899999999999999999887653
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.82 E-value=2e-09 Score=84.99 Aligned_cols=61 Identities=38% Similarity=0.500 Sum_probs=43.4
Q ss_pred CCCcEEEccCCCCCCCCCCCCCCCCCCCEEECCCCcCcCCCchhhhcCCCCcEEecccccc
Q 045449 76 SSLQTLDLSHNKLSGNIPSSIFNMHTLKLLDFSDNQLFGSLSSFIFNMSSMTTIDLSINRL 136 (823)
Q Consensus 76 ~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 136 (823)
++|++|++++|+|+...+..|.++++|++|++++|.|+...|.+|.++++|++|++++|+|
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 3567777777777755556777777777777777777766666777777777777777764
|
... |
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.76 E-value=5.7e-09 Score=82.42 Aligned_cols=59 Identities=31% Similarity=0.539 Sum_probs=33.6
Q ss_pred CccEEEeeccccccccCccccCCCCCCeEEeecccccccCCCccCCCcccCcccccCcc
Q 045449 254 NVETLNLGINSFSGTIPSSITNSSKLSDLELGENLFSGFIPNTIGNLRNLEFGNIADNY 312 (823)
Q Consensus 254 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~ 312 (823)
+|++|++++|+|+...+..|.++++|++|++++|+++.+.|.+|.++++|++|++++|+
T Consensus 2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~ 60 (61)
T PF13855_consen 2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNN 60 (61)
T ss_dssp TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSS
T ss_pred cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCc
Confidence 45555555555554444555555566666666666655555555555555555555554
|
... |
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=98.75 E-value=1e-08 Score=105.27 Aligned_cols=46 Identities=24% Similarity=0.213 Sum_probs=41.7
Q ss_pred HHHHHHHHhhhcCCCC-EEeccCCCCCEEeCCCCcEEEeecccccccC
Q 045449 678 IISSSLEYLHFGHSIP-IIHCDLKPSNVLLDEDMVAHISDFGIAKLLS 724 (823)
Q Consensus 678 ~~~~~l~~L~~~h~~~-ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~ 724 (823)
++.|++++++++|..+ |+|||+||+||+++ ++.++|+|||.|+...
T Consensus 153 i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 153 LYDDILEEMRKLYKEGELVHGDLSEYNILVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred HHHHHHHHHHHHHhcCCEEeCCCChhhEEEE-CCCEEEEEChhhhccC
Confidence 4678899999999999 99999999999999 7899999999988643
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.72 E-value=1.3e-08 Score=121.65 Aligned_cols=83 Identities=25% Similarity=0.295 Sum_probs=42.2
Q ss_pred cccceEEecCCcceeccCccccCcccccEEEcccCcCCCC-chhcccccCCCCEEEccCCCCCCcchH---hhhcCCCCC
Q 045449 355 LSLETILMANCSISGNIPQVVGNLSNLLVLELGGNNLTGP-IPVTFSQLQTLQAFDLTRNKLAGPITD---ELCHLARLH 430 (823)
Q Consensus 355 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~-~p~~~~~l~~L~~L~Ls~N~l~~~~p~---~~~~l~~L~ 430 (823)
++|+.|.+..+.....+.+....+..+..+-+..+.+.+. .-...+.++++..+.+++=.+....-. ....++.+.
T Consensus 770 ~~L~~l~l~~~~~~e~~i~~~k~~~~l~~~i~~f~~~~~l~~~~~l~~l~~i~~~~l~~~~l~~~~ve~~p~l~~~P~~~ 849 (889)
T KOG4658|consen 770 PHLTSLSLVSCRLLEDIIPKLKALLELKELILPFNKLEGLRMLCSLGGLPQLYWLPLSFLKLEELIVEECPKLGKLPLLS 849 (889)
T ss_pred CcccEEEEecccccccCCCHHHHhhhcccEEecccccccceeeecCCCCceeEecccCccchhheehhcCcccccCcccc
Confidence 5666666666555545555555555555555555665554 233444555555554444333311111 124566666
Q ss_pred EEEcccC
Q 045449 431 SLVLQGN 437 (823)
Q Consensus 431 ~L~Ls~N 437 (823)
.+.+.++
T Consensus 850 ~~~i~~~ 856 (889)
T KOG4658|consen 850 TLTIVGC 856 (889)
T ss_pred ccceecc
Confidence 6666664
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=98.67 E-value=3.1e-08 Score=114.85 Aligned_cols=103 Identities=21% Similarity=0.262 Sum_probs=74.9
Q ss_pred HHHHHHHhccCCccceeeccC----------CeEEEEEEehHh--------hHHHHHHHHHHHHHHhhcchhhHHH----
Q 045449 620 YHELLRATDRFSENNLIGIGN----------GMEVAVKVFHQQ--------YERALKSFEDECEVRKRIRHRNLVK---- 677 (823)
Q Consensus 620 ~~~l~~at~~f~~~~~lg~g~----------~~~vavK~~~~~--------~~~~~~~~~~E~~~l~~l~h~niv~---- 677 (823)
+.........|...+.||+|+ +..+++|+.... .....+++.+|++++.+++|++++.
T Consensus 325 ~~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~ 404 (535)
T PRK09605 325 WIKEEEVKRRKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIY 404 (535)
T ss_pred eccccccccccCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEE
Confidence 333334445556678899987 122344432111 1122357899999999999988764
Q ss_pred ----------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeeccccccc
Q 045449 678 ----------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLL 723 (823)
Q Consensus 678 ----------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~ 723 (823)
++.+++++|.++|+.+++|||+||+|||+ .++.++|+|||+++..
T Consensus 405 ~~~~~~~~lv~E~~~g~~L~~~l~~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~~ 477 (535)
T PRK09605 405 DVDPEEKTIVMEYIGGKDLKDVLEGNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS 477 (535)
T ss_pred EEeCCCCEEEEEecCCCcHHHHHHHHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence 34678888999999999999999999999 5778999999999874
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=98.64 E-value=2.6e-08 Score=102.45 Aligned_cols=84 Identities=18% Similarity=0.199 Sum_probs=65.1
Q ss_pred CeEEEEEEehHhh-------------HHHHHHHHHHHHHHhhcchhhH--HH----------------------------
Q 045449 641 GMEVAVKVFHQQY-------------ERALKSFEDECEVRKRIRHRNL--VK---------------------------- 677 (823)
Q Consensus 641 ~~~vavK~~~~~~-------------~~~~~~~~~E~~~l~~l~h~ni--v~---------------------------- 677 (823)
+..+|||++.... ......+.+|++++.++.|+++ ++
T Consensus 55 ~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~~~~~~~lV~e~l~G~~~L 134 (239)
T PRK01723 55 GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRHGLFYRADILIERIEGARDL 134 (239)
T ss_pred CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeecCcceeeeEEEEecCCCCCH
Confidence 3457888774211 1223568899999999988764 11
Q ss_pred ------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccC
Q 045449 678 ------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLS 724 (823)
Q Consensus 678 ------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~ 724 (823)
.+.++++++.++|+.||+|||+||+|||++.++.++|+|||.++...
T Consensus 135 ~~~l~~~~l~~~~~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~~~~~~ 193 (239)
T PRK01723 135 VALLQEAPLSEEQWQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDRGELRT 193 (239)
T ss_pred HHHHhcCCCCHHHHHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCCcccCC
Confidence 14567888999999999999999999999988899999999887643
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=98.61 E-value=8.1e-09 Score=122.64 Aligned_cols=95 Identities=15% Similarity=0.037 Sum_probs=71.8
Q ss_pred HHhhhcCCC-CEEeccCCCC-CEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCcccccCCCccccccceehh
Q 045449 684 EYLHFGHSI-PIIHCDLKPS-NVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSF 761 (823)
Q Consensus 684 ~~L~~~h~~-~ivHrdlk~~-NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~ 761 (823)
.+.++.|.+ .-.|++.+|. |++++.+...++.|||.++..............+||+.|||||++.+..|+.++|||||
T Consensus 487 ~~~~~~~~~~~~~~~~~~p~~~~~~~p~~~~~~~~~~~~~~~~~g~~~~~~~~~vGT~~Y~APE~l~~~~~~~~~DiwSl 566 (669)
T cd05610 487 SGSQSGSYPAITPTQKPRPHGNLYQTPKQVKIGTPYRTPKSVRRGAAPVEGERILGTPDYLAPELLLGKPHGPAVDWWAL 566 (669)
T ss_pred cccccCCCcccCCCCCCCCCCceeECCccccccccCCCchhhhcccccccCCceeeCccccCHHHcCCCCCCcHHHHHHH
Confidence 344455544 2234555565 66667777788999999887654433333445689999999999999999999999999
Q ss_pred hhhhccccCCCCCcCCC
Q 045449 762 GIISGGKETRSMTVGET 778 (823)
Q Consensus 762 Gvv~~~~~~~~~~~~~~ 778 (823)
||++||+++|..||.+.
T Consensus 567 G~il~ElltG~~pf~~~ 583 (669)
T cd05610 567 GVCLFEFLTGIPPFNDE 583 (669)
T ss_pred HHHHHHHHHCCCCCCCC
Confidence 99999999999998654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.60 E-value=8.9e-10 Score=121.59 Aligned_cols=127 Identities=27% Similarity=0.327 Sum_probs=75.1
Q ss_pred cccEEEcccCcCCCCchhcccccCCCCEEEccCCCCCCcchHhhhcCCCCCEEEcccCcCccccccc-ccCCCCCCeEec
Q 045449 380 NLLVLELGGNNLTGPIPVTFSQLQTLQAFDLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSC-LGNLTSVRVLYL 458 (823)
Q Consensus 380 ~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~-~~~l~~L~~L~L 458 (823)
.|.+.+.++|+|. .+..++.-++.|+.||||+|+++.. +.+..++.|++|||++|.++ .+|.. ...+. |+.|+|
T Consensus 165 ~L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v--~~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc~-L~~L~l 239 (1096)
T KOG1859|consen 165 KLATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKV--DNLRRLPKLKHLDLSYNCLR-HVPQLSMVGCK-LQLLNL 239 (1096)
T ss_pred hHhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhh--HHHHhcccccccccccchhc-cccccchhhhh-heeeee
Confidence 4566666666665 4555566666666677777766632 25566666667777777666 34432 22333 666667
Q ss_pred cCCccccccchhhhccCCCcEEeccccccccccCc-cccCCCCCcEEEcccCCCCC
Q 045449 459 GLNIFTSVLSSTIWNLKDILFIDVSSNFLDGPLSL-DIGNLKVVIGLDFSRNNLSG 513 (823)
Q Consensus 459 s~N~l~~~~p~~~~~l~~L~~LdLs~N~l~g~~p~-~~~~l~~L~~L~ls~N~l~g 513 (823)
++|.++.. ..+.++.+|+.||+|+|-|++--.- -+..+.+|+.|+|.+|.+..
T Consensus 240 rnN~l~tL--~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c 293 (1096)
T KOG1859|consen 240 RNNALTTL--RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCC 293 (1096)
T ss_pred cccHHHhh--hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCcccc
Confidence 76666543 3455666666777777766653321 24455566666666666543
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=98.58 E-value=6.8e-08 Score=96.81 Aligned_cols=82 Identities=21% Similarity=0.278 Sum_probs=64.8
Q ss_pred CeEEEEEEehHh--------hHHHHHHHHHHHHHHhhcchhhHHH---------------------------------HH
Q 045449 641 GMEVAVKVFHQQ--------YERALKSFEDECEVRKRIRHRNLVK---------------------------------II 679 (823)
Q Consensus 641 ~~~vavK~~~~~--------~~~~~~~~~~E~~~l~~l~h~niv~---------------------------------~~ 679 (823)
+..|++|+.... ......++.+|++++.+++|+++.. ++
T Consensus 17 ~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~g~~l~~~~~~~~~~~~ 96 (199)
T TIGR03724 17 GLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIEGKPLKDVIEEGNDELL 96 (199)
T ss_pred CccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEECCccHHHHHhhcHHHHH
Confidence 567899985421 1223467889999999988775432 35
Q ss_pred HHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeeccccccc
Q 045449 680 SSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLL 723 (823)
Q Consensus 680 ~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~ 723 (823)
.+++.+|.++|+.+++|||++|.||+++ ++.++++|||+++..
T Consensus 97 ~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 97 REIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred HHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 6777888899999999999999999999 789999999998764
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=98.57 E-value=9.3e-08 Score=94.77 Aligned_cols=49 Identities=24% Similarity=0.221 Sum_probs=43.7
Q ss_pred HHHHHHHHHHHhhhcCC-CCEEeccCCCCCEEeCCCCcEEEeecccccccC
Q 045449 675 LVKIISSSLEYLHFGHS-IPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLS 724 (823)
Q Consensus 675 iv~~~~~~l~~L~~~h~-~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~ 724 (823)
..+++.+++.+++++|. .+|+|||+||+||+++ ++.++++|||.+....
T Consensus 116 ~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~~~liDfg~a~~~~ 165 (187)
T cd05119 116 PEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGKVYIIDVPQAVEID 165 (187)
T ss_pred HHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCcEEEEECccccccc
Confidence 44577889999999999 9999999999999999 8899999999997654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=98.56 E-value=8e-08 Score=97.30 Aligned_cols=82 Identities=23% Similarity=0.255 Sum_probs=64.2
Q ss_pred CeEEEEEEehHhh--------HHHHHHHHHHHHHHhhcchhhHHH-----------------------------------
Q 045449 641 GMEVAVKVFHQQY--------ERALKSFEDECEVRKRIRHRNLVK----------------------------------- 677 (823)
Q Consensus 641 ~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~----------------------------------- 677 (823)
|..|+||+..... ......+.+|++++.++.|+++..
T Consensus 19 ~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~G~~L~~~~~~~~~~~~ 98 (211)
T PRK14879 19 GIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEYIEGEPLKDLINSNGMEEL 98 (211)
T ss_pred CCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEEeCCcCHHHHHHhccHHHH
Confidence 4678889754221 122356889999999998877653
Q ss_pred -HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeeccccccc
Q 045449 678 -IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLL 723 (823)
Q Consensus 678 -~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~ 723 (823)
++.++..+|.++|..+++|||++|.||+++ ++.++++|||.++..
T Consensus 99 ~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~~ 144 (211)
T PRK14879 99 ELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEFS 144 (211)
T ss_pred HHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccCC
Confidence 234677788999999999999999999999 788999999998763
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.55 E-value=4.3e-08 Score=117.42 Aligned_cols=41 Identities=17% Similarity=0.062 Sum_probs=20.4
Q ss_pred cCCCcEEeccccccccccCccccCCCCCcEEEcccCCCCCC
Q 045449 474 LKDILFIDVSSNFLDGPLSLDIGNLKVVIGLDFSRNNLSGD 514 (823)
Q Consensus 474 l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~ 514 (823)
.++|+.|.+........+.+....+..+..+-+..+.+.|.
T Consensus 769 ~~~L~~l~l~~~~~~e~~i~~~k~~~~l~~~i~~f~~~~~l 809 (889)
T KOG4658|consen 769 APHLTSLSLVSCRLLEDIIPKLKALLELKELILPFNKLEGL 809 (889)
T ss_pred cCcccEEEEecccccccCCCHHHHhhhcccEEecccccccc
Confidence 45555566555544444444444444444444555555543
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.52 E-value=3.1e-09 Score=117.38 Aligned_cols=128 Identities=27% Similarity=0.386 Sum_probs=88.8
Q ss_pred hhhhhccccccccCCccccccCCCCCcEEEccCCcccccCCcccccCCCCccEEEeeccccccccCccccCCCCCCeEEe
Q 045449 205 YLARLALATNNLVGVVPVTIFNMSALKEISLLNNSLSGSLPSRIDLSLPNVETLNLGINSFSGTIPSSITNSSKLSDLEL 284 (823)
Q Consensus 205 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 284 (823)
.|...+.+.|.++ ....++.-++.|++|+|++|+++ ... .+. .+++|+.|||++|.++ .+|..-..--+|+.|.+
T Consensus 165 ~L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~-~v~-~Lr-~l~~LkhLDlsyN~L~-~vp~l~~~gc~L~~L~l 239 (1096)
T KOG1859|consen 165 KLATASFSYNRLV-LMDESLQLLPALESLNLSHNKFT-KVD-NLR-RLPKLKHLDLSYNCLR-HVPQLSMVGCKLQLLNL 239 (1096)
T ss_pred hHhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhh-hhH-HHH-hcccccccccccchhc-cccccchhhhhheeeee
Confidence 4667788888887 34456666778888888888887 333 333 3788888888888887 44443222234888888
Q ss_pred ecccccccCCCccCCCcccCcccccCccccCCCCcccccccccCCCCceEEEeecCCCC
Q 045449 285 GENLFSGFIPNTIGNLRNLEFGNIADNYLTSSTPELSFLSSLTNCKKLKVLIVTGNPLD 343 (823)
Q Consensus 285 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~ 343 (823)
++|.++.. ..+.+|.+|+.||+++|-+.+.. -...++.+..|+.|+|.+|.+-
T Consensus 240 rnN~l~tL--~gie~LksL~~LDlsyNll~~hs----eL~pLwsLs~L~~L~LeGNPl~ 292 (1096)
T KOG1859|consen 240 RNNALTTL--RGIENLKSLYGLDLSYNLLSEHS----ELEPLWSLSSLIVLWLEGNPLC 292 (1096)
T ss_pred cccHHHhh--hhHHhhhhhhccchhHhhhhcch----hhhHHHHHHHHHHHhhcCCccc
Confidence 88887743 34667888888888888877642 2345666777888888888775
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=98.38 E-value=5e-07 Score=85.61 Aligned_cols=80 Identities=21% Similarity=0.261 Sum_probs=60.8
Q ss_pred eEEEEEEehHhhHHHHHHHHHHHHHHhhcchh--hHHH------------------------------------HHHHHH
Q 045449 642 MEVAVKVFHQQYERALKSFEDECEVRKRIRHR--NLVK------------------------------------IISSSL 683 (823)
Q Consensus 642 ~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~------------------------------------~~~~~l 683 (823)
..++||+...... ...+.+|+..+.+++|. .+.+ .+++++
T Consensus 22 ~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~~~~~~~~~~~~~~~~~~~l 99 (155)
T cd05120 22 EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETLDEVSEEEKEDIAEQLAELL 99 (155)
T ss_pred CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeecccCCHHHHHHHHHHHHHHH
Confidence 5789998865543 46788899999988763 3333 134455
Q ss_pred HHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeeccccccc
Q 045449 684 EYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLL 723 (823)
Q Consensus 684 ~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~ 723 (823)
.++|..+..+++|+|+||+||+++..+.++++|||.++..
T Consensus 100 ~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~ 139 (155)
T cd05120 100 AKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG 139 (155)
T ss_pred HHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence 5566555578999999999999999899999999988753
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG2982 consensus Uncharacterized conserved protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.33 E-value=8.2e-08 Score=96.02 Aligned_cols=189 Identities=23% Similarity=0.322 Sum_probs=98.0
Q ss_pred CCCCcEEEccCCCCCC--CCCCCCCCCCCCCEEECCCCcCcCCCchhhhcCCCCcEEecccccccCccCccccCCCCCCc
Q 045449 75 LSSLQTLDLSHNKLSG--NIPSSIFNMHTLKLLDFSDNQLFGSLSSFIFNMSSMTTIDLSINRLSGELPANICKIPSTLS 152 (823)
Q Consensus 75 l~~L~~L~Ls~N~l~g--~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~p~~~~ 152 (823)
.+.++.|||.+|.|+. .|-..+.+|+.|+.|+||.|.++..|-..=..+.+|++|-|.+..+.-.-.. +.+.
T Consensus 70 ~~~v~elDL~~N~iSdWseI~~ile~lP~l~~LNls~N~L~s~I~~lp~p~~nl~~lVLNgT~L~w~~~~------s~l~ 143 (418)
T KOG2982|consen 70 VTDVKELDLTGNLISDWSEIGAILEQLPALTTLNLSCNSLSSDIKSLPLPLKNLRVLVLNGTGLSWTQST------SSLD 143 (418)
T ss_pred hhhhhhhhcccchhccHHHHHHHHhcCccceEeeccCCcCCCccccCcccccceEEEEEcCCCCChhhhh------hhhh
Confidence 4566777777777762 1223344666777777777776543322213455666666666655422111 2235
Q ss_pred cccccceeeeccceeeccC--ccccccch-hhHHHHHhhcCCCcccCCcccCCcchhhhhccccccccCCccccccCCCC
Q 045449 153 KCKQLEELNLGFNNLSGAI--PKEIGNLT-KLKEIISTITNSTVCEIPREIGNLPYLARLALATNNLVGVVPVTIFNMSA 229 (823)
Q Consensus 153 ~l~~L~~L~Ls~N~l~~~~--p~~l~~l~-~L~~L~~l~~n~~~~~ip~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 229 (823)
.++.++.|++|.|++.-.. .......+ .++ .+..++.+..++++-|++...+| +
T Consensus 144 ~lP~vtelHmS~N~~rq~n~Dd~c~e~~s~~v~----------------tlh~~~c~~~~w~~~~~l~r~Fp-------n 200 (418)
T KOG2982|consen 144 DLPKVTELHMSDNSLRQLNLDDNCIEDWSTEVL----------------TLHQLPCLEQLWLNKNKLSRIFP-------N 200 (418)
T ss_pred cchhhhhhhhccchhhhhccccccccccchhhh----------------hhhcCCcHHHHHHHHHhHHhhcc-------c
Confidence 5666666666666443110 01111110 111 12234456666777777665544 5
Q ss_pred CcEEEccCCcccccCCcccccCCCCccEEEeeccccccc-cCccccCCCCCCeEEeeccccccc
Q 045449 230 LKEISLLNNSLSGSLPSRIDLSLPNVETLNLGINSFSGT-IPSSITNSSKLSDLELGENLFSGF 292 (823)
Q Consensus 230 L~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~ 292 (823)
+..+-+..|.+...-...-+..++.+..|+|+.|+|-.- --+.+.++++|..|.+++|.+...
T Consensus 201 v~sv~v~e~PlK~~s~ek~se~~p~~~~LnL~~~~idswasvD~Ln~f~~l~dlRv~~~Pl~d~ 264 (418)
T KOG2982|consen 201 VNSVFVCEGPLKTESSEKGSEPFPSLSCLNLGANNIDSWASVDALNGFPQLVDLRVSENPLSDP 264 (418)
T ss_pred chheeeecCcccchhhcccCCCCCcchhhhhcccccccHHHHHHHcCCchhheeeccCCccccc
Confidence 556666666554222222222355666777777776421 123455666777777777766543
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.22 E-value=7.7e-08 Score=85.50 Aligned_cols=59 Identities=24% Similarity=0.308 Sum_probs=26.7
Q ss_pred CCCEEEcccCcCcccccccccCCCCCCeEeccCCccccccchhhhccCCCcEEeccccccc
Q 045449 428 RLHSLVLQGNKFSGSIPSCLGNLTSVRVLYLGLNIFTSVLSSTIWNLKDILFIDVSSNFLD 488 (823)
Q Consensus 428 ~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~LdLs~N~l~ 488 (823)
.++.|+|++|.++ .+|..+..++.|+.|+++.|.|.. .|..+..+.+|..||..+|.+.
T Consensus 78 t~t~lNl~~neis-dvPeE~Aam~aLr~lNl~~N~l~~-~p~vi~~L~~l~~Lds~~na~~ 136 (177)
T KOG4579|consen 78 TATTLNLANNEIS-DVPEELAAMPALRSLNLRFNPLNA-EPRVIAPLIKLDMLDSPENARA 136 (177)
T ss_pred hhhhhhcchhhhh-hchHHHhhhHHhhhcccccCcccc-chHHHHHHHhHHHhcCCCCccc
Confidence 3444444444444 334444444444444444444433 3344444555555555555443
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.19 E-value=1.9e-07 Score=83.02 Aligned_cols=133 Identities=18% Similarity=0.288 Sum_probs=88.7
Q ss_pred ccceEEecCCcceeccCcc---ccCcccccEEEcccCcCCCCchhcc-cccCCCCEEEccCCCCCCcchHhhhcCCCCCE
Q 045449 356 SLETILMANCSISGNIPQV---VGNLSNLLVLELGGNNLTGPIPVTF-SQLQTLQAFDLTRNKLAGPITDELCHLARLHS 431 (823)
Q Consensus 356 ~L~~L~L~~N~l~~~~p~~---~~~l~~L~~L~Ls~N~l~g~~p~~~-~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 431 (823)
.+..++|+++++- .+++. +.....|+..+|++|.|.. .|..| ...+.++.|+|++|.|+ .+|..+..++.|+.
T Consensus 28 E~h~ldLssc~lm-~i~davy~l~~~~el~~i~ls~N~fk~-fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~ 104 (177)
T KOG4579|consen 28 ELHFLDLSSCQLM-YIADAVYMLSKGYELTKISLSDNGFKK-FPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRS 104 (177)
T ss_pred Hhhhcccccchhh-HHHHHHHHHhCCceEEEEecccchhhh-CCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhh
Confidence 4556777777765 23333 3445567777888888884 44444 45568888888888888 66778888888888
Q ss_pred EEcccCcCcccccccccCCCCCCeEeccCCccccccchhhhccCCCcEEeccccccccccCc
Q 045449 432 LVLQGNKFSGSIPSCLGNLTSVRVLYLGLNIFTSVLSSTIWNLKDILFIDVSSNFLDGPLSL 493 (823)
Q Consensus 432 L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~LdLs~N~l~g~~p~ 493 (823)
|+++.|.|. ..|+.+..+.+|-.|+.-+|...- ||-.+..-...-..++.++.+.+..+.
T Consensus 105 lNl~~N~l~-~~p~vi~~L~~l~~Lds~~na~~e-id~dl~~s~~~al~~lgnepl~~~~~~ 164 (177)
T KOG4579|consen 105 LNLRFNPLN-AEPRVIAPLIKLDMLDSPENARAE-IDVDLFYSSLPALIKLGNEPLGDETKK 164 (177)
T ss_pred cccccCccc-cchHHHHHHHhHHHhcCCCCcccc-CcHHHhccccHHHHHhcCCcccccCcc
Confidence 888888888 667777778888888888887765 333333323333334444555544443
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=98.11 E-value=8.4e-06 Score=91.46 Aligned_cols=41 Identities=32% Similarity=0.397 Sum_probs=37.4
Q ss_pred HhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCC
Q 045449 685 YLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSG 725 (823)
Q Consensus 685 ~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~ 725 (823)
+++.+|..|++|+|+||.||+++.++.++++|||+++.+..
T Consensus 269 ~l~ql~~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 269 FLNQVLRDGFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred HHHHHHhCCceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 57788999999999999999999999999999999987653
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG2982 consensus Uncharacterized conserved protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.02 E-value=1.4e-06 Score=87.42 Aligned_cols=216 Identities=20% Similarity=0.196 Sum_probs=102.4
Q ss_pred CcccCCcchhhhhccccccccCCcc-cccc-CCCCCcEEEccCCcccc--cCCcccccCCCCccEEEeeccccccccCcc
Q 045449 197 PREIGNLPYLARLALATNNLVGVVP-VTIF-NMSALKEISLLNNSLSG--SLPSRIDLSLPNVETLNLGINSFSGTIPSS 272 (823)
Q Consensus 197 p~~l~~l~~L~~L~Ls~N~l~~~~p-~~~~-~l~~L~~L~Ls~N~l~g--~lp~~~~~~l~~L~~L~Ls~N~l~~~~p~~ 272 (823)
+-.+..+..++.|.+.+..|...-. ..|+ ..+.++++||.+|.|+. .+-. +...+|.|++|+|+.|+++..|-..
T Consensus 38 ~~~v~s~ra~ellvln~~~id~~gd~~~~~~~~~~v~elDL~~N~iSdWseI~~-ile~lP~l~~LNls~N~L~s~I~~l 116 (418)
T KOG2982|consen 38 YLGVSSLRALELLVLNGSIIDNEGDVMLFGSSVTDVKELDLTGNLISDWSEIGA-ILEQLPALTTLNLSCNSLSSDIKSL 116 (418)
T ss_pred eeeeccccchhhheecCCCCCcchhHHHHHHHhhhhhhhhcccchhccHHHHHH-HHhcCccceEeeccCCcCCCccccC
Confidence 3334444555666666665542211 1122 34567777777777762 1111 2224677777777777776444322
Q ss_pred ccCCCCCCeEEeeccccccc-CCCccCCCcccCcccccCccccCCCCcccccccccCCCCceEEEeecCCCCccCCc--c
Q 045449 273 ITNSSKLSDLELGENLFSGF-IPNTIGNLRNLEFGNIADNYLTSSTPELSFLSSLTNCKKLKVLIVTGNPLDGILPK--S 349 (823)
Q Consensus 273 ~~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~--~ 349 (823)
-.-+.+|++|-|.+..+.-. ....+..++.++.|++|.|.++-. ++..|-....-|. .
T Consensus 117 p~p~~nl~~lVLNgT~L~w~~~~s~l~~lP~vtelHmS~N~~rq~-------------------n~Dd~c~e~~s~~v~t 177 (418)
T KOG2982|consen 117 PLPLKNLRVLVLNGTGLSWTQSTSSLDDLPKVTELHMSDNSLRQL-------------------NLDDNCIEDWSTEVLT 177 (418)
T ss_pred cccccceEEEEEcCCCCChhhhhhhhhcchhhhhhhhccchhhhh-------------------ccccccccccchhhhh
Confidence 12344666666666555422 122344556666666666644322 1111111110000 0
Q ss_pred ccccccccceEEecCCcceeccCccccCcccccEEEcccCcCCCCc-hhcccccCCCCEEEccCCCCCCcc-hHhhhcCC
Q 045449 350 IGNFSLSLETILMANCSISGNIPQVVGNLSNLLVLELGGNNLTGPI-PVTFSQLQTLQAFDLTRNKLAGPI-TDELCHLA 427 (823)
Q Consensus 350 ~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~-p~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~ 427 (823)
+... ..+..+.++-|++... ++++..+-+..|.+...- -..+..++.+-.|+|+.|+|.... -+.+..++
T Consensus 178 lh~~-~c~~~~w~~~~~l~r~-------Fpnv~sv~v~e~PlK~~s~ek~se~~p~~~~LnL~~~~idswasvD~Ln~f~ 249 (418)
T KOG2982|consen 178 LHQL-PCLEQLWLNKNKLSRI-------FPNVNSVFVCEGPLKTESSEKGSEPFPSLSCLNLGANNIDSWASVDALNGFP 249 (418)
T ss_pred hhcC-CcHHHHHHHHHhHHhh-------cccchheeeecCcccchhhcccCCCCCcchhhhhcccccccHHHHHHHcCCc
Confidence 0000 1122222233333322 344555556666554321 223445566667777777775322 12355666
Q ss_pred CCCEEEcccCcCc
Q 045449 428 RLHSLVLQGNKFS 440 (823)
Q Consensus 428 ~L~~L~Ls~N~l~ 440 (823)
.|..|.+++|.+.
T Consensus 250 ~l~dlRv~~~Pl~ 262 (418)
T KOG2982|consen 250 QLVDLRVSENPLS 262 (418)
T ss_pred hhheeeccCCccc
Confidence 6777777766665
|
|
| >COG5238 RNA1 Ran GTPase-activating protein (RanGAP) involved in mRNA processing and transport [Signal transduction mechanisms / RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.01 E-value=1.8e-07 Score=92.52 Aligned_cols=222 Identities=23% Similarity=0.282 Sum_probs=119.0
Q ss_pred CCCCcEEEccCCCCCC----CCCCCCCCCCCCCEEECCCCcC---cCCCc-------hhhhcCCCCcEEecccccccCcc
Q 045449 75 LSSLQTLDLSHNKLSG----NIPSSIFNMHTLKLLDFSDNQL---FGSLS-------SFIFNMSSMTTIDLSINRLSGEL 140 (823)
Q Consensus 75 l~~L~~L~Ls~N~l~g----~~p~~~~~l~~L~~L~Ls~N~l---~~~~p-------~~~~~l~~L~~L~Ls~N~l~~~~ 140 (823)
+..+..+|||+|.|.. .+...+.+-.+|+..++|.-.. ...++ .++-.++.|+..+||.|.+....
T Consensus 29 ~d~~~evdLSGNtigtEA~e~l~~~ia~~~~L~vvnfsd~ftgr~kde~~~~L~~Ll~aLlkcp~l~~v~LSDNAfg~~~ 108 (388)
T COG5238 29 MDELVEVDLSGNTIGTEAMEELCNVIANVRNLRVVNFSDAFTGRDKDELYSNLVMLLKALLKCPRLQKVDLSDNAFGSEF 108 (388)
T ss_pred hcceeEEeccCCcccHHHHHHHHHHHhhhcceeEeehhhhhhcccHHHHHHHHHHHHHHHhcCCcceeeeccccccCccc
Confidence 4556666666666642 2333445556666666665322 11222 23456677777788877776555
Q ss_pred CccccCCCCCCccccccceeeeccceeeccCccccccch-hhHHHHHhhcCCCcccCCcccCCcchhhhhccccccccCC
Q 045449 141 PANICKIPSTLSKCKQLEELNLGFNNLSGAIPKEIGNLT-KLKEIISTITNSTVCEIPREIGNLPYLARLALATNNLVGV 219 (823)
Q Consensus 141 p~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~-~L~~L~~l~~n~~~~~ip~~l~~l~~L~~L~Ls~N~l~~~ 219 (823)
|..+. ..+++-+.|++|.|++|.+- .+.. +.+- .|.+| ..|. -.++-+.|+..+...|++...
T Consensus 109 ~e~L~---d~is~~t~l~HL~l~NnGlG-p~aG--~rigkal~~l---a~nK-------Kaa~kp~Le~vicgrNRleng 172 (388)
T COG5238 109 PEELG---DLISSSTDLVHLKLNNNGLG-PIAG--GRIGKALFHL---AYNK-------KAADKPKLEVVICGRNRLENG 172 (388)
T ss_pred chHHH---HHHhcCCCceeEEeecCCCC-ccch--hHHHHHHHHH---HHHh-------hhccCCCceEEEeccchhccC
Confidence 54331 12356677888888888663 2221 1111 22222 2221 223445677777777776532
Q ss_pred ccc----cccCCCCCcEEEccCCcccccCCcc--------cccCCCCccEEEeecccccc----ccCccccCCCCCCeEE
Q 045449 220 VPV----TIFNMSALKEISLLNNSLSGSLPSR--------IDLSLPNVETLNLGINSFSG----TIPSSITNSSKLSDLE 283 (823)
Q Consensus 220 ~p~----~~~~l~~L~~L~Ls~N~l~g~lp~~--------~~~~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~ 283 (823)
.-. .+..-..|+.+.+..|.|. |.. ++ .+.+|+.|||+.|-|+- .+...++.++.|+.|.
T Consensus 173 s~~~~a~~l~sh~~lk~vki~qNgIr---pegv~~L~~~gl~-y~~~LevLDlqDNtft~~gS~~La~al~~W~~lrEL~ 248 (388)
T COG5238 173 SKELSAALLESHENLKEVKIQQNGIR---PEGVTMLAFLGLF-YSHSLEVLDLQDNTFTLEGSRYLADALCEWNLLRELR 248 (388)
T ss_pred cHHHHHHHHHhhcCceeEEeeecCcC---cchhHHHHHHHHH-HhCcceeeeccccchhhhhHHHHHHHhcccchhhhcc
Confidence 111 1112236777777777665 321 12 36677777777777752 2233455556677777
Q ss_pred eecccccccCCCcc----C--CCcccCcccccCccccCC
Q 045449 284 LGENLFSGFIPNTI----G--NLRNLEFGNIADNYLTSS 316 (823)
Q Consensus 284 Ls~N~l~~~~p~~~----~--~l~~L~~L~L~~N~l~~~ 316 (823)
+..+-++..-..++ . ..++|..|...+|...+.
T Consensus 249 lnDClls~~G~~~v~~~f~e~~~p~l~~L~~~Yne~~~~ 287 (388)
T COG5238 249 LNDCLLSNEGVKSVLRRFNEKFVPNLMPLPGDYNERRGG 287 (388)
T ss_pred ccchhhccccHHHHHHHhhhhcCCCccccccchhhhcCc
Confidence 77776664332221 1 245566666666666554
|
|
| >COG5238 RNA1 Ran GTPase-activating protein (RanGAP) involved in mRNA processing and transport [Signal transduction mechanisms / RNA processing and modification] | Back alignment and domain information |
|---|
Probab=97.97 E-value=1.6e-06 Score=85.81 Aligned_cols=167 Identities=17% Similarity=0.201 Sum_probs=103.8
Q ss_pred ccccCCCCceEEEeecCCCCccCCcccccc---ccccceEEecCCcceeccCcc-------------ccCcccccEEEcc
Q 045449 324 SSLTNCKKLKVLIVTGNPLDGILPKSIGNF---SLSLETILMANCSISGNIPQV-------------VGNLSNLLVLELG 387 (823)
Q Consensus 324 ~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~---~~~L~~L~L~~N~l~~~~p~~-------------~~~l~~L~~L~Ls 387 (823)
..+-.|++|+..+||.|.|....|..++.+ +..|++|.|++|.+--.--.. ..+-+.|++++..
T Consensus 86 ~aLlkcp~l~~v~LSDNAfg~~~~e~L~d~is~~t~l~HL~l~NnGlGp~aG~rigkal~~la~nKKaa~kp~Le~vicg 165 (388)
T COG5238 86 KALLKCPRLQKVDLSDNAFGSEFPEELGDLISSSTDLVHLKLNNNGLGPIAGGRIGKALFHLAYNKKAADKPKLEVVICG 165 (388)
T ss_pred HHHhcCCcceeeeccccccCcccchHHHHHHhcCCCceeEEeecCCCCccchhHHHHHHHHHHHHhhhccCCCceEEEec
Confidence 456677777777777777776666544432 256777777777664221111 2345778899999
Q ss_pred cCcCCCCch----hcccccCCCCEEEccCCCCCCcch-----HhhhcCCCCCEEEcccCcCccccc----ccccCCCCCC
Q 045449 388 GNNLTGPIP----VTFSQLQTLQAFDLTRNKLAGPIT-----DELCHLARLHSLVLQGNKFSGSIP----SCLGNLTSVR 454 (823)
Q Consensus 388 ~N~l~g~~p----~~~~~l~~L~~L~Ls~N~l~~~~p-----~~~~~l~~L~~L~Ls~N~l~g~~p----~~~~~l~~L~ 454 (823)
.|+|..-.. ..+..-..|+.+-+..|.|...-- ..+..+.+|+.|||+.|-|+-.-. ..+...+.|+
T Consensus 166 rNRlengs~~~~a~~l~sh~~lk~vki~qNgIrpegv~~L~~~gl~y~~~LevLDlqDNtft~~gS~~La~al~~W~~lr 245 (388)
T COG5238 166 RNRLENGSKELSAALLESHENLKEVKIQQNGIRPEGVTMLAFLGLFYSHSLEVLDLQDNTFTLEGSRYLADALCEWNLLR 245 (388)
T ss_pred cchhccCcHHHHHHHHHhhcCceeEEeeecCcCcchhHHHHHHHHHHhCcceeeeccccchhhhhHHHHHHHhcccchhh
Confidence 998863221 123333578888888888863311 122446788899999998874322 2344556688
Q ss_pred eEeccCCccccccchhhh------ccCCCcEEeccccccccc
Q 045449 455 VLYLGLNIFTSVLSSTIW------NLKDILFIDVSSNFLDGP 490 (823)
Q Consensus 455 ~L~Ls~N~l~~~~p~~~~------~l~~L~~LdLs~N~l~g~ 490 (823)
.|.+..+-++..-..++. ..++|+.|-..+|-..|.
T Consensus 246 EL~lnDClls~~G~~~v~~~f~e~~~p~l~~L~~~Yne~~~~ 287 (388)
T COG5238 246 ELRLNDCLLSNEGVKSVLRRFNEKFVPNLMPLPGDYNERRGG 287 (388)
T ss_pred hccccchhhccccHHHHHHHhhhhcCCCccccccchhhhcCc
Confidence 888888877654443322 246667777777766553
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=97.96 E-value=5.7e-06 Score=80.43 Aligned_cols=80 Identities=28% Similarity=0.264 Sum_probs=58.4
Q ss_pred CeEEEEEEehHhhHHHHHHHHHHHHHHhhcchhhHHH-------------------------------HHHHHHHHhhhc
Q 045449 641 GMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVK-------------------------------IISSSLEYLHFG 689 (823)
Q Consensus 641 ~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-------------------------------~~~~~l~~L~~~ 689 (823)
+..|++|+...... ....+.+|++++..+.+.+++. .+.++++.|..+
T Consensus 21 ~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~~~~~~lv~e~i~G~~l~~~~~~~~~~~~~l~~~l~~L 99 (170)
T cd05151 21 NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFDPETGVLITEFIEGSELLTEDFSDPENLEKIAKLLKKL 99 (170)
T ss_pred CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEeCCCCeEEEEecCCCccccccccCHHHHHHHHHHHHHH
Confidence 46799998765432 1235678888888876554432 244666677777
Q ss_pred CCCC-----EEeccCCCCCEEeCCCCcEEEeecccccc
Q 045449 690 HSIP-----IIHCDLKPSNVLLDEDMVAHISDFGIAKL 722 (823)
Q Consensus 690 h~~~-----ivHrdlk~~NiLl~~~~~~kl~DfGla~~ 722 (823)
|..+ ++|+|++|.||+++ ++.++++|||.+..
T Consensus 100 H~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 100 HSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred hCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 7776 59999999999999 56899999998875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.90 E-value=1.1e-05 Score=94.22 Aligned_cols=100 Identities=26% Similarity=0.241 Sum_probs=79.0
Q ss_pred HHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCC---------------------C---cc-----
Q 045449 679 ISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGE---------------------D---QL----- 729 (823)
Q Consensus 679 ~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~---------------------~---~~----- 729 (823)
++.....+.++|...+.|||+||.|++...+++.+++|||........ . ..
T Consensus 910 i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~ 989 (1205)
T KOG0606|consen 910 ILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEA 989 (1205)
T ss_pred hHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccccccccCcCCcccccccCccccccccccccccccchh
Confidence 455566677788888999999999999999999999999843321100 0 00
Q ss_pred ccccccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCCC
Q 045449 730 SKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 730 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
.......||+.|.|||...+...+..+|+|+.|+++.+.++|..||...
T Consensus 990 ~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~ 1038 (1205)
T KOG0606|consen 990 RRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAE 1038 (1205)
T ss_pred hccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCc
Confidence 1123457899999999999999999999999999999999999998664
|
|
| >KOG2120 consensus SCF ubiquitin ligase, Skp2 component [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=97.90 E-value=3.7e-07 Score=91.48 Aligned_cols=175 Identities=18% Similarity=0.231 Sum_probs=90.4
Q ss_pred cCcccccCccccCCCCcccccccccCCCCceEEEeecCCCCccCCccccccccccceEEecCC-cceecc-CccccCccc
Q 045449 303 LEFGNIADNYLTSSTPELSFLSSLTNCKKLKVLIVTGNPLDGILPKSIGNFSLSLETILMANC-SISGNI-PQVVGNLSN 380 (823)
Q Consensus 303 L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N-~l~~~~-p~~~~~l~~ 380 (823)
|++|||+...++... ...-+..|.+|+.|.|.++++...+-..+... .+|+.|+++.+ .|+..- .-.+.+++.
T Consensus 187 lq~lDLS~s~it~st----l~~iLs~C~kLk~lSlEg~~LdD~I~~~iAkN-~~L~~lnlsm~sG~t~n~~~ll~~scs~ 261 (419)
T KOG2120|consen 187 LQHLDLSNSVITVST----LHGILSQCSKLKNLSLEGLRLDDPIVNTIAKN-SNLVRLNLSMCSGFTENALQLLLSSCSR 261 (419)
T ss_pred hHHhhcchhheeHHH----HHHHHHHHHhhhhccccccccCcHHHHHHhcc-ccceeeccccccccchhHHHHHHHhhhh
Confidence 555555555544321 22235566777777777777776666666655 56777777654 333211 123556778
Q ss_pred ccEEEcccCcCCCCchhc-ccc-cCCCCEEEccCCCC---CCcchHhhhcCCCCCEEEcccCcCcccccccccCCCCCCe
Q 045449 381 LLVLELGGNNLTGPIPVT-FSQ-LQTLQAFDLTRNKL---AGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSVRV 455 (823)
Q Consensus 381 L~~L~Ls~N~l~g~~p~~-~~~-l~~L~~L~Ls~N~l---~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~ 455 (823)
|..|+|+++.++...-.. +.. -.+|+.|+|++..= ...+..--..+++|..||||+|.
T Consensus 262 L~~LNlsWc~l~~~~Vtv~V~hise~l~~LNlsG~rrnl~~sh~~tL~~rcp~l~~LDLSD~v----------------- 324 (419)
T KOG2120|consen 262 LDELNLSWCFLFTEKVTVAVAHISETLTQLNLSGYRRNLQKSHLSTLVRRCPNLVHLDLSDSV----------------- 324 (419)
T ss_pred HhhcCchHhhccchhhhHHHhhhchhhhhhhhhhhHhhhhhhHHHHHHHhCCceeeecccccc-----------------
Confidence 888888888776433111 111 13566666665321 11111122344555555555443
Q ss_pred EeccCCccccccchhhhccCCCcEEeccccccccccCc---cccCCCCCcEEEcc
Q 045449 456 LYLGLNIFTSVLSSTIWNLKDILFIDVSSNFLDGPLSL---DIGNLKVVIGLDFS 507 (823)
Q Consensus 456 L~Ls~N~l~~~~p~~~~~l~~L~~LdLs~N~l~g~~p~---~~~~l~~L~~L~ls 507 (823)
.++...-..|.+++.|++|.+|.+.. .+|. .+...+.|.+||+-
T Consensus 325 ------~l~~~~~~~~~kf~~L~~lSlsRCY~--i~p~~~~~l~s~psl~yLdv~ 371 (419)
T KOG2120|consen 325 ------MLKNDCFQEFFKFNYLQHLSLSRCYD--IIPETLLELNSKPSLVYLDVF 371 (419)
T ss_pred ------ccCchHHHHHHhcchheeeehhhhcC--CChHHeeeeccCcceEEEEec
Confidence 12222233444555555555555542 3332 34566777777754
|
|
| >PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B | Back alignment and domain information |
|---|
Probab=97.84 E-value=1e-05 Score=58.54 Aligned_cols=36 Identities=36% Similarity=0.518 Sum_probs=16.0
Q ss_pred CCCEEECCCCcCcCCCchhhhcCCCCcEEeccccccc
Q 045449 101 TLKLLDFSDNQLFGSLSSFIFNMSSMTTIDLSINRLS 137 (823)
Q Consensus 101 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 137 (823)
+|++|+|++|+|+ .+|..++++++|++|++++|+++
T Consensus 2 ~L~~L~l~~N~i~-~l~~~l~~l~~L~~L~l~~N~i~ 37 (44)
T PF12799_consen 2 NLEELDLSNNQIT-DLPPELSNLPNLETLNLSNNPIS 37 (44)
T ss_dssp T-SEEEETSSS-S-SHGGHGTTCTTSSEEEETSSCCS
T ss_pred cceEEEccCCCCc-ccCchHhCCCCCCEEEecCCCCC
Confidence 3444444444444 23334445555555555555444
|
... |
| >KOG2120 consensus SCF ubiquitin ligase, Skp2 component [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=97.82 E-value=3.5e-07 Score=91.65 Aligned_cols=156 Identities=22% Similarity=0.242 Sum_probs=80.3
Q ss_pred CccEEEeecccccc-ccCccccCCCCCCeEEeecccccccCCCccCCCcccCcccccCcc-ccCCCCcccccccccCCCC
Q 045449 254 NVETLNLGINSFSG-TIPSSITNSSKLSDLELGENLFSGFIPNTIGNLRNLEFGNIADNY-LTSSTPELSFLSSLTNCKK 331 (823)
Q Consensus 254 ~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~-l~~~~~~~~~~~~l~~l~~ 331 (823)
.|++||||+-.|+. ..-..+..+.+|+.|.|.++++.+.+-..++.-.+|+.|+|+... ++.. ..---+.+|+.
T Consensus 186 Rlq~lDLS~s~it~stl~~iLs~C~kLk~lSlEg~~LdD~I~~~iAkN~~L~~lnlsm~sG~t~n----~~~ll~~scs~ 261 (419)
T KOG2120|consen 186 RLQHLDLSNSVITVSTLHGILSQCSKLKNLSLEGLRLDDPIVNTIAKNSNLVRLNLSMCSGFTEN----ALQLLLSSCSR 261 (419)
T ss_pred hhHHhhcchhheeHHHHHHHHHHHHhhhhccccccccCcHHHHHHhccccceeeccccccccchh----HHHHHHHhhhh
Confidence 36666666655542 111224455667777777777777666667666777777776543 2211 11223567777
Q ss_pred ceEEEeecCCCCccC-CccccccccccceEEecCCcc---eeccCccccCcccccEEEcccCc-CCCCchhcccccCCCC
Q 045449 332 LKVLIVTGNPLDGIL-PKSIGNFSLSLETILMANCSI---SGNIPQVVGNLSNLLVLELGGNN-LTGPIPVTFSQLQTLQ 406 (823)
Q Consensus 332 L~~L~Ls~N~l~~~~-p~~~~~~~~~L~~L~L~~N~l---~~~~p~~~~~l~~L~~L~Ls~N~-l~g~~p~~~~~l~~L~ 406 (823)
|..|+|+.+.+.... ...+.....+|+.|++++..- ...+......+++|..||||.|. ++...-..|-+++.|+
T Consensus 262 L~~LNlsWc~l~~~~Vtv~V~hise~l~~LNlsG~rrnl~~sh~~tL~~rcp~l~~LDLSD~v~l~~~~~~~~~kf~~L~ 341 (419)
T KOG2120|consen 262 LDELNLSWCFLFTEKVTVAVAHISETLTQLNLSGYRRNLQKSHLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFKFNYLQ 341 (419)
T ss_pred HhhcCchHhhccchhhhHHHhhhchhhhhhhhhhhHhhhhhhHHHHHHHhCCceeeeccccccccCchHHHHHHhcchhe
Confidence 777777777665432 122233335566666665321 11111122345555555555542 3332333344455555
Q ss_pred EEEccCC
Q 045449 407 AFDLTRN 413 (823)
Q Consensus 407 ~L~Ls~N 413 (823)
+|.|+.+
T Consensus 342 ~lSlsRC 348 (419)
T KOG2120|consen 342 HLSLSRC 348 (419)
T ss_pred eeehhhh
Confidence 5555444
|
|
| >PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B | Back alignment and domain information |
|---|
Probab=97.75 E-value=3.3e-05 Score=55.95 Aligned_cols=36 Identities=33% Similarity=0.600 Sum_probs=15.5
Q ss_pred cccEEEcccCcCCCCchhcccccCCCCEEEccCCCCC
Q 045449 380 NLLVLELGGNNLTGPIPVTFSQLQTLQAFDLTRNKLA 416 (823)
Q Consensus 380 ~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~ 416 (823)
+|++|++++|+|+ .+|..++++++|++|++++|+|+
T Consensus 2 ~L~~L~l~~N~i~-~l~~~l~~l~~L~~L~l~~N~i~ 37 (44)
T PF12799_consen 2 NLEELDLSNNQIT-DLPPELSNLPNLETLNLSNNPIS 37 (44)
T ss_dssp T-SEEEETSSS-S-SHGGHGTTCTTSSEEEETSSCCS
T ss_pred cceEEEccCCCCc-ccCchHhCCCCCCEEEecCCCCC
Confidence 3444444444444 33333444444444444444444
|
... |
| >PRK15386 type III secretion protein GogB; Provisional | Back alignment and domain information |
|---|
Probab=97.74 E-value=0.00011 Score=79.67 Aligned_cols=56 Identities=11% Similarity=0.215 Sum_probs=35.6
Q ss_pred cCCCCCCcEEEccCCCCCCCCCCCCCCCCCCCEEECCCC-cCcCCCchhhhcCCCCcEEecccc
Q 045449 72 LGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLDFSDN-QLFGSLSSFIFNMSSMTTIDLSIN 134 (823)
Q Consensus 72 l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~Ls~N 134 (823)
+..+.++++|++++|.|+ .+|. + -.+|++|+++++ .+ ..+|+.+ ..+|++|++++|
T Consensus 48 ~~~~~~l~~L~Is~c~L~-sLP~-L--P~sLtsL~Lsnc~nL-tsLP~~L--P~nLe~L~Ls~C 104 (426)
T PRK15386 48 IEEARASGRLYIKDCDIE-SLPV-L--PNELTEITIENCNNL-TTLPGSI--PEGLEKLTVCHC 104 (426)
T ss_pred HHHhcCCCEEEeCCCCCc-ccCC-C--CCCCcEEEccCCCCc-ccCCchh--hhhhhheEccCc
Confidence 444577888888888777 4451 1 235888888764 43 3455444 246777777776
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.66 E-value=9.1e-05 Score=83.11 Aligned_cols=128 Identities=16% Similarity=0.170 Sum_probs=91.8
Q ss_pred CeEEEEEEehHhhHHHHHHHHHHHHHHhhcchhhHHHH-----------------------------------HHHHHHH
Q 045449 641 GMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVKI-----------------------------------ISSSLEY 685 (823)
Q Consensus 641 ~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~-----------------------------------~~~~l~~ 685 (823)
+.+|.|...+.......+...+-++-++.++||+|+++ +.|++.+
T Consensus 37 ~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~Pl~~~lk~l~~~~v~~Gl~qIl~A 116 (690)
T KOG1243|consen 37 GGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVRPLETVLKELGKEEVCLGLFQILAA 116 (690)
T ss_pred CCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccccHHHHHHHhHHHHHHHHHHHHHHH
Confidence 56788877765544344556777888999999999993 4688888
Q ss_pred hhhcC-CCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCcccccCCCccccccceehhhhh
Q 045449 686 LHFGH-SIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGII 764 (823)
Q Consensus 686 L~~~h-~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv 764 (823)
|-|+| +.+++|+++.-+-|.++..|+-||.+|-++.......... ....--..|..|+.+.... -..|.|-|||+
T Consensus 117 L~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~--~~~~~~~s~~~P~~~~~s~--~s~D~~~Lg~l 192 (690)
T KOG1243|consen 117 LSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPA--KSLYLIESFDDPEEIDPSE--WSIDSWGLGCL 192 (690)
T ss_pred HHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCccc--ccchhhhcccChhhcCccc--cchhhhhHHHH
Confidence 88886 7889999999999999999999999998876543221100 1111122456666543222 34599999999
Q ss_pred hccccCCC
Q 045449 765 SGGKETRS 772 (823)
Q Consensus 765 ~~~~~~~~ 772 (823)
.+++.-|.
T Consensus 193 i~el~ng~ 200 (690)
T KOG1243|consen 193 IEELFNGS 200 (690)
T ss_pred HHHHhCcc
Confidence 99988873
|
|
| >PRK15386 type III secretion protein GogB; Provisional | Back alignment and domain information |
|---|
Probab=97.64 E-value=0.00011 Score=79.48 Aligned_cols=159 Identities=13% Similarity=0.189 Sum_probs=77.9
Q ss_pred CCCCceEEEeecCCCCccCCccccccccccceEEecCCcceeccCccccCcccccEEEcccC-cCCCCchhcccccCCCC
Q 045449 328 NCKKLKVLIVTGNPLDGILPKSIGNFSLSLETILMANCSISGNIPQVVGNLSNLLVLELGGN-NLTGPIPVTFSQLQTLQ 406 (823)
Q Consensus 328 ~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N-~l~g~~p~~~~~l~~L~ 406 (823)
.+.+++.|++++|.++. +| .+|.+|++|.++++.--..+|..+ .++|+.|++++| ++. .+|. +|+
T Consensus 50 ~~~~l~~L~Is~c~L~s-LP----~LP~sLtsL~Lsnc~nLtsLP~~L--P~nLe~L~Ls~Cs~L~-sLP~------sLe 115 (426)
T PRK15386 50 EARASGRLYIKDCDIES-LP----VLPNELTEITIENCNNLTTLPGSI--PEGLEKLTVCHCPEIS-GLPE------SVR 115 (426)
T ss_pred HhcCCCEEEeCCCCCcc-cC----CCCCCCcEEEccCCCCcccCCchh--hhhhhheEccCccccc-cccc------ccc
Confidence 34556666666665553 23 244566666666533223445433 246677777766 443 3443 355
Q ss_pred EEEccCCCCCC--cchHhhhcCCCCCEEEcccCc-Cc-ccccccccCCCCCCeEeccCCccccccchhhhccCCCcEEec
Q 045449 407 AFDLTRNKLAG--PITDELCHLARLHSLVLQGNK-FS-GSIPSCLGNLTSVRVLYLGLNIFTSVLSSTIWNLKDILFIDV 482 (823)
Q Consensus 407 ~L~Ls~N~l~~--~~p~~~~~l~~L~~L~Ls~N~-l~-g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~LdL 482 (823)
.|+++.|.... .+|. +|+.|.+.+++ .. ..+|..+ -++|++|++++|.... .|..+. .+|+.|++
T Consensus 116 ~L~L~~n~~~~L~~LPs------sLk~L~I~~~n~~~~~~lp~~L--PsSLk~L~Is~c~~i~-LP~~LP--~SLk~L~l 184 (426)
T PRK15386 116 SLEIKGSATDSIKNVPN------GLTSLSINSYNPENQARIDNLI--SPSLKTLSLTGCSNII-LPEKLP--ESLQSITL 184 (426)
T ss_pred eEEeCCCCCcccccCcc------hHhheecccccccccccccccc--CCcccEEEecCCCccc-Cccccc--ccCcEEEe
Confidence 66666555421 2222 34555554322 11 0111111 1467777777766442 233222 46777777
Q ss_pred ccccc------ccccCccccCCCCCcEEEcccCCCC
Q 045449 483 SSNFL------DGPLSLDIGNLKVVIGLDFSRNNLS 512 (823)
Q Consensus 483 s~N~l------~g~~p~~~~~l~~L~~L~ls~N~l~ 512 (823)
+.|.. .+.+|..+ .+.....+.++.+.|+
T Consensus 185 s~n~~~sLeI~~~sLP~nl-~L~f~n~lkL~~~~f~ 219 (426)
T PRK15386 185 HIEQKTTWNISFEGFPDGL-DIDLQNSVLLSPDVFK 219 (426)
T ss_pred cccccccccCccccccccc-EechhhhcccCHHHhh
Confidence 76631 22455444 4444444444444444
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.64 E-value=3.8e-05 Score=85.26 Aligned_cols=91 Identities=24% Similarity=0.250 Sum_probs=69.2
Q ss_pred HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCC-CcEEEeecccccccCCCCccccccccccCCCcC--cccccCCCcccc
Q 045449 678 IISSSLEYLHFGHSIPIIHCDLKPSNVLLDED-MVAHISDFGIAKLLSGEDQLSKQTQTLATIGYM--APEYGTKGRVST 754 (823)
Q Consensus 678 ~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~-~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~ 754 (823)
+.+|++.+++++|++..+|+|+||+||++..+ +.-++.|||.+..+.-.. ....++.+|. +++......+..
T Consensus 371 ~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~~-----~~~~~~~r~~p~~~~~~e~~~~~~ 445 (524)
T KOG0601|consen 371 LTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFSS-----GVFHHIDRLYPIAEILLEDYPHLS 445 (524)
T ss_pred hHHHHHhccccccchhhhcccccccceeeccchhhhhccccccccccceec-----ccccccccccccchhhcccccccc
Confidence 45789999999999999999999999999876 788999999987532111 1122333444 555566677899
Q ss_pred ccceehhhhhhccccCCCC
Q 045449 755 RGDVCSFGIISGGKETRSM 773 (823)
Q Consensus 755 ~~Dv~S~Gvv~~~~~~~~~ 773 (823)
+.|++|||.-..+..++..
T Consensus 446 ~~~~~sl~~~~~e~~~~~~ 464 (524)
T KOG0601|consen 446 KADIFSLGLSVDEAITGSP 464 (524)
T ss_pred ccccccccccccccccCcc
Confidence 9999999988777777664
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=97.59 E-value=0.00014 Score=82.70 Aligned_cols=42 Identities=26% Similarity=0.381 Sum_probs=35.7
Q ss_pred HhhhcCCCCEEeccCCCCCEEeCCCC----cEEEeecccccccCCC
Q 045449 685 YLHFGHSIPIIHCDLKPSNVLLDEDM----VAHISDFGIAKLLSGE 726 (823)
Q Consensus 685 ~L~~~h~~~ivHrdlk~~NiLl~~~~----~~kl~DfGla~~~~~~ 726 (823)
|+..++..|++|+|+||.||+++.++ .+++.|||++..+...
T Consensus 272 ~~~Qif~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~~ 317 (537)
T PRK04750 272 FFTQVFRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNKE 317 (537)
T ss_pred HHHHHHhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCHH
Confidence 44555678999999999999999887 9999999999877543
|
|
| >KOG1644 consensus U2-associated snRNP A' protein [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=97.55 E-value=9.6e-05 Score=70.71 Aligned_cols=87 Identities=24% Similarity=0.346 Sum_probs=58.2
Q ss_pred CCCccEEEeeccccccccCccccCCCCCCeEEeecccccccCCCccCCCcccCcccccCccccCCCCcccccccccCCCC
Q 045449 252 LPNVETLNLGINSFSGTIPSSITNSSKLSDLELGENLFSGFIPNTIGNLRNLEFGNIADNYLTSSTPELSFLSSLTNCKK 331 (823)
Q Consensus 252 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~ 331 (823)
+.+...+||+.|.+. --+.|..++.|.+|.|++|+|+.+-|..-.-+++|..|.|.+|++.... ....+..|++
T Consensus 41 ~d~~d~iDLtdNdl~--~l~~lp~l~rL~tLll~nNrIt~I~p~L~~~~p~l~~L~LtnNsi~~l~----dl~pLa~~p~ 114 (233)
T KOG1644|consen 41 LDQFDAIDLTDNDLR--KLDNLPHLPRLHTLLLNNNRITRIDPDLDTFLPNLKTLILTNNSIQELG----DLDPLASCPK 114 (233)
T ss_pred ccccceecccccchh--hcccCCCccccceEEecCCcceeeccchhhhccccceEEecCcchhhhh----hcchhccCCc
Confidence 445666777777765 2234666777777777777777666665556677777777777776542 2345667777
Q ss_pred ceEEEeecCCCCc
Q 045449 332 LKVLIVTGNPLDG 344 (823)
Q Consensus 332 L~~L~Ls~N~l~~ 344 (823)
|++|.+-+|....
T Consensus 115 L~~Ltll~Npv~~ 127 (233)
T KOG1644|consen 115 LEYLTLLGNPVEH 127 (233)
T ss_pred cceeeecCCchhc
Confidence 7777777777653
|
|
| >KOG1644 consensus U2-associated snRNP A' protein [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=97.42 E-value=0.00021 Score=68.37 Aligned_cols=83 Identities=20% Similarity=0.208 Sum_probs=43.2
Q ss_pred cccEEEcccCcCCCCchhcccccCCCCEEEccCCCCCCcchHhhhcCCCCCEEEcccCcCcccc-cccccCCCCCCeEec
Q 045449 380 NLLVLELGGNNLTGPIPVTFSQLQTLQAFDLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSI-PSCLGNLTSVRVLYL 458 (823)
Q Consensus 380 ~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~-p~~~~~l~~L~~L~L 458 (823)
+...+||++|.+. .+ ..|..++.|.+|.|++|+|+.+-|.--.-+++|..|.|.+|+|.... -.-+..++.|++|.+
T Consensus 43 ~~d~iDLtdNdl~-~l-~~lp~l~rL~tLll~nNrIt~I~p~L~~~~p~l~~L~LtnNsi~~l~dl~pLa~~p~L~~Ltl 120 (233)
T KOG1644|consen 43 QFDAIDLTDNDLR-KL-DNLPHLPRLHTLLLNNNRITRIDPDLDTFLPNLKTLILTNNSIQELGDLDPLASCPKLEYLTL 120 (233)
T ss_pred ccceecccccchh-hc-ccCCCccccceEEecCCcceeeccchhhhccccceEEecCcchhhhhhcchhccCCccceeee
Confidence 4556666666664 22 23555666666666666666554444344455666666666654211 011334444444444
Q ss_pred cCCccc
Q 045449 459 GLNIFT 464 (823)
Q Consensus 459 s~N~l~ 464 (823)
-+|..+
T Consensus 121 l~Npv~ 126 (233)
T KOG1644|consen 121 LGNPVE 126 (233)
T ss_pred cCCchh
Confidence 444443
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.28 E-value=0.00019 Score=80.94 Aligned_cols=87 Identities=18% Similarity=0.303 Sum_probs=65.2
Q ss_pred HHHhhhcC-CCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCcccc-------ccccccCCCcCcccccCCCcccc
Q 045449 683 LEYLHFGH-SIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSK-------QTQTLATIGYMAPEYGTKGRVST 754 (823)
Q Consensus 683 l~~L~~~h-~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~ 754 (823)
.+++.+.| +.++||++|.|++|.+++.+..|++-|+++....+...+.. ..-..-...|.|||++.....+.
T Consensus 109 ~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~~~~~ 188 (700)
T KOG2137|consen 109 ADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGTTNTP 188 (700)
T ss_pred cchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccccccc
Confidence 34455555 46899999999999999999999999998766544211111 11112356899999999888899
Q ss_pred ccceehhhhhhcccc
Q 045449 755 RGDVCSFGIISGGKE 769 (823)
Q Consensus 755 ~~Dv~S~Gvv~~~~~ 769 (823)
++|+||+||+.|-.-
T Consensus 189 ~sd~fSlG~li~~i~ 203 (700)
T KOG2137|consen 189 ASDVFSLGVLIYTIY 203 (700)
T ss_pred cccceeeeeEEEEEe
Confidence 999999999977665
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST 
Original result of BLAST against Protein Data Bank
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() | |
| Query | 823 | ||||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 7e-34 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 9e-33 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 1e-18 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 4e-11 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-13 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 8e-13 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 9e-13 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 1e-12 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 3e-12 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 3e-12 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 3e-12 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 3e-12 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 3e-12 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-12 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 3e-12 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-12 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 3e-12 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 3e-12 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 3e-12 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-12 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 3e-12 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 4e-12 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 4e-12 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 4e-12 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 4e-12 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-12 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 4e-12 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 4e-12 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 1e-11 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 6e-10 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 9e-10 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-09 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-09 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-09 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-09 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-09 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-09 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 3e-09 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 3e-09 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 3e-09 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 3e-09 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 3e-09 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 3e-09 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 3e-09 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 3e-09 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-09 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 3e-09 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 3e-09 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 3e-09 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 3e-09 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 4e-09 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 4e-09 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 4e-09 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 4e-09 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 5e-09 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 5e-09 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 7e-09 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 8e-09 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 8e-09 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 4e-08 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 7e-08 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-08 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 8e-08 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-08 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-08 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 9e-08 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-07 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 1e-07 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-07 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-07 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-07 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 3e-07 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 3e-07 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 3e-07 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 3e-07 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 3e-07 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 3e-07 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 3e-07 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 3e-07 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 3e-07 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 4e-07 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 4e-07 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 4e-07 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 4e-07 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 4e-07 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 5e-07 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 5e-07 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 6e-07 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 6e-07 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 6e-07 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 7e-07 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 7e-07 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 7e-07 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 7e-07 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 7e-07 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 7e-07 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 7e-07 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 7e-07 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 8e-07 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 8e-07 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 8e-07 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 8e-07 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 8e-07 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 8e-07 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 8e-07 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 8e-07 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 8e-07 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 8e-07 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 9e-07 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 9e-07 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 1e-06 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 1e-06 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-06 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 1e-06 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 1e-06 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 1e-06 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-06 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-06 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-06 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-06 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-06 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-06 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-06 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-06 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-06 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-06 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-06 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-06 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-06 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-06 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-06 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-06 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-06 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-06 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-06 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-06 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-06 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-06 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-06 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-06 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-06 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-06 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-06 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-06 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-06 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-06 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 3e-06 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 3e-06 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 3e-06 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-06 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 3e-06 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 3e-06 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 3e-06 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 3e-06 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 3e-06 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 3e-06 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 3e-06 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 3e-06 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 3e-06 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-06 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 3e-06 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-06 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 4e-06 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 4e-06 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 4e-06 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 4e-06 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-06 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-06 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 4e-06 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 4e-06 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 4e-06 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 4e-06 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-06 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 4e-06 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 4e-06 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 4e-06 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 4e-06 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 5e-06 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-06 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-06 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-06 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 5e-06 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 5e-06 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 5e-06 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 5e-06 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 6e-06 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 6e-06 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 6e-06 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 6e-06 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 6e-06 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 6e-06 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 6e-06 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 6e-06 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 7e-06 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 7e-06 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 7e-06 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 7e-06 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 7e-06 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 7e-06 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 7e-06 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 7e-06 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 7e-06 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 8e-06 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 8e-06 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 8e-06 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 8e-06 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 8e-06 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 8e-06 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 8e-06 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 8e-06 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 8e-06 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 8e-06 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 8e-06 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 8e-06 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 8e-06 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 9e-06 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 9e-06 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 9e-06 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-05 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 1e-05 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-05 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-05 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-05 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-05 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 1e-05 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-05 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 1e-05 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-05 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 1e-05 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-05 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-05 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-05 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-05 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-05 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-05 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-05 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 2e-05 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-05 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-05 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-05 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-05 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-05 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-05 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-05 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-05 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-05 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-05 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-05 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-05 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-05 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-05 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-05 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-05 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-05 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-05 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-05 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-05 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-05 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-05 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-05 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 2e-05 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-05 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 2e-05 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-05 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-05 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-05 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-05 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-05 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-05 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-05 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-05 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 3e-05 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 3e-05 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 3e-05 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 3e-05 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 3e-05 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-05 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 3e-05 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 3e-05 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 3e-05 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 3e-05 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 3e-05 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 3e-05 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 3e-05 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 3e-05 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 3e-05 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 3e-05 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 3e-05 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 3e-05 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 3e-05 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 3e-05 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 3e-05 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 3e-05 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 3e-05 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 3e-05 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 3e-05 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 3e-05 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 3e-05 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 3e-05 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 3e-05 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 3e-05 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 3e-05 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-05 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-05 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 3e-05 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 3e-05 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 3e-05 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 3e-05 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 3e-05 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 3e-05 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 4e-05 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 4e-05 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 4e-05 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 4e-05 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 4e-05 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 4e-05 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 4e-05 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-05 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 4e-05 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 4e-05 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 4e-05 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-05 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 4e-05 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 4e-05 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 4e-05 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 4e-05 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 4e-05 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 4e-05 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-05 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-05 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 4e-05 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 4e-05 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 4e-05 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 4e-05 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 4e-05 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 4e-05 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 4e-05 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 4e-05 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-05 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-05 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 4e-05 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 4e-05 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 5e-05 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-05 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 5e-05 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 5e-05 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-05 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 5e-05 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 5e-05 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 5e-05 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 5e-05 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 5e-05 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 5e-05 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-05 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 5e-05 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 5e-05 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 5e-05 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 5e-05 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 5e-05 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 5e-05 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 5e-05 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 5e-05 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 5e-05 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 5e-05 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 5e-05 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 5e-05 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 5e-05 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-05 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-05 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 5e-05 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 5e-05 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 5e-05 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 5e-05 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 5e-05 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-05 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-05 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 5e-05 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 5e-05 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 5e-05 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 5e-05 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 5e-05 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 5e-05 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 5e-05 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 5e-05 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 5e-05 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 5e-05 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-05 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 5e-05 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 5e-05 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 5e-05 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 5e-05 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 5e-05 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 5e-05 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 5e-05 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-05 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 5e-05 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 5e-05 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 5e-05 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 5e-05 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 5e-05 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 6e-05 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 6e-05 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 6e-05 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 6e-05 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 6e-05 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 6e-05 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-05 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 6e-05 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 6e-05 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 6e-05 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 6e-05 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 6e-05 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 6e-05 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 7e-05 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 7e-05 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 7e-05 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 7e-05 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 7e-05 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 7e-05 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 7e-05 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 7e-05 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 7e-05 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 7e-05 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 7e-05 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 7e-05 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 8e-05 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 8e-05 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 8e-05 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 8e-05 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 8e-05 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 8e-05 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 8e-05 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 8e-05 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 8e-05 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 8e-05 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 8e-05 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 8e-05 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 8e-05 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 8e-05 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 8e-05 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 8e-05 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 8e-05 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 8e-05 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 8e-05 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 8e-05 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 8e-05 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-05 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 9e-05 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 9e-05 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 9e-05 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 9e-05 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 9e-05 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 9e-05 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 9e-05 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 9e-05 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 9e-05 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 9e-05 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 9e-05 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 9e-05 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 9e-05 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 9e-05 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 9e-05 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 9e-05 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 9e-05 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 9e-05 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-04 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-04 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-04 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-04 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 1e-04 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 1e-04 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-04 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-04 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-04 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-04 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-04 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-04 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-04 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-04 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 1e-04 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-04 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-04 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-04 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-04 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 1e-04 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 1e-04 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 1e-04 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 1e-04 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 1e-04 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-04 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 1e-04 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 1e-04 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 1e-04 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-04 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 1e-04 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 1e-04 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 1e-04 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 1e-04 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-04 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-04 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 1e-04 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 1e-04 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 1e-04 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 1e-04 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-04 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-04 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-04 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-04 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 1e-04 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-04 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-04 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 1e-04 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 1e-04 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-04 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 1e-04 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-04 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-04 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-04 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-04 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-04 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-04 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-04 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-04 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-04 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-04 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-04 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 2e-04 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-04 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-04 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-04 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-04 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-04 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-04 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-04 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-04 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-04 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-04 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-04 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-04 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-04 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-04 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-04 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-04 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-04 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-04 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-04 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-04 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-04 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-04 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-04 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-04 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-04 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-04 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-04 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-04 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 2e-04 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-04 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-04 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-04 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-04 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-04 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-04 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-04 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-04 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-04 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-04 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-04 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 2e-04 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-04 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 2e-04 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-04 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-04 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-04 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-04 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-04 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-04 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-04 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 2e-04 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-04 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-04 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-04 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-04 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-04 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 2e-04 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 2e-04 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-04 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-04 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-04 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-04 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 3e-04 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 3e-04 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 3e-04 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 3e-04 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 3e-04 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 3e-04 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-04 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 3e-04 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 3e-04 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 3e-04 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 4e-04 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 4e-04 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 4e-04 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 4e-04 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 4e-04 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 4e-04 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-04 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-04 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-04 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 4e-04 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 4e-04 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 4e-04 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 4e-04 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 4e-04 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 4e-04 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 4e-04 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 4e-04 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 4e-04 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 4e-04 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 4e-04 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 4e-04 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 4e-04 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 4e-04 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 4e-04 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 4e-04 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 4e-04 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 4e-04 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 5e-04 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 5e-04 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 5e-04 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 5e-04 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 5e-04 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 5e-04 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 5e-04 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 5e-04 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 5e-04 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 5e-04 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 5e-04 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 5e-04 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 5e-04 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 5e-04 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 5e-04 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 5e-04 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 5e-04 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 5e-04 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 5e-04 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 5e-04 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 5e-04 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 5e-04 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 6e-04 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 6e-04 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 6e-04 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-04 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 6e-04 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 6e-04 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 6e-04 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 6e-04 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 6e-04 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 7e-04 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 7e-04 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 7e-04 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-04 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 7e-04 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 7e-04 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-04 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 7e-04 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 7e-04 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 7e-04 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 7e-04 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 7e-04 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 8e-04 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 8e-04 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 8e-04 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 8e-04 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 8e-04 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 8e-04 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 8e-04 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 8e-04 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 8e-04 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 8e-04 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 8e-04 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-04 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 8e-04 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 8e-04 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 8e-04 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 8e-04 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 8e-04 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 9e-04 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 9e-04 |
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST 
Original result of RPS-BLAST against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 823 | |||
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 1e-121 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 1e-115 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 1e-101 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 3e-27 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 3e-75 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 9e-62 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 4e-33 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 3e-69 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 1e-66 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 4e-62 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 1e-61 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 5e-59 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 2e-40 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 3e-16 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 4e-64 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 7e-58 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 6e-64 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 1e-63 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 2e-57 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 2e-49 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 3e-30 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 6e-24 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 2e-10 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 3e-09 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 2e-62 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 5e-55 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 2e-51 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 1e-35 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 2e-21 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 8e-04 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 7e-58 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 2e-57 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 2e-51 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 3e-28 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 2e-19 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 2e-15 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 6e-53 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 6e-49 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 5e-46 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 6e-46 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 2e-45 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 2e-26 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 9e-22 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 5e-44 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 1e-43 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 3e-14 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 5e-41 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 5e-39 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 2e-31 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 1e-07 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 1e-40 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 2e-39 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 8e-39 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 1e-35 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 4e-29 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 1e-21 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 1e-20 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 9e-20 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 6e-19 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 4e-39 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 4e-33 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 2e-29 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 3e-21 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 1e-18 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 5e-18 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 6e-39 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 1e-38 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 3e-37 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 4e-26 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 1e-35 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 2e-33 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 4e-33 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 6e-33 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 8e-33 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 2e-21 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 1e-10 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 3e-35 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 9e-27 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 3e-24 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 1e-15 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 4e-35 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 8e-34 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 8e-32 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 2e-30 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 4e-11 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 6e-11 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 5e-35 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 2e-29 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 2e-11 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 3e-34 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 1e-29 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 8e-34 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 8e-18 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 3e-14 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 5e-13 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 2e-33 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 3e-30 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 3e-27 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 4e-22 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 9e-21 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 1e-16 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 6e-30 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 2e-29 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 9e-29 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 2e-25 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 7e-12 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 5e-29 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 2e-25 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 5e-25 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 1e-21 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 4e-21 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 4e-20 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 3e-18 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 1e-28 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 2e-22 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 2e-20 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 5e-17 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 4e-28 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 8e-28 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 8e-20 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 1e-15 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 9e-28 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 3e-26 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 3e-26 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 1e-25 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 3e-23 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 5e-17 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 6e-13 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 4e-12 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 7e-25 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 1e-24 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 2e-24 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 2e-19 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 5e-18 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 9e-18 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 2e-11 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 5e-24 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 1e-23 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 5e-23 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 8e-23 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 3e-22 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 1e-21 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 6e-19 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 3e-16 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 5e-13 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 3e-22 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 4e-18 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 2e-17 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 8e-12 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 1e-11 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 1e-10 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 3e-08 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 5e-22 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 6e-22 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 9e-17 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 2e-16 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 1e-08 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 6e-22 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 1e-21 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 2e-21 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 3e-21 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 2e-15 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 1e-08 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 6e-04 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 6e-21 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 4e-20 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 5e-20 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 2e-17 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 1e-11 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 1e-20 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 5e-18 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 2e-16 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 1e-08 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 2e-08 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 2e-20 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 2e-20 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 4e-20 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 5e-20 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 5e-19 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 1e-15 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 6e-13 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 3e-11 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 1e-19 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 1e-17 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 1e-14 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 4e-06 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 9e-19 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 1e-18 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 3e-17 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 4e-17 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 2e-14 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 3e-14 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 7e-14 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 2e-05 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 6e-17 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 7e-16 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 4e-15 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 2e-14 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 9e-11 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 2e-08 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 8e-16 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 4e-12 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 7e-09 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 1e-08 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 1e-06 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 2e-15 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 2e-15 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 5e-15 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 1e-14 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 7e-14 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 2e-07 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 1e-05 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 3e-15 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 8e-13 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 8e-12 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 3e-10 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 5e-09 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 2e-07 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 3e-06 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 4e-15 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 4e-15 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 7e-09 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 5e-15 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 7e-15 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 9e-15 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 1e-14 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 5e-11 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 1e-10 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 1e-14 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 5e-13 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 1e-12 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 1e-12 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 7e-12 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 2e-10 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 1e-09 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 6e-09 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 2e-14 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 3e-14 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 4e-14 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 4e-14 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 5e-14 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 5e-14 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 7e-14 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 8e-14 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 8e-14 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 9e-14 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 9e-14 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 1e-13 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 1e-13 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 2e-13 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 2e-13 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 2e-13 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 2e-13 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 2e-13 | |
| 4apc_A | 350 | Serine/threonine-protein kinase NEK1; transferase; | 3e-13 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 3e-13 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 2e-12 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 2e-12 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 4e-10 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 3e-09 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 2e-04 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 3e-13 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 4e-13 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 4e-13 | |
| 1uu3_A | 310 | HPDK1, 3-phosphoinositide dependent protein kinase | 5e-13 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 6e-13 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 1e-12 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 1e-07 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 6e-13 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 5e-12 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 3e-06 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 2e-05 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 6e-13 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 7e-13 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 8e-13 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 8e-13 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 9e-13 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 9e-13 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 9e-13 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 1e-12 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 1e-12 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 1e-12 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 2e-12 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 2e-12 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 2e-12 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 2e-12 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 2e-12 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 2e-12 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 2e-12 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 3e-12 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 3e-12 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 3e-12 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 3e-12 | |
| 3pvu_A | 695 | Beta-adrenergic receptor kinase 1; transferase, se | 3e-12 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 3e-12 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 4e-12 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 4e-12 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 5e-12 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 5e-12 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 6e-12 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 6e-12 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 6e-12 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 6e-12 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 7e-12 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 7e-12 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 8e-12 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 8e-12 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 9e-12 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 1e-11 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 1e-11 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 1e-11 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 1e-11 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 1e-11 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 1e-11 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 1e-11 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 1e-11 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 2e-11 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 2e-11 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 2e-11 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 2e-11 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 2e-11 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 2e-11 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 2e-11 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 3e-11 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 3e-11 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 3e-11 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 3e-11 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 2e-10 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 7e-09 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 4e-08 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 3e-07 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 1e-05 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 3e-11 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 3e-11 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 4e-11 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 4e-11 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 4e-11 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 4e-11 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 5e-11 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 5e-11 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 5e-11 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 5e-11 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 5e-11 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 5e-11 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 2e-09 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 5e-08 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 5e-11 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 5e-11 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 6e-11 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 6e-11 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 6e-11 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 6e-11 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 7e-11 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 7e-11 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 8e-11 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 9e-11 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 1e-10 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 1e-10 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 1e-10 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 1e-10 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 1e-10 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 2e-10 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 2e-10 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 2e-10 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 2e-10 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 2e-10 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 2e-10 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 3e-10 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 3e-10 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 3e-10 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 4e-10 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 4e-10 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 4e-10 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 4e-10 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 5e-10 | |
| 3zzw_A | 289 | Tyrosine-protein kinase transmembrane receptor RO; | 6e-10 | |
| 3g51_A | 325 | Ribosomal protein S6 kinase alpha-3; N-terminal ki | 7e-10 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 7e-10 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 7e-10 | |
| 3v5q_A | 297 | NT-3 growth factor receptor; kinase domain, kinase | 7e-10 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 8e-10 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 1e-09 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 1e-09 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 1e-09 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 2e-09 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 2e-09 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 2e-09 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 2e-09 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 2e-09 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 2e-09 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 2e-09 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 2e-09 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 2e-09 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 3e-09 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 3e-09 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 3e-09 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 3e-09 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 3e-09 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 4e-09 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 4e-09 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 4e-09 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 4e-09 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 5e-09 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 5e-09 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 6e-09 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 6e-09 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 6e-09 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 2e-07 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 7e-09 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 8e-09 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 9e-09 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 1e-08 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 1e-08 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 9e-08 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 5e-07 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 1e-05 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 1e-05 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 1e-08 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 1e-08 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 1e-08 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 1e-08 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 1e-08 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 2e-08 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 2e-08 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 3e-08 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 3e-08 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 3e-08 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 3e-08 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 2e-07 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 3e-06 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 1e-05 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 9e-05 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 3e-08 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 4e-08 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 5e-08 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 6e-08 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 6e-08 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 7e-08 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 9e-08 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 4e-06 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 3e-04 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 7e-04 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 1e-07 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 1e-07 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 1e-07 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 2e-05 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 8e-05 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 2e-07 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 2e-07 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 3e-07 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 3e-07 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 4e-07 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 9e-06 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 2e-05 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 4e-07 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 5e-07 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 5e-07 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 8e-07 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 8e-07 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 2e-04 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 2e-06 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 2e-06 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 2e-06 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 4e-06 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 4e-06 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 4e-06 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 1e-05 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 4e-04 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 7e-04 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 4e-06 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 4e-06 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 4e-06 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 4e-04 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 4e-04 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 5e-06 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 6e-06 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 7e-06 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 7e-06 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 9e-06 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 1e-05 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 1e-05 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 2e-04 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 1e-05 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 1e-05 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 3e-05 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 7e-05 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 1e-05 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 2e-05 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 2e-05 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 2e-05 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 3e-05 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 5e-04 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 7e-04 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 3e-05 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 6e-05 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 7e-05 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 1e-04 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 1e-04 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 1e-04 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 1e-04 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 2e-04 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 2e-04 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 2e-04 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 4e-04 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 4e-04 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 5e-04 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 5e-04 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 7e-04 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 9e-04 |
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 381 bits (982), Expect = e-121
Identities = 143/570 (25%), Positives = 250/570 (43%), Gaps = 84/570 (14%)
Query: 12 QALLALKAHISYDHTNLFARNWTSSTSVCIWIGITCDVNSHRVIG--------------- 56
L++ K + D L +W+S+ + C + G+TC +V
Sbjct: 15 HQLISFKDVLP-DKNLL--PDWSSNKNPCTFDGVTCR--DDKVTSIDLSSKPLNVGFSAV 69
Query: 57 -----------------------------------LNISSFNLQGTITP--QLGNLSSLQ 79
L++S +L G +T LG+ S L+
Sbjct: 70 SSSLLSLTGLESLFLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLK 129
Query: 80 TLDLSHNKLSGNIPSSIF-NMHTLKLLDFSDNQLFGSLSSFIF---NMSSMTTIDLSINR 135
L++S N L S +++L++LD S N + G+ + + +S N+
Sbjct: 130 FLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNK 189
Query: 136 LSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKEIGNLTKLKEI-ISTITNSTVC 194
+SG++ +S+C LE L++ NN S IP +G+ + L+ + IS N
Sbjct: 190 ISGDVD---------VSRCVNLEFLDVSSNNFSTGIP-FLGDCSALQHLDISG--NKLSG 237
Query: 195 EIPREIGNLPYLARLALATNNLVGVVPVTIFNMSALKEISLLNNSLSGSLPSRIDLSLPN 254
+ R I L L +++N VG +P + +L+ +SL N +G +P + +
Sbjct: 238 DFSRAISTCTELKLLNISSNQFVGPIPP--LPLKSLQYLSLAENKFTGEIPDFLSGACDT 295
Query: 255 VETLNLGINSFSGTIPSSITNSSKLSDLELGENLFSGFIP-NTIGNLRNLEFGNIADNYL 313
+ L+L N F G +P + S L L L N FSG +P +T+ +R L+ +++ N
Sbjct: 296 LTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEF 355
Query: 314 TSSTPELSFLSSLTNCK-KLKVLIVTGNPLDGILPKSIGNFSL-SLETILMANCSISGNI 371
+ P SLTN L L ++ N G + ++ +L+ + + N +G I
Sbjct: 356 SGELP-----ESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKI 410
Query: 372 PQVVGNLSNLLVLELGGNNLTGPIPVTFSQLQTLQAFDLTRNKLAGPITDELCHLARLHS 431
P + N S L+ L L N L+G IP + L L+ L N L G I EL ++ L +
Sbjct: 411 PPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLET 470
Query: 432 LVLQGNKFSGSIPSCLGNLTSVRVLYLGLNIFTSVLSSTIWNLKDILFIDVSSNFLDGPL 491
L+L N +G IPS L N T++ + L N T + I L+++ + +S+N G +
Sbjct: 471 LILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNI 530
Query: 492 SLDIGNLKVVIGLDFSRNNLSGDIPITIGE 521
++G+ + +I LD + N +G IP + +
Sbjct: 531 PAELGDCRSLIWLDLNTNLFNGTIPAAMFK 560
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 366 bits (941), Expect = e-115
Identities = 137/517 (26%), Positives = 227/517 (43%), Gaps = 34/517 (6%)
Query: 57 LNISSFNLQGTITPQL-GNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLDFSDNQLFGS 115
L+++ G I L G +L LDLS N G +P + L+ L S N G
Sbjct: 274 LSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGE 333
Query: 116 L-SSFIFNMSSMTTIDLSINRLSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKE 174
L + M + +DLS N SGELP ++ + + L L+L NN SG I
Sbjct: 334 LPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSA------SLLTLDLSSNNFSGPILPN 387
Query: 175 IGNLTKLK-EIISTITNSTVCEIPREIGNLPYLARLALATNNLVGVVPVTIFNMSALKEI 233
+ K + + N +IP + N L L L+ N L G +P ++ ++S L+++
Sbjct: 388 LCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDL 447
Query: 234 SLLNNSLSGSLPSRIDLSLPNVETLNLGINSFSGTIPSSITNSSKLSDLELGENLFSGFI 293
L N L G +P + + + +ETL L N +G IPS ++N + L+ + L N +G I
Sbjct: 448 KLWLNMLEGEIPQEL-MYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEI 506
Query: 294 PNTIGNLRNLEFGNIADNYLTSSTPELSFLSSLTNCKKLKVLIVTGNPLDGILPKSIGNF 353
P IG L NL +++N + + P + L +C+ L L + N +G +P ++
Sbjct: 507 PKWIGRLENLAILKLSNNSFSGNIP-----AELGDCRSLIWLDLNTNLFNGTIPAAMFKQ 561
Query: 354 SLSLETILMANCSISGNIPQVVGNLSNLLVLELGGN--NLTGPIPVTFSQLQTLQAFDLT 411
S +A I+G + N GN G ++L T ++T
Sbjct: 562 SG-----KIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNIT 616
Query: 412 RNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSVRVLYLGLNIFTSVLSSTI 471
G + + + L + N SG IP +G++ + +L LG N + + +
Sbjct: 617 SRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEV 676
Query: 472 WNLKDILFIDVSSNFLDGPLSLDIGNLKVVIGLDFSRNNLSGDIPITIGEGEIPRGGPFA 531
+L+ + +D+SSN LDG + + L ++ +D S NNLS G IP G F
Sbjct: 677 GDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLS---------GPIPEMGQFE 727
Query: 532 NLTAKSFMGNELLCGLPDLQVSPCKPNKPNTHKKSRK 568
F+ N LCG P + C P+ + + ++
Sbjct: 728 TFPPAKFLNNPGLCGYP---LPRCDPSNADGYAHHQR 761
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 329 bits (845), Expect = e-101
Identities = 119/481 (24%), Positives = 204/481 (42%), Gaps = 69/481 (14%)
Query: 41 IWIGITCDVNSHRVIGLNISSFNLQGTITPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMH 100
+G + L IS + G + + +L+ LD+S N S IP + +
Sbjct: 167 NVVGWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIPF-LGDCS 223
Query: 101 TLKLLDFSDNQLFGSLSSFIFNMSSMTTIDLSINRLSGELPANICKIPSTLSKCKQLEEL 160
L+ LD S N+L G S I + + +++S N+ G +P K L+ L
Sbjct: 224 ALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPP---------LPLKSLQYL 274
Query: 161 NLGFNNLSGAIPKEIGNLTKLKEIISTITNSTVCEIPREIGNLPYLARLALATNNLVGVV 220
+L N +G IP + G L L L+ N+ G V
Sbjct: 275 SLAENKFTGEIPDFLS------------------------GACDTLTGLDLSGNHFYGAV 310
Query: 221 PVTIFNMSALKEISLLNNSLSGSLPSRIDLSLPNVETLNLGINSFSGTIPSSITN-SSKL 279
P + S L+ ++L +N+ SG LP L + ++ L+L N FSG +P S+TN S+ L
Sbjct: 311 PPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASL 370
Query: 280 SDLELGENLFSGFIPNTIGNLRNLEFGNIADNYLTSSTPELSFLSSLTNCKKLKVLIVTG 339
L+L N FSG I + L+ L +
Sbjct: 371 LTLDLSSNNFSGPILPNLCQNPK---------------------------NTLQELYLQN 403
Query: 340 NPLDGILPKSIGNFSLSLETILMANCSISGNIPQVVGNLSNLLVLELGGNNLTGPIPVTF 399
N G +P ++ N S L ++ ++ +SG IP +G+LS L L+L N L G IP
Sbjct: 404 NGFTGKIPPTLSNCS-ELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQEL 462
Query: 400 SQLQTLQAFDLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSVRVLYLG 459
++TL+ L N L G I L + L+ + L N+ +G IP +G L ++ +L L
Sbjct: 463 MYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLS 522
Query: 460 LNIFTSVLSSTIWNLKDILFIDVSSNFLDGPLSLDIGNLKVVIGLDFSRNNLSGDIPITI 519
N F+ + + + + + ++++D+++N +G + + + N ++G + I
Sbjct: 523 NNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQS----GKIAANFIAGKRYVYI 578
Query: 520 G 520
Sbjct: 579 K 579
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 3e-27
Identities = 42/193 (21%), Positives = 68/193 (35%), Gaps = 33/193 (17%)
Query: 47 CDVNSHRVIGLNISSFNLQGTITPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLD 106
+ + + QG + QL LS+ +++ G+ + N ++ LD
Sbjct: 579 KNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLD 638
Query: 107 FSDNQLFGSLSSFIFNMSSMTTIDLSINRLSGELPANICKIPSTLSKCKQLEELNLGFNN 166
S N L G + I +M + ++L N +SG IP + + L L+L N
Sbjct: 639 MSYNMLSGYIPKEIGSMPYLFILNLGHNDISGS-------IPDEVGDLRGLNILDLSSNK 691
Query: 167 LSGAIPKEIGNLTKLKEIISTITNSTVCEIPREIGNLPYLARLALATNNLVGVVPVTIFN 226
L G IP+ + LT L + L+ NNL G +P
Sbjct: 692 LDGRIPQAMSALT-------------------------MLTEIDLSNNNLSGPIPEMGQ- 725
Query: 227 MSALKEISLLNNS 239
LNN
Sbjct: 726 FETFPPAKFLNNP 738
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 256 bits (656), Expect = 3e-75
Identities = 78/558 (13%), Positives = 157/558 (28%), Gaps = 112/558 (20%)
Query: 32 NWTSSTSVCIW---IGITCDVNSHRVIGLNISSFNLQGTITPQLGNLS------------ 76
NW + + +W G++ + ++ RV GL++ F G + +G L+
Sbjct: 59 NWNFNKELDMWGAQPGVSLN-SNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGE 117
Query: 77 ----------------SLQTLDLSHNKLSGNIPSSIFNMHTLKL--LDFSDNQLFGSLSS 118
S + L + + S+
Sbjct: 118 KVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKK 177
Query: 119 FIFNMSSMTTIDLSINRLSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKEIGNL 178
T I N ++ + + + +L + +G + E
Sbjct: 178 SSRITLKDTQIGQLSNNITF--------VSKAVMRLTKLRQFYMGNSPFVAENICEAWEN 229
Query: 179 TKLKEIISTITNSTVCEIPREIGNLPYLARLALATNNLVGVVPVTIFNMSALKEISLLNN 238
+ + NL L + + + +P + + ++ I++ N
Sbjct: 230 ENSE------YAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACN 283
Query: 239 SLSGSLPSRIDLS-------LPNVETLNLGINSF-SGTIPSSITNSSKLSDLELGENLFS 290
+ D ++ + +G N+ + + +S+ KL LE N
Sbjct: 284 RGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLE 343
Query: 291 GFIPNTIGNLRNLEFGNIADNYLTSSTPEL-SFLSSLT-------------------NCK 330
G +P G+ L N+A N +T F + +
Sbjct: 344 GKLP-AFGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKYIPNIFDAKSVS 402
Query: 331 KLKVLIVTGNPLDGI-------LPKSIGNFSLSLETILMANCSISGNIPQVVGNLSNLLV 383
+ + + N + + L + ++ +I ++N IS ++ S L
Sbjct: 403 VMSAIDFSYNEIGSVDGKNFDPLDPTPFKGI-NVSSINLSNNQISKFPKELFSTGSPLSS 461
Query: 384 LELGGNNLTG-------PIPVTFSQLQTLQAFDLTRNKLAG-PITDELCHLARLHSLVLQ 435
+ L GN LT F L + DL NKL L L + L
Sbjct: 462 INLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTKLSDDFRATTLPYLVGIDLS 521
Query: 436 GNKFSGSIPSCLGNLTSVRVLYLGLNIFTSVLSSTIWNLKDILFIDVSSNFLDGPLSLDI 495
N FS P+ N ++++ + D N I
Sbjct: 522 YNSFSK-FPTQPLNSSTLKGFGIRNQR------------------DAQGNRTLREWPEGI 562
Query: 496 GNLKVVIGLDFSRNNLSG 513
+ L N++
Sbjct: 563 TLCPSLTQLQIGSNDIRK 580
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 219 bits (559), Expect = 9e-62
Identities = 68/444 (15%), Positives = 135/444 (30%), Gaps = 63/444 (14%)
Query: 57 LNISSFNLQGTITPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLDFSDNQL---- 112
N T + NL L +++ + +P+ + + ++L++ + N+
Sbjct: 230 ENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGE 289
Query: 113 ----FGSLSSFIFNMSSMTTIDLSINRLSGELPANICKIPSTLSKCKQLEELNLGFNNLS 168
+ + I + N L P + ++L K K+L L +N L
Sbjct: 290 QLKDDWQALADAPVGEKIQIIYIGYNNLK-TFP-----VETSLQKMKKLGMLECLYNQLE 343
Query: 169 GAIPKEIGNLTKLKEIISTITNSTVCEIPREIGNLPYLARLALATNNLVGVVPVTIFNMS 228
G +P G+ KL L LA N + +
Sbjct: 344 GKLP-AFGSEIKLAS-------------------------LNLAYNQITEIPANFCGFTE 377
Query: 229 ALKEISLLNNSLSGSLPSRIDL-SLPNVETLNLGINSFSG-------TIPSSITNSSKLS 280
++ +S +N L +P+ D S+ + ++ N + + +S
Sbjct: 378 QVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVS 436
Query: 281 DLELGENLFSGFIPNTIGNLRNLEFGNIADNYLTSSTPEL--SFLSSLTNCKKLKVLIVT 338
+ L N S F L N+ N LT + N L + +
Sbjct: 437 SINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLR 496
Query: 339 GNPLDGILPKSIGNFSL-SLETILMANCSISGNIPQVVGNLSNLLVLELG------GNNL 391
N L + +L L I ++ S S P N S L + GN
Sbjct: 497 FNKLTKL-SDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRT 554
Query: 392 TGPIPVTFSQLQTLQAFDLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLT 451
P + +L + N + + +++ + L ++ N S +
Sbjct: 555 LREWPEGITLCPSLTQLQIGSNDIRK-VNEKI--TPNISVLDIKDNPNISIDLSYVCPYI 611
Query: 452 SVRVLYLGLNIFTSVLSSTIWNLK 475
+ L + + ++K
Sbjct: 612 EAGMYMLFYDKTQDIRGCDALDIK 635
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 4e-33
Identities = 39/289 (13%), Positives = 87/289 (30%), Gaps = 31/289 (10%)
Query: 257 TLNLGINSFSGTIPSSITNSSKLSDLELGENLFSGFIPNTIGNLRNLEFGNIADNYLTSS 316
N ++ + S+ ++ +++ L L SG +P+ IG L LE + + +
Sbjct: 61 NFNKELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVN 120
Query: 317 TPELSFLSSLTNCKKLKVLIVTGNPLDGILPKSIGNFSLS-LETILMANCSISGNIPQVV 375
L ++ + S L + + +I +
Sbjct: 121 ER-LFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSS 179
Query: 376 GNLSNLLVLELGGNNLTGPIPVTFSQLQTLQAFDLTRNKLAGPIT--------------- 420
+ NN+T + +L L+ F + +
Sbjct: 180 RITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQY 238
Query: 421 ----DELCHLARLHSLVLQGNKFSGSIPSCLGNLTSVRVLYLGLNIFTSVLS-------- 468
+ +L L + + +P+ L L ++++ + N S
Sbjct: 239 KTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQAL 298
Query: 469 STIWNLKDILFIDVSSN-FLDGPLSLDIGNLKVVIGLDFSRNNLSGDIP 516
+ + I I + N P+ + +K + L+ N L G +P
Sbjct: 299 ADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLP 347
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 241 bits (616), Expect = 3e-69
Identities = 97/485 (20%), Positives = 177/485 (36%), Gaps = 34/485 (7%)
Query: 57 LNISSFNLQGTITPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLDFSDNQLFGSL 116
LN++ L+ S L +LD+ N +S P + LK+L+ N+L
Sbjct: 30 LNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLS 89
Query: 117 SSFIFNMSSMTTIDLSINRLSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKEIG 176
+++T + L N + + K K L L+L N LS
Sbjct: 90 DKTFAFCTNLTELHLMSNSIQKI-------KNNPFVKQKNLITLDLSHNGLSSTKLGTQV 142
Query: 177 NLTKLKEI------ISTITNSTVCEIPREIGNLPYLARLALATNNLVGVVPVTIFNMSAL 230
L L+E+ I + + + +I L +L L++N + P + L
Sbjct: 143 QLENLQELLLSNNKIQALKSEEL-----DIFANSSLKKLELSSNQIKEFSPGCFHAIGRL 197
Query: 231 KEISLLNNSLSGSLPSRI--DLSLPNVETLNLGINSFSGTIPSSITN--SSKLSDLELGE 286
+ L N L SL ++ +L+ ++ L+L + S T ++ + L+ L+L
Sbjct: 198 FGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSY 257
Query: 287 NLFSGFIPNTIGNLRNLEFGNIADNYLTSSTPE----LSFLSSLTNCKKLKVLIVTGNPL 342
N + ++ L LE+ + N + L + L + ++ L
Sbjct: 258 NNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASL 317
Query: 343 DGILPKSIGNFSLSLETILMANCSISGNIPQVVGNLSNLLVLELGGN--NLTGPIPVTFS 400
I S LE + M + I G + L NL L L + +L TF
Sbjct: 318 PKIDDFSFQWLK-CLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFV 376
Query: 401 QLQT--LQAFDLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIP-SCLGNLTSVRVLY 457
L L +LT+NK++ +D L L L L N+ + L ++ +Y
Sbjct: 377 SLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIY 436
Query: 458 LGLNIFTSVLSSTIWNLKDILFIDVSSNFLDGPLSLD--IGNLKVVIGLDFSRNNLSGDI 515
L N + + ++ + + + + L S L+ + LD S NN++
Sbjct: 437 LSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANIN 496
Query: 516 PITIG 520
+
Sbjct: 497 DDMLE 501
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 233 bits (597), Expect = 1e-66
Identities = 82/492 (16%), Positives = 156/492 (31%), Gaps = 40/492 (8%)
Query: 57 LNISSFNLQGTITPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLDFSDNQLFGSL 116
LN+ L ++L L L N + + L LD S N L +
Sbjct: 78 LNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTK 137
Query: 117 SSFIFNMSSMTTIDLSINRLSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKEIG 176
+ ++ + LS N++ + + L++L L N + P
Sbjct: 138 LGTQVQLENLQELLLSNNKIQA-----LKSEELDIFANSSLKKLELSSNQIKEFSPGCFH 192
Query: 177 NLTKLKEII--STITNSTVCEIPREIGNLPYLARLALATNNLVGVVPVTIFNM--SALKE 232
+ +L + + ++ E + L+L+ + L T + + L
Sbjct: 193 AIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTM 252
Query: 233 ISLLNNSLSGSLPSRIDLSLPNVETLNLGINSFSGTIPSSITNSSKLSDLELGENL---- 288
+ L N+L+ LP +E L N+ S+ + L L +
Sbjct: 253 LDLSYNNLNVVGNDSFA-WLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQS 311
Query: 289 -----FSGFIPNTIGNLRNLEFGNIADNYLTSSTPELSFLSSLTNCKKLKVLIVTGNPLD 343
+ L+ LE N+ DN + + T LK L ++ +
Sbjct: 312 ISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKS-----NMFTGLINLKYLSLSNSFT- 365
Query: 344 GILPKSIGNFS----LSLETILMANCSISGNIPQVVGNLSNLLVLELGGNNLTGPIPV-T 398
+ + F L + + IS L +L VL+LG N + +
Sbjct: 366 SLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQE 425
Query: 399 FSQLQTLQAFDLTRNKLAGPITDELCHLARLHSLVLQGNKFSG--SIPSCLGNLTSVRVL 456
+ L+ + L+ NK + + L L+L+ S PS L ++ +L
Sbjct: 426 WRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTIL 485
Query: 457 YLGLNIFTSVLSSTIWNLKDILFIDVSSNFL--------DGPLSLDIGNLKVVIGLDFSR 508
L N ++ + L+ + +D+ N L G + L + L+
Sbjct: 486 DLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLES 545
Query: 509 NNLSGDIPITIG 520
N
Sbjct: 546 NGFDEIPVEVFK 557
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 221 bits (565), Expect = 4e-62
Identities = 89/506 (17%), Positives = 185/506 (36%), Gaps = 65/506 (12%)
Query: 57 LNISSFNLQGTITPQLGNLSSLQTLDLSHNKLSGNIPSSIF---NMHTLKLLDFSDNQLF 113
L +SS ++ + L L L++ +L ++ + +++ L S++QL
Sbjct: 176 LELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLS 235
Query: 114 GSLSSFIFNM--SSMTTIDLSINRLSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAI 171
+ ++ + +++T +DLS N L+ + + QLE L +NN+
Sbjct: 236 TTSNTTFLGLKWTNLTMLDLSYNNLNVV-------GNDSFAWLPQLEYFFLEYNNIQHLF 288
Query: 172 PKEIGNLTKLKEIISTITNSTVCEIPREIGNLPY-LARLALATNNLVGVVPVTIFNMSAL 230
+ L ++ + NL + +++ +L + + + L
Sbjct: 289 SHSLHGLFNVRYL-----------------NLKRSFTKQSISLASLPKIDDFSFQWLKCL 331
Query: 231 KEISLLNNSLSGSLPSRIDLSLPNVETLNLGINSFSGTIPSSIT----NSSKLSDLELGE 286
+ +++ +N + G + S + L N++ L+L + S ++ T S L L L +
Sbjct: 332 EHLNMEDNDIPG-IKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTK 390
Query: 287 NLFSGFIPNTIGNLRNLEFGNIADNYLTSSTPELSFLSSLTNCKKLKVLIVTGNPLDGIL 346
N S + L +LE ++ N + + + + + ++ N +
Sbjct: 391 NKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEW----RGLENIFEIYLSYNKYLQLT 446
Query: 347 PKSIGNFSLSLETILMANCSISG--NIPQVVGNLSNLLVLELGGNNLTGPIPVTFSQLQT 404
S SL+ +++ ++ + P L NL +L+L NN+ L+
Sbjct: 447 RNSFALVP-SLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEK 505
Query: 405 LQAFDLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSVRVLYLGLNIFT 464
L+ DL N LA L + G L L+ + +L L N F
Sbjct: 506 LEILDLQHNNLA----------------RLWKHANPGGPIYFLKGLSHLHILNLESNGFD 549
Query: 465 SVLSSTIWNLKDILFIDVSSNFLDGPLSLDIGNLKVVIGLDFSRNNLSGDIPITIGEGEI 524
+ +L ++ ID+ N L+ + N + L+ +N ++
Sbjct: 550 EIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVF----- 604
Query: 525 PRGGPFANLTAKSFMGNELLCGLPDL 550
G F NLT N C +
Sbjct: 605 --GPAFRNLTELDMRFNPFDCTCESI 628
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 219 bits (560), Expect = 1e-61
Identities = 85/465 (18%), Positives = 154/465 (33%), Gaps = 46/465 (9%)
Query: 75 LSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLDFSDNQLFGSLSSFIFNMSSMTTIDLSIN 134
+++ L+L+HN+L ++ L LD N + + + ++L N
Sbjct: 24 PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHN 83
Query: 135 RLSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKEIGNLTKLKEI------ISTI 188
LS T + C L EL+L N++ L + +S+
Sbjct: 84 ELSQL-------SDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSST 136
Query: 189 TNSTVCEIPREIGNLPYLARLALATNNLVGVVP--VTIFNMSALKEISLLNNSLSGSLPS 246
L L L L+ N + + + IF S+LK++ L +N + P
Sbjct: 137 -------KLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPG 189
Query: 247 RIDLSLPNVETLNLGINSFSGTIPSSIT---NSSKLSDLELGENLFSGFIPNTIGNLR-- 301
++ + L L ++ + ++ + +L L + S T L+
Sbjct: 190 CFH-AIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWT 248
Query: 302 NLEFGNIADNYLTSSTPELSFLSSLTNCKKLKVLIVTGNPLDGILPKSIGN--------F 353
NL +++ N L S +L+ + N + + S+
Sbjct: 249 NLTMLDLSYNNLNVVGN-----DSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNL 303
Query: 354 SLSLETILMANCSISGNIPQVVGNLSNLLVLELGGNNLTGPIPVTFSQLQTLQAFDLTRN 413
S ++ S+ L L L + N++ G F+ L L+ L+ +
Sbjct: 304 KRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNS 363
Query: 414 KLAG----PITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSVRVLYLGLNIFTSVLS- 468
+ T + LH L L NK S L + VL LGLN L+
Sbjct: 364 FTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTG 423
Query: 469 STIWNLKDILFIDVSSNFLDGPLSLDIGNLKVVIGLDFSRNNLSG 513
L++I I +S N + + L R L
Sbjct: 424 QEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKN 468
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 212 bits (542), Expect = 5e-59
Identities = 85/434 (19%), Positives = 147/434 (33%), Gaps = 42/434 (9%)
Query: 57 LNISSFNLQGTITPQLGNL--SSLQTLDLSHNKLSGNIPSSIFNMHTLKLLDFSDNQLFG 114
L++S+ L T L ++L LDLS+N L+ S + L+ N +
Sbjct: 227 LSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQH 286
Query: 115 SLSSFIFNMSSMTTIDLSINRLSGELPANICK--IPSTLSKCKQLEELNLGFNNLSGAIP 172
S + + ++ ++L + + + K LE LN+ N++ G
Sbjct: 287 LFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKS 346
Query: 173 KEIGNLTKLKEI--------ISTITNSTVCEIPREIGNLPYLARLALATNNLVGVVPVTI 224
L LK + + T+TN T + L L L N + +
Sbjct: 347 NMFTGLINLKYLSLSNSFTSLRTLTNETFVSLA-----HSPLHILNLTKNKISKIESDAF 401
Query: 225 FNMSALKEISLLNNSLSGSLPSRIDLSLPNVETLNLGINSFSGTIPSSITNSSKLSDLEL 284
+ L+ + L N + L + L N+ + L N + +S L L L
Sbjct: 402 SWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLML 461
Query: 285 GENLFSGF--IPNTIGNLRNLEFGNIADNYLTSSTPELSFLSSLTNCKKLKVLIVTGNPL 342
P+ LRNL ++++N + + ++ L +KL++L + N L
Sbjct: 462 RRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDM-----LEGLEKLEILDLQHNNL 516
Query: 343 DGILPKSIGNFSLSLETILMANCSISGNIPQVVGNLSNLLVLELGGNNLTGPIPVTFSQL 402
+ + G + LS+L +L L N F L
Sbjct: 517 ARLWKHAN-----------------PGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDL 559
Query: 403 QTLQAFDLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLG-NLTSVRVLYLGLN 461
L+ DL N L + L SL LQ N + G ++ L + N
Sbjct: 560 FELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFN 619
Query: 462 IFTSVLSSTIWNLK 475
F S W +
Sbjct: 620 PFDCTCESIAWFVN 633
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 2e-40
Identities = 58/298 (19%), Positives = 109/298 (36%), Gaps = 17/298 (5%)
Query: 230 LKEISLLNNSLSGSLPSRIDLSLPNVETLNLGINSFSGTIPSSITNSSKLSDLELGENLF 289
+ + L+ +P + N+ LNL N ++ T S+L+ L++G N
Sbjct: 6 HEVADCSHLKLT-QVPDDL---PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTI 61
Query: 290 SGFIPNTIGNLRNLEFGNIADNYLTSSTPELSFLSSLTNCKKLKVLIVTGNPLDGILPKS 349
S P L L+ N+ N L+ + + + C L L + N + I
Sbjct: 62 SKLEPELCQKLPMLKVLNLQHNELSQLSDK-----TFAFCTNLTELHLMSNSIQKIKNNP 116
Query: 350 IGNFSLSLETILMANCSISGNIPQVVGNLSNLLVLELGGNNLTGPIPVTFS--QLQTLQA 407
+L T+ +++ +S L NL L L N + +L+
Sbjct: 117 FVKQK-NLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKK 175
Query: 408 FDLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLG---NLTSVRVLYLGLNIFT 464
+L+ N++ + RL L L + S+ L TS+R L L + +
Sbjct: 176 LELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLS 235
Query: 465 SVLSSTIWNLKD--ILFIDVSSNFLDGPLSLDIGNLKVVIGLDFSRNNLSGDIPITIG 520
+ ++T LK + +D+S N L+ + L + NN+ ++
Sbjct: 236 TTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLH 293
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 3e-16
Identities = 28/151 (18%), Positives = 50/151 (33%), Gaps = 11/151 (7%)
Query: 58 NISSFNLQGTITPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLDFSDNQLFGSLS 117
+ G L LS L L+L N ++ LK++D N L +
Sbjct: 518 RLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPA 577
Query: 118 SFIFNMSSMTTIDLSINRLSGELPANICKIPSTLSKC-KQLEELNLGFNNLSGAIPKEIG 176
S N S+ +++L N ++ + L EL++ FN
Sbjct: 578 SVFNNQVSLKSLNLQKNLITSV-------EKKVFGPAFRNLTELDMRFNPFDCTCESIAW 630
Query: 177 NLTKLKEI---ISTITNSTVCEIPREIGNLP 204
+ + E I +++ +C P P
Sbjct: 631 FVNWINETHTNIPELSSHYLCNTPPHYHGFP 661
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 216 bits (552), Expect = 4e-64
Identities = 89/339 (26%), Positives = 134/339 (39%), Gaps = 69/339 (20%)
Query: 11 QQALLALKAHISYDHTNLFARNWTSSTSVC--IWIGITCDV--NSHRVIGLNISSFNLQG 66
+QALL +K + + T L +W +T C W+G+ CD ++RV L++S NL
Sbjct: 8 KQALLQIKKDLG-NPTTL--SSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPK 64
Query: 67 T---------------------------ITPQLGNLSSLQTLDLSHNKLSGNIPSSIFNM 99
I P + L+ L L ++H +SG IP + +
Sbjct: 65 PYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQI 124
Query: 100 HTLKLLDFSDNQLFGSLSSFIFNMSSMTTIDLSINRLSGELPANICKIPSTLSKCKQLEE 159
TL LDFS N L G+ +P ++S L
Sbjct: 125 KTLVTLDFSYNALSGT-------------------------------LPPSISSLPNLVG 153
Query: 160 LNLGFNNLSGAIPKEIGNLTKLKEIISTITNSTVCEIPREIGNLPYLARLALATNNLVGV 219
+ N +SGAIP G+ +KL ++ N +IP NL LA + L+ N L G
Sbjct: 154 ITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGD 212
Query: 220 VPVTIFNMSALKEISLLNNSLSGSLPSRIDLSLPNVETLNLGINSFSGTIPSSITNSSKL 279
V + ++I L NSL+ L N+ L+L N GT+P +T L
Sbjct: 213 ASVLFGSDKNTQKIHLAKNSLAFDLGKVG--LSKNLNGLDLRNNRIYGTLPQGLTQLKFL 270
Query: 280 SDLELGENLFSGFIPNTIGNLRNLEFGNIADNYLTSSTP 318
L + N G IP GNL+ + A+N +P
Sbjct: 271 HSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNKCLCGSP 308
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 199 bits (508), Expect = 7e-58
Identities = 84/392 (21%), Positives = 137/392 (34%), Gaps = 98/392 (25%)
Query: 170 AIPKEIGNLTKL---KEIISTITNSTVCEIPREIGNLPYLARLALATNNLVGV--VPVTI 224
I K++GN T L + + + + L L+ NL +P ++
Sbjct: 13 QIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSL 72
Query: 225 FNMSALKEISLLN-NSLSGSLPSRIDLSLPNVETLNLGINSFSGTIPSSITNSSKLSDLE 283
N+ L + + N+L G +P I L + L + + SG IP ++ L L+
Sbjct: 73 ANLPYLNFLYIGGINNLVGPIPPAIA-KLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLD 131
Query: 284 LGENLFSGFIPNTIGNLRNLEFGNIADNYLTSSTPELSFLSSLTNCKKLKVLIVTGNPLD 343
N SG +P +I +L NL N ++
Sbjct: 132 FSYNALSGTLPPSISSLPNLVGITFDGNRIS----------------------------- 162
Query: 344 GILPKSIGNFSLSLETILMANCSISGNIPQVVGNLSNLLVLELGGNNLTGPIPVTFSQLQ 403
G +P S G+FS ++ ++ ++G IP NL NL ++L N L G V F +
Sbjct: 163 GAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANL-NLAFVDLSRNMLEGDASVLFGSDK 221
Query: 404 TLQAFDLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSVRVLYLGLNIF 463
Q L +N LA + ++ L+ L L+ N+ G++P L L + L +
Sbjct: 222 NTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNV----- 275
Query: 464 TSVLSSTIWNLKDILFIDVSSNFLDGPLSLDIGNLKVVIGLDFSRNNLSGDIPITIGEGE 523
S NNL GE
Sbjct: 276 -------------------------------------------SFNNLC---------GE 283
Query: 524 IPRGGPFANLTAKSFMGNELLCGLPDLQVSPC 555
IP+GG ++ N+ LCG P + C
Sbjct: 284 IPQGGNLQRFDVSAYANNKCLCGSP---LPAC 312
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 224 bits (573), Expect = 6e-64
Identities = 82/489 (16%), Positives = 161/489 (32%), Gaps = 55/489 (11%)
Query: 57 LNISSFNLQGTITPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLDFSDNQLFGSL 116
L++S L+ + + LQ LDLS ++ + ++ L L + N +
Sbjct: 33 LDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLA 92
Query: 117 SSFIFNMSSMTTIDLSINRLSGELPANICKIPSTLSKCKQLEELNLGFNNL-SGAIPKEI 175
+SS+ + L+ + K L+ELN+ N + S +P+
Sbjct: 93 LGAFSGLSSLQKLVAVETNLASL-------ENFPIGHLKTLKELNVAHNLIQSFKLPEYF 145
Query: 176 GNLTKLKEI------ISTITNSTVCEIPREIGNLPYL----ARLALATNNLVGVVPVTIF 225
NLT L+ + I +I ++ L + L L+ N + + P F
Sbjct: 146 SNLTNLEHLDLSSNKIQSI-------YCTDLRVLHQMPLLNLSLDLSLNPMNFIQP-GAF 197
Query: 226 NMSALKEISLLNNSLSGSLPSRIDLSLPNVETLNLGINSFSGTI---PSSITNSSKLSDL 282
L +++L NN S ++ L +E L + F + L +L
Sbjct: 198 KEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNL 257
Query: 283 ELGEN------LFSGFIPNTIGNLRNLEFGNIADNYLTSSTPELSFLSSLTNCKKLKVLI 336
+ E + I + L N+ ++ + + + + L
Sbjct: 258 TIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIER-------VKDFSYNFGWQHLE 310
Query: 337 VTGNPLDGILPKSIGNF-SLSLETILMANCSISGNIPQVVGNLSNLLVLELGGNNLT--G 393
+ + + L+ S G +L +L L+L N L+ G
Sbjct: 311 LVNCKFGQFPTLKLKSLKRLTF-------TSNKGGNAFSEVDLPSLEFLDLSRNGLSFKG 363
Query: 394 PIPVTFSQLQTLQAFDLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIP-SCLGNLTS 452
+ +L+ DL+ N + ++ L +L L Q + S +L +
Sbjct: 364 CCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRN 422
Query: 453 VRVLYLGLNIFTSVLSSTIWNLKDILFIDVSSNFLDGPLSLDI-GNLKVVIGLDFSRNNL 511
+ L + + L + + ++ N DI L+ + LD S+ L
Sbjct: 423 LIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQL 482
Query: 512 SGDIPITIG 520
P
Sbjct: 483 EQLSPTAFN 491
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 223 bits (571), Expect = 1e-63
Identities = 80/495 (16%), Positives = 161/495 (32%), Gaps = 67/495 (13%)
Query: 57 LNISSFNLQGTITPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLDFSDNQLFGSL 116
L++S +Q +LS L TL L+ N + + + +L+ L + L
Sbjct: 57 LDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLE 116
Query: 117 SSFIFNMSSMTTIDLSINRLSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKEIG 176
+ I ++ ++ ++++ N + K+P S LE L+L N + ++
Sbjct: 117 NFPIGHLKTLKELNVAHNLIQSF------KLPEYFSNLTNLEHLDLSSNKIQSIYCTDLR 170
Query: 177 NLTKLKEIISTITNSTVCEIPREIGNLPYLARLALATNNLVGVVPVTIFNMSALKEISLL 236
L ++ + L L+ N + + P F L +++L
Sbjct: 171 VLHQMPLL---------------------NLSLDLSLNPMNFIQP-GAFKEIRLHKLTLR 208
Query: 237 NNSLSGSLPSRIDLSLPNVETLNLGINSFSGTI---PSSITNSSKLSDLELGEN------ 287
NN S ++ L +E L + F + L +L + E
Sbjct: 209 NNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLD 268
Query: 288 LFSGFIPNTIGNLRNLEFGNIADNYLTSSTPELSFLSSLTNCKKLKVLIVTGNPLDGILP 347
+ I + L N+ ++ + + + + L +
Sbjct: 269 YYLDDIIDLFNCLTNVSSFSLVSVTIER-------VKDFSYNFGWQHLELVNCKFGQFPT 321
Query: 348 KSIGNFSL------------------SLETILMANCSIS--GNIPQVVGNLSNLLVLELG 387
+ + SLE + ++ +S G Q ++L L+L
Sbjct: 322 LKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLS 381
Query: 388 GNNLTGPIPVTFSQLQTLQAFDLTRNKLAGPI-TDELCHLARLHSLVLQGNKFSGSIPSC 446
N + + F L+ L+ D + L L L L + +
Sbjct: 382 FNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGI 440
Query: 447 LGNLTSVRVLYLGLNIFT-SVLSSTIWNLKDILFIDVSSNFLDGPLSLDIGNLKVVIGLD 505
L+S+ VL + N F + L L+++ F+D+S L+ +L + L+
Sbjct: 441 FNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLN 500
Query: 506 FSRNNLSGDIPITIG 520
S NN
Sbjct: 501 MSHNNFFSLDTFPYK 515
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 206 bits (527), Expect = 2e-57
Identities = 88/481 (18%), Positives = 177/481 (36%), Gaps = 44/481 (9%)
Query: 57 LNISSFNLQGTITPQLGNLSSLQTLDLSHNKL-SGNIPSSIFNMHTLKLLDFSDNQLFGS 115
L NL +G+L +L+ L+++HN + S +P N+ L+ LD S N++
Sbjct: 105 LVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSI 164
Query: 116 LSSFIFNMSSMT----TIDLSINRLSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAI 171
+ + + M ++DLS+N ++ I K +L +L L N S +
Sbjct: 165 YCTDLRVLHQMPLLNLSLDLSLNPMNF--------IQPGAFKEIRLHKLTLRNNFDSLNV 216
Query: 172 PKE----IGNLTKLKEIISTITNSTVCE--IPREIGNLPYL--ARLALATNNLVGVVPVT 223
K + L + ++ N E + L L LA + +
Sbjct: 217 MKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIID 276
Query: 224 IF-NMSALKEISLLNNSLSGSLPSRIDLSLPNVETLNLGINSFSGTIPSSITNSSKLSDL 282
+F ++ + SL++ ++ + + L L F + + +L+
Sbjct: 277 LFNCLTNVSSFSLVSVTIERVKDFSYNFGW---QHLELVNCKFGQFPTLKLKSLKRLTFT 333
Query: 283 ELGENLFSGFIPNTIGNLRNLEFGNIADNYLTSSTPELSFLSSLTNCKKLKVLIVTGNPL 342
G + +L +LEF +++ N L+ T+ LK L ++ N +
Sbjct: 334 SN-----KGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTS---LKYLDLSFNGV 385
Query: 343 DGILPKSIGNFSLSLETILMANCSISGNIPQ-VVGNLSNLLVLELGGNNLTGPIPVTFSQ 401
+ + LE + + ++ V +L NL+ L++ + F+
Sbjct: 386 ITM-SSNFLGLE-QLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNG 443
Query: 402 LQTLQAFDLTRNKLAGPI-TDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSVRVLYLGL 460
L +L+ + N D L L L L + P+ +L+S++VL +
Sbjct: 444 LSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSH 503
Query: 461 NIFTSVLSSTIWNLKDILFIDVSSNFLDGP----LSLDIGNLKVVIGLDFSRNNLSGDIP 516
N F S+ + L + +D S N + L +L L+ ++N+ +
Sbjct: 504 NNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAF---LNLTQNDFACTCE 560
Query: 517 I 517
Sbjct: 561 H 561
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 183 bits (466), Expect = 2e-49
Identities = 74/436 (16%), Positives = 150/436 (34%), Gaps = 26/436 (5%)
Query: 57 LNISSFNLQGTITPQLGNLSSLQTLDLSHNKLSGNIPSSIF-NMHTLKLLDFSDNQLFGS 115
L++S + I P L L L +N S N+ + + L++ +
Sbjct: 182 LDLSLNPMNF-IQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNE 240
Query: 116 --LSSFIFN-MSSMTTIDLSINRLSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAIP 172
L F + + + + + RL+ L + I + + +L +
Sbjct: 241 GNLEKFDKSALEGLCNLTIEEFRLAY-LDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD 299
Query: 173 KEIGNLTKLKEIISTITNSTVCEIPREIGNLPYLARLALATNNLVGVVPVTIFNMSALKE 232
+ + + ++ +L L + N + ++ +L+
Sbjct: 300 --FSYNFGWQHL-ELVNCKFGQFPTLKLKSLKRLTFTSNKGGN-----AFSEVDLPSLEF 351
Query: 233 ISLLNNSLSGS-LPSRIDLSLPNVETLNLGINSFSGTIPSSITNSSKLSDLELGENLFSG 291
+ L N LS S+ D +++ L+L N T+ S+ +L L+ +
Sbjct: 352 LDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQ 410
Query: 292 FIP-NTIGNLRNLEFGNIADNYLTSSTPELSFLSSLTNCKKLKVLIVTGNPLDGILPKSI 350
+ +LRNL + +I+ + + L+VL + GN I
Sbjct: 411 MSEFSVFLSLRNLIYLDISHTHTRVAFNG-----IFNGLSSLEVLKMAGNSFQENFLPDI 465
Query: 351 GNFSLSLETILMANCSISGNIPQVVGNLSNLLVLELGGNNLTGPIPVTFSQLQTLQAFDL 410
+L + ++ C + P +LS+L VL + NN + L +LQ D
Sbjct: 466 FTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDY 525
Query: 411 TRNKLAGPITDELCHLAR-LHSLVLQGNKFSGSIPSC--LGNLTSVRVLYLGLNIFTSVL 467
+ N + EL H L L L N F+ + L + R L + +
Sbjct: 526 SLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECAT 585
Query: 468 SSTIWNLKDILFIDVS 483
S + +L ++++
Sbjct: 586 PSDKQGMP-VLSLNIT 600
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 3e-30
Identities = 43/263 (16%), Positives = 89/263 (33%), Gaps = 25/263 (9%)
Query: 53 RVIGLNISSFNLQGTITPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLDFSDNQL 112
+ L+ + + +G + +SL+ LDLS N + + S+ + L+ LDF + L
Sbjct: 350 EFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNL 408
Query: 113 FGSLSSFIF-NMSSMTTIDLSINRLSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAI 171
+F ++ ++ +D+S + LE L + N+
Sbjct: 409 KQMSEFSVFLSLRNLIYLDISHTHTRVA-------FNGIFNGLSSLEVLKMAGNSFQENF 461
Query: 172 PKEI-GNLTKLKEI------ISTITNSTVCEIPREIGNLPYLARLALATNNLVGVVPVTI 224
+I L L + + + P +L L L ++ NN +
Sbjct: 462 LPDIFTELRNLTFLDLSQCQLEQL-------SPTAFNSLSSLQVLNMSHNNFFSLDTFPY 514
Query: 225 FNMSALKEISLLNNSLSGSLPSRIDLSLPNVETLNLGINSFSGTIPSS--ITNSSKLSDL 282
+++L+ + N + S + ++ LNL N F+ T + L
Sbjct: 515 KCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQL 574
Query: 283 ELGENLFSGFIPNTIGNLRNLEF 305
+ P+ + L
Sbjct: 575 LVEVERMECATPSDKQGMPVLSL 597
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 6e-24
Identities = 34/170 (20%), Positives = 63/170 (37%), Gaps = 5/170 (2%)
Query: 352 NFSLSLETILMANCSISGNIPQVVGNLSNLLVLELGGNNLTGPIPVTFSQLQTLQAFDLT 411
N S + + ++ + + L VL+L + + L L LT
Sbjct: 25 NLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILT 84
Query: 412 RNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSVRVLYLGLNIFTSV-LSST 470
N + L+ L LV + +G+L +++ L + N+ S L
Sbjct: 85 GNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEY 144
Query: 471 IWNLKDILFIDVSSNFLDGPLSLDIGNLK----VVIGLDFSRNNLSGDIP 516
NL ++ +D+SSN + D+ L + + LD S N ++ P
Sbjct: 145 FSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQP 194
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 2e-10
Identities = 27/163 (16%), Positives = 43/163 (26%), Gaps = 50/163 (30%)
Query: 359 TILMANCSISGNIPQVVGNL-SNLLVLELGGNNLTGPIPVTFSQLQTLQAFDLTRNKLAG 417
+ C N ++ NL + L+L N L +F LQ DL+R ++
Sbjct: 8 PNITYQCM-ELNFYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQT 66
Query: 418 PITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSVRVLYLGLNIFTSVLSSTIWNLKDI 477
L+ L +L+L GN L+S++ L
Sbjct: 67 IEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA------------------- 107
Query: 478 LFIDVSSNFLDGPLSLDIGNLKVVIGLDFSRNNLSGDIPITIG 520
NL+ IG
Sbjct: 108 -----------------------------VETNLASLENFPIG 121
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 3e-09
Identities = 19/97 (19%), Positives = 39/97 (40%), Gaps = 3/97 (3%)
Query: 50 NSHRVIGLNISSFNLQGTITPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHT-LKLLDFS 108
+ + LN+S N T L+SLQ LD S N + + + + + L L+ +
Sbjct: 492 SLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLT 551
Query: 109 DNQLFGSLSS--FIFNMSSMTTIDLSINRLSGELPAN 143
N + F+ + + + + R+ P++
Sbjct: 552 QNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSD 588
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 225 bits (575), Expect = 2e-62
Identities = 76/539 (14%), Positives = 155/539 (28%), Gaps = 86/539 (15%)
Query: 32 NWTSSTSVCIWIGITCDVNSHRVIGLNISSFNLQGTITPQLGNLSSLQTLDLSHNKLSGN 91
NW + + +W L N + L L+ G
Sbjct: 301 NWNFNKELDMWGDQPGV----------------------DLDNNGRVTGLSLAGFGAKGR 338
Query: 92 IPSSIFNMHTLKLLDFSDNQLFGSLSSFIFNMSSMTTIDLSINRLSGELPANICKIPSTL 151
+P +I + LK+L F + S F + + +R+ L
Sbjct: 339 VPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRL 398
Query: 152 SKCKQLEELNLGFNNLSGAIPKEIGNLTKLKEIISTITNSTVCEIPREIGNLPYLARLAL 211
+ + L N P + + LK+ + + I + I L L +
Sbjct: 399 N---LSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYF 455
Query: 212 ATNNLVGV-------------------VPVTIFNMSALKEISLLNNSLSGSLPSRIDLSL 252
A + ++ N+ L ++ L N LP + L
Sbjct: 456 ANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFL-YDL 514
Query: 253 PNVETLNLGINSFSG---------TIPSSITNSSKLSDLELGENLFSGFIPN-TIGNLRN 302
P +++LN+ N + K+ +G N F + ++ +
Sbjct: 515 PELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVK 574
Query: 303 LEFGNIADNYLTSSTPELSFLSSLTNCKKLKVLIVTGNPLDGILPKSIGNFSLSLETILM 362
L + N + L + KL L + N ++ I P+ F+ +E +
Sbjct: 575 LGLLDCVHNKVRH-------LEAFGTNVKLTDLKLDYNQIEEI-PEDFCAFTDQVEGLGF 626
Query: 363 ANCSISGNIPQVV--GNLSNLLVLELGGNNLTGPIPVTFS-----QLQTLQAFDLTRNKL 415
++ + IP + ++ + ++ N + + L+ N++
Sbjct: 627 SHNKLKY-IPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEI 685
Query: 416 AGPITDELCHLARLHSLVLQGNKFS-------GSIPSCLGNLTSVRVLYLGLNIFTSVLS 468
T+ + + +++L N + N + + L N TS+
Sbjct: 686 QKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLTSLSD 745
Query: 469 S-TIWNLKDILFIDVSSNFLDGPLSLDIGNLKVVIGLDFSR------NNLSGDIPITIG 520
L + +DVS N N + N + P I
Sbjct: 746 DFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGIT 803
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 203 bits (519), Expect = 5e-55
Identities = 65/472 (13%), Positives = 152/472 (32%), Gaps = 60/472 (12%)
Query: 61 SFNLQGTITPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLDFSDNQLFGSLSSFI 120
N I+ + L+ LQ + +++ + + + + + + + +
Sbjct: 433 LTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVD-----WEDANSDYAKQYENEELSW 487
Query: 121 FNMSSMTTIDLSINRLSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKEIGNLTK 180
N+ +T ++L + +P L +L+ LN+ N + + T+
Sbjct: 488 SNLKDLTDVELYNCPNMTQ-------LPDFLYDLPELQSLNIACNRGIS-AAQLKADWTR 539
Query: 181 LKEIISTITNSTVCEIPREIGNLPYLARLALATNNLVGV-VPVTIFNMSALKEISLLNNS 239
+ + P + + NNL ++ M L + ++N
Sbjct: 540 ---------------LADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNK 584
Query: 240 LSGSLPSRIDLS-LPNVETLNLGINSFSGTIPSSI-TNSSKLSDLELGENLFSGFIPNT- 296
+ L + + L L N IP + ++ L N IPN
Sbjct: 585 VR-HLEA---FGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLKY-IPNIF 638
Query: 297 -IGNLRNLEFGNIADNYLTSSTPELSFLSSLTNCKKLKVLIVTGNPLDGILPKSIGNFSL 355
++ + + + N + S +S + ++ N + + S
Sbjct: 639 NAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGS- 697
Query: 356 SLETILMANCSIS-------GNIPQVVGNLSNLLVLELGGNNLTG-PIPVTFSQLQTLQA 407
+ TI+++N ++ N L ++L N LT + L L
Sbjct: 698 PISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLTSLSDDFRATTLPYLSN 757
Query: 408 FDLTRNKLAGPITDELCHLARL------HSLVLQGNKFSGSIPSCLGNLTSVRVLYLGLN 461
D++ N + + + ++L H +GN+ P+ + S+ L +G N
Sbjct: 758 MDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSN 816
Query: 462 IFTSVLSSTIWNLKDILFIDVSSN-FLDGPLSLDIGNLKV-VIGLDFSRNNL 511
V L +D++ N + ++ ++ + L + +
Sbjct: 817 DIRKVDEKLTPQLY---ILDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQD 865
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 192 bits (490), Expect = 2e-51
Identities = 70/416 (16%), Positives = 124/416 (29%), Gaps = 59/416 (14%)
Query: 57 LNISSFNLQGTITPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLDFSDNQL---- 112
N NL L ++L + +P ++++ L+ L+ + N+
Sbjct: 472 ANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAA 531
Query: 113 -----FGSLSSFIFNMSSMTTIDLSINRLSGELPANICKIPSTLSKCKQLEELNLGFNNL 167
+ L+ + + N L E P ++L K +L L+ N +
Sbjct: 532 QLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFP-----ASASLQKMVKLGLLDCVHNKV 585
Query: 168 SGAIPKEIGNLTKLKEI------ISTITNSTVCEIPREIG-NLPYLARLALATNNLVGVV 220
+ G KL ++ I EIP + + L + N L +
Sbjct: 586 R--HLEAFGTNVKLTDLKLDYNQIE--------EIPEDFCAFTDQVEGLGFSHNKLKYIP 635
Query: 221 P-VTIFNMSALKEISLLNNSLSGSLPSRI-----DLSLPNVETLNLGINSFSGTIPSSIT 274
++ + + N + S I D N T+ L N
Sbjct: 636 NIFNAKSVYVMGSVDFSYNKIG-SEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFA 694
Query: 275 NSSKLSDLELGENLFS-------GFIPNTIGNLRNLEFGNIADNYLTSSTPELSFLSSLT 327
S +S + L NL + N L ++ N LTS + + T
Sbjct: 695 TGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLTSLSDDFRA----T 750
Query: 328 NCKKLKVLIVTGNPLDGILPKSIGNFS----LSL-ETILMANCSISGNIPQVVGNLSNLL 382
L + V+ N P N S + I P + +L+
Sbjct: 751 TLPYLSNMDVSYNCFSSF-PTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLI 809
Query: 383 VLELGGNNLTGPIPVTFSQLQTLQAFDLTRNKLAGPITDELCHLARLHSLVLQGNK 438
L++G N++ QL L D+ N +C VL +K
Sbjct: 810 QLQIGSNDIRKVDEKLTPQLYIL---DIADNPNISIDVTSVCPYIEAGMYVLLYDK 862
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 1e-35
Identities = 53/303 (17%), Positives = 98/303 (32%), Gaps = 29/303 (9%)
Query: 58 NISSFNLQG---TITPQLGNLSSLQTLDLSHNKLSGNIPSSIF-NMHTLKLLDFSDNQLF 113
+ + G L L L +N++ IP ++ L FS N+L
Sbjct: 574 KLGLLDCVHNKVRHLEAFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK 632
Query: 114 GSLSSF-IFNMSSMTTIDLSINRLSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAIP 172
+ F ++ M ++D S N++ NI K + L +N +
Sbjct: 633 YIPNIFNAKSVYVMGSVDFSYNKIGS-EGRNISCSMDDY-KGINASTVTLSYNEIQKFPT 690
Query: 173 KEIGNLTKLKEI------ISTITNSTVCEIPREIGNLPYLARLALATNNLVGVVPVTIF- 225
+ + + I +++I +++ N L + L N L +
Sbjct: 691 ELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLTSLSDDFRAT 750
Query: 226 NMSALKEISLLNNSLSGSLPSRIDLSLPNVETLNL------GINSFSGTIPSSITNSSKL 279
+ L + + N S S P++ L+ ++ + N P+ IT L
Sbjct: 751 TLPYLSNMDVSYNCFS-SFPTQP-LNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSL 808
Query: 280 SDLELGENLFSGFIPNTIGNLRNLEFGNIADNYLTSSTPELSFLSSLTNCKKLKVLIVTG 339
L++G N L L +IADN S S + + VL+
Sbjct: 809 IQLQIGSNDIRKVDEKLTPQLYIL---DIADNPNISI-DVTSVCPYIEA--GMYVLLYDK 862
Query: 340 NPL 342
Sbjct: 863 TQD 865
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 99.2 bits (247), Expect = 2e-21
Identities = 40/341 (11%), Positives = 84/341 (24%), Gaps = 41/341 (12%)
Query: 223 TIFNMSALKEISLLNNSLSGSLPSRIDLSLPNVET--LNLGINSFSGTIPSSITNSSKLS 280
I + ALK I + + S + + N ++ + + N+ +++
Sbjct: 267 YIKDYKALKAIWEALDGKNWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDNNGRVT 326
Query: 281 DLELGENLFSGFIPNTIGNLRNLEFGNIADNYLTSSTPELSFLSSLTNCKKLKVLIVTGN 340
L L G +P+ IG L L+ + + T S + + + + +
Sbjct: 327 GLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMH 386
Query: 341 PLDGILPKSIGNFSLSLETILMANCSISGNIPQVVGNLSNLLVLELGGNNLTGPIPVTFS 400
L L + I + + N +T I
Sbjct: 387 YKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITF-ISKAIQ 445
Query: 401 QLQTLQAFDLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSVRVLYLGL 460
+L LQ + K + NL + + L
Sbjct: 446 RLTKLQIIYFANSPFTYDNIAVD-----WEDANSDYAKQYENEELSWSNLKDLTDVELYN 500
Query: 461 NIFTSVLSSTIWNLKDILFIDVSSNFLDGPLSLDIGNLKVVIGLDFSRNNLSGDIPITIG 520
+ L +++L L+ L+ + N +
Sbjct: 501 CPNMTQLPDFLYDLP---------------------ELQS---LNIACNRGISAAQLKAD 536
Query: 521 EGEIPRG-GPFANLTAKSFMGNEL--------LCGLPDLQV 552
+ + N L L + L +
Sbjct: 537 WTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGL 577
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 42.2 bits (99), Expect = 8e-04
Identities = 20/160 (12%), Positives = 47/160 (29%), Gaps = 1/160 (0%)
Query: 394 PIPVTFSQLQTLQAFDLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSV 453
V ++L + + A I D A +L + ++ + + +
Sbjct: 243 SFTVIDNKLTKDANVPIQLKETAEYIKDYKALKAIWEALDGKNWRYYSGTINNTIHSLN- 301
Query: 454 RVLYLGLNIFTSVLSSTIWNLKDILFIDVSSNFLDGPLSLDIGNLKVVIGLDFSRNNLSG 513
L+++ + N + + ++ G + IG L + L F ++ +
Sbjct: 302 WNFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETV 361
Query: 514 DIPITIGEGEIPRGGPFANLTAKSFMGNELLCGLPDLQVS 553
+ E P + L L +S
Sbjct: 362 SGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLS 401
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 207 bits (530), Expect = 7e-58
Identities = 94/484 (19%), Positives = 165/484 (34%), Gaps = 33/484 (6%)
Query: 57 LNISSFNLQGTITPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLDFSDNQLFGSL 116
L +++ L L +L+ L +S + N TL+ L N +
Sbjct: 86 LVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIK 145
Query: 117 SSFIFNMSSMTTIDLSINRLSGELPA------------------NICKIPSTLSKCKQLE 158
F + +D N + +I I +
Sbjct: 146 LPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQ 205
Query: 159 ELNLGFNNLSGAIPKEIGNLTKLKEIISTITNSTVCEIPREI---GNLPYLARLALATNN 215
LN G I K + N T + T + +I + + + L +
Sbjct: 206 SLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHY 265
Query: 216 LVGVVPVTIFNMSALKEISLLNNSLSGSLPSRIDLSLPNVETLNLGINSFSGTIPSSITN 275
+ T S L+E+ L LS LPS + + L ++ L L N F S +N
Sbjct: 266 FFNISSNTFHCFSGLQELDLTATHLS-ELPSGL-VGLSTLKKLVLSANKFENLCQISASN 323
Query: 276 SSKLSDLELGENLFSGFI-PNTIGNLRNLEFGNIADNYLTSSTPELSFLSSLTNCKKLKV 334
L+ L + N + + NL NL +++ + + +S L +L++ L+
Sbjct: 324 FPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSH---LQS 380
Query: 335 LIVTGNPLDGILPKSIGNFSLSLETILMANCSISGNIPQVV-GNLSNLLVLELGGNNLTG 393
L ++ N + ++ LE + +A + Q NL L VL L + L
Sbjct: 381 LNLSYNEPLSLKTEAFKECP-QLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDI 439
Query: 394 PIPVTFSQLQTLQAFDLTRNKLAGPITDE---LCHLARLHSLVLQGNKFSGSIPSCLGNL 450
F L LQ +L N + L L RL LVL S +L
Sbjct: 440 SSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSL 499
Query: 451 TSVRVLYLGLNIFTSVLSSTIWNLKDILFIDVSSNFLDGPLSLDIGNLKVVIGLDFSRNN 510
+ + L N TS + +LK ++++++SN + L + L ++ +N
Sbjct: 500 KMMNHVDLSHNRLTSSSIEALSHLK-GIYLNLASNHISIILPSLLPILSQQRTINLRQNP 558
Query: 511 LSGD 514
L
Sbjct: 559 LDCT 562
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 206 bits (527), Expect = 2e-57
Identities = 79/481 (16%), Positives = 157/481 (32%), Gaps = 38/481 (7%)
Query: 57 LNISSFNLQGTITPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLDFSDNQLFGSL 116
L S L L +L LDL+ ++ + + H L L + N L
Sbjct: 38 LEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMA 97
Query: 117 SSFIFNMSSMTTIDLSINRLSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKEIG 176
+ + ++ + +S L K LE L LG N++S +
Sbjct: 98 ETALSGPKALKHLFFIQTGISSI-------DFIPLHNQKTLESLYLGSNHISSIKLPKGF 150
Query: 177 NLTKLKEI------ISTITNSTVCEIPREIGNLPYLARLALA-TNNLVGVVPVTIFNMSA 229
KLK + I ++ + +L L+L N + + F+ +
Sbjct: 151 PTEKLKVLDFQNNAIHYLSKED-------MSSLQQATNLSLNLNGNDIAGIEPGAFDSAV 203
Query: 230 LKEISLLNNSLSGSLPSRID-LSLPNVETLNLGINSFSGTIPSSITNSSKLS--DLELGE 286
+ ++ + + ++ ++ P+ ++S + L +
Sbjct: 204 FQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQK 263
Query: 287 NLFSGFIPNTIGNLRNLEFGNIADNYLTSSTPELSFLSSLTNCKKLKVLIVTGNPLDGIL 346
+ F NT L+ ++ +L+ S L LK L+++ N + +
Sbjct: 264 HYFFNISSNTFHCFSGLQELDLTATHLS------ELPSGLVGLSTLKKLVLSANKFENLC 317
Query: 347 PKSIGNFSLSLETILMANCSISGNI-PQVVGNLSNLLVLELGGNNLT--GPIPVTFSQLQ 403
S NF SL + + + + + NL NL L+L +++ + L
Sbjct: 318 QISASNFP-SLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLS 376
Query: 404 TLQAFDLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIP-SCLGNLTSVRVLYLGLNI 462
LQ+ +L+ N+ T+ +L L L + S NL ++VL L ++
Sbjct: 377 HLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSL 436
Query: 463 FTSVLSSTIWNLKDILFIDVSSNFLDGPLSLDIG---NLKVVIGLDFSRNNLSGDIPITI 519
L + +++ N L + L S +LS
Sbjct: 437 LDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAF 496
Query: 520 G 520
Sbjct: 497 T 497
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 189 bits (482), Expect = 2e-51
Identities = 75/461 (16%), Positives = 150/461 (32%), Gaps = 37/461 (8%)
Query: 75 LSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLDFSDNQLFGSLSSFIFNMSSMTTIDLSIN 134
+S + L+ S N L ++ + L LD + Q++ + + T+ L+ N
Sbjct: 32 PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTAN 91
Query: 135 RLSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKEIGNLTKLKEI------ISTI 188
L + LS K L+ L +S + N L+ + IS+I
Sbjct: 92 PLIFM-------AETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSI 144
Query: 189 TNSTVCEIPREIGNLPYLARLALATNNLVGVVPVTIFNMSALKEISL-LNNSLSGSLPSR 247
+ L L N + + + ++ +SL LN + +
Sbjct: 145 -------KLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPG 197
Query: 248 IDLSLPNVETLNLGINSFSGTIPSSITNSS--KLSDLELGENLFSGFIPNTIGNLRNLEF 305
++LN G I + NS+ L + P L +
Sbjct: 198 A-FDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSV 256
Query: 306 G--NIADNYLTSSTPELSFLSSLTNCKKLKVLIVTGNPLDGILPKSIGNFSLSLETILMA 363
N+ +Y + + + L+ L +T L + P + S +L+ ++++
Sbjct: 257 ESINLQKHYFFNISSN-----TFHCFSGLQELDLTATHLSEL-PSGLVGLS-TLKKLVLS 309
Query: 364 NCSISGNIPQVVGNLSNLLVLELGGNNLTGPI-PVTFSQLQTLQAFDLTRNKLA--GPIT 420
N +L L + GN + L+ L+ DL+ + +
Sbjct: 310 ANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCN 369
Query: 421 DELCHLARLHSLVLQGNKFSGSIPSCLGNLTSVRVLYLGLNIFTSVLSSTIW-NLKDILF 479
+L +L+ L SL L N+ + +L L + + + NL +
Sbjct: 370 LQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKV 429
Query: 480 IDVSSNFLDGPLSLDIGNLKVVIGLDFSRNNLSGDIPITIG 520
+++S + LD L + L+ N+
Sbjct: 430 LNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTN 470
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 3e-28
Identities = 52/288 (18%), Positives = 95/288 (32%), Gaps = 17/288 (5%)
Query: 231 KEISLLNNSLSGSLPSRIDLSLPNVETLNLGINSFSGTIPSSITNSSKLSDLELGENLFS 290
K + N L+ +P + + E L N ++ + L+ L+L
Sbjct: 15 KTYNCENLGLN-EIPGTL---PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIY 70
Query: 291 GFIPNTIGNLRNLEFGNIADNYLTSSTPELSFLSSLTNCKKLKVLIVTGNPLDGILPKSI 350
+T + L+ + N L +L+ K LK L + I +
Sbjct: 71 WIHEDTFQSQHRLDTLVLTANPLIFMAET-----ALSGPKALKHLFFIQTGISSIDFIPL 125
Query: 351 GNFSLSLETILMANCSISGNIPQVVGNLSNLLVLELGGNNLTGPIPVTFSQLQTLQ--AF 408
N +LE++ + + IS L VL+ N + S LQ +
Sbjct: 126 HNQK-TLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSL 184
Query: 409 DLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGN--LTSVRVLYLGLNIFTSV 466
+L N +AG I A SL G + I L N + S+ + +
Sbjct: 185 NLNGNDIAG-IEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDI 243
Query: 467 LSSTIWNLKD--ILFIDVSSNFLDGPLSLDIGNLKVVIGLDFSRNNLS 512
+ L + + I++ ++ S + LD + +LS
Sbjct: 244 SPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS 291
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 2e-19
Identities = 35/168 (20%), Positives = 59/168 (35%), Gaps = 2/168 (1%)
Query: 351 GNFSLSLETILMANCSISGNIPQVVGNLSNLLVLELGGNNLTGPIPVTFSQLQTLQAFDL 410
G S E + + + L NL L+L + TF L L
Sbjct: 29 GTLPNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVL 88
Query: 411 TRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSVRVLYLGLNIFTSVLSST 470
T N L L L L S L N ++ LYLG N +S+
Sbjct: 89 TANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPK 148
Query: 471 IWNLKDILFIDVSSNFLDGPLSLDIGNLK--VVIGLDFSRNNLSGDIP 516
+ + + +D +N + D+ +L+ + L+ + N+++G P
Sbjct: 149 GFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEP 196
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 2e-15
Identities = 43/189 (22%), Positives = 71/189 (37%), Gaps = 18/189 (9%)
Query: 57 LNISSFNLQGTITPQLGNLSSLQTLDLSHNKLSGNI---PSSIFNMHTLKLLDFSDNQLF 113
LN+S L + L +LQ L+L N +S+ + L++L S L
Sbjct: 430 LNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLS 489
Query: 114 GSLSSFIFNMSSMTTIDLSINRLSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAIPK 173
++ M +DLS NRL+ LS K + LNL N++S +P
Sbjct: 490 SIDQHAFTSLKMMNHVDLSHNRLTSS-------SIEALSHLKGIY-LNLASNHISIILPS 541
Query: 174 EIGNLTKLKEI-ISTITNSTVCEIPREIGNLPYLARLALATNNLVGVVPVTIFNMSALKE 232
+ L++ + I + N C N+ +L L N L+
Sbjct: 542 LLPILSQQRTINLRQ--NPLDCTC----SNIYFLEWYKENMQKLEDTEDTLCENPPLLRG 595
Query: 233 ISLLNNSLS 241
+ L + +LS
Sbjct: 596 VRLSDVTLS 604
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 193 bits (493), Expect = 6e-53
Identities = 85/468 (18%), Positives = 157/468 (33%), Gaps = 28/468 (5%)
Query: 57 LNISSFNLQGTITPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLDFSDNQLFG-S 115
L ++ +Q L+SL+ L KL+ I + TLK L+ + N +
Sbjct: 85 LILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCK 144
Query: 116 LSSFIFNMSSMTTIDLSINRLSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKEI 175
L ++ N++++ +DLS N + + N + + L++ N + I +
Sbjct: 145 LPAYFSNLTNLVHVDLSYNYIQT-ITVNDLQFLRENPQ--VNLSLDMSLNPIDF-IQDQA 200
Query: 176 GNLTKLKEIISTITNSTVCEIPREIGNLPYLARLALATNNLVGVVPVTIFNMSA---LKE 232
KL E+ ++ + + NL L L + IF S L +
Sbjct: 201 FQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCD 260
Query: 233 ISLLNNSLSGSLPSRIDLS----LPNVETLNLGINSFSGTIPSSITNSSKLSDLELGENL 288
+++ L+ + D+ L NV ++L S + K L +
Sbjct: 261 VTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSI--KYLEDVPKHFKWQSLSIIRCQ 318
Query: 289 FSGFIPNTIGNLRNLEFGNIADNYLTSSTPELSFLSSLTNCKKLKVLIVTGNPLDGILPK 348
F + L++L + N + S L L ++ N L
Sbjct: 319 LKQFPTLDLPFLKSL---TLTMN-------KGSISFKKVALPSLSYLDLSRNALSFSGCC 368
Query: 349 SIGNFSL-SLETILMANCSISGNIPQVVGNLSNLLVLELGGNNLTGPIPV-TFSQLQTLQ 406
S + SL + ++ + L L L+ + L F L+ L
Sbjct: 369 SYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLL 427
Query: 407 AFDLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSC-LGNLTSVRVLYLGLNIFTS 465
D++ L L++L + GN F + S N T++ L L
Sbjct: 428 YLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQ 487
Query: 466 VLSSTIWNLKDILFIDVSSNFLDGPLSLDIGNLKVVIGLDFSRNNLSG 513
+ L + +++S N L S L + LD S N +
Sbjct: 488 ISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIET 535
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 182 bits (463), Expect = 6e-49
Identities = 88/494 (17%), Positives = 163/494 (32%), Gaps = 50/494 (10%)
Query: 57 LNISSFNLQGTITPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLDFSDNQLFGSL 116
+++S L+ + N S LQ LDLS ++ + +H L L + N +
Sbjct: 37 IDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFS 96
Query: 117 SSFIFNMSSMTTIDLSINRLSGELPANICKIPSTLSKCKQLEELNLGFNNLSGA-IPKEI 175
++S+ + +L+ + + L++LN+ N + +P
Sbjct: 97 PGSFSGLTSLENLVAVETKLASL-------ESFPIGQLITLKKLNVAHNFIHSCKLPAYF 149
Query: 176 GNLTKLKEI------ISTITNSTVCEIPREIGNLPYLARLALATNNLVGVVPVTIFNMSA 229
NLT L + I TIT + + + N L ++ N + + F
Sbjct: 150 SNLTNLVHVDLSYNYIQTITVNDLQFLRE---NPQVNLSLDMSLNPI-DFIQDQAFQGIK 205
Query: 230 LKEISLLNNSLSGSLPSRIDLSLPNVETLNLGINSFSGTIPSSITNSSKLS--------D 281
L E++L N S ++ +L + L + F I S + +
Sbjct: 206 LHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDE 265
Query: 282 LELGENLFSGFIPNTIGNLRNLEFGNIADNYLTSSTPELSFLSSLT-------------- 327
L L N+ ++A + ++
Sbjct: 266 FRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIK-YLEDVPKHFKWQSLSIIRCQLKQFPT 324
Query: 328 -NCKKLKVLIVTGNPLDGILPKSIGNFSLSLETILMANCSISGNIPQVVGNL--SNLLVL 384
+ LK L +T N K SL + ++ ++S + +L ++L L
Sbjct: 325 LDLPFLKSLTLTMNKGSISFKKV---ALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHL 381
Query: 385 ELGGNNLTGPIPVTFSQLQTLQAFDLTRNKLAG-PITDELCHLARLHSLVLQGNKFSGSI 443
+L N + F L+ LQ D + L L +L L +
Sbjct: 382 DLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDF 440
Query: 444 PSCLGNLTSVRVLYLGLNIFTSVLSSTIW-NLKDILFIDVSSNFLDGPLSLDIGNLKVVI 502
LTS+ L + N F S ++ N ++ F+D+S L+ L +
Sbjct: 441 DGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQ 500
Query: 503 GLDFSRNNLSGDIP 516
L+ S NNL
Sbjct: 501 LLNMSHNNLLFLDS 514
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 5e-46
Identities = 78/436 (17%), Positives = 148/436 (33%), Gaps = 36/436 (8%)
Query: 57 LNISSFNLQGTITPQ-LGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKL----LDFSDNQ 111
LN++ + P NL++L +DLS+N + + + + LD S N
Sbjct: 133 LNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNP 192
Query: 112 LFGSLSSFIFNMSSMTTIDLSINRLSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAI 171
+ + F + + L N S + + + L + + NL
Sbjct: 193 I-DFIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFE 251
Query: 172 PKEIGNLTKLK-EIISTITNSTVCEIPREIGNLPYLARLALATNNLVGVVPVTIFNMSAL 230
P + L + + + + + L ++ ++LA ++ + +
Sbjct: 252 PSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYLED--VPKHFKW 309
Query: 231 KEISLLNNSLSG----SLPS--RIDLS------------LPNVETLNLGINSFSGTIPSS 272
+ +S++ L LP + L+ LP++ L+L N+ S + S
Sbjct: 310 QSLSIIRCQLKQFPTLDLPFLKSLTLTMNKGSISFKKVALPSLSYLDLSRNALSFSGCCS 369
Query: 273 ITN--SSKLSDLELGENLFSGFIPNTIGNLRNLEFGNIADNYLTSSTPELSFLSSLTNCK 330
++ ++ L L+L N + L L+ + + L T S+ + +
Sbjct: 370 YSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTE----FSAFLSLE 424
Query: 331 KLKVLIVTGNPLDGILPKSIGNFSLSLETILMANCSISGNIPQVV-GNLSNLLVLELGGN 389
KL L ++ + SL T+ MA S N V N +NL L+L
Sbjct: 425 KLLYLDISYTNTKIDFDGIFLGLT-SLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKC 483
Query: 390 NLTGPIPVTFSQLQTLQAFDLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGN 449
L F L LQ +++ N L + L L +L N+ S
Sbjct: 484 QLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHF 543
Query: 450 LTSVRVLYLGLNIFTS 465
S+ L N
Sbjct: 544 PKSLAFFNLTNNSVAC 559
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 6e-46
Identities = 79/471 (16%), Positives = 154/471 (32%), Gaps = 36/471 (7%)
Query: 57 LNISSFNLQGTITPQLGNLSSLQTLDLSHNKLSG-NIPSSIFNMHTLKLLDFSDNQL--- 112
L L + +G L +L+ L+++HN + +P+ N+ L +D S N +
Sbjct: 109 LVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTI 168
Query: 113 -FGSLSSFIFNMSSMTTIDLSINRLSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAI 171
L N ++D+S+N + I + +L EL L N S I
Sbjct: 169 TVNDLQFLRENPQVNLSLDMSLNPID--------FIQDQAFQGIKLHELTLRGNFNSSNI 220
Query: 172 PKEIG----NLTKLKEIISTITNSTVCEIPRE--IGNLPYLAR--LALATNNLVGVVPVT 223
K L + I+ + EI + L + L N V
Sbjct: 221 MKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVK 280
Query: 224 IFNMSALKEISLLNNSLSGSLPSRIDLSLPNVETLNLGINSFSGTIPSSITNSSKLSDLE 283
++ + +SL S+ ++L++ + L L
Sbjct: 281 FHCLANVSAMSLAGVSIKYLEDVPKHFKW---QSLSIIRCQLKQFPTLDLPF---LKSLT 334
Query: 284 LGENLFSGFIPNTIGNLRNLEFGNIADNYLTSSTPELSFLSSLTNCKKLKVLIVTGNPLD 343
L N S I L +L + +++ N L+ S + L+ L ++ N
Sbjct: 335 LTMNKGS--ISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNS---LRHLDLSFNGA- 388
Query: 344 GILPKSIGNFSLSLETILMANCSISGNIPQVV-GNLSNLLVLELGGNNLTGPIPVTFSQL 402
I+ + L+ + + ++ +L LL L++ N F L
Sbjct: 389 IIMSANFMGLE-ELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGL 447
Query: 403 QTLQAFDLTRNKLAGPITDE-LCHLARLHSLVLQGNKFSGSIPSCLGNLTSVRVLYLGLN 461
+L + N + L L L + L +++L + N
Sbjct: 448 TSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHN 507
Query: 462 IFTSVLSSTIWNLKDILFIDVSSNFLDGPLSLDIGNLKVVIGLDFSRNNLS 512
+ SS L + +D S N ++ + K + + + N+++
Sbjct: 508 NLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVA 558
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 2e-45
Identities = 79/461 (17%), Positives = 151/461 (32%), Gaps = 47/461 (10%)
Query: 76 SSLQTLDLSHNKLSGNIPSSIFNMHTLKLLDFSDNQLFGSLSSFIFNMSSMTTIDLSINR 135
SS + +DLS N L S N L+ LD S ++ + ++ + L+ N
Sbjct: 32 SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNP 91
Query: 136 LSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKEIGNLTKLKEI------ISTIT 189
+ P + S LE L L+ IG L LK++ I +
Sbjct: 92 IQS-FS------PGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSC- 143
Query: 190 NSTVCEIPREIGNLPYLARLALATNNLVGVVPVTIFNMSALK----EISLLNNSLSGSLP 245
++P NL L + L+ N + + + + + + N + +
Sbjct: 144 -----KLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPID-FIQ 197
Query: 246 SRIDLSLPNVETLNLGINSFSGTIPS-SITNSSKLSDLELGENLFSG------FIPNTIG 298
+ + L L N S I + N + L L F F P+ +
Sbjct: 198 DQA-FQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIME 256
Query: 299 NLRNLEFGNIADNYLTSSTPELSFLSSLTNCKKLKVLIVTGNPLDGILPKSIGNFSLSLE 358
L ++ Y + ++ L N + + + G + + +
Sbjct: 257 GLCDVTIDEFRLTYTNDFSDDIVKFHCLAN---VSAMSLAGVSIKYLED---VPKHFKWQ 310
Query: 359 TILMANCSISGNIPQVVGNLSNLLVLELGGNNLTGPIPVTFSQLQTLQAFDLTRNKLA-- 416
++ + C + +L L L L N + I L +L DL+RN L+
Sbjct: 311 SLSIIRCQLKQFPTL---DLPFLKSLTLTMNKGS--ISFKKVALPSLSYLDLSRNALSFS 365
Query: 417 GPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSVRVLYLGLNIFTSVLSSTIW-NLK 475
G + L L L N + + L ++ L + V + + +L+
Sbjct: 366 GCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLE 424
Query: 476 DILFIDVSSNFLDGPLSLDIGNLKVVIGLDFSRNNLSGDIP 516
+L++D+S L + L + N+ +
Sbjct: 425 KLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTL 465
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-26
Identities = 55/267 (20%), Positives = 95/267 (35%), Gaps = 19/267 (7%)
Query: 73 GNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLDFSDNQL--FGSLSSFIFNMSSMTTID 130
+L L++L L+ NK S I + +L LD S N L G S +S+ +D
Sbjct: 325 LDLPFLKSLTLTMNKGS--ISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLD 382
Query: 131 LSINRLSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKE-IGNLTKLKEI-ISTI 188
LS N + + ++L+ L+ + L +L KL + IS
Sbjct: 383 LSFNGAII--------MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISY- 433
Query: 189 TNSTVCEIPREIGNLPYLARLALATNNLVGVVPVTIF-NMSALKEISLLNNSLSGSLPSR 247
+T + L L L +A N+ +F N + L + L L +
Sbjct: 434 -TNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLE-QISWG 491
Query: 248 IDLSLPNVETLNLGINSFSGTIPSSITNSSKLSDLELGENLFSGFIPNTIGNLRNLEFGN 307
+ +L ++ LN+ N+ S LS L+ N ++L F N
Sbjct: 492 VFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFN 551
Query: 308 IADNYLTSSTPELSFLSSLTNCKKLKV 334
+ +N + E +K +
Sbjct: 552 LTNNSVA-CICEHQKFLQWVKEQKQFL 577
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 9e-22
Identities = 50/237 (21%), Positives = 92/237 (38%), Gaps = 16/237 (6%)
Query: 291 GFIPNTIGNLRNLEFGNIADNYLTSSTPELSFLSSLTNCKKLKVLIVTGNPLDGILPKSI 350
G + I + N+ + D L+ ++ K + ++ NPL + S
Sbjct: 2 GSLNPCIEVVPNITY-QCMDQKLSKVPDDIP--------SSTKNIDLSFNPLKILKSYSF 52
Query: 351 GNFSLSLETILMANCSISGNIPQVVGNLSNLLVLELGGNNLTGPIPVTFSQLQTLQAFDL 410
NFS L+ + ++ C I + L +L L L GN + P +FS L +L+
Sbjct: 53 SNFS-ELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVA 111
Query: 411 TRNKLAGPITDELCHLARLHSLVLQGNKFSG-SIPSCLGNLTSVRVLYLGLNIFTSVLSS 469
KLA + + L L L + N +P+ NLT++ + L N ++ +
Sbjct: 112 VETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVN 171
Query: 470 TIWNLKDILF----IDVSSNFLDGPLSLDIGNLKVVIGLDFSRNNLSGDIPITIGEG 522
+ L++ +D+S N +D + + L N S +I T +
Sbjct: 172 DLQFLRENPQVNLSLDMSLNPIDF-IQDQAFQGIKLHELTLRGNFNSSNIMKTCLQN 227
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 5e-44
Identities = 83/459 (18%), Positives = 176/459 (38%), Gaps = 57/459 (12%)
Query: 63 NLQGTITPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLDFSDNQLFGSLSSFIFN 122
L + L++L ++ S+N+L+ P + N+ L + ++NQ+ + + + N
Sbjct: 55 RLGIKSIDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQI--ADITPLAN 110
Query: 123 MSSMTTIDLSINRLSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKEIGNLTKLK 182
++++T + L N+++ L L L L N +S + LT L+
Sbjct: 111 LTNLTGLTLFNNQITD---------IDPLKNLTNLNRLELSSNTISD--ISALSGLTSLQ 159
Query: 183 EI-----ISTITNSTVCEIPREIGNLPYLARLALATNNLVGVVPVTIFNMSALKEISLLN 237
++ ++ + + NL L RL +++N + + + ++ L+ + N
Sbjct: 160 QLSFGNQVTDLKP---------LANLTTLERLDISSNKVSDISV--LAKLTNLESLIATN 208
Query: 238 NSLSGSLPSRIDLSLPNVETLNLGINSFSGTIPSSITNSSKLSDLELGENLFSGFIPNTI 297
N +S P L N++ L+L N ++ + + L+DL+L N S P +
Sbjct: 209 NQISDITP---LGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--L 261
Query: 298 GNLRNLEFGNIADNYLTSSTPELSFLSSLTNCKKLKVLIVTGNPLDGILPKSIGNFSLSL 357
L L + N +++ +S L L L + N L+ I P I N +L
Sbjct: 262 SGLTKLTELKLGANQISN-------ISPLAGLTALTNLELNENQLEDISP--ISNLK-NL 311
Query: 358 ETILMANCSISGNIPQVVGNLSNLLVLELGGNNLTGPIPVTFSQLQTLQAFDLTRNKLAG 417
+ + +IS P V +L+ L L N ++ + L + N+++
Sbjct: 312 TYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSDVSS--LANLTNINWLSAGHNQISD 367
Query: 418 PITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSVRVLYLGLNIFTSVLSSTIWNLKDI 477
L +L R+ L L ++ + + N++ + + +TI +
Sbjct: 368 LT--PLANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTG--ALIAPATISDGGSY 423
Query: 478 LFIDVSSNFLDGPLSLDIGNLKVVIGLDFSRNNLSGDIP 516
D++ N + + + SG +
Sbjct: 424 TEPDITWNLPSYTNEV-SYTFSQPVTIGKGTTTFSGTVT 461
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 163 bits (416), Expect = 1e-43
Identities = 92/476 (19%), Positives = 176/476 (36%), Gaps = 63/476 (13%)
Query: 53 RVIGLNISSFNLQGTITPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLDFSDNQL 112
+ I+ I L+ L ++ + ++ + L +
Sbjct: 2 PLGSATITQDTPINQIFT-DTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGI 58
Query: 113 FGSLSSFIFNMSSMTTIDLSINRLSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAIP 172
S+ + ++++T I+ S N+L+ + L +L ++ + N ++ P
Sbjct: 59 -KSIDG-VEYLNNLTQINFSNNQLTD---------ITPLKNLTKLVDILMNNNQIADITP 107
Query: 173 KEIGNLTKLKEI------ISTITNSTVCEIPREIGNLPYLARLALATNNLVGVVPVTIFN 226
+ NLT L + I+ I + NL L RL L++N + + +
Sbjct: 108 --LANLTNLTGLTLFNNQITDIDP---------LKNLTNLNRLELSSNTISDISA--LSG 154
Query: 227 MSALKEISLLNNSLSGSLPSRIDLSLPNVETLNLGINSFSGTIPSSITNSSKLSDLELGE 286
+++L+++S N ++ P +L +E L++ N S S + + L L
Sbjct: 155 LTSLQQLS-FGNQVTDLKPLA---NLTTLERLDISSNKVSD--ISVLAKLTNLESLIATN 208
Query: 287 NLFSGFIPNTIGNLRNLEFGNIADNYLTSSTPELSFLSSLTNCKKLKVLIVTGNPLDGIL 346
N S P +G L NL+ ++ N L + +L + L L + N + +
Sbjct: 209 NQISDITP--LGILTNLDELSLNGNQLKD-------IGTLASLTNLTDLDLANNQISNLA 259
Query: 347 PKSIGNFSLSLETILMANCSISGNIPQVVGNLSNLLVLELGGNNLTGPIPVTFSQLQTLQ 406
P + + L + + IS P + L+ L LEL N L P S L+ L
Sbjct: 260 P--LSGLT-KLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLT 312
Query: 407 AFDLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSVRVLYLGLNIFTSV 466
L N ++ + L +L L NK S S L NLT++ L G N + +
Sbjct: 313 YLTLYFNNISDIS--PVSSLTKLQRLFFYNNKVSD--VSSLANLTNINWLSAGHNQISDL 368
Query: 467 LSSTIWNLKDILFIDVSSNFLDGPLSLDIGNLKVVIGLDFSRNNLSGDIPITIGEG 522
+ + NL I + ++ ++ + + P TI +G
Sbjct: 369 --TPLANLTRITQLGLNDQAWTN-APVNYKANVSIPNTVKNVTGAL-IAPATISDG 420
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 3e-14
Identities = 32/191 (16%), Positives = 70/191 (36%), Gaps = 20/191 (10%)
Query: 58 NISSFNLQG---TITPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLDFSDNQLFG 114
+++ L + NL +L L L N +S P + ++ L+ L F +N++
Sbjct: 288 ALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKV-- 343
Query: 115 SLSSFIFNMSSMTTIDLSINRLSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKE 174
S S + N++++ + N++S + L+ ++ +L L + P
Sbjct: 344 SDVSSLANLTNINWLSAGHNQISD---------LTPLANLTRITQLGLNDQAWTN-APVN 393
Query: 175 IGNLTKLKEIISTITNSTVCEIPREIGNLPYLARLALATNNLVGVVPVTIFNMSALKEIS 234
+ + +T + + P I + + T NL + S I
Sbjct: 394 YKANVSIPNTVKNVTGALI--APATISDGGSYTEPDI-TWNLPSYTNEVSYTFSQPVTIG 450
Query: 235 LLNNSLSGSLP 245
+ SG++
Sbjct: 451 KGTTTFSGTVT 461
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 5e-41
Identities = 79/371 (21%), Positives = 156/371 (42%), Gaps = 40/371 (10%)
Query: 45 ITCDVNSHRVIGLNISSFNLQGTITPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKL 104
I D + I + ++ +T L S+ L ++ K++ I + L+
Sbjct: 15 IFPDADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVAS--IQGIEYLTNLEY 70
Query: 105 LDFSDNQLFGSLSSFIFNMSSMTTIDLSINRLSGELPANICKIPSTLSKCKQLEELNLGF 164
L+ + NQ+ + S + N+ +T + + N+++ S L L EL L
Sbjct: 71 LNLNGNQI--TDISPLSNLVKLTNLYIGTNKIT---------DISALQNLTNLRELYLNE 119
Query: 165 NNLSGAIPKEIGNLTKLKEIISTITNSTVCEIPREIGNLPYLARLALATNNLVGVVPVTI 224
+N+S P + NLTK+ + + + + N+ L L + + + V P+
Sbjct: 120 DNISDISP--LANLTKMYSL--NLGANHNLSDLSPLSNMTGLNYLTVTESKVKDVTPIA- 174
Query: 225 FNMSALKEISLLNNSLSGSLPSRIDLSLPNVETLNLGINSFSGTIPSSITNSSKLSDLEL 284
N++ L +SL N + P SL ++ +N + P + N ++L+ L++
Sbjct: 175 -NLTDLYSLSLNYNQIEDISPLA---SLTSLHYFTAYVNQITDITP--VANMTRLNSLKI 228
Query: 285 GENLFSGFIPNTIGNLRNLEFGNIADNYLTSSTPELSFLSSLTNCKKLKVLIVTGNPLDG 344
G N + P + NL L + I N ++ ++++ + KLK+L V N +
Sbjct: 229 GNNKITDLSP--LANLSQLTWLEIGTNQISD-------INAVKDLTKLKMLNVGSNQISD 279
Query: 345 ILPKSIGNFSLSLETILMANCSISGNIPQVVGNLSNLLVLELGGNNLTGPIPVTFSQLQT 404
I + N S L ++ + N + +V+G L+NL L L N++T P + L
Sbjct: 280 I--SVLNNLS-QLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSK 334
Query: 405 LQAFDLTRNKL 415
+ + D +
Sbjct: 335 MDSADFANQVI 345
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 5e-39
Identities = 71/375 (18%), Positives = 144/375 (38%), Gaps = 52/375 (13%)
Query: 72 LGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLDFSDNQLFGSLSSFIFNMSSMTTIDL 131
+L+ L ++ + + ++ L + ++ S+ I ++++ ++L
Sbjct: 18 DADLAEGIRAVLQKASVTD--VVTQEELESITKLVVAGEKV-ASIQG-IEYLTNLEYLNL 73
Query: 132 SINRLSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKEIGNLTKLKEI------I 185
+ N+++ S LS +L L +G N ++ + NLT L+E+ I
Sbjct: 74 NGNQITD---------ISPLSNLVKLTNLYIGTNKIT--DISALQNLTNLRELYLNEDNI 122
Query: 186 STITNSTVCEIPREIGNLPYLARLALATNNLVGVVPVTIFNMSALKEISLLNNSLSGSLP 245
S I+ + NL + L L N+ + + + NM+ L +++ + + P
Sbjct: 123 SDISP---------LANLTKMYSLNLGANHNLSDLS-PLSNMTGLNYLTVTESKVKDVTP 172
Query: 246 SRIDLSLPNVETLNLGINSFSGTIPSSITNSSKLSDLELGENLFSGFIPNTIGNLRNLEF 305
+L ++ +L+L N P + + + L N + P + N+ L
Sbjct: 173 IA---NLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNS 225
Query: 306 GNIADNYLTSSTPELSFLSSLTNCKKLKVLIVTGNPLDGILPKSIGNFSLSLETILMANC 365
I +N +T LS L N +L L + N + I ++ + + L+ + + +
Sbjct: 226 LKIGNNKITD-------LSPLANLSQLTWLEIGTNQISDI--NAVKDLT-KLKMLNVGSN 275
Query: 366 SISGNIPQVVGNLSNLLVLELGGNNLTGPIPVTFSQLQTLQAFDLTRNKLAGPITDELCH 425
IS V+ NLS L L L N L L L L++N + L
Sbjct: 276 QISD--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIR--PLAS 331
Query: 426 LARLHSLVLQGNKFS 440
L+++ S
Sbjct: 332 LSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 2e-31
Identities = 71/379 (18%), Positives = 149/379 (39%), Gaps = 56/379 (14%)
Query: 140 LPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKEIGNLTKLKEIISTITNSTVCEIPRE 199
LPA I +I + + L +++ + L + +++ + V I
Sbjct: 8 LPAPINQI-FPDADLAEGIRAVLQKASVTDVVT--QEELESITKLV--VAGEKVASIQ-G 61
Query: 200 IGNLPYLARLALATNNLVGVVPVTIFNMSALKEISLLNNSLSGSLPSRIDLSLPNVETLN 259
I L L L L N + + P + N+ L + + N ++ S + +L N+ L
Sbjct: 62 IEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITD--ISALQ-NLTNLRELY 116
Query: 260 LGINSFSGTIPSSITNSSKLSDLELGENLFSGFIPNTIGNLRNLEFGNIADNYLTSSTPE 319
L ++ S S + N +K+ L LG N + + N+ L + + ++ +
Sbjct: 117 LNEDNISD--ISPLANLTKMYSLNLGANHNLSDLSP-LSNMTGLNYLTVTESKVKD---- 169
Query: 320 LSFLSSLTNCKKLKVLIVTGNPLDGILPKSIGNFSLSLETILMANCSISGNIPQVVGNLS 379
++ + N L L + N ++ I P + +L+
Sbjct: 170 ---VTPIANLTDLYSLSLNYNQIEDISP---------------------------LASLT 199
Query: 380 NLLVLELGGNNLTGPIPVTFSQLQTLQAFDLTRNKLAGPITDELCHLARLHSLVLQGNKF 439
+L N +T P + + L + + NK+ L +L++L L + N+
Sbjct: 200 SLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITD--LSPLANLSQLTWLEIGTNQI 255
Query: 440 SGSIPSCLGNLTSVRVLYLGLNIFTSVLSSTIWNLKDILFIDVSSNFLDGPLSLDIGNLK 499
S + + +LT +++L +G N + + S + NL + + +++N L IG L
Sbjct: 256 SD--INAVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLT 311
Query: 500 VVIGLDFSRNNLSGDIPIT 518
+ L S+N+++ P+
Sbjct: 312 NLTTLFLSQNHITDIRPLA 330
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 53.7 bits (130), Expect = 1e-07
Identities = 17/68 (25%), Positives = 30/68 (44%), Gaps = 2/68 (2%)
Query: 70 PQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLDFSDNQLFGSLSSFIFNMSSMTTI 129
L NLS L +L L++N+L I + L L S N + + + ++S M +
Sbjct: 281 SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHI--TDIRPLASLSKMDSA 338
Query: 130 DLSINRLS 137
D + +
Sbjct: 339 DFANQVIK 346
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 1e-40
Identities = 65/220 (29%), Positives = 93/220 (42%), Gaps = 73/220 (33%)
Query: 615 IRRFSYHELLRATDRFSENNLIGIG-----------NGMEVAVKVF----HQQYERALKS 659
++RFS EL A+D FS N++G G +G VAVK Q E
Sbjct: 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQ--- 73
Query: 660 FEDECEVRKRIRHRNLV------------------------------------------- 676
F+ E E+ HRNL+
Sbjct: 74 FQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKR 133
Query: 677 -KIISSS---LEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQ-LSK 731
+I S L YLH IIH D+K +N+LLDE+ A + DFG+AKL+ +D ++
Sbjct: 134 QRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT- 192
Query: 732 QTQTLATIGYMAPEYGTKGRVSTRGDVCSFG-----IISG 766
T TIG++APEY + G+ S + DV +G +I+G
Sbjct: 193 -TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITG 231
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 2e-39
Identities = 82/456 (17%), Positives = 165/456 (36%), Gaps = 36/456 (7%)
Query: 76 SSLQTLDLSHNKLSGNIPSSIFNMHTLKLLDFSDNQLFGSLSSFIF-NMSSMTTIDLSIN 134
S + LDLS N L S F+ L++LD S ++ ++ + ++S ++T+ L+ N
Sbjct: 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEI-QTIEDGAYQSLSHLSTLILTGN 86
Query: 135 RLSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKEIGNLTKLKEIISTITNSTVC 194
+ L S L++L NL+ IG+L LKE+
Sbjct: 87 PIQ-SLA------LGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSF 139
Query: 195 EIPREIGNLPYLARLALATNNLVGVVPVTIFNMSALK----EISLLNNSLSGSLPSRIDL 250
++P NL L L L++N + + + + + + L N ++ +
Sbjct: 140 KLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGA-F 197
Query: 251 SLPNVETLNLGINSFSGTIPSSITN---SSKLSDLELGE----NLFSGFIPNTIGNLRNL 303
+ L L N S + + ++ L LGE F + + L NL
Sbjct: 198 KEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNL 257
Query: 304 EFGNIADNYLTSSTPELSFLSSLTNCKKLKVLIVTGNPLDGILPKSIGNFSLSLETILMA 363
YL ++ L + + + ++ + S ++ + + +
Sbjct: 258 TIEEFRLAYLDYYLDDIIDLFN--CLTNVSSFSLVSVTIERVKDFS---YNFGWQHLELV 312
Query: 364 NCSISGNIPQVVGNLSNLLVLELGGNNLTGPIPVTFSQLQTLQAFDLTRNKLA--GPITD 421
NC P + L +L L N + L +L+ DL+RN L+ G +
Sbjct: 313 NCKFG-QFPTL--KLKSLKRLTFTSNKGGNAF--SEVDLPSLEFLDLSRNGLSFKGCCSQ 367
Query: 422 ELCHLARLHSLVLQGNKFSGSIPSCLGNLTSVRVLYLGLNIFTSVLSSTIW-NLKDILFI 480
L L L N ++ S L + L + + +++ +L++++++
Sbjct: 368 SDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYL 426
Query: 481 DVSSNFLDGPLSLDIGNLKVVIGLDFSRNNLSGDIP 516
D+S + L + L + N+ +
Sbjct: 427 DISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFL 462
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 8e-39
Identities = 95/496 (19%), Positives = 177/496 (35%), Gaps = 61/496 (12%)
Query: 57 LNISSFNLQGTITPQLGNLSSLQTLDLSHNKLSGNIPSSIF-NMHTLKLLDFSDNQLFGS 115
L++S L+ + + LQ LDLS ++ I + ++ L L + N + S
Sbjct: 33 LDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPI-QS 90
Query: 116 LSSFIF-NMSSMTTIDLSINRLSGELPANICKIPSTLSKCKQLEELNLGFNNL-SGAIPK 173
L+ F +SS+ + L+ + K L+ELN+ N + S +P+
Sbjct: 91 LALGAFSGLSSLQKLVAVETNLASL-------ENFPIGHLKTLKELNVAHNLIQSFKLPE 143
Query: 174 EIGNLTKLKEI------ISTITNSTVCEIPREIGNLPYL-ARLALATNNLVGVVPVTIFN 226
NLT L+ + I +I + + + +P L L L+ N + + F
Sbjct: 144 YFSNLTNLEHLDLSSNKIQSIYCTDLRVLH----QMPLLNLSLDLSLNPM-NFIQPGAFK 198
Query: 227 MSALKEISLLNNSLSGSLPSRIDLSLPNVETLNLGINSFSGTI------PSSITNSSKLS 280
L +++L NN S ++ L +E L + F S++ L+
Sbjct: 199 EIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLT 258
Query: 281 DLEL---GENLFSGFIPNTIGNLRNLEFGNIADNYLTSSTPELSFLSSLT---------- 327
E + + I + L N+ ++ + + S+
Sbjct: 259 IEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSYNFGWQHLELVNCKFG 317
Query: 328 -----NCKKLKVLIVTGNPLDGILPKSIGNFS--LSLETILMANCSIS--GNIPQVVGNL 378
K LK L T N + + SLE + ++ +S G Q
Sbjct: 318 QFPTLKLKSLKRLTFTSNKG-----GNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGT 372
Query: 379 SNLLVLELGGNNLTGPIPVTFSQLQTLQAFDLTRNKLAG-PITDELCHLARLHSLVLQGN 437
++L L+L N + + F L+ L+ D + L L L L +
Sbjct: 373 TSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHT 431
Query: 438 KFSGSIPSCLGNLTSVRVLYLGLNIFTSVLSSTIW-NLKDILFIDVSSNFLDGPLSLDIG 496
+ L+S+ VL + N F I+ L+++ F+D+S L+
Sbjct: 432 HTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFN 491
Query: 497 NLKVVIGLDFSRNNLS 512
+L + L+ + N L
Sbjct: 492 SLSSLQVLNMASNQLK 507
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 1e-35
Identities = 83/449 (18%), Positives = 163/449 (36%), Gaps = 45/449 (10%)
Query: 57 LNISSFNLQGTITPQLGNLSSLQTLDLSHNKL-SGNIPSSIFNMHTLKLLDFSDNQLFGS 115
L NL +G+L +L+ L+++HN + S +P N+ L+ LD S N++
Sbjct: 105 LVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSI 164
Query: 116 LSSFIFNMSSMT----TIDLSINRLSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAI 171
+ + + M ++DLS+N ++ I K +L +L L N S +
Sbjct: 165 YCTDLRVLHQMPLLNLSLDLSLNPMN--------FIQPGAFKEIRLHKLTLRNNFDSLNV 216
Query: 172 PKE-IGNLTKLKEI------------ISTITNSTVCEIPREIGNLPYLARLALATNNLVG 218
K I L L+ + S + + LA L ++++
Sbjct: 217 MKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIID 276
Query: 219 VVPVTIFNMSALKEISLLNNSLSGSLPSRIDLSLPNVETLNLGINSFSGTIPSSITNSSK 278
+ ++ + SL++ ++ + ++E +N F S
Sbjct: 277 L----FNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKS------ 326
Query: 279 LSDLELGENLFSGFIPNTIGNLRNLEFGNIADNYLTSSTPELSFLSSLTNCKKLKVLIVT 338
L L N +L +LEF +++ N L+ T+ LK L ++
Sbjct: 327 LKRLTFTSNKGGNAFSEV--DLPSLEFLDLSRNGLSFKGCCSQSDFGTTS---LKYLDLS 381
Query: 339 GNPLDGILPKSIGNFSLSLETILMANCSISGNIPQVV-GNLSNLLVLELGGNNLTGPIPV 397
N + + + LE + + ++ V +L NL+ L++ +
Sbjct: 382 FNGVITM-SSNFLGLE-QLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNG 439
Query: 398 TFSQLQTLQAFDLTRNKLAGPITDE-LCHLARLHSLVLQGNKFSGSIPSCLGNLTSVRVL 456
F+ L +L+ + N + L L L L + P+ +L+S++VL
Sbjct: 440 IFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVL 499
Query: 457 YLGLNIFTSVLSSTIWNLKDILFIDVSSN 485
+ N SV L + I + +N
Sbjct: 500 NMASNQLKSVPDGIFDRLTSLQKIWLHTN 528
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 4e-29
Identities = 68/367 (18%), Positives = 129/367 (35%), Gaps = 26/367 (7%)
Query: 57 LNISSFNLQGTITPQLGNLSSLQTLDLSHNKLSGNIPSSIFN------MHTLKLLDFSDN 110
L++S + I P L L L +N S N+ + +H L L +F +
Sbjct: 182 LDLSLNPMN-FIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNE 240
Query: 111 QLFGSLSSFIFNMSSMTTIDLSINRLSGELPANICKIPSTLSKCKQLEELNLGFNNLSGA 170
+ + + RL+ L + I + + +L +
Sbjct: 241 GNLEKFDKSALE--GLCNLTIEEFRLAY-LDYYLDDIIDLFNCLTNVSSFSLVSVTIER- 296
Query: 171 IPKEIGNLTKLKEIISTITNSTVCEIPREIGNLPYLARLALATNNLVGVVPVTIFNMSAL 230
+ N + + + N + P L L RL +N + ++ +L
Sbjct: 297 VKDFSYN-FGWQHL--ELVNCKFGQFPT--LKLKSLKRLTFTSNKGGNAF--SEVDLPSL 349
Query: 231 KEISLLNNSLSG-SLPSRIDLSLPNVETLNLGINSFSGTIPSSITNSSKLSDLELGENLF 289
+ + L N LS S+ D +++ L+L N T+ S+ +L L+ +
Sbjct: 350 EFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNL 408
Query: 290 SGFIPNTI-GNLRNLEFGNIADNYLTSSTPELSFLSSLTNCKKLKVLIVTGNPLDGILPK 348
++ +LRNL + +I+ + + + L+VL + GN
Sbjct: 409 KQMSEFSVFLSLRNLIYLDISHTHTRVAFNGI-----FNGLSSLEVLKMAGNSFQENFLP 463
Query: 349 SIGNFSLSLETILMANCSISGNIPQVVGNLSNLLVLELGGNNLTGPIPVTFSQLQTLQAF 408
I +L + ++ C + P +LS+L VL + N L F +L +LQ
Sbjct: 464 DIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKI 523
Query: 409 DLTRNKL 415
L N
Sbjct: 524 WLHTNPW 530
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 1e-21
Identities = 53/294 (18%), Positives = 103/294 (35%), Gaps = 31/294 (10%)
Query: 57 LNISSFNLQGTITPQL-GNLSSLQTLDLSHNKLSGNIPSSIF--NMHTLKLLDFSDNQLF 113
++ + L L+++ + L + + + L+L++ Q
Sbjct: 262 FRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSYNFGWQHLELVNCKFGQFP 320
Query: 114 GSLSSFIFNMSSMTTIDLSINRLSGELPANICKIPSTLSKCKQLEELNLGFNNLS--GAI 171
+ S+ + + N+ + LE L+L N LS G
Sbjct: 321 T------LKLKSLKRLTFTSNKGGN---------AFSEVDLPSLEFLDLSRNGLSFKGCC 365
Query: 172 PKEIGNLTKLKEIISTITNSTVCEIPREIGNLPYLARLALATNNLVGVVPVTIF-NMSAL 230
+ T LK + ++ + V + L L L +NL + ++F ++ L
Sbjct: 366 SQSDFGTTSLKYL--DLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNL 423
Query: 231 KEISLLNNSLSGSLPSRIDLSLPNVETLNLGINSFSGTIPSSI-TNSSKLSDLELGENLF 289
+ + + + I L ++E L + NSF I T L+ L+L +
Sbjct: 424 IYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQL 482
Query: 290 SGFIPNTIGNLRNLEFGNIADNYLTSSTPELSFLSSLTNCKKLKVLIVTGNPLD 343
P +L +L+ N+A N L S LT+ L+ + + NP D
Sbjct: 483 EQLSPTAFNSLSSLQVLNMASNQLKS--VPDGIFDRLTS---LQKIWLHTNPWD 531
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 95.6 bits (238), Expect = 1e-20
Identities = 53/278 (19%), Positives = 101/278 (36%), Gaps = 23/278 (8%)
Query: 63 NLQGTITPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLDFSDNQLFGSLSSFIFN 122
++ Q L+L + K P+ + +LK L F+ N+ G+ S + +
Sbjct: 291 SVTIERVKDFSYNFGWQHLELVNCKFG-QFPT--LKLKSLKRLTFTSNKG-GNAFSEV-D 345
Query: 123 MSSMTTIDLSINRLSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKEIGNLTKLK 182
+ S+ +DLS N LS + L+ L+L FN + + L +L+
Sbjct: 346 LPSLEFLDLSRNGLS-----FKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLE 399
Query: 183 EI------ISTITNSTVCEIPREIGNLPYLARLALATNNLVGVVPVTIFNMSALKEISLL 236
+ + ++ +V +L L L ++ + +S+L+ + +
Sbjct: 400 HLDFQHSNLKQMSEFSV------FLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMA 453
Query: 237 NNSLSGSLPSRIDLSLPNVETLNLGINSFSGTIPSSITNSSKLSDLELGENLFSGFIPNT 296
NS + I L N+ L+L P++ + S L L + N
Sbjct: 454 GNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGI 513
Query: 297 IGNLRNLEFGNIADNYLTSSTPELSFLSSLTNCKKLKV 334
L +L+ + N S P + +LS N K
Sbjct: 514 FDRLTSLQKIWLHTNPWDCSCPRIDYLSRWLNKNSQKE 551
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 92.9 bits (231), Expect = 9e-20
Identities = 55/291 (18%), Positives = 97/291 (33%), Gaps = 26/291 (8%)
Query: 237 NNSLSGSLPSRIDLSLPNVETLNLGINSFSGTIPSSITNSSKLSDLELGENLFSGFIPNT 296
+ +P + + + L+L N S + +L L+L
Sbjct: 16 ELNFY-KIPDNL---PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGA 71
Query: 297 IGNLRNLEFGNIADNYLTSSTPELSFLSSLTNCKKLKVLIVTGNPLDGILPKSIGNFSLS 356
+L +L + N + S + L+ L+ L + IG+ +
Sbjct: 72 YQSLSHLSTLILTGNPIQSLALGA-----FSGLSSLQKLVAVETNLASLENFPIGHLK-T 125
Query: 357 LETILMANCSI-SGNIPQVVGNLSNLLVLELGGNNLTGPIPVTFSQLQTLQAF----DLT 411
L+ + +A+ I S +P+ NL+NL L+L N + L + DL+
Sbjct: 126 LKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLS 185
Query: 412 RNKLAGPITDELCHLARLHSLVLQGNKFSGSIPS-CLGNLTSVRVLYLGLNIF------T 464
N + I RLH L L+ N S ++ C+ L + V L L F
Sbjct: 186 LNPMNF-IQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLE 244
Query: 465 SVLSSTIWNLKDILFIDVSSNFLDGPLSLDIG---NLKVVIGLDFSRNNLS 512
S + L ++ + +LD L I L V +
Sbjct: 245 KFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE 295
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 6e-19
Identities = 40/221 (18%), Positives = 82/221 (37%), Gaps = 36/221 (16%)
Query: 53 RVIGLNISSFNLQGTITPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLDFSDNQL 112
+ L+ + + +G + +SL+ LDLS N + + S+ + L+ LDF + L
Sbjct: 350 EFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNL 408
Query: 113 FGSLSSFIF-NMSSMTTIDLSINRLSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAI 171
+F ++ ++ +D+S + LE L + N+
Sbjct: 409 KQMSEFSVFLSLRNLIYLDISHTHTR-VAF------NGIFNGLSSLEVLKMAGNSFQENF 461
Query: 172 PKEI-GNLTKLKEIISTITNSTVCEIPREIGNLPYLARLALATNNLVGVVPVTIFNMSAL 230
+I L L L L+ L + P ++S+L
Sbjct: 462 LPDIFTELRNLTF-------------------------LDLSQCQLEQLSPTAFNSLSSL 496
Query: 231 KEISLLNNSLSGSLPSRIDLSLPNVETLNLGINSFSGTIPS 271
+ +++ +N L S+P I L +++ + L N + + P
Sbjct: 497 QVLNMASNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCSCPR 536
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 4e-39
Identities = 96/482 (19%), Positives = 167/482 (34%), Gaps = 48/482 (9%)
Query: 73 GNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLDFSDNQLFGSLSSFIF-NMSSMTTIDL 131
G +++++LDLS NK++ + L++L +++ ++ F ++ S+ +DL
Sbjct: 23 GLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRI-NTIEGDAFYSLGSLEHLDL 81
Query: 132 SINRLSGELPANICKIPSTLSKCKQLEELNLGFNNLSG-AIPKEIGNLTKLKEIISTITN 190
S N LS L S L+ LNL N + NLT L+ +
Sbjct: 82 SDNHLS-SLS------SSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVE 134
Query: 191 STVCEIPREIGNLPYLARLALATNNLVGVVPVTIFNMSALKEISLLNNSLSGSLPSRIDL 250
+ + L L L + +L ++ ++ + ++L + + L
Sbjct: 135 TFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESA-FLLEIFAD 193
Query: 251 SLPNVETLNLGINSFSGTIPSSITNSSKLSDLELGENLFSGF----------IPNTIGNL 300
L +V L L + + S + S ++ S + I L
Sbjct: 194 ILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILEL 253
Query: 301 RNLEFGNIADNYLTSSTP-ELSFLSSLTN--CKKLKVLIVTGNPLDGILPKSIGNFSLSL 357
+EF + N L P E +S L ++ L + L L +
Sbjct: 254 SEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLE-KV 312
Query: 358 ETILMANCSISGNIPQVVGNLSNLLVLELGGNNLTGPIPVT---FSQLQTLQAFDLTRNK 414
+ I + N + +L +L L+L N + +LQ L++N
Sbjct: 313 KRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNH 372
Query: 415 LA--GPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSVRVLYLGLNIFTSVLSSTIW 472
L + L L L SL + N F +P +R L L V +
Sbjct: 373 LRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIRVVKTCIPQ 431
Query: 473 NLKDILFIDVSSNFLDGPLSLDIGNLKVVIGLDFSRNNLSGDIPITIGEGEIPRGGPFAN 532
L+ +DVS+N LD SL + L+ L SRN L +P F
Sbjct: 432 TLE---VLDVSNNNLDS-FSLFLPRLQE---LYISRNKLK----------TLPDASLFPV 474
Query: 533 LT 534
L
Sbjct: 475 LL 476
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 4e-33
Identities = 75/457 (16%), Positives = 150/457 (32%), Gaps = 54/457 (11%)
Query: 74 NLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLDFSDNQLFGSLSSFIFNMSSMTTIDLSI 133
+ + D + +IPS + +K LD S N++ + +++ + L
Sbjct: 3 SCDASGVCDGRSRSFT-SIPSGLTA--AMKSLDLSFNKITYIGHGDLRACANLQVLILKS 59
Query: 134 NRLSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKEIGNLTKLKEIISTITNSTV 193
+R++ + LE L+L N+LS G L+ LK
Sbjct: 60 SRIN-TIE------GDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKY---------- 102
Query: 194 CEIPREIGNLPYLARLALATNNLVGVVPVTIF-NMSALKEISLLNNSLSGSLPSRIDLSL 252
L L N + ++F N++ L+ + + N + L
Sbjct: 103 ---------------LNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGL 147
Query: 253 PNVETLNLGINSFSGTIPSSITNSSKLSDLELGENLFSGFIPNTIGNLRNLEFGNIADNY 312
++ L + S S+ + + L L + + + L ++ + + D
Sbjct: 148 TSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTN 207
Query: 313 LTSSTPE-LSFLSSLTNCKKLKVLIVTGNPLDGILPKSIGNFSLSLETILMANCSISG-- 369
L L + KKL + + L L + +C+++G
Sbjct: 208 LARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLG 267
Query: 370 ----NIPQVVGNLS-----NLLVLELGGNNLTGPIPVTFSQLQTLQAFDLTRNKLAGPIT 420
+ VV L + L + L + +S L+ ++ + +K+
Sbjct: 268 DFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPC 327
Query: 421 DELCHLARLHSLVLQGNKFSGSI---PSCLGNLTSVRVLYLGLNIFTSV--LSSTIWNLK 475
HL L L L N +C G S++ L L N S+ + LK
Sbjct: 328 SFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLK 387
Query: 476 DILFIDVSSNFLDGPLSLDIGNLKVVIGLDFSRNNLS 512
++ +D+S N P+ + + L+ S +
Sbjct: 388 NLTSLDISRNTF-HPMPDSCQWPEKMRFLNLSSTGIR 423
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 2e-29
Identities = 67/432 (15%), Positives = 140/432 (32%), Gaps = 55/432 (12%)
Query: 57 LNISSFNLQGTITPQ-LGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLDFSDNQLFGS 115
L I + I L+SL L++ L S+ ++ + L ++
Sbjct: 128 LRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFL 187
Query: 116 LSSFIFNMSSMTTIDLSINRLSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKEI 175
L F +SS+ ++L L+ + + S K+L + S
Sbjct: 188 LEIFADILSSVRYLELRDTNLA-RFQFSPLPVDEVSSPMKKLAFRGSVLTDES------- 239
Query: 176 GNLTKLKEIISTITNSTVCEIPREIGNLPYLARLALATNNLVGVVPVTIFNMSALKEISL 235
L L R L + + F+ L +
Sbjct: 240 ------------------------FNELLKLLRYILELSEVE-------FDDCTLNGLGD 268
Query: 236 LNNSLSGSLPSRIDLSLPNVETLNLGINSFSGTIPSSITNSSKLSDLELGENLFSGFIPN 295
N S S + + + L++ + + + K+ + + + +
Sbjct: 269 FNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCS 328
Query: 296 TIGNLRNLEFGNIADNYLTSSTPELSFLSSLTNCKKLKVLIVTGNPLDGILPKSIGNFS- 354
+L++LEF ++++N + + S + L+ L+++ N L + K+
Sbjct: 329 FSQHLKSLEFLDLSENLMVEEYLKNS--ACKGAWPSLQTLVLSQNHLR-SMQKTGEILLT 385
Query: 355 -LSLETILMANCSISGNIPQVVGNLSNLLVLELGGNNLTGPIPVTFSQLQTLQAFDLTRN 413
+L ++ ++ + +P + L L + V QTL+ D++ N
Sbjct: 386 LKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIRV---VKTCIPQTLEVLDVSNN 441
Query: 414 KLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSVRVLYLGLNIFTSVLSSTIWN 473
L L RL L + NK ++P + V+ + N SV
Sbjct: 442 NL----DSFSLFLPRLQELYISRNKLK-TLPDA-SLFPVLLVMKISRNQLKSVPDGIFDR 495
Query: 474 LKDILFIDVSSN 485
L + I + +N
Sbjct: 496 LTSLQKIWLHTN 507
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 97.5 bits (243), Expect = 3e-21
Identities = 51/264 (19%), Positives = 101/264 (38%), Gaps = 20/264 (7%)
Query: 74 NLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLDFSDNQLFGSLSSFIFNMSSMTTIDLSI 133
+++ L + L ++ + + +K + ++++F SF ++ S+ +DLS
Sbjct: 284 ETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSE 343
Query: 134 NRLSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKEIG---NLTKLKEIISTITN 190
N + E N + L+ L L N+L ++ K L L + I+
Sbjct: 344 NLMVEEYLKN----SACKGAWPSLQTLVLSQNHLR-SMQKTGEILLTLKNLTSLD--ISR 396
Query: 191 STVCEIPREIGNLPYLARLALATNNLVGVVPVTIFNMSALKEISLLNNSLSGSLPSRIDL 250
+T +P + L L++ + VV I L+ + + NN+L L
Sbjct: 397 NTFHPMPDSCQWPEKMRFLNLSSTGIR-VVKTCIP--QTLEVLDVSNNNL-----DSFSL 448
Query: 251 SLPNVETLNLGINSFSGTIPSSITNSSKLSDLELGENLFSGFIPNTIGNLRNLEFGNIAD 310
LP ++ L + N T+P + + L +++ N L +L+ +
Sbjct: 449 FLPRLQELYISRNKLK-TLPDA-SLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHT 506
Query: 311 NYLTSSTPELSFLSSLTNCKKLKV 334
N S P + +LS N K
Sbjct: 507 NPWDCSCPRIDYLSRWLNKNSQKE 530
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 1e-18
Identities = 52/291 (17%), Positives = 110/291 (37%), Gaps = 23/291 (7%)
Query: 237 NNSLSGSLPSRIDLSLPNVETLNLGINSFSGTIPSSITNSSKLSDLELGENLFSGFIPNT 296
+ S + S+PS + +++L+L N + + + L L L + + +
Sbjct: 14 SRSFT-SIPSGL---TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDA 69
Query: 297 IGNLRNLEFGNIADNYLTSSTPELSFLSSLTNCKKLKVLIVTGNPLDGILPKSIGNFSLS 356
+L +LE +++DN+L+S + LK L + GNP + S+ +
Sbjct: 70 FYSLGSLEHLDLSDNHLSSLSSSW-----FGPLSSLKYLNLMGNPYQTLGVTSLFPNLTN 124
Query: 357 LETILMANCSISGNIPQVV-GNLSNLLVLELGGNNLTGPIPVTFSQLQTLQAFDLTRNKL 415
L+T+ + N I ++ L++L LE+ +L + ++ + L ++
Sbjct: 125 LQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSES 184
Query: 416 AGPITDELCHLARLHSLVLQGNK---FSGSIPSCLGNLTSVRVLYLGLNIFTSV------ 466
A + L+ + L L+ F S + ++ L ++ T
Sbjct: 185 AFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELL 244
Query: 467 -LSSTIWNLKDILFIDVSSN---FLDGPLSLDIGNLKVVIGLDFSRNNLSG 513
L I L ++ F D + N + S + L V + R ++
Sbjct: 245 KLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQ 295
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 87.5 bits (217), Expect = 5e-18
Identities = 51/311 (16%), Positives = 103/311 (33%), Gaps = 45/311 (14%)
Query: 50 NSHRVIGLNISSFNLQGTITPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMH--------T 101
+ R L SFN + + LS ++ D + N L PS + T
Sbjct: 228 LAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVT 287
Query: 102 LKLLDFSDNQLFGSLSSFIFNMSSMTTIDLSINRLSGELPANICKIPSTLSKCKQLEELN 161
++ L LF LS+ + + I + +++ +P + K LE L+
Sbjct: 288 IRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVF-LVPCSFS------QHLKSLEFLD 340
Query: 162 LGFNNLSGAIPKE---IGNLTKLKEI------ISTITNSTVCEIPREIGNLPYLARLALA 212
L N + K G L+ + + ++ + + L L L ++
Sbjct: 341 LSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKT-----GEILLTLKNLTSLDIS 395
Query: 213 TNNLVGVVPVTIFNMSALKEISLLNNSLSGSLPSRIDLSLPNVETLNLGINSFSGTIPSS 272
N +P + ++ ++L + + + + I +E L++ N+ +
Sbjct: 396 RNTF-HPMPDSCQWPEKMRFLNLSSTGIR-VVKTCI---PQTLEVLDVSNNNLD-SFSLF 449
Query: 273 ITNSSKLSDLELGENLFSGFIPNTIGNLRNLEFGNIADNYLTSSTPELSFLSSLTNCKKL 332
+ L +L + N + L I+ N L S L
Sbjct: 450 LPR---LQELYISRNKLKTLPDAS--LFPVLLVMKISRNQLKSVPD-----GIFDRLTSL 499
Query: 333 KVLIVTGNPLD 343
+ + + NP D
Sbjct: 500 QKIWLHTNPWD 510
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 6e-39
Identities = 62/227 (27%), Positives = 92/227 (40%), Gaps = 60/227 (26%)
Query: 600 SRTGPSNDGINSPQAIRRFSYHELLRATDRFSENNLIGIG-----------NGMEVAVKV 648
S + P R +L AT+ F LIG G +G +VA+K
Sbjct: 11 SINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKR 70
Query: 649 FHQQYERALKSFEDECEVRKRIRHRNLVKII-----------------SSSLEY------ 685
+ + ++ FE E E RH +LV +I + +L+
Sbjct: 71 RTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSD 130
Query: 686 ---------------------LHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLS 724
LH+ H+ IIH D+K N+LLDE+ V I+DFGI+K +
Sbjct: 131 LPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGT 190
Query: 725 GEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFG-----IISG 766
DQ T T+GY+ PEY KGR++ + DV SFG ++
Sbjct: 191 ELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCA 237
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 1e-38
Identities = 87/497 (17%), Positives = 165/497 (33%), Gaps = 83/497 (16%)
Query: 74 NLSSLQTLDLSHNKLSGNIPSSIF-NMHTLKLLDFSDNQLFGSLSSFIF-NMSSMTTIDL 131
L++ + L LS N + + +S F + L+LL+ ++ F N+ ++ +DL
Sbjct: 22 VLNTTERLLLSFNYIR-TVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDL 80
Query: 132 SINRLSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAI--PKEIGNLTKLKEI----- 184
+++ L P L EL L F LS A+ NL L +
Sbjct: 81 GSSKIY-FLH------PDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKN 133
Query: 185 -ISTITNSTVCEIPREIGNLPYLARLALATNNLVGVVPVTI--FNMSALKEISLLNNSLS 241
I ++ + G L L + ++N + V + L SL NSL
Sbjct: 134 QIRSL------YLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLY 187
Query: 242 GSLPSRIDLSLPNVETLNLGI-----------------NSFSGTIPSSITNSSKLSDLEL 284
+ + + L I N+ S + S+ + +
Sbjct: 188 SRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGF 247
Query: 285 GENLFSGFIPNTIGNLR--NLEFGNIADNYLTSSTPELSFLSSLTNCKKLKVLIVTGNPL 342
G + NT L ++ +++ ++ S K LKVL + N +
Sbjct: 248 GFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNS-----RVFETLKDLKVLNLAYNKI 302
Query: 343 DGILPKSIGNFSLSLETILMANCSISGNIPQVVGNLSNLLVLELGGNNLTGPIPVTFSQL 402
+ I ++ +L+ + ++ + L + ++L N++ TF L
Sbjct: 303 NKIADEAFYGLD-NLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFL 361
Query: 403 QTLQAFDLTRNKLAGPITDELCHLARLHSLVLQGNKFSG--------------------- 441
+ LQ DL N L + + + + L GNK
Sbjct: 362 EKLQTLDLRDNALT-----TIHFIPSIPDIFLSGNKLVTLPKINLTANLIHLSENRLENL 416
Query: 442 SIPSCLGNLTSVRVLYLGLNIFTSVLSS-TIWNLKDILFIDVSSNFLDGPLSLDI----- 495
I L + +++L L N F+S T + + + N L ++
Sbjct: 417 DILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVF 476
Query: 496 GNLKVVIGLDFSRNNLS 512
L + L + N L+
Sbjct: 477 EGLSHLQVLYLNHNYLN 493
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 3e-37
Identities = 98/511 (19%), Positives = 183/511 (35%), Gaps = 73/511 (14%)
Query: 57 LNISSFNLQGTITPQ--LGNLSSLQTLDLSHNKLSGNIPSSIF-NMHTLKLLDFSDNQLF 113
L + L + NL +L LDLS N++ F +++LK +DFS NQ+F
Sbjct: 102 LRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIF 161
Query: 114 GSLSSFIFN---MSSMTTIDLSINRLSGELPANICKIPSTLSKCKQLEELNLGFNNLSGA 170
+ +++ L+ N L + + K + + LE L++ N +
Sbjct: 162 -LVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPF-RNMVLEILDVSGNGWTVD 219
Query: 171 IPKEIGNLTKLKEIISTITNSTVCEIPREIGNL-------------PYLARLALATNNLV 217
I N + S I + N+ + L L+ +
Sbjct: 220 ITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVF 279
Query: 218 GVVPVTIFNMSALKEISLLNNSLSGSLPSRIDLSLPNVETLNLGINSFSGTIPSSITNSS 277
+ + LK ++L N ++ + L N++ LNL N S+
Sbjct: 280 SLNSRVFETLKDLKVLNLAYNKIN-KIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLP 338
Query: 278 KLSDLELGENLFSGFIPNTIGNLRNLEFGNIADNYLTSSTPELSFLSSLTNCKKLKVLIV 337
K++ ++L +N + T L L+ ++ DN LT+ + + + +
Sbjct: 339 KVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTT----------IHFIPSIPDIFL 388
Query: 338 TGNPLDGILPKSIGNFSLSLETILMANCSISG-NIPQVVGNLSNLLVLELGGNNLTG-PI 395
+GN L ++ +L+ I ++ + +I + + +L +L L N +
Sbjct: 389 SGNKL-----VTLPKINLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSG 443
Query: 396 PVTFSQLQTLQAFDLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSVRV 455
T S+ +L+ L N L ELC L+ ++V
Sbjct: 444 DQTPSENPSLEQLFLGENMLQLAWETELC-------------------WDVFEGLSHLQV 484
Query: 456 LYLGLNIFTSVLSSTIWNLKDILFIDVSSNFLDG-PLSLDIGNLKVVIGLDFSRNNLSGD 514
LYL N S+ +L + + ++SN L + NL++ LD SRN L
Sbjct: 485 LYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLPANLEI---LDISRNQLL-- 539
Query: 515 IPITIGEGEIPRGGPFANLTAKSFMGNELLC 545
P F +L+ N+ +C
Sbjct: 540 ---------APNPDVFVSLSVLDITHNKFIC 561
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 4e-26
Identities = 85/479 (17%), Positives = 170/479 (35%), Gaps = 53/479 (11%)
Query: 2 LLKSIISQHQQALLALKAHISYDHTNLFARNWTSSTSVCIWIGITCDVNSHRVIGLNISS 61
+ + + L + D T F+ + S + +H ++G
Sbjct: 197 CMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQ-------AFSLILAHHIMGAGFGF 249
Query: 62 FNLQGTITPQLGNL--SSLQTLDLSHNKLSGNIPSSIF-NMHTLKLLDFSDNQLFGSLSS 118
N++ L SS++ LDLSH + ++ S +F + LK+L+ + N++
Sbjct: 250 HNIKDPDQNTFAGLARSSVRHLDLSHGFVF-SLNSRVFETLKDLKVLNLAYNKINKIADE 308
Query: 119 FIFNMSSMTTIDLSINRLSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKEIGNL 178
+ + ++ ++LS N L EL ++ ++ ++L N+++ + L
Sbjct: 309 AFYGLDNLQVLNLSYNLLG-ELYSS------NFYGLPKVAYIDLQKNHIAIIQDQTFKFL 361
Query: 179 TKLKEIISTITNSTVCEIPREIGNLPYLARLALATNNLVGVVPVTIFNMSALKEISLLNN 238
KL+ + + + I +P + + L+ N LV + + + I L N
Sbjct: 362 EKLQTL-----DLRDNAL-TTIHFIPSIPDIFLSGNKLVTLPKINLT----ANLIHLSEN 411
Query: 239 SLSGSLPSRIDLSLPNVETLNLGINSFSGTIPSSI-TNSSKLSDLELGENLF-----SGF 292
L L +P+++ L L N FS + + L L LGEN+ +
Sbjct: 412 RLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETEL 471
Query: 293 IPNTIGNLRNLEFGNIADNYLTSSTPELSFLSSLTNCKKLKVLIVTGNPLDGILPKSIGN 352
+ L +L+ + NYL S P + ++ L+ L + N L + S +
Sbjct: 472 CWDVFEGLSHLQVLYLNHNYLNSLPPGV-----FSHLTALRGLSLNSNRLTVL---SHND 523
Query: 353 FSLSLETILMANCSISGNIPQVVGNLSNLLVLELGGNNLTGPIPVTFSQLQTLQAFDLTR 412
+LE + ++ + P V +L VL++ N L F
Sbjct: 524 LPANLEILDISRNQLLAPNPDV---FVSLSVLDITHNKFICECE--------LSTFINWL 572
Query: 413 NKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSVRVLYLGLNIFTSVLSSTI 471
N I + ++ G ++ L L I +V +
Sbjct: 573 NHTNVTIAGPPADIYCVYPDSFSGVSLFSLSTEGCDEEEVLKSLKFSLFIVCTVTLTLF 631
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 1e-35
Identities = 59/355 (16%), Positives = 114/355 (32%), Gaps = 38/355 (10%)
Query: 72 LGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLDFSDNQLFGSLSSFIFNMSSMTTIDL 131
+ S + L + + D + + N ++
Sbjct: 8 HHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQA----NSNNPQIETR 63
Query: 132 SINRLSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKEIGNLTKLKEIISTITNS 191
+ L + + L L L P + L+ L+ + TI +
Sbjct: 64 TGRALK-ATADLLED-----ATQPGRVALELRSVPLP-QFPDQAFRLSHLQHM--TIDAA 114
Query: 192 TVCEIPREIGNLPYLARLALATNNLVGVVPVTIFNMSALKEISLLNNSLSGSLPSRIDLS 251
+ E+P + L L LA N L +P +I +++ L+E+S+ LP +
Sbjct: 115 GLMELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPL--- 170
Query: 252 LPNVETLNLGINSFSGTIPSSITNSSKLSDLELGENLFSGFIPNTIGNLRNLEFGNIADN 311
S L L L +P +I NL+NL+ I ++
Sbjct: 171 -------------ASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNS 216
Query: 312 YLTSSTPELSFLSSLTNCKKLKVLIVTGNPLDGILPKSIGNFSLSLETILMANCSISGNI 371
L++ ++ + KL+ L + G P G + L+ +++ +CS +
Sbjct: 217 PLSA------LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRA-PLKRLILKDCSNLLTL 269
Query: 372 PQVVGNLSNLLVLELGGNNLTGPIPVTFSQLQTLQAFDLTRNKLAGPITDELCHL 426
P + L+ L L+L G +P +QL + + A
Sbjct: 270 PLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQHRPVAR 324
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 2e-33
Identities = 43/273 (15%), Positives = 92/273 (33%), Gaps = 21/273 (7%)
Query: 57 LNISSFNLQGTITPQLGNLSS--LQTLDLSHNKLSGNIPSSIFNMHTLKLLDFSDNQLFG 114
+ + L + + L+L L P F + L+ + L
Sbjct: 60 IETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGL-M 117
Query: 115 SLSSFIFNMSSMTTIDLSINRLSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKE 174
L + + + T+ L+ N L +P++++ +L EL++ +P+
Sbjct: 118 ELPDTMQQFAGLETLTLARNPLR--------ALPASIASLNRLRELSIRACPELTELPEP 169
Query: 175 IGNLTKLKEIIS-------TITNSTVCEIPREIGNLPYLARLALATNNLVGVVPVTIFNM 227
+ + E + + + +P I NL L L + + L + I ++
Sbjct: 170 LASTDASGEHQGLVNLQSLRLEWTGIRSLPASIANLQNLKSLKIRNSPLSAL-GPAIHHL 228
Query: 228 SALKEISLLNNSLSGSLPSRIDLSLPNVETLNLGINSFSGTIPSSITNSSKLSDLELGEN 287
L+E+ L + + P ++ L L S T+P I ++L L+L
Sbjct: 229 PKLEELDLRGCTALRNYPPIF-GGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGC 287
Query: 288 LFSGFIPNTIGNLRNLEFGNIADNYLTSSTPEL 320
+ +P+ I L + +
Sbjct: 288 VNLSRLPSLIAQLPANCIILVPPHLQAQLDQHR 320
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 4e-33
Identities = 53/344 (15%), Positives = 102/344 (29%), Gaps = 49/344 (14%)
Query: 154 CKQLEELNLGFNNLSGAIPKEIGNLTKLKEIISTITNSTVCEIPREIGNLPYLARLALAT 213
E L + + + + N
Sbjct: 11 SSGRENLYFQGSTALRPYHDVLSQWQRH-----YNADRNRWHSAWRQANS---------- 55
Query: 214 NNLVGVVPVTIFNMSALKEISLLNNSLSGSLPSRI-DLSLPNVETLNLGINSFSGTIPSS 272
+ + + +L + + D + P L L P
Sbjct: 56 --------------NNPQIETRTGRALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQ 99
Query: 273 ITNSSKLSDLELGENLFSGFIPNTIGNLRNLEFGNIADNYLTSSTPELSFLSSLTNCKKL 332
S L + + +P+T+ LE +A N L + +S+ + +L
Sbjct: 100 AFRLSHLQHMTIDAAGLME-LPDTMQQFAGLETLTLARNPLRA------LPASIASLNRL 152
Query: 333 KVLIVTGNPLDGILPKSIGNFSL--------SLETILMANCSISGNIPQVVGNLSNLLVL 384
+ L + P LP+ + + +L+++ + I ++P + NL NL L
Sbjct: 153 RELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSL 211
Query: 385 ELGGNNLTGPIPVTFSQLQTLQAFDLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIP 444
++ + L+ + L L+ DL A L L+L+ ++P
Sbjct: 212 KIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLP 270
Query: 445 SCLGNLTSVRVLYLGLNIFTSVLSSTIWNLKDILFIDVSSNFLD 488
+ LT + L L + S L S I L I V +
Sbjct: 271 LDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQA 314
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 6e-33
Identities = 49/337 (14%), Positives = 103/337 (30%), Gaps = 40/337 (11%)
Query: 57 LNISSFNLQGTITPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLDFSDNQLFGSL 116
L L D + + N + ++ + L +
Sbjct: 17 LYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQA----NSNNPQIETRTGRALKATA 72
Query: 117 SSF-IFNMSSMTTIDLSINRLSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKEI 175
++L L + P + L+ + + L +P +
Sbjct: 73 DLLEDATQPGRVALELRSVPLP--------QFPDQAFRLSHLQHMTIDAAGLM-ELPDTM 123
Query: 176 GNLTKLKEIISTITNSTVCEIPREIGNLPYLARLALATNNLVGVVPVTIFNMSALKEISL 235
L+ + T+ + + +P I +L L L++ + +P + + A E
Sbjct: 124 QQFAGLETL--TLARNPLRALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQ- 180
Query: 236 LNNSLSGSLPSRIDLSLPNVETLNLGINSFSGTIPSSITNSSKLSDLELGENLFSGFIPN 295
L N+++L L ++P+SI N L L++ + S +
Sbjct: 181 ---------------GLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGP 223
Query: 296 TIGNLRNLEFGNIADNYLTSSTPELSFLSSLTNCKKLKVLIVTGNPLDGILPKSIGNFSL 355
I +L LE ++ + P LK LI+ LP I +
Sbjct: 224 AIHHLPKLEELDLRGCTALRNYPP-----IFGGRAPLKRLILKDCSNLLTLPLDIHRLT- 277
Query: 356 SLETILMANCSISGNIPQVVGNLSNLLVLELGGNNLT 392
LE + + C +P ++ L ++ + +
Sbjct: 278 QLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQA 314
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 8e-33
Identities = 56/358 (15%), Positives = 114/358 (31%), Gaps = 42/358 (11%)
Query: 113 FGSLSSFIFNMSSMTTIDLSINRLSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAIP 172
GS + S + + + LS+ ++ + +
Sbjct: 1 MGSSHHHHHHSSGRENLYFQGST-------ALRPYHDVLSQWQRHYNADRNRWHS----A 49
Query: 173 KEIGNLTKLKEIISTITNSTVCEIPREIGNL--PYLARLALATNNLVGVVPVTIFNMSAL 230
N + T + + P L L + L P F +S L
Sbjct: 50 WRQANSNNPQIETRTGRALK--ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHL 106
Query: 231 KEISLLNNSLSGSLPSRIDLSLPNVETLNLGINSFSGTIPSSITNSSKLSDLELGENLFS 290
+ +++ L LP + +ETL L N +P+SI + ++L +L +
Sbjct: 107 QHMTIDAAGLM-ELPDTMQ-QFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPEL 163
Query: 291 GFIPNTIGNLRNLEFGNIADNYLTSSTPELSFLSSLTNCKKLKVLIVTGNPLDGILPKSI 350
+P + + L+ L + + LP SI
Sbjct: 164 TELPEPLAS--------------------TDASGEHQGLVNLQSLRLEWTGIRS-LPASI 202
Query: 351 GNFSLSLETILMANCSISGNIPQVVGNLSNLLVLELGGNNLTGPIPVTFSQLQTLQAFDL 410
N +L+++ + N +S + + +L L L+L G P F L+ L
Sbjct: 203 ANLQ-NLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLIL 260
Query: 411 TRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSVRVLYLGLNIFTSVLS 468
+ ++ L +L L L+G +PS + L + ++ + ++ +
Sbjct: 261 KDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQ 318
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 2e-21
Identities = 42/259 (16%), Positives = 84/259 (32%), Gaps = 25/259 (9%)
Query: 272 SITNSSKLSDLELGENLFSGFIPNTIGNLRNLEFGNIADNYLTSSTPELSFLSSLTNCKK 331
+SS +L + + + + + N
Sbjct: 7 HHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRN---------RWHSAWRQANSNN 57
Query: 332 LKVLIVTGNPLDGILPKSIGNFSL-SLETILMANCSISGNIPQVVGNLSNLLVLELGGNN 390
++ TG L + + + + + + + P LS+L + +
Sbjct: 58 PQIETRTGRAL-KATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAG 115
Query: 391 LTGPIPVTFSQLQTLQAFDLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGN- 449
L +P T Q L+ L RN L + + L RL L ++ +P L +
Sbjct: 116 LME-LPDTMQQFAGLETLTLARNPLRA-LPASIASLNRLRELSIRACPELTELPEPLAST 173
Query: 450 --------LTSVRVLYLGLNIFTSVLSSTIWNLKDILFIDVSSNFLDGPLSLDIGNLKVV 501
L +++ L L S L ++I NL+++ + + ++ L L I +L +
Sbjct: 174 DASGEHQGLVNLQSLRLEWTGIRS-LPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKL 231
Query: 502 IGLDFSRNNLSGDIPITIG 520
LD + P G
Sbjct: 232 EELDLRGCTALRNYPPIFG 250
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 63.0 bits (154), Expect = 1e-10
Identities = 22/181 (12%), Positives = 46/181 (25%), Gaps = 9/181 (4%)
Query: 356 SLETILMANCSISGNIPQVVGNLSNLLVLELGGNNLTGPIPVTFSQLQTLQAFDLTRNKL 415
E + + V+ + + + Q T L
Sbjct: 13 GRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHS----AWRQANSNNPQIETRTGRAL 68
Query: 416 -AGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSVRVLYLGLNIFTSVLSSTIWNL 474
A E +L L+ P L+ ++ + + L T+
Sbjct: 69 KATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLME-LPDTMQQF 126
Query: 475 KDILFIDVSSNFLDGPLSLDIGNLKVVIGLDFSRNNLSGDIPITIGEGEIPRG-GPFANL 533
+ + ++ N L L I +L + L ++P + + NL
Sbjct: 127 AGLETLTLARNPLRA-LPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNL 185
Query: 534 T 534
Sbjct: 186 Q 186
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 3e-35
Identities = 69/387 (17%), Positives = 142/387 (36%), Gaps = 63/387 (16%)
Query: 57 LNISSFNLQGTITPQLGNLSSLQTLDLSHNKLSGNIPSSIF-NMHTLKLLDFSDNQLFGS 115
++I + L++ + + ++ + +P+++ + ++LL+ +D Q+
Sbjct: 26 VHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQI-EE 83
Query: 116 LSSFIF-NMSSMTTIDLSINRLSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKE 174
+ ++ F ++ + + N + LP P L L L N+LS
Sbjct: 84 IDTYAFAYAHTIQKLYMGFNAIR-YLP------PHVFQNVPLLTVLVLERNDLS------ 130
Query: 175 IGNLTKLKEIISTITNSTVCEIPREI-GNLPYLARLALATNNLVGVVPVTIFNMSALKEI 233
+PR I N P L L+++ NNL + T ++L+ +
Sbjct: 131 --------------------SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNL 170
Query: 234 SLLNNSLSGSLPSRIDLSLPNVETLNLGINSFSGTIPSSITNSSKLSDLELGENLFSGFI 293
L +N L+ + + +P++ N+ N S++ + +L+ N +
Sbjct: 171 QLSSNRLT-HVDLSL---IPSLFHANVSYNLL-----STLAIPIAVEELDASHNSINVVR 221
Query: 294 PNTIGNLRNLEFGNIADNYLTSSTPELSFLSSLTNCKKLKVLIVTGNPLDGILPKSIGNF 353
L L + N LT + L N L + ++ N L+ I+
Sbjct: 222 GPVNVELTIL---KLQHNNLTD-------TAWLLNYPGLVEVDLSYNELEKIMYHPFVKM 271
Query: 354 SLSLETILMANCSISGNIPQVVGNLSNLLVLELGGNNLTGPIPVTFSQLQTLQAFDLTRN 413
LE + ++N + + + L VL+L N+L + Q L+ L N
Sbjct: 272 Q-RLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLLH-VERNQPQFDRLENLYLDHN 328
Query: 414 KLAGPITDELCHLARLHSLVLQGNKFS 440
+ T +L L +L L N +
Sbjct: 329 SIV---TLKLSTHHTLKNLTLSHNDWD 352
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 9e-27
Identities = 66/385 (17%), Positives = 140/385 (36%), Gaps = 61/385 (15%)
Query: 105 LDFSDNQLFGSLSSFIFNMSSMTTIDLSINRLSGELPANICKIPSTLSKCKQLEELNLGF 164
+D ++ +++ + + + +LPA + L +Q+E LNL
Sbjct: 28 IDMQTQDVYFGFEDI--TLNNQKIVTFKNSTMR-KLPAAL------LDSFRQVELLNLND 78
Query: 165 NNLSGAIPKEIGNLTKLKEIISTITNSTVCEIPREI-GNLPYLARLALATNNLVGVVPVT 223
+ EI + +L + N + + P
Sbjct: 79 LQIE--------------------------EIDTYAFAYAHTIQKLYMGFNAIRYLPPHV 112
Query: 224 IFNMSALKEISLLNNSLSGSLPSRIDLSLPNVETLNLGINSFSGTIPSSITNSSKLSDLE 283
N+ L + L N LS SLP I + P + TL++ N+ + ++ L +L+
Sbjct: 113 FQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQ 171
Query: 284 LGENLFSGFIPNTIGNLRNLEFGNIADNYLTSSTPELSFLSSLTNCKKLKVLIVTGNPLD 343
L N + + + +L N++ N L+ +L ++ L + N ++
Sbjct: 172 LSSNRLTHV---DLSLIPSLFHANVSYNLLS----------TLAIPIAVEELDASHNSIN 218
Query: 344 GILPKSIGNFSLSLETILMANCSISGNIPQVVGNLSNLLVLELGGNNLTGPIPVTFSQLQ 403
+ ++ L + + + +++ + + N L+ ++L N L + F ++Q
Sbjct: 219 VVRG----PVNVELTILKLQHNNLT-DTA-WLLNYPGLVEVDLSYNELEKIMYHPFVKMQ 272
Query: 404 TLQAFDLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSVRVLYLGLNIF 463
L+ ++ N+L + + L L L N + + LYL N
Sbjct: 273 RLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSI 330
Query: 464 TSVLSSTIWNLKDILFIDVSSNFLD 488
++ ST LK+ + +S N D
Sbjct: 331 VTLKLSTHHTLKN---LTLSHNDWD 352
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 3e-24
Identities = 51/375 (13%), Positives = 116/375 (30%), Gaps = 34/375 (9%)
Query: 171 IPKEIGNLTKLKEIISTITNSTVCEIPREIGNLPYLARLALATNNLVGVVPVTIFNMSAL 230
I + ++ + V +I L + + + + + + +
Sbjct: 13 IDSNLQYDCVFYDVHIDMQTQDVYFGFEDI-TLNNQKIVTFKNSTMRKLPAALLDSFRQV 71
Query: 231 KEISLLNNSLSGSLPSRIDLSLPNVETLNLGINSFSGTIPSSITNSSKLSDLELGENLFS 290
+ ++L + + + + ++ L +G N+ P N L+ L L N S
Sbjct: 72 ELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS 130
Query: 291 GFIPNTIGNLRNLEFGNIADNYLTSSTPELSFLSSLTNCKKLKVLIVTGNPLDGILPKSI 350
N L ++++N L + L+ L ++ N L + +
Sbjct: 131 SLPRGIFHNTPKLTTLSMSNNNLERIEDDT-----FQATTSLQNLQLSSNRLTHV---DL 182
Query: 351 GNFSLSLETILMANCSISGNIPQVVGNLSNLLVLELGGNNLTGPIPVTFSQLQTLQAFDL 410
SL ++S N+ + + L+ N++ +L L L
Sbjct: 183 SLIP-SLFHA-----NVSYNLLSTLAIPIAVEELDASHNSINVVRGPVNVELTIL---KL 233
Query: 411 TRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSVRVLYLGLNIFTSVLSST 470
N L L + L + L N+ + + + LY+ N + L+
Sbjct: 234 QHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLY 290
Query: 471 IWNLKDILFIDVSSNFLDGPLSLDIGNLKVVIGLDFSRNNLSGDIPITIGEGEIPRGGPF 530
+ + +D+S N L + + + L N++ + +
Sbjct: 291 GQPIPTLKVLDLSHNHLLH-VERNQPQFDRLENLYLDHNSIV-TLKL----------STH 338
Query: 531 ANLTAKSFMGNELLC 545
L + N+ C
Sbjct: 339 HTLKNLTLSHNDWDC 353
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 1e-15
Identities = 39/245 (15%), Positives = 88/245 (35%), Gaps = 17/245 (6%)
Query: 268 TIPSSITNSSKLSDLELGENLFSGFIPNTIGNLRNLEFGNIADNYLTSSTPELSFLSSLT 327
I S++ D+ + + L N + ++ + L L
Sbjct: 12 CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAAL-----LD 66
Query: 328 NCKKLKVLIVTGNPLDGILPKSIGNFSLSLETILMANCSISGNIPQVVGNLSNLLVLELG 387
+ +++++L + ++ I + +++ + M +I P V N+ L VL L
Sbjct: 67 SFRQVELLNLNDLQIEEIDTYAFAYAH-TIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLE 125
Query: 388 GNNLTGPIPVTFSQLQTLQAFDLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCL 447
N+L+ F L ++ N L D L +L L N+ + + L
Sbjct: 126 RNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVD--L 182
Query: 448 GNLTSVRVLYLGLNIFTSVLSSTIWNLKDILFIDVSSNFLDGPLSLDIGNLKVVIGLDFS 507
+ S+ + N+ +++ +++ +D S N ++ + + L
Sbjct: 183 SLIPSLFHANVSYNLLSTLAIPI--AVEE---LDASHNSIN---VVRGPVNVELTILKLQ 234
Query: 508 RNNLS 512
NNL+
Sbjct: 235 HNNLT 239
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 4e-35
Identities = 90/469 (19%), Positives = 164/469 (34%), Gaps = 69/469 (14%)
Query: 68 ITPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLDFSDNQLFGSLSSFIFNMSSMT 127
I P+ + + LQ + L+ +P N+ + + ++ + M
Sbjct: 3 INPRNVSNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMA 61
Query: 128 TIDLSINRLSG--ELPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKEIGNLTKLKEII 185
L EL N + S LE L N+L+ +P+ +L L
Sbjct: 62 VSRLRDCLDRQAHELELNNLGLSSLPELPPHLESLVASCNSLT-ELPELPQSLKSLLVD- 119
Query: 186 STITNSTVCEIPREIGNLPYLARLALATNNLVGVVPVTIFNMSALKEISLLNNSLSGSLP 245
N+ + + L YL +NN + +P + N S LK I + NNSL LP
Sbjct: 120 ----NNNLKALSDLPPLLEYL----GVSNNQLEKLP-ELQNSSFLKIIDVDNNSLK-KLP 169
Query: 246 SRIDLSLPNVETLNLGINSFSGTIPSSITNSSKLSDLELGENLFSGFIPNTIGNLRNLEF 305
P++E + G N + N L+ + N +P+ +L ++
Sbjct: 170 D----LPPSLEFIAAGNNQL--EELPELQNLPFLTAIYADNNSLK-KLPDLPLSLESI-- 220
Query: 306 GNIADNYLTSSTPELSFLSSLTNCKKLKVLIVTGNPLDGILPKSIGNFSLSLETILMANC 365
+N L L L N L + N L LP + LE + + +
Sbjct: 221 -VAGNNILEE-------LPELQNLPFLTTIYADNNLL-KTLPDLPPS----LEALNVRDN 267
Query: 366 SISGNIPQVVGNLSNLLVLELGGNNLTG-------------PIPVTFSQLQTLQAFDLTR 412
++ ++P++ +L+ L V E + L+ I +L+ +++
Sbjct: 268 YLT-DLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSN 326
Query: 413 NKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSVRVLYLGLNIFTSVLSSTIW 472
NKL + RL L+ N + +P NL + L++ N
Sbjct: 327 NKLIE-LPALPP---RLERLIASFNHLA-EVPELPQNL---KQLHVEYNPLRE-FPDIPE 377
Query: 473 NLKDILFIDVSSNFLDGPLSLDIGNLKVVIGLDFSRNNLSGDIPITIGE 521
+++D + ++S+ + P NLK L N L + P
Sbjct: 378 SVED---LRMNSHLAEVPEL--PQNLKQ---LHVETNPLR-EFPDIPES 417
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 8e-34
Identities = 88/453 (19%), Positives = 167/453 (36%), Gaps = 74/453 (16%)
Query: 57 LNISSFNLQGTITPQLGNLS-------------SLQTLDLSHNKLSGNIPSSIFNMHTLK 103
+ + P G L+L++ LS ++P + L+
Sbjct: 39 YYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLS-SLPELPPH---LE 94
Query: 104 LLDFSDNQLFGSLSSFIFNMSSMTTIDLSINRLSGELPA---------NICKIPSTLSKC 154
L S N L L ++ S+ + ++ LS P + K+P L
Sbjct: 95 SLVASCNSL-TELPELPQSLKSLLVDNNNLKALSDLPPLLEYLGVSNNQLEKLPE-LQNS 152
Query: 155 KQLEELNLGFNNLSGAIPKEIGNLTKLKEIISTITNSTVCEIPREIGNLPYLARLALATN 214
L+ +++ N+L +P +L + N+ + E+P E+ NLP+L + N
Sbjct: 153 SFLKIIDVDNNSLK-KLPDLPPSLEFI-----AAGNNQLEELP-ELQNLPFLTAIYADNN 205
Query: 215 NLVGVVPVTIFNMSALKEISLLNNSLSGSLPSRIDLSLPNVETLNLGINSFSGTIPSSIT 274
+L +P + L+ I NN L LP +LP + T+ N T+P
Sbjct: 206 SLK-KLPDLPLS---LESIVAGNNILE-ELPEL--QNLPFLTTIYADNNLLK-TLPDLPP 257
Query: 275 NSSKLSDLELGENLFSGFIPNTIGNLRNLEFGNIADNYLTSSTPELSFLSSLTN------ 328
+ L L + +N + +P +L L+ + L+ P L +L++ +N
Sbjct: 258 S---LEALNVRDNYLTD-LPELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLC 313
Query: 329 --CKKLKVLIVTGNPLDGILPKSIGNFSLSLETILMANCSISGNIPQVVGNLSNLLVLEL 386
L+ L V+ N L LP LE ++ + ++ +P+ NL L +
Sbjct: 314 DLPPSLEELNVSNNKLI-ELPALPPR----LERLIASFNHLA-EVPE---LPQNLKQLHV 364
Query: 387 GGNNLTGPIPVTFSQLQTLQAFDLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSC 446
N L P ++ L+ + L + + +L +LH ++ N P
Sbjct: 365 EYNPLRE-FPDIPESVEDLRM----NSHL-AEVPELPQNLKQLH---VETNPLR-EFPDI 414
Query: 447 LGNLTSVRVLYLGLNIFTSVLSSTIWNLKDILF 479
++ +R+ + T L+D +F
Sbjct: 415 PESVEDLRMNSERVVDPYEFAHETTDKLEDDVF 447
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 8e-32
Identities = 61/358 (17%), Positives = 116/358 (32%), Gaps = 64/358 (17%)
Query: 70 PQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLDFSDNQLFGSLSSFIFNMSSMTTI 129
P+L N S L+ +D+ +N L +P + L+ + +NQL L N+ +T I
Sbjct: 147 PELQNSSFLKIIDVDNNSLK-KLPDLPPS---LEFIAAGNNQL-EELPELQ-NLPFLTAI 200
Query: 130 DLSINRLSGELPANICK------------IPSTLSKCKQLEELNLGFNNLSGAIPKEIGN 177
N L +LP L L + N L +P +
Sbjct: 201 YADNNSLK-KLPDLPLSLESIVAGNNILEELPELQNLPFLTTIYADNNLLK-TLPDLPPS 258
Query: 178 LTKLKEIISTITNSTVCEIPREIGNLPYLARLALATNNLVGVVPVTIFNMSALKEISLLN 237
L L + ++ + ++P +L +L + L + P L ++ +
Sbjct: 259 LEAL-----NVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPP-------NLYYLNASS 306
Query: 238 NSLSGSLPSRIDLSLPNVETLNLGINSFSGTIPSSITNSSKLSDLELGENLFSGFIPNTI 297
N + SL P++E LN+ N +P+ L L N + +P
Sbjct: 307 NEIR-SLCD----LPPSLEELNVSNNKLI-ELPALPPR---LERLIASFNHLA-EVPELP 356
Query: 298 GNLRNLEFGNIADNYLTSSTPELSFLSSLTNCKKLKVLIVTGNPLDGILPKSIGNFSLSL 357
NL+ L ++ N L + L L +P+ N L
Sbjct: 357 QNLKQL---HVEYNPLREFPDIPESVEDLRMNSHLA-----------EVPELPQN----L 398
Query: 358 ETILMANCSISGNIPQVVGNLSNLLVLELGGNNLTGPIPVTFSQLQTLQAFDLTRNKL 415
+ + + + P + ++ +L + + P L+ +
Sbjct: 399 KQLHVETNPLR-EFPDIPESVEDL---RMNSERVVDPYEFAHETTDKLEDDVFEHHHH 452
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 2e-30
Identities = 89/416 (21%), Positives = 153/416 (36%), Gaps = 72/416 (17%)
Query: 57 LNISSFNLQGTITPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLDFSDNQLFGSL 116
L S +L + +L SL + + LS P L+ L S+NQL L
Sbjct: 96 LVASCNSLT-ELPELPQSLKSLLVDNNNLKALSDLPPL-------LEYLGVSNNQL-EKL 146
Query: 117 SSFIFNMSSMTTIDLSINRLSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKEIG 176
+ N S + ID+ N L +LP LE + G N L +P E+
Sbjct: 147 PE-LQNSSFLKIIDVDNNSLK-KLPDLP----------PSLEFIAAGNNQLE-ELP-ELQ 192
Query: 177 NLTKLKEIISTITNSTVCEIPREIGNLPYLARLALATNNLVGVVPVTIFNMSALKEISLL 236
NL L I N+++ ++P +L + +A NN++ +P + N+ L I
Sbjct: 193 NLPFLTAIY--ADNNSLKKLPDLPLSLESI----VAGNNILEELP-ELQNLPFLTTIYAD 245
Query: 237 NNSLSGSLPSRIDLSLPNVETLNLGINSFSGTIPSSITNSSKLSDLELGENLFSGFIPNT 296
NN L +LP P++E LN+ N + +P + L+ L++ EN+FSG +
Sbjct: 246 NNLLK-TLPD----LPPSLEALNVRDNYLT-DLPELPQS---LTFLDVSENIFSG-LSEL 295
Query: 297 IGNLRNLEFGNIADNYLTSSTPELSFLSSL-----------TNCKKLKVLIVTGNPLDGI 345
NL L N + N + S L L +L+ LI + N L
Sbjct: 296 PPNLYYL---NASSNEIRSLCDLPPSLEELNVSNNKLIELPALPPRLERLIASFNHL-AE 351
Query: 346 LPKSIGNFSLSLETILMANCSISGNIPQVVGNLSNLLVLELGGNNLTGPIPVTFSQLQTL 405
+P+ N L+ + + + P + ++ +L + N+ +P L+ L
Sbjct: 352 VPELPQN----LKQLHVEYNPLR-EFPDIPESVEDLRM-----NSHLAEVPELPQNLKQL 401
Query: 406 QAFDLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSVRVLYLGLN 461
+ N L D + L + + + +
Sbjct: 402 ---HVETNPLRE-FPDIPESVEDLR---MNSERVVDPYEFAHETTDKLEDDVFEHH 450
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 4e-11
Identities = 35/194 (18%), Positives = 65/194 (33%), Gaps = 43/194 (22%)
Query: 75 LSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLDFSDNQLFGSLSSFIFNMSSMTTIDLSIN 134
SL LD+S N S + N L L+ S N++ S S+ +++S N
Sbjct: 276 PQSLTFLDVSENIFS-GLSELPPN---LYYLNASSNEI----RSLCDLPPSLEELNVSNN 327
Query: 135 RLSGELPANICK-------------IPSTLSKCKQLEELNLGFNNLSGAIPKEIGNLTKL 181
+L ELPA + +P L++L++ +N L P ++ L
Sbjct: 328 KLI-ELPALPPRLERLIASFNHLAEVPELPQN---LKQLHVEYNPLR-EFPDIPESVEDL 382
Query: 182 K------EIISTITNSTV--------CEIPREIGNLPYLARLALATNNLVGVVPVTIFNM 227
+ E+ N E P ++ L + + +V
Sbjct: 383 RMNSHLAEVPELPQNLKQLHVETNPLREFPDIPESVEDLR---MNSERVVDPYEFAHETT 439
Query: 228 SALKEISLLNNSLS 241
L++ ++
Sbjct: 440 DKLEDDVFEHHHHH 453
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 6e-11
Identities = 39/248 (15%), Positives = 75/248 (30%), Gaps = 48/248 (19%)
Query: 292 FIPNTIGNLRNLEFGNIADNYLTSSTPELSFLSSLTNCKKLKVLIVTGNPLDGILPKSIG 351
FI + L+ + LT E + S T + + P G
Sbjct: 2 FINPRNVSNTFLQEPLRHSSNLTEMPVEAENVKSKTE------YYNAWSEWERNAPPGNG 55
Query: 352 N------------FSLSLETILMANCSISGNIPQVVGNLSNLLVLELGGNNLTGPIPVTF 399
+ + N +S ++P++ +L +L+ N+LT +P
Sbjct: 56 EQREMAVSRLRDCLDRQAHELELNNLGLS-SLPELPPHLESLV---ASCNSLT-ELPELP 110
Query: 400 SQLQTLQAFDLTRNKLAGPIT---------------DELCHLARLHSLVLQGNKFSGSIP 444
L++L + L+ EL + + L + + N +P
Sbjct: 111 QSLKSLLVDNNNLKALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLK-KLP 169
Query: 445 SCLGNLTSVRVLYLGLNIFTSVLSSTIWNLKDILFIDVSSNFLDGPLSLDIGNLKVVIGL 504
+L + G N + + NL + I +N L L +L+ +
Sbjct: 170 DLPPSLEF---IAAGNNQLEEL--PELQNLPFLTAIYADNNSLKK-LPDLPLSLES---I 220
Query: 505 DFSRNNLS 512
N L
Sbjct: 221 VAGNNILE 228
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 5e-35
Identities = 61/434 (14%), Positives = 131/434 (30%), Gaps = 50/434 (11%)
Query: 73 GNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLDFSDNQLFGSLSSFIFNMSSMTTIDLS 132
N + + ++ + L + S + +K LD S N L ++ + + + ++LS
Sbjct: 7 QNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLS 66
Query: 133 INRLSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKEIGNLTKLKEI------IS 186
N L L L L+L N + E+ ++ + IS
Sbjct: 67 SNVLYE---------TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS 112
Query: 187 TITNSTVCEIPREIGNLPYLARLALATNNLVGVVPVTIFNMSALKEISLLNNSLSGSLPS 246
+ + LA N + + + S ++ + L N + +
Sbjct: 113 RV----------SCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFA 162
Query: 247 RIDLSLPNVETLNLGINSFSGTIPSSITNSSKLSDLELGENLFSGFIPNTIGNLRNLEFG 306
+ S +E LNL N + + + L L+L N + F+ + + +
Sbjct: 163 ELAASSDTLEHLNLQYNFIY-DVKGQVVFAK-LKTLDLSSNKLA-FMGPEFQSAAGVTWI 219
Query: 307 NIADNYLTSSTPELSFLSSLTNCKKLKVLIVTGNPLDGILPKSIGNFSLSLETILM-ANC 365
++ +N L L F +L + + GN + + + ++T+
Sbjct: 220 SLRNNKLVLIEKALRFSQNLEH------FDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVK 273
Query: 366 SISGNIPQVVGNLSNLLVLELGGNNLTGPIPVTFSQLQTLQAFDLTRNKLAG----PITD 421
++G + + + G +L L+ + G +
Sbjct: 274 KLTGQNEE---ECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLEC 330
Query: 422 ELCHLARLHSLVLQGNKFSGSIPSCLGNLTSVRVLYLGLNIFTSVLSST---IWNLKDIL 478
E + AR + ++ I + L +S+ L L
Sbjct: 331 ERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTL 390
Query: 479 FIDVSSNFLDGPLS 492
V L
Sbjct: 391 QQAVGQIELQHATE 404
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 2e-29
Identities = 65/408 (15%), Positives = 122/408 (29%), Gaps = 45/408 (11%)
Query: 115 SLSSFIFNMSSMTTIDLSINRLSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKE 174
++ N + ++ + L + S ++EL+L N LS +
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLK-QAL------ASLRQSAWNVKELDLSGNPLSQISAAD 53
Query: 175 IGNLTKLKEI------ISTITNSTVCEIPREIGNLPYLARLALATNNLVGVVPVTIFNMS 228
+ TKL+ + + ++ +L L L L N + +
Sbjct: 54 LAPFTKLELLNLSSNVLYETL---------DLESLSTLRTLDLNNNYV-----QELLVGP 99
Query: 229 ALKEISLLNNSLSGSLPSRIDLSLPNVETLNLGINSFSGTIPSSITNSSKLSDLELGENL 288
+++ + NN++S + + + L N + S++ L+L N
Sbjct: 100 SIETLHAANNNIS-RVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNE 155
Query: 289 FSGF-IPNTIGNLRNLEFGNIADNYLTSSTPELSFLSSLTNCKKLKVLIVTGNPLDGILP 347
+ LE N+ N++ + KLK L ++ N L +
Sbjct: 156 IDTVNFAELAASSDTLEHLNLQYNFIYD-------VKGQVVFAKLKTLDLSSNKLAFM-G 207
Query: 348 KSIGNFSLSLETILMANCSISGNIPQVVGNLSNLLVLELGGNNL-TGPIPVTFSQLQTLQ 406
+ + + I + N + I + + NL +L GN G + FS+ Q +Q
Sbjct: 208 PEFQSAA-GVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQ 265
Query: 407 AFDLTRNK-LAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSVRVLYLGL-NIFT 464
K L G +E H L L L T
Sbjct: 266 TVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSET 325
Query: 465 SVLSSTIWNLKDILFIDVSSNFLDGPLSLDIGNLKVVIGLDFSRNNLS 512
L N ID + + I L+ + L
Sbjct: 326 ERLECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALD 373
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 66.4 bits (162), Expect = 2e-11
Identities = 22/150 (14%), Positives = 55/150 (36%), Gaps = 10/150 (6%)
Query: 371 IPQVVGNLSNLLVLELGGNNLTGPIPVTFSQLQTLQAFDLTRNKLAGPITDELCHLARLH 430
I ++ N + + ++ ++L + ++ DL+ N L+ +L +L
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 431 SLVLQGNKFSGSIPSCLGNLTSVRVLYLGLNIFTSVLSSTIWNLKDILFIDVSSNFLDGP 490
L L N ++ L +L+++R L L N + I + ++N +
Sbjct: 62 LLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQE-----LLVGPSIETLHAANNNIS-- 112
Query: 491 LSLDIGNLKVVIGLDFSRNNLSGDIPITIG 520
+ + + + N ++ + G
Sbjct: 113 -RVSCSRGQGKKNIYLANNKITMLRDLDEG 141
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 3e-34
Identities = 66/361 (18%), Positives = 129/361 (35%), Gaps = 59/361 (16%)
Query: 75 LSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLDFSDNQLFGSLSSFIFNMSSMTTIDLSIN 134
+ L++ + L+ +P + + L DN L +S + T+++S N
Sbjct: 39 NNGNAVLNVGESGLT-TLPDCLPA--HITTLVIPDNNL----TSLPALPPELRTLEVSGN 91
Query: 135 RLSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKEIGNLTKLKEIISTITNSTVC 194
+L+ +P +L + +L P L KL I + +
Sbjct: 92 QLT--------SLPVLPPGLLELSIFSNPLTHL----PALPSGLCKL-----WIFGNQLT 134
Query: 195 EIPREIGNLPYLARLALATNNLVGVVPVTIFNMSALKEISLLNNSLSGSLPSRIDLSLPN 254
+P L L+++ N L +P L ++ NN L+ SLP
Sbjct: 135 SLPVLPPGL---QELSVSDNQL-ASLPALPSE---LCKLWAYNNQLT-SLPM----LPSG 182
Query: 255 VETLNLGINSFSGTIPSSITNSSKLSDLELGENLFSGFIPNTIGNLRNLEFGNIADNYLT 314
++ L++ N + ++P+ + L L N + +P L+ L ++ N LT
Sbjct: 183 LQELSVSDNQLA-SLPTLPSE---LYKLWAYNNRLT-SLPALPSGLKEL---IVSGNRLT 234
Query: 315 SSTPELSFLSSLTNCKKLKVLIVTGNPLDGILPKSIGNFSLSLETILMANCSISGNIPQV 374
S S +LK L+V+GN L LP L ++ + ++ +P+
Sbjct: 235 SLPVLPS---------ELKELMVSGNRLT-SLPMLPSG----LLSLSVYRNQLT-RLPES 279
Query: 375 VGNLSNLLVLELGGNNLTGPIPVTFSQLQTLQAFDLTRNKLAGPITDELCHLARLHSLVL 434
+ +LS+ + L GN L+ ++ + + + LH
Sbjct: 280 LIHLSSETTVNLEGNPLSERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALHLAAA 339
Query: 435 Q 435
Sbjct: 340 D 340
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 1e-29
Identities = 71/369 (19%), Positives = 129/369 (34%), Gaps = 60/369 (16%)
Query: 55 IGLNISSFNLQG-TITPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLDFSDNQLF 113
+ +I++ + +T L+TL++S N+L+ ++P + L + L
Sbjct: 59 LPAHITTLVIPDNNLTSLPALPPELRTLEVSGNQLT-SLPVLPPGLLELSIFSNPLTHLP 117
Query: 114 GSLSSFIFNMSSMTTIDLSINRLSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAIPK 173
S + + + N+L+ LP L+EL++ N L+ ++P
Sbjct: 118 ALP-------SGLCKLWIFGNQLT-SLPVLP----------PGLQELSVSDNQLA-SLPA 158
Query: 174 EIGNLTKLKEIISTITNSTVCEIPREIGNLPYLARLALATNNLVGVVPVTIFNMSALKEI 233
L KL N+ + +P L L+++ N L +P L ++
Sbjct: 159 LPSELCKL-----WAYNNQLTSLPMLPSG---LQELSVSDNQLA-SLPTLPSE---LYKL 206
Query: 234 SLLNNSLSGSLPSRIDLSLPNVETLNLGINSFSGTIPSSITNSSKLSDLELGENLFSGFI 293
NN L+ SLP+ ++ L + N + ++P + L +L + N + +
Sbjct: 207 WAYNNRLT-SLPA----LPSGLKELIVSGNRLT-SLPVLPSE---LKELMVSGNRLTS-L 256
Query: 294 PNTIGNLRNLEFGNIADNYLTSSTPELSFLSSLTNCKKLKVLIVTGNPLDGILPKSIGNF 353
P L +L ++ N LT PE SL + + + GNPL
Sbjct: 257 PMLPSGLLSL---SVYRNQLT-RLPE-----SLIHLSSETTVNLEGNPLS-ERTLQALRE 306
Query: 354 SLSLETILMANCSIS---GNIPQVVGNLSNLLVLELGGNNLTGPIPVT----FSQLQTLQ 406
S + P+ L L P P F Q
Sbjct: 307 ITSAPGYSGPIIRFDMAGASAPRETRALHLAAADWLVPAREGEPAPADRWHMFGQEDNAD 366
Query: 407 AFDLTRNKL 415
AF L ++L
Sbjct: 367 AFSLFLDRL 375
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 8e-34
Identities = 69/388 (17%), Positives = 141/388 (36%), Gaps = 63/388 (16%)
Query: 56 GLNISSFNLQGTITPQLGNLSSLQTLDLSHNKLSGNIPSSIF-NMHTLKLLDFSDNQLFG 114
++I + L++ + + ++ + +P+++ + ++LL+ +D Q+
Sbjct: 31 DVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQI-E 88
Query: 115 SLSSFIF-NMSSMTTIDLSINRLSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAIPK 173
+ ++ F ++ + + N + LP P L L L N+LS
Sbjct: 89 EIDTYAFAYAHTIQKLYMGFNAIR-YLP------PHVFQNVPLLTVLVLERNDLS----- 136
Query: 174 EIGNLTKLKEIISTITNSTVCEIPREI-GNLPYLARLALATNNLVGVVPVTIFNMSALKE 232
+PR I N P L L+++ NNL + T ++L+
Sbjct: 137 ---------------------SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQN 175
Query: 233 ISLLNNSLSGSLPSRIDLSLPNVETLNLGINSFSGTIPSSITNSSKLSDLELGENLFSGF 292
+ L +N L+ + +P++ N+ N S++ + +L+ N +
Sbjct: 176 LQLSSNRLT-HVDLS---LIPSLFHANVSYNLL-----STLAIPIAVEELDASHNSINVV 226
Query: 293 IPNTIGNLRNLEFGNIADNYLTSSTPELSFLSSLTNCKKLKVLIVTGNPLDGILPKSIGN 352
L L + N LT + L N L + ++ N L+ I+
Sbjct: 227 RGPVNVELTIL---KLQHNNLTD-------TAWLLNYPGLVEVDLSYNELEKIMYHPFVK 276
Query: 353 FSLSLETILMANCSISGNIPQVVGNLSNLLVLELGGNNLTGPIPVTFSQLQTLQAFDLTR 412
LE + ++N + + + L VL+L N+L + Q L+ L
Sbjct: 277 MQ-RLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLLH-VERNQPQFDRLENLYLDH 333
Query: 413 NKLAGPITDELCHLARLHSLVLQGNKFS 440
N + T +L L +L L N +
Sbjct: 334 NSIV---TLKLSTHHTLKNLTLSHNDWD 358
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 86.9 bits (215), Expect = 8e-18
Identities = 44/300 (14%), Positives = 105/300 (35%), Gaps = 37/300 (12%)
Query: 232 EISLLNNSLSGSLPSRIDLSLPNVETLNLGINSFSGTIPSSITNSSKLSDLELGENLFSG 291
I + + D++L N + + ++ + + + ++ L L +
Sbjct: 33 HIDMQTQDVYFGFE---DITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEE 89
Query: 292 FIPNTIGNLRNLEFGNIADNYLTS-------STPELSFLS------------SLTNCKKL 332
++ + N + + P L+ L N KL
Sbjct: 90 IDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKL 149
Query: 333 KVLIVTGNPLDGILPKSIGNFSLSLETILMANCSISGNIPQVVGNLSNLLVLELGGNNLT 392
L ++ N L+ I + + SL+ + +++ ++ ++ + + +L + N L+
Sbjct: 150 TTLSMSNNNLERIEDDTFQATT-SLQNLQLSSNRLT-HVD--LSLIPSLFHANVSYNLLS 205
Query: 393 GPIPVTFSQLQTLQAFDLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTS 452
T + ++ D + N + + + L L LQ N + L N
Sbjct: 206 -----TLAIPIAVEELDASHNSINV-VRGPVN--VELTILKLQHNNLT-DTAW-LLNYPG 255
Query: 453 VRVLYLGLNIFTSVLSSTIWNLKDILFIDVSSNFLDGPLSLDIGNLKVVIGLDFSRNNLS 512
+ + L N ++ ++ + + +S+N L L+L + + LD S N+L
Sbjct: 256 LVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL 314
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 75.7 bits (186), Expect = 3e-14
Identities = 39/245 (15%), Positives = 89/245 (36%), Gaps = 17/245 (6%)
Query: 268 TIPSSITNSSKLSDLELGENLFSGFIPNTIGNLRNLEFGNIADNYLTSSTPELSFLSSLT 327
I S++ D+ + + L N + ++ + L L
Sbjct: 18 CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAAL-----LD 72
Query: 328 NCKKLKVLIVTGNPLDGILPKSIGNFSLSLETILMANCSISGNIPQVVGNLSNLLVLELG 387
+ +++++L + ++ I + +++ + M +I P V N+ L VL L
Sbjct: 73 SFRQVELLNLNDLQIEEIDTYAFAYAH-TIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLE 131
Query: 388 GNNLTGPIPVTFSQLQTLQAFDLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCL 447
N+L+ F L ++ N L D L +L L N+ + + L
Sbjct: 132 RNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVD--L 188
Query: 448 GNLTSVRVLYLGLNIFTSVLSSTIWNLKDILFIDVSSNFLDGPLSLDIGNLKVVIGLDFS 507
+ S+ + N+ +++ + +++ +D S N ++ + + L
Sbjct: 189 SLIPSLFHANVSYNLLSTL--AIPIAVEE---LDASHNSIN---VVRGPVNVELTILKLQ 240
Query: 508 RNNLS 512
NNL+
Sbjct: 241 HNNLT 245
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 71.5 bits (175), Expect = 5e-13
Identities = 57/353 (16%), Positives = 103/353 (29%), Gaps = 27/353 (7%)
Query: 67 TITPQLGNLSSLQTLDLSHNKLSGNIPSSIF-NMHTLKLLDFSDNQLFGSLSSFIFNMSS 125
T T L N L +DLS+N+L I F M L+ L S+N+L +L+ + + +
Sbjct: 245 TDTAWLLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRL-VALNLYGQPIPT 302
Query: 126 MTTIDLSINRLSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKEIGNLTKLKEII 185
+ +DLS N L + + +LE L L N++ + + LK +
Sbjct: 303 LKVLDLSHNHLL--------HVERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTLKN-L 350
Query: 186 STITNSTVCEIPREIGNLPYLARLALATNNLVGVVPVTIFNMSALKEISLLNNSLSGSLP 245
+ N C R + +AR A+ + + + + L
Sbjct: 351 TLSHNDWDCNSLRAL--FRNVARPAVDDADQHCKIDYQLEH-------GLCCKESDKPYL 401
Query: 246 SRIDLSLPNVETLNLGINSFSGTIPSSITNSSKLSDLELGENLFSGFIPNTIGNLRNLEF 305
R+ + + + + NS + + + N E
Sbjct: 402 DRLLQYIALTSVVEKVQRAQGRCSATDTINSVQSLSHYITQQGGVPLQGNEQLEAEVNEL 461
Query: 306 GNIADNYLTSSTPELSFLSSL--TNCKKLKVLIVTGNPLDGILPKSIGNFSLSLETILMA 363
+ L L L+ + + L F+ E
Sbjct: 462 RAEVQQLTNEQIQQEQLLQGLHAEIDTNLRRYRLPKDGLARSSDNLNKVFTHLKERQAFK 521
Query: 364 NCSISGNIPQVVGNLSNLLVLELGGNNLTGPI-PVTFSQLQTLQAFDLTRNKL 415
+ LE L + Q + Q L R K+
Sbjct: 522 LRETQARRTEADAKQKETEDLEQENIALEKQLDNKRAKQAELRQETSLKRQKV 574
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-33
Identities = 57/219 (26%), Positives = 86/219 (39%), Gaps = 69/219 (31%)
Query: 616 RRFSYHELLRATDRFSE------NNLIGIG----------NGMEVAVKVFHQQYERA--- 656
FS++EL T+ F E N +G G N VAVK +
Sbjct: 13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEE 72
Query: 657 -LKSFEDECEVRKRIRHRNLVKII-----------------SSSLEY------------- 685
+ F+ E +V + +H NLV+++ + SL
Sbjct: 73 LKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSW 132
Query: 686 -------------LHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQ 732
++F H IH D+K +N+LLDE A ISDFG+A+ Q
Sbjct: 133 HMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMT 192
Query: 733 TQTLATIGYMAPEYGTKGRVSTRGDVCSFG-----IISG 766
++ + T YMAPE G ++ + D+ SFG II+G
Sbjct: 193 SRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITG 230
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 3e-30
Identities = 71/374 (18%), Positives = 138/374 (36%), Gaps = 51/374 (13%)
Query: 76 SSLQTLDLSHNKLSGNIPSSIF-NMHTLKLLDFSDNQLFGSLSSFIF-NMSSMTTIDLSI 133
+ + LDL N++ + F + L+ L+ ++N + ++ F N+ ++ T+ L
Sbjct: 32 TETRLLDLGKNRIK-TLNQDEFASFPHLEELELNENIV-SAVEPGAFNNLFNLRTLGLRS 89
Query: 134 NRLSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKEIGNLTKLKEIISTITNSTV 193
NRL +P + L +L++ N +
Sbjct: 90 NRLK-LIPLG------VFTGLSNLTKLDISENKIV------------------------- 117
Query: 194 CEIPREI-GNLPYLARLALATNNLVGVVPVTIFNMSALKEISLLNNSLSGSLPSRIDLSL 252
+ + +L L L + N+LV + +++L++++L +L+ S+P+ L
Sbjct: 118 -ILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLT-SIPTEALSHL 175
Query: 253 PNVETLNLGINSFSGTIPSSITNSSKLSDLELGENLFSGFIPNTIGNLRNLEFGNIADNY 312
+ L L + + S +L LE+ + + NL +I
Sbjct: 176 HGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCN 235
Query: 313 LTSSTPELSFLSSLTNCKKLKVLIVTGNPLDGILPKSIGNFSLSLETILMANCSISGNIP 372
LT + P L+ + L+ L ++ NP+ I + L+ I + ++ P
Sbjct: 236 LT-AVPYLAV----RHLVYLRFLNLSYNPISTIEGSMLHELL-RLQEIQLVGGQLAVVEP 289
Query: 373 QVVGNLSNLLVLELGGNNLTGPIPVTFSQLQTLQAFDLTRNKLAGPITDELCHLARLHSL 432
L+ L VL + GN LT F + L+ L N L D C L +
Sbjct: 290 YAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPL---ACD--CRLLWVFRR 344
Query: 433 VLQGNKFSGSIPSC 446
F+ P+C
Sbjct: 345 -RWRLNFNRQQPTC 357
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 3e-27
Identities = 65/292 (22%), Positives = 120/292 (41%), Gaps = 33/292 (11%)
Query: 61 SFNLQGTITPQ-LGNLSSLQTLDLSHNKLSGNIPSSIF-NMHTLKLLDFSDNQLFGSLSS 118
+ N+ + P NL +L+TL L N+L IP +F + L LD S+N++ L
Sbjct: 64 NENIVSAVEPGAFNNLFNLRTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKI-VILLD 121
Query: 119 FIF-NMSSMTTIDLSINRLSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKEI-G 176
++F ++ ++ ++++ N L + S LE+L L NL+ +IP E
Sbjct: 122 YMFQDLYNLKSLEVGDNDLV-YISHR------AFSGLNSLEQLTLEKCNLT-SIPTEALS 173
Query: 177 NLTKLKEI------ISTITNSTVCEIPREIGNLPYLARLALATNNLVGVVPVTIFNMSAL 230
+L L + I+ I + + L L L ++ + + L
Sbjct: 174 HLHGLIVLRLRHLNINAIRDYS-------FKRLYRLKVLEISHWPYLDTMTPNCLYGLNL 226
Query: 231 KEISLLNNSLSGSLPSRIDLSLPNVETLNLGINSFSGTIPSSITNSSKLSDLELGENLFS 290
+S+ + +L+ ++P L + LNL N S S + +L +++L +
Sbjct: 227 TSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLA 285
Query: 291 GFIPNTIGNLRNLEFGNIADNYLTSSTPELSFLSSLTNCKKLKVLIVTGNPL 342
P L L N++ N LT+ + + L+ LI+ NPL
Sbjct: 286 VVEPYAFRGLNYLRVLNVSGNQLTTLEESV-----FHSVGNLETLILDSNPL 332
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 4e-22
Identities = 71/334 (21%), Positives = 123/334 (36%), Gaps = 31/334 (9%)
Query: 219 VVPVTIFNMSALKEISLLNNSLSGSLPSRIDLSLPNVETLNLGINSFSGTIPSSITNSSK 278
VP I + + + L N + +L S P++E L L N S P + N
Sbjct: 25 AVPEGIP--TETRLLDLGKNRIK-TLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFN 81
Query: 279 LSDLELGENLFSGFIPNTIGNLRNLEFGNIADNYLTSSTPELSFLSSLTNCKKLKVLIVT 338
L L L N L NL +I++N + + L N LK L V
Sbjct: 82 LRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYM--FQDLYN---LKSLEVG 136
Query: 339 GNPLDGILPKSIGNFSLSLETILMANCSISGNIPQVVGNLSNLLVLELGGNNLTGPIPVT 398
N L I ++ + SLE + + C+++ + + +L L+VL L N+ +
Sbjct: 137 DNDLVYISHRAFSGLN-SLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYS 195
Query: 399 FSQLQTLQAFDLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSC-LGNLTSVRVLY 457
F +L L+ +++ +T + L SL + + ++P + +L +R L
Sbjct: 196 FKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRFLN 254
Query: 458 LGLNIFTSVLSSTIWNLKDILFIDVSSNFL----DGPLSLDIGNLKVVIGLDFSRNNLSG 513
L N +++ S + L + I + L + L+V L+ S N L+
Sbjct: 255 LSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFR-GLNYLRV---LNVSGNQLT- 309
Query: 514 DIPITIGEGEIPRG--GPFANLTAKSFMGNELLC 545
+ NL N L C
Sbjct: 310 ---------TLEESVFHSVGNLETLILDSNPLAC 334
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 95.6 bits (238), Expect = 9e-21
Identities = 39/221 (17%), Positives = 87/221 (39%), Gaps = 17/221 (7%)
Query: 74 NLSSLQTLDLSHNKLSGNIPSSIF-NMHTLKLLDFSDNQLFGSLSSFIF-NMSSMTTIDL 131
+L +L++L++ N L I F +++L+ L L S+ + ++ + + L
Sbjct: 126 DLYNLKSLEVGDNDLV-YISHRAFSGLNSLEQLTLEKCNL-TSIPTEALSHLHGLIVLRL 183
Query: 132 SINRLSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKEIGNLTKLKEIISTITNS 191
++ + + + +L+ L + + L + +IT+
Sbjct: 184 RHLNIN-AIR------DYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSL--SITHC 234
Query: 192 TVCEIPRE-IGNLPYLARLALATNNLVGVVPVTIFNMSALKEISLLNNSLSGSLPSRIDL 250
+ +P + +L YL L L+ N + + + + L+EI L+ L+ +
Sbjct: 235 NLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLA-VVEPYAFR 293
Query: 251 SLPNVETLNLGINSFSGTIPSSI-TNSSKLSDLELGENLFS 290
L + LN+ N + T+ S+ + L L L N +
Sbjct: 294 GLNYLRVLNVSGNQLT-TLEESVFHSVGNLETLILDSNPLA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 82.5 bits (204), Expect = 1e-16
Identities = 36/173 (20%), Positives = 72/173 (41%), Gaps = 14/173 (8%)
Query: 72 LGNLSSLQTLDLSHNKLSGNIPSSIF-NMHTLKLLDFSDNQLFGSLSSFIFNMSSMTTID 130
L +L L L L H ++ I F ++ LK+L+ S +++ ++T++
Sbjct: 172 LSHLHGLIVLRLRHLNIN-AIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLS 230
Query: 131 LSINRLSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKEI-GNLTKLKEIISTIT 189
++ L+ +P + L LNL +N +S I + L +L+EI +
Sbjct: 231 ITHCNLT-AVPYL------AVRHLVYLRFLNLSYNPIS-TIEGSMLHELLRLQEIQ--LV 280
Query: 190 NSTVCEIPREI-GNLPYLARLALATNNLVGVVPVTIFNMSALKEISLLNNSLS 241
+ + L YL L ++ N L + ++ L+ + L +N L+
Sbjct: 281 GGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLA 333
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 6e-30
Identities = 50/280 (17%), Positives = 107/280 (38%), Gaps = 28/280 (10%)
Query: 50 NSHRVIGLNISSFNLQGTITPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLDFSD 109
N +R ++ +L+ + + +++ LDLS N LS + + L+LL+ S
Sbjct: 8 NGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSS 67
Query: 110 NQLFGSLSSFIFNMSSMTTIDLSINRLSGELPANICKIPSTLSKCKQLEELNLGFNNLSG 169
N L ++S++ T+DL+ N + L +E L+ NN+S
Sbjct: 68 NVL-YETLDL-ESLSTLRTLDLNNNYV------------QELLVGPSIETLHAANNNIS- 112
Query: 170 AIPKEIG-NLTKLKEIISTITNSTVCEIPR-EIGNLPYLARLALATNNLVGVVPVTIF-N 226
+ G + + N+ + + + G + L L N + V + +
Sbjct: 113 RVSCSRGQGKKNIY-----LANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAAS 167
Query: 227 MSALKEISLLNNSLSGSLPSRIDLSLPNVETLNLGINSFSGTIPSSITNSSKLSDLELGE 286
L+ ++L N + + + ++TL+L N + + +++ ++ + L
Sbjct: 168 SDTLEHLNLQYNFIY-DVKG--QVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRN 223
Query: 287 NLFSGFIPNTIGNLRNLEFGNIADNYLTSSTPELSFLSSL 326
N I + +NLE ++ N T F +
Sbjct: 224 NKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQ 262
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-29
Identities = 53/323 (16%), Positives = 107/323 (33%), Gaps = 43/323 (13%)
Query: 115 SLSSFIFNMSSMTTIDLSINRLSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKE 174
++ N + ++ + L + S ++EL+L N LS +
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLK-QAL------ASLRQSAWNVKELDLSGNPLSQISAAD 53
Query: 175 IGNLTKLKEI------ISTITNSTVCEIPREIGNLPYLARLALATNNLVGVVPVTIFNMS 228
+ TKL+ + + ++ +L L L L N + +
Sbjct: 54 LAPFTKLELLNLSSNVLYETL---------DLESLSTLRTLDLNNNYV-----QELLVGP 99
Query: 229 ALKEISLLNNSLSGSLPSRIDLSLPNVETLNLGINSFSGTIPSSITNSSKLSDLELGENL 288
+++ + NN++S + + + L N + S++ L+L N
Sbjct: 100 SIETLHAANNNIS-RVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNE 155
Query: 289 FSGF-IPNTIGNLRNLEFGNIADNYLTSSTPELSFLSSLTNCKKLKVLIVTGNPLDGILP 347
+ LE N+ N++ + KLK L ++ N L +
Sbjct: 156 IDTVNFAELAASSDTLEHLNLQYNFIYD-------VKGQVVFAKLKTLDLSSNKLAFM-G 207
Query: 348 KSIGNFSLSLETILMANCSISGNIPQVVGNLSNLLVLELGGNNLT-GPIPVTFSQLQTLQ 406
+ + + I + N + I + + NL +L GN G + FS+ Q +Q
Sbjct: 208 PEFQSAA-GVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQ 265
Query: 407 AFDLTRNKLAGPITDELCHLARL 429
K +E C + L
Sbjct: 266 TVAKQTVKKLTGQNEEECTVPTL 288
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 9e-29
Identities = 51/323 (15%), Positives = 110/323 (34%), Gaps = 30/323 (9%)
Query: 74 NLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLDFSDNQLFGSLSSFIFNMSSMTTIDLSI 133
N + + ++ + L + S + +K LD S N L ++ + + + ++LS
Sbjct: 8 NGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSS 67
Query: 134 NRLSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKEIGNLTKLKEIISTITNSTV 193
N L E L L L+L N + E+ ++ + N+ +
Sbjct: 68 NVLY-ETLD--------LESLSTLRTLDLNNNYVQ-----ELLVGPSIETL--HAANNNI 111
Query: 194 CEIPREIGNLPYLARLALATNNLVGVVPVTIFNMSALKEISLLNNSLSGSLPSRIDLSLP 253
+ G + LA N + + + S ++ + L N + + + S
Sbjct: 112 SRVSCSRGQG--KKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSD 169
Query: 254 NVETLNLGINSFSGTIPSSITNSSKLSDLELGENLFSGFIPNTIGNLRNLEFGNIADNYL 313
+E LNL N + + +KL L+L N + F+ + + + ++ +N L
Sbjct: 170 TLEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKL 226
Query: 314 TSSTPELSFLSSLTNCKKLKVLIVTGNPLDGILPKSIGNFSLSLETILMANCSISGNIPQ 373
L F +L + + GN + + + ++T+ +
Sbjct: 227 VLIEKALRFSQNLEH------FDLRGNGFHCGTLRDFFSKNQRVQTV---AKQTVKKLTG 277
Query: 374 VVGNLSNLLVLELGGNNLTGPIP 396
+ L G +P
Sbjct: 278 QNEEECTVPTLGHYGAYCCEDLP 300
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 2e-25
Identities = 44/255 (17%), Positives = 86/255 (33%), Gaps = 23/255 (9%)
Query: 248 IDLSLPNVETLNLGINSFSGTIPSSITNSSKLSDLELGENLFSGFIPNTIGNLRNLEFGN 307
I + + + +S + S ++ + +L+L N S + LE N
Sbjct: 5 IKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLN 64
Query: 308 IADNYLTSSTPELSFLSSLT-------------NCKKLKVLIVTGNPLDGILPKSIGNFS 354
++ N L + +L LS+L ++ L N + + S G
Sbjct: 65 LSSNVLYET-LDLESLSTLRTLDLNNNYVQELLVGPSIETLHAANNNISRV-SCSRGQ-- 120
Query: 355 LSLETILMANCSISGNIPQVVGNLSNLLVLELGGNNLTG-PIPVTFSQLQTLQAFDLTRN 413
+ I +AN I+ G S + L+L N + + TL+ +L N
Sbjct: 121 -GKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYN 179
Query: 414 KLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSVRVLYLGLNIFTSVLSSTIWN 473
+ A+L +L L NK + + + V + L N + +
Sbjct: 180 FIY--DVKGQVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLVL-IEKALRF 235
Query: 474 LKDILFIDVSSNFLD 488
+++ D+ N
Sbjct: 236 SQNLEHFDLRGNGFH 250
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 7e-12
Identities = 22/150 (14%), Positives = 53/150 (35%), Gaps = 10/150 (6%)
Query: 371 IPQVVGNLSNLLVLELGGNNLTGPIPVTFSQLQTLQAFDLTRNKLAGPITDELCHLARLH 430
I ++ N + + ++ ++L + ++ DL+ N L+ +L +L
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 431 SLVLQGNKFSGSIPSCLGNLTSVRVLYLGLNIFTSVLSSTIWNLKDILFIDVSSNFLDGP 490
L L N L +L+++R L L N + I + ++N +
Sbjct: 62 LLNLSSNVLY-ETLD-LESLSTLRTLDLNNNYVQE-----LLVGPSIETLHAANNNIS-- 112
Query: 491 LSLDIGNLKVVIGLDFSRNNLSGDIPITIG 520
+ + + + N ++ + G
Sbjct: 113 -RVSCSRGQGKKNIYLANNKITMLRDLDEG 141
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 1e-28
Identities = 76/433 (17%), Positives = 156/433 (36%), Gaps = 60/433 (13%)
Query: 57 LNISSFNLQGTITPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLDFSDNQLFGSL 116
++F +Q T T L++L +LD ++ ++ + I + L L + N + +L
Sbjct: 23 EVAAAFEMQATDTISEEQLATLTSLDCHNSSITD--MTGIEKLTGLTKLICTSNNI-TTL 79
Query: 117 SSFIFNMSSMTTIDLSINRLSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKEIG 176
+ +++T + N+L+ L ++ +L LN N L+ ++
Sbjct: 80 D--LSQNTNLTYLACDSNKLT-NLD---------VTPLTKLTYLNCDTNKLT---KLDVS 124
Query: 177 NLTKLKEIISTITNSTVCEIPREIGNLPYLARLALATNNLVGVVPVTIFNMSALKEISLL 236
L + +T+ EI + + L L N + + VT + L +
Sbjct: 125 QNPLLTYLN--CARNTLTEID--VSHNTQLTELDCHLNKKITKLDVT--PQTQLTTLDCS 178
Query: 237 NNSLSGSLPSRIDLS-LPNVETLNLGINSFSGTIPSSITNSSKLSDLELGENLFSGFIPN 295
N ++ +D+S + LN N+ + + + + +L+ L+ N +
Sbjct: 179 FNKITE-----LDVSQNKLLNRLNCDTNNIT-KLD--LNQNIQLTFLDCSSNKLTEI--- 227
Query: 296 TIGNLRNLEFGNIADNYLTSSTPELSFLSSLTNCKKLKVLIVTGNPLDGILPKSIGNFSL 355
+ L L + + + N LT ++ KL L L I + + +
Sbjct: 228 DVTPLTQLTYFDCSVNPLTE--------LDVSTLSKLTTLHCIQTDLLEI---DLTHNT- 275
Query: 356 SLETILMANCSISGNIPQVVGNLSNLLVLELGGNNLTGPIPVTFSQLQTLQAFDLTRNKL 415
L C + V + + L +L+ +T + SQ L L +L
Sbjct: 276 QLIYFQAEGCRKIKELD--VTHNTQLYLLDCQAAGIT---ELDLSQNPKLVYLYLNNTEL 330
Query: 416 AGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSVRVLYLGLNIFTSVLSSTIWNLK 475
++ H +L SL S +G + ++ + ++ T+ N
Sbjct: 331 T---ELDVSHNTKLKSLSCVNAHIQ-DFSS-VGKIPALNNNFEAEGQTITMPKETLTNNS 385
Query: 476 DILFIDVSSNFLD 488
L I VS + LD
Sbjct: 386 --LTIAVSPDLLD 396
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-22
Identities = 59/432 (13%), Positives = 141/432 (32%), Gaps = 63/432 (14%)
Query: 98 NMHTLKLLDFSDNQLFGSLSSFIFNMSSMTTIDLSINRLSGELPANICKIPSTLSKCKQL 157
N + F + ++++T++D + ++ ++ + K L
Sbjct: 19 NFASEVAAAFEMQAT---DTISEEQLATLTSLDCHNSSIT-DMTG--------IEKLTGL 66
Query: 158 EELNLGFNNLSGAIPKEIGNLTKLKEIISTITNSTVCEIPREIGNLPYLARLALATNNLV 217
+L NN++ ++ T L + ++ + + + L L L TN L
Sbjct: 67 TKLICTSNNITTL---DLSQNTNLTYLA--CDSNKLTNLD--VTPLTKLTYLNCDTNKL- 118
Query: 218 GVVPVTIFNMSALKEISLLNNSLSGSLPSRIDLS-LPNVETLNLGINSFSGTIPSSITNS 276
+ + L ++ N+L + ID+S + L+ +N + +T
Sbjct: 119 --TKLDVSQNPLLTYLNCARNTL-----TEIDVSHNTQLTELDCHLNKKITKLD--VTPQ 169
Query: 277 SKLSDLELGENLFSGFIPNTIGNLRNLEFGNIADNYLT----SSTPELSFLS-------- 324
++L+ L+ N + + + L N N +T + +L+FL
Sbjct: 170 TQLTTLDCSFNKITEL---DVSQNKLLNRLNCDTNNITKLDLNQNIQLTFLDCSSNKLTE 226
Query: 325 -SLTNCKKLKVLIVTGNPLDGILPKSIGNFSLSLETILMANCSISGNIPQVVGNLSNLLV 383
+T +L + NPL + + S L T+ + I + + + L+
Sbjct: 227 IDVTPLTQLTYFDCSVNPLTEL---DVSTLS-KLTTLHCIQTDLL-EID--LTHNTQLIY 279
Query: 384 LELGGNNLTGPIPVTFSQLQTLQAFDLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSI 443
+ G + + L D + +L +L L L + + +
Sbjct: 280 FQAEGCRKIKELD--VTHNTQLYLLDCQAAGIT---ELDLSQNPKLVYLYLNNTELT-EL 333
Query: 444 PSCLGNLTSVRVLYLGLNIFTSVLSSTIWNLKDILFIDVSSNFLDGPLSLDIGNLKVVIG 503
+ + T ++ L S++ + + + + N + I
Sbjct: 334 D--VSHNTKLKSLSCVNAHIQDF--SSVGKIPALNNNFEAEGQTITMPKETLTNNSLTIA 389
Query: 504 LDFSRNNLSGDI 515
+ + G+
Sbjct: 390 VSPDLLDQFGNP 401
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 2e-20
Identities = 62/336 (18%), Positives = 118/336 (35%), Gaps = 37/336 (11%)
Query: 63 NLQGTITPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLDFSDNQLFGSLSSFIFN 122
+ + + L TLD S NK++ + L L+ N + L +
Sbjct: 157 LNKKITKLDVTPQTQLTTLDCSFNKITE---LDVSQNKLLNRLNCDTNNIT-KLD--LNQ 210
Query: 123 MSSMTTIDLSINRLSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKEIGNLTKLK 182
+T +D S N+L+ E+ ++ QL + N L+ + + L+KL
Sbjct: 211 NIQLTFLDCSSNKLT-EID---------VTPLTQLTYFDCSVNPLT-ELD--VSTLSKLT 257
Query: 183 EIISTITNSTVCEIPREIGNLPYLARLALATNNLVGVVPVTIFNMSALKEISLLNNSLSG 242
+ T+ EI + + L + + VT + + L + ++
Sbjct: 258 TLHCIQTDLL--EID--LTHNTQLIYFQAEGCRKIKELDVT--HNTQLYLLDCQAAGIT- 310
Query: 243 SLPSRIDLS-LPNVETLNLGINSFSGTIPSSITNSSKLSDLELGENLFSGFIPNTIGNLR 301
+DLS P + L L + + +++++KL L F +++G +
Sbjct: 311 ----ELDLSQNPKLVYLYLNNTELT-ELD--VSHNTKLKSLSCVNAHIQDF--SSVGKIP 361
Query: 302 NLEFGNIADNYLTSSTPELSFLSSLTNCKKLKVLIVTGNPLDGILPKSIGNFSLSLETIL 361
L A+ + E +SLT +L GNP++ I P G + + TI
Sbjct: 362 ALNNNFEAEGQTITMPKETLTNNSLTIAVSPDLLDQFGNPMN-IEPGDGGVYDQATNTIT 420
Query: 362 MANCSISGNIPQVVGNLSNLLVLELGGNNLTGPIPV 397
N S N ++ P P+
Sbjct: 421 WENLSTDNPAVTYTFTSENGAIVGTVTTPFEAPQPI 456
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 5e-17
Identities = 54/380 (14%), Positives = 123/380 (32%), Gaps = 47/380 (12%)
Query: 140 LPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKEIGNLTKLKEIISTITNSTVCEIPRE 199
L A + + + L L + NS++ ++
Sbjct: 3 LKAGQTQSFNDWFPDDNFASEVAAAFEMQATDTISEEQLATLTSL--DCHNSSITDMT-G 59
Query: 200 IGNLPYLARLALATNNLVGVVPVTIFNMSALKEISLLNNSLSGSLPSRIDLS-LPNVETL 258
I L L +L +NN+ + + + L ++ +N L + +D++ L + L
Sbjct: 60 IEKLTGLTKLICTSNNITT---LDLSQNTNLTYLACDSNKL-----TNLDVTPLTKLTYL 111
Query: 259 NLGINSFSGTIPSSITNSSKLSDLELGENLFSGFIPNTIGNLRNLEFGNIADNYLTSSTP 318
N N + ++ + L+ L N + + + L + N +
Sbjct: 112 NCDTNKLT---KLDVSQNPLLTYLNCARNTLTEI---DVSHNTQLTELDCHLNKKITKLD 165
Query: 319 ELSFLSSLTNCKKLKVLIVTGNPLDGILPKSIGNFSLSLETILMANCSISGNIPQVVGNL 378
+T +L L + N + + + L + +I+ + +
Sbjct: 166 -------VTPQTQLTTLDCSFNKITEL---DVSQNK-LLNRLNCDTNNIT-KLD--LNQN 211
Query: 379 SNLLVLELGGNNLTGPIPVTFSQLQTLQAFDLTRNKLAGPITDELCHLARLHSLVLQGNK 438
L L+ N LT + + L L FD + N L ++ L++L +L
Sbjct: 212 IQLTFLDCSSNKLTE---IDVTPLTQLTYFDCSVNPL---TELDVSTLSKLTTLHCIQTD 265
Query: 439 FSGSIPSCLGNLTSVRVLYLGLNIFTSVLSSTIWNLKDILFIDVSSNFLDGPLSLDIGNL 498
I L + T + L + + + +D + + LD+
Sbjct: 266 LL-EID--LTHNTQLIYFQAEGCRKIKEL--DVTHNTQLYLLDCQAAGIT---ELDLSQN 317
Query: 499 KVVIGLDFSRNNLSGDIPIT 518
++ L + L+ ++ ++
Sbjct: 318 PKLVYLYLNNTELT-ELDVS 336
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 4e-28
Identities = 44/217 (20%), Positives = 69/217 (31%), Gaps = 73/217 (33%)
Query: 618 FSYHELLRATDRFSENNLIGIG----------NGMEVAVKVFHQQYERALKSFEDECEVR 667
L + + G VAVK+F Q ++ S+++E EV
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQDKQ---SWQNEYEVY 70
Query: 668 --KRIRHRNLVKIISSS------------------------------------------- 682
++H N+++ I +
Sbjct: 71 SLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANVVSWNELCHIAETM 130
Query: 683 ---LEYLH-------FGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQ 732
L YLH GH I H D+K NVLL ++ A I+DFG+A
Sbjct: 131 ARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDT 190
Query: 733 TQTLATIGYMAPEY-----GTKGRVSTRGDVCSFGII 764
+ T YMAPE + R D+ + G++
Sbjct: 191 HGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLV 227
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 8e-28
Identities = 88/453 (19%), Positives = 166/453 (36%), Gaps = 44/453 (9%)
Query: 57 LNISSFNLQGTITPQLGNLSSLQTLDLSHNKLSGNIPSSIF-NMHTLKLLDFSDNQLFGS 115
LNIS + T + +LS L+ L +SHN++ + S+F L+ LD S N+L
Sbjct: 26 LNISQNYISELWTSDILSLSKLRILIISHNRIQ-YLDISVFKFNQELEYLDLSHNKL-VK 83
Query: 116 LSSFIFNMSSMTTIDLSINRLSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKEI 175
+S ++ +DLS N LP I QL+ L L +L + I
Sbjct: 84 ISC--HPTVNLKHLDLSFNAFD-ALP-----ICKEFGNMSQLKFLGLSTTHLEKSSVLPI 135
Query: 176 GNLTKLKEIISTITNSTVCEIPREIGNLPYLARLALATNNLVGVVPVTIFNMSALKEISL 235
+L K ++ E + L +L I ++S +L
Sbjct: 136 AHLNISKVLLVLGETYGEKE---DPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANL 192
Query: 236 LNNSLSGSLPSRI------------------DLSLPNVETLNLGINSFSGTIPSSITNSS 277
+++ L +L+L N+ET + +
Sbjct: 193 ELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYF 252
Query: 278 KLSDLELGENLFSGFIPNTIGNLRNLEFGNIADNYLTSSTPELSFLSSLTNCKKLKVLIV 337
+S+++L L + +L+ L + + + +N + +
Sbjct: 253 SISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFP-QSYIYE-IFSN---MNIKNF 307
Query: 338 TGNPLDGILPKSIGNFSLSLETILMANCSISGNIPQVVGNLSNLLVLELGGNNLT--GPI 395
T + + S + +N ++ + + G+L+ L L L N L I
Sbjct: 308 TVSGTRMVHMLCPSKIS-PFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKI 366
Query: 396 PVTFSQLQTLQAFDLTRNKLAGPITDELC-HLARLHSLVLQGNKFSGSIPSCLGNLTSVR 454
+Q+++LQ D+++N ++ C L SL + N + +I CL ++
Sbjct: 367 AEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL--PPRIK 424
Query: 455 VLYLGLNIFTSVLSSTIWNLKDILFIDVSSNFL 487
VL L N S + + L+ + ++V+SN L
Sbjct: 425 VLDLHSNKIKS-IPKQVVKLEALQELNVASNQL 456
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 93.0 bits (231), Expect = 8e-20
Identities = 73/450 (16%), Positives = 147/450 (32%), Gaps = 75/450 (16%)
Query: 80 TLDLSHNKLSGNIPSSIFNMHTLKLLDFSDNQLFGSLSSFIFNMSSMTTIDLSINRLSGE 139
+D S N L ++P + +L+ S N + +S I ++S + + +S NR+
Sbjct: 4 LVDRSKNGLI-HVPKDLSQ--KTTILNISQNYISELWTSDILSLSKLRILIISHNRIQ-Y 59
Query: 140 LPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKEIGNLTKLKEI------ISTITNSTV 193
L ++ K ++LE L+L N L I LK + +
Sbjct: 60 LDISVFK------FNQELEYLDLSHNKLV-KIS--CHPTVNLKHLDLSFNAFDALP---- 106
Query: 194 CEIPREIGNLPYLARLALATNNLVGVVPVTIFNMSALKEISLLNNSLSGSLPSRIDLSLP 253
I +E GN+ L L L+T +L + I +++ K + +L + L
Sbjct: 107 --ICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDP---EGLQ 161
Query: 254 NVETLNLGINSFSGTIPSSITNSSKLSDLELGENLFSGFIPNTIGNLRNLEFGNIADNYL 313
+ T +L I + I + S + L + N++ + N +L
Sbjct: 162 DFNTESLHIVFPTNKEFHFILDVSVKTVANL-----------ELSNIKCVLEDNKCSYFL 210
Query: 314 TSSTPELSFLSSLTNCKKLKVLIVTGNPLDGILPKSIGNFSLSLETILMANCSISGNIPQ 373
S L+ L KL L + I
Sbjct: 211 -------SILAKLQTNPKLSNLTLNNIETTWNSFIRILQLV------------------- 244
Query: 374 VVGNLSNLLVLELGGNNLTGPI-----PVTFSQLQTLQAFDLTRNKLAGPITDELCHLAR 428
+ + + L G + + + L+ L + + P + +
Sbjct: 245 ---WHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSN 301
Query: 429 LHSLVLQGNKFSGSIPSCLGNLTSVRVLYLGLNIFTSVLSSTIWNLKDILFIDVSSNFLD 488
++ + C ++ L N+ T + +L ++ + + N L
Sbjct: 302 MNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLK 361
Query: 489 --GPLSLDIGNLKVVIGLDFSRNNLSGDIP 516
++ +K + LD S+N++S D
Sbjct: 362 ELSKIAEMTTQMKSLQQLDISQNSVSYDEK 391
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 79.9 bits (197), Expect = 1e-15
Identities = 46/307 (14%), Positives = 112/307 (36%), Gaps = 24/307 (7%)
Query: 27 NLFARNWTSSTSVCIWIGITCDVNSHRVIGLNISSFNLQGTITPQLGNLSSLQTLDLSHN 86
L + S+ + +++ + + + + QL +++ +S+
Sbjct: 200 VLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSF--IRILQLVWHTTVWYFSISNV 257
Query: 87 KLSGNIPSSIF-----NMHTLKLLDFSDNQLFGSLSSFIFNMSSMTTIDLSINRLSGELP 141
KL G + F ++ L + + S S+M + +++ +
Sbjct: 258 KLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTR-MVH 316
Query: 142 ANICKIPSTLSKCKQLEELNLGFNNLSGAIPKEIGNLTKLKEIISTITNSTVCEIPREIG 201
SK L+ N L+ + + G+LT+L+ +I + + + E+ +
Sbjct: 317 MLCP------SKISPFLHLDFSNNLLTDTVFENCGHLTELETLI--LQMNQLKELSKIAE 368
Query: 202 ---NLPYLARLALATNNLVGVVPVTIF-NMSALKEISLLNNSLSGSLPSRIDLSLPNVET 257
+ L +L ++ N++ +L +++ +N L+ ++ + P ++
Sbjct: 369 MTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL---PPRIKV 425
Query: 258 LNLGINSFSGTIPSSITNSSKLSDLELGENLFSGFIPNTIGNLRNLEFGNIADNYLTSST 317
L+L N +IP + L +L + N L +L+ + N S
Sbjct: 426 LDLHSNKIK-SIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSC 484
Query: 318 PELSFLS 324
P + +LS
Sbjct: 485 PRIDYLS 491
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 9e-28
Identities = 46/167 (27%), Positives = 70/167 (41%), Gaps = 45/167 (26%)
Query: 643 EVAVKVFHQQY--ERALKSFEDECEVRKRIRHRNLVK-----------II------SSSL 683
+VAVK+ + + L++F++E V ++ RH N++ I+ SS
Sbjct: 48 DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQLAIVTQWCEGSSLY 107
Query: 684 EYLH-------------------FG----HSIPIIHCDLKPSNVLLDEDMVAHISDFGIA 720
+LH G H+ IIH DLK +N+ L ED I DFG+A
Sbjct: 108 HHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLA 167
Query: 721 KLLSGEDQLSKQTQTLATIGYMAPE---YGTKGRVSTRGDVCSFGII 764
S + Q +I +MAPE S + DV +FGI+
Sbjct: 168 TEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIV 214
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 3e-26
Identities = 43/176 (24%), Positives = 68/176 (38%), Gaps = 51/176 (28%)
Query: 637 GIGNGMEVAVKVFHQQY--ERALKSFEDECEVRKRIRHRNLVK------------IIS-- 680
+G +VAVK+ +Q + F E + KR+RH N+V I++
Sbjct: 56 AEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEY 115
Query: 681 ---SSL-----------------------------EYLHFGHSIPIIHCDLKPSNVLLDE 708
SL YLH + PI+H +LK N+L+D+
Sbjct: 116 LSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH-NRNPPIVHRNLKSPNLLVDK 174
Query: 709 DMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGII 764
+ DFG+++L + T +MAPE + + DV SFG+I
Sbjct: 175 KYTVKVCDFGLSRLKA--STFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVI 228
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-25
Identities = 67/419 (15%), Positives = 128/419 (30%), Gaps = 52/419 (12%)
Query: 76 SSLQTLDLSHNKLSGNIPSSIF-NMHTLKLLDFSDNQLFGSLSSFIF-NMSSMTTIDLSI 133
+ + +DLS N ++ + + F + L+ L + + F +SS+ + L
Sbjct: 30 AHVNYVDLSLNSIA-ELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDY 88
Query: 134 NRLSGELPANICKIPSTLSKCKQLEELNLGFNNL-SGAIPKEI-GNLTKLKEIISTITNS 191
N+ +L + LE L L NL + LT L+
Sbjct: 89 NQFL-QLE------TGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEM-------- 133
Query: 192 TVCEIPREIGNLPYLARLALATNNLVGVVPVTIF-NMSALKEISLLNNSLSGSLPSRI-- 248
L L NN+ + P + F NM + L N + S+
Sbjct: 134 -----------------LVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVK-SICEEDLL 175
Query: 249 DLSLPNVETLNLGINSFSGTIPSSITNSSKLSDLELGENLFSGFIPNTIGNLRNLEFGNI 308
+ + L L ++ + ++ T +L F
Sbjct: 176 NFQGKHFTLLRLSSI--------TLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKES 227
Query: 309 ADNYLTSSTPELSFLSSLTNCKKLKVLIVTGNPLDGILPKS-IGNFSLSLETILMANCSI 367
+ S + + + G + ++T ++ I
Sbjct: 228 MAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKI 287
Query: 368 SGNIPQVVGNLSNLLVLELGGNNLTGPIPVTFSQLQTLQAFDLTRNKLAGPITDELCHLA 427
+ V + ++L L L N + F L L +L++N L + +L
Sbjct: 288 FALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLD 347
Query: 428 RLHSLVLQGNKFSGSIPSCL-GNLTSVRVLYLGLNIFTSVLSSTIWNLKDILFIDVSSN 485
+L L L N ++ L +++ L L N SV L + I + +N
Sbjct: 348 KLEVLDLSYNHIR-ALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 405
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 3e-23
Identities = 70/421 (16%), Positives = 132/421 (31%), Gaps = 73/421 (17%)
Query: 61 SFNLQGTITPQ-LGNLSSLQTLDLSHNKLSGNIPSSIF-NMHTLKLLDFSDNQLFGSLSS 118
S N + L LQ L + I ++ F + +L +L NQ L +
Sbjct: 38 SLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQF-LQLET 96
Query: 119 FIF-NMSSMTTIDLSINRL-SGELPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKEI- 175
F ++++ + L+ L L N LE L L NN+ P
Sbjct: 97 GAFNGLANLEVLTLTQCNLDGAVLSGNF------FKPLTSLEMLVLRDNNIKKIQPASFF 150
Query: 176 GNLTKLKEI------ISTITNST---VCEIPREIGNLPYLARLALATNNLVGVVPVTIFN 226
N+ + + + +I + L + + L F
Sbjct: 151 LNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFK 210
Query: 227 MSALKEISLLNNSLSGSLPSRIDLSLPNVETLNLGINSFSGTIPSSITNSSKLSDLELGE 286
+++ + L N S+ R ++ + +L +++
Sbjct: 211 NTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNS--------------------Y 250
Query: 287 NLFSGFIPNTIGNLRNLEFGNIADNYLTSSTPELSFLSSL-----TNCKKLKVLIVTGNP 341
N+ S F + N F + + + + S + +L ++ L+ L + N
Sbjct: 251 NMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNE 310
Query: 342 LDGILPKSIGNFSLSLETILMANCSISGNIPQVVGNLSNLLVLELGGNNLTGPIPVTFSQ 401
++ ++ L++LL L L N L F
Sbjct: 311 IN------------KID-------------DNAFWGLTHLLKLNLSQNFLGSIDSRMFEN 345
Query: 402 LQTLQAFDLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPS-CLGNLTSVRVLYLGL 460
L L+ DL+ N + L L L L N+ S+P LTS++ ++L
Sbjct: 346 LDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHT 404
Query: 461 N 461
N
Sbjct: 405 N 405
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 5e-17
Identities = 57/340 (16%), Positives = 113/340 (33%), Gaps = 40/340 (11%)
Query: 204 PYLARLALATNNLVGVVPVTIFNMSALKEISLLNNSLSGSLPSRIDLSLPNVETLNLGIN 263
++ + L+ N++ + + + L+ + + + + + L ++ L L N
Sbjct: 30 AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYN 89
Query: 264 SFSGTIPSSI-TNSSKLSDLELGEN-LFSGFIPNTI-GNLRNLEFGNIADNYLTSSTPEL 320
F + + + L L L + L + L +LE + DN + P
Sbjct: 90 QFL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPAS 148
Query: 321 SFLSSLTNCKKLKVLIVTGNPLDGILPKSIGNFSLSLETIL---------MANCSISGNI 371
F ++ VL +T N + I + + NF T+L M +
Sbjct: 149 FF-LNMRR---FHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEK 204
Query: 372 PQVVGNLSNLLVLELGGNNLTGPIPVTFSQLQTLQAF-------------DLTRNKLAGP 418
+++ L+L GN + F P
Sbjct: 205 CGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDP 264
Query: 419 ITDELCHLAR--LHSLVLQGNKFSGSIPSCL-GNLTSVRVLYLGLNIFTSVLSSTIWNLK 475
L + + L +K ++ + + T + L L N + + W L
Sbjct: 265 DNFTFKGLEASGVKTCDLSKSKIF-ALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLT 323
Query: 476 DILFIDVSSNFLDGPLSLDIG---NLKVVIGLDFSRNNLS 512
+L +++S NFL S+D NL + LD S N++
Sbjct: 324 HLLKLNLSQNFLG---SIDSRMFENLDKLEVLDLSYNHIR 360
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 6e-13
Identities = 54/272 (19%), Positives = 96/272 (35%), Gaps = 24/272 (8%)
Query: 74 NLSSLQTLDLSHNKLSGNIPSSIF-----------NMHTLKLLDFSDNQLFGSLSSFIFN 122
N+ LDL+ NK+ +I + ++ L D ++ L F
Sbjct: 152 NMRRFHVLDLTFNKVK-SICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFK 210
Query: 123 MSSMTTIDLSINRLSGELPANIC------KIPSTLSKCKQLEELNLGFNNLSGAIPKEIG 176
+S+TT+DLS N + KI S + + G N
Sbjct: 211 NTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFK 270
Query: 177 NLTKLKEIISTITNSTVCEIPREI-GNLPYLARLALATNNLVGVVPVTIF-NMSALKEIS 234
L ++ S + + + + + L +L LA N + + F ++ L +++
Sbjct: 271 GLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEIN-KIDDNAFWGLTHLLKLN 329
Query: 235 LLNNSLSGSLPSRIDLSLPNVETLNLGINSFSGTIPSSI-TNSSKLSDLELGENLFSGFI 293
L N L S+ SR+ +L +E L+L N + L +L L N
Sbjct: 330 LSQNFLG-SIDSRMFENLDKLEVLDLSYNHIR-ALGDQSFLGLPNLKELALDTNQLKSVP 387
Query: 294 PNTIGNLRNLEFGNIADNYLTSSTPELSFLSS 325
L +L+ + N S P + +LS
Sbjct: 388 DGIFDRLTSLQKIWLHTNPWDCSCPRIDYLSR 419
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 4e-12
Identities = 49/227 (21%), Positives = 91/227 (40%), Gaps = 30/227 (13%)
Query: 57 LNISSFNLQGTITPQLGNLSSLQTLDLSHNKLSGNIPSSIFN-MHTLKLLDFSDNQLFGS 115
+++ + L +S+ TLDLS N ++ F+ + K+ + +
Sbjct: 193 QDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNM 252
Query: 116 LSSFIFN--------------MSSMTTIDLSINRLSGELPANICKIPSTLSKCKQLEELN 161
SSF S + T DLS +++ L ++ S LE+L
Sbjct: 253 GSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIF-ALLKSVF------SHFTDLEQLT 305
Query: 162 LGFNNLSGAIPKEI-GNLTKLKEIISTITNSTVCEIPREI-GNLPYLARLALATNNLVGV 219
L N ++ I LT L ++ ++ + + I + NL L L L+ N++
Sbjct: 306 LAQNEIN-KIDDNAFWGLTHLLKL--NLSQNFLGSIDSRMFENLDKLEVLDLSYNHI-RA 361
Query: 220 VPVTIF-NMSALKEISLLNNSLSGSLPSRIDLSLPNVETLNLGINSF 265
+ F + LKE++L N L S+P I L +++ + L N +
Sbjct: 362 LGDQSFLGLPNLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTNPW 407
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 7e-25
Identities = 47/225 (20%), Positives = 68/225 (30%), Gaps = 81/225 (36%)
Query: 618 FSYHELLRATDRFSENNLIGIG----------NGMEVAVKVFHQQYERALKSFEDECEVR 667
+ E D LIG G + VAVKVF + +F +E +
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFANRQ---NFINEKNIY 59
Query: 668 K--RIRHRNLVKIISSS------------------------------------------- 682
+ + H N+ + I
Sbjct: 60 RVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRLAHS 119
Query: 683 ----LEYLH------FGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQ 732
L YLH + I H DL NVL+ D ISDFG++ L+G +
Sbjct: 120 VTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPG 179
Query: 733 TQTLA------TIGYMAPEY-------GTKGRVSTRGDVCSFGII 764
+ A TI YMAPE + D+ + G+I
Sbjct: 180 EEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLI 224
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-24
Identities = 44/173 (25%), Positives = 60/173 (34%), Gaps = 52/173 (30%)
Query: 637 GIGNGMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVKI------------------ 678
+VA+K + ER K+F E R+ H N+VK+
Sbjct: 27 AKWRAKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYGACLNPVCLVMEYAEGG 84
Query: 679 --------------------------ISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDM-V 711
S + YLH +IH DLKP N+LL V
Sbjct: 85 SLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTV 144
Query: 712 AHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGII 764
I DFG A + + T + +MAPE S + DV S+GII
Sbjct: 145 LKICDFGTACDIQ-----THMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGII 192
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 57/272 (20%), Positives = 98/272 (36%), Gaps = 42/272 (15%)
Query: 76 SSLQTLDLSHNKLSGNIPSSIF-NMHTLKLLDFSDNQL-FGSLSSFIF-NMSSMTTIDLS 132
SS L+L NKL ++P +F + L L S N L F S +S+ +DLS
Sbjct: 28 SSATRLELESNKLQ-SLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLS 86
Query: 133 INRLSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKEIGNLTKLKEIISTITNST 192
N + + S +QLE L+ +NL +
Sbjct: 87 FNGVI--------TMSSNFLGLEQLEHLDFQHSNLKQMSEFSV----------------- 121
Query: 193 VCEIPREIGNLPYLARLALATNNLVGVVPVTIF-NMSALKEISLLNNSLSGSLPSRIDLS 251
+L L L ++ + V IF +S+L+ + + NS + I
Sbjct: 122 -------FLSLRNLIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTE 173
Query: 252 LPNVETLNLGINSFSGTIPSSITNSSKLSDLELGENLFSGFIPNTIGNLRNLEFGNIADN 311
L N+ L+L P++ + S L L + N F L +L+ + + N
Sbjct: 174 LRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLN 233
Query: 312 YLTSSTPELSFLSSLTNCKKLKVLIVTGNPLD 343
++ +S + ++ L L +T N
Sbjct: 234 HIMTS-KKQELQHFPSS---LAFLNLTQNDFA 261
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 2e-19
Identities = 53/241 (21%), Positives = 95/241 (39%), Gaps = 19/241 (7%)
Query: 57 LNISSFNLQGTITPQLGNLSSLQTLDLSHNKLS-GNIPSSIF-NMHTLKLLDFSDNQLFG 114
L + S LQ L+ L L LS N LS S +LK LD S N +
Sbjct: 33 LELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGV-I 91
Query: 115 SLSSFIFNMSSMTTIDLSINRLSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKE 174
++SS + + +D + L ++ S + L L++ +
Sbjct: 92 TMSSNFLGLEQLEHLDFQHSNLK-QMSE-----FSVFLSLRNLIYLDISHTHTR-VAFNG 144
Query: 175 I-GNLTKLKEI-ISTITNSTVCEIPREI-GNLPYLARLALATNNLVGVVPVTIFNMSALK 231
I L+ L+ + ++ NS +I L L L L+ L + P ++S+L+
Sbjct: 145 IFNGLSSLEVLKMA--GNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQ 202
Query: 232 EISLLNNSLSGSLPSRIDLSLPNVETLNLGINSFSGTIPSSI--TNSSKLSDLELGENLF 289
+++ +N+ SL + L +++ L+ +N T S L+ L L +N F
Sbjct: 203 VLNMSHNNFF-SLDTFPYKCLNSLQVLDYSLNHIM-TSKKQELQHFPSSLAFLNLTQNDF 260
Query: 290 S 290
+
Sbjct: 261 A 261
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 5e-18
Identities = 51/259 (19%), Positives = 100/259 (38%), Gaps = 14/259 (5%)
Query: 231 KEISLLNNSLSGSLPSRIDLSLPNVETLNLGINSFSGTIPSSITNSSKLSDLELGENL-- 288
EI + L+ S+P+ I + L L N ++L+ L L N
Sbjct: 10 TEIRCNSKGLT-SVPTGI---PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLS 65
Query: 289 FSGFIPNTIGNLRNLEFGNIADNYLTSSTPELSFLSSLTNCKKLKVLIVTGNPLDGILPK 348
F G + +L++ +++ N + + + L L L + L +
Sbjct: 66 FKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLE------HLDFQHSNLKQMSEF 119
Query: 349 SIGNFSLSLETILMANCSISGNIPQVVGNLSNLLVLELGGNN-LTGPIPVTFSQLQTLQA 407
S+ +L + +++ + LS+L VL++ GN+ +P F++L+ L
Sbjct: 120 SVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTF 179
Query: 408 FDLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSVRVLYLGLNIFTSVL 467
DL++ +L L+ L L + N F L S++VL LN +
Sbjct: 180 LDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSK 239
Query: 468 SSTIWNLKDIL-FIDVSSN 485
+ + L F++++ N
Sbjct: 240 KQELQHFPSSLAFLNLTQN 258
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 9e-18
Identities = 56/270 (20%), Positives = 96/270 (35%), Gaps = 35/270 (12%)
Query: 195 EIPREIGNLPYLARLALATNNLVGVVPVTIFNMSALKEISLLNNSLS-GSLPSRIDLSLP 253
+P I RL L +N L + ++ L ++SL +N LS S+ D
Sbjct: 21 SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTT 78
Query: 254 NVETLNLGINSFSGTIPSSITNSSKLSDLELGENLFSGFIPNTI-GNLRNLEFGNIADNY 312
+++ L+L N T+ S+ +L L+ + ++ +LRNL + +I+ +
Sbjct: 79 SLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTH 137
Query: 313 LTSSTPELSFLSSLTNCKKLKVLIVTGNPLDGILPKSIGNFSLSLETILMANCSISGNIP 372
+ + L+VL + GN +P
Sbjct: 138 TRVAFNGI-----FNGLSSLEVLKMAGNSF------------------------QENFLP 168
Query: 373 QVVGNLSNLLVLELGGNNLTGPIPVTFSQLQTLQAFDLTRNKLAGPITDELCHLARLHSL 432
+ L NL L+L L P F+ L +LQ +++ N T L L L
Sbjct: 169 DIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVL 228
Query: 433 VLQGNKFSGSIPSCLGNL-TSVRVLYLGLN 461
N S L + +S+ L L N
Sbjct: 229 DYSLNHIMTSKKQELQHFPSSLAFLNLTQN 258
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 2e-11
Identities = 36/185 (19%), Positives = 67/185 (36%), Gaps = 6/185 (3%)
Query: 332 LKVLIVTGNPLDGILPKSIGNFSLSLETILMANCSIS--GNIPQVVGNLSNLLVLELGGN 389
L + N L + + L + +++ +S G Q ++L L+L N
Sbjct: 30 ATRLELESNKLQSLPHGVFDKLT-QLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFN 88
Query: 390 NLTGPIPVTFSQLQTLQAFDLTRNKLAG-PITDELCHLARLHSLVLQGNKFSGSIPSCLG 448
+ + F L+ L+ D + L L L L + +
Sbjct: 89 GVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFN 147
Query: 449 NLTSVRVLYLGLNIFTSVLSSTIW-NLKDILFIDVSSNFLDGPLSLDIGNLKVVIGLDFS 507
L+S+ VL + N F I+ L+++ F+D+S L+ +L + L+ S
Sbjct: 148 GLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMS 207
Query: 508 RNNLS 512
NN
Sbjct: 208 HNNFF 212
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 5e-24
Identities = 38/182 (20%), Positives = 65/182 (35%), Gaps = 58/182 (31%)
Query: 637 GIGNGMEVAVKVFHQQ----YERALKSFEDECEVRKRIRHRNLVKI-------------- 678
G EVAVK + +++ E ++ ++H N++ +
Sbjct: 26 AFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVM 85
Query: 679 ----------------------------ISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDM 710
I+ + YLH +PIIH DLK SN+L+ + +
Sbjct: 86 EFARGGPLNRVLSGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKV 145
Query: 711 VAH--------ISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFG 762
I+DFG+A+ ++S +MAPE S DV S+G
Sbjct: 146 ENGDLSNKILKITDFGLAREWHRTTKMS----AAGAYAWMAPEVIRASMFSKGSDVWSYG 201
Query: 763 II 764
++
Sbjct: 202 VL 203
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 29/180 (16%), Positives = 53/180 (29%), Gaps = 60/180 (33%)
Query: 637 GIGNGMEVAVKVFHQQY--ERALKSFEDECEVRKRIRHRNLVKI---------------- 678
G G ++ VKV + R + F +EC + H N++ +
Sbjct: 29 GRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT 88
Query: 679 -------------------------------ISSSLEYLHFGHSIPIIHCDLKPSNVLLD 707
++ + +LH I L +V++D
Sbjct: 89 HWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH-TLEPLIPRHALNSRSVMID 147
Query: 708 EDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPE---YGTKGRVSTRGDVCSFGII 764
EDM A IS + + ++APE + D+ SF ++
Sbjct: 148 EDMTARISMADVKFSFQ-------SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVL 200
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 5e-23
Identities = 32/182 (17%), Positives = 59/182 (32%), Gaps = 62/182 (34%)
Query: 639 GNGMEVAVKVFHQQ-------YERALKSFEDECEVRKRIRHRNLVKI------------- 678
+ VA+K + F+ E + + H N+VK+
Sbjct: 42 KDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPPRMVME 101
Query: 679 -----------------------------ISSSLEYLHFGHSIPIIHCDLKPSNVLLDE- 708
I+ +EY+ + PI+H DL+ N+ L
Sbjct: 102 FVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ-NQNPPIVHRDLRSPNIFLQSL 160
Query: 709 ----DMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPE--YGTKGRVSTRGDVCSFG 762
+ A ++DFG+++ + L +MAPE + + + D SF
Sbjct: 161 DENAPVCAKVADFGLSQQSV-----HSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFA 215
Query: 763 II 764
+I
Sbjct: 216 MI 217
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 8e-23
Identities = 40/177 (22%), Positives = 64/177 (36%), Gaps = 56/177 (31%)
Query: 643 EVAVKVFHQQY--ERALKSFEDECEVRKRIRHRNLVK------------IISS-----SL 683
EVA+++ + E LK+F+ E ++ RH N+V II+S +L
Sbjct: 57 EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTL 116
Query: 684 -EYLH-------------------FG----HSIPIIHCDLKPSNVLLDEDMVAHISDFGI 719
+ G H+ I+H DLK NV D V I+DFG+
Sbjct: 117 YSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYDNGKV-VITDFGL 175
Query: 720 AKLLSGEDQLSKQTQTLA---TIGYMAPE---------YGTKGRVSTRGDVCSFGII 764
+ ++ + + ++APE K S DV + G I
Sbjct: 176 FSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTI 232
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-22
Identities = 62/357 (17%), Positives = 109/357 (30%), Gaps = 100/357 (28%)
Query: 67 TITPQLGNLSSLQTLDLSHNKLSGNIPSSIF----NMHTLKLLDFSDNQLFGSLSSFIFN 122
+I + N SL + + +N +S + F L + N+ L + N
Sbjct: 2 SIMLPINNNFSL-SQNSFYNTIS-GTYADYFSAWDKWEKQALPGENRNEAVSLLKECLIN 59
Query: 123 MSSMTTIDLSINRLSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKEIGNLTKLK 182
+ + L+ LS LP N+ Q+ L + N L ++P+ +L L
Sbjct: 60 --QFSELQLNRLNLS-SLPDNLPP---------QITVLEITQNALI-SLPELPASLEYL- 105
Query: 183 EIISTITNSTVCEIPREIGNLPYLARLALATNNLVGVVPVTIFNMSALKEISLLNNSLSG 242
+N LS
Sbjct: 106 ---------------------------------------------------DACDNRLS- 113
Query: 243 SLPSRIDLSLPNVETLNLGINSFSGTIPSSITNSSKLSDLELGENLFSGFIPNTIGNLRN 302
+LP +++ L++ N + +P L + N + +P +L
Sbjct: 114 TLPE----LPASLKHLDVDNNQLT-MLPELPAL---LEYINADNNQLT-MLPELPTSLEV 164
Query: 303 LEFGNIADNYLTSSTPELSFLSSLTNCKKLKVLIVTGNPLDGILPKSIGNFSLSLETILM 362
L ++ +N LT L+ L V+ N L+ LP S ET +
Sbjct: 165 L---SVRNNQLTFLPELPE---------SLEALDVSTNLLES-LPAVPVRNHHSEETEIF 211
Query: 363 ANCSISGN----IPQVVGNLSNLLVLELGGNNLTGPIPVTFSQLQTLQAFDLTRNKL 415
C N IP+ + +L + L N L+ I + SQ + R
Sbjct: 212 FRCR--ENRITHIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYF 266
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 98.9 bits (246), Expect = 1e-21
Identities = 48/262 (18%), Positives = 93/262 (35%), Gaps = 37/262 (14%)
Query: 57 LNISSFNL-QGTITPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLDFSDNQLFGS 115
+ N + + ++ L L+ LS ++P ++ + +L+ + N L S
Sbjct: 39 QALPGENRNEAVSLLKECLINQFSELQLNRLNLS-SLPDNLPP--QITVLEITQNAL-IS 94
Query: 116 LSSFIFNMSSMTTIDLSINRLSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKEI 175
L +S+ +D NRLS LP L+ L++ N L+ +P+
Sbjct: 95 LPELP---ASLEYLDACDNRLS-TLPELPA----------SLKHLDVDNNQLT-MLPELP 139
Query: 176 GNLTKLKEIISTITNSTVCEIPREIGNLPYLARLALATNNLVGVVPVTIFNMSALKEISL 235
L + N+ + +P + L L++ N L +P + L+ + +
Sbjct: 140 ALLEYIN-----ADNNQLTMLPELPTS---LEVLSVRNNQL-TFLPELPES---LEALDV 187
Query: 236 LNNSLSGSLPSRID--LSLPNVET-LNLGINSFSGTIPSSITNSSKLSDLELGENLFSGF 292
N L SLP+ E N + IP +I + + L +N S
Sbjct: 188 STNLLE-SLPAVPVRNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSR 245
Query: 293 IPNTIGNLRNLEFGNIADNYLT 314
I ++ + Y +
Sbjct: 246 IRESLSQQTAQPDYHGPRIYFS 267
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 90.4 bits (224), Expect = 6e-19
Identities = 54/309 (17%), Positives = 99/309 (32%), Gaps = 63/309 (20%)
Query: 171 IPKEIGNLTKLKEIIS-TITNSTVCEIPREIGNLPYLARLALATNNLVGVVPVTIFNMSA 229
I I N L + + T + A N V ++ + N
Sbjct: 3 IMLPINNNFSLSQNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECLIN--Q 60
Query: 230 LKEISLLNNSLSGSLPSRIDLSLPNVETLNLGINSFSGTIPSSITNSSKLSDLELGENLF 289
E+ L +LS SLP + P + L + N+ ++P + L L+ +N
Sbjct: 61 FSELQLNRLNLS-SLPDNL---PPQITVLEITQNALI-SLPELPAS---LEYLDACDNRL 112
Query: 290 SGFIPNTIGNLRNLEFGNIADNYLTSSTPELSFLSSLTNCKKLKVLIVTGNPLDGILPKS 349
S +P +L++L ++ +N LT + L+ + N L LP+
Sbjct: 113 S-TLPELPASLKHL---DVDNNQLTMLPELPA---------LLEYINADNNQLTM-LPEL 158
Query: 350 IGNFSLSLETILMANCSISGNIPQVVGNLSNLLVLELGGNNLTGPIPVTFSQLQTLQAFD 409
+ L VL + N LT +P L+ L D
Sbjct: 159 PTS----------------------------LEVLSVRNNQLTF-LPELPESLEAL---D 186
Query: 410 LTRNKLAGPITDELCHLARLHS----LVLQGNKFSGSIPSCLGNLTSVRVLYLGLNIFTS 465
++ N L + + N+ + IP + +L + L N +S
Sbjct: 187 VSTNLLES-LPAVPVRNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSS 244
Query: 466 VLSSTIWNL 474
+ ++
Sbjct: 245 RIRESLSQQ 253
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 81.6 bits (201), Expect = 3e-16
Identities = 53/291 (18%), Positives = 97/291 (33%), Gaps = 39/291 (13%)
Query: 55 IGLNISSFNLQGTITPQLGNL----SSLQTLDLSHNKLSGNIPSSIFNMHTLKLLDFSDN 110
+ I+ + L +L +SL+ LD N+LS +P + LK LD +N
Sbjct: 78 LPPQITVLEITQN---ALISLPELPASLEYLDACDNRLS-TLPELPAS---LKHLDVDNN 130
Query: 111 QLFGSLSSFIFNMSSMTTIDLSINRLSGELPANICK-------------IPSTLSKCKQL 157
QL L + + I+ N+L+ LP +P L
Sbjct: 131 QL-TMLPELP---ALLEYINADNNQLT-MLPELPTSLEVLSVRNNQLTFLPELPE---SL 182
Query: 158 EELNLGFNNLSGAIPKEIGNLTKLKEIISTITNST--VCEIPREIGNLPYLARLALATNN 215
E L++ N L ++P +E + IP I +L + L N
Sbjct: 183 EALDVSTNLLE-SLPAVPVRNHHSEETEIFFRCRENRITHIPENILSLDPTCTIILEDNP 241
Query: 216 LVGVVPVTIFNMSALKEISLLNNSLSGSLPSRIDLSLPNVETLNLGINSFSGTIPSSITN 275
L + ++ +A + S S + L P + + F S ++
Sbjct: 242 LSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQNTLHRPLADAVT---AWFPENKQSDVSQ 298
Query: 276 SSKLSDLELGENLFSGFIPNTIGNLRNLEFGNIADNYLTSSTPELSFLSSL 326
+ E N FS + + + + + + + +LS + L
Sbjct: 299 IWHAFEHEEHANTFS-AFLDRLSDTVSARNTSGFREQVAAWLEKLSASAEL 348
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 71.5 bits (175), Expect = 5e-13
Identities = 49/277 (17%), Positives = 98/277 (35%), Gaps = 38/277 (13%)
Query: 240 LSGSLPSRIDLSLPNVETLNLGINSFSGTIPSSITNSSKLSDLELGENLFSGFIPNTIGN 299
+S LP + SL N I+ S+ K + N + +
Sbjct: 1 MSIMLPINNNFSLSQNSFYNT-ISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECL-- 57
Query: 300 LRNLEFGNIADNYLTSSTPELSFLSSLTNCKKLKVLIVTGNPLDGILPKSIGNFSLSLET 359
+ + L+S L ++ VL +T N L LP+ + LE
Sbjct: 58 INQFSELQLNRLNLSSLPDNL--------PPQITVLEITQNALI-SLPELPAS----LEY 104
Query: 360 ILMANCSISGNIPQVVGNLSNLLVLELGGNNLTGPIPVTFSQLQTLQAFDLTRNKLAGPI 419
+ + +S +P++ +L +L ++ N LT +P + L+ + + N+L +
Sbjct: 105 LDACDNRLS-TLPELPASLKHL---DVDNNQLTM-LPELPALLEYI---NADNNQLTM-L 155
Query: 420 TDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSVRVLYLGLNIFTSVLSSTIWNL----K 475
+ L L ++ N+ + +P +L L + N+ S L + +
Sbjct: 156 PELPTSLEVLS---VRNNQLT-FLPELPESL---EALDVSTNLLES-LPAVPVRNHHSEE 207
Query: 476 DILFIDVSSNFLDGPLSLDIGNLKVVIGLDFSRNNLS 512
+F N + + +I +L + N LS
Sbjct: 208 TEIFFRCRENRITH-IPENILSLDPTCTIILEDNPLS 243
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 3e-22
Identities = 80/450 (17%), Positives = 157/450 (34%), Gaps = 54/450 (12%)
Query: 74 NLSSLQTLDLSHNKLSGNIPSSIF-NMHTLKLLDFSDNQLFGSLSSFIFNMSSMTTIDLS 132
LS L+ L LSHN++ ++ +F L+ LD S N+L ++S +S+ +DLS
Sbjct: 74 FLSELRVLRLSHNRIR-SLDFHVFLFNQDLEYLDVSHNRL-QNISCCPM--ASLRHLDLS 129
Query: 133 INRLSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKEIGNLTKLKEIISTITNST 192
N LP + +L L L + +L L I+ + +
Sbjct: 130 FNDFD-VLP-----VCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHL-HLSCILLDLVSYH 182
Query: 193 VCEIPREIGNLPYLARLALATNNLVGVVPVTIFNMSALKEISLLNNSLSGS--------- 243
+ E +P L L + +++AL + L N L+
Sbjct: 183 IKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFL 242
Query: 244 -----LPSRIDLSLPNVETLNLGINSFSGTIPSSITNSSKLSDLELGENLFSGFIPNTIG 298
P+ ++++L ++ET + +L + E + +
Sbjct: 243 SELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSET 302
Query: 299 NLRNLEFGNIADNYLTSSTPEL-SFLSSLT------------------NCKKLKVLIVTG 339
L++L ++ + S L S + + + L T
Sbjct: 303 ALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQ 362
Query: 340 NPLDGILPKSIGNFSLSLETILMANCSISGNIPQVVGNLSNLLVLELGGNNLT----GPI 395
N + + L+T+++ + N +V N+ LE +L
Sbjct: 363 NVFTDSVFQGCSTLK-RLQTLILQRNGLK-NFFKVALMTKNMSSLETLDVSLNSLNSHAY 420
Query: 396 PVTFSQLQTLQAFDLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSVRV 455
T + +++ +L+ N L G + L ++ L L N+ SIP + +L +++
Sbjct: 421 DRTCAWAESILVLNLSSNMLTGSVFRCL--PPKVKVLDLHNNRIM-SIPKDVTHLQALQE 477
Query: 456 LYLGLNIFTSVLSSTIWNLKDILFIDVSSN 485
L + N SV L + +I + N
Sbjct: 478 LNVASNQLKSVPDGVFDRLTSLQYIWLHDN 507
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 87.6 bits (217), Expect = 4e-18
Identities = 79/471 (16%), Positives = 148/471 (31%), Gaps = 78/471 (16%)
Query: 58 NISSFNLQGTITPQLGNLS-----SLQTLDLSHNKLS---GNIPSSIFNMHTLKLLDFSD 109
+ SF+ + +G+++ +D S+ L+ ++P K L S
Sbjct: 8 IVGSFHFVCALALIVGSMTPFSNELESMVDYSNRNLTHVPKDLPP------RTKALSLSQ 61
Query: 110 NQLFGSLSSFIF-NMSSMTTIDLSINRLSGELPANICKIPSTLSKCKQLEELNLGFNNLS 168
N + L +S + + LS NR+ L ++ + LE L++ N L
Sbjct: 62 NSIS-ELRMPDISFLSELRVLRLSHNRIR-SLDFHVFL------FNQDLEYLDVSHNRLQ 113
Query: 169 GAIPKEIGNLTKLKEIISTITNSTVCEIPREIGNLPYLARLALATNNLVGVVPVTIF-NM 227
I + L+ L L+ N+ + F N+
Sbjct: 114 -NIS--CCPMASLRH-------------------------LDLSFNDFDVLPVCKEFGNL 145
Query: 228 SALKEISLLNNSL-SGSLPSRIDLSLPNVETLNLGINSFSGTIPSSIT--NSSKLSDLEL 284
+ L + L L L L + L+L G S+ N++ L +
Sbjct: 146 TKLTFLGLSAAKFRQLDLLPVAHLHLSCI-LLDLVSYHIKGGETESLQIPNTTVLHLVFH 204
Query: 285 GENLFSGFIPNTIGNLRNLEFGNIADNYLTSSTPELSFLSSLTNCKKLKVLIVTGNPLDG 344
+LFS + ++ L +L+ NI N L V +
Sbjct: 205 PNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWK 264
Query: 345 ILPKSIGNFSLS-LETILMANCSISGNIPQVVGNLSNLLVLELGGNNLTGPIPVTFSQLQ 403
K F +E + + N +I+ I + S L+
Sbjct: 265 CSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSET-------------------ALK 305
Query: 404 TLQAFDLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSVRVLYLGLNIF 463
+L + A ++ +L + C + +S L N+F
Sbjct: 306 SLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVF 365
Query: 464 TSVLSSTIWNLKDILFIDVSSNFLD--GPLSLDIGNLKVVIGLDFSRNNLS 512
T + LK + + + N L ++L N+ + LD S N+L+
Sbjct: 366 TDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLN 416
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 85.7 bits (212), Expect = 2e-17
Identities = 72/404 (17%), Positives = 137/404 (33%), Gaps = 25/404 (6%)
Query: 73 GNLSSLQTLDLSHNKLSGNIPSSIF-NMHTLKLLDFSDNQL-FGSLSSFIFNMSSMTTID 130
++SL+ LDLS N F N+ L L S + L S +D
Sbjct: 118 CPMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLD 177
Query: 131 LSINRLSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKEIGNLTKLK-EIISTIT 189
L + G ++ +T+ L+ +K +
Sbjct: 178 LVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQR 237
Query: 190 NSTVCEIPREIGNLPYLARLALATNNLVGVVPVTIFNMSALKEISLLNNSLSGSLPSRI- 248
T L + + T V F ++ +++ N +++ +
Sbjct: 238 LMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEF 297
Query: 249 ---DLSLPNVETLNLGINSFSGTIPSSITNSSKLSDLELGENLFSGFIPNTIGNLRNLEF 305
+ +L ++ ++ F + + + ++++ L + + + F
Sbjct: 298 TYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTF 357
Query: 306 GNIADNYLTSSTPELSFLSSLTNCKKLKVLIVTGNPLDGILPKSIGNF----SLSLETIL 361
N N T S + S+L L+ LI+ N L K SL +
Sbjct: 358 LNFTQNVFTDSVFQGC--STLKR---LQTLILQRNGLK-NFFKVALMTKNMSSLETLDVS 411
Query: 362 MANCSISGNIPQVVGNLSNLLVLELGGNNLTGPIPVTFSQL-QTLQAFDLTRNKLAGPIT 420
+ N S + ++LVL L N LTG + F L ++ DL N++ I
Sbjct: 412 L-NSLNSHAYDRTCAWAESILVLNLSSNMLTGSV---FRCLPPKVKVLDLHNNRIMS-IP 466
Query: 421 DELCHLARLHSLVLQGNKFSGSIP-SCLGNLTSVRVLYLGLNIF 463
++ HL L L + N+ S+P LTS++ ++L N +
Sbjct: 467 KDVTHLQALQELNVASNQLK-SVPDGVFDRLTSLQYIWLHDNPW 509
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 67.6 bits (165), Expect = 8e-12
Identities = 43/186 (23%), Positives = 83/186 (44%), Gaps = 16/186 (8%)
Query: 57 LNISSFNLQGTITPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLDFSDNQL--FG 114
+S + + SS L+ + N + ++ + L+ L N L F
Sbjct: 334 KMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFF 393
Query: 115 SLSSFIFNMSSMTTIDLSINRLSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKE 174
++ NMSS+ T+D+S+N L+ C + + LNL N L+G++ +
Sbjct: 394 KVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAES------ILVLNLSSNMLTGSVFRC 447
Query: 175 I-GNLTKLKEIISTITNSTVCEIPREIGNLPYLARLALATNNLVGVVPVTIF-NMSALKE 232
+ + L + N+ + IP+++ +L L L +A+N L VP +F +++L+
Sbjct: 448 LPPKVKVL-----DLHNNRIMSIPKDVTHLQALQELNVASNQLK-SVPDGVFDRLTSLQY 501
Query: 233 ISLLNN 238
I L +N
Sbjct: 502 IWLHDN 507
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 67.2 bits (164), Expect = 1e-11
Identities = 59/348 (16%), Positives = 117/348 (33%), Gaps = 27/348 (7%)
Query: 3 LKSIISQHQQALLALKAHISYDHTNLFARNWTSSTSVCIWIGITCDVNSHRVIGLNISSF 62
+K ++ Q H+ + +LF+ S + + + I LN +
Sbjct: 183 IKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQL-------SNIKLNDENC 235
Query: 63 NLQGTITPQLGNLSSLQTLDLSHNKLSGNIPSSIFN---MHTLKLLDFSDNQLFGSLSSF 119
T +L +L + L H + + +F ++ L+ + + +
Sbjct: 236 QRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDRE 295
Query: 120 IFNMSSMTTIDLSINRLSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKEIGNLT 179
F S L I + ++ + S ++ L ++ + +
Sbjct: 296 EFTYSETALKSLMIEHVKNQVFLFS--KEALYSVFAEMNIKMLSISDTPFIHMVCPPSPS 353
Query: 180 KLKEIISTITNSTVCEIPREIGNLPYLARLALATNNLVGVVPVTIFNMSALKEISLLNNS 239
++ N + + L L L L N L + + L+ S
Sbjct: 354 SF-TFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK-NFFKVALMTKNMSSLETLDVS 411
Query: 240 LSGSLPSRIDLSL----PNVETLNLGINSFSGTIPSSITNSSKLSDLELGENLFSGFIPN 295
L+ SL S ++ LNL N +G++ + K+ L+L N IP
Sbjct: 412 LN-SLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIMS-IPK 467
Query: 296 TIGNLRNLEFGNIADNYLTSSTPELSFLSSLTNCKKLKVLIVTGNPLD 343
+ +L+ L+ N+A N L S P+ F L+ + + NP D
Sbjct: 468 DVTHLQALQELNVASNQLKS-VPDGVF----DRLTSLQYIWLHDNPWD 510
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 64.1 bits (156), Expect = 1e-10
Identities = 56/315 (17%), Positives = 106/315 (33%), Gaps = 37/315 (11%)
Query: 26 TNLFARNWTSSTSVCIWIGITCD---VNSHRVIGLNISSFNLQGTI-----TPQLGNLSS 77
N T W V LNI + + I T L S
Sbjct: 247 RGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKS 306
Query: 78 LQTLDLSHNKLSGNIPSSIFNMHT-LKLLDFSDNQLFGSLSSFIFNMSSMTTIDLSINRL 136
L + + +++++ + + S + + SS T ++ + N
Sbjct: 307 LMIEHVKNQVFL-FSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVF 365
Query: 137 SGELPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKEIG---NLTKLKEIISTITNSTV 193
+ + C S K+L+ L L N L K N++ L+ + ++ +
Sbjct: 366 T-DSVFQGC------STLKRLQTLILQRNGLK-NFFKVALMTKNMSSLETLDVSLNSLNS 417
Query: 194 CEIPREIGNLPYLARLALATNNLVGVVPVTIFNMSALKEISLLNNSLSGSLPSRIDLSLP 253
R + L L++N L G V + +K + L NN + S+P + L
Sbjct: 418 HAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVT-HLQ 473
Query: 254 NVETLNLGINSFSGTIPSSI-TNSSKLSDLELGENLF----------SGFIPNTIGNLRN 302
++ LN+ N ++P + + L + L +N + S +I G +RN
Sbjct: 474 ALQELNVASNQLK-SVPDGVFDRLTSLQYIWLHDNPWDCTCPGIRYLSEWINKHSGVVRN 532
Query: 303 LEFGNIADNYLTSST 317
D+ S +
Sbjct: 533 SAGSVAPDSAKCSGS 547
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 56.0 bits (135), Expect = 3e-08
Identities = 56/347 (16%), Positives = 128/347 (36%), Gaps = 27/347 (7%)
Query: 57 LNISSFNLQGTITPQL--GNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKL--LDFSDNQL 112
L++ S++++G T L N + L + ++ S + S+ + L+L + +D
Sbjct: 176 LDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENC 235
Query: 113 FGSLSSFIFNMSSMTTIDLSINRLSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAIP 172
++ T +++++ + K+ + +E LN+ ++ I
Sbjct: 236 QRLMTFLSELTRGPTLLNVTLQHIETTWKC-SVKLFQFF-WPRPVEYLNIYNLTITERID 293
Query: 173 KEIGNLTKLKEIISTITNSTVCEIPREIGN----LPYLARLALATNNLVGVVPVTIFNMS 228
+E ++ I + + L+ ++ + V + S
Sbjct: 294 REEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPS 353
Query: 229 ALKEISLLNNSLSGSLPSRIDLSLPNVETLNLGINSFSGTIPSSITNSSKLSDLELGEN- 287
+ ++ N + + +L ++TL L N + +S LE +
Sbjct: 354 SFTFLNFTQNVFT-DSVFQGCSTLKRLQTLILQRNGLK-NFFKVALMTKNMSSLETLDVS 411
Query: 288 ---LFSGFIPNTIGNLRNLEFGNIADNYLTSSTPELSFLSSLTNCKKLKVLIVTGNPLDG 344
L S T ++ N++ N LT S L K+KVL + N +
Sbjct: 412 LNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFR-----CLP--PKVKVLDLHNNRIM- 463
Query: 345 ILPKSIGNFSLSLETILMANCSISGNIPQ-VVGNLSNLLVLELGGNN 390
+PK + + +L+ + +A+ + ++P V L++L + L N
Sbjct: 464 SIPKDVTHLQ-ALQELNVASNQLK-SVPDGVFDRLTSLQYIWLHDNP 508
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 99.1 bits (247), Expect = 5e-22
Identities = 51/232 (21%), Positives = 94/232 (40%), Gaps = 19/232 (8%)
Query: 61 SFNLQGTITP-QLGNLSSLQTLDLSHNKLSGNIPSSIF-NMHTLKLLDFSDNQLFGSLSS 118
N I +L L+ L L N + I F + +L L+ DN L + S
Sbjct: 83 MENNIQMIQADTFRHLHHLEVLQLGRNSIR-QIEVGAFNGLASLNTLELFDNWL-TVIPS 140
Query: 119 FIF-NMSSMTTIDLSINRLSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKEI-G 176
F +S + + L N + +P ++ L L+LG I +
Sbjct: 141 GAFEYLSKLRELWLRNNPIE-SIP------SYAFNRVPSLMRLDLGELKKLEYISEGAFE 193
Query: 177 NLTKLKEIISTITNSTVCEIPREIGNLPYLARLALATNNLVGVVPVTIFNMSALKEISLL 236
L LK + + + ++P + L L L ++ N+ + P + +S+LK++ ++
Sbjct: 194 GLFNLKYL--NLGMCNIKDMP-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVM 250
Query: 237 NNSLSGSLPSRIDLSLPNVETLNLGINSFSGTIPSSI-TNSSKLSDLELGEN 287
N+ +S + L ++ LNL N+ S ++P + T L +L L N
Sbjct: 251 NSQVS-LIERNAFDGLASLVELNLAHNNLS-SLPHDLFTPLRYLVELHLHHN 300
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 98.7 bits (246), Expect = 6e-22
Identities = 58/272 (21%), Positives = 104/272 (38%), Gaps = 26/272 (9%)
Query: 76 SSLQTLDLSHNKLSGNIPSSIFNMHTLKLLDFSDNQLFGSLSSFIF-NMSSMTTIDLSIN 134
+ + + LS +P I + L+ +N + + + F ++ + + L N
Sbjct: 54 NQFSKVVCTRRGLS-EVPQGIP--SNTRYLNLMENNI-QMIQADTFRHLHHLEVLQLGRN 109
Query: 135 RLSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKEI-GNLTKLKEIISTITNSTV 193
+ ++ + L L L N L+ IP L+KL+E+ + N+ +
Sbjct: 110 SIR-QIE------VGAFNGLASLNTLELFDNWLT-VIPSGAFEYLSKLREL--WLRNNPI 159
Query: 194 CEIPREI-GNLPYLARLALATNNLVGVVPVTIF-NMSALKEISLLNNSLSGSLPSRIDLS 251
IP +P L RL L + + F + LK ++L ++ +P+
Sbjct: 160 ESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMPN--LTP 216
Query: 252 LPNVETLNLGINSFSGTIPSSITNSSKLSDLELGENLFSGFIPNTIGNLRNLEFGNIADN 311
L +E L + N F P S S L L + + S N L +L N+A N
Sbjct: 217 LVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHN 276
Query: 312 YLTSSTPELSFLSSLTNCKKLKVLIVTGNPLD 343
L+S +L + L L L + NP +
Sbjct: 277 NLSSLPHDL--FTPLRY---LVELHLHHNPWN 303
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 82.9 bits (205), Expect = 9e-17
Identities = 52/259 (20%), Positives = 91/259 (35%), Gaps = 13/259 (5%)
Query: 228 SALKEISLLNNSLSGSLPSRIDLSLPNVETLNLGINSFSGTIPSSITNSSKLSDLELGEN 287
+ ++ LS +P I N LNL N+ + + L L+LG N
Sbjct: 54 NQFSKVVCTRRGLS-EVPQGIP---SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRN 109
Query: 288 LFSGFIPNTIGNLRNLEFGNIADNYLTSSTPELSFLSSLTNCKKLKVLIVTGNPLDGILP 347
L +L + DN+LT L+ L+ L + NP++ I
Sbjct: 110 SIRQIEVGAFNGLASLNTLELFDNWLTVIPSGA--FEYLSK---LRELWLRNNPIESIPS 164
Query: 348 KSIGNFSLSLETILMANCSISGNIP-QVVGNLSNLLVLELGGNNLTGPIPVTFSQLQTLQ 406
+ SL + + I L NL L LG N+ +P + L L+
Sbjct: 165 YAFNRVP-SLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKD-MP-NLTPLVGLE 221
Query: 407 AFDLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSVRVLYLGLNIFTSV 466
+++ N L+ L L + ++ S + L S+ L L N +S+
Sbjct: 222 ELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSL 281
Query: 467 LSSTIWNLKDILFIDVSSN 485
L+ ++ + + N
Sbjct: 282 PHDLFTPLRYLVELHLHHN 300
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 2e-16
Identities = 47/237 (19%), Positives = 83/237 (35%), Gaps = 14/237 (5%)
Query: 253 PNVETLNLGINSFSGTIPSSITNSSKLSDLELGENLFSGFIPNTIGNLRNLEFGNIADNY 312
+ S +P I S L L EN +T +L +LE + N
Sbjct: 54 NQFSKVVCTRRGLS-EVPQGI--PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNS 110
Query: 313 LTSSTPELSFLSSLTNCKKLKVLIVTGNPLDGILPKSIGNFSLSLETILMANCSISGNIP 372
+ + L L + N L I + S L + + N I +IP
Sbjct: 111 IRQIEVG-----AFNGLASLNTLELFDNWLTVIPSGAFEYLS-KLRELWLRNNPIE-SIP 163
Query: 373 QVV-GNLSNLLVLELGGNNLTGPIPV-TFSQLQTLQAFDLTRNKLAGPITDELCHLARLH 430
+ +L+ L+LG I F L L+ +L + L L L
Sbjct: 164 SYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDM--PNLTPLVGLE 221
Query: 431 SLVLQGNKFSGSIPSCLGNLTSVRVLYLGLNIFTSVLSSTIWNLKDILFIDVSSNFL 487
L + GN F P L+S++ L++ + + + + L ++ ++++ N L
Sbjct: 222 ELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNL 278
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 1e-08
Identities = 26/100 (26%), Positives = 44/100 (44%), Gaps = 11/100 (11%)
Query: 70 PQLGNLSSLQTLDLSHNKLSGNIPSSIF-NMHTLKLLDFSDNQLFGSLSSFIF-NMSSMT 127
P L L L+ L++S N I F + +LK L ++Q+ + F ++S+
Sbjct: 212 PNLTPLVGLEELEMSGNHFP-EIRPGSFHGLSSLKKLWVMNSQV-SLIERNAFDGLASLV 269
Query: 128 TIDLSINRLSGELPANICKIPSTLSKCKQLEELNLGFNNL 167
++L+ N LS LP + + L EL+L N
Sbjct: 270 ELNLAHNNLS-SLP------HDLFTPLRYLVELHLHHNPW 302
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 6e-22
Identities = 40/186 (21%), Positives = 61/186 (32%), Gaps = 64/186 (34%)
Query: 640 NGMEVAVKVFHQQYERALKSFEDECEVRK--RIRHRNLVKIISSS--------------- 682
G VAVK+F + E+ S+ E E+ +RH N++ I+S
Sbjct: 30 QGENVAVKIFSSRDEK---SWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITH 86
Query: 683 -------------------------------LEYLH-----FGHSIPIIHCDLKPSNVLL 706
L +LH I H DLK N+L+
Sbjct: 87 YHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILV 146
Query: 707 DEDMVAHISDFGIAKLLSGEDQLSKQTQTLA--TIGYMAPE------YGTKGRVSTRGDV 758
++ I+D G+A + S T YMAPE R D+
Sbjct: 147 KKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDI 206
Query: 759 CSFGII 764
+FG++
Sbjct: 207 WAFGLV 212
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 2e-21
Identities = 57/272 (20%), Positives = 108/272 (39%), Gaps = 47/272 (17%)
Query: 76 SSLQTLDLSHNKLSGNIPSSIF-NMHTLKLLDFSDNQLFGSLSSFIF-NMSSMTTIDLSI 133
++ + L+L N++ I + F ++ L++L S N + ++ F ++++ T++L
Sbjct: 64 TNTRLLNLHENQIQ-IIKVNSFKHLRHLEILQLSRNHI-RTIEIGAFNGLANLNTLELFD 121
Query: 134 NRLSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKEIGNLTKLKEIISTITNSTV 193
NRL+ +P +L+EL L N +
Sbjct: 122 NRLT-TIP------NGAFVYLSKLKELWLRNNPIE------------------------- 149
Query: 194 CEIPREI-GNLPYLARLALATNNLVGVVPVTIF-NMSALKEISLLNNSLSGSLPSRIDLS 251
IP +P L RL L + + F +S L+ ++L +L +P+
Sbjct: 150 -SIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIPN--LTP 205
Query: 252 LPNVETLNLGINSFSGTIPSSITNSSKLSDLELGENLFSGFIPNTIGNLRNLEFGNIADN 311
L ++ L+L N S P S L L + ++ N NL++L N+A N
Sbjct: 206 LIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHN 265
Query: 312 YLTSSTPELSFLSSLTNCKKLKVLIVTGNPLD 343
LT +L + L + L+ + + NP +
Sbjct: 266 NLTLLPHDL--FTPLHH---LERIHLHHNPWN 292
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 3e-21
Identities = 45/221 (20%), Positives = 91/221 (41%), Gaps = 18/221 (8%)
Query: 71 QLGNLSSLQTLDLSHNKLSGNIPSSIF-NMHTLKLLDFSDNQLFGSLSSFIF-NMSSMTT 128
+L L+ L LS N + I F + L L+ DN+L ++ + F +S +
Sbjct: 83 SFKHLRHLEILQLSRNHIR-TIEIGAFNGLANLNTLELFDNRL-TTIPNGAFVYLSKLKE 140
Query: 129 IDLSINRLSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKEI-GNLTKLKEIIST 187
+ L N + +P ++ L L+LG I + L+ L+ +
Sbjct: 141 LWLRNNPIE-SIP------SYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLN-- 191
Query: 188 ITNSTVCEIPREIGNLPYLARLALATNNLVGVVPVTIFNMSALKEISLLNNSLSGSLPSR 247
+ + EIP + L L L L+ N+L + P + + L+++ ++ + + +
Sbjct: 192 LAMCNLREIP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQ-VIERN 249
Query: 248 IDLSLPNVETLNLGINSFSGTIPSSI-TNSSKLSDLELGEN 287
+L ++ +NL N+ + +P + T L + L N
Sbjct: 250 AFDNLQSLVEINLAHNNLT-LLPHDLFTPLHHLERIHLHHN 289
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 2e-15
Identities = 50/222 (22%), Positives = 86/222 (38%), Gaps = 13/222 (5%)
Query: 268 TIPSSITNSSKLSDLELGENLFSGFIPNTIGNLRNLEFGNIADNYLTSSTPELSFLSSLT 327
+P I S+ L L EN N+ +LR+LE ++ N++ + +
Sbjct: 57 EVPDGI--STNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIG-----AFN 109
Query: 328 NCKKLKVLIVTGNPLDGILPKSIGNFSLSLETILMANCSISGNIPQVV-GNLSNLLVLEL 386
L L + N L I + S L+ + + N I +IP + +L L+L
Sbjct: 110 GLANLNTLELFDNRLTTIPNGAFVYLS-KLKELWLRNNPIE-SIPSYAFNRIPSLRRLDL 167
Query: 387 GGNNLTGPIPV-TFSQLQTLQAFDLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPS 445
G I F L L+ +L L L L +L L L GN S P
Sbjct: 168 GELKRLSYISEGAFEGLSNLRYLNLAMCNLREI--PNLTPLIKLDELDLSGNHLSAIRPG 225
Query: 446 CLGNLTSVRVLYLGLNIFTSVLSSTIWNLKDILFIDVSSNFL 487
L ++ L++ + + + NL+ ++ I+++ N L
Sbjct: 226 SFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNL 267
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 56.7 bits (137), Expect = 1e-08
Identities = 29/100 (29%), Positives = 42/100 (42%), Gaps = 11/100 (11%)
Query: 70 PQLGNLSSLQTLDLSHNKLSGNIPSSIF-NMHTLKLLDFSDNQLFGSLSSFIF-NMSSMT 127
P L L L LDLS N LS I F + L+ L +Q+ + F N+ S+
Sbjct: 201 PNLTPLIKLDELDLSGNHLS-AIRPGSFQGLMHLQKLWMIQSQI-QVIERNAFDNLQSLV 258
Query: 128 TIDLSINRLSGELPANICKIPSTLSKCKQLEELNLGFNNL 167
I+L+ N L+ LP + LE ++L N
Sbjct: 259 EINLAHNNLT-LLP------HDLFTPLHHLERIHLHHNPW 291
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 6e-04
Identities = 23/142 (16%), Positives = 46/142 (32%), Gaps = 11/142 (7%)
Query: 379 SNLLVLELGGNNLTGPIPVT-FSQLQTLQAFDLTRNKLAGPITDELCHLARLHSLVLQGN 437
+ + NL +P + + L +L N++ + HL L L L N
Sbjct: 43 NQFSKVICVRKNLRE-VPDGISTNTRLL---NLHENQIQIIKVNSFKHLRHLEILQLSRN 98
Query: 438 KFSGSIPSCLGNLTSVRVLYLGLNIFTSVLSSTIWNLKDILFIDVSSNFLDGPLSLDIG- 496
L ++ L L N T++ + L + + + +N ++ S+
Sbjct: 99 HIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIE---SIPSYA 155
Query: 497 --NLKVVIGLDFSRNNLSGDIP 516
+ + LD I
Sbjct: 156 FNRIPSLRRLDLGELKRLSYIS 177
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 6e-21
Identities = 62/345 (17%), Positives = 129/345 (37%), Gaps = 53/345 (15%)
Query: 77 SLQTLDLSHNKLSGNIPSSIFNMHTLKLLDFSDNQLFGSLSSFIF-NMSSMTTIDLSINR 135
L+ + S L +P + LLD +N++ + F N+ ++ T+ L N+
Sbjct: 32 HLRVVQCSDLGLE-KVPKDLPP--DTALLDLQNNKI-TEIKDGDFKNLKNLHTLILINNK 87
Query: 136 LSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKEI-GNLTKLKEIISTITNSTVC 194
+S ++ P + +LE L L N L +P+++ L +L+ + + +
Sbjct: 88 IS-KIS------PGAFAPLVKLERLYLSKNQLK-ELPEKMPKTLQELR-----VHENEIT 134
Query: 195 EIPREI-GNLPYLARLALATNNL-VGVVPVTIF-NMSALKEISLLNNSLSGSLPSRIDLS 251
++ + + L + + L TN L + F M L I + + +++ ++P +
Sbjct: 135 KVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--- 190
Query: 252 LPNVETLNLGINSFSGTIPSSITNSSKLSDLELGENLFSGFIPNTIGNLRNLEFGNIADN 311
P++ L+L N + +S+ + L+ L L N S ++ N +L ++ +N
Sbjct: 191 PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNN 250
Query: 312 YLTSSTPELSFLSSLTNCKKLKVLIVTGNPLDGILPKSIGNFSLSLETILMANCSISGNI 371
L L + K ++V+ + N + I
Sbjct: 251 KLVKVPG------GLADHKYIQVVYLHNNNISAIGSNDFCP------------------- 285
Query: 372 PQVVGNLSNLLVLELGGNNLTGPI--PVTFSQLQTLQAFDLTRNK 414
P ++ + L N + P TF + A L K
Sbjct: 286 PGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 4e-20
Identities = 57/301 (18%), Positives = 103/301 (34%), Gaps = 26/301 (8%)
Query: 195 EIPREIGNLPYLARLALATNNLVGVVPVTIFNMSALKEISLLNNSLSGSLPSRIDLSLPN 254
++P+++ P A L L N + + N+ L + L+NN +S + L
Sbjct: 45 KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKIS-KISPGAFAPLVK 101
Query: 255 VETLNLGINSFSGTIPSSITNSSKLSDLELGENLFSGFIPNTIGNLRNLEFGNIADNYLT 314
+E L L N +P + L +L + EN + + L + + N L
Sbjct: 102 LERLYLSKNQLK-ELPEKM--PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLK 158
Query: 315 SST-PELSFLSSLTNCKKLKVLIVTGNPLDGILPKSIGNFSLSLETILMANCSISGNIPQ 373
SS +F KKL + + + I G SL + + I+ +
Sbjct: 159 SSGIENGAF----QGMKKLSYIRIADTNITTIPQ---GLPP-SLTELHLDGNKIT-KVDA 209
Query: 374 VV-GNLSNLLVLELGGNNLTGPIPVTFSQLQTLQAFDLTRNKLAGPITDELCHLARLHSL 432
L+NL L L N+++ + + L+ L NKL + L + +
Sbjct: 210 ASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVK-VPGGLADHKYIQVV 268
Query: 433 VLQGNKFSG------SIPSCLGNLTSVRVLYLGLN--IFTSVLSSTIWNLKDILFIDVSS 484
L N S P S + L N + + ST + + + +
Sbjct: 269 YLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGN 328
Query: 485 N 485
Sbjct: 329 Y 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 5e-20
Identities = 55/256 (21%), Positives = 101/256 (39%), Gaps = 26/256 (10%)
Query: 71 QLGNLSSLQTLDLSHNKLSGNIPSSIF-NMHTLKLLDFSDNQLFGSLSSFIFNMSSMTTI 129
NL +L TL L +NK+S I F + L+ L S NQL L + ++ +
Sbjct: 71 DFKNLKNLHTLILINNKIS-KISPGAFAPLVKLERLYLSKNQL-KELPEKMP--KTLQEL 126
Query: 130 DLSINRLSGELPANICKIPSTLSKCKQLEELNLGFNNL-SGAIPKEI-GNLTKLKEIIST 187
+ N ++ ++ S + Q+ + LG N L S I + KL I
Sbjct: 127 RVHENEIT-KVR------KSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYI--R 177
Query: 188 ITNSTVCEIPREIGNLPYLARLALATNNLVGVVPVTIFNMSALKEISLLNNSLSGSLPSR 247
I ++ + IP+ G P L L L N + V ++ ++ L ++ L NS+S ++ +
Sbjct: 178 IADTNITTIPQ--GLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSIS-AVDNG 234
Query: 248 IDLSLPNVETLNLGINSFSGTIPSSITNSSKLSDLELGENLFSGFIPNTIG------NLR 301
+ P++ L+L N +P + + + + L N S N
Sbjct: 235 SLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKA 293
Query: 302 NLEFGNIADNYLTSST 317
+ ++ N +
Sbjct: 294 SYSGVSLFSNPVQYWE 309
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 2e-17
Identities = 54/279 (19%), Positives = 105/279 (37%), Gaps = 28/279 (10%)
Query: 259 NLGINSFSGTIPSSITNSSKLSDLELGENLFSGFIPNTIGNLRNLEFGNIADNYLTSSTP 318
+LG+ +P L+L N + NL+NL + +N ++ +P
Sbjct: 40 DLGLEKVPKDLPPDTAL------LDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISP 93
Query: 319 ELSFLSSLTNCKKLKVLIVTGNPLDGILPKSIGNFSLSLETILMANCSISGNIPQVVGNL 378
+ KL+ L ++ N L + +L+ + + I+ V L
Sbjct: 94 G-----AFAPLVKLERLYLSKNQLKEL---PEKMPK-TLQELRVHENEITKVRKSVFNGL 144
Query: 379 SNLLVLELGGNNLT-GPIPV-TFSQLQTLQAFDLTRNKLAGPITDELCHLARLHSLVLQG 436
+ ++V+ELG N L I F ++ L + + I L L L L G
Sbjct: 145 NQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITT-IPQGL--PPSLTELHLDG 201
Query: 437 NKFSGSIPS-CLGNLTSVRVLYLGLNIFTSVLSSTIWNLKDILFIDVSSNFLDGPLSLDI 495
NK + + + L L ++ L L N ++V + ++ N + + +++N L + +
Sbjct: 202 NKIT-KVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVK-VPGGL 259
Query: 496 GNLKVVIGLDFSRNNLSGDIPITIGEGEIPRGGPFANLT 534
+ K + + NN+S IG + G
Sbjct: 260 ADHKYIQVVYLHNNNIS-----AIGSNDFCPPGYNTKKA 293
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 1e-11
Identities = 22/116 (18%), Positives = 45/116 (38%), Gaps = 6/116 (5%)
Query: 72 LGNLSSLQTLDLSHNKLSGNIPSSIF-NMHTLKLLDFSDNQLFGSLSSFIFNMSSMTTID 130
L L++L L LS N +S + + N L+ L ++N+L + + + + +
Sbjct: 212 LKGLNNLAKLGLSFNSIS-AVDNGSLANTPHLRELHLNNNKL-VKVPGGLADHKYIQVVY 269
Query: 131 LSINRLSGELPANICKIPSTLSKCKQLEELNLGFNNLS-GAIPKEI-GNLTKLKEI 184
L N +S + +N P +K ++L N + I + +
Sbjct: 270 LHNNNIS-AIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAV 324
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 1e-20
Identities = 53/342 (15%), Positives = 115/342 (33%), Gaps = 49/342 (14%)
Query: 59 ISSFNLQGTITPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLDFSDNQLFGSLSS 118
I S + + + + S L+ +IPS + +K LD S+N++ +S+
Sbjct: 14 IISLSKEESSNQASLSCDRNGICKGSSGSLN-SIPSGLTE--AVKSLDLSNNRI-TYISN 69
Query: 119 FIF-NMSSMTTIDLSINRLSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKEIGN 177
++ + L+ N ++ + + + S LE L+L +N LS
Sbjct: 70 SDLQRCVNLQALVLTSNGIN-TIEED------SFSSLGSLEHLDLSYNYLS--------- 113
Query: 178 LTKLKEIISTITNSTVCEIPREI-GNLPYLARLALATNNLVGVVPVTIF-NMSALKEISL 235
+ L L L L N + ++F +++ L+ + +
Sbjct: 114 -----------------NLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRV 156
Query: 236 LNNSLSGSLPSRIDLSLPNVETLNLGINSFSGTIPSSITNSSKLSDLELGENLFSGFIPN 295
N + + L +E L + + P S+ + +S L L +
Sbjct: 157 GNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEI 216
Query: 296 TIGNLRNLEFGNIADNYLT----SSTPELSFLSSLTNCKKLKVLIVTGNPLDGILPKSIG 351
+ ++E + D L S +SL + + +T L ++
Sbjct: 217 FVDVTSSVECLELRDTDLDTFHFSELSTGET-NSLIKKFTFRNVKITDESLFQVMKLLNQ 275
Query: 352 NFSLSLETILMANCSISGNIPQ-VVGNLSNLLVLELGGNNLT 392
L + + + ++P + L++L + L N
Sbjct: 276 I--SGLLELEFSRNQLK-SVPDGIFDRLTSLQKIWLHTNPWD 314
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 85.6 bits (212), Expect = 5e-18
Identities = 58/273 (21%), Positives = 105/273 (38%), Gaps = 20/273 (7%)
Query: 72 LGNLSSLQTLDLSHNKLSGNIPSSIF-NMHTLKLLDFSDNQLFGSLSSFIF-NMSSMTTI 129
L +LQ L L+ N ++ I F ++ +L+ LD S N L +LSS F +SS+T +
Sbjct: 72 LQRCVNLQALVLTSNGIN-TIEEDSFSSLGSLEHLDLSYNYL-SNLSSSWFKPLSSLTFL 129
Query: 130 DLSINRLSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKEI-GNLTKLKEIISTI 188
+L N S S +L+ L +G + I ++ LT L+E+ I
Sbjct: 130 NLLGNPYKTLGET------SLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEEL--EI 181
Query: 189 TNSTVCEIPREI-GNLPYLARLALATNNLVGVVPVTIFNMSALKEISLLNNSLSG----S 243
S + + ++ ++ L L + ++ + + S+++ + L + L
Sbjct: 182 DASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSE 241
Query: 244 LPSRIDLSLPNVETLNLGINSFSG--TIPSSITNSSKLSDLELGENLFSGFIPNTIGNLR 301
L + SL T + + + S L +LE N L
Sbjct: 242 LSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLT 301
Query: 302 NLEFGNIADNYLTSSTPELSFLSSLTNCKKLKV 334
+L+ + N S P + +LS N K
Sbjct: 302 SLQKIWLHTNPWDCSCPRIDYLSRWLNKNSQKE 334
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 2e-16
Identities = 49/277 (17%), Positives = 98/277 (35%), Gaps = 22/277 (7%)
Query: 220 VPVTIFNMSALKEISLLNNSLSGSLPSRIDLSLPNVETLNLGINSFSGTIPSSI-TNSSK 278
+P + A+K + L NN ++ + + N++ L L N + TI ++
Sbjct: 46 IPSGLT--EAVKSLDLSNNRIT-YISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGS 101
Query: 279 LSDLELGENLFSGFIPNTIGNLRNLEFGNIADNYLTSSTPELSFLSSLTNCKKLKVLIVT 338
L L+L N S + L +L F N+ N + E S S LT L++L V
Sbjct: 102 LEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTL-GETSLFSHLTK---LQILRVG 157
Query: 339 GNPLDGILPKSIGNFS--LSLETILMANCSISGNIPQVVGNLSNLLVLELGGNNLTGPIP 396
+ + +F+ LE + + + P+ + ++ N+ L L +
Sbjct: 158 NMDTFTKIQR--KDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLE 215
Query: 397 VTFSQLQTLQAFDLTRNKLAGP--------ITDELCHLARLHSLVLQGNKFSGSIPSCLG 448
+ +++ +L L T+ L ++ + + L
Sbjct: 216 IFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLN 274
Query: 449 NLTSVRVLYLGLNIFTSVLSSTIWNLKDILFIDVSSN 485
++ + L N SV L + I + +N
Sbjct: 275 QISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTN 311
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 56.7 bits (137), Expect = 1e-08
Identities = 45/225 (20%), Positives = 77/225 (34%), Gaps = 34/225 (15%)
Query: 268 TIPSSITNSSKLSDLELGENLFSGFIPNTIGNLRNLEFGNIADNYLTSSTPELSFLSSLT 327
+IPS +T + + L+L N + + + NL+ + N + + E SF SSL
Sbjct: 45 SIPSGLTEA--VKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINT-IEEDSF-SSLG 100
Query: 328 NCKKLKVLIVTGNPLDGILPKSIGNFSLSLETILMANCSISGNIPQVVGNLSNLLVLELG 387
+ L+ L ++ N L + F LS+L L L
Sbjct: 101 S---LEHLDLSYNYLSNLSS---SWFK----------------------PLSSLTFLNLL 132
Query: 388 GNNLTG-PIPVTFSQLQTLQAFDLTRNKLAGPITDE-LCHLARLHSLVLQGNKFSGSIPS 445
GN FS L LQ + I + L L L + + P
Sbjct: 133 GNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPK 192
Query: 446 CLGNLTSVRVLYLGLNIFTSVLSSTIWNLKDILFIDVSSNFLDGP 490
L ++ +V L L + +L + + +++ LD
Sbjct: 193 SLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTF 237
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 56.3 bits (136), Expect = 2e-08
Identities = 35/222 (15%), Positives = 73/222 (32%), Gaps = 3/222 (1%)
Query: 332 LKVLIVTGNPLDGILPKSIGNFSLSLETILMANCSISGNIPQVVGNLSNLLVLELGGNNL 391
+K L ++ N + I + +L+ +++ + I+ +L +L L+L N L
Sbjct: 54 VKSLDLSNNRITYISNSDLQRCV-NLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYL 112
Query: 392 TGPIPVTFSQLQTLQAFDLTRNKLAG-PITDELCHLARLHSLVLQGNKFSGSIPS-CLGN 449
+ F L +L +L N T HL +L L + I
Sbjct: 113 SNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAG 172
Query: 450 LTSVRVLYLGLNIFTSVLSSTIWNLKDILFIDVSSNFLDGPLSLDIGNLKVVIGLDFSRN 509
LT + L + + S ++ +++++ + + L + + V L+
Sbjct: 173 LTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDT 232
Query: 510 NLSGDIPITIGEGEIPRGGPFANLTAKSFMGNELLCGLPDLQ 551
+L + GE L + L
Sbjct: 233 DLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLN 274
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 92.5 bits (230), Expect = 2e-20
Identities = 39/186 (20%), Positives = 60/186 (32%), Gaps = 64/186 (34%)
Query: 640 NGMEVAVKVFHQQYERALKSFEDECEVRK--RIRHRNLVKIISSS--------------- 682
G EVAVK+F + ER S+ E E+ + +RH N++ I++
Sbjct: 64 RGEEVAVKIFSSREER---SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD 120
Query: 683 -------------------------------LEYLH-----FGHSIPIIHCDLKPSNVLL 706
L +LH I H DLK N+L+
Sbjct: 121 YHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV 180
Query: 707 DEDMVAHISDFGIAKLLSGEDQLSKQTQTLA--TIGYMAPE------YGTKGRVSTRGDV 758
++ I+D G+A T YMAPE R D+
Sbjct: 181 KKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADI 240
Query: 759 CSFGII 764
+ G++
Sbjct: 241 YAMGLV 246
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 92.5 bits (230), Expect = 2e-20
Identities = 39/186 (20%), Positives = 59/186 (31%), Gaps = 64/186 (34%)
Query: 640 NGMEVAVKVFHQQYERALKSFEDECEVRK--RIRHRNLVKIISSS--------------- 682
G +VAVKVF E S+ E E+ + +RH N++ I++
Sbjct: 59 RGEKVAVKVFFTTEEA---SWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITD 115
Query: 683 -------------------------------LEYLH-----FGHSIPIIHCDLKPSNVLL 706
L +LH I H DLK N+L+
Sbjct: 116 YHENGSLYDYLKSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILV 175
Query: 707 DEDMVAHISDFGIAKLLSGEDQLSKQTQTLA--TIGYMAPE------YGTKGRVSTRGDV 758
++ I+D G+A + T YM PE + D+
Sbjct: 176 KKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADM 235
Query: 759 CSFGII 764
SFG+I
Sbjct: 236 YSFGLI 241
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 4e-20
Identities = 40/182 (21%), Positives = 66/182 (36%), Gaps = 59/182 (32%)
Query: 639 GNGMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVK------------IISSSLEYL 686
G + +K + E ++F E +V + + H N++K I+ EY+
Sbjct: 33 ETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFIT---EYI 89
Query: 687 HFG--------------------------------HSIPIIHCDLKPSNVLLDEDMVAHI 714
G HS+ IIH DL N L+ E+ +
Sbjct: 90 KGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVV 149
Query: 715 SDFGIAKLLSGEDQLSKQTQTLA------------TIGYMAPEYGTKGRVSTRGDVCSFG 762
+DFG+A+L+ E + ++L +MAPE + DV SFG
Sbjct: 150 ADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFG 209
Query: 763 II 764
I+
Sbjct: 210 IV 211
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 5e-20
Identities = 51/218 (23%), Positives = 81/218 (37%), Gaps = 26/218 (11%)
Query: 57 LNISSFNLQGTITPQLGNLSSLQTLDLSHNKLSGNIPSSIF-NMHTLKLLDFSDNQLFGS 115
+ + + +L L L N L+ I ++ F + L+ LD SDN S
Sbjct: 37 IFLHGNRISHVPAASFRACRNLTILWLHSNVLA-RIDAAAFTGLALLEQLDLSDNAQLRS 95
Query: 116 LSSFIF-NMSSMTTIDLSINRLSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKE 174
+ F + + T+ L L EL P L+ L L N L A+P +
Sbjct: 96 VDPATFHGLGRLHTLHLDRCGLQ-ELG------PGLFRGLAALQYLYLQDNALQ-ALPDD 147
Query: 175 I-GNLTKLKEI------ISTITNSTVCEIPREIGNLPYLARLALATNNLVGVVPVTIFNM 227
+L L + IS++ L L RL L N + V P ++
Sbjct: 148 TFRDLGNLTHLFLHGNRISSVPERA-------FRGLHSLDRLLLHQNRVAHVHPHAFRDL 200
Query: 228 SALKEISLLNNSLSGSLPSRIDLSLPNVETLNLGINSF 265
L + L N+LS +LP+ L ++ L L N +
Sbjct: 201 GRLMTLYLFANNLS-ALPTEALAPLRALQYLRLNDNPW 237
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 5e-19
Identities = 44/222 (19%), Positives = 84/222 (37%), Gaps = 28/222 (12%)
Query: 76 SSLQTLDLSHNKLSGNIPSSIF-NMHTLKLLDFSDNQLFGSLSSFIF-NMSSMTTIDLSI 133
++ Q + L N++S ++P++ F L +L N L + + F ++ + +DLS
Sbjct: 32 AASQRIFLHGNRIS-HVPAASFRACRNLTILWLHSNVL-ARIDAAAFTGLALLEQLDLSD 89
Query: 134 NRLSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKEI-GNLTKLKEI------IS 186
N + P+T +L L+L L + + L L+ + +
Sbjct: 90 NAQLRSVD------PATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQ 142
Query: 187 TITNSTVCEIPREIGNLPYLARLALATNNLVGVVPVTIFNMSALKEISLLNNSLSGSLPS 246
+ + T +L L L L N + V + +L + L N ++ +
Sbjct: 143 ALPDDT-------FRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVA-HVHP 194
Query: 247 RIDLSLPNVETLNLGINSFSGTIPSSI-TNSSKLSDLELGEN 287
L + TL L N+ S +P+ L L L +N
Sbjct: 195 HAFRDLGRLMTLYLFANNLS-ALPTEALAPLRALQYLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 1e-15
Identities = 47/250 (18%), Positives = 85/250 (34%), Gaps = 35/250 (14%)
Query: 237 NNSLSGSLPSRIDLSLPNVETLNLGINSFSGTIPSSITNSSKLSDLELGENLFSGFIPNT 296
L ++P I + + L N S +S L+ L L N+ +
Sbjct: 20 QQGLQ-AVPVGIP---AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAA 75
Query: 297 IGNLRNLEFGNIADNYLTSSTPELSFLSSLTNCKKLKVLIVTGNPLDGILPKSIGNFSLS 356
L LE +++DN S +F +L L + L
Sbjct: 76 FTGLALLEQLDLSDNAQLRSVDPATF----HGLGRLHTLHLDRCGLQ------------- 118
Query: 357 LETILMANCSISGNIPQVVGNLSNLLVLELGGNNLTGPIPV-TFSQLQTLQAFDLTRNKL 415
+ + + L+ L L L N L +P TF L L L N++
Sbjct: 119 ---------ELGPGLFR---GLAALQYLYLQDNALQA-LPDDTFRDLGNLTHLFLHGNRI 165
Query: 416 AGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSVRVLYLGLNIFTSVLSSTIWNLK 475
+ L L L+L N+ + P +L + LYL N +++ + + L+
Sbjct: 166 SSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLR 225
Query: 476 DILFIDVSSN 485
+ ++ ++ N
Sbjct: 226 ALQYLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 6e-13
Identities = 51/291 (17%), Positives = 88/291 (30%), Gaps = 67/291 (23%)
Query: 124 SSMTTIDLSINRLSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKEIGNLTKLKE 183
T L +P I P+ + + L N +S L
Sbjct: 11 EPKVTTSCPQQGLQ-AVPVGI---PAAS------QRIFLHGNRISHVPAASFRACRNLTI 60
Query: 184 IISTITNSTVCEIPREIGNLPYLARLALATNNLVGVVPVTIFNMSALKEISLLNNSLSGS 243
L L +N L + ++ L+++ L +N+ S
Sbjct: 61 -------------------------LWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRS 95
Query: 244 LPSRIDLSLPNVETLNLGINSFSGTIPSSI-TNSSKLSDLELGENLFSGFIPNTIGNLRN 302
+ L + TL+L + + + L L L +N +T +L N
Sbjct: 96 VDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGN 154
Query: 303 LEFGNIADNYLTSSTPELSFLSSLTNCKKLKVLIVTGNPLDGILPKSIGNFSLSLETILM 362
L + N ++ S PE +F L L++ N + + P + F
Sbjct: 155 LTHLFLHGNRIS-SVPERAF----RGLHSLDRLLLHQNRVAHVHPHA---FR-------- 198
Query: 363 ANCSISGNIPQVVGNLSNLLVLELGGNNLTGPIPVTFSQLQTLQAFDLTRN 413
+L L+ L L NNL+ + L+ LQ L N
Sbjct: 199 --------------DLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 3e-11
Identities = 45/220 (20%), Positives = 64/220 (29%), Gaps = 31/220 (14%)
Query: 268 TIPSSITNSSKLSDLELGENLFSGFIPNTIGNLRNLEFGNIADNYLTSSTPELSFLSSLT 327
+P I + + L N S + RNL + N L ++ T
Sbjct: 25 AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDA-----AAFT 77
Query: 328 NCKKLKVLIVTGNPLDGILPKSIGNFSLSLETILMANCSISGNIPQVVGNLSNLLVLELG 387
L+ L ++ N + P L L L L
Sbjct: 78 GLALLEQLDLSDNAQLRSVD------------------------PATFHGLGRLHTLHLD 113
Query: 388 GNNLTGPIPVTFSQLQTLQAFDLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCL 447
L P F L LQ L N L D L L L L GN+ S
Sbjct: 114 RCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAF 173
Query: 448 GNLTSVRVLYLGLNIFTSVLSSTIWNLKDILFIDVSSNFL 487
L S+ L L N V +L ++ + + +N L
Sbjct: 174 RGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNL 213
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 1e-19
Identities = 51/269 (18%), Positives = 97/269 (36%), Gaps = 23/269 (8%)
Query: 71 QLGNLSSLQTLDLSHNKLSGNIPSSIF-NMHTLKLLDFSDNQLFGSLSSFIFNMSSMTTI 129
L L L L +NK+S I F + L+ L S N L + + SS+ +
Sbjct: 73 DFKGLQHLYALVLVNNKIS-KIHEKAFSPLRKLQKLYISKNHL-VEIPPNLP--SSLVEL 128
Query: 130 DLSINRLSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKEIGNLTKLKEIISTIT 189
+ NR+ ++P S + + + +G N L E G LK I+
Sbjct: 129 RIHDNRIR-KVP------KGVFSGLRNMNCIEMGGNPLE-NSGFEPGAFDGLKLNYLRIS 180
Query: 190 NSTVCEIPREIGNLPYLARLALATNNLVGVVPVTIFNMSALKEISLLNNSLSGSLPSRID 249
+ + IP+ L L L N + + + S L + L +N + + +
Sbjct: 181 EAKLTGIPK--DLPETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIR-MIENGSL 237
Query: 250 LSLPNVETLNLGINSFSGTIPSSITNSSKLSDLELGENLFSGFIPNTIGNLR------NL 303
LP + L+L N S +P+ + + L + L N + N +
Sbjct: 238 SFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYY 296
Query: 304 EFGNIADNYLTSSTPELSFLSSLTNCKKL 332
++ +N + + + +T+ +
Sbjct: 297 NGISLFNNPVPYWEVQPATFRCVTDRLAI 325
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 1e-17
Identities = 57/348 (16%), Positives = 109/348 (31%), Gaps = 60/348 (17%)
Query: 77 SLQTLDLSHNKLSGNIPSSIFNMHTLKLLDFSDNQLFGSLSSFIF-NMSSMTTIDLSINR 135
L+ + S L +P I LLD +N + L F + + + L N+
Sbjct: 34 HLRVVQCSDLGLK-AVPKEISP--DTTLLDLQNNDI-SELRKDDFKGLQHLYALVLVNNK 89
Query: 136 LSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKEIGNLTKLKEI------ISTIT 189
+S ++ S ++L++L + N+L IP + + L E+ I +
Sbjct: 90 IS-KIH------EKAFSPLRKLQKLYISKNHLV-EIPPNL--PSSLVELRIHDNRIRKVP 139
Query: 190 NSTVCEIPREIGNLPYLARLALATNNLVGV-VPVTIFNMSALKEISLLNNSLSGSLPSRI 248
L + + + N L F+ L + + L+ +P +
Sbjct: 140 KGV-------FSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLT-GIPKDL 191
Query: 249 DLSLPNVETLNLGINSFSGTIPSSITNSSKLSDLELGENLFSGFIPNTIGNLRNLEFGNI 308
+ L+L N + SKL L LG N ++ L L ++
Sbjct: 192 ---PETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHL 248
Query: 309 ADNYLTSSTPELSFLSSLTNCKKLKVLIVTGNPLDGILPKSIGNFSLSLETILMANCSIS 368
+N L+ + L + K L+V+ + N + + +
Sbjct: 249 DNNKLSR------VPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGV----------- 291
Query: 369 GNIPQVVGNLSNLLVLELGGNNLTGPI--PVTFSQLQTLQAFDLTRNK 414
+ + L N + P TF + A K
Sbjct: 292 --------KRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 1e-14
Identities = 62/288 (21%), Positives = 114/288 (39%), Gaps = 24/288 (8%)
Query: 228 SALKEISLLNNSLSGSLPSRIDLSLPNVETLNLGINSFSGTIPSSITNSSKLSDLELGEN 287
S + ++ L + S P L V+ +LG+ + I T L+L N
Sbjct: 11 SGIPDLDSLPPTYSAMCPFGCHCHLRVVQCSDLGLKAVPKEISPDTTL------LDLQNN 64
Query: 288 LFSGFIPNTIGNLRNLEFGNIADNYLTSSTPELSFLSSLTNCKKLKVLIVTGNPLDGILP 347
S + L++L + +N ++ + + + +KL+ L ++ N L I P
Sbjct: 65 DISELRKDDFKGLQHLYALVLVNNKISKIHEK-----AFSPLRKLQKLYISKNHLVEIPP 119
Query: 348 KSIGNFSLSLETILMANCSISGNIPQVVGNLSNLLVLELGGNNLT-GPIPV-TFSQLQTL 405
S SL + + + I V L N+ +E+GGN L F L L
Sbjct: 120 ---NLPS-SLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KL 174
Query: 406 QAFDLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPS-CLGNLTSVRVLYLGLNIFT 464
++ KL G I +L L+ L L NK +I L + + L LG N
Sbjct: 175 NYLRISEAKLTG-IPKDL--PETLNELHLDHNKIQ-AIELEDLLRYSKLYRLGLGHNQIR 230
Query: 465 SVLSSTIWNLKDILFIDVSSNFLDGPLSLDIGNLKVVIGLDFSRNNLS 512
+ + ++ L + + + +N L + + +LK++ + NN++
Sbjct: 231 MIENGSLSFLPTLRELHLDNNKLSR-VPAGLPDLKLLQVVYLHTNNIT 277
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 4e-06
Identities = 36/183 (19%), Positives = 60/183 (32%), Gaps = 24/183 (13%)
Query: 379 SNLLVLELGGNNLTGPIPVTFSQLQTLQAFDLTRNKLAGPITDELCHLARLHSLVLQGNK 438
+ +L+L N+++ F LQ L A L NK++ L +L L + N
Sbjct: 54 PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNH 113
Query: 439 FSGSIPSCLGNLTSVRVLYLGLNIFTSVLSSTIWNLKDILFIDVSSNFL-DGPLSLDI-G 496
IP +S+ L + N V L+++ I++ N L +
Sbjct: 114 LV-EIPP--NLPSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFD 170
Query: 497 NLKVVIGLDFSRNNLSGDIPITIGEGEIPRGGPFANLTAKSFMGNEL-------LCGLPD 549
LK+ L S L+ IP+ L N++ L
Sbjct: 171 GLKLNY-LRISEAKLT----------GIPKDL-PETLNELHLDHNKIQAIELEDLLRYSK 218
Query: 550 LQV 552
L
Sbjct: 219 LYR 221
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 9e-19
Identities = 39/189 (20%), Positives = 63/189 (33%), Gaps = 64/189 (33%)
Query: 635 LIGIGNGM-------------EVAVKVFHQQY---ERALKSFEDECEVRKRIRHRNLV-- 676
L+G G GM VA+K+ + + E R++ ++V
Sbjct: 41 LVGRG-GMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPI 99
Query: 677 --------------------------------------KIISSSLEYLHFGHSIPIIHCD 698
I+ L H+ H D
Sbjct: 100 HDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRD 159
Query: 699 LKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIG---YMAPEYGTKGRVSTR 755
+KP N+L+ D A++ DFGIA + K TQ T+G YMAPE ++ + R
Sbjct: 160 VKPENILVSADDFAYLVDFGIASATTD----EKLTQLGNTVGTLYYMAPERFSESHATYR 215
Query: 756 GDVCSFGII 764
D+ + +
Sbjct: 216 ADIYALTCV 224
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 1e-18
Identities = 47/196 (23%), Positives = 71/196 (36%), Gaps = 64/196 (32%)
Query: 628 DRFSENNLIGIGNGM-------------EVAVKVFHQQY---ERALKSFEDECEVRKRIR 671
+R+ + +G G GM +VA+K E LK FE E ++
Sbjct: 11 ERYKIVDKLGGG-GMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLS 69
Query: 672 HRNLV----------------------------------------KIISSSLEYLHFGHS 691
H+N+V + L+ + H
Sbjct: 70 HQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHD 129
Query: 692 IPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIG---YMAPEYGT 748
+ I+H D+KP N+L+D + I DFGIAK LS + TQT +G Y +PE
Sbjct: 130 MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSE----TSLTQTNHVLGTVQYFSPEQAK 185
Query: 749 KGRVSTRGDVCSFGII 764
D+ S GI+
Sbjct: 186 GEATDECTDIYSIGIV 201
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 85.3 bits (211), Expect = 3e-17
Identities = 34/187 (18%), Positives = 59/187 (31%), Gaps = 66/187 (35%)
Query: 625 RATDRFSENNLIGIGNGMEVAVKVFHQQY-ERALKSFEDECEVRKRIRHRNLVKI----- 678
A DR N+ NG V +K A E + + H ++V+I
Sbjct: 98 LALDR----NV----NGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVE 149
Query: 679 -------------------------------ISSSLEY-------LHFGHSIPIIHCDLK 700
++ ++ Y L + HSI +++ DLK
Sbjct: 150 HTDRHGDPVGYIVMEYVGGQSLKRSKGQKLPVAEAIAYLLEILPALSYLHSIGLVYNDLK 209
Query: 701 PSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQT---LATIGYMAPEYGTKGRVSTRGD 757
P N++L E+ + + D G + T G+ APE + D
Sbjct: 210 PENIMLTEEQLK-LIDLGAVSRI---------NSFGYLYGTPGFQAPEIVR-TGPTVATD 258
Query: 758 VCSFGII 764
+ + G
Sbjct: 259 IYTVGRT 265
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 84.8 bits (209), Expect = 4e-17
Identities = 49/281 (17%), Positives = 108/281 (38%), Gaps = 47/281 (16%)
Query: 45 ITCDVNSHRVIGLNISSFNLQGTITPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKL 104
I D I N+ ++ +T L+S+ + +++ + ++ I + +
Sbjct: 14 IFPDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SV-QGIQYLPNVTK 69
Query: 105 LDFSDNQLFGSLSSFIFNMSSMTTIDLSINRLSGELPANICKIPSTLSKCKQLEELNLGF 164
L + N+L + + N+ ++ + L N++ + S+L K+L+ L+L
Sbjct: 70 LFLNGNKL--TDIKPLTNLKNLGWLFLDENKIK--------DL-SSLKDLKKLKSLSLEH 118
Query: 165 NNLSGAIPKEIGNLTKLKEI------ISTITNSTVCEIPREIGNLPYLARLALATNNLVG 218
N +S + +L +L+ + I+ IT + L L L+L N +
Sbjct: 119 NGISDING--LVHLPQLESLYLGNNKITDITV---------LSRLTKLDTLSLEDNQISD 167
Query: 219 VVPVTIFNMSALKEISLLNNSLSGSLPSRIDLS----LPNVETLNLGINSFSGTIPSSIT 274
+VP+ ++ L+ + L N +S DL L N++ L L + +
Sbjct: 168 IVPLA--GLTKLQNLYLSKNHIS-------DLRALAGLKNLDVLELFSQECLNKPINHQS 218
Query: 275 NSSKLSDLELGENLFSGFIPNTIGNLRNLEFGNIADNYLTS 315
N + ++ + P I + + E N+ +
Sbjct: 219 NLVVPNTVKNTDGSL--VTPEIISDDGDYEKPNVKWHLPEF 257
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 76.3 bits (187), Expect = 2e-14
Identities = 60/301 (19%), Positives = 104/301 (34%), Gaps = 33/301 (10%)
Query: 230 LKEISLLNNSLSGSLPSRIDLSLPNVETLNLGINSFSGTIPSSITNSSKLSDLELGENLF 289
+ E ++ + P D + NL S + + + + + +
Sbjct: 1 MGETITVSTPIKQIFP---DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDI 55
Query: 290 SGFIPNTIGNLRNLEFGNIADNYLTSSTPELSFLSSLTNCKKLKVLIVTGNPLDGILPKS 349
I L N+ + N LT + LTN K L L + N + + S
Sbjct: 56 KSVQG--IQYLPNVTKLFLNGNKLTD-------IKPLTNLKNLGWLFLDENKIKDL--SS 104
Query: 350 IGNFSLSLETILMANCSISGNIPQVVGNLSNLLVLELGGNNLTGPIPVTFSQLQTLQAFD 409
+ + L+++ + + IS +I + +L L L LG N +T S+L L
Sbjct: 105 LKDLK-KLKSLSLEHNGIS-DI-NGLVHLPQLESLYLGNNKITDITV--LSRLTKLDTLS 159
Query: 410 LTRNKLAGPITD--ELCHLARLHSLVLQGNKFSGSIPSCLGNLTSVRVLYLGLNIFTSVL 467
L N+ I+D L L +L +L L N S + L L ++ VL L +
Sbjct: 160 LEDNQ----ISDIVPLAGLTKLQNLYLSKNHIS-DL-RALAGLKNLDVLELFSQECLNKP 213
Query: 468 SSTIWNLKDILFIDVSSNFLDGPLSL----DIGNLKVVIGLDFSRNNLSGDIPITIGEGE 523
+ NL + + L P + D V L N +S + G+
Sbjct: 214 INHQSNLVVPNTVKNTDGSLVTPEIISDDGDYEKPNVKWHLPEFTNEVSFIFYQPVTIGK 273
Query: 524 I 524
Sbjct: 274 A 274
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 75.5 bits (185), Expect = 3e-14
Identities = 43/256 (16%), Positives = 100/256 (39%), Gaps = 25/256 (9%)
Query: 57 LNISSFNLQGTITPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLDFSDNQLFGSL 116
+ ++ +++ ++ + L ++ L L+ NKL+ +I + N+ L L +N++
Sbjct: 48 IIANNSDIK-SVQG-IQYLPNVTKLFLNGNKLT-DI-KPLTNLKNLGWLFLDENKI--KD 101
Query: 117 SSFIFNMSSMTTIDLSINRLSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKEIG 176
S + ++ + ++ L N +S +I + L QLE L LG N ++ +
Sbjct: 102 LSSLKDLKKLKSLSLEHNGIS-----DI----NGLVHLPQLESLYLGNNKITDITV--LS 150
Query: 177 NLTKLKEIISTITNSTVCEIPREIGNLPYLARLALATNNLVGVVPVTIFNMSALKEISLL 236
LTKL + ++ ++ + +I + L L L L+ N++ + + + L + L
Sbjct: 151 RLTKLDTL--SLEDNQISDIV-PLAGLTKLQNLYLSKNHISDLRA--LAGLKNLDVLELF 205
Query: 237 NNSLSGSLPSRIDLSLPNVETLNLGINSFSGTIPSSITNSSKLSDLELGENLFSGFIPNT 296
+ + L T+ S P I++ + +L +
Sbjct: 206 SQECLNKPINHQSN-LVVPNTVKNTDGSL--VTPEIISDDGDYEKPNVKWHLPEFTNEVS 262
Query: 297 IGNLRNLEFGNIADNY 312
+ + G +
Sbjct: 263 FIFYQPVTIGKAKARF 278
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 74.4 bits (182), Expect = 7e-14
Identities = 53/282 (18%), Positives = 92/282 (32%), Gaps = 68/282 (24%)
Query: 149 STLSKCKQLEELNLGFNNLSGAIPKEIGNLTKLKEI------ISTITNSTVCEIPREIGN 202
+ + NL +++ A+ L + +I I ++ I
Sbjct: 15 FPDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSVQG---------IQY 63
Query: 203 LPYLARLALATNNLVGVVPVTIFNMSALKEISLLNNSLSGSLPSRIDLS----LPNVETL 258
LP + +L L N L + P + N+ L + L N + DLS L +++L
Sbjct: 64 LPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIK-------DLSSLKDLKKLKSL 114
Query: 259 NLGINSFSGTIPSSITNSSKLSDLELGENLFSGFIPNTIGNLRNLEFGNIADNYLTSSTP 318
+L N S I + + + +L L LG N + + L L+ ++ DN ++
Sbjct: 115 SLEHNGIS-DI-NGLVHLPQLESLYLGNNKITDITV--LSRLTKLDTLSLEDNQISD--- 167
Query: 319 ELSFLSSLTNCKKLKVLIVTGNPLDGILPKSIGNFSLSLETILMANCSISGNIPQVVGNL 378
+ L KL+ L ++ N + + + L
Sbjct: 168 ----IVPLAGLTKLQNLYLSKNHISDLRA---------------------------LAGL 196
Query: 379 SNLLVLELGGNNLTGPIPVTFSQLQTLQAFDLTRNKLAGPIT 420
NL VLEL S L T L P
Sbjct: 197 KNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEI 238
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 46.6 bits (110), Expect = 2e-05
Identities = 28/166 (16%), Positives = 54/166 (32%), Gaps = 15/166 (9%)
Query: 57 LNISSFNLQGTITPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLDFSDNQLFGSL 116
L + + + IT L L+ L TL L N++S +I + + L+ L S N + S
Sbjct: 136 LYLGNNKIT-DITV-LSRLTKLDTLSLEDNQIS-DI-VPLAGLTKLQNLYLSKNHI--SD 189
Query: 117 SSFIFNMSSMTTIDLSINRLSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKEIG 176
+ + ++ ++L K + S + +L P+ I
Sbjct: 190 LRALAGLKNLDVLELFSQECLN-------KPINHQSNLVVPNTVKNTDGSLV--TPEIIS 240
Query: 177 NLTKLKEIISTITNSTVCEIPREIGNLPYLARLALATNNLVGVVPV 222
+ ++ I P A A + P+
Sbjct: 241 DDGDYEKPNVKWHLPEFTNEVSFIFYQPVTIGKAKARFHGRVTQPL 286
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 6e-17
Identities = 47/200 (23%), Positives = 73/200 (36%), Gaps = 66/200 (33%)
Query: 628 DRFSENNLIGIGNGM-------------EVAVKVFHQQY---ERALKSFEDECEVRKRIR 671
DR+ ++G G GM +VAVKV F E + +
Sbjct: 12 DRYELGEILGFG-GMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 672 HRNLV--------------------------------------------KIISSSLEYLH 687
H +V ++I+ + + L+
Sbjct: 71 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALN 130
Query: 688 FGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIG---YMAP 744
F H IIH D+KP+N+++ + DFGIA+ ++ D + TQT A IG Y++P
Sbjct: 131 FSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIA--DSGNSVTQTAAVIGTAQYLSP 188
Query: 745 EYGTKGRVSTRGDVCSFGII 764
E V R DV S G +
Sbjct: 189 EQARGDSVDARSDVYSLGCV 208
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 7e-16
Identities = 64/339 (18%), Positives = 124/339 (36%), Gaps = 72/339 (21%)
Query: 45 ITCDVNSHRVIGLNISSFNLQGTITPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKL 104
I D I + N+ T+T +L + TL ++ I + ++ L
Sbjct: 12 IFPDPALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TI-EGVQYLNNLIG 67
Query: 105 LDFSDNQLFGSLSSFIFNMSSMTTIDLSINRLSGELPANICKIPSTLSKCKQLEELNLGF 164
L+ DNQ+ + + + N++ +T ++LS N L K S ++ + ++ L+L
Sbjct: 68 LELKDNQI--TDLAPLKNLTKITELELSGNPL---------KNVSAIAGLQSIKTLDLTS 116
Query: 165 NNLSGAIPKEIGNLTKLKEIISTITNSTVCEIPREIGNLPYLARLALATNNLVGVVPVTI 224
I+ +T + L L L L N + + P+
Sbjct: 117 TQ------------------ITDVTP---------LAGLSNLQVLYLDLNQITNISPLA- 148
Query: 225 FNMSALKEISLLNNSLSGSLPSRIDLS----LPNVETLNLGINSFSGTIPSSITNSSKLS 280
++ L+ +S+ N +S DL+ L + TL N S S + + L
Sbjct: 149 -GLTNLQYLSIGNAQVS-------DLTPLANLSKLTTLKADDNKISDI--SPLASLPNLI 198
Query: 281 DLELGENLFSGFIPNTIGNLRNLEFGNIADNYLTSSTPELSFLSSLTNCKKLKVLIVTGN 340
++ L N S P + N NL + + +T+ N + +V G
Sbjct: 199 EVHLKNNQISDVSP--LANTSNLFIVTLTNQTITN-------QPVFYNNNLVVPNVVKGP 249
Query: 341 PLDGILPKSIGNFSLSLETILMANCSISGNIPQVVGNLS 379
I P +I + A+ +++ N+ + N+S
Sbjct: 250 SGAPIAPATISD------NGTYASPNLTWNLTSFINNVS 282
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 4e-15
Identities = 53/257 (20%), Positives = 105/257 (40%), Gaps = 38/257 (14%)
Query: 72 LGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLDFSDNQLFGSLSSFIFNMSSMTTIDL 131
+ L++L L+L N+++ ++ + + N+ + L+ S N L S I + S+ T+DL
Sbjct: 59 VQYLNNLIGLELKDNQIT-DL-APLKNLTKITELELSGNPL--KNVSAIAGLQSIKTLDL 114
Query: 132 SINRLSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKEIGNLTKLKEI------I 185
+ +++ + L+ L+ L L N ++ P + LT L+ + +
Sbjct: 115 TSTQITD---------VTPLAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQV 163
Query: 186 STITNSTVCEIPREIGNLPYLARLALATNNLVGVVPVTIFNMSALKEISLLNNSLSGSLP 245
S +T + NL L L N + + P+ ++ L E+ L NN +S P
Sbjct: 164 SDLTP---------LANLSKLTTLKADDNKISDISPLA--SLPNLIEVHLKNNQISDVSP 212
Query: 246 SRIDLSLPNVETLNLGINSFSGTIPSSITNSSKLSDLELGENLFSGFIPNTIGNLRNLEF 305
+ N+ + L + T N++ + + + P TI +
Sbjct: 213 LA---NTSNLFIVTLTNQTI--TNQPVFYNNNLVVPNVVKGPSGAPIAPATISDNGTYAS 267
Query: 306 GNIADNYLTSSTPELSF 322
N+ N LTS +S+
Sbjct: 268 PNLTWN-LTSFINNVSY 283
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 2e-14
Identities = 54/272 (19%), Positives = 102/272 (37%), Gaps = 26/272 (9%)
Query: 149 STLSKCKQLEELNLGFNNLSGAIPKEIGNLTKLKEIISTITNSTVCEIPREIGNLPYLAR 208
++ G +N++ + +L + + + + V I + L L
Sbjct: 13 FPDPALANAIKIAAGKSNVTDTVT--QADLDGITTL--SAFGTGVTTIE-GVQYLNNLIG 67
Query: 209 LALATNNLVGVVPVTIFNMSALKEISLLNNSLSGSLPSRIDLSLPNVETLNLGINSFSGT 268
L L N + + P+ N++ + E+ L N L ++ + L +++TL+L +
Sbjct: 68 LELKDNQITDLAPLK--NLTKITELELSGNPLK-NVSA--IAGLQSIKTLDLTSTQITDV 122
Query: 269 IPSSITNSSKLSDLELGENLFSGFIPNTIGNLRNLEFGNIADNYLTSSTPELSFLSSLTN 328
P + S L L L N + P + L NL++ +I + ++ L+ L N
Sbjct: 123 TP--LAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSD-------LTPLAN 171
Query: 329 CKKLKVLIVTGNPLDGILPKSIGNFSLSLETILMANCSISGNIPQVVGNLSNLLVLELGG 388
KL L N + I P + + +L + + N IS P + N SNL ++ L
Sbjct: 172 LSKLTTLKADDNKISDISP--LASLP-NLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226
Query: 389 NNLTGPIPVTFSQLQTLQAFDLTRNKLAGPIT 420
+T + L P T
Sbjct: 227 QTITNQPVFYNNNLVVPNVVKGPSGAPIAPAT 258
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 9e-11
Identities = 44/241 (18%), Positives = 92/241 (38%), Gaps = 34/241 (14%)
Query: 272 SITNSSKLSDLELGENLFSGFIPNTIGNLRNLEFGNIADNYLTSSTPELSFLSSLTNCKK 331
SIT + ++ + L N + +T + +
Sbjct: 2 SITQPTAINVIF------------PDPALANAIKIAAGKSNVTD-------TVTQADLDG 42
Query: 332 LKVLIVTGNPLDGILPKSIGNFSLSLETILMANCSISGNIPQVVGNLSNLLVLELGGNNL 391
+ L G + I + + + +L + + + I+ ++ + NL+ + LEL GN L
Sbjct: 43 ITTLSAFGTGVTTI--EGVQYLN-NLIGLELKDNQIT-DLA-PLKNLTKITELELSGNPL 97
Query: 392 TGPIPVTFSQLQTLQAFDLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLT 451
+ LQ+++ DLT ++ L L+ L L L N+ + +I L LT
Sbjct: 98 KNVSA--IAGLQSIKTLDLTSTQITD--VTPLAGLSNLQVLYLDLNQIT-NISP-LAGLT 151
Query: 452 SVRVLYLGLNIFTSVLSSTIWNLKDILFIDVSSNFLDGPLSLDIGNLKVVIGLDFSRNNL 511
+++ L +G + + + + NL + + N + L +L +I + N +
Sbjct: 152 NLQYLSIGNAQVSDL--TPLANLSKLTTLKADDNKISDISPLA--SLPNLIEVHLKNNQI 207
Query: 512 S 512
S
Sbjct: 208 S 208
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 2e-08
Identities = 48/200 (24%), Positives = 83/200 (41%), Gaps = 20/200 (10%)
Query: 70 PQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLDFSDNQLFGSLSSFIFNMSSMTTI 129
L LS+LQ L L N+++ NI S + + L+ L + Q+ S + + N+S +TT+
Sbjct: 123 TPLAGLSNLQVLYLDLNQIT-NI-SPLAGLTNLQYLSIGNAQV--SDLTPLANLSKLTTL 178
Query: 130 DLSINRLSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKEIGNLTKLKEIISTIT 189
N++S I L+ L E++L N +S P + N + L + T+T
Sbjct: 179 KADDNKIS--------DISP-LASLPNLIEVHLKNNQISDVSP--LANTSNLFIV--TLT 225
Query: 190 NSTVCEIPREIGNLPYLARLALATNNLVGVVPVTIFNMSALKEISLLNNSLSGSLPSRID 249
N T+ P N + + + + P TI + +L N S + +
Sbjct: 226 NQTITNQPVFYNNN-LVVPNVVKGPSGAPIAPATISDNGTYASPNLTWNLT--SFINNVS 282
Query: 250 LSLPNVETLNLGINSFSGTI 269
+ T FSGT+
Sbjct: 283 YTFNQSVTFKNTTVPFSGTV 302
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 80.6 bits (198), Expect = 8e-16
Identities = 50/342 (14%), Positives = 107/342 (31%), Gaps = 32/342 (9%)
Query: 8 SQHQQALLALKAHISYDHTNLFARNWTSSTSVCIWIGITCDVNSHRVIGLNISSFNLQGT 67
+ + LL +R + ++ ++ + +++
Sbjct: 229 WFYHRWLLGRAEPHDVLCCVHVSREEACLSVCFSRPLTVGSRMGTLLLMVDEAPLSVEWR 288
Query: 68 ITPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLDFSDNQLF----GSLSSFIFNM 123
S + DL L+ +P F + + L
Sbjct: 289 TPDGRNRPSHVWLCDLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECWCRDSATD 348
Query: 124 SSMTTIDLSINRLSGELPANICKIPSTLSKCKQLEELNLGFNNL---SGAIPKEIGNLTK 180
+ +LS+ + + S L CK+L+EL + + + L
Sbjct: 349 EQLFRCELSVEKS--------TVLQSELESCKELQELEPENKWCLLTIILLMRALDPLLY 400
Query: 181 LKEIISTITNSTVCEIPREIGNLPYLARLALATNNLVGVVPVTIFNMSALKEISLLNNSL 240
KE + + + R A L + + V + ++ + L + L
Sbjct: 401 EKETLQYFSTLKAVDPMR-------AAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDL 453
Query: 241 SGSLPSRIDLSLPNVETLNLGINSFSGTIPSSITNSSKLSDLELGENLFSGFIPNTIGNL 300
+ L ++ L V L+L N +P ++ L L+ +N + + NL
Sbjct: 454 T-VLCH-LE-QLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVDG-VANL 507
Query: 301 RNLEFGNIADNYLTSSTPELSFLSSLTNCKKLKVLIVTGNPL 342
L+ + +N L + + L +C +L +L + GN L
Sbjct: 508 PRLQELLLCNNRLQQ----SAAIQPLVSCPRLVLLNLQGNSL 545
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 68.6 bits (167), Expect = 4e-12
Identities = 37/158 (23%), Positives = 63/158 (39%), Gaps = 14/158 (8%)
Query: 24 DHTNLFARNWTSSTSVCIWIGITCDVNSHRVIGLNISSFNLQGTITPQLGNLSSLQTLDL 83
D + S + + + RV+ L + T+ L L + LDL
Sbjct: 415 DPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLA----HKDLTVLCHLEQLLLVTHLDL 470
Query: 84 SHNKLSGNIPSSIFNMHTLKLLDFSDNQLFGSLSSFIFNMSSMTTIDLSINRLSGELPAN 143
SHN+L +P ++ + L++L SDN L ++ + N+ + + L NRL + A
Sbjct: 471 SHNRLR-ALPPALAALRCLEVLQASDNALE-NVDG-VANLPRLQELLLCNNRLQ-QSAA- 525
Query: 144 ICKIPSTLSKCKQLEELNLGFNNLSGAIPKEIGNLTKL 181
L C +L LNL N+L L ++
Sbjct: 526 ----IQPLVSCPRLVLLNLQGNSLC-QEEGIQERLAEM 558
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 58.2 bits (140), Expect = 7e-09
Identities = 52/339 (15%), Positives = 93/339 (27%), Gaps = 45/339 (13%)
Query: 105 LDFSDNQLFGSLSSFIFNMSSMTTIDLSINRLSGELPANICKIPSTLSK--CKQLEELNL 162
+ + L S + S M T+ L ++ + + S L +L
Sbjct: 250 VSREEACLSVCFSRPLTVGSRMGTLLLMVDEAPLSVEWRTPDGRNRPSHVWLCDLPAASL 309
Query: 163 GFNNLSGAIPKEIGNLTKLKEIISTITNSTVCEIPREIGNLPYLARLALATNNLVGVVPV 222
KE + R+ L R L+ V+
Sbjct: 310 NDQLPQHTFRVIWTGSDSQKECVLLKDRPECW--CRDSATDEQLFRCELSVEKST-VLQS 366
Query: 223 TIFNMSALKEISLLNNSLSGSLPSRIDLSLPNVETLNLGINSFSGTIPSSITNSSKLSDL 282
+ + L+E+ N ++ L + ++ L + + + + L
Sbjct: 367 ELESCKELQELEPENKWCLLTII----LLMRALDPLLYEKETLQYFSTLKAVDPMRAAYL 422
Query: 283 ELGENLFSGFIPNTIGNLRNLEFGNIADNYLTSSTPELSFLSSLTNCKKLKVLIVTGNPL 342
+ + F ++ ++A LT L L + L ++ N L
Sbjct: 423 DDLRSKFLLENSVLKMEYADVRVLHLAHKDLTV-------LCHLEQLLLVTHLDLSHNRL 475
Query: 343 DGILPKSIGNFSLSLETILMANCSISGNIPQVVGNLSNLLVLELGGNNLTGPIPVTFSQL 402
+P + L L VL+ N L + + L
Sbjct: 476 R--------------------------ALPPALAALRCLEVLQASDNALEN-VD-GVANL 507
Query: 403 QTLQAFDLTRNKLAG-PITDELCHLARLHSLVLQGNKFS 440
LQ L N+L L RL L LQGN
Sbjct: 508 PRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLC 546
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 57.5 bits (138), Expect = 1e-08
Identities = 20/99 (20%), Positives = 39/99 (39%), Gaps = 6/99 (6%)
Query: 61 SFNLQGTITPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLDFSDNQLFGSLSSF- 119
S N + P L L L+ L S N L N+ + N+ L+ L +N+L ++
Sbjct: 471 SHNRLRALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNNRL-QQSAAIQ 527
Query: 120 -IFNMSSMTTIDLSINRLSGELPANICKIPSTLSKCKQL 157
+ + + ++L N L + ++ L +
Sbjct: 528 PLVSCPRLVLLNLQGNSLC-QEEGIQERLAEMLPSVSSI 565
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 50.9 bits (121), Expect = 1e-06
Identities = 45/298 (15%), Positives = 94/298 (31%), Gaps = 18/298 (6%)
Query: 226 NMSALKEISLLNNSLSGSLPSRIDLSLPNVETLNLGINSFSGTIPSSITNSSKLSDLELG 285
+S L S G+L +D + +VE + + ++ L+D
Sbjct: 256 CLSVCFSRPLTVGSRMGTLLLMVDEAPLSVEWRTPDGRNRPSHVWLCDLPAASLNDQLPQ 315
Query: 286 ENLFSGFIPNTIGNLRNLEFGNIADNYLTSSTPE--LSFLSSLTNCKKLKVLIVTGNPLD 343
+ + L S+T E S+ L+ + + L
Sbjct: 316 HTFRVIWTGSDSQKECVLLKDRPECWCRDSATDEQLFRCELSVEKSTVLQSELESCKELQ 375
Query: 344 GILPKSIGNFSLSLETILMANCSISGNIPQVVGNLSNLLVLE--------LGGNNLTGPI 395
+ P++ + L +LM + + S L ++ +
Sbjct: 376 ELEPEN--KWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLDDLRSKFLLEN 433
Query: 396 PVTFSQLQTLQAFDLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSVRV 455
V + ++ L L L L + L L N+ ++P L L + V
Sbjct: 434 SVLKMEYADVRVLHLAHKDLTVL--CHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEV 490
Query: 456 LYLGLNIFTSVLSSTIWNLKDILFIDVSSNFLDGPLSLD-IGNLKVVIGLDFSRNNLS 512
L N +V + NL + + + +N L ++ + + ++ L+ N+L
Sbjct: 491 LQASDNALENV--DGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLC 546
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 78.7 bits (194), Expect = 2e-15
Identities = 42/197 (21%), Positives = 69/197 (35%), Gaps = 64/197 (32%)
Query: 629 RFSENNLIGIG-----------NGMEVAVKVFHQQYERALK------------------- 658
F +++G G + +VAVK +
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIRYF 84
Query: 659 -SFEDE---------CE-------VRKRIRH-----RNLVKIISSSLEYLHFGHSIPIIH 696
+ +D C +K H L++ +S L +LH S+ I+H
Sbjct: 85 CTEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLH---SLNIVH 141
Query: 697 CDLKPSNVLLDE-----DMVAHISDFGIAKLLSGEDQLSKQTQTLA-TIGYMAPEY---G 747
DLKP N+L+ + A ISDFG+ K L+ + + T G++APE
Sbjct: 142 RDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSED 201
Query: 748 TKGRVSTRGDVCSFGII 764
K + D+ S G +
Sbjct: 202 CKENPTYTVDIFSAGCV 218
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 76.9 bits (189), Expect = 2e-15
Identities = 48/302 (15%), Positives = 90/302 (29%), Gaps = 19/302 (6%)
Query: 225 FNMSALKEISLLNNSLSGSLPSRIDLSLPNVETLNLGINSFSGTIP-SSITNSSKLSDLE 283
N S K + G+ + ++E L +++ + + I S L L
Sbjct: 15 CNFSDPKPDWSSAFNCLGAADVELYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLT 74
Query: 284 LGENLFSGFIPNT---IGNLRNLEFGNIADNYLTSSTPELSFLSSLTNCKKLKVLIVTGN 340
+ I + + L+ + + +T + P ++ + L + V+
Sbjct: 75 VRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWA 134
Query: 341 PLDGILPKSIGNFSLSLETILMANCSISGNIPQVVGNLSNLLVLELGGNNLTGPI----- 395
D L + L+ + +A + V L L+L N G
Sbjct: 135 TRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISA 194
Query: 396 --PVTFSQLQTLQAFDLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIP-SCLGNLTS 452
P+ F LQ L + +G + +L L L N + +
Sbjct: 195 LCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQ 254
Query: 453 VRVLYLGLNIFTSVLSSTIWNLKDILFIDVSSNFLDG-PLSLDIGNLKVVIGLDFSRNNL 511
+ L L V L +D+S N LD P ++ + L N
Sbjct: 255 LNSLNLSFTGLKQVPKGLPAKLS---VLDLSYNRLDRNPSPDELPQVGN---LSLKGNPF 308
Query: 512 SG 513
Sbjct: 309 LD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 75.7 bits (186), Expect = 5e-15
Identities = 55/303 (18%), Positives = 89/303 (29%), Gaps = 21/303 (6%)
Query: 202 NLPYLARLALATNNLVGVVPVTIFNMSALKEISLLNNSLSGSLPSRID----LSLPNVET 257
N + N +G V ++ E L L D LSL +
Sbjct: 16 NFSDPKPDWSSAFNCLGAADVELYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTV 75
Query: 258 LNLGINSFSGTIPSSITNSSKLSDLELGENLFSGFIPNTIGNL--RNLEFGNIADNYLTS 315
I S + S L +L L +G P + +L N+ + +
Sbjct: 76 RAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWAT 135
Query: 316 STPELSFLSSLTNCKKLKVLIVTGNPLDGILPKSIGNFSLSLETILMANCSISGNIP--- 372
L+ L LKVL + + + F +L T+ +++ G
Sbjct: 136 RDAWLAELQQWLK-PGLKVLSIAQAHSLNFSCEQVRVFP-ALSTLDLSDNPELGERGLIS 193
Query: 373 -QVVGNLSNLLVLELGGNNLT---GPIPVTFSQLQTLQAFDLTRNKLAGPITDELC-HLA 427
L VL L + G + LQ DL+ N L C +
Sbjct: 194 ALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPS 253
Query: 428 RLHSLVLQGNKFSGSIPSCLGNLTSVRVLYLGLNIFTSVLSSTIWNLKDILFIDVSSNFL 487
+L+SL L +P L + VL L N + L + + + N
Sbjct: 254 QLNSLNLSFTGLK-QVPKGL--PAKLSVLDLSYNRLDRN--PSPDELPQVGNLSLKGNPF 308
Query: 488 DGP 490
Sbjct: 309 LDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 74.5 bits (183), Expect = 1e-14
Identities = 48/278 (17%), Positives = 90/278 (32%), Gaps = 41/278 (14%)
Query: 49 VNSHRVIGLNISSFNLQGTITPQ---LGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKL- 104
+ S + L + + + I + +S LQ L L + +++G P + L
Sbjct: 65 IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLN 124
Query: 105 -LDFSDNQLFGSLSSFIFNMSSMTTIDLSINRLSGELPANICKIP-STLSKCKQLEELNL 162
L+ + + +++ + L + ++ A+ + L L+L
Sbjct: 125 ILNLRNVSW-ATRDAWLAELQQWLKPGLKVLSIAQ---AHSLNFSCEQVRVFPALSTLDL 180
Query: 163 GFNNLSGAIPKEIGNLTKLKEIISTITNSTVCEIPREIGNLPYLARLALATNN---LVGV 219
N G S +C P L LAL GV
Sbjct: 181 SDNPELGERGLI----------------SALCP-----LKFPTLQVLALRNAGMETPSGV 219
Query: 220 VPVTIFNMSALKEISLLNNSLSGSLPSRIDLSLPNVETLNLGINSFSGTIPSSITNSSKL 279
L+ + L +NSL + + + +LNL +P + +KL
Sbjct: 220 CSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGL--PAKL 276
Query: 280 SDLELGENLFSGF-IPNTIGNLRNLEFGNIADNYLTSS 316
S L+L N P+ + + NL ++ N S
Sbjct: 277 SVLDLSYNRLDRNPSPDELPQVGNL---SLKGNPFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 72.2 bits (177), Expect = 7e-14
Identities = 46/296 (15%), Positives = 83/296 (28%), Gaps = 50/296 (16%)
Query: 71 QLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLDFSDNQLFGSL---SSFIFNMSSMT 127
G S L + + I +LK L ++ + + + +S +
Sbjct: 39 YGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQ 98
Query: 128 TIDLSINRLSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKEIGNLTKLKEIIST 187
+ L ++G P + + L LNL N + L +
Sbjct: 99 ELTLENLEVTGTAPPPLLEATGP-----DLNILNLR-NVSWATRDAWLAELQQWL----- 147
Query: 188 ITNSTVCEIPREIGNLPYLARLALATNNLVGVVPVTIFNMSALKEISLLNNSLSGSLP-- 245
P L L++A + + + AL + L +N G
Sbjct: 148 ---------------KPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLI 192
Query: 246 -SRIDLSLPNVETLNL---GINSFSGTIPSSITNSSKLSDLELGENLFSGFIPNTI-GNL 300
+ L P ++ L L G+ + SG + +L L+L N
Sbjct: 193 SALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWP 252
Query: 301 RNLEFGNIADNYLTSSTPE--------------LSFLSSLTNCKKLKVLIVTGNPL 342
L N++ L L S ++ L + GNP
Sbjct: 253 SQLNSLNLSFTGLKQVPKGLPAKLSVLDLSYNRLDRNPSPDELPQVGNLSLKGNPF 308
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 53.0 bits (127), Expect = 2e-07
Identities = 37/231 (16%), Positives = 70/231 (30%), Gaps = 37/231 (16%)
Query: 298 GNLRNLEFGNIADNYLTSSTPELSFLSSLTNCKKLKVLIVTGNPL-DGILPKSIGNFSLS 356
G R+LE+ + + SL+ LK L V + IL ++ +S
Sbjct: 40 GGGRSLEYLLKRVDTEADLGQFTDIIKSLS----LKRLTVRAARIPSRILFGALRVLGIS 95
Query: 357 -LETILMANCSISGNIPQVVGNLSNLLVLELGGNNLTGPIPVTFS------QLQTLQAFD 409
L+ + + N ++G P + + + L N++ + L+
Sbjct: 96 GLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLS 155
Query: 410 LTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIP----SCLGNLTSVRVLYLGLNIFTS 465
+ + +++ L +L L N G C +++VL L +
Sbjct: 156 IAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMET 215
Query: 466 VLSSTIWNLKDILFIDVSSNFLDGPLSLDIGNLKVVIGLDFSRNNLSGDIP 516
G S + GLD S N+L
Sbjct: 216 ---------------------PSGVCSALAAARVQLQGLDLSHNSLRDAAG 245
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 46.8 bits (111), Expect = 1e-05
Identities = 25/177 (14%), Positives = 52/177 (29%), Gaps = 10/177 (5%)
Query: 352 NFSLSLETILMANCSISGNIPQVVGNLSNLLVLELGGNNLTGPIPVT-FSQLQTLQAFDL 410
NFS A + ++ G +L L + T + +L+ +
Sbjct: 16 NFSDPKPDWSSAFNCLGAADVELYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTV 75
Query: 411 TRNKLAGPITDELCHL---ARLHSLVLQGNKFSGSIPSCLGNLTSVRVLYLGLN------ 461
++ I + + L L L+ + +G+ P L T + L L
Sbjct: 76 RAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWAT 135
Query: 462 IFTSVLSSTIWNLKDILFIDVSSNFLDGPLSLDIGNLKVVIGLDFSRNNLSGDIPIT 518
+ W + + ++ + + LD S N G+ +
Sbjct: 136 RDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLI 192
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 3e-15
Identities = 40/193 (20%), Positives = 76/193 (39%), Gaps = 35/193 (18%)
Query: 74 NLSSLQTLDLSHNKLSGNIPSSIF-NMHTLKLLDFSDNQLFGSLSSFIF-NMSSMTTIDL 131
+LS L TL L+ N + ++ F + +L+ L + L SL +F ++ ++ +++
Sbjct: 74 SLSHLSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNV 131
Query: 132 SINRLSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKEI-GNLTKLKEIISTITN 190
+ N + +P S LE L+L N + +I L ++ +
Sbjct: 132 AHNLIQ-SFK-----LPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLL------ 178
Query: 191 STVCEIPREIGNLPYLARLALATNNLVGVVPVTIFNMSALKEISLLNNSLSGSLPSRIDL 250
L L+ N + + F LKE++L N L S+P I
Sbjct: 179 ---------------NLSLDLSLNPM-NFIQPGAFKEIRLKELALDTNQLK-SVPDGIFD 221
Query: 251 SLPNVETLNLGIN 263
L +++ + L N
Sbjct: 222 RLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 8e-13
Identities = 53/256 (20%), Positives = 96/256 (37%), Gaps = 43/256 (16%)
Query: 76 SSLQTLDLSHNKLSGNIPSSIF-NMHTLKLLDFSDNQLFGSLSSFIF-NMSSMTTIDLSI 133
S + LDLS N L ++ S F + L++LD S ++ ++ + ++S ++T+ L+
Sbjct: 28 FSTKNLDLSFNPLR-HLGSYSFFSFPELQVLDLSRCEI-QTIEDGAYQSLSHLSTLILTG 85
Query: 134 NRLSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKEIGNLTKLKEIISTITNSTV 193
N + L S L++L NL+ IG+L LK
Sbjct: 86 NPIQ-SLALGA------FSGLSSLQKLVAVETNLASLENFPIGHLKTLK----------- 127
Query: 194 CEIPREIGNLPYLARLALATNNLVGVVPVTIF-NMSALKEISLLNNSLSGSLPSRIDLSL 252
L +A N + F N++ L+ + L +N + S+ L
Sbjct: 128 --------------ELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLRVL 172
Query: 253 PNVE----TLNLGINSFSGTIPSSITNSSKLSDLELGENLFSGFIPNTIGNLRNLEFGNI 308
+ +L+L +N + I +L +L L N L +L+ +
Sbjct: 173 HQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWL 231
Query: 309 ADNYLTSSTPELSFLS 324
N S P + +LS
Sbjct: 232 HTNPWDCSCPRIDYLS 247
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 8e-12
Identities = 49/223 (21%), Positives = 95/223 (42%), Gaps = 16/223 (7%)
Query: 269 IPSSITNSSKLSDLELGENLFSGFIPNTIGNLRNLEFGNIADNYLTSSTPELSFLSSLTN 328
IP ++ S+K +L+L N + + L+ +++ + + + ++ SL++
Sbjct: 22 IPDNLPFSTK--NLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQT-IEDGAY-QSLSH 77
Query: 329 CKKLKVLIVTGNPLDGILPKSIGNFSLSLETILMANCSISGNIPQVV-GNLSNLLVLELG 387
L LI+TGNP+ + + S SL+ ++ +++ ++ G+L L L +
Sbjct: 78 ---LSTLILTGNPIQSLALGAFSGLS-SLQKLVAVETNLA-SLENFPIGHLKTLKELNVA 132
Query: 388 GNNLTG-PIPVTFSQLQTLQAFDLTRNKLAGPITDELCHLARL----HSLVLQGNKFSGS 442
N + +P FS L L+ DL+ NK+ +L L ++ SL L N +
Sbjct: 133 HNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-F 191
Query: 443 IPSCLGNLTSVRVLYLGLNIFTSVLSSTIWNLKDILFIDVSSN 485
I ++ L L N SV L + I + +N
Sbjct: 192 IQPGAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 3e-10
Identities = 49/211 (23%), Positives = 81/211 (38%), Gaps = 13/211 (6%)
Query: 208 RLALATNNLVGVVPVTIFNMSALKEISLLNNSLSGSLPSRIDLSLPNVETLNLGINSFSG 267
L L+ N L + + F+ L+ + L + ++ SL ++ TL L N
Sbjct: 32 NLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPIQ- 89
Query: 268 TIPSSI-TNSSKLSDLELGENLFSGFIPNTIGNLRNLEFGNIADNYLTSSTPELSFLSSL 326
++ + S L L E + IG+L+ L+ N+A N + S + S+L
Sbjct: 90 SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQS-FKLPEYFSNL 148
Query: 327 TNCKKLKVLIVTGNPLDGILPKSIGNFSLSLETILMANCSISGN----IPQVVGNLSNLL 382
TN L+ L ++ N + I + L +L + +S N I L
Sbjct: 149 TN---LEHLDLSSNKIQSIYCTDLRV--LHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLK 203
Query: 383 VLELGGNNLTGPIPVTFSQLQTLQAFDLTRN 413
L L N L F +L +LQ L N
Sbjct: 204 ELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 5e-09
Identities = 56/248 (22%), Positives = 80/248 (32%), Gaps = 41/248 (16%)
Query: 220 VPVTIFNMSALKEISLLNNSLSGSLPSRIDLSLPNVETLNLGINSFSGTIPSSI-TNSSK 278
+P + + K + L N L L S S P ++ L+L TI + S
Sbjct: 22 IPDNLP--FSTKNLDLSFNPLR-HLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSH 77
Query: 279 LSDLELGENLFSGFIPNTIGNLRNLEFGNIADNYLTSSTPELSFLSSLTNCKKLKVLIVT 338
LS L L N L +L+ + L S L LK L V
Sbjct: 78 LSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLAS-LENFPI-GHLKT---LKELNVA 132
Query: 339 GNPLDGILPKSIGNFSLSLETILMANCSISGNIPQVVGNLSNLLVLELGGNNLTGPIPVT 398
N + K FS NL+NL L+L N +
Sbjct: 133 HNLIQSF--KLPEYFS----------------------NLTNLEHLDLSSNKIQSIYCTD 168
Query: 399 FSQLQTLQAF----DLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPS-CLGNLTSV 453
L + DL+ N + I RL L L N+ S+P LTS+
Sbjct: 169 LRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIRLKELALDTNQLK-SVPDGIFDRLTSL 226
Query: 454 RVLYLGLN 461
+ ++L N
Sbjct: 227 QKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 2e-07
Identities = 33/119 (27%), Positives = 57/119 (47%), Gaps = 17/119 (14%)
Query: 73 GNLSSLQTLDLSHNKLSGNIPSSIF-NMHTLKLLDFSDNQLFGSLSSFIF-NMSSMT--- 127
G+L +L+ L+++HN + F N+ L+ LD S N++ S+ + M
Sbjct: 121 GHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKI-QSIYCTDLRVLHQMPLLN 179
Query: 128 -TIDLSINRLSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKEI-GNLTKLKEI 184
++DLS+N ++ I K +L+EL L N L ++P I LT L++I
Sbjct: 180 LSLDLSLNPMN--------FIQPGAFKEIRLKELALDTNQLK-SVPDGIFDRLTSLQKI 229
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 3e-06
Identities = 36/153 (23%), Positives = 62/153 (40%), Gaps = 17/153 (11%)
Query: 366 SISGNIPQVVGNLSNLLVLELGGNNLTGPIPVTFSQLQTLQAFDLTRNKLAGPITDELCH 425
I N+P + L+L N L +F LQ DL+R ++
Sbjct: 21 KIPDNLP------FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQS 74
Query: 426 LARLHSLVLQGNKFSGSIPS-CLGNLTSVRVLYLGLNIFTSVLSSTIWNLKDILFIDVSS 484
L+ L +L+L GN S+ L+S++ L S+ + I +LK + ++V+
Sbjct: 75 LSHLSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAH 133
Query: 485 NFL-----DGPLSLDIGNLKVVIGLDFSRNNLS 512
N + S ++ NL+ LD S N +
Sbjct: 134 NLIQSFKLPEYFS-NLTNLEH---LDLSSNKIQ 162
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 76.5 bits (188), Expect = 4e-15
Identities = 28/121 (23%), Positives = 47/121 (38%), Gaps = 19/121 (15%)
Query: 654 ERALKSFEDECEVRKRIRHRNLVKIISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAH 713
R + I+ ++E+LH S ++H DLKPSN+ D V
Sbjct: 154 RRCSLEDREHGVCLHIFIQ------IAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVK 204
Query: 714 ISDFGIAKLLSGEDQLSKQTQTLA----------TIGYMAPEYGTKGRVSTRGDVCSFGI 763
+ DFG+ + +++ + T YM+PE S + D+ S G+
Sbjct: 205 VGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGL 264
Query: 764 I 764
I
Sbjct: 265 I 265
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 4e-15
Identities = 50/217 (23%), Positives = 86/217 (39%), Gaps = 22/217 (10%)
Query: 74 NLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLDFSDNQLFGSLSSFIF-NMSSMTTIDLS 132
++S ++ L+ +P + +L S+N L + S + +T ++L
Sbjct: 8 KVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLL-YTFSLATLMPYTRLTQLNLD 63
Query: 133 INRLSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKEIGNLTKLKEIISTITNST 192
L+ +L L L+L N L ++P L L + ++ +
Sbjct: 64 RAELT-KLQV--------DGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVL--DVSFNR 111
Query: 193 VCEIPREI-GNLPYLARLALATNNLVGVVPVTIF-NMSALKEISLLNNSLSGSLPSRIDL 250
+ +P L L L L N L +P + L+++SL NN+L+ LP+ +
Sbjct: 112 LTSLPLGALRGLGELQELYLKGNELK-TLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLN 169
Query: 251 SLPNVETLNLGINSFSGTIPSSITNSSKLSDLELGEN 287
L N++TL L NS TIP S L L N
Sbjct: 170 GLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 7e-09
Identities = 46/235 (19%), Positives = 76/235 (32%), Gaps = 39/235 (16%)
Query: 252 LPNVETLNLGINSFSGTIPSSITNSSKLSDLELGENLFSGFIPNTIGNLRNLEFGNIADN 311
+ + +N + + +P + + L L ENL F T+ L N+
Sbjct: 9 VASHLEVNCDKRNLT-ALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRA 65
Query: 312 YLTSSTPELSFLSSLTNCKKLKVLIVTGNPLDGILPKSIGNFSLSLETILMANCSISGNI 371
LT L +L L L ++ N L ++
Sbjct: 66 ELTK----LQVDGTLPV---LGTLDLSHNQLQ--------------------------SL 92
Query: 372 PQVVGNLSNLLVLELGGNNLTGPIPVTFSQLQTLQAFDLTRNKLAGPITDELCHLARLHS 431
P + L L VL++ N LT L LQ L N+L L +L
Sbjct: 93 PLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEK 152
Query: 432 LVLQGNKFSGSIPS-CLGNLTSVRVLYLGLNIFTSVLSSTIWNLKDILFIDVSSN 485
L L N + +P+ L L ++ L L N ++ + + F + N
Sbjct: 153 LSLANNNLT-ELPAGLLNGLENLDTLLLQENSLYTI-PKGFFGSHLLPFAFLHGN 205
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 5e-15
Identities = 31/68 (45%), Positives = 40/68 (58%), Gaps = 8/68 (11%)
Query: 679 ISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLA- 737
+ +L+YL + IIH D+KP N+LLDE HI+DF IA +L E Q T+A
Sbjct: 124 LVMALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET----QITTMAG 176
Query: 738 TIGYMAPE 745
T YMAPE
Sbjct: 177 TKPYMAPE 184
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 76.6 bits (188), Expect = 7e-15
Identities = 15/91 (16%), Positives = 31/91 (34%), Gaps = 9/91 (9%)
Query: 679 ISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLAT 738
+ L LH ++H L+P +++LD+ ++ F G +S + A
Sbjct: 220 VIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD-GASAVSPIGRGFAP 275
Query: 739 IGYMAPE-----YGTKGRVSTRGDVCSFGII 764
A ++ D + G+
Sbjct: 276 PETTAERMLPFGQHHPTLMTFAFDTWTLGLA 306
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 9e-15
Identities = 39/170 (22%), Positives = 58/170 (34%), Gaps = 48/170 (28%)
Query: 639 GNGMEVAVKVFHQQY-ERALKSFEDECEVRKRIRHRNLVKI------------------- 678
+ VAVK + F E + K+ H N+V++
Sbjct: 137 ADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQG 196
Query: 679 -------------------------ISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAH 713
++ +EYL S IH DL N L+ E V
Sbjct: 197 GDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE---SKCCIHRDLAARNCLVTEKNVLK 253
Query: 714 ISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGI 763
ISDFG+++ + + + + APE GR S+ DV SFGI
Sbjct: 254 ISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGI 303
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 1e-14
Identities = 54/288 (18%), Positives = 114/288 (39%), Gaps = 48/288 (16%)
Query: 45 ITCDVNSHRVIGLNISSFNLQGTITPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKL 104
I D I N+ ++ +T L+S+ + +++ + ++ I + +
Sbjct: 17 IFSDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SV-QGIQYLPNVTK 72
Query: 105 LDFSDNQLFGSLSSFIFNMSSMTTIDLSINRLSGELPANICKIPSTLSKCKQLEELNLGF 164
L + N+L + + N+ ++ + L N++ + S+L K+L+ L+L
Sbjct: 73 LFLNGNKL--TDIKPLANLKNLGWLFLDENKVK--------DL-SSLKDLKKLKSLSLEH 121
Query: 165 NNLSGAIPKEIGNLTKLKEI------ISTITNSTVCEIPREIGNLPYLARLALATNNLVG 218
N +S + +L +L+ + I+ IT + L L L+L N +
Sbjct: 122 NGISDING--LVHLPQLESLYLGNNKITDITV---------LSRLTKLDTLSLEDNQISD 170
Query: 219 VVPVTIFNMSALKEISLLNNSLSGSLPSRIDLS----LPNVETLNLGINSFSGTIPSSIT 274
+VP+ ++ L+ + L N +S DL L N++ L L + +
Sbjct: 171 IVPLA--GLTKLQNLYLSKNHIS-------DLRALAGLKNLDVLELFSQECLNKPINHQS 221
Query: 275 NSSKLSDLELGENLFSGFIPNTIGNLRNLEFGNIADNYLTSSTPELSF 322
N + ++ + P I + + E N+ + L T E+SF
Sbjct: 222 NLVVPNTVKNTDGSLVT--PEIISDDGDYEKPNVKWH-LPEFTNEVSF 266
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 5e-11
Identities = 56/290 (19%), Positives = 97/290 (33%), Gaps = 69/290 (23%)
Query: 141 PANICKIPSTLSKCKQLEELNLGFNNLSGAIPKEIGNLTKLKEI------ISTITNSTVC 194
P I +I + + + NL +++ A+ L + +I I ++
Sbjct: 11 PTPIKQI-FSDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSVQG---- 63
Query: 195 EIPREIGNLPYLARLALATNNLVGVVPVTIFNMSALKEISLLNNSLSGSLPSRIDLS--- 251
I LP + +L L N L + P+ N+ L + L N + DLS
Sbjct: 64 -----IQYLPNVTKLFLNGNKLTDIKPLA--NLKNLGWLFLDENKVK-------DLSSLK 109
Query: 252 -LPNVETLNLGINSFSGTIPSSITNSSKLSDLELGENLFSGFIPNTIGNLRNLEFGNIAD 310
L +++L+L N S I + + + +L L LG N + + L L+ ++ D
Sbjct: 110 DLKKLKSLSLEHNGIS-DI-NGLVHLPQLESLYLGNNKITDITV--LSRLTKLDTLSLED 165
Query: 311 NYLTSSTPELSFLSSLTNCKKLKVLIVTGNPLDGILPKSIGNFSLSLETILMANCSISGN 370
N ++ + L KL+ L ++ N + +
Sbjct: 166 NQISD-------IVPLAGLTKLQNLYLSKNHISDLRA----------------------- 195
Query: 371 IPQVVGNLSNLLVLELGGNNLTGPIPVTFSQLQTLQAFDLTRNKLAGPIT 420
+ L NL VLEL S L T L P
Sbjct: 196 ----LAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEI 241
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 1e-10
Identities = 56/268 (20%), Positives = 103/268 (38%), Gaps = 35/268 (13%)
Query: 226 NMSALKEISLLNNSLSGSLPSRIDLSLPNVETLNL---GINSFSGTIPSSITNSSKLSDL 282
+ + +L S++ ++ L +++ + I S G I ++ L
Sbjct: 22 AFAETIKDNLKKKSVTDAVTQN---ELNSIDQIIANNSDIKSVQG-----IQYLPNVTKL 73
Query: 283 ELGENLFSGFIPNTIGNLRNLEFGNIADNYLTSSTPELSFLSSLTNCKKLKVLIVTGNPL 342
L N + P + NL+NL + + +N + LSSL + KKLK L + N +
Sbjct: 74 FLNGNKLTDIKP--LANLKNLGWLFLDENKVKD-------LSSLKDLKKLKSLSLEHNGI 124
Query: 343 DGILPKSIGNFSLSLETILMANCSISGNIPQVVGNLSNLLVLELGGNNLTGPIPVTFSQL 402
I + + LE++ + N I+ +I V+ L+ L L L N ++ +P + L
Sbjct: 125 SDI--NGLVHLP-QLESLYLGNNKIT-DI-TVLSRLTKLDTLSLEDNQISDIVP--LAGL 177
Query: 403 QTLQAFDLTRNKLAGPITD--ELCHLARLHSLVLQGNKFSGSIPSCLGNLTSVRVLYLGL 460
LQ L++N I+D L L L L L + + NL +
Sbjct: 178 TKLQNLYLSKNH----ISDLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTD 233
Query: 461 NIFTSVLSSTIWNLKDILFIDVSSNFLD 488
+ I + D +V + +
Sbjct: 234 GSLVTP--EIISDDGDYEKPNVKWHLPE 259
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 1e-14
Identities = 24/170 (14%), Positives = 67/170 (39%), Gaps = 15/170 (8%)
Query: 73 GNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLDFSDNQLFGSLSSFIFNMSSMTTIDLS 132
++SL + L++ ++ ++ + I H +K L ++ + + I +S++ + +
Sbjct: 41 AQMNSLTYITLANINVT-DL-TGIEYAHNIKDLTINNIHA--TNYNPISGLSNLERLRIM 96
Query: 133 INRLSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKEIGNLTKLKEIISTITNST 192
++ + LS L L++ + +I +I L K+ I ++ +
Sbjct: 97 GKDVTSD-------KIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSI--DLSYNG 147
Query: 193 VCEIPREIGNLPYLARLALATNNLVGVVPVTIFNMSALKEISLLNNSLSG 242
+ LP L L + + + + + L ++ + ++ G
Sbjct: 148 AITDIMPLKTLPELKSLNIQFDGVHDYRGIE--DFPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 5e-13
Identities = 24/113 (21%), Positives = 49/113 (43%), Gaps = 10/113 (8%)
Query: 72 LGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLDFSDNQLFGSLSSFIFNMSSMTTIDL 131
+ LS+L+ L + ++ + ++ + +L LLD S + S+ + I + + +IDL
Sbjct: 84 ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDL 143
Query: 132 SINRLSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKEIGNLTKLKEI 184
S N L +L+ LN+ F+ + I + KL ++
Sbjct: 144 SYN--------GAITDIMPLKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQL 186
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 1e-12
Identities = 30/173 (17%), Positives = 62/173 (35%), Gaps = 17/173 (9%)
Query: 296 TIGNLRNLEFGNIADNYLTSSTPELSFLSSLTNCKKLKVLIVTGNPLDGILPKSIGNFSL 355
T + +L + +A+ +T L+ + +K L + I S
Sbjct: 39 TEAQMNSLTYITLANINVTD-------LTGIEYAHNIKDLTINNIHATNY--NPISGLS- 88
Query: 356 SLETILMANCSISGNIPQVVGNLSNLLVLELGGNNLTGPIPVTFSQLQTLQAFDLTRNKL 415
+LE + + ++ + + L++L +L++ + I + L + + DL+ N
Sbjct: 89 NLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGA 148
Query: 416 AGPITD--ELCHLARLHSLVLQGNKFSGSIPSCLGNLTSVRVLYLGLNIFTSV 466
ITD L L L SL +Q + + + + LY
Sbjct: 149 ---ITDIMPLKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQTIGGK 196
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 1e-12
Identities = 25/160 (15%), Positives = 66/160 (41%), Gaps = 15/160 (9%)
Query: 57 LNISSFNLQGTITPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLDFSDNQLFGSL 116
+ +++ N+ +T + +++ L +++ + N + I + L+ L +
Sbjct: 49 ITLANINVT-DLTG-IEYAHNIKDLTINNIHAT-NY-NPISGLSNLERLRIMGKDVTSDK 104
Query: 117 SSFIFNMSSMTTIDLSINRLSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKEIG 176
+ ++S+T +D+S + I + ++ ++ ++L +N I +
Sbjct: 105 IPNLSGLTSLTLLDISHSAHDDS-------ILTKINTLPKVNSIDLSYNGAITDI-MPLK 156
Query: 177 NLTKLKEIISTITNSTVCEIPREIGNLPYLARLALATNNL 216
L +LK + I V + R I + P L +L + +
Sbjct: 157 TLPELKSL--NIQFDGVHDY-RGIEDFPKLNQLYAFSQTI 193
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 7e-12
Identities = 29/191 (15%), Positives = 68/191 (35%), Gaps = 17/191 (8%)
Query: 155 KQLEELNLGFNNLSGAIPKEIGNLTKLKEIISTITNSTVCEIPREIGNLPYLARLALATN 214
K LG ++ + ++ +LT + +T+ T I + L +
Sbjct: 23 KAYLNGLLGQSSTANITEAQMNSLTYITLANINVTDLT------GIEYAHNIKDLTINNI 76
Query: 215 NLVGVVPVTIFNMSALKEISLLNNSLSGSLPSRIDLSLPNVETLNLGINSFSGTIPSSIT 274
+ P I +S L+ + ++ ++ + L ++ L++ ++ +I + I
Sbjct: 77 HATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLS-GLTSLTLLDISHSAHDDSILTKIN 133
Query: 275 NSSKLSDLELGENLFSGFIPNTIGNLRNLEFGNIADNYLTSSTPELSFLSSLTNCKKLKV 334
K++ ++L N I + L L+ NI + + + + KL
Sbjct: 134 TLPKVNSIDLSYNGAITDIMP-LKTLPELKSLNIQFDGVHD-------YRGIEDFPKLNQ 185
Query: 335 LIVTGNPLDGI 345
L + G
Sbjct: 186 LYAFSQTIGGK 196
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 2e-10
Identities = 19/113 (16%), Positives = 44/113 (38%), Gaps = 10/113 (8%)
Query: 57 LNISSFNLQGTITPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLDFSDNQLFGSL 116
L I ++ P L L+SL LD+SH+ +I + I + + +D S N +
Sbjct: 93 LRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI 152
Query: 117 SSFIFNMSSMTTIDLSINRLSGELPANICKIPSTLSKCKQLEELNLGFNNLSG 169
+ + + ++++ + + + + +L +L + G
Sbjct: 153 MP-LKTLPELKSLNIQFDGVH-----DY----RGIEDFPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 58.0 bits (141), Expect = 1e-09
Identities = 25/216 (11%), Positives = 65/216 (30%), Gaps = 48/216 (22%)
Query: 182 KEIISTITNSTVCEIPREIGNLPYLARLALATNNLVGVVPVTIFNMSALKEISLLNNSLS 241
+ + S+ I + L + LA N+ + + +K++++ N +
Sbjct: 24 AYLNGLLGQSSTANI--TEAQMNSLTYITLANINVTDLTGIE--YAHNIKDLTINNIHAT 79
Query: 242 GSLPSRIDLS----LPNVETLNLGINSFSGTIPSSITNSSKLSDLELGENLFSGFIPNTI 297
+ + L N+E L + + +++ + L+ L++ + I I
Sbjct: 80 -------NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKI 132
Query: 298 GNLRNLEFGNIADNYLTSSTPELSFLSSLTNCKKLKVLIVTGNPLDGILPKSIGNFSLSL 357
L + +++ N + + L +LK L + + +
Sbjct: 133 NTLPKVNSIDLSYNGAITD------IMPLKTLPELKSLNIQFDGVHDYRG---------- 176
Query: 358 ETILMANCSISGNIPQVVGNLSNLLVLELGGNNLTG 393
+ + L L + G
Sbjct: 177 -----------------IEDFPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 55.7 bits (135), Expect = 6e-09
Identities = 27/141 (19%), Positives = 51/141 (36%), Gaps = 11/141 (7%)
Query: 377 NLSNLLVLELGGNNLTGPIPVTFSQLQTLQAFDLTRNKLAGPITD--ELCHLARLHSLVL 434
L LG ++ +T +Q+ +L L +TD + + + L +
Sbjct: 21 TFKAYLNGLLGQSSTA---NITEAQMNSLTYITLANIN----VTDLTGIEYAHNIKDLTI 73
Query: 435 QGNKFSGSIPSCLGNLTSVRVLYLGLNIFTSVLSSTIWNLKDILFIDVSSNFLDGPLSLD 494
+ P + L+++ L + TS + L + +D+S + D +
Sbjct: 74 NNIHATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTK 131
Query: 495 IGNLKVVIGLDFSRNNLSGDI 515
I L V +D S N DI
Sbjct: 132 INTLPKVNSIDLSYNGAITDI 152
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 2e-14
Identities = 36/174 (20%), Positives = 59/174 (33%), Gaps = 56/174 (32%)
Query: 640 NGMEVAVKVF--HQQYERALKSFEDECEVRKRIRHRNLVKIISSS--------------- 682
+EVA + + + F++E E+ K ++H N+V+ S
Sbjct: 50 TTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTE 109
Query: 683 --------------------------------LEYLHFGHSIPIIHCDLKPSNVLLD-ED 709
L++LH + PIIH DLK N+ +
Sbjct: 110 LMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLH-TRTPPIIHRDLKCDNIFITGPT 168
Query: 710 MVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGI 763
I D G+A L + + T +MAPE + DV +FG+
Sbjct: 169 GSVKIGDLGLATLKRASFAKA----VIGTPEFMAPEMYEEK-YDESVDVYAFGM 217
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 3e-14
Identities = 32/121 (26%), Positives = 45/121 (37%), Gaps = 26/121 (21%)
Query: 650 HQQYERALKSFEDECEVRKRIRHRNLVKIISSSLEYLHFGHSIPIIHCDLKPSNVLLDED 709
Q E S E +V +R +L +LH S ++H D+KP+N+ L
Sbjct: 144 QQHCEAWGASL-PEAQVWGYLRD------TLLALAHLH---SQGLVHLDVKPANIFLGPR 193
Query: 710 MVAHISDFGIAKLLSGEDQLSKQTQTLA-TIGYMAPE-----YGTKGRVSTRGDVCSFGI 763
+ DFG+ L + YMAPE YGT DV S G+
Sbjct: 194 GRCKLGDFGLLVELGTAG----AGEVQEGDPRYMAPELLQGSYGTA------ADVFSLGL 243
Query: 764 I 764
Sbjct: 244 T 244
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 4e-14
Identities = 34/179 (18%), Positives = 63/179 (35%), Gaps = 55/179 (30%)
Query: 640 NGMEVAVKV--FHQQYERALKSFEDECEVRKRIRHRNL--VKIISSS---------LEY- 685
A+K + + L S+ +E +++ + +++ +E
Sbjct: 51 KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG 110
Query: 686 -----------------------------LHFGHSIPIIHCDLKPSNVLLDEDMVAHISD 716
+H H I+H DLKP+N L+ + M+ + D
Sbjct: 111 NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGML-KLID 169
Query: 717 FGIAKLLSGEDQLSKQTQTLATIGYMAPE-----------YGTKGRVSTRGDVCSFGII 764
FGIA + + + + T+ YM PE +K ++S + DV S G I
Sbjct: 170 FGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCI 228
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 4e-14
Identities = 40/177 (22%), Positives = 63/177 (35%), Gaps = 50/177 (28%)
Query: 634 NLIGIGNGMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVKI--------------- 678
+ +G G VAVK + F+ E ++ K + +VK
Sbjct: 45 DPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLV 104
Query: 679 -------------------------------ISSSLEYLHFGHSIPIIHCDLKPSNVLLD 707
I +EYL S +H DL N+L++
Sbjct: 105 MEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYL---GSRRCVHRDLAARNILVE 161
Query: 708 EDMVAHISDFGIAKLL-SGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGI 763
+ I+DFG+AKLL +D + + I + APE + S + DV SFG+
Sbjct: 162 SEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGV 218
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 5e-14
Identities = 43/177 (24%), Positives = 66/177 (37%), Gaps = 50/177 (28%)
Query: 634 NLIGIGNGMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVKI--------------- 678
+ + G VAVK E L+ FE E E+ K ++H N+VK
Sbjct: 63 DPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLI 122
Query: 679 -------------------------------ISSSLEYLHFGHSIPIIHCDLKPSNVLLD 707
I +EYL + IH DL N+L++
Sbjct: 123 MEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVE 179
Query: 708 EDMVAHISDFGIAKLL-SGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGI 763
+ I DFG+ K+L ++ + + I + APE T+ + S DV SFG+
Sbjct: 180 NENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGV 236
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 5e-14
Identities = 41/163 (25%), Positives = 73/163 (44%), Gaps = 43/163 (26%)
Query: 642 MEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVK-----------IIS------SSLE 684
VA+K + ++F E +V K++RH LV+ I++ S L+
Sbjct: 209 TRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLD 267
Query: 685 YL--HFGHSIPI----------------------IHCDLKPSNVLLDEDMVAHISDFGIA 720
+L G + + +H DL+ +N+L+ E++V ++DFG+A
Sbjct: 268 FLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLA 327
Query: 721 KLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGI 763
+L+ + ++Q I + APE GR + + DV SFGI
Sbjct: 328 RLIEDNEYTARQGAKFP-IKWTAPEAALYGRFTIKSDVWSFGI 369
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 7e-14
Identities = 43/177 (24%), Positives = 66/177 (37%), Gaps = 50/177 (28%)
Query: 634 NLIGIGNGMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVKI--------------- 678
+ + G VAVK E L+ FE E E+ K ++H N+VK
Sbjct: 32 DPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLI 91
Query: 679 -------------------------------ISSSLEYLHFGHSIPIIHCDLKPSNVLLD 707
I +EYL + IH DL N+L++
Sbjct: 92 MEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVE 148
Query: 708 EDMVAHISDFGIAKLL-SGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGI 763
+ I DFG+ K+L ++ + + I + APE T+ + S DV SFG+
Sbjct: 149 NENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGV 205
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 8e-14
Identities = 28/92 (30%), Positives = 46/92 (50%), Gaps = 18/92 (19%)
Query: 679 ISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLAT 738
I+ ++Y+H S +I+ DLKPSN+ L + I DFG+ L + + ++ TL
Sbjct: 131 ITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLR- 186
Query: 739 IGYMAPE------YGTKGRVSTRGDVCSFGII 764
YM+PE YG + D+ + G+I
Sbjct: 187 --YMSPEQISSQDYGKE------VDLYALGLI 210
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 8e-14
Identities = 35/178 (19%), Positives = 63/178 (35%), Gaps = 51/178 (28%)
Query: 634 NLIGIGNGMEVAVKVFHQQY-ERALKSFEDECEVRKRIRHRNLVKI-------------- 678
+ G G +VAVK + + + E E+ + + H N+VK
Sbjct: 43 DPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKL 102
Query: 679 --------------------------------ISSSLEYLHFGHSIPIIHCDLKPSNVLL 706
I ++YL S +H DL NVL+
Sbjct: 103 IMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYL---GSRQYVHRDLAARNVLV 159
Query: 707 DEDMVAHISDFGIAKLL-SGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGI 763
+ + I DFG+ K + + ++ + + + + + APE + + DV SFG+
Sbjct: 160 ESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGV 217
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 9e-14
Identities = 34/179 (18%), Positives = 63/179 (35%), Gaps = 55/179 (30%)
Query: 640 NGMEVAVKV--FHQQYERALKSFEDECEVRKRIRHRNL--VKIISSS---------LEY- 685
A+K + + L S+ +E +++ + +++ +E
Sbjct: 32 KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG 91
Query: 686 -----------------------------LHFGHSIPIIHCDLKPSNVLLDEDMVAHISD 716
+H H I+H DLKP+N L+ + M+ + D
Sbjct: 92 NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGML-KLID 150
Query: 717 FGIAKLLSGEDQLSKQTQTLATIGYMAPE-----------YGTKGRVSTRGDVCSFGII 764
FGIA + + + + T+ YM PE +K ++S + DV S G I
Sbjct: 151 FGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCI 209
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 73.8 bits (181), Expect = 9e-14
Identities = 41/163 (25%), Positives = 73/163 (44%), Gaps = 43/163 (26%)
Query: 642 MEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVK-----------IIS------SSLE 684
VA+K + ++F E +V K++RH LV+ I++ S L+
Sbjct: 292 TRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLD 350
Query: 685 YL--HFGHSIPI----------------------IHCDLKPSNVLLDEDMVAHISDFGIA 720
+L G + + +H DL+ +N+L+ E++V ++DFG+A
Sbjct: 351 FLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLA 410
Query: 721 KLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGI 763
+L+ + ++Q I + APE GR + + DV SFGI
Sbjct: 411 RLIEDNEYTARQGAKFP-IKWTAPEAALYGRFTIKSDVWSFGI 452
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 1e-13
Identities = 42/173 (24%), Positives = 68/173 (39%), Gaps = 43/173 (24%)
Query: 634 NLIGIGNGMEVAVKVFHQQY-ERALKSFEDECEVRKRIRHRNLVKII-------SSSL-- 683
+ G G VAVK + ++ E ++ + + H +++K ++SL
Sbjct: 53 DPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112
Query: 684 --EYLHFG--------HSIPI----------------------IHCDLKPSNVLLDEDMV 711
EY+ G HSI + IH DL NVLLD D +
Sbjct: 113 VMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRL 172
Query: 712 AHISDFGIAKLL-SGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGI 763
I DFG+AK + G + + + + + APE + + DV SFG+
Sbjct: 173 VKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGV 225
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 72.5 bits (178), Expect = 1e-13
Identities = 38/231 (16%), Positives = 73/231 (31%), Gaps = 66/231 (28%)
Query: 599 KSRTGPSNDGINSPQAIRRFSYHELLRATDRFSENNLIGIG-----------NGMEVAVK 647
+ + G + + + +S IG G A+K
Sbjct: 27 RQHMDSPDLGTDDDDKASSSANECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIK 86
Query: 648 V--FHQQYERALKSFEDECEVRKRIRHRNL--VKIISSS---------LEY--------- 685
+ + L S+ +E +++ + +++ +E
Sbjct: 87 YVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWL 146
Query: 686 ---------------------LHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLS 724
+H H I+H DLKP+N L+ + M+ + DFGIA +
Sbjct: 147 KKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGML-KLIDFGIANQMQ 205
Query: 725 GEDQLSKQTQTLATIGYMAPE-----------YGTKGRVSTRGDVCSFGII 764
+ + + + YM PE +K ++S + DV S G I
Sbjct: 206 PDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCI 256
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 2e-13
Identities = 25/73 (34%), Positives = 41/73 (56%), Gaps = 6/73 (8%)
Query: 673 RNLVKIISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQ 732
R +++ + + LH + I+H DLKP N+LLD+DM ++DFG + L ++L
Sbjct: 127 RKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL--- 180
Query: 733 TQTLATIGYMAPE 745
+ T Y+APE
Sbjct: 181 REVCGTPSYLAPE 193
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 2e-13
Identities = 42/174 (24%), Positives = 64/174 (36%), Gaps = 55/174 (31%)
Query: 638 IGNGMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVKI------------------- 678
G A+K + S E+E V K+I+H N+V +
Sbjct: 31 RLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSG 90
Query: 679 ------------------------ISSSLEYLHFGHSIPIIHCDLKPSNVLL---DEDMV 711
+ S+++YL H I+H DLKP N+L +E+
Sbjct: 91 GELFDRILERGVYTEKDASLVIQQVLSAVKYL---HENGIVHRDLKPENLLYLTPEENSK 147
Query: 712 AHISDFGIAKLLSGEDQLSKQTQTLA-TIGYMAPEYGTKGRVSTRGDVCSFGII 764
I+DFG++K+ T T GY+APE + S D S G+I
Sbjct: 148 IMITDFGLSKMEQNG-----IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVI 196
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 2e-13
Identities = 27/95 (28%), Positives = 44/95 (46%), Gaps = 18/95 (18%)
Query: 679 ISSSLEYLHFGHSIP--IIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTL 736
++ +L+ H ++H DLKP+NV LD + DFG+A++L+ + +T
Sbjct: 120 LTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSF---AKTF 176
Query: 737 A-TIGYMAPE------YGTKGRVSTRGDVCSFGII 764
T YM+PE Y K D+ S G +
Sbjct: 177 VGTPYYMSPEQMNRMSYNEK------SDIWSLGCL 205
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 72.5 bits (178), Expect = 2e-13
Identities = 39/170 (22%), Positives = 65/170 (38%), Gaps = 50/170 (29%)
Query: 639 GNGMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVKI-------------------- 678
+ VAVK + ++ F E V K I+H NLV++
Sbjct: 243 KYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYG 301
Query: 679 -------------------------ISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAH 713
ISS++EYL IH +L N L+ E+ +
Sbjct: 302 NLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRNLAARNCLVGENHLVK 358
Query: 714 ISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGI 763
++DFG+++L++ D + I + APE + S + DV +FG+
Sbjct: 359 VADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGV 407
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 2e-13
Identities = 80/458 (17%), Positives = 143/458 (31%), Gaps = 75/458 (16%)
Query: 57 LNISSFNLQGTITPQLG-NLSSLQTLDLSHNKLS----GNIPSSIFNMHTLKLLDFSDNQ 111
L+I L +L L Q + L L+ +I S++ L L+ N+
Sbjct: 8 LDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNE 67
Query: 112 LFGSLSSFIFNM-----SSMTTIDLSINRLSGELPANICKIPSTLSKCKQLEELNLGFNN 166
L + + + L L+G + STL L+EL+L N
Sbjct: 68 LGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGA---GCGVLSSTLRTLPTLQELHLSDNL 124
Query: 167 LSGAIPKEIGNLTKLKEIISTITNSTVCEIPREIGNLPYLARLALATNNLVGVVPVTIFN 226
L A + + L +L L +L + +
Sbjct: 125 LGDAGLQLLCEGLL--------------------DPQCRLEKLQLEYCSLSAASCEPLAS 164
Query: 227 M----SALKEISLLNNSLSGS----LPSRIDLSLPNVETLNLGINSFS----GTIPSSIT 274
+ KE+++ NN ++ + L + S +E L L + + +
Sbjct: 165 VLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVA 224
Query: 275 NSSKLSDLELGENLFSG-----FIPNTIGNLRNLEFGNIADNYLTSSTPELSFLSS-LTN 328
+ + L +L LG N P + L I + +T+ L L
Sbjct: 225 SKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKG--CGDLCRVLRA 282
Query: 329 CKKLKVLIVTGNPL--DGI--LPKSIGNFSLSLETILMANCSISG----NIPQVVGNLSN 380
+ LK L + GN L +G L +++ LE++ + +CS + + V+
Sbjct: 283 KESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRF 342
Query: 381 LLVLELGGNNLTGPIPVTFSQL-----QTLQAFDLTRNKL----AGPITDELCHLARLHS 431
LL L++ N L Q L+ L + + L L
Sbjct: 343 LLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRE 402
Query: 432 LVLQGNKFSGSIPSCLG-----NLTSVRVLYLGLNIFT 464
L L N + L + L L ++
Sbjct: 403 LDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWS 440
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 3e-13
Identities = 33/176 (18%), Positives = 60/176 (34%), Gaps = 60/176 (34%)
Query: 640 NGMEVAVKV--FHQQYERALKSFEDECEVRKRIRHRNLVKIISSS---------LEY--- 685
+G + +K + + + E V ++H N+V+ S ++Y
Sbjct: 48 DGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEG 107
Query: 686 ------------------------------LHFGHSIPIIHCDLKPSNVLLDEDMVAHIS 715
L H I+H D+K N+ L +D +
Sbjct: 108 GDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLG 167
Query: 716 DFGIAKLLSGEDQLSKQTQTLA-TIGYMAPE------YGTKGRVSTRGDVCSFGII 764
DFGIA++L+ +L + T Y++PE Y K D+ + G +
Sbjct: 168 DFGIARVLNSTVEL---ARACIGTPYYLSPEICENKPYNNK------SDIWALGCV 214
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 71.0 bits (174), Expect = 3e-13
Identities = 43/240 (17%), Positives = 78/240 (32%), Gaps = 22/240 (9%)
Query: 76 SSLQTLDLSHNKLSGNIPSSIF-NMHTLKLLDFSDNQLFGSLSSFIF-NMSSMTTIDLS- 132
+ L KL I F L+ ++ S N + + + +F N+ + I +
Sbjct: 30 RNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 88
Query: 133 INRLSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKEI-GNLTKLKEIISTITNS 191
N L + P L+ L + + +P + + ++ N
Sbjct: 89 ANNLL-YIN------PEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKV-LLDIQDNI 139
Query: 192 TVCEIPREI--GNLPYLARLALATNNLVGVVPVTIFNMSALKEISLL-NNSLSGSLPSRI 248
+ I R G L L N + + + FN + L E++L NN+L LP+ +
Sbjct: 140 NIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLE-ELPNDV 197
Query: 249 DLSLPNVETLNLGINSFSGTIPSSI-TNSSKLSDLELGENLFSGFIPNTIGNLRNLEFGN 307
L++ ++PS N KL NL + L
Sbjct: 198 FHGASGPVILDISRTRIH-SLPSYGLENLKKLRARST-YNLKKLPTLEKLVALMEASLTY 255
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 68.7 bits (168), Expect = 2e-12
Identities = 41/233 (17%), Positives = 79/233 (33%), Gaps = 19/233 (8%)
Query: 57 LNISSFNLQGTITPQ-LGNLSSLQTLDLSHNKLSGNIPSSIF-NMHTLKLLDFSDNQLFG 114
L L+ I L+ +++S N + I + +F N+ L +
Sbjct: 35 LRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLL 93
Query: 115 SLSSFIF-NMSSMTTIDLSINRLSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAIPK 173
++ F N+ ++ + +S + LP Q L++ N I +
Sbjct: 94 YINPEAFQNLPNLQYLLISNTGIK-HLP------DVHKIHSLQKVLLDIQDNINIHTIER 146
Query: 174 E-IGNLTKLKEIISTITNSTVCEIPREIGNLPYLARLALATNNLVGVVPVTIF-NMSALK 231
L+ I+ N + EI N L L L+ NN + +P +F S
Sbjct: 147 NSFVGLSFESVILWLNKNG-IQEIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPV 205
Query: 232 EISLLNNSLSGSLPSRIDLSLPNVETLNLGINSFSGTIPSSITNSSKLSDLEL 284
+ + + SLPS +L + + +P ++ L + L
Sbjct: 206 ILDISRTRIH-SLPSYGLENLKKLRARSTYNLK---KLP-TLEKLVALMEASL 253
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 68.3 bits (167), Expect = 2e-12
Identities = 39/245 (15%), Positives = 74/245 (30%), Gaps = 13/245 (5%)
Query: 195 EIPREIGNLPYLARLALATNNLVGVVPVTIFNMSALKEISLLNNSLSGSLPSRIDLSLPN 254
EIP ++ L L + L++I + N + + + + +LP
Sbjct: 23 EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPK 80
Query: 255 VETLNL-GINSFSGTIPSSI-TNSSKLSDLELGENLFSGFIPNTIGNLRNLEFGNIADNY 312
+ + + N+ I N L L + + +I DN
Sbjct: 81 LHEIRIEKANNLL-YINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNI 139
Query: 313 LTSSTPELSFLSSLTNCKKLKVLIVTGNPLDGILPKSIGNFSLSLETILMANCSISGNIP 372
+ SF L+ + +L + N + I S N + E L N ++
Sbjct: 140 NIHTIERNSF-VGLSF--ESVILWLNKNGIQEI-HNSAFNGTQLDELNLSDNNNLEELPN 195
Query: 373 QVVGNLSNLLVLELGGNNLTGPIPVTFSQLQTLQAFDLTRNKLAGPITDELCHLARLHSL 432
V S ++L++ + L+ L+A K + L L
Sbjct: 196 DVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLKKLPTLE----KLVALMEA 251
Query: 433 VLQGN 437
L
Sbjct: 252 SLTYP 256
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 61.4 bits (149), Expect = 4e-10
Identities = 44/273 (16%), Positives = 86/273 (31%), Gaps = 45/273 (16%)
Query: 220 VPVTIFNMSALKEISLLNNSLSGSLPSRIDLSLPNVETLNLGINSFSGTIPSSI-TNSSK 278
+P + E+ + L + ++E + + N I + + +N K
Sbjct: 24 IPSDLP--RNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPK 80
Query: 279 LSDLEL-GENLFSGFIPNTIGNLRNLEFGNIADNYLTSSTPELSFLSSLTNCKKLKVLIV 337
L ++ + N P NL NL++ I++ + P++ + SL + +L +
Sbjct: 81 LHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHL-PDVHKIHSL----QKVLLDI 135
Query: 338 TGNP-LDGILPKSIGNFSLSLETILMANCSISGNIPQVVGNLSNLLVLELGGNNLTGPIP 396
N + I S S + + I I N + L L L NN
Sbjct: 136 QDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNN------ 188
Query: 397 VTFSQLQTLQ--AFDLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPS-CLGNLTSV 453
L+ L F + L + + S+PS L NL +
Sbjct: 189 ----NLEELPNDVFH---------------GASGPVILDISRTRIH-SLPSYGLENLKKL 228
Query: 454 RVLYLGLNIFTSVLSSTIWNLKDILFIDVSSNF 486
R + + L ++ ++
Sbjct: 229 RARS--TYNLKKLPTLE--KLVALMEASLTYPS 257
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 58.7 bits (142), Expect = 3e-09
Identities = 41/212 (19%), Positives = 78/212 (36%), Gaps = 12/212 (5%)
Query: 268 TIPSSITNSSKLSDLELGENLFSGFIPNTIGNLRNLEFGNIADNYLTSSTPELSFLSSLT 327
IPS + +L +LE I+ N + F S+L
Sbjct: 23 EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVF-SNLP 79
Query: 328 NCKKLKVLIVTGNPLDGILPKSIGNFSLSLETILMANCSISGNIPQVV-GNLSNLLVLEL 386
++++ N L I P++ N +L+ +L++N I ++P V + ++L++
Sbjct: 80 KLHEIRIE--KANNLLYINPEAFQNLP-NLQYLLISNTGIK-HLPDVHKIHSLQKVLLDI 135
Query: 387 GGNNLTGPIPV-TFSQLQT-LQAFDLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIP 444
N I +F L L +N + I + + +L L L N +P
Sbjct: 136 QDNINIHTIERNSFVGLSFESVILWLNKNGIQE-IHNSAFNGTQLDELNLSDNNNLEELP 194
Query: 445 S-CLGNLTSVRVLYLGLNIFTSVLSSTIWNLK 475
+ + +L + S+ S + NLK
Sbjct: 195 NDVFHGASGPVILDISRTRIHSLPSYGLENLK 226
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 43.7 bits (103), Expect = 2e-04
Identities = 19/122 (15%), Positives = 43/122 (35%), Gaps = 8/122 (6%)
Query: 366 SISGNIPQVVGNLSNLLVLELGGNNLTGPIPVTFSQLQTLQAFDLTRNKLAGPITDE-LC 424
I ++P N + L L FS L+ ++++N + I +
Sbjct: 23 EIPSDLP------RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFS 76
Query: 425 HLARLHSLVLQGNKFSGSIPS-CLGNLTSVRVLYLGLNIFTSVLSSTIWNLKDILFIDVS 483
+L +LH + ++ I NL +++ L + + + + +D+
Sbjct: 77 NLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQ 136
Query: 484 SN 485
N
Sbjct: 137 DN 138
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 3e-13
Identities = 33/168 (19%), Positives = 63/168 (37%), Gaps = 41/168 (24%)
Query: 637 GIGNGMEVAVKVFHQQY-ERALKSFEDECEVRKRIRHRNLVK---IISSS-----LEYLH 687
G + V +KV + ++ ++ D + H ++V+ + S +YL
Sbjct: 38 GESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPGSSLQLVTQYLP 97
Query: 688 FG----------HSIPI----------------------IHCDLKPSNVLLDEDMVAHIS 715
G ++ +H +L NVLL ++
Sbjct: 98 LGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVA 157
Query: 716 DFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGI 763
DFG+A LL +D+ ++ I +MA E G+ + + DV S+G+
Sbjct: 158 DFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGV 205
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 71.4 bits (175), Expect = 4e-13
Identities = 37/129 (28%), Positives = 61/129 (47%), Gaps = 25/129 (19%)
Query: 658 KSFEDECEVRKRIRHRNLVKIISSSLEYLHFGHSIPIIHCDLKPSNVLLD---------- 707
++ +++K +L++ I+S + +LH S+ IIH DLKP N+L+
Sbjct: 103 NVSDENLKLQKEYNPISLLRQIASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQ 159
Query: 708 ---EDMVAHISDFGIAKLL-SGEDQLSKQTQTLA-TIGYMAPE-------YGTKGRVSTR 755
E++ ISDFG+ K L SG+ + T G+ APE TK R++
Sbjct: 160 TGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRS 219
Query: 756 GDVCSFGII 764
D+ S G +
Sbjct: 220 IDIFSMGCV 228
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 4e-13
Identities = 43/169 (25%), Positives = 71/169 (42%), Gaps = 44/169 (26%)
Query: 637 GIGNG-MEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVK-----------IIS---- 680
N +VAVK ++++F E V K ++H LVK II+
Sbjct: 207 ATYNKHTKVAVKTMKPGSM-SVEAFLAEANVMKTLQHDKLVKLHAVVTKEPIYIITEFMA 265
Query: 681 --SSLEYL--HFGHSIPI----------------------IHCDLKPSNVLLDEDMVAHI 714
S L++L G P+ IH DL+ +N+L+ +V I
Sbjct: 266 KGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKI 325
Query: 715 SDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGI 763
+DFG+A+++ + +++ I + APE G + + DV SFGI
Sbjct: 326 ADFGLARVIEDNEYTAREGAKFP-IKWTAPEAINFGSFTIKSDVWSFGI 373
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 69.9 bits (172), Expect = 5e-13
Identities = 33/68 (48%), Positives = 44/68 (64%), Gaps = 5/68 (7%)
Query: 679 ISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTL-A 737
I S+LEYLH IIH DLKP N+LL+EDM I+DFG AK+LS E + ++ +
Sbjct: 139 IVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR-ANSFVG 194
Query: 738 TIGYMAPE 745
T Y++PE
Sbjct: 195 TAQYVSPE 202
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 6e-13
Identities = 48/257 (18%), Positives = 86/257 (33%), Gaps = 43/257 (16%)
Query: 57 LNISSFNLQGTITPQLGNLSSLQTLDLSHNKLSGNIPSSIF-NMHTLKLLDFSDNQLFGS 115
++ ++ P L S QTL L L IPS F N+ + + S +
Sbjct: 16 FRVTCKDI--QRIPSL--PPSTQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQQ 70
Query: 116 LSSFIF-NMSSMTTIDLSINRLSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKE 174
L S F N+S +T I++ R + P L + L+ L + L
Sbjct: 71 LESHSFYNLSKVTHIEIRNTRNLTYID------PDALKELPLLKFLGIFNTGLK-----M 119
Query: 175 IGNLTKLKEIISTITNSTVCEIPREIGNLPYLARLALATNNLVGVVPVTIFN--MSALKE 232
+LTK+ + L + N + +PV F +
Sbjct: 120 FPDLTKV-------------------YSTDIFFILEITDNPYMTSIPVNAFQGLCNETLT 160
Query: 233 ISLLNNSLSGSLPSRIDLSLPNVETLNLGINSFSGTIPSSI--TNSSKLSDLELGENLFS 290
+ L NN + S+ + ++ + L N + I S S L++ + +
Sbjct: 161 LKLYNNGFT-SVQGYA-FNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT 218
Query: 291 GFIPNTIGNLRNLEFGN 307
+ +L+ L N
Sbjct: 219 ALPSKGLEHLKELIARN 235
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 1e-12
Identities = 27/192 (14%), Positives = 60/192 (31%), Gaps = 13/192 (6%)
Query: 74 NLSSLQTLDLSHNKLSGNIPSSIF-NMHTLKLLDFSDNQLFGSLSSFIF-NMSSMTTIDL 131
NL ++ + +S + + S F N+ + ++ + + + + + + +
Sbjct: 53 NLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGI 112
Query: 132 SINRLSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKEI-GNLTKLKEIISTITN 190
L P + + L + N +IP L + N
Sbjct: 113 FNTGLK-MFPDL-----TKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNN 166
Query: 191 STVCEIPREIGNLPYLARLALATNNLVGVVPVTIFN--MSALKEISLLNNSLSGSLPSRI 248
+ N L + L N + V+ F S + + S++ +LPS+
Sbjct: 167 G-FTSVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-ALPSKG 224
Query: 249 DLSLPNVETLNL 260
L + N
Sbjct: 225 LEHLKELIARNT 236
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 1e-07
Identities = 38/233 (16%), Positives = 73/233 (31%), Gaps = 31/233 (13%)
Query: 203 LPYLARLALATNNLVGVVPVTIFNMSALKEISLLNNSLSGSLPSRIDLSLPNVETLNLGI 262
P L L +L + N+ + I + + L S +L V + +
Sbjct: 30 PPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRN 89
Query: 263 NSFSGTIPSSITNSSKLSDLELGENLFSGFIPNTIGNLRNLEFGNIADNYLTSSTPELSF 322
I P+ + L L+F I + L P+L+
Sbjct: 90 TRNLTYID-----------------------PDALKELPLLKFLGIFNTGLKMF-PDLTK 125
Query: 323 LSSLTNCKKLKVLIVTGNP-LDGILPKSIGNFSLSLETILMANCSISGNIPQVVGNLSNL 381
+ S +L +T NP + I + T+ + N + ++ N + L
Sbjct: 126 VYSTDI---FFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKL 181
Query: 382 LVLELGGNNLTGPIPV-TFSQLQT-LQAFDLTRNKLAGPITDELCHLARLHSL 432
+ L N I F + + D+++ + + L HL L +
Sbjct: 182 DAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALPSKGLEHLKELIAR 234
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 6e-13
Identities = 60/216 (27%), Positives = 95/216 (43%), Gaps = 41/216 (18%)
Query: 76 SSLQTLDLSHNKLSGNIPSSIF-NMHTLKLLDFSDNQLFGSLSSFIFN-MSSMTTIDLSI 133
+ + LDL NKLS ++PS F + L+LL +DN+L +L + IF + ++ T+ ++
Sbjct: 37 ADTKKLDLQSNKLS-SLPSKAFHRLTKLRLLYLNDNKL-QTLPAGIFKELKNLETLWVTD 94
Query: 134 NRLSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKEI-GNLTKLKEIISTITNST 192
N+L LP + L EL L N L ++P + +LTKL
Sbjct: 95 NKLQ-ALPIGVFDQLV------NLAELRLDRNQLK-SLPPRVFDSLTKLTY--------- 137
Query: 193 VCEIPREIGNLPYLARLALATNNLVGVVPVTIF-NMSALKEISLLNNSLSGSLPSRIDLS 251
L+L N L +P +F +++LKE+ L NN L +P
Sbjct: 138 ----------------LSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQLK-RVPEGAFDK 179
Query: 252 LPNVETLNLGINSFSGTIPSSITNSSKLSDLELGEN 287
L ++TL L N + + KL L+L EN
Sbjct: 180 LTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 5e-12
Identities = 50/169 (29%), Positives = 82/169 (48%), Gaps = 16/169 (9%)
Query: 74 NLSSLQTLDLSHNKLSGNIPSSIFN-MHTLKLLDFSDNQLFGSLSSFIF-NMSSMTTIDL 131
L+ L+ L L+ NKL +P+ IF + L+ L +DN+L +L +F + ++ + L
Sbjct: 59 RLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKL-QALPIGVFDQLVNLAELRL 116
Query: 132 SINRLSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKEI-GNLTKLKEIISTITN 190
N+L LP + +L+K L L+LG+N L ++PK + LT LKE+ + N
Sbjct: 117 DRNQLK-SLPPR---VFDSLTK---LTYLSLGYNELQ-SLPKGVFDKLTSLKEL--RLYN 166
Query: 191 STVCEIPREI-GNLPYLARLALATNNLVGVVPVTIFNMSALKEISLLNN 238
+ + +P L L L L N L V ++ LK + L N
Sbjct: 167 NQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 3e-06
Identities = 52/223 (23%), Positives = 71/223 (31%), Gaps = 42/223 (18%)
Query: 268 TIPSSITNSSKLSDLELGENLFSGFIPNTIGNLRNLEFGNIADNYLTSSTPELSFLSSLT 327
IPS+I + L+L N S L L + DN L + P F L
Sbjct: 30 AIPSNI--PADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQT-LPAGIF-KELK 85
Query: 328 NCKKLKVLIVTGNPLDGILPKSIGNFSLSLETILMANCSISGNIPQVVGNLSNLLVLELG 387
N L+ L VT N L ++ + L NL L L
Sbjct: 86 N---LETLWVTDNKLQ----------------------ALPIGVFD---QLVNLAELRLD 117
Query: 388 GNNLTGPIPVTFSQLQTLQAFDLTRNKL----AGPITDELCHLARLHSLVLQGNKFSGSI 443
N L P F L L L N+L G L L L L N+ +
Sbjct: 118 RNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFD----KLTSLKELRLYNNQLK-RV 172
Query: 444 PSCL-GNLTSVRVLYLGLNIFTSVLSSTIWNLKDILFIDVSSN 485
P LT ++ L L N V +L+ + + + N
Sbjct: 173 PEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 2e-05
Identities = 56/219 (25%), Positives = 76/219 (34%), Gaps = 35/219 (15%)
Query: 220 VPVTIFNMSALKEISLLNNSLSGSLPSRIDLSLPNVETLNLGINSFSGTIPSSI-TNSSK 278
+P I + K++ L +N LS SLPS+ L + L L N T+P+ I
Sbjct: 31 IPSNIP--ADTKKLDLQSNKLS-SLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKN 86
Query: 279 LSDLELGENLFSGFIPNTIGNLRNLEFGNIADNYLTSSTPELSFLSSLTNCKKLKVLIVT 338
L L + +N L NL + N L S P F SLT L L +
Sbjct: 87 LETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKS-LPPRVF-DSLTK---LTYLSLG 141
Query: 339 GNPLDGILPKSIGNFSLSLETILMANCSISGNIPQVVGNLSNLLVLELGGNNLTGPIPVT 398
N L + G F L++L L L N L
Sbjct: 142 YNELQSL---PKGVFD----------------------KLTSLKELRLYNNQLKRVPEGA 176
Query: 399 FSQLQTLQAFDLTRNKLAGPITDELCHLARLHSLVLQGN 437
F +L L+ L N+L L +L L LQ N
Sbjct: 177 FDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 6e-13
Identities = 26/96 (27%), Positives = 44/96 (45%), Gaps = 13/96 (13%)
Query: 679 ISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLAT 738
I+ ++E+LH S ++H DLKPSN+ D V + DFG+ + +++ +
Sbjct: 127 IAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPA 183
Query: 739 IG----------YMAPEYGTKGRVSTRGDVCSFGII 764
YM+PE S + D+ S G+I
Sbjct: 184 YARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLI 219
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 70.0 bits (171), Expect = 7e-13
Identities = 14/97 (14%), Positives = 35/97 (36%), Gaps = 20/97 (20%)
Query: 679 ISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLAT 738
+ L LH ++H L+P +++LD+ ++ F + + + +
Sbjct: 215 VIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV------RDGARVVSSVS 265
Query: 739 IGYMAPEY-----------GTKGRVSTRGDVCSFGII 764
G+ PE + ++ D + G++
Sbjct: 266 RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLV 302
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 8e-13
Identities = 35/177 (19%), Positives = 66/177 (37%), Gaps = 54/177 (30%)
Query: 635 LIGIGNGMEVAVKVFHQQY-ERALKSFEDECEVRKRIRHRNLVKI--------------- 678
++VA+KV Q + + E ++ ++ + +V++
Sbjct: 31 YRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALMLVMEM 90
Query: 679 ----------------------------ISSSLEYL---HFGHSIPIIHCDLKPSNVLLD 707
+S ++YL +F +H DL NVLL
Sbjct: 91 AGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNF------VHRDLAARNVLLV 144
Query: 708 EDMVAHISDFGIAKLL-SGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGI 763
A ISDFG++K L + + + ++ + + APE + S+R DV S+G+
Sbjct: 145 NRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGV 201
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 8e-13
Identities = 46/170 (27%), Positives = 67/170 (39%), Gaps = 50/170 (29%)
Query: 637 GIGNGMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVK-------------IIS--- 680
G G +VAVK ++F E V ++RH NLV+ I++
Sbjct: 212 GDYRGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 269
Query: 681 ---SSLEYL--HFGHSIP----------------------IIHCDLKPSNVLLDEDMVAH 713
S ++YL + +H DL NVL+ ED VA
Sbjct: 270 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAK 329
Query: 714 ISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGI 763
+SDFG+ K + S Q + + APE + + ST+ DV SFGI
Sbjct: 330 VSDFGLTK-----EASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGI 374
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 69.7 bits (170), Expect = 9e-13
Identities = 13/125 (10%), Positives = 31/125 (24%), Gaps = 11/125 (8%)
Query: 642 MEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVKIISSSLEYLHFGHSIPIIHCDLKP 701
M A + L + L + L ++H P
Sbjct: 167 MPAASVDLELLFST-LDFVYVFRGDEGILALHILTAQLIRLAANLQSKG---LVHGHFTP 222
Query: 702 SNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEY--GTKGRVSTRGDVC 759
N+ + D + D + ++ + + Y E+ + + +
Sbjct: 223 DNLFIMPDGRLMLGDVSALWKVG-----TRGPASSVPVTYAPREFLNASTATFTHALNAW 277
Query: 760 SFGII 764
G+
Sbjct: 278 QLGLS 282
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 69.6 bits (170), Expect = 9e-13
Identities = 33/169 (19%), Positives = 60/169 (35%), Gaps = 7/169 (4%)
Query: 598 WKSRTGPSNDGINSPQAIRRFSYHELLRATDRFSENNLIGIGNGMEVAVKVFHQQYERAL 657
R + + Y + D + I + V +
Sbjct: 119 RSKRNEFVPYKTKGARFRQGKDYVGAIP-VDLKRRLDSITSSQSSASSGFVEEKSLSDVE 177
Query: 658 KSFEDECEVRKRIRHRNLVKI---ISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHI 714
+ E + + +L+ ++ +E+L S IH DL N+LL E V I
Sbjct: 178 EEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKI 234
Query: 715 SDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGI 763
DFG+A+ + + ++ + +MAPE + + DV SFG+
Sbjct: 235 CDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGV 283
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 9e-13
Identities = 42/172 (24%), Positives = 71/172 (41%), Gaps = 52/172 (30%)
Query: 640 NGMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVKIISSS---------LEYL---- 686
N + +A+K ++ R + +E + K ++H+N+V+ + S +E +
Sbjct: 46 NQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGS 105
Query: 687 -------HFG-----------------------HSIPIIHCDLKPSNVLLDEDM-VAHIS 715
+G H I+H D+K NVL++ V IS
Sbjct: 106 LSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKIS 165
Query: 716 DFGIAKLLSGEDQLSKQTQTLA-TIGYMAPE---YGTKGRVSTRGDVCSFGI 763
DFG +K L+G ++ T+T T+ YMAPE G +G D+ S G
Sbjct: 166 DFGTSKRLAG---INPCTETFTGTLQYMAPEIIDKGPRGY-GKAADIWSLGC 213
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 1e-12
Identities = 36/163 (22%), Positives = 60/163 (36%), Gaps = 41/163 (25%)
Query: 642 MEVAVKVFHQQY-ERALKSFEDECEVRKRIRHRNLVK---IISSS--------------L 683
+ VA+K + +A K DE V + + ++ + I +S L
Sbjct: 45 IPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLL 104
Query: 684 EYLH-FGHSIPI----------------------IHCDLKPSNVLLDEDMVAHISDFGIA 720
+Y+ +I +H DL NVL+ I+DFG+A
Sbjct: 105 DYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA 164
Query: 721 KLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGI 763
KLL E++ I +MA E + + DV S+G+
Sbjct: 165 KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGV 207
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 1e-12
Identities = 37/164 (22%), Positives = 59/164 (35%), Gaps = 42/164 (25%)
Query: 642 MEVAVKVFHQQY--ERALKSFEDECEVRKRIRHRNLVKIIS-----------------SS 682
VAVK+ + E V +++ + +V++I
Sbjct: 45 KTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPL 104
Query: 683 LEYLHFGHSIPI----------------------IHCDLKPSNVLLDEDMVAHISDFGIA 720
+YL + +H DL NVLL A ISDFG++
Sbjct: 105 NKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLS 164
Query: 721 KLL-SGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGI 763
K L + E+ QT + + APE + S++ DV SFG+
Sbjct: 165 KALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGV 208
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 1e-12
Identities = 54/357 (15%), Positives = 116/357 (32%), Gaps = 77/357 (21%)
Query: 72 LGNLSSLQTLDLSHNKLSG----NIPSSIFNMHTLKLLDFSDNQL----FGSLSSFIFNM 123
+ S ++ L + ++ ++ + + ++K + S N + LS I +
Sbjct: 1 MARFS-IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASK 59
Query: 124 SSMTTIDLS---INRLSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKEIGNLTK 180
+ + S R+ E+P + + L KC +L + L N
Sbjct: 60 KDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNA-------------- 105
Query: 181 LKEIISTITNSTVCEIPREIGNLPYLARLALATNNLVGVVPVTIFNMSALKEISLLNNSL 240
+ + + L L L N L G AL+E+++ +
Sbjct: 106 -------FGPTAQEPLIDFLSKHTPLEHLYLHNNGL-GPQAGAKI-ARALQELAVNKKAK 156
Query: 241 SGSLPSRIDLSLPNVETLNLGINSFSG----TIPSSITNSSKLSDLELGEN--------- 287
+ P + ++ G N + + L +++ +N
Sbjct: 157 NA----------PPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEH 206
Query: 288 -LFSGFIPNTIGNLRNLEFGNIADNYLTSS-TPELSFLSSLTNCKKLKVLIVTGNPLDGI 345
L G L+ L ++ DN T + L+ +L + L+ L + L
Sbjct: 207 LLLEGLAYCQ--ELKVL---DLQDNTFTHLGSSALA--IALKSWPNLRELGLNDCLLSAR 259
Query: 346 LPKSIG-----NFSLSLETILMANCSISGN-----IPQVVGNLSNLLVLELGGNNLT 392
++ ++ L+T+ + I + + + +LL LEL GN +
Sbjct: 260 GAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS 316
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 2e-12
Identities = 32/170 (18%), Positives = 63/170 (37%), Gaps = 45/170 (26%)
Query: 639 GNGMEVAVKVFHQQY-ERALKSFEDECEVRKRIRHRNLVKII---SSS-------LEY-- 685
N ++ A+K + + +++F E + + + H N++ +I L Y
Sbjct: 47 QNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMC 106
Query: 686 ----LHF----GHSIPI----------------------IHCDLKPSNVLLDEDMVAHIS 715
L F + + +H DL N +LDE ++
Sbjct: 107 HGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVA 166
Query: 716 DFGIAKLLSGED--QLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGI 763
DFG+A+ + + + + + + A E R +T+ DV SFG+
Sbjct: 167 DFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGV 216
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 70.0 bits (171), Expect = 2e-12
Identities = 34/164 (20%), Positives = 65/164 (39%), Gaps = 42/164 (25%)
Query: 642 MEVAVKVFHQQY-ERALKSFEDECEVRKRIRHRNLVK---IISSS-----LEYLHFG--- 689
++VA+KV Q + + E ++ ++ + +V+ + + +E G
Sbjct: 364 IDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALMLVMEMAGGGPLH 423
Query: 690 -------HSIPI----------------------IHCDLKPSNVLLDEDMVAHISDFGIA 720
IP+ +H +L NVLL A ISDFG++
Sbjct: 424 KFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLS 483
Query: 721 KLL-SGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGI 763
K L + + + ++ + + APE + S+R DV S+G+
Sbjct: 484 KALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGV 527
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 2e-12
Identities = 35/169 (20%), Positives = 52/169 (30%), Gaps = 44/169 (26%)
Query: 639 GNGMEVAVKVFHQQY---ERALKSFEDECEVRKRIRHRNLVK---IISSS---------- 682
G + VAVK A+ F E + HRNL++ ++ +
Sbjct: 44 GKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKMVTELAP 103
Query: 683 ----LEYLH-FGHSIPI----------------------IHCDLKPSNVLLDEDMVAHIS 715
L+ L + IH DL N+LL + I
Sbjct: 104 LGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIG 163
Query: 716 DFGIAKLL-SGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGI 763
DFG+ + L +D Q + APE S D FG+
Sbjct: 164 DFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGV 212
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 2e-12
Identities = 31/85 (36%), Positives = 43/85 (50%), Gaps = 9/85 (10%)
Query: 683 LEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYM 742
LE+LH S+ IH D+KPSNVL++ + DFGI+ L D ++K YM
Sbjct: 122 LEHLHSKLSV--IHRDVKPSNVLINALGQVKMCDFGISGYLV--DDVAKDIDA-GCKPYM 176
Query: 743 APE----YGTKGRVSTRGDVCSFGI 763
APE + S + D+ S GI
Sbjct: 177 APERINPELNQKGYSVKSDIWSLGI 201
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 2e-12
Identities = 36/210 (17%), Positives = 69/210 (32%), Gaps = 79/210 (37%)
Query: 628 DRFSENNLIGIGN------------GMEVAVKVFH-QQYERALKSFEDECEVRKRIRHRN 674
+ ++++G G G A+KVF+ + R + E EV K++ H+N
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 675 LVKI------------------------------------------------ISSSLEYL 686
+VK+ + + +L
Sbjct: 69 IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128
Query: 687 HFGHSIPIIHCDLKPSNVLL----DEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYM 742
I+H ++KP N++ D V ++DFG A+ L ++Q T Y+
Sbjct: 129 ---RENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQF---VSLYGTEEYL 182
Query: 743 APEYGTKGRVSTRG--------DVCSFGII 764
P+ + + D+ S G+
Sbjct: 183 HPDMYERAVLRKDHQKKYGATVDLWSIGVT 212
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 2e-12
Identities = 34/108 (31%), Positives = 53/108 (49%), Gaps = 6/108 (5%)
Query: 659 SFEDECEVRKRIRHRNLVKI---ISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHIS 715
S+ +++ ++LV ++ +EYL S IH DL NVL+ ED V I+
Sbjct: 177 SYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIA 233
Query: 716 DFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGI 763
DFG+A+ + D K T + +MAPE + + DV SFG+
Sbjct: 234 DFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGV 281
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 3e-12
Identities = 32/85 (37%), Positives = 42/85 (49%), Gaps = 9/85 (10%)
Query: 683 LEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYM 742
L +L I IH D+KPSN+LLD + DFGI+ L D ++K T+ YM
Sbjct: 138 LNHLKENLKI--IHRDIKPSNILLDRSGNIKLCDFGISGQLV--DSIAK-TRDAGCRPYM 192
Query: 743 APE----YGTKGRVSTRGDVCSFGI 763
APE ++ R DV S GI
Sbjct: 193 APERIDPSASRQGYDVRSDVWSLGI 217
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 3e-12
Identities = 25/92 (27%), Positives = 43/92 (46%), Gaps = 17/92 (18%)
Query: 679 ISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLAT 738
+ S+LE++H S ++H D+KP+NV + V + D G+ + S + + + T
Sbjct: 145 LCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAH-SLV-GT 199
Query: 739 IGYMAPE------YGTKGRVSTRGDVCSFGII 764
YM+PE Y K D+ S G +
Sbjct: 200 PYYMSPERIHENGYNFK------SDIWSLGCL 225
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 3e-12
Identities = 26/73 (35%), Positives = 45/73 (61%), Gaps = 6/73 (8%)
Query: 673 RNLVKIISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQ 732
R++++ + ++ +LH + I+H DLKP N+LLD++M +SDFG + L ++L
Sbjct: 203 RSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKL--- 256
Query: 733 TQTLATIGYMAPE 745
+ T GY+APE
Sbjct: 257 RELCGTPGYLAPE 269
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 3e-12
Identities = 35/173 (20%), Positives = 63/173 (36%), Gaps = 51/173 (29%)
Query: 639 GNGMEVAVKVFHQQY-ERALKSFEDECEVRKRIRHRNLVKI------------------- 678
G + AVK ++ + F E + K H N++ +
Sbjct: 51 GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMK 110
Query: 679 --------------------------ISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVA 712
++ ++YL S +H DL N +LDE
Sbjct: 111 HGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA---SKKFVHRDLAARNCMLDEKFTV 167
Query: 713 HISDFGIAKLLSGEDQLSKQTQTLAT--IGYMAPEYGTKGRVSTRGDVCSFGI 763
++DFG+A+ + ++ S +T A + +MA E + +T+ DV SFG+
Sbjct: 168 KVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGV 220
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 69.1 bits (169), Expect = 3e-12
Identities = 27/68 (39%), Positives = 37/68 (54%), Gaps = 9/68 (13%)
Query: 679 ISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLA- 737
I LE++H + +++ DLKP+N+LLDE ISD G+A S K+
Sbjct: 301 IILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK-----KKPHASVG 352
Query: 738 TIGYMAPE 745
T GYMAPE
Sbjct: 353 THGYMAPE 360
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 68.7 bits (168), Expect = 3e-12
Identities = 32/68 (47%), Positives = 39/68 (57%), Gaps = 7/68 (10%)
Query: 679 ISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLA- 737
I S LE+LH II+ DLKP NVLLD+D ISD G+A L +T+ A
Sbjct: 298 IVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ---TKTKGYAG 351
Query: 738 TIGYMAPE 745
T G+MAPE
Sbjct: 352 TPGFMAPE 359
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 4e-12
Identities = 29/163 (17%), Positives = 54/163 (33%), Gaps = 55/163 (33%)
Query: 638 IGNGMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVKIISSS-------------LE 684
+ +G A+K ++ + + E ++ + H N++++++ L
Sbjct: 51 LHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLP 110
Query: 685 Y-----------------------------------LHFGHSIPIIHCDLKPSNVLLDED 709
+ L H+ H DLKP+N+LL ++
Sbjct: 111 FFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDE 170
Query: 710 MVAHISDFGIAKLLSGEDQLSKQTQTLA-------TIGYMAPE 745
+ D G + S+Q TL TI Y APE
Sbjct: 171 GQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPE 213
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 4e-12
Identities = 36/126 (28%), Positives = 48/126 (38%), Gaps = 34/126 (26%)
Query: 658 KSFEDECEVRKRIRHRNLVKIISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDF 717
+ E + L + I +L Y+H S IIH DLKP N+ +DE I DF
Sbjct: 110 NLNQQRDEYWR------LFRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDF 160
Query: 718 GIAKLLSGEDQLSKQTQTLAT---------IG---YMAPE-------YGTKGRVSTRGDV 758
G+AK + + K IG Y+A E Y K D+
Sbjct: 161 GLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEK------IDM 214
Query: 759 CSFGII 764
S GII
Sbjct: 215 YSLGII 220
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 5e-12
Identities = 46/170 (27%), Positives = 67/170 (39%), Gaps = 50/170 (29%)
Query: 637 GIGNGMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVK-------------IIS--- 680
G G +VAVK ++F E V ++RH NLV+ I++
Sbjct: 40 GDYRGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 97
Query: 681 ---SSLEYL--HFGHSIPI----------------------IHCDLKPSNVLLDEDMVAH 713
S ++YL + +H DL NVL+ ED VA
Sbjct: 98 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAK 157
Query: 714 ISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGI 763
+SDFG+ K + S Q + + APE + + ST+ DV SFGI
Sbjct: 158 VSDFGLTK-----EASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGI 202
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 5e-12
Identities = 32/90 (35%), Positives = 44/90 (48%), Gaps = 10/90 (11%)
Query: 679 ISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLA- 737
+ +EYLH IIH D+KPSN+L+ ED I+DFG++ G D L
Sbjct: 146 LIKGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDAL---LSNTVG 199
Query: 738 TIGYMAPE--YGTKGRVS-TRGDVCSFGII 764
T +MAPE T+ S DV + G+
Sbjct: 200 TPAFMAPESLSETRKIFSGKALDVWAMGVT 229
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 6e-12
Identities = 39/167 (23%), Positives = 65/167 (38%), Gaps = 44/167 (26%)
Query: 639 GNGMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVK------------IIS------ 680
+ VAVK + ++ F E V K I+H NLV+ II+
Sbjct: 36 KYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYG 94
Query: 681 SSLEYL--HFGHSIPI----------------------IHCDLKPSNVLLDEDMVAHISD 716
+ L+YL + IH DL N L+ E+ + ++D
Sbjct: 95 NLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVAD 154
Query: 717 FGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGI 763
FG+++L++ D + I + APE + S + DV +FG+
Sbjct: 155 FGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGV 200
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 6e-12
Identities = 35/86 (40%), Positives = 43/86 (50%), Gaps = 10/86 (11%)
Query: 683 LEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYM 742
L YL H + IH D+KPSN+LLDE + DFGI+ L D +K ++ YM
Sbjct: 137 LYYLKEKHGV--IHRDVKPSNILLDERGQIKLCDFGISGRLV--DDKAK-DRSAGCAAYM 191
Query: 743 APE-----YGTKGRVSTRGDVCSFGI 763
APE TK R DV S GI
Sbjct: 192 APERIDPPDPTKPDYDIRADVWSLGI 217
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 68.2 bits (166), Expect = 6e-12
Identities = 43/186 (23%), Positives = 66/186 (35%), Gaps = 74/186 (39%)
Query: 641 GMEVAVKVFHQQ-YERALKSFEDECEVRKRIRHRNLVKI--------------------- 678
G +VA+K Q+ + + + E ++ K++ H N+V
Sbjct: 39 GEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAME 98
Query: 679 -------------------------------ISSSLEYLHFGHSIPIIHCDLKPSNVLLD 707
ISS+L YLH IIH DLKP N++L
Sbjct: 99 YCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQ 155
Query: 708 ---EDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPE------YGTKGRVSTRGDV 758
+ ++ I D G AK L + T+ + T+ Y+APE Y D
Sbjct: 156 PGPQRLIHKIIDLGYAKELDQGELC---TEFVGTLQYLAPELLEQKKYTVT------VDY 206
Query: 759 CSFGII 764
SFG +
Sbjct: 207 WSFGTL 212
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 6e-12
Identities = 24/100 (24%), Positives = 42/100 (42%), Gaps = 6/100 (6%)
Query: 667 RKRIRHRNLVKI---ISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLL 723
+ +L+ ++ + +L S IH DL N+LL + I DFG+A+ +
Sbjct: 139 ELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDI 195
Query: 724 SGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGI 763
+ + + +MAPE + DV S+GI
Sbjct: 196 KNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGI 235
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 7e-12
Identities = 34/101 (33%), Positives = 48/101 (47%), Gaps = 21/101 (20%)
Query: 673 RNLVKIISSSLEYLHFGHSIPIIHCDLKPSNVLL---DEDMVAHISDFGIAKLLSGEDQL 729
+ VK I ++ YLH I+H DLKP N+L D I+DFG++K++ + +
Sbjct: 151 ADAVKQILEAVAYLH---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLM 207
Query: 730 SKQTQTLATIGYMAPE------YGTKGRVSTRGDVCSFGII 764
T GY APE YG + V D+ S GII
Sbjct: 208 ---KTVCGTPGYCAPEILRGCAYGPE--V----DMWSVGII 239
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 68.0 bits (166), Expect = 7e-12
Identities = 33/169 (19%), Positives = 59/169 (34%), Gaps = 48/169 (28%)
Query: 639 GNGMEVAVKVFHQQY-ERALKSFEDECEVRKRIRHRNLVKI------------------- 678
M VA+K + + F E ++ H ++VK+
Sbjct: 416 NPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWIIMELCTLG 475
Query: 679 ------------------------ISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHI 714
+S++L YL S +H D+ NVL+ + +
Sbjct: 476 ELRSFLQVRKFSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKL 532
Query: 715 SDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGI 763
DFG+++ + K ++ I +MAPE R ++ DV FG+
Sbjct: 533 GDFGLSRYMEDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGV 580
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 8e-12
Identities = 25/95 (26%), Positives = 48/95 (50%), Gaps = 8/95 (8%)
Query: 673 RNLVKIISSSLEYLHFGHSIPIIHCDLKPSNVLL---DEDMVAHISDFGIAKLLSGEDQL 729
+++ + S++ ++H + ++H DLKP N+L ++++ I DFG A+L ++Q
Sbjct: 109 SYIMRKLVSAVSHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ- 164
Query: 730 SKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGII 764
T+ Y APE + D+ S G+I
Sbjct: 165 -PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVI 198
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 65.7 bits (161), Expect = 8e-12
Identities = 32/180 (17%), Positives = 59/180 (32%), Gaps = 67/180 (37%)
Query: 638 IGNGMEVAVKVFHQQY---ERALKSFEDECEVRKRIRHRNLVKI---------------- 678
+ +A+KV + E E++ +RH N++++
Sbjct: 31 KQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEY 90
Query: 679 ---------------------------ISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMV 711
++++L Y H +IH D+KP N+LL
Sbjct: 91 APLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGE 147
Query: 712 AHISDFGIAKLLSGEDQLSKQTQTL-ATIGYMAPE------YGTKGRVSTRGDVCSFGII 764
I+DFG + + L T+ Y+ PE + K D+ S G++
Sbjct: 148 LKIADFGWSVHAPSS-----RRTDLCGTLDYLPPEMIEGRMHDEK------VDLWSLGVL 196
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 66.8 bits (163), Expect = 9e-12
Identities = 36/210 (17%), Positives = 69/210 (32%), Gaps = 79/210 (37%)
Query: 628 DRFSENNLIGIGN------------GMEVAVKVFH-QQYERALKSFEDECEVRKRIRHRN 674
+ ++++G G G A+KVF+ + R + E EV K++ H+N
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 675 LVKI------------------------------------------------ISSSLEYL 686
+VK+ + + +L
Sbjct: 69 IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128
Query: 687 HFGHSIPIIHCDLKPSNVLL----DEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYM 742
I+H ++KP N++ D V ++DFG A+ L ++Q T Y+
Sbjct: 129 ---RENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQF---VSLYGTEEYL 182
Query: 743 APEYGTKGRVSTRG--------DVCSFGII 764
P+ + + D+ S G+
Sbjct: 183 HPDMYERAVLRKDHQKKYGATVDLWSIGVT 212
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 1e-11
Identities = 28/101 (27%), Positives = 41/101 (40%), Gaps = 20/101 (19%)
Query: 673 RNLVKIISSSLEYLHFGHSIPIIHCDLKPSNVLL---DEDMVAHISDFGIAKLLSGEDQL 729
+ ++ I +L Y H IIH D+KP VLL + + FG+A L +
Sbjct: 133 SHYMRQILEALRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLV 189
Query: 730 SKQTQTLATIGYMAPE------YGTKGRVSTRGDVCSFGII 764
+ + T +MAPE YG DV G+I
Sbjct: 190 AG--GRVGTPHFMAPEVVKREPYGKP------VDVWGCGVI 222
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 1e-11
Identities = 38/215 (17%), Positives = 61/215 (28%), Gaps = 62/215 (28%)
Query: 605 SNDGINSPQAIRRFSYHELLRATDRFSENNLIGIG------------NGMEVAVKVFHQQ 652
N+G+ + ++ Y E + +G G G + AVK +
Sbjct: 36 DNEGVLLTEKLKPVDY-EYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLE 94
Query: 653 YERALKSFEDECEVRKRIRHRNLVKIISSS---------LEYL----------HFG---- 689
+E + +V + + +E L G
Sbjct: 95 -----VFRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPE 149
Query: 690 -----------------HSIPIIHCDLKPSNVLLDED-MVAHISDFGIAKLLSGEDQLSK 731
H+ I+H D+K NVLL D A + DFG A L +
Sbjct: 150 DRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKS 209
Query: 732 QTQTLATIG---YMAPEYGTKGRVSTRGDVCSFGI 763
G +MAPE + D+ S
Sbjct: 210 LLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCC 244
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 1e-11
Identities = 37/174 (21%), Positives = 62/174 (35%), Gaps = 55/174 (31%)
Query: 639 GNGMEVAVKVFHQQY-ERALKSFEDECEVRKRIRHRNLVKI------------------- 678
+ VA+K Y ER + F E + + H N++++
Sbjct: 75 QRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMEN 134
Query: 679 -------------------------ISSSLEYL---HFGHSIPIIHCDLKPSNVLLDEDM 710
+ + + YL + +H DL NVL+D ++
Sbjct: 135 GSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGY------VHRDLAARNVLVDSNL 188
Query: 711 VAHISDFGIAKLL-SGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGI 763
V +SDFG++++L D T I + APE S+ DV SFG+
Sbjct: 189 VCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGV 242
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 66.0 bits (161), Expect = 1e-11
Identities = 31/113 (27%), Positives = 50/113 (44%), Gaps = 19/113 (16%)
Query: 659 SFEDECEVRKRIRHRNLVKIISSS---LEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHIS 715
S + + RI + L K+ + L YL H I +H D+KPSN+L++ +
Sbjct: 117 SLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKI--MHRDVKPSNILVNSRGEIKLC 174
Query: 716 DFGIAKLLSGEDQLSKQTQTLA-----TIGYMAPEYGTKGRVSTRGDVCSFGI 763
DFG++ L ++A T YM+PE S + D+ S G+
Sbjct: 175 DFGVSGQL---------IDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGL 218
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 1e-11
Identities = 33/176 (18%), Positives = 62/176 (35%), Gaps = 57/176 (32%)
Query: 639 GNGMEVAVKVFHQQY-ERALKSFEDECEVRKRIRHRNLVKI------------------- 678
G + AVK ++ + F E + K H N++ +
Sbjct: 115 GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMK 174
Query: 679 --------------------------ISSSLEYL---HFGHSIPIIHCDLKPSNVLLDED 709
++ +++L F +H DL N +LDE
Sbjct: 175 HGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKF------VHRDLAARNCMLDEK 228
Query: 710 MVAHISDFGIAKLLSGEDQLS--KQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGI 763
++DFG+A+ + ++ S +T + +MA E + +T+ DV SFG+
Sbjct: 229 FTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGV 284
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 1e-11
Identities = 36/163 (22%), Positives = 60/163 (36%), Gaps = 41/163 (25%)
Query: 642 MEVAVKVFHQQY-ERALKSFEDECEVRKRIRHRNLVK---IISSS-----LEYLHFG--- 689
+ VA+K + +A K DE V + + ++ + I +S + + FG
Sbjct: 45 IPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLL 104
Query: 690 -------HSIPI----------------------IHCDLKPSNVLLDEDMVAHISDFGIA 720
+I +H DL NVL+ I+DFG+A
Sbjct: 105 DYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA 164
Query: 721 KLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGI 763
KLL E++ I +MA E + + DV S+G+
Sbjct: 165 KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGV 207
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 1e-11
Identities = 26/95 (27%), Positives = 47/95 (49%), Gaps = 10/95 (10%)
Query: 673 RNLVKIISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQ 732
+ ++K + +S Y+H +I H D+KPSN+L+D++ +SDFG ++ + K+
Sbjct: 154 KCIIKSVLNSFSYIHNEKNI--CHRDVKPSNILMDKNGRVKLSDFGESEYMV-----DKK 206
Query: 733 TQTLA-TIGYMAPE--YGTKGRVSTRGDVCSFGII 764
+ T +M PE + D+ S GI
Sbjct: 207 IKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGIC 241
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 64.9 bits (159), Expect = 1e-11
Identities = 30/166 (18%), Positives = 61/166 (36%), Gaps = 42/166 (25%)
Query: 639 GNGMEVAVKVFHQQY-ERALKSFEDECEVRKRIRHRNLVK---IISSS------------ 682
+ VA+K + + F E ++ H ++VK +I+ +
Sbjct: 41 NPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWIIMELCTLG 100
Query: 683 --LEYL-HFGHSIPI----------------------IHCDLKPSNVLLDEDMVAHISDF 717
+L +S+ + +H D+ NVL+ + + DF
Sbjct: 101 ELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDF 160
Query: 718 GIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGI 763
G+++ + + K ++ I +MAPE R ++ DV FG+
Sbjct: 161 GLSRYME-DSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGV 205
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 2e-11
Identities = 30/120 (25%), Positives = 53/120 (44%), Gaps = 6/120 (5%)
Query: 647 KVFHQQYERALKSFEDECEVRKRIRHRNLVKI---ISSSLEYLHFGHSIPIIHCDLKPSN 703
K + E + +E E + +L+ ++ +E+L F +H DL N
Sbjct: 146 KFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAARN 202
Query: 704 VLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGI 763
VL+ V I DFG+A+ + + + + +MAPE +G + + DV S+GI
Sbjct: 203 VLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGI 262
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 2e-11
Identities = 30/116 (25%), Positives = 53/116 (45%), Gaps = 6/116 (5%)
Query: 651 QQYERALKSFEDECEVRKRIRHRNLVKI---ISSSLEYLHFGHSIPIIHCDLKPSNVLLD 707
+ Y R+L+ V ++++ I+ + YL+ + +H DL N ++
Sbjct: 116 KSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVA 172
Query: 708 EDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGI 763
ED I DFG+ + + D K + L + +M+PE G +T DV SFG+
Sbjct: 173 EDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGV 228
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 2e-11
Identities = 27/102 (26%), Positives = 48/102 (47%), Gaps = 22/102 (21%)
Query: 673 RNLVKIISSSLEYLHFGHSIPIIHCDLKPSNVLL---DEDMVAHISDFGIAKLLSGEDQL 729
+ ++ I ++ + H + ++H +LKP N+LL + ++DFG+A + GE Q
Sbjct: 113 SHCIQQILEAVLHCH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQA 169
Query: 730 SKQTQTLA-TIGYMAPE------YGTKGRVSTRGDVCSFGII 764
A T GY++PE YG D+ + G+I
Sbjct: 170 ---WFGFAGTPGYLSPEVLRKDPYGKP------VDLWACGVI 202
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 64.5 bits (158), Expect = 2e-11
Identities = 40/165 (24%), Positives = 72/165 (43%), Gaps = 43/165 (26%)
Query: 640 NGMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVK-----------IIS------SS 682
+VAVK Q + +F E + K+++H+ LV+ II+ S
Sbjct: 36 GHTKVAVKSLKQGSM-SPDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYMENGSL 94
Query: 683 LEYL--HFGHSIPI----------------------IHCDLKPSNVLLDEDMVAHISDFG 718
+++L G + I IH DL+ +N+L+ + + I+DFG
Sbjct: 95 VDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFG 154
Query: 719 IAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGI 763
+A+L+ +++ + + I + APE G + + DV SFGI
Sbjct: 155 LARLIE-DNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGI 198
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 2e-11
Identities = 32/178 (17%), Positives = 58/178 (32%), Gaps = 63/178 (35%)
Query: 638 IGNGMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVKI------------------- 678
G + A K + + + F+ E E+ K + H N++++
Sbjct: 31 KGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTG 90
Query: 679 ------------------------ISSSLEYLHFGHSIPIIHCDLKPSNVLL---DEDMV 711
+ S++ Y H + + H DLKP N L D
Sbjct: 91 GELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSP 147
Query: 712 AHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPE-----YGTKGRVSTRGDVCSFGII 764
+ DFG+A + + T Y++P+ YG + D S G++
Sbjct: 148 LKLIDFGLAARFKPGKMM---RTKVGTPYYVSPQVLEGLYGPE------CDEWSAGVM 196
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 2e-11
Identities = 33/178 (18%), Positives = 64/178 (35%), Gaps = 53/178 (29%)
Query: 639 GNGMEVAVKVFHQQY--ERALKSFEDECEVRKRIRHRNLVKIISSS-------------- 682
G ++VAVK +R ++ F E K H N+++++
Sbjct: 60 GTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVI 119
Query: 683 LEYLHFG---------------HSIPI----------------------IHCDLKPSNVL 705
L ++ +G IP+ +H DL N +
Sbjct: 120 LPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCM 179
Query: 706 LDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGI 763
L +DM ++DFG++K + D + + ++A E +++ DV +FG+
Sbjct: 180 LRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGV 237
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 2e-11
Identities = 40/165 (24%), Positives = 67/165 (40%), Gaps = 41/165 (24%)
Query: 638 IGNGMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVKIISSSL---------EY--- 685
+ G EVA++ + Q + + +E V + ++ N+V + S L EY
Sbjct: 42 VATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAG 101
Query: 686 ---------------------------LHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFG 718
L F HS +IH D+K N+LL D ++DFG
Sbjct: 102 GSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFG 161
Query: 719 IAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGI 763
++ + SK++ + T +MAPE T+ + D+ S GI
Sbjct: 162 FCAQIT--PEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGI 204
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 3e-11
Identities = 30/170 (17%), Positives = 56/170 (32%), Gaps = 46/170 (27%)
Query: 638 IGNGMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVK-------------------- 677
G K + Y + ++E + ++ H L+
Sbjct: 73 KATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSG 132
Query: 678 ------IISSSLEY---------------LHFGHSIPIIHCDLKPSNVLL--DEDMVAHI 714
I + + L H I+H D+KP N++ + I
Sbjct: 133 GELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKI 192
Query: 715 SDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGII 764
DFG+A L+ ++ + T AT + APE + V D+ + G++
Sbjct: 193 IDFGLATKLNPDEIV---KVTTATAEFAAPEIVDREPVGFYTDMWAIGVL 239
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 3e-11
Identities = 31/179 (17%), Positives = 60/179 (33%), Gaps = 65/179 (36%)
Query: 638 IGNGMEVAVKVFHQQY---ERALKSFEDECEVRKRIRHRNLVKI---------------- 678
N +A+KV + E E E++ +RH N++++
Sbjct: 36 KQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEF 95
Query: 679 ---------------------------ISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMV 711
++ +L Y H +IH D+KP N+L+
Sbjct: 96 APRGELYKELQKHGRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGE 152
Query: 712 AHISDFGIAKLLSGEDQLSKQTQTL-ATIGYMAPEYGTKGRVSTRG-----DVCSFGII 764
I+DFG + + +T+ T+ Y+ PE + + D+ G++
Sbjct: 153 LKIADFGWSVHAPSL-----RRRTMCGTLDYLPPEM-----IEGKTHDEKVDLWCAGVL 201
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 64.1 bits (157), Expect = 3e-11
Identities = 33/104 (31%), Positives = 46/104 (44%), Gaps = 13/104 (12%)
Query: 662 DECEVRKRIRHRNLVKIISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAK 721
E E R + I + + YLH I+H DL SN+LL +M I+DFG+A
Sbjct: 110 SENEARHFMHQ------IITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLAT 160
Query: 722 LLSGEDQLSKQTQTL-ATIGYMAPEYGTKGRVSTRGDVCSFGII 764
L + TL T Y++PE T+ DV S G +
Sbjct: 161 QLKMPHEKHY---TLCGTPNYISPEIATRSAHGLESDVWSLGCM 201
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 64.9 bits (158), Expect = 3e-11
Identities = 43/173 (24%), Positives = 70/173 (40%), Gaps = 23/173 (13%)
Query: 76 SSLQTLDLSHNKLSGNIPSSIF-NMHTLKLLDFSDNQLFGSLSSFIF-NMSSMTTIDLSI 133
S LDLSHN LS + L L S N L +SS F + ++ +DLS
Sbjct: 39 SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHL-NFISSEAFVPVPNLRYLDLSS 97
Query: 134 NRLSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKEI-GNLTKLKEI------IS 186
N L L S + LE L L N++ + + ++ +L+++ IS
Sbjct: 98 NHLH-TLD------EFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQIS 149
Query: 187 TITNSTVCEIPREIGNLPYLARLALATNNLVGVVPVTIFNMSALKEISL-LNN 238
+ ++ LP L L L++N L + + + A + L L+N
Sbjct: 150 RFPVELI----KDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHN 198
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 62.6 bits (152), Expect = 2e-10
Identities = 28/119 (23%), Positives = 53/119 (44%), Gaps = 8/119 (6%)
Query: 74 NLSSLQTLDLSHNKLSGNIPSSIF-NMHTLKLLDFSDNQLFGSLSSFIF-NMSSMTTIDL 131
+ +L+ LDLS N L + +F ++ L++L +N + + F +M+ + + L
Sbjct: 86 PVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHI-VVVDRNAFEDMAQLQKLYL 143
Query: 132 SINRLSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKEIGNLTKLKEIISTITN 190
S N++S P + K + L K L L+L N L ++ L + + N
Sbjct: 144 SQNQIS-RFPVELIKDGNKLPK---LMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHN 198
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 57.5 bits (139), Expect = 7e-09
Identities = 30/156 (19%), Positives = 60/156 (38%), Gaps = 5/156 (3%)
Query: 332 LKVLIVTGNPLDGILPKSIGNFSLSLETILMANCSISGNIPQVVGNLSNLLVLELGGNNL 391
+L ++ N L + + +L ++L+++ ++ + + NL L+L N+L
Sbjct: 41 TALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHL 100
Query: 392 TGPIPVTFSQLQTLQAFDLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIP----SCL 447
FS LQ L+ L N + + +A+L L L N+ S P
Sbjct: 101 HTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKDG 159
Query: 448 GNLTSVRVLYLGLNIFTSVLSSTIWNLKDILFIDVS 483
L + +L L N + + + L + +
Sbjct: 160 NKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLY 195
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 55.2 bits (133), Expect = 4e-08
Identities = 40/189 (21%), Positives = 72/189 (38%), Gaps = 22/189 (11%)
Query: 127 TTIDLSINRLSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKEI--GNLTKLKEI 184
+ S +L +P ++ PS L+L NNLS + E LT L +
Sbjct: 21 NILSCSKQQLP-NVPQSL---PSYT------ALLDLSHNNLS-RLRAEWTPTRLTNLHSL 69
Query: 185 ISTITNSTVCEIPREI-GNLPYLARLALATNNLVGVVPVTIF-NMSALKEISLLNNSLSG 242
++++ + I E +P L L L++N+L + +F ++ AL+ + L NN +
Sbjct: 70 --LLSHNHLNFISSEAFVPVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIV- 125
Query: 243 SLPSRIDLSLPNVETLNLGINSFSGTIPSSITNSSKLSDLE---LGENLFSGFIPNTIGN 299
+ + ++ L L N S I + +KL L L N +
Sbjct: 126 VVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQK 185
Query: 300 LRNLEFGNI 308
L +
Sbjct: 186 LPAWVKNGL 194
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 52.2 bits (125), Expect = 3e-07
Identities = 30/116 (25%), Positives = 47/116 (40%), Gaps = 7/116 (6%)
Query: 377 NLSNLLVLELGGNNLTGPIPV-TFSQLQTLQAFDLTRNKLAGPITDELCHLARLHSLVLQ 435
L+NL L L N+L I F + L+ DL+ N L L L L+L
Sbjct: 62 RLTNLHSLLLSHNHLNF-ISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLY 120
Query: 436 GNKFSGSIPS-CLGNLTSVRVLYLGLNIFTSVLSSTIWN---LKDILFIDVSSNFL 487
N + ++ ++ LYL N + I + L ++ +D+SSN L
Sbjct: 121 NNHIV-VVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKL 175
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 47.5 bits (113), Expect = 1e-05
Identities = 34/180 (18%), Positives = 67/180 (37%), Gaps = 18/180 (10%)
Query: 237 NNSLSGSLPSRIDLSLPNVETLNLGINSFSGTIPSSIT--NSSKLSDLELGENLFSGFIP 294
L ++P + L+L N+ S + + T + L L L N +
Sbjct: 27 KQQLP-NVPQSLP---SYTALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLNFISS 81
Query: 295 NTIGNLRNLEFGNIADNYLTSSTPELSFLSSLTNCKKLKVLIVTGNPLDGILPKSIGNFS 354
+ NL + +++ N+L + L S L L+VL++ N + + + + +
Sbjct: 82 EAFVPVPNLRYLDLSSNHLHTLDEFL--FSDLQA---LEVLLLYNNHIVVVDRNAFEDMA 136
Query: 355 LSLETILMANCSISGNIP----QVVGNLSNLLVLELGGNNLTGPIPVTFSQLQTLQAFDL 410
L+ + ++ IS P + L L++L+L N L +L L
Sbjct: 137 -QLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGL 194
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 3e-11
Identities = 28/95 (29%), Positives = 45/95 (47%), Gaps = 10/95 (10%)
Query: 673 RNLVKIISSSLEYLHFGHSIPIIHCDLKPSNVLL---DEDMVAHISDFGIAKLLSGEDQL 729
+++ + S + Y+H I+H DLKP N+LL +D I DFG++ ++
Sbjct: 129 ARIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM 185
Query: 730 SKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGII 764
+ T Y+APE G + DV S G+I
Sbjct: 186 ---KDKIGTAYYIAPEV-LHGTYDEKCDVWSTGVI 216
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 3e-11
Identities = 37/165 (22%), Positives = 68/165 (41%), Gaps = 41/165 (24%)
Query: 638 IGNGMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVKIISSSL---------EY--- 685
+G +VAVK+ + ++ + +E + + +H N+V++ S L E+
Sbjct: 67 KHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQG 126
Query: 686 ---------------------------LHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFG 718
L + H+ +IH D+K ++LL D +SDFG
Sbjct: 127 GALTDIVSQVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFG 186
Query: 719 IAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGI 763
+S + K+ + T +MAPE ++ +T D+ S GI
Sbjct: 187 FCAQIS--KDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGI 229
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 4e-11
Identities = 30/118 (25%), Positives = 51/118 (43%), Gaps = 6/118 (5%)
Query: 649 FHQQYERALKSFEDECEVRKRIRHRNLVKI---ISSSLEYLHFGHSIPIIHCDLKPSNVL 705
F ++ R L++ R+L+ ++ + +L S IH D+ NVL
Sbjct: 140 FLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLA---SKNCIHRDVAARNVL 196
Query: 706 LDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGI 763
L VA I DFG+A+ + + + + +MAPE + + DV S+GI
Sbjct: 197 LTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGI 254
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 4e-11
Identities = 33/108 (30%), Positives = 55/108 (50%), Gaps = 6/108 (5%)
Query: 659 SFEDECEVRKRIRHRNLVKI---ISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHIS 715
S++ +++ ++LV ++ +EYL S IH DL NVL+ E+ V I+
Sbjct: 189 SYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIA 245
Query: 716 DFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGI 763
DFG+A+ ++ D K T + +MAPE + + DV SFG+
Sbjct: 246 DFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGV 293
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 4e-11
Identities = 26/101 (25%), Positives = 45/101 (44%), Gaps = 21/101 (20%)
Query: 673 RNLVKIISSSLEYLHFGHSIPIIHCDLKPSNVLL---DEDMVAHISDFGIAKLLSGEDQL 729
+ ++ I S+ Y H S I+H +LKP N+LL + ++DFG+A ++ +
Sbjct: 131 SHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW 187
Query: 730 SKQTQTLATIGYMAPE------YGTKGRVSTRGDVCSFGII 764
T GY++PE Y D+ + G+I
Sbjct: 188 ---HGFAGTPGYLSPEVLKKDPYSKP------VDIWACGVI 219
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 65.2 bits (159), Expect = 4e-11
Identities = 26/68 (38%), Positives = 34/68 (50%), Gaps = 8/68 (11%)
Query: 679 ISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLA- 737
I LE LH I++ DLKP N+LLD+ ISD G+A + +
Sbjct: 295 ICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAV----HVPEGQTIKGRVG 347
Query: 738 TIGYMAPE 745
T+GYMAPE
Sbjct: 348 TVGYMAPE 355
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 5e-11
Identities = 35/105 (33%), Positives = 48/105 (45%), Gaps = 15/105 (14%)
Query: 662 DECEVRKRIRHRNLVKIISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAK 721
E E R +R I +YLH +IH DLK N+ L+ED+ I DFG+A
Sbjct: 113 TEPEARYYLRQ------IVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLAT 163
Query: 722 LLSGEDQLSKQTQ--TLATIGYMAPEYGTKGRVSTRGDVCSFGII 764
+ + + K+ T Y+APE +K S DV S G I
Sbjct: 164 KVEYDGER-KKVLCGTPN---YIAPEVLSKKGHSFEVDVWSIGCI 204
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 64.1 bits (156), Expect = 5e-11
Identities = 28/98 (28%), Positives = 45/98 (45%), Gaps = 9/98 (9%)
Query: 673 RNLVKIISSSLEYLHFGHSIPIIHCDLKPSNVLL--DEDMVAHISDFGIAKLLSGEDQLS 730
N+++ I S+L YLH + I H D+KP N L ++ + DFG++K +
Sbjct: 171 SNIMRQIFSALHYLH---NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGE 227
Query: 731 KQT-QTLA-TIGYMAPE--YGTKGRVSTRGDVCSFGII 764
T A T ++APE T + D S G++
Sbjct: 228 YYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVL 265
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 5e-11
Identities = 30/95 (31%), Positives = 51/95 (53%), Gaps = 10/95 (10%)
Query: 673 RNLVKIISSSLEYLHFGHSIPIIHCDLKPSNVLL---DEDMVAHISDFGIAKLLSGEDQL 729
++K + S + YLH I+H DLKP N+LL ++D + I DFG++ + + ++
Sbjct: 139 AVIIKQVLSGVTYLH---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKM 195
Query: 730 SKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGII 764
+ L T Y+APE + + + DV S G+I
Sbjct: 196 ---KERLGTAYYIAPEV-LRKKYDEKCDVWSIGVI 226
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 5e-11
Identities = 32/174 (18%), Positives = 63/174 (36%), Gaps = 55/174 (31%)
Query: 639 GNGMEVAVKVFHQQY-ERALKSFEDECEVRKRIRHRNLVKI------------------- 678
+ VA+K Y E+ + F E + + H N++++
Sbjct: 71 KKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMEN 130
Query: 679 -------------------------ISSSLEYL---HFGHSIPIIHCDLKPSNVLLDEDM 710
I+S ++YL + +H DL N+L++ ++
Sbjct: 131 GSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGY------VHRDLAARNILINSNL 184
Query: 711 VAHISDFGIAKLL-SGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGI 763
V +SDFG+ ++L + I + +PE + ++ DV S+GI
Sbjct: 185 VCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGI 238
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 5e-11
Identities = 37/158 (23%), Positives = 58/158 (36%), Gaps = 59/158 (37%)
Query: 641 GMEVAVKVFH--------QQYERALKSFEDECEVRKRIRHRNLVKI-------------- 678
+VA+K+ + + E E E+ K++ H ++KI
Sbjct: 35 CKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAEDYYIVLE 94
Query: 679 ----------------------------ISSSLEYLHFGHSIPIIHCDLKPSNVLL---D 707
+ +++YL H IIH DLKP NVLL +
Sbjct: 95 LMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYL---HENGIIHRDLKPENVLLSSQE 151
Query: 708 EDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPE 745
ED + I+DFG +K+L + T Y+APE
Sbjct: 152 EDCLIKITDFGHSKILGETSLM---RTLCGTPTYLAPE 186
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 5e-11
Identities = 43/251 (17%), Positives = 85/251 (33%), Gaps = 40/251 (15%)
Query: 45 ITCDVNSHRVIGLNISSFNLQGTITPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKL 104
+ D + N+ ++ T LS +Q + ++ + ++ + + LK
Sbjct: 12 VFPDPGLANAVKQNLGKQSV--TDLVSQKELSGVQNFNGDNSNIQ-SL-AGMQFFTNLKE 67
Query: 105 LDFSDNQLFGSLSSFIFNMSSMTTIDLSINRLSGELPANICKIPSTLSKCKQLEELNLGF 164
L S NQ+ S S + +++ + + ++ NRL N+ I L L L
Sbjct: 68 LHLSHNQI--SDLSPLKDLTKLEELSVNRNRLK-----NLNGI-----PSACLSRLFLDN 115
Query: 165 NNLSGAIPKEIGNLTKLKEI------ISTITNSTVCEIPREIGNLPYLARLALATNNLVG 218
N L + +L L+ + + +I +G L L L L N +
Sbjct: 116 NELRDTDS--LIHLKNLEILSIRNNKLKSIVM---------LGFLSKLEVLDLHGNEITN 164
Query: 219 VVPVTIFNMSALKEISLLNNSLS-GSLPSRIDLSLPNVETLNLGINSFSGTIPSSITNSS 277
+T + + I L + + +L + N + P I+N
Sbjct: 165 TGGLT--RLKKVNWIDLTGQKCVNEPVKYQPELYITN----TVKDPDGRWISPYYISNGG 218
Query: 278 KLSDLELGENL 288
D + L
Sbjct: 219 SYVDGCVLWEL 229
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 2e-09
Identities = 45/214 (21%), Positives = 83/214 (38%), Gaps = 33/214 (15%)
Query: 272 SITNSSKLSDLELGENLFSGFIPNTIGNLRNLEFGNIADNYLTSSTPELSFLSSLTNCKK 331
SI + ++ + L N N+ +T L S
Sbjct: 2 SIQRPTPINQVF------------PDPGLANAVKQNLGKQSVTD-------LVSQKELSG 42
Query: 332 LKVLIVTGNPLDGILPKSIGNFSLSLETILMANCSISGNIPQVVGNLSNLLVLELGGNNL 391
++ + + + + F+ +L+ + +++ IS ++ + +L+ L L + N L
Sbjct: 43 VQNFNGDNSNIQSL--AGMQFFT-NLKELHLSHNQIS-DLSPL-KDLTKLEELSVNRNRL 97
Query: 392 TGPIPVTFSQLQTLQAFDLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLT 451
+ + L L L N+L TD L HL L L ++ NK SI LG L+
Sbjct: 98 KNLNGIPSACLSRL---FLDNNELRD--TDSLIHLKNLEILSIRNNKLK-SI-VMLGFLS 150
Query: 452 SVRVLYLGLNIFTSVLSSTIWNLKDILFIDVSSN 485
+ VL L N T+ + LK + +ID++
Sbjct: 151 KLEVLDLHGNEITNT--GGLTRLKKVNWIDLTGQ 182
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 5e-08
Identities = 34/199 (17%), Positives = 72/199 (36%), Gaps = 23/199 (11%)
Query: 72 LGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLDFSDNQLFGSLSSFIFNMSSMTTIDL 131
L +L+ L+ L ++ N+L N+ + L L +N+L + + ++ ++ + +
Sbjct: 81 LKDLTKLEELSVNRNRLK-NL--NGIPSACLSRLFLDNNEL--RDTDSLIHLKNLEILSI 135
Query: 132 SINRLSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKEIGNLTKLKEIISTITNS 191
N+L +I L +LE L+L N ++ + L K+ I +T
Sbjct: 136 RNNKLK-----SI----VMLGFLSKLEVLDLHGNEITNTGG--LTRLKKVNWI--DLTGQ 182
Query: 192 TVCEIPREIGNLPYLARLALATN-NLVGVVPVTIFNMSALKEISLLNNSLSGSLPSRIDL 250
P + P L + + + P I N + + +L + +
Sbjct: 183 KCVNEP--VKYQPELYITNTVKDPDGRWISPYYISNGGSYVDGCVLWELPVYT--DEVSY 238
Query: 251 SLPNVETLNLGINSFSGTI 269
+ F GT+
Sbjct: 239 KFSEYINVGETEAIFDGTV 257
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 64.4 bits (157), Expect = 5e-11
Identities = 30/95 (31%), Positives = 47/95 (49%), Gaps = 9/95 (9%)
Query: 673 RNLVKIISSSLEYLHFGHSIPIIHCDLKPSNVLL---DEDMVAHISDFGIAKLLSGEDQL 729
++K I +++YLH SI I H D+KP N+L + + ++DFG AK + + L
Sbjct: 164 SEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSL 220
Query: 730 SKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGII 764
T T Y+APE + D+ S G+I
Sbjct: 221 ---TTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVI 252
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 5e-11
Identities = 33/108 (30%), Positives = 55/108 (50%), Gaps = 6/108 (5%)
Query: 659 SFEDECEVRKRIRHRNLVKI---ISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHIS 715
S++ +++ ++LV ++ +EYL S IH DL NVL+ E+ V I+
Sbjct: 143 SYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIA 199
Query: 716 DFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGI 763
DFG+A+ ++ D K T + +MAPE + + DV SFG+
Sbjct: 200 DFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGV 247
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 63.0 bits (154), Expect = 6e-11
Identities = 38/171 (22%), Positives = 65/171 (38%), Gaps = 55/171 (32%)
Query: 640 NGMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVKI--------------------- 678
N +VA+K + + + F +E EV ++ H LV++
Sbjct: 31 NKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGC 89
Query: 679 -----------------------ISSSLEYL---HFGHSIPIIHCDLKPSNVLLDEDMVA 712
+ + YL IH DL N L+ E+ V
Sbjct: 90 LSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACV------IHRDLAARNCLVGENQVI 143
Query: 713 HISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGI 763
+SDFG+ + + +DQ + T T + + +PE + R S++ DV SFG+
Sbjct: 144 KVSDFGMTRFVL-DDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGV 193
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 6e-11
Identities = 28/108 (25%), Positives = 48/108 (44%), Gaps = 6/108 (5%)
Query: 659 SFEDECEVRKRIRHRNLVKI---ISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHIS 715
E + + +L+ ++ +E+L S IH DL N+LL E V I
Sbjct: 134 KVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKIC 190
Query: 716 DFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGI 763
DFG+A+ + + ++ + +MAPE + + DV SFG+
Sbjct: 191 DFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGV 238
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 6e-11
Identities = 33/95 (34%), Positives = 51/95 (53%), Gaps = 10/95 (10%)
Query: 673 RNLVKIISSSLEYLHFGHSIPIIHCDLKPSNVLL---DEDMVAHISDFGIAKLLSGEDQL 729
N++K I S + YLH + I+H D+KP N+LL + + I DFG++ S + +L
Sbjct: 149 ANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKL 205
Query: 730 SKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGII 764
L T Y+APE K + + + DV S G+I
Sbjct: 206 ---RDRLGTAYYIAPEV-LKKKYNEKCDVWSCGVI 236
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 63.0 bits (154), Expect = 6e-11
Identities = 27/101 (26%), Positives = 46/101 (45%), Gaps = 21/101 (20%)
Query: 673 RNLVKIISSSLEYLHFGHSIPIIHCDLKPSNVLL---DEDMVAHISDFGIAKLLSGEDQL 729
+ ++ I S+ Y H S I+H +LKP N+LL + ++DFG+A ++ +
Sbjct: 108 SHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW 164
Query: 730 SKQTQTLATIGYMAPE------YGTKGRVSTRGDVCSFGII 764
T GY++PE Y V D+ + G+I
Sbjct: 165 ---HGFAGTPGYLSPEVLKKDPYSKP--V----DIWACGVI 196
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 7e-11
Identities = 30/100 (30%), Positives = 47/100 (47%), Gaps = 20/100 (20%)
Query: 673 RNLVKIISSSLEYLHFGHSIPIIHCDLKPSNVLL---DEDMVAHISDFGIAKLLSGEDQL 729
++K + S + Y+H + I+H DLKP N+LL ++D I DFG++ ++
Sbjct: 124 ARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM 180
Query: 730 SKQTQTLATIGYMAPE-----YGTKGRVSTRGDVCSFGII 764
+ T Y+APE Y K DV S G+I
Sbjct: 181 ---KDRIGTAYYIAPEVLRGTYDEK------CDVWSAGVI 211
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 63.0 bits (154), Expect = 7e-11
Identities = 40/178 (22%), Positives = 63/178 (35%), Gaps = 65/178 (36%)
Query: 640 NGMEVAVKVFH--QQYERALKSFEDECEVRKRIRHRNLVKI------------------- 678
E AVKV + + + E E+ K++ H N++K+
Sbjct: 46 TQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTG 105
Query: 679 ------------------------ISSSLEYLHFGHSIPIIHCDLKPSNVLL---DEDMV 711
+ S + Y+ H I+H DLKP N+LL ++D
Sbjct: 106 GELFDEIIKRKRFSEHDAARIIKQVFSGITYM---HKHNIVHRDLKPENILLESKEKDCD 162
Query: 712 AHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPE-----YGTKGRVSTRGDVCSFGII 764
I DFG++ ++ + T Y+APE Y K DV S G+I
Sbjct: 163 IKIIDFGLSTCFQQNTKM---KDRIGTAYYIAPEVLRGTYDEK------CDVWSAGVI 211
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 8e-11
Identities = 27/100 (27%), Positives = 39/100 (39%), Gaps = 16/100 (16%)
Query: 679 ISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLA- 737
+++++H PIIH DLK N+LL + DFG A +S S Q A
Sbjct: 145 TCRAVQHMH-RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRAL 203
Query: 738 ---------TIGYMAPE----YGTKGRVSTRGDVCSFGII 764
T Y PE Y + + D+ + G I
Sbjct: 204 VEEEITRNTTPMYRTPEIIDLYS-NFPIGEKQDIWALGCI 242
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 9e-11
Identities = 35/105 (33%), Positives = 48/105 (45%), Gaps = 15/105 (14%)
Query: 662 DECEVRKRIRHRNLVKIISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAK 721
E E R +R I +YLH +IH DLK N+ L+ED+ I DFG+A
Sbjct: 139 TEPEARYYLRQ------IVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLAT 189
Query: 722 LLSGEDQLSKQTQ--TLATIGYMAPEYGTKGRVSTRGDVCSFGII 764
+ + + K+ T Y+APE +K S DV S G I
Sbjct: 190 KVEYDGER-KKVLCGTPN---YIAPEVLSKKGHSFEVDVWSIGCI 230
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 1e-10
Identities = 37/168 (22%), Positives = 63/168 (37%), Gaps = 48/168 (28%)
Query: 641 GMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVK----------------------- 677
G+++A K+ + + + ++E V ++ H NL++
Sbjct: 114 GLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173
Query: 678 ---IISSSLEY---------------LHFGHSIPIIHCDLKPSNVLL---DEDMVAHISD 716
II S + H + I+H DLKP N+L D + I D
Sbjct: 174 FDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIK-IID 232
Query: 717 FGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGII 764
FG+A+ ++L T ++APE VS D+ S G+I
Sbjct: 233 FGLARRYKPREKL---KVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVI 277
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 62.6 bits (153), Expect = 1e-10
Identities = 29/100 (29%), Positives = 51/100 (51%), Gaps = 6/100 (6%)
Query: 667 RKRIRHRNLVKI---ISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLL 723
+ + +L+ IS ++YL + ++H DL N+L+ E ISDFG+++ +
Sbjct: 144 ERALTMGDLISFAWQISQGMQYLA---EMKLVHRDLAARNILVAEGRKMKISDFGLSRDV 200
Query: 724 SGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGI 763
ED K++Q + +MA E +T+ DV SFG+
Sbjct: 201 YEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGV 240
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 1e-10
Identities = 31/103 (30%), Positives = 46/103 (44%), Gaps = 23/103 (22%)
Query: 673 RNLVKIISSSLEYLHFGHSIPIIHCDLKPSNVLL----DEDMVAHISDFGIAKLLSGEDQ 728
++ I+ ++EYLH + ++H DLKPSN+L I DFG AK L E+
Sbjct: 119 SAVLFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENG 175
Query: 729 LSKQTQTLA-TIGYMAPE------YGTKGRVSTRGDVCSFGII 764
L T T ++APE Y D+ S G++
Sbjct: 176 L---LMTPCYTANFVAPEVLERQGYDAA--C----DIWSLGVL 209
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 61.8 bits (151), Expect = 1e-10
Identities = 36/166 (21%), Positives = 60/166 (36%), Gaps = 42/166 (25%)
Query: 639 GNGMEVAVKVFHQQY-ERALKSFEDECEVRKRIRHRNLVK---IISSS------------ 682
G + VAVK + + F E + K + H ++VK II
Sbjct: 38 GEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEEPTWIIMELYPYG 97
Query: 683 --LEYL-HFGHSIPI----------------------IHCDLKPSNVLLDEDMVAHISDF 717
YL +S+ + +H D+ N+L+ + DF
Sbjct: 98 ELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDF 157
Query: 718 GIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGI 763
G+++ + ED K + T I +M+PE R +T DV F +
Sbjct: 158 GLSRYIEDEDY-YKASVTRLPIKWMSPESINFRRFTTASDVWMFAV 202
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 61.8 bits (151), Expect = 1e-10
Identities = 38/175 (21%), Positives = 61/175 (34%), Gaps = 56/175 (32%)
Query: 637 GIGNG-MEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVKI----------------- 678
G G +VAVK+ + + F E + ++ H LVK
Sbjct: 27 GKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI 85
Query: 679 ---------------------------ISSSLEYL---HFGHSIPIIHCDLKPSNVLLDE 708
+ + +L F IH DL N L+D
Sbjct: 86 SNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQF------IHRDLAARNCLVDR 139
Query: 709 DMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGI 763
D+ +SDFG+ + + +DQ T + + APE + S++ DV +FGI
Sbjct: 140 DLCVKVSDFGMTRYVL-DDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGI 193
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 2e-10
Identities = 25/81 (30%), Positives = 38/81 (46%), Gaps = 11/81 (13%)
Query: 673 RNLVKIISSSLEYLHFGHSIPIIHCDLKPSNVLL---DEDMVAHISDFGIAKLLS-GEDQ 728
+V+ ++S+L++LH + I H DLKP N+L ++ I DF + + D
Sbjct: 114 SVVVQDVASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDC 170
Query: 729 LSKQTQTLATI----GYMAPE 745
T L T YMAPE
Sbjct: 171 SPISTPELLTPCGSAEYMAPE 191
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 2e-10
Identities = 31/104 (29%), Positives = 43/104 (41%), Gaps = 16/104 (15%)
Query: 674 NLVKIISSSLEYLH-------------FGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIA 720
NL ++I L++ HS IIH DLKPSN+++ D I DFG+A
Sbjct: 115 NLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 174
Query: 721 KLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGII 764
+ + T + T Y APE D+ S G I
Sbjct: 175 RTAGTSFMM---TPYVVTRYYRAPEVILGMGYKENVDIWSVGCI 215
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 2e-10
Identities = 29/116 (25%), Positives = 51/116 (43%), Gaps = 15/116 (12%)
Query: 657 LKSF---EDECEVRKRIRHRNLVKI---ISSSLEYL---HFGHSIPIIHCDLKPSNVLLD 707
L +F E + + LV+ I+ +EYL +F IH DL N +L
Sbjct: 118 LHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNF------IHRDLAARNCMLA 171
Query: 708 EDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGI 763
EDM ++DFG+++ + D + + + ++A E + DV +FG+
Sbjct: 172 EDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGV 227
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 2e-10
Identities = 37/188 (19%), Positives = 63/188 (33%), Gaps = 63/188 (33%)
Query: 633 NNLIGIGNGMEVAVKVFHQQY-ERALKSFEDECEVRKRIRHRNLVKI------------- 678
+ + + ++VAVK + E+ F E + + H+N+V+
Sbjct: 52 SGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFIL 111
Query: 679 -------------------------------------ISSSLEYL---HFGHSIPIIHCD 698
I+ +YL HF IH D
Sbjct: 112 MELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHF------IHRD 165
Query: 699 LKPSNVLLD---EDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTR 755
+ N LL VA I DFG+A+ + K + + +M PE +G +++
Sbjct: 166 IAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSK 225
Query: 756 GDVCSFGI 763
D SFG+
Sbjct: 226 TDTWSFGV 233
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 2e-10
Identities = 29/96 (30%), Positives = 48/96 (50%), Gaps = 12/96 (12%)
Query: 673 RNLVKIISSSLEYLHFGHSIPIIHCDLKPSNVLL---DEDMVAHISDFGIAKLLSGEDQL 729
+++ I +++++LH S I H D+KP N+L ++D V ++DFG AK +
Sbjct: 131 AEIMRDIGTAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQN--- 184
Query: 730 SKQTQTLA-TIGYMAPEYGTKGRVSTRGDVCSFGII 764
QT T Y+APE + D+ S G+I
Sbjct: 185 --ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVI 218
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 2e-10
Identities = 30/171 (17%), Positives = 64/171 (37%), Gaps = 55/171 (32%)
Query: 640 NGMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVKI--------------------- 678
+VA+K+ + + F +E +V + H LV++
Sbjct: 47 GQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGC 105
Query: 679 -----------------------ISSSLEYL---HFGHSIPIIHCDLKPSNVLLDEDMVA 712
+ ++EYL F +H DL N L+++ V
Sbjct: 106 LLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQF------LHRDLAARNCLVNDQGVV 159
Query: 713 HISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGI 763
+SDFG+++ + +D+ + + + + PE + S++ D+ +FG+
Sbjct: 160 KVSDFGLSRYVL-DDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGV 209
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 3e-10
Identities = 37/188 (19%), Positives = 63/188 (33%), Gaps = 63/188 (33%)
Query: 633 NNLIGIGNGMEVAVKVFHQQY-ERALKSFEDECEVRKRIRHRNLVKI------------- 678
+ + + ++VAVK + E+ F E + + H+N+V+
Sbjct: 93 SGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFIL 152
Query: 679 -------------------------------------ISSSLEYL---HFGHSIPIIHCD 698
I+ +YL HF IH D
Sbjct: 153 LELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHF------IHRD 206
Query: 699 LKPSNVLLD---EDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTR 755
+ N LL VA I DFG+A+ + K + + +M PE +G +++
Sbjct: 207 IAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSK 266
Query: 756 GDVCSFGI 763
D SFG+
Sbjct: 267 TDTWSFGV 274
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 3e-10
Identities = 37/195 (18%), Positives = 66/195 (33%), Gaps = 69/195 (35%)
Query: 635 LIGIGN------------GMEVAVKVFHQQYERALKSFED----ECEVRKRIRHRNLVK- 677
L+G G+ AVK+ ++ R + + E E ++ +R+RH+N+++
Sbjct: 12 LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71
Query: 678 --IISSS--------LEY--------------------------------LHFGHSIPII 695
++ + +EY L + HS I+
Sbjct: 72 VDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIV 131
Query: 696 HCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATI----GYMAPE--YGTK 749
H D+KP N+LL IS G ++ T T + PE G
Sbjct: 132 HKDIKPGNLLLTTGGTLKISALG----VAEALHPFAADDTCRTSQGSPAFQPPEIANGLD 187
Query: 750 GRVSTRGDVCSFGII 764
+ D+ S G+
Sbjct: 188 TFSGFKVDIWSAGVT 202
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 3e-10
Identities = 34/171 (19%), Positives = 68/171 (39%), Gaps = 55/171 (32%)
Query: 642 MEVAVKVFHQQY-ERALKSFEDECEVRKRIRHRNLVKI---------------------- 678
+ VA+K Y E+ F E + + H N++++
Sbjct: 74 VPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGAL 133
Query: 679 ----------------------ISSSLEYL---HFGHSIPIIHCDLKPSNVLLDEDMVAH 713
I++ ++YL ++ +H DL N+L++ ++V
Sbjct: 134 DKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNY------VHRDLAARNILVNSNLVCK 187
Query: 714 ISDFGIAKLLSGEDQLSKQTQ-TLATIGYMAPEYGTKGRVSTRGDVCSFGI 763
+SDFG++++L + + + T I + APE + + ++ DV SFGI
Sbjct: 188 VSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGI 238
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 4e-10
Identities = 42/181 (23%), Positives = 66/181 (36%), Gaps = 64/181 (35%)
Query: 641 GMEVAVKVFH--------QQYERALKSFEDECEVRKRIRHRNLVKI-------------- 678
+VA+++ + + E E E+ K++ H ++KI
Sbjct: 160 CKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAEDYYIVLE 219
Query: 679 ----------------------------ISSSLEYLHFGHSIPIIHCDLKPSNVLL---D 707
+ +++YLH IIH DLKP NVLL +
Sbjct: 220 LMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQE 276
Query: 708 EDMVAHISDFGIAKLLSGEDQLSKQTQTLA-TIGYMAPE---YGTKGRVSTRGDVCSFGI 763
ED + I+DFG +K+L + TL T Y+APE + D S G+
Sbjct: 277 EDCLIKITDFGHSKILGETSLMR----TLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGV 332
Query: 764 I 764
I
Sbjct: 333 I 333
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 61.0 bits (149), Expect = 4e-10
Identities = 31/70 (44%), Positives = 40/70 (57%), Gaps = 14/70 (20%)
Query: 679 ISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHI--SDFGIAKLLSGEDQLSKQTQTL 736
+ +LEYLH S II+ DLKP N+LLD++ HI +DFG AK + T TL
Sbjct: 115 VCLALEYLH---SKDIIYRDLKPENILLDKN--GHIKITDFGFAK------YVPDVTYTL 163
Query: 737 -ATIGYMAPE 745
T Y+APE
Sbjct: 164 CGTPDYIAPE 173
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 4e-10
Identities = 41/190 (21%), Positives = 71/190 (37%), Gaps = 57/190 (30%)
Query: 627 TDRFSENNLIGIG------------NGMEVAVKVFHQQYERALKSFEDECEVRKRIRHRN 674
+ F +G G G VA+K E L+ E + ++ +
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQV--PVESDLQEIIKEISIMQQCDSPH 85
Query: 675 LVK-----------------------------------------IISSSLEYLHFGHSIP 693
+VK I+ S+L+ L + H +
Sbjct: 86 VVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMR 145
Query: 694 IIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVS 753
IH D+K N+LL+ + A ++DFG+A L+ D ++K+ + T +MAPE + +
Sbjct: 146 KIHRDIKAGNILLNTEGHAKLADFGVAGQLT--DTMAKRNTVIGTPFWMAPEVIQEIGYN 203
Query: 754 TRGDVCSFGI 763
D+ S GI
Sbjct: 204 CVADIWSLGI 213
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 60.7 bits (148), Expect = 4e-10
Identities = 31/95 (32%), Positives = 47/95 (49%), Gaps = 10/95 (10%)
Query: 673 RNLVKIISSSLEYLHFGHSIPIIHCDLKPSNVLL---DEDMVAHISDFGIAKLLSGEDQL 729
L+K + ++L Y H S ++H DLKP N+L I DFG+A+L ++
Sbjct: 127 AELMKQMMNALAYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHS 183
Query: 730 SKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGII 764
T T YMAPE K V+ + D+ S G++
Sbjct: 184 ---TNAAGTALYMAPEV-FKRDVTFKCDIWSAGVV 214
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 60.7 bits (148), Expect = 5e-10
Identities = 30/95 (31%), Positives = 47/95 (49%), Gaps = 9/95 (9%)
Query: 673 RNLVKIISSSLEYLHFGHSIPIIHCDLKPSNVLL---DEDMVAHISDFGIAKLLSGEDQL 729
L+K I + YLH + I+H DLKP N+LL I DFG+++ + +L
Sbjct: 134 IRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACEL 190
Query: 730 SKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGII 764
+ + T Y+APE ++T D+ + GII
Sbjct: 191 ---REIMGTPEYLAPEILNYDPITTATDMWNIGII 222
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 59.9 bits (146), Expect = 6e-10
Identities = 31/111 (27%), Positives = 53/111 (47%), Gaps = 12/111 (10%)
Query: 659 SFEDECEVRKRIRHRNLVKI---ISSSLEYL---HFGHSIPIIHCDLKPSNVLLDEDMVA 712
S +D+ V+ + + V + I++ +EYL H +H DL NVL+ + +
Sbjct: 114 STDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHV------VHKDLATRNVLVYDKLNV 167
Query: 713 HISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGI 763
ISD G+ + + D +L I +MAPE G+ S D+ S+G+
Sbjct: 168 KISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGV 218
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 60.3 bits (147), Expect = 7e-10
Identities = 28/70 (40%), Positives = 44/70 (62%), Gaps = 11/70 (15%)
Query: 679 ISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHI--SDFGIAKLLSGEDQLSKQTQTL 736
++ +L++LH S+ II+ DLKP N+LLDE+ HI +DFG++K + K+ +
Sbjct: 135 LALALDHLH---SLGIIYRDLKPENILLDEE--GHIKLTDFGLSKESIDHE---KKAYSF 186
Query: 737 -ATIGYMAPE 745
T+ YMAPE
Sbjct: 187 CGTVEYMAPE 196
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 7e-10
Identities = 24/70 (34%), Positives = 41/70 (58%), Gaps = 10/70 (14%)
Query: 679 ISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHI--SDFGIAKLLSGEDQLSKQTQTL 736
I +LE+LH + II+ D+K N+LLD + H+ +DFG++K ++ +++
Sbjct: 168 IVLALEHLH---KLGIIYRDIKLENILLDSN--GHVVLTDFGLSKEFVADE--TERAYDF 220
Query: 737 A-TIGYMAPE 745
TI YMAP+
Sbjct: 221 CGTIEYMAPD 230
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 61.3 bits (149), Expect = 7e-10
Identities = 24/68 (35%), Positives = 38/68 (55%), Gaps = 6/68 (8%)
Query: 679 ISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTL-A 737
I S+L+YLH ++ ++ DLK N++LD+D I+DFG+ K + +T
Sbjct: 257 IVSALDYLHSEKNV--VYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG---ATMKTFCG 311
Query: 738 TIGYMAPE 745
T Y+APE
Sbjct: 312 TPEYLAPE 319
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 59.9 bits (146), Expect = 7e-10
Identities = 28/111 (25%), Positives = 49/111 (44%), Gaps = 12/111 (10%)
Query: 659 SFEDECEVRKRIRHRNLVKI---ISSSLEYL---HFGHSIPIIHCDLKPSNVLLDEDMVA 712
+ + + ++ I I+S + YL HF +H DL N L+ +++
Sbjct: 119 VDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHF------VHRDLATRNCLVGANLLV 172
Query: 713 HISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGI 763
I DFG+++ + D T+ I +M PE + +T DV SFG+
Sbjct: 173 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGV 223
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 8e-10
Identities = 29/115 (25%), Positives = 50/115 (43%), Gaps = 12/115 (10%)
Query: 655 RALKSFEDECEVRKRIRHRNLVKI---ISSSLEYL---HFGHSIPIIHCDLKPSNVLLDE 708
A E + L+ + +++ + YL HF +H DL N L+ +
Sbjct: 140 DAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHF------VHRDLATRNCLVGQ 193
Query: 709 DMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGI 763
+V I DFG+++ + D +T+ I +M PE + +T DV SFG+
Sbjct: 194 GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGV 248
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 59.9 bits (146), Expect = 1e-09
Identities = 27/70 (38%), Positives = 37/70 (52%), Gaps = 11/70 (15%)
Query: 679 ISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHI--SDFGIAKLLSGEDQLSKQTQTL 736
IS +L +LH II+ DLKP N++L+ H+ +DFG+ K + T T
Sbjct: 130 ISMALGHLH---QKGIIYRDLKPENIMLNHQ--GHVKLTDFGLCKESIHDGT---VTHTF 181
Query: 737 A-TIGYMAPE 745
TI YMAPE
Sbjct: 182 CGTIEYMAPE 191
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 59.1 bits (144), Expect = 1e-09
Identities = 43/184 (23%), Positives = 67/184 (36%), Gaps = 54/184 (29%)
Query: 635 LIGIGN------------GMEVAVKVFH-QQYERALKSFEDECEVRKRIRHRNLVK---I 678
+G G VAVK+ ++ ++ + E + K + H N+VK
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 679 ISSS------LEY-------------------------------LHFGHSIPIIHCDLKP 701
LEY + + H I I H D+KP
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKP 133
Query: 702 SNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPE-YGTKGRVSTRGDVCS 760
N+LLDE ISDFG+A + ++ + T+ Y+APE + + DV S
Sbjct: 134 ENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWS 193
Query: 761 FGII 764
GI+
Sbjct: 194 CGIV 197
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 1e-09
Identities = 26/118 (22%), Positives = 46/118 (38%), Gaps = 12/118 (10%)
Query: 652 QYERALKSFEDECEVRKRIRHRNLVKI---ISSSLEYL---HFGHSIPIIHCDLKPSNVL 705
+ + + I +++ + YL F +H DL N L
Sbjct: 153 SHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKF------VHRDLATRNCL 206
Query: 706 LDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGI 763
+ E+MV I+DFG+++ + D I +M PE R +T DV ++G+
Sbjct: 207 VGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGV 264
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 58.7 bits (143), Expect = 2e-09
Identities = 26/96 (27%), Positives = 40/96 (41%), Gaps = 10/96 (10%)
Query: 673 RNLVKIISSSLEYLHFGHSIPIIHCDLKPSNVLL----DEDMVAHISDFGIAKLLSGEDQ 728
+K I + YLH I H DLKP N++L + + DFGIA + ++
Sbjct: 111 TQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE 167
Query: 729 LSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGII 764
T ++APE + D+ S G+I
Sbjct: 168 F---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVI 200
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 59.8 bits (145), Expect = 2e-09
Identities = 19/70 (27%), Positives = 36/70 (51%), Gaps = 10/70 (14%)
Query: 679 ISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHI--SDFGIAKLLSGEDQLSKQTQTL 736
+ +++ +H + +H D+KP N+L+D + HI +DFG L + + Q+
Sbjct: 184 MVIAIDSVH---QLHYVHRDIKPDNILMDMN--GHIRLADFGSCLKLMEDG--TVQSSVA 236
Query: 737 -ATIGYMAPE 745
T Y++PE
Sbjct: 237 VGTPDYISPE 246
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 2e-09
Identities = 26/70 (37%), Positives = 39/70 (55%), Gaps = 11/70 (15%)
Query: 679 ISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHI--SDFGIAKLLSGEDQLSKQTQTL 736
I S+LEYLH S +++ D+K N++LD+D HI +DFG+ K + +T
Sbjct: 114 IVSALEYLH---SRDVVYRDIKLENLMLDKD--GHIKITDFGLCKEGISDG---ATMKTF 165
Query: 737 -ATIGYMAPE 745
T Y+APE
Sbjct: 166 CGTPEYLAPE 175
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 2e-09
Identities = 30/81 (37%), Positives = 44/81 (54%), Gaps = 5/81 (6%)
Query: 683 LEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYM 742
L+YLH S IH D+K +NVLL E ++DFG+A L+ D K+ + T +M
Sbjct: 132 LDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLT--DTQIKRNTFVGTPFWM 186
Query: 743 APEYGTKGRVSTRGDVCSFGI 763
APE + ++ D+ S GI
Sbjct: 187 APEVIKQSAYDSKADIWSLGI 207
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 2e-09
Identities = 27/70 (38%), Positives = 40/70 (57%), Gaps = 14/70 (20%)
Query: 679 ISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHI--SDFGIAKLLSGEDQLSKQTQTL 736
I + EYLH S+ +I+ DLKP N+L+D+ +I +DFG AK ++ +T TL
Sbjct: 150 IVLTFEYLH---SLDLIYRDLKPENLLIDQQ--GYIQVTDFGFAK------RVKGRTWTL 198
Query: 737 -ATIGYMAPE 745
T +APE
Sbjct: 199 CGTPEALAPE 208
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 2e-09
Identities = 25/94 (26%), Positives = 39/94 (41%), Gaps = 8/94 (8%)
Query: 673 RNLVKIISSSLEYLHFGHSIPIIHCDLKPSNVLL--DEDMVAHISDFGIAKLLSGEDQLS 730
+ V + +L++LH + I H D++P N++ I +FG A+ L D
Sbjct: 105 VSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF- 160
Query: 731 KQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGII 764
Y APE VST D+ S G +
Sbjct: 161 --RLLFTAPEYYAPEVHQHDVVSTATDMWSLGTL 192
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 2e-09
Identities = 29/70 (41%), Positives = 39/70 (55%), Gaps = 11/70 (15%)
Query: 679 ISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHI--SDFGIAKLLSGEDQLSKQTQTL 736
I+S+L YLH S+ I++ DLKP N+LLD HI +DFG+ K + T T
Sbjct: 148 IASALGYLH---SLNIVYRDLKPENILLDSQ--GHIVLTDFGLCKENIEHNST---TSTF 199
Query: 737 -ATIGYMAPE 745
T Y+APE
Sbjct: 200 CGTPEYLAPE 209
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 59.8 bits (145), Expect = 2e-09
Identities = 30/167 (17%), Positives = 48/167 (28%), Gaps = 46/167 (27%)
Query: 641 GMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVK----------------------- 677
G A K +E ++ E + +RH LV
Sbjct: 182 GNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGEL 241
Query: 678 ---IISSSLEY---------------LHFGHSIPIIHCDLKPSNVLLDEDMVAHI--SDF 717
+ + L H +H DLKP N++ + DF
Sbjct: 242 FEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDF 301
Query: 718 GIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGII 764
G+ L + + T T + APE V D+ S G++
Sbjct: 302 GLTAHLDPKQSV---KVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVL 345
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 2e-09
Identities = 28/70 (40%), Positives = 35/70 (50%), Gaps = 11/70 (15%)
Query: 679 ISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHI--SDFGIAKLLSGEDQLSKQTQTL 736
IS +L YLH II+ DLK NVLLD + HI +D+G+ K T T
Sbjct: 119 ISLALNYLH---ERGIIYRDLKLDNVLLDSE--GHIKLTDYGMCKEGLRPG---DTTSTF 170
Query: 737 -ATIGYMAPE 745
T Y+APE
Sbjct: 171 CGTPNYIAPE 180
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 3e-09
Identities = 27/93 (29%), Positives = 45/93 (48%), Gaps = 14/93 (15%)
Query: 679 ISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHI--SDFGIAKLLSGEDQLSKQTQTL 736
+ +L+ +H S+ IH D+KP N+LLD+ H+ +DFG ++ E + T
Sbjct: 177 VVLALDAIH---SMGFIHRDVKPDNMLLDKS--GHLKLADFGTCMKMNKEGM--VRCDTA 229
Query: 737 -ATIGYMAPE-YGTKGRVSTRGDVC---SFGII 764
T Y++PE ++G G C S G+
Sbjct: 230 VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVF 262
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 3e-09
Identities = 28/70 (40%), Positives = 35/70 (50%), Gaps = 11/70 (15%)
Query: 679 ISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHI--SDFGIAKLLSGEDQLSKQTQTL 736
IS +L YLH II+ DLK NVLLD + HI +D+G+ K T T
Sbjct: 162 ISLALNYLH---ERGIIYRDLKLDNVLLDSE--GHIKLTDYGMCKEGLRPG---DTTSTF 213
Query: 737 -ATIGYMAPE 745
T Y+APE
Sbjct: 214 CGTPNYIAPE 223
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 3e-09
Identities = 43/184 (23%), Positives = 67/184 (36%), Gaps = 54/184 (29%)
Query: 635 LIGIGN------------GMEVAVKVFH-QQYERALKSFEDECEVRKRIRHRNLVK---I 678
+G G VAVK+ ++ ++ + E + K + H N+VK
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 679 ISSS------LEY-------------------------------LHFGHSIPIIHCDLKP 701
LEY + + H I I H D+KP
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKP 133
Query: 702 SNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPE-YGTKGRVSTRGDVCS 760
N+LLDE ISDFG+A + ++ + T+ Y+APE + + DV S
Sbjct: 134 ENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWS 193
Query: 761 FGII 764
GI+
Sbjct: 194 CGIV 197
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 3e-09
Identities = 24/61 (39%), Positives = 36/61 (59%), Gaps = 1/61 (1%)
Query: 686 LHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQ-TQTLATIGYMAP 744
L + HS ++H DLKPSN+LL+ I DFG+A++ + + T+ +AT Y AP
Sbjct: 141 LKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 200
Query: 745 E 745
E
Sbjct: 201 E 201
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 3e-09
Identities = 28/138 (20%), Positives = 57/138 (41%), Gaps = 19/138 (13%)
Query: 623 LLRATDRFSENNLIGIGNGMEVAVKVFHQQYERALKSFED--------ECEVRKRIRHRN 674
++R R +N++ + + +L E ++ +
Sbjct: 61 IIR---RLDHDNIVKVFE-ILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGP 116
Query: 675 LVKIISSSLEY-----LHFGHSIPIIHCDLKPSNVLLD-EDMVAHISDFGIAKLLSGEDQ 728
L++ + Y L + HS ++H DLKP+N+ ++ ED+V I DFG+A+++
Sbjct: 117 LLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYS 176
Query: 729 LSKQ-TQTLATIGYMAPE 745
++ L T Y +P
Sbjct: 177 HKGHLSEGLVTKWYRSPR 194
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 4e-09
Identities = 19/60 (31%), Positives = 29/60 (48%), Gaps = 3/60 (5%)
Query: 686 LHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPE 745
LH H ++H DL P N+LL ++ I DF +A+ + + T + Y APE
Sbjct: 147 LHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANK---THYVTHRWYRAPE 203
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 4e-09
Identities = 25/96 (26%), Positives = 39/96 (40%), Gaps = 10/96 (10%)
Query: 673 RNLVKIISSSLEYLHFGHSIPIIHCDLKPSNVLL----DEDMVAHISDFGIAKLLSGEDQ 728
+ +K I + YLH I H DLKP N++L + DFG+A + +
Sbjct: 118 TSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE 174
Query: 729 LSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGII 764
T ++APE + D+ S G+I
Sbjct: 175 F---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVI 207
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 58.0 bits (141), Expect = 4e-09
Identities = 25/96 (26%), Positives = 39/96 (40%), Gaps = 10/96 (10%)
Query: 673 RNLVKIISSSLEYLHFGHSIPIIHCDLKPSNVLL----DEDMVAHISDFGIAKLLSGEDQ 728
+ +K I + YLH I H DLKP N++L + DFG+A + +
Sbjct: 118 TSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE 174
Query: 729 LSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGII 764
T ++APE + D+ S G+I
Sbjct: 175 F---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVI 207
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 58.0 bits (141), Expect = 4e-09
Identities = 27/96 (28%), Positives = 42/96 (43%), Gaps = 10/96 (10%)
Query: 673 RNLVKIISSSLEYLHFGHSIPIIHCDLKPSNVLL----DEDMVAHISDFGIAKLLSGEDQ 728
+K I + + YLH S+ I H DLKP N++L I DFG+A + ++
Sbjct: 117 TEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE 173
Query: 729 LSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGII 764
T ++APE + D+ S G+I
Sbjct: 174 F---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVI 206
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 58.0 bits (141), Expect = 5e-09
Identities = 26/70 (37%), Positives = 36/70 (51%), Gaps = 11/70 (15%)
Query: 679 ISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHI--SDFGIAKLLSGEDQLSKQTQTL 736
I+ L +L S II+ DLK NV+LD + HI +DFG+ K + T+T
Sbjct: 130 IAIGLFFLQ---SKGIIYRDLKLDNVMLDSE--GHIKIADFGMCKENIWDG---VTTKTF 181
Query: 737 -ATIGYMAPE 745
T Y+APE
Sbjct: 182 CGTPDYIAPE 191
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 58.9 bits (142), Expect = 5e-09
Identities = 26/70 (37%), Positives = 36/70 (51%), Gaps = 11/70 (15%)
Query: 679 ISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHI--SDFGIAKLLSGEDQLSKQTQTL 736
I+ L +L S II+ DLK NV+LD + HI +DFG+ K + T+T
Sbjct: 451 IAIGLFFLQ---SKGIIYRDLKLDNVMLDSE--GHIKIADFGMCKENIWDG---VTTKTF 502
Query: 737 A-TIGYMAPE 745
T Y+APE
Sbjct: 503 CGTPDYIAPE 512
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 6e-09
Identities = 47/184 (25%), Positives = 67/184 (36%), Gaps = 58/184 (31%)
Query: 636 IGIGN------------GMEVAVKVF--HQQYERALKSFEDECEVRKRIRHRNLVK---I 678
IG GN G EVA+K+ Q +L+ E + K + H N+VK +
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 679 ISSS------LEY-------------------------------LHFGHSIPIIHCDLKP 701
I + +EY + + H I+H DLK
Sbjct: 83 IETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKA 142
Query: 702 SNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPE-YGTKGRVSTRGDVCS 760
N+LLD DM I+DFG + + +L Y APE + K DV S
Sbjct: 143 ENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPP---YAAPELFQGKKYDGPEVDVWS 199
Query: 761 FGII 764
G+I
Sbjct: 200 LGVI 203
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 57.6 bits (140), Expect = 6e-09
Identities = 27/70 (38%), Positives = 34/70 (48%), Gaps = 11/70 (15%)
Query: 679 ISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHI--SDFGIAKLLSGEDQLSKQTQTL 736
I S+L +LH II+ DLK NVLLD + H +DFG+ K T T
Sbjct: 133 IISALMFLH---DKGIIYRDLKLDNVLLDHE--GHCKLADFGMCKEGICNGVT---TATF 184
Query: 737 -ATIGYMAPE 745
T Y+APE
Sbjct: 185 CGTPDYIAPE 194
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 58.7 bits (141), Expect = 6e-09
Identities = 80/534 (14%), Positives = 157/534 (29%), Gaps = 176/534 (32%)
Query: 7 ISQHQQALLALKAHISYDHTNL-------FARNWTSSTSVCIWIGITCDVNSHRVIGLNI 59
+ +QALL L+ N+ + W + VC+ + C ++ LN+
Sbjct: 137 YLKLRQALLELR-----PAKNVLIDGVLGSGKTWVAL-DVCLSYKVQC-KMDFKIFWLNL 189
Query: 60 SSFNLQGTITPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLK---------------L 104
+ N T+ L L L +D + S + + +H+++ L
Sbjct: 190 KNCNSPETVLEMLQKL--LYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCL 247
Query: 105 L---DFSDNQLFGSLSSFIFNMSS---MTTIDLSI-NRLSGELPANICKIPSTLSKCKQL 157
L + + + + + FN+S +TT + + LS +I L
Sbjct: 248 LVLLNVQNAKAWNA-----FNLSCKILLTTRFKQVTDFLSAATTTHIS-----------L 291
Query: 158 EELNLGFNNLSGAIPKEIGNLTKLKEIISTITNSTVCEIPREIGNLPYLARLALATNNLV 217
+ ++ P E +K ++ + ++PRE L TN
Sbjct: 292 DHHSMTLT------PDE------VKSLLLKYLDCRPQDLPRE----------VLTTNPRR 329
Query: 218 GVVPVTIFNMSALKEISLLNNSLSGSLPSRIDLSLPNVETLNLGINSFSGTIPSSITNSS 277
+S++ S+ + D N + +N + + I SS+
Sbjct: 330 ---------------LSIIAESIR-DGLATWD----NWKHVN--CDKLTTIIESSLNV-- 365
Query: 278 KLSDLELGENLFSGF--------IPNTI-----GNLRNLEFGNIAD------------NY 312
L E +F IP + ++ + + +
Sbjct: 366 -LEPAEY-RKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKE 423
Query: 313 LTSSTPELSFLSSLTNCKKLKVL---IVT------GNPLDGILPKSIGNFSLS-----LE 358
T S P + +L + L IV D ++P + + S L+
Sbjct: 424 STISIPSI-YLELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGHHLK 482
Query: 359 TILMANCSISGNIPQVVGNLSNLLV--------LELGGNNLTGPIPVTFSQLQTLQAFDL 410
I + + + + + + L TLQ
Sbjct: 483 NIEHP---------ERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSI----LNTLQQLKF 529
Query: 411 TRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTS---VRVLYLGLN 461
+ I D RL + +L F +P NL +L + L
Sbjct: 530 YKPY----ICDNDPKYERLVNAIL---DF---LPKIEENLICSKYTDLLRIALM 573
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 53.7 bits (128), Expect = 2e-07
Identities = 85/527 (16%), Positives = 167/527 (31%), Gaps = 151/527 (28%)
Query: 281 DLELGE------NLFSGFIPNTIGNLRNLEFGNIADNYLTSSTPELSFLSSLTNCKKLKV 334
D E GE ++ S F + N + ++ D S+ + +++
Sbjct: 8 DFETGEHQYQYKDILSVFEDAFV---DNFDCKDVQD-----------MPKSILSKEEIDH 53
Query: 335 LIVTGNPLDGILPKSIGNFSLSLETILMANCSISGNIPQVVGNLSNLLVLELGGNNLTGP 394
+I++ + + G L T+L + + + V VL + L P
Sbjct: 54 IIMSKDAVSGTL--------RLFWTLLSKQEEM---VQKFVEE-----VLRINYKFLMSP 97
Query: 395 I------P------------VTFSQLQTLQAFDLTRNKLAGPITDELCHLARLHSLVLQG 436
I P ++ Q ++++R + + L L ++++ G
Sbjct: 98 IKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDG 157
Query: 437 NKFSGSIPSCLGN--LTSVRVL-YLGLNIFTSVLSSTIWNLKDILFIDVSSNFLDGPLSL 493
SG + + S +V + IF W +++ + +
Sbjct: 158 VLGSGK--TWVALDVCLSYKVQCKMDFKIF--------W-------LNLKNCNSPETVLE 200
Query: 494 DIGNLKVVIGLDF-SRNNLSGDIPITIGEGE-----IPRGGPFAN-L----------TAK 536
+ L I ++ SR++ S +I + I + + + P+ N L
Sbjct: 201 MLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWN 260
Query: 537 SFMGNELLCGLPDLQVSPCK-----PNKPNTHKKSRKMLLLVIVLPLSTALIVVVTLTLK 591
+F +L CK K T S + + S L +L
Sbjct: 261 AF----------NLS---CKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSL- 306
Query: 592 WKLIKCWKSRTG--PSNDGINSPQAIRRFSYHELLR---AT-DRFSENNLIGIGNGMEVA 645
L+K R P +P+ + + E +R AT D + N + +E +
Sbjct: 307 --LLKYLDCRPQDLPREVLTTNPRRLSIIA--ESIRDGLATWDNWKHVNCDKLTTIIESS 362
Query: 646 VKVF----HQQYERALKSFEDE------------CEVRKRIRHRNLVKIISSSL------ 683
+ V +++ L F +V K + K+ SL
Sbjct: 363 LNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPK 422
Query: 684 EYLHFGHSIPIIHCDLKPSNVLLDEDMVAH---ISDFGIAKLLSGED 727
E SIP I+ +LK L+ + H + + I K +D
Sbjct: 423 EST---ISIPSIYLELKVK---LENEYALHRSIVDHYNIPKTFDSDD 463
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 7e-09
Identities = 28/108 (25%), Positives = 51/108 (47%), Gaps = 9/108 (8%)
Query: 659 SFEDECEVRKRIRHRNLVKI---ISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHIS 715
+F + + L+ ++ ++YL IH DL N+L+ E+ VA I+
Sbjct: 128 AFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIA 184
Query: 716 DFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGI 763
DFG+++ G++ K+T + +MA E +T DV S+G+
Sbjct: 185 DFGLSR---GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGV 229
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 57.9 bits (140), Expect = 8e-09
Identities = 27/83 (32%), Positives = 38/83 (45%), Gaps = 6/83 (7%)
Query: 682 SLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGY 741
+++LH IIH DLKPSN+++ D I DFG+A+ + T + T Y
Sbjct: 176 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM---TPYVVTRYY 229
Query: 742 MAPEYGTKGRVSTRGDVCSFGII 764
APE D+ S G I
Sbjct: 230 RAPEVILGMGYKENVDIWSVGCI 252
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 57.2 bits (139), Expect = 9e-09
Identities = 28/70 (40%), Positives = 38/70 (54%), Gaps = 11/70 (15%)
Query: 679 ISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHI--SDFGIAKLLSGEDQLSKQTQTL 736
I L++LH S I++ DLK N+LLD+D HI +DFG+ K D +T T
Sbjct: 127 IILGLQFLH---SKGIVYRDLKLDNILLDKD--GHIKIADFGMCKENMLGD---AKTNTF 178
Query: 737 -ATIGYMAPE 745
T Y+APE
Sbjct: 179 CGTPDYIAPE 188
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 1e-08
Identities = 20/70 (28%), Positives = 35/70 (50%), Gaps = 10/70 (14%)
Query: 679 ISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHI--SDFGIAKLLSGEDQLSKQTQTL 736
I +++ +H + +H D+KP N+LLD HI +DFG L + + ++
Sbjct: 171 IVMAIDSVH---RLGYVHRDIKPDNILLDRC--GHIRLADFGSCLKLRADG--TVRSLVA 223
Query: 737 -ATIGYMAPE 745
T Y++PE
Sbjct: 224 VGTPDYLSPE 233
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 1e-08
Identities = 32/166 (19%), Positives = 64/166 (38%), Gaps = 38/166 (22%)
Query: 76 SSLQTLDLSHNKLSGNIPSSIFNMHT-LKLLDFSDNQLFGSLSSFIFN-MSSMTTIDLSI 133
++ + L N + IP F+ + L+ +D S+NQ+ L+ F + S+ ++ L
Sbjct: 32 ETITEIRLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQI-SELAPDAFQGLRSLNSLVLYG 89
Query: 134 NRLSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKEIGNLTKLKEIISTITNSTV 193
N+++ ELP ++ L+ L L N ++
Sbjct: 90 NKIT-ELPKSL------FEGLFSLQLLLLNANKIN------------------------- 117
Query: 194 CEIPREI-GNLPYLARLALATNNLVGVVPVTIFNMSALKEISLLNN 238
+ + +L L L+L N L + T + A++ + L N
Sbjct: 118 -CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 9e-08
Identities = 24/114 (21%), Positives = 46/114 (40%), Gaps = 13/114 (11%)
Query: 74 NLSSLQTLDLSHNKLSGNIPSSIFN-MHTLKLLDFSDNQLFGSLSSFIF-NMSSMTTIDL 131
L+ +DLS+N++S + F + +L L N++ L +F + S+ + L
Sbjct: 54 PYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKI-TELPKSLFEGLFSLQLLLL 111
Query: 132 SINRLSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKEI-GNLTKLKEI 184
+ N+++ L L L+L N L I K L ++ +
Sbjct: 112 NANKIN-CLR------VDAFQDLHNLNLLSLYDNKLQ-TIAKGTFSPLRAIQTM 157
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 5e-07
Identities = 24/110 (21%), Positives = 45/110 (40%), Gaps = 2/110 (1%)
Query: 377 NLSNLLVLELGGNNLTGPIPVTFSQLQTLQAFDLTRNKLAGPITDELCHLARLHSLVLQG 436
L ++L N ++ P F L++L + L NK+ L L L+L
Sbjct: 54 PYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNA 113
Query: 437 NKFSGSIPS-CLGNLTSVRVLYLGLNIFTSVLSSTIWNLKDILFIDVSSN 485
NK + + +L ++ +L L N ++ T L+ I + ++ N
Sbjct: 114 NKIN-CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 1e-05
Identities = 31/123 (25%), Positives = 53/123 (43%), Gaps = 8/123 (6%)
Query: 366 SISGNIPQVVGNLSNLLVLELGGNNLTGPIPVTFSQLQTLQAFDLTRNKLAGPITDELCH 425
I N+P + + L N + P FS + L+ DL+ N+++ D
Sbjct: 25 EIPTNLP------ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQG 78
Query: 426 LARLHSLVLQGNKFSGSIPS-CLGNLTSVRVLYLGLNIFTSVLSSTIWNLKDILFIDVSS 484
L L+SLVL GNK + +P L S+++L L N + +L ++ + +
Sbjct: 79 LRSLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYD 137
Query: 485 NFL 487
N L
Sbjct: 138 NKL 140
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 1e-05
Identities = 35/165 (21%), Positives = 66/165 (40%), Gaps = 16/165 (9%)
Query: 127 TTIDLSINRLSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKEIGNLTKLKEIIS 186
+D L+ E+P N+ P T+ E+ L N + P KL+ I
Sbjct: 14 NIVDCRGKGLT-EIPTNL---PETI------TEIRLEQNTIKVIPPGAFSPYKKLRRI-- 61
Query: 187 TITNSTVCEIPREI-GNLPYLARLALATNNLVGVVPVTIF-NMSALKEISLLNNSLSGSL 244
++N+ + E+ + L L L L N + +P ++F + +L+ + L N ++ L
Sbjct: 62 DLSNNQISELAPDAFQGLRSLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKIN-CL 119
Query: 245 PSRIDLSLPNVETLNLGINSFSGTIPSSITNSSKLSDLELGENLF 289
L N+ L+L N + + + + L +N F
Sbjct: 120 RVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPF 164
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 56.7 bits (137), Expect = 1e-08
Identities = 26/84 (30%), Positives = 34/84 (40%), Gaps = 12/84 (14%)
Query: 662 DECEVRKRIRHRNLVKIISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAK 721
DE R + S++ YL IIH D+K N+++ ED + DFG A
Sbjct: 128 DEPLASYIFRQ------LVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAA 178
Query: 722 LLSGEDQLSKQTQTLATIGYMAPE 745
L T TI Y APE
Sbjct: 179 YLERGKLFY--T-FCGTIEYCAPE 199
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 1e-08
Identities = 54/357 (15%), Positives = 123/357 (34%), Gaps = 57/357 (15%)
Query: 72 LGNLSSLQTLDLSHNKLSGNIPSSIF-----NMHTLKLLDFSDNQL----FGSLSSFI-F 121
+ +LDLS N L + ++ L+ S N L L +
Sbjct: 18 TSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAA 77
Query: 122 NMSSMTTIDLSINRLSGELPANICKIPSTLSKCK-QLEELNLGFNNLSGAIPKEIGNLTK 180
+++T+++LS N LS + + ++ TL+ + L+LG+N+ S E
Sbjct: 78 IPANVTSLNLSGNFLSYK---SSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQA-- 132
Query: 181 LKEIISTIT--NSTVCEIPREIGNLPYLARLALATNNLVGVVPVTIFNMSALKEISLLNN 238
+ ++IT N ++ + + L + LA + + ++L N
Sbjct: 133 FSNLPASITSLNLRGNDLGIKSSD--ELIQ-ILAAIP------------ANVNSLNLRGN 177
Query: 239 SLS----GSLPSRIDLSLPNVETLNLGINSFSGTIPSSI-----TNSSKLSDLELGENLF 289
+L+ L + +V +L+L N + + + + + L L N
Sbjct: 178 NLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCL 237
Query: 290 SG----FIPNTIGNLRNLEFGNIADNYLTSSTPEL--SFLSSLTNCKKLKVLIVTGNPL- 342
G + +L++L+ + + + + + E + ++ N +K+ ++ G +
Sbjct: 238 HGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIH 297
Query: 343 -DGI--LPKSIGNFSLSLETILMANCSIS-----GNIPQVVGNLSNLLVLELGGNNL 391
+ I S + + N + + + L L
Sbjct: 298 PSHSIPISNLIRELSGKADVPSLLNQCLIFAQKHQTNIEDLNIPDELRESIQTCKPL 354
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 1e-08
Identities = 41/136 (30%), Positives = 60/136 (44%), Gaps = 30/136 (22%)
Query: 623 LLRATDRFSENNLIGIGNGMEVAVKVFHQQYERALKSFED--------ECEVRKRIRHRN 674
LL+ N+IG+ + VF R+L+ F D ++ ++ +
Sbjct: 81 LLK---HMKHENVIGLLD-------VFTPA--RSLEEFNDVYLVTHLMGADLNNIVKCQK 128
Query: 675 LVKIISSSLEY-----LHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQL 729
L L Y L + HS IIH DLKPSN+ ++ED I DFG+A+ + E
Sbjct: 129 LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE--- 185
Query: 730 SKQTQTLATIGYMAPE 745
T +AT Y APE
Sbjct: 186 --MTGYVATRWYRAPE 199
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 1e-08
Identities = 36/190 (18%), Positives = 59/190 (31%), Gaps = 61/190 (32%)
Query: 634 NLIGIGNGMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVKIIS------------- 680
G + EV +KV + + +SF + + ++ H++LV
Sbjct: 33 GDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQE 92
Query: 681 -----SSLEYLH-FGHSIPI----------------------IHCDLKPSNVLLD----- 707
S YL + I I IH ++ N+LL
Sbjct: 93 FVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDR 152
Query: 708 ---EDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRV-STRGDVCSFG- 762
+SD GI+ + +D I ++ PE + + D SFG
Sbjct: 153 KTGNPPFIKLSDPGISITVLPKD------ILQERIPWVPPECIENPKNLNLATDKWSFGT 206
Query: 763 ----IISGGK 768
I SGG
Sbjct: 207 TLWEICSGGD 216
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 1e-08
Identities = 31/91 (34%), Positives = 43/91 (47%), Gaps = 19/91 (20%)
Query: 683 LEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIG-- 740
LEYLH IH D+K N+LL ED I+DFG++ L+ +++ +G
Sbjct: 134 LEYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTP 190
Query: 741 -YMAPE-------YGTKGRVSTRGDVCSFGI 763
+MAPE Y K D+ SFGI
Sbjct: 191 CWMAPEVMEQVRGYDFK------ADIWSFGI 215
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 2e-08
Identities = 20/68 (29%), Positives = 35/68 (51%), Gaps = 8/68 (11%)
Query: 686 LHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQ--------TQTLA 737
+ H +IH DLKPSN+L++ + + DFG+A+++ + + + +A
Sbjct: 125 VKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVA 184
Query: 738 TIGYMAPE 745
T Y APE
Sbjct: 185 TRWYRAPE 192
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 2e-08
Identities = 29/88 (32%), Positives = 42/88 (47%), Gaps = 10/88 (11%)
Query: 663 ECEVRKRIRHRNLVKIISSSLEY-----LHFGHSIPIIHCDLKPSNVLLDEDMVAHISDF 717
++ K ++H L + L Y L + H+ IIH DLKP N+ ++ED I DF
Sbjct: 113 GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDF 172
Query: 718 GIAKLLSGEDQLSKQTQTLATIGYMAPE 745
G+A+ E T + T Y APE
Sbjct: 173 GLARQADSE-----MTGYVVTRWYRAPE 195
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 3e-08
Identities = 38/172 (22%), Positives = 60/172 (34%), Gaps = 52/172 (30%)
Query: 638 IGNGMEVAVKV---FHQQYERALKSFEDECEVRKRIRHRNLVKIISSSL---------EY 685
+ N VA+K +Q + E +++RH N ++ L EY
Sbjct: 76 VRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEY 135
Query: 686 -------------------------------LHFGHSIPIIHCDLKPSNVLLDEDMVAHI 714
L + HS +IH D+K N+LL E + +
Sbjct: 136 CLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKL 195
Query: 715 SDFGIAKLLSGEDQLSKQTQTLATIGYMAPE---YGTKGRVSTRGDVCSFGI 763
DFG A ++ + T +MAPE +G+ + DV S GI
Sbjct: 196 GDFGSAS------IMAPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGI 241
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 3e-08
Identities = 41/195 (21%), Positives = 65/195 (33%), Gaps = 60/195 (30%)
Query: 627 TDRFSENNLIGIG------------NGMEVAVKVFHQQYERALKSFEDECEVRKRIRHRN 674
+ + +G G G A KV + E L+ + E E+ H
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPY 77
Query: 675 LVKIISSSL---------EY--------------------------------LHFGHSIP 693
+VK++ + E+ L+F HS
Sbjct: 78 IVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKR 137
Query: 694 IIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVS 753
IIH DLK NVL+ + ++DFG++ L K+ + T +MAPE +
Sbjct: 138 IIHRDLKAGNVLMTLEGDIRLADFGVSAKNL--KTLQKRDSFIGTPYWMAPEVVMCETMK 195
Query: 754 TRG-----DVCSFGI 763
D+ S GI
Sbjct: 196 DTPYDYKADIWSLGI 210
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 54.5 bits (132), Expect = 3e-08
Identities = 45/189 (23%), Positives = 75/189 (39%), Gaps = 65/189 (34%)
Query: 635 LIGIGN------------GMEVAVKVFHQQYERALKSFED------ECEVRKRIRHRNLV 676
+G+G G +VAVK+ ++Q ++S + E + K RH +++
Sbjct: 18 TLGVGTFGKVKIGEHQLTGHKVAVKILNRQ---KIRSLDVVGKIKREIQNLKLFRHPHII 74
Query: 677 K---IISSS------LEY-------------------------------LHFGHSIPIIH 696
K +IS+ +EY + + H ++H
Sbjct: 75 KLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVH 134
Query: 697 CDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPE-YGTKGRVSTR 755
DLKP NVLLD M A I+DFG++ ++S + L + Y APE +
Sbjct: 135 RDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPN---YAAPEVISGRLYAGPE 191
Query: 756 GDVCSFGII 764
D+ S G+I
Sbjct: 192 VDIWSCGVI 200
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 3e-08
Identities = 30/165 (18%), Positives = 59/165 (35%), Gaps = 35/165 (21%)
Query: 76 SSLQTLDLSHNKLSGNIPSSIFNMHT-LKLLDFSDNQLFGSLSSFIFN-MSSMTTIDLSI 133
L L++N+ + + IF L+ ++FS+N++ + F S + I L+
Sbjct: 32 QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKI-TDIEEGAFEGASGVNEILLTS 90
Query: 134 NRLSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKEIGNLTKLKEIISTITNSTV 193
NRL + + + L+ L L N ++ + +
Sbjct: 91 NRLE-NVQHKM------FKGLESLKTLMLRSNRIT-CVGNDSFI---------------- 126
Query: 194 CEIPREIGNLPYLARLALATNNLVGVVPVTIFNMSALKEISLLNN 238
L + L+L N + V P + +L ++LL N
Sbjct: 127 --------GLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 2e-07
Identities = 20/114 (17%), Positives = 47/114 (41%), Gaps = 13/114 (11%)
Query: 74 NLSSLQTLDLSHNKLSGNIPSSIFN-MHTLKLLDFSDNQLFGSLSSFIF-NMSSMTTIDL 131
L L+ ++ S+NK++ +I F + + + N+L ++ +F + S+ T+ L
Sbjct: 55 KLPQLRKINFSNNKIT-DIEEGAFEGASGVNEILLTSNRL-ENVQHKMFKGLESLKTLML 112
Query: 132 SINRLSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKEI-GNLTKLKEI 184
NR++ + + + L+L N ++ + L L +
Sbjct: 113 RSNRIT-CVG------NDSFIGLSSVRLLSLYDNQIT-TVAPGAFDTLHSLSTL 158
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 3e-06
Identities = 25/110 (22%), Positives = 44/110 (40%), Gaps = 2/110 (1%)
Query: 377 NLSNLLVLELGGNNLTGPIPVTFSQLQTLQAFDLTRNKLAGPITDELCHLARLHSLVLQG 436
L L + N +T F + LT N+L L L +L+L+
Sbjct: 55 KLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRS 114
Query: 437 NKFSGSIPS-CLGNLTSVRVLYLGLNIFTSVLSSTIWNLKDILFIDVSSN 485
N+ + + + L+SVR+L L N T+V L + +++ +N
Sbjct: 115 NRIT-CVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 1e-05
Identities = 21/94 (22%), Positives = 40/94 (42%), Gaps = 12/94 (12%)
Query: 75 LSSLQTLDLSHNKLSGNIPSSIF-NMHTLKLLDFSDNQLFGSLSSFIF-NMSSMTTIDLS 132
S + + L+ N+L N+ +F + +LK L N++ + + F +SS+ + L
Sbjct: 80 ASGVNEILLTSNRLE-NVQHKMFKGLESLKTLMLRSNRI-TCVGNDSFIGLSSVRLLSLY 137
Query: 133 INRLSGELPANICKIPSTLSKCKQLEELNLGFNN 166
N+++ + P L LNL N
Sbjct: 138 DNQIT-TVA------PGAFDTLHSLSTLNL-LAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 9e-05
Identities = 18/63 (28%), Positives = 37/63 (58%), Gaps = 4/63 (6%)
Query: 74 NLSSLQTLDLSHNKLSGNIPSSIF-NMHTLKLLDFSDNQLFGSLSSFIF-NMSSMTTIDL 131
L SL+TL L N+++ + + F + +++LL DNQ+ +++ F + S++T++L
Sbjct: 103 GLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQI-TTVAPGAFDTLHSLSTLNL 160
Query: 132 SIN 134
N
Sbjct: 161 LAN 163
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 3e-08
Identities = 44/201 (21%), Positives = 62/201 (30%), Gaps = 73/201 (36%)
Query: 602 TGPSNDGINSPQAIRRFSYHELLRATDRFSENNLIGIGN------------GMEVAVKVF 649
P G + ++ ++ IG GN VAVK
Sbjct: 3 RAPVTTGPLDMPIMHDSDRYDFVK---------DIGSGNFGVARLMRDKLTKELVAVKYI 53
Query: 650 HQQYERALKSFED---ECEVRKRIRHRNLVK---IISSS------LEY------------ 685
ER E+ E + +RH N+V+ +I + +EY
Sbjct: 54 ----ERGAAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICN 109
Query: 686 -------------------LHFGHSIPIIHCDLKPSNVLLDEDMVAH--ISDFGIAKLLS 724
+ + HS+ I H DLK N LLD I DFG +K
Sbjct: 110 AGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 169
Query: 725 GEDQLSKQTQTLATIGYMAPE 745
Q T A Y+APE
Sbjct: 170 LHSQPKSTVGTPA---YIAPE 187
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 4e-08
Identities = 42/188 (22%), Positives = 72/188 (38%), Gaps = 64/188 (34%)
Query: 635 LIGIGN------------GMEVAVKVFHQQYERALKSFEDECEVR------KRIRHRNLV 676
+G G+ +VA+K +Q LK + V K +RH +++
Sbjct: 16 TLGEGSFGKVKLATHYKTQQKVALKFISRQ---LLKKSDMHMRVEREISYLKLLRHPHII 72
Query: 677 K---IISSS------LEY------------------------------LHFGHSIPIIHC 697
K +I++ +EY + + H I+H
Sbjct: 73 KLYDVITTPTDIVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHR 132
Query: 698 DLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPE-YGTKGRVSTRG 756
DLKP N+LLD+++ I+DFG++ +++ + L + Y APE K
Sbjct: 133 DLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPN---YAAPEVINGKLYAGPEV 189
Query: 757 DVCSFGII 764
DV S GI+
Sbjct: 190 DVWSCGIV 197
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 5e-08
Identities = 23/60 (38%), Positives = 32/60 (53%), Gaps = 5/60 (8%)
Query: 686 LHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPE 745
L + HS ++H DLKP N+ ++ED I DFG+A+ E T + T Y APE
Sbjct: 139 LKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE-----MTGYVVTRWYRAPE 193
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 54.9 bits (132), Expect = 6e-08
Identities = 27/183 (14%), Positives = 53/183 (28%), Gaps = 63/183 (34%)
Query: 638 IGNGMEVAVKVF--HQQYERALKSFEDECEVRKRIRHRNLVKIISSSL---------EYL 686
G V V+ + + E V K H N+V ++ + ++
Sbjct: 49 KPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 108
Query: 687 HFG---------------------------------HSIPIIHCDLKPSNVLLDEDMVAH 713
+G H + +H +K S++L+ D +
Sbjct: 109 AYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVY 168
Query: 714 ISDFGIAKLLS--GEDQLSKQTQTLATIG---YMAPE--------YGTKGRVSTRGDVCS 760
+S + G+ Q ++ +++PE Y K D+ S
Sbjct: 169 LSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAK------SDIYS 222
Query: 761 FGI 763
GI
Sbjct: 223 VGI 225
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 54.8 bits (132), Expect = 7e-08
Identities = 22/74 (29%), Positives = 33/74 (44%), Gaps = 4/74 (5%)
Query: 686 LHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPE 745
+F H IIH DLKP+N LL++D + DFG+A+ ++ E +
Sbjct: 142 ENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHN 201
Query: 746 YGTKGR----VSTR 755
K + V TR
Sbjct: 202 KNLKKQLTSHVVTR 215
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 9e-08
Identities = 25/117 (21%), Positives = 39/117 (33%), Gaps = 9/117 (7%)
Query: 324 SSLTNCKKLKVLIVTGNPLDGILPKSIGNFSLSLETILMANCSIS--GNIPQVVGNLSNL 381
+ TN + + L + G + I +++G + I ++ I P L L
Sbjct: 13 AQYTNAVRDRELDLRGYKIPVI--ENLGATLDQFDAIDFSDNEIRKLDGFP----LLRRL 66
Query: 382 LVLELGGNNLTGPIPVTFSQLQTLQAFDLTRNKLAGPIT-DELCHLARLHSLVLQGN 437
L + N + L L LT N L D L L L L + N
Sbjct: 67 KTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 4e-06
Identities = 22/120 (18%), Positives = 39/120 (32%), Gaps = 14/120 (11%)
Query: 226 NMSALKEISLLNNSLSGSLPSRIDLSLPNVETLNL---GINSFSGTIPSSITNSSKLSDL 282
N +E+ L + + + +L + ++ I G +L L
Sbjct: 17 NAVRDRELDLRGYKIP--VIENLGATLDQFDAIDFSDNEIRKLDG-----FPLLRRLKTL 69
Query: 283 ELGENLFSGFIPNTIGNLRNLEFGNIADNYLTSSTPELSFLSSLTNCKKLKVLIVTGNPL 342
+ N L +L + +N L EL L L + K L L + NP+
Sbjct: 70 LVNNNRICRIGEGLDQALPDLTELILTNNSLV----ELGDLDPLASLKSLTYLCILRNPV 125
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 3e-04
Identities = 27/136 (19%), Positives = 45/136 (33%), Gaps = 22/136 (16%)
Query: 135 RLSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKEIGNLTKLKEI------ISTI 188
+L+ EL I + + + EL+L + I L + I I +
Sbjct: 3 KLTAEL---IEQAAQ-YTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKL 57
Query: 189 TNSTVCEIPREIGNLPYLARLALATNNLVGVVPVTIFNMSALKEISLLNNSLSGSLPSRI 248
L L L + N + + + L E+ L NNSL L
Sbjct: 58 DG---------FPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV-ELGDLD 107
Query: 249 DLS-LPNVETLNLGIN 263
L+ L ++ L + N
Sbjct: 108 PLASLKSLTYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 40.4 bits (95), Expect = 7e-04
Identities = 17/87 (19%), Positives = 30/87 (34%), Gaps = 7/87 (8%)
Query: 377 NLSNLLVLELGGNNLT--GPIPVTFSQLQTLQAFDLTRNKLAGPITDELCHLARLHSLVL 434
N L+L G + + T Q + D + N++ + L RL +L++
Sbjct: 17 NAVRDRELDLRGYKIPVIENLGATLDQFDAI---DFSDNEIR-KLDG-FPLLRRLKTLLV 71
Query: 435 QGNKFSGSIPSCLGNLTSVRVLYLGLN 461
N+ L + L L N
Sbjct: 72 NNNRICRIGEGLDQALPDLTELILTNN 98
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 1e-07
Identities = 25/86 (29%), Positives = 38/86 (44%), Gaps = 10/86 (11%)
Query: 683 LEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYM 742
L +LH +IH D+K NVLL E+ + DFG++ L + ++ + T +M
Sbjct: 142 LSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLD--RTVGRRNTFIGTPYWM 196
Query: 743 APEYGTKGRVSTRG-----DVCSFGI 763
APE D+ S GI
Sbjct: 197 APEVIACDENPDATYDFKSDLWSLGI 222
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 54.0 bits (130), Expect = 1e-07
Identities = 46/189 (24%), Positives = 75/189 (39%), Gaps = 65/189 (34%)
Query: 635 LIGIGN------------GMEVAVKVFHQQ---YERALKSFEDECEVRKRIRHRNLVK-- 677
+G+G G +VAVK+ ++Q + E + K RH +++K
Sbjct: 23 TLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLY 82
Query: 678 -IISSS------LEY-------------------------------LHFGHSIPIIHCDL 699
+IS+ +EY + + H ++H DL
Sbjct: 83 QVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDL 142
Query: 700 KPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIG---YMAPE-YGTKGRVSTR 755
KP NVLLD M A I+DFG++ ++S + L +T + G Y APE +
Sbjct: 143 KPENVLLDAHMNAKIADFGLSNMMSDGEFL--RT----SCGSPNYAAPEVISGRLYAGPE 196
Query: 756 GDVCSFGII 764
D+ S G+I
Sbjct: 197 VDIWSSGVI 205
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 1e-07
Identities = 25/116 (21%), Positives = 46/116 (39%), Gaps = 14/116 (12%)
Query: 68 ITPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLDFSDNQLFGSLSSFIFNMSSMT 127
+ L L + + L LS N + I SS+ M L++L N + + + ++
Sbjct: 40 MDATLSTLKACKHLALSTNNIE-KI-SSLSGMENLRILSLGRNLI-KKIENLDAVADTLE 96
Query: 128 TIDLSINRLSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKEIGNLTKLKE 183
+ +S N+ I + S + K L L + N ++ EI L L +
Sbjct: 97 ELWISYNQ--------IASL-SGIEKLVNLRVLYMSNNKITN--WGEIDKLAALDK 141
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 2e-05
Identities = 28/119 (23%), Positives = 51/119 (42%), Gaps = 9/119 (7%)
Query: 72 LGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLDFSDNQLFGSLSSFIFNMSSMTTIDL 131
L + +L+ L L N + I + TL+ L S NQ+ SLS + ++ + +
Sbjct: 66 LSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQI-ASLSGIE-KLVNLRVLYM 122
Query: 132 SINRLSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKEIGNLTKLKEIISTITN 190
S N+++ N +I L+ +LE+L L N L + E++ + N
Sbjct: 123 SNNKIT-----NWGEI-DKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPN 175
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 8e-05
Identities = 28/119 (23%), Positives = 51/119 (42%), Gaps = 14/119 (11%)
Query: 226 NMSALKEISLLNNSLSGSLPSRID--LSLPNVETLNLGINSFSGTIPSSITNSSKLSDLE 283
+ A K ++L N++ +I + N+ L+LG N I + + L +L
Sbjct: 46 TLKACKHLALSTNNIE-----KISSLSGMENLRILSLGRNLIK-KIENLDAVADTLEELW 99
Query: 284 LGENLFSGFIPNTIGNLRNLEFGNIADNYLTSSTPELSFLSSLTNCKKLKVLIVTGNPL 342
+ N + + I L NL +++N +T + L KL+ L++ GNPL
Sbjct: 100 ISYNQIA-SLSG-IEKLVNLRVLYMSNNKIT----NWGEIDKLAALDKLEDLLLAGNPL 152
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 17/97 (17%), Positives = 32/97 (32%), Gaps = 14/97 (14%)
Query: 679 ISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAH-----------ISDFGIAKLLSGED 727
+ +E +H IIH D+KP N +L + + D G + +
Sbjct: 181 MLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFP 237
Query: 728 QLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGII 764
+ + T T G+ E + + + D
Sbjct: 238 KGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAAT 274
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 52.9 bits (127), Expect = 2e-07
Identities = 20/79 (25%), Positives = 34/79 (43%), Gaps = 9/79 (11%)
Query: 686 LHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPE 745
+ + HS I+H DLKP+N L+++D + DFG+A+ + + + Q M
Sbjct: 169 VKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLV 228
Query: 746 YGTKGR---------VSTR 755
+ V TR
Sbjct: 229 TFPHTKNLKRQLTGHVVTR 247
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 3e-07
Identities = 24/140 (17%), Positives = 47/140 (33%), Gaps = 48/140 (34%)
Query: 651 QQYERALKSFEDECEVRKRIRHRNLVKIISSSLEYLHFGHSIPIIHCDLKPSNVLLDED- 709
+ R + F E E++ + + L Y+H S+ ++H D+KPSN+ +
Sbjct: 103 SENYRIMSYF-KEAELKDLLLQ------VGRGLRYIH---SMSLVHMDIKPSNIFISRTS 152
Query: 710 ------------------MVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPE------ 745
++ I D G +S S Q + ++A E
Sbjct: 153 IPNAASEEGDEDDWASNKVMFKIGDLGHVTRIS-----SPQVEE-GDSRFLANEVLQENY 206
Query: 746 -YGTKGRVSTRGDVCSFGII 764
+ K D+ + +
Sbjct: 207 THLPK------ADIFALALT 220
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 3e-07
Identities = 16/73 (21%), Positives = 34/73 (46%), Gaps = 3/73 (4%)
Query: 686 LHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPE 745
+ + HS ++H D+KPSN+LL+ + ++DFG+++ +++ +
Sbjct: 122 IKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFD 181
Query: 746 YGTK---GRVSTR 755
V+TR
Sbjct: 182 DDQPILTDYVATR 194
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 52.0 bits (124), Expect = 4e-07
Identities = 21/82 (25%), Positives = 31/82 (37%), Gaps = 4/82 (4%)
Query: 57 LNISSFNLQGTITPQ-LGNLSSLQTLDLSHNKLSGNIPSSIF-NMHTLKLLDFSDNQLFG 114
L I + + + L L L+ L + + L + F L L+ S N L
Sbjct: 36 LYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFTPRLSRLNLSFNAL-E 93
Query: 115 SLSSFIFNMSSMTTIDLSINRL 136
SLS S+ + LS N L
Sbjct: 94 SLSWKTVQGLSLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 47.8 bits (113), Expect = 9e-06
Identities = 21/96 (21%), Positives = 37/96 (38%), Gaps = 5/96 (5%)
Query: 147 IPSTLSKCKQLEELNLGFNNLSGAIPKE-IGNLTKLKEIISTITNSTVCEIPREI-GNLP 204
L + L EL + + + L +L+ + TI S + + + P
Sbjct: 23 SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNL--TIVKSGLRFVAPDAFHFTP 80
Query: 205 YLARLALATNNLVGVVPVTIFNMSALKEISLLNNSL 240
L+RL L+ N L + +L+E+ L N L
Sbjct: 81 RLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 46.7 bits (110), Expect = 2e-05
Identities = 17/100 (17%), Positives = 35/100 (35%), Gaps = 11/100 (11%)
Query: 70 PQLGNLSSLQTLDLSHNKLSGNIPSSIF-NMHTLKLLDFSDNQLFGSLSSFIF-NMSSMT 127
L +L L + + + ++ + L+ L + L ++ F ++
Sbjct: 25 HHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGL-RFVAPDAFHFTPRLS 83
Query: 128 TIDLSINRLSGELPANICKIPSTLSKCKQLEELNLGFNNL 167
++LS N L + + L+EL L N L
Sbjct: 84 RLNLSFNALE--------SLSWKTVQGLSLQELVLSGNPL 115
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 4e-07
Identities = 19/52 (36%), Positives = 30/52 (57%), Gaps = 6/52 (11%)
Query: 673 RNLVKIISSSLEYLHFGHSIPIIHCDLKPSNVLL---DEDMVAHISDFGIAK 721
++K I +++YLH SI I H D+KP N+L + + ++DFG AK
Sbjct: 120 SEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 51.7 bits (124), Expect = 5e-07
Identities = 20/65 (30%), Positives = 34/65 (52%), Gaps = 7/65 (10%)
Query: 682 SLEYLHFGHSIPIIHCDLKPSNVLLD-EDMVAHISDFGIAKLLSGEDQLSKQTQTLATIG 740
++ ++H S+ I H D+KP N+L++ +D + DFG AK L + + +
Sbjct: 153 AVGFIH---SLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPS---VAYICSRF 206
Query: 741 YMAPE 745
Y APE
Sbjct: 207 YRAPE 211
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 5e-07
Identities = 18/163 (11%), Positives = 30/163 (18%), Gaps = 70/163 (42%)
Query: 643 EVAVKVFHQQY---ERALKSFEDECEVRKRIRHRNLV----------------------- 676
+VA+ Q + L+ RI +
Sbjct: 58 QVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGS 117
Query: 677 ---------------KIISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAK 721
+ + S H + PS V + D G
Sbjct: 118 LQEVADTSPSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSID--------GDVV 169
Query: 722 LLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGII 764
LA M + + D+ G
Sbjct: 170 --------------LAYPATMPD-------ANPQDDIRGIGAS 191
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 8e-07
Identities = 23/65 (35%), Positives = 33/65 (50%), Gaps = 5/65 (7%)
Query: 682 SLEYLHFGHSIPIIHCDLKPSNVLLD-EDMVAHISDFGIAKLLSGEDQLSKQTQTLATIG 740
S+ LH S+ + H D+KP NVL++ D + DFG AK LS + + +
Sbjct: 141 SIGCLH-LPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPN---VAYICSRY 196
Query: 741 YMAPE 745
Y APE
Sbjct: 197 YRAPE 201
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 8e-07
Identities = 26/113 (23%), Positives = 47/113 (41%), Gaps = 7/113 (6%)
Query: 328 NCKKLKVLIVTGNPLDGILPKSIGNFSLSLETILMANCSIS--GNIPQVVGNLSNLLVLE 385
+K L++ + + + + + LE + N ++ N+P L+ L LE
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSIANLP----KLNKLKKLE 70
Query: 386 LGGNNLTGPIPVTFSQLQTLQAFDLTRNKLAGPIT-DELCHLARLHSLVLQGN 437
L N ++G + V + L +L+ NK+ T + L L L SL L
Sbjct: 71 LSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 2e-04
Identities = 26/120 (21%), Positives = 48/120 (40%), Gaps = 10/120 (8%)
Query: 275 NSSKLSDLELGENLFS-GFIPNTIGNLRNLEFGNIADNYLTSSTPELSFLSSLTNCKKLK 333
S + +L L + + G + LEF + + LTS +++L KLK
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTS-------IANLPKLNKLK 67
Query: 334 VLIVTGNPLDGILPKSIGNFSLSLETILMANCSISG-NIPQVVGNLSNLLVLELGGNNLT 392
L ++ N + G L +L + ++ I + + + L NL L+L +T
Sbjct: 68 KLELSDNRVSGGLEVLAEKCP-NLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVT 126
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 49.5 bits (119), Expect = 2e-06
Identities = 28/84 (33%), Positives = 44/84 (52%), Gaps = 5/84 (5%)
Query: 683 LEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYM 742
L + H I+H DLKP N+L++ D ++DFG+A+ + T + T+ Y
Sbjct: 129 LRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFG--IPVRSYTHEVVTLWYR 186
Query: 743 APE--YGTKGRVSTRGDVCSFGII 764
AP+ G+K + ST D+ S G I
Sbjct: 187 APDVLMGSK-KYSTSVDIWSIGCI 209
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 49.4 bits (119), Expect = 2e-06
Identities = 26/84 (30%), Positives = 45/84 (53%), Gaps = 5/84 (5%)
Query: 683 LEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYM 742
L+ L F HS ++H DLKP N+L++ + +++FG+A+ + + + T+ Y
Sbjct: 111 LKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFG--IPVRCYSAEVVTLWYR 168
Query: 743 APE--YGTKGRVSTRGDVCSFGII 764
P+ +G K ST D+ S G I
Sbjct: 169 PPDVLFGAK-LYSTSIDMWSAGCI 191
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 49.5 bits (118), Expect = 4e-06
Identities = 48/348 (13%), Positives = 116/348 (33%), Gaps = 39/348 (11%)
Query: 74 NLSSLQTLDLS--HNKLSGNIPSSIF-NMHTLKLLDFSDNQLFGSLSSFIFNMSSMTTID 130
+SL +L++S +++S + + LK L + L++ + + +
Sbjct: 182 TYTSLVSLNISCLASEVSFSALERLVTRCPNLKSLKLNRAVPLEKLATLLQRAPQLEELG 241
Query: 131 LSINRLSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKEIGNLTKLKEII---ST 187
P + LS CK+L L+ ++ + +P ++L + +T
Sbjct: 242 TGGYTAEVR-PDVYSGLSVALSGCKELRCLSGFWDAVPAYLPAVYSVCSRLTTLNLSYAT 300
Query: 188 ITNSTVCEIPREIGNLPYLARLALATNNLVGVVPVTIFNMSALKEISLLNNSLSGSLPSR 247
+ + + ++ + P L RL + + V L+E+ + + P+
Sbjct: 301 VQSYDLVKL---LCQCPKLQRLWVLDYIEDAGLEVLASTCKDLRELRVFPSEPFVMEPNV 357
Query: 248 ---------IDLSLPNVETLNLGINSFSG-TIPSSITNSSKLSDLELGENLFSGFIPNTI 297
+ + P +E++ + + + N ++ L I
Sbjct: 358 ALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLC------IIEPKA 411
Query: 298 GNLRNLEFGNIADNYLTSSTPELSFLS------------SLTNCKKLKVLIVTGNPLDGI 345
+ LE +I + +L LS T KK+++L V +
Sbjct: 412 PDYLTLEPLDIGFGAIVEHCKDLRRLSLSGLLTDKVFEYIGTYAKKMEMLSVAFAGDSDL 471
Query: 346 LPKSIGNFSLSLETILMANCSISGN-IPQVVGNLSNLLVLELGGNNLT 392
+ + SL + + +C + L + L + +++
Sbjct: 472 GMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSCSVS 519
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 4e-06
Identities = 25/73 (34%), Positives = 35/73 (47%), Gaps = 9/73 (12%)
Query: 683 LEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYM 742
+ + F HS IIH D+KP N+L+ + V + DFG A+ L+ +AT Y
Sbjct: 134 INGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLA--APGEVYDDEVATRWYR 191
Query: 743 APE-------YGT 748
APE YG
Sbjct: 192 APELLVGDVKYGK 204
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 48.2 bits (115), Expect = 4e-06
Identities = 48/164 (29%), Positives = 80/164 (48%), Gaps = 16/164 (9%)
Query: 79 QTLDLSHNKLSGNIPSSIFNMHTLKLLDFSDNQLFGSLSSFIFN-MSSMTTIDLSINRLS 137
+ LDL L+ ++ + L L+ NQL +LS+ +F+ ++ + T+ L+ N+L+
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQL-QTLSAGVFDDLTELGTLGLANNQLA 96
Query: 138 GELPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKEI-GNLTKLKEIISTITNSTVCEI 196
LP + QL++L LG N L ++P + LTKLKE+ + + + I
Sbjct: 97 -SLPLGV------FDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKEL--RLNTNQLQSI 146
Query: 197 PREI-GNLPYLARLALATNNLVGVVPVTIF-NMSALKEISLLNN 238
P L L L+L+TN L VP F + L+ I+L N
Sbjct: 147 PAGAFDKLTNLQTLSLSTNQLQS-VPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 1e-05
Identities = 34/112 (30%), Positives = 54/112 (48%), Gaps = 11/112 (9%)
Query: 75 LSSLQTLDLSHNKLSGNIPSSIFNMHT-LKLLDFSDNQLFGSLSSFIF-NMSSMTTIDLS 132
L+ L TL L++N+L+ ++P +F+ T L L NQL SL S +F ++ + + L+
Sbjct: 82 LTELGTLGLANNQLA-SLPLGVFDHLTQLDKLYLGGNQL-KSLPSGVFDRLTKLKELRLN 139
Query: 133 INRLSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKEIGNLTKLKEI 184
N+L +PA K L+ L+L N L L KL+ I
Sbjct: 140 TNQLQ-SIPAGA------FDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTI 184
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 4e-04
Identities = 34/118 (28%), Positives = 45/118 (38%), Gaps = 14/118 (11%)
Query: 378 LSNLLVLELGGNNLTGPIPVTFSQLQTLQAFDLTRNKL----AGPITDELCHLARLHSLV 433
L+ L L L N L F L L L N+L +G + D L L L
Sbjct: 82 LTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSG-VFDRLTKLKELR--- 137
Query: 434 LQGNKFSGSIPSCLG---NLTSVRVLYLGLNIFTSVLSSTIWNLKDILFIDVSSNFLD 488
L N+ SIP+ G LT+++ L L N SV L + I + N D
Sbjct: 138 LNTNQLQ-SIPA--GAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFD 192
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 7e-04
Identities = 38/154 (24%), Positives = 65/154 (42%), Gaps = 9/154 (5%)
Query: 208 RLALATNNLVGVVPVTIFNMSALKEISLLNNSLSGSLPSRIDLSLPNVETLNLGINSFSG 267
+L L + L + T ++ L ++L N L +L + + L + TL L N +
Sbjct: 39 KLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTELGTLGLANNQLA- 96
Query: 268 TIPSSITNS-SKLSDLELGENLFSGFIPNTIGNLRNLEFGNIADNYLTSSTPELSFLSSL 326
++P + + ++L L LG N L L+ + N L S P +F L
Sbjct: 97 SLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQ-SIPAGAF-DKL 154
Query: 327 TNCKKLKVLIVTGNPLDGILPKSIGNFSLSLETI 360
TN L+ L ++ N L + P + L+TI
Sbjct: 155 TN---LQTLSLSTNQLQSV-PHGAFDRLGKLQTI 184
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 48.3 bits (116), Expect = 4e-06
Identities = 25/73 (34%), Positives = 37/73 (50%), Gaps = 9/73 (12%)
Query: 683 LEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYM 742
L+ ++F H IH D+KP N+L+ + V + DFG A+LL+G +AT Y
Sbjct: 112 LQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD--YYDDEVATRWYR 169
Query: 743 APE-------YGT 748
+PE YG
Sbjct: 170 SPELLVGDTQYGP 182
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 48.3 bits (116), Expect = 4e-06
Identities = 28/84 (33%), Positives = 46/84 (54%), Gaps = 5/84 (5%)
Query: 683 LEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYM 742
L + + H ++H DLKP N+L++ + I+DFG+A+ + K T + T+ Y
Sbjct: 110 LNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFG--IPVRKYTHEIVTLWYR 167
Query: 743 APE--YGTKGRVSTRGDVCSFGII 764
AP+ G+K + ST D+ S G I
Sbjct: 168 APDVLMGSK-KYSTTIDIWSVGCI 190
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 4e-06
Identities = 31/206 (15%), Positives = 64/206 (31%), Gaps = 21/206 (10%)
Query: 74 NLSSLQTLDLSHNKLSGN----IPSSIFNMHTLKLLDFSDNQL----FGSLSSFIFNMSS 125
+ + TL LS+N L+ + + ++ L L L++ +
Sbjct: 153 DQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQ 212
Query: 126 MTTIDLSINRLSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKEIGNLTKLKEII 185
+ ++++ N + + LE L+L FN LS + + +L E
Sbjct: 213 LQELNVAYNGAG---DTAALALARAAREHPSLELLHLYFNELSSEGRQVLRDLGGAAEGG 269
Query: 186 STIT--NSTVCEIPREIGNLPYLARLALATNNLVGVVPVTIFNMSALKEISLLNNSLSGS 243
+ + + + + L+ NL + L L ++ +
Sbjct: 270 ARVVVSLTEGTAVSEY-----WSVILSEVQRNLNSWDRARVQRHLELLLRDLEDSRGATL 324
Query: 244 LPSRIDLSL---PNVETLNLGINSFS 266
P R L V L + S
Sbjct: 325 NPWRKAQLLRVEGEVRALLEQLGSSG 350
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 4e-04
Identities = 18/101 (17%), Positives = 37/101 (36%), Gaps = 9/101 (8%)
Query: 74 NLSSLQTLDLSHNKLSGNIPSSIFNM-HTLKLLDFSDNQL----FGSLSSFI-FNMSSMT 127
+L ++L+ +L ++ + + L N L L + + +T
Sbjct: 99 GRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLLHDQCQIT 158
Query: 128 TIDLSINRLSGELPANICKIPSTLSKCKQLEELNLGFNNLS 168
T+ LS N L+ A + + L+ + L+L L
Sbjct: 159 TLRLSNNPLT---AAGVAVLMEGLAGNTSVTHLSLLHTGLG 196
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 4e-04
Identities = 21/105 (20%), Positives = 37/105 (35%), Gaps = 12/105 (11%)
Query: 75 LSSLQTLDLSHNKLSGNIPSSI-----FNMHTLKLLDFSDNQL----FGSLSSFIFNMSS 125
+ L L N L + + + L S+N L L + +S
Sbjct: 125 FLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTS 184
Query: 126 MTTIDLSINRLSGELPANICKIPSTLSKCKQLEELNLGFNNLSGA 170
+T + L L E + + L + +QL+ELN+ +N
Sbjct: 185 VTHLSLLHTGLGDEGLELLA---AQLDRNRQLQELNVAYNGAGDT 226
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 5e-06
Identities = 34/116 (29%), Positives = 53/116 (45%), Gaps = 14/116 (12%)
Query: 657 LKSFEDECEVRKRIRH--RNLVKIIS----SSLEYLHFGHSIPIIHCDLKPSNVLLDEDM 710
LK + D V R NLVK L + H I+H DLKP N+L+++
Sbjct: 89 LKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRG 145
Query: 711 VAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPE--YGTKGRVSTRGDVCSFGII 764
+ DFG+A+ ++ + + T+ Y AP+ G++ ST D+ S G I
Sbjct: 146 QLKLGDFGLARAFG--IPVNTFSSEVVTLWYRAPDVLMGSR-TYSTSIDIWSCGCI 198
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 6e-06
Identities = 26/65 (40%), Positives = 33/65 (50%), Gaps = 7/65 (10%)
Query: 682 SLEYLHFGHSIPIIHCDLKPSNVLLDEDM-VAHISDFGIAKLLSGEDQLSKQTQTLATIG 740
SL Y+H S I H D+KP N+LLD D V + DFG AK L + + +
Sbjct: 168 SLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN---VSYICSRY 221
Query: 741 YMAPE 745
Y APE
Sbjct: 222 YRAPE 226
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 48.0 bits (115), Expect = 7e-06
Identities = 25/84 (29%), Positives = 41/84 (48%), Gaps = 5/84 (5%)
Query: 683 LEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYM 742
L L + H ++H DLKP N+L++E ++DFG+A+ S + T+ Y
Sbjct: 110 LRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKS--IPTKTYDNEVVTLWYR 167
Query: 743 APE--YGTKGRVSTRGDVCSFGII 764
P+ G+ ST+ D+ G I
Sbjct: 168 PPDILLGST-DYSTQIDMWGVGCI 190
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 48.0 bits (115), Expect = 7e-06
Identities = 26/72 (36%), Positives = 38/72 (52%), Gaps = 9/72 (12%)
Query: 683 LEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYM 742
L L F HS ++H DLKP N+L+ ++DFG+A++ S + L T + T+ Y
Sbjct: 130 LRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL---TSVVVTLWYR 186
Query: 743 APE------YGT 748
APE Y T
Sbjct: 187 APEVLLQSSYAT 198
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 47.6 bits (114), Expect = 9e-06
Identities = 25/75 (33%), Positives = 39/75 (52%), Gaps = 9/75 (12%)
Query: 683 LEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLS--GEDQLSKQTQTLATIG 740
L L++ H I+H D+K +NVL+ D V ++DFG+A+ S Q ++ T + T+
Sbjct: 134 LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLW 193
Query: 741 YMAPE-------YGT 748
Y PE YG
Sbjct: 194 YRPPELLLGERDYGP 208
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 47.2 bits (113), Expect = 1e-05
Identities = 26/72 (36%), Positives = 38/72 (52%), Gaps = 9/72 (12%)
Query: 683 LEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYM 742
L L F H+ I+H DLKP N+L+ ++DFG+A++ S + L T + T+ Y
Sbjct: 130 LRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMAL---TPVVVTLWYR 186
Query: 743 APE------YGT 748
APE Y T
Sbjct: 187 APEVLLQSTYAT 198
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 1e-05
Identities = 47/169 (27%), Positives = 81/169 (47%), Gaps = 40/169 (23%)
Query: 74 NLSSLQTLDLSHNKLSGNIPSSIFNMHT-LKLLDFSDNQLFGSLSSFIFN-MSSMTTIDL 131
L++L L L+ N+L ++P+ +F+ T LK L +NQL SL +F+ ++++T ++L
Sbjct: 83 ELTNLTYLILTGNQLQ-SLPNGVFDKLTNLKELVLVENQL-QSLPDGVFDKLTNLTYLNL 140
Query: 132 SINRLSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKEI-GNLTKLKEIISTITN 190
+ N+L LP + K L EL+L +N L ++P+ + LT+LK
Sbjct: 141 AHNQLQ-SLPKGV------FDKLTNLTELDLSYNQLQ-SLPEGVFDKLTQLK-------- 184
Query: 191 STVCEIPREIGNLPYLARLALATNNLVGVVPVTIF-NMSALKEISLLNN 238
L L N L VP +F +++L+ I L +N
Sbjct: 185 -----------------DLRLYQNQLKS-VPDGVFDRLTSLQYIWLHDN 215
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 2e-04
Identities = 56/269 (20%), Positives = 97/269 (36%), Gaps = 55/269 (20%)
Query: 79 QTLDLSHNKLSGNIPSSIFNMHTLKLLDFSDNQLFGSLSSFIFNMSSMTTIDLSINRLSG 138
+T+ +S P F + + + ++S+ I + + +
Sbjct: 1 ETITVSTPIKQ-IFPDDAFA--ETIKANLKKKSV-TDAVTQN-ELNSIDQIIANNSDIK- 54
Query: 139 ELPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKEIGNLTKLKEIISTITNSTVCEIPR 198
+ I + L LG N L +I L +L
Sbjct: 55 SVQG----IQYL----PNVRYLALGGNKL-----HDISALKELTN--------------- 86
Query: 199 EIGNLPYLARLALATNNLVGVVPVTIFN-MSALKEISLLNNSLSGSLPSRIDLSLPNVET 257
L L L N L + P +F+ ++ LKE+ L+ N L SLP + L N+
Sbjct: 87 -------LTYLILTGNQLQSL-PNGVFDKLTNLKELVLVENQLQ-SLPDGVFDKLTNLTY 137
Query: 258 LNLGINSFSGTIPSSITNS-SKLSDLELGEN-LFSGFIPNTI-GNLRNLEFGNIADNYLT 314
LNL N ++P + + + L++L+L N L S +P + L L+ + N L
Sbjct: 138 LNLAHNQLQ-SLPKGVFDKLTNLTELDLSYNQLQS--LPEGVFDKLTQLKDLRLYQNQLK 194
Query: 315 SSTPELSFLSSLTNCKKLKVLIVTGNPLD 343
S P+ F L+ + + NP D
Sbjct: 195 -SVPDGVF----DRLTSLQYIWLHDNPWD 218
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 1e-05
Identities = 23/88 (26%), Positives = 38/88 (43%), Gaps = 9/88 (10%)
Query: 679 ISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDM-VAHISDFGIAKLLSGEDQLSKQTQTLA 737
+ +++++ H S ++H D+K N+L+D A + DFG LL T
Sbjct: 148 VVAAIQHCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHD----EPYTDFDG 200
Query: 738 TIGYMAPEY-GTKGRVSTRGDVCSFGII 764
T Y PE+ + V S GI+
Sbjct: 201 TRVYSPPEWISRHQYHALPATVWSLGIL 228
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 1e-05
Identities = 33/118 (27%), Positives = 45/118 (38%), Gaps = 9/118 (7%)
Query: 372 PQVVGNLSNLLVLELGGNNLTGPIPVTFSQLQTLQAFDLTRNKL----AGPITDELCHLA 427
P V +L NL L LG N L F L L DL N+L + + D L HL
Sbjct: 57 PGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLTVLPSA-VFDRLVHLK 115
Query: 428 RLHSLVLQGNKFSGSIPSCLGNLTSVRVLYLGLNIFTSVLSSTIWNLKDILFIDVSSN 485
L + NK + +P + LT + L L N S+ L + + N
Sbjct: 116 ELF---MCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 3e-05
Identities = 42/163 (25%), Positives = 68/163 (41%), Gaps = 39/163 (23%)
Query: 79 QTLDLSHNKLSGNIPSSIFNMHT-LKLLDFSDNQLFGSLSSFIFN-MSSMTTIDLSINRL 136
Q L L N+++ + +F+ LK L NQL G+L +F+ ++ +T +DL N+L
Sbjct: 43 QILYLHDNQIT-KLEPGVFDSLINLKELYLGSNQL-GALPVGVFDSLTQLTVLDLGTNQL 100
Query: 137 SGELPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKEIGNLTKLKEIISTITNSTVCEI 196
+ LP+ + + L+EL + N L+ +P+ I LT L
Sbjct: 101 T-VLPSAV------FDRLVHLKELFMCCNKLT-ELPRGIERLTHLT-------------- 138
Query: 197 PREIGNLPYLARLALATNNLVGVVPVTIF-NMSALKEISLLNN 238
LAL N L +P F +S+L L N
Sbjct: 139 -----------HLALDQNQLKS-IPHGAFDRLSSLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 7e-05
Identities = 28/113 (24%), Positives = 49/113 (43%), Gaps = 12/113 (10%)
Query: 74 NLSSLQTLDLSHNKLSGNIPSSIFNMHT-LKLLDFSDNQLFGSLSSFIFN-MSSMTTIDL 131
+L +L+ L L N+L +P +F+ T L +LD NQL L S +F+ + + + +
Sbjct: 62 SLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTNQL-TVLPSAVFDRLVHLKELFM 119
Query: 132 SINRLSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKEIGNLTKLKEI 184
N+L+ ++P + + L L L N L L+ L
Sbjct: 120 CCNKLT--------ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHA 164
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 46.8 bits (112), Expect = 1e-05
Identities = 30/84 (35%), Positives = 44/84 (52%), Gaps = 5/84 (5%)
Query: 683 LEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYM 742
L+ L + H I+H DLKP+N+LLDE+ V ++DFG+AK T + T Y
Sbjct: 122 LQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFG--SPNRAYTHQVVTRWYR 179
Query: 743 APE--YGTKGRVSTRGDVCSFGII 764
APE +G + D+ + G I
Sbjct: 180 APELLFGAR-MYGVGVDMWAVGCI 202
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 2e-05
Identities = 31/120 (25%), Positives = 46/120 (38%), Gaps = 33/120 (27%)
Query: 665 EVRKRIRHR----NLVKIIS----SSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAH--- 713
+ K+ HR VK IS L+Y+H I IH D+KP NVL++
Sbjct: 118 ALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGI--IHTDIKPENVLMEIVDSPENLI 175
Query: 714 ---ISDFGIAKLLSGEDQLSKQTQTLATIGYMAPE------YGTKGRVSTRGDVCSFGII 764
I+D G A ++ + QT Y +PE +G D+ S +
Sbjct: 176 QIKIADLGNA--CWYDEHYTNSIQTRE---YRSPEVLLGAPWGCG------ADIWSTACL 224
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 47.1 bits (112), Expect = 2e-05
Identities = 22/78 (28%), Positives = 38/78 (48%), Gaps = 12/78 (15%)
Query: 683 LEYLHFGHSIPIIHCDLKPSNVLLDEDMVAH----ISDFGIAKLLSGEDQ-LSKQTQTLA 737
L+ +H+ H+ ++H DLKP+N+L+ + I+D G A+L + + L+ +
Sbjct: 138 LDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV 197
Query: 738 TIGYMAPE-------YGT 748
T Y APE Y
Sbjct: 198 TFWYRAPELLLGARHYTK 215
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 2e-05
Identities = 19/64 (29%), Positives = 34/64 (53%), Gaps = 4/64 (6%)
Query: 683 LEYLHFGHSIPIIHCDLKPSNVLLD-EDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGY 741
L+ L + HS+ I+H D+KP NV++D E + D+G+A+ + +A+ +
Sbjct: 140 LKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY---NVRVASRYF 196
Query: 742 MAPE 745
PE
Sbjct: 197 KGPE 200
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 3e-05
Identities = 26/113 (23%), Positives = 46/113 (40%), Gaps = 7/113 (6%)
Query: 328 NCKKLKVLIVTGNPLDGILPKSIGNFSLSLETILMANCSIS--GNIPQVVGNLSNLLVLE 385
++ L++ + + + ++LE + + N + N+P L L LE
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISVSNLP----KLPKLKKLE 77
Query: 386 LGGNNLTGPIPVTFSQLQTLQAFDLTRNKLAGPIT-DELCHLARLHSLVLQGN 437
L N + G + + +L L +L+ NKL T + L L L SL L
Sbjct: 78 LSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 40.5 bits (95), Expect = 5e-04
Identities = 27/143 (18%), Positives = 50/143 (34%), Gaps = 35/143 (24%)
Query: 122 NMSSMTTIDLSINRLSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKEIGNLTKL 181
+++ + L + N KI ++ LE L+L L + NL KL
Sbjct: 22 TPAAVRELVLDNCKS------NDGKIEGLTAEFVNLEFLSLINVGL-----ISVSNLPKL 70
Query: 182 KEIISTITNSTVCEIPREIGNLPYLARLALATNNLVGVVPVTIFNMSALKEISLLNNSLS 241
P L +L L+ N + G + + + L ++L N L
Sbjct: 71 ----------------------PKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLK 108
Query: 242 GSLPSRIDLS-LPNVETLNLGIN 263
+ + L L +++L+L
Sbjct: 109 -DISTLEPLKKLECLKSLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 40.1 bits (94), Expect = 7e-04
Identities = 30/151 (19%), Positives = 51/151 (33%), Gaps = 25/151 (16%)
Query: 275 NSSKLSDLEL-GENLFSGFIPNTIGNLRNLEFGNIADNYLTSSTPELSFLSSLTNCKKLK 333
+ + +L L G I NLEF ++ + L S +S+L KLK
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLIS-------VSNLPKLPKLK 74
Query: 334 VLIVTGNPLDGILPKSIGNFSLSLETILMANCSISG-NIPQVVGNLSNLLVLELGGNNLT 392
L ++ N + G L +L + ++ + + + + L L L+L
Sbjct: 75 KLELSENRIFGGLDMLAEKLP-NLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNC--- 130
Query: 393 GPIPVT---------FSQLQTLQAFDLTRNK 414
VT F L L D +
Sbjct: 131 ---EVTNLNDYRESVFKLLPQLTYLDGYDRE 158
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 3e-05
Identities = 21/93 (22%), Positives = 37/93 (39%), Gaps = 19/93 (20%)
Query: 679 ISSSLEYLHFGHSIPIIHCDLKPSNVLLDED-MVAHISDFGIAKLLSGEDQLSKQTQTLA 737
+ ++ + H + ++H D+K N+L+D + + DFG LL + T
Sbjct: 158 VLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD----TVYTDFDG 210
Query: 738 TIGYMAPEYGTKGRVSTRG------DVCSFGII 764
T Y PE+ + V S GI+
Sbjct: 211 TRVYSPPEW-----IRYHRYHGRSAAVWSLGIL 238
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 6e-05
Identities = 20/40 (50%), Positives = 25/40 (62%), Gaps = 1/40 (2%)
Query: 686 LHFGHSIPIIHCDLKPSNVLLDEDM-VAHISDFGIAKLLS 724
L + HSI I H D+KP N+LLD V + DFG AK+L
Sbjct: 154 LAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILI 193
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 44.9 bits (107), Expect = 7e-05
Identities = 27/89 (30%), Positives = 42/89 (47%), Gaps = 10/89 (11%)
Query: 683 LEYLHFGHSIPIIHCDLKPSNVLLDEDMVAH-----ISDFGIAKLLSGEDQLSKQTQTLA 737
+ ++F HS +H DLKP N+LL + I DFG+A+ + + T +
Sbjct: 142 INGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFG--IPIRQFTHEII 199
Query: 738 TIGYMAPE--YGTKGRVSTRGDVCSFGII 764
T+ Y PE G++ ST D+ S I
Sbjct: 200 TLWYRPPEILLGSR-HYSTSVDIWSIACI 227
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 1e-04
Identities = 18/63 (28%), Positives = 35/63 (55%), Gaps = 4/63 (6%)
Query: 74 NLSSLQTLDLSHNKLSGNIPSSIFN-MHTLKLLDFSDNQLFGSLSSFIF-NMSSMTTIDL 131
N++ L TL LS+N+L IP F+ + +L+LL N + + F ++S+++ + +
Sbjct: 76 NMTQLLTLILSYNRLR-CIPPRTFDGLKSLRLLSLHGNDI-SVVPEGAFNDLSALSHLAI 133
Query: 132 SIN 134
N
Sbjct: 134 GAN 136
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 1e-04
Identities = 14/44 (31%), Positives = 26/44 (59%), Gaps = 7/44 (15%)
Query: 681 SSLEYLHFGHSIPIIHCDLKPSNVLL---DEDMVAHISDFGIAK 721
LEY+H +H D+K +N+LL + D V +++D+G++
Sbjct: 162 DVLEYIH---ENEYVHGDIKAANLLLGYKNPDQV-YLADYGLSY 201
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 1e-04
Identities = 21/48 (43%), Positives = 27/48 (56%), Gaps = 3/48 (6%)
Query: 674 NLVKIISSS-LEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHIS--DFG 718
LV+ + S L+ L H IIHCDLKP N+LL + + I DFG
Sbjct: 200 PLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFG 247
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A Length = 267 | Back alignment and structure |
|---|
Score = 43.4 bits (102), Expect = 1e-04
Identities = 33/192 (17%), Positives = 65/192 (33%), Gaps = 18/192 (9%)
Query: 1 MLLKSIISQHQQALLALKAHISYDHTNLFARNWTSSTSVCIWIGITCDVNSHRVIGLNIS 60
LL I S+ ++ H F + ++++++ D + R+ + S
Sbjct: 39 WLLSMIQSKCSVPFTPIEFHYENTRAQFFVEDASTASALKAVNYKILDRENRRISIIINS 98
Query: 61 SFNLQGTITPQLGNLSSLQTLDLSHN--------KLSGNIPSSIFNMHTLKLLDFSDNQL 112
S + L +S L G + ++ + +
Sbjct: 99 SAPPHTILNELKPEQVEQLKLIMSKRYDGSQQALDLKGLRSDPDLVAQNIDVVLNRRSCM 158
Query: 113 FGSLSSFIFNMSSMTTIDLSINRLSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAIP 172
+L N+ + +++LS NRL + + S + K L+ LNL N L
Sbjct: 159 AATLRIIEENIPELLSLNLSNNRLY-----RLDDMSSIVQKAPNLKILNLSGNEL----- 208
Query: 173 KEIGNLTKLKEI 184
K L K+K +
Sbjct: 209 KSERELDKIKGL 220
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 43.6 bits (103), Expect = 2e-04
Identities = 16/44 (36%), Positives = 25/44 (56%), Gaps = 7/44 (15%)
Query: 681 SSLEYLHFGHSIPIIHCDLKPSNVLL---DEDMVAHISDFGIAK 721
LEY+H +H D+K SN+LL + D V ++ D+G+A
Sbjct: 163 DILEYIH---EHEYVHGDIKASNLLLNYKNPDQV-YLVDYGLAY 202
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 43.4 bits (101), Expect = 2e-04
Identities = 26/156 (16%), Positives = 55/156 (35%), Gaps = 18/156 (11%)
Query: 35 SSTSVCIWIGITCDVNSH-RVIGLNISSFNLQGTITPQLG--NLSSLQTLDL---SHNKL 88
++ + ++ + L I S L ++ + +L +L+ L L +
Sbjct: 175 NNLKIKGTNNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYG 234
Query: 89 SGNIPSSIF------NMHTLKLLDFSDNQLFGSLSSFIFN---MSSMTTIDLSINRLSGE 139
+ LK L D + + + + T+D+S L+ E
Sbjct: 235 FDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDE 294
Query: 140 LPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKEI 175
+ + K K L+ +N+ +N LS + KE+
Sbjct: 295 GARLLLD---HVDKIKHLKFINMKYNYLSDEMKKEL 327
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 43.6 bits (103), Expect = 2e-04
Identities = 10/44 (22%), Positives = 21/44 (47%), Gaps = 7/44 (15%)
Query: 681 SSLEYLHFGHSIPIIHCDLKPSNVLL---DEDMVAHISDFGIAK 721
+LE+LH +H ++ N+ + D+ V ++ +G A
Sbjct: 170 DALEFLH---ENEYVHGNVTAENIFVDPEDQSQV-TLAGYGFAF 209
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 4e-04
Identities = 18/50 (36%), Positives = 27/50 (54%), Gaps = 3/50 (6%)
Query: 673 RNLVKIISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHIS--DFGIA 720
R + + ++L +L + IIHCDLKP N+LL + I DFG +
Sbjct: 160 RKFAQQMCTALLFLA-TPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS 208
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 4e-04
Identities = 20/63 (31%), Positives = 36/63 (57%), Gaps = 4/63 (6%)
Query: 74 NLSSLQTLDLSHNKLSGNIPSSIFN-MHTLKLLDFSDNQLFGSLSSFIF-NMSSMTTIDL 131
S +Q L L NK+ I + +F +H LK L+ DNQ+ + F +++S+T+++L
Sbjct: 76 GASHIQELQLGENKIK-EISNKMFLGLHQLKTLNLYDNQI-SCVMPGSFEHLNSLTSLNL 133
Query: 132 SIN 134
+ N
Sbjct: 134 ASN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 5e-04
Identities = 24/109 (22%), Positives = 40/109 (36%), Gaps = 12/109 (11%)
Query: 79 QTLDLSHNKLSGNIPSSIFNMHT-LKLLDFSDNQLFGSLSSFIF-NMSSMTTIDLSINRL 136
L L+ N+L +F L L+ NQL + F S + + L N++
Sbjct: 32 TELLLNDNELGRISSDGLFGRLPHLVKLELKRNQL-TGIEPNAFEGASHIQELQLGENKI 90
Query: 137 SGELPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKEI-GNLTKLKEI 184
E+ + QL+ LNL N +S + +L L +
Sbjct: 91 K-EISNKM------FLGLHQLKTLNLYDNQIS-CVMPGSFEHLNSLTSL 131
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 42.6 bits (100), Expect = 5e-04
Identities = 58/448 (12%), Positives = 122/448 (27%), Gaps = 73/448 (16%)
Query: 52 HRVIGLNISSFNLQGTITPQLGNLSS----LQTLDLSHNKLSGNIPSSIFNMHTLKLLDF 107
++ + T LS L++L L M L ++
Sbjct: 45 FKIDSETREHVTMALCYTATPDRLSRRFPNLRSLKLKG--------KPRAAMFNLIPENW 96
Query: 108 SDNQLFGSLSSFIFNMSSMTTIDLSINRLSGELPANICKIPSTLSKCKQLEELNL-GFNN 166
++ N+ + ++ +S + K ++ LE L L +
Sbjct: 97 GGYVTPW-VTEISNNLRQLKSVHFRRMIVSDLDLDRLAK-----ARADDLETLKLDKCSG 150
Query: 167 LSGAIPKEIG-NLTKLKEI------ISTITNSTVCEIPREIGNLPYLARLALATNNLVGV 219
+ I + K+K + S + E+ + + L L +
Sbjct: 151 FTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQ---HNTSLEVLNFYMTEFAKI 207
Query: 220 VPVTIF----NMSALKEISLLNNSLSGSLPSRIDLSLPNVETLNLGINSFSGTIPSSITN 275
P + N +L + + + N+E G + +P N
Sbjct: 208 SPKDLETIARNCRSLVSVKV--GDFEILELVGFFKAAANLEEFCGGSLNEDIGMPEKYMN 265
Query: 276 SSKLSDLEL--GENLFSGFIPNTIGNLRNLEFGNIADNYLTSSTPELSFLSSLTNCKKLK 333
L + +P + ++ L + + + C L+
Sbjct: 266 LVFPRKLCRLGLSYMGPNEMPILFPFAAQIRKLDLLYALLETE----DHCTLIQKCPNLE 321
Query: 334 VLIVTGNPLDGILPKSIGNFSLSLETILMANCSISGNIPQVVGNLS------------NL 381
VL D L + + + L+ + + + + G +S L
Sbjct: 322 VLETRNVIGDRGL-EVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQEL 380
Query: 382 LVLELGGNNLTGPIPVTFSQ-LQTLQAFDLTRNKLAGPITDE---------LCHLARLHS 431
+ + +++T + L+ L F L ITD L +L
Sbjct: 381 EYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRR 440
Query: 432 LVLQGNKFSGSIPSCLGNLTSVRVLYLG 459
G LT + + Y+G
Sbjct: 441 FAFY---------LRQGGLTDLGLSYIG 459
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 7e-04
Identities = 12/37 (32%), Positives = 21/37 (56%), Gaps = 1/37 (2%)
Query: 674 NLVKIISSS-LEYLHFGHSIPIIHCDLKPSNVLLDED 709
+K+ L+ L++ + + H DLKP N+LLD+
Sbjct: 137 EDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDP 173
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 40.4 bits (95), Expect = 9e-04
Identities = 45/166 (27%), Positives = 69/166 (41%), Gaps = 38/166 (22%)
Query: 76 SSLQTLDLSHNKLSGNIPSSIFNMHTLKLLDFSDNQLFGSLSSFIFN-MSSMTTIDLSIN 134
+ LDL N L + +L L N+L SL + +FN ++S+T ++LS N
Sbjct: 28 AQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKL-QSLPNGVFNKLTSLTYLNLSTN 86
Query: 135 RLSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKEI-GNLTKLKEIISTITNSTV 193
+L LP + K QL+EL L N L ++P + LT+LK
Sbjct: 87 QLQ-SLPNGV------FDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLK----------- 127
Query: 194 CEIPREIGNLPYLARLALATNNLVGVVPVTIF-NMSALKEISLLNN 238
L L N L VP +F +++L+ I L +N
Sbjct: 128 --------------DLRLYQNQLKS-VPDGVFDRLTSLQYIWLHDN 158
|
Structure Templates Detected by HHsearch 
Original result of HHsearch against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 823 | |||
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 100.0 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 100.0 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 100.0 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 100.0 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 100.0 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 100.0 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 100.0 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 100.0 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 100.0 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 100.0 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 100.0 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 100.0 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 100.0 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 100.0 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 100.0 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 100.0 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 100.0 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 100.0 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 100.0 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 100.0 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 100.0 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 100.0 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 100.0 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 100.0 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 100.0 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 100.0 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 100.0 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 100.0 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 100.0 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 100.0 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 100.0 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 100.0 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 100.0 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 100.0 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 100.0 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 100.0 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 100.0 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 100.0 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 100.0 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 100.0 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 100.0 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 100.0 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 100.0 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 100.0 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 99.97 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.97 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 99.97 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 99.97 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 99.97 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.97 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 99.97 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 99.97 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 99.97 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 99.97 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 99.97 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.97 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.97 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 99.97 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 99.97 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.97 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.97 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.96 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 99.96 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.96 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 99.96 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.96 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 99.96 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.96 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.96 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.96 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.96 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.96 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.96 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.96 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.96 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.96 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.96 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 99.95 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.95 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.95 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.95 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 99.95 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 99.94 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 99.94 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.94 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.94 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 99.94 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.93 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.93 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.93 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.93 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.92 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 99.92 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.91 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 99.91 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.91 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.91 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 99.91 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.91 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 99.91 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.91 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.91 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 99.91 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 99.91 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 99.91 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 99.91 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.91 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 99.91 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 99.9 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 99.9 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 99.9 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 99.9 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 99.9 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 99.9 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 99.9 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.9 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.9 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 99.9 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 99.9 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 99.9 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 99.9 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 99.9 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.9 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 99.9 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 99.9 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 99.9 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 99.9 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 99.9 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 99.9 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 99.89 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 99.89 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.89 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 99.89 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 99.89 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 99.89 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 99.89 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 99.89 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 99.89 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 99.89 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 99.89 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 99.89 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 99.89 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 99.89 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 99.89 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.89 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 99.89 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.89 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.89 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 99.89 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 99.89 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 99.89 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 99.89 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 99.89 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 99.89 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 99.89 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 99.89 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 99.89 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 99.89 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 99.89 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 99.88 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 99.88 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 99.88 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 99.88 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 99.88 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 99.88 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 99.88 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 99.88 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 99.88 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 99.88 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.88 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 99.88 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 99.88 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 99.88 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 99.88 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 99.88 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 99.88 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 99.88 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 99.88 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 99.88 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 99.88 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 99.88 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 99.88 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 99.88 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 99.88 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 99.88 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 99.88 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 99.88 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 99.88 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 99.88 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 99.88 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 99.88 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 99.88 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 99.88 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 99.88 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 99.88 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.88 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 99.88 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 99.88 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 99.88 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 99.88 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.88 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 99.87 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 99.87 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 99.87 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 99.87 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 99.87 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 99.87 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 99.87 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 99.87 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 99.87 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 99.87 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 99.87 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 99.87 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 99.87 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 99.87 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 99.87 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 99.87 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 99.87 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 99.87 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 99.87 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 99.87 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.87 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.87 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 99.87 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 99.87 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 99.87 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 99.87 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 99.87 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 99.87 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 99.87 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 99.87 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 99.87 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 99.87 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 99.87 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 99.87 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 99.87 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 99.87 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 99.87 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 99.87 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 99.86 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 99.86 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.86 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 99.86 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 99.86 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 99.86 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 99.86 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 99.86 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 99.86 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 99.86 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 99.86 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 99.86 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 99.86 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 99.86 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 99.86 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 99.86 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 99.86 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 99.86 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 99.86 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 99.86 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 99.86 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 99.86 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 99.86 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 99.86 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 99.86 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 99.86 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 99.86 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 99.86 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.86 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 99.86 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 99.86 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 99.86 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 99.86 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 99.86 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 99.86 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 99.86 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 99.86 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 99.86 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 99.86 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 99.86 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 99.86 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 99.86 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 99.85 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 99.85 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 99.85 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 99.85 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 99.85 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 99.85 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 99.85 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 99.85 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 99.85 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 99.85 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.85 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.85 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 99.85 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 99.85 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 99.85 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.85 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 99.85 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 99.85 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 99.85 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 99.85 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 99.85 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 99.85 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.85 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 99.85 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 99.85 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 99.85 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 99.85 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 99.85 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 99.85 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 99.85 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 99.85 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 99.85 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 99.85 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 99.84 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 99.84 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 99.84 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 99.84 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 99.84 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 99.84 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 99.84 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 99.84 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 99.84 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 99.84 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 99.84 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 99.84 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 99.84 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 99.84 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.84 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 99.84 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 99.84 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 99.84 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 99.83 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 99.83 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 99.83 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 99.83 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 99.83 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.82 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.82 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 99.82 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 99.82 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.82 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 99.82 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.81 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 99.81 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.81 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.81 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.81 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.81 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 99.81 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.81 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.81 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.81 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.8 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.8 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.8 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.79 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.79 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.78 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.76 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.75 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.75 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.75 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.75 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.74 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.74 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.72 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.7 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.69 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.69 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.68 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.68 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.68 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.67 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.65 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.65 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.64 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.63 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.63 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.6 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.58 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.58 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.56 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.56 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.55 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.5 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 99.48 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.48 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 99.47 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.46 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.46 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.45 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.36 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.35 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.34 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.3 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 99.17 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 99.15 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.07 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.86 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.85 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 98.8 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 98.79 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 98.78 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.58 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.58 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.55 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.52 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.41 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.31 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 97.29 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 97.15 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 97.02 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 97.0 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.69 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.46 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 96.11 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 92.92 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 92.59 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 89.95 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 89.43 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 84.16 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 83.52 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 83.46 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 82.84 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 82.41 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 82.12 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 81.23 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 80.03 |
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-77 Score=722.61 Aligned_cols=538 Identities=31% Similarity=0.480 Sum_probs=416.1
Q ss_pred chHHHHHHHHHHHHhccCCCccccccccCCCCCCccceeeeeCCCCCcEEEEEcCCCCCccc---cC-------------
Q 045449 6 IISQHQQALLALKAHISYDHTNLFARNWTSSTSVCIWIGITCDVNSHRVIGLNISSFNLQGT---IT------------- 69 (823)
Q Consensus 6 ~~~~~~~aLl~~k~~~~~~~~~~~~~~W~~~~~~c~w~gv~c~~~~~~v~~L~L~~~~l~g~---~~------------- 69 (823)
..++||+|||+||+++. ||. .++ +|+.++|||+|.||+|+ +++|++|||+++.+.|. ++
T Consensus 9 ~~~~~~~all~~k~~~~-~~~-~l~-~W~~~~~~C~w~gv~C~--~~~v~~L~L~~~~l~g~~~~l~~~l~~L~~L~~l~ 83 (768)
T 3rgz_A 9 SLYREIHQLISFKDVLP-DKN-LLP-DWSSNKNPCTFDGVTCR--DDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLF 83 (768)
T ss_dssp CHHHHHHHHHHHHTTCS-CTT-SST-TCCTTSCGGGSTTEEEE--TTEEEEEECTTSCCCEEHHHHHHHTTTCTTCCEEE
T ss_pred CCHHHHHHHHHHHhhCC-Ccc-ccc-CCCCCCCCcCCcceEEC--CCcEEEEECCCCCcCCccCccChhHhccCcccccC
Confidence 46899999999999986 777 676 99988999999999998 68999999999999887 54
Q ss_pred ----------cccCCCCCCcEEEccCCCCCCCCCC--CCCCCCCCCEEECCCCcCcCCCchhh-hcCCCCcEEecccccc
Q 045449 70 ----------PQLGNLSSLQTLDLSHNKLSGNIPS--SIFNMHTLKLLDFSDNQLFGSLSSFI-FNMSSMTTIDLSINRL 136 (823)
Q Consensus 70 ----------~~l~~l~~L~~L~Ls~N~l~g~~p~--~~~~l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~Ls~N~l 136 (823)
+.++++++|++|||++|.++|.+|. .++++++|++|||++|.+++.+|..+ .++++|++|||++|++
T Consensus 84 ~~~~~~~~l~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l 163 (768)
T 3rgz_A 84 LSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSI 163 (768)
T ss_dssp CTTSCEEECCCCCCCCTTCCEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCCSCCCCTTCSEEECCSSCC
T ss_pred CcCCCcCCCchhhccCCCCCEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCHHHhccCCCCCEEECCCCcc
Confidence 4566777788888888887777776 77777777777777777766665543 4455555555555554
Q ss_pred cCccCcc---c--------------------------------------cCCCCCCccccccceeeeccceeeccCcccc
Q 045449 137 SGELPAN---I--------------------------------------CKIPSTLSKCKQLEELNLGFNNLSGAIPKEI 175 (823)
Q Consensus 137 ~~~~p~~---~--------------------------------------~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l 175 (823)
++..|.. + ...+..++++++|++|+|++|++++.+|..+
T Consensus 164 ~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~l~~L~~L~Ls~n~l~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~l 243 (768)
T 3rgz_A 164 SGANVVGWVLSDGCGELKHLAISGNKISGDVDVSRCVNLEFLDVSSNNFSTGIPFLGDCSALQHLDISGNKLSGDFSRAI 243 (768)
T ss_dssp EEETHHHHHHTTCCTTCCEEECCSSEEESCCBCTTCTTCCEEECCSSCCCSCCCBCTTCCSCCEEECCSSCCCSCHHHHT
T ss_pred CCcCChhhhhhccCCCCCEEECCCCcccccCCcccCCcCCEEECcCCcCCCCCcccccCCCCCEEECcCCcCCCcccHHH
Confidence 4333221 0 0111225666777777777777776666666
Q ss_pred ccchhhHHHHHhhcCCCc----------------------ccCCcccCCc-chhhhhccccccccCCccccccCCCCCcE
Q 045449 176 GNLTKLKEIISTITNSTV----------------------CEIPREIGNL-PYLARLALATNNLVGVVPVTIFNMSALKE 232 (823)
Q Consensus 176 ~~l~~L~~L~~l~~n~~~----------------------~~ip~~l~~l-~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 232 (823)
+++++|++|. +..|.+. +.+|..+... ++|++|+|++|++++.+|..|.++++|++
T Consensus 244 ~~l~~L~~L~-Ls~n~l~~~~~~~~l~~L~~L~L~~n~l~~~ip~~~~~~~~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~ 322 (768)
T 3rgz_A 244 STCTELKLLN-ISSNQFVGPIPPLPLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLES 322 (768)
T ss_dssp TTCSSCCEEE-CCSSCCEESCCCCCCTTCCEEECCSSEEEESCCCCSCTTCTTCSEEECCSSEEEECCCGGGGGCTTCCE
T ss_pred hcCCCCCEEE-CCCCcccCccCccccCCCCEEECcCCccCCccCHHHHhhcCcCCEEECcCCcCCCccchHHhcCCCccE
Confidence 6666666553 4444443 3555555554 77777777777777777777777777777
Q ss_pred EEccCCcccccCCcccccCCCCccEEEeeccccccccCccccCC---------------------------CCCCeEEee
Q 045449 233 ISLLNNSLSGSLPSRIDLSLPNVETLNLGINSFSGTIPSSITNS---------------------------SKLSDLELG 285 (823)
Q Consensus 233 L~Ls~N~l~g~lp~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l---------------------------~~L~~L~Ls 285 (823)
|+|++|.++|.+|...+..+++|++|+|++|++++.+|..+.++ ++|++|+++
T Consensus 323 L~L~~n~l~~~ip~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~ 402 (768)
T 3rgz_A 323 LALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQ 402 (768)
T ss_dssp EECCSSEEEEECCHHHHTTCTTCCEEECCSSEEEECCCTTHHHHTTTCSEEECCSSEEEEECCTTTTCSTTCCCCEEECC
T ss_pred EECCCCcccCcCCHHHHhcCCCCCEEeCcCCccCccccHHHHhhhcCCcEEEccCCCcCCCcChhhhhcccCCccEEECC
Confidence 77777777777776644446777777777777666666655444 345555555
Q ss_pred cccccccCCCccCCCcccCcccccCccccCCCCcccccccccCCCCceEEEeecCCCCccCCccccccccccceEEecCC
Q 045449 286 ENLFSGFIPNTIGNLRNLEFGNIADNYLTSSTPELSFLSSLTNCKKLKVLIVTGNPLDGILPKSIGNFSLSLETILMANC 365 (823)
Q Consensus 286 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N 365 (823)
+|++++.+|..++++++|++|++++|++++. .+..+.++++|+.|++++|.+++.+|..+..+ ++|++|++++|
T Consensus 403 ~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~-----~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l-~~L~~L~L~~N 476 (768)
T 3rgz_A 403 NNGFTGKIPPTLSNCSELVSLHLSFNYLSGT-----IPSSLGSLSKLRDLKLWLNMLEGEIPQELMYV-KTLETLILDFN 476 (768)
T ss_dssp SSEEEEECCGGGGGCTTCCEEECCSSEEESC-----CCGGGGGCTTCCEEECCSSCCCSCCCGGGGGC-TTCCEEECCSS
T ss_pred CCccccccCHHHhcCCCCCEEECcCCcccCc-----ccHHHhcCCCCCEEECCCCcccCcCCHHHcCC-CCceEEEecCC
Confidence 5555556666677777777777777777766 55678888888888888888888888888888 68999999999
Q ss_pred cceeccCccccCcccccEEEcccCcCCCCchhcccccCCCCEEEccCCCCCCcchHhhhcCCCCCEEEcccCcCcccccc
Q 045449 366 SISGNIPQVVGNLSNLLVLELGGNNLTGPIPVTFSQLQTLQAFDLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPS 445 (823)
Q Consensus 366 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~ 445 (823)
++++.+|..+.++++|++|+|++|+++|.+|.+++.+++|++|+|++|+++|.+|..++.+++|+.|+|++|+++|.+|.
T Consensus 477 ~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~ 556 (768)
T 3rgz_A 477 DLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPA 556 (768)
T ss_dssp CCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEECCGGGGGCTTCCEEECCSSEEESBCCG
T ss_pred cccCcCCHHHhcCCCCCEEEccCCccCCcCChHHhcCCCCCEEECCCCcccCcCCHHHcCCCCCCEEECCCCccCCcCCh
Confidence 99988898899999999999999999988999999999999999999999999999999999999999999988887776
Q ss_pred ccc----------------------------------------------------------------------CCCCCCe
Q 045449 446 CLG----------------------------------------------------------------------NLTSVRV 455 (823)
Q Consensus 446 ~~~----------------------------------------------------------------------~l~~L~~ 455 (823)
.+. .+++|+.
T Consensus 557 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~ 636 (768)
T 3rgz_A 557 AMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMF 636 (768)
T ss_dssp GGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCE
T ss_pred HHhcccchhhhhccccccccccccccccccccccccccccccccchhhhccccccccccccceecccCchhhhccccccE
Confidence 442 3467888
Q ss_pred EeccCCccccccchhhhccCCCcEEeccccccccccCccccCCCCCcEEEcccCCCCCCCCCccc---------------
Q 045449 456 LYLGLNIFTSVLSSTIWNLKDILFIDVSSNFLDGPLSLDIGNLKVVIGLDFSRNNLSGDIPITIG--------------- 520 (823)
Q Consensus 456 L~Ls~N~l~~~~p~~~~~l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~~--------------- 520 (823)
|||++|+++|.+|..++.++.|+.||||+|+++|.+|..+++++.|+.|||++|+++|.||..++
T Consensus 637 LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l 716 (768)
T 3rgz_A 637 LDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNL 716 (768)
T ss_dssp EECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSEE
T ss_pred EECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCcc
Confidence 99999999999999999999999999999999999999999999999999999999999998765
Q ss_pred CccCCCCCCCCCCCcccccCCcccCCCCCCCCCCCCCC
Q 045449 521 EGEIPRGGPFANLTAKSFMGNELLCGLPDLQVSPCKPN 558 (823)
Q Consensus 521 ~g~ip~~~~~~~~~~~~~~~n~~~c~~~~~~~~~c~~~ 558 (823)
+|.||..+++.++...+|.||+++||.|.. +|...
T Consensus 717 ~g~iP~~~~~~~~~~~~~~gN~~Lcg~~l~---~C~~~ 751 (768)
T 3rgz_A 717 SGPIPEMGQFETFPPAKFLNNPGLCGYPLP---RCDPS 751 (768)
T ss_dssp EEECCSSSSGGGSCGGGGCSCTEEESTTSC---CCCSC
T ss_pred cccCCCchhhccCCHHHhcCCchhcCCCCc---CCCCC
Confidence 689999999999999999999999998853 68644
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-63 Score=599.28 Aligned_cols=456 Identities=30% Similarity=0.465 Sum_probs=389.2
Q ss_pred cEEEEEcCCCCCccccCcccCCCCCCcEEEccCCCCCCCCCCCCCCCCCCCEEECCCCcCcCCCchhhhcCCCCcEEecc
Q 045449 53 RVIGLNISSFNLQGTITPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLDFSDNQLFGSLSSFIFNMSSMTTIDLS 132 (823)
Q Consensus 53 ~v~~L~L~~~~l~g~~~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 132 (823)
+++.|++++|.+.+.++. .++++|++|+|++|++++.+|. |+++++|++|+|++|.+++.+|..|+++++|++|+|+
T Consensus 179 ~L~~L~Ls~n~l~~~~~~--~~l~~L~~L~Ls~n~l~~~~~~-l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~Ls 255 (768)
T 3rgz_A 179 ELKHLAISGNKISGDVDV--SRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNIS 255 (768)
T ss_dssp TCCEEECCSSEEESCCBC--TTCTTCCEEECCSSCCCSCCCB-CTTCCSCCEEECCSSCCCSCHHHHTTTCSSCCEEECC
T ss_pred CCCEEECCCCcccccCCc--ccCCcCCEEECcCCcCCCCCcc-cccCCCCCEEECcCCcCCCcccHHHhcCCCCCEEECC
Confidence 456666666666554432 5566666666666666655554 6666666666666666666666666666666666666
Q ss_pred cccccCccCccc---------------cCCCCCCccc-cccceeeeccceeeccCccccccchhhHHHHHhhcCCCcccC
Q 045449 133 INRLSGELPANI---------------CKIPSTLSKC-KQLEELNLGFNNLSGAIPKEIGNLTKLKEIISTITNSTVCEI 196 (823)
Q Consensus 133 ~N~l~~~~p~~~---------------~~~p~~~~~l-~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~~l~~n~~~~~i 196 (823)
+|++++.+|..- ..+|..+..+ ++|++|+|++|++++.+|..|+++++|++|. +.+|.+.+.+
T Consensus 256 ~n~l~~~~~~~~l~~L~~L~L~~n~l~~~ip~~~~~~~~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~-L~~n~l~~~i 334 (768)
T 3rgz_A 256 SNQFVGPIPPLPLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLA-LSSNNFSGEL 334 (768)
T ss_dssp SSCCEESCCCCCCTTCCEEECCSSEEEESCCCCSCTTCTTCSEEECCSSEEEECCCGGGGGCTTCCEEE-CCSSEEEEEC
T ss_pred CCcccCccCccccCCCCEEECcCCccCCccCHHHHhhcCcCCEEECcCCcCCCccchHHhcCCCccEEE-CCCCcccCcC
Confidence 666555444310 0234444554 8999999999999999999999999998886 8888888888
Q ss_pred Ccc-cCCcchhhhhccccccccCCccccccCCC-CCcEEEccCCcccccCCcccccC-CCCccEEEeeccccccccCccc
Q 045449 197 PRE-IGNLPYLARLALATNNLVGVVPVTIFNMS-ALKEISLLNNSLSGSLPSRIDLS-LPNVETLNLGINSFSGTIPSSI 273 (823)
Q Consensus 197 p~~-l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~Ls~N~l~g~lp~~~~~~-l~~L~~L~Ls~N~l~~~~p~~~ 273 (823)
|.. +.++++|++|+|++|++++.+|..+.+++ +|++|++++|.++|.+|..+... +++|++|+|++|++++.+|..+
T Consensus 335 p~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~l 414 (768)
T 3rgz_A 335 PMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTL 414 (768)
T ss_dssp CHHHHTTCTTCCEEECCSSEEEECCCTTHHHHTTTCSEEECCSSEEEEECCTTTTCSTTCCCCEEECCSSEEEEECCGGG
T ss_pred CHHHHhcCCCCCEEeCcCCccCccccHHHHhhhcCCcEEEccCCCcCCCcChhhhhcccCCccEEECCCCccccccCHHH
Confidence 876 89999999999999999989999998887 89999999999998888776532 6789999999999999999999
Q ss_pred cCCCCCCeEEeecccccccCCCccCCCcccCcccccCccccCCCCcccccccccCCCCceEEEeecCCCCccCCcccccc
Q 045449 274 TNSSKLSDLELGENLFSGFIPNTIGNLRNLEFGNIADNYLTSSTPELSFLSSLTNCKKLKVLIVTGNPLDGILPKSIGNF 353 (823)
Q Consensus 274 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~ 353 (823)
.++++|++|+|++|++++.+|..|+.+++|++|++++|.+++. ++..+..+++|+.|++++|++++.+|..+..+
T Consensus 415 ~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~-----~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l 489 (768)
T 3rgz_A 415 SNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGE-----IPQELMYVKTLETLILDFNDLTGEIPSGLSNC 489 (768)
T ss_dssp GGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCCSC-----CCGGGGGCTTCCEEECCSSCCCSCCCGGGGGC
T ss_pred hcCCCCCEEECcCCcccCcccHHHhcCCCCCEEECCCCcccCc-----CCHHHcCCCCceEEEecCCcccCcCCHHHhcC
Confidence 9999999999999999999999999999999999999999987 56788999999999999999999999999999
Q ss_pred ccccceEEecCCcceeccCccccCcccccEEEcccCcCCCCchhcccccCCCCEEEccCCCCCCcchHhhh---------
Q 045449 354 SLSLETILMANCSISGNIPQVVGNLSNLLVLELGGNNLTGPIPVTFSQLQTLQAFDLTRNKLAGPITDELC--------- 424 (823)
Q Consensus 354 ~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~--------- 424 (823)
++|++|++++|++++.+|.+++.+++|++|+|++|+++|.+|..+..+++|++|+|++|+++|.+|..+.
T Consensus 490 -~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~~~~~ 568 (768)
T 3rgz_A 490 -TNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAAN 568 (768)
T ss_dssp -TTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEECCGGGGGCTTCCEEECCSSEEESBCCGGGGTTTTCBCCS
T ss_pred -CCCCEEEccCCccCCcCChHHhcCCCCCEEECCCCcccCcCCHHHcCCCCCCEEECCCCccCCcCChHHhcccchhhhh
Confidence 7999999999999999999999999999999999999999999999999999999999999988887543
Q ss_pred -------------------------------------------------------------cCCCCCEEEcccCcCcccc
Q 045449 425 -------------------------------------------------------------HLARLHSLVLQGNKFSGSI 443 (823)
Q Consensus 425 -------------------------------------------------------------~l~~L~~L~Ls~N~l~g~~ 443 (823)
.+++|+.|||++|+++|.+
T Consensus 569 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~i 648 (768)
T 3rgz_A 569 FIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYI 648 (768)
T ss_dssp TTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCC
T ss_pred ccccccccccccccccccccccccccccccccchhhhccccccccccccceecccCchhhhccccccEEECcCCcccccC
Confidence 2467899999999999999
Q ss_pred cccccCCCCCCeEeccCCccccccchhhhccCCCcEEeccccccccccCccccCCCCCcEEEcccCCCCCCCCCc
Q 045449 444 PSCLGNLTSVRVLYLGLNIFTSVLSSTIWNLKDILFIDVSSNFLDGPLSLDIGNLKVVIGLDFSRNNLSGDIPIT 518 (823)
Q Consensus 444 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~ip~~ 518 (823)
|..+++++.|+.|+|++|+++|.+|..++++++|+.||||+|+++|.+|..+++++.|++||+++|+|+|.||..
T Consensus 649 p~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~iP~~ 723 (768)
T 3rgz_A 649 PKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEM 723 (768)
T ss_dssp CGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSEEEEECCSS
T ss_pred CHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCcccccCCCc
Confidence 999999999999999999999999999999999999999999999999999999999999999999999999976
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-61 Score=567.93 Aligned_cols=474 Identities=19% Similarity=0.265 Sum_probs=297.1
Q ss_pred HHHHHHHHHHHHhccCCCcc-------ccccccCCCCCCccc---eeeeeCCCCCcEEEEEcCCCCCccccCcccCCCCC
Q 045449 8 SQHQQALLALKAHISYDHTN-------LFARNWTSSTSVCIW---IGITCDVNSHRVIGLNISSFNLQGTITPQLGNLSS 77 (823)
Q Consensus 8 ~~~~~aLl~~k~~~~~~~~~-------~~~~~W~~~~~~c~w---~gv~c~~~~~~v~~L~L~~~~l~g~~~~~l~~l~~ 77 (823)
.+|++||.+||+++..+... ... +|+.+.|||.| .||+|+.. +||+.|+|++++++|.+|+++++|++
T Consensus 29 ~~d~~aL~~~~~~~~~~~w~~~~~~~~~~~-~W~~~~~~c~w~~~~GV~C~~~-~~V~~L~L~~~~l~g~lp~~l~~L~~ 106 (636)
T 4eco_A 29 IKDYLALKEIWDALNGKNWSQQGFGTQPGA-NWNFNKELDMWGAQPGVSLNSN-GRVTGLSLEGFGASGRVPDAIGQLTE 106 (636)
T ss_dssp HHHHHHHHHHHHHTTGGGCCCCC------C-CCCCSSCGGGTTCCTTEEECTT-CCEEEEECTTSCCEEEECGGGGGCTT
T ss_pred HHHHHHHHHHHHHcCCCCcccCCcCCccCC-CCCCCCCcccccCCCCeEEcCC-CCEEEEEecCcccCCcCChHHhcCcc
Confidence 47999999999997544322 122 79989999999 99999865 89999999999999999999999999
Q ss_pred CcEEEccCCCCC------C------CCCCCCCCCCCCCEEECCCCcCcCCCchhhhcC-CC------------------C
Q 045449 78 LQTLDLSHNKLS------G------NIPSSIFNMHTLKLLDFSDNQLFGSLSSFIFNM-SS------------------M 126 (823)
Q Consensus 78 L~~L~Ls~N~l~------g------~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~~------------------L 126 (823)
|++|||++|.+. | .+|... +..|+ +++++|.+.+.+|..+..+ .. +
T Consensus 107 L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~--~~~l~-l~l~~~~l~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~l 183 (636)
T 4eco_A 107 LEVLALGSHGEKVNERLFGPKGISANMSDEQ--KQKMR-MHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITL 183 (636)
T ss_dssp CCEEESCCGGGGGTCCSBSTTSBCTTCCHHH--HHHHH-THHHHHHTCCCGGGGSCHHHHHHHHHCTTSCCCCCCCCCCC
T ss_pred ceEEECcCCccccCCccccccccccCchHHH--HHHHH-hhHHHhhhccCchhhHHHHHHHHhhcCccccccccccccch
Confidence 999999999872 2 233322 34566 7777777777766665421 11 1
Q ss_pred cEEecc--cccccCccCccccCCCCCCccccccceeeeccceeecc-----------------Cccccc--cchhhHHHH
Q 045449 127 TTIDLS--INRLSGELPANICKIPSTLSKCKQLEELNLGFNNLSGA-----------------IPKEIG--NLTKLKEII 185 (823)
Q Consensus 127 ~~L~Ls--~N~l~~~~p~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~-----------------~p~~l~--~l~~L~~L~ 185 (823)
+.+.+. .|+++| +|..+ +++++|++|+|++|+++|. +|..++ ++++|++|.
T Consensus 184 ~~l~l~~~~n~l~~-ip~~l-------~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~ 255 (636)
T 4eco_A 184 KDTQIGQLSNNITF-VSKAV-------MRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVE 255 (636)
T ss_dssp CTTTTTCCSCEEEE-ECGGG-------GGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEE
T ss_pred hhhhhccccCCCcc-CCHHH-------hcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEE
Confidence 222221 466665 55554 6777777777777777764 555555 555555443
Q ss_pred HhhcCCCcccCCcccCCcchhhhhcccccc-ccC-CccccccCC------CCCcEEEccCCcccccCCc--ccccCCCCc
Q 045449 186 STITNSTVCEIPREIGNLPYLARLALATNN-LVG-VVPVTIFNM------SALKEISLLNNSLSGSLPS--RIDLSLPNV 255 (823)
Q Consensus 186 ~l~~n~~~~~ip~~l~~l~~L~~L~Ls~N~-l~~-~~p~~~~~l------~~L~~L~Ls~N~l~g~lp~--~~~~~l~~L 255 (823)
+.+|.+.+.+|..|+++++|++|+|++|+ +++ .+|..++++ ++|++|+|++|+++ .+|. .+.. +++|
T Consensus 256 -L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~-l~~L 332 (636)
T 4eco_A 256 -VYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQK-MKKL 332 (636)
T ss_dssp -EECCTTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTT-CTTC
T ss_pred -ecCCcCCccChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhcc-CCCC
Confidence 44444555555555555666666666665 665 566555554 66666666666666 5665 4433 6666
Q ss_pred cEEEeeccccccccCccccCCCCCCeEEeecccccccCCCccCCCcc-cCcccccCccccCCCCcccccccccCCC--Cc
Q 045449 256 ETLNLGINSFSGTIPSSITNSSKLSDLELGENLFSGFIPNTIGNLRN-LEFGNIADNYLTSSTPELSFLSSLTNCK--KL 332 (823)
Q Consensus 256 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~-L~~L~L~~N~l~~~~~~~~~~~~l~~l~--~L 332 (823)
++|+|++|+++|.+| .+..+++|++|+|++|+++ .+|..+..+++ |++|++++|.++.. |..+..++ +|
T Consensus 333 ~~L~L~~N~l~g~ip-~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N~l~~l------p~~~~~~~l~~L 404 (636)
T 4eco_A 333 GMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQIT-EIPANFCGFTEQVENLSFAHNKLKYI------PNIFDAKSVSVM 404 (636)
T ss_dssp CEEECCSCCCEEECC-CCEEEEEESEEECCSSEEE-ECCTTSEEECTTCCEEECCSSCCSSC------CSCCCTTCSSCE
T ss_pred CEEeCcCCcCccchh-hhCCCCCCCEEECCCCccc-cccHhhhhhcccCcEEEccCCcCccc------chhhhhcccCcc
Confidence 666666666666666 5666666666666666666 55555666666 66666666666532 23333332 56
Q ss_pred eEEEeecCCCCccCCcccc-------ccccccceEEecCCcceeccCccccCcccccEEEcccCcCCCCchhc-cccc--
Q 045449 333 KVLIVTGNPLDGILPKSIG-------NFSLSLETILMANCSISGNIPQVVGNLSNLLVLELGGNNLTGPIPVT-FSQL-- 402 (823)
Q Consensus 333 ~~L~Ls~N~l~~~~p~~~~-------~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~-~~~l-- 402 (823)
+.|++++|.+++.+|..+. .+ .+|++|++++|+++...+..+..+++|++|+|++|+++ .+|.. +...
T Consensus 405 ~~L~Ls~N~l~~~~p~~l~~~~~~~~~~-~~L~~L~Ls~N~l~~lp~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~~~~~ 482 (636)
T 4eco_A 405 SAIDFSYNEIGSVDGKNFDPLDPTPFKG-INVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLT-EIPKNSLKDENE 482 (636)
T ss_dssp EEEECCSSCTTTTTTCSSCTTCSSCCCC-CCEEEEECCSSCCCSCCTHHHHTTCCCSEEECCSSCCS-BCCSSSSEETTE
T ss_pred CEEECcCCcCCCcchhhhcccccccccC-CCCCEEECcCCccCcCCHHHHccCCCCCEEECCCCCCC-CcCHHHhccccc
Confidence 6666666666666665555 44 45666666666666333333445666666666666666 34432 2222
Q ss_pred -----CCCCEEEccCCCCCCcchHhhh--cCCCCCEEEcccCcCcccccccccCCCCCCeEec------cCCccccccch
Q 045449 403 -----QTLQAFDLTRNKLAGPITDELC--HLARLHSLVLQGNKFSGSIPSCLGNLTSVRVLYL------GLNIFTSVLSS 469 (823)
Q Consensus 403 -----~~L~~L~Ls~N~l~~~~p~~~~--~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L------s~N~l~~~~p~ 469 (823)
++|++|+|++|+++ .+|..+. .+++|+.|+|++|++++ +|..+.++++|+.|+| ++|++.+.+|.
T Consensus 483 ~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~Ls~N~~ls~N~l~~~~p~ 560 (636)
T 4eco_A 483 NFKNTYLLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPE 560 (636)
T ss_dssp ECTTGGGCCEEECCSSCCC-BCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCSSCCEEECCSCBCTTCCBCCCCCCT
T ss_pred cccccCCccEEECcCCcCC-ccChhhhhccCCCcCEEECCCCCCCC-cChhhhcCCCCCEEECCCCcccccCcccccChH
Confidence 26666666666666 4555554 66666666666666665 5666666666666666 34556666666
Q ss_pred hhhccCCCcEEeccccccccccCccccCCCCCcEEEcccCCCC
Q 045449 470 TIWNLKDILFIDVSSNFLDGPLSLDIGNLKVVIGLDFSRNNLS 512 (823)
Q Consensus 470 ~~~~l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~ls~N~l~ 512 (823)
.+..+++|+.|||++|.+ +.+|..+. +.|+.||+++|++.
T Consensus 561 ~l~~l~~L~~L~Ls~N~l-~~ip~~~~--~~L~~L~Ls~N~l~ 600 (636)
T 4eco_A 561 GITLCPSLTQLQIGSNDI-RKVNEKIT--PNISVLDIKDNPNI 600 (636)
T ss_dssp TGGGCSSCCEEECCSSCC-CBCCSCCC--TTCCEEECCSCTTC
T ss_pred HHhcCCCCCEEECCCCcC-CccCHhHh--CcCCEEECcCCCCc
Confidence 666666666666666666 55565544 56666666666554
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-58 Score=553.68 Aligned_cols=457 Identities=18% Similarity=0.227 Sum_probs=293.8
Q ss_pred chHHHHHHHHHHHHhccCCCccccccccCCCC-----CC--ccc------------eeeeeCCCCCcEEEEEcCCCCCcc
Q 045449 6 IISQHQQALLALKAHISYDHTNLFARNWTSST-----SV--CIW------------IGITCDVNSHRVIGLNISSFNLQG 66 (823)
Q Consensus 6 ~~~~~~~aLl~~k~~~~~~~~~~~~~~W~~~~-----~~--c~w------------~gv~c~~~~~~v~~L~L~~~~l~g 66 (823)
.-.+|++||++||+++. || +|+.+. +| |.| .||+|+. .+||+.|+|+++++.|
T Consensus 266 ~~~~d~~ALl~~k~~l~-~~------~W~~~~~~~~~~~~~C~W~~~~~~~~w~~~~GV~C~~-~~~V~~L~Ls~~~L~G 337 (876)
T 4ecn_A 266 EYIKDYKALKAIWEALD-GK------NWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDN-NGRVTGLSLAGFGAKG 337 (876)
T ss_dssp HHHHHHHHHHHHHHHTT-GG------GCCCCCSSCSSCCCCCSCCCSSCGGGTTCCTTEEECT-TSCEEEEECTTTCCEE
T ss_pred cchHHHHHHHHHHHHcC-CC------CCCcCCCcccccCCccccccccccccccCcCceEecC-CCCEEEEECccCCCCC
Confidence 45689999999999974 44 676443 55 999 9999986 6899999999999999
Q ss_pred ccCcccCCCCCCcEEEc-cCCCCCCCCCCCC-------------------------------------------------
Q 045449 67 TITPQLGNLSSLQTLDL-SHNKLSGNIPSSI------------------------------------------------- 96 (823)
Q Consensus 67 ~~~~~l~~l~~L~~L~L-s~N~l~g~~p~~~------------------------------------------------- 96 (823)
.+|+++++|++|++||| ++|.++|..|...
T Consensus 338 ~ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l~~~~l~~~~~~~~i 417 (876)
T 4ecn_A 338 RVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPI 417 (876)
T ss_dssp EECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHTCTTSCCC
T ss_pred cCchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHHHHHHhhhCcccccc
Confidence 99999999999999999 8998887744221
Q ss_pred --CCCCCCCEEECCC--CcCcCCCchhhhcCCCCcEEecccccccCc-cCccccC---------CCCCCc--ccccccee
Q 045449 97 --FNMHTLKLLDFSD--NQLFGSLSSFIFNMSSMTTIDLSINRLSGE-LPANICK---------IPSTLS--KCKQLEEL 160 (823)
Q Consensus 97 --~~l~~L~~L~Ls~--N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~-~p~~~~~---------~p~~~~--~l~~L~~L 160 (823)
.....++.+.++. |+|++ +|..|+++++|++|+|++|+|+|. +|..+.. +|..++ ++++|++|
T Consensus 418 ~~~~~l~l~~l~l~~~~N~L~~-IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L 496 (876)
T 4ecn_A 418 KKDSRISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDV 496 (876)
T ss_dssp CCCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEE
T ss_pred ccccccchhhceeccccCcccc-hhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEE
Confidence 1122334444443 77777 788888888888888888888872 2221111 344435 77777777
Q ss_pred eeccceeeccCccccccchhhHHHHHhhcCCCcccCCcccCCcchhhhhcccccc-ccC-CccccccCCC-------CCc
Q 045449 161 NLGFNNLSGAIPKEIGNLTKLKEIISTITNSTVCEIPREIGNLPYLARLALATNN-LVG-VVPVTIFNMS-------ALK 231 (823)
Q Consensus 161 ~Ls~N~l~~~~p~~l~~l~~L~~L~~l~~n~~~~~ip~~l~~l~~L~~L~Ls~N~-l~~-~~p~~~~~l~-------~L~ 231 (823)
+|++|++.+.+|..|++++ +|+.|+|++|+ +++ .+|..+.+++ +|+
T Consensus 497 ~Ls~N~l~~~iP~~l~~L~-------------------------~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~ 551 (876)
T 4ecn_A 497 ELYNCPNMTQLPDFLYDLP-------------------------ELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQ 551 (876)
T ss_dssp EEESCTTCCSCCGGGGGCS-------------------------SCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCC
T ss_pred ECcCCCCCccChHHHhCCC-------------------------CCCEEECcCCCCcccccchHHHHhhhhcccccCCcc
Confidence 7777777666666555555 44555555555 555 4554444333 566
Q ss_pred EEEccCCcccccCCc--ccccCCCCccEEEeeccccccccCccccCCCCCCeEEeecccccccCCCccCCCcc-cCcccc
Q 045449 232 EISLLNNSLSGSLPS--RIDLSLPNVETLNLGINSFSGTIPSSITNSSKLSDLELGENLFSGFIPNTIGNLRN-LEFGNI 308 (823)
Q Consensus 232 ~L~Ls~N~l~g~lp~--~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~-L~~L~L 308 (823)
+|+|++|.++ .+|. .+.. +++|++|+|++|+++ .+| .|..+++|+.|+|++|+++ .+|..+..+++ |+.|+|
T Consensus 552 ~L~Ls~N~L~-~ip~~~~l~~-L~~L~~L~Ls~N~l~-~lp-~~~~L~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~L 626 (876)
T 4ecn_A 552 IFYMGYNNLE-EFPASASLQK-MVKLGLLDCVHNKVR-HLE-AFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGF 626 (876)
T ss_dssp EEECCSSCCC-BCCCHHHHTT-CTTCCEEECTTSCCC-BCC-CCCTTSEESEEECCSSCCS-CCCTTSCEECTTCCEEEC
T ss_pred EEEeeCCcCC-ccCChhhhhc-CCCCCEEECCCCCcc-cch-hhcCCCcceEEECcCCccc-cchHHHhhccccCCEEEC
Confidence 6666666665 5555 3332 556666666666655 455 5555566666666666665 55555555555 666666
Q ss_pred cCccccCCCCcccccccccCCC--CceEEEeecCCCCccCCccc---ccc-ccccceEEecCCcceeccCccccCccccc
Q 045449 309 ADNYLTSSTPELSFLSSLTNCK--KLKVLIVTGNPLDGILPKSI---GNF-SLSLETILMANCSISGNIPQVVGNLSNLL 382 (823)
Q Consensus 309 ~~N~l~~~~~~~~~~~~l~~l~--~L~~L~Ls~N~l~~~~p~~~---~~~-~~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 382 (823)
++|.++.. |..+..++ +|+.|+|++|.++|.+|... ..+ ..+|++|+|++|+++...+..+..+++|+
T Consensus 627 s~N~L~~l------p~~~~~~~~~~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L~~lp~~~~~~l~~L~ 700 (876)
T 4ecn_A 627 SHNKLKYI------PNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPIS 700 (876)
T ss_dssp CSSCCCSC------CSCCCTTCSSCEEEEECCSSCTTTTSSSCSSCTTTCCCCCEEEEECCSSCCCSCCHHHHHTTCCCS
T ss_pred cCCCCCcC------chhhhccccCCCCEEECcCCcCCCccccchhhhccccCCCcCEEEccCCcCCccCHHHHccCCCCC
Confidence 66665532 23333333 26666666666665544221 111 02566666666666632222233566666
Q ss_pred EEEcccCcCCCCchhcccc--------cCCCCEEEccCCCCCCcchHhhh--cCCCCCEEEcccCcCcccccccccCCCC
Q 045449 383 VLELGGNNLTGPIPVTFSQ--------LQTLQAFDLTRNKLAGPITDELC--HLARLHSLVLQGNKFSGSIPSCLGNLTS 452 (823)
Q Consensus 383 ~L~Ls~N~l~g~~p~~~~~--------l~~L~~L~Ls~N~l~~~~p~~~~--~l~~L~~L~Ls~N~l~g~~p~~~~~l~~ 452 (823)
.|+|++|+++ .+|..+.. +++|++|+|++|+|+ .+|..+. .+++|+.|+|++|+|++ +|..+.++++
T Consensus 701 ~L~Ls~N~L~-~ip~~~~~~~~~~l~nl~~L~~L~Ls~N~L~-~lp~~l~~~~l~~L~~L~Ls~N~L~~-lp~~l~~L~~ 777 (876)
T 4ecn_A 701 TIILSNNLMT-SIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQ 777 (876)
T ss_dssp EEECCSCCCS-CCCTTSSSCTTSCCTTGGGCCEEECCSSCCC-CCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCTT
T ss_pred EEECCCCcCC-ccChHHhccccccccccCCccEEECCCCCCc-cchHHhhhccCCCcCEEEeCCCCCCc-cchhhhcCCC
Confidence 6666666666 44443322 226666666666666 5555554 66666666666666665 5666666666
Q ss_pred CCeEeccC------CccccccchhhhccCCCcEEeccccccccccCccccCCCCCcEEEcccCCCCC
Q 045449 453 VRVLYLGL------NIFTSVLSSTIWNLKDILFIDVSSNFLDGPLSLDIGNLKVVIGLDFSRNNLSG 513 (823)
Q Consensus 453 L~~L~Ls~------N~l~~~~p~~~~~l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g 513 (823)
|+.|+|++ |++.+.+|..+..+++|+.|+|++|++ +.+|..+. +.|+.|||++|++..
T Consensus 778 L~~L~Ls~N~~ls~N~l~~~ip~~l~~L~~L~~L~Ls~N~L-~~Ip~~l~--~~L~~LdLs~N~l~~ 841 (876)
T 4ecn_A 778 LKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDI-RKVDEKLT--PQLYILDIADNPNIS 841 (876)
T ss_dssp CCEEECCCCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCC--SSSCEEECCSCTTCE
T ss_pred CCEEECCCCCCcccccccccChHHHhcCCCCCEEECCCCCC-CccCHhhc--CCCCEEECCCCCCCc
Confidence 66666654 777788888888888888888888888 67777665 578888888888764
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-56 Score=525.25 Aligned_cols=482 Identities=20% Similarity=0.197 Sum_probs=423.9
Q ss_pred ceeeeeCCC---------CCcEEEEEcCCCCCccccCcccCCCCCCcEEEccCCCCCCCCCCCCCCCCCCCEEECCCCcC
Q 045449 42 WIGITCDVN---------SHRVIGLNISSFNLQGTITPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLDFSDNQL 112 (823)
Q Consensus 42 w~gv~c~~~---------~~~v~~L~L~~~~l~g~~~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l 112 (823)
+.-|.|... ...++.|||++|.+++..|.+|+++++|++|||++|+|++..|.+|.++++|++|+|++|.+
T Consensus 14 ~~~~~c~~~~l~~iP~~l~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l 93 (606)
T 3t6q_A 14 NKTYNCENLGLNEIPGTLPNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPL 93 (606)
T ss_dssp TTEEECTTSCCSSCCTTSCTTCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCC
T ss_pred CceEECCCCCcccCcCCCCCcCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcc
Confidence 456778642 24789999999999998899999999999999999999999999999999999999999999
Q ss_pred cCCCchhhhcCCCCcEEecccccccCccCccccCCCCCCccccccceeeeccceeeccCccccccchhhHHHHHhhcCCC
Q 045449 113 FGSLSSFIFNMSSMTTIDLSINRLSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKEIGNLTKLKEIISTITNST 192 (823)
Q Consensus 113 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~~l~~n~~ 192 (823)
++..|..|+++++|++|+|++|++++..|..+ +++++|++|+|++|++++..+..+..+++|++|. +.+|.+
T Consensus 94 ~~~~~~~~~~l~~L~~L~L~~n~i~~l~~~~~-------~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~-L~~n~l 165 (606)
T 3t6q_A 94 IFMAETALSGPKALKHLFFIQTGISSIDFIPL-------HNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLD-FQNNAI 165 (606)
T ss_dssp SEECTTTTSSCTTCCEEECTTSCCSCGGGSCC-------TTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEE-CCSSCC
T ss_pred cccChhhhcccccccEeeccccCcccCCcchh-------ccCCcccEEECCCCcccccCcccccCCcccCEEE-cccCcc
Confidence 99999999999999999999999996545444 8899999999999999975444455588888885 888888
Q ss_pred cccCCcccCCcchhh--hhccccccccCCccccccCC-------------------------------------------
Q 045449 193 VCEIPREIGNLPYLA--RLALATNNLVGVVPVTIFNM------------------------------------------- 227 (823)
Q Consensus 193 ~~~ip~~l~~l~~L~--~L~Ls~N~l~~~~p~~~~~l------------------------------------------- 227 (823)
.+..|..++.+++|+ .|++++|++++..|..+...
T Consensus 166 ~~~~~~~~~~l~~L~~l~L~l~~n~l~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~l~~~~l~~l~~~~~~~~~~~~i~~ 245 (606)
T 3t6q_A 166 HYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISP 245 (606)
T ss_dssp CEECHHHHHTTTTCCSEEEECTTCCCCEECTTTTTTCEEEEEECTTCSCHHHHHHHTTTCEEEEEECCCCTTSCCCCCCG
T ss_pred cccChhhhhhhcccceeEEecCCCccCccChhHhhhccccccccCCchhHHHHhhhccccchhheechhhccccccccCh
Confidence 888888899999998 89999999998877665431
Q ss_pred --------CCCcEEEccCCcccccCCcccccCCCCccEEEeeccccccccCccccCCCCCCeEEeecccccccCCCccCC
Q 045449 228 --------SALKEISLLNNSLSGSLPSRIDLSLPNVETLNLGINSFSGTIPSSITNSSKLSDLELGENLFSGFIPNTIGN 299 (823)
Q Consensus 228 --------~~L~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 299 (823)
.+|+.|++++|.++ .++...+..+++|++|++++|+++ .+|..+.++++|++|++++|++++..|..+..
T Consensus 246 ~~~~~l~~~~L~~L~l~~n~l~-~~~~~~~~~l~~L~~L~l~~n~l~-~lp~~l~~l~~L~~L~l~~n~l~~~~~~~~~~ 323 (606)
T 3t6q_A 246 AVFEGLCEMSVESINLQKHYFF-NISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASN 323 (606)
T ss_dssp GGGGGGGGSEEEEEECTTCCCS-SCCTTTTTTCTTCSEEECTTSCCS-CCCSSCCSCTTCCEEECTTCCCSBGGGGCGGG
T ss_pred hHhchhhcCceeEEEeecCccC-ccCHHHhccccCCCEEeccCCccC-CCChhhcccccCCEEECccCCcCcCchhhhhc
Confidence 16788899999998 455554556999999999999998 78999999999999999999999998999999
Q ss_pred CcccCcccccCccccCCCCcccccccccCCCCceEEEeecCCCCccC--CccccccccccceEEecCCcceeccCccccC
Q 045449 300 LRNLEFGNIADNYLTSSTPELSFLSSLTNCKKLKVLIVTGNPLDGIL--PKSIGNFSLSLETILMANCSISGNIPQVVGN 377 (823)
Q Consensus 300 l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~--p~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~ 377 (823)
+++|++|++++|.+.+..+ ...+..+++|++|++++|.+++.. |..+..+ ++|++|++++|.+++..|..|..
T Consensus 324 l~~L~~L~l~~n~~~~~~~----~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~~L~~L~l~~n~l~~~~~~~~~~ 398 (606)
T 3t6q_A 324 FPSLTHLSIKGNTKRLELG----TGCLENLENLRELDLSHDDIETSDCCNLQLRNL-SHLQSLNLSYNEPLSLKTEAFKE 398 (606)
T ss_dssp CTTCSEEECCSCSSCCBCC----SSTTTTCTTCCEEECCSSCCCEEEESTTTTTTC-TTCCEEECCSCSCEEECTTTTTT
T ss_pred cCcCCEEECCCCCcccccc----hhhhhccCcCCEEECCCCccccccCcchhcccC-CCCCEEECCCCcCCcCCHHHhcC
Confidence 9999999999999886532 235889999999999999999876 7788888 79999999999999999999999
Q ss_pred cccccEEEcccCcCCCCchhc-ccccCCCCEEEccCCCCCCcchHhhhcCCCCCEEEcccCcCccc---ccccccCCCCC
Q 045449 378 LSNLLVLELGGNNLTGPIPVT-FSQLQTLQAFDLTRNKLAGPITDELCHLARLHSLVLQGNKFSGS---IPSCLGNLTSV 453 (823)
Q Consensus 378 l~~L~~L~Ls~N~l~g~~p~~-~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~---~p~~~~~l~~L 453 (823)
+++|++|++++|++++..|.. +..+++|++|++++|.+++..|..+..+++|++|+|++|++++. .+..+..+++|
T Consensus 399 l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L 478 (606)
T 3t6q_A 399 CPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRL 478 (606)
T ss_dssp CTTCSEEECTTCCEECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTC
T ss_pred CccCCeEECCCCcCCCcccchhhhCcccCCEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCc
Confidence 999999999999999877654 89999999999999999999999999999999999999999873 33678999999
Q ss_pred CeEeccCCccccccchhhhccCCCcEEeccccccccccCccccCCCCCcEEEcccCCCCCCCCCcccCccCCCCCCCCCC
Q 045449 454 RVLYLGLNIFTSVLSSTIWNLKDILFIDVSSNFLDGPLSLDIGNLKVVIGLDFSRNNLSGDIPITIGEGEIPRGGPFANL 533 (823)
Q Consensus 454 ~~L~Ls~N~l~~~~p~~~~~l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~~~g~ip~~~~~~~~ 533 (823)
+.|+|++|++++.+|..+..+++|+.|||++|++++..|..+.+++.| .|++++|++++.+|..+. .+..+
T Consensus 479 ~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L-~L~L~~N~l~~~~~~~~~--------~l~~L 549 (606)
T 3t6q_A 479 EILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLP--------ILSQQ 549 (606)
T ss_dssp CEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCGGGGGGGTTCCSC-EEECCSSCCCCCCGGGHH--------HHHTS
T ss_pred cEEECCCCccCccChhhhccccCCCEEECCCCccCcCChhHhCccccc-EEECcCCcccccCHhhcc--------cCCCC
Confidence 999999999999999999999999999999999999999999999999 999999999976665542 24566
Q ss_pred CcccccCCcccCCC
Q 045449 534 TAKSFMGNELLCGL 547 (823)
Q Consensus 534 ~~~~~~~n~~~c~~ 547 (823)
...++.+|++.|..
T Consensus 550 ~~L~l~~N~~~c~c 563 (606)
T 3t6q_A 550 RTINLRQNPLDCTC 563 (606)
T ss_dssp SEEECTTCCEECSG
T ss_pred CEEeCCCCCccccC
Confidence 78899999999864
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-55 Score=533.98 Aligned_cols=477 Identities=20% Similarity=0.206 Sum_probs=372.9
Q ss_pred ccceeeeeCCCCCcEEEEEcCCCCCccccCcccCCCCCCcEEEccCCCCCCCC-CCCCCCCCCCCEEECCCCcCcCCCch
Q 045449 40 CIWIGITCDVNSHRVIGLNISSFNLQGTITPQLGNLSSLQTLDLSHNKLSGNI-PSSIFNMHTLKLLDFSDNQLFGSLSS 118 (823)
Q Consensus 40 c~w~gv~c~~~~~~v~~L~L~~~~l~g~~~~~l~~l~~L~~L~Ls~N~l~g~~-p~~~~~l~~L~~L~Ls~N~l~~~~p~ 118 (823)
|.|..|.+ ...+++.|||++|.+++..+.+|.++++|++|||++|.+.+.+ |.+|.++++|++|+|++|.|++..|.
T Consensus 14 ~~L~~vP~--lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~ 91 (844)
T 3j0a_A 14 CNLTQVPQ--VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPD 91 (844)
T ss_dssp CCSSCCCS--SCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTT
T ss_pred CCCCCCCC--CCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHh
Confidence 67888887 4578999999999999999999999999999999999777666 78999999999999999999999999
Q ss_pred hhhcCCCCcEEecccccccCccCccccCCCCCCccccccceeeeccceeeccCc-cccccchhhHHHHHhhcCCCcccCC
Q 045449 119 FIFNMSSMTTIDLSINRLSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAIP-KEIGNLTKLKEIISTITNSTVCEIP 197 (823)
Q Consensus 119 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~l~~l~~L~~L~~l~~n~~~~~ip 197 (823)
+|+++++|++|+|++|++++.+|.. ..|.++++|++|+|++|.+++..+ ..|+++++|++|. +..|.+.+..|
T Consensus 92 ~~~~l~~L~~L~Ls~n~l~~~~~~~-----~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~-Ls~N~i~~~~~ 165 (844)
T 3j0a_A 92 AFQGLFHLFELRLYFCGLSDAVLKD-----GYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSID-FSSNQIFLVCE 165 (844)
T ss_dssp SSCSCSSCCCEECTTCCCSSCCSTT-----CCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEE-EESSCCCCCCS
T ss_pred HccCCcccCEeeCcCCCCCcccccC-----ccccccCCCCEEECCCCcccccccchhHhhCCCCCEEE-CCCCcCCeeCH
Confidence 9999999999999999999866653 124889999999999999987765 5789999999886 88888888888
Q ss_pred cccCCc--chhhhhccccccccCCccccccCCCC------CcEEEccCCcccccCCcccccC------------------
Q 045449 198 REIGNL--PYLARLALATNNLVGVVPVTIFNMSA------LKEISLLNNSLSGSLPSRIDLS------------------ 251 (823)
Q Consensus 198 ~~l~~l--~~L~~L~Ls~N~l~~~~p~~~~~l~~------L~~L~Ls~N~l~g~lp~~~~~~------------------ 251 (823)
..+..+ ++|+.|+|+.|.+.+..|..+..+++ |++|++++|.+++.+|..+...
T Consensus 166 ~~l~~l~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~~~ 245 (844)
T 3j0a_A 166 HELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGA 245 (844)
T ss_dssp GGGHHHHHCSSCCCEECCSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCCBC
T ss_pred HHcccccCCccceEECCCCccccccccchhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceecccccccc
Confidence 888887 78999999999999888877766655 8899999988876666543321
Q ss_pred -------------------CCCccEEEeeccccccccCccccCCCCCCeEEeecccccccCCCccCCCcccCcccccCcc
Q 045449 252 -------------------LPNVETLNLGINSFSGTIPSSITNSSKLSDLELGENLFSGFIPNTIGNLRNLEFGNIADNY 312 (823)
Q Consensus 252 -------------------l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~ 312 (823)
.++|+.|+|++|.+.+..|..|..+++|+.|+|++|++++..|..|..+++|++|+|++|.
T Consensus 246 ~~~~~~l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~ 325 (844)
T 3j0a_A 246 GFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNL 325 (844)
T ss_dssp SSSCSSSTTGGGTTTTTTTTSCCCEEECTTCCCCEECSCCSSSCCCCCEEEEESCCCCEECTTTTTTCSSCCEEEEESCC
T ss_pred cccccccCCCChhhhhccccCCccEEECCCCcccccChhhhhcCCCCCEEECCCCcCCCCChHHhcCCCCCCEEECCCCC
Confidence 2578888888888888888888888888888888888888888888888888888888888
Q ss_pred ccCCCCcccccccccCCCCceEEEeecCCCCccCCccccccccccceEEecCCcceeccCccccCcccccEEEcccCcCC
Q 045449 313 LTSSTPELSFLSSLTNCKKLKVLIVTGNPLDGILPKSIGNFSLSLETILMANCSISGNIPQVVGNLSNLLVLELGGNNLT 392 (823)
Q Consensus 313 l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 392 (823)
+++. .+..|.++++|+.|++++|.+++..+..|..+ ++|++|+|++|.+++.. .+++|+.|++++|+++
T Consensus 326 l~~~-----~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l-~~L~~L~Ls~N~l~~i~-----~~~~L~~L~l~~N~l~ 394 (844)
T 3j0a_A 326 LGEL-----YSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFL-EKLQTLDLRDNALTTIH-----FIPSIPDIFLSGNKLV 394 (844)
T ss_dssp CSCC-----CSCSCSSCTTCCEEECCSCCCCCCCSSCSCSC-CCCCEEEEETCCSCCCS-----SCCSCSEEEEESCCCC
T ss_pred CCcc-----CHHHhcCCCCCCEEECCCCCCCccChhhhcCC-CCCCEEECCCCCCCccc-----CCCCcchhccCCCCcc
Confidence 8776 44577888888888888888888777777777 68888888888887432 2455555555555554
Q ss_pred --------------------CC-chhcccccCCCCEEEccCCCCCCcchH-hhhcCCCCCEEEcccCcCc-----ccccc
Q 045449 393 --------------------GP-IPVTFSQLQTLQAFDLTRNKLAGPITD-ELCHLARLHSLVLQGNKFS-----GSIPS 445 (823)
Q Consensus 393 --------------------g~-~p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~-----g~~p~ 445 (823)
+. .+..+..+++|++|+|++|++++..+. .+..+++|+.|+|++|.++ +..|.
T Consensus 395 ~l~~~~~~l~~L~ls~N~l~~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~ 474 (844)
T 3j0a_A 395 TLPKINLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWD 474 (844)
T ss_dssp CCCCCCTTCCEEECCSCCCCSSTTHHHHTTCTTCCEEEEESCCCCCCCSSSSSCSCTTCCBCEEESCCCSSSCCSCCCSS
T ss_pred cccccccccceeecccCccccCchhhhhhcCCccceeeCCCCcccccccccccccCCccccccCCCCccccccccccchh
Confidence 32 112234666777777777777654333 2445667777777777765 33445
Q ss_pred cccCCCCCCeEeccCCccccccchhhhccCCCcEEeccccccccccCccccCCCCCcEEEcccCCCCCCCCCcccCccCC
Q 045449 446 CLGNLTSVRVLYLGLNIFTSVLSSTIWNLKDILFIDVSSNFLDGPLSLDIGNLKVVIGLDFSRNNLSGDIPITIGEGEIP 525 (823)
Q Consensus 446 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~~~g~ip 525 (823)
.|.++++|+.|+|++|++++.+|..+..+++|+.|||++|+|++..|..+. +.|+.||+++|+|+|.+|..
T Consensus 475 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~--~~L~~L~Ls~N~l~~~~~~~------- 545 (844)
T 3j0a_A 475 VFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP--ANLEILDISRNQLLAPNPDV------- 545 (844)
T ss_dssp CSSCBCCEECCCCCHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCC--SCCCEEEEEEECCCCCCSCC-------
T ss_pred hhcCcccccEEECCCCcccccChhHccchhhhheeECCCCCCCccChhhhh--ccccEEECCCCcCCCCChhH-------
Confidence 677777777777777777777777777777777777777777776665554 67777777777777665544
Q ss_pred CCCCCCCCCcccccCCcccCCCC
Q 045449 526 RGGPFANLTAKSFMGNELLCGLP 548 (823)
Q Consensus 526 ~~~~~~~~~~~~~~~n~~~c~~~ 548 (823)
+..+...++.+|++.|..+
T Consensus 546 ----~~~L~~l~l~~Np~~C~c~ 564 (844)
T 3j0a_A 546 ----FVSLSVLDITHNKFICECE 564 (844)
T ss_dssp ----CSSCCEEEEEEECCCCSSS
T ss_pred ----hCCcCEEEecCCCcccccc
Confidence 3456778899999998554
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-54 Score=514.08 Aligned_cols=480 Identities=21% Similarity=0.222 Sum_probs=294.8
Q ss_pred CcEEEEEcCCCCCccccCcccCCCCCCcEEEccCCCCCCCCCCCCCCCCCCCEEECCCCcCcCCCchhhhcCCCCcEEec
Q 045449 52 HRVIGLNISSFNLQGTITPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLDFSDNQLFGSLSSFIFNMSSMTTIDL 131 (823)
Q Consensus 52 ~~v~~L~L~~~~l~g~~~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 131 (823)
.+++.|+|++|++++..+..|.++++|++|||++|.+++..|..|+++++|++|+|++|.+++..+..|+++++|++|+|
T Consensus 25 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L 104 (680)
T 1ziw_A 25 TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHL 104 (680)
T ss_dssp TTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEEC
T ss_pred CCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccCccChhhhccCCCCCEEEC
Confidence 46888888888888777777888888888888888888888888888888888888888888666667888888888888
Q ss_pred ccccccCccCccccCCCCCCccccccceeeeccceeeccCccccccchhhHHHHHhhcCCCcccCCcccC--Ccchhhhh
Q 045449 132 SINRLSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKEIGNLTKLKEIISTITNSTVCEIPREIG--NLPYLARL 209 (823)
Q Consensus 132 s~N~l~~~~p~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~~l~~n~~~~~ip~~l~--~l~~L~~L 209 (823)
++|++++..|..+ +++++|++|+|++|.+++..|..++++++|++|. +..|.+.+..|..++ .+++|++|
T Consensus 105 ~~n~l~~~~~~~~-------~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~-L~~n~l~~~~~~~~~~~~~~~L~~L 176 (680)
T 1ziw_A 105 MSNSIQKIKNNPF-------VKQKNLITLDLSHNGLSSTKLGTQVQLENLQELL-LSNNKIQALKSEELDIFANSSLKKL 176 (680)
T ss_dssp CSSCCCCCCSCTT-------TTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEE-CCSSCCCCBCHHHHGGGTTCEESEE
T ss_pred CCCccCccChhHc-------cccCCCCEEECCCCcccccCchhhcccccCCEEE-ccCCcccccCHHHhhccccccccEE
Confidence 8888875444444 5556666666666666655555555555555553 444444433333222 22344444
Q ss_pred cccccccc---------------------------------------------------CCccccccCCCC--CcEEEcc
Q 045449 210 ALATNNLV---------------------------------------------------GVVPVTIFNMSA--LKEISLL 236 (823)
Q Consensus 210 ~Ls~N~l~---------------------------------------------------~~~p~~~~~l~~--L~~L~Ls 236 (823)
++++|+++ +..|.+|.+++. |++|+|+
T Consensus 177 ~L~~n~l~~~~~~~~~~l~~L~~L~l~~~~l~~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~~~~~l~~~~L~~L~Ls 256 (680)
T 1ziw_A 177 ELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLS 256 (680)
T ss_dssp ECTTCCCCCBCTTGGGGSSEECEEECTTCCCHHHHHHHHHHHHTTSCCCEEECTTSCCCEECTTTTGGGGGSCCCEEECT
T ss_pred ECCCCcccccChhhhhhhhhhhhhhccccccChhhHHHHHHHhhhccccEEEccCCcccccChhHhhccCcCCCCEEECC
Confidence 44444443 333444444432 5666666
Q ss_pred CCcccccCCcccccCCCCccEEEeeccccccccCccc---------------------------------cCCCCCCeEE
Q 045449 237 NNSLSGSLPSRIDLSLPNVETLNLGINSFSGTIPSSI---------------------------------TNSSKLSDLE 283 (823)
Q Consensus 237 ~N~l~g~lp~~~~~~l~~L~~L~Ls~N~l~~~~p~~~---------------------------------~~l~~L~~L~ 283 (823)
+|.+++..|..+. .+++|++|+|++|++++..|..| ..+++|++|+
T Consensus 257 ~n~l~~~~~~~~~-~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i~~~~~~~l~~L~~L~ 335 (680)
T 1ziw_A 257 YNNLNVVGNDSFA-WLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLN 335 (680)
T ss_dssp TSCCCEECTTTTT-TCTTCCEEECCSCCBSEECTTTTTTCTTCCEEECTTCBCCC------CCEECTTTTTTCTTCCEEE
T ss_pred CCCcCccCccccc-CcccccEeeCCCCccCccChhhhcCCCCccEEeccchhhhcccccccccccChhhcccCCCCCEEE
Confidence 6665544433333 35666666666666655444433 3344455555
Q ss_pred eecccccccCCCccCCCcccCcccccCccccCCCCc-----------------------ccccccccCCCCceEEEeecC
Q 045449 284 LGENLFSGFIPNTIGNLRNLEFGNIADNYLTSSTPE-----------------------LSFLSSLTNCKKLKVLIVTGN 340 (823)
Q Consensus 284 Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~-----------------------~~~~~~l~~l~~L~~L~Ls~N 340 (823)
+++|++++..+..|..+++|++|++++|.++..... ...+..+.++++|+.|++++|
T Consensus 336 l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N 415 (680)
T 1ziw_A 336 MEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLN 415 (680)
T ss_dssp CCSCCBCCCCTTTTTTCTTCCEEECTTCBSCCCEECTTTTGGGTTSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred CCCCccCCCChhHhccccCCcEEECCCCchhhhhcchhhhcccccCcCceEECCCCCCCeEChhhhhCCCCCCEEeCCCC
Confidence 555555555555555555555555555543211000 001223444555555555555
Q ss_pred CCCccCC-ccccccccccceEEecCCcceeccCccccCcccccEEEcccCcCC--CCchhcccccCCCCEEEccCCCCCC
Q 045449 341 PLDGILP-KSIGNFSLSLETILMANCSISGNIPQVVGNLSNLLVLELGGNNLT--GPIPVTFSQLQTLQAFDLTRNKLAG 417 (823)
Q Consensus 341 ~l~~~~p-~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~--g~~p~~~~~l~~L~~L~Ls~N~l~~ 417 (823)
.+++.+| ..+.++ .+|++|++++|++++..+..|..+++|+.|++++|.++ +.+|..|..+++|++|+|++|++++
T Consensus 416 ~l~~~~~~~~~~~l-~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~~L~~L~Ls~N~l~~ 494 (680)
T 1ziw_A 416 EIGQELTGQEWRGL-ENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIAN 494 (680)
T ss_dssp CCEEECCSGGGTTC-TTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTTTTCTTCCEEECCSSCCCC
T ss_pred cCccccCcccccCc-ccccEEecCCCCcceeChhhhhcCcccccchhccccccccccCCcccccCCCCCEEECCCCCCCc
Confidence 5554443 344444 45555555555555555555555555555555555554 4556667777777777777777776
Q ss_pred cchHhhhcCCCCCEEEcccCcCccccc--------ccccCCCCCCeEeccCCccccccchhhhccCCCcEEecccccccc
Q 045449 418 PITDELCHLARLHSLVLQGNKFSGSIP--------SCLGNLTSVRVLYLGLNIFTSVLSSTIWNLKDILFIDVSSNFLDG 489 (823)
Q Consensus 418 ~~p~~~~~l~~L~~L~Ls~N~l~g~~p--------~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~LdLs~N~l~g 489 (823)
..+..|.++++|++|+|++|++++..+ ..|.++++|+.|+|++|+++.+.+..|.++++|+.|||++|++++
T Consensus 495 i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~ 574 (680)
T 1ziw_A 495 INDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNT 574 (680)
T ss_dssp CCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCC
T ss_pred CChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCCCCCHHHcccccCcceeECCCCCCCc
Confidence 666667777777777777777765321 236667777777777777776555567777777777777777776
Q ss_pred ccCccccCCCCCcEEEcccCCCCCCCCCcccCccCCCCCCCCCCCcccccCCcccCCCC
Q 045449 490 PLSLDIGNLKVVIGLDFSRNNLSGDIPITIGEGEIPRGGPFANLTAKSFMGNELLCGLP 548 (823)
Q Consensus 490 ~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~~~g~ip~~~~~~~~~~~~~~~n~~~c~~~ 548 (823)
..+..+..++.|+.|++++|++++..|..+. ..+..+...++.+|++.|+.+
T Consensus 575 l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~-------~~~~~L~~l~l~~N~~~c~c~ 626 (680)
T 1ziw_A 575 LPASVFNNQVSLKSLNLQKNLITSVEKKVFG-------PAFRNLTELDMRFNPFDCTCE 626 (680)
T ss_dssp CCTTTTTTCTTCCEEECTTSCCCBCCHHHHH-------HHHTTCSEEECTTCCCCBCCC
T ss_pred CCHhHhCCCCCCCEEECCCCcCCccChhHhc-------ccccccCEEEccCCCcccCCc
Confidence 5555667777777777777777754443321 024567788899999999754
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-54 Score=506.80 Aligned_cols=465 Identities=19% Similarity=0.149 Sum_probs=404.6
Q ss_pred CcEEEEEcCCCCCccccCcccCCCCCCcEEEccCCCCCCCCCCCCCCCCCCCEEECCCCcCcCCCchhhhcCCCCcEEec
Q 045449 52 HRVIGLNISSFNLQGTITPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLDFSDNQLFGSLSSFIFNMSSMTTIDL 131 (823)
Q Consensus 52 ~~v~~L~L~~~~l~g~~~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 131 (823)
.+++.|+|++|.+++..+..|.++++|++|||++|+|++..|.+|.++++|++|+|++|.+++..|..|+++++|++|+|
T Consensus 32 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L 111 (606)
T 3vq2_A 32 SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVA 111 (606)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEEC
T ss_pred CCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccChhhcCCcccCCEEEc
Confidence 57999999999999988889999999999999999999988999999999999999999999999999999999999999
Q ss_pred ccccccCccCccccCCCCCCccccccceeeeccceeec-cCccccccchhhHHHHHhhcCCCcccCCcccCCcchhh---
Q 045449 132 SINRLSGELPANICKIPSTLSKCKQLEELNLGFNNLSG-AIPKEIGNLTKLKEIISTITNSTVCEIPREIGNLPYLA--- 207 (823)
Q Consensus 132 s~N~l~~~~p~~~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~p~~l~~l~~L~~L~~l~~n~~~~~ip~~l~~l~~L~--- 207 (823)
++|++++..+..+ +++++|++|+|++|++++ .+|..|+++++|++|. +.+|.+.+..|..++.+++|+
T Consensus 112 ~~n~l~~~~~~~~-------~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~-Ls~n~l~~~~~~~~~~l~~L~~~l 183 (606)
T 3vq2_A 112 VETKLASLESFPI-------GQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVD-LSYNYIQTITVNDLQFLRENPQVN 183 (606)
T ss_dssp TTSCCCCSSSSCC-------TTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEE-CCSSCCCEECTTTTHHHHHCTTCC
T ss_pred cCCcccccccccc-------CCCCCCCEEeCCCCcccceechHhHhhcCCCCEEE-ccCCcceecChhhhhhhhcccccc
Confidence 9999986554544 889999999999999986 6799999999999986 888888888888888888876
Q ss_pred -hhccccccccCCccccccCCCCCcEEEccCCcccc--------------------------------------------
Q 045449 208 -RLALATNNLVGVVPVTIFNMSALKEISLLNNSLSG-------------------------------------------- 242 (823)
Q Consensus 208 -~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g-------------------------------------------- 242 (823)
.|++++|++++..+..+... +|++|++++|.+++
T Consensus 184 ~~L~l~~n~l~~~~~~~~~~~-~L~~L~L~~n~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~l~~~~~~~~~~l~~l~ 262 (606)
T 3vq2_A 184 LSLDMSLNPIDFIQDQAFQGI-KLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVT 262 (606)
T ss_dssp CEEECTTCCCCEECTTTTTTC-EEEEEEEESCCSCHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCGGGGTTGGGSE
T ss_pred ceeeccCCCcceeCcccccCc-eeeeeeccCCccchhHHHHHhccccccccccccccccccCCcccccChHHhhhhhhcc
Confidence 69999999987666665544 89999988887642
Q ss_pred --------------cCCcccccCCCCccEEEeeccccccccCccccCCCCCCeEEeecccccccCCCccCCCcccCcccc
Q 045449 243 --------------SLPSRIDLSLPNVETLNLGINSFSGTIPSSITNSSKLSDLELGENLFSGFIPNTIGNLRNLEFGNI 308 (823)
Q Consensus 243 --------------~lp~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 308 (823)
.+|. +..+++|+.|++++|.+. .+| .+..+++|++|++++|.+ +.+| .+ .+++|+.|++
T Consensus 263 l~~l~l~~~~~~~~~~~~--~~~l~~L~~L~l~~~~~~-~l~-~l~~~~~L~~L~l~~n~l-~~lp-~~-~l~~L~~L~l 335 (606)
T 3vq2_A 263 IDEFRLTYTNDFSDDIVK--FHCLANVSAMSLAGVSIK-YLE-DVPKHFKWQSLSIIRCQL-KQFP-TL-DLPFLKSLTL 335 (606)
T ss_dssp EEEEEECCCTTCCGGGGS--CGGGTTCSEEEEESCCCC-CCC-CCCTTCCCSEEEEESCCC-SSCC-CC-CCSSCCEEEE
T ss_pred Hhheeccccccccccccc--cccCCCCCEEEecCccch-hhh-hccccccCCEEEcccccC-cccc-cC-CCCccceeec
Confidence 2222 223678888888888886 455 788888899999999988 5677 44 8888999999
Q ss_pred cCccccCCCCcccccccccCCCCceEEEeecCCCCcc--CCccccccccccceEEecCCcceeccCccccCcccccEEEc
Q 045449 309 ADNYLTSSTPELSFLSSLTNCKKLKVLIVTGNPLDGI--LPKSIGNFSLSLETILMANCSISGNIPQVVGNLSNLLVLEL 386 (823)
Q Consensus 309 ~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~--~p~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 386 (823)
++|...+. ..+..+++|+.|++++|.+++. .|..+..+ ++|++|++++|.+++ +|..+..+++|++|++
T Consensus 336 ~~n~~~~~-------~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~-~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~l 406 (606)
T 3vq2_A 336 TMNKGSIS-------FKKVALPSLSYLDLSRNALSFSGCCSYSDLGT-NSLRHLDLSFNGAII-MSANFMGLEELQHLDF 406 (606)
T ss_dssp ESCSSCEE-------CCCCCCTTCCEEECCSSCEEEEEECCHHHHCC-SCCCEEECCSCSEEE-ECCCCTTCTTCCEEEC
T ss_pred cCCcCccc-------hhhccCCCCCEEECcCCccCCCcchhhhhccC-CcccEeECCCCcccc-chhhccCCCCCCeeEC
Confidence 88855443 2567899999999999999977 48888888 799999999999986 5688999999999999
Q ss_pred ccCcCCCCch-hcccccCCCCEEEccCCCCCCcchHhhhcCCCCCEEEcccCcCcc-cccccccCCCCCCeEeccCCccc
Q 045449 387 GGNNLTGPIP-VTFSQLQTLQAFDLTRNKLAGPITDELCHLARLHSLVLQGNKFSG-SIPSCLGNLTSVRVLYLGLNIFT 464 (823)
Q Consensus 387 s~N~l~g~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g-~~p~~~~~l~~L~~L~Ls~N~l~ 464 (823)
++|++++..| ..+..+++|++|++++|++++..|..+.++++|++|++++|.+++ .+|..++.+++|+.|+|++|+++
T Consensus 407 ~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~ 486 (606)
T 3vq2_A 407 QHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLE 486 (606)
T ss_dssp TTSEEESTTTTTTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCC
T ss_pred CCCccCCccChhhhhccccCCEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCC
Confidence 9999998887 689999999999999999999999999999999999999999998 47999999999999999999999
Q ss_pred cccchhhhccCCCcEEeccccccccccCccccCCCCCcEEEcccCCCCCCCCCcccCccCCCCCCCCCCCcccccCCccc
Q 045449 465 SVLSSTIWNLKDILFIDVSSNFLDGPLSLDIGNLKVVIGLDFSRNNLSGDIPITIGEGEIPRGGPFANLTAKSFMGNELL 544 (823)
Q Consensus 465 ~~~p~~~~~l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~~~g~ip~~~~~~~~~~~~~~~n~~~ 544 (823)
+.+|..+..+++|+.|++++|++++.+|..+++++.|+.||+++|+++ .+|..+. ..| ..+....+.+|++.
T Consensus 487 ~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~-~~p~~~~--~l~-----~~L~~l~l~~N~~~ 558 (606)
T 3vq2_A 487 QISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIE-TSKGILQ--HFP-----KSLAFFNLTNNSVA 558 (606)
T ss_dssp EECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEECTTSCCC-CEESCGG--GSC-----TTCCEEECCSCCCC
T ss_pred ccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCCEEECCCCcCc-ccCHhHh--hhc-----ccCcEEEccCCCcc
Confidence 999999999999999999999999999999999999999999999999 5665542 122 24677889999999
Q ss_pred CCCCC
Q 045449 545 CGLPD 549 (823)
Q Consensus 545 c~~~~ 549 (823)
|+.+.
T Consensus 559 c~c~~ 563 (606)
T 3vq2_A 559 CICEH 563 (606)
T ss_dssp CSSTT
T ss_pred cCCcc
Confidence 97553
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-54 Score=504.64 Aligned_cols=450 Identities=20% Similarity=0.176 Sum_probs=407.9
Q ss_pred CcEEEEEcCCCCCccccCcccCCCCCCcEEEccCCCCCCCCCCCCCCCCCCCEEECCCCcCcCCCchhhhcCCCCcEEec
Q 045449 52 HRVIGLNISSFNLQGTITPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLDFSDNQLFGSLSSFIFNMSSMTTIDL 131 (823)
Q Consensus 52 ~~v~~L~L~~~~l~g~~~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 131 (823)
.+++.|+|++|.+.+..|.+|+++++|++|+|++|++++..|..|+++++|++|+|++|.+++..|..|+++++|++|+|
T Consensus 57 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~l~~~~~~~l~~L~~L~L 136 (606)
T 3t6q_A 57 INLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYL 136 (606)
T ss_dssp TTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCSEECTTTTSSCTTCCEEECTTSCCSCGGGSCCTTCTTCCEEEC
T ss_pred ccceEEECCCCccceeChhhccCccccCeeeCCCCcccccChhhhcccccccEeeccccCcccCCcchhccCCcccEEEC
Confidence 47899999999999988999999999999999999999999999999999999999999999888899999999999999
Q ss_pred ccccccCccCccccCCCCCCccccccceeeeccceeeccCccccccchhhH--HHHHhhcCCCcccCCcccCCc------
Q 045449 132 SINRLSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKEIGNLTKLK--EIISTITNSTVCEIPREIGNL------ 203 (823)
Q Consensus 132 s~N~l~~~~p~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~--~L~~l~~n~~~~~ip~~l~~l------ 203 (823)
++|++++..+..+ ..+++|++|+|++|++++..|..|+.+++|+ .|. +.+|.+.+..|..+...
T Consensus 137 ~~n~l~~~~~~~~-------~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~l~L~-l~~n~l~~~~~~~~~~~~L~~L~ 208 (606)
T 3t6q_A 137 GSNHISSIKLPKG-------FPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLN-LNGNDIAGIEPGAFDSAVFQSLN 208 (606)
T ss_dssp CSSCCCCCCCCTT-------CCCTTCCEEECCSSCCCEECHHHHHTTTTCCSEEEE-CTTCCCCEECTTTTTTCEEEEEE
T ss_pred CCCcccccCcccc-------cCCcccCEEEcccCcccccChhhhhhhcccceeEEe-cCCCccCccChhHhhhccccccc
Confidence 9999986332222 3489999999999999988888899888887 553 77788877766655431
Q ss_pred ---------------------------------------------chhhhhccccccccCCccccccCCCCCcEEEccCC
Q 045449 204 ---------------------------------------------PYLARLALATNNLVGVVPVTIFNMSALKEISLLNN 238 (823)
Q Consensus 204 ---------------------------------------------~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 238 (823)
.+|+.|++++|++++..+..|.++++|++|++++|
T Consensus 209 l~~~~~~~~~~~~l~~~~l~~l~~~~~~~~~~~~i~~~~~~~l~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n 288 (606)
T 3t6q_A 209 FGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTAT 288 (606)
T ss_dssp CTTCSCHHHHHHHTTTCEEEEEECCCCTTSCCCCCCGGGGGGGGGSEEEEEECTTCCCSSCCTTTTTTCTTCSEEECTTS
T ss_pred cCCchhHHHHhhhccccchhheechhhccccccccChhHhchhhcCceeEEEeecCccCccCHHHhccccCCCEEeccCC
Confidence 16888999999999998889999999999999999
Q ss_pred cccccCCcccccCCCCccEEEeeccccccccCccccCCCCCCeEEeecccccccCCC-ccCCCcccCcccccCccccCCC
Q 045449 239 SLSGSLPSRIDLSLPNVETLNLGINSFSGTIPSSITNSSKLSDLELGENLFSGFIPN-TIGNLRNLEFGNIADNYLTSST 317 (823)
Q Consensus 239 ~l~g~lp~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~L~~N~l~~~~ 317 (823)
.++ .+|..+.. +++|++|++++|++++..|..+.++++|++|++++|.+.+.+|. .+..+++|++|++++|.+++..
T Consensus 289 ~l~-~lp~~l~~-l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~ 366 (606)
T 3t6q_A 289 HLS-ELPSGLVG-LSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSD 366 (606)
T ss_dssp CCS-CCCSSCCS-CTTCCEEECTTCCCSBGGGGCGGGCTTCSEEECCSCSSCCBCCSSTTTTCTTCCEEECCSSCCCEEE
T ss_pred ccC-CCChhhcc-cccCCEEECccCCcCcCchhhhhccCcCCEEECCCCCcccccchhhhhccCcCCEEECCCCcccccc
Confidence 998 89988765 99999999999999998899999999999999999999977665 4999999999999999998762
Q ss_pred CcccccccccCCCCceEEEeecCCCCccCCccccccccccceEEecCCcceeccCcc-ccCcccccEEEcccCcCCCCch
Q 045449 318 PELSFLSSLTNCKKLKVLIVTGNPLDGILPKSIGNFSLSLETILMANCSISGNIPQV-VGNLSNLLVLELGGNNLTGPIP 396 (823)
Q Consensus 318 ~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~p~~-~~~l~~L~~L~Ls~N~l~g~~p 396 (823)
. .+..+.++++|+.|++++|.+.+..|..+..+ ++|++|++++|.+++..|.. +..+++|++|++++|.+++..|
T Consensus 367 ~---~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l-~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~ 442 (606)
T 3t6q_A 367 C---CNLQLRNLSHLQSLNLSYNEPLSLKTEAFKEC-PQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSE 442 (606)
T ss_dssp E---STTTTTTCTTCCEEECCSCSCEEECTTTTTTC-TTCSEEECTTCCEECCTTCCTTTTCTTCCEEECTTCCCBTTCT
T ss_pred C---cchhcccCCCCCEEECCCCcCCcCCHHHhcCC-ccCCeEECCCCcCCCcccchhhhCcccCCEEECCCCccCCcCH
Confidence 1 14578999999999999999999999999998 79999999999999887654 8999999999999999999999
Q ss_pred hcccccCCCCEEEccCCCCCCc---chHhhhcCCCCCEEEcccCcCcccccccccCCCCCCeEeccCCccccccchhhhc
Q 045449 397 VTFSQLQTLQAFDLTRNKLAGP---ITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSVRVLYLGLNIFTSVLSSTIWN 473 (823)
Q Consensus 397 ~~~~~l~~L~~L~Ls~N~l~~~---~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 473 (823)
..+..+++|++|++++|++++. .+..+..+++|+.|+|++|++++..|..|.++++|+.|+|++|++++.+|..+..
T Consensus 443 ~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~ 522 (606)
T 3t6q_A 443 QLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSH 522 (606)
T ss_dssp TTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCGGGGGGGTT
T ss_pred HHHhCCCCCCEEECCCCCCCccccccchhhccCCCccEEECCCCccCccChhhhccccCCCEEECCCCccCcCChhHhCc
Confidence 9999999999999999999873 3356899999999999999999999999999999999999999999999999999
Q ss_pred cCCCcEEeccccccccccCccccCCCCCcEEEcccCCCCCCCC
Q 045449 474 LKDILFIDVSSNFLDGPLSLDIGNLKVVIGLDFSRNNLSGDIP 516 (823)
Q Consensus 474 l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~ip 516 (823)
++.| .||+++|.+++..|..+..++.|+.|++++|++++..+
T Consensus 523 l~~L-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 564 (606)
T 3t6q_A 523 LKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDCTCS 564 (606)
T ss_dssp CCSC-EEECCSSCCCCCCGGGHHHHHTSSEEECTTCCEECSGG
T ss_pred cccc-EEECcCCcccccCHhhcccCCCCCEEeCCCCCccccCC
Confidence 9999 99999999999999999999999999999999998766
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-51 Score=484.38 Aligned_cols=442 Identities=16% Similarity=0.134 Sum_probs=392.7
Q ss_pred CcEEEEEcCCCCCccccCcccCCCCCCcEEEccCCCCCCCCCCCCCCCCCCCEEECCCCcCcCCCchhhhcCCCCcEEec
Q 045449 52 HRVIGLNISSFNLQGTITPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLDFSDNQLFGSLSSFIFNMSSMTTIDL 131 (823)
Q Consensus 52 ~~v~~L~L~~~~l~g~~~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 131 (823)
.+++.|+|++|.+++..|.+|.++++|++|+|++|.|++..|..|+++++|++|+|++|.+++..+..|+++++|++|+|
T Consensus 56 ~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 135 (606)
T 3vq2_A 56 SELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNV 135 (606)
T ss_dssp TTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEECTTSCCCCSSSSCCTTCTTCCEEEC
T ss_pred ccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccChhhcCCcccCCEEEccCCccccccccccCCCCCCCEEeC
Confidence 47999999999999988899999999999999999999999999999999999999999999888899999999999999
Q ss_pred ccccccC-ccCccccCCCCCCccccccceeeeccceeeccCccccccchhhH----HHHHhhcCCCcccCCcccCCcchh
Q 045449 132 SINRLSG-ELPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKEIGNLTKLK----EIISTITNSTVCEIPREIGNLPYL 206 (823)
Q Consensus 132 s~N~l~~-~~p~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~----~L~~l~~n~~~~~ip~~l~~l~~L 206 (823)
++|++++ .+|..+ +++++|++|+|++|++++..|..|+.+++|+ ++. +..|.+.+..+..+... +|
T Consensus 136 ~~n~l~~~~lp~~~-------~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~~l~~L~-l~~n~l~~~~~~~~~~~-~L 206 (606)
T 3vq2_A 136 AHNFIHSCKLPAYF-------SNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLD-MSLNPIDFIQDQAFQGI-KL 206 (606)
T ss_dssp CSSCCCCCCCCGGG-------GTCTTCCEEECCSSCCCEECTTTTHHHHHCTTCCCEEE-CTTCCCCEECTTTTTTC-EE
T ss_pred CCCcccceechHhH-------hhcCCCCEEEccCCcceecChhhhhhhhccccccceee-ccCCCcceeCcccccCc-ee
Confidence 9999985 455555 8999999999999999998898899888776 353 66777765555555544 88
Q ss_pred hhhcccccccc----------------------------------------------------------CCccccccCCC
Q 045449 207 ARLALATNNLV----------------------------------------------------------GVVPVTIFNMS 228 (823)
Q Consensus 207 ~~L~Ls~N~l~----------------------------------------------------------~~~p~~~~~l~ 228 (823)
+.|++++|.++ +.+|. +..++
T Consensus 207 ~~L~L~~n~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~-~~~l~ 285 (606)
T 3vq2_A 207 HELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVK-FHCLA 285 (606)
T ss_dssp EEEEEESCCSCHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCGGGGTTGGGSEEEEEEECCCTTCCGGGGS-CGGGT
T ss_pred eeeeccCCccchhHHHHHhccccccccccccccccccCCcccccChHHhhhhhhccHhheeccccccccccccc-cccCC
Confidence 88888888654 33343 67789
Q ss_pred CCcEEEccCCcccccCCcccccCCCCccEEEeeccccccccCccccCCCCCCeEEeecccccccCCCccCCCcccCcccc
Q 045449 229 ALKEISLLNNSLSGSLPSRIDLSLPNVETLNLGINSFSGTIPSSITNSSKLSDLELGENLFSGFIPNTIGNLRNLEFGNI 308 (823)
Q Consensus 229 ~L~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 308 (823)
+|+.|++++|.++ .+| .+. .+++|++|++++|++ +.+| .+ .+++|++|++++|...+.+ .+..+++|++|++
T Consensus 286 ~L~~L~l~~~~~~-~l~-~l~-~~~~L~~L~l~~n~l-~~lp-~~-~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~l 357 (606)
T 3vq2_A 286 NVSAMSLAGVSIK-YLE-DVP-KHFKWQSLSIIRCQL-KQFP-TL-DLPFLKSLTLTMNKGSISF--KKVALPSLSYLDL 357 (606)
T ss_dssp TCSEEEEESCCCC-CCC-CCC-TTCCCSEEEEESCCC-SSCC-CC-CCSSCCEEEEESCSSCEEC--CCCCCTTCCEEEC
T ss_pred CCCEEEecCccch-hhh-hcc-ccccCCEEEcccccC-cccc-cC-CCCccceeeccCCcCccch--hhccCCCCCEEEC
Confidence 9999999999997 677 444 489999999999999 6888 45 9999999999999766544 6789999999999
Q ss_pred cCccccCCCCcccccccccCCCCceEEEeecCCCCccCCccccccccccceEEecCCcceeccC-ccccCcccccEEEcc
Q 045449 309 ADNYLTSSTPELSFLSSLTNCKKLKVLIVTGNPLDGILPKSIGNFSLSLETILMANCSISGNIP-QVVGNLSNLLVLELG 387 (823)
Q Consensus 309 ~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~Ls 387 (823)
++|.+++... .+..+..+++|+.|++++|.+++ +|..+..+ ++|++|++++|++++..| ..+..+++|++|+++
T Consensus 358 s~n~l~~~~~---~~~~~~~~~~L~~L~L~~n~l~~-~~~~~~~l-~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~ 432 (606)
T 3vq2_A 358 SRNALSFSGC---CSYSDLGTNSLRHLDLSFNGAII-MSANFMGL-EELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDIS 432 (606)
T ss_dssp CSSCEEEEEE---CCHHHHCCSCCCEEECCSCSEEE-ECCCCTTC-TTCCEEECTTSEEESTTTTTTTTTCTTCCEEECT
T ss_pred cCCccCCCcc---hhhhhccCCcccEeECCCCcccc-chhhccCC-CCCCeeECCCCccCCccChhhhhccccCCEEECc
Confidence 9999987521 24678899999999999999986 56888888 799999999999999888 789999999999999
Q ss_pred cCcCCCCchhcccccCCCCEEEccCCCCCC-cchHhhhcCCCCCEEEcccCcCcccccccccCCCCCCeEeccCCccccc
Q 045449 388 GNNLTGPIPVTFSQLQTLQAFDLTRNKLAG-PITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSVRVLYLGLNIFTSV 466 (823)
Q Consensus 388 ~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~ 466 (823)
+|++++.+|..+..+++|++|++++|++++ .+|..|..+++|+.|+|++|++++..|..|.++++|+.|+|++|++++.
T Consensus 433 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 512 (606)
T 3vq2_A 433 YTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFL 512 (606)
T ss_dssp TSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCE
T ss_pred CCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEEECCCCcCCCc
Confidence 999999999999999999999999999998 4788899999999999999999999999999999999999999999999
Q ss_pred cchhhhccCCCcEEeccccccccccCccccCCC-CCcEEEcccCCCCCCCCC
Q 045449 467 LSSTIWNLKDILFIDVSSNFLDGPLSLDIGNLK-VVIGLDFSRNNLSGDIPI 517 (823)
Q Consensus 467 ~p~~~~~l~~L~~LdLs~N~l~g~~p~~~~~l~-~L~~L~ls~N~l~g~ip~ 517 (823)
+|..+..+++|+.||+++|+++ .+|..+..++ .|+.|++++|++.+..+.
T Consensus 513 ~~~~~~~l~~L~~L~l~~N~l~-~~p~~~~~l~~~L~~l~l~~N~~~c~c~~ 563 (606)
T 3vq2_A 513 DSSHYNQLYSLSTLDCSFNRIE-TSKGILQHFPKSLAFFNLTNNSVACICEH 563 (606)
T ss_dssp EGGGTTTCTTCCEEECTTSCCC-CEESCGGGSCTTCCEEECCSCCCCCSSTT
T ss_pred CHHHccCCCcCCEEECCCCcCc-ccCHhHhhhcccCcEEEccCCCcccCCcc
Confidence 9999999999999999999999 6777799987 699999999999987664
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-51 Score=477.62 Aligned_cols=481 Identities=19% Similarity=0.217 Sum_probs=394.5
Q ss_pred CccceeeeeCCC-----------CCcEEEEEcCCCCCccccCcccCCCCCCcEEEccCCCCCCCCCCCCCCCCCCCEEEC
Q 045449 39 VCIWIGITCDVN-----------SHRVIGLNISSFNLQGTITPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLDF 107 (823)
Q Consensus 39 ~c~w~gv~c~~~-----------~~~v~~L~L~~~~l~g~~~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L 107 (823)
.|.|.|| ||.. ..+++.|+|++|++++..|.++.++++|++|+|++|+|++..|.+|+++++|++|||
T Consensus 3 ~C~~~~~-c~~~~~~l~~ip~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L 81 (549)
T 2z81_A 3 SCDASGV-CDGRSRSFTSIPSGLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDL 81 (549)
T ss_dssp EECTTSE-EECTTSCCSSCCSCCCTTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEC
T ss_pred cCCCCce-EECCCCccccccccCCCCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEEC
Confidence 4999998 8743 137899999999999988899999999999999999999988999999999999999
Q ss_pred CCCcCcCCCchhhhcCCCCcEEecccccccCc-cCccccCCCCCCccccccceeeeccceeeccCc-cccccchhhHHHH
Q 045449 108 SDNQLFGSLSSFIFNMSSMTTIDLSINRLSGE-LPANICKIPSTLSKCKQLEELNLGFNNLSGAIP-KEIGNLTKLKEII 185 (823)
Q Consensus 108 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~-~p~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~l~~l~~L~~L~ 185 (823)
++|++++..|..|+++++|++|+|++|++++. +|. .|+++++|++|++++|++.+.+| ..|.++++|++|.
T Consensus 82 s~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~-------~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~ 154 (549)
T 2z81_A 82 SDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTS-------LFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELE 154 (549)
T ss_dssp TTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSC-------SCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEE
T ss_pred CCCccCccCHHHhccCCCCcEEECCCCcccccchhh-------hhhccCCccEEECCCCccccccCHhhhhcccccCeee
Confidence 99999999999999999999999999999852 333 45899999999999999555555 6899999999886
Q ss_pred HhhcCCCcccCCcccCCcchhhhhccccccccCCccccccCCCCCcEEEccCCcccccC--CcccccCCCCccEEEeecc
Q 045449 186 STITNSTVCEIPREIGNLPYLARLALATNNLVGVVPVTIFNMSALKEISLLNNSLSGSL--PSRIDLSLPNVETLNLGIN 263 (823)
Q Consensus 186 ~l~~n~~~~~ip~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~l--p~~~~~~l~~L~~L~Ls~N 263 (823)
+.+|.+.+.+|..++.+++|++|+++.|.+....+..+..+++|++|++++|.+++.. |..+...+++|+.|++++|
T Consensus 155 -L~~n~l~~~~~~~l~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~~L~l~~n 233 (549)
T 2z81_A 155 -IKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGS 233 (549)
T ss_dssp -EEETTCCEECTTTTTTCSEEEEEEEECSBSTTHHHHHHHSTTTBSEEEEESCBCTTCCCCCCSSCCCCCCCCEEEEESC
T ss_pred -ccCCcccccChhhhhccccCceEecccCcccccchhhHhhcccccEEEccCCccccccccccchhhhhhcccceecccc
Confidence 8889999999999999999999999999987543334457899999999999998632 3334445789999999999
Q ss_pred ccccccCc----cccCCCCCCeEEeecccccccC------CCccCCCcccCcccccCccccCCCCcccccccccCCCCce
Q 045449 264 SFSGTIPS----SITNSSKLSDLELGENLFSGFI------PNTIGNLRNLEFGNIADNYLTSSTPELSFLSSLTNCKKLK 333 (823)
Q Consensus 264 ~l~~~~p~----~~~~l~~L~~L~Ls~N~l~~~~------p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~ 333 (823)
.+++..+. .+..+++|+.|++++|.+.+.. ...+..+.+|+.|++.++.+............+...++|+
T Consensus 234 ~l~~~~~~~l~~~~~~~~~L~~l~l~~~~~~~~~~~~~~~~~~~~~l~~L~~L~l~~~~i~~~~~~~~l~~~~~~~~~L~ 313 (549)
T 2z81_A 234 VLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVK 313 (549)
T ss_dssp EEEHHHHHHHHGGGGGCTTCCEEEEESCEEECCSCCCCCTTTCCCCCTTCCEEEEESCBCSCGGGSCCCCHHHHHSTTCC
T ss_pred ccchhHHHHHHHHhhhhccccccccccccccccccccccchhhhhhhcccccccccccccchhhhcccchhhhhhcccce
Confidence 99875543 4467789999999999988742 2345678889999998888765321111122234467899
Q ss_pred EEEeecCCCCccCCcccc-ccccccceEEecCCcceeccC---ccccCcccccEEEcccCcCCCCch--hcccccCCCCE
Q 045449 334 VLIVTGNPLDGILPKSIG-NFSLSLETILMANCSISGNIP---QVVGNLSNLLVLELGGNNLTGPIP--VTFSQLQTLQA 407 (823)
Q Consensus 334 ~L~Ls~N~l~~~~p~~~~-~~~~~L~~L~L~~N~l~~~~p---~~~~~l~~L~~L~Ls~N~l~g~~p--~~~~~l~~L~~ 407 (823)
.|++++|.+. .+|..+. .+ ++|++|++++|++++.+| ..++.+++|++|+|++|++++..+ ..+..+++|++
T Consensus 314 ~L~l~~n~l~-~ip~~~~~~l-~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~~ 391 (549)
T 2z81_A 314 RITVENSKVF-LVPCSFSQHL-KSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTS 391 (549)
T ss_dssp EEEEESSCCC-CCCHHHHHHC-TTCCEEECCSSCCCHHHHHHHTCTTSSTTCCEEECTTSCCCCHHHHHHHGGGCTTCCE
T ss_pred EEEeccCccc-cCCHHHHhcC-ccccEEEccCCccccccccchhhhhccccCcEEEccCCcccccccchhhhhcCCCCCE
Confidence 9999999997 5677664 56 799999999999998774 447889999999999999986543 56889999999
Q ss_pred EEccCCCCCCcchHhhhcCCCCCEEEcccCcCcccccccccCCCCCCeEeccCCccccccchhhhccCCCcEEecccccc
Q 045449 408 FDLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSVRVLYLGLNIFTSVLSSTIWNLKDILFIDVSSNFL 487 (823)
Q Consensus 408 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~LdLs~N~l 487 (823)
|+|++|+++ .+|..+..+++|++|+|++|++++ +|..+. ++|++|+|++|++++.+ ..+++|++|||++|++
T Consensus 392 L~Ls~N~l~-~lp~~~~~~~~L~~L~Ls~N~l~~-l~~~~~--~~L~~L~Ls~N~l~~~~----~~l~~L~~L~Ls~N~l 463 (549)
T 2z81_A 392 LDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIRV-VKTCIP--QTLEVLDVSNNNLDSFS----LFLPRLQELYISRNKL 463 (549)
T ss_dssp EECTTCCCC-CCCSCCCCCTTCCEEECTTSCCSC-CCTTSC--TTCSEEECCSSCCSCCC----CCCTTCCEEECCSSCC
T ss_pred EECCCCCCc-cCChhhcccccccEEECCCCCccc-ccchhc--CCceEEECCCCChhhhc----ccCChhcEEECCCCcc
Confidence 999999999 678888899999999999999984 454442 68999999999999864 5789999999999999
Q ss_pred ccccCccccCCCCCcEEEcccCCCCCCCCCcccCccCCCCCCCCCCCcccccCCcccCCCC
Q 045449 488 DGPLSLDIGNLKVVIGLDFSRNNLSGDIPITIGEGEIPRGGPFANLTAKSFMGNELLCGLP 548 (823)
Q Consensus 488 ~g~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~~~g~ip~~~~~~~~~~~~~~~n~~~c~~~ 548 (823)
+ .+|. ...++.|++||+++|++++.+|..+. .+..+..+++.+|++.|..|
T Consensus 464 ~-~ip~-~~~l~~L~~L~Ls~N~l~~~~~~~~~--------~l~~L~~L~l~~N~~~~~~~ 514 (549)
T 2z81_A 464 K-TLPD-ASLFPVLLVMKISRNQLKSVPDGIFD--------RLTSLQKIWLHTNPWDCSCP 514 (549)
T ss_dssp S-SCCC-GGGCTTCCEEECCSSCCCCCCTTGGG--------GCTTCCEEECCSSCBCCCHH
T ss_pred C-cCCC-cccCccCCEEecCCCccCCcCHHHHh--------cCcccCEEEecCCCccCCCc
Confidence 8 6776 56799999999999999977666553 35567788999999988643
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-51 Score=476.19 Aligned_cols=467 Identities=19% Similarity=0.168 Sum_probs=326.9
Q ss_pred CcEEEEEcCCCCCccccCcccCCCCCCcEEEccCCCCCCCCCCCCCCCCCCCEEECCCCcCcCCCchhhhcCCCCcEEec
Q 045449 52 HRVIGLNISSFNLQGTITPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLDFSDNQLFGSLSSFIFNMSSMTTIDL 131 (823)
Q Consensus 52 ~~v~~L~L~~~~l~g~~~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 131 (823)
.+++.|||++|++++..+.+|.++++|++|||++|+|++..|..|.++++|++|+|++|.+++..|.+|+++++|++|+|
T Consensus 28 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 107 (570)
T 2z63_A 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA 107 (570)
T ss_dssp SSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEEC
T ss_pred ccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcCccccccccc
Confidence 47899999999999888889999999999999999999888899999999999999999999988999999999999999
Q ss_pred ccccccCccCccccCCCCCCccccccceeeeccceeec-cCccccccchhhHHHHHhhcCCCcccCCcccCCcchh----
Q 045449 132 SINRLSGELPANICKIPSTLSKCKQLEELNLGFNNLSG-AIPKEIGNLTKLKEIISTITNSTVCEIPREIGNLPYL---- 206 (823)
Q Consensus 132 s~N~l~~~~p~~~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~p~~l~~l~~L~~L~~l~~n~~~~~ip~~l~~l~~L---- 206 (823)
++|++++..+.. |+++++|++|+|++|.+++ .+|..|+++++|++|. +.+|.+.+..|..++.+++|
T Consensus 108 ~~n~l~~l~~~~-------~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~-l~~n~l~~~~~~~~~~l~~L~~~~ 179 (570)
T 2z63_A 108 VETNLASLENFP-------IGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLD-LSSNKIQSIYCTDLRVLHQMPLLN 179 (570)
T ss_dssp TTSCCCCSTTCS-------CTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEE-CTTSCCCEECGGGGHHHHTCTTCC
T ss_pred cccccccCCCcc-------ccccccccEEecCCCccceecChhhhcccCCCCEEe-CcCCccceecHHHccchhccchhh
Confidence 999998543323 4899999999999999987 4799999999999986 88888888878889988888
Q ss_pred hhhccccccccCCccccccCCCCCcEEEccCCcccc------------------------------cCCcccccCCC--C
Q 045449 207 ARLALATNNLVGVVPVTIFNMSALKEISLLNNSLSG------------------------------SLPSRIDLSLP--N 254 (823)
Q Consensus 207 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g------------------------------~lp~~~~~~l~--~ 254 (823)
+.|++++|.+++..|..+... +|+.|++++|.... .++...+..++ .
T Consensus 180 ~~L~l~~n~l~~~~~~~~~~~-~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~l~~l~ 258 (570)
T 2z63_A 180 LSLDLSLNPMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLT 258 (570)
T ss_dssp CEEECTTCCCCEECTTTTTTC-EEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCCCSSCEECCTTTTGGGGGSE
T ss_pred hhcccCCCCceecCHHHhccC-cceeEecccccccccchhhhhcCccccceeeeccccccCchhhhhcchhhhccccccc
Confidence 889999999998888887766 89999999883221 11111111111 2
Q ss_pred ccEEEeecc-ccccccCccccCCCCCCeEEeecccccccCCCccCCCcccCcccccCccccCCCCcccccccccCCCCce
Q 045449 255 VETLNLGIN-SFSGTIPSSITNSSKLSDLELGENLFSGFIPNTIGNLRNLEFGNIADNYLTSSTPELSFLSSLTNCKKLK 333 (823)
Q Consensus 255 L~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~ 333 (823)
++.+++++| .+.+.+|..+..+++|++|++++|.++ .+|..+..+ +|+.|++++|.++..+ . ..+++|+
T Consensus 259 l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~l~~~~l~-~l~~~~~~~-~L~~L~l~~n~~~~l~------~--~~l~~L~ 328 (570)
T 2z63_A 259 IEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSYNF-GWQHLELVNCKFGQFP------T--LKLKSLK 328 (570)
T ss_dssp EEEEEEEETTEEESCSTTTTGGGTTCSEEEEESCEEC-SCCBCCSCC-CCSEEEEESCBCSSCC------B--CBCSSCC
T ss_pred hhhhhhhcchhhhhhchhhhcCcCcccEEEecCccch-hhhhhhccC-CccEEeeccCcccccC------c--ccccccC
Confidence 344555555 556666666666667777777777666 355566666 6667777666666331 1 3455666
Q ss_pred EEEeecCCCCccCCccccccccccceEEecCCcceecc--CccccCcccccEEEcccCcCCCCchhcccccCCCCEEEcc
Q 045449 334 VLIVTGNPLDGILPKSIGNFSLSLETILMANCSISGNI--PQVVGNLSNLLVLELGGNNLTGPIPVTFSQLQTLQAFDLT 411 (823)
Q Consensus 334 ~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~--p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls 411 (823)
.|++++|.+.+..+. ..+ ++|++|++++|++++.. |..+.++++|++|++++|++++..+. +..+++|++|+++
T Consensus 329 ~L~l~~n~~~~~~~~--~~~-~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~-~~~l~~L~~L~l~ 404 (570)
T 2z63_A 329 RLTFTSNKGGNAFSE--VDL-PSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSN-FLGLEQLEHLDFQ 404 (570)
T ss_dssp EEEEESCBSCCBCCC--CBC-TTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEEEEEE-EETCTTCCEEECT
T ss_pred EEeCcCCcccccccc--ccC-CCCCEEeCcCCccCccccccccccccCccCEEECCCCcccccccc-ccccCCCCEEEcc
Confidence 666666666655544 333 46666666666666543 55556666666666666666643333 6666666666666
Q ss_pred CCCCCCcch-HhhhcCCCCCEEEcccCcCcccccccccCCCCCCeEeccCCccc-cccchhhhccCCCcEEecccccccc
Q 045449 412 RNKLAGPIT-DELCHLARLHSLVLQGNKFSGSIPSCLGNLTSVRVLYLGLNIFT-SVLSSTIWNLKDILFIDVSSNFLDG 489 (823)
Q Consensus 412 ~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~LdLs~N~l~g 489 (823)
+|++++..| ..+.++++|++|++++|.+++.+|..+.++++|++|+|++|.++ +.+|..+..+++|+.|++++|.+++
T Consensus 405 ~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~ 484 (570)
T 2z63_A 405 HSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQ 484 (570)
T ss_dssp TSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCE
T ss_pred CCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCcccc
Confidence 666665544 34556666666666666666666666666666666666666665 4566666666666666666666666
Q ss_pred ccCccccCCCCCcEEEcccCCCCCCCCCcccCccCCCCCCCCCCCcccccCCcccCCCCC
Q 045449 490 PLSLDIGNLKVVIGLDFSRNNLSGDIPITIGEGEIPRGGPFANLTAKSFMGNELLCGLPD 549 (823)
Q Consensus 490 ~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~~~g~ip~~~~~~~~~~~~~~~n~~~c~~~~ 549 (823)
..|..+..++.|+.|++++|++++.+|..+ ..+..+....+.+|++.|..|.
T Consensus 485 ~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~--------~~l~~L~~L~l~~N~~~~~~~~ 536 (570)
T 2z63_A 485 LSPTAFNSLSSLQVLNMASNQLKSVPDGIF--------DRLTSLQKIWLHTNPWDCSCPR 536 (570)
T ss_dssp ECTTTTTTCTTCCEEECCSSCCSCCCTTTT--------TTCTTCCEEECCSSCBCCCTTT
T ss_pred CChhhhhcccCCCEEeCCCCcCCCCCHHHh--------hcccCCcEEEecCCcccCCCcc
Confidence 666666666666666666666664433332 1234455556666666665543
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-50 Score=480.90 Aligned_cols=446 Identities=21% Similarity=0.211 Sum_probs=301.0
Q ss_pred EEEcCCCCCccccCcccCCCCCCcEEEccCCCCCCCCCCCCCCCCCCCEEECCCCcCcCCCchhhhcCCCCcEEeccccc
Q 045449 56 GLNISSFNLQGTITPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLDFSDNQLFGSLSSFIFNMSSMTTIDLSINR 135 (823)
Q Consensus 56 ~L~L~~~~l~g~~~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 135 (823)
.+|+++++++ .+|..+. +++++|||++|+|++..+..|.++++|++|||++|.+++..|.+|+++++|++|+|++|+
T Consensus 8 ~~~cs~~~L~-~ip~~~~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~ 84 (680)
T 1ziw_A 8 VADCSHLKLT-QVPDDLP--TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNE 84 (680)
T ss_dssp EEECCSSCCS-SCCSCSC--TTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSC
T ss_pred eeECCCCCcc-ccccccC--CCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCCc
Confidence 4666777776 5676664 799999999999998888899999999999999999999999999999999999999999
Q ss_pred ccCccCccccCCCCCCccccccceeeeccceeeccCccccccchhhHHHHHhhcCCCcccCCcccCCcchhhhhcccccc
Q 045449 136 LSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKEIGNLTKLKEIISTITNSTVCEIPREIGNLPYLARLALATNN 215 (823)
Q Consensus 136 l~~~~p~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~~l~~n~~~~~ip~~l~~l~~L~~L~Ls~N~ 215 (823)
+++..+. .|+++++|++|+|++|++++..|..|+++++|++|. +..|.+.+..|..++++++|++|++++|+
T Consensus 85 l~~l~~~-------~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~-Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~ 156 (680)
T 1ziw_A 85 LSQLSDK-------TFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLD-LSHNGLSSTKLGTQVQLENLQELLLSNNK 156 (680)
T ss_dssp CCCCCTT-------TTTTCTTCSEEECCSSCCCCCCSCTTTTCTTCCEEE-CCSSCCSCCCCCSSSCCTTCCEEECCSSC
T ss_pred cCccChh-------hhccCCCCCEEECCCCccCccChhHccccCCCCEEE-CCCCcccccCchhhcccccCCEEEccCCc
Confidence 9843222 358999999999999999987788999999999996 88999999999999999999999999999
Q ss_pred ccCCcccccc--CCCCCcEEEccCCcccccCCccccc--------------------------CCCCccEEEeecccccc
Q 045449 216 LVGVVPVTIF--NMSALKEISLLNNSLSGSLPSRIDL--------------------------SLPNVETLNLGINSFSG 267 (823)
Q Consensus 216 l~~~~p~~~~--~l~~L~~L~Ls~N~l~g~lp~~~~~--------------------------~l~~L~~L~Ls~N~l~~ 267 (823)
+++..+..+. .+++|++|++++|.+++..|..+.. ..++|+.|++++|++++
T Consensus 157 l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~~~l~~~~~~~~~~~l~~~~L~~L~L~~n~l~~ 236 (680)
T 1ziw_A 157 IQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLST 236 (680)
T ss_dssp CCCBCHHHHGGGTTCEESEEECTTCCCCCBCTTGGGGSSEECEEECTTCCCHHHHHHHHHHHHTTSCCCEEECTTSCCCE
T ss_pred ccccCHHHhhccccccccEEECCCCcccccChhhhhhhhhhhhhhccccccChhhHHHHHHHhhhccccEEEccCCcccc
Confidence 9998887664 5689999999999998666543321 12456677777777777
Q ss_pred ccCccccCCCC--CCeEEeecccccccCCCccCCCcccCcccccCccccCCCCcc------------------------c
Q 045449 268 TIPSSITNSSK--LSDLELGENLFSGFIPNTIGNLRNLEFGNIADNYLTSSTPEL------------------------S 321 (823)
Q Consensus 268 ~~p~~~~~l~~--L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~------------------------~ 321 (823)
..|..+.+++. |++|+|++|++++..|..|+.+++|++|++++|++++..+.. .
T Consensus 237 ~~~~~~~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~~~~ 316 (680)
T 1ziw_A 237 TSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLAS 316 (680)
T ss_dssp ECTTTTGGGGGSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSCCBSEECTTTTTTCTTCCEEECTTCBCCC------
T ss_pred cChhHhhccCcCCCCEEECCCCCcCccCcccccCcccccEeeCCCCccCccChhhhcCCCCccEEeccchhhhccccccc
Confidence 77777766644 777777777777777777777777777777777776652210 0
Q ss_pred ccc----cccCCCCceEEEeecCCCCccCCccccccccccceEEecCCccee--ccCccccCc--ccccEEEcccCcCCC
Q 045449 322 FLS----SLTNCKKLKVLIVTGNPLDGILPKSIGNFSLSLETILMANCSISG--NIPQVVGNL--SNLLVLELGGNNLTG 393 (823)
Q Consensus 322 ~~~----~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~--~~p~~~~~l--~~L~~L~Ls~N~l~g 393 (823)
++. .+..+++|+.|++++|.+++..|..|..+ ++|++|++++|.+++ ..+..|..+ ++|+.|++++|++++
T Consensus 317 lp~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l-~~L~~L~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~ 395 (680)
T 1ziw_A 317 LPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGL-INLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISK 395 (680)
T ss_dssp CCEECTTTTTTCTTCCEEECCSCCBCCCCTTTTTTC-TTCCEEECTTCBSCCCEECTTTTGGGTTSCCCEEECTTSCCCE
T ss_pred ccccChhhcccCCCCCEEECCCCccCCCChhHhccc-cCCcEEECCCCchhhhhcchhhhcccccCcCceEECCCCCCCe
Confidence 111 34445555555555555555555555544 345555444443221 111122221 244444444455554
Q ss_pred CchhcccccCCCCEEEccCCCCCCcch-HhhhcCCCCCEEEcccCcCcccccccccCCCCCCeEeccCCccc--cccchh
Q 045449 394 PIPVTFSQLQTLQAFDLTRNKLAGPIT-DELCHLARLHSLVLQGNKFSGSIPSCLGNLTSVRVLYLGLNIFT--SVLSST 470 (823)
Q Consensus 394 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~--~~~p~~ 470 (823)
..|..|..+++|++|+|++|++++.+| ..|.++++|++|++++|++++..+..|..+++|+.|++++|.++ +.+|..
T Consensus 396 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~ 475 (680)
T 1ziw_A 396 IESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSP 475 (680)
T ss_dssp ECTTTTTTCTTCCEEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCT
T ss_pred EChhhhhCCCCCCEEeCCCCcCccccCcccccCcccccEEecCCCCcceeChhhhhcCcccccchhccccccccccCCcc
Confidence 445555555555555555555554433 34555555555555555555555555555555555555555544 344555
Q ss_pred hhccCCCcEEeccccccccccCccccCCCCCcEEEcccCCCCC
Q 045449 471 IWNLKDILFIDVSSNFLDGPLSLDIGNLKVVIGLDFSRNNLSG 513 (823)
Q Consensus 471 ~~~l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g 513 (823)
+..+++|+.||+++|.+++..|..+..++.|++|++++|++++
T Consensus 476 ~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~ 518 (680)
T 1ziw_A 476 FQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLAR 518 (680)
T ss_dssp TTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGG
T ss_pred cccCCCCCEEECCCCCCCcCChhhhccccccCEEeCCCCCccc
Confidence 5555555555555555555444555555555555555555553
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-50 Score=493.96 Aligned_cols=442 Identities=20% Similarity=0.198 Sum_probs=373.5
Q ss_pred CcEEEEEcCCCCCcccc-CcccCCCCCCcEEEccCCCCCCCCCCCCCCCCCCCEEECCCCcCcCCCchh--hhcCCCCcE
Q 045449 52 HRVIGLNISSFNLQGTI-TPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLDFSDNQLFGSLSSF--IFNMSSMTT 128 (823)
Q Consensus 52 ~~v~~L~L~~~~l~g~~-~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~--~~~l~~L~~ 128 (823)
.+++.|||++|...+.+ |.+|.++++|++|+|++|.|++..|..|+++++|++|+|++|.+++.+|.. |.++++|++
T Consensus 48 ~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~ 127 (844)
T 3j0a_A 48 EQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTR 127 (844)
T ss_dssp CSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTSSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCE
T ss_pred ccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhHccCCcccCEeeCcCCCCCcccccCccccccCCCCE
Confidence 47899999999887777 677999999999999999999999999999999999999999999877665 999999999
Q ss_pred EecccccccCccCccccCCCCCCccccccceeeeccceeeccCccccccc--hhhHHHHHhhcCCCcccCCcccCCcch-
Q 045449 129 IDLSINRLSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKEIGNL--TKLKEIISTITNSTVCEIPREIGNLPY- 205 (823)
Q Consensus 129 L~Ls~N~l~~~~p~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l--~~L~~L~~l~~n~~~~~ip~~l~~l~~- 205 (823)
|||++|.+++..+. ..|+++++|++|+|++|.+++..|..+..+ ++|+.|. +..|.+.+.+|..++.+++
T Consensus 128 L~Ls~N~l~~~~~~------~~~~~L~~L~~L~Ls~N~i~~~~~~~l~~l~~~~L~~L~-L~~n~l~~~~~~~~~~~~~~ 200 (844)
T 3j0a_A 128 LDLSKNQIRSLYLH------PSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFS-LAANSLYSRVSVDWGKCMNP 200 (844)
T ss_dssp EEEESCCCCCCCCC------GGGGTCSSCCEEEEESSCCCCCCSGGGHHHHHCSSCCCE-ECCSBSCCCCCCCCCSSSCT
T ss_pred EECCCCcccccccc------hhHhhCCCCCEEECCCCcCCeeCHHHcccccCCccceEE-CCCCccccccccchhhcCCc
Confidence 99999999876443 225899999999999999999999998887 6787775 8888888888888777666
Q ss_pred -----hhhhccccccccCCccccccC--------------------------------------CCCCcEEEccCCcccc
Q 045449 206 -----LARLALATNNLVGVVPVTIFN--------------------------------------MSALKEISLLNNSLSG 242 (823)
Q Consensus 206 -----L~~L~Ls~N~l~~~~p~~~~~--------------------------------------l~~L~~L~Ls~N~l~g 242 (823)
|+.|++++|++++..|..+.. .++|++|+|++|.+++
T Consensus 201 ~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~~~~~~~~~l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~ 280 (844)
T 3j0a_A 201 FRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFS 280 (844)
T ss_dssp TTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCCBCSSSCSSSTTGGGTTTTTTTTSCCCEEECTTCCCCE
T ss_pred cccCceeEEecCCCcCchhHHHHHHhhcCcccccceecccccccccccccccCCCChhhhhccccCCccEEECCCCcccc
Confidence 999999999887766654432 2679999999999986
Q ss_pred cCCcccccCCCCccEEEeeccccccccCccccCCCCCCeEEeecccccccCCCccCCCcccCcccccCccccCCCCcccc
Q 045449 243 SLPSRIDLSLPNVETLNLGINSFSGTIPSSITNSSKLSDLELGENLFSGFIPNTIGNLRNLEFGNIADNYLTSSTPELSF 322 (823)
Q Consensus 243 ~lp~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~ 322 (823)
..|..+. .+++|++|+|++|++++..|..|.++++|++|+|++|++++..|..|..+++|++|++++|++++..
T Consensus 281 ~~~~~~~-~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~----- 354 (844)
T 3j0a_A 281 LNSRVFE-TLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQ----- 354 (844)
T ss_dssp ECSCCSS-SCCCCCEEEEESCCCCEECTTTTTTCSSCCEEEEESCCCSCCCSCSCSSCTTCCEEECCSCCCCCCC-----
T ss_pred cChhhhh-cCCCCCEEECCCCcCCCCChHHhcCCCCCCEEECCCCCCCccCHHHhcCCCCCCEEECCCCCCCccC-----
Confidence 5555544 5999999999999999888999999999999999999999888999999999999999999998873
Q ss_pred cccccCCCCceEEEeecCCCCccCCccccccccccceEEecCCcce--------------------ecc-CccccCcccc
Q 045449 323 LSSLTNCKKLKVLIVTGNPLDGILPKSIGNFSLSLETILMANCSIS--------------------GNI-PQVVGNLSNL 381 (823)
Q Consensus 323 ~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~--------------------~~~-p~~~~~l~~L 381 (823)
+..|.++++|+.|+|++|.+++... + ++|+.|++++|+++ +.. +..+.++++|
T Consensus 355 ~~~~~~l~~L~~L~Ls~N~l~~i~~-----~-~~L~~L~l~~N~l~~l~~~~~~l~~L~ls~N~l~~l~~~~~~~~l~~L 428 (844)
T 3j0a_A 355 DQTFKFLEKLQTLDLRDNALTTIHF-----I-PSIPDIFLSGNKLVTLPKINLTANLIHLSENRLENLDILYFLLRVPHL 428 (844)
T ss_dssp SSCSCSCCCCCEEEEETCCSCCCSS-----C-CSCSEEEEESCCCCCCCCCCTTCCEEECCSCCCCSSTTHHHHTTCTTC
T ss_pred hhhhcCCCCCCEEECCCCCCCcccC-----C-CCcchhccCCCCcccccccccccceeecccCccccCchhhhhhcCCcc
Confidence 3468888999999999998875321 2 34555555555544 321 1224578999
Q ss_pred cEEEcccCcCCCCchh-cccccCCCCEEEccCCCCC-----CcchHhhhcCCCCCEEEcccCcCcccccccccCCCCCCe
Q 045449 382 LVLELGGNNLTGPIPV-TFSQLQTLQAFDLTRNKLA-----GPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSVRV 455 (823)
Q Consensus 382 ~~L~Ls~N~l~g~~p~-~~~~l~~L~~L~Ls~N~l~-----~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~ 455 (823)
++|+|++|++++..+. .+..+++|++|+|++|.++ +..+..|.++++|+.|+|++|+|++.+|..|.++++|+.
T Consensus 429 ~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~ 508 (844)
T 3j0a_A 429 QILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRG 508 (844)
T ss_dssp CEEEEESCCCCCCCSSSSSCSCTTCCBCEEESCCCSSSCCSCCCSSCSSCBCCEECCCCCHHHHTTCCTTSSSSCCSCSE
T ss_pred ceeeCCCCcccccccccccccCCccccccCCCCccccccccccchhhhcCcccccEEECCCCcccccChhHccchhhhhe
Confidence 9999999999976544 4667899999999999997 445567889999999999999999999999999999999
Q ss_pred EeccCCccccccchhhhccCCCcEEeccccccccccCccccCCCCCcEEEcccCCCCCCCCC
Q 045449 456 LYLGLNIFTSVLSSTIWNLKDILFIDVSSNFLDGPLSLDIGNLKVVIGLDFSRNNLSGDIPI 517 (823)
Q Consensus 456 L~Ls~N~l~~~~p~~~~~l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~ip~ 517 (823)
|+|++|++++.+|..+. ++|+.|||++|++++.+|..+ ..|+.|++++|.+.+.++.
T Consensus 509 L~Ls~N~l~~l~~~~~~--~~L~~L~Ls~N~l~~~~~~~~---~~L~~l~l~~Np~~C~c~~ 565 (844)
T 3j0a_A 509 LSLNSNRLTVLSHNDLP--ANLEILDISRNQLLAPNPDVF---VSLSVLDITHNKFICECEL 565 (844)
T ss_dssp EEEESCCCSSCCCCCCC--SCCCEEEEEEECCCCCCSCCC---SSCCEEEEEEECCCCSSSC
T ss_pred eECCCCCCCccChhhhh--ccccEEECCCCcCCCCChhHh---CCcCEEEecCCCccccccc
Confidence 99999999998877766 899999999999999999765 4788999999999987663
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-51 Score=486.74 Aligned_cols=444 Identities=19% Similarity=0.221 Sum_probs=384.6
Q ss_pred CCCcEEEccCCCCCCCCCCCCCCCCCCCEEECCCCcC------cC------CCchhhhcCCCCcEEecccccccCccCcc
Q 045449 76 SSLQTLDLSHNKLSGNIPSSIFNMHTLKLLDFSDNQL------FG------SLSSFIFNMSSMTTIDLSINRLSGELPAN 143 (823)
Q Consensus 76 ~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l------~~------~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~ 143 (823)
.+++.|+|++|.++|.+|++|++|++|++|||++|.+ .| .+|... +..|+ ++++.|.+.+.+|..
T Consensus 81 ~~V~~L~L~~~~l~g~lp~~l~~L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~--~~~l~-l~l~~~~l~~~~~~~ 157 (636)
T 4eco_A 81 GRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQ--KQKMR-MHYQKTFVDYDPRED 157 (636)
T ss_dssp CCEEEEECTTSCCEEEECGGGGGCTTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHH--HHHHH-THHHHHHTCCCGGGG
T ss_pred CCEEEEEecCcccCCcCChHHhcCccceEEECcCCccccCCccccccccccCchHHH--HHHHH-hhHHHhhhccCchhh
Confidence 4689999999999999999999999999999999976 33 455544 56778 999999999988876
Q ss_pred ccCC------------CCCCccccccceeeec--cceeeccCccccccchhhHHHHHhhcCCCccc--------------
Q 045449 144 ICKI------------PSTLSKCKQLEELNLG--FNNLSGAIPKEIGNLTKLKEIISTITNSTVCE-------------- 195 (823)
Q Consensus 144 ~~~~------------p~~~~~l~~L~~L~Ls--~N~l~~~~p~~l~~l~~L~~L~~l~~n~~~~~-------------- 195 (823)
+..+ +-.......++.+++. +|+++| +|.+|+++++|++|. +..|.+.+.
T Consensus 158 ~~~~~~~l~~~~l~~~~~~~~~~~~l~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~-Ls~n~l~~~~~~~~~~~~~~~~~ 235 (636)
T 4eco_A 158 FSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFY-MGNSPFVAENICEAWENENSEYA 235 (636)
T ss_dssp SCHHHHHHHHHCTTSCCCCCCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEE-EESCCCCGGGBSSSCSCTTSHHH
T ss_pred HHHHHHHHhhcCccccccccccccchhhhhhccccCCCcc-CCHHHhcccCCCEEE-CcCCccccccccccccccccchh
Confidence 6311 0000122234444443 689999 999999999999996 899999996
Q ss_pred ---CCcccC--CcchhhhhccccccccCCccccccCCCCCcEEEccCCc-ccc-cCCccccc-----CCCCccEEEeecc
Q 045449 196 ---IPREIG--NLPYLARLALATNNLVGVVPVTIFNMSALKEISLLNNS-LSG-SLPSRIDL-----SLPNVETLNLGIN 263 (823)
Q Consensus 196 ---ip~~l~--~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~-l~g-~lp~~~~~-----~l~~L~~L~Ls~N 263 (823)
+|..++ ++++|++|+|++|++.+.+|..|.++++|++|+|++|+ ++| .+|..++. .+++|++|+|++|
T Consensus 236 ~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n 315 (636)
T 4eco_A 236 QQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYN 315 (636)
T ss_dssp HHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSS
T ss_pred cccCchhhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCC
Confidence 999999 99999999999999999999999999999999999998 998 89988765 1389999999999
Q ss_pred ccccccCc--cccCCCCCCeEEeecccccccCCCccCCCcccCcccccCccccCCCCcccccccccCCCC-ceEEEeecC
Q 045449 264 SFSGTIPS--SITNSSKLSDLELGENLFSGFIPNTIGNLRNLEFGNIADNYLTSSTPELSFLSSLTNCKK-LKVLIVTGN 340 (823)
Q Consensus 264 ~l~~~~p~--~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~-L~~L~Ls~N 340 (823)
+++ .+|. .++++++|++|++++|+++|.+| .|+.+++|++|++++|+++. ++..+..+++ |+.|++++|
T Consensus 316 ~l~-~ip~~~~l~~l~~L~~L~L~~N~l~g~ip-~~~~l~~L~~L~L~~N~l~~------lp~~l~~l~~~L~~L~Ls~N 387 (636)
T 4eco_A 316 NLK-TFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQITE------IPANFCGFTEQVENLSFAHN 387 (636)
T ss_dssp CCS-SCCCHHHHTTCTTCCEEECCSCCCEEECC-CCEEEEEESEEECCSSEEEE------CCTTSEEECTTCCEEECCSS
T ss_pred cCC-ccCchhhhccCCCCCEEeCcCCcCccchh-hhCCCCCCCEEECCCCcccc------ccHhhhhhcccCcEEEccCC
Confidence 999 8998 99999999999999999999999 99999999999999999994 4567899999 999999999
Q ss_pred CCCccCCccccccc-cccceEEecCCcceeccCcccc-------CcccccEEEcccCcCCCCchhcccccCCCCEEEccC
Q 045449 341 PLDGILPKSIGNFS-LSLETILMANCSISGNIPQVVG-------NLSNLLVLELGGNNLTGPIPVTFSQLQTLQAFDLTR 412 (823)
Q Consensus 341 ~l~~~~p~~~~~~~-~~L~~L~L~~N~l~~~~p~~~~-------~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~ 412 (823)
.++ .+|..+.... .+|++|++++|.+++.+|..+. .+++|++|+|++|++++..+..+..+++|++|+|++
T Consensus 388 ~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~L~~L~Ls~N~l~~lp~~~~~~l~~L~~L~Ls~ 466 (636)
T 4eco_A 388 KLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMG 466 (636)
T ss_dssp CCS-SCCSCCCTTCSSCEEEEECCSSCTTTTTTCSSCTTCSSCCCCCCEEEEECCSSCCCSCCTHHHHTTCCCSEEECCS
T ss_pred cCc-ccchhhhhcccCccCEEECcCCcCCCcchhhhcccccccccCCCCCEEECcCCccCcCCHHHHccCCCCCEEECCC
Confidence 999 7888877652 3799999999999999999998 888999999999999954444567799999999999
Q ss_pred CCCCCcchHh-hhcCC-------CCCEEEcccCcCccccccccc--CCCCCCeEeccCCccccccchhhhccCCCcEEec
Q 045449 413 NKLAGPITDE-LCHLA-------RLHSLVLQGNKFSGSIPSCLG--NLTSVRVLYLGLNIFTSVLSSTIWNLKDILFIDV 482 (823)
Q Consensus 413 N~l~~~~p~~-~~~l~-------~L~~L~Ls~N~l~g~~p~~~~--~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~LdL 482 (823)
|+++ .+|.. +..+. +|+.|+|++|+++ .+|..+. .+++|+.|+|++|++++ +|..+..+++|+.|+|
T Consensus 467 N~l~-~i~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~L 543 (636)
T 4eco_A 467 NMLT-EIPKNSLKDENENFKNTYLLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGI 543 (636)
T ss_dssp SCCS-BCCSSSSEETTEECTTGGGCCEEECCSSCCC-BCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCSSCCEEEC
T ss_pred CCCC-CcCHHHhccccccccccCCccEEECcCCcCC-ccChhhhhccCCCcCEEECCCCCCCC-cChhhhcCCCCCEEEC
Confidence 9999 55554 33332 8999999999999 7888887 99999999999999999 8999999999999999
Q ss_pred ------cccccccccCccccCCCCCcEEEcccCCCCCCCCCcccCccCCCCCCCCCCCcccccCCcccCCC
Q 045449 483 ------SSNFLDGPLSLDIGNLKVVIGLDFSRNNLSGDIPITIGEGEIPRGGPFANLTAKSFMGNELLCGL 547 (823)
Q Consensus 483 ------s~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~~~g~ip~~~~~~~~~~~~~~~n~~~c~~ 547 (823)
++|.+.+.+|..+++++.|+.|++++|++ +.||..+. ..+..+++.+|+..|-.
T Consensus 544 s~N~~ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l-~~ip~~~~----------~~L~~L~Ls~N~l~~~~ 603 (636)
T 4eco_A 544 RNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDI-RKVNEKIT----------PNISVLDIKDNPNISID 603 (636)
T ss_dssp CSCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCC----------TTCCEEECCSCTTCEEE
T ss_pred CCCcccccCcccccChHHHhcCCCCCEEECCCCcC-CccCHhHh----------CcCCEEECcCCCCcccc
Confidence 56889999999999999999999999999 77886642 46777889999887743
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-49 Score=463.60 Aligned_cols=455 Identities=19% Similarity=0.166 Sum_probs=384.5
Q ss_pred EEcCCCCCccccCcccCCCCCCcEEEccCCCCCCCCCCCCCCCCCCCEEECCCCcCcCCCchhhhcCCCCcEEecccccc
Q 045449 57 LNISSFNLQGTITPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLDFSDNQLFGSLSSFIFNMSSMTTIDLSINRL 136 (823)
Q Consensus 57 L~L~~~~l~g~~~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 136 (823)
++.++.+++ .+|..+. +++++|||++|+|++..+.+|.++++|++|||++|.+++..|..|.++++|++|+|++|++
T Consensus 12 ~~c~~~~l~-~ip~~l~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l 88 (570)
T 2z63_A 12 YQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPI 88 (570)
T ss_dssp EECCSSCCS-SCCSSSC--SSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCC
T ss_pred EEeCCCCcc-ccCCCcc--ccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcC
Confidence 444455555 4565443 5799999999999988899999999999999999999998899999999999999999999
Q ss_pred cCccCccccCCCCCCccccccceeeeccceeeccCccccccchhhHHHHHhhcCCCcc-cCCcccCCcchhhhhcccccc
Q 045449 137 SGELPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKEIGNLTKLKEIISTITNSTVC-EIPREIGNLPYLARLALATNN 215 (823)
Q Consensus 137 ~~~~p~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~~l~~n~~~~-~ip~~l~~l~~L~~L~Ls~N~ 215 (823)
++..|..| .++++|++|+|++|++++..+..++++++|++|. +.+|.+.+ .+|..|+++++|++|++++|+
T Consensus 89 ~~~~~~~~-------~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~-L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~ 160 (570)
T 2z63_A 89 QSLALGAF-------SGLSSLQKLVAVETNLASLENFPIGHLKTLKELN-VAHNLIQSFKLPEYFSNLTNLEHLDLSSNK 160 (570)
T ss_dssp CEECTTTT-------TTCTTCCEEECTTSCCCCSTTCSCTTCTTCCEEE-CCSSCCCCCCCCGGGGGCTTCCEEECTTSC
T ss_pred CccCHhhh-------cCccccccccccccccccCCCccccccccccEEe-cCCCccceecChhhhcccCCCCEEeCcCCc
Confidence 86555544 8999999999999999976666799999999986 78888877 579999999999999999999
Q ss_pred ccCCccccccCCCCC----cEEEccCCcccccCCcccccCCCCccEEEeecccccc-ccC--------------------
Q 045449 216 LVGVVPVTIFNMSAL----KEISLLNNSLSGSLPSRIDLSLPNVETLNLGINSFSG-TIP-------------------- 270 (823)
Q Consensus 216 l~~~~p~~~~~l~~L----~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~Ls~N~l~~-~~p-------------------- 270 (823)
+++..|..+..+++| ++|++++|.+++..|.. +. ..+|++|++++|.... .+|
T Consensus 161 l~~~~~~~~~~l~~L~~~~~~L~l~~n~l~~~~~~~-~~-~~~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~ 238 (570)
T 2z63_A 161 IQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGA-FK-EIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFR 238 (570)
T ss_dssp CCEECGGGGHHHHTCTTCCCEEECTTCCCCEECTTT-TT-TCEEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECC
T ss_pred cceecHHHccchhccchhhhhcccCCCCceecCHHH-hc-cCcceeEecccccccccchhhhhcCccccceeeecccccc
Confidence 999888889988888 89999999999655544 43 3489999999884321 111
Q ss_pred ----------ccccCCC--CCCeEEeecc-cccccCCCccCCCcccCcccccCccccCCCCcccccccccCCCCceEEEe
Q 045449 271 ----------SSITNSS--KLSDLELGEN-LFSGFIPNTIGNLRNLEFGNIADNYLTSSTPELSFLSSLTNCKKLKVLIV 337 (823)
Q Consensus 271 ----------~~~~~l~--~L~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~L 337 (823)
..+..+. .++.+++++| .+.+.+|..+..+++|+.|++++|.++.. +..+..+ +|+.|++
T Consensus 239 ~~~~l~~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~l~~~~l~~l------~~~~~~~-~L~~L~l 311 (570)
T 2z63_A 239 NEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERV------KDFSYNF-GWQHLEL 311 (570)
T ss_dssp CCSSCEECCTTTTGGGGGSEEEEEEEEETTEEESCSTTTTGGGTTCSEEEEESCEECSC------CBCCSCC-CCSEEEE
T ss_pred CchhhhhcchhhhccccccchhhhhhhcchhhhhhchhhhcCcCcccEEEecCccchhh------hhhhccC-CccEEee
Confidence 1122222 2456777777 88889999999999999999999999864 4567777 9999999
Q ss_pred ecCCCCccCCccccccccccceEEecCCcceeccCccccCcccccEEEcccCcCCCCc--hhcccccCCCCEEEccCCCC
Q 045449 338 TGNPLDGILPKSIGNFSLSLETILMANCSISGNIPQVVGNLSNLLVLELGGNNLTGPI--PVTFSQLQTLQAFDLTRNKL 415 (823)
Q Consensus 338 s~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~--p~~~~~l~~L~~L~Ls~N~l 415 (823)
++|.+. .+|. ..+ ++|++|++++|.+.+..+. ..+++|++|++++|++++.. |..+..+++|++|++++|++
T Consensus 312 ~~n~~~-~l~~--~~l-~~L~~L~l~~n~~~~~~~~--~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l 385 (570)
T 2z63_A 312 VNCKFG-QFPT--LKL-KSLKRLTFTSNKGGNAFSE--VDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGV 385 (570)
T ss_dssp ESCBCS-SCCB--CBC-SSCCEEEEESCBSCCBCCC--CBCTTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSE
T ss_pred ccCccc-ccCc--ccc-cccCEEeCcCCcccccccc--ccCCCCCEEeCcCCccCccccccccccccCccCEEECCCCcc
Confidence 999998 5565 345 6899999999999887766 78999999999999999754 78899999999999999999
Q ss_pred CCcchHhhhcCCCCCEEEcccCcCccccc-ccccCCCCCCeEeccCCccccccchhhhccCCCcEEeccccccc-cccCc
Q 045449 416 AGPITDELCHLARLHSLVLQGNKFSGSIP-SCLGNLTSVRVLYLGLNIFTSVLSSTIWNLKDILFIDVSSNFLD-GPLSL 493 (823)
Q Consensus 416 ~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~LdLs~N~l~-g~~p~ 493 (823)
++..+. +..+++|+.|++++|.+++..| ..+.++++|++|++++|.+++.+|..+..+++|+.|++++|.++ +.+|.
T Consensus 386 ~~~~~~-~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~ 464 (570)
T 2z63_A 386 ITMSSN-FLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPD 464 (570)
T ss_dssp EEEEEE-EETCTTCCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECS
T ss_pred cccccc-ccccCCCCEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchh
Confidence 976555 9999999999999999998877 57899999999999999999999999999999999999999998 68999
Q ss_pred cccCCCCCcEEEcccCCCCCCCCCcccCccCCCCCCCCCCCcccccCCcccCC
Q 045449 494 DIGNLKVVIGLDFSRNNLSGDIPITIGEGEIPRGGPFANLTAKSFMGNELLCG 546 (823)
Q Consensus 494 ~~~~l~~L~~L~ls~N~l~g~ip~~~~~g~ip~~~~~~~~~~~~~~~n~~~c~ 546 (823)
.+..++.|+.|++++|++++.+|..+. .+..+..+.+.+|....-
T Consensus 465 ~~~~l~~L~~L~l~~n~l~~~~~~~~~--------~l~~L~~L~l~~n~l~~~ 509 (570)
T 2z63_A 465 IFTELRNLTFLDLSQCQLEQLSPTAFN--------SLSSLQVLNMASNQLKSV 509 (570)
T ss_dssp CCTTCTTCCEEECTTSCCCEECTTTTT--------TCTTCCEEECCSSCCSCC
T ss_pred hhhcccCCCEEECCCCccccCChhhhh--------cccCCCEEeCCCCcCCCC
Confidence 999999999999999999976666553 345677778888865443
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-49 Score=457.97 Aligned_cols=454 Identities=20% Similarity=0.195 Sum_probs=363.6
Q ss_pred EEEEcCCCCCccccCcccCCCCCCcEEEccCCCCCCCCCCCCCCCCCCCEEECCCCcCcCCCchhhhcCCCCcEEecccc
Q 045449 55 IGLNISSFNLQGTITPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLDFSDNQLFGSLSSFIFNMSSMTTIDLSIN 134 (823)
Q Consensus 55 ~~L~L~~~~l~g~~~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 134 (823)
+.||+++|+++ .+|..+. ++|++|||++|+|++..|..|.++++|++|+|++|+|++..|..|+++++|++|||++|
T Consensus 3 ~~l~ls~n~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N 79 (520)
T 2z7x_B 3 FLVDRSKNGLI-HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHN 79 (520)
T ss_dssp CEEECTTSCCS-SCCCSCC--TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSS
T ss_pred ceEecCCCCcc-ccccccc--ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCC
Confidence 36888999888 5777666 88999999999998877788889999999999999998888888999999999999999
Q ss_pred cccCccCccccCCCCCCccccccceeeeccceeec-cCccccccchhhHHHHHhhcCCCcccCCcccCCcchh--hhhcc
Q 045449 135 RLSGELPANICKIPSTLSKCKQLEELNLGFNNLSG-AIPKEIGNLTKLKEIISTITNSTVCEIPREIGNLPYL--ARLAL 211 (823)
Q Consensus 135 ~l~~~~p~~~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~p~~l~~l~~L~~L~~l~~n~~~~~ip~~l~~l~~L--~~L~L 211 (823)
+++ .+|. . .+++|++|+|++|++++ .+|..|+++++|++|. +.+|.+.+ ..+..+++| ++|++
T Consensus 80 ~l~-~lp~-------~--~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~-L~~n~l~~---~~~~~l~~L~L~~L~l 145 (520)
T 2z7x_B 80 KLV-KISC-------H--PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLG-LSTTHLEK---SSVLPIAHLNISKVLL 145 (520)
T ss_dssp CCC-EEEC-------C--CCCCCSEEECCSSCCSSCCCCGGGGGCTTCCEEE-EEESSCCG---GGGGGGTTSCEEEEEE
T ss_pred cee-ecCc-------c--ccCCccEEeccCCccccccchhhhccCCcceEEE-ecCcccch---hhccccccceeeEEEe
Confidence 887 3443 2 67889999999999887 5788888888888885 77777766 356667777 99999
Q ss_pred ccccc--cCCccccccCCC-CCcEEEccCCcccccCCcccccCCCCccEEEeeccc-------cccccCccccCCCCCCe
Q 045449 212 ATNNL--VGVVPVTIFNMS-ALKEISLLNNSLSGSLPSRIDLSLPNVETLNLGINS-------FSGTIPSSITNSSKLSD 281 (823)
Q Consensus 212 s~N~l--~~~~p~~~~~l~-~L~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~Ls~N~-------l~~~~p~~~~~l~~L~~ 281 (823)
++|++ .+..|..+.++. +...+++++|.+.+.++...+..+++|+.|++++|. +.+.+| .+..+++|+.
T Consensus 146 ~~n~l~~~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~-~l~~l~~L~~ 224 (520)
T 2z7x_B 146 VLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILA-KLQTNPKLSN 224 (520)
T ss_dssp EECTTTTSSCCTTTTTTCCEEEEEEECCSSSCCCCCCCCCCTTCSEEEECCEEECCSTTTTHHHHHHHH-GGGGCTTCCE
T ss_pred ecccccccccccccccccccceEEEEeccCcchhhhhhhhhhcccceeeccccccccccccceeecchh-hhccccchhh
Confidence 99999 788888887766 455678889998888888777778999999999987 777776 7888999999
Q ss_pred EEeecccccccCCCccC---CCcccCcccccCccccCCCCcccccccc-----cCCCCceEEEeecCCCCccCC-ccccc
Q 045449 282 LELGENLFSGFIPNTIG---NLRNLEFGNIADNYLTSSTPELSFLSSL-----TNCKKLKVLIVTGNPLDGILP-KSIGN 352 (823)
Q Consensus 282 L~Ls~N~l~~~~p~~~~---~l~~L~~L~L~~N~l~~~~~~~~~~~~l-----~~l~~L~~L~Ls~N~l~~~~p-~~~~~ 352 (823)
|++++|.+++..+..+. ..++|++|++++|++++. ++..+ ..+++|+.+++++|.+ .+| ..+..
T Consensus 225 L~l~~~~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~-----~p~~~~~~~~~~l~~L~~l~l~~n~~--~~p~~~~~~ 297 (520)
T 2z7x_B 225 LTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQ-----LDFRDFDYSGTSLKALSIHQVVSDVF--GFPQSYIYE 297 (520)
T ss_dssp EEEEEEEEEHHHHHHHHHHHHTSSCSEEEEEEEEEESC-----CCCCCCCCCSCCCCEEEEEEEEECCC--CSCTHHHHH
T ss_pred ccccccccCHHHHHHHHHHhhhCcccEEEeecccccCc-----cccchhhcccccCceeEeccccccce--ecchhhhhc
Confidence 99999888764332221 145889999999999876 34455 7889999999999998 455 44443
Q ss_pred cc--cccceEEecCCcceeccCccccCcccccEEEcccCcCCCCchhcccccCCCCEEEccCCCCCC--cchHhhhcCCC
Q 045449 353 FS--LSLETILMANCSISGNIPQVVGNLSNLLVLELGGNNLTGPIPVTFSQLQTLQAFDLTRNKLAG--PITDELCHLAR 428 (823)
Q Consensus 353 ~~--~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~ 428 (823)
+. .+|++|++++|.+.... .+..+++|++|++++|++++.+|..+..+++|++|+|++|++++ .+|..+..+++
T Consensus 298 ~~~~~~L~~L~l~~n~l~~~~--~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~ 375 (520)
T 2z7x_B 298 IFSNMNIKNFTVSGTRMVHML--CPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKS 375 (520)
T ss_dssp HHHTCCCSEEEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTT
T ss_pred ccccCceeEEEcCCCcccccc--chhhCCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCC
Confidence 31 35899999999886532 12678889999999999998888889999999999999999987 56677889999
Q ss_pred CCEEEcccCcCccccccc-ccCCCCCCeEeccCCccccccchhhhccCCCcEEeccccccccccCccccCCCCCcEEEcc
Q 045449 429 LHSLVLQGNKFSGSIPSC-LGNLTSVRVLYLGLNIFTSVLSSTIWNLKDILFIDVSSNFLDGPLSLDIGNLKVVIGLDFS 507 (823)
Q Consensus 429 L~~L~Ls~N~l~g~~p~~-~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~ls 507 (823)
|++|+|++|.+++.+|.. +..+++|+.|+|++|++++.+|..+. ++|+.||+++|.++ .+|..+..++.|+.|+++
T Consensus 376 L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~ 452 (520)
T 2z7x_B 376 LQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVA 452 (520)
T ss_dssp CCEEECCSSCCBCCGGGCSCCCCTTCCEEECCSSCCCGGGGGSCC--TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECC
T ss_pred CCEEECCCCcCCcccccchhccCccCCEEECcCCCCCcchhhhhc--ccCCEEECCCCccc-ccchhhhcCCCCCEEECC
Confidence 999999999998866654 78888999999999999888777664 78999999999998 788888889999999999
Q ss_pred cCCCCCCCCCcccCccCCCCCCCCCCCcccccCCcccCC
Q 045449 508 RNNLSGDIPITIGEGEIPRGGPFANLTAKSFMGNELLCG 546 (823)
Q Consensus 508 ~N~l~g~ip~~~~~g~ip~~~~~~~~~~~~~~~n~~~c~ 546 (823)
+|+++ .+|... ...+..+....+.+|++.|.
T Consensus 453 ~N~l~-~l~~~~-------~~~l~~L~~L~l~~N~~~c~ 483 (520)
T 2z7x_B 453 SNQLK-SVPDGI-------FDRLTSLQKIWLHTNPWDCS 483 (520)
T ss_dssp SSCCC-CCCTTT-------TTTCTTCCEEECCSSCBCCC
T ss_pred CCcCC-ccCHHH-------hccCCcccEEECcCCCCccc
Confidence 99988 455431 12355677788889988775
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-49 Score=472.09 Aligned_cols=428 Identities=16% Similarity=0.205 Sum_probs=355.2
Q ss_pred CCCcEEEccCCCCCCCCCCCCCCCCCCCEEEC-CCCcCcCCCchhh----------------------------------
Q 045449 76 SSLQTLDLSHNKLSGNIPSSIFNMHTLKLLDF-SDNQLFGSLSSFI---------------------------------- 120 (823)
Q Consensus 76 ~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L-s~N~l~~~~p~~~---------------------------------- 120 (823)
.+++.|+|++|.++|.+|++|++|++|++||| ++|.++|..|...
T Consensus 323 ~~V~~L~Ls~~~L~G~ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~ 402 (876)
T 4ecn_A 323 GRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSD 402 (876)
T ss_dssp SCEEEEECTTTCCEEEECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCH
T ss_pred CCEEEEECccCCCCCcCchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhH
Confidence 47899999999999999999999999999999 9998887743221
Q ss_pred -----------------hcCCCCcEEeccc--ccccCccCccccCCCCCCccccccceeeeccceeec-cCccccccchh
Q 045449 121 -----------------FNMSSMTTIDLSI--NRLSGELPANICKIPSTLSKCKQLEELNLGFNNLSG-AIPKEIGNLTK 180 (823)
Q Consensus 121 -----------------~~l~~L~~L~Ls~--N~l~~~~p~~~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~p~~l~~l~~ 180 (823)
.....++.+.+.. |++++ +|..+ +++++|++|+|++|+|+| .+|..+...
T Consensus 403 l~~~~l~~~~~~~~i~~~~~l~l~~l~l~~~~N~L~~-IP~~l-------~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~-- 472 (876)
T 4ecn_A 403 LLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITF-ISKAI-------QRLTKLQIIYFANSPFTYDNIAVDWEDA-- 472 (876)
T ss_dssp HHHHHHHTCTTSCCCCCCCCCCCCTTTTTCCSCEEEE-ECGGG-------GGCTTCCEEEEESCCCCGGGBSSSCSCT--
T ss_pred HHHHHhhhCccccccccccccchhhceeccccCcccc-hhHHH-------hcCCCCCEEECcCCcCCCCccccccccc--
Confidence 1111233333333 66665 55544 778888888888888876 333332221
Q ss_pred hHHHHHhhcCCCcccCCcccC--CcchhhhhccccccccCCccccccCCCCCcEEEccCCc-ccc-cCCccccc------
Q 045449 181 LKEIISTITNSTVCEIPREIG--NLPYLARLALATNNLVGVVPVTIFNMSALKEISLLNNS-LSG-SLPSRIDL------ 250 (823)
Q Consensus 181 L~~L~~l~~n~~~~~ip~~l~--~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~-l~g-~lp~~~~~------ 250 (823)
..|...+.+|..++ ++++|++|+|++|++.+.+|..|.++++|++|+|++|+ ++| .+|..+..
T Consensus 473 -------s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~ 545 (876)
T 4ecn_A 473 -------NSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDED 545 (876)
T ss_dssp -------TSHHHHHHTTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTT
T ss_pred -------ccccccccCChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhccc
Confidence 12334467899988 99999999999999999999999999999999999998 998 88876543
Q ss_pred CCCCccEEEeeccccccccCc--cccCCCCCCeEEeecccccccCCCccCCCcccCcccccCccccCCCCcccccccccC
Q 045449 251 SLPNVETLNLGINSFSGTIPS--SITNSSKLSDLELGENLFSGFIPNTIGNLRNLEFGNIADNYLTSSTPELSFLSSLTN 328 (823)
Q Consensus 251 ~l~~L~~L~Ls~N~l~~~~p~--~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~ 328 (823)
.+++|++|+|++|+++ .+|. .+.++++|+.|+|++|+++ .+| .|+.+++|+.|+|++|+++. ++..+.+
T Consensus 546 ~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp-~~~~L~~L~~L~Ls~N~l~~------lp~~l~~ 616 (876)
T 4ecn_A 546 TGPKIQIFYMGYNNLE-EFPASASLQKMVKLGLLDCVHNKVR-HLE-AFGTNVKLTDLKLDYNQIEE------IPEDFCA 616 (876)
T ss_dssp TTTTCCEEECCSSCCC-BCCCHHHHTTCTTCCEEECTTSCCC-BCC-CCCTTSEESEEECCSSCCSC------CCTTSCE
T ss_pred ccCCccEEEeeCCcCC-ccCChhhhhcCCCCCEEECCCCCcc-cch-hhcCCCcceEEECcCCcccc------chHHHhh
Confidence 3459999999999999 8998 9999999999999999999 778 99999999999999999994 4567889
Q ss_pred CCC-ceEEEeecCCCCccCCccccccc-cccceEEecCCcceeccCccc---c--CcccccEEEcccCcCCCCchhc-cc
Q 045449 329 CKK-LKVLIVTGNPLDGILPKSIGNFS-LSLETILMANCSISGNIPQVV---G--NLSNLLVLELGGNNLTGPIPVT-FS 400 (823)
Q Consensus 329 l~~-L~~L~Ls~N~l~~~~p~~~~~~~-~~L~~L~L~~N~l~~~~p~~~---~--~l~~L~~L~Ls~N~l~g~~p~~-~~ 400 (823)
+++ |+.|+|++|.++ .+|..+.... .+|++|++++|++++.+|... . .+++|+.|+|++|+++ .+|.. +.
T Consensus 617 l~~~L~~L~Ls~N~L~-~lp~~~~~~~~~~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L~-~lp~~~~~ 694 (876)
T 4ecn_A 617 FTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQ-KFPTELFA 694 (876)
T ss_dssp ECTTCCEEECCSSCCC-SCCSCCCTTCSSCEEEEECCSSCTTTTSSSCSSCTTTCCCCCEEEEECCSSCCC-SCCHHHHH
T ss_pred ccccCCEEECcCCCCC-cCchhhhccccCCCCEEECcCCcCCCccccchhhhccccCCCcCEEEccCCcCC-ccCHHHHc
Confidence 999 999999999999 7788877662 249999999999998877543 2 3458999999999999 45554 56
Q ss_pred ccCCCCEEEccCCCCCCcchHhhhcC--------CCCCEEEcccCcCccccccccc--CCCCCCeEeccCCccccccchh
Q 045449 401 QLQTLQAFDLTRNKLAGPITDELCHL--------ARLHSLVLQGNKFSGSIPSCLG--NLTSVRVLYLGLNIFTSVLSST 470 (823)
Q Consensus 401 ~l~~L~~L~Ls~N~l~~~~p~~~~~l--------~~L~~L~Ls~N~l~g~~p~~~~--~l~~L~~L~Ls~N~l~~~~p~~ 470 (823)
.+++|+.|+|++|+|+ .+|..+... ++|+.|+|++|+|+ .+|..+. .+++|+.|+|++|++++ +|..
T Consensus 695 ~l~~L~~L~Ls~N~L~-~ip~~~~~~~~~~l~nl~~L~~L~Ls~N~L~-~lp~~l~~~~l~~L~~L~Ls~N~L~~-lp~~ 771 (876)
T 4ecn_A 695 TGSPISTIILSNNLMT-SIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQ 771 (876)
T ss_dssp TTCCCSEEECCSCCCS-CCCTTSSSCTTSCCTTGGGCCEEECCSSCCC-CCCGGGSTTTCTTCCEEECCSSCCSS-CCCG
T ss_pred cCCCCCEEECCCCcCC-ccChHHhccccccccccCCccEEECCCCCCc-cchHHhhhccCCCcCEEEeCCCCCCc-cchh
Confidence 8999999999999999 566654432 38999999999999 7898887 99999999999999999 7999
Q ss_pred hhccCCCcEEeccc------cccccccCccccCCCCCcEEEcccCCCCCCCCCcccCccCCCCCCCCCCCcccccCCccc
Q 045449 471 IWNLKDILFIDVSS------NFLDGPLSLDIGNLKVVIGLDFSRNNLSGDIPITIGEGEIPRGGPFANLTAKSFMGNELL 544 (823)
Q Consensus 471 ~~~l~~L~~LdLs~------N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~~~g~ip~~~~~~~~~~~~~~~n~~~ 544 (823)
++.+++|+.|+|++ |.+.+.+|..+.+++.|+.|+|++|++ +.||..+. ..+..+++.+|+..
T Consensus 772 l~~L~~L~~L~Ls~N~~ls~N~l~~~ip~~l~~L~~L~~L~Ls~N~L-~~Ip~~l~----------~~L~~LdLs~N~l~ 840 (876)
T 4ecn_A 772 PLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDI-RKVDEKLT----------PQLYILDIADNPNI 840 (876)
T ss_dssp GGGCTTCCEEECCCCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCC----------SSSCEEECCSCTTC
T ss_pred hhcCCCCCEEECCCCCCcccccccccChHHHhcCCCCCEEECCCCCC-CccCHhhc----------CCCCEEECCCCCCC
Confidence 99999999999976 889999999999999999999999999 78887652 35677788888765
Q ss_pred C
Q 045449 545 C 545 (823)
Q Consensus 545 c 545 (823)
.
T Consensus 841 ~ 841 (876)
T 4ecn_A 841 S 841 (876)
T ss_dssp E
T ss_pred c
Confidence 4
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-48 Score=449.75 Aligned_cols=436 Identities=19% Similarity=0.223 Sum_probs=375.8
Q ss_pred CcEEEEEcCCCCCccccCcccCCCCCCcEEEccCCCCCCCCCCCCCCCCCCCEEECCCCcCcCCCchhhhcCCCCcEEec
Q 045449 52 HRVIGLNISSFNLQGTITPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLDFSDNQLFGSLSSFIFNMSSMTTIDL 131 (823)
Q Consensus 52 ~~v~~L~L~~~~l~g~~~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 131 (823)
.+++.|+|++|.+++..|..|.++++|++|+|++|+|++..|..|+++++|++|||++|+|+ .+|.. .+++|++|+|
T Consensus 21 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~l~~L~~L~L 97 (520)
T 2z7x_B 21 QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV-KISCH--PTVNLKHLDL 97 (520)
T ss_dssp TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCCC-EEECC--CCCCCSEEEC
T ss_pred ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCCcee-ecCcc--ccCCccEEec
Confidence 58999999999999888889999999999999999999988999999999999999999998 46665 8999999999
Q ss_pred ccccccC-ccCccccCCCCCCccccccceeeeccceeeccCccccccchhh--HHHHHhhcCCC--cccCCcccCCcc-h
Q 045449 132 SINRLSG-ELPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKEIGNLTKL--KEIISTITNST--VCEIPREIGNLP-Y 205 (823)
Q Consensus 132 s~N~l~~-~~p~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L--~~L~~l~~n~~--~~~ip~~l~~l~-~ 205 (823)
++|++++ .+|..+ +++++|++|+|++|++++ ..+..+++| +.|. +..|.+ .+.+|..+..+. .
T Consensus 98 ~~N~l~~~~~p~~~-------~~l~~L~~L~L~~n~l~~---~~~~~l~~L~L~~L~-l~~n~l~~~~~~~~~l~~l~~~ 166 (520)
T 2z7x_B 98 SFNAFDALPICKEF-------GNMSQLKFLGLSTTHLEK---SSVLPIAHLNISKVL-LVLGETYGEKEDPEGLQDFNTE 166 (520)
T ss_dssp CSSCCSSCCCCGGG-------GGCTTCCEEEEEESSCCG---GGGGGGTTSCEEEEE-EEECTTTTSSCCTTTTTTCCEE
T ss_pred cCCccccccchhhh-------ccCCcceEEEecCcccch---hhccccccceeeEEE-eecccccccccccccccccccc
Confidence 9999986 455555 899999999999999986 356667777 7775 888888 788899988876 3
Q ss_pred hhhhccccccccCCccc-cccCCCCCcEEEccCCc-------ccccCCcccccCCCCccEEEeeccccccccCcccc---
Q 045449 206 LARLALATNNLVGVVPV-TIFNMSALKEISLLNNS-------LSGSLPSRIDLSLPNVETLNLGINSFSGTIPSSIT--- 274 (823)
Q Consensus 206 L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~Ls~N~-------l~g~lp~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~--- 274 (823)
...+++++|++.+.++. .+.++++|+.|++++|. +.+.+| .+. .+++|+.|++++|.+++..+..+.
T Consensus 167 ~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~-~l~-~l~~L~~L~l~~~~l~~~~~~~~~~~~ 244 (520)
T 2z7x_B 167 SLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILA-KLQ-TNPKLSNLTLNNIETTWNSFIRILQLV 244 (520)
T ss_dssp EEEEECCSSSCCCCCCCCCCTTCSEEEECCEEECCSTTTTHHHHHHHH-GGG-GCTTCCEEEEEEEEEEHHHHHHHHHHH
T ss_pred eEEEEeccCcchhhhhhhhhhcccceeeccccccccccccceeecchh-hhc-cccchhhccccccccCHHHHHHHHHHh
Confidence 45678999998877665 66789999999999998 777776 444 499999999999998865433322
Q ss_pred CCCCCCeEEeecccccccCCCcc-----CCCcccCcccccCccccCCCCcccccccccCC---CCceEEEeecCCCCccC
Q 045449 275 NSSKLSDLELGENLFSGFIPNTI-----GNLRNLEFGNIADNYLTSSTPELSFLSSLTNC---KKLKVLIVTGNPLDGIL 346 (823)
Q Consensus 275 ~l~~L~~L~Ls~N~l~~~~p~~~-----~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l---~~L~~L~Ls~N~l~~~~ 346 (823)
..++|++|++++|+++|.+|..+ +.+++|+.+++++|.+ ..+. ..+..+ .+|+.|++++|.+.+..
T Consensus 245 ~~~~L~~L~l~~n~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~~-~~p~-----~~~~~~~~~~~L~~L~l~~n~l~~~~ 318 (520)
T 2z7x_B 245 WHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVF-GFPQ-----SYIYEIFSNMNIKNFTVSGTRMVHML 318 (520)
T ss_dssp HTSSCSEEEEEEEEEESCCCCCCCCCCSCCCCEEEEEEEEECCC-CSCT-----HHHHHHHHTCCCSEEEEESSCCCCCC
T ss_pred hhCcccEEEeecccccCccccchhhcccccCceeEeccccccce-ecch-----hhhhcccccCceeEEEcCCCcccccc
Confidence 24689999999999999999998 9999999999999999 3221 233333 67999999999987543
Q ss_pred CccccccccccceEEecCCcceeccCccccCcccccEEEcccCcCCC--CchhcccccCCCCEEEccCCCCCCcchHh-h
Q 045449 347 PKSIGNFSLSLETILMANCSISGNIPQVVGNLSNLLVLELGGNNLTG--PIPVTFSQLQTLQAFDLTRNKLAGPITDE-L 423 (823)
Q Consensus 347 p~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g--~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~-~ 423 (823)
- +..+ ++|++|++++|++++.+|..++.+++|++|+|++|++++ .+|..+..+++|++|+|++|++++.+|.. +
T Consensus 319 ~--~~~l-~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~ 395 (520)
T 2z7x_B 319 C--PSKI-SPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDC 395 (520)
T ss_dssp C--CSSC-CCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSC
T ss_pred c--hhhC-CcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchh
Confidence 1 1345 789999999999999999999999999999999999997 56788999999999999999999866765 8
Q ss_pred hcCCCCCEEEcccCcCcccccccccCCCCCCeEeccCCccccccchhhhccCCCcEEeccccccccccCcc-ccCCCCCc
Q 045449 424 CHLARLHSLVLQGNKFSGSIPSCLGNLTSVRVLYLGLNIFTSVLSSTIWNLKDILFIDVSSNFLDGPLSLD-IGNLKVVI 502 (823)
Q Consensus 424 ~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~LdLs~N~l~g~~p~~-~~~l~~L~ 502 (823)
..+++|+.|+|++|++++.+|..+. ++|+.|+|++|+++ .+|..+..+++|+.|++++|+++ .+|.. +..++.|+
T Consensus 396 ~~l~~L~~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~-~l~~~~~~~l~~L~ 471 (520)
T 2z7x_B 396 SWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLK-SVPDGIFDRLTSLQ 471 (520)
T ss_dssp CCCTTCCEEECCSSCCCGGGGGSCC--TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCCTTTTTTCTTCC
T ss_pred ccCccCCEEECcCCCCCcchhhhhc--ccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCC-ccCHHHhccCCccc
Confidence 8899999999999999999888775 79999999999999 58888889999999999999999 46665 99999999
Q ss_pred EEEcccCCCCCCCC
Q 045449 503 GLDFSRNNLSGDIP 516 (823)
Q Consensus 503 ~L~ls~N~l~g~ip 516 (823)
.|++++|++++.++
T Consensus 472 ~L~l~~N~~~c~c~ 485 (520)
T 2z7x_B 472 KIWLHTNPWDCSCP 485 (520)
T ss_dssp EEECCSSCBCCCHH
T ss_pred EEECcCCCCcccCC
Confidence 99999999998765
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=436.43 Aligned_cols=464 Identities=21% Similarity=0.200 Sum_probs=386.8
Q ss_pred eeCCCCCcEEEEEcCCCCCccccCcccCCCCCCcEEEccCCCCCCCCCCCCCCCCCCCEEECCCCcCcCCCchhhhcCCC
Q 045449 46 TCDVNSHRVIGLNISSFNLQGTITPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLDFSDNQLFGSLSSFIFNMSS 125 (823)
Q Consensus 46 ~c~~~~~~v~~L~L~~~~l~g~~~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 125 (823)
.|.. ..+ .|+++++++ .+|+.+. ++|++|||++|+|++..|..|.++++|++|+|++|+|++..|.+|+++++
T Consensus 3 ~C~~--~~~--c~~~~~~l~-~ip~~~~--~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~ 75 (549)
T 2z81_A 3 SCDA--SGV--CDGRSRSFT-SIPSGLT--AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGS 75 (549)
T ss_dssp EECT--TSE--EECTTSCCS-SCCSCCC--TTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTT
T ss_pred cCCC--Cce--EECCCCccc-cccccCC--CCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhcccccc
Confidence 5753 223 799999998 6777664 79999999999999999999999999999999999999999999999999
Q ss_pred CcEEecccccccCccCccccCCCCCCccccccceeeeccceeec-cCccccccchhhHHHHHhhcCCCcccCC-cccCCc
Q 045449 126 MTTIDLSINRLSGELPANICKIPSTLSKCKQLEELNLGFNNLSG-AIPKEIGNLTKLKEIISTITNSTVCEIP-REIGNL 203 (823)
Q Consensus 126 L~~L~Ls~N~l~~~~p~~~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~p~~l~~l~~L~~L~~l~~n~~~~~ip-~~l~~l 203 (823)
|++|||++|++++..|..+ +++++|++|+|++|++++ .+|..++++++|++|. +..|...+.+| ..|.++
T Consensus 76 L~~L~Ls~n~l~~~~~~~~-------~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~-L~~n~~~~~~~~~~~~~l 147 (549)
T 2z81_A 76 LEHLDLSDNHLSSLSSSWF-------GPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLR-IGNVETFSEIRRIDFAGL 147 (549)
T ss_dssp CCEEECTTSCCCSCCHHHH-------TTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEE-EEESSSCCEECTTTTTTC
T ss_pred CCEEECCCCccCccCHHHh-------ccCCCCcEEECCCCcccccchhhhhhccCCccEEE-CCCCccccccCHhhhhcc
Confidence 9999999999997665555 889999999999999987 4678899999999986 78888777776 689999
Q ss_pred chhhhhccccccccCCccccccCCCCCcEEEccCCcccccCCcccccCCCCccEEEeecccccccc--C-ccccCCCCCC
Q 045449 204 PYLARLALATNNLVGVVPVTIFNMSALKEISLLNNSLSGSLPSRIDLSLPNVETLNLGINSFSGTI--P-SSITNSSKLS 280 (823)
Q Consensus 204 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~Ls~N~l~~~~--p-~~~~~l~~L~ 280 (823)
++|++|++++|++++..|..+.++++|++|+++.|.++ .+|..+...+++|++|++++|++++.. | .....+++|+
T Consensus 148 ~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~~~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~ 226 (549)
T 2z81_A 148 TSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESA-FLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMK 226 (549)
T ss_dssp CEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSBST-THHHHHHHSTTTBSEEEEESCBCTTCCCCCCSSCCCCCCCC
T ss_pred cccCeeeccCCcccccChhhhhccccCceEecccCccc-ccchhhHhhcccccEEEccCCccccccccccchhhhhhccc
Confidence 99999999999999999999999999999999999986 677776666999999999999999752 2 2234578999
Q ss_pred eEEeecccccccCC----CccCCCcccCcccccCccccCCCCcc-cccccccCCCCceEEEeecCCCCcc-----CCccc
Q 045449 281 DLELGENLFSGFIP----NTIGNLRNLEFGNIADNYLTSSTPEL-SFLSSLTNCKKLKVLIVTGNPLDGI-----LPKSI 350 (823)
Q Consensus 281 ~L~Ls~N~l~~~~p----~~~~~l~~L~~L~L~~N~l~~~~~~~-~~~~~l~~l~~L~~L~Ls~N~l~~~-----~p~~~ 350 (823)
.|++++|.+++..+ ..+..+++|+.+++++|.+.+..... .....+..+.+|+.|++.++.+... ++..+
T Consensus 227 ~L~l~~n~l~~~~~~~l~~~~~~~~~L~~l~l~~~~~~~~~~~~~~~~~~~~~l~~L~~L~l~~~~i~~~~~~~~l~~~~ 306 (549)
T 2z81_A 227 KLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVY 306 (549)
T ss_dssp EEEEESCEEEHHHHHHHHGGGGGCTTCCEEEEESCEEECCSCCCCCTTTCCCCCTTCCEEEEESCBCSCGGGSCCCCHHH
T ss_pred ceeccccccchhHHHHHHHHhhhhccccccccccccccccccccccchhhhhhhcccccccccccccchhhhcccchhhh
Confidence 99999999987644 34567889999999999998753210 0123456788999999999987643 12212
Q ss_pred cccccccceEEecCCcceeccCccc-cCcccccEEEcccCcCCCCchh---cccccCCCCEEEccCCCCCCcch--Hhhh
Q 045449 351 GNFSLSLETILMANCSISGNIPQVV-GNLSNLLVLELGGNNLTGPIPV---TFSQLQTLQAFDLTRNKLAGPIT--DELC 424 (823)
Q Consensus 351 ~~~~~~L~~L~L~~N~l~~~~p~~~-~~l~~L~~L~Ls~N~l~g~~p~---~~~~l~~L~~L~Ls~N~l~~~~p--~~~~ 424 (823)
... .+|++|++++|.++ .+|..+ ..+++|++|+|++|++++.+|. .++.+++|++|+|++|++++..+ ..+.
T Consensus 307 ~~~-~~L~~L~l~~n~l~-~ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~ 384 (549)
T 2z81_A 307 SLL-EKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILL 384 (549)
T ss_dssp HHS-TTCCEEEEESSCCC-CCCHHHHHHCTTCCEEECCSSCCCHHHHHHHTCTTSSTTCCEEECTTSCCCCHHHHHHHGG
T ss_pred hhc-ccceEEEeccCccc-cCCHHHHhcCccccEEEccCCccccccccchhhhhccccCcEEEccCCcccccccchhhhh
Confidence 222 68999999999998 566655 6799999999999999987754 47889999999999999997643 5689
Q ss_pred cCCCCCEEEcccCcCcccccccccCCCCCCeEeccCCccccccchhhhccCCCcEEeccccccccccCccccCCCCCcEE
Q 045449 425 HLARLHSLVLQGNKFSGSIPSCLGNLTSVRVLYLGLNIFTSVLSSTIWNLKDILFIDVSSNFLDGPLSLDIGNLKVVIGL 504 (823)
Q Consensus 425 ~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L 504 (823)
.+++|++|+|++|+++ .+|..+..+++|++|+|++|.+++. |..+ .++|++||+++|++++.+ ..++.|+.|
T Consensus 385 ~l~~L~~L~Ls~N~l~-~lp~~~~~~~~L~~L~Ls~N~l~~l-~~~~--~~~L~~L~Ls~N~l~~~~----~~l~~L~~L 456 (549)
T 2z81_A 385 TLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIRVV-KTCI--PQTLEVLDVSNNNLDSFS----LFLPRLQEL 456 (549)
T ss_dssp GCTTCCEEECTTCCCC-CCCSCCCCCTTCCEEECTTSCCSCC-CTTS--CTTCSEEECCSSCCSCCC----CCCTTCCEE
T ss_pred cCCCCCEEECCCCCCc-cCChhhcccccccEEECCCCCcccc-cchh--cCCceEEECCCCChhhhc----ccCChhcEE
Confidence 9999999999999999 6899999999999999999999863 4333 268999999999999864 578999999
Q ss_pred EcccCCCCCCCCCcccCccCCCCCCCCCCCcccccCCcccC
Q 045449 505 DFSRNNLSGDIPITIGEGEIPRGGPFANLTAKSFMGNELLC 545 (823)
Q Consensus 505 ~ls~N~l~g~ip~~~~~g~ip~~~~~~~~~~~~~~~n~~~c 545 (823)
++++|+++ .||.. ..+..+..+++.+|....
T Consensus 457 ~Ls~N~l~-~ip~~---------~~l~~L~~L~Ls~N~l~~ 487 (549)
T 2z81_A 457 YISRNKLK-TLPDA---------SLFPVLLVMKISRNQLKS 487 (549)
T ss_dssp ECCSSCCS-SCCCG---------GGCTTCCEEECCSSCCCC
T ss_pred ECCCCccC-cCCCc---------ccCccCCEEecCCCccCC
Confidence 99999999 55542 235567788888886654
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-45 Score=433.69 Aligned_cols=465 Identities=19% Similarity=0.172 Sum_probs=366.8
Q ss_pred CcEEEEEcCCCCCccccCcccCCCCCCcEEEccCCCCCCCCCCCCCCCCCCCEEECCCCcCcCCCchhhhcCCCCcEEec
Q 045449 52 HRVIGLNISSFNLQGTITPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLDFSDNQLFGSLSSFIFNMSSMTTIDL 131 (823)
Q Consensus 52 ~~v~~L~L~~~~l~g~~~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 131 (823)
..++.|||++|+|++..+.+|.++++|++|||++|+|+++.|++|.++++|++|+|++|+|++..+.+|.++++|++|+|
T Consensus 52 ~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~L 131 (635)
T 4g8a_A 52 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA 131 (635)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEEC
T ss_pred cCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEEC
Confidence 36899999999999887889999999999999999999888889999999999999999999888899999999999999
Q ss_pred ccccccCccCccccCCCCCCccccccceeeeccceeec-cCccccccchhhHHHHHhhcCCCcccCCcccCCcchhh---
Q 045449 132 SINRLSGELPANICKIPSTLSKCKQLEELNLGFNNLSG-AIPKEIGNLTKLKEIISTITNSTVCEIPREIGNLPYLA--- 207 (823)
Q Consensus 132 s~N~l~~~~p~~~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~p~~l~~l~~L~~L~~l~~n~~~~~ip~~l~~l~~L~--- 207 (823)
++|++++..+.. |+++++|++|+|++|++++ .+|..++.+++|++|. +..|.+.+..|..|..+.++.
T Consensus 132 s~N~l~~l~~~~-------~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~-L~~N~l~~~~~~~l~~L~~l~~~~ 203 (635)
T 4g8a_A 132 VETNLASLENFP-------IGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLD-LSSNKIQSIYCTDLRVLHQMPLLN 203 (635)
T ss_dssp TTSCCCCSTTCC-------CTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEE-CCSSCCCEECGGGGHHHHTCTTCC
T ss_pred CCCcCCCCChhh-------hhcCcccCeeccccCccccCCCchhhccchhhhhhc-ccCccccccccccccchhhhhhhh
Confidence 999998544433 4899999999999999975 4688889999999885 888888888888887776655
Q ss_pred -hhccccccccCCccccccCCCCCcEEEccCCcccccCCcccccC-----------------------------------
Q 045449 208 -RLALATNNLVGVVPVTIFNMSALKEISLLNNSLSGSLPSRIDLS----------------------------------- 251 (823)
Q Consensus 208 -~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~lp~~~~~~----------------------------------- 251 (823)
.++++.|.++...+..+. ...+..+++++|..+..++...+..
T Consensus 204 ~~~~ls~n~l~~i~~~~~~-~~~~~~l~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~ 282 (635)
T 4g8a_A 204 LSLDLSLNPMNFIQPGAFK-EIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLT 282 (635)
T ss_dssp CEEECTTCCCCEECTTTTT-TCEEEEEEEESCCSSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCTTTTGGGGGSE
T ss_pred hhhhcccCcccccCccccc-chhhhhhhhhcccccccccchhhcCCcccccccccccccccccccccccccccccccchh
Confidence 467888888866555443 3456667777765432222211111
Q ss_pred ----------------------CCCccEEEeeccccccccCccccCCCCCCeEEeecccccccCCCccCCCcccCccccc
Q 045449 252 ----------------------LPNVETLNLGINSFSGTIPSSITNSSKLSDLELGENLFSGFIPNTIGNLRNLEFGNIA 309 (823)
Q Consensus 252 ----------------------l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 309 (823)
+.+++.+++..|.+.... .+....+|+.|++++|.+.+..+. .+..|+.+++.
T Consensus 283 ~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~~--~~~~~~~L~~L~l~~~~~~~~~~~---~l~~L~~l~l~ 357 (635)
T 4g8a_A 283 IEEFRLAYLDYYLDGIIDLFNCLTNVSSFSLVSVTIERVK--DFSYNFGWQHLELVNCKFGQFPTL---KLKSLKRLTFT 357 (635)
T ss_dssp EEEEEEECCCSCEEECTTTTGGGTTCSEEEEESCEEEECG--GGGSCCCCSEEEEESCEESSCCCC---BCTTCCEEEEE
T ss_pred hhhhhhhhhcccccchhhhhhhhccccccccccccccccc--ccccchhhhhhhcccccccCcCcc---cchhhhhcccc
Confidence 223444444444443221 233444566666666666544332 33455556666
Q ss_pred CccccCCCCcccccccccCCCCceEEEeecCCCCc--cCCccccccccccceEEecCCcceeccCccccCcccccEEEcc
Q 045449 310 DNYLTSSTPELSFLSSLTNCKKLKVLIVTGNPLDG--ILPKSIGNFSLSLETILMANCSISGNIPQVVGNLSNLLVLELG 387 (823)
Q Consensus 310 ~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~--~~p~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls 387 (823)
.|.+... .....+++|+.|++++|.+.. ..+..+... .+|++++++.|.+.. .+..+..+++|+.++++
T Consensus 358 ~n~~~~~-------~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~-~~L~~L~~~~~~~~~-~~~~~~~l~~L~~l~l~ 428 (635)
T 4g8a_A 358 SNKGGNA-------FSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGT-ISLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQ 428 (635)
T ss_dssp SCCSCCB-------CCCCBCTTCCEEECCSSCCBEEEECCHHHHSC-SCCCEEECCSCSEEE-ECSCCTTCTTCCEEECT
T ss_pred cccCCCC-------cccccccccccchhhccccccccccccchhhh-hhhhhhhcccccccc-ccccccccccccchhhh
Confidence 6655443 234568899999999999864 355566666 689999999998875 45668889999999999
Q ss_pred cCcCCCCch-hcccccCCCCEEEccCCCCCCcchHhhhcCCCCCEEEcccCcC-cccccccccCCCCCCeEeccCCcccc
Q 045449 388 GNNLTGPIP-VTFSQLQTLQAFDLTRNKLAGPITDELCHLARLHSLVLQGNKF-SGSIPSCLGNLTSVRVLYLGLNIFTS 465 (823)
Q Consensus 388 ~N~l~g~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l-~g~~p~~~~~l~~L~~L~Ls~N~l~~ 465 (823)
.|+.....+ ..|..+.+++.+++++|.+++..+..+..++.|+.|+|++|.+ .+.+|..|..+++|++|+|++|++++
T Consensus 429 ~~~~~~~~~~~~~~~l~~l~~l~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~ 508 (635)
T 4g8a_A 429 HSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQ 508 (635)
T ss_dssp TSEEESTTSSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCE
T ss_pred hccccccccccccccccccccccccccccccccccccccchhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCC
Confidence 998876654 4578999999999999999999999999999999999999985 55678899999999999999999999
Q ss_pred ccchhhhccCCCcEEeccccccccccCccccCCCCCcEEEcccCCCCCCCCCcccCccCCCCCCCCCCCcccccCCcccC
Q 045449 466 VLSSTIWNLKDILFIDVSSNFLDGPLSLDIGNLKVVIGLDFSRNNLSGDIPITIGEGEIPRGGPFANLTAKSFMGNELLC 545 (823)
Q Consensus 466 ~~p~~~~~l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~~~g~ip~~~~~~~~~~~~~~~n~~~c 545 (823)
.+|..|.++++|++|+|++|+|++..|..+..++.|++|||++|+|++.+|..+. .. ..++..+.+.+|++.|
T Consensus 509 l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~--~l-----~~~L~~L~L~~Np~~C 581 (635)
T 4g8a_A 509 LSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQ--HF-----PSSLAFLNLTQNDFAC 581 (635)
T ss_dssp ECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTT--CC-----CTTCCEEECTTCCBCC
T ss_pred cChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHH--hh-----hCcCCEEEeeCCCCcc
Confidence 9999999999999999999999999999999999999999999999988777663 11 1456778899999999
Q ss_pred C
Q 045449 546 G 546 (823)
Q Consensus 546 ~ 546 (823)
+
T Consensus 582 ~ 582 (635)
T 4g8a_A 582 T 582 (635)
T ss_dssp S
T ss_pred c
Confidence 6
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-46 Score=433.85 Aligned_cols=460 Identities=19% Similarity=0.195 Sum_probs=310.6
Q ss_pred EEEEcCCCCCccccCcccCCCCCCcEEEccCCCCCCCCCCCCCCCCCCCEEECCCCcCcCCCchhhhcCCCCcEEecccc
Q 045449 55 IGLNISSFNLQGTITPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLDFSDNQLFGSLSSFIFNMSSMTTIDLSIN 134 (823)
Q Consensus 55 ~~L~L~~~~l~g~~~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 134 (823)
+.+|++++++++ +|..+. ++|++|||++|+|++..|..|.++++|++|+|++|+|++..|.+|.++++|++|||++|
T Consensus 34 ~~l~ls~~~L~~-ip~~~~--~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N 110 (562)
T 3a79_B 34 SMVDYSNRNLTH-VPKDLP--PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHN 110 (562)
T ss_dssp CEEECTTSCCCS-CCTTSC--TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTS
T ss_pred cEEEcCCCCCcc-CCCCCC--CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCC
Confidence 689999999995 776664 78999999999999888889999999999999999999888999999999999999999
Q ss_pred cccCccCccccCCCCCCccccccceeeeccceeec-cCccccccchhhHHHHHhhcCCCcccCCcccCCcchh--hhhcc
Q 045449 135 RLSGELPANICKIPSTLSKCKQLEELNLGFNNLSG-AIPKEIGNLTKLKEIISTITNSTVCEIPREIGNLPYL--ARLAL 211 (823)
Q Consensus 135 ~l~~~~p~~~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~p~~l~~l~~L~~L~~l~~n~~~~~ip~~l~~l~~L--~~L~L 211 (823)
+++ .+|. . .+++|++|+|++|++++ .+|..|+++++|++|. +..|.+.+. .+..+++| ++|++
T Consensus 111 ~l~-~lp~-------~--~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~-L~~n~l~~~---~~~~l~~L~L~~L~L 176 (562)
T 3a79_B 111 RLQ-NISC-------C--PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLG-LSAAKFRQL---DLLPVAHLHLSCILL 176 (562)
T ss_dssp CCC-EECS-------C--CCTTCSEEECCSSCCSBCCCCGGGGGCTTCCEEE-EECSBCCTT---TTGGGTTSCEEEEEE
T ss_pred cCC-ccCc-------c--ccccCCEEECCCCCccccCchHhhcccCcccEEe-cCCCccccC---chhhhhhceeeEEEe
Confidence 987 4443 2 68899999999999986 4578899999999885 777777653 34445555 99999
Q ss_pred ccccc--cCCccccccCCC-CCcEEEccCCcccccCCcccccCCCCccEEEeeccc-----cccccCccccCCCCCCeEE
Q 045449 212 ATNNL--VGVVPVTIFNMS-ALKEISLLNNSLSGSLPSRIDLSLPNVETLNLGINS-----FSGTIPSSITNSSKLSDLE 283 (823)
Q Consensus 212 s~N~l--~~~~p~~~~~l~-~L~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~Ls~N~-----l~~~~p~~~~~l~~L~~L~ 283 (823)
++|++ ++..|..+.+++ +.-.++++.|.+.+.++......+++|+.|++++|+ +.+. ...+..+++|+.|+
T Consensus 177 ~~n~l~~~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~~~-~~~l~~l~~L~~L~ 255 (562)
T 3a79_B 177 DLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTF-LSELTRGPTLLNVT 255 (562)
T ss_dssp EESSCCCCSSSCCEEEECCEEEEEEEECSSSCCCCCCEEEESSEEEEEEEEEECCSTTHHHHHHH-HHHHHSCSSCEEEE
T ss_pred ecccccccccCcccccccCcceEEEEecCccchhhhhhhcccccceEEEecccccccccchHHHH-HHHHhccCcceEEE
Confidence 99999 888888887765 223668888888887877777678888888888884 2222 23456666677676
Q ss_pred eecccccccC----CCccCCCcccCcccccCccccCCCCcccccccccCCCCceEEEeecCCCCccCC-cccccc--ccc
Q 045449 284 LGENLFSGFI----PNTIGNLRNLEFGNIADNYLTSSTPELSFLSSLTNCKKLKVLIVTGNPLDGILP-KSIGNF--SLS 356 (823)
Q Consensus 284 Ls~N~l~~~~----p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p-~~~~~~--~~~ 356 (823)
++++.+++.. +..+ ..++|++|++++|.+++..+...+.....+++.|+.++++.|.+ .+| .++..+ ..+
T Consensus 256 L~~~~l~~~~~~~~~~~~-~~~~L~~L~l~~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~--~~p~~~~~~~~~~~~ 332 (562)
T 3a79_B 256 LQHIETTWKCSVKLFQFF-WPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVF--LFSKEALYSVFAEMN 332 (562)
T ss_dssp EEEEEECHHHHHHHHHHH-TTSSEEEEEEEEEEECSCCCCCCCCCCSCSCCEEEEEEEEECCC--SSCHHHHHHHHHTCC
T ss_pred ecCCcCcHHHHHHHHHhh-hcccccEEEEeccEeeccccchhhhcccccchheehhhccccee--ecChhhhhhhhccCc
Confidence 6666655321 1111 12367777777777765522210001115566666666666666 334 222211 024
Q ss_pred cceEEecCCcceeccCccccCcccccEEEcccCcCCCCchhcccccCCCCEEEccCCCCCC--cchHhhhcCCCCCEEEc
Q 045449 357 LETILMANCSISGNIPQVVGNLSNLLVLELGGNNLTGPIPVTFSQLQTLQAFDLTRNKLAG--PITDELCHLARLHSLVL 434 (823)
Q Consensus 357 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~L 434 (823)
|++|++++|.+.... ....+++|++|++++|++++.+|..+..+++|++|+|++|++++ .+|..|.++++|+.|+|
T Consensus 333 L~~L~l~~n~~~~~~--~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l 410 (562)
T 3a79_B 333 IKMLSISDTPFIHMV--CPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDV 410 (562)
T ss_dssp CSEEEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEEC
T ss_pred ceEEEccCCCccccc--CccCCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEEC
Confidence 666777766664321 11456666777777777766666666666777777777777665 23455666667777777
Q ss_pred ccCcCcccccc-cccCCCCCCeEeccCCccccccchhhhccCCCcEEeccccccccccCccccCCCCCcEEEcccCCCCC
Q 045449 435 QGNKFSGSIPS-CLGNLTSVRVLYLGLNIFTSVLSSTIWNLKDILFIDVSSNFLDGPLSLDIGNLKVVIGLDFSRNNLSG 513 (823)
Q Consensus 435 s~N~l~g~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g 513 (823)
++|++++.+|. .+..+++|+.|+|++|++++.+|..+. ++|+.|||++|+++ .+|..+..++.|+.|++++|+++
T Consensus 411 ~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~- 486 (562)
T 3a79_B 411 SLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLK- 486 (562)
T ss_dssp TTSCCBSCCSSCCCCCCTTCCEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCC-CCCTTTTSSCCCSEEECCSSCCC-
T ss_pred CCCcCCCccChhhhcCcccCCEEECCCCCCCcchhhhhc--CcCCEEECCCCcCc-ccChhhcCCCCCCEEECCCCCCC-
Confidence 77776664443 366666677777777776665555443 56667777777666 56665556667777777777666
Q ss_pred CCCCcccCccCCCCCCCCCCCcccccCCcccCCCC
Q 045449 514 DIPITIGEGEIPRGGPFANLTAKSFMGNELLCGLP 548 (823)
Q Consensus 514 ~ip~~~~~g~ip~~~~~~~~~~~~~~~n~~~c~~~ 548 (823)
.+|... ...+..+....+.+|++.|..+
T Consensus 487 ~l~~~~-------~~~l~~L~~L~l~~N~~~c~c~ 514 (562)
T 3a79_B 487 SVPDGV-------FDRLTSLQYIWLHDNPWDCTCP 514 (562)
T ss_dssp CCCTTS-------TTTCTTCCCEECCSCCBCCCHH
T ss_pred CCCHHH-------HhcCCCCCEEEecCCCcCCCcc
Confidence 344330 1223445556666676666544
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=397.08 Aligned_cols=296 Identities=31% Similarity=0.495 Sum_probs=261.4
Q ss_pred cchHHHHHHHHHHHHhccCCCccccccccCCCCCCcc--ceeeeeCCCC--CcEEEEEcCCCCCcc--ccCcccCCCCCC
Q 045449 5 SIISQHQQALLALKAHISYDHTNLFARNWTSSTSVCI--WIGITCDVNS--HRVIGLNISSFNLQG--TITPQLGNLSSL 78 (823)
Q Consensus 5 ~~~~~~~~aLl~~k~~~~~~~~~~~~~~W~~~~~~c~--w~gv~c~~~~--~~v~~L~L~~~~l~g--~~~~~l~~l~~L 78 (823)
.|.++|++||++||+++. ||. .++ +|..+.|||. |.||+|+..+ ++|+.|+|++++++| .+|+.++++++|
T Consensus 2 ~c~~~~~~aL~~~k~~~~-~~~-~l~-~W~~~~~~C~~~w~gv~C~~~~~~~~l~~L~L~~~~l~~~~~~~~~l~~l~~L 78 (313)
T 1ogq_A 2 LCNPQDKQALLQIKKDLG-NPT-TLS-SWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYL 78 (313)
T ss_dssp CSCHHHHHHHHHHHHHTT-CCG-GGT-TCCTTSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTC
T ss_pred CCCHHHHHHHHHHHHhcC-Ccc-ccc-CCCCCCCCCcCCCcceEeCCCCCCceEEEEECCCCCccCCcccChhHhCCCCC
Confidence 589999999999999984 665 566 9988889999 9999998765 899999999999999 999999999999
Q ss_pred cEEEccC-CCCCCCCCCCCCCCCCCCEEECCCCcCcCCCchhhhcCCCCcEEecccccccCccCccccCCCCCCcccccc
Q 045449 79 QTLDLSH-NKLSGNIPSSIFNMHTLKLLDFSDNQLFGSLSSFIFNMSSMTTIDLSINRLSGELPANICKIPSTLSKCKQL 157 (823)
Q Consensus 79 ~~L~Ls~-N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~p~~~~~l~~L 157 (823)
++|+|++ |++.+.+|..|+++++|++|+|++|.+++.+|..|.++++|++|+|++|++++.+|..+ ..+++|
T Consensus 79 ~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~-------~~l~~L 151 (313)
T 1ogq_A 79 NFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSI-------SSLPNL 151 (313)
T ss_dssp SEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGG-------GGCTTC
T ss_pred CeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCCcCChHH-------hcCCCC
Confidence 9999995 99999999999999999999999999999999999999999999999999998887766 889999
Q ss_pred ceeeeccceeeccCccccccch-hhHHHHHhhcCCCcccCCcccCCcchhhhhccccccccCCccccccCCCCCcEEEcc
Q 045449 158 EELNLGFNNLSGAIPKEIGNLT-KLKEIISTITNSTVCEIPREIGNLPYLARLALATNNLVGVVPVTIFNMSALKEISLL 236 (823)
Q Consensus 158 ~~L~Ls~N~l~~~~p~~l~~l~-~L~~L~~l~~n~~~~~ip~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 236 (823)
++|+|++|++++.+|..++.++ +|++|. +..|.+.+.+|..+..++ |++|+|++|++++..|..|.++++|++|+|+
T Consensus 152 ~~L~L~~N~l~~~~p~~l~~l~~~L~~L~-L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~ 229 (313)
T 1ogq_A 152 VGITFDGNRISGAIPDSYGSFSKLFTSMT-ISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLA 229 (313)
T ss_dssp CEEECCSSCCEEECCGGGGCCCTTCCEEE-CCSSEEEEECCGGGGGCC-CSEEECCSSEEEECCGGGCCTTSCCSEEECC
T ss_pred CeEECcCCcccCcCCHHHhhhhhcCcEEE-CcCCeeeccCChHHhCCc-ccEEECcCCcccCcCCHHHhcCCCCCEEECC
Confidence 9999999999999999998887 787775 778888888888888887 8888888888888888888888888888888
Q ss_pred CCcccccCCcccccCCCCccEEEeeccccccccCccccCCCCCCeEEeecccccccCCCccCCCcccCcccccCcc-ccC
Q 045449 237 NNSLSGSLPSRIDLSLPNVETLNLGINSFSGTIPSSITNSSKLSDLELGENLFSGFIPNTIGNLRNLEFGNIADNY-LTS 315 (823)
Q Consensus 237 ~N~l~g~lp~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~-l~~ 315 (823)
+|.+++.+|. +. .+++|++|+|++|++++.+|..+..+++|++|+|++|+++|.+|.. ..+++|+.|++++|. +.|
T Consensus 230 ~N~l~~~~~~-~~-~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~-~~l~~L~~l~l~~N~~lc~ 306 (313)
T 1ogq_A 230 KNSLAFDLGK-VG-LSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG-GNLQRFDVSAYANNKCLCG 306 (313)
T ss_dssp SSEECCBGGG-CC-CCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCS-TTGGGSCGGGTCSSSEEES
T ss_pred CCceeeecCc-cc-ccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCCCC-ccccccChHHhcCCCCccC
Confidence 8888866665 33 4788888888888888888888888888888888888888888876 788888888888887 444
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=410.04 Aligned_cols=393 Identities=18% Similarity=0.191 Sum_probs=263.7
Q ss_pred CCcccee--eeeCCCCCcEEEEEcCCCCCccccCcccCCCCCCcEEEccCCCCCCCCCCCCCCCCCCCEEECCCCcCcCC
Q 045449 38 SVCIWIG--ITCDVNSHRVIGLNISSFNLQGTITPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLDFSDNQLFGS 115 (823)
Q Consensus 38 ~~c~w~g--v~c~~~~~~v~~L~L~~~~l~g~~~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~ 115 (823)
+.|.|.+ |.|+. ++++ .+|. + .++|++|||++|+|++..|..|+++++|++|+|++|.+.+.
T Consensus 6 ~~c~~~~~~~~c~~------------~~l~-~lp~-l--~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~ 69 (455)
T 3v47_A 6 SECSVIGYNAICIN------------RGLH-QVPE-L--PAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLV 69 (455)
T ss_dssp -CCEEETTEEECCS------------SCCS-SCCC-C--CTTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCE
T ss_pred ceeEEEccccCcCC------------CCcc-cCCC-C--CCccCEEEecCCccCcCChhHhccCccccEEECcCCcccce
Confidence 4577766 66653 2333 3444 2 26788888888888887788888888888888888888755
Q ss_pred C-chhhhcCCCCcEEecccccccCccCccccCCCCCCccccccceeeeccceeeccCccccccchhhHHHHHhhcCCCcc
Q 045449 116 L-SSFIFNMSSMTTIDLSINRLSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKEIGNLTKLKEIISTITNSTVC 194 (823)
Q Consensus 116 ~-p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~~l~~n~~~~ 194 (823)
+ +..|.++++|++|+|++|++++..|..+ +++++|++|+|++|++++.+|..
T Consensus 70 i~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~-------~~l~~L~~L~L~~n~l~~~~~~~-------------------- 122 (455)
T 3v47_A 70 IRNNTFRGLSSLIILKLDYNQFLQLETGAF-------NGLANLEVLTLTQCNLDGAVLSG-------------------- 122 (455)
T ss_dssp ECTTTTTTCTTCCEEECTTCTTCEECTTTT-------TTCTTCCEEECTTSCCBTHHHHS--------------------
T ss_pred ECcccccccccCCEEeCCCCccCccChhhc-------cCcccCCEEeCCCCCCCccccCc--------------------
Confidence 5 5678888888888888888876655544 77888888888888887543321
Q ss_pred cCCcccCCcchhhhhccccccccCCcccc-ccCCCCCcEEEccCCcccccCCccccc-CCCCccEEEeeccccccccCcc
Q 045449 195 EIPREIGNLPYLARLALATNNLVGVVPVT-IFNMSALKEISLLNNSLSGSLPSRIDL-SLPNVETLNLGINSFSGTIPSS 272 (823)
Q Consensus 195 ~ip~~l~~l~~L~~L~Ls~N~l~~~~p~~-~~~l~~L~~L~Ls~N~l~g~lp~~~~~-~l~~L~~L~Ls~N~l~~~~p~~ 272 (823)
..+.++++|++|+|++|++++..|.. +.++++|++|++++|.+++..|..+.. ...+|+.|++++|.+.+..+..
T Consensus 123 ---~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~~~L~~L~l~~n~l~~~~~~~ 199 (455)
T 3v47_A 123 ---NFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYW 199 (455)
T ss_dssp ---STTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCBSCCCTTTSGGGTTCEEEEEECTTCBCTTCSTTC
T ss_pred ---ccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCcccccChhhhhccccccccccccccCcccccchhh
Confidence 22556667788888888888877766 778888888888888888666655543 1257778888888777554433
Q ss_pred c--------cCCCCCCeEEeecccccccCCCccCCCcccCcccccCccccCCCCcccccccccCCCCceEEEeecCCCCc
Q 045449 273 I--------TNSSKLSDLELGENLFSGFIPNTIGNLRNLEFGNIADNYLTSSTPELSFLSSLTNCKKLKVLIVTGNPLDG 344 (823)
Q Consensus 273 ~--------~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~ 344 (823)
+ ..+++|++|++++|++++.+|..+..+ ...++|+.|++++|.+.+
T Consensus 200 ~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~--------------------------~~~~~L~~L~l~~~~~~~ 253 (455)
T 3v47_A 200 LGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDA--------------------------IAGTKIQSLILSNSYNMG 253 (455)
T ss_dssp TTHHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHH--------------------------TTTCCEEEEECTTCTTTS
T ss_pred ccccccccccccceeeeEecCCCcccccchhhhhcc--------------------------ccccceeeEeeccccccc
Confidence 2 244566666666666666555544332 011344444444444332
Q ss_pred cCCccccccccccceEEecCCcceeccCccccC--cccccEEEcccCcCCCCchhcccccCCCCEEEccCCCCCCcchHh
Q 045449 345 ILPKSIGNFSLSLETILMANCSISGNIPQVVGN--LSNLLVLELGGNNLTGPIPVTFSQLQTLQAFDLTRNKLAGPITDE 422 (823)
Q Consensus 345 ~~p~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~--l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~ 422 (823)
... ..+.+.+..+..+.. .++|++|++++|++++.+|..|..+++|++|+|++|++++..|..
T Consensus 254 ~~~---------------~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~ 318 (455)
T 3v47_A 254 SSF---------------GHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNA 318 (455)
T ss_dssp CCT---------------TCCSSCCCCTTTTGGGTTSCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTT
T ss_pred ccc---------------chhhhccCcccccccccccCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhH
Confidence 210 011111122222222 246677777777777666666777777777777777777666666
Q ss_pred hhcCCCCCEEEcccCcCcccccccccCCCCCCeEeccCCccccccchhhhccCCCcEEeccccccccccCccccCCCCCc
Q 045449 423 LCHLARLHSLVLQGNKFSGSIPSCLGNLTSVRVLYLGLNIFTSVLSSTIWNLKDILFIDVSSNFLDGPLSLDIGNLKVVI 502 (823)
Q Consensus 423 ~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~LdLs~N~l~g~~p~~~~~l~~L~ 502 (823)
|.++++|++|+|++|.+++..|..|+++++|++|+|++|++++..|..+..+++|++|+|++|++++..+..+..++.|+
T Consensus 319 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~ 398 (455)
T 3v47_A 319 FWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQ 398 (455)
T ss_dssp TTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCC
T ss_pred hcCcccCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhccccccccEEECCCCccccCCHhHhccCCccc
Confidence 77777777777777777766677777777777777777777777777777777777777777777766566667778888
Q ss_pred EEEcccCCCCCCCCC
Q 045449 503 GLDFSRNNLSGDIPI 517 (823)
Q Consensus 503 ~L~ls~N~l~g~ip~ 517 (823)
.|++++|+++|.+|.
T Consensus 399 ~L~l~~N~l~~~~~~ 413 (455)
T 3v47_A 399 KIWLHTNPWDCSCPR 413 (455)
T ss_dssp EEECCSSCBCCCTTT
T ss_pred EEEccCCCcccCCCc
Confidence 888888888877763
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=402.72 Aligned_cols=393 Identities=18% Similarity=0.215 Sum_probs=294.1
Q ss_pred cEEEccCCCCCCCCCCCCCCCCCCCEEECCCCcCcCCCchhhhcCCCCcEEecccccccCccCccccCCCCCCccccccc
Q 045449 79 QTLDLSHNKLSGNIPSSIFNMHTLKLLDFSDNQLFGSLSSFIFNMSSMTTIDLSINRLSGELPANICKIPSTLSKCKQLE 158 (823)
Q Consensus 79 ~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~p~~~~~l~~L~ 158 (823)
+.++.+++.++ .+|. + .++|++|||++|.|++..|..|+++++|++|+|++|.+.+.++.. .|.++++|+
T Consensus 13 ~~~~c~~~~l~-~lp~-l--~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~------~~~~l~~L~ 82 (455)
T 3v47_A 13 YNAICINRGLH-QVPE-L--PAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNN------TFRGLSSLI 82 (455)
T ss_dssp TEEECCSSCCS-SCCC-C--CTTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTT------TTTTCTTCC
T ss_pred cccCcCCCCcc-cCCC-C--CCccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcc------cccccccCC
Confidence 46788888887 5665 3 278999999999999888999999999999999999887665432 257888899
Q ss_pred eeeeccceeeccCccccccchhhHHHHHhhcCCCcccCCcccCCcchhhhhccccccccCCcccc--ccCCCCCcEEEcc
Q 045449 159 ELNLGFNNLSGAIPKEIGNLTKLKEIISTITNSTVCEIPREIGNLPYLARLALATNNLVGVVPVT--IFNMSALKEISLL 236 (823)
Q Consensus 159 ~L~Ls~N~l~~~~p~~l~~l~~L~~L~~l~~n~~~~~ip~~l~~l~~L~~L~Ls~N~l~~~~p~~--~~~l~~L~~L~Ls 236 (823)
+|+|++|++++..|.. |+++++|++|+|++|++++..|.. |.++++|++|+|+
T Consensus 83 ~L~Ls~n~l~~~~~~~-------------------------~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~ 137 (455)
T 3v47_A 83 ILKLDYNQFLQLETGA-------------------------FNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLR 137 (455)
T ss_dssp EEECTTCTTCEECTTT-------------------------TTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECC
T ss_pred EEeCCCCccCccChhh-------------------------ccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECC
Confidence 9999888887554433 344455667777777777654443 6666666666666
Q ss_pred CCcccccCCcccccCCCCccEEEeeccccccccCccccCC--CCCCeEEeecccccccCCCccCCCcccCcccccCcccc
Q 045449 237 NNSLSGSLPSRIDLSLPNVETLNLGINSFSGTIPSSITNS--SKLSDLELGENLFSGFIPNTIGNLRNLEFGNIADNYLT 314 (823)
Q Consensus 237 ~N~l~g~lp~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l--~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 314 (823)
+|.+++..|..++..+++|++|+|++|++++..|..+..+ .+|+.|++++|.+.+..+..++
T Consensus 138 ~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~~~L~~L~l~~n~l~~~~~~~~~---------------- 201 (455)
T 3v47_A 138 DNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLG---------------- 201 (455)
T ss_dssp SSBCCSCCCCGGGGGCTTCCEEECTTCCBSCCCTTTSGGGTTCEEEEEECTTCBCTTCSTTCTT----------------
T ss_pred CCccCccCcccccCCCCcccEEeCCCCcccccChhhhhccccccccccccccCcccccchhhcc----------------
Confidence 6666655555433346666666666666665555555544 3455555555555543322211
Q ss_pred CCCCcccccccccCCCCceEEEeecCCCCccCCccccccc--cccceEEecCCcceeccCccccCcccccEEEcccCcCC
Q 045449 315 SSTPELSFLSSLTNCKKLKVLIVTGNPLDGILPKSIGNFS--LSLETILMANCSISGNIPQVVGNLSNLLVLELGGNNLT 392 (823)
Q Consensus 315 ~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~--~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 392 (823)
......+..+++|+.|++++|.+++..|..+.... .+|+.|++++|.+.+.. +..+.+.
T Consensus 202 -----~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~--------------~~~~~~~ 262 (455)
T 3v47_A 202 -----WEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSS--------------FGHTNFK 262 (455)
T ss_dssp -----HHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTTTCCEEEEECTTCTTTSCC--------------TTCCSSC
T ss_pred -----ccccccccccceeeeEecCCCcccccchhhhhccccccceeeEeeccccccccc--------------cchhhhc
Confidence 00122345668899999999999988887775431 46788888887765431 2334444
Q ss_pred CCchhccccc--CCCCEEEccCCCCCCcchHhhhcCCCCCEEEcccCcCcccccccccCCCCCCeEeccCCccccccchh
Q 045449 393 GPIPVTFSQL--QTLQAFDLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSVRVLYLGLNIFTSVLSST 470 (823)
Q Consensus 393 g~~p~~~~~l--~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~ 470 (823)
+..+..+..+ ++|++|++++|++++.+|..|..+++|+.|+|++|++++..|..|.++++|++|+|++|.+++..|..
T Consensus 263 ~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~ 342 (455)
T 3v47_A 263 DPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRM 342 (455)
T ss_dssp CCCTTTTGGGTTSCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGG
T ss_pred cCcccccccccccCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhH
Confidence 4444445443 68999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred hhccCCCcEEeccccccccccCccccCCCCCcEEEcccCCCCCCCCCcccCccCCCCCCCCCCCcccccCCcccCCCCC
Q 045449 471 IWNLKDILFIDVSSNFLDGPLSLDIGNLKVVIGLDFSRNNLSGDIPITIGEGEIPRGGPFANLTAKSFMGNELLCGLPD 549 (823)
Q Consensus 471 ~~~l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~~~g~ip~~~~~~~~~~~~~~~n~~~c~~~~ 549 (823)
+..+++|+.|||++|.+++..|..+..++.|++|++++|++++..+..+ ..+..+..+.+.+|++.|..|.
T Consensus 343 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~--------~~l~~L~~L~l~~N~l~~~~~~ 413 (455)
T 3v47_A 343 FENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIF--------DRLTSLQKIWLHTNPWDCSCPR 413 (455)
T ss_dssp GTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTT--------TTCTTCCEEECCSSCBCCCTTT
T ss_pred hcCcccCCEEECCCCcccccChhhccccccccEEECCCCccccCCHhHh--------ccCCcccEEEccCCCcccCCCc
Confidence 9999999999999999999999999999999999999999995333222 2356788889999999999874
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-44 Score=416.79 Aligned_cols=438 Identities=20% Similarity=0.199 Sum_probs=361.0
Q ss_pred CcEEEEEcCCCCCccccCcccCCCCCCcEEEccCCCCCCCCCCCCCCCCCCCEEECCCCcCcCCCchhhhcCCCCcEEec
Q 045449 52 HRVIGLNISSFNLQGTITPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLDFSDNQLFGSLSSFIFNMSSMTTIDL 131 (823)
Q Consensus 52 ~~v~~L~L~~~~l~g~~~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 131 (823)
.+++.|+|++|.+++..+.+|.++++|++|+|++|+|++..|..|.++++|++|||++|+|+ .+|.. .+++|++|||
T Consensus 52 ~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~l~~L~~L~L 128 (562)
T 3a79_B 52 PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQ-NISCC--PMASLRHLDL 128 (562)
T ss_dssp TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTSCCC-EECSC--CCTTCSEEEC
T ss_pred CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCCcCC-ccCcc--ccccCCEEEC
Confidence 57899999999999888889999999999999999999999999999999999999999998 45655 8999999999
Q ss_pred ccccccC-ccCccccCCCCCCccccccceeeeccceeeccCccccccchhh--HHHHHhhcCCC--cccCCcccCCcc--
Q 045449 132 SINRLSG-ELPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKEIGNLTKL--KEIISTITNST--VCEIPREIGNLP-- 204 (823)
Q Consensus 132 s~N~l~~-~~p~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L--~~L~~l~~n~~--~~~ip~~l~~l~-- 204 (823)
++|++++ .+|.. |+++++|++|+|++|++++. .+..+++| ++|. +..|.+ .+..|..+..+.
T Consensus 129 s~N~l~~l~~p~~-------~~~l~~L~~L~L~~n~l~~~---~~~~l~~L~L~~L~-L~~n~l~~~~~~~~~l~~l~~~ 197 (562)
T 3a79_B 129 SFNDFDVLPVCKE-------FGNLTKLTFLGLSAAKFRQL---DLLPVAHLHLSCIL-LDLVSYHIKGGETESLQIPNTT 197 (562)
T ss_dssp CSSCCSBCCCCGG-------GGGCTTCCEEEEECSBCCTT---TTGGGTTSCEEEEE-EEESSCCCCSSSCCEEEECCEE
T ss_pred CCCCccccCchHh-------hcccCcccEEecCCCccccC---chhhhhhceeeEEE-eecccccccccCcccccccCcc
Confidence 9999985 33444 48999999999999999864 44555555 7775 888888 888888888765
Q ss_pred hhhhhccccccccCCccc-cccCCCCCcEEEccCCc-----ccccCCcccccCCCCccEEEeecccccccc----Ccccc
Q 045449 205 YLARLALATNNLVGVVPV-TIFNMSALKEISLLNNS-----LSGSLPSRIDLSLPNVETLNLGINSFSGTI----PSSIT 274 (823)
Q Consensus 205 ~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~Ls~N~-----l~g~lp~~~~~~l~~L~~L~Ls~N~l~~~~----p~~~~ 274 (823)
.+ .++++.|.+.+.++. .+.++++|+.|++++|. +.+.++ .+. .+++|+.|+|+++.+++.. +..+
T Consensus 198 ~l-~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~~~~~-~l~-~l~~L~~L~L~~~~l~~~~~~~~~~~~- 273 (562)
T 3a79_B 198 VL-HLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLS-ELT-RGPTLLNVTLQHIETTWKCSVKLFQFF- 273 (562)
T ss_dssp EE-EEEECSSSCCCCCCEEEESSEEEEEEEEEECCSTTHHHHHHHHH-HHH-SCSSCEEEEEEEEEECHHHHHHHHHHH-
T ss_pred eE-EEEecCccchhhhhhhcccccceEEEecccccccccchHHHHHH-HHh-ccCcceEEEecCCcCcHHHHHHHHHhh-
Confidence 34 568999999887665 45678999999999995 333222 233 4889999999888776432 2222
Q ss_pred CCCCCCeEEeecccccccCCCcc-----CCCcccCcccccCccccCCCCcccccccccCCCCceEEEeecCCCCccCCcc
Q 045449 275 NSSKLSDLELGENLFSGFIPNTI-----GNLRNLEFGNIADNYLTSSTPELSFLSSLTNCKKLKVLIVTGNPLDGILPKS 349 (823)
Q Consensus 275 ~l~~L~~L~Ls~N~l~~~~p~~~-----~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~ 349 (823)
..++|++|++++|.++|.+|..+ ..++.|+.++++.|.+ ..+.+ ....+....+|+.|++++|.+.....
T Consensus 274 ~~~~L~~L~l~~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~-~~p~~--~~~~~~~~~~L~~L~l~~n~~~~~~~-- 348 (562)
T 3a79_B 274 WPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVF-LFSKE--ALYSVFAEMNIKMLSISDTPFIHMVC-- 348 (562)
T ss_dssp TTSSEEEEEEEEEEECSCCCCCCCCCCSCSCCEEEEEEEEECCC-SSCHH--HHHHHHHTCCCSEEEEESSCCCCCCC--
T ss_pred hcccccEEEEeccEeeccccchhhhcccccchheehhhccccee-ecChh--hhhhhhccCcceEEEccCCCcccccC--
Confidence 23489999999999999999888 7888888888888877 22111 11112223679999999999864421
Q ss_pred ccccccccceEEecCCcceeccCccccCcccccEEEcccCcCCCC--chhcccccCCCCEEEccCCCCCCcchH-hhhcC
Q 045449 350 IGNFSLSLETILMANCSISGNIPQVVGNLSNLLVLELGGNNLTGP--IPVTFSQLQTLQAFDLTRNKLAGPITD-ELCHL 426 (823)
Q Consensus 350 ~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~--~p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l 426 (823)
...+ ++|++|++++|++++.+|..+.++++|++|+|++|++++. +|..+..+++|++|+|++|++++.+|. .+..+
T Consensus 349 ~~~l-~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l 427 (562)
T 3a79_B 349 PPSP-SSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWA 427 (562)
T ss_dssp CSSC-CCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCC
T ss_pred ccCC-CCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCc
Confidence 1344 7899999999999999999999999999999999999973 467799999999999999999985665 48889
Q ss_pred CCCCEEEcccCcCcccccccccCCCCCCeEeccCCccccccchhhhccCCCcEEeccccccccccCcc-ccCCCCCcEEE
Q 045449 427 ARLHSLVLQGNKFSGSIPSCLGNLTSVRVLYLGLNIFTSVLSSTIWNLKDILFIDVSSNFLDGPLSLD-IGNLKVVIGLD 505 (823)
Q Consensus 427 ~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~LdLs~N~l~g~~p~~-~~~l~~L~~L~ 505 (823)
++|+.|+|++|++++.+|..+. ++|+.|+|++|+++. +|..++.+++|+.|||++|+++ .+|.. +..++.|+.|+
T Consensus 428 ~~L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~~-ip~~~~~l~~L~~L~L~~N~l~-~l~~~~~~~l~~L~~L~ 503 (562)
T 3a79_B 428 ESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIMS-IPKDVTHLQALQELNVASNQLK-SVPDGVFDRLTSLQYIW 503 (562)
T ss_dssp TTCCEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCCC-CCTTTTSSCCCSEEECCSSCCC-CCCTTSTTTCTTCCCEE
T ss_pred ccCCEEECCCCCCCcchhhhhc--CcCCEEECCCCcCcc-cChhhcCCCCCCEEECCCCCCC-CCCHHHHhcCCCCCEEE
Confidence 9999999999999998887765 789999999999995 7777779999999999999999 56665 99999999999
Q ss_pred cccCCCCCCCCC
Q 045449 506 FSRNNLSGDIPI 517 (823)
Q Consensus 506 ls~N~l~g~ip~ 517 (823)
+++|+++|.+|.
T Consensus 504 l~~N~~~c~c~~ 515 (562)
T 3a79_B 504 LHDNPWDCTCPG 515 (562)
T ss_dssp CCSCCBCCCHHH
T ss_pred ecCCCcCCCcch
Confidence 999999988764
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-43 Score=394.85 Aligned_cols=377 Identities=22% Similarity=0.279 Sum_probs=205.5
Q ss_pred CcEEEEEcCCCCCccccCcccCCCCCCcEEEccCCCCCCCCCCCCCCCCCC-------------CEEECCCCcCcCCCch
Q 045449 52 HRVIGLNISSFNLQGTITPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTL-------------KLLDFSDNQLFGSLSS 118 (823)
Q Consensus 52 ~~v~~L~L~~~~l~g~~~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L-------------~~L~Ls~N~l~~~~p~ 118 (823)
.++++|++++|++ |.+|++++++++|++|+|++|+++|.+|.+++++++| ++|++++|.+++. |.
T Consensus 11 ~~L~~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~~l~~l-p~ 88 (454)
T 1jl5_A 11 TFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLSSL-PE 88 (454)
T ss_dssp ------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTSCCSCC-CS
T ss_pred ccchhhhcccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhccCCCEEEecCCccccC-CC
Confidence 4688899999999 8899999999999999999999999999999988865 8899999988863 33
Q ss_pred hhhcCCCCcEEecccccccCccCccccCCCCCCccccccceeeeccceeeccCccccccchhhHHHHHhhcCCCcccCCc
Q 045449 119 FIFNMSSMTTIDLSINRLSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKEIGNLTKLKEIISTITNSTVCEIPR 198 (823)
Q Consensus 119 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~~l~~n~~~~~ip~ 198 (823)
. .++|++|+|++|++++ +|.. +++|++|++++|++++ +|...
T Consensus 89 ~---~~~L~~L~l~~n~l~~-lp~~----------~~~L~~L~l~~n~l~~-l~~~~----------------------- 130 (454)
T 1jl5_A 89 L---PPHLESLVASCNSLTE-LPEL----------PQSLKSLLVDNNNLKA-LSDLP----------------------- 130 (454)
T ss_dssp C---CTTCSEEECCSSCCSS-CCCC----------CTTCCEEECCSSCCSC-CCSCC-----------------------
T ss_pred C---cCCCCEEEccCCcCCc-cccc----------cCCCcEEECCCCccCc-ccCCC-----------------------
Confidence 2 3688999999998885 5532 2678899999988874 22211
Q ss_pred ccCCcchhhhhccccccccCCccccccCCCCCcEEEccCCcccccCCcccccCCCCccEEEeeccccccccCccccCCCC
Q 045449 199 EIGNLPYLARLALATNNLVGVVPVTIFNMSALKEISLLNNSLSGSLPSRIDLSLPNVETLNLGINSFSGTIPSSITNSSK 278 (823)
Q Consensus 199 ~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 278 (823)
++|++|++++|++++ +| .|.++++|++|++++|++++ +|.. .++|++|++++|++++ +| .+.++++
T Consensus 131 -----~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l~~N~l~~-lp~~----~~~L~~L~L~~n~l~~-l~-~~~~l~~ 196 (454)
T 1jl5_A 131 -----PLLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVDNNSLKK-LPDL----PPSLEFIAAGNNQLEE-LP-ELQNLPF 196 (454)
T ss_dssp -----TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSC-CCCC----CTTCCEEECCSSCCSS-CC-CCTTCTT
T ss_pred -----CCCCEEECcCCCCCC-Cc-ccCCCCCCCEEECCCCcCcc-cCCC----cccccEEECcCCcCCc-Cc-cccCCCC
Confidence 345566666666664 44 36666666666666666653 4432 2356666666666664 34 4666666
Q ss_pred CCeEEeecccccccCCCccCCCcccCcccccCccccCCCCcccccccccCCCCceEEEeecCCCCccCCccccccccccc
Q 045449 279 LSDLELGENLFSGFIPNTIGNLRNLEFGNIADNYLTSSTPELSFLSSLTNCKKLKVLIVTGNPLDGILPKSIGNFSLSLE 358 (823)
Q Consensus 279 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~ 358 (823)
|++|++++|++++ +|... ++|++|++++|.++.. + .+..+++|+.|++++|++++ +|.. +.+|+
T Consensus 197 L~~L~l~~N~l~~-l~~~~---~~L~~L~l~~n~l~~l------p-~~~~l~~L~~L~l~~N~l~~-l~~~----~~~L~ 260 (454)
T 1jl5_A 197 LTAIYADNNSLKK-LPDLP---LSLESIVAGNNILEEL------P-ELQNLPFLTTIYADNNLLKT-LPDL----PPSLE 260 (454)
T ss_dssp CCEEECCSSCCSS-CCCCC---TTCCEEECCSSCCSSC------C-CCTTCTTCCEEECCSSCCSS-CCSC----CTTCC
T ss_pred CCEEECCCCcCCc-CCCCc---CcccEEECcCCcCCcc------c-ccCCCCCCCEEECCCCcCCc-cccc----ccccC
Confidence 6666666666664 23222 3566666666666532 2 25566666666666666664 2321 14566
Q ss_pred eEEecCCcceeccCccccCcccccEEEcccCcCCCCchhcccccCCCCEEEccCCCCCCcchHhhhcC-CCCCEEEcccC
Q 045449 359 TILMANCSISGNIPQVVGNLSNLLVLELGGNNLTGPIPVTFSQLQTLQAFDLTRNKLAGPITDELCHL-ARLHSLVLQGN 437 (823)
Q Consensus 359 ~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~~L~~L~Ls~N 437 (823)
+|++++|++++ +|.. .++|++|++++|++++ +|.. .++|++|++++|++++. + .+ ++|+.|++++|
T Consensus 261 ~L~l~~N~l~~-l~~~---~~~L~~L~ls~N~l~~-l~~~---~~~L~~L~l~~N~l~~i-~----~~~~~L~~L~Ls~N 327 (454)
T 1jl5_A 261 ALNVRDNYLTD-LPEL---PQSLTFLDVSENIFSG-LSEL---PPNLYYLNASSNEIRSL-C----DLPPSLEELNVSNN 327 (454)
T ss_dssp EEECCSSCCSC-CCCC---CTTCCEEECCSSCCSE-ESCC---CTTCCEEECCSSCCSEE-C----CCCTTCCEEECCSS
T ss_pred EEECCCCcccc-cCcc---cCcCCEEECcCCccCc-ccCc---CCcCCEEECcCCcCCcc-c----CCcCcCCEEECCCC
Confidence 66666666664 3332 2556666666666664 2211 14566666666666642 1 22 35666666666
Q ss_pred cCcccccccccCCCCCCeEeccCCccccccchhhhccCCCcEEecccccccc--ccCccccCC-------------CCCc
Q 045449 438 KFSGSIPSCLGNLTSVRVLYLGLNIFTSVLSSTIWNLKDILFIDVSSNFLDG--PLSLDIGNL-------------KVVI 502 (823)
Q Consensus 438 ~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~LdLs~N~l~g--~~p~~~~~l-------------~~L~ 502 (823)
++++ +|.. +++|+.|++++|++++ +|. .+++|++|++++|++++ .+|.+++.+ +.|+
T Consensus 328 ~l~~-lp~~---~~~L~~L~L~~N~l~~-lp~---~l~~L~~L~L~~N~l~~l~~ip~~l~~L~~n~~~~~i~~~~~~L~ 399 (454)
T 1jl5_A 328 KLIE-LPAL---PPRLERLIASFNHLAE-VPE---LPQNLKQLHVEYNPLREFPDIPESVEDLRMNSHLAEVPELPQNLK 399 (454)
T ss_dssp CCSC-CCCC---CTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSSCCCCCTTCCEEECCC-------------
T ss_pred cccc-cccc---CCcCCEEECCCCcccc-ccc---hhhhccEEECCCCCCCcCCCChHHHHhhhhcccccccccccCcCC
Confidence 6664 4443 3556666666666664 333 35666666666666666 566666555 7899
Q ss_pred EEEcccCCCCC--CCCCcc
Q 045449 503 GLDFSRNNLSG--DIPITI 519 (823)
Q Consensus 503 ~L~ls~N~l~g--~ip~~~ 519 (823)
.||+++|+++| .||.++
T Consensus 400 ~L~ls~N~l~~~~~iP~sl 418 (454)
T 1jl5_A 400 QLHVETNPLREFPDIPESV 418 (454)
T ss_dssp -------------------
T ss_pred EEECCCCcCCccccchhhH
Confidence 99999999997 666554
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-43 Score=394.74 Aligned_cols=385 Identities=24% Similarity=0.274 Sum_probs=242.6
Q ss_pred cEEEEEcCCCCCccccCcccCCCCCC-------------cEEEccCCCCCCCCCCCCCCCCCCCEEECCCCcCcCCCchh
Q 045449 53 RVIGLNISSFNLQGTITPQLGNLSSL-------------QTLDLSHNKLSGNIPSSIFNMHTLKLLDFSDNQLFGSLSSF 119 (823)
Q Consensus 53 ~v~~L~L~~~~l~g~~~~~l~~l~~L-------------~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~ 119 (823)
+++.|++++|.+.|.+|.+++++++| ++|++++|++++ +|.. .++|++|+|++|.+++ +|..
T Consensus 35 ~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~~l~~-lp~~---~~~L~~L~l~~n~l~~-lp~~ 109 (454)
T 1jl5_A 35 SKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLSS-LPEL---PPHLESLVASCNSLTE-LPEL 109 (454)
T ss_dssp CHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTSCCSC-CCSC---CTTCSEEECCSSCCSS-CCCC
T ss_pred chhhhhccCCcccccCCcccccchhcchhhhhhhhccCCCEEEecCCcccc-CCCC---cCCCCEEEccCCcCCc-cccc
Confidence 57789999999999999999999875 999999999996 4442 3789999999999998 6653
Q ss_pred hhcCCCCcEEecccccccCccCccccCCCCCCccccccceeeeccceeeccCccccccchhhHHHHHhhcCCCcccCCcc
Q 045449 120 IFNMSSMTTIDLSINRLSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKEIGNLTKLKEIISTITNSTVCEIPRE 199 (823)
Q Consensus 120 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~~l~~n~~~~~ip~~ 199 (823)
+++|++|++++|++++ +|. + .++|++|+|++|++++ +| +|+++++|++|. +.+|.+.+ +|..
T Consensus 110 ---~~~L~~L~l~~n~l~~-l~~----~------~~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~-l~~N~l~~-lp~~ 171 (454)
T 1jl5_A 110 ---PQSLKSLLVDNNNLKA-LSD----L------PPLLEYLGVSNNQLEK-LP-ELQNSSFLKIID-VDNNSLKK-LPDL 171 (454)
T ss_dssp ---CTTCCEEECCSSCCSC-CCS----C------CTTCCEEECCSSCCSS-CC-CCTTCTTCCEEE-CCSSCCSC-CCCC
T ss_pred ---cCCCcEEECCCCccCc-ccC----C------CCCCCEEECcCCCCCC-Cc-ccCCCCCCCEEE-CCCCcCcc-cCCC
Confidence 4899999999999984 221 1 1689999999999996 77 588888887774 66666554 5654
Q ss_pred cCCcchhhhhccccccccCCccccccCCCCCcEEEccCCcccccCCcccccCCCCccEEEeeccccccccCccccCCCCC
Q 045449 200 IGNLPYLARLALATNNLVGVVPVTIFNMSALKEISLLNNSLSGSLPSRIDLSLPNVETLNLGINSFSGTIPSSITNSSKL 279 (823)
Q Consensus 200 l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 279 (823)
+ .+|++|++++|++++ +| .+.++++|++|++++|.+++ +|.. .++|++|++++|+++ .+|. +..+++|
T Consensus 172 ~---~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~N~l~~-l~~~----~~~L~~L~l~~n~l~-~lp~-~~~l~~L 239 (454)
T 1jl5_A 172 P---PSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYADNNSLKK-LPDL----PLSLESIVAGNNILE-ELPE-LQNLPFL 239 (454)
T ss_dssp C---TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSS-CCCC----CTTCCEEECCSSCCS-SCCC-CTTCTTC
T ss_pred c---ccccEEECcCCcCCc-Cc-cccCCCCCCEEECCCCcCCc-CCCC----cCcccEEECcCCcCC-cccc-cCCCCCC
Confidence 4 367777888888776 45 57777888888888888773 5542 347788888888777 5663 7777788
Q ss_pred CeEEeecccccccCCCccCCCcccCcccccCccccCCCCcccccccccCCCCceEEEeecCCCCccCCccccccccccce
Q 045449 280 SDLELGENLFSGFIPNTIGNLRNLEFGNIADNYLTSSTPELSFLSSLTNCKKLKVLIVTGNPLDGILPKSIGNFSLSLET 359 (823)
Q Consensus 280 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~ 359 (823)
++|++++|++++ +|.. +++|+.|++++|++++.+. ..++|+.|++++|.+++. | ..+.+|++
T Consensus 240 ~~L~l~~N~l~~-l~~~---~~~L~~L~l~~N~l~~l~~---------~~~~L~~L~ls~N~l~~l-~----~~~~~L~~ 301 (454)
T 1jl5_A 240 TTIYADNNLLKT-LPDL---PPSLEALNVRDNYLTDLPE---------LPQSLTFLDVSENIFSGL-S----ELPPNLYY 301 (454)
T ss_dssp CEEECCSSCCSS-CCSC---CTTCCEEECCSSCCSCCCC---------CCTTCCEEECCSSCCSEE-S----CCCTTCCE
T ss_pred CEEECCCCcCCc-cccc---ccccCEEECCCCcccccCc---------ccCcCCEEECcCCccCcc-c----CcCCcCCE
Confidence 888888887775 3432 3677778888887776422 126777788888877762 1 12256777
Q ss_pred EEecCCcceeccCccccCcccccEEEcccCcCCCCchhcccccCCCCEEEccCCCCCCcchHhhhcCCCCCEEEcccCcC
Q 045449 360 ILMANCSISGNIPQVVGNLSNLLVLELGGNNLTGPIPVTFSQLQTLQAFDLTRNKLAGPITDELCHLARLHSLVLQGNKF 439 (823)
Q Consensus 360 L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 439 (823)
|++++|++++. +.. .++|++|++++|++++ +|.. +++|++|++++|++++ +|. .+++|++|++++|++
T Consensus 302 L~l~~N~l~~i-~~~---~~~L~~L~Ls~N~l~~-lp~~---~~~L~~L~L~~N~l~~-lp~---~l~~L~~L~L~~N~l 369 (454)
T 1jl5_A 302 LNASSNEIRSL-CDL---PPSLEELNVSNNKLIE-LPAL---PPRLERLIASFNHLAE-VPE---LPQNLKQLHVEYNPL 369 (454)
T ss_dssp EECCSSCCSEE-CCC---CTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCC
T ss_pred EECcCCcCCcc-cCC---cCcCCEEECCCCcccc-cccc---CCcCCEEECCCCcccc-ccc---hhhhccEEECCCCCC
Confidence 77777777752 211 1477777787777775 5543 4677777777777774 444 357777777777777
Q ss_pred cc--cccccccCCCCCCeEeccCCccccccchhhhccCCCcEEecccccccc--ccCccccCCCCCcEEEcccCCCCCCC
Q 045449 440 SG--SIPSCLGNLTSVRVLYLGLNIFTSVLSSTIWNLKDILFIDVSSNFLDG--PLSLDIGNLKVVIGLDFSRNNLSGDI 515 (823)
Q Consensus 440 ~g--~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~LdLs~N~l~g--~~p~~~~~l~~L~~L~ls~N~l~g~i 515 (823)
++ .+|.+++. |+.|.+.|.+|.. +++|+.||+++|++++ .+|.+ ++.|.+++|.+.+.+
T Consensus 370 ~~l~~ip~~l~~--------L~~n~~~~~i~~~---~~~L~~L~ls~N~l~~~~~iP~s------l~~L~~~~~~~~~~~ 432 (454)
T 1jl5_A 370 REFPDIPESVED--------LRMNSHLAEVPEL---PQNLKQLHVETNPLREFPDIPES------VEDLRMNSERVVDPY 432 (454)
T ss_dssp SSCCCCCTTCCE--------EECCC-------------------------------------------------------
T ss_pred CcCCCChHHHHh--------hhhcccccccccc---cCcCCEEECCCCcCCccccchhh------HhheeCcCcccCCcc
Confidence 77 56655543 3346666666653 4789999999999998 77765 455678888888766
Q ss_pred CCcc
Q 045449 516 PITI 519 (823)
Q Consensus 516 p~~~ 519 (823)
|...
T Consensus 433 ~~~~ 436 (454)
T 1jl5_A 433 EFAH 436 (454)
T ss_dssp ----
T ss_pred ccCH
Confidence 6443
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=402.04 Aligned_cols=443 Identities=18% Similarity=0.159 Sum_probs=360.9
Q ss_pred cEEEEEcCCCCCccccCcccCCCCCCcEEEccCCCCCCCCCCCCCCCCCCCEEECCCCcCcCCCchhhhcCCCCcEEecc
Q 045449 53 RVIGLNISSFNLQGTITPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLDFSDNQLFGSLSSFIFNMSSMTTIDLS 132 (823)
Q Consensus 53 ~v~~L~L~~~~l~g~~~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 132 (823)
+++.|||++|+|++..+.+|.++++|++|+|++|+|++..+..|.++++|++|+|++|+|++..+..|+++++|++|+|+
T Consensus 77 ~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls 156 (635)
T 4g8a_A 77 ELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVA 156 (635)
T ss_dssp TCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECC
T ss_pred CCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEECCCCcCCCCChhhhhcCcccCeeccc
Confidence 68999999999998888889999999999999999998888899999999999999999999888899999999999999
Q ss_pred cccccCc-cCccccCCCCCCccccccceeeeccceeeccCccccccchhhHHHH---HhhcCCCcccCCcccCCcchhhh
Q 045449 133 INRLSGE-LPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKEIGNLTKLKEII---STITNSTVCEIPREIGNLPYLAR 208 (823)
Q Consensus 133 ~N~l~~~-~p~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~---~l~~n~~~~~ip~~l~~l~~L~~ 208 (823)
+|++++. +|. .++.+++|++|+|++|++++..|..|..+.+++.+. .+..|.+....+..+. ...+..
T Consensus 157 ~N~l~~~~~~~-------~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~l~~~~~~~~ls~n~l~~i~~~~~~-~~~~~~ 228 (635)
T 4g8a_A 157 HNLIQSFKLPE-------YFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFK-EIRLHK 228 (635)
T ss_dssp SSCCCCCCCCG-------GGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCCEEECTTCCCCEECTTTTT-TCEEEE
T ss_pred cCccccCCCch-------hhccchhhhhhcccCccccccccccccchhhhhhhhhhhhcccCcccccCccccc-chhhhh
Confidence 9999753 344 348899999999999999998888888777655321 1233444333233222 223334
Q ss_pred hccccccccC----------------------------------------------------------CccccccCCCCC
Q 045449 209 LALATNNLVG----------------------------------------------------------VVPVTIFNMSAL 230 (823)
Q Consensus 209 L~Ls~N~l~~----------------------------------------------------------~~p~~~~~l~~L 230 (823)
+++.+|.... ..+..+..+.++
T Consensus 229 l~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~~~~~~~~~~l 308 (635)
T 4g8a_A 229 LTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDGIIDLFNCLTNV 308 (635)
T ss_dssp EEEESCCSSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCTTTTGGGGGSEEEEEEEECCCSCEEECTTTTGGGTTC
T ss_pred hhhhcccccccccchhhcCCcccccccccccccccccccccccccccccccchhhhhhhhhhhcccccchhhhhhhhccc
Confidence 4444332210 011223345567
Q ss_pred cEEEccCCcccccCCcccccCCCCccEEEeeccccccccCccccCCCCCCeEEeecccccccCCCccCCCcccCcccccC
Q 045449 231 KEISLLNNSLSGSLPSRIDLSLPNVETLNLGINSFSGTIPSSITNSSKLSDLELGENLFSGFIPNTIGNLRNLEFGNIAD 310 (823)
Q Consensus 231 ~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 310 (823)
+.+++.+|.+.+ ++. + .....|+.|++++|.+.+..+. .+..|+.++++.|.+... .....+++|+.|++++
T Consensus 309 ~~l~~~~~~~~~-~~~-~-~~~~~L~~L~l~~~~~~~~~~~---~l~~L~~l~l~~n~~~~~--~~~~~l~~L~~L~ls~ 380 (635)
T 4g8a_A 309 SSFSLVSVTIER-VKD-F-SYNFGWQHLELVNCKFGQFPTL---KLKSLKRLTFTSNKGGNA--FSEVDLPSLEFLDLSR 380 (635)
T ss_dssp SEEEEESCEEEE-CGG-G-GSCCCCSEEEEESCEESSCCCC---BCTTCCEEEEESCCSCCB--CCCCBCTTCCEEECCS
T ss_pred cccccccccccc-ccc-c-ccchhhhhhhcccccccCcCcc---cchhhhhcccccccCCCC--cccccccccccchhhc
Confidence 777777777763 332 2 2367899999999999865443 467799999999988754 3456899999999999
Q ss_pred ccccCCCCcccccccccCCCCceEEEeecCCCCccCCccccccccccceEEecCCcceeccC-ccccCcccccEEEcccC
Q 045449 311 NYLTSSTPELSFLSSLTNCKKLKVLIVTGNPLDGILPKSIGNFSLSLETILMANCSISGNIP-QVVGNLSNLLVLELGGN 389 (823)
Q Consensus 311 N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~Ls~N 389 (823)
|.+..... .+..+..+.+|+.++++.|.+.+. +..+..+ .+|+.++++.|++....+ ..|..+++++.++++.|
T Consensus 381 n~l~~~~~---~~~~~~~~~~L~~L~~~~~~~~~~-~~~~~~l-~~L~~l~l~~~~~~~~~~~~~~~~l~~l~~l~ls~n 455 (635)
T 4g8a_A 381 NGLSFKGC---CSQSDFGTISLKYLDLSFNGVITM-SSNFLGL-EQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHT 455 (635)
T ss_dssp SCCBEEEE---CCHHHHSCSCCCEEECCSCSEEEE-CSCCTTC-TTCCEEECTTSEEESTTSSCTTTTCTTCCEEECTTS
T ss_pred cccccccc---cccchhhhhhhhhhhccccccccc-ccccccc-ccccchhhhhcccccccccccccccccccccccccc
Confidence 99875421 344566788999999999998764 4456666 799999999998877654 56889999999999999
Q ss_pred cCCCCchhcccccCCCCEEEccCCCC-CCcchHhhhcCCCCCEEEcccCcCcccccccccCCCCCCeEeccCCccccccc
Q 045449 390 NLTGPIPVTFSQLQTLQAFDLTRNKL-AGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSVRVLYLGLNIFTSVLS 468 (823)
Q Consensus 390 ~l~g~~p~~~~~l~~L~~L~Ls~N~l-~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p 468 (823)
++.+..+..+..+++|++|+|++|++ .+.+|..|..+++|++|+|++|+|++.+|..|.++++|++|+|++|+|++.+|
T Consensus 456 ~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~ 535 (635)
T 4g8a_A 456 HTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDT 535 (635)
T ss_dssp CCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCC
T ss_pred ccccccccccccchhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCCh
Confidence 99999999999999999999999985 44678889999999999999999999999999999999999999999999999
Q ss_pred hhhhccCCCcEEeccccccccccCccccCC-CCCcEEEcccCCCCCCCC
Q 045449 469 STIWNLKDILFIDVSSNFLDGPLSLDIGNL-KVVIGLDFSRNNLSGDIP 516 (823)
Q Consensus 469 ~~~~~l~~L~~LdLs~N~l~g~~p~~~~~l-~~L~~L~ls~N~l~g~ip 516 (823)
..+..+++|++|||++|+|++..|..+..+ ++|+.|+|++|+|++...
T Consensus 536 ~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~C~ 584 (635)
T 4g8a_A 536 FPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCE 584 (635)
T ss_dssp GGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCSGG
T ss_pred hHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCcccCC
Confidence 999999999999999999999999999988 789999999999998654
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=385.30 Aligned_cols=353 Identities=17% Similarity=0.188 Sum_probs=257.4
Q ss_pred cEEEEEcCCCCCccccCcccCCCCCCcEEEccCCCCCCCCCCCCCCCCCCCEEECCCCcCcCCCchhhhcCCCCcEEecc
Q 045449 53 RVIGLNISSFNLQGTITPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLDFSDNQLFGSLSSFIFNMSSMTTIDLS 132 (823)
Q Consensus 53 ~v~~L~L~~~~l~g~~~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 132 (823)
+++.|++++|++++. | .++.+++|++|+|++|+|++. | ++.+++|++|+|++|.|++. + ++++++|++|+|+
T Consensus 43 ~L~~L~Ls~n~l~~~-~-~l~~l~~L~~L~Ls~n~l~~~-~--~~~l~~L~~L~Ls~N~l~~~-~--~~~l~~L~~L~L~ 114 (457)
T 3bz5_A 43 TLTSLDCHNSSITDM-T-GIEKLTGLTKLICTSNNITTL-D--LSQNTNLTYLACDSNKLTNL-D--VTPLTKLTYLNCD 114 (457)
T ss_dssp TCCEEECCSSCCCCC-T-TGGGCTTCSEEECCSSCCSCC-C--CTTCTTCSEEECCSSCCSCC-C--CTTCTTCCEEECC
T ss_pred CCCEEEccCCCcccC-h-hhcccCCCCEEEccCCcCCeE-c--cccCCCCCEEECcCCCCcee-e--cCCCCcCCEEECC
Confidence 566777777777754 3 577777777777777777753 3 67777777777777777664 2 6677777777777
Q ss_pred cccccCccCccccCCCCCCccccccceeeeccceeeccCccccccchhhHHHHHhhcCCCcccCCcccCCcchhhhhccc
Q 045449 133 INRLSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKEIGNLTKLKEIISTITNSTVCEIPREIGNLPYLARLALA 212 (823)
Q Consensus 133 ~N~l~~~~p~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~~l~~n~~~~~ip~~l~~l~~L~~L~Ls 212 (823)
+|++++ +| ++.+++|++|++++|++++. + ++++++|++|+++
T Consensus 115 ~N~l~~-l~---------~~~l~~L~~L~l~~N~l~~l-~---------------------------l~~l~~L~~L~l~ 156 (457)
T 3bz5_A 115 TNKLTK-LD---------VSQNPLLTYLNCARNTLTEI-D---------------------------VSHNTQLTELDCH 156 (457)
T ss_dssp SSCCSC-CC---------CTTCTTCCEEECTTSCCSCC-C---------------------------CTTCTTCCEEECT
T ss_pred CCcCCe-ec---------CCCCCcCCEEECCCCcccee-c---------------------------cccCCcCCEEECC
Confidence 777764 22 36667777777777776642 1 3345567777777
Q ss_pred cccccCCccccccCCCCCcEEEccCCcccccCCcccccCCCCccEEEeeccccccccCccccCCCCCCeEEeeccccccc
Q 045449 213 TNNLVGVVPVTIFNMSALKEISLLNNSLSGSLPSRIDLSLPNVETLNLGINSFSGTIPSSITNSSKLSDLELGENLFSGF 292 (823)
Q Consensus 213 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 292 (823)
+|+..+.+ .+..+++|++|++++|++++ +| +. .+++|++|++++|++++. .+..+++|++|++++|++++
T Consensus 157 ~n~~~~~~--~~~~l~~L~~L~ls~n~l~~-l~--l~-~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~- 226 (457)
T 3bz5_A 157 LNKKITKL--DVTPQTQLTTLDCSFNKITE-LD--VS-QNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTE- 226 (457)
T ss_dssp TCSCCCCC--CCTTCTTCCEEECCSSCCCC-CC--CT-TCTTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCSC-
T ss_pred CCCccccc--ccccCCcCCEEECCCCccce-ec--cc-cCCCCCEEECcCCcCCee---ccccCCCCCEEECcCCcccc-
Confidence 77655554 36677788888888888874 55 33 477788888888888764 37777788888888888877
Q ss_pred CCCccCCCcccCcccccCccccCCCCcccccccccCCCCceEEEeecCCCCccCCccccccccccceEEecCCcceeccC
Q 045449 293 IPNTIGNLRNLEFGNIADNYLTSSTPELSFLSSLTNCKKLKVLIVTGNPLDGILPKSIGNFSLSLETILMANCSISGNIP 372 (823)
Q Consensus 293 ~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~p 372 (823)
+| ++.+++|++|++++|++++.+ +..+++|+.|++++| +|++|++++|.+.+.+|
T Consensus 227 ip--~~~l~~L~~L~l~~N~l~~~~--------~~~l~~L~~L~l~~n---------------~L~~L~l~~n~~~~~~~ 281 (457)
T 3bz5_A 227 ID--VTPLTQLTYFDCSVNPLTELD--------VSTLSKLTTLHCIQT---------------DLLEIDLTHNTQLIYFQ 281 (457)
T ss_dssp CC--CTTCTTCSEEECCSSCCSCCC--------CTTCTTCCEEECTTC---------------CCSCCCCTTCTTCCEEE
T ss_pred cC--ccccCCCCEEEeeCCcCCCcC--------HHHCCCCCEEeccCC---------------CCCEEECCCCccCCccc
Confidence 34 777788888888888887752 345677777777655 35567788888877776
Q ss_pred ccccCcccccEEEcccCcCCCCchhcccccCCCCEEEccCCCCCCcchHhhhcCCCCCEEEcccCcCcccccccccCCCC
Q 045449 373 QVVGNLSNLLVLELGGNNLTGPIPVTFSQLQTLQAFDLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTS 452 (823)
Q Consensus 373 ~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~ 452 (823)
++.+++|+.|++++|.+.|.+|. ...+|+.|++++| ++|+.|+|++|+|++. + ++++++
T Consensus 282 --~~~l~~L~~L~Ls~n~~l~~l~~---~~~~L~~L~l~~~-------------~~L~~L~L~~N~l~~l-~--l~~l~~ 340 (457)
T 3bz5_A 282 --AEGCRKIKELDVTHNTQLYLLDC---QAAGITELDLSQN-------------PKLVYLYLNNTELTEL-D--VSHNTK 340 (457)
T ss_dssp --CTTCTTCCCCCCTTCTTCCEEEC---TTCCCSCCCCTTC-------------TTCCEEECTTCCCSCC-C--CTTCTT
T ss_pred --ccccccCCEEECCCCcccceecc---CCCcceEechhhc-------------ccCCEEECCCCccccc-c--cccCCc
Confidence 46788888888888888887775 3456666666665 5789999999999984 3 889999
Q ss_pred CCeEeccCCccccccchhhhccCCCcEEeccccccccccCccccCCCCCcEEEcccCCCCCCCCCccc
Q 045449 453 VRVLYLGLNIFTSVLSSTIWNLKDILFIDVSSNFLDGPLSLDIGNLKVVIGLDFSRNNLSGDIPITIG 520 (823)
Q Consensus 453 L~~L~Ls~N~l~~~~p~~~~~l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~~ 520 (823)
|+.|++++|++++ ++.|..|++++|.++|. +++..|..+++++|+|+|.||..+.
T Consensus 341 L~~L~l~~N~l~~--------l~~L~~L~l~~n~l~g~-----~~~~~l~~l~l~~N~l~g~ip~~~~ 395 (457)
T 3bz5_A 341 LKSLSCVNAHIQD--------FSSVGKIPALNNNFEAE-----GQTITMPKETLTNNSLTIAVSPDLL 395 (457)
T ss_dssp CSEEECCSSCCCB--------CTTGGGSSGGGTSEEEE-----EEEEECCCBCCBTTBEEEECCTTCB
T ss_pred CcEEECCCCCCCC--------ccccccccccCCcEEec-----ceeeecCccccccCcEEEEcChhHh
Confidence 9999999999987 35677788999999987 3556778889999999988887653
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=366.26 Aligned_cols=343 Identities=24% Similarity=0.382 Sum_probs=182.9
Q ss_pred cEEEEEcCCCCCccccCcccCCCCCCcEEEccCCCCCCCCCCCCCCCCCCCEEECCCCcCcCCCchhhhcCCCCcEEecc
Q 045449 53 RVIGLNISSFNLQGTITPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLDFSDNQLFGSLSSFIFNMSSMTTIDLS 132 (823)
Q Consensus 53 ~v~~L~L~~~~l~g~~~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 132 (823)
+++.|+++++++.. +| .+..+++|++|||++|.+++..| +.++++|++|+|++|.+++..+ ++++++|++|+|+
T Consensus 47 ~l~~L~l~~~~i~~-l~-~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~ 120 (466)
T 1o6v_A 47 QVTTLQADRLGIKS-ID-GVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLF 120 (466)
T ss_dssp TCCEEECCSSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECC
T ss_pred cccEEecCCCCCcc-Cc-chhhhcCCCEEECCCCccCCchh--hhccccCCEEECCCCccccChh--hcCCCCCCEEECC
Confidence 46667777766653 33 36666777777777777765433 6677777777777777765544 6667777777777
Q ss_pred cccccCccCccccCCCCCCccccccceeeeccceeeccCccccccchhhHHHHHhhcCCCcccCCcccCCcchhhhhccc
Q 045449 133 INRLSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKEIGNLTKLKEIISTITNSTVCEIPREIGNLPYLARLALA 212 (823)
Q Consensus 133 ~N~l~~~~p~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~~l~~n~~~~~ip~~l~~l~~L~~L~Ls 212 (823)
+|++++..+ +.++++|++|+|++|.+++ ++ .++.+++|++|+++
T Consensus 121 ~n~l~~~~~---------~~~l~~L~~L~l~~n~l~~-~~--------------------------~~~~l~~L~~L~l~ 164 (466)
T 1o6v_A 121 NNQITDIDP---------LKNLTNLNRLELSSNTISD-IS--------------------------ALSGLTSLQQLSFG 164 (466)
T ss_dssp SSCCCCCGG---------GTTCTTCSEEEEEEEEECC-CG--------------------------GGTTCTTCSEEEEE
T ss_pred CCCCCCChH---------HcCCCCCCEEECCCCccCC-Ch--------------------------hhccCCcccEeecC
Confidence 776664311 3566677777777776653 11 12333444555553
Q ss_pred cccccCCccccccCCCCCcEEEccCCcccccCCcccccCCCCccEEEeeccccccccCccccCCCCCCeEEeeccccccc
Q 045449 213 TNNLVGVVPVTIFNMSALKEISLLNNSLSGSLPSRIDLSLPNVETLNLGINSFSGTIPSSITNSSKLSDLELGENLFSGF 292 (823)
Q Consensus 213 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 292 (823)
|.+.+..+ +.++++|++|++++|.++ .++. +. .+++|++|++++|++++..| ++.+++|+.|++++|+++
T Consensus 165 -~~~~~~~~--~~~l~~L~~L~l~~n~l~-~~~~-l~-~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~-- 234 (466)
T 1o6v_A 165 -NQVTDLKP--LANLTTLERLDISSNKVS-DISV-LA-KLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLK-- 234 (466)
T ss_dssp -ESCCCCGG--GTTCTTCCEEECCSSCCC-CCGG-GG-GCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCC--
T ss_pred -CcccCchh--hccCCCCCEEECcCCcCC-CChh-hc-cCCCCCEEEecCCccccccc--ccccCCCCEEECCCCCcc--
Confidence 33433222 555555555555555554 2221 11 24445555555444443333 334444444444444444
Q ss_pred CCCccCCCcccCcccccCccccCCCCcccccccccCCCCceEEEeecCCCCccCCccccccccccceEEecCCcceeccC
Q 045449 293 IPNTIGNLRNLEFGNIADNYLTSSTPELSFLSSLTNCKKLKVLIVTGNPLDGILPKSIGNFSLSLETILMANCSISGNIP 372 (823)
Q Consensus 293 ~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~p 372 (823)
+. ..+..+++|+.|++++|.+++..| +..+ ++|++|++++|.+++..+
T Consensus 235 ----------------------~~-------~~l~~l~~L~~L~l~~n~l~~~~~--~~~l-~~L~~L~l~~n~l~~~~~ 282 (466)
T 1o6v_A 235 ----------------------DI-------GTLASLTNLTDLDLANNQISNLAP--LSGL-TKLTELKLGANQISNISP 282 (466)
T ss_dssp ----------------------CC-------GGGGGCTTCSEEECCSSCCCCCGG--GTTC-TTCSEEECCSSCCCCCGG
T ss_pred ----------------------cc-------hhhhcCCCCCEEECCCCccccchh--hhcC-CCCCEEECCCCccCcccc
Confidence 32 123344444444445444444322 3333 344555555554444332
Q ss_pred ccccCcccccEEEcccCcCCCCchhcccccCCCCEEEccCCCCCCcchHhhhcCCCCCEEEcccCcCcccccccccCCCC
Q 045449 373 QVVGNLSNLLVLELGGNNLTGPIPVTFSQLQTLQAFDLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTS 452 (823)
Q Consensus 373 ~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~ 452 (823)
+..+++|++|++++|++++..+ +..+++|++|+|++|++++..| +..+++|+.|++++|.+++. ..+.++++
T Consensus 283 --~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~ 354 (466)
T 1o6v_A 283 --LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSDV--SSLANLTN 354 (466)
T ss_dssp --GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCCC--GGGTTCTT
T ss_pred --ccCCCccCeEEcCCCcccCchh--hcCCCCCCEEECcCCcCCCchh--hccCccCCEeECCCCccCCc--hhhccCCC
Confidence 4455555666666666554333 4555556666666666655444 45555566666666655543 34555555
Q ss_pred CCeEeccCCccccccchhhhccCCCcEEecccccccc
Q 045449 453 VRVLYLGLNIFTSVLSSTIWNLKDILFIDVSSNFLDG 489 (823)
Q Consensus 453 L~~L~Ls~N~l~~~~p~~~~~l~~L~~LdLs~N~l~g 489 (823)
|+.|++++|++++.+| +..+++|+.|++++|.+++
T Consensus 355 L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~~~~ 389 (466)
T 1o6v_A 355 INWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTN 389 (466)
T ss_dssp CCEEECCSSCCCBCGG--GTTCTTCCEEECCCEEEEC
T ss_pred CCEEeCCCCccCccch--hhcCCCCCEEeccCCcccC
Confidence 5555555555555544 5555555555555555554
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-40 Score=369.27 Aligned_cols=333 Identities=17% Similarity=0.153 Sum_probs=268.3
Q ss_pred CcEEEEEcCCCCCccccCcccCCCCCCcEEEccCCCCCCCCCCCCCCCCCCCEEECCCCcCcCCCchhhhcCCCCcEEec
Q 045449 52 HRVIGLNISSFNLQGTITPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLDFSDNQLFGSLSSFIFNMSSMTTIDL 131 (823)
Q Consensus 52 ~~v~~L~L~~~~l~g~~~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 131 (823)
.+++.|+|++|++++. | ++.+++|++|+|++|+|++. | |+.+++|++|+|++|++++. | ++.+++|++|+|
T Consensus 64 ~~L~~L~Ls~n~l~~~-~--~~~l~~L~~L~Ls~N~l~~~-~--~~~l~~L~~L~L~~N~l~~l-~--~~~l~~L~~L~l 134 (457)
T 3bz5_A 64 TGLTKLICTSNNITTL-D--LSQNTNLTYLACDSNKLTNL-D--VTPLTKLTYLNCDTNKLTKL-D--VSQNPLLTYLNC 134 (457)
T ss_dssp TTCSEEECCSSCCSCC-C--CTTCTTCSEEECCSSCCSCC-C--CTTCTTCCEEECCSSCCSCC-C--CTTCTTCCEEEC
T ss_pred CCCCEEEccCCcCCeE-c--cccCCCCCEEECcCCCCcee-e--cCCCCcCCEEECCCCcCCee-c--CCCCCcCCEEEC
Confidence 4789999999999985 3 99999999999999999975 4 99999999999999999974 4 899999999999
Q ss_pred ccccccCccCccccCCCCCCccccccceeeeccceeeccCccccccchhhHHHHHhhcCCCcccCCcccCCcchhhhhcc
Q 045449 132 SINRLSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKEIGNLTKLKEIISTITNSTVCEIPREIGNLPYLARLAL 211 (823)
Q Consensus 132 s~N~l~~~~p~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~~l~~n~~~~~ip~~l~~l~~L~~L~L 211 (823)
++|++++. + ++.+++|++|++++|+..+.++ ++.+++|++|++
T Consensus 135 ~~N~l~~l-~---------l~~l~~L~~L~l~~n~~~~~~~---------------------------~~~l~~L~~L~l 177 (457)
T 3bz5_A 135 ARNTLTEI-D---------VSHNTQLTELDCHLNKKITKLD---------------------------VTPQTQLTTLDC 177 (457)
T ss_dssp TTSCCSCC-C---------CTTCTTCCEEECTTCSCCCCCC---------------------------CTTCTTCCEEEC
T ss_pred CCCcccee-c---------cccCCcCCEEECCCCCcccccc---------------------------cccCCcCCEEEC
Confidence 99999863 2 3789999999999997554431 345677889999
Q ss_pred ccccccCCccccccCCCCCcEEEccCCcccccCCcccccCCCCccEEEeeccccccccCccccCCCCCCeEEeecccccc
Q 045449 212 ATNNLVGVVPVTIFNMSALKEISLLNNSLSGSLPSRIDLSLPNVETLNLGINSFSGTIPSSITNSSKLSDLELGENLFSG 291 (823)
Q Consensus 212 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 291 (823)
++|++++. | +..+++|+.|++++|.+++ ++ +. .+++|++|+|++|++++ +| +..+++|++|++++|++++
T Consensus 178 s~n~l~~l-~--l~~l~~L~~L~l~~N~l~~-~~--l~-~l~~L~~L~Ls~N~l~~-ip--~~~l~~L~~L~l~~N~l~~ 247 (457)
T 3bz5_A 178 SFNKITEL-D--VSQNKLLNRLNCDTNNITK-LD--LN-QNIQLTFLDCSSNKLTE-ID--VTPLTQLTYFDCSVNPLTE 247 (457)
T ss_dssp CSSCCCCC-C--CTTCTTCCEEECCSSCCSC-CC--CT-TCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSC
T ss_pred CCCcccee-c--cccCCCCCEEECcCCcCCe-ec--cc-cCCCCCEEECcCCcccc-cC--ccccCCCCEEEeeCCcCCC
Confidence 99999974 4 7889999999999999985 33 33 48999999999999997 56 8889999999999999998
Q ss_pred cCCCccCCCcccCcccccCccccCCCCcccccccccCCCCceEEEeecCCCCccCCccccccccccceEEecCCcceecc
Q 045449 292 FIPNTIGNLRNLEFGNIADNYLTSSTPELSFLSSLTNCKKLKVLIVTGNPLDGILPKSIGNFSLSLETILMANCSISGNI 371 (823)
Q Consensus 292 ~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~ 371 (823)
.. ++.+++|+.|++++|+++ .|++++|.+.+.+| ++.+ ++|++|++++|.+.+.+
T Consensus 248 ~~---~~~l~~L~~L~l~~n~L~-------------------~L~l~~n~~~~~~~--~~~l-~~L~~L~Ls~n~~l~~l 302 (457)
T 3bz5_A 248 LD---VSTLSKLTTLHCIQTDLL-------------------EIDLTHNTQLIYFQ--AEGC-RKIKELDVTHNTQLYLL 302 (457)
T ss_dssp CC---CTTCTTCCEEECTTCCCS-------------------CCCCTTCTTCCEEE--CTTC-TTCCCCCCTTCTTCCEE
T ss_pred cC---HHHCCCCCEEeccCCCCC-------------------EEECCCCccCCccc--cccc-ccCCEEECCCCccccee
Confidence 64 456677888877766543 45677777777766 3455 67888888888887777
Q ss_pred CccccCcccccEEEcccCcCCCCchhcccccCCCCEEEccCCCCCCcchHhhhcCCCCCEEEcccCcCcccccccccCCC
Q 045449 372 PQVVGNLSNLLVLELGGNNLTGPIPVTFSQLQTLQAFDLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLT 451 (823)
Q Consensus 372 p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~ 451 (823)
|. ..++|+.|++++| ++|++|++++|+|++. + ++++++|+.|++++|+|++ ++
T Consensus 303 ~~---~~~~L~~L~l~~~-------------~~L~~L~L~~N~l~~l-~--l~~l~~L~~L~l~~N~l~~--------l~ 355 (457)
T 3bz5_A 303 DC---QAAGITELDLSQN-------------PKLVYLYLNNTELTEL-D--VSHNTKLKSLSCVNAHIQD--------FS 355 (457)
T ss_dssp EC---TTCCCSCCCCTTC-------------TTCCEEECTTCCCSCC-C--CTTCTTCSEEECCSSCCCB--------CT
T ss_pred cc---CCCcceEechhhc-------------ccCCEEECCCCccccc-c--cccCCcCcEEECCCCCCCC--------cc
Confidence 74 3455666666555 6788888888888874 3 7888889999999998886 24
Q ss_pred CCCeEeccCCccccccchhhhccCCCcEEeccccccccccCccccC
Q 045449 452 SVRVLYLGLNIFTSVLSSTIWNLKDILFIDVSSNFLDGPLSLDIGN 497 (823)
Q Consensus 452 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~LdLs~N~l~g~~p~~~~~ 497 (823)
.|..|++++|.++|. +.+..|..+|+++|+++|.+|..+..
T Consensus 356 ~L~~L~l~~n~l~g~-----~~~~~l~~l~l~~N~l~g~ip~~~~~ 396 (457)
T 3bz5_A 356 SVGKIPALNNNFEAE-----GQTITMPKETLTNNSLTIAVSPDLLD 396 (457)
T ss_dssp TGGGSSGGGTSEEEE-----EEEEECCCBCCBTTBEEEECCTTCBC
T ss_pred ccccccccCCcEEec-----ceeeecCccccccCcEEEEcChhHhc
Confidence 567778888988886 35677888899999999999876543
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=361.91 Aligned_cols=322 Identities=27% Similarity=0.412 Sum_probs=235.7
Q ss_pred CcEEEEEcCCCCCccccCcccCCCCCCcEEEccCCCCCCCCCCCCCCCCCCCEEECCCCcCcCCCchhhhcCCCCcEEec
Q 045449 52 HRVIGLNISSFNLQGTITPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLDFSDNQLFGSLSSFIFNMSSMTTIDL 131 (823)
Q Consensus 52 ~~v~~L~L~~~~l~g~~~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 131 (823)
.+++.|||++|.+++..+ +.++++|++|+|++|++++..+ ++++++|++|+|++|.+++..+ +.++++|++|+|
T Consensus 68 ~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l 141 (466)
T 1o6v_A 68 NNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLEL 141 (466)
T ss_dssp TTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GTTCTTCSEEEE
T ss_pred cCCCEEECCCCccCCchh--hhccccCCEEECCCCccccChh--hcCCCCCCEEECCCCCCCCChH--HcCCCCCCEEEC
Confidence 478999999999997644 9999999999999999997655 9999999999999999987654 899999999999
Q ss_pred ccccccCccCccccCCCCCCccccccceeeeccceeeccCccccccchhhHHHHHhhcCCCcccCCcccCCcchhhhhcc
Q 045449 132 SINRLSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKEIGNLTKLKEIISTITNSTVCEIPREIGNLPYLARLAL 211 (823)
Q Consensus 132 s~N~l~~~~p~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~~l~~n~~~~~ip~~l~~l~~L~~L~L 211 (823)
++|++++ ++ .+..+++|++|+++ |.+.+. ..+.++++|++|++
T Consensus 142 ~~n~l~~-~~--------~~~~l~~L~~L~l~-~~~~~~---------------------------~~~~~l~~L~~L~l 184 (466)
T 1o6v_A 142 SSNTISD-IS--------ALSGLTSLQQLSFG-NQVTDL---------------------------KPLANLTTLERLDI 184 (466)
T ss_dssp EEEEECC-CG--------GGTTCTTCSEEEEE-ESCCCC---------------------------GGGTTCTTCCEEEC
T ss_pred CCCccCC-Ch--------hhccCCcccEeecC-CcccCc---------------------------hhhccCCCCCEEEC
Confidence 9999985 22 24889999999996 444321 12566778999999
Q ss_pred ccccccCCccccccCCCCCcEEEccCCcccccCCcccccCCCCccEEEeeccccccccCccccCCCCCCeEEeecccccc
Q 045449 212 ATNNLVGVVPVTIFNMSALKEISLLNNSLSGSLPSRIDLSLPNVETLNLGINSFSGTIPSSITNSSKLSDLELGENLFSG 291 (823)
Q Consensus 212 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 291 (823)
++|++++. ..+..+++|++|++++|.+++..| +. .+++|++|++++|++++. +.+..+++|++|++++|.+++
T Consensus 185 ~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~-~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~ 257 (466)
T 1o6v_A 185 SSNKVSDI--SVLAKLTNLESLIATNNQISDITP--LG-ILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISN 257 (466)
T ss_dssp CSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GG-GCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCC
T ss_pred cCCcCCCC--hhhccCCCCCEEEecCCccccccc--cc-ccCCCCEEECCCCCcccc--hhhhcCCCCCEEECCCCcccc
Confidence 99999865 348899999999999999996555 33 489999999999999864 468899999999999999997
Q ss_pred cCCCccCCCcccCcccccCccccCCCCcccccccccCCCCceEEEeecCCCCccCCccccccccccceEEecCCcceecc
Q 045449 292 FIPNTIGNLRNLEFGNIADNYLTSSTPELSFLSSLTNCKKLKVLIVTGNPLDGILPKSIGNFSLSLETILMANCSISGNI 371 (823)
Q Consensus 292 ~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~ 371 (823)
..+ +..+++|+.|++++|.+++.. .+..+++|+.|++++|.+++..| +.
T Consensus 258 ~~~--~~~l~~L~~L~l~~n~l~~~~-------~~~~l~~L~~L~L~~n~l~~~~~--~~-------------------- 306 (466)
T 1o6v_A 258 LAP--LSGLTKLTELKLGANQISNIS-------PLAGLTALTNLELNENQLEDISP--IS-------------------- 306 (466)
T ss_dssp CGG--GTTCTTCSEEECCSSCCCCCG-------GGTTCTTCSEEECCSSCCSCCGG--GG--------------------
T ss_pred chh--hhcCCCCCEEECCCCccCccc-------cccCCCccCeEEcCCCcccCchh--hc--------------------
Confidence 765 788888888888888887752 25667777777777777665433 33
Q ss_pred CccccCcccccEEEcccCcCCCCchhcccccCCCCEEEccCCCCCCcchHhhhcCCCCCEEEcccCcCcccccccccCCC
Q 045449 372 PQVVGNLSNLLVLELGGNNLTGPIPVTFSQLQTLQAFDLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLT 451 (823)
Q Consensus 372 p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~ 451 (823)
.+++|+.|+|++|++++..| +..+++|++|++++|++++. ..+..+++|+.|++++|++++..| +..++
T Consensus 307 -----~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~ 375 (466)
T 1o6v_A 307 -----NLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSDV--SSLANLTNINWLSAGHNQISDLTP--LANLT 375 (466)
T ss_dssp -----GCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCBCGG--GTTCT
T ss_pred -----CCCCCCEEECcCCcCCCchh--hccCccCCEeECCCCccCCc--hhhccCCCCCEEeCCCCccCccch--hhcCC
Confidence 44444455555555444333 34445555555555555443 234445555555555555554444 44555
Q ss_pred CCCeEeccCCcccc
Q 045449 452 SVRVLYLGLNIFTS 465 (823)
Q Consensus 452 ~L~~L~Ls~N~l~~ 465 (823)
+|+.|++++|.+++
T Consensus 376 ~L~~L~l~~n~~~~ 389 (466)
T 1o6v_A 376 RITQLGLNDQAWTN 389 (466)
T ss_dssp TCCEEECCCEEEEC
T ss_pred CCCEEeccCCcccC
Confidence 55555555555554
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-38 Score=369.63 Aligned_cols=174 Identities=18% Similarity=0.211 Sum_probs=127.8
Q ss_pred ccceEEecCCcceeccCccccCcccccEEEcccCcCCCCchhcccccCCCCEEEccCCCCCCcchHhhhcCCCCCEEEcc
Q 045449 356 SLETILMANCSISGNIPQVVGNLSNLLVLELGGNNLTGPIPVTFSQLQTLQAFDLTRNKLAGPITDELCHLARLHSLVLQ 435 (823)
Q Consensus 356 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 435 (823)
+|++|++++|.++...+.. .++|+.|+|++|++++ +..+..+++|++|+|++|.+++.+|..|..+++|+.|+|+
T Consensus 212 ~L~~L~ls~n~l~~~~~~~---~~~L~~L~L~~n~l~~--~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls 286 (597)
T 3oja_B 212 AVEELDASHNSINVVRGPV---NVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYIS 286 (597)
T ss_dssp TCSEEECCSSCCCEEECSC---CSCCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECT
T ss_pred hhheeeccCCccccccccc---CCCCCEEECCCCCCCC--ChhhccCCCCCEEECCCCccCCCCHHHhcCccCCCEEECC
Confidence 3444445555444332222 2467788888888875 3567788888888888888888888888888888888888
Q ss_pred cCcCcccccccccCCCCCCeEeccCCccccccchhhhccCCCcEEeccccccccccCccccCCCCCcEEEcccCCCCCCC
Q 045449 436 GNKFSGSIPSCLGNLTSVRVLYLGLNIFTSVLSSTIWNLKDILFIDVSSNFLDGPLSLDIGNLKVVIGLDFSRNNLSGDI 515 (823)
Q Consensus 436 ~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~i 515 (823)
+|.+++ +|..+..+++|+.|+|++|.+++ +|..+..+++|+.|+|++|.+++. | +..++.|+.|++++|+++|..
T Consensus 287 ~N~l~~-l~~~~~~l~~L~~L~Ls~N~l~~-i~~~~~~l~~L~~L~L~~N~l~~~-~--~~~~~~L~~L~l~~N~~~~~~ 361 (597)
T 3oja_B 287 NNRLVA-LNLYGQPIPTLKVLDLSHNHLLH-VERNQPQFDRLENLYLDHNSIVTL-K--LSTHHTLKNLTLSHNDWDCNS 361 (597)
T ss_dssp TSCCCE-EECSSSCCTTCCEEECCSSCCCC-CGGGHHHHTTCSEEECCSSCCCCC-C--CCTTCCCSEEECCSSCEEHHH
T ss_pred CCCCCC-CCcccccCCCCcEEECCCCCCCc-cCcccccCCCCCEEECCCCCCCCc-C--hhhcCCCCEEEeeCCCCCChh
Confidence 888885 57777778889999999998885 677788889999999999998765 2 677889999999999988543
Q ss_pred CCcccCccCCCCCCCCCCCcccccCCcccCCCCC
Q 045449 516 PITIGEGEIPRGGPFANLTAKSFMGNELLCGLPD 549 (823)
Q Consensus 516 p~~~~~g~ip~~~~~~~~~~~~~~~n~~~c~~~~ 549 (823)
+..+ +..+....+.++...|+.+.
T Consensus 362 ~~~~----------~~~~~~~~~~~~~~~C~~~~ 385 (597)
T 3oja_B 362 LRAL----------FRNVARPAVDDADQHCKIDY 385 (597)
T ss_dssp HHHH----------TTTCCTTTBCCCCCCCCTTC
T ss_pred HHHH----------HHHHhhhccccccccCCcch
Confidence 2221 33444456778888888654
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-38 Score=358.90 Aligned_cols=329 Identities=20% Similarity=0.165 Sum_probs=278.2
Q ss_pred hhhhhccccccccCCccccccCCCCCcEEEccCCcccccCCcccccCCCCccEEEeeccccccccCccccCCCCCCeEEe
Q 045449 205 YLARLALATNNLVGVVPVTIFNMSALKEISLLNNSLSGSLPSRIDLSLPNVETLNLGINSFSGTIPSSITNSSKLSDLEL 284 (823)
Q Consensus 205 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 284 (823)
+++.|+|++|++++..|..|.++++|++|+|++|.+++..|..+. .+++|++|+|++|++++..+..|.++++|++|+|
T Consensus 33 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~-~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 111 (477)
T 2id5_A 33 ETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFN-NLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDI 111 (477)
T ss_dssp TCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTT-TCTTCCEEECCSSCCCSCCTTSSTTCTTCCEEEC
T ss_pred CCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhh-CCccCCEEECCCCcCCccCcccccCCCCCCEEEC
Confidence 577889999999888888888999999999999998866566555 4889999999999998766677888999999999
Q ss_pred ecccccccCCCccCCCcccCcccccCccccCCCCcccccccccCCCCceEEEeecCCCCccCCccccccccccceEEecC
Q 045449 285 GENLFSGFIPNTIGNLRNLEFGNIADNYLTSSTPELSFLSSLTNCKKLKVLIVTGNPLDGILPKSIGNFSLSLETILMAN 364 (823)
Q Consensus 285 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~ 364 (823)
++|++++..|..|..+++|++|+|++|.+++. .+..|.++++|+.|++++|.+++..+..+..+ ++|++|++++
T Consensus 112 s~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~-----~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l-~~L~~L~l~~ 185 (477)
T 2id5_A 112 SENKIVILLDYMFQDLYNLKSLEVGDNDLVYI-----SHRAFSGLNSLEQLTLEKCNLTSIPTEALSHL-HGLIVLRLRH 185 (477)
T ss_dssp TTSCCCEECTTTTTTCTTCCEEEECCTTCCEE-----CTTSSTTCTTCCEEEEESCCCSSCCHHHHTTC-TTCCEEEEES
T ss_pred CCCccccCChhHccccccCCEEECCCCcccee-----ChhhccCCCCCCEEECCCCcCcccChhHhccc-CCCcEEeCCC
Confidence 99999988888899999999999999988876 34578888999999999999988777778888 7899999999
Q ss_pred CcceeccCccccCcccccEEEcccCcCCCCchhcccccCCCCEEEccCCCCCCcchHhhhcCCCCCEEEcccCcCccccc
Q 045449 365 CSISGNIPQVVGNLSNLLVLELGGNNLTGPIPVTFSQLQTLQAFDLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIP 444 (823)
Q Consensus 365 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p 444 (823)
|.+++..+..|..+++|+.|++++|.+.+.+|..+....+|++|+|++|++++..+..|..+++|+.|+|++|.+++..+
T Consensus 186 n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~ 265 (477)
T 2id5_A 186 LNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEG 265 (477)
T ss_dssp CCCCEECTTCSCSCTTCCEEEEECCTTCCEECTTTTTTCCCSEEEEESSCCCSCCHHHHTTCTTCCEEECCSSCCCEECT
T ss_pred CcCcEeChhhcccCcccceeeCCCCccccccCcccccCccccEEECcCCcccccCHHHhcCccccCeeECCCCcCCccCh
Confidence 99998888899999999999999999888888877777799999999999997766788999999999999999998888
Q ss_pred ccccCCCCCCeEeccCCccccccchhhhccCCCcEEeccccccccccCccccCCCCCcEEEcccCCCCCCCCCcccCccC
Q 045449 445 SCLGNLTSVRVLYLGLNIFTSVLSSTIWNLKDILFIDVSSNFLDGPLSLDIGNLKVVIGLDFSRNNLSGDIPITIGEGEI 524 (823)
Q Consensus 445 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~~~g~i 524 (823)
..|..+++|+.|+|++|++++..|..+..+++|+.|||++|.+++..+..+..++.|+.|++++|++++..+...-
T Consensus 266 ~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~c~c~~~~~---- 341 (477)
T 2id5_A 266 SMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLACDCRLLWV---- 341 (477)
T ss_dssp TSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSSCCSCCCGGGBSCGGGCCEEECCSSCEECSGGGHHH----
T ss_pred hhccccccCCEEECCCCccceECHHHhcCcccCCEEECCCCcCceeCHhHcCCCcccCEEEccCCCccCccchHhH----
Confidence 8899999999999999999999999999999999999999999987777889999999999999999876543211
Q ss_pred CCCCCCCCCCcccccCCcccCCCCC
Q 045449 525 PRGGPFANLTAKSFMGNELLCGLPD 549 (823)
Q Consensus 525 p~~~~~~~~~~~~~~~n~~~c~~~~ 549 (823)
+.......+.++...|..|.
T Consensus 342 -----~~~~~~~~~~~~~~~C~~p~ 361 (477)
T 2id5_A 342 -----FRRRWRLNFNRQQPTCATPE 361 (477)
T ss_dssp -----HTTTTSSCCTTCCCBEEESG
T ss_pred -----HhhhhccccCccCceeCCch
Confidence 11112234556666776554
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=344.29 Aligned_cols=173 Identities=17% Similarity=0.207 Sum_probs=121.6
Q ss_pred ccceEEecCCcceeccCccccCcccccEEEcccCcCCCCchhcccccCCCCEEEccCCCCCCcchHhhhcCCCCCEEEcc
Q 045449 356 SLETILMANCSISGNIPQVVGNLSNLLVLELGGNNLTGPIPVTFSQLQTLQAFDLTRNKLAGPITDELCHLARLHSLVLQ 435 (823)
Q Consensus 356 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 435 (823)
+|++|++++|.++..... ..++|+.|++++|++++. ..+..+++|++|+|++|.+++..|..|..+++|+.|+|+
T Consensus 206 ~L~~L~l~~n~l~~~~~~---~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~ 280 (390)
T 3o6n_A 206 AVEELDASHNSINVVRGP---VNVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYIS 280 (390)
T ss_dssp SCSEEECCSSCCCEEECC---CCSSCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECC
T ss_pred cceEEECCCCeeeecccc---ccccccEEECCCCCCccc--HHHcCCCCccEEECCCCcCCCcChhHccccccCCEEECC
Confidence 344455555554433221 135677778888877753 467778888888888888887778888888888888888
Q ss_pred cCcCcccccccccCCCCCCeEeccCCccccccchhhhccCCCcEEeccccccccccCccccCCCCCcEEEcccCCCCCCC
Q 045449 436 GNKFSGSIPSCLGNLTSVRVLYLGLNIFTSVLSSTIWNLKDILFIDVSSNFLDGPLSLDIGNLKVVIGLDFSRNNLSGDI 515 (823)
Q Consensus 436 ~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~i 515 (823)
+|++++ +|..+..+++|+.|+|++|++++ +|..+..+++|+.|++++|.++.. | +..++.|+.|++++|++++.-
T Consensus 281 ~n~l~~-~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~L~~N~i~~~-~--~~~~~~L~~L~l~~N~~~~~~ 355 (390)
T 3o6n_A 281 NNRLVA-LNLYGQPIPTLKVLDLSHNHLLH-VERNQPQFDRLENLYLDHNSIVTL-K--LSTHHTLKNLTLSHNDWDCNS 355 (390)
T ss_dssp SSCCCE-EECSSSCCTTCCEEECCSSCCCC-CGGGHHHHTTCSEEECCSSCCCCC-C--CCTTCCCSEEECCSSCEEHHH
T ss_pred CCcCcc-cCcccCCCCCCCEEECCCCccee-cCccccccCcCCEEECCCCcccee-C--chhhccCCEEEcCCCCccchh
Confidence 888875 56666778888888888888885 566778888899999999988754 3 677888999999999888532
Q ss_pred CCcccCccCCCCCCCCCCCcccccCCcccCCCC
Q 045449 516 PITIGEGEIPRGGPFANLTAKSFMGNELLCGLP 548 (823)
Q Consensus 516 p~~~~~g~ip~~~~~~~~~~~~~~~n~~~c~~~ 548 (823)
...+ +..+....+.+++..|..+
T Consensus 356 ~~~~----------~~~~~~~~~~~~~~~c~~~ 378 (390)
T 3o6n_A 356 LRAL----------FRNVARPAVDDADQHCKID 378 (390)
T ss_dssp HHHH----------TTTCCTTTBCCCCSCCCTT
T ss_pred HHHH----------HHHHHhhcccccCceeccc
Confidence 2111 2233334456666667654
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-37 Score=351.82 Aligned_cols=316 Identities=20% Similarity=0.204 Sum_probs=231.2
Q ss_pred CCCCCccccCcccCCCCCCcEEEccCCCCCCCCCCCCCCCCCCCEEECCCCcCcCCCchhhhcCCCCcEEecccccccCc
Q 045449 60 SSFNLQGTITPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLDFSDNQLFGSLSSFIFNMSSMTTIDLSINRLSGE 139 (823)
Q Consensus 60 ~~~~l~g~~~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 139 (823)
++++++ .+|..+. +++++|||++|+|++..|..|.++++|++|+|++|.|++..|.+|.++++|++|+|++|++++.
T Consensus 19 ~~~~l~-~ip~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~ 95 (477)
T 2id5_A 19 HRKRFV-AVPEGIP--TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLI 95 (477)
T ss_dssp CSCCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCSC
T ss_pred CCCCcC-cCCCCCC--CCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCcCCcc
Confidence 344454 4555543 5899999999999988899999999999999999999998899999999999999999999843
Q ss_pred cCccccCCCCCCccccccceeeeccceeeccCccccccchhhHHHHHhhcCCCcccCCcccCCcchhhhhccccccccCC
Q 045449 140 LPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKEIGNLTKLKEIISTITNSTVCEIPREIGNLPYLARLALATNNLVGV 219 (823)
Q Consensus 140 ~p~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~~l~~n~~~~~ip~~l~~l~~L~~L~Ls~N~l~~~ 219 (823)
.+.. |.++++|++|+|++|++++..|. .|.++++|++|+|++|++++.
T Consensus 96 ~~~~-------~~~l~~L~~L~Ls~n~i~~~~~~-------------------------~~~~l~~L~~L~l~~n~l~~~ 143 (477)
T 2id5_A 96 PLGV-------FTGLSNLTKLDISENKIVILLDY-------------------------MFQDLYNLKSLEVGDNDLVYI 143 (477)
T ss_dssp CTTS-------STTCTTCCEEECTTSCCCEECTT-------------------------TTTTCTTCCEEEECCTTCCEE
T ss_pred Cccc-------ccCCCCCCEEECCCCccccCChh-------------------------HccccccCCEEECCCCcccee
Confidence 3222 48899999999999998865443 345556778888888988888
Q ss_pred ccccccCCCCCcEEEccCCcccccCCcccccCCCCccEEEeeccccccccCccccCCCCCCeEEeecccccccCCCccCC
Q 045449 220 VPVTIFNMSALKEISLLNNSLSGSLPSRIDLSLPNVETLNLGINSFSGTIPSSITNSSKLSDLELGENLFSGFIPNTIGN 299 (823)
Q Consensus 220 ~p~~~~~l~~L~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 299 (823)
.|..|.++++|++|+|++|.++ .+|...+..+++|+.|+|++|.+.+..+..|..+++|+.|++++|.+.+.+|..+..
T Consensus 144 ~~~~~~~l~~L~~L~l~~n~l~-~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~ 222 (477)
T 2id5_A 144 SHRAFSGLNSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLY 222 (477)
T ss_dssp CTTSSTTCTTCCEEEEESCCCS-SCCHHHHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCEECTTTTT
T ss_pred ChhhccCCCCCCEEECCCCcCc-ccChhHhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCccccccCccccc
Confidence 8888888889999999999888 555554555888888888888888887788888888888888888877777766666
Q ss_pred CcccCcccccCccccCCCCcccccccccCCCCceEEEeecCCCCccCCccccccccccceEEecCCcceeccCccccCcc
Q 045449 300 LRNLEFGNIADNYLTSSTPELSFLSSLTNCKKLKVLIVTGNPLDGILPKSIGNFSLSLETILMANCSISGNIPQVVGNLS 379 (823)
Q Consensus 300 l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~ 379 (823)
..+|+.|+|++|.++.. ....+.++++|+.|+|++|.+++..+..|..+ .+|++|+|++|++++..|..|.+++
T Consensus 223 ~~~L~~L~l~~n~l~~~-----~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l-~~L~~L~L~~n~l~~~~~~~~~~l~ 296 (477)
T 2id5_A 223 GLNLTSLSITHCNLTAV-----PYLAVRHLVYLRFLNLSYNPISTIEGSMLHEL-LRLQEIQLVGGQLAVVEPYAFRGLN 296 (477)
T ss_dssp TCCCSEEEEESSCCCSC-----CHHHHTTCTTCCEEECCSSCCCEECTTSCTTC-TTCCEEECCSSCCSEECTTTBTTCT
T ss_pred CccccEEECcCCccccc-----CHHHhcCccccCeeECCCCcCCccChhhcccc-ccCCEEECCCCccceECHHHhcCcc
Confidence 66777777777776654 12345566666666666666665555555555 4555555555555555555555555
Q ss_pred cccEEEcccCcCCCCchhcccccCCCCEEEccCCCCCC
Q 045449 380 NLLVLELGGNNLTGPIPVTFSQLQTLQAFDLTRNKLAG 417 (823)
Q Consensus 380 ~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~ 417 (823)
+|++|+|++|++++..+..|..+++|++|+|++|.++.
T Consensus 297 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~c 334 (477)
T 2id5_A 297 YLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLAC 334 (477)
T ss_dssp TCCEEECCSSCCSCCCGGGBSCGGGCCEEECCSSCEEC
T ss_pred cCCEEECCCCcCceeCHhHcCCCcccCEEEccCCCccC
Confidence 55555555555555444455555555555555555543
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-37 Score=332.30 Aligned_cols=279 Identities=18% Similarity=0.252 Sum_probs=193.0
Q ss_pred ccchHHHHHHHHHHHHhccCCCcccccccc----CCCCCCccceeeeeCC--------CCCcEEEEEcCCCCCccccCcc
Q 045449 4 KSIISQHQQALLALKAHISYDHTNLFARNW----TSSTSVCIWIGITCDV--------NSHRVIGLNISSFNLQGTITPQ 71 (823)
Q Consensus 4 ~~~~~~~~~aLl~~k~~~~~~~~~~~~~~W----~~~~~~c~w~gv~c~~--------~~~~v~~L~L~~~~l~g~~~~~ 71 (823)
+..+++|++||++||+++..|+.+... +| ....++|.|.|+.|+. ...+|+.|+|++|+++ .+|+.
T Consensus 22 ~~~~~~~~~aLl~~k~~~~~~~~~~~~-~w~~~~~~~~~~~~~~g~~~~~~~~~l~~~~~~~l~~L~L~~n~l~-~lp~~ 99 (328)
T 4fcg_A 22 STALRPYHDVLSQWQRHYNADRNRWHS-AWRQANSNNPQIETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQ 99 (328)
T ss_dssp -CCCCCHHHHHHHHHHHHHHCCTTHHH-HHHHHTTTCTTSCCSHHHHHHHHHHHHHHHTSTTCCEEEEESSCCS-SCCSC
T ss_pred cccCchHHHHHHHHHHhccCCchhhhh-hhcccccccccccccCCcchhhhHHHHhcccccceeEEEccCCCch-hcChh
Confidence 346778999999999998778877776 89 4567899999999952 3457888888888887 67777
Q ss_pred cCCCCCCcEEEccCCCCCCCCCCCCCCCCCCCEEECCCCcCcCCCchhhhcCCCCcEEecccccccCccCccccC--CCC
Q 045449 72 LGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLDFSDNQLFGSLSSFIFNMSSMTTIDLSINRLSGELPANICK--IPS 149 (823)
Q Consensus 72 l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~--~p~ 149 (823)
++++++|++|+|++|.|+ .+|..|+.+++|++|+|++|.|+ .+|..|+++++|++|+|++|++.+.+|..+.. ++.
T Consensus 100 l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~~~~~ 177 (328)
T 4fcg_A 100 AFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASG 177 (328)
T ss_dssp GGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEEC-CC
T ss_pred hhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCccccChhHhhccchh
Confidence 888888888888888888 78888888888888888888887 66777888888888888888777777765521 233
Q ss_pred CCccccccceeeeccceeeccCccccccchhhHHHHHhhcCCCcccCCcccCCcchhhhhccccccccCCccccccCCCC
Q 045449 150 TLSKCKQLEELNLGFNNLSGAIPKEIGNLTKLKEIISTITNSTVCEIPREIGNLPYLARLALATNNLVGVVPVTIFNMSA 229 (823)
Q Consensus 150 ~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~~l~~n~~~~~ip~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 229 (823)
.|.++++|++|+|++|+++ .+|..+ +++++|++|+|++|++++ +|..+.++++
T Consensus 178 ~~~~l~~L~~L~L~~n~l~-~lp~~l-------------------------~~l~~L~~L~L~~N~l~~-l~~~l~~l~~ 230 (328)
T 4fcg_A 178 EHQGLVNLQSLRLEWTGIR-SLPASI-------------------------ANLQNLKSLKIRNSPLSA-LGPAIHHLPK 230 (328)
T ss_dssp CEEESTTCCEEEEEEECCC-CCCGGG-------------------------GGCTTCCEEEEESSCCCC-CCGGGGGCTT
T ss_pred hhccCCCCCEEECcCCCcC-cchHhh-------------------------cCCCCCCEEEccCCCCCc-CchhhccCCC
Confidence 3445667777777777665 444333 233445556666666664 3445666666
Q ss_pred CcEEEccCCcccccCCcccccCCCCccEEEeeccccccccCccccCCCCCCeEEeecccccccCCCccCCCcccCccccc
Q 045449 230 LKEISLLNNSLSGSLPSRIDLSLPNVETLNLGINSFSGTIPSSITNSSKLSDLELGENLFSGFIPNTIGNLRNLEFGNIA 309 (823)
Q Consensus 230 L~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 309 (823)
|++|+|++|.+.+.+|..+.. +++|++|+|++|++.+.+|..+.++++|++|+|++|++.+.+|..++++++|+.+++.
T Consensus 231 L~~L~Ls~n~~~~~~p~~~~~-l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~L~~L~~l~l~ 309 (328)
T 4fcg_A 231 LEELDLRGCTALRNYPPIFGG-RAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVP 309 (328)
T ss_dssp CCEEECTTCTTCCBCCCCTTC-CCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGGGGSCTTCEEECC
T ss_pred CCEEECcCCcchhhhHHHhcC-CCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHHhhccCceEEeCC
Confidence 666666666666666655443 6666666666666666666666666666666666666666666666666666666655
Q ss_pred Ccccc
Q 045449 310 DNYLT 314 (823)
Q Consensus 310 ~N~l~ 314 (823)
.|.+.
T Consensus 310 ~~~~~ 314 (328)
T 4fcg_A 310 PHLQA 314 (328)
T ss_dssp GGGSC
T ss_pred HHHHH
Confidence 55444
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=319.87 Aligned_cols=257 Identities=28% Similarity=0.461 Sum_probs=199.1
Q ss_pred CCccEEEeecccccc--ccCccccCCCCCCeEEeec-ccccccCCCccCCCcccCcccccCccccCCCCcccccccccCC
Q 045449 253 PNVETLNLGINSFSG--TIPSSITNSSKLSDLELGE-NLFSGFIPNTIGNLRNLEFGNIADNYLTSSTPELSFLSSLTNC 329 (823)
Q Consensus 253 ~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l 329 (823)
.+++.|+|++|++++ .+|..+.++++|++|+|++ |.+.+.+|..|+++
T Consensus 50 ~~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l----------------------------- 100 (313)
T 1ogq_A 50 YRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKL----------------------------- 100 (313)
T ss_dssp CCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGC-----------------------------
T ss_pred ceEEEEECCCCCccCCcccChhHhCCCCCCeeeCCCCCcccccCChhHhcC-----------------------------
Confidence 467777777777777 6777777777777777774 77766666555444
Q ss_pred CCceEEEeecCCCCccCCccccccccccceEEecCCcceeccCccccCcccccEEEcccCcCCCCchhcccccC-CCCEE
Q 045449 330 KKLKVLIVTGNPLDGILPKSIGNFSLSLETILMANCSISGNIPQVVGNLSNLLVLELGGNNLTGPIPVTFSQLQ-TLQAF 408 (823)
Q Consensus 330 ~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~-~L~~L 408 (823)
++|++|+|++|.+++.+|..+..+ ++|++|++++|.+++.+|..+..+++|++|+|++|+++|.+|..+..++ +|++|
T Consensus 101 ~~L~~L~Ls~n~l~~~~p~~~~~l-~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L 179 (313)
T 1ogq_A 101 TQLHYLYITHTNVSGAIPDFLSQI-KTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSM 179 (313)
T ss_dssp TTCSEEEEEEECCEEECCGGGGGC-TTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEE
T ss_pred CCCCEEECcCCeeCCcCCHHHhCC-CCCCEEeCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEE
Confidence 455555555666655666666666 5777777777777777777777788888888888888877888887777 78888
Q ss_pred EccCCCCCCcchHhhhcCCCCCEEEcccCcCcccccccccCCCCCCeEeccCCccccccchhhhccCCCcEEeccccccc
Q 045449 409 DLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSVRVLYLGLNIFTSVLSSTIWNLKDILFIDVSSNFLD 488 (823)
Q Consensus 409 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~LdLs~N~l~ 488 (823)
+|++|++++.+|..+..++ |+.|+|++|.+++.+|..|..+++|+.|+|++|.+++.+|. +..+++|++|+|++|.++
T Consensus 180 ~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~ 257 (313)
T 1ogq_A 180 TISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIY 257 (313)
T ss_dssp ECCSSEEEEECCGGGGGCC-CSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCE
T ss_pred ECcCCeeeccCChHHhCCc-ccEEECcCCcccCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECcCCccc
Confidence 8888888888888888876 88888888888888888888888888888888888877666 777888899999999998
Q ss_pred cccCccccCCCCCcEEEcccCCCCCCCCCcccCccCCCCCCCCCCCcccccCCcccCCCCCC
Q 045449 489 GPLSLDIGNLKVVIGLDFSRNNLSGDIPITIGEGEIPRGGPFANLTAKSFMGNELLCGLPDL 550 (823)
Q Consensus 489 g~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~~~g~ip~~~~~~~~~~~~~~~n~~~c~~~~~ 550 (823)
|.+|..+..++.|+.|++++|+++|.+| ....+..+....+.+|+++||.|..
T Consensus 258 ~~~p~~l~~l~~L~~L~Ls~N~l~~~ip---------~~~~l~~L~~l~l~~N~~lc~~p~~ 310 (313)
T 1ogq_A 258 GTLPQGLTQLKFLHSLNVSFNNLCGEIP---------QGGNLQRFDVSAYANNKCLCGSPLP 310 (313)
T ss_dssp ECCCGGGGGCTTCCEEECCSSEEEEECC---------CSTTGGGSCGGGTCSSSEEESTTSS
T ss_pred CcCChHHhcCcCCCEEECcCCcccccCC---------CCccccccChHHhcCCCCccCCCCC
Confidence 8888888889999999999999885444 4445677888899999999998754
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-34 Score=309.71 Aligned_cols=306 Identities=22% Similarity=0.345 Sum_probs=255.0
Q ss_pred ccccccceeeeccceeeccCccccccchhhHHHHHhhcCCCcccCCcccCCcchhhhhccccccccCCccccccCCCCCc
Q 045449 152 SKCKQLEELNLGFNNLSGAIPKEIGNLTKLKEIISTITNSTVCEIPREIGNLPYLARLALATNNLVGVVPVTIFNMSALK 231 (823)
Q Consensus 152 ~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~~l~~n~~~~~ip~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 231 (823)
..+++|++|++++|.++. +| .+..+++|++|++++|++++..+ +.++++|+
T Consensus 41 ~~l~~L~~L~l~~~~i~~-~~--------------------------~~~~~~~L~~L~l~~n~i~~~~~--~~~l~~L~ 91 (347)
T 4fmz_A 41 EELESITKLVVAGEKVAS-IQ--------------------------GIEYLTNLEYLNLNGNQITDISP--LSNLVKLT 91 (347)
T ss_dssp HHHTTCSEEECCSSCCCC-CT--------------------------TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCC
T ss_pred hhcccccEEEEeCCcccc-ch--------------------------hhhhcCCccEEEccCCccccchh--hhcCCcCC
Confidence 567889999999988762 22 13445678889999999986544 88899999
Q ss_pred EEEccCCcccccCCcccccCCCCccEEEeeccccccccCccccCCCCCCeEEeecccccccCCCccCCCcccCcccccCc
Q 045449 232 EISLLNNSLSGSLPSRIDLSLPNVETLNLGINSFSGTIPSSITNSSKLSDLELGENLFSGFIPNTIGNLRNLEFGNIADN 311 (823)
Q Consensus 232 ~L~Ls~N~l~g~lp~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 311 (823)
+|++++|.++ .+| .+ ..+++|++|++++|++++..+ +..+++|++|++++|.....++ .+..+++|++|++++|
T Consensus 92 ~L~L~~n~i~-~~~-~~-~~l~~L~~L~l~~n~i~~~~~--~~~l~~L~~L~l~~n~~~~~~~-~~~~l~~L~~L~l~~~ 165 (347)
T 4fmz_A 92 NLYIGTNKIT-DIS-AL-QNLTNLRELYLNEDNISDISP--LANLTKMYSLNLGANHNLSDLS-PLSNMTGLNYLTVTES 165 (347)
T ss_dssp EEECCSSCCC-CCG-GG-TTCTTCSEEECTTSCCCCCGG--GTTCTTCCEEECTTCTTCCCCG-GGTTCTTCCEEECCSS
T ss_pred EEEccCCccc-Cch-HH-cCCCcCCEEECcCCcccCchh--hccCCceeEEECCCCCCccccc-chhhCCCCcEEEecCC
Confidence 9999999988 455 33 358999999999999986433 8889999999999996665544 4889999999999999
Q ss_pred cccCCCCcccccccccCCCCceEEEeecCCCCccCCccccccccccceEEecCCcceeccCccccCcccccEEEcccCcC
Q 045449 312 YLTSSTPELSFLSSLTNCKKLKVLIVTGNPLDGILPKSIGNFSLSLETILMANCSISGNIPQVVGNLSNLLVLELGGNNL 391 (823)
Q Consensus 312 ~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 391 (823)
.+++.. .+..+++|+.|++++|.+.+..+ +..+ .+|++|++++|.+++..+ +..+++|++|++++|++
T Consensus 166 ~~~~~~-------~~~~l~~L~~L~l~~n~l~~~~~--~~~l-~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l 233 (347)
T 4fmz_A 166 KVKDVT-------PIANLTDLYSLSLNYNQIEDISP--LASL-TSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKI 233 (347)
T ss_dssp CCCCCG-------GGGGCTTCSEEECTTSCCCCCGG--GGGC-TTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCC
T ss_pred CcCCch-------hhccCCCCCEEEccCCccccccc--ccCC-CccceeecccCCCCCCch--hhcCCcCCEEEccCCcc
Confidence 988762 27888999999999999986544 6666 789999999999987655 88899999999999999
Q ss_pred CCCchhcccccCCCCEEEccCCCCCCcchHhhhcCCCCCEEEcccCcCcccccccccCCCCCCeEeccCCccccccchhh
Q 045449 392 TGPIPVTFSQLQTLQAFDLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSVRVLYLGLNIFTSVLSSTI 471 (823)
Q Consensus 392 ~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 471 (823)
++..+ +..+++|++|++++|.+++. ..+..+++|+.|++++|.+++. ..+..+++|+.|++++|.+++..|..+
T Consensus 234 ~~~~~--~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~~~l 307 (347)
T 4fmz_A 234 TDLSP--LANLSQLTWLEIGTNQISDI--NAVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVI 307 (347)
T ss_dssp CCCGG--GTTCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCGGGHHHH
T ss_pred CCCcc--hhcCCCCCEEECCCCccCCC--hhHhcCCCcCEEEccCCccCCC--hhhcCCCCCCEEECcCCcCCCcChhHh
Confidence 86544 88999999999999999864 4688899999999999999865 468899999999999999999999999
Q ss_pred hccCCCcEEeccccccccccCccccCCCCCcEEEcccCCCC
Q 045449 472 WNLKDILFIDVSSNFLDGPLSLDIGNLKVVIGLDFSRNNLS 512 (823)
Q Consensus 472 ~~l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~ls~N~l~ 512 (823)
..+++|+.|++++|.+++..| +..++.|+.||+++|+++
T Consensus 308 ~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~N~i~ 346 (347)
T 4fmz_A 308 GGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346 (347)
T ss_dssp HTCTTCSEEECCSSSCCCCGG--GGGCTTCSEESSSCC---
T ss_pred hccccCCEEEccCCccccccC--hhhhhccceeehhhhccc
Confidence 999999999999999998777 888999999999999876
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-33 Score=308.00 Aligned_cols=307 Identities=24% Similarity=0.374 Sum_probs=160.6
Q ss_pred cCCCCCCcEEEccCCCCCCCCCCCCCCCCCCCEEECCCCcCcCCCchhhhcCCCCcEEecccccccCccCccccCCCCCC
Q 045449 72 LGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLDFSDNQLFGSLSSFIFNMSSMTTIDLSINRLSGELPANICKIPSTL 151 (823)
Q Consensus 72 l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~p~~~ 151 (823)
+..+++|++|++++|.+.. +| .+..+++|++|+|++|.+++..+ +..+++|++|+|++|+++. +| .+
T Consensus 40 ~~~l~~L~~L~l~~~~i~~-~~-~~~~~~~L~~L~l~~n~i~~~~~--~~~l~~L~~L~L~~n~i~~-~~--------~~ 106 (347)
T 4fmz_A 40 QEELESITKLVVAGEKVAS-IQ-GIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITD-IS--------AL 106 (347)
T ss_dssp HHHHTTCSEEECCSSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-CG--------GG
T ss_pred chhcccccEEEEeCCcccc-ch-hhhhcCCccEEEccCCccccchh--hhcCCcCCEEEccCCcccC-ch--------HH
Confidence 3456778888888888763 44 37778888888888888775443 7777778888887777763 22 23
Q ss_pred ccccccceeeeccceeeccCccccccchhhHHHHHhhcCCCcccCCcccCCcchhhhhccccccccCCccccccCCCCCc
Q 045449 152 SKCKQLEELNLGFNNLSGAIPKEIGNLTKLKEIISTITNSTVCEIPREIGNLPYLARLALATNNLVGVVPVTIFNMSALK 231 (823)
Q Consensus 152 ~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~~l~~n~~~~~ip~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 231 (823)
..+++|++|+|++|++++. +. +..+++|++|++++|.....++. +..+++|+
T Consensus 107 ~~l~~L~~L~l~~n~i~~~-~~--------------------------~~~l~~L~~L~l~~n~~~~~~~~-~~~l~~L~ 158 (347)
T 4fmz_A 107 QNLTNLRELYLNEDNISDI-SP--------------------------LANLTKMYSLNLGANHNLSDLSP-LSNMTGLN 158 (347)
T ss_dssp TTCTTCSEEECTTSCCCCC-GG--------------------------GTTCTTCCEEECTTCTTCCCCGG-GTTCTTCC
T ss_pred cCCCcCCEEECcCCcccCc-hh--------------------------hccCCceeEEECCCCCCcccccc-hhhCCCCc
Confidence 6677777777777776521 11 22334445555555543332222 44455555
Q ss_pred EEEccCCcccccCCcccccCCCCccEEEeeccccccccCccccCCCCCCeEEeecccccccCCCccCCCcccCcccccCc
Q 045449 232 EISLLNNSLSGSLPSRIDLSLPNVETLNLGINSFSGTIPSSITNSSKLSDLELGENLFSGFIPNTIGNLRNLEFGNIADN 311 (823)
Q Consensus 232 ~L~Ls~N~l~g~lp~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 311 (823)
+|++++|.++ +..+ +..+++|++|++++|.+++..+ +..+++|+.|++++|
T Consensus 159 ~L~l~~~~~~-------------------------~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n 209 (347)
T 4fmz_A 159 YLTVTESKVK-------------------------DVTP--IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVN 209 (347)
T ss_dssp EEECCSSCCC-------------------------CCGG--GGGCTTCSEEECTTSCCCCCGG--GGGCTTCCEEECCSS
T ss_pred EEEecCCCcC-------------------------Cchh--hccCCCCCEEEccCCccccccc--ccCCCccceeecccC
Confidence 5555555544 2211 3334444444444444433221 333334444444444
Q ss_pred cccCCCCcccccccccCCCCceEEEeecCCCCccCCccccccccccceEEecCCcceeccCccccCcccccEEEcccCcC
Q 045449 312 YLTSSTPELSFLSSLTNCKKLKVLIVTGNPLDGILPKSIGNFSLSLETILMANCSISGNIPQVVGNLSNLLVLELGGNNL 391 (823)
Q Consensus 312 ~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 391 (823)
.+++.. .+..+++|+.|++++|.+++ ..+ +..+++|++|++++|++
T Consensus 210 ~l~~~~-------~~~~~~~L~~L~l~~n~l~~-------------------------~~~--~~~l~~L~~L~l~~n~l 255 (347)
T 4fmz_A 210 QITDIT-------PVANMTRLNSLKIGNNKITD-------------------------LSP--LANLSQLTWLEIGTNQI 255 (347)
T ss_dssp CCCCCG-------GGGGCTTCCEEECCSSCCCC-------------------------CGG--GTTCTTCCEEECCSSCC
T ss_pred CCCCCc-------hhhcCCcCCEEEccCCccCC-------------------------Ccc--hhcCCCCCEEECCCCcc
Confidence 333321 13333333444444443332 211 34444555555555555
Q ss_pred CCCchhcccccCCCCEEEccCCCCCCcchHhhhcCCCCCEEEcccCcCcccccccccCCCCCCeEeccCCccccccchhh
Q 045449 392 TGPIPVTFSQLQTLQAFDLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSVRVLYLGLNIFTSVLSSTI 471 (823)
Q Consensus 392 ~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 471 (823)
++. ..+..+++|++|++++|++++. ..+..+++|+.|++++|.+++..|..++.+++|+.|+|++|++++..| +
T Consensus 256 ~~~--~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~--~ 329 (347)
T 4fmz_A 256 SDI--NAVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--L 329 (347)
T ss_dssp CCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCCCGG--G
T ss_pred CCC--hhHhcCCCcCEEEccCCccCCC--hhhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEEccCCccccccC--h
Confidence 432 2345555555555555555543 234555555555555555555555555555566666666666555444 5
Q ss_pred hccCCCcEEeccccccc
Q 045449 472 WNLKDILFIDVSSNFLD 488 (823)
Q Consensus 472 ~~l~~L~~LdLs~N~l~ 488 (823)
..+++|+.||+++|.++
T Consensus 330 ~~l~~L~~L~l~~N~i~ 346 (347)
T 4fmz_A 330 ASLSKMDSADFANQVIK 346 (347)
T ss_dssp GGCTTCSEESSSCC---
T ss_pred hhhhccceeehhhhccc
Confidence 55666666666666553
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=314.39 Aligned_cols=311 Identities=15% Similarity=0.108 Sum_probs=266.1
Q ss_pred cchhhhhccccccccCCccccccCCCCCcEEEccCCcccccCCcccccCCCCccEEEeeccccccccCccccCCCCCCeE
Q 045449 203 LPYLARLALATNNLVGVVPVTIFNMSALKEISLLNNSLSGSLPSRIDLSLPNVETLNLGINSFSGTIPSSITNSSKLSDL 282 (823)
Q Consensus 203 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 282 (823)
++++++|++++|.++...+..|.++++|++|+|++|.+++..+..+ ..+++|++|+|++|++++..|..|.++++|++|
T Consensus 44 l~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~-~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 122 (390)
T 3o6n_A 44 LNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAF-AYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVL 122 (390)
T ss_dssp GCCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTT-TTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred cCCceEEEecCCchhhCChhHhcccccCcEEECCCCcccccChhhc-cCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEE
Confidence 4567889999999987766678889999999999999985444444 459999999999999998888889999999999
Q ss_pred EeecccccccCCCccCCCcccCcccccCccccCCCCcccccccccCCCCceEEEeecCCCCccCCccccccccccceEEe
Q 045449 283 ELGENLFSGFIPNTIGNLRNLEFGNIADNYLTSSTPELSFLSSLTNCKKLKVLIVTGNPLDGILPKSIGNFSLSLETILM 362 (823)
Q Consensus 283 ~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L 362 (823)
+|++|+++...+..|..+++|++|++++|.+++. .+..+..+++|+.|++++|.+++.. +..+ ++|++|++
T Consensus 123 ~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~-----~~~~~~~l~~L~~L~l~~n~l~~~~---~~~l-~~L~~L~l 193 (390)
T 3o6n_A 123 VLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERI-----EDDTFQATTSLQNLQLSSNRLTHVD---LSLI-PSLFHANV 193 (390)
T ss_dssp ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBC-----CTTTTSSCTTCCEEECCSSCCSBCC---GGGC-TTCSEEEC
T ss_pred ECCCCccCcCCHHHhcCCCCCcEEECCCCccCcc-----ChhhccCCCCCCEEECCCCcCCccc---cccc-cccceeec
Confidence 9999999977667789999999999999999887 3456889999999999999998762 4455 68999999
Q ss_pred cCCcceeccCccccCcccccEEEcccCcCCCCchhcccccCCCCEEEccCCCCCCcchHhhhcCCCCCEEEcccCcCccc
Q 045449 363 ANCSISGNIPQVVGNLSNLLVLELGGNNLTGPIPVTFSQLQTLQAFDLTRNKLAGPITDELCHLARLHSLVLQGNKFSGS 442 (823)
Q Consensus 363 ~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ 442 (823)
++|.+++. ...++|+.|++++|+++.. |.. ..++|+.|++++|++++. ..+..+++|+.|+|++|.+++.
T Consensus 194 ~~n~l~~~-----~~~~~L~~L~l~~n~l~~~-~~~--~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~Ls~n~l~~~ 263 (390)
T 3o6n_A 194 SYNLLSTL-----AIPIAVEELDASHNSINVV-RGP--VNVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKI 263 (390)
T ss_dssp CSSCCSEE-----ECCSSCSEEECCSSCCCEE-ECC--CCSSCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCEE
T ss_pred cccccccc-----CCCCcceEEECCCCeeeec-ccc--ccccccEEECCCCCCccc--HHHcCCCCccEEECCCCcCCCc
Confidence 99998854 3346899999999999854 443 357999999999999975 5789999999999999999999
Q ss_pred ccccccCCCCCCeEeccCCccccccchhhhccCCCcEEeccccccccccCccccCCCCCcEEEcccCCCCCCCCCcccCc
Q 045449 443 IPSCLGNLTSVRVLYLGLNIFTSVLSSTIWNLKDILFIDVSSNFLDGPLSLDIGNLKVVIGLDFSRNNLSGDIPITIGEG 522 (823)
Q Consensus 443 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~~~g 522 (823)
.|..|..+++|+.|+|++|++++ +|..+..+++|+.|++++|.++ .+|..+..++.|+.|++++|++++. |
T Consensus 264 ~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~L~~N~i~~~-~------ 334 (390)
T 3o6n_A 264 MYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTL-K------ 334 (390)
T ss_dssp ESGGGTTCSSCCEEECCSSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCC-C------
T ss_pred ChhHccccccCCEEECCCCcCcc-cCcccCCCCCCCEEECCCCcce-ecCccccccCcCCEEECCCCcccee-C------
Confidence 99999999999999999999998 5667788999999999999998 5677889999999999999999842 2
Q ss_pred cCCCCCCCCCCCcccccCCcccCC
Q 045449 523 EIPRGGPFANLTAKSFMGNELLCG 546 (823)
Q Consensus 523 ~ip~~~~~~~~~~~~~~~n~~~c~ 546 (823)
...+..+..+.+.+|++.|.
T Consensus 335 ----~~~~~~L~~L~l~~N~~~~~ 354 (390)
T 3o6n_A 335 ----LSTHHTLKNLTLSHNDWDCN 354 (390)
T ss_dssp ----CCTTCCCSEEECCSSCEEHH
T ss_pred ----chhhccCCEEEcCCCCccch
Confidence 23356778889999998875
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-34 Score=332.60 Aligned_cols=311 Identities=14% Similarity=0.104 Sum_probs=265.5
Q ss_pred chhhhhccccccccCCccccccCCCCCcEEEccCCcccccCCcccccCCCCccEEEeeccccccccCccccCCCCCCeEE
Q 045449 204 PYLARLALATNNLVGVVPVTIFNMSALKEISLLNNSLSGSLPSRIDLSLPNVETLNLGINSFSGTIPSSITNSSKLSDLE 283 (823)
Q Consensus 204 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 283 (823)
++++.|++++|.++...+..|.++++|++|+|++|.+++..|..+. .+++|++|+|++|.+++..|..|+++++|++|+
T Consensus 51 ~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~-~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 129 (597)
T 3oja_B 51 NNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFA-YAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLV 129 (597)
T ss_dssp CCCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTT-TCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCChHHhc-CCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEE
Confidence 4567888999998877777788899999999999999865555554 489999999999999988888889999999999
Q ss_pred eecccccccCCCccCCCcccCcccccCccccCCCCcccccccccCCCCceEEEeecCCCCccCCccccccccccceEEec
Q 045449 284 LGENLFSGFIPNTIGNLRNLEFGNIADNYLTSSTPELSFLSSLTNCKKLKVLIVTGNPLDGILPKSIGNFSLSLETILMA 363 (823)
Q Consensus 284 Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~ 363 (823)
|++|.+++..+..|+++++|++|+|++|.+++. .+..|.++++|+.|++++|.+++.. +..+ ++|++|+++
T Consensus 130 L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~-----~~~~~~~l~~L~~L~L~~N~l~~~~---~~~l-~~L~~L~l~ 200 (597)
T 3oja_B 130 LERNDLSSLPRGIFHNTPKLTTLSMSNNNLERI-----EDDTFQATTSLQNLQLSSNRLTHVD---LSLI-PSLFHANVS 200 (597)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBC-----CTTTTTTCTTCCEEECTTSCCSBCC---GGGC-TTCSEEECC
T ss_pred eeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCC-----ChhhhhcCCcCcEEECcCCCCCCcC---hhhh-hhhhhhhcc
Confidence 999999987777789999999999999999887 4457888999999999999998763 3445 689999999
Q ss_pred CCcceeccCccccCcccccEEEcccCcCCCCchhcccccCCCCEEEccCCCCCCcchHhhhcCCCCCEEEcccCcCcccc
Q 045449 364 NCSISGNIPQVVGNLSNLLVLELGGNNLTGPIPVTFSQLQTLQAFDLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSI 443 (823)
Q Consensus 364 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~ 443 (823)
+|.+++. ....+|+.|++++|.++.. |..+ .++|+.|+|++|.+++. ..+..+++|+.|+|++|.+++.+
T Consensus 201 ~n~l~~l-----~~~~~L~~L~ls~n~l~~~-~~~~--~~~L~~L~L~~n~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~ 270 (597)
T 3oja_B 201 YNLLSTL-----AIPIAVEELDASHNSINVV-RGPV--NVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIM 270 (597)
T ss_dssp SSCCSEE-----ECCTTCSEEECCSSCCCEE-ECSC--CSCCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCEEE
T ss_pred cCccccc-----cCCchhheeeccCCccccc-cccc--CCCCCEEECCCCCCCCC--hhhccCCCCCEEECCCCccCCCC
Confidence 9998863 3456899999999999854 3333 36899999999999974 67899999999999999999999
Q ss_pred cccccCCCCCCeEeccCCccccccchhhhccCCCcEEeccccccccccCccccCCCCCcEEEcccCCCCCCCCCcccCcc
Q 045449 444 PSCLGNLTSVRVLYLGLNIFTSVLSSTIWNLKDILFIDVSSNFLDGPLSLDIGNLKVVIGLDFSRNNLSGDIPITIGEGE 523 (823)
Q Consensus 444 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~~~g~ 523 (823)
|..|+.+++|+.|+|++|.+++ +|..+..+++|+.|+|++|.++ .+|..+..++.|+.|++++|++++. |
T Consensus 271 ~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~l~~L~~L~L~~N~l~~~-~------- 340 (597)
T 3oja_B 271 YHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTL-K------- 340 (597)
T ss_dssp SGGGTTCSSCCEEECTTSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCC-C-------
T ss_pred HHHhcCccCCCEEECCCCCCCC-CCcccccCCCCcEEECCCCCCC-ccCcccccCCCCCEEECCCCCCCCc-C-------
Confidence 9999999999999999999998 5777788999999999999999 6888899999999999999999843 2
Q ss_pred CCCCCCCCCCCcccccCCcccCCC
Q 045449 524 IPRGGPFANLTAKSFMGNELLCGL 547 (823)
Q Consensus 524 ip~~~~~~~~~~~~~~~n~~~c~~ 547 (823)
...+..+..+.+.+|++.|..
T Consensus 341 ---~~~~~~L~~L~l~~N~~~~~~ 361 (597)
T 3oja_B 341 ---LSTHHTLKNLTLSHNDWDCNS 361 (597)
T ss_dssp ---CCTTCCCSEEECCSSCEEHHH
T ss_pred ---hhhcCCCCEEEeeCCCCCChh
Confidence 123567788899999998864
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-33 Score=300.12 Aligned_cols=289 Identities=21% Similarity=0.256 Sum_probs=234.5
Q ss_pred chhhhhccccccccCCccccccCCCCCcEEEccCCcccccCCcccccCCCCccEEEeeccccccccCccccCCCCCCeEE
Q 045449 204 PYLARLALATNNLVGVVPVTIFNMSALKEISLLNNSLSGSLPSRIDLSLPNVETLNLGINSFSGTIPSSITNSSKLSDLE 283 (823)
Q Consensus 204 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 283 (823)
.+++.++++++.++ .+|..+. ++|++|+|++|.+++..|..+. .+++|++|+|++|++++..|..|.++++|++|+
T Consensus 33 c~l~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~i~~~~~~~~~-~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 108 (332)
T 2ft3_A 33 CHLRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFK-GLQHLYALVLVNNKISKIHEKAFSPLRKLQKLY 108 (332)
T ss_dssp EETTEEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCEECTTTTT-TCTTCCEEECCSSCCCEECGGGSTTCTTCCEEE
T ss_pred ccCCEEECCCCCcc-ccCCCCC--CCCeEEECCCCcCCccCHhHhh-CCCCCcEEECCCCccCccCHhHhhCcCCCCEEE
Confidence 46888899999888 4565553 6889999999998854444444 588999999999999988888899999999999
Q ss_pred eecccccccCCCccCCCcccCcccccCccccCCCCcccccccccCCCCceEEEeecCCCC--ccCCccccccccccceEE
Q 045449 284 LGENLFSGFIPNTIGNLRNLEFGNIADNYLTSSTPELSFLSSLTNCKKLKVLIVTGNPLD--GILPKSIGNFSLSLETIL 361 (823)
Q Consensus 284 Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~--~~~p~~~~~~~~~L~~L~ 361 (823)
|++|+++. +|..+. ++|++|++++|.++..+ +..+.++++|+.|++++|.++ +..|..+..+ +|++|+
T Consensus 109 L~~n~l~~-l~~~~~--~~L~~L~l~~n~i~~~~-----~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l--~L~~L~ 178 (332)
T 2ft3_A 109 ISKNHLVE-IPPNLP--SSLVELRIHDNRIRKVP-----KGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL--KLNYLR 178 (332)
T ss_dssp CCSSCCCS-CCSSCC--TTCCEEECCSSCCCCCC-----SGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC--CCSCCB
T ss_pred CCCCcCCc-cCcccc--ccCCEEECCCCccCccC-----HhHhCCCccCCEEECCCCccccCCCCcccccCC--ccCEEE
Confidence 99999884 454444 78999999999988763 345788899999999999986 4677777765 799999
Q ss_pred ecCCcceeccCccccCcccccEEEcccCcCCCCchhcccccCCCCEEEccCCCCCCcchHhhhcCCCCCEEEcccCcCcc
Q 045449 362 MANCSISGNIPQVVGNLSNLLVLELGGNNLTGPIPVTFSQLQTLQAFDLTRNKLAGPITDELCHLARLHSLVLQGNKFSG 441 (823)
Q Consensus 362 L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g 441 (823)
+++|++++ +|..+. ++|++|++++|++++..+..|..+++|++|+|++|++++..+..|..+++|+.|+|++|+++
T Consensus 179 l~~n~l~~-l~~~~~--~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~- 254 (332)
T 2ft3_A 179 ISEAKLTG-IPKDLP--ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS- 254 (332)
T ss_dssp CCSSBCSS-CCSSSC--SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-
T ss_pred CcCCCCCc-cCcccc--CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-
Confidence 99999886 455443 68899999999999888888899999999999999999888888889999999999999998
Q ss_pred cccccccCCCCCCeEeccCCccccccchhhhcc------CCCcEEeccccccc--cccCccccCCCCCcEEEcccCC
Q 045449 442 SIPSCLGNLTSVRVLYLGLNIFTSVLSSTIWNL------KDILFIDVSSNFLD--GPLSLDIGNLKVVIGLDFSRNN 510 (823)
Q Consensus 442 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l------~~L~~LdLs~N~l~--g~~p~~~~~l~~L~~L~ls~N~ 510 (823)
.+|..+..+++|+.|++++|++++..+..+... ..|+.|++++|.+. +..|..+..++.|+.+++++|+
T Consensus 255 ~lp~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~l~~L~l~~N~~~~~~~~~~~~~~l~~L~~l~l~~n~ 331 (332)
T 2ft3_A 255 RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331 (332)
T ss_dssp BCCTTGGGCTTCCEEECCSSCCCBCCTTSSSCSSCCSSSCCBSEEECCSSSSCGGGSCGGGGTTBCCSTTEEC----
T ss_pred ecChhhhcCccCCEEECCCCCCCccChhHccccccccccccccceEeecCcccccccCcccccccchhhhhhccccc
Confidence 788888899999999999999998777776553 67889999999887 5667778889999999998874
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=345.71 Aligned_cols=290 Identities=18% Similarity=0.155 Sum_probs=169.7
Q ss_pred cccccCCCCCcEEEccCCcccccCCccc----ccCCCCccEEEeeccccccc----cCccccCCCCCCeEEeeccccccc
Q 045449 221 PVTIFNMSALKEISLLNNSLSGSLPSRI----DLSLPNVETLNLGINSFSGT----IPSSITNSSKLSDLELGENLFSGF 292 (823)
Q Consensus 221 p~~~~~l~~L~~L~Ls~N~l~g~lp~~~----~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~ 292 (823)
+..+..+++|++|+|++|.+++..+..+ ....++|++|+|++|++++. ++..+..+++|++|++++|.+++.
T Consensus 106 ~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~ 185 (461)
T 1z7x_W 106 SSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEA 185 (461)
T ss_dssp HHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCTTCCEEECCSSBCHHH
T ss_pred HHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHHHHHHHHhhCCCCCEEECcCCCcchH
Confidence 4444555555555555555543222211 11234566666666655542 244445556666666666666544
Q ss_pred CCCccC-----CCcccCcccccCccccCCCCcccccccccCCCCceEEEeecCCCCccCC-----ccccccccccceEEe
Q 045449 293 IPNTIG-----NLRNLEFGNIADNYLTSSTPELSFLSSLTNCKKLKVLIVTGNPLDGILP-----KSIGNFSLSLETILM 362 (823)
Q Consensus 293 ~p~~~~-----~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p-----~~~~~~~~~L~~L~L 362 (823)
.+..+. ..++|++|++++|.++..... .++..+..+++|+.|++++|.+++... ..+..+ .+|++|++
T Consensus 186 ~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~-~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~-~~L~~L~L 263 (461)
T 1z7x_W 186 GVRVLCQGLKDSPCQLEALKLESCGVTSDNCR-DLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPS-SRLRTLWI 263 (461)
T ss_dssp HHHHHHHHHHHSCCCCCEEECTTSCCBTTHHH-HHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTT-CCCCEEEC
T ss_pred HHHHHHHHHhcCCCCceEEEccCCCCcHHHHH-HHHHHHHhCCCccEEeccCCcCChHHHHHHHHHHhcCC-CCceEEEC
Confidence 333332 244666666666666543110 123445566667777777776654321 111123 56777777
Q ss_pred cCCcceec----cCccccCcccccEEEcccCcCCCCchhcccc-----cCCCCEEEccCCCCCCc----chHhhhcCCCC
Q 045449 363 ANCSISGN----IPQVVGNLSNLLVLELGGNNLTGPIPVTFSQ-----LQTLQAFDLTRNKLAGP----ITDELCHLARL 429 (823)
Q Consensus 363 ~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~-----l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L 429 (823)
++|.+++. ++..+..+++|++|+|++|.+++..+..+.. .++|++|+|++|.+++. ++..+..+++|
T Consensus 264 ~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L 343 (461)
T 1z7x_W 264 WECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFL 343 (461)
T ss_dssp TTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSC
T ss_pred cCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCc
Confidence 77777654 4556666777777778777776544443332 25778888888877765 45556667778
Q ss_pred CEEEcccCcCcccccccccC-----CCCCCeEeccCCcccc----ccchhhhccCCCcEEeccccccccccCcccc----
Q 045449 430 HSLVLQGNKFSGSIPSCLGN-----LTSVRVLYLGLNIFTS----VLSSTIWNLKDILFIDVSSNFLDGPLSLDIG---- 496 (823)
Q Consensus 430 ~~L~Ls~N~l~g~~p~~~~~-----l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~LdLs~N~l~g~~p~~~~---- 496 (823)
++|+|++|.+++..+..+.. .++|+.|+|++|.+++ .+|..+..+++|++||+++|.+++.-...+.
T Consensus 344 ~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~N~i~~~~~~~l~~~l~ 423 (461)
T 1z7x_W 344 LELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVR 423 (461)
T ss_dssp CEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCHHHHHHHHHHHT
T ss_pred cEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCChhhHHHHHHHHHhCCCccEEECCCCCCCHHHHHHHHHHhc
Confidence 88888888777665544432 5678888888888776 6777777778888888888877764221111
Q ss_pred -CCCCCcEEEcccCCCC
Q 045449 497 -NLKVVIGLDFSRNNLS 512 (823)
Q Consensus 497 -~l~~L~~L~ls~N~l~ 512 (823)
....|+.|++.++.+.
T Consensus 424 ~~~~~L~~L~~~~~~~~ 440 (461)
T 1z7x_W 424 QPGCLLEQLVLYDIYWS 440 (461)
T ss_dssp STTCCCCEEECTTCCCC
T ss_pred cCCcchhheeecccccC
Confidence 2335666766666554
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-32 Score=297.35 Aligned_cols=214 Identities=19% Similarity=0.257 Sum_probs=117.8
Q ss_pred EEEEcCCCCCccccCcccCCCCCCcEEEccCCCCCCCCCCCCCCCCCCCEEECCCCcCcCCCchhhhcCCCCcEEecccc
Q 045449 55 IGLNISSFNLQGTITPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLDFSDNQLFGSLSSFIFNMSSMTTIDLSIN 134 (823)
Q Consensus 55 ~~L~L~~~~l~g~~~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 134 (823)
+.+++++++++ .+|..+. ++|++|+|++|+|++..|..|.++++|++|+|++|.|++..|..|.++++|++|+|++|
T Consensus 36 ~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n 112 (332)
T 2ft3_A 36 RVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKN 112 (332)
T ss_dssp TEEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCSS
T ss_pred CEEECCCCCcc-ccCCCCC--CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECCCC
Confidence 34555566665 4555553 57788888888887666777778888888888888877777777777777777777777
Q ss_pred cccCccCccccCCCCCCccccccceeeeccceeeccCccccccchhhHHHHHhhcCCCcccCCcccCCcchhhhhccccc
Q 045449 135 RLSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKEIGNLTKLKEIISTITNSTVCEIPREIGNLPYLARLALATN 214 (823)
Q Consensus 135 ~l~~~~p~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~~l~~n~~~~~ip~~l~~l~~L~~L~Ls~N 214 (823)
+++ .+|..+ . ++|++|++++|++++..+. .|.++++|++|++++|
T Consensus 113 ~l~-~l~~~~-------~--~~L~~L~l~~n~i~~~~~~-------------------------~~~~l~~L~~L~l~~n 157 (332)
T 2ft3_A 113 HLV-EIPPNL-------P--SSLVELRIHDNRIRKVPKG-------------------------VFSGLRNMNCIEMGGN 157 (332)
T ss_dssp CCC-SCCSSC-------C--TTCCEEECCSSCCCCCCSG-------------------------GGSSCSSCCEEECCSC
T ss_pred cCC-ccCccc-------c--ccCCEEECCCCccCccCHh-------------------------HhCCCccCCEEECCCC
Confidence 776 444433 2 5677777777766532221 2333444555556665
Q ss_pred ccc--CCccccccCCCCCcEEEccCCcccccCCcccccCCCCccEEEeeccccccccCccccCCCCCCeEEeeccccccc
Q 045449 215 NLV--GVVPVTIFNMSALKEISLLNNSLSGSLPSRIDLSLPNVETLNLGINSFSGTIPSSITNSSKLSDLELGENLFSGF 292 (823)
Q Consensus 215 ~l~--~~~p~~~~~l~~L~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 292 (823)
.++ +..|..+..+ +|++|++++|.++ .+|..+. ++|++|+|++|++++..|..+.++++|++|+|++|++++.
T Consensus 158 ~l~~~~~~~~~~~~l-~L~~L~l~~n~l~-~l~~~~~---~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~ 232 (332)
T 2ft3_A 158 PLENSGFEPGAFDGL-KLNYLRISEAKLT-GIPKDLP---ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMI 232 (332)
T ss_dssp CCBGGGSCTTSSCSC-CCSCCBCCSSBCS-SCCSSSC---SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCC
T ss_pred ccccCCCCcccccCC-ccCEEECcCCCCC-ccCcccc---CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcC
Confidence 554 2444444444 5555555555554 2443321 3344444444444433333444444444444444444433
Q ss_pred CCCccCCCcccCcccccCc
Q 045449 293 IPNTIGNLRNLEFGNIADN 311 (823)
Q Consensus 293 ~p~~~~~l~~L~~L~L~~N 311 (823)
.+..|..+++|++|+|++|
T Consensus 233 ~~~~~~~l~~L~~L~L~~N 251 (332)
T 2ft3_A 233 ENGSLSFLPTLRELHLDNN 251 (332)
T ss_dssp CTTGGGGCTTCCEEECCSS
T ss_pred ChhHhhCCCCCCEEECCCC
Confidence 3333333333333333333
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=346.23 Aligned_cols=398 Identities=19% Similarity=0.150 Sum_probs=246.2
Q ss_pred CcEEEEEcCCCCCccccCcc-cCCCCCCcEEEccCCCCCC----CCCCCCCCCCCCCEEECCCCcCcCCCchhhh-cCC-
Q 045449 52 HRVIGLNISSFNLQGTITPQ-LGNLSSLQTLDLSHNKLSG----NIPSSIFNMHTLKLLDFSDNQLFGSLSSFIF-NMS- 124 (823)
Q Consensus 52 ~~v~~L~L~~~~l~g~~~~~-l~~l~~L~~L~Ls~N~l~g----~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-~l~- 124 (823)
.+++.|||++++++...... +..+++|++|+|++|+++. .++..+..+++|++|||++|.+++..+..+. .+.
T Consensus 3 ~~l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~ 82 (461)
T 1z7x_W 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQT 82 (461)
T ss_dssp EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCS
T ss_pred ccceehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHhh
Confidence 36888999999887544333 6778889999999999874 3566777888999999999988765554443 455
Q ss_pred ---CCcEEecccccccCccCccccCCCCCCccccccceeeeccceeeccCccccccchhhHHHHHhhcCCCcccCCcccC
Q 045449 125 ---SMTTIDLSINRLSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKEIGNLTKLKEIISTITNSTVCEIPREIG 201 (823)
Q Consensus 125 ---~L~~L~Ls~N~l~~~~p~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~~l~~n~~~~~ip~~l~ 201 (823)
+|++|+|++|+++..- +..+|..+..+++|++|+|++|.+++..+..+.. . .+.
T Consensus 83 ~~~~L~~L~L~~n~i~~~~---~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~------~--------------l~~ 139 (461)
T 1z7x_W 83 PSCKIQKLSLQNCCLTGAG---CGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCE------G--------------LLD 139 (461)
T ss_dssp TTCCCCEEECTTSCCBGGG---HHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHH------H--------------HTS
T ss_pred CCCceeEEEccCCCCCHHH---HHHHHHHHccCCceeEEECCCCcCchHHHHHHHH------H--------------Hhc
Confidence 6999999999887321 1112333478888999999999876433222210 0 012
Q ss_pred CcchhhhhccccccccCCc----cccccCCCCCcEEEccCCcccccCCcccc----cCCCCccEEEeeccccccc----c
Q 045449 202 NLPYLARLALATNNLVGVV----PVTIFNMSALKEISLLNNSLSGSLPSRID----LSLPNVETLNLGINSFSGT----I 269 (823)
Q Consensus 202 ~l~~L~~L~Ls~N~l~~~~----p~~~~~l~~L~~L~Ls~N~l~g~lp~~~~----~~l~~L~~L~Ls~N~l~~~----~ 269 (823)
..++|++|+|++|++++.. +..+..+++|++|++++|.+++..+..+. ...++|++|+|++|.+++. +
T Consensus 140 ~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l 219 (461)
T 1z7x_W 140 PQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDL 219 (461)
T ss_dssp TTCCCCEEECTTSCCBGGGHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHH
T ss_pred CCCcceEEECCCCCCCHHHHHHHHHHHhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHHHH
Confidence 3446788888888887643 45556677888888888877643333222 1345777777777777653 4
Q ss_pred CccccCCCCCCeEEeecccccccC-----CCccCCCcccCcccccCccccCCCCcccccccccCCCCceEEEeecCCCCc
Q 045449 270 PSSITNSSKLSDLELGENLFSGFI-----PNTIGNLRNLEFGNIADNYLTSSTPELSFLSSLTNCKKLKVLIVTGNPLDG 344 (823)
Q Consensus 270 p~~~~~l~~L~~L~Ls~N~l~~~~-----p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~ 344 (823)
+..+..+++|++|++++|.+++.. +..+..+++|++|++++|.++..... .++..+..+++|+.|++++|.+++
T Consensus 220 ~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~-~l~~~l~~~~~L~~L~Ls~n~i~~ 298 (461)
T 1z7x_W 220 CGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCG-DLCRVLRAKESLKELSLAGNELGD 298 (461)
T ss_dssp HHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHH-HHHHHHHHCTTCCEEECTTCCCHH
T ss_pred HHHHHhCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHH-HHHHHHhhCCCcceEECCCCCCch
Confidence 666666777777777777766432 22223455555555555555432100 012233444455555555554443
Q ss_pred cCCccccccccccceEEecCCcceeccCccccCcccccEEEcccCcCCCC----chhcccccCCCCEEEccCCCCCCcch
Q 045449 345 ILPKSIGNFSLSLETILMANCSISGNIPQVVGNLSNLLVLELGGNNLTGP----IPVTFSQLQTLQAFDLTRNKLAGPIT 420 (823)
Q Consensus 345 ~~p~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~----~p~~~~~l~~L~~L~Ls~N~l~~~~p 420 (823)
..+..+... .....++|++|+|++|.+++. ++..+..+++|++|+|++|++++..+
T Consensus 299 ~~~~~l~~~--------------------l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~ 358 (461)
T 1z7x_W 299 EGARLLCET--------------------LLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGV 358 (461)
T ss_dssp HHHHHHHHH--------------------HTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHH
T ss_pred HHHHHHHHH--------------------hccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccH
Confidence 222222111 001124677777777777654 45556666777777777777776555
Q ss_pred Hhhhc-----CCCCCEEEcccCcCcc----cccccccCCCCCCeEeccCCccccccchhhh-----ccCCCcEEeccccc
Q 045449 421 DELCH-----LARLHSLVLQGNKFSG----SIPSCLGNLTSVRVLYLGLNIFTSVLSSTIW-----NLKDILFIDVSSNF 486 (823)
Q Consensus 421 ~~~~~-----l~~L~~L~Ls~N~l~g----~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-----~l~~L~~LdLs~N~ 486 (823)
..++. .++|+.|+|++|.+++ .+|..+..+++|++|+|++|++++.....+. ....|+.|++.++.
T Consensus 359 ~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~N~i~~~~~~~l~~~l~~~~~~L~~L~~~~~~ 438 (461)
T 1z7x_W 359 RELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIY 438 (461)
T ss_dssp HHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCC
T ss_pred HHHHHHHcCCCCceEEEECCCCCCChhhHHHHHHHHHhCCCccEEECCCCCCCHHHHHHHHHHhccCCcchhheeecccc
Confidence 54443 5677777777777775 6677777777777777777777764333322 12357777777776
Q ss_pred cccccCc
Q 045449 487 LDGPLSL 493 (823)
Q Consensus 487 l~g~~p~ 493 (823)
+....+.
T Consensus 439 ~~~~~~~ 445 (461)
T 1z7x_W 439 WSEEMED 445 (461)
T ss_dssp CCHHHHH
T ss_pred cCHHHHH
Confidence 6654443
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-32 Score=293.96 Aligned_cols=291 Identities=22% Similarity=0.238 Sum_probs=207.0
Q ss_pred cchhhhhccccccccCCccccccCCCCCcEEEccCCcccccCCcccccCCCCccEEEeeccccccccCccccCCCCCCeE
Q 045449 203 LPYLARLALATNNLVGVVPVTIFNMSALKEISLLNNSLSGSLPSRIDLSLPNVETLNLGINSFSGTIPSSITNSSKLSDL 282 (823)
Q Consensus 203 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 282 (823)
..+++.++++++.++. +|..+. +.+++|+|++|.+++ ++...+..+++|++|+|++|++++..|..|.++++|++|
T Consensus 30 ~c~l~~l~~~~~~l~~-lp~~~~--~~l~~L~L~~n~i~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 105 (330)
T 1xku_A 30 QCHLRVVQCSDLGLEK-VPKDLP--PDTALLDLQNNKITE-IKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERL 105 (330)
T ss_dssp EEETTEEECTTSCCCS-CCCSCC--TTCCEEECCSSCCCC-BCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEE
T ss_pred cCCCeEEEecCCCccc-cCccCC--CCCeEEECCCCcCCE-eChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEE
Confidence 3466777777777773 454443 567778888888774 443333347788888888888877777778888888888
Q ss_pred EeecccccccCCCccCCCcccCcccccCccccCCCCcccccccccCCCCceEEEeecCCCCc--cCCccccccccccceE
Q 045449 283 ELGENLFSGFIPNTIGNLRNLEFGNIADNYLTSSTPELSFLSSLTNCKKLKVLIVTGNPLDG--ILPKSIGNFSLSLETI 360 (823)
Q Consensus 283 ~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~--~~p~~~~~~~~~L~~L 360 (823)
+|++|+++. +|..+. ++|++|++++|.+++. .+..+.++++|+.|++++|.+.. ..+..+..+ ++|++|
T Consensus 106 ~Ls~n~l~~-l~~~~~--~~L~~L~l~~n~l~~~-----~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~~L~~L 176 (330)
T 1xku_A 106 YLSKNQLKE-LPEKMP--KTLQELRVHENEITKV-----RKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGM-KKLSYI 176 (330)
T ss_dssp ECCSSCCSB-CCSSCC--TTCCEEECCSSCCCBB-----CHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGC-TTCCEE
T ss_pred ECCCCcCCc-cChhhc--ccccEEECCCCccccc-----CHhHhcCCccccEEECCCCcCCccCcChhhccCC-CCcCEE
Confidence 888887774 344433 6777888888877765 34457777788888888887753 566677777 678888
Q ss_pred EecCCcceeccCccccCcccccEEEcccCcCCCCchhcccccCCCCEEEccCCCCCCcchHhhhcCCCCCEEEcccCcCc
Q 045449 361 LMANCSISGNIPQVVGNLSNLLVLELGGNNLTGPIPVTFSQLQTLQAFDLTRNKLAGPITDELCHLARLHSLVLQGNKFS 440 (823)
Q Consensus 361 ~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 440 (823)
++++|.++. +|..+. ++|++|++++|++++..|..|..+++|++|+|++|++++..+..+..+++|+.|+|++|+++
T Consensus 177 ~l~~n~l~~-l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~ 253 (330)
T 1xku_A 177 RIADTNITT-IPQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV 253 (330)
T ss_dssp ECCSSCCCS-CCSSCC--TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS
T ss_pred ECCCCcccc-CCcccc--ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc
Confidence 888887774 444433 67888888888887777777788888888888888887776767777888888888888887
Q ss_pred ccccccccCCCCCCeEeccCCccccccchhhhc------cCCCcEEecccccccc--ccCccccCCCCCcEEEcccCC
Q 045449 441 GSIPSCLGNLTSVRVLYLGLNIFTSVLSSTIWN------LKDILFIDVSSNFLDG--PLSLDIGNLKVVIGLDFSRNN 510 (823)
Q Consensus 441 g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~------l~~L~~LdLs~N~l~g--~~p~~~~~l~~L~~L~ls~N~ 510 (823)
.+|..+..+++|++|+|++|++++..+..|.. ...|+.|++++|.+.. ..|..+..+..++.+++++|+
T Consensus 254 -~lp~~l~~l~~L~~L~l~~N~i~~~~~~~f~~~~~~~~~~~l~~l~l~~N~~~~~~i~~~~f~~~~~l~~l~L~~N~ 330 (330)
T 1xku_A 254 -KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330 (330)
T ss_dssp -SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGGSCGGGGTTCCCGGGEEC----
T ss_pred -cCChhhccCCCcCEEECCCCcCCccChhhcCCcccccccccccceEeecCcccccccCccccccccceeEEEecccC
Confidence 67777777888888888888887766666543 3667788888887763 445667777888888888774
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-32 Score=292.15 Aligned_cols=244 Identities=21% Similarity=0.289 Sum_probs=177.1
Q ss_pred EEEcCCCCCccccCcccCCCCCCcEEEccCCCCCCCCCCCCCCCCCCCEEECCCCcCcCCCchhhhcCCCCcEEeccccc
Q 045449 56 GLNISSFNLQGTITPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLDFSDNQLFGSLSSFIFNMSSMTTIDLSINR 135 (823)
Q Consensus 56 ~L~L~~~~l~g~~~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 135 (823)
.+++++++++ .+|..+. ++|++|+|++|+|++..+..|.++++|++|+|++|.+++..|..|.++++|++|+|++|+
T Consensus 35 ~l~~~~~~l~-~lp~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~ 111 (330)
T 1xku_A 35 VVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQ 111 (330)
T ss_dssp EEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSC
T ss_pred EEEecCCCcc-ccCccCC--CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECCCCc
Confidence 3444455555 4555443 689999999999998888899999999999999999998889999999999999999999
Q ss_pred ccCccCccccCCCCCCccccccceeeeccceeeccCccccccchhhHHHHHhhcCCCcccCCcccCCcchhhhhcccccc
Q 045449 136 LSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKEIGNLTKLKEIISTITNSTVCEIPREIGNLPYLARLALATNN 215 (823)
Q Consensus 136 l~~~~p~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~~l~~n~~~~~ip~~l~~l~~L~~L~Ls~N~ 215 (823)
++ .+|..+ . ++|++|++++|++++..+.. |.++++|++|++++|+
T Consensus 112 l~-~l~~~~-------~--~~L~~L~l~~n~l~~~~~~~-------------------------~~~l~~L~~L~l~~n~ 156 (330)
T 1xku_A 112 LK-ELPEKM-------P--KTLQELRVHENEITKVRKSV-------------------------FNGLNQMIVVELGTNP 156 (330)
T ss_dssp CS-BCCSSC-------C--TTCCEEECCSSCCCBBCHHH-------------------------HTTCTTCCEEECCSSC
T ss_pred CC-ccChhh-------c--ccccEEECCCCcccccCHhH-------------------------hcCCccccEEECCCCc
Confidence 87 455433 2 68999999999887543322 3455667788888888
Q ss_pred ccC--CccccccCCCCCcEEEccCCcccccCCcccccCCCCccEEEeeccccccccCccccCCCCCCeEEeecccccccC
Q 045449 216 LVG--VVPVTIFNMSALKEISLLNNSLSGSLPSRIDLSLPNVETLNLGINSFSGTIPSSITNSSKLSDLELGENLFSGFI 293 (823)
Q Consensus 216 l~~--~~p~~~~~l~~L~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 293 (823)
++. ..+..+.++++|++|++++|.++ .+|..+. ++|++|+|++|++++..|..+.++++|++|+|++|++++..
T Consensus 157 l~~~~~~~~~~~~l~~L~~L~l~~n~l~-~l~~~~~---~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~ 232 (330)
T 1xku_A 157 LKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGLP---PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVD 232 (330)
T ss_dssp CCGGGBCTTGGGGCTTCCEEECCSSCCC-SCCSSCC---TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEEC
T ss_pred CCccCcChhhccCCCCcCEEECCCCccc-cCCcccc---ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeC
Confidence 853 66777778888888888888887 5665543 57777777777777777777777777777777777777766
Q ss_pred CCccCCCcccCcccccCccccCCCCcccccccccCCCCceEEEeecCCCCccCC
Q 045449 294 PNTIGNLRNLEFGNIADNYLTSSTPELSFLSSLTNCKKLKVLIVTGNPLDGILP 347 (823)
Q Consensus 294 p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p 347 (823)
+..|..+++|++|+|++|+++.. +..+..+++|++|++++|++++..+
T Consensus 233 ~~~~~~l~~L~~L~L~~N~l~~l------p~~l~~l~~L~~L~l~~N~i~~~~~ 280 (330)
T 1xku_A 233 NGSLANTPHLRELHLNNNKLVKV------PGGLADHKYIQVVYLHNNNISAIGS 280 (330)
T ss_dssp TTTGGGSTTCCEEECCSSCCSSC------CTTTTTCSSCCEEECCSSCCCCCCT
T ss_pred hhhccCCCCCCEEECCCCcCccC------ChhhccCCCcCEEECCCCcCCccCh
Confidence 66666666666666666666532 3344555555555555555554433
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=8.4e-34 Score=299.50 Aligned_cols=151 Identities=30% Similarity=0.435 Sum_probs=133.6
Q ss_pred ccCCccceeeccC------------CeEEEEEEehHhh---HHHHHHHHHHHHHHhhcchhhHHH---------------
Q 045449 628 DRFSENNLIGIGN------------GMEVAVKVFHQQY---ERALKSFEDECEVRKRIRHRNLVK--------------- 677 (823)
Q Consensus 628 ~~f~~~~~lg~g~------------~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~--------------- 677 (823)
++|...+.||+|+ |+.||||++.+.. ....+.+.+|++++++++|||||+
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 5788999999997 6779999997543 233468999999999999999998
Q ss_pred -------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccc
Q 045449 678 -------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQ 732 (823)
Q Consensus 678 -------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~ 732 (823)
+++|++.+|+|+|+++|+||||||+|||++.++.+||+|||+|+.+.........
T Consensus 112 Ey~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~~~~ 191 (311)
T 4aw0_A 112 SYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARA 191 (311)
T ss_dssp CCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTCCCB
T ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCcccc
Confidence 4789999999999999999999999999999999999999999987654443445
Q ss_pred cccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCCC
Q 045449 733 TQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 733 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
...+||+.|||||++.+..|+.++||||+||++|+|++|..||.+.
T Consensus 192 ~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~ 237 (311)
T 4aw0_A 192 NSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG 237 (311)
T ss_dssp CCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 5678999999999999999999999999999999999999999764
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.5e-34 Score=337.54 Aligned_cols=438 Identities=14% Similarity=0.088 Sum_probs=302.1
Q ss_pred CCccceeeeeCCCCCcEEEEEcCCCCCccccCcccCCCCCCcEEEccCCCC---CCCCCCCCC------------CCCCC
Q 045449 38 SVCIWIGITCDVNSHRVIGLNISSFNLQGTITPQLGNLSSLQTLDLSHNKL---SGNIPSSIF------------NMHTL 102 (823)
Q Consensus 38 ~~c~w~gv~c~~~~~~v~~L~L~~~~l~g~~~~~l~~l~~L~~L~Ls~N~l---~g~~p~~~~------------~l~~L 102 (823)
-|++|.++.+.. . ..+.+.. .....++..+..+++|++|+|+++.. .+.+|..++ .+++|
T Consensus 40 vck~W~~~~~~~--~--~~l~~~~-~~~~~~~~~~~~~~~L~~L~L~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~L 114 (592)
T 3ogk_B 40 VCRRWFKIDSET--R--EHVTMAL-CYTATPDRLSRRFPNLRSLKLKGKPRAAMFNLIPENWGGYVTPWVTEISNNLRQL 114 (592)
T ss_dssp SCHHHHHHHHHH--C--CEEEESC-GGGSCHHHHHHHCTTCSEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTC
T ss_pred HhHHHHHhhhcc--c--cEEEEee-ccccChHHHHHhCCCCeEEEecCCcchhhcccccccccccchHHHHHHHhhCCCC
Confidence 355899996532 1 2233332 23333444567788999999988543 245665555 68999
Q ss_pred CEEECCCCcCcCCCchhhhcC--CCCcEEecccccccCccCccccCCCCCCccccccceeeeccceeeccCccccccchh
Q 045449 103 KLLDFSDNQLFGSLSSFIFNM--SSMTTIDLSINRLSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKEIGNLTK 180 (823)
Q Consensus 103 ~~L~Ls~N~l~~~~p~~~~~l--~~L~~L~Ls~N~l~~~~p~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~ 180 (823)
++|+|++|.+++..+..+... .+|++|+|++|.-. .+..+ +....++++|++|+|++|.+++.-..++.
T Consensus 115 ~~L~L~~~~i~~~~~~~l~~~~~~~L~~L~L~~~~~~--~~~~l---~~~~~~~~~L~~L~L~~~~~~~~~~~~l~---- 185 (592)
T 3ogk_B 115 KSVHFRRMIVSDLDLDRLAKARADDLETLKLDKCSGF--TTDGL---LSIVTHCRKIKTLLMEESSFSEKDGKWLH---- 185 (592)
T ss_dssp CEEEEESCBCCHHHHHHHHHHHGGGCCEEEEESCEEE--EHHHH---HHHHHHCTTCSEEECTTCEEECCCSHHHH----
T ss_pred CeEEeeccEecHHHHHHHHHhccccCcEEECcCCCCc--CHHHH---HHHHhhCCCCCEEECccccccCcchhHHH----
Confidence 999999999988878877764 45999999998721 11111 11125789999999999998754322211
Q ss_pred hHHHHHhhcCCCcccCCcccCCcchhhhhccccccccC----CccccccCCCCCcEEEccCCcccccCCcccccCCCCcc
Q 045449 181 LKEIISTITNSTVCEIPREIGNLPYLARLALATNNLVG----VVPVTIFNMSALKEISLLNNSLSGSLPSRIDLSLPNVE 256 (823)
Q Consensus 181 L~~L~~l~~n~~~~~ip~~l~~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~g~lp~~~~~~l~~L~ 256 (823)
. .+.++++|++|+++.|.+++ .++..+.++++|++|+|++|.+.+ +|..+.. +++|+
T Consensus 186 --~---------------~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~-l~~~~~~-~~~L~ 246 (592)
T 3ogk_B 186 --E---------------LAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILE-LVGFFKA-AANLE 246 (592)
T ss_dssp --H---------------HHHHCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGG-GHHHHHH-CTTCC
T ss_pred --H---------------HHhcCCCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHH-HHHHHhh-hhHHH
Confidence 1 12345677888888888873 344455678888888888888874 6655544 88888
Q ss_pred EEEeeccccc---cccCccccCCCCCCeEEeecccccccCCCccCCCcccCcccccCccccCCCCcccccccccCCCCce
Q 045449 257 TLNLGINSFS---GTIPSSITNSSKLSDLELGENLFSGFIPNTIGNLRNLEFGNIADNYLTSSTPELSFLSSLTNCKKLK 333 (823)
Q Consensus 257 ~L~Ls~N~l~---~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~ 333 (823)
+|+++.+... +..+..+..+++|+.|+++++. .+.+|..+..+++|++|+|++|.+++.. ....+..+++|+
T Consensus 247 ~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~-~~~l~~~~~~~~~L~~L~Ls~~~l~~~~----~~~~~~~~~~L~ 321 (592)
T 3ogk_B 247 EFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMG-PNEMPILFPFAAQIRKLDLLYALLETED----HCTLIQKCPNLE 321 (592)
T ss_dssp EEEECBCCCCTTCTTSSSCCCCCTTCCEEEETTCC-TTTGGGGGGGGGGCCEEEETTCCCCHHH----HHHHHTTCTTCC
T ss_pred hhcccccccccchHHHHHHhhccccccccCccccc-hhHHHHHHhhcCCCcEEecCCCcCCHHH----HHHHHHhCcCCC
Confidence 8888754332 3445567778888888888753 3456777788888888888888865431 223457788888
Q ss_pred EEEeecCCCCccCCccccccccccceEEec-----------CCcceecc-CccccCcccccEEEcccCcCCCCchhcccc
Q 045449 334 VLIVTGNPLDGILPKSIGNFSLSLETILMA-----------NCSISGNI-PQVVGNLSNLLVLELGGNNLTGPIPVTFSQ 401 (823)
Q Consensus 334 ~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~-----------~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~ 401 (823)
.|+++++...+.++..+..+ ++|++|+++ .|.+++.. +..+..+++|++|+++.|++++..+..+..
T Consensus 322 ~L~L~~~~~~~~l~~~~~~~-~~L~~L~L~~g~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~L~l~~~~l~~~~~~~l~~ 400 (592)
T 3ogk_B 322 VLETRNVIGDRGLEVLAQYC-KQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGT 400 (592)
T ss_dssp EEEEEGGGHHHHHHHHHHHC-TTCCEEEEECCCCSSTTSSTTCCCCHHHHHHHHHHCTTCSEEEEEESCCCHHHHHHHHH
T ss_pred EEeccCccCHHHHHHHHHhC-CCCCEEEeecCccccccccccCccCHHHHHHHHhhCccCeEEEeecCCccHHHHHHHHh
Confidence 88888433333333333445 678888888 35666442 333456788888888888888777776665
Q ss_pred -cCCCCEEEcc----CCCCCCc-----chHhhhcCCCCCEEEcccC--cCcccccccccC-CCCCCeEeccCCccccc-c
Q 045449 402 -LQTLQAFDLT----RNKLAGP-----ITDELCHLARLHSLVLQGN--KFSGSIPSCLGN-LTSVRVLYLGLNIFTSV-L 467 (823)
Q Consensus 402 -l~~L~~L~Ls----~N~l~~~-----~p~~~~~l~~L~~L~Ls~N--~l~g~~p~~~~~-l~~L~~L~Ls~N~l~~~-~ 467 (823)
+++|+.|+++ .|++++. ++..+.++++|+.|+|+++ .+++..+..+.. +++|+.|+|++|.+++. +
T Consensus 401 ~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~ 480 (592)
T 3ogk_B 401 YLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGL 480 (592)
T ss_dssp HCCSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHH
T ss_pred hCCCCcEEEEeecCCCccccCchHHHHHHHHHHhCCCCCEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCHHHH
Confidence 8888888885 7788864 4555677888888888743 366665555543 78888889988888773 4
Q ss_pred chhhhccCCCcEEeccccccccc-cCccccCCCCCcEEEcccCCCCCC
Q 045449 468 SSTIWNLKDILFIDVSSNFLDGP-LSLDIGNLKVVIGLDFSRNNLSGD 514 (823)
Q Consensus 468 p~~~~~l~~L~~LdLs~N~l~g~-~p~~~~~l~~L~~L~ls~N~l~g~ 514 (823)
+..+..+++|+.|++++|.+++. ++..+..++.|++|++++|++++.
T Consensus 481 ~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ls~n~it~~ 528 (592)
T 3ogk_B 481 MEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRASMT 528 (592)
T ss_dssp HHHHTCCTTCCEEEEESCCCBHHHHHHHHHHCSSCCEEEEESCBCCTT
T ss_pred HHHHhcCcccCeeeccCCCCcHHHHHHHHHhcCccCeeECcCCcCCHH
Confidence 55567788888999998888765 344456788888899998888764
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=5.4e-33 Score=294.14 Aligned_cols=151 Identities=27% Similarity=0.392 Sum_probs=122.2
Q ss_pred ccCCccceeeccC---------CeEEEEEEehHh--hHHHHHHHHHHHHHHhhcchhhHHH-------------------
Q 045449 628 DRFSENNLIGIGN---------GMEVAVKVFHQQ--YERALKSFEDECEVRKRIRHRNLVK------------------- 677 (823)
Q Consensus 628 ~~f~~~~~lg~g~---------~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~------------------- 677 (823)
+++...+.||+|+ ...||||+++.. .....++|.+|++++++++|||||+
T Consensus 36 ~~l~l~~~iG~G~fG~Vy~~~~~~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~iVmEy~~g 115 (307)
T 3omv_A 36 SEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEG 115 (307)
T ss_dssp TSCCEEEECCCCSSSEEEEEESSSEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEEEECCSS
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEECCeEEEEEEcCCC
Confidence 4566678899987 335899998633 2455688999999999999999998
Q ss_pred ---------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccc
Q 045449 678 ---------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTL 736 (823)
Q Consensus 678 ---------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~ 736 (823)
++.|++.+|+|+|+++||||||||+|||+++++.+||+|||+|+..............+
T Consensus 116 GsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~ 195 (307)
T 3omv_A 116 SSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPT 195 (307)
T ss_dssp CBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC------------CC
T ss_pred CCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecccCCcceeecccc
Confidence 46788999999999999999999999999999999999999999765443333345678
Q ss_pred cCCCcCcccccCC---CccccccceehhhhhhccccCCCCCcCCC
Q 045449 737 ATIGYMAPEYGTK---GRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 737 gt~~y~aPE~~~~---~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
||+.|||||++.+ +.|+.++|||||||++||+++|+.||.+.
T Consensus 196 GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~ 240 (307)
T 3omv_A 196 GSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHI 240 (307)
T ss_dssp CCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred cCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCC
Confidence 9999999999853 46899999999999999999999999764
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.1e-33 Score=300.91 Aligned_cols=149 Identities=25% Similarity=0.299 Sum_probs=130.8
Q ss_pred ccCCccceeeccC------------CeEEEEEEehHhhHHHHHHHHHHHHHHhhcchhhHHH------------------
Q 045449 628 DRFSENNLIGIGN------------GMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVK------------------ 677 (823)
Q Consensus 628 ~~f~~~~~lg~g~------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------------ 677 (823)
+.|+..+.||+|+ |+.||||++........+.+.+|++++++++|||||+
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 4577778899986 6779999997655444567899999999999999998
Q ss_pred ---------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccc
Q 045449 678 ---------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTL 736 (823)
Q Consensus 678 ---------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~ 736 (823)
++.|++.+|+|+|+.+||||||||+|||++.++.+||+|||+|+.+..... .....+
T Consensus 154 ~gg~L~~~l~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~--~~~~~~ 231 (346)
T 4fih_A 154 EGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RRKSLV 231 (346)
T ss_dssp TTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC--CBCCCC
T ss_pred CCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCCC--cccccc
Confidence 468999999999999999999999999999999999999999998754332 234678
Q ss_pred cCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCCC
Q 045449 737 ATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 737 gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
||+.|||||++.+..|+.++||||+||++|+|++|..||.+.
T Consensus 232 GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~ 273 (346)
T 4fih_A 232 GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE 273 (346)
T ss_dssp SCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred cCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 999999999999999999999999999999999999999764
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.1e-33 Score=296.01 Aligned_cols=151 Identities=25% Similarity=0.340 Sum_probs=128.7
Q ss_pred cCCccceeeccC-----------------CeEEEEEEehHhhHHHHHHHHHHHHHHhhcchhhHHH--------------
Q 045449 629 RFSENNLIGIGN-----------------GMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVK-------------- 677 (823)
Q Consensus 629 ~f~~~~~lg~g~-----------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-------------- 677 (823)
+|...+.||+|+ +..||||+++.......++|.+|++++++++|||||+
T Consensus 14 ~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV 93 (299)
T 4asz_A 14 NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMV 93 (299)
T ss_dssp GEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEE
T ss_pred HeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 455567777775 3569999998776777789999999999999999998
Q ss_pred ---------------------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecc
Q 045449 678 ---------------------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFG 718 (823)
Q Consensus 678 ---------------------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfG 718 (823)
++.|++++|+|+|+++||||||||+|||++.++.+||+|||
T Consensus 94 ~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~~Ki~DFG 173 (299)
T 4asz_A 94 FEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFG 173 (299)
T ss_dssp EECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCS
T ss_pred EEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCcEEECCcc
Confidence 24588889999999999999999999999999999999999
Q ss_pred cccccCCCCccccccccccCCCcCcccccCCCccccccceehhhhhhccccC-CCCCcCCCc
Q 045449 719 IAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKET-RSMTVGETC 779 (823)
Q Consensus 719 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~-~~~~~~~~~ 779 (823)
+|+.....+.........||+.|||||++.++.|+.++|||||||++||+++ |+.||.+..
T Consensus 174 la~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~ 235 (299)
T 4asz_A 174 MSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLS 235 (299)
T ss_dssp CHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred cceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC
Confidence 9997655444333445679999999999999999999999999999999998 899997753
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=8.7e-31 Score=286.76 Aligned_cols=278 Identities=17% Similarity=0.168 Sum_probs=205.8
Q ss_pred CCCcEEEccCCcccccCCcccccCCCCccEEEeeccccccccCccccCCCCCCeEEeecccccccCCCccCCCcccCccc
Q 045449 228 SALKEISLLNNSLSGSLPSRIDLSLPNVETLNLGINSFSGTIPSSITNSSKLSDLELGENLFSGFIPNTIGNLRNLEFGN 307 (823)
Q Consensus 228 ~~L~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 307 (823)
+.....++++|.++ .+|..+. ++|++|+|++|++++..+..+.++++|++|+|++|++++..|..|.++++|++|+
T Consensus 31 ~~~~~c~~~~~~l~-~iP~~~~---~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 106 (353)
T 2z80_A 31 DRNGICKGSSGSLN-SIPSGLT---EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLD 106 (353)
T ss_dssp CTTSEEECCSTTCS-SCCTTCC---TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEE
T ss_pred CCCeEeeCCCCCcc-ccccccc---ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEE
Confidence 33445666777776 6666543 4677777777777765555677777777777777777777777777777777777
Q ss_pred ccCccccCCCCcccccccccCCCCceEEEeecCCCCccCC-ccccccccccceEEecCC-cceeccCccccCcccccEEE
Q 045449 308 IADNYLTSSTPELSFLSSLTNCKKLKVLIVTGNPLDGILP-KSIGNFSLSLETILMANC-SISGNIPQVVGNLSNLLVLE 385 (823)
Q Consensus 308 L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p-~~~~~~~~~L~~L~L~~N-~l~~~~p~~~~~l~~L~~L~ 385 (823)
|++|++++. .+..+.++++|++|++++|++++..+ ..+..+ ++|++|++++| .+++..+..|.++++|++|+
T Consensus 107 Ls~n~l~~~-----~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l-~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~ 180 (353)
T 2z80_A 107 LSYNYLSNL-----SSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHL-TKLQILRVGNMDTFTKIQRKDFAGLTFLEELE 180 (353)
T ss_dssp CCSSCCSSC-----CHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTC-TTCCEEEEEESSSCCEECTTTTTTCCEEEEEE
T ss_pred CCCCcCCcC-----CHhHhCCCccCCEEECCCCCCcccCchhhhccC-CCCcEEECCCCccccccCHHHccCCCCCCEEE
Confidence 777777765 22346677777777777777775443 356666 67888888877 46666677788888888888
Q ss_pred cccCcCCCCchhcccccCCCCEEEccCCCCCCcchHhhhcCCCCCEEEcccCcCccccccccc---CCCCCCeEeccCCc
Q 045449 386 LGGNNLTGPIPVTFSQLQTLQAFDLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLG---NLTSVRVLYLGLNI 462 (823)
Q Consensus 386 Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~---~l~~L~~L~Ls~N~ 462 (823)
+++|++++..|..+..+++|++|++++|+++...+..+..+++|+.|+|++|.+++..+..+. ..+.++.++|++|.
T Consensus 181 l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~~~~~~l~~l~L~~~~ 260 (353)
T 2z80_A 181 IDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVK 260 (353)
T ss_dssp EEETTCCEECTTTTTTCSEEEEEEEECSCSTTHHHHHHHHTTTEEEEEEESCBCTTCCCC------CCCCCCEEEEESCB
T ss_pred CCCCCcCccCHHHHhccccCCeecCCCCccccchhhhhhhcccccEEECCCCccccccccccccccccchhhcccccccc
Confidence 888888877788888888888888888888754444455678888888888888876655443 35667888888888
Q ss_pred ccc----ccchhhhccCCCcEEeccccccccccCcc-ccCCCCCcEEEcccCCCCCCCC
Q 045449 463 FTS----VLSSTIWNLKDILFIDVSSNFLDGPLSLD-IGNLKVVIGLDFSRNNLSGDIP 516 (823)
Q Consensus 463 l~~----~~p~~~~~l~~L~~LdLs~N~l~g~~p~~-~~~l~~L~~L~ls~N~l~g~ip 516 (823)
+++ .+|..+..+++|+.||+++|.++ .+|.. ++.++.|++|++++|+++|.+|
T Consensus 261 l~~~~l~~l~~~l~~l~~L~~L~Ls~N~l~-~i~~~~~~~l~~L~~L~L~~N~~~~~~~ 318 (353)
T 2z80_A 261 ITDESLFQVMKLLNQISGLLELEFSRNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCSCP 318 (353)
T ss_dssp CCHHHHHHHHHHHHTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred ccCcchhhhHHHHhcccCCCEEECCCCCCC-ccCHHHHhcCCCCCEEEeeCCCccCcCC
Confidence 877 36788889999999999999998 56655 5889999999999999998776
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.3e-33 Score=299.06 Aligned_cols=149 Identities=21% Similarity=0.329 Sum_probs=127.2
Q ss_pred ccCCccceeeccC------------CeEEEEEEehHhh--HHHHHHHHHHHHHHhhcchhhHHH----------------
Q 045449 628 DRFSENNLIGIGN------------GMEVAVKVFHQQY--ERALKSFEDECEVRKRIRHRNLVK---------------- 677 (823)
Q Consensus 628 ~~f~~~~~lg~g~------------~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~---------------- 677 (823)
++|...+.||+|+ |+.||||++.... ....+.|.+|++++++++|||||+
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 6788888999986 6779999996432 445678999999999999999998
Q ss_pred --------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCcccc
Q 045449 678 --------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSK 731 (823)
Q Consensus 678 --------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~ 731 (823)
++.|++.+|+|+|+++||||||||+|||++.++.+||+|||+|+...... ..
T Consensus 104 y~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~--~~ 181 (350)
T 4b9d_A 104 YCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV--EL 181 (350)
T ss_dssp CCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHH--HH
T ss_pred CCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCCc--cc
Confidence 46799999999999999999999999999999999999999999764321 12
Q ss_pred ccccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCCC
Q 045449 732 QTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 732 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
....+||+.|||||++.+..|+.++||||+||++|+|++|+.||.+.
T Consensus 182 ~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~ 228 (350)
T 4b9d_A 182 ARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAG 228 (350)
T ss_dssp HHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 34568999999999999999999999999999999999999999764
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=8.3e-33 Score=296.83 Aligned_cols=151 Identities=25% Similarity=0.351 Sum_probs=120.7
Q ss_pred cCCccceeeccC-----------------CeEEEEEEehHhhHHHHHHHHHHHHHHhhcchhhHHH--------------
Q 045449 629 RFSENNLIGIGN-----------------GMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVK-------------- 677 (823)
Q Consensus 629 ~f~~~~~lg~g~-----------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-------------- 677 (823)
+|...+.||+|+ ++.||||+++.......++|.+|++++++++|||||+
T Consensus 42 d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV 121 (329)
T 4aoj_A 42 DIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMV 121 (329)
T ss_dssp GEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEE
T ss_pred HeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 455566778775 3569999998777777789999999999999999998
Q ss_pred -----------------------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEee
Q 045449 678 -----------------------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISD 716 (823)
Q Consensus 678 -----------------------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~D 716 (823)
++.|++.+|+|+|+++||||||||+|||++.++.+||+|
T Consensus 122 ~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~~~Ki~D 201 (329)
T 4aoj_A 122 FEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGD 201 (329)
T ss_dssp EECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECC
T ss_pred EEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCCCcEEEcc
Confidence 245788899999999999999999999999999999999
Q ss_pred cccccccCCCCccccccccccCCCcCcccccCCCccccccceehhhhhhccccC-CCCCcCCCc
Q 045449 717 FGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKET-RSMTVGETC 779 (823)
Q Consensus 717 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~-~~~~~~~~~ 779 (823)
||+|+.....+........+||+.|||||++.+..|+.++|||||||++||+++ |+.||.+..
T Consensus 202 FGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~ 265 (329)
T 4aoj_A 202 FGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLS 265 (329)
T ss_dssp CC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSC
T ss_pred cccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCC
Confidence 999997755444444455789999999999999999999999999999999998 899997753
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.8e-32 Score=285.33 Aligned_cols=148 Identities=25% Similarity=0.418 Sum_probs=117.2
Q ss_pred ccCCccceeeccC------------CeEEEEEEehHhh---HHHHHHHHHHHHHHhhcchhhHHH---------------
Q 045449 628 DRFSENNLIGIGN------------GMEVAVKVFHQQY---ERALKSFEDECEVRKRIRHRNLVK--------------- 677 (823)
Q Consensus 628 ~~f~~~~~lg~g~------------~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~--------------- 677 (823)
++|...+.||+|+ |+.||||++.... ....+.+.+|++++++++|||||+
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 6899999999986 6779999996432 233467999999999999999998
Q ss_pred ------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCcccccc
Q 045449 678 ------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQT 733 (823)
Q Consensus 678 ------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~ 733 (823)
+++|++.+|+|+|+++|+||||||+|||++.++.+||+|||+|+...... ...
T Consensus 93 Ey~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~---~~~ 169 (275)
T 3hyh_A 93 EYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN---FLK 169 (275)
T ss_dssp ECCCEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC-------------
T ss_pred eCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCCC---ccC
Confidence 47899999999999999999999999999999999999999998764332 234
Q ss_pred ccccCCCcCcccccCCCcc-ccccceehhhhhhccccCCCCCcCCC
Q 045449 734 QTLATIGYMAPEYGTKGRV-STRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 734 ~~~gt~~y~aPE~~~~~~~-~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
..+||+.|||||++.+..| +.++||||+||++|+|++|+.||.+.
T Consensus 170 ~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~ 215 (275)
T 3hyh_A 170 TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDE 215 (275)
T ss_dssp -----CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCC
Confidence 5789999999999998876 57999999999999999999999764
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-32 Score=301.67 Aligned_cols=149 Identities=25% Similarity=0.299 Sum_probs=131.1
Q ss_pred ccCCccceeeccC------------CeEEEEEEehHhhHHHHHHHHHHHHHHhhcchhhHHH------------------
Q 045449 628 DRFSENNLIGIGN------------GMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVK------------------ 677 (823)
Q Consensus 628 ~~f~~~~~lg~g~------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------------ 677 (823)
+.|...+.||+|+ |+.||||++........+.+.+|++++++++|||||+
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~ 230 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 230 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence 4588888999996 6779999997554444567899999999999999998
Q ss_pred ---------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccc
Q 045449 678 ---------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTL 736 (823)
Q Consensus 678 ---------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~ 736 (823)
++.|++.+|+|+|+.+||||||||+|||++.++.+||+|||+|+.+..... .....+
T Consensus 231 ~gG~L~~~i~~~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~--~~~~~~ 308 (423)
T 4fie_A 231 EGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RRKSLV 308 (423)
T ss_dssp TTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC--CBCCCE
T ss_pred CCCcHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCCCc--cccccc
Confidence 468999999999999999999999999999999999999999998654332 235678
Q ss_pred cCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCCC
Q 045449 737 ATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 737 gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
||+.|||||++.+..|+.++||||+||++|+|++|..||.+.
T Consensus 309 GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~ 350 (423)
T 4fie_A 309 GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE 350 (423)
T ss_dssp ECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred cCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 999999999999999999999999999999999999999764
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=99.97 E-value=7.8e-32 Score=283.12 Aligned_cols=143 Identities=28% Similarity=0.369 Sum_probs=121.6
Q ss_pred CccceeeccC------------CeEEEEEEehHhh--HHHHHHHHHHHHHHhhcchhhHHH-------------------
Q 045449 631 SENNLIGIGN------------GMEVAVKVFHQQY--ERALKSFEDECEVRKRIRHRNLVK------------------- 677 (823)
Q Consensus 631 ~~~~~lg~g~------------~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~------------------- 677 (823)
...+.||+|+ +..||||++.... ....+.|.+|++++++++|||||+
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 4456799986 5679999996443 445678999999999999999998
Q ss_pred -------------------------HHHHHHHHhhhcCCCC--EEeccCCCCCEEeCC-CCcEEEeecccccccCCCCcc
Q 045449 678 -------------------------IISSSLEYLHFGHSIP--IIHCDLKPSNVLLDE-DMVAHISDFGIAKLLSGEDQL 729 (823)
Q Consensus 678 -------------------------~~~~~l~~L~~~h~~~--ivHrdlk~~NiLl~~-~~~~kl~DfGla~~~~~~~~~ 729 (823)
++.|++.+|+|+|+++ ||||||||+|||++. ++.+||+|||+|+.....
T Consensus 109 Ey~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~~--- 185 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS--- 185 (290)
T ss_dssp ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCTT---
T ss_pred eCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCCC---
Confidence 3678999999999988 999999999999984 789999999999864322
Q ss_pred ccccccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCCC
Q 045449 730 SKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 730 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
.....+||+.|||||++.+ .|+.++|||||||++|+|++|+.||.+.
T Consensus 186 -~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~ 232 (290)
T 3fpq_A 186 -FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSEC 232 (290)
T ss_dssp -SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred -ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 2345689999999998864 6999999999999999999999999754
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.1e-30 Score=277.71 Aligned_cols=281 Identities=23% Similarity=0.225 Sum_probs=193.2
Q ss_pred hhhccccccccCCccccccCCCCCcEEEccCCcccccCCcccccCCCCccEEEeecccccc--ccCccccCCCCCCeEEe
Q 045449 207 ARLALATNNLVGVVPVTIFNMSALKEISLLNNSLSGSLPSRIDLSLPNVETLNLGINSFSG--TIPSSITNSSKLSDLEL 284 (823)
Q Consensus 207 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~L 284 (823)
+.++++++.++. +|..+. ++|++|+|++|.++ .+|..++..+++|++|+|++|+++. ..|..+..+++|++|+|
T Consensus 10 ~~l~c~~~~l~~-ip~~~~--~~l~~L~L~~n~l~-~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~L 85 (306)
T 2z66_A 10 TEIRCNSKGLTS-VPTGIP--SSATRLELESNKLQ-SLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDL 85 (306)
T ss_dssp TEEECCSSCCSS-CCSCCC--TTCCEEECCSSCCC-CCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEEC
T ss_pred CEEEcCCCCccc-CCCCCC--CCCCEEECCCCccC-ccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEEC
Confidence 356777777763 344332 57788888888877 6676655567788888888887763 33566667778888888
Q ss_pred ecccccccCCCccCCCcccCcccccCccccCCCCcccccccccCCCCceEEEeecCCCCccCCccccccccccceEEecC
Q 045449 285 GENLFSGFIPNTIGNLRNLEFGNIADNYLTSSTPELSFLSSLTNCKKLKVLIVTGNPLDGILPKSIGNFSLSLETILMAN 364 (823)
Q Consensus 285 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~ 364 (823)
++|.++. +|..+..+++|++|++++|.+++... ...+..+++|++|++++|.+++..|..+..+ ++|++|++++
T Consensus 86 s~n~i~~-l~~~~~~l~~L~~L~l~~n~l~~~~~----~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l-~~L~~L~l~~ 159 (306)
T 2z66_A 86 SFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSE----FSVFLSLRNLIYLDISHTHTRVAFNGIFNGL-SSLEVLKMAG 159 (306)
T ss_dssp CSCSEEE-EEEEEETCTTCCEEECTTSEEESSTT----TTTTTTCTTCCEEECTTSCCEECSTTTTTTC-TTCCEEECTT
T ss_pred CCCcccc-ChhhcCCCCCCCEEECCCCccccccc----chhhhhccCCCEEECCCCcCCccchhhcccC-cCCCEEECCC
Confidence 8888774 45567777888888888887776532 1356677777777777777777777777766 5777777777
Q ss_pred Cccee-ccCccccCcccccEEEcccCcCCCCchhcccccCCCCEEEccCCCCCCcchHhhhcCCCCCEEEcccCcCcccc
Q 045449 365 CSISG-NIPQVVGNLSNLLVLELGGNNLTGPIPVTFSQLQTLQAFDLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSI 443 (823)
Q Consensus 365 N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~ 443 (823)
|.+++ .+|..+..+++|++|+|++|++++..|..|..+++|++|+|++|++++..+..+..+++|+.|+|++|++++..
T Consensus 160 n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 239 (306)
T 2z66_A 160 NSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSK 239 (306)
T ss_dssp CEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSCCCBCS
T ss_pred CccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeECCCCCCcccC
Confidence 77776 56777777777777777777777666777777777777777777777666666777777777777777777777
Q ss_pred cccccCCC-CCCeEeccCCccccccc--hhhhccCCCcEEeccccccccccCccccC
Q 045449 444 PSCLGNLT-SVRVLYLGLNIFTSVLS--STIWNLKDILFIDVSSNFLDGPLSLDIGN 497 (823)
Q Consensus 444 p~~~~~l~-~L~~L~Ls~N~l~~~~p--~~~~~l~~L~~LdLs~N~l~g~~p~~~~~ 497 (823)
|..+..++ +|+.|+|++|.+++..+ .....+...+.+.+..+.+.+..|..+..
T Consensus 240 ~~~~~~~~~~L~~L~L~~N~~~~~c~~~~~~~~l~~~~~~~~~~~~~~C~~p~~~~g 296 (306)
T 2z66_A 240 KQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDKQG 296 (306)
T ss_dssp SSSCCCCCTTCCEEECTTCCEECSGGGHHHHHHHHHTGGGBSCGGGCBEEESGGGTT
T ss_pred HHHHHhhhccCCEEEccCCCeecccChHHHHHHHHhhhhhhccccccccCCchhhCC
Confidence 77777763 67777777777766432 11233344444555566666666655544
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.97 E-value=8.5e-30 Score=275.41 Aligned_cols=234 Identities=20% Similarity=0.248 Sum_probs=177.4
Q ss_pred CCccEEEeeccccccccCccccCCCCCCeEEeecccccccCCCccCCCcccCcccccCccccCCCCcccccccccCCCCc
Q 045449 253 PNVETLNLGINSFSGTIPSSITNSSKLSDLELGENLFSGFIPNTIGNLRNLEFGNIADNYLTSSTPELSFLSSLTNCKKL 332 (823)
Q Consensus 253 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L 332 (823)
++++.|+|++|+++ .+|..+.++++|++|+|++|.++ .+|..++.+++|++|+|++|.++. ++..+.++++|
T Consensus 81 ~~l~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~~------lp~~l~~l~~L 152 (328)
T 4fcg_A 81 PGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLRA------LPASIASLNRL 152 (328)
T ss_dssp TTCCEEEEESSCCS-SCCSCGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCCC------CCGGGGGCTTC
T ss_pred cceeEEEccCCCch-hcChhhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCcccc------CcHHHhcCcCC
Confidence 44555555555555 44555555555555555555555 455555555555555555555552 34456667777
Q ss_pred eEEEeecCCCCccCCccccccccccceEEecCCcceeccCccccCcccccEEEcccCcCCCCchhcccccCCCCEEEccC
Q 045449 333 KVLIVTGNPLDGILPKSIGNFSLSLETILMANCSISGNIPQVVGNLSNLLVLELGGNNLTGPIPVTFSQLQTLQAFDLTR 412 (823)
Q Consensus 333 ~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~ 412 (823)
++|++++|++.+.+|..+... ..+..|.++++|++|+|++|+++ .+|..+..+++|++|+|++
T Consensus 153 ~~L~L~~n~~~~~~p~~~~~~----------------~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~ 215 (328)
T 4fcg_A 153 RELSIRACPELTELPEPLAST----------------DASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRN 215 (328)
T ss_dssp CEEEEEEETTCCCCCSCSEEE----------------C-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEES
T ss_pred CEEECCCCCCccccChhHhhc----------------cchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccC
Confidence 777777777777777665532 22345677888999999999988 7888888899999999999
Q ss_pred CCCCCcchHhhhcCCCCCEEEcccCcCcccccccccCCCCCCeEeccCCccccccchhhhccCCCcEEeccccccccccC
Q 045449 413 NKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSVRVLYLGLNIFTSVLSSTIWNLKDILFIDVSSNFLDGPLS 492 (823)
Q Consensus 413 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~LdLs~N~l~g~~p 492 (823)
|++++ +|..+..+++|++|+|++|++.+.+|..++.+++|+.|+|++|++.+.+|..+..+++|+.|||++|.+.+.+|
T Consensus 216 N~l~~-l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP 294 (328)
T 4fcg_A 216 SPLSA-LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLP 294 (328)
T ss_dssp SCCCC-CCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCC
T ss_pred CCCCc-CchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhcc
Confidence 99985 55578889999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCcEEEcccCCCC
Q 045449 493 LDIGNLKVVIGLDFSRNNLS 512 (823)
Q Consensus 493 ~~~~~l~~L~~L~ls~N~l~ 512 (823)
..+++++.|+.+++..|.+.
T Consensus 295 ~~l~~L~~L~~l~l~~~~~~ 314 (328)
T 4fcg_A 295 SLIAQLPANCIILVPPHLQA 314 (328)
T ss_dssp GGGGGSCTTCEEECCGGGSC
T ss_pred HHHhhccCceEEeCCHHHHH
Confidence 99999999999999877665
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.2e-32 Score=292.28 Aligned_cols=147 Identities=23% Similarity=0.208 Sum_probs=122.8
Q ss_pred hccCCccceeeccC------------CeEEEEEEehHhhHHHHHHHHHHHHHHhhcchhhHHH-----------------
Q 045449 627 TDRFSENNLIGIGN------------GMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVK----------------- 677 (823)
Q Consensus 627 t~~f~~~~~lg~g~------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~----------------- 677 (823)
.+.|...+.||+|+ |+.||||+++.+. .+.+|++++++++|||||+
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~-----~~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 131 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV-----FRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL 131 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT-----CCTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHH-----hHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 35677778899986 6779999997542 2357999999999999998
Q ss_pred -----------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCC-cEEEeecccccccCCCCcc---c
Q 045449 678 -----------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDM-VAHISDFGIAKLLSGEDQL---S 730 (823)
Q Consensus 678 -----------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~-~~kl~DfGla~~~~~~~~~---~ 730 (823)
++.|++.+|+|+|+++||||||||+|||++.++ ++||+|||+|+.+...... .
T Consensus 132 ~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~ 211 (336)
T 4g3f_A 132 LEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLL 211 (336)
T ss_dssp CTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC----------
T ss_pred cCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCccccee
Confidence 468999999999999999999999999999887 6999999999986543221 1
Q ss_pred cccccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCCC
Q 045449 731 KQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 731 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
.....+||+.|||||++.+..|+.++||||+||++|+|++|..||.+.
T Consensus 212 ~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~ 259 (336)
T 4g3f_A 212 TGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQY 259 (336)
T ss_dssp --CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTT
T ss_pred cCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCC
Confidence 123467999999999999999999999999999999999999999764
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=99.97 E-value=2.2e-32 Score=290.75 Aligned_cols=178 Identities=20% Similarity=0.208 Sum_probs=132.9
Q ss_pred eEEEEEEehHhh-HHHHHHHHHHHHHHhhcchhhHHH-------------------------------------------
Q 045449 642 MEVAVKVFHQQY-ERALKSFEDECEVRKRIRHRNLVK------------------------------------------- 677 (823)
Q Consensus 642 ~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~------------------------------------------- 677 (823)
+.||||+++... ....++|.+|+.++++++|||||+
T Consensus 57 ~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~ 136 (308)
T 4gt4_A 57 QAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDR 136 (308)
T ss_dssp EEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----C
T ss_pred eEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEEEEEcCCCCcHHHHHHhhCcccccccccccc
Confidence 469999997543 234578999999999999999998
Q ss_pred -------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCcc
Q 045449 678 -------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAP 744 (823)
Q Consensus 678 -------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aP 744 (823)
++.|++.+|+|+|+.+||||||||+|||+++++.+||+|||+|+.....+........+||+.||||
T Consensus 137 ~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAP 216 (308)
T 4gt4_A 137 TVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAP 216 (308)
T ss_dssp CEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCH
T ss_pred ccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECCCCCEEECCcccceeccCCCceeEecccccCCcccCH
Confidence 2457888999999999999999999999999999999999999977554444444567899999999
Q ss_pred cccCCCccccccceehhhhhhccccC-CCCCcCCCcccccccccccCCcccccccCCCcccccccccccccccccCC
Q 045449 745 EYGTKGRVSTRGDVCSFGIISGGKET-RSMTVGETCTPVRESKYEVHPATTTIMEHPLPRVGEVMDVDRGKARIQGK 820 (823)
Q Consensus 745 E~~~~~~~~~~~Dv~S~Gvv~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 820 (823)
|++.++.|+.++|||||||++||+++ |..||.+............ ....+.++...+.+.+++..+....+-+||
T Consensus 217 E~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i~~-~~~~~~p~~~~~~~~~li~~C~~~dP~~RP 292 (308)
T 4gt4_A 217 EAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRN-RQVLPCPDDCPAWVYALMIECWNEFPSRRP 292 (308)
T ss_dssp HHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHHHHT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSC
T ss_pred HHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-CCCCCCcccchHHHHHHHHHHcCCChhHCc
Confidence 99999999999999999999999998 7889977532211111100 011112334445555555555555444444
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-30 Score=278.91 Aligned_cols=250 Identities=19% Similarity=0.228 Sum_probs=143.9
Q ss_pred cEEEccCCcccccCCcccccCCCCccEEEeeccccccccCccccCCCCCCeEEeeccccccc--CCCccCCCcccCcccc
Q 045449 231 KEISLLNNSLSGSLPSRIDLSLPNVETLNLGINSFSGTIPSSITNSSKLSDLELGENLFSGF--IPNTIGNLRNLEFGNI 308 (823)
Q Consensus 231 ~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~--~p~~~~~l~~L~~L~L 308 (823)
+.++++++.++ .+|..+ .++|++|+|++|+++...+..|.++++|++|+|++|+++.. .+..+..+++|++|++
T Consensus 10 ~~l~c~~~~l~-~ip~~~---~~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~L 85 (306)
T 2z66_A 10 TEIRCNSKGLT-SVPTGI---PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDL 85 (306)
T ss_dssp TEEECCSSCCS-SCCSCC---CTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEEC
T ss_pred CEEEcCCCCcc-cCCCCC---CCCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEEC
Confidence 46777777777 677654 34677778877777754444567777777777777777632 2445555666666666
Q ss_pred cCccccCCCCcccccccccCCCCceEEEeecCCCCccCCccccccccccceEEecCCcceeccCccccCcccccEEEccc
Q 045449 309 ADNYLTSSTPELSFLSSLTNCKKLKVLIVTGNPLDGILPKSIGNFSLSLETILMANCSISGNIPQVVGNLSNLLVLELGG 388 (823)
Q Consensus 309 ~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~ 388 (823)
++|.++. ++..+..+++|+.|++++|.+++..+ ...+..+++|++|++++
T Consensus 86 s~n~i~~------l~~~~~~l~~L~~L~l~~n~l~~~~~------------------------~~~~~~l~~L~~L~l~~ 135 (306)
T 2z66_A 86 SFNGVIT------MSSNFLGLEQLEHLDFQHSNLKQMSE------------------------FSVFLSLRNLIYLDISH 135 (306)
T ss_dssp CSCSEEE------EEEEEETCTTCCEEECTTSEEESSTT------------------------TTTTTTCTTCCEEECTT
T ss_pred CCCcccc------ChhhcCCCCCCCEEECCCCccccccc------------------------chhhhhccCCCEEECCC
Confidence 6666554 23334455555555555555544332 03444555555555555
Q ss_pred CcCCCCchhcccccCCCCEEEccCCCCCC-cchHhhhcCCCCCEEEcccCcCcccccccccCCCCCCeEeccCCcccccc
Q 045449 389 NNLTGPIPVTFSQLQTLQAFDLTRNKLAG-PITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSVRVLYLGLNIFTSVL 467 (823)
Q Consensus 389 N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~ 467 (823)
|++++..+..+..+++|++|+|++|.+++ .+|..+..+++|++|+|++|.+++..|..+..+++|+.|+|++|.+++..
T Consensus 136 n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 215 (306)
T 2z66_A 136 THTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLD 215 (306)
T ss_dssp SCCEECSTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCC
T ss_pred CcCCccchhhcccCcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccC
Confidence 55554445555555555555555555544 34445555555555555555555555555555555555555555555555
Q ss_pred chhhhccCCCcEEeccccccccccCccccCC-CCCcEEEcccCCCCCC
Q 045449 468 SSTIWNLKDILFIDVSSNFLDGPLSLDIGNL-KVVIGLDFSRNNLSGD 514 (823)
Q Consensus 468 p~~~~~l~~L~~LdLs~N~l~g~~p~~~~~l-~~L~~L~ls~N~l~g~ 514 (823)
+..+..+++|+.||+++|.+++..|..+..+ +.|++|++++|++++.
T Consensus 216 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~~ 263 (306)
T 2z66_A 216 TFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACT 263 (306)
T ss_dssp SGGGTTCTTCCEEECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEECS
T ss_pred hhhccCcccCCEeECCCCCCcccCHHHHHhhhccCCEEEccCCCeecc
Confidence 5555555555666666666655555555555 2566666666666544
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.4e-30 Score=283.26 Aligned_cols=280 Identities=18% Similarity=0.177 Sum_probs=236.0
Q ss_pred chhhhhccccccccCCccccccCCCCCcEEEccCCcccccCCcccccCCCCccEEEeeccccccccCccccCCCCCCeEE
Q 045449 204 PYLARLALATNNLVGVVPVTIFNMSALKEISLLNNSLSGSLPSRIDLSLPNVETLNLGINSFSGTIPSSITNSSKLSDLE 283 (823)
Q Consensus 204 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 283 (823)
+.....++++|+++. +|..+. ++|++|++++|.+++ +|...+..+++|++|+|++|++++..|..|.++++|++|+
T Consensus 31 ~~~~~c~~~~~~l~~-iP~~~~--~~L~~L~l~~n~i~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 106 (353)
T 2z80_A 31 DRNGICKGSSGSLNS-IPSGLT--EAVKSLDLSNNRITY-ISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLD 106 (353)
T ss_dssp CTTSEEECCSTTCSS-CCTTCC--TTCCEEECTTSCCCE-ECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEE
T ss_pred CCCeEeeCCCCCccc-cccccc--ccCcEEECCCCcCcc-cCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEE
Confidence 334457888999984 565554 489999999999984 5554445599999999999999988889999999999999
Q ss_pred eecccccccCCCccCCCcccCcccccCccccCCCCcccccccccCCCCceEEEeecC-CCCccCCccccccccccceEEe
Q 045449 284 LGENLFSGFIPNTIGNLRNLEFGNIADNYLTSSTPELSFLSSLTNCKKLKVLIVTGN-PLDGILPKSIGNFSLSLETILM 362 (823)
Q Consensus 284 Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N-~l~~~~p~~~~~~~~~L~~L~L 362 (823)
|++|++++..+..|+.+++|++|++++|+++..+. ...+.++++|+.|++++| .+.+..|..+..+ ++|++|++
T Consensus 107 Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~----~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l-~~L~~L~l 181 (353)
T 2z80_A 107 LSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGE----TSLFSHLTKLQILRVGNMDTFTKIQRKDFAGL-TFLEELEI 181 (353)
T ss_dssp CCSSCCSSCCHHHHTTCTTCSEEECTTCCCSSSCS----SCSCTTCTTCCEEEEEESSSCCEECTTTTTTC-CEEEEEEE
T ss_pred CCCCcCCcCCHhHhCCCccCCEEECCCCCCcccCc----hhhhccCCCCcEEECCCCccccccCHHHccCC-CCCCEEEC
Confidence 99999998777779999999999999999997532 136889999999999999 5777778888888 79999999
Q ss_pred cCCcceeccCccccCcccccEEEcccCcCCCCchhcccccCCCCEEEccCCCCCCcchHhhh---cCCCCCEEEcccCcC
Q 045449 363 ANCSISGNIPQVVGNLSNLLVLELGGNNLTGPIPVTFSQLQTLQAFDLTRNKLAGPITDELC---HLARLHSLVLQGNKF 439 (823)
Q Consensus 363 ~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~---~l~~L~~L~Ls~N~l 439 (823)
++|.+++..|..+..+++|++|++++|+++...+..+..+++|++|++++|++++..+..+. ....++.++|++|.+
T Consensus 182 ~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~~~~~~l~~l~L~~~~l 261 (353)
T 2z80_A 182 DASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKI 261 (353)
T ss_dssp EETTCCEECTTTTTTCSEEEEEEEECSCSTTHHHHHHHHTTTEEEEEEESCBCTTCCCC------CCCCCCEEEEESCBC
T ss_pred CCCCcCccCHHHHhccccCCeecCCCCccccchhhhhhhcccccEEECCCCccccccccccccccccchhhccccccccc
Confidence 99999999999999999999999999999744444456789999999999999987655443 467789999999999
Q ss_pred cc----cccccccCCCCCCeEeccCCccccccchhhhccCCCcEEeccccccccccC
Q 045449 440 SG----SIPSCLGNLTSVRVLYLGLNIFTSVLSSTIWNLKDILFIDVSSNFLDGPLS 492 (823)
Q Consensus 440 ~g----~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~LdLs~N~l~g~~p 492 (823)
++ .+|..+..+++|+.|+|++|+++...+..+..+++|++|++++|.+++..|
T Consensus 262 ~~~~l~~l~~~l~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~~~~~~~ 318 (353)
T 2z80_A 262 TDESLFQVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 318 (353)
T ss_dssp CHHHHHHHHHHHHTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred cCcchhhhHHHHhcccCCCEEECCCCCCCccCHHHHhcCCCCCEEEeeCCCccCcCC
Confidence 87 478889999999999999999996544446899999999999999998765
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.3e-29 Score=294.76 Aligned_cols=122 Identities=23% Similarity=0.260 Sum_probs=74.9
Q ss_pred CCccccccccCCCCCCccceeeeeC------CCCCcEEEEEcCCCCCccccCcccCCCCCCcEEEccCCCCCCCCCCCCC
Q 045449 24 DHTNLFARNWTSSTSVCIWIGITCD------VNSHRVIGLNISSFNLQGTITPQLGNLSSLQTLDLSHNKLSGNIPSSIF 97 (823)
Q Consensus 24 ~~~~~~~~~W~~~~~~c~w~gv~c~------~~~~~v~~L~L~~~~l~g~~~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~ 97 (823)
|+...++ +|....+||.|+|..|. .....++.|++++++++ .+|..+. ++|++|+|++|+|+ .+|.
T Consensus 7 ~~~~~w~-~W~~~~~~~~~~~r~~~~~~~~~c~~~~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~-~lp~--- 78 (622)
T 3g06_A 7 EYDAVWS-AWRRAAPAEESRGRAAVVQKMRACLNNGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA--- 78 (622)
T ss_dssp ---CHHH-HHHHTCCGGGHHHHHHHHHHHHHHHHHCCCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCS-CCCC---
T ss_pred HHHHHHH-HHHhcCCcchhccccccCcccccccCCCCcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCC-CCCC---
Confidence 3444555 89888899999775331 11124677777777777 5666554 67777777777777 4444
Q ss_pred CCCCCCEEECCCCcCcCCCchhhhcCCCCcEEecccccccCccCccccCCCCCCccccccceeeeccceee
Q 045449 98 NMHTLKLLDFSDNQLFGSLSSFIFNMSSMTTIDLSINRLSGELPANICKIPSTLSKCKQLEELNLGFNNLS 168 (823)
Q Consensus 98 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~p~~~~~l~~L~~L~Ls~N~l~ 168 (823)
.+++|++|+|++|+|++ +|. .+++|++|+|++|++++ +|. .+++|++|+|++|+++
T Consensus 79 ~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-l~~----------~l~~L~~L~L~~N~l~ 134 (622)
T 3g06_A 79 LPPELRTLEVSGNQLTS-LPV---LPPGLLELSIFSNPLTH-LPA----------LPSGLCKLWIFGNQLT 134 (622)
T ss_dssp CCTTCCEEEECSCCCSC-CCC---CCTTCCEEEECSCCCCC-CCC----------CCTTCCEEECCSSCCS
T ss_pred cCCCCCEEEcCCCcCCc-CCC---CCCCCCEEECcCCcCCC-CCC----------CCCCcCEEECCCCCCC
Confidence 45677777777777663 333 45666666666666653 221 2355666666666655
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=7.8e-32 Score=285.74 Aligned_cols=147 Identities=26% Similarity=0.370 Sum_probs=117.0
Q ss_pred ccCCccceeeccC------------CeEEEEEEehHh-hHHHHHHHHHHHHHHhhcchhhHHH-----------------
Q 045449 628 DRFSENNLIGIGN------------GMEVAVKVFHQQ-YERALKSFEDECEVRKRIRHRNLVK----------------- 677 (823)
Q Consensus 628 ~~f~~~~~lg~g~------------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~----------------- 677 (823)
++|+..+.||+|+ |+.||||+++.. .+...+.|.+|++++++++|||||+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 4578888999986 667999998643 2445578999999999999999986
Q ss_pred --------------------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeeccc
Q 045449 678 --------------------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGI 719 (823)
Q Consensus 678 --------------------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGl 719 (823)
++.|++++|+|+|+++|+||||||+|||++.++.+||+|||+
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DFGl 164 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGL 164 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCCC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccCcc
Confidence 356899999999999999999999999999999999999999
Q ss_pred ccccCCCCcc----------ccccccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCC
Q 045449 720 AKLLSGEDQL----------SKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGE 777 (823)
Q Consensus 720 a~~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~ 777 (823)
|+........ ...+..+||+.|||||++.+..|+.++||||+||++|||++ ||..
T Consensus 165 a~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~ 229 (299)
T 4g31_A 165 VTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFST 229 (299)
T ss_dssp C--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSS
T ss_pred ceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCC
Confidence 9986543221 12234689999999999999999999999999999999986 6654
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.4e-29 Score=268.50 Aligned_cols=254 Identities=20% Similarity=0.200 Sum_probs=138.9
Q ss_pred cEEEccCCcccccCCcccccCCCCccEEEeeccccccccCccccCCCCCCeEEeecccccccCCCccCCCcccCcccccC
Q 045449 231 KEISLLNNSLSGSLPSRIDLSLPNVETLNLGINSFSGTIPSSITNSSKLSDLELGENLFSGFIPNTIGNLRNLEFGNIAD 310 (823)
Q Consensus 231 ~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 310 (823)
+.++.+++.++ .+|..+ .++|++|+|++|++++..+..|.++++|++|+|++|.+++..|..|..+++|++|++++
T Consensus 14 ~~~~c~~~~l~-~ip~~~---~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 89 (285)
T 1ozn_A 14 VTTSCPQQGLQ-AVPVGI---PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSD 89 (285)
T ss_dssp CEEECCSSCCS-SCCTTC---CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred eEEEcCcCCcc-cCCcCC---CCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCC
Confidence 56677777776 566543 35677777777777766666777777777777777777776676677666666666666
Q ss_pred cc-ccCCCCcccccccccCCCCceEEEeecCCCCccCCccccccccccceEEecCCcceeccCccccCcccccEEEcccC
Q 045449 311 NY-LTSSTPELSFLSSLTNCKKLKVLIVTGNPLDGILPKSIGNFSLSLETILMANCSISGNIPQVVGNLSNLLVLELGGN 389 (823)
Q Consensus 311 N~-l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N 389 (823)
|. ++.. .+..+..+++|++|++++|.+++..|. .|.++++|++|++++|
T Consensus 90 n~~l~~~-----~~~~~~~l~~L~~L~l~~n~l~~~~~~-------------------------~~~~l~~L~~L~l~~n 139 (285)
T 1ozn_A 90 NAQLRSV-----DPATFHGLGRLHTLHLDRCGLQELGPG-------------------------LFRGLAALQYLYLQDN 139 (285)
T ss_dssp CTTCCCC-----CTTTTTTCTTCCEEECTTSCCCCCCTT-------------------------TTTTCTTCCEEECCSS
T ss_pred CCCcccc-----CHHHhcCCcCCCEEECCCCcCCEECHh-------------------------HhhCCcCCCEEECCCC
Confidence 65 5544 223444555555555555555444444 4444444445555555
Q ss_pred cCCCCchhcccccCCCCEEEccCCCCCCcchHhhhcCCCCCEEEcccCcCcccccccccCCCCCCeEeccCCccccccch
Q 045449 390 NLTGPIPVTFSQLQTLQAFDLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSVRVLYLGLNIFTSVLSS 469 (823)
Q Consensus 390 ~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 469 (823)
++++..+..|..+++|++|+|++|++++..+..|..+++|+.|+|++|.+++..|..|..+++|+.|+|++|.+++..+.
T Consensus 140 ~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~ 219 (285)
T 1ozn_A 140 ALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTE 219 (285)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHH
T ss_pred cccccCHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCHH
Confidence 55444444444455555555555555544333445555555555555555555555555555555555555555554444
Q ss_pred hhhccCCCcEEeccccccccccCccccCCCCCcEEEcccCCCCCCCCCcc
Q 045449 470 TIWNLKDILFIDVSSNFLDGPLSLDIGNLKVVIGLDFSRNNLSGDIPITI 519 (823)
Q Consensus 470 ~~~~l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~ 519 (823)
.+..+++|+.|++++|.+++..+.. ..+..++.++.+.|.+.+..|..+
T Consensus 220 ~~~~l~~L~~L~l~~N~~~c~~~~~-~~~~~l~~~~~~~~~~~c~~p~~l 268 (285)
T 1ozn_A 220 ALAPLRALQYLRLNDNPWVCDCRAR-PLWAWLQKFRGSSSEVPCSLPQRL 268 (285)
T ss_dssp HHTTCTTCCEEECCSSCEECSGGGH-HHHHHHHHCCSEECCCBEEESGGG
T ss_pred HcccCcccCEEeccCCCccCCCCcH-HHHHHHHhcccccCccccCCchHh
Confidence 4555555555555555555433321 011223333444555555444443
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.8e-31 Score=288.75 Aligned_cols=154 Identities=25% Similarity=0.301 Sum_probs=131.0
Q ss_pred HhccCCccceeeccC-----------------CeEEEEEEehHhh-HHHHHHHHHHHHHHhhcch-hhHHH---------
Q 045449 626 ATDRFSENNLIGIGN-----------------GMEVAVKVFHQQY-ERALKSFEDECEVRKRIRH-RNLVK--------- 677 (823)
Q Consensus 626 at~~f~~~~~lg~g~-----------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h-~niv~--------- 677 (823)
..++|...+.||+|+ ++.||||++.... ....++|.+|++++.++.| ||||+
T Consensus 62 ~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~ 141 (353)
T 4ase_A 62 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 141 (353)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred cHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecC
Confidence 346788889999997 2459999997543 3445789999999999965 99998
Q ss_pred ------------------------------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCC
Q 045449 678 ------------------------------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDED 709 (823)
Q Consensus 678 ------------------------------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~ 709 (823)
++.|++.+|+|+|+++||||||||+|||++++
T Consensus 142 ~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~~~ 221 (353)
T 4ase_A 142 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK 221 (353)
T ss_dssp SCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG
T ss_pred CEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceeeCCC
Confidence 13478899999999999999999999999999
Q ss_pred CcEEEeecccccccCCCCccccccccccCCCcCcccccCCCccccccceehhhhhhccccC-CCCCcCCCc
Q 045449 710 MVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKET-RSMTVGETC 779 (823)
Q Consensus 710 ~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~-~~~~~~~~~ 779 (823)
+.+||+|||+|+..............+||+.|||||++.++.|+.++|||||||++||+++ |+.||.+..
T Consensus 222 ~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~ 292 (353)
T 4ase_A 222 NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 292 (353)
T ss_dssp GCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred CCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCC
Confidence 9999999999998765544444556789999999999999999999999999999999998 899997653
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.3e-30 Score=295.08 Aligned_cols=235 Identities=19% Similarity=0.158 Sum_probs=142.9
Q ss_pred CCCccEEEeeccccccccCccccCCCCCCeEEeecccccccCCCccCCCcccCcccccCccccCCCCcccccccccCCCC
Q 045449 252 LPNVETLNLGINSFSGTIPSSITNSSKLSDLELGENLFSGFIPNTIGNLRNLEFGNIADNYLTSSTPELSFLSSLTNCKK 331 (823)
Q Consensus 252 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~ 331 (823)
+++|++|+|++|.+++..|..|..+++|++|+|++|.+++.+| |..+++|++|+|++|.+++.+ ..++
T Consensus 33 ~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~----------~~~~ 100 (487)
T 3oja_A 33 AWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELL----------VGPS 100 (487)
T ss_dssp GGGCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEE----------ECTT
T ss_pred CCCccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCC----------CCCC
Confidence 4478888888888888777888888888888888888887665 778888888888888877642 1256
Q ss_pred ceEEEeecCCCCccCCccccccccccceEEecCCcceeccCccccCcccccEEEcccCcCCCCchhccc-ccCCCCEEEc
Q 045449 332 LKVLIVTGNPLDGILPKSIGNFSLSLETILMANCSISGNIPQVVGNLSNLLVLELGGNNLTGPIPVTFS-QLQTLQAFDL 410 (823)
Q Consensus 332 L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~-~l~~L~~L~L 410 (823)
|+.|++++|.+++..+.. + ++|++|+|++|.+++..|..++.+++|++|+|++|++++.+|..+. .+++|++|+|
T Consensus 101 L~~L~L~~N~l~~~~~~~---l-~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~L 176 (487)
T 3oja_A 101 IETLHAANNNISRVSCSR---G-QGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNL 176 (487)
T ss_dssp CCEEECCSSCCCCEEECC---C-SSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEEC
T ss_pred cCEEECcCCcCCCCCccc---c-CCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEec
Confidence 677777777776654432 2 3456666666666655555555556666666666666555555543 4555555555
Q ss_pred cCCCCCCcchHhhhcCCCCCEEEcccCcCcccccccccCCCCCCeEeccCCccccccchhhhccCCCcEEeccccccc-c
Q 045449 411 TRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSVRVLYLGLNIFTSVLSSTIWNLKDILFIDVSSNFLD-G 489 (823)
Q Consensus 411 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~LdLs~N~l~-g 489 (823)
++|.|++..+ +..+++|+.|+|++|.|++..| .+..+++|+.|+|++|.+++ +|..+..+++|+.|++++|.++ +
T Consensus 177 s~N~l~~~~~--~~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N~l~c~ 252 (487)
T 3oja_A 177 QYNFIYDVKG--QVVFAKLKTLDLSSNKLAFMGP-EFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCG 252 (487)
T ss_dssp TTSCCCEEEC--CCCCTTCCEEECCSSCCCEECG-GGGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCBCHH
T ss_pred CCCccccccc--cccCCCCCEEECCCCCCCCCCH-hHcCCCCccEEEecCCcCcc-cchhhccCCCCCEEEcCCCCCcCc
Confidence 5555554422 2235555555555555554322 35555555555555555554 3444555555555555555555 4
Q ss_pred ccCccccCCCCCcEEEc
Q 045449 490 PLSLDIGNLKVVIGLDF 506 (823)
Q Consensus 490 ~~p~~~~~l~~L~~L~l 506 (823)
.+|..+..++.|+.+++
T Consensus 253 ~~~~~~~~l~~L~~l~~ 269 (487)
T 3oja_A 253 TLRDFFSKNQRVQTVAK 269 (487)
T ss_dssp HHHHHHTTCHHHHHHHH
T ss_pred chHHHHHhCCCCcEEec
Confidence 44444444444444444
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.7e-32 Score=289.58 Aligned_cols=149 Identities=28% Similarity=0.352 Sum_probs=120.1
Q ss_pred ccCCccceeeccC---------------CeEEEEEEehHhh--HHHHHHHHHHHHHHhhcchhhHHH-------------
Q 045449 628 DRFSENNLIGIGN---------------GMEVAVKVFHQQY--ERALKSFEDECEVRKRIRHRNLVK------------- 677 (823)
Q Consensus 628 ~~f~~~~~lg~g~---------------~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~------------- 677 (823)
++|+..+.||+|+ ++.||||+++... .....++.+|++++++++|||||+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 5688888888885 4569999986432 112246889999999999999998
Q ss_pred ---------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccc
Q 045449 678 ---------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLS 730 (823)
Q Consensus 678 ---------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~ 730 (823)
+++|++.+|+|+|+++|+||||||+|||++.++.+||+|||+|+.......
T Consensus 104 vmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~-- 181 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK-- 181 (304)
T ss_dssp EECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC-----C--
T ss_pred EEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceeccCCCc--
Confidence 478999999999999999999999999999999999999999987543322
Q ss_pred cccccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCCC
Q 045449 731 KQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 731 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
.....+||+.|||||++.+..|+.++||||+||++|+|++|..||.+.
T Consensus 182 ~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~ 229 (304)
T 3ubd_A 182 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGK 229 (304)
T ss_dssp CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCc
Confidence 234578999999999999999999999999999999999999999764
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.4e-30 Score=279.89 Aligned_cols=250 Identities=17% Similarity=0.158 Sum_probs=177.6
Q ss_pred ccCCCCCcEEEccCCcccccCCcccccCCCCccEEEeecccc-ccccCcccc-------CCCCCCeEEeecccccccCCC
Q 045449 224 IFNMSALKEISLLNNSLSGSLPSRIDLSLPNVETLNLGINSF-SGTIPSSIT-------NSSKLSDLELGENLFSGFIPN 295 (823)
Q Consensus 224 ~~~l~~L~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~Ls~N~l-~~~~p~~~~-------~l~~L~~L~Ls~N~l~~~~p~ 295 (823)
+...++|++|++++|.+ .+|..+.. .|+.|+|++|++ .+.+|..+. ++++|++|+|++|++++.+|.
T Consensus 39 ~~~~~~L~~l~l~~n~l--~~p~~~~~---~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~ 113 (312)
T 1wwl_A 39 YGGGRSLEYLLKRVDTE--ADLGQFTD---IIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPP 113 (312)
T ss_dssp EEEEEECTTHHHHCCTT--CCCHHHHH---HHHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCC
T ss_pred EccCCCceeEeeccccc--ccHHHHHH---HHhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHH
Confidence 34455667777777776 56665544 266667777776 344555444 566677777777776666665
Q ss_pred cc--CCCcccCcccccCccccCCCCcccccccccCCCCceEEEeecCCCCccCCcccccc----ccccceEEecCCccee
Q 045449 296 TI--GNLRNLEFGNIADNYLTSSTPELSFLSSLTNCKKLKVLIVTGNPLDGILPKSIGNF----SLSLETILMANCSISG 369 (823)
Q Consensus 296 ~~--~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~----~~~L~~L~L~~N~l~~ 369 (823)
.+ ..+++| ++|+|++|.+++. |..+..+ .++|++|++++|++++
T Consensus 114 ~~~~~~l~~L-----------------------------~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~ 163 (312)
T 1wwl_A 114 PLLEATGPDL-----------------------------NILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLN 163 (312)
T ss_dssp CSSSCCSCCC-----------------------------SEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCC
T ss_pred HHHHhcCCCc-----------------------------cEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCcc
Confidence 44 444444 4555555555544 4444443 1467777777777777
Q ss_pred ccCccccCcccccEEEcccCcCCCC--chhcc--cccCCCCEEEccCCCCCCc--ch-HhhhcCCCCCEEEcccCcCccc
Q 045449 370 NIPQVVGNLSNLLVLELGGNNLTGP--IPVTF--SQLQTLQAFDLTRNKLAGP--IT-DELCHLARLHSLVLQGNKFSGS 442 (823)
Q Consensus 370 ~~p~~~~~l~~L~~L~Ls~N~l~g~--~p~~~--~~l~~L~~L~Ls~N~l~~~--~p-~~~~~l~~L~~L~Ls~N~l~g~ 442 (823)
..|..|+.+++|++|+|++|++.|. .|..+ ..+++|++|+|++|++++. ++ ..+.++++|+.|+|++|++++.
T Consensus 164 ~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 243 (312)
T 1wwl_A 164 FSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDA 243 (312)
T ss_dssp CCTTTCCCCSSCCEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSS
T ss_pred chHHHhccCCCCCEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcc
Confidence 7777888888888888888888765 33444 7888888999999888842 22 3356778899999999999887
Q ss_pred cc-ccccCCCCCCeEeccCCccccccchhhhccCCCcEEeccccccccccCccccCCCCCcEEEcccCCCCC
Q 045449 443 IP-SCLGNLTSVRVLYLGLNIFTSVLSSTIWNLKDILFIDVSSNFLDGPLSLDIGNLKVVIGLDFSRNNLSG 513 (823)
Q Consensus 443 ~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g 513 (823)
+| ..+..+++|++|+|++|+++ .+|..+. ++|++|||++|++++. |. +..++.|+.|++++|++++
T Consensus 244 ~~~~~~~~l~~L~~L~Ls~N~l~-~ip~~~~--~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l~~ 310 (312)
T 1wwl_A 244 AGAPSCDWPSQLNSLNLSFTGLK-QVPKGLP--AKLSVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPFLD 310 (312)
T ss_dssp CCCSCCCCCTTCCEEECTTSCCS-SCCSSCC--SEEEEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTTTC
T ss_pred cchhhhhhcCCCCEEECCCCccC-hhhhhcc--CCceEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCCCC
Confidence 75 45667888999999999998 5677666 8899999999999877 55 8889999999999999885
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.96 E-value=1.3e-28 Score=278.83 Aligned_cols=249 Identities=20% Similarity=0.244 Sum_probs=167.5
Q ss_pred CCcEEEccCCcccccCCcccccCCCCccEEEeeccccccccCccccCCCCCCeEEeecccccccCCCccCCCcccCcccc
Q 045449 229 ALKEISLLNNSLSGSLPSRIDLSLPNVETLNLGINSFSGTIPSSITNSSKLSDLELGENLFSGFIPNTIGNLRNLEFGNI 308 (823)
Q Consensus 229 ~L~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 308 (823)
....++.+++.++ .+|..+. ++|++|+|++|+|++..|..|.++++|++|+|++|++++..|..|.++++|++|+|
T Consensus 55 ~~~~v~c~~~~l~-~iP~~~~---~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L 130 (452)
T 3zyi_A 55 QFSKVVCTRRGLS-EVPQGIP---SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLEL 130 (452)
T ss_dssp SSCEEECCSSCCS-SCCSCCC---TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEEC
T ss_pred CCcEEEECCCCcC-ccCCCCC---CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEEC
Confidence 3456778888887 6776553 57888888888888888888888888888888888888888888888888888888
Q ss_pred cCccccCCCCcccccccccCCCCceEEEeecCCCCccCCccccccccccceEEecC-CcceeccCccccCcccccEEEcc
Q 045449 309 ADNYLTSSTPELSFLSSLTNCKKLKVLIVTGNPLDGILPKSIGNFSLSLETILMAN-CSISGNIPQVVGNLSNLLVLELG 387 (823)
Q Consensus 309 ~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~Ls 387 (823)
++|+++..+ +..|.++++|++|+|++|.+++..+..|..+ ++|++|++++ |.+....+..|.++++|++|+|+
T Consensus 131 ~~n~l~~~~-----~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l-~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~ 204 (452)
T 3zyi_A 131 FDNWLTVIP-----SGAFEYLSKLRELWLRNNPIESIPSYAFNRV-PSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLG 204 (452)
T ss_dssp CSSCCSBCC-----TTTSSSCTTCCEEECCSCCCCEECTTTTTTC-TTCCEEECCCCTTCCEECTTTTTTCTTCCEEECT
T ss_pred CCCcCCccC-----hhhhcccCCCCEEECCCCCcceeCHhHHhcC-CcccEEeCCCCCCccccChhhccCCCCCCEEECC
Confidence 888887663 3346667777777777777776555556665 5666666666 33443334456666666666666
Q ss_pred cCcCCCCchhcccccCCCCEEEccCCCCCCcchHhhhcCCCCCEEEcccCcCcccccccccCCCCCCeEeccCCcccccc
Q 045449 388 GNNLTGPIPVTFSQLQTLQAFDLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSVRVLYLGLNIFTSVL 467 (823)
Q Consensus 388 ~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~ 467 (823)
+|++++ +| .+..+++|++|+|++|+|++..|..|.++++|+.|+|++|++++..|..|.++++|+.|+|++|++++..
T Consensus 205 ~n~l~~-~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 282 (452)
T 3zyi_A 205 MCNIKD-MP-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLP 282 (452)
T ss_dssp TSCCSS-CC-CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCC
T ss_pred CCcccc-cc-cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccC
Confidence 666663 23 3555666666666666666655666666666666666666666655666666666666666666666555
Q ss_pred chhhhccCCCcEEecccccccc
Q 045449 468 SSTIWNLKDILFIDVSSNFLDG 489 (823)
Q Consensus 468 p~~~~~l~~L~~LdLs~N~l~g 489 (823)
+..+..+++|+.|+|++|.+..
T Consensus 283 ~~~~~~l~~L~~L~L~~Np~~C 304 (452)
T 3zyi_A 283 HDLFTPLRYLVELHLHHNPWNC 304 (452)
T ss_dssp TTSSTTCTTCCEEECCSSCEEC
T ss_pred hHHhccccCCCEEEccCCCcCC
Confidence 5555555566666666665543
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.7e-30 Score=279.21 Aligned_cols=255 Identities=20% Similarity=0.201 Sum_probs=160.2
Q ss_pred cCCcchhhhhccccccccCCccccccCCCCCcEEEccCCcc-cccCCcccc------cCCCCccEEEeeccccccccCcc
Q 045449 200 IGNLPYLARLALATNNLVGVVPVTIFNMSALKEISLLNNSL-SGSLPSRID------LSLPNVETLNLGINSFSGTIPSS 272 (823)
Q Consensus 200 l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l-~g~lp~~~~------~~l~~L~~L~Ls~N~l~~~~p~~ 272 (823)
++..++|+.|++++|.+ .+|..+... |+.|+|++|.+ .+.+|..+. ..+++|++|+|++|++++.+|..
T Consensus 39 ~~~~~~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~ 114 (312)
T 1wwl_A 39 YGGGRSLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPP 114 (312)
T ss_dssp EEEEEECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCCC
T ss_pred EccCCCceeEeeccccc--ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHHH
Confidence 45566677777777777 556555443 77777777777 345555443 13677888888888888777776
Q ss_pred c--cCCCCCCeEEeecccccccCCCccCCCcccCcccccCccccCCCCcccccccccCCCCceEEEeecCCCCccCCccc
Q 045449 273 I--TNSSKLSDLELGENLFSGFIPNTIGNLRNLEFGNIADNYLTSSTPELSFLSSLTNCKKLKVLIVTGNPLDGILPKSI 350 (823)
Q Consensus 273 ~--~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~ 350 (823)
+ ..+++|++|+|++|++++. |..++.+.. ..+++|++|+|++|++++..|..+
T Consensus 115 ~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~------------------------~~~~~L~~L~L~~N~l~~~~~~~~ 169 (312)
T 1wwl_A 115 LLEATGPDLNILNLRNVSWATR-DAWLAELQQ------------------------WLKPGLKVLSIAQAHSLNFSCEQV 169 (312)
T ss_dssp SSSCCSCCCSEEEEESCBCSSS-SSHHHHHHT------------------------TCCTTCCEEEEESCSCCCCCTTTC
T ss_pred HHHhcCCCccEEEccCCCCcch-hHHHHHHHH------------------------hhcCCCcEEEeeCCCCccchHHHh
Confidence 5 7778888888888888776 665554410 001333344444444444334444
Q ss_pred cccccccceEEecCCcceec--cCccc--cCcccccEEEcccCcCCC--Cch-hcccccCCCCEEEccCCCCCCcch-Hh
Q 045449 351 GNFSLSLETILMANCSISGN--IPQVV--GNLSNLLVLELGGNNLTG--PIP-VTFSQLQTLQAFDLTRNKLAGPIT-DE 422 (823)
Q Consensus 351 ~~~~~~L~~L~L~~N~l~~~--~p~~~--~~l~~L~~L~Ls~N~l~g--~~p-~~~~~l~~L~~L~Ls~N~l~~~~p-~~ 422 (823)
+.+ ++|++|++++|++.+. .|..+ ..+++|++|+|++|++++ .++ ..+..+++|++|+|++|++++.+| ..
T Consensus 170 ~~l-~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 248 (312)
T 1wwl_A 170 RVF-PALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPS 248 (312)
T ss_dssp CCC-SSCCEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSC
T ss_pred ccC-CCCCEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhh
Confidence 444 3444455555444433 12222 566777777777777763 122 234566777777777777776654 33
Q ss_pred hhcCCCCCEEEcccCcCcccccccccCCCCCCeEeccCCccccccchhhhccCCCcEEecccccccc
Q 045449 423 LCHLARLHSLVLQGNKFSGSIPSCLGNLTSVRVLYLGLNIFTSVLSSTIWNLKDILFIDVSSNFLDG 489 (823)
Q Consensus 423 ~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~LdLs~N~l~g 489 (823)
+..+++|++|+|++|+|+ .+|..+. ++|+.|+|++|++++. |. +..+++|++|++++|++++
T Consensus 249 ~~~l~~L~~L~Ls~N~l~-~ip~~~~--~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l~~ 310 (312)
T 1wwl_A 249 CDWPSQLNSLNLSFTGLK-QVPKGLP--AKLSVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPFLD 310 (312)
T ss_dssp CCCCTTCCEEECTTSCCS-SCCSSCC--SEEEEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTTTC
T ss_pred hhhcCCCCEEECCCCccC-hhhhhcc--CCceEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCCCC
Confidence 455677777777777777 6666665 6777788888877775 44 7777788888888887765
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.96 E-value=6.6e-32 Score=316.97 Aligned_cols=407 Identities=11% Similarity=0.014 Sum_probs=302.5
Q ss_pred CCCCCCCCCCCCCEEECCCCcC---cCCCchh------------hhcCCCCcEEecccccccCccCccccCCCCCCcc-c
Q 045449 91 NIPSSIFNMHTLKLLDFSDNQL---FGSLSSF------------IFNMSSMTTIDLSINRLSGELPANICKIPSTLSK-C 154 (823)
Q Consensus 91 ~~p~~~~~l~~L~~L~Ls~N~l---~~~~p~~------------~~~l~~L~~L~Ls~N~l~~~~p~~~~~~p~~~~~-l 154 (823)
..+..+..+++|++|+|+++.. .+.+|.. ...+++|++|+|++|.+++..+..+ .. +
T Consensus 64 ~~~~~~~~~~~L~~L~L~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~i~~~~~~~l-------~~~~ 136 (592)
T 3ogk_B 64 TPDRLSRRFPNLRSLKLKGKPRAAMFNLIPENWGGYVTPWVTEISNNLRQLKSVHFRRMIVSDLDLDRL-------AKAR 136 (592)
T ss_dssp CHHHHHHHCTTCSEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCCEEEEESCBCCHHHHHHH-------HHHH
T ss_pred ChHHHHHhCCCCeEEEecCCcchhhcccccccccccchHHHHHHHhhCCCCCeEEeeccEecHHHHHHH-------HHhc
Confidence 3444556788999999987532 1233322 2378999999999998886655555 33 3
Q ss_pred c-ccceeeeccceeeccCccccccchhhHHHHHhhcCCCcccCCcccCCcchhhhhccccccccCC----ccccccCCCC
Q 045449 155 K-QLEELNLGFNNLSGAIPKEIGNLTKLKEIISTITNSTVCEIPREIGNLPYLARLALATNNLVGV----VPVTIFNMSA 229 (823)
Q Consensus 155 ~-~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~~l~~n~~~~~ip~~l~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~ 229 (823)
+ +|++|+|++|.-. .+. .+..+ ..++++|++|+|++|.+++. ++..+.++++
T Consensus 137 ~~~L~~L~L~~~~~~--~~~------~l~~~---------------~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~ 193 (592)
T 3ogk_B 137 ADDLETLKLDKCSGF--TTD------GLLSI---------------VTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTS 193 (592)
T ss_dssp GGGCCEEEEESCEEE--EHH------HHHHH---------------HHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCC
T ss_pred cccCcEEECcCCCCc--CHH------HHHHH---------------HhhCCCCCEEECccccccCcchhHHHHHHhcCCC
Confidence 3 4999999998721 111 11111 23467899999999998876 4445668899
Q ss_pred CcEEEccCCccc----ccCCcccccCCCCccEEEeeccccccccCccccCCCCCCeEEeeccccc---ccCCCccCCCcc
Q 045449 230 LKEISLLNNSLS----GSLPSRIDLSLPNVETLNLGINSFSGTIPSSITNSSKLSDLELGENLFS---GFIPNTIGNLRN 302 (823)
Q Consensus 230 L~~L~Ls~N~l~----g~lp~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~---~~~p~~~~~l~~ 302 (823)
|++|++++|.++ +.++..+. .+++|++|+|++|.+.+ +|..+.++++|+.|+++++... +..+..+..+++
T Consensus 194 L~~L~L~~n~~~~~~~~~l~~~~~-~~~~L~~L~L~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~ 271 (592)
T 3ogk_B 194 LEVLNFYMTEFAKISPKDLETIAR-NCRSLVSVKVGDFEILE-LVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRK 271 (592)
T ss_dssp CCEEECTTCCCSSCCHHHHHHHHH-HCTTCCEEECSSCBGGG-GHHHHHHCTTCCEEEECBCCCCTTCTTSSSCCCCCTT
T ss_pred ccEEEeeccCCCccCHHHHHHHHh-hCCCCcEEeccCccHHH-HHHHHhhhhHHHhhcccccccccchHHHHHHhhcccc
Confidence 999999999997 23333333 48999999999999986 7788999999999999974433 344567788899
Q ss_pred cCcccccCccccCCCCcccccccccCCCCceEEEeecCCCCccCC-ccccccccccceEEecCCcceeccCccccCcccc
Q 045449 303 LEFGNIADNYLTSSTPELSFLSSLTNCKKLKVLIVTGNPLDGILP-KSIGNFSLSLETILMANCSISGNIPQVVGNLSNL 381 (823)
Q Consensus 303 L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p-~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L 381 (823)
|+.|+++++.... ++..+..+++|+.|+|++|.+++... ..+..+ ++|++|+++++...+.++..+..+++|
T Consensus 272 L~~L~l~~~~~~~------l~~~~~~~~~L~~L~Ls~~~l~~~~~~~~~~~~-~~L~~L~L~~~~~~~~l~~~~~~~~~L 344 (592)
T 3ogk_B 272 LCRLGLSYMGPNE------MPILFPFAAQIRKLDLLYALLETEDHCTLIQKC-PNLEVLETRNVIGDRGLEVLAQYCKQL 344 (592)
T ss_dssp CCEEEETTCCTTT------GGGGGGGGGGCCEEEETTCCCCHHHHHHHHTTC-TTCCEEEEEGGGHHHHHHHHHHHCTTC
T ss_pred ccccCccccchhH------HHHHHhhcCCCcEEecCCCcCCHHHHHHHHHhC-cCCCEEeccCccCHHHHHHHHHhCCCC
Confidence 9999998863332 55677889999999999999876544 334566 799999999444344455556778999
Q ss_pred cEEEcc-----------cCcCCCC-chhcccccCCCCEEEccCCCCCCcchHhhhc-CCCCCEEEcc----cCcCccc--
Q 045449 382 LVLELG-----------GNNLTGP-IPVTFSQLQTLQAFDLTRNKLAGPITDELCH-LARLHSLVLQ----GNKFSGS-- 442 (823)
Q Consensus 382 ~~L~Ls-----------~N~l~g~-~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-l~~L~~L~Ls----~N~l~g~-- 442 (823)
++|+++ .|.+++. ++..+..+++|++|+++.|++++..+..+.. +++|+.|+|+ .|.+++.
T Consensus 345 ~~L~L~~g~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~ 424 (592)
T 3ogk_B 345 KRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPL 424 (592)
T ss_dssp CEEEEECCCCSSTTSSTTCCCCHHHHHHHHHHCTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSCCC
T ss_pred CEEEeecCccccccccccCccCHHHHHHHHhhCccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCchH
Confidence 999999 4677754 3333566899999999999999888888766 9999999997 7788864
Q ss_pred ---ccccccCCCCCCeEeccCC--ccccccchhhhc-cCCCcEEecccccccc-ccCccccCCCCCcEEEcccCCCCCCC
Q 045449 443 ---IPSCLGNLTSVRVLYLGLN--IFTSVLSSTIWN-LKDILFIDVSSNFLDG-PLSLDIGNLKVVIGLDFSRNNLSGDI 515 (823)
Q Consensus 443 ---~p~~~~~l~~L~~L~Ls~N--~l~~~~p~~~~~-l~~L~~LdLs~N~l~g-~~p~~~~~l~~L~~L~ls~N~l~g~i 515 (823)
++..+.++++|+.|+|+.+ .+++..+..+.. +++|+.|++++|.+++ .++..+..++.|++|++++|++++..
T Consensus 425 ~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~ 504 (592)
T 3ogk_B 425 DNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERA 504 (592)
T ss_dssp HHHHHHHHHHCTTCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHHH
T ss_pred HHHHHHHHHhCCCCCEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcHHH
Confidence 5555778999999999853 478777777655 8999999999999987 45556688999999999999987432
Q ss_pred CCcccCccCCCCCCCCCCCcccccCCcc
Q 045449 516 PITIGEGEIPRGGPFANLTAKSFMGNEL 543 (823)
Q Consensus 516 p~~~~~g~ip~~~~~~~~~~~~~~~n~~ 543 (823)
...+. ..+..+..+.+.+|..
T Consensus 505 ~~~~~-------~~l~~L~~L~ls~n~i 525 (592)
T 3ogk_B 505 IAAAV-------TKLPSLRYLWVQGYRA 525 (592)
T ss_dssp HHHHH-------HHCSSCCEEEEESCBC
T ss_pred HHHHH-------HhcCccCeeECcCCcC
Confidence 22111 1245566777888873
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.6e-28 Score=277.15 Aligned_cols=248 Identities=23% Similarity=0.250 Sum_probs=164.8
Q ss_pred CCcEEEccCCcccccCCcccccCCCCccEEEeeccccccccCccccCCCCCCeEEeecccccccCCCccCCCcccCcccc
Q 045449 229 ALKEISLLNNSLSGSLPSRIDLSLPNVETLNLGINSFSGTIPSSITNSSKLSDLELGENLFSGFIPNTIGNLRNLEFGNI 308 (823)
Q Consensus 229 ~L~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 308 (823)
....++.+++.++ .+|..+. ++++.|+|++|++++..+..|.++++|++|+|++|++++..+..|.++++|++|+|
T Consensus 44 ~~~~v~c~~~~l~-~iP~~~~---~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L 119 (440)
T 3zyj_A 44 QFSKVICVRKNLR-EVPDGIS---TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLEL 119 (440)
T ss_dssp TSCEEECCSCCCS-SCCSCCC---TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEEC
T ss_pred CCCEEEeCCCCcC-cCCCCCC---CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEEC
Confidence 3557778888887 7777653 57888888888888877788888888888888888888877778888888888888
Q ss_pred cCccccCCCCcccccccccCCCCceEEEeecCCCCccCCccccccccccceEEecCC-cceeccCccccCcccccEEEcc
Q 045449 309 ADNYLTSSTPELSFLSSLTNCKKLKVLIVTGNPLDGILPKSIGNFSLSLETILMANC-SISGNIPQVVGNLSNLLVLELG 387 (823)
Q Consensus 309 ~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N-~l~~~~p~~~~~l~~L~~L~Ls 387 (823)
++|+++..+ +..|..+++|+.|+|++|.+++..+..|..+ ++|++|++++| .+....+..|.++++|++|+|+
T Consensus 120 ~~n~l~~~~-----~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l-~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~ 193 (440)
T 3zyj_A 120 FDNRLTTIP-----NGAFVYLSKLKELWLRNNPIESIPSYAFNRI-PSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLA 193 (440)
T ss_dssp CSSCCSSCC-----TTTSCSCSSCCEEECCSCCCCEECTTTTTTC-TTCCEEECCCCTTCCEECTTTTTTCSSCCEEECT
T ss_pred CCCcCCeeC-----HhHhhccccCceeeCCCCcccccCHHHhhhC-cccCEeCCCCCCCcceeCcchhhcccccCeecCC
Confidence 888777652 2356667777777777777766555566665 56666666663 3333334456666666666666
Q ss_pred cCcCCCCchhcccccCCCCEEEccCCCCCCcchHhhhcCCCCCEEEcccCcCcccccccccCCCCCCeEeccCCcccccc
Q 045449 388 GNNLTGPIPVTFSQLQTLQAFDLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSVRVLYLGLNIFTSVL 467 (823)
Q Consensus 388 ~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~ 467 (823)
+|+++ .+| .+..+++|++|+|++|++++..|..|.++++|+.|+|++|++++..|..|.++++|+.|+|++|++++..
T Consensus 194 ~n~l~-~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 271 (440)
T 3zyj_A 194 MCNLR-EIP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLP 271 (440)
T ss_dssp TSCCS-SCC-CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCC
T ss_pred CCcCc-ccc-ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccC
Confidence 66666 333 2555666666666666666555556666666666666666666555555666666666666666666555
Q ss_pred chhhhccCCCcEEeccccccc
Q 045449 468 SSTIWNLKDILFIDVSSNFLD 488 (823)
Q Consensus 468 p~~~~~l~~L~~LdLs~N~l~ 488 (823)
+..+..+++|+.|+|++|.+.
T Consensus 272 ~~~~~~l~~L~~L~L~~Np~~ 292 (440)
T 3zyj_A 272 HDLFTPLHHLERIHLHHNPWN 292 (440)
T ss_dssp TTTTSSCTTCCEEECCSSCEE
T ss_pred hhHhccccCCCEEEcCCCCcc
Confidence 555555555555555555554
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4.9e-29 Score=264.25 Aligned_cols=229 Identities=22% Similarity=0.230 Sum_probs=185.6
Q ss_pred cEEEeeccccccccCccccCCCCCCeEEeecccccccCCCccCCCcccCcccccCccccCCCCcccccccccCCCCceEE
Q 045449 256 ETLNLGINSFSGTIPSSITNSSKLSDLELGENLFSGFIPNTIGNLRNLEFGNIADNYLTSSTPELSFLSSLTNCKKLKVL 335 (823)
Q Consensus 256 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L 335 (823)
++++.+++.++ .+|..+ .++|++|++++|.+++..+..|..+++ |++|
T Consensus 14 ~~~~c~~~~l~-~ip~~~--~~~l~~L~l~~n~i~~~~~~~~~~~~~-----------------------------L~~L 61 (285)
T 1ozn_A 14 VTTSCPQQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRN-----------------------------LTIL 61 (285)
T ss_dssp CEEECCSSCCS-SCCTTC--CTTCSEEECTTSCCCEECTTTTTTCTT-----------------------------CCEE
T ss_pred eEEEcCcCCcc-cCCcCC--CCCceEEEeeCCcCCccCHHHcccCCC-----------------------------CCEE
Confidence 45666666665 344433 245666666666666555555555544 4555
Q ss_pred EeecCCCCccCCccccccccccceEEecCCc-ceeccCccccCcccccEEEcccCcCCCCchhcccccCCCCEEEccCCC
Q 045449 336 IVTGNPLDGILPKSIGNFSLSLETILMANCS-ISGNIPQVVGNLSNLLVLELGGNNLTGPIPVTFSQLQTLQAFDLTRNK 414 (823)
Q Consensus 336 ~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~-l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~ 414 (823)
++++|.+++..|..+..+ ++|++|++++|. ++...|..|..+++|++|++++|++++..|..|..+++|++|++++|+
T Consensus 62 ~l~~n~l~~~~~~~~~~l-~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~ 140 (285)
T 1ozn_A 62 WLHSNVLARIDAAAFTGL-ALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNA 140 (285)
T ss_dssp ECCSSCCCEECTTTTTTC-TTCCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred ECCCCccceeCHhhcCCc-cCCCEEeCCCCCCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCc
Confidence 555555555555556665 567777777775 666667888899999999999999998889999999999999999999
Q ss_pred CCCcchHhhhcCCCCCEEEcccCcCcccccccccCCCCCCeEeccCCccccccchhhhccCCCcEEeccccccccccCcc
Q 045449 415 LAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSVRVLYLGLNIFTSVLSSTIWNLKDILFIDVSSNFLDGPLSLD 494 (823)
Q Consensus 415 l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~LdLs~N~l~g~~p~~ 494 (823)
+++..+..|..+++|++|+|++|++++..+..|..+++|+.|+|++|.+++..|..+..+++|+.|++++|.+++..+..
T Consensus 141 l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~ 220 (285)
T 1ozn_A 141 LQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEA 220 (285)
T ss_dssp CCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHH
T ss_pred ccccCHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCHHH
Confidence 99888888999999999999999999877778999999999999999999999999999999999999999999877778
Q ss_pred ccCCCCCcEEEcccCCCCCCCCC
Q 045449 495 IGNLKVVIGLDFSRNNLSGDIPI 517 (823)
Q Consensus 495 ~~~l~~L~~L~ls~N~l~g~ip~ 517 (823)
+..++.|+.|++++|++.+..+.
T Consensus 221 ~~~l~~L~~L~l~~N~~~c~~~~ 243 (285)
T 1ozn_A 221 LAPLRALQYLRLNDNPWVCDCRA 243 (285)
T ss_dssp HTTCTTCCEEECCSSCEECSGGG
T ss_pred cccCcccCEEeccCCCccCCCCc
Confidence 99999999999999999976654
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.3e-30 Score=280.63 Aligned_cols=267 Identities=19% Similarity=0.157 Sum_probs=175.3
Q ss_pred CcEEEccCCcccccCCcccccCCCCccEEEeeccccccccCccccCCCCCCeEEeecccccccCCCccCCCcccCccccc
Q 045449 230 LKEISLLNNSLSGSLPSRIDLSLPNVETLNLGINSFSGTIPSSITNSSKLSDLELGENLFSGFIPNTIGNLRNLEFGNIA 309 (823)
Q Consensus 230 L~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 309 (823)
++..+++.+.+. ..+..++..+++|++|+|++|++++..|..|.++++|++|+|++|++++..+ +..+++|++|+++
T Consensus 12 l~i~~ls~~~l~-~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls 88 (317)
T 3o53_A 12 YKIEKVTDSSLK-QALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLN 88 (317)
T ss_dssp EEEESCCTTTHH-HHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECC
T ss_pred eeEeeccccchh-hhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECc
Confidence 344455555554 3333333345556666666666665555566666666666666666665443 5666666666666
Q ss_pred CccccCCCCcccccccccCCCCceEEEeecCCCCccCCccccccccccceEEecCCcceeccCccccCcccccEEEcccC
Q 045449 310 DNYLTSSTPELSFLSSLTNCKKLKVLIVTGNPLDGILPKSIGNFSLSLETILMANCSISGNIPQVVGNLSNLLVLELGGN 389 (823)
Q Consensus 310 ~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N 389 (823)
+|++++.. ..++|+.|++++|.+++..+.. + ++|++|++++|++++..+..+..+++|++|+|++|
T Consensus 89 ~n~l~~l~----------~~~~L~~L~l~~n~l~~~~~~~---~-~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N 154 (317)
T 3o53_A 89 NNYVQELL----------VGPSIETLHAANNNISRVSCSR---G-QGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLN 154 (317)
T ss_dssp SSEEEEEE----------ECTTCCEEECCSSCCSEEEECC---C-SSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTS
T ss_pred CCcccccc----------CCCCcCEEECCCCccCCcCccc---c-CCCCEEECCCCCCCCccchhhhccCCCCEEECCCC
Confidence 66665431 2256666777777766654433 2 46777777777777777777777777788888888
Q ss_pred cCCCCchhcc-cccCCCCEEEccCCCCCCcchHhhhcCCCCCEEEcccCcCcccccccccCCCCCCeEeccCCccccccc
Q 045449 390 NLTGPIPVTF-SQLQTLQAFDLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSVRVLYLGLNIFTSVLS 468 (823)
Q Consensus 390 ~l~g~~p~~~-~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p 468 (823)
++++..+..+ ..+++|++|+|++|++++. +. ...+++|+.|+|++|++++. |..+..+++|+.|+|++|++++ +|
T Consensus 155 ~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~-~~~l~~L~~L~Ls~N~l~~l-~~~~~~l~~L~~L~L~~N~l~~-l~ 230 (317)
T 3o53_A 155 EIDTVNFAELAASSDTLEHLNLQYNFIYDV-KG-QVVFAKLKTLDLSSNKLAFM-GPEFQSAAGVTWISLRNNKLVL-IE 230 (317)
T ss_dssp CCCEEEGGGGGGGTTTCCEEECTTSCCCEE-EC-CCCCTTCCEEECCSSCCCEE-CGGGGGGTTCSEEECTTSCCCE-EC
T ss_pred CCCcccHHHHhhccCcCCEEECCCCcCccc-cc-ccccccCCEEECCCCcCCcc-hhhhcccCcccEEECcCCcccc-hh
Confidence 7776666655 3677788888888877754 22 23477788888888888753 4447777888888888888775 56
Q ss_pred hhhhccCCCcEEeccccccc-cccCccccCCCCCcEEEcc-cCCCCCCCCC
Q 045449 469 STIWNLKDILFIDVSSNFLD-GPLSLDIGNLKVVIGLDFS-RNNLSGDIPI 517 (823)
Q Consensus 469 ~~~~~l~~L~~LdLs~N~l~-g~~p~~~~~l~~L~~L~ls-~N~l~g~ip~ 517 (823)
..+..+++|+.|++++|.++ +.+|..+..++.|+.|+++ .+.++|..|.
T Consensus 231 ~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~~~~~l~~~~~~ 281 (317)
T 3o53_A 231 KALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEE 281 (317)
T ss_dssp TTCCCCTTCCEEECTTCCCBHHHHHHHHHTCHHHHHHHHHHHHHHHSSSSC
T ss_pred hHhhcCCCCCEEEccCCCccCcCHHHHHhccccceEEECCCchhccCCchh
Confidence 66777788888888888887 6677777778888888887 4556654443
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.96 E-value=2.2e-28 Score=276.89 Aligned_cols=252 Identities=19% Similarity=0.221 Sum_probs=227.5
Q ss_pred CccEEEeeccccccccCccccCCCCCCeEEeecccccccCCCccCCCcccCcccccCccccCCCCcccccccccCCCCce
Q 045449 254 NVETLNLGINSFSGTIPSSITNSSKLSDLELGENLFSGFIPNTIGNLRNLEFGNIADNYLTSSTPELSFLSSLTNCKKLK 333 (823)
Q Consensus 254 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~ 333 (823)
....++.+++.++ .+|..+. +++++|+|++|++++..|..|.++++|++|+|++|.+++. .+..|.++++|+
T Consensus 55 ~~~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~-----~~~~~~~l~~L~ 126 (452)
T 3zyi_A 55 QFSKVVCTRRGLS-EVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQI-----EVGAFNGLASLN 126 (452)
T ss_dssp SSCEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEE-----CTTTTTTCTTCC
T ss_pred CCcEEEECCCCcC-ccCCCCC--CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCc-----ChhhccCcccCC
Confidence 4567889988888 5777665 5899999999999999999999999999999999999987 446789999999
Q ss_pred EEEeecCCCCccCCccccccccccceEEecCCcceeccCccccCcccccEEEcccCcCCCCch-hcccccCCCCEEEccC
Q 045449 334 VLIVTGNPLDGILPKSIGNFSLSLETILMANCSISGNIPQVVGNLSNLLVLELGGNNLTGPIP-VTFSQLQTLQAFDLTR 412 (823)
Q Consensus 334 ~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p-~~~~~l~~L~~L~Ls~ 412 (823)
+|+|++|.+++..+..|..+ ++|++|+|++|+++...+..|.++++|++|+|++|+..+.++ ..|.++++|++|+|++
T Consensus 127 ~L~L~~n~l~~~~~~~~~~l-~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~ 205 (452)
T 3zyi_A 127 TLELFDNWLTVIPSGAFEYL-SKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGM 205 (452)
T ss_dssp EEECCSSCCSBCCTTTSSSC-TTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTT
T ss_pred EEECCCCcCCccChhhhccc-CCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCC
Confidence 99999999998888888888 799999999999998888899999999999999954444554 5689999999999999
Q ss_pred CCCCCcchHhhhcCCCCCEEEcccCcCcccccccccCCCCCCeEeccCCccccccchhhhccCCCcEEeccccccccccC
Q 045449 413 NKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSVRVLYLGLNIFTSVLSSTIWNLKDILFIDVSSNFLDGPLS 492 (823)
Q Consensus 413 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~LdLs~N~l~g~~p 492 (823)
|++++. | .+..+++|+.|+|++|.+++..|..|.++++|+.|+|++|++++..|..+..+++|+.|||++|+|++..+
T Consensus 206 n~l~~~-~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 283 (452)
T 3zyi_A 206 CNIKDM-P-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPH 283 (452)
T ss_dssp SCCSSC-C-CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCT
T ss_pred Cccccc-c-cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccCh
Confidence 999965 4 47889999999999999999999999999999999999999999999999999999999999999998888
Q ss_pred ccccCCCCCcEEEcccCCCCCCCC
Q 045449 493 LDIGNLKVVIGLDFSRNNLSGDIP 516 (823)
Q Consensus 493 ~~~~~l~~L~~L~ls~N~l~g~ip 516 (823)
..+..++.|+.|+|++|.+.+...
T Consensus 284 ~~~~~l~~L~~L~L~~Np~~CdC~ 307 (452)
T 3zyi_A 284 DLFTPLRYLVELHLHHNPWNCDCD 307 (452)
T ss_dssp TSSTTCTTCCEEECCSSCEECSTT
T ss_pred HHhccccCCCEEEccCCCcCCCCC
Confidence 889999999999999999987654
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=4.2e-28 Score=273.63 Aligned_cols=251 Identities=20% Similarity=0.226 Sum_probs=224.5
Q ss_pred CccEEEeeccccccccCccccCCCCCCeEEeecccccccCCCccCCCcccCcccccCccccCCCCcccccccccCCCCce
Q 045449 254 NVETLNLGINSFSGTIPSSITNSSKLSDLELGENLFSGFIPNTIGNLRNLEFGNIADNYLTSSTPELSFLSSLTNCKKLK 333 (823)
Q Consensus 254 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~ 333 (823)
....++.+++.++ .+|..+. ++++.|+|++|++++..+..|.++++|++|+|++|.++.. .+..|.++++|+
T Consensus 44 ~~~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i-----~~~~~~~l~~L~ 115 (440)
T 3zyj_A 44 QFSKVICVRKNLR-EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTI-----EIGAFNGLANLN 115 (440)
T ss_dssp TSCEEECCSCCCS-SCCSCCC--TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEE-----CGGGGTTCSSCC
T ss_pred CCCEEEeCCCCcC-cCCCCCC--CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCcc-----ChhhccCCccCC
Confidence 4568889999988 6787665 5899999999999999999999999999999999999886 456789999999
Q ss_pred EEEeecCCCCccCCccccccccccceEEecCCcceeccCccccCcccccEEEcccCcCCCCch-hcccccCCCCEEEccC
Q 045449 334 VLIVTGNPLDGILPKSIGNFSLSLETILMANCSISGNIPQVVGNLSNLLVLELGGNNLTGPIP-VTFSQLQTLQAFDLTR 412 (823)
Q Consensus 334 ~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p-~~~~~l~~L~~L~Ls~ 412 (823)
.|+|++|++++..+..|..+ .+|++|+|++|.++...+..|.++++|++|+|++|+..+.++ ..|.++++|++|+|++
T Consensus 116 ~L~L~~n~l~~~~~~~~~~l-~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~ 194 (440)
T 3zyj_A 116 TLELFDNRLTTIPNGAFVYL-SKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAM 194 (440)
T ss_dssp EEECCSSCCSSCCTTTSCSC-SSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTT
T ss_pred EEECCCCcCCeeCHhHhhcc-ccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCC
Confidence 99999999998877788888 799999999999998888899999999999999955444444 5789999999999999
Q ss_pred CCCCCcchHhhhcCCCCCEEEcccCcCcccccccccCCCCCCeEeccCCccccccchhhhccCCCcEEeccccccccccC
Q 045449 413 NKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSVRVLYLGLNIFTSVLSSTIWNLKDILFIDVSSNFLDGPLS 492 (823)
Q Consensus 413 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~LdLs~N~l~g~~p 492 (823)
|+++. +| .+..+++|+.|+|++|++++..|..|.++++|+.|+|++|++++..+..|..+++|+.|||++|++++..+
T Consensus 195 n~l~~-~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 272 (440)
T 3zyj_A 195 CNLRE-IP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPH 272 (440)
T ss_dssp SCCSS-CC-CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCT
T ss_pred CcCcc-cc-ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccCh
Confidence 99994 45 47889999999999999999889999999999999999999999999999999999999999999998888
Q ss_pred ccccCCCCCcEEEcccCCCCCCC
Q 045449 493 LDIGNLKVVIGLDFSRNNLSGDI 515 (823)
Q Consensus 493 ~~~~~l~~L~~L~ls~N~l~g~i 515 (823)
..+..++.|+.|+|++|.+.+..
T Consensus 273 ~~~~~l~~L~~L~L~~Np~~CdC 295 (440)
T 3zyj_A 273 DLFTPLHHLERIHLHHNPWNCNC 295 (440)
T ss_dssp TTTSSCTTCCEEECCSSCEECSS
T ss_pred hHhccccCCCEEEcCCCCccCCC
Confidence 88899999999999999988654
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.96 E-value=9e-30 Score=274.19 Aligned_cols=267 Identities=18% Similarity=0.136 Sum_probs=189.8
Q ss_pred hhccccccccCCccccccCCCCCcEEEccCCcccccCCcccccCCCCccEEEeeccccccccCccccCCCCCCeEEeecc
Q 045449 208 RLALATNNLVGVVPVTIFNMSALKEISLLNNSLSGSLPSRIDLSLPNVETLNLGINSFSGTIPSSITNSSKLSDLELGEN 287 (823)
Q Consensus 208 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 287 (823)
..+++.+.+....+..+..+++|++|+|++|.+++..|..+. .+++|++|+|++|++++..| +..+++|++|+|++|
T Consensus 14 i~~ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~-~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~n 90 (317)
T 3o53_A 14 IEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLA-PFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNN 90 (317)
T ss_dssp EESCCTTTHHHHHHHHHTTGGGCSEEECTTSCCCCCCHHHHT-TCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECCSS
T ss_pred EeeccccchhhhHHHHhccCCCCCEEECcCCccCcCCHHHhh-CCCcCCEEECCCCcCCcchh--hhhcCCCCEEECcCC
Confidence 334444444433344444455566666666666533333332 35666666666666654443 566666666666666
Q ss_pred cccccCCCccCCCcccCcccccCccccCCCCcccccccccCCCCceEEEeecCCCCccCCccccccccccceEEecCCcc
Q 045449 288 LFSGFIPNTIGNLRNLEFGNIADNYLTSSTPELSFLSSLTNCKKLKVLIVTGNPLDGILPKSIGNFSLSLETILMANCSI 367 (823)
Q Consensus 288 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l 367 (823)
++++..+ .++|++|++++|++++.. ...+++|+.|++++|.+++..|..+..+ ++|++|++++|.+
T Consensus 91 ~l~~l~~-----~~~L~~L~l~~n~l~~~~--------~~~~~~L~~L~l~~N~l~~~~~~~~~~l-~~L~~L~Ls~N~l 156 (317)
T 3o53_A 91 YVQELLV-----GPSIETLHAANNNISRVS--------CSRGQGKKNIYLANNKITMLRDLDEGCR-SRVQYLDLKLNEI 156 (317)
T ss_dssp EEEEEEE-----CTTCCEEECCSSCCSEEE--------ECCCSSCEEEECCSSCCCSGGGBCTGGG-SSEEEEECTTSCC
T ss_pred ccccccC-----CCCcCEEECCCCccCCcC--------ccccCCCCEEECCCCCCCCccchhhhcc-CCCCEEECCCCCC
Confidence 6664432 256666666666666542 1235667888888888887777777777 6888888888888
Q ss_pred eeccCcccc-CcccccEEEcccCcCCCCchhcccccCCCCEEEccCCCCCCcchHhhhcCCCCCEEEcccCcCccccccc
Q 045449 368 SGNIPQVVG-NLSNLLVLELGGNNLTGPIPVTFSQLQTLQAFDLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSC 446 (823)
Q Consensus 368 ~~~~p~~~~-~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~ 446 (823)
++..+..+. .+++|++|+|++|++++. |. ...+++|++|+|++|++++. |..+..+++|+.|+|++|+++ .+|..
T Consensus 157 ~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~-~~~l~~L~~L~Ls~N~l~~l-~~~~~~l~~L~~L~L~~N~l~-~l~~~ 232 (317)
T 3o53_A 157 DTVNFAELAASSDTLEHLNLQYNFIYDV-KG-QVVFAKLKTLDLSSNKLAFM-GPEFQSAAGVTWISLRNNKLV-LIEKA 232 (317)
T ss_dssp CEEEGGGGGGGTTTCCEEECTTSCCCEE-EC-CCCCTTCCEEECCSSCCCEE-CGGGGGGTTCSEEECTTSCCC-EECTT
T ss_pred CcccHHHHhhccCcCCEEECCCCcCccc-cc-ccccccCCEEECCCCcCCcc-hhhhcccCcccEEECcCCccc-chhhH
Confidence 887777664 688999999999999854 33 34588999999999999965 445889999999999999999 57888
Q ss_pred ccCCCCCCeEeccCCccc-cccchhhhccCCCcEEecc-ccccccccCccc
Q 045449 447 LGNLTSVRVLYLGLNIFT-SVLSSTIWNLKDILFIDVS-SNFLDGPLSLDI 495 (823)
Q Consensus 447 ~~~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~LdLs-~N~l~g~~p~~~ 495 (823)
+..+++|+.|+|++|.++ +.+|..+..++.|+.|+++ .+.++|..|...
T Consensus 233 ~~~l~~L~~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~~~~~l~~~~~~~~ 283 (317)
T 3o53_A 233 LRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEEC 283 (317)
T ss_dssp CCCCTTCCEEECTTCCCBHHHHHHHHHTCHHHHHHHHHHHHHHHSSSSCCC
T ss_pred hhcCCCCCEEEccCCCccCcCHHHHHhccccceEEECCCchhccCCchhcc
Confidence 999999999999999999 7888999999999999999 456777766543
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.5e-29 Score=278.53 Aligned_cols=151 Identities=30% Similarity=0.379 Sum_probs=127.8
Q ss_pred ccCCccceeeccC------------CeEEEEEEehHhh--HHHHHHHHHHHHHHhhcchhhHHH----------------
Q 045449 628 DRFSENNLIGIGN------------GMEVAVKVFHQQY--ERALKSFEDECEVRKRIRHRNLVK---------------- 677 (823)
Q Consensus 628 ~~f~~~~~lg~g~------------~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~---------------- 677 (823)
++|...+.||+|+ |+.||||+++... ....+.+.+|++++++++|||||+
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 5788889999996 6779999996543 345578999999999999999997
Q ss_pred -----------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCc
Q 045449 678 -----------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQ 728 (823)
Q Consensus 678 -----------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~ 728 (823)
++.|++.+|+|+|+.+||||||||+|||++.++.+||+|||+|+.+.....
T Consensus 134 ~~ivmE~~~g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~~~ 213 (398)
T 4b99_A 134 VYVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPA 213 (398)
T ss_dssp EEEEEECCSEEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC-----
T ss_pred EEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeecccCcc
Confidence 468999999999999999999999999999999999999999987643221
Q ss_pred --cccccccccCCCcCcccccCCC-ccccccceehhhhhhccccCCCCCcCCC
Q 045449 729 --LSKQTQTLATIGYMAPEYGTKG-RVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 729 --~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
.......+||+.|||||++.+. .|+.++||||+||++|+|++|..||.+.
T Consensus 214 ~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~ 266 (398)
T 4b99_A 214 EHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGK 266 (398)
T ss_dssp --CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCS
T ss_pred ccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCC
Confidence 1233467899999999998775 4699999999999999999999999754
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.95 E-value=3e-27 Score=274.87 Aligned_cols=265 Identities=23% Similarity=0.263 Sum_probs=218.2
Q ss_pred hhhhhccccccccCCccccccCCCCCcEEEccCCcccccCCcccccCCCCccEEEeeccccccccCccccCCCCCCeEEe
Q 045449 205 YLARLALATNNLVGVVPVTIFNMSALKEISLLNNSLSGSLPSRIDLSLPNVETLNLGINSFSGTIPSSITNSSKLSDLEL 284 (823)
Q Consensus 205 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 284 (823)
+++.|++++|+++ .+|..+. ++|++|+|++|.|+ .+|. .+++|++|+|++|+|++ +|. .+++|++|+|
T Consensus 41 ~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~-~lp~----~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~L 108 (622)
T 3g06_A 41 GNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA----LPPELRTLEVSGNQLTS-LPV---LPPGLLELSI 108 (622)
T ss_dssp CCCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCS-CCCC----CCTTCCEEEECSCCCSC-CCC---CCTTCCEEEE
T ss_pred CCcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCC-CCCC----cCCCCCEEEcCCCcCCc-CCC---CCCCCCEEEC
Confidence 4778999999998 5676665 78999999999998 6776 37899999999999984 665 6788999999
Q ss_pred ecccccccCCCccCCCcccCcccccCccccCCCCcccccccccCCCCceEEEeecCCCCccCCccccccccccceEEecC
Q 045449 285 GENLFSGFIPNTIGNLRNLEFGNIADNYLTSSTPELSFLSSLTNCKKLKVLIVTGNPLDGILPKSIGNFSLSLETILMAN 364 (823)
Q Consensus 285 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~ 364 (823)
++|++++. |. .+++|+.|++++|+++..+. .+++|++|++++|.+++. |.. +.+|+.|++++
T Consensus 109 s~N~l~~l-~~---~l~~L~~L~L~~N~l~~lp~---------~l~~L~~L~Ls~N~l~~l-~~~----~~~L~~L~L~~ 170 (622)
T 3g06_A 109 FSNPLTHL-PA---LPSGLCKLWIFGNQLTSLPV---------LPPGLQELSVSDNQLASL-PAL----PSELCKLWAYN 170 (622)
T ss_dssp CSCCCCCC-CC---CCTTCCEEECCSSCCSCCCC---------CCTTCCEEECCSSCCSCC-CCC----CTTCCEEECCS
T ss_pred cCCcCCCC-CC---CCCCcCEEECCCCCCCcCCC---------CCCCCCEEECcCCcCCCc-CCc----cCCCCEEECCC
Confidence 99999875 33 56889999999999988632 248899999999999864 432 26799999999
Q ss_pred CcceeccCccccCcccccEEEcccCcCCCCchhcccccCCCCEEEccCCCCCCcchHhhhcCCCCCEEEcccCcCccccc
Q 045449 365 CSISGNIPQVVGNLSNLLVLELGGNNLTGPIPVTFSQLQTLQAFDLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIP 444 (823)
Q Consensus 365 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p 444 (823)
|.+++ +| ..+++|+.|++++|++++ +|.. +++|+.|++++|.++. +|. .+++|+.|+|++|+|++ +|
T Consensus 171 N~l~~-l~---~~~~~L~~L~Ls~N~l~~-l~~~---~~~L~~L~L~~N~l~~-l~~---~~~~L~~L~Ls~N~L~~-lp 237 (622)
T 3g06_A 171 NQLTS-LP---MLPSGLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRLTS-LPA---LPSGLKELIVSGNRLTS-LP 237 (622)
T ss_dssp SCCSC-CC---CCCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSS-CCC---CCTTCCEEECCSSCCSC-CC
T ss_pred CCCCC-Cc---ccCCCCcEEECCCCCCCC-CCCc---cchhhEEECcCCcccc-cCC---CCCCCCEEEccCCccCc-CC
Confidence 99986 45 457889999999999985 5543 4789999999999984 443 34789999999999996 66
Q ss_pred ccccCCCCCCeEeccCCccccccchhhhccCCCcEEeccccccccccCccccCCCCCcEEEcccCCCCCCCCCccc
Q 045449 445 SCLGNLTSVRVLYLGLNIFTSVLSSTIWNLKDILFIDVSSNFLDGPLSLDIGNLKVVIGLDFSRNNLSGDIPITIG 520 (823)
Q Consensus 445 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~~ 520 (823)
..+++|+.|+|++|.|++ +|. .+++|+.|+|++|.|+ .+|..+.+++.|+.|+|++|+++|.+|..+.
T Consensus 238 ---~~l~~L~~L~Ls~N~L~~-lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L~~N~l~~~~~~~l~ 305 (622)
T 3g06_A 238 ---VLPSELKELMVSGNRLTS-LPM---LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALR 305 (622)
T ss_dssp ---CCCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEECCSCCCCHHHHHHHH
T ss_pred ---CCCCcCcEEECCCCCCCc-CCc---ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEecCCCCCCcCHHHHH
Confidence 456889999999999996 444 6788999999999999 7898999999999999999999988777553
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.95 E-value=9.7e-31 Score=307.14 Aligned_cols=431 Identities=15% Similarity=0.181 Sum_probs=279.9
Q ss_pred CCccceeeeeCCCCCcEEEEEcCCCCCccccCcccCCCCCCcEEEccCCCCC---CCCCCCC------------CCCCCC
Q 045449 38 SVCIWIGITCDVNSHRVIGLNISSFNLQGTITPQLGNLSSLQTLDLSHNKLS---GNIPSSI------------FNMHTL 102 (823)
Q Consensus 38 ~~c~w~gv~c~~~~~~v~~L~L~~~~l~g~~~~~l~~l~~L~~L~Ls~N~l~---g~~p~~~------------~~l~~L 102 (823)
-|++|.++.. .....++++..... .....+..+++|++|+|+++... +..|..+ ..+++|
T Consensus 33 vck~W~~~~~----~~~~~l~~~~~~~~-~~~~~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~~l~~l~~~~~~L 107 (594)
T 2p1m_B 33 VCKSWYEIER----WCRRKVFIGNCYAV-SPATVIRRFPKVRSVELKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYTWL 107 (594)
T ss_dssp SCHHHHHHHH----HHCCEEEESSTTSS-CHHHHHHHCTTCCEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTC
T ss_pred HHHHHHHhhh----hhceEEeecccccc-CHHHHHhhCCCceEEeccCCCchhhcccccccccchhhHHHHHHHHhCCCC
Confidence 3567998832 12345566543322 11233567788999999987632 1223222 357889
Q ss_pred CEEECCCCcCcCCCchhhh-cCCCCcEEecccc-cccCc-cCccccCCCCCCccccccceeeeccceeeccCccccccch
Q 045449 103 KLLDFSDNQLFGSLSSFIF-NMSSMTTIDLSIN-RLSGE-LPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKEIGNLT 179 (823)
Q Consensus 103 ~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~Ls~N-~l~~~-~p~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~ 179 (823)
++|+|++|.+++..+..+. .+++|++|+|++| .++.. ++. + +.++++|++|+|++|.+++..+..+..
T Consensus 108 ~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~-~------~~~~~~L~~L~L~~~~i~~~~~~~l~~-- 178 (594)
T 2p1m_B 108 EEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAA-I------AATCRNLKELDLRESDVDDVSGHWLSH-- 178 (594)
T ss_dssp CEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHH-H------HHHCTTCCEEECTTCEEECCCGGGGGG--
T ss_pred CeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHH-H------HHhCCCCCEEeCcCCccCCcchHHHHH--
Confidence 9999999998887777776 7899999999988 45432 222 1 257889999999999988655443321
Q ss_pred hhHHHHHhhcCCCcccCCcccCCcchhhhhcccccc--ccCC-ccccccCCCCCcEEEccCC-cccccCCcccccCCCCc
Q 045449 180 KLKEIISTITNSTVCEIPREIGNLPYLARLALATNN--LVGV-VPVTIFNMSALKEISLLNN-SLSGSLPSRIDLSLPNV 255 (823)
Q Consensus 180 ~L~~L~~l~~n~~~~~ip~~l~~l~~L~~L~Ls~N~--l~~~-~p~~~~~l~~L~~L~Ls~N-~l~g~lp~~~~~~l~~L 255 (823)
....+++|+.|+++.|. ++.. ++..+.++++|++|+|++| .++ .+|..+.. +++|
T Consensus 179 -------------------~~~~~~~L~~L~l~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~-~l~~~~~~-~~~L 237 (594)
T 2p1m_B 179 -------------------FPDTYTSLVSLNISCLASEVSFSALERLVTRCPNLKSLKLNRAVPLE-KLATLLQR-APQL 237 (594)
T ss_dssp -------------------SCTTCCCCCEEECTTCCSCCCHHHHHHHHHHCTTCCEEECCTTSCHH-HHHHHHHH-CTTC
T ss_pred -------------------HhhcCCcCcEEEecccCCcCCHHHHHHHHHhCCCCcEEecCCCCcHH-HHHHHHhc-CCcc
Confidence 22345677788888776 2211 1122235688888888887 444 35555544 7888
Q ss_pred cEEEe-------eccccccccCccccCCCCCCeE-EeecccccccCCCccCCCcccCcccccCccccCCCCccccccccc
Q 045449 256 ETLNL-------GINSFSGTIPSSITNSSKLSDL-ELGENLFSGFIPNTIGNLRNLEFGNIADNYLTSSTPELSFLSSLT 327 (823)
Q Consensus 256 ~~L~L-------s~N~l~~~~p~~~~~l~~L~~L-~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~ 327 (823)
++|++ +.|.+.+ ++..+.++++|+.| .+.+... +.++..+..+++|+.|+|++|.+++.. +...+.
T Consensus 238 ~~L~l~~~~~~~~~~~~~~-l~~~l~~~~~L~~Ls~~~~~~~-~~l~~~~~~~~~L~~L~L~~~~l~~~~----l~~~~~ 311 (594)
T 2p1m_B 238 EELGTGGYTAEVRPDVYSG-LSVALSGCKELRCLSGFWDAVP-AYLPAVYSVCSRLTTLNLSYATVQSYD----LVKLLC 311 (594)
T ss_dssp SEEECSBCCCCCCHHHHHH-HHHHHHTCTTCCEEECCBTCCG-GGGGGGHHHHTTCCEEECTTCCCCHHH----HHHHHT
T ss_pred eEcccccccCccchhhHHH-HHHHHhcCCCcccccCCcccch-hhHHHHHHhhCCCCEEEccCCCCCHHH----HHHHHh
Confidence 88884 4444554 34467788888887 3433322 234555556788888888888865431 223356
Q ss_pred CCCCceEEEeecCCCCcc-CCccccccccccceEEe---------cCCcceeccCcccc-CcccccEEEcccCcCCCCch
Q 045449 328 NCKKLKVLIVTGNPLDGI-LPKSIGNFSLSLETILM---------ANCSISGNIPQVVG-NLSNLLVLELGGNNLTGPIP 396 (823)
Q Consensus 328 ~l~~L~~L~Ls~N~l~~~-~p~~~~~~~~~L~~L~L---------~~N~l~~~~p~~~~-~l~~L~~L~Ls~N~l~g~~p 396 (823)
.+++|+.|++++| +... ++.....+ ++|++|++ +.+.+++.....+. ++++|+.|+++.|++++..+
T Consensus 312 ~~~~L~~L~l~~~-~~~~~l~~l~~~~-~~L~~L~L~~~~~~g~~~~~~l~~~~l~~l~~~~~~L~~L~~~~~~l~~~~~ 389 (594)
T 2p1m_B 312 QCPKLQRLWVLDY-IEDAGLEVLASTC-KDLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAAL 389 (594)
T ss_dssp TCTTCCEEEEEGG-GHHHHHHHHHHHC-TTCCEEEEECSCTTCSSCSSCCCHHHHHHHHHHCTTCCEEEEEESCCCHHHH
T ss_pred cCCCcCEEeCcCc-cCHHHHHHHHHhC-CCCCEEEEecCcccccccCCCCCHHHHHHHHHhchhHHHHHHhcCCcCHHHH
Confidence 7788888888877 4322 12222234 57888887 33455544333333 47888888888888887665
Q ss_pred hccc-ccCCCCEEEcc--C----CCCCCc-----chHhhhcCCCCCEEEcccCcCcccccccccC-CCCCCeEeccCCcc
Q 045449 397 VTFS-QLQTLQAFDLT--R----NKLAGP-----ITDELCHLARLHSLVLQGNKFSGSIPSCLGN-LTSVRVLYLGLNIF 463 (823)
Q Consensus 397 ~~~~-~l~~L~~L~Ls--~----N~l~~~-----~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~-l~~L~~L~Ls~N~l 463 (823)
..+. .+++|+.|+|+ + |.+++. ++..+..+++|+.|+|++ .+++..+..+.. +++|+.|+|++|.+
T Consensus 390 ~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i 468 (594)
T 2p1m_B 390 ITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGD 468 (594)
T ss_dssp HHHHHHCTTCCEEEEEESSTTCCCTTTCCCTHHHHHHHHHHCTTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCS
T ss_pred HHHHhhCCCcceeEeecccCCCcccccCCchhhHHHHHHhhCCCccEEeecC-cccHHHHHHHHHhchhccEeeccCCCC
Confidence 5554 57888888888 4 566632 223356778888888876 666665555655 78888888888888
Q ss_pred ccccchhh-hccCCCcEEeccccccccccCc-cccCCCCCcEEEcccCCCC
Q 045449 464 TSVLSSTI-WNLKDILFIDVSSNFLDGPLSL-DIGNLKVVIGLDFSRNNLS 512 (823)
Q Consensus 464 ~~~~p~~~-~~l~~L~~LdLs~N~l~g~~p~-~~~~l~~L~~L~ls~N~l~ 512 (823)
++..+..+ ..+++|+.|+|++|.+++.... ....++.|+.|++++|+++
T Consensus 469 ~~~~~~~l~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~~ 519 (594)
T 2p1m_B 469 SDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSCSVS 519 (594)
T ss_dssp SHHHHHHHHHHCTTCCEEEEESCSCCHHHHHHTGGGGGGSSEEEEESSCCB
T ss_pred cHHHHHHHHhcCCCcCEEECcCCCCcHHHHHHHHHhCCCCCEEeeeCCCCC
Confidence 77666555 6688888888888888665443 3455788888888888774
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.95 E-value=3e-28 Score=277.56 Aligned_cols=234 Identities=20% Similarity=0.163 Sum_probs=164.4
Q ss_pred CCcEEEccCCcccccCCcccccCCCCccEEEeeccccccccCccccCCCCCCeEEeecccccccCCCccCCCcccCcccc
Q 045449 229 ALKEISLLNNSLSGSLPSRIDLSLPNVETLNLGINSFSGTIPSSITNSSKLSDLELGENLFSGFIPNTIGNLRNLEFGNI 308 (823)
Q Consensus 229 ~L~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 308 (823)
+|++|+|++|.+++..|..+. .+++|++|+|++|.+++..| +..+++|++|+|++|.+++..+. ++|++|++
T Consensus 35 ~L~~L~Ls~n~l~~~~~~~~~-~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~~-----~~L~~L~L 106 (487)
T 3oja_A 35 NVKELDLSGNPLSQISAADLA-PFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLVG-----PSIETLHA 106 (487)
T ss_dssp GCCEEECCSSCCCCCCGGGGT-TCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEEEC-----TTCCEEEC
T ss_pred CccEEEeeCCcCCCCCHHHHh-CCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCCCC-----CCcCEEEC
Confidence 444444444444432222222 24445555555555444333 45555555555555555543321 55666666
Q ss_pred cCccccCCCCcccccccccCCCCceEEEeecCCCCccCCccccccccccceEEecCCcceeccCcccc-CcccccEEEcc
Q 045449 309 ADNYLTSSTPELSFLSSLTNCKKLKVLIVTGNPLDGILPKSIGNFSLSLETILMANCSISGNIPQVVG-NLSNLLVLELG 387 (823)
Q Consensus 309 ~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~Ls 387 (823)
++|.+++.+ + ..+++|+.|+|++|.+++..|..++.+ ++|++|+|++|.+++..|..+. .+++|++|+|+
T Consensus 107 ~~N~l~~~~-----~---~~l~~L~~L~L~~N~l~~~~~~~~~~l-~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls 177 (487)
T 3oja_A 107 ANNNISRVS-----C---SRGQGKKNIYLANNKITMLRDLDEGCR-SRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQ 177 (487)
T ss_dssp CSSCCCCEE-----E---CCCSSCEEEECCSSCCCSGGGBCGGGG-SSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECT
T ss_pred cCCcCCCCC-----c---cccCCCCEEECCCCCCCCCCchhhcCC-CCCCEEECCCCCCCCcChHHHhhhCCcccEEecC
Confidence 666665541 1 234667788888888887777777777 6888888888888888887776 78899999999
Q ss_pred cCcCCCCchhcccccCCCCEEEccCCCCCCcchHhhhcCCCCCEEEcccCcCcccccccccCCCCCCeEeccCCccc-cc
Q 045449 388 GNNLTGPIPVTFSQLQTLQAFDLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSVRVLYLGLNIFT-SV 466 (823)
Q Consensus 388 ~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~-~~ 466 (823)
+|.+++..+ +..+++|++|+|++|+|++.+| .+..+++|+.|+|++|.|++ +|..+..+++|+.|++++|.++ +.
T Consensus 178 ~N~l~~~~~--~~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N~l~c~~ 253 (487)
T 3oja_A 178 YNFIYDVKG--QVVFAKLKTLDLSSNKLAFMGP-EFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGT 253 (487)
T ss_dssp TSCCCEEEC--CCCCTTCCEEECCSSCCCEECG-GGGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCBCHHH
T ss_pred CCccccccc--cccCCCCCEEECCCCCCCCCCH-hHcCCCCccEEEecCCcCcc-cchhhccCCCCCEEEcCCCCCcCcc
Confidence 999986532 3458899999999999997555 48889999999999999995 7888899999999999999998 77
Q ss_pred cchhhhccCCCcEEecc
Q 045449 467 LSSTIWNLKDILFIDVS 483 (823)
Q Consensus 467 ~p~~~~~l~~L~~LdLs 483 (823)
+|..+..++.|+.++++
T Consensus 254 ~~~~~~~l~~L~~l~~~ 270 (487)
T 3oja_A 254 LRDFFSKNQRVQTVAKQ 270 (487)
T ss_dssp HHHHHTTCHHHHHHHHH
T ss_pred hHHHHHhCCCCcEEecc
Confidence 88888888888888886
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=3.2e-29 Score=266.97 Aligned_cols=149 Identities=28% Similarity=0.336 Sum_probs=112.9
Q ss_pred ccCCccceeeccC----------CeEEEEEEehHhhHHHHHHHHHHHHHHhhcchhhHHH--------------------
Q 045449 628 DRFSENNLIGIGN----------GMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVK-------------------- 677 (823)
Q Consensus 628 ~~f~~~~~lg~g~----------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-------------------- 677 (823)
+++...+.||+|+ |+.||||++....... ..++.|+..+.+++|||||+
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~~g~~VAvK~l~~~~~~~-~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~E 81 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERS-WFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD 81 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTEEEEEEEECGGGHHH-HHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccchhh-HHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEec
Confidence 3455667888886 6789999997654322 33456677778899999998
Q ss_pred -----------------------HHHHHHHHhhhcCCC--------CEEeccCCCCCEEeCCCCcEEEeecccccccCCC
Q 045449 678 -----------------------IISSSLEYLHFGHSI--------PIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGE 726 (823)
Q Consensus 678 -----------------------~~~~~l~~L~~~h~~--------~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~ 726 (823)
++.|++.+|+|+|+. +||||||||+|||++.++.+||+|||+|+.....
T Consensus 82 y~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~ 161 (303)
T 3hmm_A 82 YHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSA 161 (303)
T ss_dssp CCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEETT
T ss_pred CCCCCcHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccccCC
Confidence 244666666666654 9999999999999999999999999999876544
Q ss_pred Ccc--ccccccccCCCcCcccccCCC------ccccccceehhhhhhccccCCCCCcCC
Q 045449 727 DQL--SKQTQTLATIGYMAPEYGTKG------RVSTRGDVCSFGIISGGKETRSMTVGE 777 (823)
Q Consensus 727 ~~~--~~~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~S~Gvv~~~~~~~~~~~~~ 777 (823)
... ......+||+.|||||++.+. .|+.++|||||||++||+++|..|+..
T Consensus 162 ~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~ 220 (303)
T 3hmm_A 162 TDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI 220 (303)
T ss_dssp TTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTB
T ss_pred CCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCc
Confidence 322 122346899999999998654 478899999999999999999876643
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=99.94 E-value=2e-28 Score=280.76 Aligned_cols=146 Identities=25% Similarity=0.243 Sum_probs=123.4
Q ss_pred ccCCccceeeccC------------CeEEEEEEehHhhH------HHHHHHHHHHHHHhhcchhhHHH------------
Q 045449 628 DRFSENNLIGIGN------------GMEVAVKVFHQQYE------RALKSFEDECEVRKRIRHRNLVK------------ 677 (823)
Q Consensus 628 ~~f~~~~~lg~g~------------~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~------------ 677 (823)
++|...+.||+|+ |+.||||++.+... ........++++++.++|||||+
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly 268 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 268 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence 5788889999997 67799999975431 12223344567777889999998
Q ss_pred ----------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCcc
Q 045449 678 ----------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQL 729 (823)
Q Consensus 678 ----------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~ 729 (823)
+++|++.+|+|+|+.|||||||||+|||++.+|++||+|||+|+......
T Consensus 269 lVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~~-- 346 (689)
T 3v5w_A 269 FILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-- 346 (689)
T ss_dssp EEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCC--
T ss_pred EEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeecCCCC--
Confidence 47899999999999999999999999999999999999999999765432
Q ss_pred ccccccccCCCcCcccccCC-CccccccceehhhhhhccccCCCCCcCC
Q 045449 730 SKQTQTLATIGYMAPEYGTK-GRVSTRGDVCSFGIISGGKETRSMTVGE 777 (823)
Q Consensus 730 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~ 777 (823)
..+.+||+.|||||++.+ ..|+.++||||+||++|+|++|..||.+
T Consensus 347 --~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~ 393 (689)
T 3v5w_A 347 --PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQ 393 (689)
T ss_dssp --CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCG
T ss_pred --CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 345689999999999965 5799999999999999999999999965
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.1e-28 Score=268.84 Aligned_cols=151 Identities=23% Similarity=0.236 Sum_probs=123.6
Q ss_pred HHhccCCccceeeccC---------------CeEEEEEEehHhhHHHHHHHHHHHHHHhhc-chhhHHH-----------
Q 045449 625 RATDRFSENNLIGIGN---------------GMEVAVKVFHQQYERALKSFEDECEVRKRI-RHRNLVK----------- 677 (823)
Q Consensus 625 ~at~~f~~~~~lg~g~---------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~----------- 677 (823)
+..++|...+.||+|+ ++.||||++..... ..++.+|++++.++ +|||||+
T Consensus 18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~--~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~ 95 (361)
T 4f9c_A 18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH--PIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV 95 (361)
T ss_dssp GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC--HHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC--HHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence 4567899999999996 34599998865432 24688999999998 6999998
Q ss_pred --------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCC-CcEEEeecccccccCCCCc--
Q 045449 678 --------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDED-MVAHISDFGIAKLLSGEDQ-- 728 (823)
Q Consensus 678 --------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~-~~~kl~DfGla~~~~~~~~-- 728 (823)
++.|++.+|+|+|+.||+||||||+|||++.+ +.+||+|||+|+.......
T Consensus 96 ~lvmE~~~g~~L~~~~~~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~~~ 175 (361)
T 4f9c_A 96 VIAMPYLEHESFLDILNSLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIEL 175 (361)
T ss_dssp EEEEECCCCCCHHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSCGG
T ss_pred EEEEeCCCcccHHHHHcCCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCccccc
Confidence 47899999999999999999999999999876 7999999999986543211
Q ss_pred ------------------------cccccccccCCCcCcccccCCC-ccccccceehhhhhhccccCCCCCcCC
Q 045449 729 ------------------------LSKQTQTLATIGYMAPEYGTKG-RVSTRGDVCSFGIISGGKETRSMTVGE 777 (823)
Q Consensus 729 ------------------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvv~~~~~~~~~~~~~ 777 (823)
....+..+||+.|||||++.+. .|+.++||||+||++|+|++|+.||..
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~ 249 (361)
T 4f9c_A 176 LKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYK 249 (361)
T ss_dssp GGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSC
T ss_pred cccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCC
Confidence 0112345799999999998775 489999999999999999999999854
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.4e-26 Score=243.28 Aligned_cols=219 Identities=21% Similarity=0.284 Sum_probs=144.1
Q ss_pred CCCccceeeeeCCCCCcEEEEEcCCCCCccccCcccCCCCCCcEEEccCCCCCCCCCCCCCCCCCCCEEECCCCcCcCCC
Q 045449 37 TSVCIWIGITCDVNSHRVIGLNISSFNLQGTITPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLDFSDNQLFGSL 116 (823)
Q Consensus 37 ~~~c~w~gv~c~~~~~~v~~L~L~~~~l~g~~~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~ 116 (823)
.++|.|.|+.|+.. ..++.+++++++++. +|..+. ++|++|+|++|+|++..+..|.++++|++|+|++|.|+...
T Consensus 2 ~~~C~~~~~~C~c~-~~~~~l~~~~~~l~~-ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~ 77 (270)
T 2o6q_A 2 EALCKKDGGVCSCN-NNKNSVDCSSKKLTA-IPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLP 77 (270)
T ss_dssp CCCBGGGTCSBEEE-TTTTEEECTTSCCSS-CCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCC
T ss_pred CccCCCCCCCCEeC-CCCCEEEccCCCCCc-cCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeC
Confidence 47899999998643 346789999999884 666554 67899999999998777778889999999999999988776
Q ss_pred chhhhcCCCCcEEecccccccCccCccccCCCCCCccccccceeeeccceeeccCccccccchhhHHHHHhhcCCCcccC
Q 045449 117 SSFIFNMSSMTTIDLSINRLSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKEIGNLTKLKEIISTITNSTVCEI 196 (823)
Q Consensus 117 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~~l~~n~~~~~i 196 (823)
+..|.++++|++|+|++|++++..+.. |..+++|++|+|++|++++..+.
T Consensus 78 ~~~~~~l~~L~~L~l~~n~l~~~~~~~-------~~~l~~L~~L~l~~n~l~~~~~~----------------------- 127 (270)
T 2o6q_A 78 AGIFKELKNLETLWVTDNKLQALPIGV-------FDQLVNLAELRLDRNQLKSLPPR----------------------- 127 (270)
T ss_dssp TTTTSSCTTCCEEECCSSCCCCCCTTT-------TTTCSSCCEEECCSSCCCCCCTT-----------------------
T ss_pred hhhhcCCCCCCEEECCCCcCCcCCHhH-------cccccCCCEEECCCCccCeeCHH-----------------------
Confidence 777788888888888888887433322 36777788888887777643222
Q ss_pred CcccCCcchhhhhccccccccCCccccccCCCCCcEEEccCCcccccCCcccccCCCCccEEEeeccccccccCccccCC
Q 045449 197 PREIGNLPYLARLALATNNLVGVVPVTIFNMSALKEISLLNNSLSGSLPSRIDLSLPNVETLNLGINSFSGTIPSSITNS 276 (823)
Q Consensus 197 p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 276 (823)
.|..+++|++|+|++|++++..+..|..++ +|++|+|++|++++..+..|.++
T Consensus 128 --~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~-------------------------~L~~L~L~~n~l~~~~~~~~~~l 180 (270)
T 2o6q_A 128 --VFDSLTKLTYLSLGYNELQSLPKGVFDKLT-------------------------SLKELRLYNNQLKRVPEGAFDKL 180 (270)
T ss_dssp --TTTTCTTCCEEECCSSCCCCCCTTTTTTCT-------------------------TCCEEECCSSCCSCCCTTTTTTC
T ss_pred --HhCcCcCCCEEECCCCcCCccCHhHccCCc-------------------------ccceeEecCCcCcEeChhHhccC
Confidence 223334445555555555544444444444 44555555554444444445555
Q ss_pred CCCCeEEeecccccccCCCccCCCcccCcccccCccccCC
Q 045449 277 SKLSDLELGENLFSGFIPNTIGNLRNLEFGNIADNYLTSS 316 (823)
Q Consensus 277 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 316 (823)
++|++|+|++|++++..+..|..+++|+.|+|++|.+...
T Consensus 181 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 220 (270)
T 2o6q_A 181 TELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDCT 220 (270)
T ss_dssp TTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCS
T ss_pred CCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCeeCC
Confidence 5555555555555555444555555555566655555543
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.3e-29 Score=295.43 Aligned_cols=423 Identities=14% Similarity=0.116 Sum_probs=300.6
Q ss_pred CcEEEEEcCCCCCccc---cCc------------ccCCCCCCcEEEccCCCCCCCCCCCCC-CCCCCCEEECCCC-cCcC
Q 045449 52 HRVIGLNISSFNLQGT---ITP------------QLGNLSSLQTLDLSHNKLSGNIPSSIF-NMHTLKLLDFSDN-QLFG 114 (823)
Q Consensus 52 ~~v~~L~L~~~~l~g~---~~~------------~l~~l~~L~~L~Ls~N~l~g~~p~~~~-~l~~L~~L~Ls~N-~l~~ 114 (823)
.+++.|+|+++..... .|. ....+++|++|+|++|.+++..+..+. .+++|++|+|++| .++.
T Consensus 66 ~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~ 145 (594)
T 2p1m_B 66 PKVRSVELKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFST 145 (594)
T ss_dssp TTCCEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEH
T ss_pred CCceEEeccCCCchhhcccccccccchhhHHHHHHHHhCCCCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCH
Confidence 4688899988753211 111 124678999999999999877666665 6899999999999 5654
Q ss_pred C-CchhhhcCCCCcEEecccccccCccCccccCCCCCCccccccceeeeccceeeccCccccccchhhHHHHHhhcCCCc
Q 045449 115 S-LSSFIFNMSSMTTIDLSINRLSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKEIGNLTKLKEIISTITNSTV 193 (823)
Q Consensus 115 ~-~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~~l~~n~~~ 193 (823)
. ++..+.++++|++|+|++|.+++..+..+..++ ..+++|++|+|++|. +.+.. ..+..+
T Consensus 146 ~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~---~~~~~L~~L~l~~~~--~~~~~-----~~l~~l--------- 206 (594)
T 2p1m_B 146 DGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFP---DTYTSLVSLNISCLA--SEVSF-----SALERL--------- 206 (594)
T ss_dssp HHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSC---TTCCCCCEEECTTCC--SCCCH-----HHHHHH---------
T ss_pred HHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHh---hcCCcCcEEEecccC--CcCCH-----HHHHHH---------
Confidence 3 455566899999999999999876666553333 467899999999997 22221 112222
Q ss_pred ccCCcccCCcchhhhhccccc-cccCCccccccCCCCCcEEEccCC-------cccccCCcccccCCCCccEE-Eeeccc
Q 045449 194 CEIPREIGNLPYLARLALATN-NLVGVVPVTIFNMSALKEISLLNN-------SLSGSLPSRIDLSLPNVETL-NLGINS 264 (823)
Q Consensus 194 ~~ip~~l~~l~~L~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~Ls~N-------~l~g~lp~~~~~~l~~L~~L-~Ls~N~ 264 (823)
+.++++|++|++++| .+.+ +|..+.++++|++|+++.+ .+++ ++..+. .+++|+.| .+....
T Consensus 207 ------~~~~~~L~~L~L~~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~-l~~~l~-~~~~L~~Ls~~~~~~ 277 (594)
T 2p1m_B 207 ------VTRCPNLKSLKLNRAVPLEK-LATLLQRAPQLEELGTGGYTAEVRPDVYSG-LSVALS-GCKELRCLSGFWDAV 277 (594)
T ss_dssp ------HHHCTTCCEEECCTTSCHHH-HHHHHHHCTTCSEEECSBCCCCCCHHHHHH-HHHHHH-TCTTCCEEECCBTCC
T ss_pred ------HHhCCCCcEEecCCCCcHHH-HHHHHhcCCcceEcccccccCccchhhHHH-HHHHHh-cCCCcccccCCcccc
Confidence 123567889999988 4444 7778888899999985544 4442 444443 48889988 444333
Q ss_pred cccccCccccCCCCCCeEEeecccccccCC-CccCCCcccCcccccCccccCCCCcccccccccCCCCceEEEeec----
Q 045449 265 FSGTIPSSITNSSKLSDLELGENLFSGFIP-NTIGNLRNLEFGNIADNYLTSSTPELSFLSSLTNCKKLKVLIVTG---- 339 (823)
Q Consensus 265 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~---- 339 (823)
. +.+|..+..+++|++|+|++|.+++... ..+..+++|+.|++++| ++.. .+......+++|+.|++++
T Consensus 278 ~-~~l~~~~~~~~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~~----~l~~l~~~~~~L~~L~L~~~~~~ 351 (594)
T 2p1m_B 278 P-AYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IEDA----GLEVLASTCKDLRELRVFPSEPF 351 (594)
T ss_dssp G-GGGGGGHHHHTTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GHHH----HHHHHHHHCTTCCEEEEECSCTT
T ss_pred h-hhHHHHHHhhCCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cCHH----HHHHHHHhCCCCCEEEEecCccc
Confidence 2 3456666678899999999998775432 33567899999999988 4321 1222334588999999843
Q ss_pred -----CCCCccCCccccc-cccccceEEecCCcceeccCcccc-CcccccEEEcc--c----CcCCCC-----chhcccc
Q 045449 340 -----NPLDGILPKSIGN-FSLSLETILMANCSISGNIPQVVG-NLSNLLVLELG--G----NNLTGP-----IPVTFSQ 401 (823)
Q Consensus 340 -----N~l~~~~p~~~~~-~~~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~Ls--~----N~l~g~-----~p~~~~~ 401 (823)
+.+++.....+.. + ++|++|.++.|.+++..+..+. .+++|+.|+|+ + |++++. ++..+..
T Consensus 352 g~~~~~~l~~~~l~~l~~~~-~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~ 430 (594)
T 2p1m_B 352 VMEPNVALTEQGLVSVSMGC-PKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEH 430 (594)
T ss_dssp CSSCSSCCCHHHHHHHHHHC-TTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCCCTHHHHHHHHHH
T ss_pred ccccCCCCCHHHHHHHHHhc-hhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccCCchhhHHHHHHhh
Confidence 5555433333332 4 6899999999999877666665 58999999999 4 666632 2233677
Q ss_pred cCCCCEEEccCCCCCCcchHhhhc-CCCCCEEEcccCcCcccccccc-cCCCCCCeEeccCCccccccch-hhhccCCCc
Q 045449 402 LQTLQAFDLTRNKLAGPITDELCH-LARLHSLVLQGNKFSGSIPSCL-GNLTSVRVLYLGLNIFTSVLSS-TIWNLKDIL 478 (823)
Q Consensus 402 l~~L~~L~Ls~N~l~~~~p~~~~~-l~~L~~L~Ls~N~l~g~~p~~~-~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~ 478 (823)
+++|+.|+|++ .+++..+..+.. +++|+.|+|++|.+++..+..+ ..+++|+.|+|++|.+++.... .+..+++|+
T Consensus 431 ~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~ 509 (594)
T 2p1m_B 431 CKDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMR 509 (594)
T ss_dssp CTTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCHHHHHHTGGGGGGSS
T ss_pred CCCccEEeecC-cccHHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcHHHHHHHHHhCCCCC
Confidence 89999999987 787776666665 8999999999999987766655 6789999999999999765554 445689999
Q ss_pred EEeccccccccccCccc-cCCCCCcEEEcccCC
Q 045449 479 FIDVSSNFLDGPLSLDI-GNLKVVIGLDFSRNN 510 (823)
Q Consensus 479 ~LdLs~N~l~g~~p~~~-~~l~~L~~L~ls~N~ 510 (823)
.|++++|.++......+ ..++.|+...+..+.
T Consensus 510 ~L~l~~~~~~~~~~~~l~~~lp~l~i~~~~~~~ 542 (594)
T 2p1m_B 510 SLWMSSCSVSFGACKLLGQKMPKLNVEVIDERG 542 (594)
T ss_dssp EEEEESSCCBHHHHHHHHHHCTTEEEEEECSSS
T ss_pred EEeeeCCCCCHHHHHHHHHhCCCCEEEEecCCC
Confidence 99999999965544444 456777666665543
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=99.94 E-value=4.8e-28 Score=279.78 Aligned_cols=149 Identities=23% Similarity=0.310 Sum_probs=131.5
Q ss_pred hccCCccceeeccC------------CeEEEEEEehHhhHHHHHHHHHHHHHHhhcchhhHHH-----------------
Q 045449 627 TDRFSENNLIGIGN------------GMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVK----------------- 677 (823)
Q Consensus 627 t~~f~~~~~lg~g~------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~----------------- 677 (823)
.++|...+.||+|+ |+.||||++........+.+.+|+++|++++|||||+
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 36788889999986 6779999997666566678999999999999999998
Q ss_pred ------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCC--CcEEEeecccccccCCCCcccc
Q 045449 678 ------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDED--MVAHISDFGIAKLLSGEDQLSK 731 (823)
Q Consensus 678 ------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~--~~~kl~DfGla~~~~~~~~~~~ 731 (823)
+++|++++|+|+|+++|+||||||+|||++.+ +.+||+|||+|+.+.....
T Consensus 236 ~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~--- 312 (573)
T 3uto_A 236 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS--- 312 (573)
T ss_dssp CCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSE---
T ss_pred cCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCCc---
Confidence 46899999999999999999999999999854 8999999999998754432
Q ss_pred ccccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCCC
Q 045449 732 QTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 732 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
....+||+.|||||++.+..|+.++||||+||++|+|++|..||.+.
T Consensus 313 ~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~ 359 (573)
T 3uto_A 313 VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGE 359 (573)
T ss_dssp EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCS
T ss_pred eeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 34568999999999999999999999999999999999999999764
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1e-25 Score=237.38 Aligned_cols=229 Identities=17% Similarity=0.191 Sum_probs=106.1
Q ss_pred EEEccCCcccccCCcccccCCCCccEEEeeccccccccCccccCCCCCCeEEeecccccccCCCccCCCcccCcccccCc
Q 045449 232 EISLLNNSLSGSLPSRIDLSLPNVETLNLGINSFSGTIPSSITNSSKLSDLELGENLFSGFIPNTIGNLRNLEFGNIADN 311 (823)
Q Consensus 232 ~L~Ls~N~l~g~lp~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 311 (823)
.++..+..++ .+|..+. ++|++|+|++|++++..+..|.++++|++|+|++|++++..+..|..+++|++|+|++|
T Consensus 11 ~~~c~~~~l~-~ip~~l~---~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n 86 (276)
T 2z62_A 11 TYQCMELNFY-KIPDNLP---FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGN 86 (276)
T ss_dssp EEECTTSCCS-SCCSSSC---TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTC
T ss_pred eEEecCCCcc-ccCCCCC---CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCC
Confidence 3444555554 4554332 34555555555555544445555555555555555555444444444444444333333
Q ss_pred cccCCCCcccccccccCCCCceEEEeecCCCCccCCccccccccccceEEecCCcceeccCccccCcccccEEEcccCcC
Q 045449 312 YLTSSTPELSFLSSLTNCKKLKVLIVTGNPLDGILPKSIGNFSLSLETILMANCSISGNIPQVVGNLSNLLVLELGGNNL 391 (823)
Q Consensus 312 ~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 391 (823)
.+ ++..|..+.++ .+|++|++++|.+++..+..+..+++|++|++++|++
T Consensus 87 ~l-----------------------------~~~~~~~~~~l-~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l 136 (276)
T 2z62_A 87 PI-----------------------------QSLALGAFSGL-SSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLI 136 (276)
T ss_dssp CC-----------------------------CEECTTTTTTC-TTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCC
T ss_pred cc-----------------------------CccChhhhcCC-ccccEEECCCCCccccCchhcccCCCCCEEECcCCcc
Confidence 33 33223333333 2333333333333333333344444444444444444
Q ss_pred CCC-chhcccccCCCCEEEccCCCCCCcchHhhhcCCCCCEEEcccCcCcccccccccCCCCCC-eEeccCCccccccch
Q 045449 392 TGP-IPVTFSQLQTLQAFDLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSVR-VLYLGLNIFTSVLSS 469 (823)
Q Consensus 392 ~g~-~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~-~L~Ls~N~l~~~~p~ 469 (823)
++. +|..|..+++|++|+|++|++++..+..+..+.+|+ .|. .|++++|.+++..+.
T Consensus 137 ~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~---------------------~l~l~L~ls~n~l~~~~~~ 195 (276)
T 2z62_A 137 QSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMP---------------------LLNLSLDLSLNPMNFIQPG 195 (276)
T ss_dssp CCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCT---------------------TCCEEEECCSSCCCEECTT
T ss_pred ceecCchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhcc---------------------ccceeeecCCCcccccCcc
Confidence 432 344444444444444444444444333333333333 000 445555555443333
Q ss_pred hhhccCCCcEEeccccccccccCccccCCCCCcEEEcccCCCCCCCC
Q 045449 470 TIWNLKDILFIDVSSNFLDGPLSLDIGNLKVVIGLDFSRNNLSGDIP 516 (823)
Q Consensus 470 ~~~~l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~ip 516 (823)
.+. ..+|+.|++++|.+++..+..+..++.|+.|++++|++++..|
T Consensus 196 ~~~-~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 241 (276)
T 2z62_A 196 AFK-EIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 241 (276)
T ss_dssp SSC-SCCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCCCTT
T ss_pred ccC-CCcccEEECCCCceeecCHhHhcccccccEEEccCCcccccCC
Confidence 222 2245555555555555444445556666666666666665544
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.8e-25 Score=235.50 Aligned_cols=209 Identities=23% Similarity=0.220 Sum_probs=155.8
Q ss_pred CceEEEeecCCCCccCCccccccccccceEEecCCcceeccCccccCcccccEEEcccCcCCCCchhcccccCCCCEEEc
Q 045449 331 KLKVLIVTGNPLDGILPKSIGNFSLSLETILMANCSISGNIPQVVGNLSNLLVLELGGNNLTGPIPVTFSQLQTLQAFDL 410 (823)
Q Consensus 331 ~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L 410 (823)
+|+.|++++|.+++..+..|..+ ++|++|++++|++++..+..|.++++|++|+|++|++++..+..|.++++|++|++
T Consensus 29 ~l~~L~ls~n~l~~~~~~~~~~l-~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l 107 (276)
T 2z62_A 29 STKNLDLSFNPLRHLGSYSFFSF-PELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA 107 (276)
T ss_dssp TCCEEECTTCCCCEECTTTTTTC-TTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEEC
T ss_pred CccEEECCCCcccccCHhHhccc-cCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEEC
Confidence 35555555555555544455555 46666666666666666667777777777788877777666677777788888888
Q ss_pred cCCCCCCcchHhhhcCCCCCEEEcccCcCccc-ccccccCCCCCCeEeccCCccccccchhhhccCCCc----EEecccc
Q 045449 411 TRNKLAGPITDELCHLARLHSLVLQGNKFSGS-IPSCLGNLTSVRVLYLGLNIFTSVLSSTIWNLKDIL----FIDVSSN 485 (823)
Q Consensus 411 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~-~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~----~LdLs~N 485 (823)
++|++++..+..+..+++|++|++++|.+++. +|..+.++++|+.|+|++|++++..+..+..+..|+ .|++++|
T Consensus 108 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~n 187 (276)
T 2z62_A 108 VETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLN 187 (276)
T ss_dssp TTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCEEEECCSS
T ss_pred CCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhccccceeeecCCC
Confidence 88888776666677888888888888888763 588888888888888888888888788887777777 8999999
Q ss_pred ccccccCccccCCCCCcEEEcccCCCCCCCCCcccCccCCCCCCCCCCCcccccCCcccCCCCC
Q 045449 486 FLDGPLSLDIGNLKVVIGLDFSRNNLSGDIPITIGEGEIPRGGPFANLTAKSFMGNELLCGLPD 549 (823)
Q Consensus 486 ~l~g~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~~~g~ip~~~~~~~~~~~~~~~n~~~c~~~~ 549 (823)
.+++..+..+.. ..|+.|++++|++++..+..+ ..+..+..+.+.+|++.|..+.
T Consensus 188 ~l~~~~~~~~~~-~~L~~L~L~~n~l~~~~~~~~--------~~l~~L~~L~l~~N~~~c~c~~ 242 (276)
T 2z62_A 188 PMNFIQPGAFKE-IRLKELALDTNQLKSVPDGIF--------DRLTSLQKIWLHTNPWDCSCPR 242 (276)
T ss_dssp CCCEECTTSSCS-CCEEEEECCSSCCSCCCTTTT--------TTCCSCCEEECCSSCBCCCTTT
T ss_pred cccccCccccCC-CcccEEECCCCceeecCHhHh--------cccccccEEEccCCcccccCCc
Confidence 999776655544 489999999999995433222 2356778889999999998664
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.93 E-value=1.6e-25 Score=235.37 Aligned_cols=228 Identities=22% Similarity=0.270 Sum_probs=138.3
Q ss_pred cchhhhhccccccccCCccccccCCCCCcEEEccCCcccccCCcccccCCCCccEEEeeccccccccCccccCCCCCCeE
Q 045449 203 LPYLARLALATNNLVGVVPVTIFNMSALKEISLLNNSLSGSLPSRIDLSLPNVETLNLGINSFSGTIPSSITNSSKLSDL 282 (823)
Q Consensus 203 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 282 (823)
+..+..+++..+.+... ..+..+++|+.|++++|.++ .++. +. .+++|++|+|++|++++. +.+..+++|++|
T Consensus 18 ~~~l~~l~l~~~~~~~~--~~~~~l~~L~~L~l~~~~i~-~~~~-l~-~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L 90 (272)
T 3rfs_A 18 FAETIKANLKKKSVTDA--VTQNELNSIDQIIANNSDIK-SVQG-IQ-YLPNVRYLALGGNKLHDI--SALKELTNLTYL 90 (272)
T ss_dssp HHHHHHHHHTCSCTTSE--ECHHHHTTCCEEECTTSCCC-CCTT-GG-GCTTCCEEECTTSCCCCC--GGGTTCTTCCEE
T ss_pred HHHHHHHHhcCcccccc--cccccccceeeeeeCCCCcc-cccc-cc-cCCCCcEEECCCCCCCCc--hhhcCCCCCCEE
Confidence 34566777777777654 34567788888888888887 4443 33 378888888888888753 467788888888
Q ss_pred EeecccccccCCCccCCCcccCcccccCccccCCCCcccccccccCCCCceEEEeecCCCCccCCccccccccccceEEe
Q 045449 283 ELGENLFSGFIPNTIGNLRNLEFGNIADNYLTSSTPELSFLSSLTNCKKLKVLIVTGNPLDGILPKSIGNFSLSLETILM 362 (823)
Q Consensus 283 ~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L 362 (823)
+|++|.+++..+..|..+++|++|++++|++++.+ +..+.++++|++|++++|.+++..|..+
T Consensus 91 ~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~-----~~~~~~l~~L~~L~L~~n~l~~~~~~~~------------ 153 (272)
T 3rfs_A 91 ILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLP-----DGVFDKLTNLTYLNLAHNQLQSLPKGVF------------ 153 (272)
T ss_dssp ECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCC-----TTTTTTCTTCCEEECCSSCCCCCCTTTT------------
T ss_pred ECCCCccCccChhHhcCCcCCCEEECCCCcCCccC-----HHHhccCCCCCEEECCCCccCccCHHHh------------
Confidence 88888888777777777777777777777776652 2335555566666666665554444444
Q ss_pred cCCcceeccCccccCcccccEEEcccCcCCCCchhcccccCCCCEEEccCCCCCCcchHhhhcCCCCCEEEcccCcCccc
Q 045449 363 ANCSISGNIPQVVGNLSNLLVLELGGNNLTGPIPVTFSQLQTLQAFDLTRNKLAGPITDELCHLARLHSLVLQGNKFSGS 442 (823)
Q Consensus 363 ~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ 442 (823)
..+++|++|++++|++++..+..|..+++|++|+|++|++++..+..|..+++|+.|+|++|.+.+.
T Consensus 154 -------------~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~ 220 (272)
T 3rfs_A 154 -------------DKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCT 220 (272)
T ss_dssp -------------TTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCC
T ss_pred -------------ccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCcccc
Confidence 4444455555555555444444444455555555555555544444444555555555555544432
Q ss_pred ccccccCCCCCCeEeccCCccccccchhhhcc
Q 045449 443 IPSCLGNLTSVRVLYLGLNIFTSVLSSTIWNL 474 (823)
Q Consensus 443 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 474 (823)
++.|+.|+++.|.++|.+|.+++.+
T Consensus 221 -------~~~l~~l~~~~n~~~g~ip~~~~~~ 245 (272)
T 3rfs_A 221 -------CPGIRYLSEWINKHSGVVRNSAGSV 245 (272)
T ss_dssp -------TTTTHHHHHHHHHTGGGBBCTTSCB
T ss_pred -------CcHHHHHHHHHHhCCCcccCccccc
Confidence 2244555555555555555555443
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.93 E-value=7.5e-26 Score=237.86 Aligned_cols=158 Identities=23% Similarity=0.200 Sum_probs=88.9
Q ss_pred ccceEEecCCcceeccCccccCcccccEEEcccCcCCCCchhcccccCCCCEEEccCCCCCCcchHhhhcCCCCCEEEcc
Q 045449 356 SLETILMANCSISGNIPQVVGNLSNLLVLELGGNNLTGPIPVTFSQLQTLQAFDLTRNKLAGPITDELCHLARLHSLVLQ 435 (823)
Q Consensus 356 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 435 (823)
+|++|++++|.+++..+..|.++++|++|+|++|++++..+..|..+++|++|+|++|++++..+..|..+++|+.|+|+
T Consensus 86 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~ 165 (272)
T 3rfs_A 86 NLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLS 165 (272)
T ss_dssp TCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECC
Confidence 34444444444443444444555555555555555555444445555555555555555555555455555556666666
Q ss_pred cCcCcccccccccCCCCCCeEeccCCccccccchhhhccCCCcEEeccccccccccCccccCCCCCcEEEcccCCCCCCC
Q 045449 436 GNKFSGSIPSCLGNLTSVRVLYLGLNIFTSVLSSTIWNLKDILFIDVSSNFLDGPLSLDIGNLKVVIGLDFSRNNLSGDI 515 (823)
Q Consensus 436 ~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~i 515 (823)
+|++++..|..++.+++|+.|+|++|++++..|..+..+++|+.|++++|.+++.. +.|+.|+++.|+++|.|
T Consensus 166 ~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~-------~~l~~l~~~~n~~~g~i 238 (272)
T 3rfs_A 166 YNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTC-------PGIRYLSEWINKHSGVV 238 (272)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCT-------TTTHHHHHHHHHTGGGB
T ss_pred CCCcCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCccccC-------cHHHHHHHHHHhCCCcc
Confidence 66665555555555666666666666666655555566666666666666665433 34666666677777666
Q ss_pred CCccc
Q 045449 516 PITIG 520 (823)
Q Consensus 516 p~~~~ 520 (823)
|.+++
T Consensus 239 p~~~~ 243 (272)
T 3rfs_A 239 RNSAG 243 (272)
T ss_dssp BCTTS
T ss_pred cCccc
Confidence 66553
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.92 E-value=3.5e-26 Score=250.91 Aligned_cols=183 Identities=15% Similarity=0.155 Sum_probs=105.1
Q ss_pred hccccccccCCccccccCCCCCcEEEccCCcccccCCc---ccccCCC-CccEEEeeccccccccCccccCC-----CCC
Q 045449 209 LALATNNLVGVVPVTIFNMSALKEISLLNNSLSGSLPS---RIDLSLP-NVETLNLGINSFSGTIPSSITNS-----SKL 279 (823)
Q Consensus 209 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~lp~---~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l-----~~L 279 (823)
++++.|++++.+|..+...++|++|+|++|.+++..+. ..+..++ +|++|+|++|++++..+..+..+ ++|
T Consensus 3 ~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L 82 (362)
T 3goz_A 3 YKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANV 82 (362)
T ss_dssp EECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTC
T ss_pred cccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCc
Confidence 56788888888887777777788888888888744331 2223466 78888888888877666666664 778
Q ss_pred CeEEeecccccccCCCccCC----C-cccCcccccCccccCCCCcccccccccC-CCCceEEEeecCCCCccCCc----c
Q 045449 280 SDLELGENLFSGFIPNTIGN----L-RNLEFGNIADNYLTSSTPELSFLSSLTN-CKKLKVLIVTGNPLDGILPK----S 349 (823)
Q Consensus 280 ~~L~Ls~N~l~~~~p~~~~~----l-~~L~~L~L~~N~l~~~~~~~~~~~~l~~-l~~L~~L~Ls~N~l~~~~p~----~ 349 (823)
++|+|++|++++..+..+.. + ++|++|+|++|.+++..... +...+.. .++|++|+|++|.+++..+. .
T Consensus 83 ~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~-l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~ 161 (362)
T 3goz_A 83 TSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSE-FKQAFSNLPASITSLNLRGNDLGIKSSDELIQI 161 (362)
T ss_dssp CEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHH-HHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHH
T ss_pred cEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHH-HHHHHHhCCCceeEEEccCCcCCHHHHHHHHHH
Confidence 88888888877666554333 2 66677777777666542211 1122333 24566666666666543222 2
Q ss_pred ccccccccceEEecCCcceeccCccccC----c-ccccEEEcccCcCC
Q 045449 350 IGNFSLSLETILMANCSISGNIPQVVGN----L-SNLLVLELGGNNLT 392 (823)
Q Consensus 350 ~~~~~~~L~~L~L~~N~l~~~~p~~~~~----l-~~L~~L~Ls~N~l~ 392 (823)
+...+.+|++|+|++|++++..+..+.. + ++|++|||++|+++
T Consensus 162 l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~ 209 (362)
T 3goz_A 162 LAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLG 209 (362)
T ss_dssp HHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGG
T ss_pred HhcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCC
Confidence 2222224445555555444433332221 2 34444444444444
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=5.6e-27 Score=262.22 Aligned_cols=159 Identities=19% Similarity=0.261 Sum_probs=133.2
Q ss_pred CHHHHHHHhccCCccceeeccC------------CeEEEEEEehHhhHHH---HHHHHHHHHHHhhcchhhHHH------
Q 045449 619 SYHELLRATDRFSENNLIGIGN------------GMEVAVKVFHQQYERA---LKSFEDECEVRKRIRHRNLVK------ 677 (823)
Q Consensus 619 ~~~~l~~at~~f~~~~~lg~g~------------~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~------ 677 (823)
.+.++...+++|...+.||+|+ ++.||||++....... .+.+.+|+.++.+++||||++
T Consensus 65 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 144 (437)
T 4aw2_A 65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ 144 (437)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence 4555566678999999999996 5679999997643221 234899999999999999998
Q ss_pred -----------------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccc
Q 045449 678 -----------------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKL 722 (823)
Q Consensus 678 -----------------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~ 722 (823)
+++|++.+|+|+|+.+|+||||||+|||++.++.+||+|||+|+.
T Consensus 145 ~~~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~ 224 (437)
T 4aw2_A 145 DDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLK 224 (437)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred eCCEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhh
Confidence 467899999999999999999999999999999999999999987
Q ss_pred cCCCCccccccccccCCCcCcccccC-----CCccccccceehhhhhhccccCCCCCcCCC
Q 045449 723 LSGEDQLSKQTQTLATIGYMAPEYGT-----KGRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 723 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
...... ......+||+.|+|||++. .+.|+.++||||+||++|+|++|..||.+.
T Consensus 225 ~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~ 284 (437)
T 4aw2_A 225 LMEDGT-VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAE 284 (437)
T ss_dssp CCTTSC-EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred cccCCC-cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCC
Confidence 654332 2234468999999999986 567899999999999999999999999764
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.91 E-value=7.6e-24 Score=222.31 Aligned_cols=184 Identities=21% Similarity=0.194 Sum_probs=115.8
Q ss_pred ceEEEeecCCCCccCCccccccccccceEEecCCcceeccCccccCcccccEEEcccCcCCCCchhcccccCCCCEEEcc
Q 045449 332 LKVLIVTGNPLDGILPKSIGNFSLSLETILMANCSISGNIPQVVGNLSNLLVLELGGNNLTGPIPVTFSQLQTLQAFDLT 411 (823)
Q Consensus 332 L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls 411 (823)
|+.|++++|.+++..+..|..+ .+|++|++++|.++...+..|.++++|++|+|++|++++..+..|..+++|++|+|+
T Consensus 39 l~~L~l~~n~l~~~~~~~~~~l-~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~ 117 (270)
T 2o6q_A 39 TKKLDLQSNKLSSLPSKAFHRL-TKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLD 117 (270)
T ss_dssp CSEEECCSSCCSCCCTTSSSSC-TTCCEEECCSSCCSCCCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECC
T ss_pred CCEEECcCCCCCeeCHHHhcCC-CCCCEEECCCCccCeeChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECC
Confidence 4444444444444444444444 455555555555554444555666666666666666665555556666666666666
Q ss_pred CCCCCCcchHhhhcCCCCCEEEcccCcCcccccccccCCCCCCeEeccCCccccccchhhhccCCCcEEecccccccccc
Q 045449 412 RNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSVRVLYLGLNIFTSVLSSTIWNLKDILFIDVSSNFLDGPL 491 (823)
Q Consensus 412 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~LdLs~N~l~g~~ 491 (823)
+|++++..+..|..+++|++|+|++|.+++..+..|..+++|+.|+|++|.+++..+..+..+++|+.|+|++|.+++..
T Consensus 118 ~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 197 (270)
T 2o6q_A 118 RNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVP 197 (270)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSCCC
T ss_pred CCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCcCC
Confidence 66666666666666666777777777666555555666677777777777777666666666777777777777777655
Q ss_pred CccccCCCCCcEEEcccCCCCCCCC
Q 045449 492 SLDIGNLKVVIGLDFSRNNLSGDIP 516 (823)
Q Consensus 492 p~~~~~l~~L~~L~ls~N~l~g~ip 516 (823)
+..+..++.|+.|++++|.+.+..+
T Consensus 198 ~~~~~~l~~L~~L~l~~N~~~c~c~ 222 (270)
T 2o6q_A 198 EGAFDSLEKLKMLQLQENPWDCTCN 222 (270)
T ss_dssp TTTTTTCTTCCEEECCSSCBCCSSS
T ss_pred HHHhccccCCCEEEecCCCeeCCCc
Confidence 5556677777777777777765443
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=7.1e-26 Score=244.14 Aligned_cols=162 Identities=24% Similarity=0.297 Sum_probs=137.2
Q ss_pred ccccCHHHHHHHhcc----------CCccceeeccC------------CeEEEEEEehHhhHHHHHHHHHHHHHHhhcch
Q 045449 615 IRRFSYHELLRATDR----------FSENNLIGIGN------------GMEVAVKVFHQQYERALKSFEDECEVRKRIRH 672 (823)
Q Consensus 615 ~~~~~~~~l~~at~~----------f~~~~~lg~g~------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h 672 (823)
.+.++++++.++++. |...+.||.|+ |+.||||++........+.+.+|+.++++++|
T Consensus 22 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h 101 (321)
T 2c30_A 22 SGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQH 101 (321)
T ss_dssp ---CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCC
T ss_pred CCcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCC
Confidence 356999999999875 55667899886 67799999976554555779999999999999
Q ss_pred hhHHH---------------------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEE
Q 045449 673 RNLVK---------------------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAH 713 (823)
Q Consensus 673 ~niv~---------------------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~k 713 (823)
|||++ ++.|++.+|+|+|+.+|+||||||+||+++.++.+|
T Consensus 102 ~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~k 181 (321)
T 2c30_A 102 FNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVK 181 (321)
T ss_dssp TTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEE
T ss_pred CCcceEEEEEEECCEEEEEEecCCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEE
Confidence 99998 367888999999999999999999999999999999
Q ss_pred EeecccccccCCCCccccccccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCCC
Q 045449 714 ISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 714 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
|+|||+++....... ......||+.|+|||++.+..++.++|||||||+++++++|..||...
T Consensus 182 l~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~ 244 (321)
T 2c30_A 182 LSDFGFCAQISKDVP--KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSD 244 (321)
T ss_dssp ECCCTTCEECCSSSC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred EeeeeeeeecccCcc--ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 999999987654322 234567999999999999999999999999999999999999998654
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.91 E-value=8e-26 Score=250.44 Aligned_cols=249 Identities=19% Similarity=0.250 Sum_probs=171.4
Q ss_pred cCCcccccCCCCccEEEeeccccccccC----ccccCCCCCCeEEeecc---cccccCCCccCCCcccCcccccCccccC
Q 045449 243 SLPSRIDLSLPNVETLNLGINSFSGTIP----SSITNSSKLSDLELGEN---LFSGFIPNTIGNLRNLEFGNIADNYLTS 315 (823)
Q Consensus 243 ~lp~~~~~~l~~L~~L~Ls~N~l~~~~p----~~~~~l~~L~~L~Ls~N---~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 315 (823)
.++..+.. +++|++|+|++|+++...+ ..+..+++|++|+|++| ++++.+|..+..
T Consensus 23 ~l~~~l~~-~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~---------------- 85 (386)
T 2ca6_A 23 SVFAVLLE-DDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRL---------------- 85 (386)
T ss_dssp TTSHHHHH-CSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHH----------------
T ss_pred HHHHHHhc-CCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHH----------------
Confidence 44444443 6677777777777765433 33556667777777764 344444443310
Q ss_pred CCCcccccccccCCCCceEEEeecCCCCc----cCCccccccccccceEEecCCcceeccCcccc----Cc---------
Q 045449 316 STPELSFLSSLTNCKKLKVLIVTGNPLDG----ILPKSIGNFSLSLETILMANCSISGNIPQVVG----NL--------- 378 (823)
Q Consensus 316 ~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~----~~p~~~~~~~~~L~~L~L~~N~l~~~~p~~~~----~l--------- 378 (823)
+...+..+++|++|+|++|.+++ .+|..+..+ ++|++|+|++|.+++..+..+. .+
T Consensus 86 ------l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~-~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~ 158 (386)
T 2ca6_A 86 ------LLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKH-TPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNA 158 (386)
T ss_dssp ------HHHHHTTCTTCCEEECCSCCCCTTTHHHHHHHHHHC-TTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTC
T ss_pred ------HHHHHhhCCcccEEECCCCcCCHHHHHHHHHHHHhC-CCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccC
Confidence 11123444555555555555544 244444444 4555555555555433332222 23
Q ss_pred ccccEEEcccCcCC-CCch---hcccccCCCCEEEccCCCCC--C---cchHhhhcCCCCCEEEcccCcCc----ccccc
Q 045449 379 SNLLVLELGGNNLT-GPIP---VTFSQLQTLQAFDLTRNKLA--G---PITDELCHLARLHSLVLQGNKFS----GSIPS 445 (823)
Q Consensus 379 ~~L~~L~Ls~N~l~-g~~p---~~~~~l~~L~~L~Ls~N~l~--~---~~p~~~~~l~~L~~L~Ls~N~l~----g~~p~ 445 (823)
++|++|+|++|+++ +.+| ..+..+++|++|+|++|+++ | ..+..+..+++|+.|+|++|.++ +.+|.
T Consensus 159 ~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~ 238 (386)
T 2ca6_A 159 PPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAI 238 (386)
T ss_dssp CCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHH
T ss_pred CCCcEEECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHH
Confidence 88999999999997 4455 46778889999999999998 3 34447888999999999999996 67888
Q ss_pred cccCCCCCCeEeccCCccccc----cchhhh--ccCCCcEEecccccccc----ccCccc-cCCCCCcEEEcccCCCCCC
Q 045449 446 CLGNLTSVRVLYLGLNIFTSV----LSSTIW--NLKDILFIDVSSNFLDG----PLSLDI-GNLKVVIGLDFSRNNLSGD 514 (823)
Q Consensus 446 ~~~~l~~L~~L~Ls~N~l~~~----~p~~~~--~l~~L~~LdLs~N~l~g----~~p~~~-~~l~~L~~L~ls~N~l~g~ 514 (823)
.+..+++|+.|+|++|.+++. +|..+. .+++|+.|+|++|.+++ .+|..+ .+++.|+.|++++|++++.
T Consensus 239 ~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~~ 318 (386)
T 2ca6_A 239 ALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEE 318 (386)
T ss_dssp HGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTT
T ss_pred HHccCCCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCcc
Confidence 899999999999999999886 566663 38999999999999998 588877 6789999999999999854
Q ss_pred C
Q 045449 515 I 515 (823)
Q Consensus 515 i 515 (823)
.
T Consensus 319 ~ 319 (386)
T 2ca6_A 319 D 319 (386)
T ss_dssp S
T ss_pred h
Confidence 3
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.91 E-value=7.4e-26 Score=245.71 Aligned_cols=212 Identities=18% Similarity=0.239 Sum_probs=142.8
Q ss_pred CCCccceeeeeCCCCCcEEEEEcCCCCCccccCcccCCC--CCCcEEEccCCCCCCCCCCCCCCCCCCCEEECCCCcCcC
Q 045449 37 TSVCIWIGITCDVNSHRVIGLNISSFNLQGTITPQLGNL--SSLQTLDLSHNKLSGNIPSSIFNMHTLKLLDFSDNQLFG 114 (823)
Q Consensus 37 ~~~c~w~gv~c~~~~~~v~~L~L~~~~l~g~~~~~l~~l--~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~ 114 (823)
.-|.+|.++.|+. ..++.||++++.+. +..+..+ +++++|++++|.+.+..+. +..+++|++|+|++|.+++
T Consensus 34 ~vc~~W~~~~~~~--~~~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~ 107 (336)
T 2ast_B 34 GVCKRWYRLASDE--SLWQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEV 107 (336)
T ss_dssp SSCHHHHHHHTCS--TTSSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECH
T ss_pred HHHHHHHHHhcCc--hhheeeccccccCC---HHHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCH
Confidence 4566899999873 35789999999887 4556677 8999999999999977665 5679999999999999987
Q ss_pred C-CchhhhcCCCCcEEecccccccCccCccccCCCCCCccccccceeeeccc-eeecc-CccccccchhhHHHHHhhcCC
Q 045449 115 S-LSSFIFNMSSMTTIDLSINRLSGELPANICKIPSTLSKCKQLEELNLGFN-NLSGA-IPKEIGNLTKLKEIISTITNS 191 (823)
Q Consensus 115 ~-~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~p~~~~~l~~L~~L~Ls~N-~l~~~-~p~~l~~l~~L~~L~~l~~n~ 191 (823)
. +|..+..+++|++|+|++|.+++..+..+ ..+++|++|+|++| .+++. ++
T Consensus 108 ~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l-------~~~~~L~~L~L~~~~~l~~~~l~------------------- 161 (336)
T 2ast_B 108 STLHGILSQCSKLQNLSLEGLRLSDPIVNTL-------AKNSNLVRLNLSGCSGFSEFALQ------------------- 161 (336)
T ss_dssp HHHHHHHTTBCCCSEEECTTCBCCHHHHHHH-------TTCTTCSEEECTTCBSCCHHHHH-------------------
T ss_pred HHHHHHHhhCCCCCEEeCcCcccCHHHHHHH-------hcCCCCCEEECCCCCCCCHHHHH-------------------
Confidence 6 88889999999999999999887766666 67889999999998 56531 11
Q ss_pred CcccCCcccCCcchhhhhccccc-cccCC-ccccccCCC-CCcEEEccCC--ccc-ccCCcccccCCCCccEEEeeccc-
Q 045449 192 TVCEIPREIGNLPYLARLALATN-NLVGV-VPVTIFNMS-ALKEISLLNN--SLS-GSLPSRIDLSLPNVETLNLGINS- 264 (823)
Q Consensus 192 ~~~~ip~~l~~l~~L~~L~Ls~N-~l~~~-~p~~~~~l~-~L~~L~Ls~N--~l~-g~lp~~~~~~l~~L~~L~Ls~N~- 264 (823)
..+.++++|++|++++| ++++. ++..+..++ +|++|++++| .++ +.+|..+.. +++|++|+|++|.
T Consensus 162 ------~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~-~~~L~~L~l~~~~~ 234 (336)
T 2ast_B 162 ------TLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRR-CPNLVHLDLSDSVM 234 (336)
T ss_dssp ------HHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHH-CTTCSEEECTTCTT
T ss_pred ------HHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeCCCcccCCHHHHHHHHhh-CCCCCEEeCCCCCc
Confidence 11223445566666666 66543 344455555 5666666655 233 233332222 4455555555554
Q ss_pred cccccCccccCCCCCCeEEeecc
Q 045449 265 FSGTIPSSITNSSKLSDLELGEN 287 (823)
Q Consensus 265 l~~~~p~~~~~l~~L~~L~Ls~N 287 (823)
+++..+..+..+++|++|++++|
T Consensus 235 l~~~~~~~l~~l~~L~~L~l~~~ 257 (336)
T 2ast_B 235 LKNDCFQEFFQLNYLQHLSLSRC 257 (336)
T ss_dssp CCGGGGGGGGGCTTCCEEECTTC
T ss_pred CCHHHHHHHhCCCCCCEeeCCCC
Confidence 44444444444444444444444
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=99.91 E-value=1.1e-25 Score=243.85 Aligned_cols=149 Identities=22% Similarity=0.280 Sum_probs=127.7
Q ss_pred ccCCccceeeccC------------CeEEEEEEehHhh---HHHHHHHHHHHHHHhhcchhhHHH---------------
Q 045449 628 DRFSENNLIGIGN------------GMEVAVKVFHQQY---ERALKSFEDECEVRKRIRHRNLVK--------------- 677 (823)
Q Consensus 628 ~~f~~~~~lg~g~------------~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~--------------- 677 (823)
++|...+.||+|+ |+.||||+++... ....+.+.+|++++++++||||++
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 84 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence 5778888899886 6679999997653 223467899999999999999998
Q ss_pred -------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccc
Q 045449 678 -------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQ 732 (823)
Q Consensus 678 -------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~ 732 (823)
+++|++.+|+|+|+.+|+||||||+|||++.++.+||+|||+|+....... ..
T Consensus 85 E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~--~~ 162 (337)
T 1o6l_A 85 EYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TM 162 (337)
T ss_dssp ECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC--CB
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCCC--cc
Confidence 367899999999999999999999999999999999999999986432221 23
Q ss_pred cccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCCC
Q 045449 733 TQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 733 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
...+||+.|+|||++.+..|+.++||||+||++|+|++|..||.+.
T Consensus 163 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~ 208 (337)
T 1o6l_A 163 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 208 (337)
T ss_dssp CCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCC
Confidence 4568999999999999999999999999999999999999999654
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.91 E-value=9.3e-24 Score=223.76 Aligned_cols=204 Identities=21% Similarity=0.239 Sum_probs=142.2
Q ss_pred ccCCCCCcEEEccCCcccccCCcccccCCCCccEEEeeccccccccCccccCCCCCCeEEeecccccccCCCccCCCccc
Q 045449 224 IFNMSALKEISLLNNSLSGSLPSRIDLSLPNVETLNLGINSFSGTIPSSITNSSKLSDLELGENLFSGFIPNTIGNLRNL 303 (823)
Q Consensus 224 ~~~l~~L~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 303 (823)
+.++++++++++++|.++ .+|..+. +++++|+|++|++++..|..|.++++|++|+|++|.+++..+. +.+++|
T Consensus 6 ~~~l~~l~~l~~~~~~l~-~ip~~~~---~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~--~~l~~L 79 (290)
T 1p9a_G 6 VSKVASHLEVNCDKRNLT-ALPPDLP---KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVD--GTLPVL 79 (290)
T ss_dssp EECSTTCCEEECTTSCCS-SCCSCCC---TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEECC--SCCTTC
T ss_pred ccccCCccEEECCCCCCC-cCCCCCC---CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccCC--CCCCcC
Confidence 556677777777777777 6665543 4677777777777766667777777777777777777654332 445555
Q ss_pred CcccccCccccCCCCcccccccccCCCCceEEEeecCCCCccCCccccccccccceEEecCCcceeccCccccCcccccE
Q 045449 304 EFGNIADNYLTSSTPELSFLSSLTNCKKLKVLIVTGNPLDGILPKSIGNFSLSLETILMANCSISGNIPQVVGNLSNLLV 383 (823)
Q Consensus 304 ~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 383 (823)
++|+|++|+++. +|..+..+ ++|++|++++|+|++..|..|.++++|++
T Consensus 80 ~~L~Ls~N~l~~------------------------------l~~~~~~l-~~L~~L~l~~N~l~~l~~~~~~~l~~L~~ 128 (290)
T 1p9a_G 80 GTLDLSHNQLQS------------------------------LPLLGQTL-PALTVLDVSFNRLTSLPLGALRGLGELQE 128 (290)
T ss_dssp CEEECCSSCCSS------------------------------CCCCTTTC-TTCCEEECCSSCCCCCCSSTTTTCTTCCE
T ss_pred CEEECCCCcCCc------------------------------CchhhccC-CCCCEEECCCCcCcccCHHHHcCCCCCCE
Confidence 555555555443 34444444 45666666666666666667777777888
Q ss_pred EEcccCcCCCCchhcccccCCCCEEEccCCCCCCcchHhhhcCCCCCEEEcccCcCcccccccccCCCCCCeEeccCCcc
Q 045449 384 LELGGNNLTGPIPVTFSQLQTLQAFDLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSVRVLYLGLNIF 463 (823)
Q Consensus 384 L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l 463 (823)
|+|++|++++..+..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|+|+ .+|..+..+++|+.|+|++|.+
T Consensus 129 L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~ 207 (290)
T 1p9a_G 129 LYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207 (290)
T ss_dssp EECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCB
T ss_pred EECCCCCCCccChhhcccccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCc
Confidence 888888887666666777888888888888888666666777888888888888887 6777777777888888888887
Q ss_pred cc
Q 045449 464 TS 465 (823)
Q Consensus 464 ~~ 465 (823)
..
T Consensus 208 ~C 209 (290)
T 1p9a_G 208 LC 209 (290)
T ss_dssp CC
T ss_pred cC
Confidence 65
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=99.91 E-value=1e-25 Score=243.23 Aligned_cols=149 Identities=28% Similarity=0.393 Sum_probs=128.6
Q ss_pred hccCCccceeeccC------------CeEEEEEEehHhh--HHHHHHHHHHHHHHhhcchhhHHH---------------
Q 045449 627 TDRFSENNLIGIGN------------GMEVAVKVFHQQY--ERALKSFEDECEVRKRIRHRNLVK--------------- 677 (823)
Q Consensus 627 t~~f~~~~~lg~g~------------~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~--------------- 677 (823)
.++|...+.||.|+ |+.||||++.... ....+++.+|++++++++||||++
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 46788888999886 6779999996542 445678999999999999999998
Q ss_pred -------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccc
Q 045449 678 -------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQ 732 (823)
Q Consensus 678 -------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~ 732 (823)
++.|++.+|+|+|+.+|+||||||+||+++.++.+||+|||+++....... .
T Consensus 94 e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~---~ 170 (328)
T 3fe3_A 94 EYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK---L 170 (328)
T ss_dssp CCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSCG---G
T ss_pred ECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCCc---c
Confidence 467899999999999999999999999999999999999999987654322 3
Q ss_pred cccccCCCcCcccccCCCccc-cccceehhhhhhccccCCCCCcCCC
Q 045449 733 TQTLATIGYMAPEYGTKGRVS-TRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 733 ~~~~gt~~y~aPE~~~~~~~~-~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
...+||+.|+|||++.+..+. .++||||+||++|++++|..||.+.
T Consensus 171 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 217 (328)
T 3fe3_A 171 DAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQ 217 (328)
T ss_dssp GTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCC
Confidence 456799999999999887764 7899999999999999999999764
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.91 E-value=1.5e-25 Score=245.99 Aligned_cols=231 Identities=17% Similarity=0.225 Sum_probs=130.5
Q ss_pred EEEccCCcccccCCcccccCCCCccEEEeeccccccccC----ccccCCC-CCCeEEeecccccccCCCccCCC-----c
Q 045449 232 EISLLNNSLSGSLPSRIDLSLPNVETLNLGINSFSGTIP----SSITNSS-KLSDLELGENLFSGFIPNTIGNL-----R 301 (823)
Q Consensus 232 ~L~Ls~N~l~g~lp~~~~~~l~~L~~L~Ls~N~l~~~~p----~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l-----~ 301 (823)
++.++.|.++|.+|..+.. .++|++|||++|.+++..+ ..+..++ +|++|+|++|++++..+..+..+ +
T Consensus 2 ~~~ls~n~~~~~~~~~~~~-~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~ 80 (362)
T 3goz_A 2 NYKLTLHPGSNPVEEFTSI-PHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPA 80 (362)
T ss_dssp EEECCCCTTCCHHHHHHTS-CTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCT
T ss_pred ccccccccchHHHHHHHhC-CCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCC
Confidence 4677888888777765443 5558888888888876665 6667777 78888888888887766666664 7
Q ss_pred ccCcccccCccccCCCCcccccccccCC-CCceEEEeecCCCCccCCcccccc----ccccceEEecCCcceecc----C
Q 045449 302 NLEFGNIADNYLTSSTPELSFLSSLTNC-KKLKVLIVTGNPLDGILPKSIGNF----SLSLETILMANCSISGNI----P 372 (823)
Q Consensus 302 ~L~~L~L~~N~l~~~~~~~~~~~~l~~l-~~L~~L~Ls~N~l~~~~p~~~~~~----~~~L~~L~L~~N~l~~~~----p 372 (823)
+|++|+|++|.+++..+.. +...+..+ ++|+.|+|++|.+++..+..+... +.+|++|+|++|.+++.. +
T Consensus 81 ~L~~L~Ls~n~l~~~~~~~-l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~ 159 (362)
T 3goz_A 81 NVTSLNLSGNFLSYKSSDE-LVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELI 159 (362)
T ss_dssp TCCEEECCSSCGGGSCHHH-HHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHH
T ss_pred CccEEECcCCcCChHHHHH-HHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHH
Confidence 7777777777777653211 12223444 667777777777766555443321 235566666666555322 2
Q ss_pred ccccCcc-cccEEEcccCcCCCCchhcccc----c-CCCCEEEccCCCCCCc----chHhhhc-CCCCCEEEcccCcCcc
Q 045449 373 QVVGNLS-NLLVLELGGNNLTGPIPVTFSQ----L-QTLQAFDLTRNKLAGP----ITDELCH-LARLHSLVLQGNKFSG 441 (823)
Q Consensus 373 ~~~~~l~-~L~~L~Ls~N~l~g~~p~~~~~----l-~~L~~L~Ls~N~l~~~----~p~~~~~-l~~L~~L~Ls~N~l~g 441 (823)
..+..++ +|++|+|++|++++..+..+.. . ++|++|+|++|++++. ++..+.. .++|++|+|++|.+++
T Consensus 160 ~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~ 239 (362)
T 3goz_A 160 QILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHG 239 (362)
T ss_dssp HHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHHSCTTCCEEECCSSCCCC
T ss_pred HHHhcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHHHHhcCCCCceEEECcCCCCCc
Confidence 2223333 5555555555555444433322 2 3555555555555542 2333333 2355555555555554
Q ss_pred ccc----ccccCCCCCCeEeccCCccc
Q 045449 442 SIP----SCLGNLTSVRVLYLGLNIFT 464 (823)
Q Consensus 442 ~~p----~~~~~l~~L~~L~Ls~N~l~ 464 (823)
..+ ..+..+++|+.|+|++|.+.
T Consensus 240 ~~~~~l~~~~~~l~~L~~L~L~~n~l~ 266 (362)
T 3goz_A 240 PSLENLKLLKDSLKHLQTVYLDYDIVK 266 (362)
T ss_dssp CCHHHHHHTTTTTTTCSEEEEEHHHHT
T ss_pred HHHHHHHHHHhcCCCccEEEeccCCcc
Confidence 332 22344455555555555533
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.91 E-value=1.2e-23 Score=223.00 Aligned_cols=178 Identities=19% Similarity=0.197 Sum_probs=101.4
Q ss_pred ceEEEeecCCCCccCCccccccccccceEEecCCcceeccCccccCcccccEEEcccCcCCCCchhcccccCCCCEEEcc
Q 045449 332 LKVLIVTGNPLDGILPKSIGNFSLSLETILMANCSISGNIPQVVGNLSNLLVLELGGNNLTGPIPVTFSQLQTLQAFDLT 411 (823)
Q Consensus 332 L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls 411 (823)
++.|+|++|.+++..|..|..+ .+|++|++++|.+++..+. +.+++|++|+|++|+++ .+|..+..+++|++|+|+
T Consensus 33 l~~L~L~~N~l~~~~~~~~~~l-~~L~~L~L~~n~l~~~~~~--~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~ 108 (290)
T 1p9a_G 33 TTILHLSENLLYTFSLATLMPY-TRLTQLNLDRAELTKLQVD--GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVS 108 (290)
T ss_dssp CCEEECTTSCCSEEEGGGGTTC-TTCCEEECTTSCCCEEECC--SCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECC
T ss_pred CCEEEcCCCcCCccCHHHhhcC-CCCCEEECCCCccCcccCC--CCCCcCCEEECCCCcCC-cCchhhccCCCCCEEECC
Confidence 3444444444444444444444 3444444444444433222 45556666666666665 455555666666666666
Q ss_pred CCCCCCcchHhhhcCCCCCEEEcccCcCcccccccccCCCCCCeEeccCCccccccchhhhccCCCcEEecccccccccc
Q 045449 412 RNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSVRVLYLGLNIFTSVLSSTIWNLKDILFIDVSSNFLDGPL 491 (823)
Q Consensus 412 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~LdLs~N~l~g~~ 491 (823)
+|+|++..+..|..+++|+.|+|++|++++..+..|..+++|+.|+|++|++++..+..+..+++|+.|+|++|+++ .+
T Consensus 109 ~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~-~i 187 (290)
T 1p9a_G 109 FNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TI 187 (290)
T ss_dssp SSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CC
T ss_pred CCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCcCC-cc
Confidence 66666555555666666666666666666555555566666666666666666555555556666666666666665 45
Q ss_pred CccccCCCCCcEEEcccCCCCCC
Q 045449 492 SLDIGNLKVVIGLDFSRNNLSGD 514 (823)
Q Consensus 492 p~~~~~l~~L~~L~ls~N~l~g~ 514 (823)
|..+..+..|+.|++++|.+.+.
T Consensus 188 p~~~~~~~~L~~l~L~~Np~~C~ 210 (290)
T 1p9a_G 188 PKGFFGSHLLPFAFLHGNPWLCN 210 (290)
T ss_dssp CTTTTTTCCCSEEECCSCCBCCS
T ss_pred ChhhcccccCCeEEeCCCCccCc
Confidence 55555566666666666666543
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=1e-25 Score=240.07 Aligned_cols=150 Identities=27% Similarity=0.382 Sum_probs=129.8
Q ss_pred hccCCccceeeccC------------CeEEEEEEehHhhHHHHHHHHHHHHHHhhcchhhHHH-----------------
Q 045449 627 TDRFSENNLIGIGN------------GMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVK----------------- 677 (823)
Q Consensus 627 t~~f~~~~~lg~g~------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~----------------- 677 (823)
.++|...+.||.|+ +..||||++........+.+.+|+.++++++||||++
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 35788888899886 5679999997655444577999999999999999998
Q ss_pred ----------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCcccccccc
Q 045449 678 ----------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQT 735 (823)
Q Consensus 678 ----------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 735 (823)
++.|++.+|+|+|+.+|+||||||+||+++.++.+||+|||+++....... .....
T Consensus 99 ~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~ 176 (297)
T 3fxz_A 99 LAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KRSTM 176 (297)
T ss_dssp CTTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC--CBCCC
T ss_pred CCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc--ccCCc
Confidence 367889999999999999999999999999999999999999987654332 23456
Q ss_pred ccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCCC
Q 045449 736 LATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 736 ~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
.||+.|+|||++.+..++.++||||+||++|++++|..||...
T Consensus 177 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 219 (297)
T 3fxz_A 177 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNE 219 (297)
T ss_dssp CSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred cCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 7999999999999999999999999999999999999999664
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=99.91 E-value=3.7e-25 Score=239.42 Aligned_cols=148 Identities=24% Similarity=0.378 Sum_probs=126.6
Q ss_pred ccCCccceeeccC------------CeEEEEEEehHhhHH---HHHHHHHHHHHHhhcchhhHHH---------------
Q 045449 628 DRFSENNLIGIGN------------GMEVAVKVFHQQYER---ALKSFEDECEVRKRIRHRNLVK--------------- 677 (823)
Q Consensus 628 ~~f~~~~~lg~g~------------~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~--------------- 677 (823)
++|...+.||.|+ +..||||++...... ..+.+.+|++++++++||||++
T Consensus 9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 88 (336)
T 3h4j_B 9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI 88 (336)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 5778888888886 567999999765322 2357899999999999999998
Q ss_pred ------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCcccccc
Q 045449 678 ------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQT 733 (823)
Q Consensus 678 ------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~ 733 (823)
++.|++.+|+|+|+.||+||||||+||+++.++.+||+|||+++....... ..
T Consensus 89 E~~~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~~---~~ 165 (336)
T 3h4j_B 89 EYAGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNF---LK 165 (336)
T ss_dssp CCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSBT---TC
T ss_pred ECCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCCcc---cc
Confidence 467899999999999999999999999999999999999999987654322 34
Q ss_pred ccccCCCcCcccccCCCcc-ccccceehhhhhhccccCCCCCcCCC
Q 045449 734 QTLATIGYMAPEYGTKGRV-STRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 734 ~~~gt~~y~aPE~~~~~~~-~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
..+||+.|+|||++.+..+ +.++||||+||++|++++|..||.+.
T Consensus 166 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~ 211 (336)
T 3h4j_B 166 TSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDE 211 (336)
T ss_dssp CCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCS
T ss_pred cccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCc
Confidence 4679999999999988776 78999999999999999999999764
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.4e-25 Score=240.34 Aligned_cols=151 Identities=28% Similarity=0.407 Sum_probs=120.0
Q ss_pred hccCCccceeeccC----------CeEEEEEEehHhh--HHHHHHHHHHHHHHhhcchhhHHH-----------------
Q 045449 627 TDRFSENNLIGIGN----------GMEVAVKVFHQQY--ERALKSFEDECEVRKRIRHRNLVK----------------- 677 (823)
Q Consensus 627 t~~f~~~~~lg~g~----------~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~----------------- 677 (823)
.++|...+.||.|+ +..||||++.... ....++|.+|++++++++||||++
T Consensus 36 ~~~y~i~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 115 (309)
T 3p86_A 36 WCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEY 115 (309)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEEC
T ss_pred hhHceeeeEeecCCCeEEEEEEECCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEec
Confidence 46788888999986 6679999986443 445578999999999999999998
Q ss_pred --------------------------HHHHHHHHhhhcCCCC--EEeccCCCCCEEeCCCCcEEEeecccccccCCCCcc
Q 045449 678 --------------------------IISSSLEYLHFGHSIP--IIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQL 729 (823)
Q Consensus 678 --------------------------~~~~~l~~L~~~h~~~--ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~ 729 (823)
++.|++.+|+|+|+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 116 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~-- 193 (309)
T 3p86_A 116 LSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTF-- 193 (309)
T ss_dssp CTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC-----------
T ss_pred CCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCccccccc--
Confidence 3568899999999999 9999999999999999999999999998653322
Q ss_pred ccccccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCCCc
Q 045449 730 SKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGETC 779 (823)
Q Consensus 730 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~~ 779 (823)
.......||+.|+|||++.+..++.++||||+||++|++++|..||....
T Consensus 194 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~ 243 (309)
T 3p86_A 194 LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLN 243 (309)
T ss_dssp --------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSC
T ss_pred cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 12334679999999999999999999999999999999999999997653
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=2.5e-25 Score=238.70 Aligned_cols=152 Identities=26% Similarity=0.363 Sum_probs=127.7
Q ss_pred hccCCccceeeccC------------CeEEEEEEehHhhHHHHHHHHHHHHHHhhcchhhHHH-----------------
Q 045449 627 TDRFSENNLIGIGN------------GMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVK----------------- 677 (823)
Q Consensus 627 t~~f~~~~~lg~g~------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~----------------- 677 (823)
.++|...+.||.|+ +..||+|++........+.|.+|++++++++||||++
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 35677788888886 5679999987666667789999999999999999998
Q ss_pred ------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccc---
Q 045449 678 ------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLS--- 730 (823)
Q Consensus 678 ------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~--- 730 (823)
++.|++++|+|+|+.+|+||||||+||+++.++.+||+|||+++.........
T Consensus 89 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 168 (310)
T 3s95_A 89 IKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGL 168 (310)
T ss_dssp CTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC---------
T ss_pred cCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceeccccccccccc
Confidence 35788999999999999999999999999999999999999998764332211
Q ss_pred ---------cccccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCCC
Q 045449 731 ---------KQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 731 ---------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
.....+||+.|+|||++.+..++.++|||||||++|++++|..|+...
T Consensus 169 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~ 225 (310)
T 3s95_A 169 RSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDY 225 (310)
T ss_dssp -----------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTT
T ss_pred ccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcch
Confidence 111457999999999999999999999999999999999999887654
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.91 E-value=1.6e-25 Score=248.12 Aligned_cols=249 Identities=19% Similarity=0.250 Sum_probs=166.7
Q ss_pred CccccccCCCCCcEEEccCCcccccCCccc---ccCCCCccEEEeecc---ccccccCccc-------cCCCCCCeEEee
Q 045449 219 VVPVTIFNMSALKEISLLNNSLSGSLPSRI---DLSLPNVETLNLGIN---SFSGTIPSSI-------TNSSKLSDLELG 285 (823)
Q Consensus 219 ~~p~~~~~l~~L~~L~Ls~N~l~g~lp~~~---~~~l~~L~~L~Ls~N---~l~~~~p~~~-------~~l~~L~~L~Ls 285 (823)
.++..+..+++|++|+|++|.+++..+..+ ...+++|++|+|++| ++++.+|..+ ..+++|++|+|+
T Consensus 23 ~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls 102 (386)
T 2ca6_A 23 SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLS 102 (386)
T ss_dssp TTSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECC
T ss_pred HHHHHHhcCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECC
Confidence 355677788999999999999986544332 224899999999995 5566667665 678888899999
Q ss_pred cccccc----cCCCccCCCcccCcccccCccccCCCCcccccccccCC---------CCceEEEeecCCCCccCCccccc
Q 045449 286 ENLFSG----FIPNTIGNLRNLEFGNIADNYLTSSTPELSFLSSLTNC---------KKLKVLIVTGNPLDGILPKSIGN 352 (823)
Q Consensus 286 ~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l---------~~L~~L~Ls~N~l~~~~p~~~~~ 352 (823)
+|.+++ .+|..+..+++|++|+|++|.++...+. .+...+..+ ++|+.|++++|+++.
T Consensus 103 ~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~-~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~-------- 173 (386)
T 2ca6_A 103 DNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGA-KIARALQELAVNKKAKNAPPLRSIICGRNRLEN-------- 173 (386)
T ss_dssp SCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHH-HHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTG--------
T ss_pred CCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHH-HHHHHHHHHhhhhhcccCCCCcEEECCCCCCCc--------
Confidence 888887 4566667777777777777776543111 012222222 455555555555441
Q ss_pred cccccceEEecCCcceeccC---ccccCcccccEEEcccCcCC--C---CchhcccccCCCCEEEccCCCCC----Ccch
Q 045449 353 FSLSLETILMANCSISGNIP---QVVGNLSNLLVLELGGNNLT--G---PIPVTFSQLQTLQAFDLTRNKLA----GPIT 420 (823)
Q Consensus 353 ~~~~L~~L~L~~N~l~~~~p---~~~~~l~~L~~L~Ls~N~l~--g---~~p~~~~~l~~L~~L~Ls~N~l~----~~~p 420 (823)
+.+| ..+..+++|++|+|++|+++ | .+|..+..+++|++|+|++|.++ +.+|
T Consensus 174 ----------------~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~ 237 (386)
T 2ca6_A 174 ----------------GSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALA 237 (386)
T ss_dssp ----------------GGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHH
T ss_pred ----------------HHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHH
Confidence 2222 34455666777777777766 2 23436667777777777777775 4566
Q ss_pred HhhhcCCCCCEEEcccCcCccc----ccccc--cCCCCCCeEeccCCcccc----ccchhh-hccCCCcEEecccccccc
Q 045449 421 DELCHLARLHSLVLQGNKFSGS----IPSCL--GNLTSVRVLYLGLNIFTS----VLSSTI-WNLKDILFIDVSSNFLDG 489 (823)
Q Consensus 421 ~~~~~l~~L~~L~Ls~N~l~g~----~p~~~--~~l~~L~~L~Ls~N~l~~----~~p~~~-~~l~~L~~LdLs~N~l~g 489 (823)
..+..+++|+.|+|++|.+++. +|..+ +.+++|+.|+|++|.+++ .+|..+ .++++|++|++++|.+++
T Consensus 238 ~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~ 317 (386)
T 2ca6_A 238 IALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSE 317 (386)
T ss_dssp HHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCT
T ss_pred HHHccCCCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCc
Confidence 6677777777777777777655 45555 337778888888888777 466666 557888888888888877
Q ss_pred ccC
Q 045449 490 PLS 492 (823)
Q Consensus 490 ~~p 492 (823)
..+
T Consensus 318 ~~~ 320 (386)
T 2ca6_A 318 EDD 320 (386)
T ss_dssp TSH
T ss_pred chh
Confidence 664
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.3e-25 Score=249.20 Aligned_cols=158 Identities=20% Similarity=0.221 Sum_probs=131.8
Q ss_pred HHHHHHHhccCCccceeeccC------------CeEEEEEEehHhhHH---HHHHHHHHHHHHhhcchhhHHH-------
Q 045449 620 YHELLRATDRFSENNLIGIGN------------GMEVAVKVFHQQYER---ALKSFEDECEVRKRIRHRNLVK------- 677 (823)
Q Consensus 620 ~~~l~~at~~f~~~~~lg~g~------------~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~------- 677 (823)
+.++....++|...+.||+|+ +..||||++...... ..+.+.+|+++++.++|||||+
T Consensus 61 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 140 (410)
T 3v8s_A 61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 140 (410)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred HHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence 344555678899999999986 567999999754321 1235889999999999999998
Q ss_pred --------------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCC
Q 045449 678 --------------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSG 725 (823)
Q Consensus 678 --------------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~ 725 (823)
+++|++.+|+|+|+.+|+||||||+|||++.++++||+|||+|+....
T Consensus 141 ~~~~~lV~E~~~gg~L~~~l~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~ 220 (410)
T 3v8s_A 141 DRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNK 220 (410)
T ss_dssp SSEEEEEECCCTTEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred CCEEEEEEeCCCCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeecc
Confidence 467899999999999999999999999999999999999999987654
Q ss_pred CCccccccccccCCCcCcccccCCCc----cccccceehhhhhhccccCCCCCcCCC
Q 045449 726 EDQLSKQTQTLATIGYMAPEYGTKGR----VSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 726 ~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
... ......+||+.|+|||++.+.. |+.++||||+||++|+|++|..||.+.
T Consensus 221 ~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~ 276 (410)
T 3v8s_A 221 EGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD 276 (410)
T ss_dssp TSE-EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred CCc-ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCC
Confidence 332 2234568999999999987655 889999999999999999999999654
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=7.7e-26 Score=243.98 Aligned_cols=162 Identities=36% Similarity=0.516 Sum_probs=137.1
Q ss_pred ccCHHHHHHHhccCCccceeeccC-----------CeEEEEEEehHhhHHHHHHHHHHHHHHhhcchhhHHH--------
Q 045449 617 RFSYHELLRATDRFSENNLIGIGN-----------GMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVK-------- 677 (823)
Q Consensus 617 ~~~~~~l~~at~~f~~~~~lg~g~-----------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-------- 677 (823)
++++.++..++++|...+.||.|+ +..||||++........+.|.+|++++++++||||++
T Consensus 28 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 107 (321)
T 2qkw_B 28 RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDER 107 (321)
T ss_dssp --CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCT
T ss_pred eecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCC
Confidence 455566677889999999999886 5679999987665556678999999999999999998
Q ss_pred ------------------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeeccccc
Q 045449 678 ------------------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAK 721 (823)
Q Consensus 678 ------------------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~ 721 (823)
++.|++.+|+|+|+.+|+||||||+||+++.++.+||+|||+++
T Consensus 108 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~ 187 (321)
T 2qkw_B 108 NEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISK 187 (321)
T ss_dssp TCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCE
T ss_pred CeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeeccccc
Confidence 35688899999999999999999999999999999999999998
Q ss_pred ccCCCCccccccccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCCC
Q 045449 722 LLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 722 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
...............||+.|+|||++.+..++.++|||||||++|++++|+.||.+.
T Consensus 188 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~ 244 (321)
T 2qkw_B 188 KGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQS 244 (321)
T ss_dssp ECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCS
T ss_pred ccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCccccc
Confidence 754333322334456999999999998889999999999999999999999998654
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.90 E-value=2.2e-25 Score=247.46 Aligned_cols=160 Identities=21% Similarity=0.285 Sum_probs=133.6
Q ss_pred cCHHHHHHHhccCCccceeeccC------------CeEEEEEEehHhhH---HHHHHHHHHHHHHhhcchhhHHH-----
Q 045449 618 FSYHELLRATDRFSENNLIGIGN------------GMEVAVKVFHQQYE---RALKSFEDECEVRKRIRHRNLVK----- 677 (823)
Q Consensus 618 ~~~~~l~~at~~f~~~~~lg~g~------------~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~----- 677 (823)
++++++....++|...+.||+|+ |+.||||++..... ...+.+.+|++++.+++||||++
T Consensus 51 ~~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~ 130 (412)
T 2vd5_A 51 VRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAF 130 (412)
T ss_dssp HHHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred hhhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEE
Confidence 44555566678999999999986 66799999975432 22346889999999999999998
Q ss_pred ------------------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeeccccc
Q 045449 678 ------------------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAK 721 (823)
Q Consensus 678 ------------------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~ 721 (823)
+++|++.+|+|+|+.+|+||||||+|||++.++++||+|||+|+
T Consensus 131 ~~~~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~ 210 (412)
T 2vd5_A 131 QDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCL 210 (412)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred eeCCEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhhe
Confidence 46789999999999999999999999999999999999999998
Q ss_pred ccCCCCccccccccccCCCcCcccccC-------CCccccccceehhhhhhccccCCCCCcCCC
Q 045449 722 LLSGEDQLSKQTQTLATIGYMAPEYGT-------KGRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 722 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
....... ......+||+.|+|||++. ...|+.++||||+||++|+|++|..||...
T Consensus 211 ~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~ 273 (412)
T 2vd5_A 211 KLRADGT-VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYAD 273 (412)
T ss_dssp ECCTTSC-EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred eccCCCc-cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCC
Confidence 7654332 1223468999999999986 457899999999999999999999999664
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=3.9e-25 Score=250.11 Aligned_cols=149 Identities=28% Similarity=0.322 Sum_probs=124.5
Q ss_pred hccCCccceeeccC------------CeEEEEEEehHh--hHHHHHHHHHHHHHHhhcchhhHHH---------------
Q 045449 627 TDRFSENNLIGIGN------------GMEVAVKVFHQQ--YERALKSFEDECEVRKRIRHRNLVK--------------- 677 (823)
Q Consensus 627 t~~f~~~~~lg~g~------------~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~--------------- 677 (823)
.++|...+.||.|+ ++.||||++... .....+++.+|+.++++++|||||+
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 46788889999986 567999999653 3445678999999999999999997
Q ss_pred ----------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCcc
Q 045449 678 ----------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQL 729 (823)
Q Consensus 678 ----------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~ 729 (823)
++.|++.+|+|+|+.+|+||||||+|||++.++.+||+|||+|+......
T Consensus 141 ~~~lv~E~~~~~l~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-- 218 (464)
T 3ttj_A 141 DVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF-- 218 (464)
T ss_dssp EEEEEEECCSEEHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC-----CC--
T ss_pred eEEEEEeCCCCCHHHHHhhcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeecCCCc--
Confidence 36789999999999999999999999999999999999999998764332
Q ss_pred ccccccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCCC
Q 045449 730 SKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 730 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
.....+||+.|+|||++.+..|+.++||||+||++|++++|+.||.+.
T Consensus 219 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~ 266 (464)
T 3ttj_A 219 -MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR 266 (464)
T ss_dssp -CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred -ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 234568999999999999999999999999999999999999999764
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.90 E-value=3.4e-25 Score=243.63 Aligned_cols=147 Identities=30% Similarity=0.355 Sum_probs=125.9
Q ss_pred ccCCccceeeccC------------CeEEEEEEehHhh---HHHHHHHHHHHHHHhhcchhhHHH---------------
Q 045449 628 DRFSENNLIGIGN------------GMEVAVKVFHQQY---ERALKSFEDECEVRKRIRHRNLVK--------------- 677 (823)
Q Consensus 628 ~~f~~~~~lg~g~------------~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~--------------- 677 (823)
++|...+.||.|+ +..||||++.... ....+.+.+|++++++++|||||+
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 94 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV 94 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 5788888999886 5669999997543 223467889999999999999998
Q ss_pred -------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccc
Q 045449 678 -------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQ 732 (823)
Q Consensus 678 -------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~ 732 (823)
+++|++.+|+|+|+.||+||||||+|||++.++.+||+|||+|+...... ..
T Consensus 95 e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~---~~ 171 (384)
T 4fr4_A 95 DLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET---QI 171 (384)
T ss_dssp CCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTC---CB
T ss_pred ecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccCCC---ce
Confidence 46799999999999999999999999999999999999999998765432 23
Q ss_pred cccccCCCcCcccccCC---CccccccceehhhhhhccccCCCCCcCC
Q 045449 733 TQTLATIGYMAPEYGTK---GRVSTRGDVCSFGIISGGKETRSMTVGE 777 (823)
Q Consensus 733 ~~~~gt~~y~aPE~~~~---~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~ 777 (823)
...+||+.|+|||++.. ..|+.++||||+||++|++++|..||..
T Consensus 172 ~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~ 219 (384)
T 4fr4_A 172 TTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHI 219 (384)
T ss_dssp CCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred eccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCC
Confidence 45689999999999864 4589999999999999999999999964
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=1.5e-25 Score=242.26 Aligned_cols=163 Identities=37% Similarity=0.534 Sum_probs=137.2
Q ss_pred ccccccCHHHHHHHhccCCccceeeccC-----------CeEEEEEEehHhhH-HHHHHHHHHHHHHhhcchhhHHH---
Q 045449 613 QAIRRFSYHELLRATDRFSENNLIGIGN-----------GMEVAVKVFHQQYE-RALKSFEDECEVRKRIRHRNLVK--- 677 (823)
Q Consensus 613 ~~~~~~~~~~l~~at~~f~~~~~lg~g~-----------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~--- 677 (823)
...+.|++.++..++++|...+.||.|+ +..||||++..... .....|.+|++++++++||||++
T Consensus 15 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~ 94 (326)
T 3uim_A 15 GQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRG 94 (326)
T ss_dssp CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCE
T ss_pred CccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEE
Confidence 4567899999999999999999999986 56699999975542 22237899999999999999998
Q ss_pred -----------------------------------------HHHHHHHHhhhcCCC---CEEeccCCCCCEEeCCCCcEE
Q 045449 678 -----------------------------------------IISSSLEYLHFGHSI---PIIHCDLKPSNVLLDEDMVAH 713 (823)
Q Consensus 678 -----------------------------------------~~~~~l~~L~~~h~~---~ivHrdlk~~NiLl~~~~~~k 713 (823)
++.|++.+|+|+|+. +|+||||||+||+++.++.+|
T Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~k 174 (326)
T 3uim_A 95 FCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV 174 (326)
T ss_dssp EECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEE
T ss_pred EEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEE
Confidence 345677777778877 999999999999999999999
Q ss_pred EeecccccccCCCCccccccccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcC
Q 045449 714 ISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVG 776 (823)
Q Consensus 714 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~ 776 (823)
|+|||+++....... .......||+.|+|||++.+..++.++||||+||+++++++|..||.
T Consensus 175 l~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 236 (326)
T 3uim_A 175 VGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 236 (326)
T ss_dssp ECCCSSCEECCSSSS-CEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBC
T ss_pred eccCccccccCcccc-cccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCccc
Confidence 999999987643332 22344569999999999988889999999999999999999999985
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.90 E-value=2.5e-25 Score=242.64 Aligned_cols=150 Identities=24% Similarity=0.250 Sum_probs=124.1
Q ss_pred hccCCccceeeccC------------CeEEEEEEehHhh---HHHHHHHHHHHHHHhhc-chhhHHH-------------
Q 045449 627 TDRFSENNLIGIGN------------GMEVAVKVFHQQY---ERALKSFEDECEVRKRI-RHRNLVK------------- 677 (823)
Q Consensus 627 t~~f~~~~~lg~g~------------~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~------------- 677 (823)
.++|...+.||+|+ +..||||++.... ....+.+.+|++++.++ +||||++
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 101 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF 101 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence 46888889999986 5679999997653 23446788999999988 7999998
Q ss_pred ---------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccc
Q 045449 678 ---------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLS 730 (823)
Q Consensus 678 ---------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~ 730 (823)
+++|++.+|+|+|+.+|+||||||+|||++.++++||+|||+|+...... .
T Consensus 102 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~--~ 179 (353)
T 3txo_A 102 VMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNG--V 179 (353)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC-----
T ss_pred EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeecccCC--c
Confidence 46789999999999999999999999999999999999999998643222 2
Q ss_pred cccccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCCC
Q 045449 731 KQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 731 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
.....+||+.|+|||++.+..|+.++||||+||++|+|++|..||...
T Consensus 180 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~ 227 (353)
T 3txo_A 180 TTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAE 227 (353)
T ss_dssp ------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCC
Confidence 234568999999999999889999999999999999999999999654
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.90 E-value=6e-25 Score=249.16 Aligned_cols=144 Identities=29% Similarity=0.379 Sum_probs=112.5
Q ss_pred hccCCccceeeccC------------CeEEEEEEehHh--hHHHHHHHHHHHHHHhhcchhhHHH---------------
Q 045449 627 TDRFSENNLIGIGN------------GMEVAVKVFHQQ--YERALKSFEDECEVRKRIRHRNLVK--------------- 677 (823)
Q Consensus 627 t~~f~~~~~lg~g~------------~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~--------------- 677 (823)
.++|...+.||.|+ +..||||++... .....+++.+|++++++++|||||+
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 36788888888875 567999998643 2445578999999999999999997
Q ss_pred -----------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCc
Q 045449 678 -----------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQ 728 (823)
Q Consensus 678 -----------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~ 728 (823)
++.|++.+|+|+|+.+|+||||||+|||++.++.+||+|||+|+.......
T Consensus 132 ~~lv~e~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~ 211 (458)
T 3rp9_A 132 LYVVLEIADSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPEN 211 (458)
T ss_dssp EEEEECCCSEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTSCTT
T ss_pred EEEEEeccccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhccCccc
Confidence 467899999999999999999999999999999999999999987642211
Q ss_pred c-------------------------ccccccccCCCcCccccc-CCCccccccceehhhhhhccccC
Q 045449 729 L-------------------------SKQTQTLATIGYMAPEYG-TKGRVSTRGDVCSFGIISGGKET 770 (823)
Q Consensus 729 ~-------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~S~Gvv~~~~~~ 770 (823)
. ...+..+||+.|+|||++ ....|+.++||||+||++|+|++
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~ellt 279 (458)
T 3rp9_A 212 GNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLN 279 (458)
T ss_dssp CCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHT
T ss_pred cccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHH
Confidence 0 123456789999999976 45679999999999999999998
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.90 E-value=6.2e-24 Score=220.41 Aligned_cols=193 Identities=22% Similarity=0.263 Sum_probs=162.2
Q ss_pred CCCccceeeeeCCCCCcEEEEEcCCCCCccccCcccCCCCCCcEEEccCCCCCCCCCCCCCCCCCCCEEECCCCcCcCCC
Q 045449 37 TSVCIWIGITCDVNSHRVIGLNISSFNLQGTITPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLDFSDNQLFGSL 116 (823)
Q Consensus 37 ~~~c~w~gv~c~~~~~~v~~L~L~~~~l~g~~~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~ 116 (823)
.+||.|.|++|.. ..+.+++++++++ .+|..+. ++|++|+|++|+|++..+..|.++++|++|+|++|.|++..
T Consensus 2 ~~Cp~~~gC~C~~---~~~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~ 75 (251)
T 3m19_A 2 KTCETVTGCTCNE---GKKEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLS 75 (251)
T ss_dssp --CHHHHSSEEEG---GGTEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCC
T ss_pred ccCCCCCceEcCC---CCeEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccC
Confidence 3699999999953 3457899999998 5666665 68999999999999999999999999999999999999999
Q ss_pred chhhhcCCCCcEEecccccccCccCccccCCCCCCccccccceeeeccceeeccCccccccchhhHHHHHhhcCCCcccC
Q 045449 117 SSFIFNMSSMTTIDLSINRLSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKEIGNLTKLKEIISTITNSTVCEI 196 (823)
Q Consensus 117 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~~l~~n~~~~~i 196 (823)
+..|.++++|++|+|++|++++..+.. |..+++|++|+|++|++++..+.
T Consensus 76 ~~~~~~l~~L~~L~L~~n~l~~~~~~~-------~~~l~~L~~L~L~~N~l~~~~~~----------------------- 125 (251)
T 3m19_A 76 AGVFDDLTELGTLGLANNQLASLPLGV-------FDHLTQLDKLYLGGNQLKSLPSG----------------------- 125 (251)
T ss_dssp TTTTTTCTTCCEEECTTSCCCCCCTTT-------TTTCTTCCEEECCSSCCCCCCTT-----------------------
T ss_pred HhHhccCCcCCEEECCCCcccccChhH-------hcccCCCCEEEcCCCcCCCcChh-----------------------
Confidence 999999999999999999998554443 48899999999999999854332
Q ss_pred CcccCCcchhhhhccccccccCCccccccCCCCCcEEEccCCcccccCCcccccCCCCccEEEeeccccccc
Q 045449 197 PREIGNLPYLARLALATNNLVGVVPVTIFNMSALKEISLLNNSLSGSLPSRIDLSLPNVETLNLGINSFSGT 268 (823)
Q Consensus 197 p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~Ls~N~l~~~ 268 (823)
.|..+++|++|+|++|+|++..+..|.++++|++|+|++|.++ .+|...+..+++|++|+|++|.+.+.
T Consensus 126 --~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~l~~N~~~c~ 194 (251)
T 3m19_A 126 --VFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQ-SVPHGAFDRLGKLQTITLFGNQFDCS 194 (251)
T ss_dssp --TTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCS-CCCTTTTTTCTTCCEEECCSCCBCTT
T ss_pred --HhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCC-ccCHHHHhCCCCCCEEEeeCCceeCC
Confidence 3455667888999999999888878999999999999999998 45544445589999999999999865
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.90 E-value=6.6e-24 Score=227.55 Aligned_cols=205 Identities=18% Similarity=0.142 Sum_probs=123.2
Q ss_pred CCCCeEEeecccccccCCCcc--CCCcccCcccccCccccCCCCcccccccccCCCCceEEEeecCCCCccCCccccccc
Q 045449 277 SKLSDLELGENLFSGFIPNTI--GNLRNLEFGNIADNYLTSSTPELSFLSSLTNCKKLKVLIVTGNPLDGILPKSIGNFS 354 (823)
Q Consensus 277 ~~L~~L~Ls~N~l~~~~p~~~--~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~ 354 (823)
++|++|++++|.+++..|..+ ..+++|++|+|++|.+++..+... ...+..+++|++|+|++|.++
T Consensus 91 ~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~-~~~~~~~~~L~~L~Ls~n~l~----------- 158 (310)
T 4glp_A 91 SRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLA-ELQQWLKPGLKVLSIAQAHSP----------- 158 (310)
T ss_dssp SCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHH-HHHTTBCSCCCEEEEECCSSC-----------
T ss_pred CceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhH-HHHhhhccCCCEEEeeCCCcc-----------
Confidence 446666666666666666555 556666666666666554322110 012234445555555555544
Q ss_pred cccceEEecCCcceeccCccccCcccccEEEcccCcCCCC--ch--hcccccCCCCEEEccCCCCCCcchH----hhhcC
Q 045449 355 LSLETILMANCSISGNIPQVVGNLSNLLVLELGGNNLTGP--IP--VTFSQLQTLQAFDLTRNKLAGPITD----ELCHL 426 (823)
Q Consensus 355 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~--~p--~~~~~l~~L~~L~Ls~N~l~~~~p~----~~~~l 426 (823)
+..|..|+.+++|++|||++|++.+. ++ ..+..+++|++|+|++|+++. ++. .+.++
T Consensus 159 --------------~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~~l 223 (310)
T 4glp_A 159 --------------AFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMET-PTGVCAALAAAG 223 (310)
T ss_dssp --------------CCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCC-HHHHHHHHHHHT
T ss_pred --------------hhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCc-hHHHHHHHHhcC
Confidence 44445555556666666666665542 11 223566677777777777752 222 24566
Q ss_pred CCCCEEEcccCcCcccccccccCC---CCCCeEeccCCccccccchhhhccCCCcEEeccccccccccCccccCCCCCcE
Q 045449 427 ARLHSLVLQGNKFSGSIPSCLGNL---TSVRVLYLGLNIFTSVLSSTIWNLKDILFIDVSSNFLDGPLSLDIGNLKVVIG 503 (823)
Q Consensus 427 ~~L~~L~Ls~N~l~g~~p~~~~~l---~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~ 503 (823)
++|++|||++|++++.+|..+..+ ++|++|+|++|+++. +|..+. ++|+.|||++|++++. |. +..++.|+.
T Consensus 224 ~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~~-lp~~~~--~~L~~L~Ls~N~l~~~-~~-~~~l~~L~~ 298 (310)
T 4glp_A 224 VQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLEQ-VPKGLP--AKLRVLDLSSNRLNRA-PQ-PDELPEVDN 298 (310)
T ss_dssp CCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCCS-CCSCCC--SCCSCEECCSCCCCSC-CC-TTSCCCCSC
T ss_pred CCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCCc-hhhhhc--CCCCEEECCCCcCCCC-ch-hhhCCCccE
Confidence 777777777777777667666665 577777777777773 555553 6778888888887763 22 466777888
Q ss_pred EEcccCCCCC
Q 045449 504 LDFSRNNLSG 513 (823)
Q Consensus 504 L~ls~N~l~g 513 (823)
|++++|+++.
T Consensus 299 L~L~~N~l~~ 308 (310)
T 4glp_A 299 LTLDGNPFLV 308 (310)
T ss_dssp EECSSTTTSC
T ss_pred EECcCCCCCC
Confidence 8888888763
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.90 E-value=1.5e-24 Score=233.19 Aligned_cols=146 Identities=27% Similarity=0.332 Sum_probs=126.6
Q ss_pred ccCCccceeeccC------------CeEEEEEEehHhhH---HHHHHHHHHHHHHhhcchhhHHH---------------
Q 045449 628 DRFSENNLIGIGN------------GMEVAVKVFHQQYE---RALKSFEDECEVRKRIRHRNLVK--------------- 677 (823)
Q Consensus 628 ~~f~~~~~lg~g~------------~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~--------------- 677 (823)
++|...+.||+|+ |+.||||++..... ...+.+.+|+.++++++||||++
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~ 85 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 85 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence 5677888888885 66799999976532 23467889999999999999998
Q ss_pred -------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccc
Q 045449 678 -------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQ 732 (823)
Q Consensus 678 -------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~ 732 (823)
+++|++.+|+|+|+.+|+||||||+||+++.++.+||+|||+++..... .
T Consensus 86 e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~-----~ 160 (318)
T 1fot_A 86 DYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-----T 160 (318)
T ss_dssp CCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC-----B
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCCc-----c
Confidence 3678999999999999999999999999999999999999999875432 2
Q ss_pred cccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCCC
Q 045449 733 TQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 733 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
...+||+.|+|||++.+..++.++||||+||++|++++|..||.+.
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 206 (318)
T 1fot_A 161 YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDS 206 (318)
T ss_dssp CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred ccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCC
Confidence 3467999999999999999999999999999999999999998654
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.90 E-value=4.9e-25 Score=234.98 Aligned_cols=149 Identities=27% Similarity=0.388 Sum_probs=122.3
Q ss_pred ccCCccceeeccC------------CeEEEEEEehHhhH--------------------------HHHHHHHHHHHHHhh
Q 045449 628 DRFSENNLIGIGN------------GMEVAVKVFHQQYE--------------------------RALKSFEDECEVRKR 669 (823)
Q Consensus 628 ~~f~~~~~lg~g~------------~~~vavK~~~~~~~--------------------------~~~~~~~~E~~~l~~ 669 (823)
++|...+.||.|+ +..||||++..... ...+.+.+|++++++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 92 (298)
T 2zv2_A 13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKK 92 (298)
T ss_dssp TTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHT
T ss_pred cceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHh
Confidence 5788888898885 57799999864321 123578999999999
Q ss_pred cchhhHHH-----------------------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCC
Q 045449 670 IRHRNLVK-----------------------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDE 708 (823)
Q Consensus 670 l~h~niv~-----------------------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~ 708 (823)
++||||++ ++.|++++|+|+|+.+|+||||||+||+++.
T Consensus 93 l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~ 172 (298)
T 2zv2_A 93 LDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGE 172 (298)
T ss_dssp CCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECT
T ss_pred CCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECC
Confidence 99999998 4678999999999999999999999999999
Q ss_pred CCcEEEeecccccccCCCCccccccccccCCCcCcccccCCCc---cccccceehhhhhhccccCCCCCcCCC
Q 045449 709 DMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGR---VSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 709 ~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
++.+||+|||+++....... ......||+.|+|||++.+.. ++.++||||+||++|++++|..||.+.
T Consensus 173 ~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 243 (298)
T 2zv2_A 173 DGHIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDE 243 (298)
T ss_dssp TSCEEECCCTTCEECSSSSC--EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CCCEEEecCCCccccccccc--cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCc
Confidence 99999999999987654322 233467999999999987655 478899999999999999999999764
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=99.90 E-value=6.6e-25 Score=241.28 Aligned_cols=152 Identities=28% Similarity=0.369 Sum_probs=127.2
Q ss_pred ccCCccceeeccC-------------------CeEEEEEEehHhh-HHHHHHHHHHHHHHhhc-chhhHHH---------
Q 045449 628 DRFSENNLIGIGN-------------------GMEVAVKVFHQQY-ERALKSFEDECEVRKRI-RHRNLVK--------- 677 (823)
Q Consensus 628 ~~f~~~~~lg~g~-------------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~--------- 677 (823)
++|...+.||+|+ +..||||+++... ....+++.+|+++++++ +||||++
T Consensus 81 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~ 160 (370)
T 2psq_A 81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 160 (370)
T ss_dssp GGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSS
T ss_pred HHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCC
Confidence 5677778888875 1248999997543 45567899999999999 8999998
Q ss_pred -----------------------------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCC
Q 045449 678 -----------------------------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDM 710 (823)
Q Consensus 678 -----------------------------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~ 710 (823)
++.|++.+|+|+|+.+|+||||||+|||++.++
T Consensus 161 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~ 240 (370)
T 2psq_A 161 PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENN 240 (370)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTC
T ss_pred CEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEECCCC
Confidence 134788899999999999999999999999999
Q ss_pred cEEEeecccccccCCCCccccccccccCCCcCcccccCCCccccccceehhhhhhccccC-CCCCcCCCc
Q 045449 711 VAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKET-RSMTVGETC 779 (823)
Q Consensus 711 ~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~-~~~~~~~~~ 779 (823)
.+||+|||+|+...............+|+.|+|||++.+..|+.++|||||||++|++++ |..||.+..
T Consensus 241 ~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~ 310 (370)
T 2psq_A 241 VMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP 310 (370)
T ss_dssp CEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred CEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCC
Confidence 999999999987654443333344567899999999999999999999999999999998 899987653
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=1.3e-24 Score=232.73 Aligned_cols=165 Identities=33% Similarity=0.465 Sum_probs=139.7
Q ss_pred cccccCHHHHHHHhccCCcc------ceeeccC----------CeEEEEEEehHhh----HHHHHHHHHHHHHHhhcchh
Q 045449 614 AIRRFSYHELLRATDRFSEN------NLIGIGN----------GMEVAVKVFHQQY----ERALKSFEDECEVRKRIRHR 673 (823)
Q Consensus 614 ~~~~~~~~~l~~at~~f~~~------~~lg~g~----------~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~ 673 (823)
....|++.++.+++++|... +.||.|+ +..||||++.... ....+.|.+|++++++++||
T Consensus 11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 90 (307)
T 2nru_A 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE 90 (307)
T ss_dssp CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEESSSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCT
T ss_pred CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEECCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCC
Confidence 45789999999999999988 8899986 5679999986422 34457899999999999999
Q ss_pred hHHH-------------------------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCC
Q 045449 674 NLVK-------------------------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDM 710 (823)
Q Consensus 674 niv~-------------------------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~ 710 (823)
||++ ++.|++.+|+|+|+.+|+||||||+||+++.++
T Consensus 91 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~ 170 (307)
T 2nru_A 91 NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAF 170 (307)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTC
T ss_pred CeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCC
Confidence 9998 356888999999999999999999999999999
Q ss_pred cEEEeecccccccCCCCccccccccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCCCc
Q 045449 711 VAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGETC 779 (823)
Q Consensus 711 ~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~~ 779 (823)
.+||+|||+++...............||+.|+|||++.+ .++.++||||+||+++++++|..||....
T Consensus 171 ~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 238 (307)
T 2nru_A 171 TAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHR 238 (307)
T ss_dssp CEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTB
T ss_pred cEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCc
Confidence 999999999987654333223344679999999998764 58999999999999999999999987643
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.90 E-value=6.7e-24 Score=227.49 Aligned_cols=201 Identities=16% Similarity=0.161 Sum_probs=166.0
Q ss_pred CCCceEEEeecCCCCccCCccc--cccccccceEEecCCcceeccC----ccccCcccccEEEcccCcCCCCchhccccc
Q 045449 329 CKKLKVLIVTGNPLDGILPKSI--GNFSLSLETILMANCSISGNIP----QVVGNLSNLLVLELGGNNLTGPIPVTFSQL 402 (823)
Q Consensus 329 l~~L~~L~Ls~N~l~~~~p~~~--~~~~~~L~~L~L~~N~l~~~~p----~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l 402 (823)
+++|++|++++|.+++..|..+ ..+ .+|++|++++|.+++..+ ..+..+++|++|+|++|++++..|..|..+
T Consensus 90 ~~~L~~L~l~~n~l~~~~~~~~~~~~~-~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l 168 (310)
T 4glp_A 90 YSRLKELTLEDLKITGTMPPLPLEATG-LALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAF 168 (310)
T ss_dssp HSCCCEEEEESCCCBSCCCCCSSSCCC-BCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCC
T ss_pred cCceeEEEeeCCEeccchhhhhhhccC-CCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccC
Confidence 4568888888888888888777 666 688889999988887655 345679999999999999998888999999
Q ss_pred CCCCEEEccCCCCCCc--ch--HhhhcCCCCCEEEcccCcCcccccc----cccCCCCCCeEeccCCccccccchhhhcc
Q 045449 403 QTLQAFDLTRNKLAGP--IT--DELCHLARLHSLVLQGNKFSGSIPS----CLGNLTSVRVLYLGLNIFTSVLSSTIWNL 474 (823)
Q Consensus 403 ~~L~~L~Ls~N~l~~~--~p--~~~~~l~~L~~L~Ls~N~l~g~~p~----~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 474 (823)
++|++|+|++|++.+. ++ ..+..+++|++|+|++|+++. +|. .++.+++|++|+|++|++++.+|..+..+
T Consensus 169 ~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~ 247 (310)
T 4glp_A 169 PALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMET-PTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRC 247 (310)
T ss_dssp TTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCC-HHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSC
T ss_pred CCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCc-hHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhc
Confidence 9999999999999763 22 224689999999999999973 333 35788999999999999999988888777
Q ss_pred ---CCCcEEeccccccccccCccccCCCCCcEEEcccCCCCCCCCCcccCccCCCCCCCCCCCcccccCCccc
Q 045449 475 ---KDILFIDVSSNFLDGPLSLDIGNLKVVIGLDFSRNNLSGDIPITIGEGEIPRGGPFANLTAKSFMGNELL 544 (823)
Q Consensus 475 ---~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~~~g~ip~~~~~~~~~~~~~~~n~~~ 544 (823)
++|++|+|++|.++ .+|..+. +.|+.|||++|++++. |....+..+..+.+.+|+..
T Consensus 248 ~~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~~----------~~~~~l~~L~~L~L~~N~l~ 307 (310)
T 4glp_A 248 MWSSALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNRA----------PQPDELPEVDNLTLDGNPFL 307 (310)
T ss_dssp CCCTTCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCSC----------CCTTSCCCCSCEECSSTTTS
T ss_pred cCcCcCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCCC----------chhhhCCCccEEECcCCCCC
Confidence 69999999999999 7787774 8999999999999952 22234567778889999764
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=99.90 E-value=3.8e-25 Score=235.38 Aligned_cols=151 Identities=28% Similarity=0.470 Sum_probs=122.7
Q ss_pred ccCCccceeeccC------------CeEEEEEEehH---hhHHHHHHHHHHHHHHhhcchhhHHH---------------
Q 045449 628 DRFSENNLIGIGN------------GMEVAVKVFHQ---QYERALKSFEDECEVRKRIRHRNLVK--------------- 677 (823)
Q Consensus 628 ~~f~~~~~lg~g~------------~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~--------------- 677 (823)
++|...+.||.|+ +..||||++.. ......+.|.+|+.++++++||||++
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 90 (294)
T 4eqm_A 11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVM 90 (294)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEE
Confidence 5677788888875 56799998843 22455678999999999999999998
Q ss_pred -------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccc
Q 045449 678 -------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQ 732 (823)
Q Consensus 678 -------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~ 732 (823)
++.|++.+|+|+|+.+|+||||||+||+++.++.+||+|||+++....... ...
T Consensus 91 e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~ 169 (294)
T 4eqm_A 91 EYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSL-TQT 169 (294)
T ss_dssp ECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC---------
T ss_pred eCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCccccccccc-ccc
Confidence 357889999999999999999999999999999999999999987643322 223
Q ss_pred cccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCCCc
Q 045449 733 TQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGETC 779 (823)
Q Consensus 733 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~~ 779 (823)
....||+.|+|||++.+..++.++||||+||++|++++|..||.+..
T Consensus 170 ~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~ 216 (294)
T 4eqm_A 170 NHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGET 216 (294)
T ss_dssp -----CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSC
T ss_pred CccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 34579999999999999999999999999999999999999997643
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.90 E-value=5.2e-25 Score=243.01 Aligned_cols=149 Identities=22% Similarity=0.225 Sum_probs=126.4
Q ss_pred hccCCccceeeccC------------CeEEEEEEehHhh---HHHHHHHHHHHHHHhhc-chhhHHH-------------
Q 045449 627 TDRFSENNLIGIGN------------GMEVAVKVFHQQY---ERALKSFEDECEVRKRI-RHRNLVK------------- 677 (823)
Q Consensus 627 t~~f~~~~~lg~g~------------~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~------------- 677 (823)
.++|...+.||+|+ ++.||||+++... ....+.+.+|..++.++ +|||||+
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 36788889999986 5679999997653 33345688999999887 8999998
Q ss_pred ---------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccc
Q 045449 678 ---------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLS 730 (823)
Q Consensus 678 ---------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~ 730 (823)
+++|++.+|+|+|+.+|+||||||+|||++.++.+||+|||+|+...... .
T Consensus 131 V~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~--~ 208 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG--D 208 (396)
T ss_dssp EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT--C
T ss_pred EEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeecccCC--C
Confidence 46789999999999999999999999999999999999999998633222 1
Q ss_pred cccccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCC
Q 045449 731 KQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGE 777 (823)
Q Consensus 731 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~ 777 (823)
.....+||+.|+|||++.+..|+.++||||+||++|+|++|..||..
T Consensus 209 ~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~ 255 (396)
T 4dc2_A 209 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 255 (396)
T ss_dssp CBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTT
T ss_pred ccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcc
Confidence 23457899999999999999999999999999999999999999953
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=3.2e-25 Score=239.16 Aligned_cols=152 Identities=26% Similarity=0.371 Sum_probs=125.4
Q ss_pred hccCCccceeeccC------------CeEEEEEEehHhh-HHHHHHHHHHHHHHhhcchhhHHH----------------
Q 045449 627 TDRFSENNLIGIGN------------GMEVAVKVFHQQY-ERALKSFEDECEVRKRIRHRNLVK---------------- 677 (823)
Q Consensus 627 t~~f~~~~~lg~g~------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~---------------- 677 (823)
.++|...+.||+|+ ++.||||++.... ....+.+.+|+.++++++||||++
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 35788888899886 5679999986433 333467899999999999999998
Q ss_pred ------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCcccccc
Q 045449 678 ------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQT 733 (823)
Q Consensus 678 ------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~ 733 (823)
++.|++.+|+|+|+.+|+||||||+||+++.++.+||+|||+++............
T Consensus 86 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 165 (323)
T 3tki_A 86 YCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN 165 (323)
T ss_dssp CCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBC
T ss_pred cCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCcccccC
Confidence 46789999999999999999999999999999999999999998764333323334
Q ss_pred ccccCCCcCcccccCCCcc-ccccceehhhhhhccccCCCCCcCCC
Q 045449 734 QTLATIGYMAPEYGTKGRV-STRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 734 ~~~gt~~y~aPE~~~~~~~-~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
..+||+.|+|||++.+..+ +.++||||+||++|++++|..||...
T Consensus 166 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 211 (323)
T 3tki_A 166 KMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQP 211 (323)
T ss_dssp SCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSS
T ss_pred CCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCC
Confidence 5689999999999887775 78899999999999999999999754
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=99.90 E-value=2.7e-25 Score=240.35 Aligned_cols=152 Identities=24% Similarity=0.312 Sum_probs=121.5
Q ss_pred ccCCccceeeccC------------C----eEEEEEEehHhh-HHHHHHHHHHHHHHhhcchhhHHH-------------
Q 045449 628 DRFSENNLIGIGN------------G----MEVAVKVFHQQY-ERALKSFEDECEVRKRIRHRNLVK------------- 677 (823)
Q Consensus 628 ~~f~~~~~lg~g~------------~----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~------------- 677 (823)
++|...+.||.|+ + ..||+|.+.... ....++|.+|++++++++||||++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~v 94 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLI 94 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSSEEEE
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEE
Confidence 5677788888886 1 236888886443 344578999999999999999997
Q ss_pred ---------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccc
Q 045449 678 ---------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLS 730 (823)
Q Consensus 678 ---------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~ 730 (823)
++.|++.+|+|+|+.+|+||||||+|||++.++.+||+|||+|+.........
T Consensus 95 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 174 (327)
T 3poz_A 95 TQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY 174 (327)
T ss_dssp EECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTTCC--
T ss_pred EEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEccCCcccc
Confidence 35788999999999999999999999999999999999999999875544433
Q ss_pred cccccccCCCcCcccccCCCccccccceehhhhhhccccC-CCCCcCCCc
Q 045449 731 KQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKET-RSMTVGETC 779 (823)
Q Consensus 731 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~-~~~~~~~~~ 779 (823)
......||+.|+|||++.+..++.++|||||||++|++++ |..||....
T Consensus 175 ~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 224 (327)
T 3poz_A 175 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP 224 (327)
T ss_dssp -----CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred cccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCC
Confidence 3344567889999999999999999999999999999999 999997653
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=1.4e-24 Score=236.20 Aligned_cols=148 Identities=23% Similarity=0.231 Sum_probs=127.2
Q ss_pred ccCCccceeeccC------------CeEEEEEEehHhh---HHHHHHHHHHHHHHhhc-chhhHHH--------------
Q 045449 628 DRFSENNLIGIGN------------GMEVAVKVFHQQY---ERALKSFEDECEVRKRI-RHRNLVK-------------- 677 (823)
Q Consensus 628 ~~f~~~~~lg~g~------------~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~-------------- 677 (823)
++|...+.||+|+ ++.||||++.... ....+.+.+|+.++.++ +||||++
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 5678888899886 6779999997543 44557789999999988 8999998
Q ss_pred --------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCcccc
Q 045449 678 --------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSK 731 (823)
Q Consensus 678 --------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~ 731 (823)
+++|++.+|+|+|+.+|+||||||+|||++.++.+||+|||+|+....... .
T Consensus 89 ~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~~--~ 166 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--T 166 (345)
T ss_dssp ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTTC--C
T ss_pred EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccCCCC--c
Confidence 467899999999999999999999999999999999999999986432221 2
Q ss_pred ccccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCC
Q 045449 732 QTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGE 777 (823)
Q Consensus 732 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~ 777 (823)
....+||+.|+|||++.+..|+.++||||+||++|++++|..||..
T Consensus 167 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 212 (345)
T 3a8x_A 167 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 212 (345)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred ccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCC
Confidence 3456899999999999999999999999999999999999999964
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.89 E-value=1.2e-24 Score=241.25 Aligned_cols=153 Identities=24% Similarity=0.320 Sum_probs=120.9
Q ss_pred HhccCCccceeeccC------------CeEEEEEEehHh--hHHHHHHHHHHHHHHhhcc-hhhHHH-------------
Q 045449 626 ATDRFSENNLIGIGN------------GMEVAVKVFHQQ--YERALKSFEDECEVRKRIR-HRNLVK------------- 677 (823)
Q Consensus 626 at~~f~~~~~lg~g~------------~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~------------- 677 (823)
..++|...+.||.|+ |..||||++... .....+++.+|+.++.++. ||||++
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 86 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence 456788888888875 677999998543 2445577889999999997 999998
Q ss_pred ---------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCC---
Q 045449 678 ---------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGED--- 727 (823)
Q Consensus 678 ---------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~--- 727 (823)
++.|++.+|+|+|+.||+||||||+|||++.++.+||+|||+|+......
T Consensus 87 ~lv~e~~~~~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~ 166 (388)
T 3oz6_A 87 YLVFDYMETDLHAVIRANILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVT 166 (388)
T ss_dssp EEEEECCSEEHHHHHHHTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSCCCCC
T ss_pred EEEecccCcCHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCccccccccccccc
Confidence 35789999999999999999999999999999999999999998753211
Q ss_pred ----------------ccccccccccCCCcCcccccCC-CccccccceehhhhhhccccCCCCCcCCC
Q 045449 728 ----------------QLSKQTQTLATIGYMAPEYGTK-GRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 728 ----------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
.....+..+||+.|+|||++.+ ..|+.++||||+||+++++++|..||.+.
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 234 (388)
T 3oz6_A 167 NNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGS 234 (388)
T ss_dssp CCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Confidence 0112344689999999999876 67899999999999999999999999664
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=8.6e-25 Score=237.45 Aligned_cols=152 Identities=25% Similarity=0.256 Sum_probs=128.4
Q ss_pred HHhccCCccceeeccC------------CeEEEEEEehHhh---HHHHHHHHHHHHHHhhc-chhhHHH-----------
Q 045449 625 RATDRFSENNLIGIGN------------GMEVAVKVFHQQY---ERALKSFEDECEVRKRI-RHRNLVK----------- 677 (823)
Q Consensus 625 ~at~~f~~~~~lg~g~------------~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~----------- 677 (823)
...++|...+.||+|+ ++.||||+++... ....+.+..|.+++.++ +||||++
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~ 93 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL 93 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence 3457899999999986 6679999997653 22346788899999887 9999998
Q ss_pred -----------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCc
Q 045449 678 -----------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQ 728 (823)
Q Consensus 678 -----------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~ 728 (823)
+++|++.+|+|+|+.+|+||||||+|||++.++.+||+|||+|+.......
T Consensus 94 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~ 173 (345)
T 1xjd_A 94 FFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA 173 (345)
T ss_dssp EEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhcccCCC
Confidence 467899999999999999999999999999999999999999986432221
Q ss_pred cccccccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCCC
Q 045449 729 LSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 729 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
.....+||+.|+|||++.+..|+.++||||+||++|++++|..||.+.
T Consensus 174 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~ 221 (345)
T 1xjd_A 174 --KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQ 221 (345)
T ss_dssp --CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred --cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCC
Confidence 234568999999999999999999999999999999999999999654
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.89 E-value=1.6e-24 Score=235.23 Aligned_cols=253 Identities=13% Similarity=0.146 Sum_probs=167.0
Q ss_pred CCcEEEccCCcccccCCcccccCC--CCccEEEeeccccccccCccccCCCCCCeEEeeccccccc-CCCccCCCcccCc
Q 045449 229 ALKEISLLNNSLSGSLPSRIDLSL--PNVETLNLGINSFSGTIPSSITNSSKLSDLELGENLFSGF-IPNTIGNLRNLEF 305 (823)
Q Consensus 229 ~L~~L~Ls~N~l~g~lp~~~~~~l--~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~ 305 (823)
.++.+++++|.+. |..+.. + ++++.|++++|.+.+..+. +..+++|++|+|++|.+++. +|..+..+++|++
T Consensus 48 ~~~~l~l~~~~~~---~~~~~~-~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~ 122 (336)
T 2ast_B 48 LWQTLDLTGKNLH---PDVTGR-LLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQN 122 (336)
T ss_dssp TSSEEECTTCBCC---HHHHHH-HHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSE
T ss_pred hheeeccccccCC---HHHHHh-hhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCE
Confidence 3677788777765 222222 3 5677777777777665544 44566677777776666544 4555555555555
Q ss_pred ccccCccccCCCCcccccccccCCCCceEEEeecCCCCccCCccccccccccceEEecCC-cceec-cCccccCcccccE
Q 045449 306 GNIADNYLTSSTPELSFLSSLTNCKKLKVLIVTGNPLDGILPKSIGNFSLSLETILMANC-SISGN-IPQVVGNLSNLLV 383 (823)
Q Consensus 306 L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N-~l~~~-~p~~~~~l~~L~~ 383 (823)
|+|++|.+ ++..|..+..+ ++|++|++++| .+++. ++..+.++++|++
T Consensus 123 L~L~~~~l-----------------------------~~~~~~~l~~~-~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~ 172 (336)
T 2ast_B 123 LSLEGLRL-----------------------------SDPIVNTLAKN-SNLVRLNLSGCSGFSEFALQTLLSSCSRLDE 172 (336)
T ss_dssp EECTTCBC-----------------------------CHHHHHHHTTC-TTCSEEECTTCBSCCHHHHHHHHHHCTTCCE
T ss_pred EeCcCccc-----------------------------CHHHHHHHhcC-CCCCEEECCCCCCCCHHHHHHHHhcCCCCCE
Confidence 55555544 44444444444 45555555555 45442 4555667778888
Q ss_pred EEcccC-cCCCC-chhcccccC-CCCEEEccCC--CCC-CcchHhhhcCCCCCEEEcccCc-CcccccccccCCCCCCeE
Q 045449 384 LELGGN-NLTGP-IPVTFSQLQ-TLQAFDLTRN--KLA-GPITDELCHLARLHSLVLQGNK-FSGSIPSCLGNLTSVRVL 456 (823)
Q Consensus 384 L~Ls~N-~l~g~-~p~~~~~l~-~L~~L~Ls~N--~l~-~~~p~~~~~l~~L~~L~Ls~N~-l~g~~p~~~~~l~~L~~L 456 (823)
|++++| .+++. ++..+..++ +|++|+|++| .++ +.+|..+..+++|+.|+|++|. +++..+..+..+++|+.|
T Consensus 173 L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~~L 252 (336)
T 2ast_B 173 LNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHL 252 (336)
T ss_dssp EECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEE
T ss_pred EcCCCCCCcChHHHHHHHHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCCCCCEe
Confidence 888888 77754 566677788 8888888888 555 4567777788888888888888 777777788888888888
Q ss_pred eccCCc-cccccchhhhccCCCcEEeccccccccccCccccCC-CCCcEEEcccCCCCCCCCCccc
Q 045449 457 YLGLNI-FTSVLSSTIWNLKDILFIDVSSNFLDGPLSLDIGNL-KVVIGLDFSRNNLSGDIPITIG 520 (823)
Q Consensus 457 ~Ls~N~-l~~~~p~~~~~l~~L~~LdLs~N~l~g~~p~~~~~l-~~L~~L~ls~N~l~g~ip~~~~ 520 (823)
++++|. ++......+..+++|+.|++++| ++. ..+..+ ..+..|++++|+++|.+|..++
T Consensus 253 ~l~~~~~~~~~~~~~l~~~~~L~~L~l~~~-i~~---~~~~~l~~~l~~L~l~~n~l~~~~~~~~~ 314 (336)
T 2ast_B 253 SLSRCYDIIPETLLELGEIPTLKTLQVFGI-VPD---GTLQLLKEALPHLQINCSHFTTIARPTIG 314 (336)
T ss_dssp ECTTCTTCCGGGGGGGGGCTTCCEEECTTS-SCT---TCHHHHHHHSTTSEESCCCSCCTTCSSCS
T ss_pred eCCCCCCCCHHHHHHHhcCCCCCEEeccCc-cCH---HHHHHHHhhCcceEEecccCccccCCccc
Confidence 888884 33332336778888999999988 332 233333 2366677899999988777664
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=1e-24 Score=244.87 Aligned_cols=151 Identities=26% Similarity=0.373 Sum_probs=128.1
Q ss_pred HhccCCccceeeccC------------CeEEEEEEehHhh--HHHHHHHHHHHHHHhhcchhhHHH--------------
Q 045449 626 ATDRFSENNLIGIGN------------GMEVAVKVFHQQY--ERALKSFEDECEVRKRIRHRNLVK-------------- 677 (823)
Q Consensus 626 at~~f~~~~~lg~g~------------~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~-------------- 677 (823)
..++|...+.||.|+ |..||+|++.... ....+.+.+|++++++++||||++
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI 88 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence 356788889999886 5679999986432 344578999999999999999998
Q ss_pred --------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeC---CCCcEEEeecccccccCCCCc
Q 045449 678 --------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLD---EDMVAHISDFGIAKLLSGEDQ 728 (823)
Q Consensus 678 --------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~---~~~~~kl~DfGla~~~~~~~~ 728 (823)
++.|++++|+|+|+.+|+||||||+|||++ .++.+||+|||+|+.......
T Consensus 89 ~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~ 168 (444)
T 3soa_A 89 FDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQ 168 (444)
T ss_dssp ECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCC
T ss_pred EEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCCc
Confidence 467899999999999999999999999998 467899999999987654322
Q ss_pred cccccccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCCC
Q 045449 729 LSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 729 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
.....+||+.|+|||++.+..|+.++||||+||++|++++|..||.+.
T Consensus 169 --~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~ 216 (444)
T 3soa_A 169 --AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDE 216 (444)
T ss_dssp --BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred --eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCc
Confidence 234567999999999999989999999999999999999999998654
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=99.89 E-value=6.7e-25 Score=239.02 Aligned_cols=146 Identities=23% Similarity=0.313 Sum_probs=127.1
Q ss_pred ccCCccceeeccC------------CeEEEEEEehHhhH---HHHHHHHHHHHHHhhcchhhHHH---------------
Q 045449 628 DRFSENNLIGIGN------------GMEVAVKVFHQQYE---RALKSFEDECEVRKRIRHRNLVK--------------- 677 (823)
Q Consensus 628 ~~f~~~~~lg~g~------------~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~--------------- 677 (823)
++|...+.||.|+ |..||||++..... ...+.+.+|++++++++||||++
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 5788888888885 56799999975532 23467899999999999999998
Q ss_pred -------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccc
Q 045449 678 -------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQ 732 (823)
Q Consensus 678 -------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~ 732 (823)
+++|++.+|+|+|+.+|+||||||+|||++.++.+||+|||+++..... .
T Consensus 121 e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~-----~ 195 (350)
T 1rdq_E 121 EYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----T 195 (350)
T ss_dssp ECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-----B
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccCC-----c
Confidence 4678999999999999999999999999999999999999999876432 2
Q ss_pred cccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCCC
Q 045449 733 TQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 733 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
...+||+.|+|||++.+..++.++||||+||++|++++|..||...
T Consensus 196 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~ 241 (350)
T 1rdq_E 196 WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD 241 (350)
T ss_dssp CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCC
Confidence 3467999999999999999999999999999999999999999764
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=99.89 E-value=8.7e-25 Score=239.50 Aligned_cols=150 Identities=27% Similarity=0.427 Sum_probs=128.0
Q ss_pred HhccCCccceeeccC------------CeEEEEEEehHhh--HHHHHHHHHHHHHHhhcchhhHHH--------------
Q 045449 626 ATDRFSENNLIGIGN------------GMEVAVKVFHQQY--ERALKSFEDECEVRKRIRHRNLVK-------------- 677 (823)
Q Consensus 626 at~~f~~~~~lg~g~------------~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~-------------- 677 (823)
..++|...+.||.|+ +..||||++.... ....+.+.+|++++++++||||++
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 456788889999886 6679999996442 345578999999999999999998
Q ss_pred --------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCC---CcEEEeecccccccCCCCc
Q 045449 678 --------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDED---MVAHISDFGIAKLLSGEDQ 728 (823)
Q Consensus 678 --------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~---~~~kl~DfGla~~~~~~~~ 728 (823)
++.|++++|+|+|+.+|+||||||+||+++.+ +.+||+|||+++.......
T Consensus 107 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~~ 186 (362)
T 2bdw_A 107 FDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA 186 (362)
T ss_dssp ECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCCS
T ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCCcc
Confidence 36789999999999999999999999999864 4699999999987653322
Q ss_pred cccccccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCCC
Q 045449 729 LSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 729 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
....+||+.|+|||++.+..|+.++||||+||++|++++|..||.+.
T Consensus 187 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~ 233 (362)
T 2bdw_A 187 ---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDE 233 (362)
T ss_dssp ---CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ---cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence 23467999999999999989999999999999999999999998664
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=9.7e-25 Score=239.80 Aligned_cols=149 Identities=17% Similarity=0.128 Sum_probs=123.7
Q ss_pred HhccCCccceeeccC-----------------CeEEEEEEehHhhHHHHHHHHHHHHHHhhcc---hhhHHH--------
Q 045449 626 ATDRFSENNLIGIGN-----------------GMEVAVKVFHQQYERALKSFEDECEVRKRIR---HRNLVK-------- 677 (823)
Q Consensus 626 at~~f~~~~~lg~g~-----------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~-------- 677 (823)
..++|...+.||+|+ +..||||++..... .++.+|++++.+++ |+||++
T Consensus 63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~ 139 (365)
T 3e7e_A 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANP---WEFYIGTQLMERLKPSMQHMFMKFYSAHLFQ 139 (365)
T ss_dssp SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCH---HHHHHHHHHHHHSCGGGGGGBCCEEEEEECS
T ss_pred CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCCh---hHHHHHHHHHHHhhhhhhhhhhhhheeeecC
Confidence 346788888888876 34589999876543 46777888888776 899887
Q ss_pred -------------------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCC-----------C
Q 045449 678 -------------------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDE-----------D 709 (823)
Q Consensus 678 -------------------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~-----------~ 709 (823)
++.|++.+|+|+|+.+|+||||||+|||++. +
T Consensus 140 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~~~ 219 (365)
T 3e7e_A 140 NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLS 219 (365)
T ss_dssp SCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC------C
T ss_pred CCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCcccccccc
Confidence 3578899999999999999999999999998 8
Q ss_pred CcEEEeecccccccCCCCccccccccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCC
Q 045449 710 MVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGE 777 (823)
Q Consensus 710 ~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~ 777 (823)
+.+||+|||+|+.+............+||+.|+|||++.+..|+.++|||||||++|++++|+.||..
T Consensus 220 ~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~ 287 (365)
T 3e7e_A 220 AGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVK 287 (365)
T ss_dssp TTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEE
T ss_pred CCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCcccc
Confidence 99999999999765433222334567899999999999999999999999999999999999999854
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=99.89 E-value=9.7e-25 Score=238.30 Aligned_cols=151 Identities=25% Similarity=0.325 Sum_probs=127.1
Q ss_pred hccCCccceeeccC------------CeEEEEEEehHhhHH-----HHHHHHHHHHHHhhcchhhHHH------------
Q 045449 627 TDRFSENNLIGIGN------------GMEVAVKVFHQQYER-----ALKSFEDECEVRKRIRHRNLVK------------ 677 (823)
Q Consensus 627 t~~f~~~~~lg~g~------------~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~------------ 677 (823)
.++|...+.||+|+ ++.||||++...... ..+.+.+|++++++++||||++
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 35688888999886 677999999654321 2467999999999999999998
Q ss_pred --------------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCC---cEEEeecccccc
Q 045449 678 --------------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDM---VAHISDFGIAKL 722 (823)
Q Consensus 678 --------------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~---~~kl~DfGla~~ 722 (823)
++.|++++|+|+|+.+|+||||||+||+++.++ .+||+|||+++.
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~ 182 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ 182 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEE
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcceeE
Confidence 356889999999999999999999999998654 499999999987
Q ss_pred cCCCCccccccccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCCCc
Q 045449 723 LSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGETC 779 (823)
Q Consensus 723 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~~ 779 (823)
...... .....+||+.|+|||++.+..|+.++||||+||++|++++|..||.+..
T Consensus 183 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 237 (351)
T 3c0i_A 183 LGESGL--VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK 237 (351)
T ss_dssp CCTTSC--BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH
T ss_pred ecCCCe--eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH
Confidence 654322 2334679999999999999999999999999999999999999997653
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=5.7e-25 Score=239.44 Aligned_cols=152 Identities=25% Similarity=0.369 Sum_probs=119.6
Q ss_pred ccCCccceeeccC-----------CeEEEEEEehHh--hHHHHHHHHHHHHHHhhcch--hhHHH---------------
Q 045449 628 DRFSENNLIGIGN-----------GMEVAVKVFHQQ--YERALKSFEDECEVRKRIRH--RNLVK--------------- 677 (823)
Q Consensus 628 ~~f~~~~~lg~g~-----------~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h--~niv~--------------- 677 (823)
++|...+.||.|+ +..||||++... .....+.|.+|++++.+++| +||++
T Consensus 9 ~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 88 (343)
T 3dbq_A 9 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 88 (343)
T ss_dssp CEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEE
Confidence 4677778888876 566999998643 34556789999999999977 89987
Q ss_pred ------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCcccccc
Q 045449 678 ------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQT 733 (823)
Q Consensus 678 ------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~ 733 (823)
++.|++.+|+|+|+.+|+||||||+|||++ ++.+||+|||+++............
T Consensus 89 e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~~ 167 (343)
T 3dbq_A 89 ECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKD 167 (343)
T ss_dssp CCCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC----------
T ss_pred eCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCcccccccCC
Confidence 467899999999999999999999999997 5789999999998765443332334
Q ss_pred ccccCCCcCcccccCC-----------CccccccceehhhhhhccccCCCCCcCCCcc
Q 045449 734 QTLATIGYMAPEYGTK-----------GRVSTRGDVCSFGIISGGKETRSMTVGETCT 780 (823)
Q Consensus 734 ~~~gt~~y~aPE~~~~-----------~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~~~ 780 (823)
..+||+.|+|||++.+ ..++.++|||||||+++++++|..||.+...
T Consensus 168 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~ 225 (343)
T 3dbq_A 168 SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN 225 (343)
T ss_dssp --CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCS
T ss_pred CCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhh
Confidence 5679999999999854 6789999999999999999999999977543
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=1.6e-24 Score=233.65 Aligned_cols=151 Identities=25% Similarity=0.287 Sum_probs=126.2
Q ss_pred hccCCccceeeccC----------CeEEEEEEehHhhHHHHHHHHHHHHHHhhcchhhHHH-------------------
Q 045449 627 TDRFSENNLIGIGN----------GMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVK------------------- 677 (823)
Q Consensus 627 t~~f~~~~~lg~g~----------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------------- 677 (823)
.++|...+.||.|+ +..||||++..... ....+.+|+.++++++||||++
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~ 101 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQDK-QSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLIT 101 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEETTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred hhhchhhheecccCceEEEEEEECCCEEEEEEeecCch-HHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEE
Confidence 36788888999886 56799999976543 3356677999999999999998
Q ss_pred ------------------------HHHHHHHHhhhcCCC----------CEEeccCCCCCEEeCCCCcEEEeeccccccc
Q 045449 678 ------------------------IISSSLEYLHFGHSI----------PIIHCDLKPSNVLLDEDMVAHISDFGIAKLL 723 (823)
Q Consensus 678 ------------------------~~~~~l~~L~~~h~~----------~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~ 723 (823)
++.|++.+|+|+|+. +|+||||||+||+++.++.+||+|||+|+..
T Consensus 102 e~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a~~~ 181 (322)
T 3soc_A 102 AFHEKGSLSDFLKANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKF 181 (322)
T ss_dssp ECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTTCEEE
T ss_pred ecCCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCccccc
Confidence 356788888889988 9999999999999999999999999999877
Q ss_pred CCCCccccccccccCCCcCcccccCC-----CccccccceehhhhhhccccCCCCCcCCC
Q 045449 724 SGEDQLSKQTQTLATIGYMAPEYGTK-----GRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 724 ~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
.............||+.|+|||++.+ ..++.++|||||||++|++++|..||.+.
T Consensus 182 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~ 241 (322)
T 3soc_A 182 EAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGP 241 (322)
T ss_dssp CTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSC
T ss_pred ccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCC
Confidence 65444333445679999999999876 45778899999999999999999998764
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=7.1e-25 Score=238.90 Aligned_cols=150 Identities=23% Similarity=0.178 Sum_probs=127.8
Q ss_pred hccCCccceeeccC------------CeEEEEEEehHhhH---HHHHHHHHHHHHHhhc-chhhHHH-------------
Q 045449 627 TDRFSENNLIGIGN------------GMEVAVKVFHQQYE---RALKSFEDECEVRKRI-RHRNLVK------------- 677 (823)
Q Consensus 627 t~~f~~~~~lg~g~------------~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~h~niv~------------- 677 (823)
.++|...+.||+|+ ++.||||++..... ...+.+..|.+++.++ +||+|++
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 98 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 98 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence 46788889999986 45699999976532 2346788999999988 8999997
Q ss_pred ---------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccc
Q 045449 678 ---------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLS 730 (823)
Q Consensus 678 ---------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~ 730 (823)
+++|++.+|+|+|+.||+||||||+|||++.++++||+|||+|+.......
T Consensus 99 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~-- 176 (353)
T 2i0e_A 99 VMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV-- 176 (353)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC--
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcccccccCCc--
Confidence 467899999999999999999999999999999999999999986432221
Q ss_pred cccccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCCC
Q 045449 731 KQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 731 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
.....+||+.|+|||++.+..++.++||||+||++|+|++|..||.+.
T Consensus 177 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~ 224 (353)
T 2i0e_A 177 TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE 224 (353)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCC
Confidence 234568999999999999999999999999999999999999999764
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=99.89 E-value=2.3e-24 Score=229.08 Aligned_cols=147 Identities=25% Similarity=0.311 Sum_probs=123.5
Q ss_pred ccCCccceeeccC------------CeEEEEEEehHhh--HHHHHHHHHHHHHHhhcchhhHHH----------------
Q 045449 628 DRFSENNLIGIGN------------GMEVAVKVFHQQY--ERALKSFEDECEVRKRIRHRNLVK---------------- 677 (823)
Q Consensus 628 ~~f~~~~~lg~g~------------~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~---------------- 677 (823)
++|...+.||.|+ ++.||||++.... ....+.+.+|++++++++||||++
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 4677778888875 5679999986432 334467889999999999999998
Q ss_pred ------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCcccccc
Q 045449 678 ------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQT 733 (823)
Q Consensus 678 ------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~ 733 (823)
++.|++.+|+|+|+.+|+||||||+||+++.++.+||+|||+++...... ....
T Consensus 82 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~ 159 (292)
T 3o0g_A 82 FCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV--RCYS 159 (292)
T ss_dssp CCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCC--SCCC
T ss_pred cCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCcc--cccc
Confidence 36789999999999999999999999999999999999999998764322 2234
Q ss_pred ccccCCCcCcccccCCCc-cccccceehhhhhhccccCCCCCcC
Q 045449 734 QTLATIGYMAPEYGTKGR-VSTRGDVCSFGIISGGKETRSMTVG 776 (823)
Q Consensus 734 ~~~gt~~y~aPE~~~~~~-~~~~~Dv~S~Gvv~~~~~~~~~~~~ 776 (823)
...||+.|+|||++.+.. ++.++||||+||++++++++..|+.
T Consensus 160 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~ 203 (292)
T 3o0g_A 160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLF 203 (292)
T ss_dssp SCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSC
T ss_pred CCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCc
Confidence 467899999999987766 7999999999999999999888853
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=99.89 E-value=1.4e-24 Score=248.02 Aligned_cols=149 Identities=26% Similarity=0.291 Sum_probs=128.5
Q ss_pred ccCCccceeeccC------------CeEEEEEEehHhhH---HHHHHHHHHHHHHhhcchhhHHH---------------
Q 045449 628 DRFSENNLIGIGN------------GMEVAVKVFHQQYE---RALKSFEDECEVRKRIRHRNLVK--------------- 677 (823)
Q Consensus 628 ~~f~~~~~lg~g~------------~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~--------------- 677 (823)
++|...+.||+|+ |+.||||++..... ...+.+.+|++++++++||||++
T Consensus 185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm 264 (543)
T 3c4z_A 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM 264 (543)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence 5677778899886 67799999976542 23467899999999999999998
Q ss_pred -----------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCc
Q 045449 678 -----------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQ 728 (823)
Q Consensus 678 -----------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~ 728 (823)
+++|++.+|+|+|+.+|+||||||+|||++.++.+||+|||+++.......
T Consensus 265 E~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~~ 344 (543)
T 3c4z_A 265 TIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQT 344 (543)
T ss_dssp CCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCC
T ss_pred EeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeeccCCCc
Confidence 367899999999999999999999999999999999999999987654322
Q ss_pred cccccccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCCC
Q 045449 729 LSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 729 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
.....+||+.|+|||++.+..|+.++||||+||++|+|++|..||...
T Consensus 345 --~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~ 392 (543)
T 3c4z_A 345 --KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRAR 392 (543)
T ss_dssp --CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCT
T ss_pred --ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCC
Confidence 223458999999999999999999999999999999999999999764
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=2.4e-24 Score=231.13 Aligned_cols=150 Identities=26% Similarity=0.332 Sum_probs=124.2
Q ss_pred hccCCccceeeccC-----------CeEEEEEEehHhh--HHHHHHHHHHHHHHhhcchhhHHH----------------
Q 045449 627 TDRFSENNLIGIGN-----------GMEVAVKVFHQQY--ERALKSFEDECEVRKRIRHRNLVK---------------- 677 (823)
Q Consensus 627 t~~f~~~~~lg~g~-----------~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~---------------- 677 (823)
.++|...+.||.|+ +..||||++.... ....+.+.+|++++++++||||++
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 99 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE 99 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence 46788888899886 5679999987543 223467899999999999999998
Q ss_pred ------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCcccccc
Q 045449 678 ------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQT 733 (823)
Q Consensus 678 ------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~ 733 (823)
++.|++.+|+|+|+.+|+||||||+||+++.++.+||+|||+++....... ...
T Consensus 100 ~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~--~~~ 177 (311)
T 3niz_A 100 FMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVR--SYT 177 (311)
T ss_dssp CCSEEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC-----
T ss_pred CCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCCCcc--ccc
Confidence 367899999999999999999999999999999999999999987643222 234
Q ss_pred ccccCCCcCcccccCC-CccccccceehhhhhhccccCCCCCcCCC
Q 045449 734 QTLATIGYMAPEYGTK-GRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 734 ~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
...||+.|+|||++.+ ..++.++||||+||+++++++|..||.+.
T Consensus 178 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 223 (311)
T 3niz_A 178 HEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGV 223 (311)
T ss_dssp CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred CCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCC
Confidence 4578999999999876 56899999999999999999999999764
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=99.89 E-value=7.9e-25 Score=240.03 Aligned_cols=161 Identities=27% Similarity=0.346 Sum_probs=136.7
Q ss_pred cccccccCHHHHHHHhccCCccceeeccC------------CeEEEEEEehHhhHHHHHHHHHHHHHHhhcc-----hhh
Q 045449 612 PQAIRRFSYHELLRATDRFSENNLIGIGN------------GMEVAVKVFHQQYERALKSFEDECEVRKRIR-----HRN 674 (823)
Q Consensus 612 ~~~~~~~~~~~l~~at~~f~~~~~lg~g~------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h~n 674 (823)
......+++.+.....++|...+.||.|+ +..||||++... ....+.+..|+++++++. |||
T Consensus 19 ~~~~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~ 97 (360)
T 3llt_A 19 DDEIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNN 97 (360)
T ss_dssp -CGGGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGG
T ss_pred CccceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCC
Confidence 34566777777777889999999999986 567999999743 334467888999999996 999
Q ss_pred HHH-----------------------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCC-----
Q 045449 675 LVK-----------------------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDE----- 708 (823)
Q Consensus 675 iv~-----------------------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~----- 708 (823)
|++ ++.|++.+|+|+|+.+|+||||||+|||++.
T Consensus 98 iv~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~ 177 (360)
T 3llt_A 98 IVKYHGKFMYYDHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEK 177 (360)
T ss_dssp BCCEEEEEEETTEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCE
T ss_pred eecccceeeECCeeEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccc
Confidence 998 3678999999999999999999999999975
Q ss_pred --------------------CCcEEEeecccccccCCCCccccccccccCCCcCcccccCCCccccccceehhhhhhccc
Q 045449 709 --------------------DMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGK 768 (823)
Q Consensus 709 --------------------~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~ 768 (823)
++.+||+|||+|+..... .....||+.|+|||++.+..++.++||||+||++|++
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el 252 (360)
T 3llt_A 178 SLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAEL 252 (360)
T ss_dssp EEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHH
T ss_pred cccchhcccccccccccccCCCCEEEEeccCceecCCC-----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHH
Confidence 789999999999865432 2345799999999999999999999999999999999
Q ss_pred cCCCCCcCCC
Q 045449 769 ETRSMTVGET 778 (823)
Q Consensus 769 ~~~~~~~~~~ 778 (823)
++|..||...
T Consensus 253 l~g~~pf~~~ 262 (360)
T 3llt_A 253 YTGSLLFRTH 262 (360)
T ss_dssp HHSSCSCCCS
T ss_pred HHCCCCCCCC
Confidence 9999999654
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.89 E-value=1.2e-22 Score=210.74 Aligned_cols=182 Identities=21% Similarity=0.245 Sum_probs=153.2
Q ss_pred CceEEEeecCCCCccCCccccccccccceEEecCCcceeccCccccCcccccEEEcccCcCCCCchhcccccCCCCEEEc
Q 045449 331 KLKVLIVTGNPLDGILPKSIGNFSLSLETILMANCSISGNIPQVVGNLSNLLVLELGGNNLTGPIPVTFSQLQTLQAFDL 410 (823)
Q Consensus 331 ~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L 410 (823)
..+.++++++.++. +|..+. .++++|+|++|++++..+..|.++++|++|+|++|++++..|..|..+++|++|+|
T Consensus 15 ~~~~l~~~~~~l~~-~p~~~~---~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 90 (251)
T 3m19_A 15 GKKEVDCQGKSLDS-VPSGIP---ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGL 90 (251)
T ss_dssp GGTEEECTTCCCSS-CCSCCC---TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCeEEecCCCCccc-cCCCCC---CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEEC
Confidence 45667777777773 455443 57888888888888888888888899999999999998888888888899999999
Q ss_pred cCCCCCCcchHhhhcCCCCCEEEcccCcCcccccccccCCCCCCeEeccCCccccccchhhhccCCCcEEeccccccccc
Q 045449 411 TRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSVRVLYLGLNIFTSVLSSTIWNLKDILFIDVSSNFLDGP 490 (823)
Q Consensus 411 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~LdLs~N~l~g~ 490 (823)
++|++++..+..|..+++|++|+|++|+|++..+..|..+++|+.|+|++|++++..+..+..+++|+.|||++|++++.
T Consensus 91 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 170 (251)
T 3m19_A 91 ANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSV 170 (251)
T ss_dssp TTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCC
T ss_pred CCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCcc
Confidence 99999888778888889999999999999877777788889999999999999988777888899999999999999988
Q ss_pred cCccccCCCCCcEEEcccCCCCCCCC
Q 045449 491 LSLDIGNLKVVIGLDFSRNNLSGDIP 516 (823)
Q Consensus 491 ~p~~~~~l~~L~~L~ls~N~l~g~ip 516 (823)
.+..+..++.|+.|++++|++++..+
T Consensus 171 ~~~~~~~l~~L~~L~l~~N~~~c~~~ 196 (251)
T 3m19_A 171 PHGAFDRLGKLQTITLFGNQFDCSRC 196 (251)
T ss_dssp CTTTTTTCTTCCEEECCSCCBCTTST
T ss_pred CHHHHhCCCCCCEEEeeCCceeCCcc
Confidence 78788889999999999999987633
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=1.2e-24 Score=235.03 Aligned_cols=152 Identities=24% Similarity=0.392 Sum_probs=123.3
Q ss_pred ccCCccceeeccC---------------CeEEEEEEehHh-hHHHHHHHHHHHHHHhhcchhhHHH--------------
Q 045449 628 DRFSENNLIGIGN---------------GMEVAVKVFHQQ-YERALKSFEDECEVRKRIRHRNLVK-------------- 677 (823)
Q Consensus 628 ~~f~~~~~lg~g~---------------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~-------------- 677 (823)
++|...+.||.|+ +..||||++... .....+.|.+|++++++++||||++
T Consensus 49 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 128 (325)
T 3kul_A 49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIV 128 (325)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEE
T ss_pred hHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEE
Confidence 4566678899886 234999999754 3455678999999999999999998
Q ss_pred ---------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCcc-
Q 045449 678 ---------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQL- 729 (823)
Q Consensus 678 ---------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~- 729 (823)
++.|++.+|+|+|+.+|+||||||+||+++.++.+||+|||+++........
T Consensus 129 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 208 (325)
T 3kul_A 129 TEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAA 208 (325)
T ss_dssp EECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEECC----CC
T ss_pred eeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCcccccccCccce
Confidence 3578889999999999999999999999999999999999999876543221
Q ss_pred ccccccccCCCcCcccccCCCccccccceehhhhhhccccC-CCCCcCCCc
Q 045449 730 SKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKET-RSMTVGETC 779 (823)
Q Consensus 730 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~-~~~~~~~~~ 779 (823)
.......+|+.|+|||++.+..++.++|||||||++|++++ |..||.+..
T Consensus 209 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~ 259 (325)
T 3kul_A 209 YTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMT 259 (325)
T ss_dssp EECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSC
T ss_pred eeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCC
Confidence 12233456788999999988899999999999999999998 999986653
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.89 E-value=4.2e-23 Score=212.45 Aligned_cols=86 Identities=19% Similarity=0.207 Sum_probs=46.8
Q ss_pred CCccEEEeeccccccccCccccCCCCCCeEEeeccc-ccccCCCccCCCcccCcccccC-ccccCCCCcccccccccCCC
Q 045449 253 PNVETLNLGINSFSGTIPSSITNSSKLSDLELGENL-FSGFIPNTIGNLRNLEFGNIAD-NYLTSSTPELSFLSSLTNCK 330 (823)
Q Consensus 253 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~~~l~~l~ 330 (823)
++|++|+|++|++++..+..|.++++|++|++++|+ ++++.+..|..+++|++|++++ |.++... +..|.+++
T Consensus 31 ~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~-----~~~f~~l~ 105 (239)
T 2xwt_C 31 PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYID-----PDALKELP 105 (239)
T ss_dssp TTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEEC-----TTSEECCT
T ss_pred CcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcC-----HHHhCCCC
Confidence 366666666666665555566666666666666665 6555555555555555555554 5544431 12344444
Q ss_pred CceEEEeecCCCC
Q 045449 331 KLKVLIVTGNPLD 343 (823)
Q Consensus 331 ~L~~L~Ls~N~l~ 343 (823)
+|+.|++++|.++
T Consensus 106 ~L~~L~l~~n~l~ 118 (239)
T 2xwt_C 106 LLKFLGIFNTGLK 118 (239)
T ss_dssp TCCEEEEEEECCC
T ss_pred CCCEEeCCCCCCc
Confidence 4444444444444
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.89 E-value=4.9e-23 Score=211.97 Aligned_cols=87 Identities=22% Similarity=0.329 Sum_probs=56.0
Q ss_pred CCcEEEccCCcccccCCcccccCCCCccEEEeeccc-cccccCccccCCCCCCeEEeec-ccccccCCCccCCCcccCcc
Q 045449 229 ALKEISLLNNSLSGSLPSRIDLSLPNVETLNLGINS-FSGTIPSSITNSSKLSDLELGE-NLFSGFIPNTIGNLRNLEFG 306 (823)
Q Consensus 229 ~L~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L 306 (823)
+|++|++++|+++ .+|...+..+++|++|++++|+ +++..+..|.++++|++|++++ |++++..+..|..+++|++|
T Consensus 32 ~l~~L~l~~n~l~-~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L 110 (239)
T 2xwt_C 32 STQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFL 110 (239)
T ss_dssp TCCEEEEESCCCS-EECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEE
T ss_pred cccEEEEeCCcce-EECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEE
Confidence 6667777777766 3444333346667777777775 6655555666666777777776 66666666666666777777
Q ss_pred cccCccccCC
Q 045449 307 NIADNYLTSS 316 (823)
Q Consensus 307 ~L~~N~l~~~ 316 (823)
++++|.+++.
T Consensus 111 ~l~~n~l~~l 120 (239)
T 2xwt_C 111 GIFNTGLKMF 120 (239)
T ss_dssp EEEEECCCSC
T ss_pred eCCCCCCccc
Confidence 7777766653
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=1.2e-24 Score=237.04 Aligned_cols=145 Identities=28% Similarity=0.379 Sum_probs=123.6
Q ss_pred ccCCccceeeccC------------CeEEEEEEehHh---hHHHHHHHHHHHHHHhhcchhhHHH---------------
Q 045449 628 DRFSENNLIGIGN------------GMEVAVKVFHQQ---YERALKSFEDECEVRKRIRHRNLVK--------------- 677 (823)
Q Consensus 628 ~~f~~~~~lg~g~------------~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~--------------- 677 (823)
++|...+.||.|+ +..||||++... .....++|.+|++++++++||||++
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 4577778888876 667999998632 2445578999999999999999998
Q ss_pred -------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccc
Q 045449 678 -------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQ 732 (823)
Q Consensus 678 -------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~ 732 (823)
++.|++.+|+|+|+.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 134 e~~~g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~------ 207 (348)
T 1u5q_A 134 EYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA------ 207 (348)
T ss_dssp ECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB------
T ss_pred ecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCCC------
Confidence 3568899999999999999999999999999999999999999875422
Q ss_pred cccccCCCcCcccccC---CCccccccceehhhhhhccccCCCCCcCCC
Q 045449 733 TQTLATIGYMAPEYGT---KGRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 733 ~~~~gt~~y~aPE~~~---~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
....||+.|+|||++. .+.++.++|||||||+++++++|..||...
T Consensus 208 ~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~ 256 (348)
T 1u5q_A 208 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 256 (348)
T ss_dssp CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 2357999999999874 567899999999999999999999998654
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=5.7e-25 Score=242.61 Aligned_cols=153 Identities=26% Similarity=0.321 Sum_probs=126.2
Q ss_pred hccCCccceeeccC------------CeEEEEEEehHhh-HHHHHHHHHHHHHHhhcchhhHHH----------------
Q 045449 627 TDRFSENNLIGIGN------------GMEVAVKVFHQQY-ERALKSFEDECEVRKRIRHRNLVK---------------- 677 (823)
Q Consensus 627 t~~f~~~~~lg~g~------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~---------------- 677 (823)
.++|...+.||.|+ +..||||+++... ....++|.+|++++++++||||++
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 192 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME 192 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence 35677778888885 5679999987543 344568999999999999999998
Q ss_pred -------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccc
Q 045449 678 -------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQ 732 (823)
Q Consensus 678 -------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~ 732 (823)
++.|++++|+|+|+.+|+||||||+|||++.++.+||+|||+++...........
T Consensus 193 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~~~ 272 (377)
T 3cbl_A 193 LVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASG 272 (377)
T ss_dssp CCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEECCS
T ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCceeecC
Confidence 3578889999999999999999999999999999999999999875433221111
Q ss_pred cccccCCCcCcccccCCCccccccceehhhhhhccccC-CCCCcCCCc
Q 045449 733 TQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKET-RSMTVGETC 779 (823)
Q Consensus 733 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~-~~~~~~~~~ 779 (823)
....+++.|+|||++.++.++.++|||||||++|++++ |..||....
T Consensus 273 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~ 320 (377)
T 3cbl_A 273 GLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLS 320 (377)
T ss_dssp SCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSC
T ss_pred CCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 22345778999999988899999999999999999998 899987654
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=1.2e-24 Score=240.83 Aligned_cols=151 Identities=25% Similarity=0.363 Sum_probs=121.2
Q ss_pred ccCCccceeeccC-----------CeEEEEEEehHh--hHHHHHHHHHHHHHHhhcc--hhhHHH---------------
Q 045449 628 DRFSENNLIGIGN-----------GMEVAVKVFHQQ--YERALKSFEDECEVRKRIR--HRNLVK--------------- 677 (823)
Q Consensus 628 ~~f~~~~~lg~g~-----------~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~--h~niv~--------------- 677 (823)
++|...+.||.|+ +..||||++... .....+.|.+|++++.+++ ||||++
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 4588888999886 566999998643 2455678999999999996 499987
Q ss_pred ------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCcccccc
Q 045449 678 ------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQT 733 (823)
Q Consensus 678 ------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~ 733 (823)
++.|++.+|+|+|+.+|+||||||+|||++ ++.+||+|||+++............
T Consensus 136 E~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~~ 214 (390)
T 2zmd_A 136 ECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKD 214 (390)
T ss_dssp ECCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC---------C
T ss_pred ecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCccccCC
Confidence 367899999999999999999999999996 5789999999998765433322334
Q ss_pred ccccCCCcCcccccCC-----------CccccccceehhhhhhccccCCCCCcCCCc
Q 045449 734 QTLATIGYMAPEYGTK-----------GRVSTRGDVCSFGIISGGKETRSMTVGETC 779 (823)
Q Consensus 734 ~~~gt~~y~aPE~~~~-----------~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~~ 779 (823)
..+||+.|+|||++.+ ..|+.++|||||||++|++++|..||.+..
T Consensus 215 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~ 271 (390)
T 2zmd_A 215 SQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII 271 (390)
T ss_dssp CSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred CCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhh
Confidence 5679999999999864 468999999999999999999999997653
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=1.7e-24 Score=236.75 Aligned_cols=149 Identities=23% Similarity=0.373 Sum_probs=127.1
Q ss_pred hccCCccceeeccC------------CeEEEEEEehHhhHH------HHHHHHHHHHHHhhcchhhHHH-----------
Q 045449 627 TDRFSENNLIGIGN------------GMEVAVKVFHQQYER------ALKSFEDECEVRKRIRHRNLVK----------- 677 (823)
Q Consensus 627 t~~f~~~~~lg~g~------------~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~----------- 677 (823)
.++|...+.||.|+ |..||||++...... ..+.+.+|++++++++||||++
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 46788888999886 667999998654311 2467999999999999999998
Q ss_pred -----------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCC----cEEEeecccccccC
Q 045449 678 -----------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDM----VAHISDFGIAKLLS 724 (823)
Q Consensus 678 -----------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~----~~kl~DfGla~~~~ 724 (823)
++.|++.+|+|+|+.||+||||||+||+++.++ .+||+|||+++...
T Consensus 91 ~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~ 170 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE 170 (361)
T ss_dssp EEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEECC
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceEcC
Confidence 467899999999999999999999999998776 79999999998765
Q ss_pred CCCccccccccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCCC
Q 045449 725 GEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 725 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
.... ....+||+.|+|||++.+..|+.++||||+||++|++++|..||.+.
T Consensus 171 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~ 221 (361)
T 2yab_A 171 DGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD 221 (361)
T ss_dssp TTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCS
T ss_pred CCCc---cccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence 4322 34467999999999999889999999999999999999999999654
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=2e-24 Score=247.31 Aligned_cols=149 Identities=23% Similarity=0.291 Sum_probs=128.5
Q ss_pred hccCCccceeeccC------------CeEEEEEEehHhhH---HHHHHHHHHHHHHhhcchhhHHH--------------
Q 045449 627 TDRFSENNLIGIGN------------GMEVAVKVFHQQYE---RALKSFEDECEVRKRIRHRNLVK-------------- 677 (823)
Q Consensus 627 t~~f~~~~~lg~g~------------~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~-------------- 677 (823)
.++|...+.||+|+ |..||||++..... ...+.+.+|++++++++|||||+
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 35688888899886 66799999975432 23457889999999999999998
Q ss_pred ----------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCcc
Q 045449 678 ----------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQL 729 (823)
Q Consensus 678 ----------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~ 729 (823)
+++|++.+|+|+|+.+|+||||||+|||++.++.+||+|||+|+.......
T Consensus 263 mEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~~- 341 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT- 341 (576)
T ss_dssp ECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCC-
T ss_pred EEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceecccCcc-
Confidence 367899999999999999999999999999999999999999987654322
Q ss_pred ccccccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCCC
Q 045449 730 SKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 730 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
....+||+.|+|||++.+..|+.++||||+||++|+|++|..||...
T Consensus 342 --~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~ 388 (576)
T 2acx_A 342 --IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQR 388 (576)
T ss_dssp --EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCS
T ss_pred --ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCccc
Confidence 23458999999999999989999999999999999999999999764
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=6.2e-25 Score=235.74 Aligned_cols=153 Identities=26% Similarity=0.461 Sum_probs=121.9
Q ss_pred hccCCccceeeccC------------CeEEEEEEehHh---hHHHHHHHHHHHHHHhhcchhhHHH--------------
Q 045449 627 TDRFSENNLIGIGN------------GMEVAVKVFHQQ---YERALKSFEDECEVRKRIRHRNLVK-------------- 677 (823)
Q Consensus 627 t~~f~~~~~lg~g~------------~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~-------------- 677 (823)
.++|...+.||.|+ ++.||||++... .....+.|.+|++++++++||||++
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 36788888899886 677999999754 2455578999999999999999998
Q ss_pred ------------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCC
Q 045449 678 ------------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGED 727 (823)
Q Consensus 678 ------------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~ 727 (823)
++.|++.+|+|+|+.+|+||||||+||+++.++.+||+|||+++......
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 170 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSG 170 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC-------
T ss_pred cEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCcccccccc
Confidence 36788999999999999999999999999999999999999998764332
Q ss_pred c-cccccccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCCCc
Q 045449 728 Q-LSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGETC 779 (823)
Q Consensus 728 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~~ 779 (823)
. ........||+.|+|||++.+..++.++||||+||++|++++|..||.+..
T Consensus 171 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~ 223 (311)
T 3ork_A 171 NSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS 223 (311)
T ss_dssp -----------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 2 122334579999999999999899999999999999999999999997643
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=3.9e-24 Score=240.28 Aligned_cols=150 Identities=27% Similarity=0.340 Sum_probs=121.7
Q ss_pred hccCCccceeeccC------------CeEEEEEEehHh--hHHHHHHHHHHHHHHhhcchhhHHH---------------
Q 045449 627 TDRFSENNLIGIGN------------GMEVAVKVFHQQ--YERALKSFEDECEVRKRIRHRNLVK--------------- 677 (823)
Q Consensus 627 t~~f~~~~~lg~g~------------~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~--------------- 677 (823)
.++|...+.||.|+ +..||||++... .....+++.+|++++++++||||++
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 46888889999886 567999999643 2445578999999999999999997
Q ss_pred -----------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCc
Q 045449 678 -----------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQ 728 (823)
Q Consensus 678 -----------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~ 728 (823)
++.|++.+|+|+|+.+|+||||||+|||++.++.+||+|||+|+.......
T Consensus 105 ~~lv~e~~~~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 184 (432)
T 3n9x_A 105 LYIVLEIADSDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKD 184 (432)
T ss_dssp EEEEEECCSEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC-----
T ss_pred EEEEEecCCcCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCccccccccc
Confidence 467999999999999999999999999999999999999999997643321
Q ss_pred c--------------------ccccccccCCCcCccccc-CCCccccccceehhhhhhccccCCCCCcC
Q 045449 729 L--------------------SKQTQTLATIGYMAPEYG-TKGRVSTRGDVCSFGIISGGKETRSMTVG 776 (823)
Q Consensus 729 ~--------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~ 776 (823)
. ...+..+||+.|+|||++ ....|+.++||||+||++|++++|..|+.
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 185 TNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp --------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred ccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 1 123557899999999985 55669999999999999999998655553
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.89 E-value=2.8e-24 Score=237.04 Aligned_cols=149 Identities=22% Similarity=0.330 Sum_probs=128.3
Q ss_pred hccCCccceeeccC------------CeEEEEEEehHhhHHHHHHHHHHHHHHhhcchhhHHH-----------------
Q 045449 627 TDRFSENNLIGIGN------------GMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVK----------------- 677 (823)
Q Consensus 627 t~~f~~~~~lg~g~------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~----------------- 677 (823)
.++|...+.||.|+ +..||+|++..........+.+|++++++++||||++
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 46788888999886 5679999997665555578999999999999999998
Q ss_pred ------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCC--CCcEEEeecccccccCCCCcccc
Q 045449 678 ------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDE--DMVAHISDFGIAKLLSGEDQLSK 731 (823)
Q Consensus 678 ------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~--~~~~kl~DfGla~~~~~~~~~~~ 731 (823)
++.|++.+|+|+|+.+|+||||||+|||++. ++.+||+|||+|+.......
T Consensus 130 ~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~--- 206 (387)
T 1kob_A 130 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI--- 206 (387)
T ss_dssp CCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC---
T ss_pred CCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCCcc---
Confidence 4678999999999999999999999999974 57899999999987654322
Q ss_pred ccccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCCC
Q 045449 732 QTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 732 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
.....||+.|+|||++.+..++.++||||+||++|++++|..||.+.
T Consensus 207 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~ 253 (387)
T 1kob_A 207 VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGE 253 (387)
T ss_dssp EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCS
T ss_pred eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCC
Confidence 23457999999999999999999999999999999999999999764
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.89 E-value=2.2e-24 Score=232.36 Aligned_cols=148 Identities=23% Similarity=0.275 Sum_probs=127.1
Q ss_pred hccCCccceeeccC------------CeEEEEEEehHhhHHHHHHHHHHHHHHhhcchhhHHH-----------------
Q 045449 627 TDRFSENNLIGIGN------------GMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVK----------------- 677 (823)
Q Consensus 627 t~~f~~~~~lg~g~------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~----------------- 677 (823)
.++|...+.||.|+ +..||+|++.... ...+.+.+|++++++++||||++
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 46788888899886 5679999986543 33467899999999999999998
Q ss_pred ------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCC--CCcEEEeecccccccCCCCcccc
Q 045449 678 ------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDE--DMVAHISDFGIAKLLSGEDQLSK 731 (823)
Q Consensus 678 ------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~--~~~~kl~DfGla~~~~~~~~~~~ 731 (823)
++.|++.+|+|+|+.+|+||||||+||+++. ++.+||+|||+++.......
T Consensus 83 ~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~--- 159 (321)
T 1tki_A 83 ISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN--- 159 (321)
T ss_dssp CCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE---
T ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCc---
Confidence 4678999999999999999999999999986 78999999999987654332
Q ss_pred ccccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCCC
Q 045449 732 QTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 732 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
.....||+.|+|||++.+..++.++||||+||++|++++|..||.+.
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 206 (321)
T 1tki_A 160 FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAE 206 (321)
T ss_dssp EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCC
Confidence 23457999999999999888999999999999999999999999664
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=1.1e-24 Score=238.98 Aligned_cols=150 Identities=26% Similarity=0.279 Sum_probs=118.4
Q ss_pred hccCCccceeeccC------------CeEEEEEEehHhh---HHHHHHHHHHHHH-HhhcchhhHHH-------------
Q 045449 627 TDRFSENNLIGIGN------------GMEVAVKVFHQQY---ERALKSFEDECEV-RKRIRHRNLVK------------- 677 (823)
Q Consensus 627 t~~f~~~~~lg~g~------------~~~vavK~~~~~~---~~~~~~~~~E~~~-l~~l~h~niv~------------- 677 (823)
.++|...+.||+|+ +..||||++.... ....+.+.+|..+ ++.++||||++
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 35788888999886 5669999997553 3344567778877 57789999998
Q ss_pred ---------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccc
Q 045449 678 ---------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLS 730 (823)
Q Consensus 678 ---------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~ 730 (823)
+++|++.+|+|+|+.+|+||||||+|||++.++++||+|||+++.......
T Consensus 117 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~~-- 194 (373)
T 2r5t_A 117 VLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNS-- 194 (373)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCCC--
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccccccccCCC--
Confidence 467899999999999999999999999999999999999999986433221
Q ss_pred cccccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCCC
Q 045449 731 KQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 731 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
.....+||+.|+|||++.+..|+.++||||+||++|+|++|..||.+.
T Consensus 195 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~ 242 (373)
T 2r5t_A 195 TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR 242 (373)
T ss_dssp CCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred ccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCC
Confidence 234568999999999999999999999999999999999999999654
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=2.7e-24 Score=236.44 Aligned_cols=144 Identities=24% Similarity=0.357 Sum_probs=121.8
Q ss_pred cceeeccC------------CeEEEEEEehHhhHHHHHHHHHHHHHHhhcchhhHHH-----------------------
Q 045449 633 NNLIGIGN------------GMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVK----------------------- 677 (823)
Q Consensus 633 ~~~lg~g~------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~----------------------- 677 (823)
.+.||.|+ |..||||++........+.|.+|++++++++||||++
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L 173 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence 45677764 6679999998765556678999999999999999998
Q ss_pred ------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEe--CCCCcEEEeecccccccCCCCcccccccccc
Q 045449 678 ------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLL--DEDMVAHISDFGIAKLLSGEDQLSKQTQTLA 737 (823)
Q Consensus 678 ------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl--~~~~~~kl~DfGla~~~~~~~~~~~~~~~~g 737 (823)
++.|++.+|+|+|+.+|+||||||+|||+ +.++.+||+|||+++....... ....+|
T Consensus 174 ~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~---~~~~~g 250 (373)
T 2x4f_A 174 FDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK---LKVNFG 250 (373)
T ss_dssp HHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB---CCCCCS
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc---cccccC
Confidence 35789999999999999999999999999 5678999999999987654332 234579
Q ss_pred CCCcCcccccCCCccccccceehhhhhhccccCCCCCcCCCc
Q 045449 738 TIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGETC 779 (823)
Q Consensus 738 t~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~~ 779 (823)
|+.|+|||++.+..++.++|||||||+++++++|..||.+..
T Consensus 251 t~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~ 292 (373)
T 2x4f_A 251 TPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDN 292 (373)
T ss_dssp SCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred CCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999999998899999999999999999999999997643
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=1.2e-24 Score=238.37 Aligned_cols=163 Identities=23% Similarity=0.288 Sum_probs=134.3
Q ss_pred ccCHHHHHHHhccCCccceeeccC-----------------CeEEEEEEehHhh-HHHHHHHHHHHHHHhhc-chhhHHH
Q 045449 617 RFSYHELLRATDRFSENNLIGIGN-----------------GMEVAVKVFHQQY-ERALKSFEDECEVRKRI-RHRNLVK 677 (823)
Q Consensus 617 ~~~~~~l~~at~~f~~~~~lg~g~-----------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~ 677 (823)
.+...+..-..++|...+.||.|+ ++.||||++.... ....+.|.+|++++.++ +||||++
T Consensus 11 ~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~ 90 (359)
T 3vhe_A 11 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 90 (359)
T ss_dssp CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceee
Confidence 345556666678999999999986 2569999997543 44557899999999999 8899998
Q ss_pred H-------------------------------------------------------------------------------
Q 045449 678 I------------------------------------------------------------------------------- 678 (823)
Q Consensus 678 ~------------------------------------------------------------------------------- 678 (823)
+
T Consensus 91 ~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (359)
T 3vhe_A 91 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEE 170 (359)
T ss_dssp EEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------
T ss_pred eeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccc
Confidence 1
Q ss_pred ----------------------------HHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccc
Q 045449 679 ----------------------------ISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLS 730 (823)
Q Consensus 679 ----------------------------~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~ 730 (823)
+.|++.+|+|+|+.+|+||||||+||+++.++.+||+|||+++.........
T Consensus 171 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 250 (359)
T 3vhe_A 171 KSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV 250 (359)
T ss_dssp -------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCE
T ss_pred cccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccch
Confidence 1377889999999999999999999999999999999999998765443333
Q ss_pred cccccccCCCcCcccccCCCccccccceehhhhhhccccC-CCCCcCCCc
Q 045449 731 KQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKET-RSMTVGETC 779 (823)
Q Consensus 731 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~-~~~~~~~~~ 779 (823)
......||+.|+|||++.+..++.++|||||||++|++++ |..||.+..
T Consensus 251 ~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 300 (359)
T 3vhe_A 251 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 300 (359)
T ss_dssp EC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred hccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccc
Confidence 3445678999999999988899999999999999999998 999997643
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=2.7e-24 Score=232.44 Aligned_cols=149 Identities=23% Similarity=0.291 Sum_probs=116.0
Q ss_pred ccCCccceeeccC---------------CeEEEEEEehHhh----HHHHHHHHHHHHHHhhcchhhHHH-----------
Q 045449 628 DRFSENNLIGIGN---------------GMEVAVKVFHQQY----ERALKSFEDECEVRKRIRHRNLVK----------- 677 (823)
Q Consensus 628 ~~f~~~~~lg~g~---------------~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~----------- 677 (823)
++|...+.||.|+ +..||||+++... ......+.+|++++++++||||++
T Consensus 17 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 96 (327)
T 3a62_A 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKL 96 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCE
T ss_pred HHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEE
Confidence 5677778888775 5669999987542 234467889999999999999998
Q ss_pred -----------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCc
Q 045449 678 -----------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQ 728 (823)
Q Consensus 678 -----------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~ 728 (823)
+++|++.+|+|+|+.+|+||||||+||+++.++.+||+|||+++.......
T Consensus 97 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 176 (327)
T 3a62_A 97 YLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGT 176 (327)
T ss_dssp EEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC--------
T ss_pred EEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCcccccccCCc
Confidence 367899999999999999999999999999999999999999986433221
Q ss_pred cccccccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCCC
Q 045449 729 LSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 729 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
.....+||+.|+|||++.+..++.++||||+||++|++++|..||...
T Consensus 177 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 224 (327)
T 3a62_A 177 --VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGE 224 (327)
T ss_dssp ----CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred --cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCC
Confidence 233467999999999999989999999999999999999999999764
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=99.88 E-value=5.4e-24 Score=240.52 Aligned_cols=148 Identities=27% Similarity=0.433 Sum_probs=126.5
Q ss_pred ccCCccceeeccC------------CeEEEEEEehHhhH---HHHHHHHHHHHHHhhcchhhHHH---------------
Q 045449 628 DRFSENNLIGIGN------------GMEVAVKVFHQQYE---RALKSFEDECEVRKRIRHRNLVK--------------- 677 (823)
Q Consensus 628 ~~f~~~~~lg~g~------------~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~--------------- 677 (823)
++|...+.||.|+ |+.||||++..... ...+.+.+|++++++++||||++
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 95 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM 95 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 5677778888875 67799999976532 23467999999999999999998
Q ss_pred -------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccc
Q 045449 678 -------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQ 732 (823)
Q Consensus 678 -------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~ 732 (823)
++.|++.+|+|+|+.+|+||||||+||+++.++.+||+|||+++....... .
T Consensus 96 E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~~---~ 172 (476)
T 2y94_A 96 EYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF---L 172 (476)
T ss_dssp ECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTCC---B
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhcccccc---c
Confidence 467999999999999999999999999999999999999999987654322 2
Q ss_pred cccccCCCcCcccccCCCcc-ccccceehhhhhhccccCCCCCcCCC
Q 045449 733 TQTLATIGYMAPEYGTKGRV-STRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 733 ~~~~gt~~y~aPE~~~~~~~-~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
...+||+.|+|||++.+..+ +.++||||+||++|++++|..||.+.
T Consensus 173 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~ 219 (476)
T 2y94_A 173 RTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDD 219 (476)
T ss_dssp CCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCC
Confidence 34679999999999988776 78999999999999999999999764
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=99.88 E-value=4.5e-24 Score=236.62 Aligned_cols=152 Identities=19% Similarity=0.288 Sum_probs=126.7
Q ss_pred hccCCccceeecc--C------------CeEEEEEEehHhh--HHHHHHHHHHHHHHhhcchhhHHH-------------
Q 045449 627 TDRFSENNLIGIG--N------------GMEVAVKVFHQQY--ERALKSFEDECEVRKRIRHRNLVK------------- 677 (823)
Q Consensus 627 t~~f~~~~~lg~g--~------------~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~------------- 677 (823)
.++|...+.||.| + +..||||++.... ....+.+.+|++++++++|||||+
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 4678888899988 4 6679999997553 455678999999999999999998
Q ss_pred -----------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCc
Q 045449 678 -----------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQ 728 (823)
Q Consensus 678 -----------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~ 728 (823)
++.|++.+|+|+|+.+|+||||||+|||++.++.+||+|||.+........
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~~ 183 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQ 183 (389)
T ss_dssp EEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEECEETTE
T ss_pred EEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccceeeccccc
Confidence 356889999999999999999999999999999999999999875432111
Q ss_pred -----cccccccccCCCcCcccccCC--CccccccceehhhhhhccccCCCCCcCCC
Q 045449 729 -----LSKQTQTLATIGYMAPEYGTK--GRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 729 -----~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
.......+||+.|+|||++.+ ..|+.++||||+||++|++++|..||.+.
T Consensus 184 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 240 (389)
T 3gni_B 184 RQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDM 240 (389)
T ss_dssp ECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred cccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCC
Confidence 111223478999999999887 57999999999999999999999999763
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.88 E-value=1e-24 Score=239.62 Aligned_cols=152 Identities=23% Similarity=0.284 Sum_probs=123.6
Q ss_pred ccCCccceeeccC-----------------CeEEEEEEehHh-hHHHHHHHHHHHHHHhhcchhhHHH------------
Q 045449 628 DRFSENNLIGIGN-----------------GMEVAVKVFHQQ-YERALKSFEDECEVRKRIRHRNLVK------------ 677 (823)
Q Consensus 628 ~~f~~~~~lg~g~-----------------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~------------ 677 (823)
++|...+.||.|+ +..||||++... ......+|.+|+.++++++||||++
T Consensus 71 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 150 (367)
T 3l9p_A 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRF 150 (367)
T ss_dssp GGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred hHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCE
Confidence 4566667777775 346999998643 2445568999999999999999998
Q ss_pred -----------------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCC---cEEEeeccc
Q 045449 678 -----------------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDM---VAHISDFGI 719 (823)
Q Consensus 678 -----------------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~---~~kl~DfGl 719 (823)
++.|++.+|+|+|+.+|+||||||+|||++.++ .+||+|||+
T Consensus 151 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL~DFG~ 230 (367)
T 3l9p_A 151 ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGM 230 (367)
T ss_dssp EEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCCHH
T ss_pred EEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEECCCcc
Confidence 356888999999999999999999999999554 599999999
Q ss_pred ccccCCCCccccccccccCCCcCcccccCCCccccccceehhhhhhccccC-CCCCcCCCc
Q 045449 720 AKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKET-RSMTVGETC 779 (823)
Q Consensus 720 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~-~~~~~~~~~ 779 (823)
|+...............||+.|+|||++.+..++.++|||||||+++++++ |..||....
T Consensus 231 a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~ 291 (367)
T 3l9p_A 231 ARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS 291 (367)
T ss_dssp HHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred ccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 986543322223344578999999999988899999999999999999998 889987643
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=99.88 E-value=2.3e-24 Score=228.63 Aligned_cols=152 Identities=30% Similarity=0.397 Sum_probs=117.4
Q ss_pred hccCCccceeeccC---------CeEEEEEEehHhh--HHHHHHHHHHHHHHhhcchhhHHH------------------
Q 045449 627 TDRFSENNLIGIGN---------GMEVAVKVFHQQY--ERALKSFEDECEVRKRIRHRNLVK------------------ 677 (823)
Q Consensus 627 t~~f~~~~~lg~g~---------~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~------------------ 677 (823)
.++|...+.||.|+ ...||||++.... ....+.|.+|++++++++||||++
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~lv~e~~~ 102 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQLAIVTQWCE 102 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESSSEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEEEECCC
T ss_pred ccceeeeeEecCCCCeEEEEEEEcCceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeeccCCccEEEEEecC
Confidence 35788889999987 3348999986432 455678999999999999999997
Q ss_pred ----------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCcccccccc
Q 045449 678 ----------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQT 735 (823)
Q Consensus 678 ----------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 735 (823)
++.|++.+|+|+|+.+|+||||||+||+++.++.+||+|||+++..............
T Consensus 103 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 182 (289)
T 3og7_A 103 GSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQL 182 (289)
T ss_dssp EEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC-----------------
T ss_pred CCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceecccccccccccccccc
Confidence 3578899999999999999999999999999999999999999865433222233446
Q ss_pred ccCCCcCcccccC---CCccccccceehhhhhhccccCCCCCcCCC
Q 045449 736 LATIGYMAPEYGT---KGRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 736 ~gt~~y~aPE~~~---~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
.||+.|+|||++. +..++.++||||+||+++++++|..||...
T Consensus 183 ~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 228 (289)
T 3og7_A 183 SGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNI 228 (289)
T ss_dssp -CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSC
T ss_pred CCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCcccc
Confidence 7999999999886 566889999999999999999999999764
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=1.1e-24 Score=246.04 Aligned_cols=150 Identities=23% Similarity=0.269 Sum_probs=118.5
Q ss_pred hccCCccceeeccC------------CeEEEEEEehHhh---HHHHHHHHHHHHHHhhcchhhHHH--------------
Q 045449 627 TDRFSENNLIGIGN------------GMEVAVKVFHQQY---ERALKSFEDECEVRKRIRHRNLVK-------------- 677 (823)
Q Consensus 627 t~~f~~~~~lg~g~------------~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~-------------- 677 (823)
.++|...+.||.|+ |..||||++.... ......+.+|++++++++||||++
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 46788889999986 5679999997653 334467889999999999999998
Q ss_pred --------------------------HHHHHHHHhhhcCC-CCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccc
Q 045449 678 --------------------------IISSSLEYLHFGHS-IPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLS 730 (823)
Q Consensus 678 --------------------------~~~~~l~~L~~~h~-~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~ 730 (823)
++.|++.+|+|+|+ .+|+||||||+|||++.++.+||+|||+|+.......
T Consensus 227 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~-- 304 (446)
T 4ejn_A 227 MEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA-- 304 (446)
T ss_dssp ECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-----
T ss_pred EeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccCCCc--
Confidence 35788999999998 9999999999999999999999999999986433222
Q ss_pred cccccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCCC
Q 045449 731 KQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 731 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
.....+||+.|+|||++.+..|+.++||||+||+++++++|..||...
T Consensus 305 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~ 352 (446)
T 4ejn_A 305 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 352 (446)
T ss_dssp --CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCC
Confidence 234568999999999999999999999999999999999999999664
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.88 E-value=2.3e-24 Score=232.58 Aligned_cols=154 Identities=21% Similarity=0.331 Sum_probs=115.8
Q ss_pred HhccCCccceeeccC------------C---eEEEEEEehHhh--HHHHHHHHHHHHHHhhcchhhHHH-----------
Q 045449 626 ATDRFSENNLIGIGN------------G---MEVAVKVFHQQY--ERALKSFEDECEVRKRIRHRNLVK----------- 677 (823)
Q Consensus 626 at~~f~~~~~lg~g~------------~---~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~----------- 677 (823)
..++|...+.||.|+ + ..||||++.... ....++|.+|++++++++||||++
T Consensus 21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 100 (323)
T 3qup_A 21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK 100 (323)
T ss_dssp C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence 356788889999886 1 268999997542 344678999999999999999987
Q ss_pred -----------------------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEee
Q 045449 678 -----------------------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISD 716 (823)
Q Consensus 678 -----------------------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~D 716 (823)
++.|++.+|+|+|+.+|+||||||+||+++.++.+||+|
T Consensus 101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~kl~D 180 (323)
T 3qup_A 101 GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVAD 180 (323)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECC
T ss_pred cCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCEEEee
Confidence 356888999999999999999999999999999999999
Q ss_pred cccccccCCCCccccccccccCCCcCcccccCCCccccccceehhhhhhccccC-CCCCcCCCc
Q 045449 717 FGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKET-RSMTVGETC 779 (823)
Q Consensus 717 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~-~~~~~~~~~ 779 (823)
||+|+...............+|+.|+|||++.+..++.++||||+||+++++++ |..||.+..
T Consensus 181 fg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~ 244 (323)
T 3qup_A 181 FGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIE 244 (323)
T ss_dssp CCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred ccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccC
Confidence 999987654443333344567889999999998899999999999999999999 888887643
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.88 E-value=2e-24 Score=233.35 Aligned_cols=149 Identities=24% Similarity=0.372 Sum_probs=126.4
Q ss_pred hccCCccceeeccC------------CeEEEEEEehHhhH------HHHHHHHHHHHHHhhcchhhHHH-----------
Q 045449 627 TDRFSENNLIGIGN------------GMEVAVKVFHQQYE------RALKSFEDECEVRKRIRHRNLVK----------- 677 (823)
Q Consensus 627 t~~f~~~~~lg~g~------------~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~----------- 677 (823)
.++|...+.||.|+ +..||||++..... ...+.+.+|++++++++||||++
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 35677888899886 66799999864321 13467999999999999999998
Q ss_pred -----------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCC----cEEEeecccccccC
Q 045449 678 -----------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDM----VAHISDFGIAKLLS 724 (823)
Q Consensus 678 -----------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~----~~kl~DfGla~~~~ 724 (823)
++.|++.+|+|+|+.+|+||||||+||+++.++ .+||+|||+++...
T Consensus 90 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~ 169 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID 169 (326)
T ss_dssp EEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEECC
T ss_pred EEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeECC
Confidence 467899999999999999999999999998877 89999999998765
Q ss_pred CCCccccccccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCCC
Q 045449 725 GEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 725 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
.... .....||+.|+|||++.+..++.++||||+||++|++++|..||.+.
T Consensus 170 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 220 (326)
T 2y0a_A 170 FGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD 220 (326)
T ss_dssp TTSC---CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCS
T ss_pred CCCc---cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCC
Confidence 3322 23457999999999999889999999999999999999999999654
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=6.4e-25 Score=237.75 Aligned_cols=149 Identities=22% Similarity=0.227 Sum_probs=124.5
Q ss_pred ccCCccceeeccC------------CeEEEEEEehHhhHHHHHHHHHHHHHHhhc-chhhHHH-----------------
Q 045449 628 DRFSENNLIGIGN------------GMEVAVKVFHQQYERALKSFEDECEVRKRI-RHRNLVK----------------- 677 (823)
Q Consensus 628 ~~f~~~~~lg~g~------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~----------------- 677 (823)
++|...+.||.|+ +..||||++..... .+.+.+|+++++++ +||||++
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~ 86 (330)
T 2izr_A 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLEL 86 (330)
T ss_dssp TTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEEC
T ss_pred CCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEe
Confidence 5677777788775 67799999865432 24688999999999 9999997
Q ss_pred -----------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCc-----EEEeecccccccCCCCcc
Q 045449 678 -----------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMV-----AHISDFGIAKLLSGEDQL 729 (823)
Q Consensus 678 -----------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~-----~kl~DfGla~~~~~~~~~ 729 (823)
++.|++.+|+|+|+.+|+||||||+|||++.++. +||+|||+|+........
T Consensus 87 ~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~~~ 166 (330)
T 2izr_A 87 LGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETK 166 (330)
T ss_dssp CCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTTTC
T ss_pred CCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCCCC
Confidence 4678999999999999999999999999998887 999999999876443221
Q ss_pred c-----cccccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCCC
Q 045449 730 S-----KQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 730 ~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
. ......||+.|+|||++.+..++.++|||||||++|++++|..||.+.
T Consensus 167 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~ 220 (330)
T 2izr_A 167 KHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGL 220 (330)
T ss_dssp CBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred ccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCcccc
Confidence 1 124567999999999999999999999999999999999999999764
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.88 E-value=1.8e-22 Score=215.91 Aligned_cols=212 Identities=21% Similarity=0.375 Sum_probs=130.0
Q ss_pred chhhhhccccccccCCccccccCCCCCcEEEccCCcccccCCcccccCCCCccEEEeeccccccccCccccCCCCCCeEE
Q 045449 204 PYLARLALATNNLVGVVPVTIFNMSALKEISLLNNSLSGSLPSRIDLSLPNVETLNLGINSFSGTIPSSITNSSKLSDLE 283 (823)
Q Consensus 204 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 283 (823)
..+..+.+..+.++..+ .+.++++|++|++++|.++ .+| .+. .+++|++|+|++|++++..+ +..+++|++|+
T Consensus 19 ~~~~~~~l~~~~~~~~~--~~~~l~~L~~L~l~~~~i~-~l~-~~~-~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~ 91 (308)
T 1h6u_A 19 ANAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVT-TIE-GVQ-YLNNLIGLELKDNQITDLAP--LKNLTKITELE 91 (308)
T ss_dssp HHHHHHHTTCSSTTSEE--CHHHHHTCCEEECTTSCCC-CCT-TGG-GCTTCCEEECCSSCCCCCGG--GTTCCSCCEEE
T ss_pred HHHHHHHhCCCCcCcee--cHHHcCCcCEEEeeCCCcc-Cch-hhh-ccCCCCEEEccCCcCCCChh--HccCCCCCEEE
Confidence 34455566666666543 3456778888888888887 565 333 37888888888888875444 77888888888
Q ss_pred eecccccccCCCccCCCcccCcccccCccccCCCCcccccccccCCCCceEEEeecCCCCccCCccccccccccceEEec
Q 045449 284 LGENLFSGFIPNTIGNLRNLEFGNIADNYLTSSTPELSFLSSLTNCKKLKVLIVTGNPLDGILPKSIGNFSLSLETILMA 363 (823)
Q Consensus 284 Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~ 363 (823)
|++|++++. +.+..+++|++|++++|.+++. ..+..+++|+.|++++|.+++..+ +..+ ++|++|+++
T Consensus 92 L~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~~-------~~l~~l~~L~~L~l~~n~l~~~~~--l~~l-~~L~~L~l~ 159 (308)
T 1h6u_A 92 LSGNPLKNV--SAIAGLQSIKTLDLTSTQITDV-------TPLAGLSNLQVLYLDLNQITNISP--LAGL-TNLQYLSIG 159 (308)
T ss_dssp CCSCCCSCC--GGGTTCTTCCEEECTTSCCCCC-------GGGTTCTTCCEEECCSSCCCCCGG--GGGC-TTCCEEECC
T ss_pred ccCCcCCCc--hhhcCCCCCCEEECCCCCCCCc-------hhhcCCCCCCEEECCCCccCcCcc--ccCC-CCccEEEcc
Confidence 888888764 3577777777777777777764 136666777777777776665432 4444 455555555
Q ss_pred CCcceeccCccccCcccccEEEcccCcCCCCchhcccccCCCCEEEccCCCCCCcchHhhhcCCCCCEEEcccCcCc
Q 045449 364 NCSISGNIPQVVGNLSNLLVLELGGNNLTGPIPVTFSQLQTLQAFDLTRNKLAGPITDELCHLARLHSLVLQGNKFS 440 (823)
Q Consensus 364 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 440 (823)
+|++++..+ +..+++|+.|++++|++++..+ +..+++|++|+|++|++++..+ +..+++|+.|+|++|.++
T Consensus 160 ~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~l~~N~i~ 230 (308)
T 1h6u_A 160 NAQVSDLTP--LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTIT 230 (308)
T ss_dssp SSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEEEEEEEEEE
T ss_pred CCcCCCChh--hcCCCCCCEEECCCCccCcChh--hcCCCCCCEEEccCCccCcccc--ccCCCCCCEEEccCCeee
Confidence 555554322 4555555555555555553322 4455555555555555554332 445555555555555554
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=1.6e-24 Score=234.90 Aligned_cols=152 Identities=24% Similarity=0.310 Sum_probs=126.7
Q ss_pred hccCCccceeeccC-----------------CeEEEEEEehHhh-HHHHHHHHHHHHHHhhc-chhhHHH----------
Q 045449 627 TDRFSENNLIGIGN-----------------GMEVAVKVFHQQY-ERALKSFEDECEVRKRI-RHRNLVK---------- 677 (823)
Q Consensus 627 t~~f~~~~~lg~g~-----------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~---------- 677 (823)
.++|...+.||.|+ ...||||++.... ....+.+.+|+++++++ +||||++
T Consensus 45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 124 (333)
T 2i1m_A 45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGP 124 (333)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCc
Confidence 46788889999986 1259999987543 34557899999999999 8999998
Q ss_pred --------------------------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEE
Q 045449 678 --------------------------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAH 713 (823)
Q Consensus 678 --------------------------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~k 713 (823)
++.|++.+|+|+|+.+|+||||||+||+++.++.+|
T Consensus 125 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~k 204 (333)
T 2i1m_A 125 VLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAK 204 (333)
T ss_dssp CEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEGGGEEE
T ss_pred eEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECCCCeEE
Confidence 124788899999999999999999999999999999
Q ss_pred EeecccccccCCCCccccccccccCCCcCcccccCCCccccccceehhhhhhccccC-CCCCcCCC
Q 045449 714 ISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKET-RSMTVGET 778 (823)
Q Consensus 714 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~-~~~~~~~~ 778 (823)
|+|||+++...............||+.|+|||++.+..++.++|||||||+++++++ |..||.+.
T Consensus 205 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 270 (333)
T 2i1m_A 205 IGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGI 270 (333)
T ss_dssp BCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred ECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCccc
Confidence 999999987644333223344567889999999988899999999999999999998 88888764
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=99.88 E-value=1.6e-24 Score=230.59 Aligned_cols=151 Identities=29% Similarity=0.393 Sum_probs=122.2
Q ss_pred ccCCccceeeccC----------------CeEEEEEEehHhhHHHHHHHHHHHHHHhhcchhhHHH--------------
Q 045449 628 DRFSENNLIGIGN----------------GMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVK-------------- 677 (823)
Q Consensus 628 ~~f~~~~~lg~g~----------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-------------- 677 (823)
++|...+.||.|+ +..||||++........+.|.+|++++++++||||++
T Consensus 10 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (295)
T 3ugc_A 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK 89 (295)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCE
T ss_pred HHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceE
Confidence 4566667777764 4679999998766677788999999999999999997
Q ss_pred -----------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCc
Q 045449 678 -----------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQ 728 (823)
Q Consensus 678 -----------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~ 728 (823)
++.|++.+|+|+|+.+|+||||||+||+++.++.+||+|||+++.......
T Consensus 90 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 169 (295)
T 3ugc_A 90 LIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKE 169 (295)
T ss_dssp EEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC-------
T ss_pred EEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCcccccccCCcc
Confidence 356889999999999999999999999999999999999999987654322
Q ss_pred c-ccccccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCCC
Q 045449 729 L-SKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 729 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
. .......+|..|+|||++.+..++.++|||||||+++++++|..|+...
T Consensus 170 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~ 220 (295)
T 3ugc_A 170 FFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSP 220 (295)
T ss_dssp ------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSH
T ss_pred eeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCC
Confidence 1 1223345778899999999889999999999999999999998887654
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=1.4e-24 Score=234.48 Aligned_cols=152 Identities=21% Similarity=0.302 Sum_probs=122.2
Q ss_pred ccCCccceeeccC------------Ce----EEEEEEehHhh-HHHHHHHHHHHHHHhhcchhhHHH-------------
Q 045449 628 DRFSENNLIGIGN------------GM----EVAVKVFHQQY-ERALKSFEDECEVRKRIRHRNLVK------------- 677 (823)
Q Consensus 628 ~~f~~~~~lg~g~------------~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~------------- 677 (823)
++|...+.||.|+ +. .||+|++.... ....+.+.+|+.++++++||||++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~v 92 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPGSSLQLV 92 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEECBSSEEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCccEEE
Confidence 4566777888876 12 27888775332 222356789999999999999998
Q ss_pred ---------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccc
Q 045449 678 ---------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLS 730 (823)
Q Consensus 678 ---------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~ 730 (823)
++.|++.+|+|+|+.+|+||||||+|||++.++.+||+|||+++.........
T Consensus 93 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~ 172 (325)
T 3kex_A 93 TQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQL 172 (325)
T ss_dssp EECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCCTTCC
T ss_pred EEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcccccCcccccc
Confidence 35789999999999999999999999999999999999999999876544433
Q ss_pred cccccccCCCcCcccccCCCccccccceehhhhhhccccC-CCCCcCCCc
Q 045449 731 KQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKET-RSMTVGETC 779 (823)
Q Consensus 731 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~-~~~~~~~~~ 779 (823)
......||+.|+|||++.++.++.++||||+||++|++++ |..||.+..
T Consensus 173 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~ 222 (325)
T 3kex_A 173 LYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLR 222 (325)
T ss_dssp C-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC
T ss_pred cccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccC
Confidence 3445678889999999998899999999999999999999 999997643
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=99.88 E-value=4.4e-24 Score=235.59 Aligned_cols=146 Identities=15% Similarity=0.248 Sum_probs=119.0
Q ss_pred hccCCccceeeccC------------CeEEEEEEehHh---hHHHHHHHHHHH---HHHhhcchhhHHHH----------
Q 045449 627 TDRFSENNLIGIGN------------GMEVAVKVFHQQ---YERALKSFEDEC---EVRKRIRHRNLVKI---------- 678 (823)
Q Consensus 627 t~~f~~~~~lg~g~------------~~~vavK~~~~~---~~~~~~~~~~E~---~~l~~l~h~niv~~---------- 678 (823)
.++|...+.||.|+ |..||||++... .....+.|.+|+ +.+++++|||||++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 35677778899885 667999998632 234557899999 55666689999752
Q ss_pred ------------------------------------------------------------HHHHHHHhhhcCCCCEEecc
Q 045449 679 ------------------------------------------------------------ISSSLEYLHFGHSIPIIHCD 698 (823)
Q Consensus 679 ------------------------------------------------------------~~~~l~~L~~~h~~~ivHrd 698 (823)
+.|++.+|+|+|+.+|+|||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrD 231 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTY 231 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECCSEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred hhccCCccccccccCCCceEEEEEEEEEeccCCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCC
Confidence 35778899999999999999
Q ss_pred CCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCcccccCCC-----------ccccccceehhhhhhcc
Q 045449 699 LKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKG-----------RVSTRGDVCSFGIISGG 767 (823)
Q Consensus 699 lk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~Dv~S~Gvv~~~ 767 (823)
|||+|||++.++.+||+|||+|+.... .....+| +.|+|||++.+. .++.++|||||||++|+
T Consensus 232 ikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~e 305 (377)
T 3byv_A 232 LRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYW 305 (377)
T ss_dssp CCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHH
T ss_pred CCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHH
Confidence 999999999999999999999986432 2234567 999999999887 89999999999999999
Q ss_pred ccCCCCCcCCC
Q 045449 768 KETRSMTVGET 778 (823)
Q Consensus 768 ~~~~~~~~~~~ 778 (823)
+++|..||.+.
T Consensus 306 lltg~~Pf~~~ 316 (377)
T 3byv_A 306 IWCADLPITKD 316 (377)
T ss_dssp HHHSSCCC---
T ss_pred HHHCCCCCccc
Confidence 99999999664
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.88 E-value=7.5e-24 Score=232.60 Aligned_cols=147 Identities=30% Similarity=0.372 Sum_probs=122.3
Q ss_pred hccCCccceeeccC------------CeEEEEEEehHh--hHHHHHHHHHHHHHHhhcchhhHHH---------------
Q 045449 627 TDRFSENNLIGIGN------------GMEVAVKVFHQQ--YERALKSFEDECEVRKRIRHRNLVK--------------- 677 (823)
Q Consensus 627 t~~f~~~~~lg~g~------------~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~--------------- 677 (823)
.++|...+.||.|+ |..||||++... .....+++.+|++++++++||||++
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 35677777788775 677999998543 2445578999999999999999987
Q ss_pred -----------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCc
Q 045449 678 -----------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQ 728 (823)
Q Consensus 678 -----------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~ 728 (823)
++.|++.+|+|+|+.+|+||||||+||+++.++.+||+|||+|+.....
T Consensus 104 ~~~lv~e~~~~~L~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~-- 181 (367)
T 1cm8_A 104 DFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE-- 181 (367)
T ss_dssp CCEEEEECCSEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSS--
T ss_pred eEEEEEecCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeecccccccc--
Confidence 3568999999999999999999999999999999999999999875432
Q ss_pred cccccccccCCCcCcccccCC-CccccccceehhhhhhccccCCCCCcCCC
Q 045449 729 LSKQTQTLATIGYMAPEYGTK-GRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 729 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
....+||+.|+|||++.+ ..++.++||||+||+++++++|+.||.+.
T Consensus 182 ---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 229 (367)
T 1cm8_A 182 ---MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGS 229 (367)
T ss_dssp ---CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ---cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCC
Confidence 234678999999998876 67999999999999999999999999764
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=4.1e-24 Score=229.99 Aligned_cols=150 Identities=27% Similarity=0.346 Sum_probs=114.2
Q ss_pred hccCCccceeeccC------------CeEEEEEEehHhh-HHHHHHHHHHHHHHhhcchhhHHH----------------
Q 045449 627 TDRFSENNLIGIGN------------GMEVAVKVFHQQY-ERALKSFEDECEVRKRIRHRNLVK---------------- 677 (823)
Q Consensus 627 t~~f~~~~~lg~g~------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~---------------- 677 (823)
.++|...+.||.|+ |..||||++.... ....+.+.+|++++++++||||++
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 34666667777764 6779999986433 223357889999999999999998
Q ss_pred -----------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCc
Q 045449 678 -----------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQ 728 (823)
Q Consensus 678 -----------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~ 728 (823)
++.|++++|+|+|+.+|+||||||+||+++.++.+||+|||+++.......
T Consensus 84 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 163 (317)
T 2pmi_A 84 FMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVN 163 (317)
T ss_dssp CCCCBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETTSCCC
T ss_pred ecCCCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecCCCcc
Confidence 245889999999999999999999999999999999999999987643221
Q ss_pred cccccccccCCCcCcccccCCC-ccccccceehhhhhhccccCCCCCcCCC
Q 045449 729 LSKQTQTLATIGYMAPEYGTKG-RVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 729 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
......||+.|+|||++.+. .++.++||||+||++|++++|..||.+.
T Consensus 164 --~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 212 (317)
T 2pmi_A 164 --TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGT 212 (317)
T ss_dssp --CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred --cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 22345789999999998764 6899999999999999999999999764
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.88 E-value=5.4e-24 Score=228.04 Aligned_cols=150 Identities=30% Similarity=0.368 Sum_probs=122.9
Q ss_pred HhccCCccceeeccC------------CeEEEEEEehHhh-----HHHHHHHHHHHHHHhhcc---hhhHHH--------
Q 045449 626 ATDRFSENNLIGIGN------------GMEVAVKVFHQQY-----ERALKSFEDECEVRKRIR---HRNLVK-------- 677 (823)
Q Consensus 626 at~~f~~~~~lg~g~------------~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~---h~niv~-------- 677 (823)
.+++|...+.||.|+ ++.||||++.... ......+.+|++++++++ ||||++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 367899899999886 5679999986322 111245667887777775 999997
Q ss_pred --------------------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeeccc
Q 045449 678 --------------------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGI 719 (823)
Q Consensus 678 --------------------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGl 719 (823)
++.|++.+|+|+|+.+|+||||||+||+++.++.+||+|||+
T Consensus 87 ~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~ 166 (308)
T 3g33_A 87 RTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGL 166 (308)
T ss_dssp CSSSEEEEEEEEECCCCBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSCSC
T ss_pred CCCCceeEEEEehhhhcCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeCcc
Confidence 367899999999999999999999999999999999999999
Q ss_pred ccccCCCCccccccccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCCC
Q 045449 720 AKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 720 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
|+...... ......||+.|+|||++.+..++.++||||+||++|++++|..||.+.
T Consensus 167 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 222 (308)
T 3g33_A 167 ARIYSYQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGN 222 (308)
T ss_dssp TTTSTTCC---CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCS
T ss_pred ccccCCCc---ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCC
Confidence 98764332 234567999999999999999999999999999999999999999664
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.88 E-value=1.5e-24 Score=234.47 Aligned_cols=152 Identities=24% Similarity=0.302 Sum_probs=117.2
Q ss_pred ccCCccceeeccC------------Ce----EEEEEEehHhh-HHHHHHHHHHHHHHhhcchhhHHH-------------
Q 045449 628 DRFSENNLIGIGN------------GM----EVAVKVFHQQY-ERALKSFEDECEVRKRIRHRNLVK------------- 677 (823)
Q Consensus 628 ~~f~~~~~lg~g~------------~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~------------- 677 (823)
++|...+.||.|+ +. .||+|.+.... ....+.+.+|+.++++++||||++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~v 94 (327)
T 3lzb_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLI 94 (327)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSSEEEE
T ss_pred hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCCceEE
Confidence 5678888899886 11 25777775322 234468999999999999999998
Q ss_pred ---------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccc
Q 045449 678 ---------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLS 730 (823)
Q Consensus 678 ---------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~ 730 (823)
++.|++.+|+|+|+.+|+||||||+||+++.++.+||+|||+++.........
T Consensus 95 ~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~~~~ 174 (327)
T 3lzb_A 95 TQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY 174 (327)
T ss_dssp ECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC-----------
T ss_pred EEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEccCccccc
Confidence 35788999999999999999999999999999999999999998765443333
Q ss_pred cccccccCCCcCcccccCCCccccccceehhhhhhccccC-CCCCcCCCc
Q 045449 731 KQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKET-RSMTVGETC 779 (823)
Q Consensus 731 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~-~~~~~~~~~ 779 (823)
......||+.|+|||++.+..++.++||||+||++|++++ |..||....
T Consensus 175 ~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~ 224 (327)
T 3lzb_A 175 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP 224 (327)
T ss_dssp -----CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred cccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCC
Confidence 3344567889999999999999999999999999999999 999997653
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=99.88 E-value=3.8e-24 Score=234.92 Aligned_cols=158 Identities=26% Similarity=0.335 Sum_probs=129.8
Q ss_pred HHHHHHhccCCccceeeccC------------CeEEEEEEehHhh-HHHHHHHHHHHHHHhhcchhhHHH----------
Q 045449 621 HELLRATDRFSENNLIGIGN------------GMEVAVKVFHQQY-ERALKSFEDECEVRKRIRHRNLVK---------- 677 (823)
Q Consensus 621 ~~l~~at~~f~~~~~lg~g~------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~---------- 677 (823)
.++....++|...+.||.|+ +..||||++.... ....+.+.+|++++.+++||||++
T Consensus 20 g~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 99 (364)
T 3qyz_A 20 GQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTI 99 (364)
T ss_dssp -CBCCCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSST
T ss_pred cEeccccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCc
Confidence 44444567899999999986 5679999986432 445578999999999999999986
Q ss_pred ---------------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccC
Q 045449 678 ---------------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLS 724 (823)
Q Consensus 678 ---------------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~ 724 (823)
++.|++.+|+|+|+.+|+||||||+||+++.++.+||+|||+++...
T Consensus 100 ~~~~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~ 179 (364)
T 3qyz_A 100 EQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVAD 179 (364)
T ss_dssp TTCCCEEEEEECCSEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred cccceEEEEEcccCcCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecC
Confidence 36789999999999999999999999999999999999999998764
Q ss_pred CCCccc-cccccccCCCcCcccccCC-CccccccceehhhhhhccccCCCCCcCCC
Q 045449 725 GEDQLS-KQTQTLATIGYMAPEYGTK-GRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 725 ~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
...... .....+||+.|+|||++.+ ..++.++||||+||+++++++|..||.+.
T Consensus 180 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 235 (364)
T 3qyz_A 180 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGK 235 (364)
T ss_dssp GGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCC
Confidence 332211 1234589999999998654 45899999999999999999999999664
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=6.1e-24 Score=228.10 Aligned_cols=153 Identities=24% Similarity=0.311 Sum_probs=127.6
Q ss_pred hccCCccceeeccC-----------------CeEEEEEEehHhh-HHHHHHHHHHHHHHhhcchhhHHH-----------
Q 045449 627 TDRFSENNLIGIGN-----------------GMEVAVKVFHQQY-ERALKSFEDECEVRKRIRHRNLVK----------- 677 (823)
Q Consensus 627 t~~f~~~~~lg~g~-----------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~----------- 677 (823)
.++|...+.||.|+ +..||||++.... ....+.+.+|++++++++||||++
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 101 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL 101 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence 45677777888775 2569999997543 455678999999999999999997
Q ss_pred -----------------------------------------------------HHHHHHHHhhhcCCCCEEeccCCCCCE
Q 045449 678 -----------------------------------------------------IISSSLEYLHFGHSIPIIHCDLKPSNV 704 (823)
Q Consensus 678 -----------------------------------------------------~~~~~l~~L~~~h~~~ivHrdlk~~Ni 704 (823)
++.|++++|+|+|+.+|+||||||+||
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~NI 181 (314)
T 2ivs_A 102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNI 181 (314)
T ss_dssp EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccchheE
Confidence 134788899999999999999999999
Q ss_pred EeCCCCcEEEeecccccccCCCCccccccccccCCCcCcccccCCCccccccceehhhhhhccccC-CCCCcCCCc
Q 045449 705 LLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKET-RSMTVGETC 779 (823)
Q Consensus 705 Ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~-~~~~~~~~~ 779 (823)
+++.++.+||+|||+++...............+|+.|+|||++.+..++.++||||+||+++++++ |..||.+..
T Consensus 182 li~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 257 (314)
T 2ivs_A 182 LVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIP 257 (314)
T ss_dssp EEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred EEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 999999999999999987655443333344567899999999988889999999999999999999 999987653
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=8e-24 Score=225.74 Aligned_cols=142 Identities=30% Similarity=0.404 Sum_probs=115.7
Q ss_pred hccCCccceeeccC----------CeEEEEEEehHhhHHHHHHHHHHHHHHhh--cchhhHHH-----------------
Q 045449 627 TDRFSENNLIGIGN----------GMEVAVKVFHQQYERALKSFEDECEVRKR--IRHRNLVK----------------- 677 (823)
Q Consensus 627 t~~f~~~~~lg~g~----------~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~----------------- 677 (823)
.++|...+.||.|+ +..||||++..... +.+.+|.+++.. ++||||++
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~---~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~l 83 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRDE---KSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWL 83 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEETTEEEEEEEECGGGH---HHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEECCEEEEEEEeccccc---hhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEE
Confidence 46788888999886 67799999976533 456667777666 79999998
Q ss_pred --------------------------HHHHHHHHhhhcC--------CCCEEeccCCCCCEEeCCCCcEEEeeccccccc
Q 045449 678 --------------------------IISSSLEYLHFGH--------SIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLL 723 (823)
Q Consensus 678 --------------------------~~~~~l~~L~~~h--------~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~ 723 (823)
++.|++.+|+|+| +.+|+||||||+|||++.++.+||+|||+|+..
T Consensus 84 v~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~ 163 (301)
T 3q4u_A 84 ITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMH 163 (301)
T ss_dssp EECCCTTCBHHHHHTTCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred ehhhccCCCHHHHHhhcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCCCeeec
Confidence 3568888888889 999999999999999999999999999999876
Q ss_pred CCCCccc--cccccccCCCcCcccccCCC------ccccccceehhhhhhccccCC
Q 045449 724 SGEDQLS--KQTQTLATIGYMAPEYGTKG------RVSTRGDVCSFGIISGGKETR 771 (823)
Q Consensus 724 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~S~Gvv~~~~~~~ 771 (823)
....... ......||+.|+|||++.+. .++.++|||||||++|++++|
T Consensus 164 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg 219 (301)
T 3q4u_A 164 SQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARR 219 (301)
T ss_dssp ETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred ccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhh
Confidence 5433211 12335799999999998876 567899999999999999999
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.88 E-value=9.1e-25 Score=234.40 Aligned_cols=146 Identities=23% Similarity=0.275 Sum_probs=116.9
Q ss_pred ccCCccceeeccC------------CeEEEEEEehHhh--HHHHHHHHHHHHHHhhc-chhhHHH---------------
Q 045449 628 DRFSENNLIGIGN------------GMEVAVKVFHQQY--ERALKSFEDECEVRKRI-RHRNLVK--------------- 677 (823)
Q Consensus 628 ~~f~~~~~lg~g~------------~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~--------------- 677 (823)
++|+..+.||.|+ ++.||||++.... ......+..|+..+.++ +||||++
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~ 136 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence 6788889999986 6679999885422 33334566666666665 8999987
Q ss_pred -------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccc
Q 045449 678 -------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQ 732 (823)
Q Consensus 678 -------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~ 732 (823)
++.|++.+|+|+|+.+|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 137 e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~---~~ 213 (311)
T 3p1a_A 137 ELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG---AG 213 (311)
T ss_dssp ECCCCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC--------
T ss_pred eccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecccCC---CC
Confidence 46788999999999999999999999999999999999999998764332 22
Q ss_pred cccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCC
Q 045449 733 TQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGE 777 (823)
Q Consensus 733 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~ 777 (823)
....||+.|+|||++.+ .++.++|||||||+++++++|..++..
T Consensus 214 ~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~ 257 (311)
T 3p1a_A 214 EVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHG 257 (311)
T ss_dssp -CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSS
T ss_pred cccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 34569999999998875 799999999999999999999766543
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=4.4e-24 Score=225.56 Aligned_cols=152 Identities=22% Similarity=0.297 Sum_probs=115.4
Q ss_pred hccCCccceeeccC---------------CeEEEEEEehHhh-HHHHHHHHHHHHHHhhcchhhHHH-------------
Q 045449 627 TDRFSENNLIGIGN---------------GMEVAVKVFHQQY-ERALKSFEDECEVRKRIRHRNLVK------------- 677 (823)
Q Consensus 627 t~~f~~~~~lg~g~---------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~------------- 677 (823)
.++|...+.||.|+ +..||||++.... ....+.|.+|+.++++++||||++
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~lv 93 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWII 93 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSCEEE
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEccCccEEE
Confidence 35677778888875 2358999987532 455678999999999999999998
Q ss_pred ---------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccc
Q 045449 678 ---------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLS 730 (823)
Q Consensus 678 ---------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~ 730 (823)
++.|++.+|+|+|+.+|+||||||+||+++.++.+||+|||+++....... .
T Consensus 94 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~ 172 (281)
T 1mp8_A 94 MELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY-Y 172 (281)
T ss_dssp EECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC--------------
T ss_pred EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccccccccCcccc-c
Confidence 356889999999999999999999999999999999999999987644322 1
Q ss_pred cccccccCCCcCcccccCCCccccccceehhhhhhccccC-CCCCcCCCc
Q 045449 731 KQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKET-RSMTVGETC 779 (823)
Q Consensus 731 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~-~~~~~~~~~ 779 (823)
......+|+.|+|||++.+..++.++||||+||+++++++ |..||.+..
T Consensus 173 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~ 222 (281)
T 1mp8_A 173 KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK 222 (281)
T ss_dssp ------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred ccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCC
Confidence 2233457889999999988899999999999999999986 888987653
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=99.88 E-value=7.9e-24 Score=249.94 Aligned_cols=150 Identities=23% Similarity=0.189 Sum_probs=127.7
Q ss_pred hccCCccceeeccC------------CeEEEEEEehHhh---HHHHHHHHHHHHHHhhc-chhhHHH-------------
Q 045449 627 TDRFSENNLIGIGN------------GMEVAVKVFHQQY---ERALKSFEDECEVRKRI-RHRNLVK------------- 677 (823)
Q Consensus 627 t~~f~~~~~lg~g~------------~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~------------- 677 (823)
.++|...+.||+|+ ++.||||++.... ....+.+..|.+++..+ +||+|++
T Consensus 340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~l 419 (674)
T 3pfq_A 340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 419 (674)
T ss_dssp CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEE
T ss_pred ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEE
Confidence 46788888999886 5669999997543 22346788999999987 7899887
Q ss_pred ---------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccc
Q 045449 678 ---------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLS 730 (823)
Q Consensus 678 ---------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~ 730 (823)
+++|++.+|+|+|+.+|+||||||+|||++.++++||+|||+|+.......
T Consensus 420 V~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~-- 497 (674)
T 3pfq_A 420 VMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV-- 497 (674)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCCTTC--
T ss_pred EEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeeccccCCc--
Confidence 468999999999999999999999999999999999999999986433222
Q ss_pred cccccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCCC
Q 045449 731 KQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 731 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
.....+||+.|+|||++.+..|+.++|||||||++|||++|..||.+.
T Consensus 498 ~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~ 545 (674)
T 3pfq_A 498 TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE 545 (674)
T ss_dssp CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCC
Confidence 234578999999999999999999999999999999999999999764
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=99.88 E-value=8.8e-24 Score=232.60 Aligned_cols=149 Identities=28% Similarity=0.317 Sum_probs=118.9
Q ss_pred hccCCccceeeccC------------CeEEEEEEehHh--hHHHHHHHHHHHHHHhhcchhhHHH---------------
Q 045449 627 TDRFSENNLIGIGN------------GMEVAVKVFHQQ--YERALKSFEDECEVRKRIRHRNLVK--------------- 677 (823)
Q Consensus 627 t~~f~~~~~lg~g~------------~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~--------------- 677 (823)
.++|...+.||.|+ +..||||++... .....+.+.+|+.++++++||||++
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 36788888899886 567999998643 2445578999999999999999986
Q ss_pred ----------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCcc
Q 045449 678 ----------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQL 729 (823)
Q Consensus 678 ----------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~ 729 (823)
++.|++.+|+|+|+.+|+||||||+||+++.++.+||+|||+|+......
T Consensus 104 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~-- 181 (371)
T 2xrw_A 104 DVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF-- 181 (371)
T ss_dssp EEEEEEECCSEEHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC----------
T ss_pred ceEEEEEcCCCCHHHHHhhccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeeccccccccc--
Confidence 36789999999999999999999999999999999999999998754322
Q ss_pred ccccccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCCC
Q 045449 730 SKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 730 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
.....+||+.|+|||++.+..++.++||||+||+++++++|..||.+.
T Consensus 182 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 229 (371)
T 2xrw_A 182 -MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGT 229 (371)
T ss_dssp ---------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred -ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 223467999999999999989999999999999999999999999764
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=99.88 E-value=4e-24 Score=224.42 Aligned_cols=148 Identities=26% Similarity=0.394 Sum_probs=115.9
Q ss_pred ccCCccceeeccC----------CeEEEEEEehHhhH----HHHHHHHHHHHHHhhcchhhHHH----------------
Q 045449 628 DRFSENNLIGIGN----------GMEVAVKVFHQQYE----RALKSFEDECEVRKRIRHRNLVK---------------- 677 (823)
Q Consensus 628 ~~f~~~~~lg~g~----------~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~---------------- 677 (823)
++|...+.||.|+ +..||||++..... ...+.+.+|++++++++||||++
T Consensus 7 ~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (271)
T 3dtc_A 7 AELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVME 86 (271)
T ss_dssp TSEEEEEEEEEETTEEEEEEEETTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEEE
T ss_pred hheeeeeeeccCCCeEEEEEEEcCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEE
Confidence 5677788899886 57799999875432 23468999999999999999998
Q ss_pred -----------------------HHHHHHHHhhhcCCCC---EEeccCCCCCEEeCC--------CCcEEEeeccccccc
Q 045449 678 -----------------------IISSSLEYLHFGHSIP---IIHCDLKPSNVLLDE--------DMVAHISDFGIAKLL 723 (823)
Q Consensus 678 -----------------------~~~~~l~~L~~~h~~~---ivHrdlk~~NiLl~~--------~~~~kl~DfGla~~~ 723 (823)
++.|++.+|+|+|+.+ |+||||||+||+++. ++.+||+|||+++..
T Consensus 87 ~~~~~~L~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~~ 166 (271)
T 3dtc_A 87 FARGGPLNRVLSGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREW 166 (271)
T ss_dssp CCTTEEHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC----
T ss_pred cCCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCccccc
Confidence 3578889999999998 999999999999986 678999999999865
Q ss_pred CCCCccccccccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCCCc
Q 045449 724 SGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGETC 779 (823)
Q Consensus 724 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~~ 779 (823)
.... .....||+.|+|||++.+..++.++||||+||+++++++|..||.+..
T Consensus 167 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 218 (271)
T 3dtc_A 167 HRTT----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGID 218 (271)
T ss_dssp -------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSC
T ss_pred cccc----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 4332 224579999999999988889999999999999999999999997754
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.88 E-value=4.2e-24 Score=232.68 Aligned_cols=153 Identities=22% Similarity=0.323 Sum_probs=125.3
Q ss_pred hccCCccceeeccC-----------------CeEEEEEEehHhh-HHHHHHHHHHHHHHhhc-chhhHHH----------
Q 045449 627 TDRFSENNLIGIGN-----------------GMEVAVKVFHQQY-ERALKSFEDECEVRKRI-RHRNLVK---------- 677 (823)
Q Consensus 627 t~~f~~~~~lg~g~-----------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~---------- 677 (823)
.++|...+.||.|+ +..||||++.... ....+.+.+|++++.++ +||||++
T Consensus 44 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 123 (344)
T 1rjb_A 44 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 123 (344)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCc
Confidence 46788888999886 2359999997543 33457899999999999 8999997
Q ss_pred -----------------------------------------------------HHHHHHHHhhhcCCCCEEeccCCCCCE
Q 045449 678 -----------------------------------------------------IISSSLEYLHFGHSIPIIHCDLKPSNV 704 (823)
Q Consensus 678 -----------------------------------------------------~~~~~l~~L~~~h~~~ivHrdlk~~Ni 704 (823)
++.|++++|+|+|+.+|+||||||+||
T Consensus 124 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NI 203 (344)
T 1rjb_A 124 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNV 203 (344)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGE
T ss_pred cEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhE
Confidence 134788899999999999999999999
Q ss_pred EeCCCCcEEEeecccccccCCCCccccccccccCCCcCcccccCCCccccccceehhhhhhccccC-CCCCcCCCc
Q 045449 705 LLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKET-RSMTVGETC 779 (823)
Q Consensus 705 Ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~-~~~~~~~~~ 779 (823)
+++.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||+++++++ |..||.+..
T Consensus 204 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 279 (344)
T 1rjb_A 204 LVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 279 (344)
T ss_dssp EEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred EEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCC
Confidence 999999999999999987654433333345568899999999988899999999999999999998 999987653
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=99.88 E-value=2.5e-24 Score=228.26 Aligned_cols=149 Identities=26% Similarity=0.368 Sum_probs=120.4
Q ss_pred ccCCccceeeccC-----------CeEEEEEEehHhh--HHHHHHHHHHHHHHhhcchhhHHH-----------------
Q 045449 628 DRFSENNLIGIGN-----------GMEVAVKVFHQQY--ERALKSFEDECEVRKRIRHRNLVK----------------- 677 (823)
Q Consensus 628 ~~f~~~~~lg~g~-----------~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~----------------- 677 (823)
++|...+.||.|+ +..||||++.... ....+.+.+|++++++++||||++
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 4567777888775 5679999986432 222367889999999999999998
Q ss_pred -----------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccc
Q 045449 678 -----------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQ 734 (823)
Q Consensus 678 -----------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 734 (823)
++.|++++|+|+|+.+|+||||||+||+++.++.+||+|||+++....... ....
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~ 159 (288)
T 1ob3_A 82 LDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR--KYTH 159 (288)
T ss_dssp CSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---------
T ss_pred cCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCcccc--cccc
Confidence 367899999999999999999999999999999999999999987643221 2234
Q ss_pred cccCCCcCcccccCCC-ccccccceehhhhhhccccCCCCCcCCC
Q 045449 735 TLATIGYMAPEYGTKG-RVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 735 ~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
..||+.|+|||++.+. .++.++||||+||+++++++|..||.+.
T Consensus 160 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 204 (288)
T 1ob3_A 160 EIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGV 204 (288)
T ss_dssp --CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 5789999999998764 5899999999999999999999999764
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=1.2e-23 Score=222.40 Aligned_cols=149 Identities=27% Similarity=0.431 Sum_probs=126.6
Q ss_pred hccCCccceeeccC------------CeEEEEEEehHhh--HHHHHHHHHHHHHHhhcchhhHHH---------------
Q 045449 627 TDRFSENNLIGIGN------------GMEVAVKVFHQQY--ERALKSFEDECEVRKRIRHRNLVK--------------- 677 (823)
Q Consensus 627 t~~f~~~~~lg~g~------------~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~--------------- 677 (823)
.++|...+.||.|+ +..||||++.... ....+.+.+|++++++++||||++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 46788888898875 6679999986543 445578999999999999999998
Q ss_pred -------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCc---EEEeecccccccCCCCcc
Q 045449 678 -------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMV---AHISDFGIAKLLSGEDQL 729 (823)
Q Consensus 678 -------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~---~kl~DfGla~~~~~~~~~ 729 (823)
++.|++.+|.|+|+.+|+||||||+||+++.++. +||+|||+++.......
T Consensus 85 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~- 163 (284)
T 3kk8_A 85 DLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA- 163 (284)
T ss_dssp CCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSCB-
T ss_pred ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCcc-
Confidence 3678899999999999999999999999986554 99999999987653322
Q ss_pred ccccccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCCC
Q 045449 730 SKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 730 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
.....||+.|+|||++.+..++.++||||+||+++++++|..||.+.
T Consensus 164 --~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 210 (284)
T 3kk8_A 164 --WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDE 210 (284)
T ss_dssp --CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred --ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCC
Confidence 23467999999999999999999999999999999999999998664
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.88 E-value=4e-24 Score=233.12 Aligned_cols=148 Identities=28% Similarity=0.343 Sum_probs=111.1
Q ss_pred HhccCCccceeeccC------------CeEEEEEEehHhhHHHHHHHHHHHHHHhhcchhhHHH----------------
Q 045449 626 ATDRFSENNLIGIGN------------GMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVK---------------- 677 (823)
Q Consensus 626 at~~f~~~~~lg~g~------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~---------------- 677 (823)
..++|...+.||+|+ +..||||++.... ..+.+.+|++++++++||||++
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 128 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE 128 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence 356788889999886 5679999997553 3367889999999999999998
Q ss_pred ------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCC---CCcEEEeecccccccCCCCccc
Q 045449 678 ------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDE---DMVAHISDFGIAKLLSGEDQLS 730 (823)
Q Consensus 678 ------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~---~~~~kl~DfGla~~~~~~~~~~ 730 (823)
++.|++.+|+|+|+.+|+||||||+||+++. ++.+||+|||+++......
T Consensus 129 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~--- 205 (349)
T 2w4o_A 129 LVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV--- 205 (349)
T ss_dssp CCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC------------
T ss_pred eCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCccc---
Confidence 3678899999999999999999999999975 7899999999998764322
Q ss_pred cccccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCCC
Q 045449 731 KQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 731 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
......||+.|+|||++.+..++.++|||||||++|++++|..||.+.
T Consensus 206 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 253 (349)
T 2w4o_A 206 LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDE 253 (349)
T ss_dssp -------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCT
T ss_pred ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCC
Confidence 223467999999999999989999999999999999999999998654
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.88 E-value=2.2e-24 Score=233.81 Aligned_cols=151 Identities=24% Similarity=0.289 Sum_probs=127.2
Q ss_pred HhccCCccceeeccC------------CeEEEEEEehHhhH--------HHHHHHHHHHHHHhhcchhhHHH--------
Q 045449 626 ATDRFSENNLIGIGN------------GMEVAVKVFHQQYE--------RALKSFEDECEVRKRIRHRNLVK-------- 677 (823)
Q Consensus 626 at~~f~~~~~lg~g~------------~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~-------- 677 (823)
..++|...+.||.|+ +..||||++..... ...+.+.+|++++++++||||++
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 356788888899886 66799999875421 12346788999999999999998
Q ss_pred ---------------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccC
Q 045449 678 ---------------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLS 724 (823)
Q Consensus 678 ---------------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~ 724 (823)
++.|++.+|+|+|+.+|+||||||+||+++.++.+||+|||+++...
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~ 181 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLE 181 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred CEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceECC
Confidence 46788999999999999999999999999999999999999998765
Q ss_pred CCCccccccccccCCCcCcccccCCCcc-ccccceehhhhhhccccCCCCCcCCCc
Q 045449 725 GEDQLSKQTQTLATIGYMAPEYGTKGRV-STRGDVCSFGIISGGKETRSMTVGETC 779 (823)
Q Consensus 725 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~S~Gvv~~~~~~~~~~~~~~~ 779 (823)
.... ....+||+.|+|||++.+..+ +.++||||+||++|++++|..||.+..
T Consensus 182 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 234 (335)
T 3dls_A 182 RGKL---FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELE 234 (335)
T ss_dssp TTCC---BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGG
T ss_pred CCCc---eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHH
Confidence 4322 234679999999999988877 889999999999999999999997643
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=99.88 E-value=3.9e-24 Score=235.36 Aligned_cols=151 Identities=21% Similarity=0.416 Sum_probs=113.5
Q ss_pred ccCCccceeeccC---------------CeEEEEEEehHhh-HHHHHHHHHHHHHHhhcchhhHHH--------------
Q 045449 628 DRFSENNLIGIGN---------------GMEVAVKVFHQQY-ERALKSFEDECEVRKRIRHRNLVK-------------- 677 (823)
Q Consensus 628 ~~f~~~~~lg~g~---------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~-------------- 677 (823)
++|...+.||.|+ +..||||+++... ....++|.+|++++++++||||++
T Consensus 45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 124 (373)
T 2qol_A 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV 124 (373)
T ss_dssp GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEE
Confidence 4677778888875 2349999997543 445678999999999999999998
Q ss_pred ---------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccc
Q 045449 678 ---------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLS 730 (823)
Q Consensus 678 ---------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~ 730 (823)
++.|++++|+|+|+.+|+||||||+||+++.++.+||+|||+++.........
T Consensus 125 ~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 204 (373)
T 2qol_A 125 TEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAA 204 (373)
T ss_dssp EECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-------------
T ss_pred EeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCccccccccCCccc
Confidence 35788899999999999999999999999999999999999998765432211
Q ss_pred -cccccccCCCcCcccccCCCccccccceehhhhhhccccC-CCCCcCCC
Q 045449 731 -KQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKET-RSMTVGET 778 (823)
Q Consensus 731 -~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~-~~~~~~~~ 778 (823)
......+|+.|+|||++.+..++.++|||||||++|++++ |..||.+.
T Consensus 205 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~ 254 (373)
T 2qol_A 205 YTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEM 254 (373)
T ss_dssp ---------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTC
T ss_pred eeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCC
Confidence 1122345788999999998899999999999999999887 99998664
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=99.88 E-value=2.7e-24 Score=243.19 Aligned_cols=150 Identities=27% Similarity=0.410 Sum_probs=126.5
Q ss_pred hccCCccceeeccC-----------CeEEEEEEehHhhHHHHHHHHHHHHHHhhcchhhHHH------------------
Q 045449 627 TDRFSENNLIGIGN-----------GMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVK------------------ 677 (823)
Q Consensus 627 t~~f~~~~~lg~g~-----------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------------ 677 (823)
.++|...+.||.|+ +..||||+++... ...+.|.+|++++++++|||||+
T Consensus 187 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~lv~e~~~ 265 (454)
T 1qcf_A 187 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTKEPIYIITEFMA 265 (454)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEEECCCT
T ss_pred hHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEeCCccEEEEeecC
Confidence 46777788888886 4669999997543 23578999999999999999998
Q ss_pred -----------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccc
Q 045449 678 -----------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQ 734 (823)
Q Consensus 678 -----------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 734 (823)
++.|++.+|+|+|+.+|+||||||+|||++.++.+||+|||+++...... ......
T Consensus 266 ~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~-~~~~~~ 344 (454)
T 1qcf_A 266 KGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE-YTAREG 344 (454)
T ss_dssp TCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHH-HHTTCS
T ss_pred CCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCc-eeccCC
Confidence 35788999999999999999999999999999999999999998764322 122233
Q ss_pred cccCCCcCcccccCCCccccccceehhhhhhccccC-CCCCcCCC
Q 045449 735 TLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKET-RSMTVGET 778 (823)
Q Consensus 735 ~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~-~~~~~~~~ 778 (823)
..+|+.|+|||++..+.++.++|||||||+++++++ |..||.+.
T Consensus 345 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~ 389 (454)
T 1qcf_A 345 AKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGM 389 (454)
T ss_dssp SSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred CcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCC
Confidence 456789999999988899999999999999999998 99999764
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=2e-23 Score=229.83 Aligned_cols=146 Identities=12% Similarity=0.146 Sum_probs=114.7
Q ss_pred ccCCccceeeccC------------CeEEEEEEehHhh---HHHHHHHHHHHHHHhhc--chhhHHH-------------
Q 045449 628 DRFSENNLIGIGN------------GMEVAVKVFHQQY---ERALKSFEDECEVRKRI--RHRNLVK------------- 677 (823)
Q Consensus 628 ~~f~~~~~lg~g~------------~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l--~h~niv~------------- 677 (823)
..|...+.||.|+ +..||||++.... ....+.+.+|++++..+ +||||++
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence 4577788899886 6779999997532 34556788886655555 5999653
Q ss_pred ---------------------------------------------------------HHHHHHHHhhhcCCCCEEeccCC
Q 045449 678 ---------------------------------------------------------IISSSLEYLHFGHSIPIIHCDLK 700 (823)
Q Consensus 678 ---------------------------------------------------------~~~~~l~~L~~~h~~~ivHrdlk 700 (823)
++.|++.+|+|+|+.+|+|||||
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDik 221 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFT 221 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCSEEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTCS
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCCCCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcCC
Confidence 12688899999999999999999
Q ss_pred CCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCcccccCC--CccccccceehhhhhhccccCCCCCcCCC
Q 045449 701 PSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTK--GRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 701 ~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
|+|||++.++.+||+|||+|+..... .....||+.|+|||++.+ ..++.++|||||||++|++++|..||.+.
T Consensus 222 p~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~ 296 (371)
T 3q60_A 222 PDNLFIMPDGRLMLGDVSALWKVGTR-----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLV 296 (371)
T ss_dssp GGGEEECTTSCEEECCGGGEEETTCE-----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBC
T ss_pred HHHEEECCCCCEEEEecceeeecCCC-----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCc
Confidence 99999999999999999999875422 113567799999999987 67999999999999999999999999775
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.88 E-value=3.8e-22 Score=213.44 Aligned_cols=208 Identities=23% Similarity=0.331 Sum_probs=122.0
Q ss_pred EEeeccccccccCccccCCCCCCeEEeecccccccCCCccCCCcccCcccccCccccCCCCcccccccccCCCCceEEEe
Q 045449 258 LNLGINSFSGTIPSSITNSSKLSDLELGENLFSGFIPNTIGNLRNLEFGNIADNYLTSSTPELSFLSSLTNCKKLKVLIV 337 (823)
Q Consensus 258 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~L 337 (823)
+.+..+.+...+ .+.++++|++|++++|.++.. | .+..+++|++|++++|.+++.. . +..+++|++|++
T Consensus 24 ~~l~~~~~~~~~--~~~~l~~L~~L~l~~~~i~~l-~-~~~~l~~L~~L~L~~n~i~~~~------~-~~~l~~L~~L~L 92 (308)
T 1h6u_A 24 IAAGKSNVTDTV--TQADLDGITTLSAFGTGVTTI-E-GVQYLNNLIGLELKDNQITDLA------P-LKNLTKITELEL 92 (308)
T ss_dssp HHTTCSSTTSEE--CHHHHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCG------G-GTTCCSCCEEEC
T ss_pred HHhCCCCcCcee--cHHHcCCcCEEEeeCCCccCc-h-hhhccCCCCEEEccCCcCCCCh------h-HccCCCCCEEEc
Confidence 344455554332 245677888888888888753 3 5777888888888888877651 2 667777777777
Q ss_pred ecCCCCccCCccccccccccceEEecCCcceeccCccccCcccccEEEcccCcCCCCchhcccccCCCCEEEccCCCCCC
Q 045449 338 TGNPLDGILPKSIGNFSLSLETILMANCSISGNIPQVVGNLSNLLVLELGGNNLTGPIPVTFSQLQTLQAFDLTRNKLAG 417 (823)
Q Consensus 338 s~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~ 417 (823)
++|.+++. | .+..+ .+|++|++++|++++.. .+..+++|++|++++|++++..+ +..+++|++|+|++|++++
T Consensus 93 ~~n~l~~~-~-~~~~l-~~L~~L~l~~n~l~~~~--~l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~ 165 (308)
T 1h6u_A 93 SGNPLKNV-S-AIAGL-QSIKTLDLTSTQITDVT--PLAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSD 165 (308)
T ss_dssp CSCCCSCC-G-GGTTC-TTCCEEECTTSCCCCCG--GGTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCC
T ss_pred cCCcCCCc-h-hhcCC-CCCCEEECCCCCCCCch--hhcCCCCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcCCC
Confidence 77777653 2 35554 45666666666665432 15555566666666666554332 5555555556665555554
Q ss_pred cchHhhhcCCCCCEEEcccCcCcccccccccCCCCCCeEeccCCccccccchhhhccCCCcEEecccccccc
Q 045449 418 PITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSVRVLYLGLNIFTSVLSSTIWNLKDILFIDVSSNFLDG 489 (823)
Q Consensus 418 ~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~LdLs~N~l~g 489 (823)
..+ +..+++|+.|+|++|.+++..+ +..+++|+.|+|++|++++..+ +..+++|+.|++++|.+++
T Consensus 166 ~~~--l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~l~~N~i~~ 231 (308)
T 1h6u_A 166 LTP--LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITN 231 (308)
T ss_dssp CGG--GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEEEEEEEEEEC
T ss_pred Chh--hcCCCCCCEEECCCCccCcChh--hcCCCCCCEEEccCCccCcccc--ccCCCCCCEEEccCCeeec
Confidence 332 5555555555555555554332 4555555555555555555432 4555555555555555543
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=99.88 E-value=7.5e-24 Score=239.13 Aligned_cols=146 Identities=31% Similarity=0.399 Sum_probs=123.7
Q ss_pred hccCCccceeeccC----------CeEEEEEEehHhhHHHHHHHHHHHHHHhhcchhhHHH-------------------
Q 045449 627 TDRFSENNLIGIGN----------GMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVK------------------- 677 (823)
Q Consensus 627 t~~f~~~~~lg~g~----------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------------- 677 (823)
.++|...+.||.|+ +..||||+++... ..+.|.+|++++++++||||++
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~ 269 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 269 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECC
T ss_pred hHHeEEEeeecCcCCeeEEEEEecCCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEec
Confidence 35677778899886 6779999997653 3468999999999999999998
Q ss_pred ------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCcccccc
Q 045449 678 ------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQT 733 (823)
Q Consensus 678 ------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~ 733 (823)
++.|++++|+|+|+.+|+||||||+|||++.++.+||+|||+++..... ..
T Consensus 270 ~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-----~~ 344 (450)
T 1k9a_A 270 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-----QD 344 (450)
T ss_dssp TTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC---------
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCccccccc-----cc
Confidence 3578899999999999999999999999999999999999999864322 12
Q ss_pred ccccCCCcCcccccCCCccccccceehhhhhhccccC-CCCCcCCCc
Q 045449 734 QTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKET-RSMTVGETC 779 (823)
Q Consensus 734 ~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~-~~~~~~~~~ 779 (823)
...+++.|+|||++.+..++.++|||||||++|++++ |..||.+..
T Consensus 345 ~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~ 391 (450)
T 1k9a_A 345 TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP 391 (450)
T ss_dssp --CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSC
T ss_pred CCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 2357899999999999999999999999999999998 999987653
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.88 E-value=7.2e-24 Score=234.25 Aligned_cols=152 Identities=30% Similarity=0.363 Sum_probs=127.7
Q ss_pred hccCCccceeeccC-------------------CeEEEEEEehHhh-HHHHHHHHHHHHHHhhc-chhhHHH--------
Q 045449 627 TDRFSENNLIGIGN-------------------GMEVAVKVFHQQY-ERALKSFEDECEVRKRI-RHRNLVK-------- 677 (823)
Q Consensus 627 t~~f~~~~~lg~g~-------------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~-------- 677 (823)
.++|...+.||+|+ +..||||++.... ....+++.+|+++++++ +||||++
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 147 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 147 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence 35777778888886 1359999997543 45567899999999999 9999998
Q ss_pred ------------------------------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCC
Q 045449 678 ------------------------------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDED 709 (823)
Q Consensus 678 ------------------------------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~ 709 (823)
++.|++.+|.|+|+.+|+||||||+||+++.+
T Consensus 148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~ 227 (382)
T 3tt0_A 148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTED 227 (382)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT
T ss_pred CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEEEcCC
Confidence 24578889999999999999999999999999
Q ss_pred CcEEEeecccccccCCCCccccccccccCCCcCcccccCCCccccccceehhhhhhccccC-CCCCcCCC
Q 045449 710 MVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKET-RSMTVGET 778 (823)
Q Consensus 710 ~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~-~~~~~~~~ 778 (823)
+.+||+|||+|+...............||+.|+|||++.+..++.++|||||||+++++++ |..||.+.
T Consensus 228 ~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~ 297 (382)
T 3tt0_A 228 NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV 297 (382)
T ss_dssp CCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred CcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999999987654443333445568899999999999999999999999999999998 99998764
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=99.88 E-value=8.6e-24 Score=231.95 Aligned_cols=147 Identities=33% Similarity=0.391 Sum_probs=114.0
Q ss_pred hccCCccceeeccC------------CeEEEEEEehHh--hHHHHHHHHHHHHHHhhcchhhHHH---------------
Q 045449 627 TDRFSENNLIGIGN------------GMEVAVKVFHQQ--YERALKSFEDECEVRKRIRHRNLVK--------------- 677 (823)
Q Consensus 627 t~~f~~~~~lg~g~------------~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~--------------- 677 (823)
.++|...+.||.|+ |..||||++... .....+.+.+|++++++++||||++
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 36777777888775 677999998643 2345578899999999999999987
Q ss_pred -----------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCc
Q 045449 678 -----------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQ 728 (823)
Q Consensus 678 -----------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~ 728 (823)
++.|++.+|+|+|+.||+||||||+||+++.++.+||+|||+++.....
T Consensus 108 ~~~lv~e~~~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~-- 185 (367)
T 2fst_X 108 DVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE-- 185 (367)
T ss_dssp CCEEEEECCCEECC-----CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC------------
T ss_pred eEEEEecccCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeecccccccccc--
Confidence 3678999999999999999999999999999999999999999875422
Q ss_pred cccccccccCCCcCcccccCC-CccccccceehhhhhhccccCCCCCcCCC
Q 045449 729 LSKQTQTLATIGYMAPEYGTK-GRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 729 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
....+||+.|+|||++.+ ..++.++||||+||+++++++|+.||.+.
T Consensus 186 ---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 233 (367)
T 2fst_X 186 ---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 233 (367)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ---CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 234679999999999876 67899999999999999999999999764
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=5.6e-24 Score=225.36 Aligned_cols=147 Identities=22% Similarity=0.305 Sum_probs=121.0
Q ss_pred ccCCccceeeccC------------CeEEEEEEehHhh----HHH---HHHHHHHHHHHhhcchhhHHH-----------
Q 045449 628 DRFSENNLIGIGN------------GMEVAVKVFHQQY----ERA---LKSFEDECEVRKRIRHRNLVK----------- 677 (823)
Q Consensus 628 ~~f~~~~~lg~g~------------~~~vavK~~~~~~----~~~---~~~~~~E~~~l~~l~h~niv~----------- 677 (823)
++|...+.||.|+ +..||||++.... ... .+.|.+|++++++++||||++
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~l 98 (287)
T 4f0f_A 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPPRM 98 (287)
T ss_dssp TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTTEE
T ss_pred ccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCCeE
Confidence 5677777888775 5679999985322 111 268999999999999999998
Q ss_pred ----------------------------HHHHHHHHhhhcCCCC--EEeccCCCCCEEeCCCCc-----EEEeecccccc
Q 045449 678 ----------------------------IISSSLEYLHFGHSIP--IIHCDLKPSNVLLDEDMV-----AHISDFGIAKL 722 (823)
Q Consensus 678 ----------------------------~~~~~l~~L~~~h~~~--ivHrdlk~~NiLl~~~~~-----~kl~DfGla~~ 722 (823)
++.|++.+|+|+|+.+ |+||||||+||+++.++. +||+|||+++.
T Consensus 99 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~~~~ 178 (287)
T 4f0f_A 99 VMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ 178 (287)
T ss_dssp EEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCCTTCBC
T ss_pred EEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCCCCcccc
Confidence 4678899999999999 999999999999987765 99999999985
Q ss_pred cCCCCccccccccccCCCcCccccc--CCCccccccceehhhhhhccccCCCCCcCCCc
Q 045449 723 LSGEDQLSKQTQTLATIGYMAPEYG--TKGRVSTRGDVCSFGIISGGKETRSMTVGETC 779 (823)
Q Consensus 723 ~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~~ 779 (823)
... ......||+.|+|||++ ....++.++||||+||++|++++|..||....
T Consensus 179 ~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 232 (287)
T 4f0f_A 179 SVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYS 232 (287)
T ss_dssp CSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred ccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCcccc
Confidence 432 12346799999999998 44567899999999999999999999997643
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.88 E-value=9.8e-24 Score=227.25 Aligned_cols=147 Identities=25% Similarity=0.391 Sum_probs=124.7
Q ss_pred ccCCccceeeccC------------CeEEEEEEehHhh-HHHHHHHHHHHHHHhhcchhhHHH-----------------
Q 045449 628 DRFSENNLIGIGN------------GMEVAVKVFHQQY-ERALKSFEDECEVRKRIRHRNLVK----------------- 677 (823)
Q Consensus 628 ~~f~~~~~lg~g~------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~----------------- 677 (823)
++|...+.||+|+ +..||||++.... ....+.+.+|++++++++||||++
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence 5677888899886 6679999997543 233567889999999999999998
Q ss_pred ----------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEe----CCCCcEEEeecccccccCC
Q 045449 678 ----------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLL----DEDMVAHISDFGIAKLLSG 725 (823)
Q Consensus 678 ----------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl----~~~~~~kl~DfGla~~~~~ 725 (823)
++.|++.+|+|+|+.+|+||||||+||++ +.++.+||+|||+++....
T Consensus 89 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~~ 168 (319)
T 4euu_A 89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED 168 (319)
T ss_dssp ECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEECCT
T ss_pred eCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCceecCC
Confidence 35788999999999999999999999999 7888999999999987654
Q ss_pred CCccccccccccCCCcCcccccC--------CCccccccceehhhhhhccccCCCCCcCC
Q 045449 726 EDQLSKQTQTLATIGYMAPEYGT--------KGRVSTRGDVCSFGIISGGKETRSMTVGE 777 (823)
Q Consensus 726 ~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~ 777 (823)
... .....||+.|+|||++. +..++.++|||||||++|++++|..||..
T Consensus 169 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 225 (319)
T 4euu_A 169 DEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRP 225 (319)
T ss_dssp TCC---BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEEC
T ss_pred CCc---eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 332 23457999999999875 46789999999999999999999999964
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.87 E-value=8.6e-24 Score=228.72 Aligned_cols=151 Identities=26% Similarity=0.345 Sum_probs=123.3
Q ss_pred hccCCccceeeccC------------CeEEEEEEehHhh-HHHHHHHHHHHHHHhhcchhhHHH----------------
Q 045449 627 TDRFSENNLIGIGN------------GMEVAVKVFHQQY-ERALKSFEDECEVRKRIRHRNLVK---------------- 677 (823)
Q Consensus 627 t~~f~~~~~lg~g~------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~---------------- 677 (823)
.++|...+.||.|+ +..||||++.... ....+.+.+|++++++++||||++
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 46788888899885 6679999986332 334578999999999999999873
Q ss_pred --------------------------------------------------------------------------------
Q 045449 678 -------------------------------------------------------------------------------- 677 (823)
Q Consensus 678 -------------------------------------------------------------------------------- 677 (823)
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence
Q ss_pred ----HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCcc----------ccccccccCCCcCc
Q 045449 678 ----IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQL----------SKQTQTLATIGYMA 743 (823)
Q Consensus 678 ----~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~----------~~~~~~~gt~~y~a 743 (823)
++.|++.+|+|+|+.+|+||||||+||+++.++.+||+|||+++........ ......+||+.|+|
T Consensus 165 ~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 244 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMS 244 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSC
T ss_pred HHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccC
Confidence 3568889999999999999999999999999999999999999876543211 12234579999999
Q ss_pred ccccCCCccccccceehhhhhhccccCCCCCcCC
Q 045449 744 PEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGE 777 (823)
Q Consensus 744 PE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~ 777 (823)
||++.+..++.++||||+||++++++++..++.+
T Consensus 245 PE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~ 278 (332)
T 3qd2_B 245 PEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME 278 (332)
T ss_dssp HHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH
T ss_pred hHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH
Confidence 9999998999999999999999999998776543
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=99.87 E-value=6.8e-24 Score=237.25 Aligned_cols=144 Identities=28% Similarity=0.366 Sum_probs=120.1
Q ss_pred ccCCccceeeccC------------CeEEEEEEehHhhHHHHHHHHHHHHHHhhcchhhHHH------------------
Q 045449 628 DRFSENNLIGIGN------------GMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVK------------------ 677 (823)
Q Consensus 628 ~~f~~~~~lg~g~------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------------ 677 (823)
.+|...+.||+|+ |..||||++.... +.+.+|++++++++|||||+
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 3577778899886 6679999986542 23457999999999999987
Q ss_pred -------------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCC-CcEEEeecccccccCC
Q 045449 678 -------------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDED-MVAHISDFGIAKLLSG 725 (823)
Q Consensus 678 -------------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~-~~~kl~DfGla~~~~~ 725 (823)
++.|++.+|+|+|+.+|+||||||+|||++.+ +.+||+|||+|+....
T Consensus 130 lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~ 209 (420)
T 1j1b_A 130 LVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR 209 (420)
T ss_dssp EEEECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred eehhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhhhccc
Confidence 25688999999999999999999999999955 6789999999987644
Q ss_pred CCccccccccccCCCcCcccccCCC-ccccccceehhhhhhccccCCCCCcCCC
Q 045449 726 EDQLSKQTQTLATIGYMAPEYGTKG-RVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 726 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
... ....+||+.|+|||++.+. .|+.++||||+||++|+|++|+.||.+.
T Consensus 210 ~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~ 260 (420)
T 1j1b_A 210 GEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD 260 (420)
T ss_dssp TCC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CCC---ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence 322 2346799999999998764 7899999999999999999999999764
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.87 E-value=9.6e-24 Score=224.79 Aligned_cols=147 Identities=21% Similarity=0.319 Sum_probs=120.4
Q ss_pred CCccceeeccC---------------CeEEEEEEehHhh-HHHHHHHHHHHHHHhhcchhhHHH----------------
Q 045449 630 FSENNLIGIGN---------------GMEVAVKVFHQQY-ERALKSFEDECEVRKRIRHRNLVK---------------- 677 (823)
Q Consensus 630 f~~~~~lg~g~---------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~---------------- 677 (823)
|...+.||.|+ +..||||++.... ....+.|.+|++++++++||||++
T Consensus 23 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~ 102 (298)
T 3pls_A 23 THSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLL 102 (298)
T ss_dssp EEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEE
T ss_pred EccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEE
Confidence 44457788876 1258999987533 455678999999999999999998
Q ss_pred --------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCc--c
Q 045449 678 --------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQ--L 729 (823)
Q Consensus 678 --------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~--~ 729 (823)
++.|++.+|+|+|+.+|+||||||+||+++.++.+||+|||+++....... .
T Consensus 103 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 182 (298)
T 3pls_A 103 PYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSV 182 (298)
T ss_dssp CCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGGGCS
T ss_pred ecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCccccc
Confidence 356889999999999999999999999999999999999999986543321 1
Q ss_pred ccccccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcC
Q 045449 730 SKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVG 776 (823)
Q Consensus 730 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~ 776 (823)
.......+|+.|+|||.+.+..++.++||||+||+++++++|..|+.
T Consensus 183 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~ 229 (298)
T 3pls_A 183 QQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPY 229 (298)
T ss_dssp CCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTT
T ss_pred ccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCC
Confidence 12234568899999999999999999999999999999999665543
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=5.5e-24 Score=228.39 Aligned_cols=152 Identities=25% Similarity=0.300 Sum_probs=126.5
Q ss_pred ccCCccceeeccC-----------------CeEEEEEEehHhh-HHHHHHHHHHHHHHhhc-chhhHHH-----------
Q 045449 628 DRFSENNLIGIGN-----------------GMEVAVKVFHQQY-ERALKSFEDECEVRKRI-RHRNLVK----------- 677 (823)
Q Consensus 628 ~~f~~~~~lg~g~-----------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~----------- 677 (823)
++|...+.||.|+ +..||||++.... ....+.+.+|+++++++ +||||++
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~ 102 (313)
T 1t46_A 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT 102 (313)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCc
Confidence 5677778888775 2469999997543 34457899999999999 9999997
Q ss_pred -----------------------------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCC
Q 045449 678 -----------------------------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDM 710 (823)
Q Consensus 678 -----------------------------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~ 710 (823)
++.|++.+|+|+|+.+|+||||||+||+++.++
T Consensus 103 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~ 182 (313)
T 1t46_A 103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGR 182 (313)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEETTT
T ss_pred EEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEcCCC
Confidence 134778899999999999999999999999999
Q ss_pred cEEEeecccccccCCCCccccccccccCCCcCcccccCCCccccccceehhhhhhccccC-CCCCcCCCc
Q 045449 711 VAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKET-RSMTVGETC 779 (823)
Q Consensus 711 ~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~-~~~~~~~~~ 779 (823)
.+||+|||+++...............||+.|+|||++.+..++.++||||+||+++++++ |..||.+..
T Consensus 183 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 252 (313)
T 1t46_A 183 ITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP 252 (313)
T ss_dssp EEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred CEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCccc
Confidence 999999999987655443333344567889999999988899999999999999999998 999987653
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=99.87 E-value=4.3e-24 Score=229.56 Aligned_cols=161 Identities=24% Similarity=0.292 Sum_probs=132.9
Q ss_pred cCHHHHHHHhccCCccceeeccC-----------------CeEEEEEEehHhh-HHHHHHHHHHHHHHhhc-chhhHHH-
Q 045449 618 FSYHELLRATDRFSENNLIGIGN-----------------GMEVAVKVFHQQY-ERALKSFEDECEVRKRI-RHRNLVK- 677 (823)
Q Consensus 618 ~~~~~l~~at~~f~~~~~lg~g~-----------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~- 677 (823)
+...+..-..++|...+.||.|+ +..||||++.... ....+.+.+|++++.++ +||||++
T Consensus 17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 96 (316)
T 2xir_A 17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 96 (316)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence 44445555567888889999886 2568999987543 34557899999999999 7999997
Q ss_pred --------------------------------------------------------HHHHHHHHhhhcCCCCEEeccCCC
Q 045449 678 --------------------------------------------------------IISSSLEYLHFGHSIPIIHCDLKP 701 (823)
Q Consensus 678 --------------------------------------------------------~~~~~l~~L~~~h~~~ivHrdlk~ 701 (823)
++.|++.+|+|+|+.+|+||||||
T Consensus 97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp 176 (316)
T 2xir_A 97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAA 176 (316)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCcc
Confidence 135788999999999999999999
Q ss_pred CCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCcccccCCCccccccceehhhhhhccccC-CCCCcCCC
Q 045449 702 SNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKET-RSMTVGET 778 (823)
Q Consensus 702 ~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~-~~~~~~~~ 778 (823)
+||+++.++.+||+|||+++...............||+.|+|||++.+..++.++||||+||+++++++ |..||.+.
T Consensus 177 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~ 254 (316)
T 2xir_A 177 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 254 (316)
T ss_dssp GGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred ceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCccc
Confidence 999999999999999999987654433333345678999999999988899999999999999999998 99998664
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=7.1e-24 Score=222.20 Aligned_cols=151 Identities=25% Similarity=0.337 Sum_probs=125.9
Q ss_pred hccCCccceeeccC-----------CeEEEEEEehHhhHHHHHHHHHHHHHHhhcchhhHHH------------------
Q 045449 627 TDRFSENNLIGIGN-----------GMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVK------------------ 677 (823)
Q Consensus 627 t~~f~~~~~lg~g~-----------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------------ 677 (823)
.++|...+.||.|+ +..||||++..... ..+++.+|++++.+++||||++
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI 85 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence 35677778888876 45699999975432 2367999999999999999998
Q ss_pred -----------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccc
Q 045449 678 -----------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQ 734 (823)
Q Consensus 678 -----------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 734 (823)
++.|++++|+|+|+.+|+||||||+||+++.++.+||+|||+++....... .....
T Consensus 86 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~-~~~~~ 164 (268)
T 3sxs_A 86 SNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY-VSSVG 164 (268)
T ss_dssp TTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCE-EECCS
T ss_pred CCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchhhh-hcccC
Confidence 357889999999999999999999999999999999999999987654332 22334
Q ss_pred cccCCCcCcccccCCCccccccceehhhhhhccccC-CCCCcCCCc
Q 045449 735 TLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKET-RSMTVGETC 779 (823)
Q Consensus 735 ~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~-~~~~~~~~~ 779 (823)
..+|+.|+|||++.+..++.++||||+||+++++++ |..||....
T Consensus 165 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~ 210 (268)
T 3sxs_A 165 TKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYT 210 (268)
T ss_dssp CCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred CCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccC
Confidence 557788999999988899999999999999999998 999987643
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.87 E-value=9.6e-24 Score=229.91 Aligned_cols=158 Identities=22% Similarity=0.333 Sum_probs=126.5
Q ss_pred HHHHHhccCCccceeeccC------------CeEEEEEEehHhh-----HHHHHHHHHHHHHHhhcchhhHHH-------
Q 045449 622 ELLRATDRFSENNLIGIGN------------GMEVAVKVFHQQY-----ERALKSFEDECEVRKRIRHRNLVK------- 677 (823)
Q Consensus 622 ~l~~at~~f~~~~~lg~g~------------~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~------- 677 (823)
++....++|...+.||.|+ +..||||++.... ....+.+.+|++++++++||||++
T Consensus 20 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 99 (345)
T 3hko_A 20 SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED 99 (345)
T ss_dssp CHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred hhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc
Confidence 3456678899999999986 5568999997543 234578999999999999999986
Q ss_pred -------------------------------------------------------------------------HHHHHHH
Q 045449 678 -------------------------------------------------------------------------IISSSLE 684 (823)
Q Consensus 678 -------------------------------------------------------------------------~~~~~l~ 684 (823)
++.|+++
T Consensus 100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~ 179 (345)
T 3hko_A 100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS 179 (345)
T ss_dssp SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence 2357888
Q ss_pred HhhhcCCCCEEeccCCCCCEEeCCCC--cEEEeecccccccCCCCc--cccccccccCCCcCcccccCC--Cccccccce
Q 045449 685 YLHFGHSIPIIHCDLKPSNVLLDEDM--VAHISDFGIAKLLSGEDQ--LSKQTQTLATIGYMAPEYGTK--GRVSTRGDV 758 (823)
Q Consensus 685 ~L~~~h~~~ivHrdlk~~NiLl~~~~--~~kl~DfGla~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv 758 (823)
+|+|+|+.+|+||||||+||+++.++ .+||+|||+++....... ........||+.|+|||++.+ ..++.++||
T Consensus 180 ~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di 259 (345)
T 3hko_A 180 ALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDA 259 (345)
T ss_dssp HHHHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHH
T ss_pred HHHHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHH
Confidence 99999999999999999999998766 899999999986533211 112345679999999999865 678999999
Q ss_pred ehhhhhhccccCCCCCcCCCc
Q 045449 759 CSFGIISGGKETRSMTVGETC 779 (823)
Q Consensus 759 ~S~Gvv~~~~~~~~~~~~~~~ 779 (823)
|||||+++++++|..||.+..
T Consensus 260 wslG~il~el~~g~~pf~~~~ 280 (345)
T 3hko_A 260 WSAGVLLHLLLMGAVPFPGVN 280 (345)
T ss_dssp HHHHHHHHHHHHSSCSSCCSS
T ss_pred HHHHHHHHHHHHCCCCCCCCC
Confidence 999999999999999997653
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.87 E-value=9.3e-24 Score=228.96 Aligned_cols=151 Identities=25% Similarity=0.284 Sum_probs=111.7
Q ss_pred ccCCccceeeccC------------CeEEEEEEehHhhHHHHHHHHHHHHHHhhcc-hhhHHH-----------------
Q 045449 628 DRFSENNLIGIGN------------GMEVAVKVFHQQYERALKSFEDECEVRKRIR-HRNLVK----------------- 677 (823)
Q Consensus 628 ~~f~~~~~lg~g~------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~----------------- 677 (823)
.+|...+.||.|+ +..||||++........+.+.+|+.++.++. ||||++
T Consensus 28 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~ 107 (337)
T 3ll6_A 28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQA 107 (337)
T ss_dssp EEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSE
T ss_pred ceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCc
Confidence 5788888899886 5679999987666666678999999999996 999986
Q ss_pred ---------------------------------HHHHHHHHhhhcCCCC--EEeccCCCCCEEeCCCCcEEEeecccccc
Q 045449 678 ---------------------------------IISSSLEYLHFGHSIP--IIHCDLKPSNVLLDEDMVAHISDFGIAKL 722 (823)
Q Consensus 678 ---------------------------------~~~~~l~~L~~~h~~~--ivHrdlk~~NiLl~~~~~~kl~DfGla~~ 722 (823)
++.|++.+|+|+|+.+ |+||||||+||+++.++.+||+|||+++.
T Consensus 108 ~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 187 (337)
T 3ll6_A 108 EFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATT 187 (337)
T ss_dssp EEEEEEECCSEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCCCTTCBC
T ss_pred eEEEEEEecCCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEecCcccee
Confidence 3568889999999999 99999999999999999999999999987
Q ss_pred cCCCCccc----------cccccccCCCcCccccc---CCCccccccceehhhhhhccccCCCCCcCCC
Q 045449 723 LSGEDQLS----------KQTQTLATIGYMAPEYG---TKGRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 723 ~~~~~~~~----------~~~~~~gt~~y~aPE~~---~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
........ ......||+.|+|||++ .+..++.++|||||||+++++++|..||.+.
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~ 256 (337)
T 3ll6_A 188 ISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDG 256 (337)
T ss_dssp CSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC---
T ss_pred ccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcch
Confidence 65332211 11245689999999998 5667899999999999999999999998653
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=99.87 E-value=1.1e-23 Score=222.12 Aligned_cols=150 Identities=24% Similarity=0.358 Sum_probs=124.4
Q ss_pred HhccCCccceeeccC------------CeEEEEEEehHhhH---HHHHHHHHHHHHHhhcchhhHHH-------------
Q 045449 626 ATDRFSENNLIGIGN------------GMEVAVKVFHQQYE---RALKSFEDECEVRKRIRHRNLVK------------- 677 (823)
Q Consensus 626 at~~f~~~~~lg~g~------------~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~------------- 677 (823)
+.++|...+.||.|+ +..||||++..... ...+.+.+|++++++++||||++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 86 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence 356788888999886 55699999865432 22467899999999999999998
Q ss_pred ---------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccc
Q 045449 678 ---------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLS 730 (823)
Q Consensus 678 ---------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~ 730 (823)
++.|++.+|+|+|+.+|+||||||+||+++.++.+||+|||++.......
T Consensus 87 v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~--- 163 (279)
T 3fdn_A 87 ILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR--- 163 (279)
T ss_dssp EECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC-------
T ss_pred EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCccc---
Confidence 36788999999999999999999999999999999999999986543321
Q ss_pred cccccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCCCc
Q 045449 731 KQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGETC 779 (823)
Q Consensus 731 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~~ 779 (823)
.....||+.|+|||++.+..++.++||||+||+++++++|..||....
T Consensus 164 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 211 (279)
T 3fdn_A 164 -RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 211 (279)
T ss_dssp -----CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred -ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCc
Confidence 234579999999999999899999999999999999999999997643
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=5.9e-24 Score=226.43 Aligned_cols=149 Identities=19% Similarity=0.201 Sum_probs=123.6
Q ss_pred ccCCccceeeccC------------CeEEEEEEehHhhHHHHHHHHHHHHHHhhc-chhhHHH-----------------
Q 045449 628 DRFSENNLIGIGN------------GMEVAVKVFHQQYERALKSFEDECEVRKRI-RHRNLVK----------------- 677 (823)
Q Consensus 628 ~~f~~~~~lg~g~------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~----------------- 677 (823)
++|...+.||.|+ +..||||++.... ..+.+.+|++++.++ +|+++++
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~ 87 (298)
T 1csn_A 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL 87 (298)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEe
Confidence 4677778888875 6779999986442 224688899999999 7888876
Q ss_pred -----------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCc-----EEEeecccccccCCCCcc
Q 045449 678 -----------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMV-----AHISDFGIAKLLSGEDQL 729 (823)
Q Consensus 678 -----------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~-----~kl~DfGla~~~~~~~~~ 729 (823)
++.|++++|+|+|+.+|+||||||+||+++.++. +||+|||+++........
T Consensus 88 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~ 167 (298)
T 1csn_A 88 LGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTK 167 (298)
T ss_dssp CCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTC
T ss_pred cCCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECcccccccccccc
Confidence 4678999999999999999999999999987765 999999999876543221
Q ss_pred -----ccccccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCCC
Q 045449 730 -----SKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 730 -----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
.......||+.|+|||++.+..++.++|||||||+++++++|..||...
T Consensus 168 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 221 (298)
T 1csn_A 168 QHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGL 221 (298)
T ss_dssp CBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSC
T ss_pred ccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchh
Confidence 1234567999999999999999999999999999999999999999774
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=99.87 E-value=6.1e-24 Score=242.69 Aligned_cols=150 Identities=24% Similarity=0.393 Sum_probs=125.4
Q ss_pred ccCCccceeeccC------------CeEEEEEEehHhhHHHHHHHHHHHHHHhhcchhhHHH------------------
Q 045449 628 DRFSENNLIGIGN------------GMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVK------------------ 677 (823)
Q Consensus 628 ~~f~~~~~lg~g~------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------------ 677 (823)
++|...+.||.|+ +..||||+++.... ..++|.+|++++++++|||||+
T Consensus 220 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~ 298 (495)
T 1opk_A 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 298 (495)
T ss_dssp GGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred HHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc-chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEcc
Confidence 4566677788775 56799999975432 3468999999999999999998
Q ss_pred ------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCcccccc
Q 045449 678 ------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQT 733 (823)
Q Consensus 678 ------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~ 733 (823)
++.|++.+|+|+|+.+|+||||||+|||++.++.+||+|||+++...... .....
T Consensus 299 ~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-~~~~~ 377 (495)
T 1opk_A 299 TYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT-YTAHA 377 (495)
T ss_dssp TTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCC-EECCT
T ss_pred CCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceeccCCc-eeecC
Confidence 35688999999999999999999999999999999999999998765332 22233
Q ss_pred ccccCCCcCcccccCCCccccccceehhhhhhccccC-CCCCcCCCc
Q 045449 734 QTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKET-RSMTVGETC 779 (823)
Q Consensus 734 ~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~-~~~~~~~~~ 779 (823)
...+++.|+|||++.+..++.++|||||||++|++++ |..||.+..
T Consensus 378 ~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~ 424 (495)
T 1opk_A 378 GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID 424 (495)
T ss_dssp TCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred CCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCC
Confidence 4456789999999998899999999999999999998 888887643
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=8.8e-24 Score=222.63 Aligned_cols=149 Identities=22% Similarity=0.336 Sum_probs=126.6
Q ss_pred hccCCccceeeccC------------CeEEEEEEehHhhHHHHHHHHHHHHHHhhcchhhHHH-----------------
Q 045449 627 TDRFSENNLIGIGN------------GMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVK----------------- 677 (823)
Q Consensus 627 t~~f~~~~~lg~g~------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~----------------- 677 (823)
.++|...+.||.|+ +..||+|++........+.+.+|++++++++||||++
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL 87 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence 46788888899886 4568999997665555678999999999999999998
Q ss_pred -----------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEe---CCCCcEEEeecccccccCCCCcccc
Q 045449 678 -----------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLL---DEDMVAHISDFGIAKLLSGEDQLSK 731 (823)
Q Consensus 678 -----------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl---~~~~~~kl~DfGla~~~~~~~~~~~ 731 (823)
++.|++.+|.|+|+.+|+||||||+||++ +.++.+||+|||+++.......
T Consensus 88 ~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~~--- 164 (277)
T 3f3z_A 88 CTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM--- 164 (277)
T ss_dssp CCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTSC---
T ss_pred cCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCccc---
Confidence 46788999999999999999999999999 7788999999999987654322
Q ss_pred ccccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCCCc
Q 045449 732 QTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGETC 779 (823)
Q Consensus 732 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~~ 779 (823)
.....||+.|+|||++.+ .++.++||||+||+++++++|..||....
T Consensus 165 ~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 211 (277)
T 3f3z_A 165 MRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPT 211 (277)
T ss_dssp BCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred hhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCC
Confidence 234579999999998865 48999999999999999999999997643
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=99.87 E-value=1.3e-23 Score=221.22 Aligned_cols=152 Identities=26% Similarity=0.371 Sum_probs=127.1
Q ss_pred hccCCccceeeccC------------CeEEEEEEehHhh-HHHHHHHHHHHHHHhhcchhhHHH----------------
Q 045449 627 TDRFSENNLIGIGN------------GMEVAVKVFHQQY-ERALKSFEDECEVRKRIRHRNLVK---------------- 677 (823)
Q Consensus 627 t~~f~~~~~lg~g~------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~---------------- 677 (823)
.++|...+.||.|+ +..||||++.... ....+.+.+|++++++++||||++
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 45677778888875 5679999986443 344578999999999999999998
Q ss_pred ------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCcccccc
Q 045449 678 ------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQT 733 (823)
Q Consensus 678 ------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~ 733 (823)
++.|++++|+|+|+.+|+||||||+||+++.++.+||+|||.++............
T Consensus 86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 165 (276)
T 2yex_A 86 YCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN 165 (276)
T ss_dssp CCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBC
T ss_pred ecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchhccc
Confidence 46789999999999999999999999999999999999999998754332222234
Q ss_pred ccccCCCcCcccccCCCcc-ccccceehhhhhhccccCCCCCcCCC
Q 045449 734 QTLATIGYMAPEYGTKGRV-STRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 734 ~~~gt~~y~aPE~~~~~~~-~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
...||+.|+|||++.+..+ +.++||||+||+++++++|..||...
T Consensus 166 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 211 (276)
T 2yex_A 166 KMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQP 211 (276)
T ss_dssp CCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCS
T ss_pred CCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Confidence 5679999999999987765 78999999999999999999999764
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=3.9e-24 Score=224.37 Aligned_cols=150 Identities=25% Similarity=0.361 Sum_probs=125.2
Q ss_pred ccCCccceeeccC-----------CeEEEEEEehHhhHHHHHHHHHHHHHHhhcchhhHHH-------------------
Q 045449 628 DRFSENNLIGIGN-----------GMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVK------------------- 677 (823)
Q Consensus 628 ~~f~~~~~lg~g~-----------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------------- 677 (823)
++|...+.||.|+ +..||||++..... ..+++.+|++++++++||||++
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 88 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 88 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred hhceeeheecCCCccEEEEEEecCCCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCC
Confidence 4677778888886 46699999975432 2357999999999999999998
Q ss_pred ----------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCcccccccc
Q 045449 678 ----------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQT 735 (823)
Q Consensus 678 ----------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 735 (823)
++.|++++|+|+|+.+|+||||||+||+++.++.+||+|||+++....... ......
T Consensus 89 ~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~ 167 (269)
T 4hcu_A 89 HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TSSTGT 167 (269)
T ss_dssp TCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHH-HSTTST
T ss_pred CCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEecccccccccccccc-ccccCc
Confidence 357889999999999999999999999999999999999999987643322 223345
Q ss_pred ccCCCcCcccccCCCccccccceehhhhhhccccC-CCCCcCCCc
Q 045449 736 LATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKET-RSMTVGETC 779 (823)
Q Consensus 736 ~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~-~~~~~~~~~ 779 (823)
.+|+.|+|||++.+..++.++||||+||+++++++ |..||....
T Consensus 168 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~ 212 (269)
T 4hcu_A 168 KFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS 212 (269)
T ss_dssp TCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred ccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCC
Confidence 67889999999988899999999999999999999 899987643
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.87 E-value=2e-23 Score=223.67 Aligned_cols=152 Identities=24% Similarity=0.309 Sum_probs=117.6
Q ss_pred hccCCccceeeccC------------CeEEEEEEehHhh---HHHHHHHHHHHHHHhhcchhhHHH--------------
Q 045449 627 TDRFSENNLIGIGN------------GMEVAVKVFHQQY---ERALKSFEDECEVRKRIRHRNLVK-------------- 677 (823)
Q Consensus 627 t~~f~~~~~lg~g~------------~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~-------------- 677 (823)
.++|...+.||.|+ +..||||++.... ....+.+.+|++++++++||||++
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 46788888888875 5679999997543 345578999999999999999998
Q ss_pred --------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCcccc
Q 045449 678 --------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSK 731 (823)
Q Consensus 678 --------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~ 731 (823)
++.|++.+|+|+|+.+|+||||||+||+++.++.+||+|||+++....... ..
T Consensus 113 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~-~~ 191 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKL-TQ 191 (309)
T ss_dssp EECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC------------
T ss_pred EEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCcccccccc-cc
Confidence 367889999999999999999999999999999999999999987643321 22
Q ss_pred ccccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCCCc
Q 045449 732 QTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGETC 779 (823)
Q Consensus 732 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~~ 779 (823)
.....||+.|+|||++.+..++.++|||||||+++++++|..||....
T Consensus 192 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 239 (309)
T 2h34_A 192 LGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQ 239 (309)
T ss_dssp -----CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCH
T ss_pred ccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCch
Confidence 334579999999999999899999999999999999999999997654
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.87 E-value=7.7e-24 Score=230.43 Aligned_cols=154 Identities=23% Similarity=0.295 Sum_probs=126.8
Q ss_pred HhccCCccceeeccC-----------------CeEEEEEEehHhh-HHHHHHHHHHHHHHhhcchhhHHH----------
Q 045449 626 ATDRFSENNLIGIGN-----------------GMEVAVKVFHQQY-ERALKSFEDECEVRKRIRHRNLVK---------- 677 (823)
Q Consensus 626 at~~f~~~~~lg~g~-----------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~---------- 677 (823)
..++|...+.||.|+ +..||||+++... ....+.|.+|++++++++||||++
T Consensus 45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 124 (343)
T 1luf_A 45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP 124 (343)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCc
Confidence 356788888888876 1679999997543 445678999999999999999997
Q ss_pred ------------------------------------------------------HHHHHHHHhhhcCCCCEEeccCCCCC
Q 045449 678 ------------------------------------------------------IISSSLEYLHFGHSIPIIHCDLKPSN 703 (823)
Q Consensus 678 ------------------------------------------------------~~~~~l~~L~~~h~~~ivHrdlk~~N 703 (823)
++.|++++|+|+|+.+|+||||||+|
T Consensus 125 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~N 204 (343)
T 1luf_A 125 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRN 204 (343)
T ss_dssp CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred eEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcce
Confidence 13477889999999999999999999
Q ss_pred EEeCCCCcEEEeecccccccCCCCccccccccccCCCcCcccccCCCccccccceehhhhhhccccC-CCCCcCCCc
Q 045449 704 VLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKET-RSMTVGETC 779 (823)
Q Consensus 704 iLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~-~~~~~~~~~ 779 (823)
|+++.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|++++ |..||.+..
T Consensus 205 Il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 281 (343)
T 1luf_A 205 CLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA 281 (343)
T ss_dssp EEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred EEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCC
Confidence 9999999999999999987644332223344568999999999988899999999999999999998 888987653
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=1.8e-23 Score=224.56 Aligned_cols=154 Identities=20% Similarity=0.318 Sum_probs=117.7
Q ss_pred HhccCCccceeeccC---------------CeEEEEEEehHh--hHHHHHHHHHHHHHHhhcchhhHHH-----------
Q 045449 626 ATDRFSENNLIGIGN---------------GMEVAVKVFHQQ--YERALKSFEDECEVRKRIRHRNLVK----------- 677 (823)
Q Consensus 626 at~~f~~~~~lg~g~---------------~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~----------- 677 (823)
..++|...+.||.|+ +..||||++... .....+.|.+|++++++++||||++
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 111 (313)
T 3brb_A 32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQ 111 (313)
T ss_dssp CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC----
T ss_pred CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecccc
Confidence 456777778888876 235999998754 2445678999999999999999987
Q ss_pred ----------------------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeec
Q 045449 678 ----------------------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDF 717 (823)
Q Consensus 678 ----------------------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~Df 717 (823)
++.|++++|+|+|+.+|+||||||+||+++.++.+||+||
T Consensus 112 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kl~Df 191 (313)
T 3brb_A 112 GIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADF 191 (313)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEEECSC
T ss_pred CCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEEeec
Confidence 3568889999999999999999999999999999999999
Q ss_pred ccccccCCCCccccccccccCCCcCcccccCCCccccccceehhhhhhccccC-CCCCcCCCc
Q 045449 718 GIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKET-RSMTVGETC 779 (823)
Q Consensus 718 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~-~~~~~~~~~ 779 (823)
|+++...............+++.|+|||++.+..++.++|||||||+++++++ |..||....
T Consensus 192 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~ 254 (313)
T 3brb_A 192 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQ 254 (313)
T ss_dssp SCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred CcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCC
Confidence 99987654433223334567889999999998899999999999999999999 888886643
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.87 E-value=2.7e-23 Score=219.08 Aligned_cols=150 Identities=26% Similarity=0.419 Sum_probs=105.9
Q ss_pred hccCCccceeeccC------------CeEEEEEEehHhhH---HHHHHHHHHHHHHhhcchhhHHH--------------
Q 045449 627 TDRFSENNLIGIGN------------GMEVAVKVFHQQYE---RALKSFEDECEVRKRIRHRNLVK-------------- 677 (823)
Q Consensus 627 t~~f~~~~~lg~g~------------~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~-------------- 677 (823)
.++|...+.||.|+ +..||||++..... ...+.+.+|++++++++||||++
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 35677778888875 56799999975532 22467999999999999999998
Q ss_pred ---------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccc
Q 045449 678 ---------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLS 730 (823)
Q Consensus 678 ---------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~ 730 (823)
++.|++++|+|+|+.+|+||||||+||+++.++.+||+|||+++.......
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~-- 167 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHE-- 167 (278)
T ss_dssp EECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC------
T ss_pred EecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCC--
Confidence 367889999999999999999999999999999999999999987643221
Q ss_pred cccccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCCC
Q 045449 731 KQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 731 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
......||+.|+|||++.+..++.++||||+||+++++++|..||...
T Consensus 168 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 215 (278)
T 3cok_A 168 KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTD 215 (278)
T ss_dssp ------------------------CTHHHHHHHHHHHHHHSSCSSCCC
T ss_pred cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCh
Confidence 123457899999999999888999999999999999999999998654
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.87 E-value=1.4e-23 Score=228.65 Aligned_cols=152 Identities=26% Similarity=0.335 Sum_probs=120.2
Q ss_pred HHhccCCccceeeccC------------CeEEEEEEehHhhH-----HHHHHHHHHHHHHhhcchhhHHH----------
Q 045449 625 RATDRFSENNLIGIGN------------GMEVAVKVFHQQYE-----RALKSFEDECEVRKRIRHRNLVK---------- 677 (823)
Q Consensus 625 ~at~~f~~~~~lg~g~------------~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~---------- 677 (823)
...++|...+.||.|+ |..||||++..... ...+.+.+|++++++++||||++
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN 86 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence 3457888889999886 56799999975432 12347889999999999999998
Q ss_pred ------------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCC
Q 045449 678 ------------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGED 727 (823)
Q Consensus 678 ------------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~ 727 (823)
++.|++++|+|+|+.+|+||||||+||+++.++.+||+|||+++......
T Consensus 87 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 166 (346)
T 1ua2_A 87 ISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN 166 (346)
T ss_dssp CEEEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC
T ss_pred eEEEEEcCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccCCc
Confidence 46788999999999999999999999999999999999999998764332
Q ss_pred ccccccccccCCCcCcccccCCC-ccccccceehhhhhhccccCCCCCcCCC
Q 045449 728 QLSKQTQTLATIGYMAPEYGTKG-RVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 728 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
. ......||+.|+|||++.+. .++.++||||+||++|++++|..||.+.
T Consensus 167 ~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~ 216 (346)
T 1ua2_A 167 R--AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGD 216 (346)
T ss_dssp C--CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred c--cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCC
Confidence 2 23456799999999998654 4899999999999999999999888654
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=99.87 E-value=1.1e-23 Score=235.59 Aligned_cols=151 Identities=26% Similarity=0.349 Sum_probs=118.0
Q ss_pred HHhccCCccceeeccC------------CeEEEEEEehHhh--------HHHHHHHHHHHHHHhhcchhhHHH-------
Q 045449 625 RATDRFSENNLIGIGN------------GMEVAVKVFHQQY--------ERALKSFEDECEVRKRIRHRNLVK------- 677 (823)
Q Consensus 625 ~at~~f~~~~~lg~g~------------~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~------- 677 (823)
...++|...+.||.|+ +..||||++.... ......+.+|++++++++||||++
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~ 211 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 211 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 3457899999999986 5679999986542 122346889999999999999998
Q ss_pred --------------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCC---CcEEEeecccccc
Q 045449 678 --------------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDED---MVAHISDFGIAKL 722 (823)
Q Consensus 678 --------------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~---~~~kl~DfGla~~ 722 (823)
++.|++.+|+|+|+.+|+||||||+|||++.+ ..+||+|||+|+.
T Consensus 212 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~ 291 (419)
T 3i6u_A 212 EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI 291 (419)
T ss_dssp SEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTS
T ss_pred CceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeeccccee
Confidence 46789999999999999999999999999654 4699999999987
Q ss_pred cCCCCccccccccccCCCcCcccccCC---CccccccceehhhhhhccccCCCCCcCCC
Q 045449 723 LSGEDQLSKQTQTLATIGYMAPEYGTK---GRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 723 ~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
..... .....+||+.|+|||++.+ ..|+.++||||+||++|++++|..||.+.
T Consensus 292 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~ 347 (419)
T 3i6u_A 292 LGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEH 347 (419)
T ss_dssp CC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCC
T ss_pred cCCCc---cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCC
Confidence 64322 2344679999999999753 56889999999999999999999999764
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.87 E-value=4.9e-22 Score=216.76 Aligned_cols=241 Identities=16% Similarity=0.141 Sum_probs=156.7
Q ss_pred hhhccccccccCCccccccCCCCCcEEEccCCcccccCCcccccCCCCccEEEeeccccccccC-ccccCCCCCCe-EEe
Q 045449 207 ARLALATNNLVGVVPVTIFNMSALKEISLLNNSLSGSLPSRIDLSLPNVETLNLGINSFSGTIP-SSITNSSKLSD-LEL 284 (823)
Q Consensus 207 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~-L~L 284 (823)
+.++.++++++ .+|..+ .+++++|+|++|+|+ .+|...+.++++|++|+|++|++.+.+| .+|.+++++.. +++
T Consensus 12 ~~v~C~~~~Lt-~iP~~l--~~~l~~L~Ls~N~i~-~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~ 87 (350)
T 4ay9_X 12 RVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIE 87 (350)
T ss_dssp TEEEEESTTCC-SCCTTC--CTTCSEEEEESCCCS-EECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEE
T ss_pred CEEEecCCCCC-ccCcCc--CCCCCEEEccCCcCC-CcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcc
Confidence 45677778887 455544 256788888888887 6776666668888888888888766555 45677777664 566
Q ss_pred ecccccccCCCccCCCcccCcccccCccccCCCCcccccccccCCCCceEEEeec-CCCCccCCccccccccccceEEec
Q 045449 285 GENLFSGFIPNTIGNLRNLEFGNIADNYLTSSTPELSFLSSLTNCKKLKVLIVTG-NPLDGILPKSIGNFSLSLETILMA 363 (823)
Q Consensus 285 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~-N~l~~~~p~~~~~~~~~L~~L~L~ 363 (823)
+.|+++.+.|..|..+++|++|++++|.++..++ ..+....++..|++.+ |++....+..|..+...+++|+|+
T Consensus 88 ~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~-----~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~ 162 (350)
T 4ay9_X 88 KANNLLYINPEAFQNLPNLQYLLISNTGIKHLPD-----VHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLN 162 (350)
T ss_dssp EETTCCEECTTSBCCCTTCCEEEEEEECCSSCCC-----CTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECC
T ss_pred cCCcccccCchhhhhccccccccccccccccCCc-----hhhcccchhhhhhhccccccccccccchhhcchhhhhhccc
Confidence 6788887777888888888888888888877632 2344556677777755 456655555666654567777777
Q ss_pred CCcceeccCccccCcccccEEEccc-CcCCCCchhcccccCCCCEEEccCCCCCCcchHhhhcCCCCCEEEcccCcCccc
Q 045449 364 NCSISGNIPQVVGNLSNLLVLELGG-NNLTGPIPVTFSQLQTLQAFDLTRNKLAGPITDELCHLARLHSLVLQGNKFSGS 442 (823)
Q Consensus 364 ~N~l~~~~p~~~~~l~~L~~L~Ls~-N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ 442 (823)
+|+|+...+..| ...+|+.|++++ |.++...+..|..+++|++|||++|+|+...+.. +.+|+.|.+.++.--..
T Consensus 163 ~N~i~~i~~~~f-~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~lp~~~---~~~L~~L~~l~~~~l~~ 238 (350)
T 4ay9_X 163 KNGIQEIHNSAF-NGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYG---LENLKKLRARSTYNLKK 238 (350)
T ss_dssp SSCCCEECTTSS-TTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCCCCCSSS---CTTCCEEECTTCTTCCC
T ss_pred cccccCCChhhc-cccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcCccChhh---hccchHhhhccCCCcCc
Confidence 777775444444 345677777764 4455333345677777777777777777443333 33445555444432234
Q ss_pred ccccccCCCCCCeEeccCC
Q 045449 443 IPSCLGNLTSVRVLYLGLN 461 (823)
Q Consensus 443 ~p~~~~~l~~L~~L~Ls~N 461 (823)
+| .+.++++|+.++++++
T Consensus 239 lP-~l~~l~~L~~l~l~~~ 256 (350)
T 4ay9_X 239 LP-TLEKLVALMEASLTYP 256 (350)
T ss_dssp CC-CTTTCCSCCEEECSCH
T ss_pred CC-CchhCcChhhCcCCCC
Confidence 55 3666677777776654
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.87 E-value=8.4e-23 Score=234.57 Aligned_cols=207 Identities=23% Similarity=0.336 Sum_probs=163.3
Q ss_pred ccCCCCCCc-----cceee-eeCCCCCcEEEEEcCCCCCccccCcccCCCCCCcEEEccCCCCCCCCCCCCCCCCCCCEE
Q 045449 32 NWTSSTSVC-----IWIGI-TCDVNSHRVIGLNISSFNLQGTITPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLL 105 (823)
Q Consensus 32 ~W~~~~~~c-----~w~gv-~c~~~~~~v~~L~L~~~~l~g~~~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L 105 (823)
+|..+.++| .|.|+ .|.. .+++.|+|++|++++ +|+.+. ++|++|+|++|+|+ .+| ..+++|++|
T Consensus 35 ~W~~~~~~~~~~~~~~~~l~~C~~--~~L~~L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~-~ip---~~l~~L~~L 105 (571)
T 3cvr_A 35 KWEKQALPGENRNEAVSLLKECLI--NQFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALI-SLP---ELPASLEYL 105 (571)
T ss_dssp HHHTTCCTTCCHHHHHHHHHHHHH--TTCSEEECCSSCCSC-CCSCCC--TTCSEEECCSSCCS-CCC---CCCTTCCEE
T ss_pred HHhccCCccccccchhhhcccccc--CCccEEEeCCCCCCc-cCHhHc--CCCCEEECcCCCCc-ccc---cccCCCCEE
Confidence 787777788 79999 7863 479999999999997 777664 78999999999999 677 457899999
Q ss_pred ECCCCcCcCCCchhhhcCCCCcEEecccccccCccCccccCCCCCCccccccceeeeccceeeccCccccccchhhHHHH
Q 045449 106 DFSDNQLFGSLSSFIFNMSSMTTIDLSINRLSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKEIGNLTKLKEII 185 (823)
Q Consensus 106 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ 185 (823)
+|++|.|++ +|. +.+ +|++|+|++|+|++ +|. .+++|++|+|++|+|++ +|.
T Consensus 106 ~Ls~N~l~~-ip~-l~~--~L~~L~Ls~N~l~~-lp~----------~l~~L~~L~Ls~N~l~~-lp~------------ 157 (571)
T 3cvr_A 106 DACDNRLST-LPE-LPA--SLKHLDVDNNQLTM-LPE----------LPALLEYINADNNQLTM-LPE------------ 157 (571)
T ss_dssp ECCSSCCSC-CCC-CCT--TCCEEECCSSCCSC-CCC----------CCTTCCEEECCSSCCSC-CCC------------
T ss_pred EccCCCCCC-cch-hhc--CCCEEECCCCcCCC-CCC----------cCccccEEeCCCCccCc-CCC------------
Confidence 999999987 666 655 89999999999985 443 36789999999999874 443
Q ss_pred HhhcCCCcccCCcccCCcchhhhhccccccccCCccccccCCCCCcEEEccCCcccccCCcccccCCCCc-------cEE
Q 045449 186 STITNSTVCEIPREIGNLPYLARLALATNNLVGVVPVTIFNMSALKEISLLNNSLSGSLPSRIDLSLPNV-------ETL 258 (823)
Q Consensus 186 ~l~~n~~~~~ip~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~lp~~~~~~l~~L-------~~L 258 (823)
.+++|++|+|++|+|++ +|. |. ++|++|+|++|.|+ .+|. +.. +| ++|
T Consensus 158 ----------------~l~~L~~L~Ls~N~L~~-lp~-l~--~~L~~L~Ls~N~L~-~lp~-~~~---~L~~~~~~L~~L 212 (571)
T 3cvr_A 158 ----------------LPTSLEVLSVRNNQLTF-LPE-LP--ESLEALDVSTNLLE-SLPA-VPV---RNHHSEETEIFF 212 (571)
T ss_dssp ----------------CCTTCCEEECCSSCCSC-CCC-CC--TTCCEEECCSSCCS-SCCC-CC-----------CCEEE
T ss_pred ----------------cCCCcCEEECCCCCCCC-cch-hh--CCCCEEECcCCCCC-chhh-HHH---hhhcccccceEE
Confidence 23467788888998887 565 55 78889999999888 7777 432 55 888
Q ss_pred EeeccccccccCccccCCCCCCeEEeecccccccCCCccCCCc
Q 045449 259 NLGINSFSGTIPSSITNSSKLSDLELGENLFSGFIPNTIGNLR 301 (823)
Q Consensus 259 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 301 (823)
+|++|+|+ .+|..+..+++|+.|+|++|.+++.+|..+..++
T Consensus 213 ~Ls~N~l~-~lp~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~ 254 (571)
T 3cvr_A 213 RCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQT 254 (571)
T ss_dssp ECCSSCCC-CCCGGGGGSCTTEEEECCSSSCCHHHHHHHHHHH
T ss_pred ecCCCcce-ecCHHHhcCCCCCEEEeeCCcCCCcCHHHHHHhh
Confidence 88888887 5777777788888888888888887777666544
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=9.2e-24 Score=223.02 Aligned_cols=151 Identities=23% Similarity=0.292 Sum_probs=123.0
Q ss_pred hccCCccceeeccC---------------CeEEEEEEehHh-hHHHHHHHHHHHHHHhhcchhhHHH-------------
Q 045449 627 TDRFSENNLIGIGN---------------GMEVAVKVFHQQ-YERALKSFEDECEVRKRIRHRNLVK------------- 677 (823)
Q Consensus 627 t~~f~~~~~lg~g~---------------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~------------- 677 (823)
.++|...+.||+|+ +..||||++... .....+.|.+|++++++++||||++
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v 90 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEEPTWII 90 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSSSCEEE
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCEEE
Confidence 46777778888875 224999998754 2445678999999999999999998
Q ss_pred ---------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccc
Q 045449 678 ---------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLS 730 (823)
Q Consensus 678 ---------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~ 730 (823)
++.|++.+|+|+|+.+|+||||||+||+++.++.+||+|||+++....... .
T Consensus 91 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~ 169 (281)
T 3cc6_A 91 MELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDY-Y 169 (281)
T ss_dssp EECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC-------
T ss_pred EecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCcccccccc-c
Confidence 356889999999999999999999999999999999999999987654322 1
Q ss_pred cccccccCCCcCcccccCCCccccccceehhhhhhccccC-CCCCcCCC
Q 045449 731 KQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKET-RSMTVGET 778 (823)
Q Consensus 731 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~-~~~~~~~~ 778 (823)
......+|+.|+|||++.+..++.++|||||||+++++++ |..||...
T Consensus 170 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~ 218 (281)
T 3cc6_A 170 KASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWL 218 (281)
T ss_dssp ---CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred ccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccC
Confidence 2234467889999999988889999999999999999997 99998654
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=99.87 E-value=1e-23 Score=224.35 Aligned_cols=153 Identities=23% Similarity=0.260 Sum_probs=123.1
Q ss_pred HHhccCCccceeeccC------------CeEEEEEEehHhhHHHHHHHHHHHHHHhhcchhhHHH---------------
Q 045449 625 RATDRFSENNLIGIGN------------GMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVK--------------- 677 (823)
Q Consensus 625 ~at~~f~~~~~lg~g~------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~--------------- 677 (823)
...++|...+.||.|+ +..||||++.... ..+++.+|++++++++|++++.
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 83 (296)
T 4hgt_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 83 (296)
T ss_dssp -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc--cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEE
Confidence 3457888899999886 5679999865442 2246889999999999888775
Q ss_pred --------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEe---CCCCcEEEeecccccccCCCCc
Q 045449 678 --------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLL---DEDMVAHISDFGIAKLLSGEDQ 728 (823)
Q Consensus 678 --------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl---~~~~~~kl~DfGla~~~~~~~~ 728 (823)
++.|++.+|+|+|+.+|+||||||+||++ +.++.+||+|||+++.......
T Consensus 84 ~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~ 163 (296)
T 4hgt_A 84 MELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART 163 (296)
T ss_dssp EECCCCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTT
T ss_pred EEccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCccc
Confidence 46789999999999999999999999999 7889999999999987654322
Q ss_pred c-----ccccccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCCCc
Q 045449 729 L-----SKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGETC 779 (823)
Q Consensus 729 ~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~~ 779 (823)
. .......||+.|+|||++.+..++.++||||+||+++++++|+.||.+..
T Consensus 164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 219 (296)
T 4hgt_A 164 HQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLK 219 (296)
T ss_dssp CCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred CccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccc
Confidence 1 12234679999999999999999999999999999999999999997643
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=3.1e-23 Score=227.53 Aligned_cols=159 Identities=23% Similarity=0.289 Sum_probs=127.2
Q ss_pred ccCHHHHHHHhccCCccceeeccC-----------CeEEEEEEehHh-----------hHHHHHHHHHHHHHHhhcchhh
Q 045449 617 RFSYHELLRATDRFSENNLIGIGN-----------GMEVAVKVFHQQ-----------YERALKSFEDECEVRKRIRHRN 674 (823)
Q Consensus 617 ~~~~~~l~~at~~f~~~~~lg~g~-----------~~~vavK~~~~~-----------~~~~~~~~~~E~~~l~~l~h~n 674 (823)
+....++....++|...+.||.|+ |..||||++... .....+.+.+|++++++++|||
T Consensus 11 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 90 (362)
T 3pg1_A 11 RDLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPN 90 (362)
T ss_dssp HHHHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTT
T ss_pred HHHHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcC
Confidence 345678888899999999999986 567999988432 2334578999999999999999
Q ss_pred HHH---------------------------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCC
Q 045449 675 LVK---------------------------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDED 709 (823)
Q Consensus 675 iv~---------------------------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~ 709 (823)
|++ ++.|++.+|+|+|+.+|+||||||+||+++.+
T Consensus 91 iv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~ 170 (362)
T 3pg1_A 91 ILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADN 170 (362)
T ss_dssp BCCCSEEEEECCTTTCCEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT
T ss_pred ccceeeeEEeccCCCcceEEEEEccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCC
Confidence 997 36789999999999999999999999999999
Q ss_pred CcEEEeecccccccCCCCccccccccccCCCcCcccccCC-CccccccceehhhhhhccccCCCCCcCCC
Q 045449 710 MVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTK-GRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 710 ~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
+.+||+|||+++...... ......||+.|+|||++.+ ..++.++||||+||+++++++|..||.+.
T Consensus 171 ~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 237 (362)
T 3pg1_A 171 NDITICDFNLAREDTADA---NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGS 237 (362)
T ss_dssp CCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred CCEEEEecCccccccccc---ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCC
Confidence 999999999998644322 2234578999999998876 67899999999999999999999999764
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.87 E-value=1.8e-23 Score=223.89 Aligned_cols=144 Identities=31% Similarity=0.373 Sum_probs=113.0
Q ss_pred ccCCccceeeccC----------CeEEEEEEehHhhHHHHHHHHHHHHHHhhcchhhHHH--------------------
Q 045449 628 DRFSENNLIGIGN----------GMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVK-------------------- 677 (823)
Q Consensus 628 ~~f~~~~~lg~g~----------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-------------------- 677 (823)
++|...+.||+|+ +..||||++.... ..+.|.+|++++++++||||++
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~lv~e~~~~~~ 85 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESES--ERKAFIVELRQLSRVNHPNIVKLYGACLNPVCLVMEYAEGGS 85 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEETTEEEEEEECSSTT--HHHHHHHHHHHHHHCCCTTBCCEEEBCTTTTEEEEECCTTCB
T ss_pred hHeeeeeEeecCCCceEEEEEECCeeEEEEEecChh--HHHHHHHHHHHHhcCCCCCcCeEEEEEcCCcEEEEEcCCCCC
Confidence 4677778888886 5679999996543 3468999999999999999998
Q ss_pred ---------------------HHHHHHHHhhhcCC---CCEEeccCCCCCEEeCCCCc-EEEeecccccccCCCCccccc
Q 045449 678 ---------------------IISSSLEYLHFGHS---IPIIHCDLKPSNVLLDEDMV-AHISDFGIAKLLSGEDQLSKQ 732 (823)
Q Consensus 678 ---------------------~~~~~l~~L~~~h~---~~ivHrdlk~~NiLl~~~~~-~kl~DfGla~~~~~~~~~~~~ 732 (823)
++.|++++|+|+|+ .+|+||||||+||+++.++. +||+|||+++..... .
T Consensus 86 L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~-----~ 160 (307)
T 2eva_A 86 LYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH-----M 160 (307)
T ss_dssp HHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-------------
T ss_pred HHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc-----c
Confidence 23455666666666 89999999999999988775 799999999865322 2
Q ss_pred cccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCCC
Q 045449 733 TQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 733 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
....||+.|+|||++.+..++.++|||||||+++++++|+.||...
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 206 (307)
T 2eva_A 161 TNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEI 206 (307)
T ss_dssp ----CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTT
T ss_pred ccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhh
Confidence 2346999999999999989999999999999999999999999754
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=99.87 E-value=1.8e-23 Score=222.70 Aligned_cols=150 Identities=24% Similarity=0.321 Sum_probs=120.5
Q ss_pred ccCCccceeeccC---------------CeEEEEEEehHhh-HHHHHHHHHHHHHHhhcchhhHHH--------------
Q 045449 628 DRFSENNLIGIGN---------------GMEVAVKVFHQQY-ERALKSFEDECEVRKRIRHRNLVK-------------- 677 (823)
Q Consensus 628 ~~f~~~~~lg~g~---------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~-------------- 677 (823)
.+|...+.||.|+ ...||||++.... ....+.|.+|++++++++||||++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 104 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence 3566677888876 2247999887533 445578999999999999999998
Q ss_pred ----------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCcc
Q 045449 678 ----------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQL 729 (823)
Q Consensus 678 ----------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~ 729 (823)
++.|++.+|+|+|+.+|+||||||+||+++.++.+||+|||+++........
T Consensus 105 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~ 184 (298)
T 3f66_A 105 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYY 184 (298)
T ss_dssp EEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGGGC
T ss_pred EEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccccccccccchh
Confidence 3568899999999999999999999999999999999999999876443221
Q ss_pred --ccccccccCCCcCcccccCCCccccccceehhhhhhccccCC-CCCcCC
Q 045449 730 --SKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETR-SMTVGE 777 (823)
Q Consensus 730 --~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~-~~~~~~ 777 (823)
.......||+.|+|||.+.+..++.++||||+||+++++++| ..||..
T Consensus 185 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~ 235 (298)
T 3f66_A 185 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD 235 (298)
T ss_dssp BC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred ccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCcc
Confidence 122345678899999999888999999999999999999994 455544
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=99.87 E-value=8.1e-24 Score=223.66 Aligned_cols=151 Identities=20% Similarity=0.353 Sum_probs=123.3
Q ss_pred hccCCccceeeccC-----------CeEEEEEEehHhhHHHHHHHHHHHHHHhhcchhhHHH------------------
Q 045449 627 TDRFSENNLIGIGN-----------GMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVK------------------ 677 (823)
Q Consensus 627 t~~f~~~~~lg~g~-----------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------------ 677 (823)
.++|...+.||.|+ +..||||++..... ..+++.+|++++.+++||||++
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 101 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 101 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCC
T ss_pred HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEecc
Confidence 45677778888875 45699999975532 2367899999999999999998
Q ss_pred -----------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccc
Q 045449 678 -----------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQ 734 (823)
Q Consensus 678 -----------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 734 (823)
++.|++.+|+|+|+.+|+||||||+||+++.++.+||+|||+++....... .....
T Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~-~~~~~ 180 (283)
T 3gen_A 102 ANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-TSSVG 180 (283)
T ss_dssp TTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHH-HSTTS
T ss_pred CCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEcccccccccccccc-ccccC
Confidence 367889999999999999999999999999999999999999987643322 22334
Q ss_pred cccCCCcCcccccCCCccccccceehhhhhhccccC-CCCCcCCCc
Q 045449 735 TLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKET-RSMTVGETC 779 (823)
Q Consensus 735 ~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~-~~~~~~~~~ 779 (823)
..+|+.|+|||++.+..++.++||||+||+++++++ |..||....
T Consensus 181 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~ 226 (283)
T 3gen_A 181 SKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT 226 (283)
T ss_dssp TTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred CccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccC
Confidence 457888999999998899999999999999999998 999987643
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=99.87 E-value=1.2e-23 Score=226.79 Aligned_cols=158 Identities=23% Similarity=0.347 Sum_probs=129.6
Q ss_pred HHHHHHhccCCccceeeccC-----------------CeEEEEEEehHhh-HHHHHHHHHHHHHHhhcchhhHHH-----
Q 045449 621 HELLRATDRFSENNLIGIGN-----------------GMEVAVKVFHQQY-ERALKSFEDECEVRKRIRHRNLVK----- 677 (823)
Q Consensus 621 ~~l~~at~~f~~~~~lg~g~-----------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~----- 677 (823)
++...+.++|...+.||.|+ +..||||++.... ......|.+|++++++++||||++
T Consensus 18 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 97 (322)
T 1p4o_A 18 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV 97 (322)
T ss_dssp CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred hhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEE
Confidence 33444567888888999886 2358999987543 344567999999999999999998
Q ss_pred ---------------------------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcE
Q 045449 678 ---------------------------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVA 712 (823)
Q Consensus 678 ---------------------------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~ 712 (823)
++.|++.+|+|+|+.+|+||||||+||+++.++.+
T Consensus 98 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~ 177 (322)
T 1p4o_A 98 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTV 177 (322)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCE
T ss_pred ccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCeE
Confidence 24578889999999999999999999999999999
Q ss_pred EEeecccccccCCCCccccccccccCCCcCcccccCCCccccccceehhhhhhccccC-CCCCcCCC
Q 045449 713 HISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKET-RSMTVGET 778 (823)
Q Consensus 713 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~-~~~~~~~~ 778 (823)
||+|||+++...............||+.|+|||++.+..++.++||||+||+++++++ |..||...
T Consensus 178 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~ 244 (322)
T 1p4o_A 178 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL 244 (322)
T ss_dssp EECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS
T ss_pred EECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccC
Confidence 9999999987654333233344567899999999988889999999999999999998 88888764
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.87 E-value=2.8e-23 Score=222.71 Aligned_cols=149 Identities=28% Similarity=0.379 Sum_probs=119.8
Q ss_pred ccCCccceeeccC------------CeEEEEEEehHhh--HHHHHHHHHHHHHHhhcchhhHHH----------------
Q 045449 628 DRFSENNLIGIGN------------GMEVAVKVFHQQY--ERALKSFEDECEVRKRIRHRNLVK---------------- 677 (823)
Q Consensus 628 ~~f~~~~~lg~g~------------~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~---------------- 677 (823)
++|...+.||.|+ |..||||++.... ....+.+.+|++++++++||||++
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 5677788888886 5679999885432 344577899999999999999998
Q ss_pred ------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCcccccc
Q 045449 678 ------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQT 733 (823)
Q Consensus 678 ------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~ 733 (823)
++.|++.+|+|+|+.+|+||||||+||+++.++.+||+|||+++....... ...
T Consensus 83 ~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~ 160 (311)
T 4agu_A 83 YCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD--YYD 160 (311)
T ss_dssp CCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC---------
T ss_pred eCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCccc--ccC
Confidence 356889999999999999999999999999999999999999987653322 223
Q ss_pred ccccCCCcCcccccCC-CccccccceehhhhhhccccCCCCCcCCC
Q 045449 734 QTLATIGYMAPEYGTK-GRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 734 ~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
...||+.|+|||++.+ ..++.++||||+||+++++++|..||.+.
T Consensus 161 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 206 (311)
T 4agu_A 161 DEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGK 206 (311)
T ss_dssp -----GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred CCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence 4578999999998875 56899999999999999999999998664
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=2.5e-23 Score=231.07 Aligned_cols=146 Identities=27% Similarity=0.309 Sum_probs=124.3
Q ss_pred hccCCccceeeccC------------CeEEEEEEehHhhHHHHHHHHHHHHHHhhcc--------hhhHHH---------
Q 045449 627 TDRFSENNLIGIGN------------GMEVAVKVFHQQYERALKSFEDECEVRKRIR--------HRNLVK--------- 677 (823)
Q Consensus 627 t~~f~~~~~lg~g~------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--------h~niv~--------- 677 (823)
.++|...+.||.|+ ++.||||++... ....+.+.+|++++++++ |+||++
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 36788889999886 677999999754 344578899999999996 677776
Q ss_pred ------------------------------------HHHHHHHHhhhcCCC-CEEeccCCCCCEEeCCCC----------
Q 045449 678 ------------------------------------IISSSLEYLHFGHSI-PIIHCDLKPSNVLLDEDM---------- 710 (823)
Q Consensus 678 ------------------------------------~~~~~l~~L~~~h~~-~ivHrdlk~~NiLl~~~~---------- 710 (823)
++.|++.+|+|+|+. +|+||||||+|||++.++
T Consensus 115 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~~~~ 194 (397)
T 1wak_A 115 VNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEA 194 (397)
T ss_dssp TTEEEEEEEECCCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHHHHH
T ss_pred CCCceEEEEEeccCccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhhhhh
Confidence 467899999999998 999999999999999775
Q ss_pred ---------------------------------------cEEEeecccccccCCCCccccccccccCCCcCcccccCCCc
Q 045449 711 ---------------------------------------VAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGR 751 (823)
Q Consensus 711 ---------------------------------------~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 751 (823)
.+||+|||+|+..... ....+||+.|+|||++.+..
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~ 269 (397)
T 1wak_A 195 TEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRSLEVLIGSG 269 (397)
T ss_dssp C---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCCHHHHHTSC
T ss_pred HHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcccCChhhcCCC
Confidence 7999999999876432 23457999999999999989
Q ss_pred cccccceehhhhhhccccCCCCCcCCC
Q 045449 752 VSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 752 ~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
++.++|||||||++|++++|..||...
T Consensus 270 ~~~~~DiwslG~il~elltg~~pf~~~ 296 (397)
T 1wak_A 270 YNTPADIWSTACMAFELATGDYLFEPH 296 (397)
T ss_dssp CCTHHHHHHHHHHHHHHHHSSCSCCCC
T ss_pred CCcHHHHHHHHHHHHHHhhCCCCCCCC
Confidence 999999999999999999999999653
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=99.87 E-value=6.2e-24 Score=233.23 Aligned_cols=153 Identities=20% Similarity=0.178 Sum_probs=121.1
Q ss_pred HhccCCccceeeccC-----------------CeEEEEEEehHhhHHH-----------HHHHHHHHHHHhhcchhhHHH
Q 045449 626 ATDRFSENNLIGIGN-----------------GMEVAVKVFHQQYERA-----------LKSFEDECEVRKRIRHRNLVK 677 (823)
Q Consensus 626 at~~f~~~~~lg~g~-----------------~~~vavK~~~~~~~~~-----------~~~~~~E~~~l~~l~h~niv~ 677 (823)
..++|...+.||.|+ +..||||++....... ...+..|+..+.+++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 346788888899886 2568999986443211 123456667778888998876
Q ss_pred --------------------------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeC--CCCc
Q 045449 678 --------------------------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLD--EDMV 711 (823)
Q Consensus 678 --------------------------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~--~~~~ 711 (823)
++.|++.+|+|+|+.+|+||||||+|||++ .++.
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~~ 192 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQ 192 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECEEEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTTC
T ss_pred EEeeeeeccCCcceEEEEEeCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCCe
Confidence 467889999999999999999999999998 8899
Q ss_pred EEEeecccccccCCCCccc-----cccccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCCC
Q 045449 712 AHISDFGIAKLLSGEDQLS-----KQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 712 ~kl~DfGla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
+||+|||+|+.+....... ......||+.|+|||++.+..++.++|||||||++|++++|..||.+.
T Consensus 193 ~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~ 264 (364)
T 3op5_A 193 VYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDN 264 (364)
T ss_dssp EEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred EEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccc
Confidence 9999999998764332111 113345999999999999999999999999999999999999999853
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=1.8e-23 Score=228.33 Aligned_cols=152 Identities=26% Similarity=0.334 Sum_probs=124.9
Q ss_pred hccCCccceeeccC------------CeEEEEEEehHhh--HHHHHHHHHHHHHHhhcchhhHHH---------------
Q 045449 627 TDRFSENNLIGIGN------------GMEVAVKVFHQQY--ERALKSFEDECEVRKRIRHRNLVK--------------- 677 (823)
Q Consensus 627 t~~f~~~~~lg~g~------------~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~--------------- 677 (823)
.++|...+.||.|+ |+.||||++.... ......+.+|++++++++||||++
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 35777788888875 6679999885432 222357889999999999999986
Q ss_pred ---------------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccC
Q 045449 678 ---------------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLS 724 (823)
Q Consensus 678 ---------------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~ 724 (823)
++.|++.+|+|+|+.||+||||||+||+++.++.+||+|||+|+...
T Consensus 96 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~ 175 (351)
T 3mi9_A 96 KGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFS 175 (351)
T ss_dssp -CEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred CceEEEEEeccCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhccccc
Confidence 36788999999999999999999999999999999999999998764
Q ss_pred CCCc--cccccccccCCCcCcccccCC-CccccccceehhhhhhccccCCCCCcCCC
Q 045449 725 GEDQ--LSKQTQTLATIGYMAPEYGTK-GRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 725 ~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
.... ........||+.|+|||++.+ ..++.++||||+||+++++++|..||.+.
T Consensus 176 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 232 (351)
T 3mi9_A 176 LAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGN 232 (351)
T ss_dssp CCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCC
Confidence 3221 122345678999999998876 45899999999999999999999998764
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=2.8e-23 Score=224.95 Aligned_cols=149 Identities=28% Similarity=0.388 Sum_probs=119.7
Q ss_pred ccCCccceeeccC------------CeEEEEEEehHhh--HHHHHHHHHHHHHHhhcchhhHHH----------------
Q 045449 628 DRFSENNLIGIGN------------GMEVAVKVFHQQY--ERALKSFEDECEVRKRIRHRNLVK---------------- 677 (823)
Q Consensus 628 ~~f~~~~~lg~g~------------~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~---------------- 677 (823)
++|...+.||.|+ +..||||++.... ....+.+.+|++++++++||||++
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 104 (331)
T 4aaa_A 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFE 104 (331)
T ss_dssp GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEe
Confidence 5677777888775 6679999885332 344567889999999999999998
Q ss_pred ------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCcccccc
Q 045449 678 ------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQT 733 (823)
Q Consensus 678 ------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~ 733 (823)
++.|++.+|.|+|+.+|+||||||+||+++.++.+||+|||+++....... ...
T Consensus 105 ~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~ 182 (331)
T 4aaa_A 105 FVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE--VYD 182 (331)
T ss_dssp CCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC-------------
T ss_pred cCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCcc--ccC
Confidence 367889999999999999999999999999999999999999987543322 223
Q ss_pred ccccCCCcCcccccCCC-ccccccceehhhhhhccccCCCCCcCCC
Q 045449 734 QTLATIGYMAPEYGTKG-RVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 734 ~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
...||+.|+|||++.+. .++.++||||+||++|++++|..||...
T Consensus 183 ~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 228 (331)
T 4aaa_A 183 DEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGD 228 (331)
T ss_dssp -CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred CCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 45799999999998775 6899999999999999999999998664
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=99.87 E-value=1.7e-23 Score=225.67 Aligned_cols=149 Identities=23% Similarity=0.360 Sum_probs=126.5
Q ss_pred hccCCccceeeccC------------CeEEEEEEehHhhH------HHHHHHHHHHHHHhhcchhhHHH-----------
Q 045449 627 TDRFSENNLIGIGN------------GMEVAVKVFHQQYE------RALKSFEDECEVRKRIRHRNLVK----------- 677 (823)
Q Consensus 627 t~~f~~~~~lg~g~------------~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~----------- 677 (823)
.++|...+.||.|+ |..||||++..... ...+.+.+|++++++++||||++
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 45688888899886 56799999864321 12467999999999999999998
Q ss_pred -----------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCC----cEEEeecccccccC
Q 045449 678 -----------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDM----VAHISDFGIAKLLS 724 (823)
Q Consensus 678 -----------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~----~~kl~DfGla~~~~ 724 (823)
++.|++.+|+|+|+.+|+||||||+||+++.++ .+||+|||+++...
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~ 170 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE 170 (321)
T ss_dssp EEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEECC
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccceecC
Confidence 467889999999999999999999999999887 79999999998765
Q ss_pred CCCccccccccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCCC
Q 045449 725 GEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 725 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
.... .....||+.|+|||++.+..++.++||||+||+++++++|..||.+.
T Consensus 171 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 221 (321)
T 2a2a_A 171 DGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD 221 (321)
T ss_dssp TTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCS
T ss_pred cccc---ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCC
Confidence 4322 23457999999999999889999999999999999999999999664
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.87 E-value=3.9e-23 Score=220.91 Aligned_cols=152 Identities=22% Similarity=0.309 Sum_probs=126.6
Q ss_pred hccCCccceeeccC------------CeEEEEEEehHhhH----HHHHHHHHHHHHHhhcchhhHHH-------------
Q 045449 627 TDRFSENNLIGIGN------------GMEVAVKVFHQQYE----RALKSFEDECEVRKRIRHRNLVK------------- 677 (823)
Q Consensus 627 t~~f~~~~~lg~g~------------~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~------------- 677 (823)
.++|...+.||.|+ +..||||++..... ...+.+.+|++++++++||||++
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 46788888999886 56799999976532 34578999999999999999998
Q ss_pred ------------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCC
Q 045449 678 ------------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGED 727 (823)
Q Consensus 678 ------------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~ 727 (823)
++.|++.+|+|+|+.+|+||||||+||+++.++.+||+|||+++......
T Consensus 84 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~ 163 (305)
T 2wtk_C 84 YMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFA 163 (305)
T ss_dssp EEEEECCSEEHHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTTC
T ss_pred EEEehhccCCHHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccCccc
Confidence 35688999999999999999999999999999999999999998765332
Q ss_pred ccccccccccCCCcCcccccCCCc--cccccceehhhhhhccccCCCCCcCCC
Q 045449 728 QLSKQTQTLATIGYMAPEYGTKGR--VSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 728 ~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
.........||+.|+|||++.+.. ++.++||||+||+++++.+|..||...
T Consensus 164 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 216 (305)
T 2wtk_C 164 ADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGD 216 (305)
T ss_dssp SSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCc
Confidence 222334567999999999987643 478999999999999999999998764
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=3.6e-23 Score=220.01 Aligned_cols=149 Identities=23% Similarity=0.320 Sum_probs=127.4
Q ss_pred ccCCccceeeccC------------CeEEEEEEehHhh---HHHHHHHHHHHHHHhhcchhhHHH---------------
Q 045449 628 DRFSENNLIGIGN------------GMEVAVKVFHQQY---ERALKSFEDECEVRKRIRHRNLVK--------------- 677 (823)
Q Consensus 628 ~~f~~~~~lg~g~------------~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~--------------- 677 (823)
++|...+.||+|+ +..||+|++.... ....+.+.+|++++++++||||++
T Consensus 15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 94 (294)
T 2rku_A 15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL 94 (294)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEE
Confidence 5677788888886 5679999986542 445678999999999999999998
Q ss_pred -------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccc
Q 045449 678 -------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQ 732 (823)
Q Consensus 678 -------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~ 732 (823)
++.|++++|+|+|+.+|+||||||+||+++.++.+||+|||+++....... ..
T Consensus 95 e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~--~~ 172 (294)
T 2rku_A 95 ELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE--RK 172 (294)
T ss_dssp ECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTC--CB
T ss_pred ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccCcc--cc
Confidence 367889999999999999999999999999999999999999987643222 22
Q ss_pred cccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCCC
Q 045449 733 TQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 733 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
....||+.|+|||++.+..++.++||||+||+++++++|..||...
T Consensus 173 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~ 218 (294)
T 2rku_A 173 KVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETS 218 (294)
T ss_dssp CCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred ccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 3457999999999999888999999999999999999999998764
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=99.86 E-value=4.5e-23 Score=228.99 Aligned_cols=143 Identities=26% Similarity=0.344 Sum_probs=112.6
Q ss_pred ccCCcc-ceeeccC------------CeEEEEEEehHhhHHHHHHHHHHHHHHhh-cchhhHHH----------------
Q 045449 628 DRFSEN-NLIGIGN------------GMEVAVKVFHQQYERALKSFEDECEVRKR-IRHRNLVK---------------- 677 (823)
Q Consensus 628 ~~f~~~-~~lg~g~------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~---------------- 677 (823)
++|... ++||.|+ +..||||++... ..+.+|++++.+ .+||||++
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~ 135 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 135 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence 344443 5788875 567999999643 356788888754 48999987
Q ss_pred ------------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCC---CCcEEEeecccccccC
Q 045449 678 ------------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDE---DMVAHISDFGIAKLLS 724 (823)
Q Consensus 678 ------------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~---~~~~kl~DfGla~~~~ 724 (823)
++.|++.+|+|+|+.+|+||||||+|||++. ++.+||+|||+++...
T Consensus 136 lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~ 215 (400)
T 1nxk_A 136 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT 215 (400)
T ss_dssp EEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred EEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecccccccC
Confidence 3678899999999999999999999999997 7899999999998754
Q ss_pred CCCccccccccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCCC
Q 045449 725 GEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 725 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
... .....+||+.|+|||++.+..|+.++|||||||++|++++|..||...
T Consensus 216 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 266 (400)
T 1nxk_A 216 SHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSN 266 (400)
T ss_dssp --------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCC
T ss_pred CCC---ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCC
Confidence 322 234567999999999999999999999999999999999999999654
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=99.86 E-value=1.2e-23 Score=223.30 Aligned_cols=152 Identities=24% Similarity=0.290 Sum_probs=116.8
Q ss_pred ccCCccceeeccC---------------CeEEEEEEehHhh---HHHHHHHHHHHHHHhhcchhhHHH------------
Q 045449 628 DRFSENNLIGIGN---------------GMEVAVKVFHQQY---ERALKSFEDECEVRKRIRHRNLVK------------ 677 (823)
Q Consensus 628 ~~f~~~~~lg~g~---------------~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~------------ 677 (823)
++|...+.||.|+ +..||||+++... ....+.|.+|++++++++||||++
T Consensus 18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 97 (291)
T 1u46_A 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKM 97 (291)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEE
T ss_pred hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCCcee
Confidence 4566666666654 2258999987542 345578999999999999999998
Q ss_pred ----------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCcc
Q 045449 678 ----------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQL 729 (823)
Q Consensus 678 ----------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~ 729 (823)
++.|++++|+|+|+.+|+||||||+||+++.++.+||+|||+++........
T Consensus 98 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 177 (291)
T 1u46_A 98 VTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDH 177 (291)
T ss_dssp EEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-CCE
T ss_pred eEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEccccccccccccccc
Confidence 3568899999999999999999999999999999999999999876543321
Q ss_pred -ccccccccCCCcCcccccCCCccccccceehhhhhhccccC-CCCCcCCCc
Q 045449 730 -SKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKET-RSMTVGETC 779 (823)
Q Consensus 730 -~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~-~~~~~~~~~ 779 (823)
.......+|+.|+|||++.+..++.++||||+||+++++++ |..||....
T Consensus 178 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~ 229 (291)
T 1u46_A 178 YVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN 229 (291)
T ss_dssp EEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred hhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCC
Confidence 12234567889999999988889999999999999999999 999987643
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.86 E-value=3.3e-21 Score=210.19 Aligned_cols=241 Identities=15% Similarity=0.113 Sum_probs=156.8
Q ss_pred cEEEccCCcccccCCcccccCCCCccEEEeeccccccccCccccCCCCCCeEEeecccccccCC-CccCCCcccCc-ccc
Q 045449 231 KEISLLNNSLSGSLPSRIDLSLPNVETLNLGINSFSGTIPSSITNSSKLSDLELGENLFSGFIP-NTIGNLRNLEF-GNI 308 (823)
Q Consensus 231 ~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~-L~L 308 (823)
++++.++|+++ .+|..+ .+++++|+|++|+|+...+.+|.++++|++|+|++|++.+.+| .+|.++++|.. +.+
T Consensus 12 ~~v~C~~~~Lt-~iP~~l---~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~ 87 (350)
T 4ay9_X 12 RVFLCQESKVT-EIPSDL---PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIE 87 (350)
T ss_dssp TEEEEESTTCC-SCCTTC---CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEE
T ss_pred CEEEecCCCCC-ccCcCc---CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcc
Confidence 45777777777 677655 3467778888888775555667777888888888887765444 46777777654 556
Q ss_pred cCccccCCCCcccccccccCCCCceEEEeecCCCCccCCccccccccccceEEecC-CcceeccCccccCcc-cccEEEc
Q 045449 309 ADNYLTSSTPELSFLSSLTNCKKLKVLIVTGNPLDGILPKSIGNFSLSLETILMAN-CSISGNIPQVVGNLS-NLLVLEL 386 (823)
Q Consensus 309 ~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~-N~l~~~~p~~~~~l~-~L~~L~L 386 (823)
+.|+++.. .+..|.++++|++|++++|.+++..+..+... ..+..+++.+ |++....+..|..+. .++.|+|
T Consensus 88 ~~N~l~~l-----~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~-~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L 161 (350)
T 4ay9_X 88 KANNLLYI-----NPEAFQNLPNLQYLLISNTGIKHLPDVHKIHS-LQKVLLDIQDNINIHTIERNSFVGLSFESVILWL 161 (350)
T ss_dssp EETTCCEE-----CTTSBCCCTTCCEEEEEEECCSSCCCCTTCCB-SSCEEEEEESCTTCCEECTTSSTTSBSSCEEEEC
T ss_pred cCCccccc-----CchhhhhccccccccccccccccCCchhhccc-chhhhhhhccccccccccccchhhcchhhhhhcc
Confidence 66777765 33467777778888888888776666555554 4666777754 566666666666654 5777788
Q ss_pred ccCcCCCCchhcccccCCCCEEEccC-CCCCCcchHhhhcCCCCCEEEcccCcCcccccccccCCCCCCeEeccCC-ccc
Q 045449 387 GGNNLTGPIPVTFSQLQTLQAFDLTR-NKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSVRVLYLGLN-IFT 464 (823)
Q Consensus 387 s~N~l~g~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N-~l~ 464 (823)
++|+|+. +|.......+|+.|++++ |.++...+..|.++++|+.|||++|+|+...+..|.+ |+.|.+.++ +++
T Consensus 162 ~~N~i~~-i~~~~f~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~lp~~~~~~---L~~L~~l~~~~l~ 237 (350)
T 4ay9_X 162 NKNGIQE-IHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLEN---LKKLRARSTYNLK 237 (350)
T ss_dssp CSSCCCE-ECTTSSTTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCCCCCSSSCTT---CCEEECTTCTTCC
T ss_pred ccccccC-CChhhccccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcCccChhhhcc---chHhhhccCCCcC
Confidence 8888773 444444456777777764 5555444455777777888888888877444444444 344443333 333
Q ss_pred cccchhhhccCCCcEEecccccc
Q 045449 465 SVLSSTIWNLKDILFIDVSSNFL 487 (823)
Q Consensus 465 ~~~p~~~~~l~~L~~LdLs~N~l 487 (823)
.+| .+..+++|+.++++++.-
T Consensus 238 -~lP-~l~~l~~L~~l~l~~~~~ 258 (350)
T 4ay9_X 238 -KLP-TLEKLVALMEASLTYPSH 258 (350)
T ss_dssp -CCC-CTTTCCSCCEEECSCHHH
T ss_pred -cCC-CchhCcChhhCcCCCCcc
Confidence 344 366777777777776543
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=3.1e-23 Score=224.91 Aligned_cols=150 Identities=23% Similarity=0.317 Sum_probs=127.9
Q ss_pred hccCCccceeeccC------------CeEEEEEEehHhh---HHHHHHHHHHHHHHhhcchhhHHH--------------
Q 045449 627 TDRFSENNLIGIGN------------GMEVAVKVFHQQY---ERALKSFEDECEVRKRIRHRNLVK-------------- 677 (823)
Q Consensus 627 t~~f~~~~~lg~g~------------~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~-------------- 677 (823)
.++|...+.||+|+ +..||+|++.... ....+.+.+|++++++++||||++
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 35777788888885 5679999986542 445678999999999999999998
Q ss_pred --------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCcccc
Q 045449 678 --------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSK 731 (823)
Q Consensus 678 --------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~ 731 (823)
++.|++++|+|+|+.+|+||||||+||+++.++.+||+|||+++....... .
T Consensus 120 ~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~--~ 197 (335)
T 2owb_A 120 LELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE--R 197 (335)
T ss_dssp ECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTC--C
T ss_pred EecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccCcc--c
Confidence 367889999999999999999999999999999999999999987643222 2
Q ss_pred ccccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCCC
Q 045449 732 QTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 732 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
.....||+.|+|||++.+..++.++|||||||++|++++|..||...
T Consensus 198 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 244 (335)
T 2owb_A 198 KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETS 244 (335)
T ss_dssp BCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred ccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCC
Confidence 23457999999999998888999999999999999999999998764
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=1.4e-23 Score=226.96 Aligned_cols=151 Identities=26% Similarity=0.316 Sum_probs=127.2
Q ss_pred ccCCccceeeccC----------------CeEEEEEEehHhhHHHHHHHHHHHHHHhhcchhhHHH--------------
Q 045449 628 DRFSENNLIGIGN----------------GMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVK-------------- 677 (823)
Q Consensus 628 ~~f~~~~~lg~g~----------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-------------- 677 (823)
++|...+.||.|+ +..||||++........+.|.+|++++++++||||++
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 102 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR 102 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence 4566667777664 4669999998776666788999999999999999998
Q ss_pred -----------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCc
Q 045449 678 -----------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQ 728 (823)
Q Consensus 678 -----------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~ 728 (823)
++.|++.+|+|+|+.+|+||||||+||+++.++.+||+|||+++.......
T Consensus 103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 182 (327)
T 3lxl_A 103 LVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKD 182 (327)
T ss_dssp EEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCEECCTTCS
T ss_pred EEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccceecccCCc
Confidence 356889999999999999999999999999999999999999987654332
Q ss_pred c-ccccccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCCC
Q 045449 729 L-SKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 729 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
. .......||+.|+|||++.+..++.++||||+||+++++++|..||...
T Consensus 183 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~ 233 (327)
T 3lxl_A 183 YYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSP 233 (327)
T ss_dssp EEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSH
T ss_pred cceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccc
Confidence 1 1223456888999999998888999999999999999999999888654
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=99.86 E-value=4.6e-23 Score=226.86 Aligned_cols=147 Identities=28% Similarity=0.345 Sum_probs=123.0
Q ss_pred hccCCccceeeccC------------CeEEEEEEehHh--hHHHHHHHHHHHHHHhhcchhhHHH---------------
Q 045449 627 TDRFSENNLIGIGN------------GMEVAVKVFHQQ--YERALKSFEDECEVRKRIRHRNLVK--------------- 677 (823)
Q Consensus 627 t~~f~~~~~lg~g~------------~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~--------------- 677 (823)
.++|...+.||.|+ |..||||++... .....+.+.+|++++++++||||++
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 46778888899886 677999999753 2445678999999999999999997
Q ss_pred ----------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCcc
Q 045449 678 ----------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQL 729 (823)
Q Consensus 678 ----------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~ 729 (823)
++.|++.+|+|+|+.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 121 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~--- 197 (371)
T 4exu_A 121 DFYLVMPFMQTDLQKIMGMEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE--- 197 (371)
T ss_dssp CCEEEEECCCEEHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC---------
T ss_pred eEEEEEccccccHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCcccccccC---
Confidence 3578999999999999999999999999999999999999999865432
Q ss_pred ccccccccCCCcCcccccCC-CccccccceehhhhhhccccCCCCCcCCC
Q 045449 730 SKQTQTLATIGYMAPEYGTK-GRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 730 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
....+||+.|+|||++.+ ..++.++||||+||+++++++|..||.+.
T Consensus 198 --~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 245 (371)
T 4exu_A 198 --MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGK 245 (371)
T ss_dssp ----CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred --cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCC
Confidence 234578999999999877 67899999999999999999999999764
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.86 E-value=9.2e-24 Score=232.15 Aligned_cols=149 Identities=24% Similarity=0.318 Sum_probs=111.8
Q ss_pred CCccceeeccC---------------CeEEEEEEehHhh-HHHHHHHHHHHHHHhhcchhhHHH----------------
Q 045449 630 FSENNLIGIGN---------------GMEVAVKVFHQQY-ERALKSFEDECEVRKRIRHRNLVK---------------- 677 (823)
Q Consensus 630 f~~~~~lg~g~---------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~---------------- 677 (823)
|...+.||+|+ +..||||++.... ....++|.+|+.++++++||||++
T Consensus 91 ~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~ 170 (373)
T 3c1x_A 91 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL 170 (373)
T ss_dssp EEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEE
T ss_pred eecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEE
Confidence 45567888886 1247999886432 345678999999999999999998
Q ss_pred --------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCcc--
Q 045449 678 --------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQL-- 729 (823)
Q Consensus 678 --------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~-- 729 (823)
++.|++++|+|+|+.+|+||||||+||+++.++.+||+|||+++........
T Consensus 171 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~ 250 (373)
T 3c1x_A 171 PYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV 250 (373)
T ss_dssp ECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC--------------
T ss_pred ECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeeccccccccccccccc
Confidence 3568899999999999999999999999999999999999999876433211
Q ss_pred ccccccccCCCcCcccccCCCccccccceehhhhhhccccC-CCCCcCCC
Q 045449 730 SKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKET-RSMTVGET 778 (823)
Q Consensus 730 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~-~~~~~~~~ 778 (823)
.......+|+.|+|||++.+..++.++|||||||++|++++ +..||.+.
T Consensus 251 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~ 300 (373)
T 3c1x_A 251 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV 300 (373)
T ss_dssp -------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTS
T ss_pred cccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCC
Confidence 11234567889999999998899999999999999999999 56666553
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=99.86 E-value=1.5e-23 Score=229.75 Aligned_cols=148 Identities=28% Similarity=0.345 Sum_probs=114.2
Q ss_pred hccCCccceeeccC------------CeEEEEEEehHhhHHHHHHHHHHHHHHhhcchhhHHH-----------------
Q 045449 627 TDRFSENNLIGIGN------------GMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVK----------------- 677 (823)
Q Consensus 627 t~~f~~~~~lg~g~------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~----------------- 677 (823)
.++|...+.||.|+ ++.||||++..... ..+.+.+|+.++++++||||++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 97 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY 97 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence 46788888888886 56799999965432 2356889999999999999998
Q ss_pred -----------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCc--EEEeecccccccCCCCccccc
Q 045449 678 -----------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMV--AHISDFGIAKLLSGEDQLSKQ 732 (823)
Q Consensus 678 -----------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~--~kl~DfGla~~~~~~~~~~~~ 732 (823)
++.|++.+|+|+|+.+|+||||||+||+++.++. +||+|||+|+...... ..
T Consensus 98 ~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~---~~ 174 (361)
T 3uc3_A 98 ASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---QP 174 (361)
T ss_dssp CCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC------------
T ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCccccccccC---CC
Confidence 4678999999999999999999999999987665 9999999998543222 22
Q ss_pred cccccCCCcCcccccCCCccccc-cceehhhhhhccccCCCCCcCCC
Q 045449 733 TQTLATIGYMAPEYGTKGRVSTR-GDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 733 ~~~~gt~~y~aPE~~~~~~~~~~-~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
...+||+.|+|||++.+..+..+ +||||+||++|++++|..||...
T Consensus 175 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~ 221 (361)
T 3uc3_A 175 KSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDP 221 (361)
T ss_dssp ------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC--
T ss_pred CCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCC
Confidence 34579999999999988877655 89999999999999999999764
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=1.5e-23 Score=226.89 Aligned_cols=153 Identities=27% Similarity=0.350 Sum_probs=117.1
Q ss_pred HHHhccCCccceeeccC------------CeEEEEEEehHhh--HHHHHHHHHHHHHHhhcchhhHHH------------
Q 045449 624 LRATDRFSENNLIGIGN------------GMEVAVKVFHQQY--ERALKSFEDECEVRKRIRHRNLVK------------ 677 (823)
Q Consensus 624 ~~at~~f~~~~~lg~g~------------~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~------------ 677 (823)
....++|...+.||.|+ +..||||++.... ....+.+.+|++++++++||||++
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (329)
T 3gbz_A 30 ATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLH 109 (329)
T ss_dssp --CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEE
T ss_pred ccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEE
Confidence 34457888889999886 6679999996443 333467889999999999999998
Q ss_pred ---------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEe-----CCCCcEEEeecccccccCC
Q 045449 678 ---------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLL-----DEDMVAHISDFGIAKLLSG 725 (823)
Q Consensus 678 ---------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl-----~~~~~~kl~DfGla~~~~~ 725 (823)
++.|++.+|+|+|+.+|+||||||+||++ +.++.+||+|||+|+....
T Consensus 110 lv~e~~~~~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~ 189 (329)
T 3gbz_A 110 LIFEYAENDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGI 189 (329)
T ss_dssp EEEECCSEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC-
T ss_pred EEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccccCC
Confidence 46789999999999999999999999999 4556699999999987643
Q ss_pred CCccccccccccCCCcCcccccCCC-ccccccceehhhhhhccccCCCCCcCCC
Q 045449 726 EDQLSKQTQTLATIGYMAPEYGTKG-RVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 726 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
... .....+||+.|+|||++.+. .++.++||||+||+++++++|..||...
T Consensus 190 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 241 (329)
T 3gbz_A 190 PIR--QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGD 241 (329)
T ss_dssp ------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ccc--ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCC
Confidence 322 23445789999999998775 4899999999999999999999998664
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=99.86 E-value=7.9e-23 Score=216.20 Aligned_cols=147 Identities=22% Similarity=0.344 Sum_probs=125.5
Q ss_pred ccCCccceeeccC------------CeEEEEEEehHhhH---HHHHHHHHHHHHHhhcchhhHHH---------------
Q 045449 628 DRFSENNLIGIGN------------GMEVAVKVFHQQYE---RALKSFEDECEVRKRIRHRNLVK--------------- 677 (823)
Q Consensus 628 ~~f~~~~~lg~g~------------~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~--------------- 677 (823)
++|...+.||.|+ +..||||++..... ...+.+.+|++++++++||||++
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 93 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML 93 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence 5677788888875 56799999965432 22467999999999999999998
Q ss_pred -------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccc
Q 045449 678 -------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQ 732 (823)
Q Consensus 678 -------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~ 732 (823)
++.|++++|+|+|+.+|+||||||+||+++.++.+||+|||++....... .
T Consensus 94 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~----~ 169 (284)
T 2vgo_A 94 EFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR----R 169 (284)
T ss_dssp CCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSSC----B
T ss_pred EeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCcccc----c
Confidence 35788999999999999999999999999999999999999997654322 2
Q ss_pred cccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCCC
Q 045449 733 TQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 733 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
....||+.|+|||++.+..++.++||||+||+++++++|..||...
T Consensus 170 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 215 (284)
T 2vgo_A 170 RTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSP 215 (284)
T ss_dssp CCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred ccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCC
Confidence 3457999999999999989999999999999999999999999764
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=99.86 E-value=1.2e-23 Score=237.72 Aligned_cols=150 Identities=25% Similarity=0.442 Sum_probs=120.0
Q ss_pred hccCCccceeeccC-----------CeEEEEEEehHhhHHHHHHHHHHHHHHhhcchhhHHH------------------
Q 045449 627 TDRFSENNLIGIGN-----------GMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVK------------------ 677 (823)
Q Consensus 627 t~~f~~~~~lg~g~-----------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------------ 677 (823)
.++|...+.||.|+ +..||||+++.... ..++|.+|++++++++||||++
T Consensus 183 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~iv~e~~~ 261 (452)
T 1fmk_A 183 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMS 261 (452)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEECCCT
T ss_pred hhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEcCCceEEEehhhc
Confidence 35677778888886 35699999975432 2367999999999999999998
Q ss_pred -----------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccc
Q 045449 678 -----------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQ 734 (823)
Q Consensus 678 -----------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 734 (823)
++.|++++|+|+|+.+|+||||||+|||++.++.+||+|||+++....... .....
T Consensus 262 ~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~-~~~~~ 340 (452)
T 1fmk_A 262 KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-TARQG 340 (452)
T ss_dssp TCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC-------------
T ss_pred CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecCCCce-ecccC
Confidence 356889999999999999999999999999999999999999987643221 22233
Q ss_pred cccCCCcCcccccCCCccccccceehhhhhhccccC-CCCCcCCC
Q 045449 735 TLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKET-RSMTVGET 778 (823)
Q Consensus 735 ~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~-~~~~~~~~ 778 (823)
..+|+.|+|||++.++.++.++|||||||+++++++ |..||.+.
T Consensus 341 ~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~ 385 (452)
T 1fmk_A 341 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM 385 (452)
T ss_dssp --CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred CcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCC
Confidence 457889999999988899999999999999999999 89998764
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=1.4e-23 Score=222.50 Aligned_cols=142 Identities=22% Similarity=0.273 Sum_probs=119.5
Q ss_pred ccCCccceeeccC------------C-------eEEEEEEehHhhHHHHHHHHHHHHHHhhcchhhHHH-----------
Q 045449 628 DRFSENNLIGIGN------------G-------MEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVK----------- 677 (823)
Q Consensus 628 ~~f~~~~~lg~g~------------~-------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~----------- 677 (823)
++|...+.||.|+ + ..||+|++........+.|.+|++++++++||||++
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (289)
T 4fvq_A 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDEN 87 (289)
T ss_dssp GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCC
T ss_pred hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCC
Confidence 4677778888876 1 459999997766666688999999999999999998
Q ss_pred ------------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCc--------EEEeeccc
Q 045449 678 ------------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMV--------AHISDFGI 719 (823)
Q Consensus 678 ------------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~--------~kl~DfGl 719 (823)
++.|++.+|+|+|+.+|+||||||+||+++.++. +||+|||+
T Consensus 88 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Dfg~ 167 (289)
T 4fvq_A 88 ILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGI 167 (289)
T ss_dssp EEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEEECCCCS
T ss_pred EEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceeeeccCcc
Confidence 3578899999999999999999999999988776 99999999
Q ss_pred ccccCCCCccccccccccCCCcCcccccCC-CccccccceehhhhhhccccCCCCCc
Q 045449 720 AKLLSGEDQLSKQTQTLATIGYMAPEYGTK-GRVSTRGDVCSFGIISGGKETRSMTV 775 (823)
Q Consensus 720 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvv~~~~~~~~~~~ 775 (823)
++..... ....||+.|+|||++.+ ..++.++||||+||+++++++|..++
T Consensus 168 ~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~ 218 (289)
T 4fvq_A 168 SITVLPK------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKP 218 (289)
T ss_dssp CTTTSCH------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred cccccCc------cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCC
Confidence 9765322 23458999999999887 67899999999999999999965444
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.86 E-value=1e-23 Score=227.67 Aligned_cols=149 Identities=25% Similarity=0.305 Sum_probs=116.9
Q ss_pred ccCCccceeeccC------------CeEEEEEEehHhhHH-HHHHHHHHHHHHhhcchhhHHH-----------------
Q 045449 628 DRFSENNLIGIGN------------GMEVAVKVFHQQYER-ALKSFEDECEVRKRIRHRNLVK----------------- 677 (823)
Q Consensus 628 ~~f~~~~~lg~g~------------~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~----------------- 677 (823)
++|...+.||.|+ +..||||++...... ....+.+|++++++++||||++
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 4677778888886 567999998754322 2235678999999999999998
Q ss_pred -----------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccc
Q 045449 678 -----------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQ 734 (823)
Q Consensus 678 -----------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 734 (823)
++.|++.+|+|+|+.+|+||||||+||+++.++.+||+|||+++....... ....
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~--~~~~ 159 (324)
T 3mtl_A 82 LDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK--TYDN 159 (324)
T ss_dssp CSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC-----------
T ss_pred cccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCcc--cccc
Confidence 357899999999999999999999999999999999999999986543221 2334
Q ss_pred cccCCCcCcccccCC-CccccccceehhhhhhccccCCCCCcCCC
Q 045449 735 TLATIGYMAPEYGTK-GRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 735 ~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
..||+.|+|||++.+ ..++.++||||+||+++++++|..||.+.
T Consensus 160 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 204 (324)
T 3mtl_A 160 EVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGS 204 (324)
T ss_dssp ---CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 578999999999876 56899999999999999999999999764
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=99.86 E-value=1.8e-23 Score=221.62 Aligned_cols=152 Identities=24% Similarity=0.390 Sum_probs=127.7
Q ss_pred HhccCCccceeeccC------------CeEEEEEEehHhhHHHHHHHHHHHHHHhhcchhhHHH----------------
Q 045449 626 ATDRFSENNLIGIGN------------GMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVK---------------- 677 (823)
Q Consensus 626 at~~f~~~~~lg~g~------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~---------------- 677 (823)
..++|...+.||.|+ +..||||++.... ...+.|.+|++++++++||||++
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 89 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 89 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEE
Confidence 346777778888875 5679999997543 23478999999999999999998
Q ss_pred --------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCcccc
Q 045449 678 --------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSK 731 (823)
Q Consensus 678 --------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~ 731 (823)
++.|++.+|+|+|+.+|+||||||+||+++.++.+||+|||+++....... ..
T Consensus 90 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~-~~ 168 (288)
T 3kfa_A 90 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY-TA 168 (288)
T ss_dssp CCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSS-EE
T ss_pred cCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceeccCCcc-cc
Confidence 356889999999999999999999999999999999999999987654332 22
Q ss_pred ccccccCCCcCcccccCCCccccccceehhhhhhccccC-CCCCcCCCc
Q 045449 732 QTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKET-RSMTVGETC 779 (823)
Q Consensus 732 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~-~~~~~~~~~ 779 (823)
.....+|+.|+|||++.+..++.++||||+||+++++++ |..||....
T Consensus 169 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~ 217 (288)
T 3kfa_A 169 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID 217 (288)
T ss_dssp ETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred ccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 344567889999999988899999999999999999999 888887643
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=99.86 E-value=2e-23 Score=222.13 Aligned_cols=150 Identities=23% Similarity=0.263 Sum_probs=124.8
Q ss_pred hccCCccceeeccC------------CeEEEEEEehHhhHHHHHHHHHHHHHHhhcchhhHHH-----------------
Q 045449 627 TDRFSENNLIGIGN------------GMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVK----------------- 677 (823)
Q Consensus 627 t~~f~~~~~lg~g~------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~----------------- 677 (823)
.++|...+.||.|+ ++.||||++..... .+++.+|++++++++|++++.
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence 46788888888875 67799999864432 246889999999999887665
Q ss_pred ------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeC---CCCcEEEeecccccccCCCCcc-
Q 045449 678 ------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLD---EDMVAHISDFGIAKLLSGEDQL- 729 (823)
Q Consensus 678 ------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~---~~~~~kl~DfGla~~~~~~~~~- 729 (823)
++.|++.+|+|+|+.+|+||||||+||+++ .++.+||+|||+++........
T Consensus 86 ~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~ 165 (296)
T 3uzp_A 86 LLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQ 165 (296)
T ss_dssp CCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCC
T ss_pred ecCCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccccccc
Confidence 467899999999999999999999999994 7889999999999876543321
Q ss_pred ----ccccccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCCC
Q 045449 730 ----SKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 730 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
.......||+.|+|||++.+..++.++|||||||+++++++|+.||...
T Consensus 166 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 218 (296)
T 3uzp_A 166 HIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGL 218 (296)
T ss_dssp BCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSC
T ss_pred ccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCc
Confidence 1124567999999999999999999999999999999999999999764
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=99.86 E-value=3.4e-23 Score=224.51 Aligned_cols=151 Identities=28% Similarity=0.381 Sum_probs=126.0
Q ss_pred ccCCccceeeccC-------------------CeEEEEEEehHhh-HHHHHHHHHHHHHHhhc-chhhHHH---------
Q 045449 628 DRFSENNLIGIGN-------------------GMEVAVKVFHQQY-ERALKSFEDECEVRKRI-RHRNLVK--------- 677 (823)
Q Consensus 628 ~~f~~~~~lg~g~-------------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~--------- 677 (823)
++|...+.||.|+ +..||||++.... ....+.+.+|+++++++ +||||++
T Consensus 35 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 114 (334)
T 2pvf_A 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 114 (334)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred hHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccCC
Confidence 5777778888875 2358999997543 45567899999999999 8999997
Q ss_pred -----------------------------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCC
Q 045449 678 -----------------------------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDM 710 (823)
Q Consensus 678 -----------------------------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~ 710 (823)
++.|++++|+|+|+.+|+||||||+||+++.++
T Consensus 115 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~ 194 (334)
T 2pvf_A 115 PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENN 194 (334)
T ss_dssp CCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC
T ss_pred ceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEEcCCC
Confidence 135788899999999999999999999999999
Q ss_pred cEEEeecccccccCCCCccccccccccCCCcCcccccCCCccccccceehhhhhhccccC-CCCCcCCC
Q 045449 711 VAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKET-RSMTVGET 778 (823)
Q Consensus 711 ~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~-~~~~~~~~ 778 (823)
.+||+|||+++...............+|+.|+|||++.+..++.++||||+||+++++++ |..||.+.
T Consensus 195 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~ 263 (334)
T 2pvf_A 195 VMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI 263 (334)
T ss_dssp CEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred CEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcC
Confidence 999999999987654433333344567889999999988889999999999999999998 99998764
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=99.86 E-value=4.8e-23 Score=222.31 Aligned_cols=141 Identities=26% Similarity=0.380 Sum_probs=100.9
Q ss_pred cceeeccC------------CeEEEEEEehHhhHHHHHHHHHHHHHHhhcc-hhhHHH----------------------
Q 045449 633 NNLIGIGN------------GMEVAVKVFHQQYERALKSFEDECEVRKRIR-HRNLVK---------------------- 677 (823)
Q Consensus 633 ~~~lg~g~------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~---------------------- 677 (823)
.+.||+|+ ++.||||++.... ...+.+|++++.++. ||||++
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 92 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKRM---EANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE 92 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGGG---HHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChhh---hhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence 35677775 6779999997653 256788999999997 999998
Q ss_pred ------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCC---cEEEeecccccccCCCCccccccccc
Q 045449 678 ------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDM---VAHISDFGIAKLLSGEDQLSKQTQTL 736 (823)
Q Consensus 678 ------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~---~~kl~DfGla~~~~~~~~~~~~~~~~ 736 (823)
++.|++.+|+|+|+.+|+||||||+||+++.++ .+||+|||+++....... .....+
T Consensus 93 L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~ 170 (325)
T 3kn6_A 93 LFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ--PLKTPC 170 (325)
T ss_dssp HHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-----------
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC--cccccC
Confidence 467899999999999999999999999997655 899999999987543322 234467
Q ss_pred cCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCCC
Q 045449 737 ATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 737 gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
||+.|+|||++.+..++.++||||+||++|++++|..||...
T Consensus 171 ~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 212 (325)
T 3kn6_A 171 FTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSH 212 (325)
T ss_dssp -------------CCCCHHHHHHHHHHHHHHHHHSSCTTC--
T ss_pred CCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCC
Confidence 899999999999999999999999999999999999999753
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=5.1e-23 Score=224.91 Aligned_cols=152 Identities=28% Similarity=0.338 Sum_probs=124.5
Q ss_pred hccCCccceeeccC------------CeEEEEEEehHh-hHHHHHHHHHHHHHHhhcchhhHHH----------------
Q 045449 627 TDRFSENNLIGIGN------------GMEVAVKVFHQQ-YERALKSFEDECEVRKRIRHRNLVK---------------- 677 (823)
Q Consensus 627 t~~f~~~~~lg~g~------------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~---------------- 677 (823)
.++|...+.||.|+ |..||||++... ......++.+|++++++++||||++
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 46788888899886 677999998643 2445568899999999999999986
Q ss_pred ---------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCcc-
Q 045449 678 ---------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQL- 729 (823)
Q Consensus 678 ---------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~- 729 (823)
++.|++.+|+|+|+.+|+||||||+||+++.++.+||+|||+++........
T Consensus 90 ~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~ 169 (353)
T 2b9h_A 90 YIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADN 169 (353)
T ss_dssp EEEECCCSEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC------
T ss_pred EEEEeccCccHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEecccccccccccccc
Confidence 3678899999999999999999999999999999999999999876432211
Q ss_pred -------ccccccccCCCcCcccccCC-CccccccceehhhhhhccccCCCCCcCCC
Q 045449 730 -------SKQTQTLATIGYMAPEYGTK-GRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 730 -------~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
......+||+.|+|||++.+ ..++.++||||+||+++++++|..||.+.
T Consensus 170 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 226 (353)
T 2b9h_A 170 SEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGR 226 (353)
T ss_dssp ----------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 01223578999999998654 67899999999999999999999998764
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=99.86 E-value=9.7e-23 Score=216.22 Aligned_cols=144 Identities=28% Similarity=0.364 Sum_probs=120.8
Q ss_pred CCccceeeccC------------CeEEEEEEehHhh--HHHHHHHHHHHHHHhhcchhhHHH------------------
Q 045449 630 FSENNLIGIGN------------GMEVAVKVFHQQY--ERALKSFEDECEVRKRIRHRNLVK------------------ 677 (823)
Q Consensus 630 f~~~~~lg~g~------------~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~------------------ 677 (823)
|...+.||.|+ +..||+|++.... ....+.+.+|++++++++||||++
T Consensus 28 ~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv 107 (290)
T 1t4h_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEE
Confidence 55566788876 5569999986543 455678999999999999999997
Q ss_pred --------------------------HHHHHHHHhhhcCCCC--EEeccCCCCCEEeC-CCCcEEEeecccccccCCCCc
Q 045449 678 --------------------------IISSSLEYLHFGHSIP--IIHCDLKPSNVLLD-EDMVAHISDFGIAKLLSGEDQ 728 (823)
Q Consensus 678 --------------------------~~~~~l~~L~~~h~~~--ivHrdlk~~NiLl~-~~~~~kl~DfGla~~~~~~~~ 728 (823)
++.|++.+|+|+|+.+ |+||||||+||+++ .++.+||+|||+++......
T Consensus 108 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~~~- 186 (290)
T 1t4h_A 108 TELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF- 186 (290)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTTS-
T ss_pred EEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcccccccc-
Confidence 3578899999999999 99999999999998 78999999999997654322
Q ss_pred cccccccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCCC
Q 045449 729 LSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 729 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
.....||+.|+|||++. +.++.++||||+||+++++++|..||.+.
T Consensus 187 ---~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 232 (290)
T 1t4h_A 187 ---AKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSEC 232 (290)
T ss_dssp ---BEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred ---cccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCc
Confidence 23457999999999876 46899999999999999999999999764
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.86 E-value=3.7e-23 Score=219.11 Aligned_cols=139 Identities=23% Similarity=0.339 Sum_probs=117.4
Q ss_pred CeEEEEEEehHhh-HHHHHHHHHHHHHHhhcchhhHHH----------------------------------------HH
Q 045449 641 GMEVAVKVFHQQY-ERALKSFEDECEVRKRIRHRNLVK----------------------------------------II 679 (823)
Q Consensus 641 ~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~----------------------------------------~~ 679 (823)
+..||||++.... ....+.+.+|++++++++||||++ ++
T Consensus 37 ~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 116 (287)
T 1u59_A 37 QIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELL 116 (287)
T ss_dssp CEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHH
T ss_pred cceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEecCCCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHH
Confidence 4569999997542 455678999999999999999998 36
Q ss_pred HHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCcc-ccccccccCCCcCcccccCCCccccccce
Q 045449 680 SSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQL-SKQTQTLATIGYMAPEYGTKGRVSTRGDV 758 (823)
Q Consensus 680 ~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv 758 (823)
.|++.+|+|+|+.+|+||||||+||+++.++.+||+|||+++........ .......||+.|+|||++.+..++.++||
T Consensus 117 ~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di 196 (287)
T 1u59_A 117 HQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDV 196 (287)
T ss_dssp HHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHH
T ss_pred HHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeeeccCcceeeccccccccccccCHHHhccCCCCchhhH
Confidence 78899999999999999999999999999999999999999876543321 12233457899999999988889999999
Q ss_pred ehhhhhhccccC-CCCCcCCCc
Q 045449 759 CSFGIISGGKET-RSMTVGETC 779 (823)
Q Consensus 759 ~S~Gvv~~~~~~-~~~~~~~~~ 779 (823)
||+||+++++++ |..||....
T Consensus 197 ~slG~il~ellt~g~~p~~~~~ 218 (287)
T 1u59_A 197 WSYGVTMWEALSYGQKPYKKMK 218 (287)
T ss_dssp HHHHHHHHHHHTTSCCTTTTCC
T ss_pred HHHHHHHHHHHcCCCCCcccCC
Confidence 999999999998 999997643
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=99.86 E-value=3.1e-23 Score=218.72 Aligned_cols=149 Identities=26% Similarity=0.411 Sum_probs=125.1
Q ss_pred ccCCccceeeccC-----------CeEEEEEEehHhhHHHHHHHHHHHHHHhhcchhhHHH-------------------
Q 045449 628 DRFSENNLIGIGN-----------GMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVK------------------- 677 (823)
Q Consensus 628 ~~f~~~~~lg~g~-----------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------------- 677 (823)
++|...+.||.|+ +..||||++..... ..+.|.+|++++++++||||++
T Consensus 13 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v~e~~~~ 91 (279)
T 1qpc_A 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM-SPDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYMEN 91 (279)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEEECCTT
T ss_pred HhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcc-cHHHHHHHHHHHHhCCCcCcceEEEEEcCCCcEEEEecCCC
Confidence 5677778888875 45799999875432 2467999999999999999998
Q ss_pred ----------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCcccccccc
Q 045449 678 ----------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQT 735 (823)
Q Consensus 678 ----------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 735 (823)
++.|++++|+|+|+.+|+||||||+||+++.++.+||+|||+++....... ......
T Consensus 92 ~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~ 170 (279)
T 1qpc_A 92 GSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY-TAREGA 170 (279)
T ss_dssp CBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE-ECCTTC
T ss_pred CCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccccCccc-ccccCC
Confidence 367889999999999999999999999999999999999999987654322 222344
Q ss_pred ccCCCcCcccccCCCccccccceehhhhhhccccC-CCCCcCCC
Q 045449 736 LATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKET-RSMTVGET 778 (823)
Q Consensus 736 ~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~-~~~~~~~~ 778 (823)
.+++.|+|||++.++.++.++||||+||+++++++ |..||.+.
T Consensus 171 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~ 214 (279)
T 1qpc_A 171 KFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM 214 (279)
T ss_dssp CCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred CCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCccc
Confidence 57889999999988889999999999999999999 88898764
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=4.9e-23 Score=230.88 Aligned_cols=146 Identities=27% Similarity=0.324 Sum_probs=122.6
Q ss_pred hccCCccceeeccC------------CeEEEEEEehHhhHHHHHHHHHHHHHHhhcc------hhhHHH-----------
Q 045449 627 TDRFSENNLIGIGN------------GMEVAVKVFHQQYERALKSFEDECEVRKRIR------HRNLVK----------- 677 (823)
Q Consensus 627 t~~f~~~~~lg~g~------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------h~niv~----------- 677 (823)
..+|...+.||.|+ +..||||++.... ...+.+.+|++++..++ |+||++
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 174 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK-RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI 174 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc-chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence 35688889999986 5779999997543 34467888998888874 457765
Q ss_pred ------------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCc--EEEeecccccccCC
Q 045449 678 ------------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMV--AHISDFGIAKLLSG 725 (823)
Q Consensus 678 ------------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~--~kl~DfGla~~~~~ 725 (823)
++.|++.+|+|+|+.+|+||||||+|||++.++. +||+|||+|+....
T Consensus 175 ~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~~ 254 (429)
T 3kvw_A 175 CMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQ 254 (429)
T ss_dssp EEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTCEETTC
T ss_pred EEEEeccCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecccceecCC
Confidence 4678899999999999999999999999998877 99999999976432
Q ss_pred CCccccccccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCCC
Q 045449 726 EDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 726 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
. ....+||+.|+|||++.+..|+.++|||||||++|++++|..||.+.
T Consensus 255 ~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~ 302 (429)
T 3kvw_A 255 R-----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGE 302 (429)
T ss_dssp C-----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred c-----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCC
Confidence 2 23467999999999999999999999999999999999999998664
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.86 E-value=7.8e-23 Score=223.51 Aligned_cols=147 Identities=28% Similarity=0.345 Sum_probs=122.5
Q ss_pred hccCCccceeeccC------------CeEEEEEEehHh--hHHHHHHHHHHHHHHhhcchhhHHH---------------
Q 045449 627 TDRFSENNLIGIGN------------GMEVAVKVFHQQ--YERALKSFEDECEVRKRIRHRNLVK--------------- 677 (823)
Q Consensus 627 t~~f~~~~~lg~g~------------~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~--------------- 677 (823)
.++|...+.||.|+ |..||||++... .....+.+.+|+.++++++||||++
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 35677788888886 677999998643 2445578999999999999999997
Q ss_pred ----------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCcc
Q 045449 678 ----------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQL 729 (823)
Q Consensus 678 ----------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~ 729 (823)
++.|++.+|+|+|+.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 103 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~--- 179 (353)
T 3coi_A 103 DFYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE--- 179 (353)
T ss_dssp CCEEEEECCSEEGGGTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC-------
T ss_pred eEEEEeccccCCHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCCCCC---
Confidence 3678999999999999999999999999999999999999999865322
Q ss_pred ccccccccCCCcCcccccCC-CccccccceehhhhhhccccCCCCCcCCC
Q 045449 730 SKQTQTLATIGYMAPEYGTK-GRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 730 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
.....||+.|+|||++.+ ..++.++||||+||+++++++|..||.+.
T Consensus 180 --~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 227 (353)
T 3coi_A 180 --MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGK 227 (353)
T ss_dssp ------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSS
T ss_pred --ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 234578999999998876 67899999999999999999999998764
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=99.86 E-value=1.1e-22 Score=223.31 Aligned_cols=155 Identities=28% Similarity=0.394 Sum_probs=129.2
Q ss_pred HHHHHHhccCCccceeeccC------------CeEEEEEEehHhh--------HHHHHHHHHHHHHHhhc-chhhHHH--
Q 045449 621 HELLRATDRFSENNLIGIGN------------GMEVAVKVFHQQY--------ERALKSFEDECEVRKRI-RHRNLVK-- 677 (823)
Q Consensus 621 ~~l~~at~~f~~~~~lg~g~------------~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l-~h~niv~-- 677 (823)
.......++|...+.||.|+ |..||||++.... ....+.+.+|++++.++ +||||++
T Consensus 87 ~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 166 (365)
T 2y7j_A 87 AAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLI 166 (365)
T ss_dssp HHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred hhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEE
Confidence 33445567888889999885 6789999985432 33456789999999999 7999998
Q ss_pred --------------------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeeccc
Q 045449 678 --------------------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGI 719 (823)
Q Consensus 678 --------------------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGl 719 (823)
++.|++.+|+|+|+.||+||||||+||+++.++.+||+|||+
T Consensus 167 ~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~ 246 (365)
T 2y7j_A 167 DSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGF 246 (365)
T ss_dssp EEEEBSSEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred EEEeeCCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCc
Confidence 467889999999999999999999999999999999999999
Q ss_pred ccccCCCCccccccccccCCCcCcccccCC------CccccccceehhhhhhccccCCCCCcCCC
Q 045449 720 AKLLSGEDQLSKQTQTLATIGYMAPEYGTK------GRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 720 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
++....... .....||+.|+|||++.+ ..++.++|||||||++|++++|..||...
T Consensus 247 ~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~ 308 (365)
T 2y7j_A 247 SCHLEPGEK---LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHR 308 (365)
T ss_dssp CEECCTTCC---BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ccccCCCcc---cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCC
Confidence 987654332 234679999999998753 35889999999999999999999999764
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=99.86 E-value=8.4e-24 Score=229.70 Aligned_cols=146 Identities=27% Similarity=0.413 Sum_probs=121.8
Q ss_pred HhccCCccceeeccC------------CeEEEEEEehHhhHHHHHHHHHHHHHHhhc-chhhHHH---------------
Q 045449 626 ATDRFSENNLIGIGN------------GMEVAVKVFHQQYERALKSFEDECEVRKRI-RHRNLVK--------------- 677 (823)
Q Consensus 626 at~~f~~~~~lg~g~------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~--------------- 677 (823)
..++|...+.||.|+ +..||||++.... ..+.+|++++.++ +||||++
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~----~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ 95 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSK----RDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT 95 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTT----CCCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEccc----CChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence 356788889999886 6679999997543 2356788888888 7999998
Q ss_pred -------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCC----CcEEEeecccccccCCCCc
Q 045449 678 -------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDED----MVAHISDFGIAKLLSGEDQ 728 (823)
Q Consensus 678 -------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~----~~~kl~DfGla~~~~~~~~ 728 (823)
++.|++++|+|+|+.||+||||||+||++..+ +.+||+|||+++.......
T Consensus 96 E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~ 175 (342)
T 2qr7_A 96 ELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENG 175 (342)
T ss_dssp CCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTTC
T ss_pred eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCCC
Confidence 46789999999999999999999999998532 3599999999987654322
Q ss_pred cccccccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCC
Q 045449 729 LSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGE 777 (823)
Q Consensus 729 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~ 777 (823)
.....+||+.|+|||++.+..|+.++||||+||++|++++|..||..
T Consensus 176 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~ 222 (342)
T 2qr7_A 176 --LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFAN 222 (342)
T ss_dssp --CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCS
T ss_pred --ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCC
Confidence 23456799999999999888899999999999999999999999975
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=3e-23 Score=217.49 Aligned_cols=145 Identities=22% Similarity=0.313 Sum_probs=122.0
Q ss_pred ccCCccceeeccC----------CeEEEEEEehHhh--HHHHHHHHHHHHHHhhcchhhHHH------------------
Q 045449 628 DRFSENNLIGIGN----------GMEVAVKVFHQQY--ERALKSFEDECEVRKRIRHRNLVK------------------ 677 (823)
Q Consensus 628 ~~f~~~~~lg~g~----------~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~------------------ 677 (823)
++|...+.||.|+ +..||||++.... ....+.|.+|++++++++||||++
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e 89 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITH 89 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEETTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEE
T ss_pred HHhHHHHHhcCCCcceEEEEEECCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeec
Confidence 5677778888886 6679999997542 445578999999999999999998
Q ss_pred --------------------------HHHHHHHHhhhcCCCC--EEeccCCCCCEEeCCCCcEEEeecccccccCCCCcc
Q 045449 678 --------------------------IISSSLEYLHFGHSIP--IIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQL 729 (823)
Q Consensus 678 --------------------------~~~~~l~~L~~~h~~~--ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~ 729 (823)
++.|++.+|+|+|+.+ |+||||||+||+++.++.++++|||++.....
T Consensus 90 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~---- 165 (271)
T 3kmu_A 90 WMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS---- 165 (271)
T ss_dssp CCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC----
T ss_pred ccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceeeecc----
Confidence 3678899999999999 99999999999999999999999998765322
Q ss_pred ccccccccCCCcCcccccCCCcccc---ccceehhhhhhccccCCCCCcCCCc
Q 045449 730 SKQTQTLATIGYMAPEYGTKGRVST---RGDVCSFGIISGGKETRSMTVGETC 779 (823)
Q Consensus 730 ~~~~~~~gt~~y~aPE~~~~~~~~~---~~Dv~S~Gvv~~~~~~~~~~~~~~~ 779 (823)
....||+.|+|||++.+..++. ++||||+||++|++++|..||.+..
T Consensus 166 ---~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~ 215 (271)
T 3kmu_A 166 ---PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLS 215 (271)
T ss_dssp ---TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSC
T ss_pred ---cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccC
Confidence 2356899999999988765544 7999999999999999999997653
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.86 E-value=4.3e-23 Score=223.56 Aligned_cols=150 Identities=23% Similarity=0.414 Sum_probs=116.0
Q ss_pred cCCccceeeccC----------------CeEEEEEEehHhh-HHHHHHHHHHHHHHhhcchhhHHH--------------
Q 045449 629 RFSENNLIGIGN----------------GMEVAVKVFHQQY-ERALKSFEDECEVRKRIRHRNLVK-------------- 677 (823)
Q Consensus 629 ~f~~~~~lg~g~----------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~-------------- 677 (823)
+|...+.||.|+ +..||||++.... ......|.+|++++++++||||++
T Consensus 45 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 124 (333)
T 1mqb_A 45 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMII 124 (333)
T ss_dssp TEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEE
T ss_pred HhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEEE
Confidence 344467889886 1239999997543 444568999999999999999998
Q ss_pred ---------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCcc-
Q 045449 678 ---------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQL- 729 (823)
Q Consensus 678 ---------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~- 729 (823)
++.|++++|+|+|+.+|+||||||+||+++.++.+||+|||+++........
T Consensus 125 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~ 204 (333)
T 1mqb_A 125 TEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAT 204 (333)
T ss_dssp EECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-----------
T ss_pred EeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchhhccccccc
Confidence 3578899999999999999999999999999999999999999876533221
Q ss_pred ccccccccCCCcCcccccCCCccccccceehhhhhhccccC-CCCCcCCC
Q 045449 730 SKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKET-RSMTVGET 778 (823)
Q Consensus 730 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~-~~~~~~~~ 778 (823)
.......+|+.|+|||++.+..++.++|||||||+++++++ |..||.+.
T Consensus 205 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~ 254 (333)
T 1mqb_A 205 YTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL 254 (333)
T ss_dssp ------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred cccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccC
Confidence 11223456889999999988899999999999999999998 99998654
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=99.86 E-value=2.6e-23 Score=222.21 Aligned_cols=148 Identities=30% Similarity=0.385 Sum_probs=123.2
Q ss_pred hccCCccceeeccC------------CeEEEEEEehHhhHHHHHHHHHHHHHHhhcchhhHHH-----------------
Q 045449 627 TDRFSENNLIGIGN------------GMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVK----------------- 677 (823)
Q Consensus 627 t~~f~~~~~lg~g~------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~----------------- 677 (823)
.++|...+.||.|+ |+.||||++........+.+.+|++++++++||||++
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL 87 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence 35677788888875 6679999997655444567999999999999999998
Q ss_pred -----------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEe---CCCCcEEEeecccccccCCCCcccc
Q 045449 678 -----------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLL---DEDMVAHISDFGIAKLLSGEDQLSK 731 (823)
Q Consensus 678 -----------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl---~~~~~~kl~DfGla~~~~~~~~~~~ 731 (823)
++.|++.+|+|+|+.+|+||||||+||++ +.++.+||+|||+++..... .
T Consensus 88 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~----~ 163 (304)
T 2jam_A 88 VSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG----I 163 (304)
T ss_dssp CCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB----T
T ss_pred CCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC----c
Confidence 35788999999999999999999999999 77889999999999764322 1
Q ss_pred ccccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCCC
Q 045449 732 QTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 732 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
.....||+.|+|||++.+..++.++||||+||+++++++|..||.+.
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 210 (304)
T 2jam_A 164 MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEE 210 (304)
T ss_dssp THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence 23456999999999999999999999999999999999999998764
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.86 E-value=2.3e-23 Score=231.34 Aligned_cols=147 Identities=25% Similarity=0.393 Sum_probs=124.3
Q ss_pred ccCCccceeeccC------------CeEEEEEEehHhh-HHHHHHHHHHHHHHhhcchhhHHH-----------------
Q 045449 628 DRFSENNLIGIGN------------GMEVAVKVFHQQY-ERALKSFEDECEVRKRIRHRNLVK----------------- 677 (823)
Q Consensus 628 ~~f~~~~~lg~g~------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~----------------- 677 (823)
++|...+.||.|+ +..||||++.... ....+.+.+|++++++++||||++
T Consensus 9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~ 88 (396)
T 4eut_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (396)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEE
Confidence 5677888899886 6679999997543 233467889999999999999998
Q ss_pred ----------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEe----CCCCcEEEeecccccccCC
Q 045449 678 ----------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLL----DEDMVAHISDFGIAKLLSG 725 (823)
Q Consensus 678 ----------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl----~~~~~~kl~DfGla~~~~~ 725 (823)
++.|++.+|+|+|+.+|+||||||+||++ +.++.+||+|||+|+....
T Consensus 89 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~~ 168 (396)
T 4eut_A 89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED 168 (396)
T ss_dssp CCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEECCC
T ss_pred ecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCceEccC
Confidence 35788999999999999999999999999 7788899999999987654
Q ss_pred CCccccccccccCCCcCcccccCC--------CccccccceehhhhhhccccCCCCCcCC
Q 045449 726 EDQLSKQTQTLATIGYMAPEYGTK--------GRVSTRGDVCSFGIISGGKETRSMTVGE 777 (823)
Q Consensus 726 ~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~ 777 (823)
... .....||+.|+|||++.+ ..++.++|||||||++|++++|..||..
T Consensus 169 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~ 225 (396)
T 4eut_A 169 DEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRP 225 (396)
T ss_dssp GGG---SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEEC
T ss_pred CCc---cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 322 234679999999998765 5688999999999999999999999964
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=3.3e-23 Score=218.38 Aligned_cols=146 Identities=30% Similarity=0.395 Sum_probs=118.0
Q ss_pred hccCCccceeeccC----------CeEEEEEEehHhhHHHHHHHHHHHHHHhhcchhhHHH-------------------
Q 045449 627 TDRFSENNLIGIGN----------GMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVK------------------- 677 (823)
Q Consensus 627 t~~f~~~~~lg~g~----------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------------- 677 (823)
.++|...+.||.|+ |..||||++.... ..+.|.+|++++++++||||++
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~ 97 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 97 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred hhhceEEeEEecCCCceEEEEEEcCCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecC
Confidence 35777788888886 6779999997543 3467999999999999999998
Q ss_pred ------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCcccccc
Q 045449 678 ------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQT 733 (823)
Q Consensus 678 ------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~ 733 (823)
++.|++++|+|+|+.+|+||||||+||+++.++.+||+|||+++...... .
T Consensus 98 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-----~ 172 (278)
T 1byg_A 98 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-----D 172 (278)
T ss_dssp TTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC--------------
T ss_pred CCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeeccccccccccc-----c
Confidence 35688889999999999999999999999999999999999998654321 2
Q ss_pred ccccCCCcCcccccCCCccccccceehhhhhhccccC-CCCCcCCCc
Q 045449 734 QTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKET-RSMTVGETC 779 (823)
Q Consensus 734 ~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~-~~~~~~~~~ 779 (823)
...+++.|+|||++.+..++.++||||+||+++++++ |..||....
T Consensus 173 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~ 219 (278)
T 1byg_A 173 TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP 219 (278)
T ss_dssp ---CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSC
T ss_pred CCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCC
Confidence 3457899999999988889999999999999999997 999987653
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=5.1e-23 Score=235.00 Aligned_cols=148 Identities=28% Similarity=0.408 Sum_probs=123.6
Q ss_pred hccCCccceeeccC------------CeEEEEEEehHhhH--HHHHHHHHHHHHHhhcchhhHHH---------------
Q 045449 627 TDRFSENNLIGIGN------------GMEVAVKVFHQQYE--RALKSFEDECEVRKRIRHRNLVK--------------- 677 (823)
Q Consensus 627 t~~f~~~~~lg~g~------------~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~--------------- 677 (823)
.++|...+.||.|+ +..||||++..... ...+.+.+|++++++++||||++
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 100 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence 46788889999886 56799999965432 23467899999999999999998
Q ss_pred -------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeC---CCCcEEEeecccccccCCCCcc
Q 045449 678 -------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLD---EDMVAHISDFGIAKLLSGEDQL 729 (823)
Q Consensus 678 -------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~---~~~~~kl~DfGla~~~~~~~~~ 729 (823)
++.|++.+|+|+|+.+|+||||||+|||++ .++.+||+|||+|+......
T Consensus 101 e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~-- 178 (486)
T 3mwu_A 101 ELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT-- 178 (486)
T ss_dssp CCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC---
T ss_pred EcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCC--
Confidence 467899999999999999999999999995 45689999999998764432
Q ss_pred ccccccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCCC
Q 045449 730 SKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 730 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
.....+||+.|+|||++.+ .|+.++||||+||++|++++|..||.+.
T Consensus 179 -~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~ 225 (486)
T 3mwu_A 179 -KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGK 225 (486)
T ss_dssp ----CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred -ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 2334679999999999865 5999999999999999999999999764
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=1.2e-23 Score=240.09 Aligned_cols=149 Identities=30% Similarity=0.437 Sum_probs=125.6
Q ss_pred hccCCccceeeccC------------CeEEEEEEehHhh---HHHHHHHHHHHHHHhhcchhhHHH--------------
Q 045449 627 TDRFSENNLIGIGN------------GMEVAVKVFHQQY---ERALKSFEDECEVRKRIRHRNLVK-------------- 677 (823)
Q Consensus 627 t~~f~~~~~lg~g~------------~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~-------------- 677 (823)
.++|...+.||.|+ +..||||++.... ....+.+.+|++++++++||||++
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 35788888899886 6679999986432 233467999999999999999998
Q ss_pred --------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEe---CCCCcEEEeecccccccCCCCc
Q 045449 678 --------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLL---DEDMVAHISDFGIAKLLSGEDQ 728 (823)
Q Consensus 678 --------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl---~~~~~~kl~DfGla~~~~~~~~ 728 (823)
++.|++.+|+|+|+.+|+||||||+|||+ +.++.+||+|||+|+.......
T Consensus 105 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~ 184 (484)
T 3nyv_A 105 GEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK 184 (484)
T ss_dssp ECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCCCS
T ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccccc
Confidence 46789999999999999999999999999 4678999999999987654332
Q ss_pred cccccccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCCCc
Q 045449 729 LSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGETC 779 (823)
Q Consensus 729 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~~ 779 (823)
....+||+.|+|||++.+ .|+.++||||+||++|++++|..||.+..
T Consensus 185 ---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~ 231 (484)
T 3nyv_A 185 ---MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGAN 231 (484)
T ss_dssp ---HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ---cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCC
Confidence 234579999999999865 69999999999999999999999997653
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=2.2e-23 Score=244.41 Aligned_cols=138 Identities=24% Similarity=0.318 Sum_probs=112.9
Q ss_pred eEEEEEEehHhh--HHHHHHHHHHHHHHhhcchhhHHH---------------------------------------HHH
Q 045449 642 MEVAVKVFHQQY--ERALKSFEDECEVRKRIRHRNLVK---------------------------------------IIS 680 (823)
Q Consensus 642 ~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~---------------------------------------~~~ 680 (823)
..||||+++... ....++|.+|++++++++|||||+ ++.
T Consensus 397 ~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~ 476 (635)
T 4fl3_A 397 KTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVH 476 (635)
T ss_dssp EEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHH
T ss_pred eEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEEEccCCCCHHHHHhhCCCCCHHHHHHHHH
Confidence 569999997543 234578999999999999999998 467
Q ss_pred HHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCc-cccccccccCCCcCcccccCCCcccccccee
Q 045449 681 SSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQ-LSKQTQTLATIGYMAPEYGTKGRVSTRGDVC 759 (823)
Q Consensus 681 ~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~ 759 (823)
|++.+|+|+|+.+|+||||||+|||++.++.+||+|||+|+....... ........+|+.|+|||++.+..++.++|||
T Consensus 477 qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvw 556 (635)
T 4fl3_A 477 QVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVW 556 (635)
T ss_dssp HHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-------------CGGGSCHHHHHHCCCCHHHHHH
T ss_pred HHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccccCCCCceeeeChhhhcCCCCCcHHHHH
Confidence 899999999999999999999999999999999999999987654332 1222334578899999999988999999999
Q ss_pred hhhhhhccccC-CCCCcCCCc
Q 045449 760 SFGIISGGKET-RSMTVGETC 779 (823)
Q Consensus 760 S~Gvv~~~~~~-~~~~~~~~~ 779 (823)
||||++|++++ |..||.+..
T Consensus 557 SlGv~l~ellt~G~~Pf~~~~ 577 (635)
T 4fl3_A 557 SFGVLMWEAFSYGQKPYRGMK 577 (635)
T ss_dssp HHHHHHHHHHTTTCCSSTTCC
T ss_pred HHHHHHHHHHhCCCCCCCCCC
Confidence 99999999998 999997753
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=99.86 E-value=7e-23 Score=221.57 Aligned_cols=144 Identities=22% Similarity=0.339 Sum_probs=122.7
Q ss_pred ccCCccceeeccC------------CeEEEEEEehHhhHHHHHHHHHHHHHHhhcc-hhhHHH-----------------
Q 045449 628 DRFSENNLIGIGN------------GMEVAVKVFHQQYERALKSFEDECEVRKRIR-HRNLVK----------------- 677 (823)
Q Consensus 628 ~~f~~~~~lg~g~------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~----------------- 677 (823)
++|...+.||.|+ +..||||++.... .+.+.+|++++++++ ||||++
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~ 112 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 112 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc---hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence 5677888899886 5679999997543 257899999999997 999997
Q ss_pred ----------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCC-cEEEeecccccccCCCCccccccc
Q 045449 678 ----------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDM-VAHISDFGIAKLLSGEDQLSKQTQ 734 (823)
Q Consensus 678 ----------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~-~~kl~DfGla~~~~~~~~~~~~~~ 734 (823)
++.|++.+|+|+|+.+|+||||||+||+++.++ .+||+|||+|+....... ...
T Consensus 113 e~~~~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~---~~~ 189 (330)
T 3nsz_A 113 EHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE---YNV 189 (330)
T ss_dssp ECCCCCCHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTCC---CCS
T ss_pred eccCchhHHHHHHhCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCCc---ccc
Confidence 467899999999999999999999999999776 899999999987654332 234
Q ss_pred cccCCCcCcccccCC-CccccccceehhhhhhccccCCCCCcCC
Q 045449 735 TLATIGYMAPEYGTK-GRVSTRGDVCSFGIISGGKETRSMTVGE 777 (823)
Q Consensus 735 ~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~ 777 (823)
..||+.|+|||++.+ ..++.++||||+||+++++++|..||..
T Consensus 190 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~ 233 (330)
T 3nsz_A 190 RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFH 233 (330)
T ss_dssp CCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSC
T ss_pred ccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 578999999999877 6689999999999999999999999844
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=99.86 E-value=2.7e-23 Score=235.29 Aligned_cols=151 Identities=21% Similarity=0.241 Sum_probs=123.7
Q ss_pred hccCCccceeeccC------------CeEEEEEEehHhhHHHHHHHHHHHHHHhhcchhhHHH-----------------
Q 045449 627 TDRFSENNLIGIGN------------GMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVK----------------- 677 (823)
Q Consensus 627 t~~f~~~~~lg~g~------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~----------------- 677 (823)
.++|...+.||.|+ +..||||++..... .+++.+|++++..++|++.+.
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 35788888888875 56799998764432 245888999999998754443
Q ss_pred ------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEe---CCCCcEEEeecccccccCCCCcc-
Q 045449 678 ------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLL---DEDMVAHISDFGIAKLLSGEDQL- 729 (823)
Q Consensus 678 ------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl---~~~~~~kl~DfGla~~~~~~~~~- 729 (823)
++.|++.+|+|+|+.+|+||||||+|||+ +.++.+||+|||+++........
T Consensus 84 ~~g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~ 163 (483)
T 3sv0_A 84 LLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQ 163 (483)
T ss_dssp CCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCC
T ss_pred CCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCcccc
Confidence 46789999999999999999999999999 57889999999999876543321
Q ss_pred ----ccccccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCCCc
Q 045449 730 ----SKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGETC 779 (823)
Q Consensus 730 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~~ 779 (823)
.......||+.|+|||++.+..++.++|||||||++|++++|..||.+..
T Consensus 164 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~ 217 (483)
T 3sv0_A 164 HIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLK 217 (483)
T ss_dssp BCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred ccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccc
Confidence 12235679999999999999999999999999999999999999998753
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.86 E-value=2.6e-23 Score=220.04 Aligned_cols=148 Identities=30% Similarity=0.453 Sum_probs=119.5
Q ss_pred ccCCccceeeccC------------CeEEEEEEehHhh-HHHHHHHHHHHHHHhhcchhhHHH-----------------
Q 045449 628 DRFSENNLIGIGN------------GMEVAVKVFHQQY-ERALKSFEDECEVRKRIRHRNLVK----------------- 677 (823)
Q Consensus 628 ~~f~~~~~lg~g~------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~----------------- 677 (823)
++|...+.||.|+ +..||||++.... ....+.+.+|++++++++||||++
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 101 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET 101 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence 5677788899886 5678999987554 223478999999999999999998
Q ss_pred ---------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEe---CCCCcEEEeecccccccCCCC
Q 045449 678 ---------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLL---DEDMVAHISDFGIAKLLSGED 727 (823)
Q Consensus 678 ---------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl---~~~~~~kl~DfGla~~~~~~~ 727 (823)
++.|++.+|+|+|+.+|+||||||+||++ +.++.+||+|||+++......
T Consensus 102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~ 181 (285)
T 3is5_A 102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDE 181 (285)
T ss_dssp CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-----
T ss_pred CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecCCcc
Confidence 35688899999999999999999999999 456789999999998764332
Q ss_pred ccccccccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCCCc
Q 045449 728 QLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGETC 779 (823)
Q Consensus 728 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~~ 779 (823)
. .....||+.|+|||++. +.++.++||||+||+++++++|..||.+..
T Consensus 182 ~---~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~ 229 (285)
T 3is5_A 182 H---STNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTS 229 (285)
T ss_dssp --------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred c---CcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCC
Confidence 2 23457999999999875 568999999999999999999999997653
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=6.2e-23 Score=219.21 Aligned_cols=150 Identities=27% Similarity=0.361 Sum_probs=127.4
Q ss_pred hccCCccceeeccC------------CeEEEEEEehHhh-HHHHHHHHHHHHHHhhcchhhHHH----------------
Q 045449 627 TDRFSENNLIGIGN------------GMEVAVKVFHQQY-ERALKSFEDECEVRKRIRHRNLVK---------------- 677 (823)
Q Consensus 627 t~~f~~~~~lg~g~------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~---------------- 677 (823)
.+.|...+.||.|+ +..||||++.... ....+.+.+|+.++++++||||++
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 35677778888875 5679999986443 334578999999999999999998
Q ss_pred -----------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccc
Q 045449 678 -----------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQ 734 (823)
Q Consensus 678 -----------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 734 (823)
++.|++.+|+|+|+.+|+||||||+||+++.++.+||+|||+++....... ....
T Consensus 101 ~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~ 178 (303)
T 3a7i_A 101 YLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI--KRNT 178 (303)
T ss_dssp CCTTEEHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBC--CBCC
T ss_pred eCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCcccc--ccCc
Confidence 467889999999999999999999999999999999999999987653321 2234
Q ss_pred cccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCCC
Q 045449 735 TLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 735 ~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
..||+.|+|||++.+..++.++|||||||+++++++|..||...
T Consensus 179 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 222 (303)
T 3a7i_A 179 FVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSEL 222 (303)
T ss_dssp CCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred cCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCc
Confidence 57999999999999999999999999999999999999998764
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=2.1e-23 Score=221.56 Aligned_cols=153 Identities=24% Similarity=0.317 Sum_probs=122.7
Q ss_pred hccCCccc-eeeccC--------------CeEEEEEEehHhh--HHHHHHHHHHHHHHhhcchhhHHH------------
Q 045449 627 TDRFSENN-LIGIGN--------------GMEVAVKVFHQQY--ERALKSFEDECEVRKRIRHRNLVK------------ 677 (823)
Q Consensus 627 t~~f~~~~-~lg~g~--------------~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~------------ 677 (823)
.++|...+ .||.|+ +..||||++.... ....++|.+|++++++++||||++
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~l 94 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWML 94 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESSSEEE
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEECCCCcEE
Confidence 34566555 788775 3569999987543 234578999999999999999998
Q ss_pred ---------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCcc-
Q 045449 678 ---------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQL- 729 (823)
Q Consensus 678 ---------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~- 729 (823)
++.|++.+|+|+|+.+|+||||||+||+++.++.+||+|||+++........
T Consensus 95 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 174 (291)
T 1xbb_A 95 VMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 174 (291)
T ss_dssp EEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE
T ss_pred EEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceeeccCCCcc
Confidence 3678899999999999999999999999999999999999999876543321
Q ss_pred ccccccccCCCcCcccccCCCccccccceehhhhhhccccC-CCCCcCCCc
Q 045449 730 SKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKET-RSMTVGETC 779 (823)
Q Consensus 730 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~-~~~~~~~~~ 779 (823)
.......+|+.|+|||++.+..++.++||||+||+++++++ |..||.+..
T Consensus 175 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~ 225 (291)
T 1xbb_A 175 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK 225 (291)
T ss_dssp EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred cccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCC
Confidence 11223456789999999988889999999999999999998 999997653
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.86 E-value=2.9e-23 Score=226.77 Aligned_cols=146 Identities=13% Similarity=0.154 Sum_probs=121.4
Q ss_pred ccCCccceeeccC--------------------CeEEEEEEehHhhHHHHHHHHHHHHHHhhcchhhHHH----------
Q 045449 628 DRFSENNLIGIGN--------------------GMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVK---------- 677 (823)
Q Consensus 628 ~~f~~~~~lg~g~--------------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~---------- 677 (823)
++|...+.||.|+ +..||||++... +.+.+|++++++++||||++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 116 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPL 116 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTT
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCc
Confidence 5677777777764 356999998754 46889999999999999996
Q ss_pred -----------------------------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCC
Q 045449 678 -----------------------------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDM 710 (823)
Q Consensus 678 -----------------------------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~ 710 (823)
++.|++.+|+|+|+.+|+||||||+||+++.++
T Consensus 117 ~~i~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~~~~~ 196 (352)
T 2jii_A 117 LAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPED 196 (352)
T ss_dssp CSCCCCCEEEEETTTEEEEEEECCCEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEEETTE
T ss_pred cCccchhhccccCCcEEEEEecCCCcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEcCCC
Confidence 256888999999999999999999999999988
Q ss_pred --cEEEeecccccccCCCCcc-----ccccccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCCC
Q 045449 711 --VAHISDFGIAKLLSGEDQL-----SKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 711 --~~kl~DfGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
.+||+|||+++........ .......||+.|+|||++.+..++.++|||||||++|++++|..||...
T Consensus 197 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 271 (352)
T 2jii_A 197 QSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNC 271 (352)
T ss_dssp EEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred CceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence 9999999999876433211 1123457999999999999989999999999999999999999999764
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=5e-23 Score=235.47 Aligned_cols=149 Identities=28% Similarity=0.423 Sum_probs=122.6
Q ss_pred hccCCccceeeccC------------CeEEEEEEehHhh--HHHHHHHHHHHHHHhhcchhhHHH---------------
Q 045449 627 TDRFSENNLIGIGN------------GMEVAVKVFHQQY--ERALKSFEDECEVRKRIRHRNLVK--------------- 677 (823)
Q Consensus 627 t~~f~~~~~lg~g~------------~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~--------------- 677 (823)
.++|...+.||.|+ +..||||++.... ....+.+.+|++++++++|||||+
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 45677888899886 5668999987543 223467899999999999999998
Q ss_pred -------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCC---CCcEEEeecccccccCCCCcc
Q 045449 678 -------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDE---DMVAHISDFGIAKLLSGEDQL 729 (823)
Q Consensus 678 -------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~---~~~~kl~DfGla~~~~~~~~~ 729 (823)
++.|++.+|+|+|+.+|+||||||+|||++. ++.+||+|||+|+......
T Consensus 116 e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~-- 193 (494)
T 3lij_A 116 ECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK-- 193 (494)
T ss_dssp ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTB--
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCc--
Confidence 3678899999999999999999999999975 4569999999998765432
Q ss_pred ccccccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCCCc
Q 045449 730 SKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGETC 779 (823)
Q Consensus 730 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~~ 779 (823)
.....+||+.|+|||++. +.|+.++||||+||++|++++|..||.+..
T Consensus 194 -~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 241 (494)
T 3lij_A 194 -KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQT 241 (494)
T ss_dssp -CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred -cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCC
Confidence 234567999999999876 569999999999999999999999997643
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.86 E-value=3.8e-23 Score=219.79 Aligned_cols=148 Identities=29% Similarity=0.414 Sum_probs=119.7
Q ss_pred cCCccceeeccC------------CeEEEEEEehHhhHHHHHHHHHHHHHHhhcchhhHHH-------------------
Q 045449 629 RFSENNLIGIGN------------GMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVK------------------- 677 (823)
Q Consensus 629 ~f~~~~~lg~g~------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------------- 677 (823)
+|....+||.|+ +..||||++........+.+.+|+.++++++||||++
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 102 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP 102 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence 344455788775 5679999997665555678999999999999999998
Q ss_pred ------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCC-CCcEEEeecccccccCCCCccccc
Q 045449 678 ------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDE-DMVAHISDFGIAKLLSGEDQLSKQ 732 (823)
Q Consensus 678 ------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~-~~~~kl~DfGla~~~~~~~~~~~~ 732 (823)
++.|++.+|+|+|+.+|+||||||+||+++. ++.+||+|||+++....... ..
T Consensus 103 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~--~~ 180 (295)
T 2clq_A 103 GGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP--CT 180 (295)
T ss_dssp EEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-------
T ss_pred CCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCCCCC--cc
Confidence 2468899999999999999999999999987 89999999999987643221 12
Q ss_pred cccccCCCcCcccccCCCc--cccccceehhhhhhccccCCCCCcCCC
Q 045449 733 TQTLATIGYMAPEYGTKGR--VSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 733 ~~~~gt~~y~aPE~~~~~~--~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
....||+.|+|||++.+.. ++.++|||||||+++++++|..||.+.
T Consensus 181 ~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 228 (295)
T 2clq_A 181 ETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYEL 228 (295)
T ss_dssp CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGG
T ss_pred cccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCC
Confidence 3457999999999987654 789999999999999999999998654
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=99.86 E-value=4e-23 Score=229.10 Aligned_cols=144 Identities=28% Similarity=0.355 Sum_probs=119.6
Q ss_pred ccCCccceeeccC-----------CeEEEEEEehHhhHHHHHHHHHHHHHHhhcchhhHHH-------------------
Q 045449 628 DRFSENNLIGIGN-----------GMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVK------------------- 677 (823)
Q Consensus 628 ~~f~~~~~lg~g~-----------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------------- 677 (823)
.+|...+.||.|+ +..||||++.... +...+|++++++++||||++
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~----~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l 115 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDK----RFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNL 115 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEE
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCc----chHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEE
Confidence 4678888999886 3448888775432 22347999999999999997
Q ss_pred ------------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeC-CCCcEEEeecccccccCCC
Q 045449 678 ------------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLD-EDMVAHISDFGIAKLLSGE 726 (823)
Q Consensus 678 ------------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~-~~~~~kl~DfGla~~~~~~ 726 (823)
++.|++.+|+|+|+.+|+||||||+|||++ .++.+||+|||+|+.....
T Consensus 116 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~ 195 (394)
T 4e7w_A 116 VLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAG 195 (394)
T ss_dssp EEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred EeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCC
Confidence 356889999999999999999999999999 7899999999999876443
Q ss_pred CccccccccccCCCcCcccccCCC-ccccccceehhhhhhccccCCCCCcCCC
Q 045449 727 DQLSKQTQTLATIGYMAPEYGTKG-RVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 727 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
.. ....+||+.|+|||++.+. .|+.++||||+||++|++++|..||.+.
T Consensus 196 ~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 245 (394)
T 4e7w_A 196 EP---NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGE 245 (394)
T ss_dssp CC---CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CC---CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 32 2346789999999998765 5899999999999999999999999764
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=99.85 E-value=4.7e-23 Score=218.52 Aligned_cols=148 Identities=26% Similarity=0.281 Sum_probs=109.8
Q ss_pred hccCCccceeeccC------------CeEEEEEEehHhh--HHHHHHHHHHHHHHhhcchhhHHH---------------
Q 045449 627 TDRFSENNLIGIGN------------GMEVAVKVFHQQY--ERALKSFEDECEVRKRIRHRNLVK--------------- 677 (823)
Q Consensus 627 t~~f~~~~~lg~g~------------~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~--------------- 677 (823)
.++|...+.||.|+ ++.||||++.... ....+.+.+|...++.++||||++
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 36778888888886 6679999997542 233344555666688889999998
Q ss_pred ----------------------------HHHHHHHHhhhcCCC-CEEeccCCCCCEEeCCCCcEEEeecccccccCCCCc
Q 045449 678 ----------------------------IISSSLEYLHFGHSI-PIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQ 728 (823)
Q Consensus 678 ----------------------------~~~~~l~~L~~~h~~-~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~ 728 (823)
++.|++.+|+|+|+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 86 e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 165 (290)
T 3fme_A 86 ELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVA 165 (290)
T ss_dssp ECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC-----------
T ss_pred ehhccchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCccccccccc
Confidence 357889999999997 999999999999999999999999999987643322
Q ss_pred cccccccccCCCcCccccc----CCCccccccceehhhhhhccccCCCCCcCC
Q 045449 729 LSKQTQTLATIGYMAPEYG----TKGRVSTRGDVCSFGIISGGKETRSMTVGE 777 (823)
Q Consensus 729 ~~~~~~~~gt~~y~aPE~~----~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~ 777 (823)
.....||+.|+|||++ .+..++.++||||+||+++++++|..||..
T Consensus 166 ---~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 215 (290)
T 3fme_A 166 ---KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDS 215 (290)
T ss_dssp -------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCC
T ss_pred ---ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccc
Confidence 2334699999999995 556789999999999999999999999975
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.85 E-value=2.6e-23 Score=243.22 Aligned_cols=138 Identities=22% Similarity=0.337 Sum_probs=111.8
Q ss_pred eEEEEEEehHhh-HHHHHHHHHHHHHHhhcchhhHHH----------------------------------------HHH
Q 045449 642 MEVAVKVFHQQY-ERALKSFEDECEVRKRIRHRNLVK----------------------------------------IIS 680 (823)
Q Consensus 642 ~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~----------------------------------------~~~ 680 (823)
..||||+++... ....++|.+|++++++++|||||+ ++.
T Consensus 364 ~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~ 443 (613)
T 2ozo_A 364 IDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLH 443 (613)
T ss_dssp EEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEESSSEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHH
T ss_pred EEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEeccCCeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHH
Confidence 459999997543 234578999999999999999998 367
Q ss_pred HHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCcc-ccccccccCCCcCcccccCCCcccccccee
Q 045449 681 SSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQL-SKQTQTLATIGYMAPEYGTKGRVSTRGDVC 759 (823)
Q Consensus 681 ~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~ 759 (823)
|++.+|+|+|+.+|+||||||+|||++.++.+||+|||+|+........ .......+|+.|+|||++.+..++.++|||
T Consensus 444 qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvw 523 (613)
T 2ozo_A 444 QVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVW 523 (613)
T ss_dssp HHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC--------------CCTTSCHHHHHHCCCCHHHHHH
T ss_pred HHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHH
Confidence 8899999999999999999999999999999999999999876433221 112233467899999999988999999999
Q ss_pred hhhhhhccccC-CCCCcCCCc
Q 045449 760 SFGIISGGKET-RSMTVGETC 779 (823)
Q Consensus 760 S~Gvv~~~~~~-~~~~~~~~~ 779 (823)
||||++|++++ |..||.+..
T Consensus 524 SlGv~l~ellt~G~~Pf~~~~ 544 (613)
T 2ozo_A 524 SYGVTMWEALSYGQKPYKKMK 544 (613)
T ss_dssp HHHHHHHHHHTTSCCTTTTCC
T ss_pred HHHHHHHHHHHCCCCCCCCCC
Confidence 99999999997 999997653
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=99.85 E-value=2.8e-23 Score=239.38 Aligned_cols=150 Identities=25% Similarity=0.446 Sum_probs=125.5
Q ss_pred hccCCccceeeccC-----------CeEEEEEEehHhhHHHHHHHHHHHHHHhhcchhhHHH------------------
Q 045449 627 TDRFSENNLIGIGN-----------GMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVK------------------ 677 (823)
Q Consensus 627 t~~f~~~~~lg~g~-----------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------------ 677 (823)
.++|...+.||+|+ +..||||+++.... ..++|.+|++++++++||||++
T Consensus 266 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~lv~e~~~ 344 (535)
T 2h8h_A 266 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMS 344 (535)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEECCCT
T ss_pred hhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEeeccceEeeehhc
Confidence 45677778899886 35699999975432 2367999999999999999998
Q ss_pred -----------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccc
Q 045449 678 -----------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQ 734 (823)
Q Consensus 678 -----------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 734 (823)
++.|++++|+|+|+.+|+||||||+|||++.++.+||+|||+++...... ......
T Consensus 345 ~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-~~~~~~ 423 (535)
T 2h8h_A 345 KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-YTARQG 423 (535)
T ss_dssp TEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHH-HHTTCS
T ss_pred CCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCc-eecccC
Confidence 35688999999999999999999999999999999999999998764321 112233
Q ss_pred cccCCCcCcccccCCCccccccceehhhhhhccccC-CCCCcCCC
Q 045449 735 TLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKET-RSMTVGET 778 (823)
Q Consensus 735 ~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~-~~~~~~~~ 778 (823)
..++..|+|||++.++.++.++|||||||++|++++ |..||.+.
T Consensus 424 ~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~ 468 (535)
T 2h8h_A 424 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM 468 (535)
T ss_dssp TTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTC
T ss_pred CcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 457889999999988899999999999999999999 89998764
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=5.5e-23 Score=221.23 Aligned_cols=148 Identities=25% Similarity=0.341 Sum_probs=123.3
Q ss_pred CccceeeccC----------------CeEEEEEEehHhh-HHHHHHHHHHHHHHhhcchhhHHH----------------
Q 045449 631 SENNLIGIGN----------------GMEVAVKVFHQQY-ERALKSFEDECEVRKRIRHRNLVK---------------- 677 (823)
Q Consensus 631 ~~~~~lg~g~----------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~---------------- 677 (823)
...+.||.|+ ++.||||++.... ....+.|.+|++++++++||||++
T Consensus 34 ~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 113 (318)
T 3lxp_A 34 KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLV 113 (318)
T ss_dssp EEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEEE
T ss_pred hhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEEE
Confidence 5566777765 4569999997543 445678999999999999999998
Q ss_pred -------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCcc-cc
Q 045449 678 -------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQL-SK 731 (823)
Q Consensus 678 -------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~-~~ 731 (823)
++.|++.+|.|+|+.+|+||||||+||+++.++.+||+|||+++........ ..
T Consensus 114 ~e~~~~~~L~~~l~~~~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~ 193 (318)
T 3lxp_A 114 MEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRV 193 (318)
T ss_dssp ECCCTTCBHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECCTTCSEEEC
T ss_pred EecccCCcHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCcccccccccccccccc
Confidence 3678899999999999999999999999999999999999999877543321 12
Q ss_pred ccccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCCC
Q 045449 732 QTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 732 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
.....||+.|+|||++.+..++.++||||+||+++++++|..||...
T Consensus 194 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~ 240 (318)
T 3lxp_A 194 REDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSP 240 (318)
T ss_dssp ---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSH
T ss_pred ccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCccccc
Confidence 33456888999999999889999999999999999999999998654
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=3.9e-23 Score=220.60 Aligned_cols=150 Identities=23% Similarity=0.328 Sum_probs=122.2
Q ss_pred ccCCccceeeccC----------------CeEEEEEEehHhh-HHHHHHHHHHHHHHhhcchhhHHH-------------
Q 045449 628 DRFSENNLIGIGN----------------GMEVAVKVFHQQY-ERALKSFEDECEVRKRIRHRNLVK------------- 677 (823)
Q Consensus 628 ~~f~~~~~lg~g~----------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~------------- 677 (823)
++|...+.||.|+ +..||||++.... ....+.+.+|++++++++||||++
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 3456666777664 5679999997543 233478999999999999999998
Q ss_pred ------------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCC
Q 045449 678 ------------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGED 727 (823)
Q Consensus 678 ------------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~ 727 (823)
++.|++.+|+|+|+.+|+||||||+||+++.++.+||+|||+++......
T Consensus 101 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 180 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDK 180 (302)
T ss_dssp EEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTC
T ss_pred EEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECcccccccccCCC
Confidence 35688999999999999999999999999999999999999998765443
Q ss_pred cc-ccccccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCC
Q 045449 728 QL-SKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGE 777 (823)
Q Consensus 728 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~ 777 (823)
.. .......||..|+|||++.+..++.++||||+||+++++++|..|+..
T Consensus 181 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 231 (302)
T 4e5w_A 181 EYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSS 231 (302)
T ss_dssp CEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGS
T ss_pred cceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcc
Confidence 21 223345688899999999888999999999999999999999887644
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=99.85 E-value=6.5e-23 Score=224.71 Aligned_cols=154 Identities=27% Similarity=0.325 Sum_probs=120.6
Q ss_pred HHHHHHhccCCccceeeccC------------CeEEEEEEehHhhHHHHHHHHHHHHHHhhcchhhHHH-----------
Q 045449 621 HELLRATDRFSENNLIGIGN------------GMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVK----------- 677 (823)
Q Consensus 621 ~~l~~at~~f~~~~~lg~g~------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~----------- 677 (823)
.+.....++|...+.||.|+ +..||||++.... .....+.+|++.+++++||||++
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~ 94 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER 94 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence 55667788999999999886 6679999885432 22245677888889999999987
Q ss_pred ---------------------------------------HHHHHHHHhhhcC--CCCEEeccCCCCCEEeCC-CCcEEEe
Q 045449 678 ---------------------------------------IISSSLEYLHFGH--SIPIIHCDLKPSNVLLDE-DMVAHIS 715 (823)
Q Consensus 678 ---------------------------------------~~~~~l~~L~~~h--~~~ivHrdlk~~NiLl~~-~~~~kl~ 715 (823)
++.|++.+|+|+| +.+|+||||||+|||++. ++.+||+
T Consensus 95 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~ 174 (360)
T 3e3p_A 95 DRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLC 174 (360)
T ss_dssp CTTCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEEC
T ss_pred cccceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEe
Confidence 2457788888888 999999999999999996 8999999
Q ss_pred ecccccccCCCCccccccccccCCCcCcccccCCCc-cccccceehhhhhhccccCCCCCcCCC
Q 045449 716 DFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGR-VSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 716 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
|||+++....... .....||+.|+|||++.+.. ++.++|||||||++|++++|..||.+.
T Consensus 175 Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~ 235 (360)
T 3e3p_A 175 DFGSAKKLSPSEP---NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGD 235 (360)
T ss_dssp CCTTCBCCCTTSC---CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred eCCCceecCCCCC---cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCC
Confidence 9999987654332 23457899999999986654 899999999999999999999999764
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.85 E-value=1e-23 Score=227.76 Aligned_cols=161 Identities=25% Similarity=0.339 Sum_probs=122.8
Q ss_pred ccccCHHHHHHHhccCCccceeeccC------------CeEEEEEEehHhhHHHHHHHHHHHHHHhhc-chhhHHH----
Q 045449 615 IRRFSYHELLRATDRFSENNLIGIGN------------GMEVAVKVFHQQYERALKSFEDECEVRKRI-RHRNLVK---- 677 (823)
Q Consensus 615 ~~~~~~~~l~~at~~f~~~~~lg~g~------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~---- 677 (823)
.+.+++.++....++|...+.||.|+ +..||||++.... ...+.+.+|+++++++ +||||++
T Consensus 11 ~~~~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~ 89 (326)
T 2x7f_A 11 LDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGA 89 (326)
T ss_dssp -----CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEE
T ss_pred chhccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeE
Confidence 34455566666788999999999886 5679999986432 2236788999999999 8999987
Q ss_pred --------------------------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEE
Q 045449 678 --------------------------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAH 713 (823)
Q Consensus 678 --------------------------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~k 713 (823)
++.|++.+|+|+|+.+|+||||||+||+++.++.+|
T Consensus 90 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~k 169 (326)
T 2x7f_A 90 FIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVK 169 (326)
T ss_dssp EEECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEE
T ss_pred EeeccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEE
Confidence 356889999999999999999999999999999999
Q ss_pred EeecccccccCCCCccccccccccCCCcCcccccC-----CCccccccceehhhhhhccccCCCCCcCCC
Q 045449 714 ISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGT-----KGRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 714 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
|+|||+++....... ......||+.|+|||++. ...++.++|||||||+++++++|..||.+.
T Consensus 170 l~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 237 (326)
T 2x7f_A 170 LVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDM 237 (326)
T ss_dssp ECCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred EeeCcCceecCcCcc--ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCC
Confidence 999999987543211 223457999999999986 566899999999999999999999998764
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.85 E-value=6.9e-23 Score=226.52 Aligned_cols=148 Identities=26% Similarity=0.347 Sum_probs=121.0
Q ss_pred HHHhccCCccceeeccC------------CeEEEEEEehHhhHHHHHHHHHHHHHHhhcchhhHHH--------------
Q 045449 624 LRATDRFSENNLIGIGN------------GMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVK-------------- 677 (823)
Q Consensus 624 ~~at~~f~~~~~lg~g~------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-------------- 677 (823)
....++|...+.||.|+ |..||||++.... +...+|++++++++|||||+
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 78 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP----RYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence 34567888899999986 5679999886442 23457999999999999863
Q ss_pred -------------------------------------------------------------------HHHHHHHHhhhcC
Q 045449 678 -------------------------------------------------------------------IISSSLEYLHFGH 690 (823)
Q Consensus 678 -------------------------------------------------------------------~~~~~l~~L~~~h 690 (823)
++.|++.+|+|+|
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH 158 (383)
T 3eb0_A 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH 158 (383)
T ss_dssp -------------------------------CCEEEEEECCCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCCCceEEEEEEecCCccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 2468899999999
Q ss_pred CCCEEeccCCCCCEEeC-CCCcEEEeecccccccCCCCccccccccccCCCcCcccccCCC-ccccccceehhhhhhccc
Q 045449 691 SIPIIHCDLKPSNVLLD-EDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKG-RVSTRGDVCSFGIISGGK 768 (823)
Q Consensus 691 ~~~ivHrdlk~~NiLl~-~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvv~~~~ 768 (823)
+.||+||||||+||+++ .++.+||+|||+|+....... .....||+.|+|||++.+. .++.++||||+||+++++
T Consensus 159 ~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el 235 (383)
T 3eb0_A 159 SLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP---SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGEL 235 (383)
T ss_dssp TTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC---CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHH
T ss_pred HCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC---CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHH
Confidence 99999999999999997 688999999999987644332 2345789999999988765 489999999999999999
Q ss_pred cCCCCCcCCC
Q 045449 769 ETRSMTVGET 778 (823)
Q Consensus 769 ~~~~~~~~~~ 778 (823)
++|..||.+.
T Consensus 236 l~g~~pf~~~ 245 (383)
T 3eb0_A 236 ILGKPLFSGE 245 (383)
T ss_dssp HHSSCSSCCS
T ss_pred HhCCCCCCCC
Confidence 9999999764
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=99.85 E-value=1.1e-22 Score=233.32 Aligned_cols=149 Identities=26% Similarity=0.367 Sum_probs=123.3
Q ss_pred hccCCccceeeccC------------CeEEEEEEehHhhH-------------HHHHHHHHHHHHHhhcchhhHHH----
Q 045449 627 TDRFSENNLIGIGN------------GMEVAVKVFHQQYE-------------RALKSFEDECEVRKRIRHRNLVK---- 677 (823)
Q Consensus 627 t~~f~~~~~lg~g~------------~~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~h~niv~---- 677 (823)
.++|...+.||.|+ +..||||++..... ...+.+.+|++++++++||||++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 57788889999886 56799999864321 23467899999999999999998
Q ss_pred ------------------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCC---cEEEeecc
Q 045449 678 ------------------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDM---VAHISDFG 718 (823)
Q Consensus 678 ------------------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~---~~kl~DfG 718 (823)
++.|++.+|+|+|+.+|+||||||+||+++.++ .+||+|||
T Consensus 115 ~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg 194 (504)
T 3q5i_A 115 FEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFG 194 (504)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECCCT
T ss_pred EEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEECC
Confidence 467899999999999999999999999998765 69999999
Q ss_pred cccccCCCCccccccccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCCCc
Q 045449 719 IAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGETC 779 (823)
Q Consensus 719 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~~ 779 (823)
+|+....... ....+||+.|+|||++. +.|+.++||||+||++|++++|..||.+..
T Consensus 195 ~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 251 (504)
T 3q5i_A 195 LSSFFSKDYK---LRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQN 251 (504)
T ss_dssp TCEECCTTSC---BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CCEEcCCCCc---cccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 9987654322 34467999999999976 569999999999999999999999997653
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.85 E-value=4.9e-23 Score=229.52 Aligned_cols=136 Identities=24% Similarity=0.301 Sum_probs=106.4
Q ss_pred CeEEEEEEehHhhHHHHHHHHHHHHHHhhcchhhHHH-------------------------------------------
Q 045449 641 GMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVK------------------------------------------- 677 (823)
Q Consensus 641 ~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------------------------------------- 677 (823)
+..||||++.... ..+.+.+|++++++++|||||+
T Consensus 48 ~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l 125 (405)
T 3rgf_A 48 DKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQL 125 (405)
T ss_dssp CCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEECCSEEHHHHHHHHHHHC-------C
T ss_pred CeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeCCCCCHHHHHHHhccccccccccCC
Confidence 4569999986442 1246889999999999999997
Q ss_pred -------HHHHHHHHhhhcCCCCEEeccCCCCCEEe----CCCCcEEEeecccccccCCCCc-cccccccccCCCcCccc
Q 045449 678 -------IISSSLEYLHFGHSIPIIHCDLKPSNVLL----DEDMVAHISDFGIAKLLSGEDQ-LSKQTQTLATIGYMAPE 745 (823)
Q Consensus 678 -------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl----~~~~~~kl~DfGla~~~~~~~~-~~~~~~~~gt~~y~aPE 745 (823)
++.|++.+|+|+|+.+|+||||||+|||+ +.++.+||+|||+|+....... .......+||+.|+|||
T Consensus 126 ~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE 205 (405)
T 3rgf_A 126 PRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPE 205 (405)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEECCTTCCC----------------CCCTTCCHH
T ss_pred CHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEEECCCceecCCCCcccccCCCceecCcccCch
Confidence 24588999999999999999999999999 6778999999999987643221 12234567999999999
Q ss_pred ccCCC-ccccccceehhhhhhccccCCCCCcCCC
Q 045449 746 YGTKG-RVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 746 ~~~~~-~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
++.+. .++.++||||+||++|++++|..||...
T Consensus 206 ~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 239 (405)
T 3rgf_A 206 LLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 239 (405)
T ss_dssp HHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCC
T ss_pred hhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCc
Confidence 98874 4899999999999999999999999654
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.85 E-value=2.3e-21 Score=194.89 Aligned_cols=177 Identities=22% Similarity=0.220 Sum_probs=144.6
Q ss_pred eEEEeecCCCCccCCccccccccccceEEecCCcceeccCccccCcccccEEEcccCcCCCCchhcccccCCCCEEEccC
Q 045449 333 KVLIVTGNPLDGILPKSIGNFSLSLETILMANCSISGNIPQVVGNLSNLLVLELGGNNLTGPIPVTFSQLQTLQAFDLTR 412 (823)
Q Consensus 333 ~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~ 412 (823)
+.++.+++.++. +|..+ +.+|++|++++|++++..+..|..+++|++|++++|++++..+..|..+++|++|+|++
T Consensus 10 ~~v~c~~~~l~~-~p~~~---~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~ 85 (208)
T 2o6s_A 10 TTVECYSQGRTS-VPTGI---PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLST 85 (208)
T ss_dssp TEEECCSSCCSS-CCSCC---CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CEEEecCCCccC-CCCCC---CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCC
Confidence 355666666653 34333 25788888888888877777788889999999999999876667788889999999999
Q ss_pred CCCCCcchHhhhcCCCCCEEEcccCcCcccccccccCCCCCCeEeccCCccccccchhhhccCCCcEEeccccccccccC
Q 045449 413 NKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSVRVLYLGLNIFTSVLSSTIWNLKDILFIDVSSNFLDGPLS 492 (823)
Q Consensus 413 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~LdLs~N~l~g~~p 492 (823)
|++++..+..|..+++|++|+|++|++++..+..|..+++|+.|+|++|++++..+..+..+++|+.|++++|.+.+.
T Consensus 86 n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~-- 163 (208)
T 2o6s_A 86 NQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCT-- 163 (208)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCCC--
T ss_pred CcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCeecC--
Confidence 999877777788889999999999999877777788899999999999999987777788899999999999988754
Q ss_pred ccccCCCCCcEEEcccCCCCCCCCCccc
Q 045449 493 LDIGNLKVVIGLDFSRNNLSGDIPITIG 520 (823)
Q Consensus 493 ~~~~~l~~L~~L~ls~N~l~g~ip~~~~ 520 (823)
++.|++|+++.|+++|.||..++
T Consensus 164 -----~~~l~~L~~~~n~~~g~ip~~~~ 186 (208)
T 2o6s_A 164 -----CPGIRYLSEWINKHSGVVRNSAG 186 (208)
T ss_dssp -----TTTTHHHHHHHHHCTTTBBCTTS
T ss_pred -----CCCHHHHHHHHHhCCceeeccCc
Confidence 45788899999999988888774
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.85 E-value=1.2e-22 Score=226.65 Aligned_cols=146 Identities=15% Similarity=0.199 Sum_probs=117.8
Q ss_pred hccCCccceeeccC------------CeEEEEEEehHhh---HHHHHHHHHHHHHHhhcch-hh----------------
Q 045449 627 TDRFSENNLIGIGN------------GMEVAVKVFHQQY---ERALKSFEDECEVRKRIRH-RN---------------- 674 (823)
Q Consensus 627 t~~f~~~~~lg~g~------------~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h-~n---------------- 674 (823)
+..|...++||+|+ |..||||++.... ....+.|.+|+.+++.++| +|
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 156 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 156 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence 44577778899886 6779999987322 2335678999999988876 11
Q ss_pred --------------------------------------------------------HHHHHHHHHHHhhhcCCCCEEecc
Q 045449 675 --------------------------------------------------------LVKIISSSLEYLHFGHSIPIIHCD 698 (823)
Q Consensus 675 --------------------------------------------------------iv~~~~~~l~~L~~~h~~~ivHrd 698 (823)
+..++.|++++|+|+|+.+|+|||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrD 236 (413)
T 3dzo_A 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTY 236 (413)
T ss_dssp EECCC---------------CCSEEEEEECCSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred cccCCCCccccccCCCccccccceEEEeehhcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Confidence 111347899999999999999999
Q ss_pred CCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCccccc----------CCCccccccceehhhhhhccc
Q 045449 699 LKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYG----------TKGRVSTRGDVCSFGIISGGK 768 (823)
Q Consensus 699 lk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~Dv~S~Gvv~~~~ 768 (823)
|||+|||++.++.+||+|||+++..... ....+| +.|+|||++ .+..|+.++|||||||++|++
T Consensus 237 iKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~el 310 (413)
T 3dzo_A 237 LRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWI 310 (413)
T ss_dssp CCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHH
T ss_pred cccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHH
Confidence 9999999999999999999999865322 334567 999999998 566689999999999999999
Q ss_pred cCCCCCcCCC
Q 045449 769 ETRSMTVGET 778 (823)
Q Consensus 769 ~~~~~~~~~~ 778 (823)
++|+.||...
T Consensus 311 ltg~~Pf~~~ 320 (413)
T 3dzo_A 311 WCADLPNTDD 320 (413)
T ss_dssp HHSSCCCCTT
T ss_pred HHCCCCCCCc
Confidence 9999999764
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.85 E-value=9.3e-23 Score=219.36 Aligned_cols=152 Identities=26% Similarity=0.381 Sum_probs=121.6
Q ss_pred ccCCccceeeccC------------CeEEEEEEehHhhHHHHHHHHHHHHHHhhcchhhHHH------------------
Q 045449 628 DRFSENNLIGIGN------------GMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVK------------------ 677 (823)
Q Consensus 628 ~~f~~~~~lg~g~------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------------ 677 (823)
++|...+.||.|+ ++.||||++........+++.+|++++++++||||++
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 90 (320)
T 2i6l_A 11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGS 90 (320)
T ss_dssp TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----
T ss_pred CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccccc
Confidence 5667777777774 6789999997666666788999999999999999875
Q ss_pred ----------------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeC-CCCcEEEeecccccc
Q 045449 678 ----------------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLD-EDMVAHISDFGIAKL 722 (823)
Q Consensus 678 ----------------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~-~~~~~kl~DfGla~~ 722 (823)
++.|++++|+|+|+.+|+||||||+||+++ +++.+||+|||+++.
T Consensus 91 ~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~Dfg~~~~ 170 (320)
T 2i6l_A 91 LTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARI 170 (320)
T ss_dssp CCSCSEEEEEEECCSEEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEECCCTTCBC
T ss_pred ccccCceeEEeeccCCCHHHHhhcCCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEccCccccc
Confidence 356889999999999999999999999997 567999999999987
Q ss_pred cCCCCc-cccccccccCCCcCcccccCC-CccccccceehhhhhhccccCCCCCcCCCc
Q 045449 723 LSGEDQ-LSKQTQTLATIGYMAPEYGTK-GRVSTRGDVCSFGIISGGKETRSMTVGETC 779 (823)
Q Consensus 723 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~~ 779 (823)
...... ........||+.|+|||++.+ ..++.++|||||||+++++++|..||....
T Consensus 171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 229 (320)
T 2i6l_A 171 MDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAH 229 (320)
T ss_dssp C--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCC
Confidence 643211 112234568999999998765 678999999999999999999999997643
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=5.8e-23 Score=220.50 Aligned_cols=159 Identities=23% Similarity=0.355 Sum_probs=121.8
Q ss_pred HHHHHHHhccCCccceeeccC-----------CeEEEEEEehHh--hHHHHHHHHHHHHHHhhcch--hhHHH-------
Q 045449 620 YHELLRATDRFSENNLIGIGN-----------GMEVAVKVFHQQ--YERALKSFEDECEVRKRIRH--RNLVK------- 677 (823)
Q Consensus 620 ~~~l~~at~~f~~~~~lg~g~-----------~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h--~niv~------- 677 (823)
+..+.-..++|...+.||.|+ +..||||++... .....+.+.+|++++.+++| +||++
T Consensus 20 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~ 99 (313)
T 3cek_A 20 FQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT 99 (313)
T ss_dssp CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEEC
T ss_pred eeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeec
Confidence 333334456788888888876 567999998643 24556789999999999975 89987
Q ss_pred --------------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCC
Q 045449 678 --------------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSG 725 (823)
Q Consensus 678 --------------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~ 725 (823)
++.|++++|+|+|+.+|+||||||+||++++ +.+||+|||+++....
T Consensus 100 ~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~ 178 (313)
T 3cek_A 100 DQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQP 178 (313)
T ss_dssp SSEEEEEECCCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET-TEEEECCCSSSCC---
T ss_pred CCEEEEEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEEC-CeEEEeeccccccccC
Confidence 4678999999999999999999999999964 8999999999987654
Q ss_pred CCccccccccccCCCcCcccccCC-----------CccccccceehhhhhhccccCCCCCcCCCc
Q 045449 726 EDQLSKQTQTLATIGYMAPEYGTK-----------GRVSTRGDVCSFGIISGGKETRSMTVGETC 779 (823)
Q Consensus 726 ~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~~ 779 (823)
...........||+.|+|||++.+ ..++.++|||||||+++++++|..||.+..
T Consensus 179 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 243 (313)
T 3cek_A 179 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII 243 (313)
T ss_dssp -----------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred ccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHH
Confidence 332222334579999999999865 468899999999999999999999997653
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.85 E-value=3.5e-21 Score=193.59 Aligned_cols=163 Identities=20% Similarity=0.238 Sum_probs=131.3
Q ss_pred CCceEEEeecCCCCccCCccccccccccceEEecCCcceeccCccccCcccccEEEcccCcCCCCchhcccccCCCCEEE
Q 045449 330 KKLKVLIVTGNPLDGILPKSIGNFSLSLETILMANCSISGNIPQVVGNLSNLLVLELGGNNLTGPIPVTFSQLQTLQAFD 409 (823)
Q Consensus 330 ~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ 409 (823)
++|++|++++|.+++..+..+..+ .+|++|++++|++++..+..|..+++|++|+|++|++++..+..|..+++|++|+
T Consensus 28 ~~l~~L~l~~n~l~~~~~~~~~~l-~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~ 106 (208)
T 2o6s_A 28 AQTTYLDLETNSLKSLPNGVFDEL-TSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELA 106 (208)
T ss_dssp TTCSEEECCSSCCCCCCTTTTTTC-TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCcEEEcCCCccCcCChhhhccc-ccCcEEECCCCccCccChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEE
Confidence 356666666666666555556666 5777778877777776667778888888888888888876667788888899999
Q ss_pred ccCCCCCCcchHhhhcCCCCCEEEcccCcCcccccccccCCCCCCeEeccCCccccccchhhhccCCCcEEecccccccc
Q 045449 410 LTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSVRVLYLGLNIFTSVLSSTIWNLKDILFIDVSSNFLDG 489 (823)
Q Consensus 410 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~LdLs~N~l~g 489 (823)
|++|++++..+..|..+++|+.|+|++|++++..+..+..+++|+.|+|++|.+++. ++.|++|+++.|.++|
T Consensus 107 L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~-------~~~l~~L~~~~n~~~g 179 (208)
T 2o6s_A 107 LNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCT-------CPGIRYLSEWINKHSG 179 (208)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCCC-------TTTTHHHHHHHHHCTT
T ss_pred cCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCeecC-------CCCHHHHHHHHHhCCc
Confidence 999998877777788888999999999999877777788889999999999988763 5578899999999999
Q ss_pred ccCccccCCCC
Q 045449 490 PLSLDIGNLKV 500 (823)
Q Consensus 490 ~~p~~~~~l~~ 500 (823)
.+|.++++++.
T Consensus 180 ~ip~~~~~l~~ 190 (208)
T 2o6s_A 180 VVRNSAGSVAP 190 (208)
T ss_dssp TBBCTTSSBCT
T ss_pred eeeccCccccC
Confidence 99998887765
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=3.3e-23 Score=216.83 Aligned_cols=149 Identities=25% Similarity=0.367 Sum_probs=124.0
Q ss_pred ccCCccceeeccC-----------CeEEEEEEehHhhHHHHHHHHHHHHHHhhcchhhHHH-------------------
Q 045449 628 DRFSENNLIGIGN-----------GMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVK------------------- 677 (823)
Q Consensus 628 ~~f~~~~~lg~g~-----------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------------- 677 (823)
++|...+.||.|+ +..||||++..... ..+.+.+|++++++++||||++
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFME 86 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCT
T ss_pred hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCC
Confidence 4666677788775 46799999976532 2367999999999999999998
Q ss_pred ----------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCcccccccc
Q 045449 678 ----------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQT 735 (823)
Q Consensus 678 ----------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 735 (823)
++.|++++|+|+|+.+++||||||+||+++.++.+||+|||+++...... .......
T Consensus 87 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~-~~~~~~~ 165 (267)
T 3t9t_A 87 HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YTSSTGT 165 (267)
T ss_dssp TCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH-HHSTTST
T ss_pred CCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEccccccccccccc-ccccccc
Confidence 35788999999999999999999999999999999999999998764322 1222345
Q ss_pred ccCCCcCcccccCCCccccccceehhhhhhccccC-CCCCcCCC
Q 045449 736 LATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKET-RSMTVGET 778 (823)
Q Consensus 736 ~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~-~~~~~~~~ 778 (823)
.+|+.|+|||++.+..++.++||||+|++++++++ |..||...
T Consensus 166 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~ 209 (267)
T 3t9t_A 166 KFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR 209 (267)
T ss_dssp TCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred cccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCC
Confidence 67889999999988889999999999999999999 88888764
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=99.85 E-value=6e-23 Score=216.91 Aligned_cols=149 Identities=26% Similarity=0.393 Sum_probs=122.2
Q ss_pred ccCCccceeeccC------------CeEEEEEEehHhhH------HHHHHHHHHHHHHhhcchhhHHH------------
Q 045449 628 DRFSENNLIGIGN------------GMEVAVKVFHQQYE------RALKSFEDECEVRKRIRHRNLVK------------ 677 (823)
Q Consensus 628 ~~f~~~~~lg~g~------------~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~------------ 677 (823)
++|...+.||.|+ +..||||++..... ...+.|.+|++++++++||||++
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 4677778888875 66799999864321 12468999999999999999998
Q ss_pred ----------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCC----cEEEeecccccccCC
Q 045449 678 ----------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDM----VAHISDFGIAKLLSG 725 (823)
Q Consensus 678 ----------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~----~~kl~DfGla~~~~~ 725 (823)
++.|++.+|+|+|+.+|+||||||+||+++.++ .+||+|||+++....
T Consensus 85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~ 164 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEA 164 (283)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC-
T ss_pred EEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceeccC
Confidence 367889999999999999999999999998876 899999999987643
Q ss_pred CCccccccccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCCCc
Q 045449 726 EDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGETC 779 (823)
Q Consensus 726 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~~ 779 (823)
... .....||+.|+|||++.+..++.++||||+||+++++++|..||....
T Consensus 165 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 215 (283)
T 3bhy_A 165 GNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGET 215 (283)
T ss_dssp ----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred CCc---ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcc
Confidence 322 234569999999999998899999999999999999999999987643
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=1.6e-22 Score=227.17 Aligned_cols=146 Identities=26% Similarity=0.367 Sum_probs=113.0
Q ss_pred CCccceeeccC-----------CeEEEEEEehHhhHHHHHHHHHHHHHHhhc-chhhHHH--------------------
Q 045449 630 FSENNLIGIGN-----------GMEVAVKVFHQQYERALKSFEDECEVRKRI-RHRNLVK-------------------- 677 (823)
Q Consensus 630 f~~~~~lg~g~-----------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~-------------------- 677 (823)
|...+.||.|+ |+.||||++..... +.+.+|++++.++ +|||||+
T Consensus 17 ~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~g 93 (434)
T 2rio_A 17 VVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFC---DIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCNL 93 (434)
T ss_dssp EEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGGH---HHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCSE
T ss_pred eeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCCC
Confidence 34456677775 66799999876532 4678999999887 8999998
Q ss_pred --------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCC-------------CcEEEeecc
Q 045449 678 --------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDED-------------MVAHISDFG 718 (823)
Q Consensus 678 --------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~-------------~~~kl~DfG 718 (823)
++.|++.+|+|+|+.+|+||||||+|||++.+ +.+||+|||
T Consensus 94 sL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG 173 (434)
T 2rio_A 94 NLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFG 173 (434)
T ss_dssp EHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCCT
T ss_pred CHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceEEEEcccc
Confidence 25688899999999999999999999999654 489999999
Q ss_pred cccccCCCCcc--ccccccccCCCcCcccccCC-------CccccccceehhhhhhccccC-CCCCcCCC
Q 045449 719 IAKLLSGEDQL--SKQTQTLATIGYMAPEYGTK-------GRVSTRGDVCSFGIISGGKET-RSMTVGET 778 (823)
Q Consensus 719 la~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~S~Gvv~~~~~~-~~~~~~~~ 778 (823)
+|+........ ......+||+.|+|||++.+ ..++.++||||+||+++++++ |..||.+.
T Consensus 174 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~ 243 (434)
T 2rio_A 174 LCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDK 243 (434)
T ss_dssp TCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCST
T ss_pred cceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCc
Confidence 99986543221 11234579999999999865 568999999999999999998 89998654
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=99.85 E-value=4e-23 Score=222.01 Aligned_cols=151 Identities=25% Similarity=0.303 Sum_probs=116.0
Q ss_pred ccCCc-cceeeccC------------CeEEEEEEehHhhHHHHHHHHHHHHHHhhc-chhhHHH----------------
Q 045449 628 DRFSE-NNLIGIGN------------GMEVAVKVFHQQYERALKSFEDECEVRKRI-RHRNLVK---------------- 677 (823)
Q Consensus 628 ~~f~~-~~~lg~g~------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~---------------- 677 (823)
++|.. .+.||+|+ +..||||++........+.+.+|++++.++ +||||++
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 91 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE 91 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence 34544 35677765 567999999755444456889999999985 7999998
Q ss_pred ------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCc---EEEeecccccccCCCCc--
Q 045449 678 ------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMV---AHISDFGIAKLLSGEDQ-- 728 (823)
Q Consensus 678 ------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~---~kl~DfGla~~~~~~~~-- 728 (823)
++.|++.+|+|+|+.+|+||||||+||+++.++. +||+|||+++.......
T Consensus 92 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~ 171 (316)
T 2ac3_A 92 KMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCS 171 (316)
T ss_dssp CCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC---------
T ss_pred cCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCccc
Confidence 3678999999999999999999999999987765 99999999986542211
Q ss_pred ---cccccccccCCCcCcccccCC-----CccccccceehhhhhhccccCCCCCcCCC
Q 045449 729 ---LSKQTQTLATIGYMAPEYGTK-----GRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 729 ---~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
.......+||+.|+|||++.+ ..++.++||||+||++|++++|..||.+.
T Consensus 172 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 229 (316)
T 2ac3_A 172 PISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGR 229 (316)
T ss_dssp ----------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCC
T ss_pred cccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccc
Confidence 111224569999999999865 56899999999999999999999999764
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=5.1e-23 Score=222.47 Aligned_cols=151 Identities=23% Similarity=0.292 Sum_probs=119.3
Q ss_pred ccCCccceeeccC-----------------CeEEEEEEehHh-hHHHHHHHHHHHHHHhhcchhhHHH------------
Q 045449 628 DRFSENNLIGIGN-----------------GMEVAVKVFHQQ-YERALKSFEDECEVRKRIRHRNLVK------------ 677 (823)
Q Consensus 628 ~~f~~~~~lg~g~-----------------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~------------ 677 (823)
++|...+.||.|+ +..||||++... ......+|.+|+.++++++||||++
T Consensus 30 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (327)
T 2yfx_A 30 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRF 109 (327)
T ss_dssp GGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred hheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCcE
Confidence 4566666677664 346999998643 2445578999999999999999998
Q ss_pred -----------------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCC---CCcEEEeeccc
Q 045449 678 -----------------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDE---DMVAHISDFGI 719 (823)
Q Consensus 678 -----------------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~---~~~~kl~DfGl 719 (823)
++.|++++|+|+|+.+|+||||||+||+++. +..+||+|||+
T Consensus 110 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl~Dfg~ 189 (327)
T 2yfx_A 110 ILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGM 189 (327)
T ss_dssp EEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCCHH
T ss_pred EEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEECcccc
Confidence 3468889999999999999999999999984 45699999999
Q ss_pred ccccCCCCccccccccccCCCcCcccccCCCccccccceehhhhhhccccC-CCCCcCCC
Q 045449 720 AKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKET-RSMTVGET 778 (823)
Q Consensus 720 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~-~~~~~~~~ 778 (823)
++...............||+.|+|||++.+..++.++|||||||+++++++ |..||...
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~ 249 (327)
T 2yfx_A 190 ARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK 249 (327)
T ss_dssp HHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred ccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCc
Confidence 986544333223344568999999999988899999999999999999998 88888764
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.85 E-value=1.3e-23 Score=229.82 Aligned_cols=149 Identities=24% Similarity=0.316 Sum_probs=120.4
Q ss_pred ccCCccceeeccC---------------CeEEEEEEehHhh----HHHHHHHHHHHHHHhhc-chhhHHH----------
Q 045449 628 DRFSENNLIGIGN---------------GMEVAVKVFHQQY----ERALKSFEDECEVRKRI-RHRNLVK---------- 677 (823)
Q Consensus 628 ~~f~~~~~lg~g~---------------~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~---------- 677 (823)
++|...+.||.|+ +..||||+++... ....+.+.+|++++.++ +||||++
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 133 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 133 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence 5677778888775 4669999986432 12335678899999999 6999998
Q ss_pred ------------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCC
Q 045449 678 ------------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGED 727 (823)
Q Consensus 678 ------------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~ 727 (823)
++.|++.+|+|+|+.+|+||||||+|||++.++.+||+|||+++......
T Consensus 134 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~ 213 (355)
T 1vzo_A 134 LHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADE 213 (355)
T ss_dssp EEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCGGG
T ss_pred EEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCeecccCC
Confidence 35689999999999999999999999999999999999999998754322
Q ss_pred ccccccccccCCCcCcccccCC--CccccccceehhhhhhccccCCCCCcCC
Q 045449 728 QLSKQTQTLATIGYMAPEYGTK--GRVSTRGDVCSFGIISGGKETRSMTVGE 777 (823)
Q Consensus 728 ~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~ 777 (823)
. ......+||+.|+|||++.+ ..++.++|||||||++|++++|..||..
T Consensus 214 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~ 264 (355)
T 1vzo_A 214 T-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTV 264 (355)
T ss_dssp G-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSC
T ss_pred C-CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCcc
Confidence 2 22334679999999999875 3478999999999999999999999864
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.85 E-value=3.3e-21 Score=221.36 Aligned_cols=188 Identities=23% Similarity=0.334 Sum_probs=110.0
Q ss_pred CCcEEEccCCcccccCCcccccCCCCccEEEeeccccccccCccccCCCCCCeEEeecccccccCCCccCCCcccCcccc
Q 045449 229 ALKEISLLNNSLSGSLPSRIDLSLPNVETLNLGINSFSGTIPSSITNSSKLSDLELGENLFSGFIPNTIGNLRNLEFGNI 308 (823)
Q Consensus 229 ~L~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 308 (823)
+|+.|+|++|.|++ +|..++ ++|++|+|++|+|+ .+| ..+++|++|+|++|+|++ +|. +.. +|++|+|
T Consensus 60 ~L~~L~Ls~n~L~~-lp~~l~---~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~L 127 (571)
T 3cvr_A 60 QFSELQLNRLNLSS-LPDNLP---PQITVLEITQNALI-SLP---ELPASLEYLDACDNRLST-LPE-LPA--SLKHLDV 127 (571)
T ss_dssp TCSEEECCSSCCSC-CCSCCC---TTCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSC-CCC-CCT--TCCEEEC
T ss_pred CccEEEeCCCCCCc-cCHhHc---CCCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCC-cch-hhc--CCCEEEC
Confidence 78888888888874 776653 67888888888887 566 346777888888887776 455 444 6666666
Q ss_pred cCccccCCCCcccccccccCCCCceEEEeecCCCCccCCccccccccccceEEecCCcceeccCccccCcccccEEEccc
Q 045449 309 ADNYLTSSTPELSFLSSLTNCKKLKVLIVTGNPLDGILPKSIGNFSLSLETILMANCSISGNIPQVVGNLSNLLVLELGG 388 (823)
Q Consensus 309 ~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~ 388 (823)
++|++++++ . .+++|+.|+|++|.|++ +|. .+++|++|+|++
T Consensus 128 s~N~l~~lp------~---~l~~L~~L~Ls~N~l~~-lp~----------------------------~l~~L~~L~Ls~ 169 (571)
T 3cvr_A 128 DNNQLTMLP------E---LPALLEYINADNNQLTM-LPE----------------------------LPTSLEVLSVRN 169 (571)
T ss_dssp CSSCCSCCC------C---CCTTCCEEECCSSCCSC-CCC----------------------------CCTTCCEEECCS
T ss_pred CCCcCCCCC------C---cCccccEEeCCCCccCc-CCC----------------------------cCCCcCEEECCC
Confidence 666666531 1 34455555555555543 222 234455555555
Q ss_pred CcCCCCchhcccccCCCCEEEccCCCCCCcchHhhhcCCCC-------CEEEcccCcCcccccccccCCCCCCeEeccCC
Q 045449 389 NNLTGPIPVTFSQLQTLQAFDLTRNKLAGPITDELCHLARL-------HSLVLQGNKFSGSIPSCLGNLTSVRVLYLGLN 461 (823)
Q Consensus 389 N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L-------~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N 461 (823)
|+|++ +|. |. ++|++|+|++|+|+ .+|. |.. +| +.|+|++|+|+ .+|..+..+++|+.|+|++|
T Consensus 170 N~L~~-lp~-l~--~~L~~L~Ls~N~L~-~lp~-~~~--~L~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~L~~N 240 (571)
T 3cvr_A 170 NQLTF-LPE-LP--ESLEALDVSTNLLE-SLPA-VPV--RNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDN 240 (571)
T ss_dssp SCCSC-CCC-CC--TTCCEEECCSSCCS-SCCC-CC----------CCEEEECCSSCCC-CCCGGGGGSCTTEEEECCSS
T ss_pred CCCCC-cch-hh--CCCCEEECcCCCCC-chhh-HHH--hhhcccccceEEecCCCcce-ecCHHHhcCCCCCEEEeeCC
Confidence 55543 333 33 45555555555555 3333 322 34 66666666666 45555555666666666666
Q ss_pred ccccccchhhhccC
Q 045449 462 IFTSVLSSTIWNLK 475 (823)
Q Consensus 462 ~l~~~~p~~~~~l~ 475 (823)
.+++.+|..+..+.
T Consensus 241 ~l~~~~p~~l~~l~ 254 (571)
T 3cvr_A 241 PLSSRIRESLSQQT 254 (571)
T ss_dssp SCCHHHHHHHHHHH
T ss_pred cCCCcCHHHHHHhh
Confidence 66666666655543
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.85 E-value=1.5e-22 Score=219.60 Aligned_cols=148 Identities=30% Similarity=0.368 Sum_probs=115.5
Q ss_pred hccCCccceeeccC----------CeEEEEEEehHhhHHHHHHHHHHHHH--HhhcchhhHHH-----------------
Q 045449 627 TDRFSENNLIGIGN----------GMEVAVKVFHQQYERALKSFEDECEV--RKRIRHRNLVK----------------- 677 (823)
Q Consensus 627 t~~f~~~~~lg~g~----------~~~vavK~~~~~~~~~~~~~~~E~~~--l~~l~h~niv~----------------- 677 (823)
.++|...+.||.|+ +..||||++..... +.+..|.++ +..++||||++
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~---~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 88 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFANR---QNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYL 88 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEETTEEEEEEEEEGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEE
T ss_pred hHHhheeeecccCCCeEEEEEEECCeEEEEEEeeccch---hhHHHHHHHHHHHhccCcchhhheecccccccCCCceEE
Confidence 35777788888886 67799999975543 234444444 55689999987
Q ss_pred ---------------------------HHHHHHHHhhhcCCC---------CEEeccCCCCCEEeCCCCcEEEeeccccc
Q 045449 678 ---------------------------IISSSLEYLHFGHSI---------PIIHCDLKPSNVLLDEDMVAHISDFGIAK 721 (823)
Q Consensus 678 ---------------------------~~~~~l~~L~~~h~~---------~ivHrdlk~~NiLl~~~~~~kl~DfGla~ 721 (823)
++.|++.+|.|+|+. +|+||||||+|||++.++.+||+|||+|+
T Consensus 89 lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG~a~ 168 (336)
T 3g2f_A 89 LVMEYYPNGSLXKYLSLHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSM 168 (336)
T ss_dssp EEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEecCCCCcHHHHHhhcccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeecccee
Confidence 356888889999988 99999999999999999999999999998
Q ss_pred ccCCCCc------cccccccccCCCcCcccccCC-------CccccccceehhhhhhccccCCCCCcCC
Q 045449 722 LLSGEDQ------LSKQTQTLATIGYMAPEYGTK-------GRVSTRGDVCSFGIISGGKETRSMTVGE 777 (823)
Q Consensus 722 ~~~~~~~------~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~ 777 (823)
.+..... ........||+.|+|||++.+ ..++.++|||||||++|++++|..|+..
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~ 237 (336)
T 3g2f_A 169 RLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFP 237 (336)
T ss_dssp ECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGST
T ss_pred ecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCC
Confidence 7643221 112234579999999999876 4678899999999999999999777643
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=4.6e-23 Score=217.32 Aligned_cols=151 Identities=23% Similarity=0.332 Sum_probs=123.6
Q ss_pred hccCCccceeeccC------------CeEEEEEEehHhh--HHHHHHHHHHHHHHhhcchhhHHH---------------
Q 045449 627 TDRFSENNLIGIGN------------GMEVAVKVFHQQY--ERALKSFEDECEVRKRIRHRNLVK--------------- 677 (823)
Q Consensus 627 t~~f~~~~~lg~g~------------~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~--------------- 677 (823)
.++|...+.||.|+ ++.||+|++.... ....+.+.+|++++++++||||++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 35677778888875 5679999986432 445678999999999999999998
Q ss_pred -------------------------------HHHHHHHHhhhcCCCC-----EEeccCCCCCEEeCCCCcEEEeeccccc
Q 045449 678 -------------------------------IISSSLEYLHFGHSIP-----IIHCDLKPSNVLLDEDMVAHISDFGIAK 721 (823)
Q Consensus 678 -------------------------------~~~~~l~~L~~~h~~~-----ivHrdlk~~NiLl~~~~~~kl~DfGla~ 721 (823)
++.|++.+|+|+|+.+ |+||||||+||+++.++.+||+|||+++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 3567888999999988 9999999999999999999999999998
Q ss_pred ccCCCCccccccccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCCCc
Q 045449 722 LLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGETC 779 (823)
Q Consensus 722 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~~ 779 (823)
....... ......||+.|+|||++.+..++.++||||+||+++++++|..||....
T Consensus 165 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 220 (279)
T 2w5a_A 165 ILNHDTS--FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS 220 (279)
T ss_dssp HC---CH--HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred eeccccc--cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccC
Confidence 7643321 1234578999999999988889999999999999999999999987653
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.85 E-value=3.1e-23 Score=225.89 Aligned_cols=150 Identities=19% Similarity=0.183 Sum_probs=117.3
Q ss_pred ccCCccceeeccC---------------CeEEEEEEehHhhH-----------HHHHHHHHHHHHHhhcchhhHHH----
Q 045449 628 DRFSENNLIGIGN---------------GMEVAVKVFHQQYE-----------RALKSFEDECEVRKRIRHRNLVK---- 677 (823)
Q Consensus 628 ~~f~~~~~lg~g~---------------~~~vavK~~~~~~~-----------~~~~~~~~E~~~l~~l~h~niv~---- 677 (823)
++|...+.||.|+ +..||||+...... ...+.+.+|+..+..++||||++
T Consensus 37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~ 116 (345)
T 2v62_A 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS 116 (345)
T ss_dssp CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence 4566667777664 35589998864321 11235778999999999999876
Q ss_pred ---------------------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCC--cEEEee
Q 045449 678 ---------------------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDM--VAHISD 716 (823)
Q Consensus 678 ---------------------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~--~~kl~D 716 (823)
++.|++.+|+|+|+.+|+||||||+||+++.++ .+||+|
T Consensus 117 ~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kL~D 196 (345)
T 2v62_A 117 GLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLAD 196 (345)
T ss_dssp EEEESSSCEEEEEEEECEEEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEEECC
T ss_pred cccccCCCcEEEEEEeccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEEEEe
Confidence 467899999999999999999999999998777 999999
Q ss_pred cccccccCCCCcc-----ccccccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCC
Q 045449 717 FGIAKLLSGEDQL-----SKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGE 777 (823)
Q Consensus 717 fGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~ 777 (823)
||+|+.+...... .......||+.|+|||++.+..++.++|||||||++|++++|..||.+
T Consensus 197 fg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~ 262 (345)
T 2v62_A 197 YGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQ 262 (345)
T ss_dssp CTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGG
T ss_pred CCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 9999876432211 112345799999999999988999999999999999999999999954
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=9.8e-23 Score=215.59 Aligned_cols=146 Identities=19% Similarity=0.262 Sum_probs=120.0
Q ss_pred HhccCCccceeeccC------------CeEEEEEEehHh--hHHHHHHHHHHHHHHhhc-chhhHHH-------------
Q 045449 626 ATDRFSENNLIGIGN------------GMEVAVKVFHQQ--YERALKSFEDECEVRKRI-RHRNLVK------------- 677 (823)
Q Consensus 626 at~~f~~~~~lg~g~------------~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~------------- 677 (823)
.+++|...+.||.|+ +..||||++... ......++.+|+..+.++ +||||++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l 88 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI 88 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 356788888999885 677999998743 233456788999999999 9999998
Q ss_pred -------------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCC------------------
Q 045449 678 -------------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDE------------------ 708 (823)
Q Consensus 678 -------------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~------------------ 708 (823)
++.|++.+|+|+|+.+|+||||||+||+++.
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~ 168 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWAS 168 (289)
T ss_dssp EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC-------------------
T ss_pred EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccccC
Confidence 3578899999999999999999999999984
Q ss_pred -CCcEEEeecccccccCCCCccccccccccCCCcCcccccCCC-ccccccceehhhhhhccccCCCCCcCC
Q 045449 709 -DMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKG-RVSTRGDVCSFGIISGGKETRSMTVGE 777 (823)
Q Consensus 709 -~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvv~~~~~~~~~~~~~ 777 (823)
...+||+|||.++...... ...||+.|+|||++.+. .++.++||||+||+++++.++..++..
T Consensus 169 ~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~ 233 (289)
T 1x8b_A 169 NKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRN 233 (289)
T ss_dssp -CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSS
T ss_pred CceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcc
Confidence 4479999999998764322 24599999999998766 567899999999999999999876644
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=1.2e-22 Score=217.81 Aligned_cols=150 Identities=23% Similarity=0.331 Sum_probs=115.3
Q ss_pred hccCCccceeeccC------------CeEEEEEEehHh---hHHHHHHHHHHHHHHhhcchhhHHH--------------
Q 045449 627 TDRFSENNLIGIGN------------GMEVAVKVFHQQ---YERALKSFEDECEVRKRIRHRNLVK-------------- 677 (823)
Q Consensus 627 t~~f~~~~~lg~g~------------~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~-------------- 677 (823)
.++|...+.||.|+ |..||||++... .....+++.+|++++++++||||++
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 110 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence 35677788888875 567999998642 2455678999999999999999998
Q ss_pred ------------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCC
Q 045449 678 ------------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGED 727 (823)
Q Consensus 678 ------------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~ 727 (823)
++.|++++|.|+|+.+++||||||+||+++.++.+||+|||+++......
T Consensus 111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~~ 190 (310)
T 2wqm_A 111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 190 (310)
T ss_dssp EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC----------
T ss_pred EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeecCCC
Confidence 35688899999999999999999999999999999999999998754322
Q ss_pred ccccccccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCCC
Q 045449 728 QLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 728 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
. ......||+.|+|||++.+..++.++|||||||+++++++|..||.+.
T Consensus 191 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 239 (310)
T 2wqm_A 191 T--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 239 (310)
T ss_dssp ----------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC--
T ss_pred c--cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCccc
Confidence 1 223457899999999999889999999999999999999999998654
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.85 E-value=8.1e-23 Score=228.96 Aligned_cols=149 Identities=28% Similarity=0.393 Sum_probs=115.1
Q ss_pred hccCCccceeeccC-----------CeEEEEEEehHhhHHHHHHHHHHHHHHhhc-chhhHHH-----------------
Q 045449 627 TDRFSENNLIGIGN-----------GMEVAVKVFHQQYERALKSFEDECEVRKRI-RHRNLVK----------------- 677 (823)
Q Consensus 627 t~~f~~~~~lg~g~-----------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~----------------- 677 (823)
..+|...+.||.|+ ++.||||++..... ..+.+|+++++++ +|||||+
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~ 99 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIEL 99 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEEC
Confidence 34677778888875 56799999865421 3467899999999 8999998
Q ss_pred -----------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCC-----CCcEEEeecccccccCCCCc-
Q 045449 678 -----------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDE-----DMVAHISDFGIAKLLSGEDQ- 728 (823)
Q Consensus 678 -----------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~-----~~~~kl~DfGla~~~~~~~~- 728 (823)
++.|++.+|+|+|+.+|+||||||+||+++. ...+||+|||+|+.......
T Consensus 100 ~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~ 179 (432)
T 3p23_A 100 CAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHS 179 (432)
T ss_dssp CSEEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC------
T ss_pred CCCCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCcc
Confidence 4678999999999999999999999999943 34688999999987653321
Q ss_pred cccccccccCCCcCcccccC---CCccccccceehhhhhhccccC-CCCCcCCC
Q 045449 729 LSKQTQTLATIGYMAPEYGT---KGRVSTRGDVCSFGIISGGKET-RSMTVGET 778 (823)
Q Consensus 729 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~S~Gvv~~~~~~-~~~~~~~~ 778 (823)
.......+||+.|+|||++. ...++.++||||+||+++++++ |..||...
T Consensus 180 ~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~ 233 (432)
T 3p23_A 180 FSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKS 233 (432)
T ss_dssp ------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBST
T ss_pred eeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchh
Confidence 12234567999999999987 4567889999999999999999 88888654
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.85 E-value=1.5e-22 Score=217.68 Aligned_cols=151 Identities=21% Similarity=0.223 Sum_probs=123.1
Q ss_pred hccCCccceeeccC------------CeEEEEEEehHhhHHHHHHHHHHHHHHhhcchhhHHH-----------------
Q 045449 627 TDRFSENNLIGIGN------------GMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVK----------------- 677 (823)
Q Consensus 627 t~~f~~~~~lg~g~------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~----------------- 677 (823)
.++|...+.||.|+ +..||||++........+.+.+|++++++++||||++
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 107 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL 107 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence 35777788888875 5679999987665666788999999999999999997
Q ss_pred -------------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCC
Q 045449 678 -------------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGE 726 (823)
Q Consensus 678 -------------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~ 726 (823)
++.|++++|+|+|+.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~ 187 (317)
T 2buj_A 108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIH 187 (317)
T ss_dssp EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSCEESCEE
T ss_pred EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcchhcccc
Confidence 3568889999999999999999999999999999999999998765321
Q ss_pred Ccc-------ccccccccCCCcCcccccCCCc---cccccceehhhhhhccccCCCCCcCC
Q 045449 727 DQL-------SKQTQTLATIGYMAPEYGTKGR---VSTRGDVCSFGIISGGKETRSMTVGE 777 (823)
Q Consensus 727 ~~~-------~~~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~S~Gvv~~~~~~~~~~~~~ 777 (823)
... .......||+.|+|||++.+.. ++.++|||||||+++++++|..||..
T Consensus 188 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 248 (317)
T 2buj_A 188 VEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDM 248 (317)
T ss_dssp EESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHH
T ss_pred cccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhh
Confidence 110 0112345799999999987543 68999999999999999999999854
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.85 E-value=7.2e-23 Score=221.15 Aligned_cols=151 Identities=29% Similarity=0.389 Sum_probs=125.2
Q ss_pred ccCCccceeeccC----------------CeEEEEEEehHhhHHHHHHHHHHHHHHhhcchhhHHH--------------
Q 045449 628 DRFSENNLIGIGN----------------GMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVK-------------- 677 (823)
Q Consensus 628 ~~f~~~~~lg~g~----------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-------------- 677 (823)
++|...+.||.|+ +..||||++........+.|.+|++++++++||||++
T Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 120 (326)
T 2w1i_A 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK 120 (326)
T ss_dssp GGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCE
T ss_pred HHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceE
Confidence 3455566677664 5679999997666666688999999999999999997
Q ss_pred -----------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCc
Q 045449 678 -----------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQ 728 (823)
Q Consensus 678 -----------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~ 728 (823)
++.|++++|+++|+.+|+||||||+||+++.++.+||+|||+++.......
T Consensus 121 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~~~~ 200 (326)
T 2w1i_A 121 LIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKE 200 (326)
T ss_dssp EEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCSSCS
T ss_pred EEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchhhcccccc
Confidence 356889999999999999999999999999999999999999987654332
Q ss_pred c-ccccccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCCC
Q 045449 729 L-SKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 729 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
. .......++..|+|||++.+..++.++||||+||+++++++|..|+...
T Consensus 201 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~ 251 (326)
T 2w1i_A 201 YYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSP 251 (326)
T ss_dssp EEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSH
T ss_pred ccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCC
Confidence 1 1123345788899999998888999999999999999999998887643
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=1.2e-22 Score=218.88 Aligned_cols=149 Identities=28% Similarity=0.356 Sum_probs=120.6
Q ss_pred hccCCccceeeccC------------CeEEEEEEehHhh--------HHHHHHHHHHHHHHhhcchhhHHH---------
Q 045449 627 TDRFSENNLIGIGN------------GMEVAVKVFHQQY--------ERALKSFEDECEVRKRIRHRNLVK--------- 677 (823)
Q Consensus 627 t~~f~~~~~lg~g~------------~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~--------- 677 (823)
.++|...+.||.|+ +..||||++.... ......+.+|++++++++||||++
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 88 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED 88 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence 46788888999886 5679999986432 122346889999999999999998
Q ss_pred ------------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCC---cEEEeecccccccC
Q 045449 678 ------------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDM---VAHISDFGIAKLLS 724 (823)
Q Consensus 678 ------------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~---~~kl~DfGla~~~~ 724 (823)
++.|++.+|+|+|+.+|+||||||+||+++.++ .+||+|||+++...
T Consensus 89 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 168 (322)
T 2ycf_A 89 YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG 168 (322)
T ss_dssp EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEECC
T ss_pred eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccceecc
Confidence 367899999999999999999999999998655 49999999998764
Q ss_pred CCCccccccccccCCCcCcccccC---CCccccccceehhhhhhccccCCCCCcCCC
Q 045449 725 GEDQLSKQTQTLATIGYMAPEYGT---KGRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 725 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
... ......||+.|+|||++. ...++.++||||+||++|++++|..||...
T Consensus 169 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 222 (322)
T 2ycf_A 169 ETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEH 222 (322)
T ss_dssp CCH---HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCST
T ss_pred ccc---ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCccc
Confidence 322 123457999999999863 567899999999999999999999999654
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=99.85 E-value=1e-22 Score=223.12 Aligned_cols=147 Identities=23% Similarity=0.331 Sum_probs=123.9
Q ss_pred ccCCccceeeccC------------CeEEEEEEehHh-hHHHHHHHHHHHHHHhhcchhhHHH-----------------
Q 045449 628 DRFSENNLIGIGN------------GMEVAVKVFHQQ-YERALKSFEDECEVRKRIRHRNLVK----------------- 677 (823)
Q Consensus 628 ~~f~~~~~lg~g~------------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~----------------- 677 (823)
++|...+.||.|+ +..||+|++... .....+.+.+|++++++++||||++
T Consensus 33 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 112 (360)
T 3eqc_A 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 112 (360)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEEC
Confidence 5678888899886 567999998754 2445578999999999999999998
Q ss_pred -----------------------HHHHHHHHhhhcCCC-CEEeccCCCCCEEeCCCCcEEEeecccccccCCCCcccccc
Q 045449 678 -----------------------IISSSLEYLHFGHSI-PIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQT 733 (823)
Q Consensus 678 -----------------------~~~~~l~~L~~~h~~-~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~ 733 (823)
++.+++.+|+|+|+. +|+||||||+||+++.++.+||+|||+++..... ...
T Consensus 113 ~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~----~~~ 188 (360)
T 3eqc_A 113 MDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MAN 188 (360)
T ss_dssp CTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH----C--
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc----ccc
Confidence 356788889999985 9999999999999999999999999999765321 123
Q ss_pred ccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCCC
Q 045449 734 QTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 734 ~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
...||+.|+|||++.+..++.++||||+||+++++++|..||...
T Consensus 189 ~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 233 (360)
T 3eqc_A 189 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP 233 (360)
T ss_dssp --CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCC
T ss_pred CCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 457999999999999999999999999999999999999999764
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=3e-22 Score=217.69 Aligned_cols=149 Identities=28% Similarity=0.370 Sum_probs=120.5
Q ss_pred HHHHHHHhccCCccceeeccC----------CeEEEEEEehHhhHHHHHHHHHHHHHHhh--cchhhHHH----------
Q 045449 620 YHELLRATDRFSENNLIGIGN----------GMEVAVKVFHQQYERALKSFEDECEVRKR--IRHRNLVK---------- 677 (823)
Q Consensus 620 ~~~l~~at~~f~~~~~lg~g~----------~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~---------- 677 (823)
...-....++|...+.||.|+ ++.||||++..... +.+.+|++++.. ++||||++
T Consensus 34 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~---~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~ 110 (342)
T 1b6c_B 34 LLVQRTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREE---RSWFREAEIYQTVMLRHENILGFIAADNKDNG 110 (342)
T ss_dssp HHHHHHHHHHCEEEEEEEEETTEEEEEEEETTEEEEEEEECGGGH---HHHHHHHHHHHHSCCCCTTBCCEEEEEECCCS
T ss_pred eeecccccccEEEEeeecCCCCcEEEEEEEcCccEEEEEeCchhH---HHHHHHHHHHHHhhcCCCcEEEEEeeecccCC
Confidence 333344567899999999986 67799999975533 567888888887 79999997
Q ss_pred ---------------------------------HHHHHHHHhhhcC--------CCCEEeccCCCCCEEeCCCCcEEEee
Q 045449 678 ---------------------------------IISSSLEYLHFGH--------SIPIIHCDLKPSNVLLDEDMVAHISD 716 (823)
Q Consensus 678 ---------------------------------~~~~~l~~L~~~h--------~~~ivHrdlk~~NiLl~~~~~~kl~D 716 (823)
++.|++.+|+|+| +.+|+||||||+||+++.++.+||+|
T Consensus 111 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 190 (342)
T 1b6c_B 111 TWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD 190 (342)
T ss_dssp SCCCEEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECC
T ss_pred ccceeEEEEeecCCCcHHHHHhccCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEE
Confidence 3567888888888 89999999999999999999999999
Q ss_pred cccccccCCCCccc--cccccccCCCcCcccccCCC------ccccccceehhhhhhccccCC
Q 045449 717 FGIAKLLSGEDQLS--KQTQTLATIGYMAPEYGTKG------RVSTRGDVCSFGIISGGKETR 771 (823)
Q Consensus 717 fGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~S~Gvv~~~~~~~ 771 (823)
||+++......... ......||+.|+|||++.+. .++.++|||||||++|++++|
T Consensus 191 fg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg 253 (342)
T 1b6c_B 191 LGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARR 253 (342)
T ss_dssp CTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhc
Confidence 99998765433211 22345799999999998765 345789999999999999999
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=1.5e-22 Score=213.00 Aligned_cols=148 Identities=27% Similarity=0.445 Sum_probs=116.9
Q ss_pred ccCCccceeeccC------------CeEEEEEEehHhhH---HHHHHHHHHHHHHhhcchhhHHH---------------
Q 045449 628 DRFSENNLIGIGN------------GMEVAVKVFHQQYE---RALKSFEDECEVRKRIRHRNLVK--------------- 677 (823)
Q Consensus 628 ~~f~~~~~lg~g~------------~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~--------------- 677 (823)
++|...+.||.|+ ++.||||++..... ...+.+.+|++++++++||||++
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (276)
T 2h6d_A 11 GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVM 90 (276)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEE
Confidence 5677778888875 66799999975532 23467899999999999999998
Q ss_pred -------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccc
Q 045449 678 -------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQ 732 (823)
Q Consensus 678 -------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~ 732 (823)
++.|++++|+|+|+.+|+||||||+||+++.++.+||+|||+++....... .
T Consensus 91 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~---~ 167 (276)
T 2h6d_A 91 EYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF---L 167 (276)
T ss_dssp ECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-------
T ss_pred eccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCCCcc---e
Confidence 357889999999999999999999999999999999999999987643321 2
Q ss_pred cccccCCCcCcccccCCCcc-ccccceehhhhhhccccCCCCCcCCC
Q 045449 733 TQTLATIGYMAPEYGTKGRV-STRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 733 ~~~~gt~~y~aPE~~~~~~~-~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
....||+.|+|||++.+..+ +.++||||+|++++++++|..||.+.
T Consensus 168 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~ 214 (276)
T 2h6d_A 168 RTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDE 214 (276)
T ss_dssp ---------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCC
Confidence 34578999999999887765 68999999999999999999998764
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=99.84 E-value=1.8e-22 Score=222.19 Aligned_cols=145 Identities=25% Similarity=0.297 Sum_probs=119.8
Q ss_pred ccCCccceeeccC------------CeEEEEEEehHhhHHHHHHHHHHHHHHhhcc-----------hhhHHH-------
Q 045449 628 DRFSENNLIGIGN------------GMEVAVKVFHQQYERALKSFEDECEVRKRIR-----------HRNLVK------- 677 (823)
Q Consensus 628 ~~f~~~~~lg~g~------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~------- 677 (823)
++|...+.||.|+ ++.||||++.... ...+.+.+|++++.++. |+||++
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~ 97 (373)
T 1q8y_A 19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 97 (373)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc-cchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhc
Confidence 5788888898886 6679999997543 34467889999999886 778876
Q ss_pred --------------------------------------HHHHHHHHhhhcCCC-CEEeccCCCCCEEeC------CCCcE
Q 045449 678 --------------------------------------IISSSLEYLHFGHSI-PIIHCDLKPSNVLLD------EDMVA 712 (823)
Q Consensus 678 --------------------------------------~~~~~l~~L~~~h~~-~ivHrdlk~~NiLl~------~~~~~ 712 (823)
++.|++.+|+|+|+. +|+||||||+|||++ ..+.+
T Consensus 98 ~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~~~~~ 177 (373)
T 1q8y_A 98 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQI 177 (373)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEE
T ss_pred cCCCCceEEEEEecCCCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcCcceE
Confidence 357889999999998 999999999999994 44589
Q ss_pred EEeecccccccCCCCccccccccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCCC
Q 045449 713 HISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 713 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
||+|||+++..... .....||+.|+|||++.+..++.++||||+||++|++++|..||...
T Consensus 178 kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 238 (373)
T 1q8y_A 178 KIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPD 238 (373)
T ss_dssp EECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---
T ss_pred EEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999876432 23457999999999999989999999999999999999999999743
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=2.5e-22 Score=213.81 Aligned_cols=149 Identities=26% Similarity=0.397 Sum_probs=125.2
Q ss_pred hccCCccceeeccC------------CeEEEEEEehHh---------hHHHHHHHHHHHHHHhhcc-hhhHHH-------
Q 045449 627 TDRFSENNLIGIGN------------GMEVAVKVFHQQ---------YERALKSFEDECEVRKRIR-HRNLVK------- 677 (823)
Q Consensus 627 t~~f~~~~~lg~g~------------~~~vavK~~~~~---------~~~~~~~~~~E~~~l~~l~-h~niv~------- 677 (823)
.++|...+.||.|+ ++.||||++... .....+.+.+|+++++++. ||||++
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 46788888899885 677999998532 2344578899999999995 999998
Q ss_pred ---------------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccC
Q 045449 678 ---------------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLS 724 (823)
Q Consensus 678 ---------------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~ 724 (823)
++.|++.+|+|+|+.+|+||||||+||+++.++.+||+|||+++...
T Consensus 96 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 175 (298)
T 1phk_A 96 NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD 175 (298)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred CCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccchhhcC
Confidence 36788999999999999999999999999999999999999998765
Q ss_pred CCCccccccccccCCCcCcccccC------CCccccccceehhhhhhccccCCCCCcCCC
Q 045449 725 GEDQLSKQTQTLATIGYMAPEYGT------KGRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 725 ~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
.... .....||+.|+|||++. ...++.++||||+||+++++++|..||...
T Consensus 176 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~ 232 (298)
T 1phk_A 176 PGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHR 232 (298)
T ss_dssp TTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CCcc---cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCc
Confidence 4322 23457899999999874 456889999999999999999999998654
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=2.1e-22 Score=217.67 Aligned_cols=148 Identities=28% Similarity=0.344 Sum_probs=102.3
Q ss_pred ccCCccceeeccC------------CeEEEEEEehHhh-HHHHHHHHHHHH-HHhhcchhhHHH----------------
Q 045449 628 DRFSENNLIGIGN------------GMEVAVKVFHQQY-ERALKSFEDECE-VRKRIRHRNLVK---------------- 677 (823)
Q Consensus 628 ~~f~~~~~lg~g~------------~~~vavK~~~~~~-~~~~~~~~~E~~-~l~~l~h~niv~---------------- 677 (823)
++|...+.||.|+ ++.||||++.... .....++..|+. +++.++||||++
T Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e 101 (327)
T 3aln_A 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICME 101 (327)
T ss_dssp CSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred HHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEe
Confidence 5677778888875 6779999996542 334456666666 677789999998
Q ss_pred ----------------------------HHHHHHHHhhhcCCC-CEEeccCCCCCEEeCCCCcEEEeecccccccCCCCc
Q 045449 678 ----------------------------IISSSLEYLHFGHSI-PIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQ 728 (823)
Q Consensus 678 ----------------------------~~~~~l~~L~~~h~~-~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~ 728 (823)
++.|++.+|+|+|+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 102 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 181 (327)
T 3aln_A 102 LMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIA 181 (327)
T ss_dssp CCSEEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC------
T ss_pred ecCCChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCceecccccc
Confidence 356788899999998 999999999999999999999999999987643321
Q ss_pred cccccccccCCCcCccccc----CCCccccccceehhhhhhccccCCCCCcCCC
Q 045449 729 LSKQTQTLATIGYMAPEYG----TKGRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 729 ~~~~~~~~gt~~y~aPE~~----~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
.....||+.|+|||++ .+..++.++|||||||+++++++|..||.+.
T Consensus 182 ---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 232 (327)
T 3aln_A 182 ---KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKW 232 (327)
T ss_dssp ---------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC
T ss_pred ---cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCc
Confidence 2334799999999998 4567899999999999999999999998763
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.84 E-value=4.7e-22 Score=215.63 Aligned_cols=149 Identities=29% Similarity=0.388 Sum_probs=114.5
Q ss_pred HHHHhccCCccceeeccC----------CeEEEEEEehHhhHHHHHHHHHHHHHHhh--cchhhHHH-------------
Q 045449 623 LLRATDRFSENNLIGIGN----------GMEVAVKVFHQQYERALKSFEDECEVRKR--IRHRNLVK------------- 677 (823)
Q Consensus 623 l~~at~~f~~~~~lg~g~----------~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~------------- 677 (823)
-....++|...+.||.|+ +..||||++..... ..+.+|.+++.. ++||||++
T Consensus 32 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~---~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 108 (337)
T 3mdy_A 32 QRTIAKQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTTEE---ASWFRETEIYQTVLMRHENILGFIAADIKGTGSWT 108 (337)
T ss_dssp HTTHHHHCEEEEEEEEETTEEEEEEEETTEEEEEEEEEGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGC
T ss_pred ccccccceEEEeEeecCCCeEEEEEEECCceEEEEEEecccc---chhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCC
Confidence 334457899999999986 67799999865533 334555555554 49999987
Q ss_pred ------------------------------HHHHHHHHhhhcCCC--------CEEeccCCCCCEEeCCCCcEEEeeccc
Q 045449 678 ------------------------------IISSSLEYLHFGHSI--------PIIHCDLKPSNVLLDEDMVAHISDFGI 719 (823)
Q Consensus 678 ------------------------------~~~~~l~~L~~~h~~--------~ivHrdlk~~NiLl~~~~~~kl~DfGl 719 (823)
++.|++.+|+|+|+. +|+||||||+||+++.++.+||+|||+
T Consensus 109 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~ 188 (337)
T 3mdy_A 109 QLYLITDYHENGSLYDYLKSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 188 (337)
T ss_dssp EEEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred ceEEEEeccCCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCCC
Confidence 356788888888988 999999999999999999999999999
Q ss_pred ccccCCCCccc--cccccccCCCcCcccccCCCccccc------cceehhhhhhccccCCCCC
Q 045449 720 AKLLSGEDQLS--KQTQTLATIGYMAPEYGTKGRVSTR------GDVCSFGIISGGKETRSMT 774 (823)
Q Consensus 720 a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~------~Dv~S~Gvv~~~~~~~~~~ 774 (823)
|+......... ......||+.|+|||++.+..++.+ +|||||||++|++++|..+
T Consensus 189 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~ 251 (337)
T 3mdy_A 189 AVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVS 251 (337)
T ss_dssp CEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCB
T ss_pred ceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCc
Confidence 98764332211 1224579999999999887766554 9999999999999999433
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=9.6e-23 Score=220.27 Aligned_cols=156 Identities=23% Similarity=0.313 Sum_probs=124.4
Q ss_pred HHHHHHHhccCCcc-ceeeccC------------CeEEEEEEehHhh--HHHHHHHHHHHHHHhhc-chhhHHH------
Q 045449 620 YHELLRATDRFSEN-NLIGIGN------------GMEVAVKVFHQQY--ERALKSFEDECEVRKRI-RHRNLVK------ 677 (823)
Q Consensus 620 ~~~l~~at~~f~~~-~~lg~g~------------~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~------ 677 (823)
|.......++|... +.||.|+ ++.||||++.... ......+.+|+.++.++ +||||++
T Consensus 20 ~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~ 99 (327)
T 3lm5_A 20 FQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYE 99 (327)
T ss_dssp SBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred HHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEE
Confidence 33344445666665 7899886 6679999986433 22346789999999999 5699998
Q ss_pred ------------------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCC---CCcEEEeecc
Q 045449 678 ------------------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDE---DMVAHISDFG 718 (823)
Q Consensus 678 ------------------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~---~~~~kl~DfG 718 (823)
++.|++.+|+|+|+.+|+||||||+||+++. ++.+||+|||
T Consensus 100 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg 179 (327)
T 3lm5_A 100 NTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFG 179 (327)
T ss_dssp CSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGG
T ss_pred eCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCc
Confidence 4678999999999999999999999999987 7899999999
Q ss_pred cccccCCCCccccccccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCCC
Q 045449 719 IAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 719 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
+++....... .....||+.|+|||++.+..++.++||||+||+++++++|..||...
T Consensus 180 ~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 236 (327)
T 3lm5_A 180 MSRKIGHACE---LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGE 236 (327)
T ss_dssp GCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cccccCCccc---cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 9987643322 23457999999999999999999999999999999999999998664
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=6.7e-23 Score=218.74 Aligned_cols=150 Identities=28% Similarity=0.313 Sum_probs=120.6
Q ss_pred hccCCccceeeccC------------CeEEEEEEehHhhHHHHHHHHHHHHHHhhcchhhHHH-----------------
Q 045449 627 TDRFSENNLIGIGN------------GMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVK----------------- 677 (823)
Q Consensus 627 t~~f~~~~~lg~g~------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~----------------- 677 (823)
.++|...+.||.|+ +..||+|++........+.|.+|++++++++||||++
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 97 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEF 97 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEEC
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEe
Confidence 46777788888875 5679999997665555678999999999999999998
Q ss_pred ------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCcccccc
Q 045449 678 ------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQT 733 (823)
Q Consensus 678 ------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~ 733 (823)
++.|++.+|.|+|+.+++||||||+||+++.++.+||+|||+++...... ....
T Consensus 98 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~ 175 (302)
T 2j7t_A 98 CPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL--QKRD 175 (302)
T ss_dssp CTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH--HC--
T ss_pred CCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCccccccc--cccc
Confidence 35688899999999999999999999999999999999999986432111 1123
Q ss_pred ccccCCCcCccccc-----CCCccccccceehhhhhhccccCCCCCcCCC
Q 045449 734 QTLATIGYMAPEYG-----TKGRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 734 ~~~gt~~y~aPE~~-----~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
...||+.|+|||++ ....++.++||||+||+++++.+|..||...
T Consensus 176 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 225 (302)
T 2j7t_A 176 SFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL 225 (302)
T ss_dssp ---CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred cccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccC
Confidence 45789999999987 4667899999999999999999999998764
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=6.1e-23 Score=219.02 Aligned_cols=152 Identities=27% Similarity=0.398 Sum_probs=108.3
Q ss_pred hccCCccceeeccC------------CeEEEEEEehHhh-HHHHHHHHHHHHHHhhcchhhHHH----------------
Q 045449 627 TDRFSENNLIGIGN------------GMEVAVKVFHQQY-ERALKSFEDECEVRKRIRHRNLVK---------------- 677 (823)
Q Consensus 627 t~~f~~~~~lg~g~------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~---------------- 677 (823)
.++|...+.||.|+ +..||||++.... ....+++.+|++++++++||||++
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 93 (303)
T 2vwi_A 14 RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMK 93 (303)
T ss_dssp CCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEE
T ss_pred hhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEeh
Confidence 46777788888875 5679999986543 344578899999999999999998
Q ss_pred --------------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCC
Q 045449 678 --------------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSG 725 (823)
Q Consensus 678 --------------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~ 725 (823)
++.|++++|+|+|+.+|+||||||+||+++.++.+||+|||+++....
T Consensus 94 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 173 (303)
T 2vwi_A 94 LLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLAT 173 (303)
T ss_dssp CCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHHHHHCC-
T ss_pred hccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccchheecc
Confidence 245788999999999999999999999999999999999999987643
Q ss_pred CCcc---ccccccccCCCcCcccccCC-CccccccceehhhhhhccccCCCCCcCCC
Q 045449 726 EDQL---SKQTQTLATIGYMAPEYGTK-GRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 726 ~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
.... .......||+.|+|||++.+ ..++.++||||+||+++++.+|..||...
T Consensus 174 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 230 (303)
T 2vwi_A 174 GGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKY 230 (303)
T ss_dssp --------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred CCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccC
Confidence 3211 11234579999999999865 46899999999999999999999998764
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.84 E-value=2.1e-22 Score=216.22 Aligned_cols=148 Identities=26% Similarity=0.352 Sum_probs=123.0
Q ss_pred hccCCccceeeccC------------CeEEEEEEehHhhHHHHHHHHHHHHHHhhcchhhHHH-----------------
Q 045449 627 TDRFSENNLIGIGN------------GMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVK----------------- 677 (823)
Q Consensus 627 t~~f~~~~~lg~g~------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~----------------- 677 (823)
.++|...+.||.|+ |..||||++.... ..+.+.+|++++.+++||||++
T Consensus 28 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 105 (314)
T 3com_A 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEY 105 (314)
T ss_dssp --CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeec
Confidence 45677788888875 6779999987543 2367899999999999999998
Q ss_pred ------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCcccccc
Q 045449 678 ------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQT 733 (823)
Q Consensus 678 ------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~ 733 (823)
++.|++.+|.|+|+.+++||||||+||+++.++.+||+|||+++....... ...
T Consensus 106 ~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~--~~~ 183 (314)
T 3com_A 106 CGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA--KRN 183 (314)
T ss_dssp CTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBS--CBC
T ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhcc--ccC
Confidence 357888999999999999999999999999999999999999987643321 233
Q ss_pred ccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCCC
Q 045449 734 QTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 734 ~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
...||+.|+|||++.+..++.++||||+||+++++++|..||...
T Consensus 184 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 228 (314)
T 3com_A 184 TVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADI 228 (314)
T ss_dssp CCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred ccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence 457999999999999989999999999999999999999999764
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=1.6e-22 Score=238.01 Aligned_cols=151 Identities=23% Similarity=0.303 Sum_probs=122.4
Q ss_pred ccCCccceeeccC---------------CeEEEEEEehHh-hHHHHHHHHHHHHHHhhcchhhHHH--------------
Q 045449 628 DRFSENNLIGIGN---------------GMEVAVKVFHQQ-YERALKSFEDECEVRKRIRHRNLVK-------------- 677 (823)
Q Consensus 628 ~~f~~~~~lg~g~---------------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~-------------- 677 (823)
++|...+.||+|+ +..||||++... .....+.|.+|+.++++++||||++
T Consensus 390 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~lv~ 469 (656)
T 2j0j_A 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWIIM 469 (656)
T ss_dssp GGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEE
T ss_pred ccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCceEEEE
Confidence 5677778888885 245899998643 3455578999999999999999998
Q ss_pred --------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCcccc
Q 045449 678 --------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSK 731 (823)
Q Consensus 678 --------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~ 731 (823)
++.|++.+|+|+|+.+|+||||||+|||++.++.+||+|||+++....... ..
T Consensus 470 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~~~-~~ 548 (656)
T 2j0j_A 470 ELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY-YK 548 (656)
T ss_dssp ECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC------
T ss_pred EcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeecCCCcc-ee
Confidence 356889999999999999999999999999999999999999987644322 12
Q ss_pred ccccccCCCcCcccccCCCccccccceehhhhhhccccC-CCCCcCCCc
Q 045449 732 QTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKET-RSMTVGETC 779 (823)
Q Consensus 732 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~-~~~~~~~~~ 779 (823)
.....+|+.|+|||++.+..++.++|||||||+++++++ |..||.+..
T Consensus 549 ~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~ 597 (656)
T 2j0j_A 549 ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK 597 (656)
T ss_dssp -----CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred ccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCC
Confidence 234567889999999988899999999999999999987 888987653
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=99.84 E-value=5.4e-22 Score=216.31 Aligned_cols=149 Identities=22% Similarity=0.329 Sum_probs=125.7
Q ss_pred hccCCccceeeccC----------CeEEEEEEehHhhHHH-----------------HHHHHHHHHHHhhcchhhHHH--
Q 045449 627 TDRFSENNLIGIGN----------GMEVAVKVFHQQYERA-----------------LKSFEDECEVRKRIRHRNLVK-- 677 (823)
Q Consensus 627 t~~f~~~~~lg~g~----------~~~vavK~~~~~~~~~-----------------~~~~~~E~~~l~~l~h~niv~-- 677 (823)
.++|...+.||.|+ +..||||++....... .+.|.+|++++++++||||++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 109 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCE 109 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEETTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCS
T ss_pred cCceEEEEEEcCCCCeEEEEEEcCCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEE
Confidence 35778888888875 6779999997654321 178999999999999999987
Q ss_pred ----------------------------------------------HHHHHHHHhhhcCC-CCEEeccCCCCCEEeCCCC
Q 045449 678 ----------------------------------------------IISSSLEYLHFGHS-IPIIHCDLKPSNVLLDEDM 710 (823)
Q Consensus 678 ----------------------------------------------~~~~~l~~L~~~h~-~~ivHrdlk~~NiLl~~~~ 710 (823)
++.|++.+|+|+|+ .+|+||||||+||+++.++
T Consensus 110 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~~~~~ 189 (348)
T 2pml_X 110 GIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNG 189 (348)
T ss_dssp EEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEECTTS
T ss_pred EEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEEcCCC
Confidence 35788999999998 9999999999999999999
Q ss_pred cEEEeecccccccCCCCccccccccccCCCcCcccccCCC-cccc-ccceehhhhhhccccCCCCCcCCCc
Q 045449 711 VAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKG-RVST-RGDVCSFGIISGGKETRSMTVGETC 779 (823)
Q Consensus 711 ~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~Dv~S~Gvv~~~~~~~~~~~~~~~ 779 (823)
.+||+|||.++..... ......||+.|+|||++.+. .++. ++||||+||+++++++|..||....
T Consensus 190 ~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 256 (348)
T 2pml_X 190 RVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKI 256 (348)
T ss_dssp CEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999999876433 23346799999999999877 6766 9999999999999999999997643
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=5.8e-22 Score=216.45 Aligned_cols=146 Identities=25% Similarity=0.279 Sum_probs=122.8
Q ss_pred hccCCccceeeccC-------------CeEEEEEEehHhhHHHHHHHHHHHHHHhhcchhh------HHH----------
Q 045449 627 TDRFSENNLIGIGN-------------GMEVAVKVFHQQYERALKSFEDECEVRKRIRHRN------LVK---------- 677 (823)
Q Consensus 627 t~~f~~~~~lg~g~-------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~---------- 677 (823)
.++|...+.||.|+ +..||||++... ....+.+.+|++++++++|++ ++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 96 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH 96 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence 36788888888875 367999999754 334578889999999998887 332
Q ss_pred -------------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEe-------------------C
Q 045449 678 -------------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLL-------------------D 707 (823)
Q Consensus 678 -------------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl-------------------~ 707 (823)
++.|++.+|+|+|+.+|+||||||+|||+ +
T Consensus 97 ~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~ 176 (355)
T 2eu9_A 97 MCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSV 176 (355)
T ss_dssp EEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCCEEEE
T ss_pred EEEEEeccCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccccccccccccccccc
Confidence 46789999999999999999999999999 5
Q ss_pred CCCcEEEeecccccccCCCCccccccccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCCC
Q 045449 708 EDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 708 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
.++.+||+|||+++..... .....||+.|+|||++.+..++.++||||+||++|++++|..||...
T Consensus 177 ~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 242 (355)
T 2eu9_A 177 KNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTH 242 (355)
T ss_dssp SCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred CCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCC
Confidence 6789999999999864322 23457999999999999999999999999999999999999999764
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.84 E-value=1.9e-22 Score=240.21 Aligned_cols=233 Identities=22% Similarity=0.241 Sum_probs=112.4
Q ss_pred ccchHHHHHHHHHHHHhccCCCccccccccC-CCCCCccceeeeeCCCCCcEEEEEcCCCCCccccCcccCCCCCCcEEE
Q 045449 4 KSIISQHQQALLALKAHISYDHTNLFARNWT-SSTSVCIWIGITCDVNSHRVIGLNISSFNLQGTITPQLGNLSSLQTLD 82 (823)
Q Consensus 4 ~~~~~~~~~aLl~~k~~~~~~~~~~~~~~W~-~~~~~c~w~gv~c~~~~~~v~~L~L~~~~l~g~~~~~l~~l~~L~~L~ 82 (823)
.++.+.+|+||+++......+....-. .|. ..+.++.|.++.+.. .+++.|+|.++++... +..+ |+.++
T Consensus 127 ~s~~~~~~~~l~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~s~--~~~~~l~L~~n~~~~~-~~~~-----l~~l~ 197 (727)
T 4b8c_D 127 KSLVDCTKQALMEMADTLTDSKTAKKQ-QPTGDSTPSGTATNSAVST--PLTPKIELFANGKDEA-NQAL-----LQHKK 197 (727)
T ss_dssp -----CCCHHHHHHHHHHHHHHTTC-------------------------------------------------------
T ss_pred hhccccchhhhhhhhhhcccccCcccC-CCcCCCCccccCCCceecC--CccceEEeeCCCCCcc-hhhH-----hhcCc
Confidence 346678899999999886433222222 564 345578899998864 6899999999998863 3333 34444
Q ss_pred ccCCCCCC---------CCCCCCCCCCCCCEEECCCCcCcCCCchhhhcCCCCcEEecccccccCccCccccCCCCCCcc
Q 045449 83 LSHNKLSG---------NIPSSIFNMHTLKLLDFSDNQLFGSLSSFIFNMSSMTTIDLSINRLSGELPANICKIPSTLSK 153 (823)
Q Consensus 83 Ls~N~l~g---------~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~p~~~~~ 153 (823)
|+.|.|.+ ..|..|..++.|+.|+|++|.|. .+|..+.++++|++|+|++|+|+ .+|..+ ++
T Consensus 198 Ls~~~i~~~~~~~n~~~~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~-------~~ 268 (727)
T 4b8c_D 198 LSQYSIDEDDDIENRMVMPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEI-------KN 268 (727)
T ss_dssp ------------------------CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGG-------GG
T ss_pred cCcccccCccccccceecChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhh-------hC
Confidence 55444433 45777888888888888888887 66766778888888888888887 555554 78
Q ss_pred ccccceeeeccceeeccCccccccchhhHHHHHhhcCCCcccCCcccCCcchhhhhccccccccCCccccccCCCCCcEE
Q 045449 154 CKQLEELNLGFNNLSGAIPKEIGNLTKLKEIISTITNSTVCEIPREIGNLPYLARLALATNNLVGVVPVTIFNMSALKEI 233 (823)
Q Consensus 154 l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~~l~~n~~~~~ip~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 233 (823)
+++|++|+|++|+|+ .+|..|++ +++|++|+|++|.|+ .+|..|.++++|++|
T Consensus 269 l~~L~~L~Ls~N~l~-~lp~~~~~-------------------------l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L 321 (727)
T 4b8c_D 269 LSNLRVLDLSHNRLT-SLPAELGS-------------------------CFQLKYFYFFDNMVT-TLPWEFGNLCNLQFL 321 (727)
T ss_dssp GTTCCEEECTTSCCS-SCCSSGGG-------------------------GTTCSEEECCSSCCC-CCCSSTTSCTTCCCE
T ss_pred CCCCCEEeCcCCcCC-ccChhhcC-------------------------CCCCCEEECCCCCCC-ccChhhhcCCCccEE
Confidence 888888888888887 55655443 445566777777776 556667777777777
Q ss_pred EccCCcccccCCcccccCCCCccEEEeeccccccccCccccCCCCCCeEEeecc
Q 045449 234 SLLNNSLSGSLPSRIDLSLPNVETLNLGINSFSGTIPSSITNSSKLSDLELGEN 287 (823)
Q Consensus 234 ~Ls~N~l~g~lp~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 287 (823)
+|++|.|++.+|..+......+..|+|++|.++|.+|.. |+.|++++|
T Consensus 322 ~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~~------l~~l~l~~n 369 (727)
T 4b8c_D 322 GVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPHE------RRFIEINTD 369 (727)
T ss_dssp ECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCCC---------------
T ss_pred eCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCccc------cceeEeecc
Confidence 777777776666655431112234667777777766653 445556655
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=99.84 E-value=2.1e-22 Score=214.66 Aligned_cols=144 Identities=29% Similarity=0.372 Sum_probs=113.5
Q ss_pred HhccCCccceeeccC------------CeEEEEEEehHhhHHHHHHHHHHHHHHhhcchhhHHH----------------
Q 045449 626 ATDRFSENNLIGIGN------------GMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVK---------------- 677 (823)
Q Consensus 626 at~~f~~~~~lg~g~------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~---------------- 677 (823)
..++|...+.||.|+ +..||||++... ....+.+.+|++++++++||||++
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT 82 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence 346788888888885 667999999654 344578999999999999999864
Q ss_pred --------------------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeeccc
Q 045449 678 --------------------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGI 719 (823)
Q Consensus 678 --------------------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGl 719 (823)
++.|++++|.|+|+.+|+||||||+||+++.++.+||+|||+
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~ 162 (303)
T 1zy4_A 83 AVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGL 162 (303)
T ss_dssp ---CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred ccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeCcc
Confidence 356889999999999999999999999999999999999999
Q ss_pred ccccCCCCc------------cccccccccCCCcCcccccCCC-ccccccceehhhhhhccccC
Q 045449 720 AKLLSGEDQ------------LSKQTQTLATIGYMAPEYGTKG-RVSTRGDVCSFGIISGGKET 770 (823)
Q Consensus 720 a~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvv~~~~~~ 770 (823)
++....... ........||+.|+|||++.+. .++.++||||+||++|++++
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~ 226 (303)
T 1zy4_A 163 AKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY 226 (303)
T ss_dssp CSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS
T ss_pred hhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh
Confidence 987542210 1122345799999999998764 68999999999999999987
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=6.3e-22 Score=214.63 Aligned_cols=145 Identities=26% Similarity=0.290 Sum_probs=121.4
Q ss_pred ccCCccceeeccC-------------CeEEEEEEehHhhHHHHHHHHHHHHHHhhcchhh------HHH-----------
Q 045449 628 DRFSENNLIGIGN-------------GMEVAVKVFHQQYERALKSFEDECEVRKRIRHRN------LVK----------- 677 (823)
Q Consensus 628 ~~f~~~~~lg~g~-------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~----------- 677 (823)
++|...+.||.|+ +..||||++... ....+.+.+|++++++++|++ +++
T Consensus 14 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~ 92 (339)
T 1z57_A 14 ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHI 92 (339)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEE
T ss_pred CceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcE
Confidence 4677777777765 567999999754 344578899999999998886 443
Q ss_pred ------------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCC-------------------
Q 045449 678 ------------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDE------------------- 708 (823)
Q Consensus 678 ------------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~------------------- 708 (823)
++.|++.+|+|+|+.+|+||||||+||+++.
T Consensus 93 ~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~~ 172 (339)
T 1z57_A 93 CIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLI 172 (339)
T ss_dssp EEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----CEEEEES
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCcccccccccc
Confidence 4678999999999999999999999999987
Q ss_pred CCcEEEeecccccccCCCCccccccccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCCC
Q 045449 709 DMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 709 ~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
++.+||+|||+++..... .....||+.|+|||++.+..++.++||||+||+++++++|..||...
T Consensus 173 ~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 237 (339)
T 1z57_A 173 NPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTH 237 (339)
T ss_dssp CCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred CCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence 668999999999874322 23457999999999999989999999999999999999999998764
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=9e-22 Score=217.47 Aligned_cols=149 Identities=27% Similarity=0.318 Sum_probs=121.5
Q ss_pred HHHhccCCccceeeccC------------CeEEEEEEehHhhHHHHHHHHHHHHHHhhcc-hhh-----HHH--------
Q 045449 624 LRATDRFSENNLIGIGN------------GMEVAVKVFHQQYERALKSFEDECEVRKRIR-HRN-----LVK-------- 677 (823)
Q Consensus 624 ~~at~~f~~~~~lg~g~------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~n-----iv~-------- 677 (823)
....++|...+.||.|+ +..||||++... ....+++.+|++++..++ |++ |++
T Consensus 50 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~ 128 (382)
T 2vx3_A 50 EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFR 128 (382)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEET
T ss_pred CEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccC
Confidence 33467899999999986 567999999754 334567888999888885 443 433
Q ss_pred ---------------------------------HHHHHHHHhhhcC--CCCEEeccCCCCCEEeC--CCCcEEEeecccc
Q 045449 678 ---------------------------------IISSSLEYLHFGH--SIPIIHCDLKPSNVLLD--EDMVAHISDFGIA 720 (823)
Q Consensus 678 ---------------------------------~~~~~l~~L~~~h--~~~ivHrdlk~~NiLl~--~~~~~kl~DfGla 720 (823)
++.|++.+|.|+| +.+|+||||||+|||++ .++.+||+|||+|
T Consensus 129 ~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a 208 (382)
T 2vx3_A 129 NHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS 208 (382)
T ss_dssp TEEEEEEECCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred CceEEEEecCCCCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccCc
Confidence 4567888888888 57999999999999995 4788999999999
Q ss_pred cccCCCCccccccccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCCC
Q 045449 721 KLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 721 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
+..... ....+||+.|+|||++.+..++.++|||||||+++++++|..||.+.
T Consensus 209 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~ 261 (382)
T 2vx3_A 209 CQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGA 261 (382)
T ss_dssp EETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred eecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 876432 23467999999999999999999999999999999999999999764
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=99.83 E-value=1.4e-21 Score=226.06 Aligned_cols=147 Identities=28% Similarity=0.379 Sum_probs=123.2
Q ss_pred ccCCccceeeccC------------CeEEEEEEehHh-hHHHHHHHHHHHHHHhhcchhhHHH-----------------
Q 045449 628 DRFSENNLIGIGN------------GMEVAVKVFHQQ-YERALKSFEDECEVRKRIRHRNLVK----------------- 677 (823)
Q Consensus 628 ~~f~~~~~lg~g~------------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~----------------- 677 (823)
++|...+.||.|+ |..||||++... .....+.|.+|++++++++||||++
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~ 93 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP 93 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence 6788888888875 567999998654 3455678999999999999999985
Q ss_pred --------------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCC---cEEEeecccccc
Q 045449 678 --------------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDM---VAHISDFGIAKL 722 (823)
Q Consensus 678 --------------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~---~~kl~DfGla~~ 722 (823)
++.|++.+|+|+|+.||+||||||+||+++.++ .+||+|||+++.
T Consensus 94 ~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~~ 173 (676)
T 3qa8_A 94 LLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKE 173 (676)
T ss_dssp CCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCCCB
T ss_pred EEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcccccccc
Confidence 357888999999999999999999999998665 499999999987
Q ss_pred cCCCCccccccccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCC
Q 045449 723 LSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGE 777 (823)
Q Consensus 723 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~ 777 (823)
...... .....||+.|+|||++.+..++.++||||+||++|++++|..||..
T Consensus 174 ~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~ 225 (676)
T 3qa8_A 174 LDQGEL---CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLP 225 (676)
T ss_dssp TTSCCC---CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cccccc---cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence 654322 2346799999999999999999999999999999999999999865
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=99.83 E-value=4.6e-22 Score=210.06 Aligned_cols=144 Identities=27% Similarity=0.390 Sum_probs=122.7
Q ss_pred hccCCccceeeccC------------CeEEEEEEehHhhHHHHHHHHHHHHHHhhcchhhHHH-----------------
Q 045449 627 TDRFSENNLIGIGN------------GMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVK----------------- 677 (823)
Q Consensus 627 t~~f~~~~~lg~g~------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~----------------- 677 (823)
.++|...+.||.|+ +..||||++.... +.+.+|++++++++||||++
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 85 (284)
T 2a19_B 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSK 85 (284)
T ss_dssp HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC------
T ss_pred ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccc
Confidence 45677888888875 6679999987543 45788999999999999974
Q ss_pred -----------------------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEee
Q 045449 678 -----------------------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISD 716 (823)
Q Consensus 678 -----------------------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~D 716 (823)
++.|++.+|+|+|+.+|+||||||+||+++.++.+||+|
T Consensus 86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~D 165 (284)
T 2a19_B 86 NSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGD 165 (284)
T ss_dssp ---CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECC
T ss_pred cccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEEECc
Confidence 356888999999999999999999999999999999999
Q ss_pred cccccccCCCCccccccccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCC
Q 045449 717 FGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGE 777 (823)
Q Consensus 717 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~ 777 (823)
||+++....... .....||+.|+|||++.+..++.++||||+||++++++++..|+.+
T Consensus 166 fg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~ 223 (284)
T 2a19_B 166 FGLVTSLKNDGK---RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFE 223 (284)
T ss_dssp CTTCEESSCCSC---CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHH
T ss_pred chhheecccccc---ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchh
Confidence 999987654322 2345699999999999988999999999999999999999988754
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=99.83 E-value=3.1e-22 Score=216.32 Aligned_cols=149 Identities=24% Similarity=0.345 Sum_probs=118.2
Q ss_pred ccCCccceeeccC------------Ce--EEEEEEehHhh-HHHHHHHHHHHHHHhhc-chhhHHH--------------
Q 045449 628 DRFSENNLIGIGN------------GM--EVAVKVFHQQY-ERALKSFEDECEVRKRI-RHRNLVK-------------- 677 (823)
Q Consensus 628 ~~f~~~~~lg~g~------------~~--~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~-------------- 677 (823)
++|...+.||.|+ +. .||||++.... ....+.+.+|++++.++ +||||++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 5677788898885 33 35899886432 34456799999999999 9999997
Q ss_pred ------------------------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEe
Q 045449 678 ------------------------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHIS 715 (823)
Q Consensus 678 ------------------------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~ 715 (823)
++.|++++|+|+|+.+|+||||||+||+++.++.+||+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kL~ 184 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIA 184 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEEC
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCCeEEEc
Confidence 24578889999999999999999999999999999999
Q ss_pred ecccccccCCCCccccccccccCCCcCcccccCCCccccccceehhhhhhccccC-CCCCcCCCc
Q 045449 716 DFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKET-RSMTVGETC 779 (823)
Q Consensus 716 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~-~~~~~~~~~ 779 (823)
|||+++..... .......+++.|+|||++.+..++.++||||+||+++++++ |..||.+..
T Consensus 185 Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~ 246 (327)
T 1fvr_A 185 DFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT 246 (327)
T ss_dssp CTTCEESSCEE---CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred ccCcCcccccc---ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCc
Confidence 99999753221 12233457889999999988889999999999999999998 999987643
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=99.83 E-value=2.5e-22 Score=216.84 Aligned_cols=151 Identities=30% Similarity=0.352 Sum_probs=124.0
Q ss_pred HHhccCCccceeeccC-------------CeEEEEEEehHhh--HHHHHHHHHHHHHHhhc---chhhHHH---------
Q 045449 625 RATDRFSENNLIGIGN-------------GMEVAVKVFHQQY--ERALKSFEDECEVRKRI---RHRNLVK--------- 677 (823)
Q Consensus 625 ~at~~f~~~~~lg~g~-------------~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~--------- 677 (823)
++.++|...+.||.|+ +..||||++.... ......+.+|+++++++ +||||++
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 87 (326)
T 1blx_A 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 87 (326)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence 3557888888888875 5679999986432 11123567788877776 8999987
Q ss_pred -------------------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccc
Q 045449 678 -------------------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIA 720 (823)
Q Consensus 678 -------------------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla 720 (823)
++.|++++|+|+|+.||+||||||+||+++.++.+||+|||++
T Consensus 88 ~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~ 167 (326)
T 1blx_A 88 TDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLA 167 (326)
T ss_dssp CSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSC
T ss_pred cCCCceEEEEEecCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCccc
Confidence 3568899999999999999999999999999999999999999
Q ss_pred cccCCCCccccccccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCCC
Q 045449 721 KLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 721 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
+...... ......||+.|+|||++.+..++.++||||+||+++++++|..||.+.
T Consensus 168 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 222 (326)
T 1blx_A 168 RIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGS 222 (326)
T ss_dssp CCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccccCCC---CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCC
Confidence 8754322 233467899999999999989999999999999999999999999764
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.83 E-value=4.7e-22 Score=213.78 Aligned_cols=149 Identities=28% Similarity=0.340 Sum_probs=107.5
Q ss_pred hccCCccceeeccC------------CeEEEEEEehHhh--HHHHHHHHHHHHHHhhcchhhHHH---------------
Q 045449 627 TDRFSENNLIGIGN------------GMEVAVKVFHQQY--ERALKSFEDECEVRKRIRHRNLVK--------------- 677 (823)
Q Consensus 627 t~~f~~~~~lg~g~------------~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~--------------- 677 (823)
.++|...+.||.|+ |..||||++.... ....+.+..+..+++.++||||++
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 35566667777764 6789999996542 233344555666788889999998
Q ss_pred -------------------------HHHHHHHHhhhcCCC-CEEeccCCCCCEEeCCCCcEEEeecccccccCCCCcccc
Q 045449 678 -------------------------IISSSLEYLHFGHSI-PIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSK 731 (823)
Q Consensus 678 -------------------------~~~~~l~~L~~~h~~-~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~ 731 (823)
++.|++++|+|+|+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 104 e~~~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~--- 180 (318)
T 2dyl_A 104 ELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKA--- 180 (318)
T ss_dssp CCCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC-----------
T ss_pred eccCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCCcc---
Confidence 356888899999985 999999999999999999999999999986543321
Q ss_pred ccccccCCCcCcccccC-----CCccccccceehhhhhhccccCCCCCcCCC
Q 045449 732 QTQTLATIGYMAPEYGT-----KGRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 732 ~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
.....||+.|+|||++. ...++.++|||||||+++++++|..||...
T Consensus 181 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 232 (318)
T 2dyl_A 181 KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNC 232 (318)
T ss_dssp ------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCC
Confidence 23457999999999984 456889999999999999999999999763
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.82 E-value=1.1e-21 Score=212.67 Aligned_cols=143 Identities=19% Similarity=0.184 Sum_probs=118.0
Q ss_pred hccCCccceeeccC----------CeEEEEEEehHhh--------HHHHHHHHHHHHHHhhcc-----------------
Q 045449 627 TDRFSENNLIGIGN----------GMEVAVKVFHQQY--------ERALKSFEDECEVRKRIR----------------- 671 (823)
Q Consensus 627 t~~f~~~~~lg~g~----------~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~----------------- 671 (823)
.++|...+.||+|+ |+.||||++.... ....+.+.+|++++++++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~ 98 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLN 98 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEETTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEE
T ss_pred cccchheeeecccCceEEEEEEeCCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhc
Confidence 35677788899886 6789999997542 223367889999999887
Q ss_pred ---------hhhHHH----------------------------------------------------HHHHHHHHhhhcC
Q 045449 672 ---------HRNLVK----------------------------------------------------IISSSLEYLHFGH 690 (823)
Q Consensus 672 ---------h~niv~----------------------------------------------------~~~~~l~~L~~~h 690 (823)
||||++ ++.|++.+|+|+|
T Consensus 99 ~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~~~~~~~~~~~i~~qi~~aL~~lH 178 (336)
T 2vuw_A 99 SVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAE 178 (336)
T ss_dssp EEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTTTCCCHHHHHHHHHHHHHHHHHHH
T ss_pred ceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHhcCCCHHHHHHHHHHHHHHHHHHH
Confidence 888876 3568899999999
Q ss_pred -CCCEEeccCCCCCEEeCCCC--------------------cEEEeecccccccCCCCccccccccccCCCcCcccccCC
Q 045449 691 -SIPIIHCDLKPSNVLLDEDM--------------------VAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTK 749 (823)
Q Consensus 691 -~~~ivHrdlk~~NiLl~~~~--------------------~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 749 (823)
+.+|+||||||+|||++.++ .+||+|||+|+..... ..+||+.|+|||++.+
T Consensus 179 ~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------~~~gt~~y~aPE~~~g 251 (336)
T 2vuw_A 179 ASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------IVVFCDVSMDEDLFTG 251 (336)
T ss_dssp HHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------EEECCCCTTCSGGGCC
T ss_pred HhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------cEEEeecccChhhhcC
Confidence 99999999999999999876 8999999999876422 3479999999999986
Q ss_pred Cccccccceehhhhh-hccccCCCCCcCC
Q 045449 750 GRVSTRGDVCSFGII-SGGKETRSMTVGE 777 (823)
Q Consensus 750 ~~~~~~~Dv~S~Gvv-~~~~~~~~~~~~~ 777 (823)
.. +.++||||+|++ .+++..|..||.+
T Consensus 252 ~~-~~~~Diwsl~~~~~~~~~~g~~p~~~ 279 (336)
T 2vuw_A 252 DG-DYQFDIYRLMKKENNNRWGEYHPYSN 279 (336)
T ss_dssp CS-SHHHHHHHHHHHHHTTCTTSCCTHHH
T ss_pred CC-ccceehhhhhCCCCcccccccCCCcc
Confidence 65 889999998777 7888888888854
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.82 E-value=5.6e-20 Score=187.59 Aligned_cols=165 Identities=23% Similarity=0.283 Sum_probs=129.6
Q ss_pred ccCCCCCCccceeeeeCCCCCcEEEEEcCCCCCccccCcccCCCCCCcEEEccCCCCCCCCCCCCCCCCCCCEEECCCCc
Q 045449 32 NWTSSTSVCIWIGITCDVNSHRVIGLNISSFNLQGTITPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLDFSDNQ 111 (823)
Q Consensus 32 ~W~~~~~~c~w~gv~c~~~~~~v~~L~L~~~~l~g~~~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~ 111 (823)
-|..+.+.|+|.+|.|+.. ++. .+|..+. ++|++|+|++|+|++..|..|..+++|++|+|++|+
T Consensus 11 ~~~~~~~~Cs~~~v~c~~~------------~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~ 75 (229)
T 3e6j_A 11 AACPSQCSCSGTTVDCRSK------------RHA-SVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQ 75 (229)
T ss_dssp CCCCTTCEEETTEEECTTS------------CCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred ccCCCCCEEeCCEeEccCC------------CcC-ccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCC
Confidence 4566788999999999742 233 4555443 889999999999999989999999999999999999
Q ss_pred CcCCCchhhhcCCCCcEEecccccccCccCccccCCCCCCccccccceeeeccceeeccCccccccchhhHHHHHhhcCC
Q 045449 112 LFGSLSSFIFNMSSMTTIDLSINRLSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKEIGNLTKLKEIISTITNS 191 (823)
Q Consensus 112 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~~l~~n~ 191 (823)
|++..+..|.++++|++|+|++|+|++..+.. |..+++|++|+|++|+++ .+|..+
T Consensus 76 l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~-------~~~l~~L~~L~Ls~N~l~-~lp~~~---------------- 131 (229)
T 3e6j_A 76 LGALPVGVFDSLTQLTVLDLGTNQLTVLPSAV-------FDRLVHLKELFMCCNKLT-ELPRGI---------------- 131 (229)
T ss_dssp CCCCCTTTTTTCTTCCEEECCSSCCCCCCTTT-------TTTCTTCCEEECCSSCCC-SCCTTG----------------
T ss_pred CCCcChhhcccCCCcCEEECCCCcCCccChhH-------hCcchhhCeEeccCCccc-ccCccc----------------
Confidence 98777788899999999999999998544433 478899999999999887 445433
Q ss_pred CcccCCcccCCcchhhhhccccccccCCccccccCCCCCcEEEccCCcccccC
Q 045449 192 TVCEIPREIGNLPYLARLALATNNLVGVVPVTIFNMSALKEISLLNNSLSGSL 244 (823)
Q Consensus 192 ~~~~ip~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~l 244 (823)
..+++|++|+|++|+|++..+..|..+++|+.|+|++|.+++..
T Consensus 132 ---------~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c 175 (229)
T 3e6j_A 132 ---------ERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDCEC 175 (229)
T ss_dssp ---------GGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCTTB
T ss_pred ---------ccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccCCc
Confidence 34456677788888888766667777777888888877776543
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.82 E-value=1e-22 Score=219.11 Aligned_cols=152 Identities=26% Similarity=0.317 Sum_probs=116.9
Q ss_pred hccCCccceeeccC---------CeEEEEEEehHhh--HHHHHHHHHHHHHHhhcchhhHHH------------------
Q 045449 627 TDRFSENNLIGIGN---------GMEVAVKVFHQQY--ERALKSFEDECEVRKRIRHRNLVK------------------ 677 (823)
Q Consensus 627 t~~f~~~~~lg~g~---------~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~------------------ 677 (823)
.++|...+.||.|+ +..||||++.... ....+.|.+|++++++++||||++
T Consensus 32 ~~~~~~~~~lg~G~~g~V~~~~~~~~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~ 111 (319)
T 2y4i_B 32 FEQLEIGELIGKGRFGQVYHGRWHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLC 111 (319)
T ss_dssp CSCEECCCBCCCSSSSEEEEEEESSSEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECBCC
T ss_pred HHHeEEeeEeccCCceEEEEEEEcCeEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEeecc
Confidence 46677788888886 2348899886432 222356889999999999999998
Q ss_pred -----------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCc---ccc
Q 045449 678 -----------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQ---LSK 731 (823)
Q Consensus 678 -----------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~---~~~ 731 (823)
++.|++.+|+|+|+.+|+||||||+||+++ ++.+||+|||+++....... ...
T Consensus 112 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~~~~~ 190 (319)
T 2y4i_B 112 KGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDK 190 (319)
T ss_dssp CSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC----------CCS
T ss_pred cCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCccccccccccccccc
Confidence 467889999999999999999999999998 67999999999876532111 112
Q ss_pred ccccccCCCcCcccccCC---------CccccccceehhhhhhccccCCCCCcCCCc
Q 045449 732 QTQTLATIGYMAPEYGTK---------GRVSTRGDVCSFGIISGGKETRSMTVGETC 779 (823)
Q Consensus 732 ~~~~~gt~~y~aPE~~~~---------~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~~ 779 (823)
.....||+.|+|||++.+ ..++.++|||||||+++++++|..||....
T Consensus 191 ~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~ 247 (319)
T 2y4i_B 191 LRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQP 247 (319)
T ss_dssp CBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCC
T ss_pred cccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 234568999999998864 457899999999999999999999997653
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=99.82 E-value=2.1e-22 Score=216.87 Aligned_cols=148 Identities=22% Similarity=0.292 Sum_probs=121.4
Q ss_pred hccCCccceeeccC------------CeEEEEEEehHhhH------HHHHHHHHHHHHHhhcc--hhhHHH---------
Q 045449 627 TDRFSENNLIGIGN------------GMEVAVKVFHQQYE------RALKSFEDECEVRKRIR--HRNLVK--------- 677 (823)
Q Consensus 627 t~~f~~~~~lg~g~------------~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~--h~niv~--------- 677 (823)
.++|...+.||.|+ +..||||++..... ...+.+.+|++++++++ |+||++
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~ 121 (320)
T 3a99_A 42 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 121 (320)
T ss_dssp TTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred cCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCC
Confidence 46677778888875 67799999975431 12245778999999996 588887
Q ss_pred --------------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeC-CCCcEEEeecccccccC
Q 045449 678 --------------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLD-EDMVAHISDFGIAKLLS 724 (823)
Q Consensus 678 --------------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~-~~~~~kl~DfGla~~~~ 724 (823)
++.|++++|+|+|+.+|+||||||+||+++ +++.+||+|||+++...
T Consensus 122 ~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~~~ 201 (320)
T 3a99_A 122 SFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK 201 (320)
T ss_dssp EEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred cEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCccccccc
Confidence 356889999999999999999999999999 77999999999998765
Q ss_pred CCCccccccccccCCCcCcccccCCCcc-ccccceehhhhhhccccCCCCCcCCC
Q 045449 725 GEDQLSKQTQTLATIGYMAPEYGTKGRV-STRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 725 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
... .....||+.|+|||++.+..+ +.++|||||||+++++++|..||...
T Consensus 202 ~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 252 (320)
T 3a99_A 202 DTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 252 (320)
T ss_dssp SSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH
T ss_pred ccc----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCCh
Confidence 322 234579999999999877665 78899999999999999999998754
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.82 E-value=7.4e-20 Score=185.41 Aligned_cols=155 Identities=19% Similarity=0.203 Sum_probs=97.6
Q ss_pred eEEEeecCCCCccCCccccccccccceEEecCCcceeccC-ccccCcccccEEEcccCcCCCCchhcccccCCCCEEEcc
Q 045449 333 KVLIVTGNPLDGILPKSIGNFSLSLETILMANCSISGNIP-QVVGNLSNLLVLELGGNNLTGPIPVTFSQLQTLQAFDLT 411 (823)
Q Consensus 333 ~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls 411 (823)
+.+++++|.++. +|..+. ..+++|+|++|+|++..| ..|..+++|++|+|++|++++..+..|..+++|++|+|+
T Consensus 14 ~~l~~s~n~l~~-iP~~~~---~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls 89 (220)
T 2v70_A 14 TTVDCSNQKLNK-IPEHIP---QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLT 89 (220)
T ss_dssp TEEECCSSCCSS-CCSCCC---TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC
T ss_pred CEeEeCCCCccc-CccCCC---CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECC
Confidence 356666666664 454433 345667777777766643 346666667777777777666555566666666666666
Q ss_pred CCCCCCcchHhhhcCCCCCEEEcccCcCcccccccccCCCCCCeEeccCCccccccchhhhccCCCcEEecccccccccc
Q 045449 412 RNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSVRVLYLGLNIFTSVLSSTIWNLKDILFIDVSSNFLDGPL 491 (823)
Q Consensus 412 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~LdLs~N~l~g~~ 491 (823)
+|++++..+..|..+++|++|+|++|+|++..|..|..+++|+.|+|++|++++..|..+..+++|+.|+|++|.+++..
T Consensus 90 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c 169 (220)
T 2v70_A 90 SNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNC 169 (220)
T ss_dssp SSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECSG
T ss_pred CCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCCC
Confidence 66666666666666666666666666666666666666666666666666666655666666666666666666655443
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=99.82 E-value=7.9e-22 Score=208.88 Aligned_cols=150 Identities=27% Similarity=0.380 Sum_probs=123.7
Q ss_pred HhccCCccceeeccC------------CeEEEEEEehHhh--HHHHHHHHHHHHHHhhcchhhHHH--------------
Q 045449 626 ATDRFSENNLIGIGN------------GMEVAVKVFHQQY--ERALKSFEDECEVRKRIRHRNLVK-------------- 677 (823)
Q Consensus 626 at~~f~~~~~lg~g~------------~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~-------------- 677 (823)
..++|...+.||.|+ ++.||||++.... ....+.+.+|++++++++||||++
T Consensus 20 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 99 (287)
T 2wei_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (287)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEE
Confidence 346788888999885 5679999986543 233467999999999999999998
Q ss_pred --------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCC---CcEEEeecccccccCCCCc
Q 045449 678 --------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDED---MVAHISDFGIAKLLSGEDQ 728 (823)
Q Consensus 678 --------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~---~~~kl~DfGla~~~~~~~~ 728 (823)
++.|++.+|.|+|+.+|+||||||+||+++.+ +.+||+|||+++.......
T Consensus 100 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~~ 179 (287)
T 2wei_A 100 GELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK 179 (287)
T ss_dssp ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCSS
T ss_pred EEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCCCc
Confidence 35788999999999999999999999999754 4799999999987643322
Q ss_pred cccccccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCCCc
Q 045449 729 LSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGETC 779 (823)
Q Consensus 729 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~~ 779 (823)
.....||+.|+|||++.+ .++.++||||+||+++++++|..||....
T Consensus 180 ---~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 226 (287)
T 2wei_A 180 ---MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKN 226 (287)
T ss_dssp ---CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ---cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCC
Confidence 233468999999998865 58999999999999999999999987643
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.81 E-value=6.8e-20 Score=185.69 Aligned_cols=159 Identities=17% Similarity=0.216 Sum_probs=144.9
Q ss_pred ccceEEecCCcceeccCccccCcccccEEEcccCcCCCCch-hcccccCCCCEEEccCCCCCCcchHhhhcCCCCCEEEc
Q 045449 356 SLETILMANCSISGNIPQVVGNLSNLLVLELGGNNLTGPIP-VTFSQLQTLQAFDLTRNKLAGPITDELCHLARLHSLVL 434 (823)
Q Consensus 356 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 434 (823)
.-+++++++|.++. +|..+. ..+++|+|++|++++..| ..|..+++|++|+|++|+|++..+..|.++++|++|+|
T Consensus 12 ~~~~l~~s~n~l~~-iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~L 88 (220)
T 2v70_A 12 EGTTVDCSNQKLNK-IPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILL 88 (220)
T ss_dssp ETTEEECCSSCCSS-CCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEEC
T ss_pred CCCEeEeCCCCccc-CccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEEC
Confidence 34689999999985 566553 457899999999997755 45899999999999999999888889999999999999
Q ss_pred ccCcCcccccccccCCCCCCeEeccCCccccccchhhhccCCCcEEeccccccccccCccccCCCCCcEEEcccCCCCCC
Q 045449 435 QGNKFSGSIPSCLGNLTSVRVLYLGLNIFTSVLSSTIWNLKDILFIDVSSNFLDGPLSLDIGNLKVVIGLDFSRNNLSGD 514 (823)
Q Consensus 435 s~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~ 514 (823)
++|++++..|..|..+++|++|+|++|++++..|..+..+++|+.|+|++|.+++..|..+..++.|+.|++++|.+++.
T Consensus 89 s~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~ 168 (220)
T 2v70_A 89 TSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCN 168 (220)
T ss_dssp CSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECS
T ss_pred CCCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCC
Confidence 99999998888999999999999999999999999999999999999999999999999999999999999999999987
Q ss_pred CCC
Q 045449 515 IPI 517 (823)
Q Consensus 515 ip~ 517 (823)
.+.
T Consensus 169 c~l 171 (220)
T 2v70_A 169 CYL 171 (220)
T ss_dssp GGG
T ss_pred Cch
Confidence 663
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.81 E-value=1e-21 Score=210.67 Aligned_cols=151 Identities=22% Similarity=0.310 Sum_probs=120.2
Q ss_pred HHHhccCCccceeeccC------------CeEEEEEEehHhhH------HHHHHHHHHHHHHhhc----chhhHHH----
Q 045449 624 LRATDRFSENNLIGIGN------------GMEVAVKVFHQQYE------RALKSFEDECEVRKRI----RHRNLVK---- 677 (823)
Q Consensus 624 ~~at~~f~~~~~lg~g~------------~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l----~h~niv~---- 677 (823)
....++|...+.||.|+ +..||||++..... .....+.+|++++.++ +||||++
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~ 106 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW 106 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence 34457899999999886 56799999964421 2234567899999999 8999998
Q ss_pred -------------------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeC-CCCcEEEeeccc
Q 045449 678 -------------------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLD-EDMVAHISDFGI 719 (823)
Q Consensus 678 -------------------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~-~~~~~kl~DfGl 719 (823)
++.|++++|+|+|+.+|+||||||+||+++ .++.+||+|||+
T Consensus 107 ~~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~ 186 (312)
T 2iwi_A 107 FETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGS 186 (312)
T ss_dssp C-----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCSS
T ss_pred EecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcch
Confidence 356889999999999999999999999999 889999999999
Q ss_pred ccccCCCCccccccccccCCCcCcccccCCCcc-ccccceehhhhhhccccCCCCCcCCC
Q 045449 720 AKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRV-STRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 720 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
++...... .....||+.|+|||++.+..+ +.++||||+||+++++++|..||...
T Consensus 187 ~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 242 (312)
T 2iwi_A 187 GALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERD 242 (312)
T ss_dssp CEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH
T ss_pred hhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCCh
Confidence 98765332 234569999999999877666 45899999999999999999998654
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.81 E-value=5.2e-20 Score=201.53 Aligned_cols=178 Identities=23% Similarity=0.252 Sum_probs=122.3
Q ss_pred eEEEeecCCCCccCCccccccccccceEEecCCcceeccCcccc-CcccccEEEcccCcCCCCchhcccccCCCCEEEcc
Q 045449 333 KVLIVTGNPLDGILPKSIGNFSLSLETILMANCSISGNIPQVVG-NLSNLLVLELGGNNLTGPIPVTFSQLQTLQAFDLT 411 (823)
Q Consensus 333 ~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls 411 (823)
+.+++++|.++. +|..+. ..++.|+|++|+|++..+..|. ++++|++|+|++|+|++..+..|..+++|++|+|+
T Consensus 21 ~~l~c~~~~l~~-iP~~~~---~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls 96 (361)
T 2xot_A 21 NILSCSKQQLPN-VPQSLP---SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLS 96 (361)
T ss_dssp TEEECCSSCCSS-CCSSCC---TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC
T ss_pred CEEEeCCCCcCc-cCccCC---CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECC
Confidence 456666666664 454433 4567777777777777777676 77777777777777776666667777777777777
Q ss_pred CCCCCCcchHhhhcCCCCCEEEcccCcCcccccccccCCCCCCeEeccCCccccccchhh---hccCCCcEEeccccccc
Q 045449 412 RNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSVRVLYLGLNIFTSVLSSTI---WNLKDILFIDVSSNFLD 488 (823)
Q Consensus 412 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~---~~l~~L~~LdLs~N~l~ 488 (823)
+|+|++..+..|.++++|+.|+|++|+|++..|..|.++++|+.|+|++|++++..+..+ ..+++|+.|||++|.|+
T Consensus 97 ~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~ 176 (361)
T 2xot_A 97 SNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLK 176 (361)
T ss_dssp SSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCC
T ss_pred CCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCC
Confidence 777776666667777777777777777777767777777777777777777777554444 45777777777777777
Q ss_pred cccCccccCCCC--CcEEEcccCCCCCC
Q 045449 489 GPLSLDIGNLKV--VIGLDFSRNNLSGD 514 (823)
Q Consensus 489 g~~p~~~~~l~~--L~~L~ls~N~l~g~ 514 (823)
+..+..+..++. ++.|+|++|.+.+.
T Consensus 177 ~l~~~~~~~l~~~~l~~l~l~~N~~~C~ 204 (361)
T 2xot_A 177 KLPLTDLQKLPAWVKNGLYLHNNPLECD 204 (361)
T ss_dssp CCCHHHHHHSCHHHHTTEECCSSCEECC
T ss_pred ccCHHHhhhccHhhcceEEecCCCccCC
Confidence 555555666655 36677777766643
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.81 E-value=1.6e-21 Score=225.37 Aligned_cols=131 Identities=19% Similarity=0.104 Sum_probs=94.8
Q ss_pred CeEEEEEEehHh----------hHHHHHHHHHHHHHHhhc-chhhHHH--------------------------------
Q 045449 641 GMEVAVKVFHQQ----------YERALKSFEDECEVRKRI-RHRNLVK-------------------------------- 677 (823)
Q Consensus 641 ~~~vavK~~~~~----------~~~~~~~~~~E~~~l~~l-~h~niv~-------------------------------- 677 (823)
|..||||++... .+...++|.+|+++|+++ .|+||++
T Consensus 259 g~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVMEyv~G~~L~d~i~~~~~ 338 (569)
T 4azs_A 259 GEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVMEKLPGRLLSDMLAAGEE 338 (569)
T ss_dssp CSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEEECCCSEEHHHHHHTTCC
T ss_pred cceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEEecCCCCcHHHHHHhCCC
Confidence 567999998532 245567899999999999 7999998
Q ss_pred -----HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCcccccCCCcc
Q 045449 678 -----IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRV 752 (823)
Q Consensus 678 -----~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 752 (823)
+++|++++|+|+|++|||||||||+|||++.++.+||+|||+|+...... ......+||++|||||++.+ .+
T Consensus 339 l~~~~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~--~~~~t~vGTp~YmAPE~l~g-~~ 415 (569)
T 4azs_A 339 IDREKILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDC--SWPTNLVQSFFVFVNELFAE-NK 415 (569)
T ss_dssp CCHHHHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC-----CCSHHHHHHHHHHHHHHC-----
T ss_pred CCHHHHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCCC--ccccCceechhhccHHHhCC-CC
Confidence 57899999999999999999999999999999999999999998765432 23345789999999999865 56
Q ss_pred ccccceehhhhhhccccCCCCC
Q 045449 753 STRGDVCSFGIISGGKETRSMT 774 (823)
Q Consensus 753 ~~~~Dv~S~Gvv~~~~~~~~~~ 774 (823)
..++|+||+|++.++++++..+
T Consensus 416 ~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 416 SWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp -------------CCCCTTHHH
T ss_pred CCcccccccccchhhhccccch
Confidence 7789999999998888776543
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.81 E-value=1.3e-19 Score=210.39 Aligned_cols=241 Identities=20% Similarity=0.254 Sum_probs=146.2
Q ss_pred cchhhhhccccccccCCccccccCCCCCcEEEccCCcccccCCcccccCCCCccEEEeeccccccccCccccCCCCCCeE
Q 045449 203 LPYLARLALATNNLVGVVPVTIFNMSALKEISLLNNSLSGSLPSRIDLSLPNVETLNLGINSFSGTIPSSITNSSKLSDL 282 (823)
Q Consensus 203 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 282 (823)
+..+..+.++.+.+....+ +..+++|+.|++++|.++ .+|. +. .+++|+.|+|++|+|++..| +..+++|+.|
T Consensus 20 l~~l~~l~l~~~~i~~~~~--~~~L~~L~~L~l~~n~i~-~l~~-l~-~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L 92 (605)
T 1m9s_A 20 FAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQG-IQ-YLPNVTKLFLNGNKLTDIKP--LTNLKNLGWL 92 (605)
T ss_dssp HHHHHHHHTTCSCTTSEEC--HHHHTTCCCCBCTTCCCC-CCTT-GG-GCTTCCEEECTTSCCCCCGG--GGGCTTCCEE
T ss_pred HHHHHHHhccCCCcccccc--hhcCCCCCEEECcCCCCC-CChH-Hc-cCCCCCEEEeeCCCCCCChh--hccCCCCCEE
Confidence 3455667777777775443 456778888888888877 4553 33 37778888888887776544 7777777777
Q ss_pred EeecccccccCCCccCCCcccCcccccCccccCCCCcccccccccCCCCceEEEeecCCCCccCCccccccccccceEEe
Q 045449 283 ELGENLFSGFIPNTIGNLRNLEFGNIADNYLTSSTPELSFLSSLTNCKKLKVLIVTGNPLDGILPKSIGNFSLSLETILM 362 (823)
Q Consensus 283 ~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L 362 (823)
+|++|.+++. +.+..+++|+.|+|++|.+++. ..+..+++|+.|+|++|.++
T Consensus 93 ~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~l-------~~l~~l~~L~~L~Ls~N~l~------------------- 144 (605)
T 1m9s_A 93 FLDENKIKDL--SSLKDLKKLKSLSLEHNGISDI-------NGLVHLPQLESLYLGNNKIT------------------- 144 (605)
T ss_dssp ECCSSCCCCC--TTSTTCTTCCEEECTTSCCCCC-------GGGGGCTTCSEEECCSSCCC-------------------
T ss_pred ECcCCCCCCC--hhhccCCCCCEEEecCCCCCCC-------ccccCCCccCEEECCCCccC-------------------
Confidence 7777777753 2566666666666666666543 23444555555555555444
Q ss_pred cCCcceeccCccccCcccccEEEcccCcCCCCchhcccccCCCCEEEccCCCCCCcchHhhhcCCCCCEEEcccCcCccc
Q 045449 363 ANCSISGNIPQVVGNLSNLLVLELGGNNLTGPIPVTFSQLQTLQAFDLTRNKLAGPITDELCHLARLHSLVLQGNKFSGS 442 (823)
Q Consensus 363 ~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ 442 (823)
+. ..+..+++|+.|+|++|++++..| +..+++|+.|+|++|+|++. | .+..+++|+.|+|++|.+++.
T Consensus 145 ------~l--~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~i~~l-~-~l~~l~~L~~L~L~~N~l~~~ 212 (605)
T 1m9s_A 145 ------DI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISDL-R-ALAGLKNLDVLELFSQECLNK 212 (605)
T ss_dssp ------CC--GGGGSCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCBC-G-GGTTCTTCSEEECCSEEEECC
T ss_pred ------Cc--hhhcccCCCCEEECcCCcCCCchh--hccCCCCCEEECcCCCCCCC-h-HHccCCCCCEEEccCCcCcCC
Confidence 32 345566777777777777776555 67777777777777777754 2 467777777777777777754
Q ss_pred ccccccCCCCCCeEeccCCccccccchhhhccCCCcEEeccccccccccCccccCCCCC
Q 045449 443 IPSCLGNLTSVRVLYLGLNIFTSVLSSTIWNLKDILFIDVSSNFLDGPLSLDIGNLKVV 501 (823)
Q Consensus 443 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~LdLs~N~l~g~~p~~~~~l~~L 501 (823)
....+..+..+..+..- -+.....+.+...++...|.++..+..+...
T Consensus 213 p~~~~~~l~~~~~l~~l-----------~g~~~~~~~i~~~g~~~~~~i~~~l~~~~~~ 260 (605)
T 1m9s_A 213 PINHQSNLVVPNTVKNT-----------DGSLVTPEIISDDGDYEKPNVKWHLPEFTNE 260 (605)
T ss_dssp CCCCCSSCEEECCCBCS-----------SSCBCCCSEESTTCEEETTEEECCCSSCCSE
T ss_pred cccccccEEeccccccc-----------CCCCcCchhcccCCcccCCcceeccccccce
Confidence 33333322222111100 0112233455556666666666555555443
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.81 E-value=1e-19 Score=192.89 Aligned_cols=172 Identities=20% Similarity=0.328 Sum_probs=100.9
Q ss_pred cCCCCceEEEeecCCCCccCCccccccccccceEEecCCcceeccCccccCcccccEEEcccCcCCCCchhcccccCCCC
Q 045449 327 TNCKKLKVLIVTGNPLDGILPKSIGNFSLSLETILMANCSISGNIPQVVGNLSNLLVLELGGNNLTGPIPVTFSQLQTLQ 406 (823)
Q Consensus 327 ~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~ 406 (823)
..+++|+.|++++|.++.. | .+..+ ++|++|++++|++++..+ +..+++|++|+|++|++++ +| .+..+++|+
T Consensus 43 ~~l~~L~~L~l~~~~i~~~-~-~~~~l-~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~-~~-~l~~l~~L~ 115 (291)
T 1h6t_A 43 NELNSIDQIIANNSDIKSV-Q-GIQYL-PNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKD-LS-SLKDLKKLK 115 (291)
T ss_dssp HHHHTCCEEECTTSCCCCC-T-TGGGC-TTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-GG-GGTTCTTCC
T ss_pred hhcCcccEEEccCCCcccC-h-hHhcC-CCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCC-Ch-hhccCCCCC
Confidence 3445555555555555533 2 24444 455666666666554433 5566666666666666653 22 256666666
Q ss_pred EEEccCCCCCCcchHhhhcCCCCCEEEcccCcCcccccccccCCCCCCeEeccCCccccccchhhhccCCCcEEeccccc
Q 045449 407 AFDLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSVRVLYLGLNIFTSVLSSTIWNLKDILFIDVSSNF 486 (823)
Q Consensus 407 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~LdLs~N~ 486 (823)
+|+|++|++++. ..+..+++|+.|++++|++++. ..+..+++|+.|+|++|++++..| +..+++|+.|++++|.
T Consensus 116 ~L~L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~L~~N~ 189 (291)
T 1h6t_A 116 SLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNH 189 (291)
T ss_dssp EEECTTSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSC
T ss_pred EEECCCCcCCCC--hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccccchh--hcCCCccCEEECCCCc
Confidence 666666666643 3455666666666666666643 456666666666666666666544 6666666666666666
Q ss_pred cccccCccccCCCCCcEEEcccCCCCC
Q 045449 487 LDGPLSLDIGNLKVVIGLDFSRNNLSG 513 (823)
Q Consensus 487 l~g~~p~~~~~l~~L~~L~ls~N~l~g 513 (823)
+++. | .+..++.|+.|++++|+++.
T Consensus 190 i~~l-~-~l~~l~~L~~L~l~~n~i~~ 214 (291)
T 1h6t_A 190 ISDL-R-ALAGLKNLDVLELFSQECLN 214 (291)
T ss_dssp CCBC-G-GGTTCTTCSEEEEEEEEEEC
T ss_pred CCCC-h-hhccCCCCCEEECcCCcccC
Confidence 6653 2 36666666666666666653
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=99.81 E-value=3.7e-21 Score=208.56 Aligned_cols=144 Identities=25% Similarity=0.284 Sum_probs=96.6
Q ss_pred hccCCc-cceeeccC------------CeEEEEEEehHhhHHHHHHHHHHHHHHhhcchhhHHH----------------
Q 045449 627 TDRFSE-NNLIGIGN------------GMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVK---------------- 677 (823)
Q Consensus 627 t~~f~~-~~~lg~g~------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~---------------- 677 (823)
.++|.. .++||.|+ ++.||||++..... ..+++ ...+..+.||||++
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~e~---~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 102 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPK-ARQEV---DHHWQASGGPHIVCILDVYENMHHGKRCLL 102 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHH-HHHHH---HHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHH-HHHHH---HHHHHhcCCCChHHHHHHHhhccCCCceEE
Confidence 567777 45689886 67799999965422 22222 22345668999887
Q ss_pred ------------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCC---CCcEEEeecccccccC
Q 045449 678 ------------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDE---DMVAHISDFGIAKLLS 724 (823)
Q Consensus 678 ------------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~---~~~~kl~DfGla~~~~ 724 (823)
++.|++.+|+|+|+.+|+||||||+||+++. ++.+||+|||+++...
T Consensus 103 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~ 182 (336)
T 3fhr_A 103 IIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETT 182 (336)
T ss_dssp EEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC-
T ss_pred EEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccccceecc
Confidence 4678899999999999999999999999975 4569999999998654
Q ss_pred CCCccccccccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCCC
Q 045449 725 GEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 725 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
... .....||+.|+|||++.+..++.++||||+||+++++++|..||...
T Consensus 183 ~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 232 (336)
T 3fhr_A 183 QNA----LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSN 232 (336)
T ss_dssp -------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---
T ss_pred ccc----cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCc
Confidence 321 23457899999999998889999999999999999999999998654
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.81 E-value=4.1e-21 Score=228.16 Aligned_cols=142 Identities=23% Similarity=0.291 Sum_probs=121.0
Q ss_pred ccCCccceeeccC-------------CeEEEEEEehHh-hHHHHHHHHHHHHHHhhcchhhHHH----------------
Q 045449 628 DRFSENNLIGIGN-------------GMEVAVKVFHQQ-YERALKSFEDECEVRKRIRHRNLVK---------------- 677 (823)
Q Consensus 628 ~~f~~~~~lg~g~-------------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~---------------- 677 (823)
++|...+.||.|+ ++.||||++... .....+.|.+|++++.+++||||++
T Consensus 80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~ 159 (681)
T 2pzi_A 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVG 159 (681)
T ss_dssp TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCcee
Confidence 6788888898875 567999988643 3455678999999999999999997
Q ss_pred ---------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccc
Q 045449 678 ---------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLS 730 (823)
Q Consensus 678 ---------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~ 730 (823)
++.|++.+|+|+|+.+|+||||||+|||++.+ .+||+|||+++.....
T Consensus 160 ~lv~E~~~g~~L~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~~---- 234 (681)
T 2pzi_A 160 YIVMEYVGGQSLKRSKGQKLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSF---- 234 (681)
T ss_dssp EEEEECCCCEECC----CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEETTCC----
T ss_pred EEEEEeCCCCcHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchhcccC----
Confidence 46789999999999999999999999999975 8999999999876432
Q ss_pred cccccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCC
Q 045449 731 KQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGE 777 (823)
Q Consensus 731 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~ 777 (823)
....||+.|+|||++.++ ++.++|||||||+++++.+|..|+.+
T Consensus 235 --~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~ 278 (681)
T 2pzi_A 235 --GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNG 278 (681)
T ss_dssp --SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETT
T ss_pred --CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCcc
Confidence 345799999999988654 48899999999999999999887765
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.81 E-value=6.1e-22 Score=228.63 Aligned_cols=204 Identities=17% Similarity=0.173 Sum_probs=128.0
Q ss_pred cCCCCCCeEEeecccccccCCCccCCCcccCcccccCcc-------------ccCCCCcccccccccCCCCceEEE-eec
Q 045449 274 TNSSKLSDLELGENLFSGFIPNTIGNLRNLEFGNIADNY-------------LTSSTPELSFLSSLTNCKKLKVLI-VTG 339 (823)
Q Consensus 274 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~-------------l~~~~~~~~~~~~l~~l~~L~~L~-Ls~ 339 (823)
..+++|+.|+|++|+++ .+|..++++++|+.|++++|. +.+. .+..++++++|+.|+ ++.
T Consensus 346 ~~~~~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~-----~~~~l~~l~~L~~L~~l~~ 419 (567)
T 1dce_A 346 ATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLY-----EKETLQYFSTLKAVDPMRA 419 (567)
T ss_dssp STTTTSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGG-----HHHHHHHHHHHHHHCGGGH
T ss_pred ccCccceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHHHHHHhcccccC-----CHHHHHHHHhcccCcchhh
Confidence 34455666666666665 445666666666666665443 1111 233444444454444 333
Q ss_pred CCCCccCCccccccccccceEEecCCcceeccCccccCcccccEEEcccCcCCCCchhcccccCCCCEEEccCCCCCCcc
Q 045449 340 NPLDGILPKSIGNFSLSLETILMANCSISGNIPQVVGNLSNLLVLELGGNNLTGPIPVTFSQLQTLQAFDLTRNKLAGPI 419 (823)
Q Consensus 340 N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~ 419 (823)
|.+ ..|..+.+++|.++...+ ..|+.|+|++|+|++ +|. |+.+++|+.|+|++|+|+ .+
T Consensus 420 n~~------------~~L~~l~l~~n~i~~l~~------~~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~l 478 (567)
T 1dce_A 420 AYL------------DDLRSKFLLENSVLKMEY------ADVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-AL 478 (567)
T ss_dssp HHH------------HHHHHHHHHHHHHHHHHH------TTCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CC
T ss_pred ccc------------chhhhhhhhcccccccCc------cCceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-cc
Confidence 332 234444455555554322 136777777777775 555 777777777777777777 66
Q ss_pred hHhhhcCCCCCEEEcccCcCcccccccccCCCCCCeEeccCCcccccc-chhhhccCCCcEEeccccccccccCcc---c
Q 045449 420 TDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSVRVLYLGLNIFTSVL-SSTIWNLKDILFIDVSSNFLDGPLSLD---I 495 (823)
Q Consensus 420 p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~LdLs~N~l~g~~p~~---~ 495 (823)
|..|+++++|+.|+|++|.|++ +| .++.+++|+.|+|++|++++.+ |..++.+++|+.|+|++|.+++..|.. +
T Consensus 479 p~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~l~ 556 (567)
T 1dce_A 479 PPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLA 556 (567)
T ss_dssp CGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTHHH
T ss_pred chhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccHHHHHH
Confidence 7777777777777777777775 56 6777777777777777777766 777777777777777777777765532 2
Q ss_pred cCCCCCcEEEc
Q 045449 496 GNLKVVIGLDF 506 (823)
Q Consensus 496 ~~l~~L~~L~l 506 (823)
..++.|+.||+
T Consensus 557 ~~lp~L~~L~l 567 (567)
T 1dce_A 557 EMLPSVSSILT 567 (567)
T ss_dssp HHCTTCSEEEC
T ss_pred HHCcccCccCC
Confidence 34677777764
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.81 E-value=2.7e-22 Score=231.55 Aligned_cols=202 Identities=17% Similarity=0.203 Sum_probs=153.0
Q ss_pred CCCccEEEeeccccccccCccccCCCCCCeEEeeccc-------------ccccCCCccCCCcccCccc-ccCccccCCC
Q 045449 252 LPNVETLNLGINSFSGTIPSSITNSSKLSDLELGENL-------------FSGFIPNTIGNLRNLEFGN-IADNYLTSST 317 (823)
Q Consensus 252 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~-------------l~~~~p~~~~~l~~L~~L~-L~~N~l~~~~ 317 (823)
+++|+.|+|+.|+++ .+|..++++++|+.|++++|. +.+.+|..++.+++|+.|+ ++.|.+..
T Consensus 348 ~~~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~l~~n~~~~-- 424 (567)
T 1dce_A 348 DEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLDD-- 424 (567)
T ss_dssp TTTSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCGGGHHHHHH--
T ss_pred CccceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcchhhcccch--
Confidence 455555555555554 455555555555555555443 5667788888888888888 67665532
Q ss_pred CcccccccccCCCCceEEEeecCCCCccCCccccccccccceEEecCCcceeccCccccCcccccEEEcccCcCCCCchh
Q 045449 318 PELSFLSSLTNCKKLKVLIVTGNPLDGILPKSIGNFSLSLETILMANCSISGNIPQVVGNLSNLLVLELGGNNLTGPIPV 397 (823)
Q Consensus 318 ~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~ 397 (823)
|+.+.+++|.++...+ ..|++|+|++|+|++ +|. |+.+++|+.|+|++|+|+ .+|.
T Consensus 425 --------------L~~l~l~~n~i~~l~~-------~~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~ 480 (567)
T 1dce_A 425 --------------LRSKFLLENSVLKMEY-------ADVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPP 480 (567)
T ss_dssp --------------HHHHHHHHHHHHHHHH-------TTCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCG
T ss_pred --------------hhhhhhhcccccccCc-------cCceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccch
Confidence 3344556666654321 357888888888886 565 888999999999999998 7888
Q ss_pred cccccCCCCEEEccCCCCCCcchHhhhcCCCCCEEEcccCcCcccc-cccccCCCCCCeEeccCCccccccch---hhhc
Q 045449 398 TFSQLQTLQAFDLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSI-PSCLGNLTSVRVLYLGLNIFTSVLSS---TIWN 473 (823)
Q Consensus 398 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~-p~~~~~l~~L~~L~Ls~N~l~~~~p~---~~~~ 473 (823)
.|+.+++|++|+|++|+|++ +| .++.+++|+.|+|++|+|++.+ |..++.+++|+.|+|++|.+++.+|. .+..
T Consensus 481 ~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~l~~~ 558 (567)
T 1dce_A 481 ALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEM 558 (567)
T ss_dssp GGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHH
T ss_pred hhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccHHHHHHHH
Confidence 89999999999999999997 56 7889999999999999999887 89999999999999999999987653 3455
Q ss_pred cCCCcEEec
Q 045449 474 LKDILFIDV 482 (823)
Q Consensus 474 l~~L~~LdL 482 (823)
+++|+.||+
T Consensus 559 lp~L~~L~l 567 (567)
T 1dce_A 559 LPSVSSILT 567 (567)
T ss_dssp CTTCSEEEC
T ss_pred CcccCccCC
Confidence 889999875
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.80 E-value=1e-19 Score=211.32 Aligned_cols=191 Identities=24% Similarity=0.304 Sum_probs=103.6
Q ss_pred CccEEEeeccccccccCccccCCCCCCeEEeecccccccCCCccCCCcccCcccccCccccCCCCcccccccccCCCCce
Q 045449 254 NVETLNLGINSFSGTIPSSITNSSKLSDLELGENLFSGFIPNTIGNLRNLEFGNIADNYLTSSTPELSFLSSLTNCKKLK 333 (823)
Q Consensus 254 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~ 333 (823)
++..+.++.+.+....+ +..+++|+.|++++|.+... | .+..+++|+.|+|++|.+++.. .+..+++|+
T Consensus 22 ~l~~l~l~~~~i~~~~~--~~~L~~L~~L~l~~n~i~~l-~-~l~~l~~L~~L~Ls~N~l~~~~-------~l~~l~~L~ 90 (605)
T 1m9s_A 22 ETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIK-------PLTNLKNLG 90 (605)
T ss_dssp HHHHHHTTCSCTTSEEC--HHHHTTCCCCBCTTCCCCCC-T-TGGGCTTCCEEECTTSCCCCCG-------GGGGCTTCC
T ss_pred HHHHHhccCCCcccccc--hhcCCCCCEEECcCCCCCCC-h-HHccCCCCCEEEeeCCCCCCCh-------hhccCCCCC
Confidence 34444555555553332 34555666666666666543 2 3555555555555555555431 144455555
Q ss_pred EEEeecCCCCccCCccccccccccceEEecCCcceeccCccccCcccccEEEcccCcCCCCchhcccccCCCCEEEccCC
Q 045449 334 VLIVTGNPLDGILPKSIGNFSLSLETILMANCSISGNIPQVVGNLSNLLVLELGGNNLTGPIPVTFSQLQTLQAFDLTRN 413 (823)
Q Consensus 334 ~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N 413 (823)
.|+|++|.+++. ..+..+++|+.|+|++|++++ + ..+..+++|+.|+|++|
T Consensus 91 ~L~Ls~N~l~~l---------------------------~~l~~l~~L~~L~Ls~N~l~~-l-~~l~~l~~L~~L~Ls~N 141 (605)
T 1m9s_A 91 WLFLDENKIKDL---------------------------SSLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLGNN 141 (605)
T ss_dssp EEECCSSCCCCC---------------------------TTSTTCTTCCEEECTTSCCCC-C-GGGGGCTTCSEEECCSS
T ss_pred EEECcCCCCCCC---------------------------hhhccCCCCCEEEecCCCCCC-C-ccccCCCccCEEECCCC
Confidence 555555554431 134555556666666666553 2 23555566666666666
Q ss_pred CCCCcchHhhhcCCCCCEEEcccCcCcccccccccCCCCCCeEeccCCccccccchhhhccCCCcEEeccccccccc
Q 045449 414 KLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSVRVLYLGLNIFTSVLSSTIWNLKDILFIDVSSNFLDGP 490 (823)
Q Consensus 414 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~LdLs~N~l~g~ 490 (823)
+|++. ..+..+++|+.|+|++|.|++..| +..+++|+.|+|++|++++. ..+..+++|+.|+|++|.+++.
T Consensus 142 ~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~i~~l--~~l~~l~~L~~L~L~~N~l~~~ 212 (605)
T 1m9s_A 142 KITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFSQECLNK 212 (605)
T ss_dssp CCCCC--GGGGSCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCBC--GGGTTCTTCSEEECCSEEEECC
T ss_pred ccCCc--hhhcccCCCCEEECcCCcCCCchh--hccCCCCCEEECcCCCCCCC--hHHccCCCCCEEEccCCcCcCC
Confidence 66543 345556666666666666665444 55566666666666666553 2455566666666666666543
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.80 E-value=2.1e-19 Score=182.14 Aligned_cols=153 Identities=20% Similarity=0.251 Sum_probs=109.0
Q ss_pred eEEEeecCCCCccCCccccccccccceEEecCCcceeccCccccCcccccEEEcccCcCCCCchhcccccCCCCEEEccC
Q 045449 333 KVLIVTGNPLDGILPKSIGNFSLSLETILMANCSISGNIPQVVGNLSNLLVLELGGNNLTGPIPVTFSQLQTLQAFDLTR 412 (823)
Q Consensus 333 ~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~ 412 (823)
+.+++++|.++. +|..+. .++++|++++|+|++..+..|..+++|++|+|++|++++..|..|.++++|++|+|++
T Consensus 14 ~~v~c~~~~l~~-iP~~l~---~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~ 89 (220)
T 2v9t_B 14 NIVDCRGKGLTE-IPTNLP---ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYG 89 (220)
T ss_dssp TEEECTTSCCSS-CCSSCC---TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCS
T ss_pred CEEEcCCCCcCc-CCCccC---cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCC
Confidence 467778887774 454433 5677777777777777677777777777777777777766677777777777777777
Q ss_pred CCCCCcchHhhhcCCCCCEEEcccCcCcccccccccCCCCCCeEeccCCccccccchhhhccCCCcEEecccccccc
Q 045449 413 NKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSVRVLYLGLNIFTSVLSSTIWNLKDILFIDVSSNFLDG 489 (823)
Q Consensus 413 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~LdLs~N~l~g 489 (823)
|+|+...+..|..+++|+.|+|++|++++..|..|..+++|+.|+|++|++++..+..+..+++|+.|+|++|.+..
T Consensus 90 N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c 166 (220)
T 2v9t_B 90 NKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFIC 166 (220)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEEC
T ss_pred CcCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCC
Confidence 77776555556777777777777777777667777777777777777777777666666666677777777776654
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.80 E-value=2.9e-19 Score=181.02 Aligned_cols=154 Identities=21% Similarity=0.295 Sum_probs=103.6
Q ss_pred ceEEecCCcceeccCccccCcccccEEEcccCcCCCCchhcccccCCCCEEEccCCCCCCcchHhhhcCCCCCEEEcccC
Q 045449 358 ETILMANCSISGNIPQVVGNLSNLLVLELGGNNLTGPIPVTFSQLQTLQAFDLTRNKLAGPITDELCHLARLHSLVLQGN 437 (823)
Q Consensus 358 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 437 (823)
+.+++++|.++. +|..+. ++|+.|+|++|++++..+..|..+++|++|+|++|++++..|..|.++++|++|+|++|
T Consensus 14 ~~v~c~~~~l~~-iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N 90 (220)
T 2v9t_B 14 NIVDCRGKGLTE-IPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGN 90 (220)
T ss_dssp TEEECTTSCCSS-CCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSS
T ss_pred CEEEcCCCCcCc-CCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCC
Confidence 456666666663 344333 56677777777776555556667777777777777777666666777777777777777
Q ss_pred cCcccccccccCCCCCCeEeccCCccccccchhhhccCCCcEEeccccccccccCccccCCCCCcEEEcccCCCCCC
Q 045449 438 KFSGSIPSCLGNLTSVRVLYLGLNIFTSVLSSTIWNLKDILFIDVSSNFLDGPLSLDIGNLKVVIGLDFSRNNLSGD 514 (823)
Q Consensus 438 ~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~ 514 (823)
+|++..+..|..+++|+.|+|++|++++..|..|..+++|+.|+|++|.+++..+..+..++.|+.|++++|.+.+.
T Consensus 91 ~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~ 167 (220)
T 2v9t_B 91 KITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFICD 167 (220)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEECS
T ss_pred cCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCCC
Confidence 77755555566677777777777777776666777777777777777777766666666677777777777776653
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.79 E-value=6.3e-19 Score=179.76 Aligned_cols=137 Identities=20% Similarity=0.205 Sum_probs=73.4
Q ss_pred ccccEEEcccCcCCCCchhcccccCCCCEEEccCCCCCCcchHhhhcCCCCCEEEcccCcCcccccccccCCCCCCeEec
Q 045449 379 SNLLVLELGGNNLTGPIPVTFSQLQTLQAFDLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSVRVLYL 458 (823)
Q Consensus 379 ~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L 458 (823)
++|++|+|++|++++..|..|..+++|++|+|++|+|+...+..|..+++|+.|+|++|+|++..+..|..+++|+.|+|
T Consensus 40 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L 119 (229)
T 3e6j_A 40 TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFM 119 (229)
T ss_dssp TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCCCcCCccChhHhCcchhhCeEec
Confidence 44555555555555544555555555555555555554444444455555555555555555444444555555555555
Q ss_pred cCCccccccchhhhccCCCcEEeccccccccccCccccCCCCCcEEEcccCCCCCCCC
Q 045449 459 GLNIFTSVLSSTIWNLKDILFIDVSSNFLDGPLSLDIGNLKVVIGLDFSRNNLSGDIP 516 (823)
Q Consensus 459 s~N~l~~~~p~~~~~l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~ip 516 (823)
++|+++ .+|..+..+++|+.|+|++|+|++..+..+..++.|+.|++++|.+++..+
T Consensus 120 s~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 176 (229)
T 3e6j_A 120 CCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDCECR 176 (229)
T ss_dssp CSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCTTBG
T ss_pred cCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccCCcc
Confidence 555555 345555555555555555555555444455555666666666666555443
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.79 E-value=2.7e-19 Score=189.50 Aligned_cols=186 Identities=23% Similarity=0.291 Sum_probs=119.3
Q ss_pred EEeeccccccccCccccCCCCCCeEEeecccccccCCCccCCCcccCcccccCccccCCCCcccccccccCCCCceEEEe
Q 045449 258 LNLGINSFSGTIPSSITNSSKLSDLELGENLFSGFIPNTIGNLRNLEFGNIADNYLTSSTPELSFLSSLTNCKKLKVLIV 337 (823)
Q Consensus 258 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~L 337 (823)
+.+..+.+++.. .+..+++|+.|++++|.++.. + .+..+++|++|++++|++++.. . +.++++|+.|++
T Consensus 29 ~~l~~~~~~~~~--~~~~l~~L~~L~l~~~~i~~~-~-~~~~l~~L~~L~L~~n~l~~~~------~-l~~l~~L~~L~l 97 (291)
T 1h6t_A 29 DNLKKKSVTDAV--TQNELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIK------P-LANLKNLGWLFL 97 (291)
T ss_dssp HHTTCSCTTSEE--CHHHHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCG------G-GTTCTTCCEEEC
T ss_pred HHhcCCCccccc--chhhcCcccEEEccCCCcccC-h-hHhcCCCCCEEEccCCccCCCc------c-cccCCCCCEEEC
Confidence 344444444322 234566777777777777654 2 3556666666666666665541 1 445555555555
Q ss_pred ecCCCCccCCccccccccccceEEecCCcceeccCccccCcccccEEEcccCcCCCCchhcccccCCCCEEEccCCCCCC
Q 045449 338 TGNPLDGILPKSIGNFSLSLETILMANCSISGNIPQVVGNLSNLLVLELGGNNLTGPIPVTFSQLQTLQAFDLTRNKLAG 417 (823)
Q Consensus 338 s~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~ 417 (823)
++|.++ +. ..+..+++|++|+|++|++++. ..+..+++|++|++++|++++
T Consensus 98 ~~n~l~-------------------------~~--~~l~~l~~L~~L~L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~ 148 (291)
T 1h6t_A 98 DENKVK-------------------------DL--SSLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITD 148 (291)
T ss_dssp CSSCCC-------------------------CG--GGGTTCTTCCEEECTTSCCCCC--GGGGGCTTCCEEECCSSCCCC
T ss_pred CCCcCC-------------------------CC--hhhccCCCCCEEECCCCcCCCC--hhhcCCCCCCEEEccCCcCCc
Confidence 555544 31 1256667777777777777653 346677777777777777775
Q ss_pred cchHhhhcCCCCCEEEcccCcCcccccccccCCCCCCeEeccCCccccccchhhhccCCCcEEecccccccc
Q 045449 418 PITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSVRVLYLGLNIFTSVLSSTIWNLKDILFIDVSSNFLDG 489 (823)
Q Consensus 418 ~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~LdLs~N~l~g 489 (823)
. ..+..+++|+.|+|++|++++..| +..+++|+.|+|++|.+++. | .+..+++|+.|++++|.++.
T Consensus 149 ~--~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~L~~N~i~~l-~-~l~~l~~L~~L~l~~n~i~~ 214 (291)
T 1h6t_A 149 I--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISDL-R-ALAGLKNLDVLELFSQECLN 214 (291)
T ss_dssp C--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCBC-G-GGTTCTTCSEEEEEEEEEEC
T ss_pred c--hhhccCCCCCEEEccCCccccchh--hcCCCccCEEECCCCcCCCC-h-hhccCCCCCEEECcCCcccC
Confidence 4 456777777777777777776544 77777788888888877774 3 37778888888888887775
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.78 E-value=5.5e-19 Score=193.35 Aligned_cols=176 Identities=20% Similarity=0.230 Sum_probs=94.2
Q ss_pred cEEEccCCcccccCCcccccCCCCccEEEeeccccccccCcccc-CCCCCCeEEeecccccccCCCccCCCcccCccccc
Q 045449 231 KEISLLNNSLSGSLPSRIDLSLPNVETLNLGINSFSGTIPSSIT-NSSKLSDLELGENLFSGFIPNTIGNLRNLEFGNIA 309 (823)
Q Consensus 231 ~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 309 (823)
+.+++++|.++ .+|..+. +.++.|+|++|+|++..+..+. ++++|++|+|++|+|++..+..|..+++|++|+|+
T Consensus 21 ~~l~c~~~~l~-~iP~~~~---~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls 96 (361)
T 2xot_A 21 NILSCSKQQLP-NVPQSLP---SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLS 96 (361)
T ss_dssp TEEECCSSCCS-SCCSSCC---TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC
T ss_pred CEEEeCCCCcC-ccCccCC---CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECC
Confidence 46677777766 5665442 3456666666666655555555 66666666666666665555555555544444444
Q ss_pred CccccCCCCcccccccccCCCCceEEEeecCCCCccCCccccccccccceEEecCCcceeccCccccCcccccEEEcccC
Q 045449 310 DNYLTSSTPELSFLSSLTNCKKLKVLIVTGNPLDGILPKSIGNFSLSLETILMANCSISGNIPQVVGNLSNLLVLELGGN 389 (823)
Q Consensus 310 ~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N 389 (823)
+|+++. ..+..|..+ .+|++|+|++|+|++..|..|.++++|++|+|++|
T Consensus 97 ~N~l~~-----------------------------~~~~~~~~l-~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N 146 (361)
T 2xot_A 97 SNHLHT-----------------------------LDEFLFSDL-QALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQN 146 (361)
T ss_dssp SSCCCE-----------------------------ECTTTTTTC-TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred CCcCCc-----------------------------CCHHHhCCC-cCCCEEECCCCcccEECHHHhCCcccCCEEECCCC
Confidence 444433 333333333 34555555555555555555555666666666666
Q ss_pred cCCCCchhcc---cccCCCCEEEccCCCCCCcchHhhhcCCCC--CEEEcccCcCc
Q 045449 390 NLTGPIPVTF---SQLQTLQAFDLTRNKLAGPITDELCHLARL--HSLVLQGNKFS 440 (823)
Q Consensus 390 ~l~g~~p~~~---~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L--~~L~Ls~N~l~ 440 (823)
+|++..+..| ..+++|++|+|++|+|++..+..+..++.+ +.|+|++|.+.
T Consensus 147 ~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~~~l~~l~l~~N~~~ 202 (361)
T 2xot_A 147 QISRFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPLE 202 (361)
T ss_dssp CCCSCCGGGTC----CTTCCEEECCSSCCCCCCHHHHHHSCHHHHTTEECCSSCEE
T ss_pred cCCeeCHHHhcCcccCCcCCEEECCCCCCCccCHHHhhhccHhhcceEEecCCCcc
Confidence 6664333333 345556666666666655444445554442 44455554443
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.76 E-value=1.2e-19 Score=216.04 Aligned_cols=155 Identities=22% Similarity=0.260 Sum_probs=104.3
Q ss_pred hhccccccccCCccccccCCCCCcEEEccCCcccccCCcccccCCCCccEEEeeccccccccCccccCCCCCCeEEeecc
Q 045449 208 RLALATNNLVGVVPVTIFNMSALKEISLLNNSLSGSLPSRIDLSLPNVETLNLGINSFSGTIPSSITNSSKLSDLELGEN 287 (823)
Q Consensus 208 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 287 (823)
.++++.|.+. ..|..+..++.|+.|+|++|.++ .+|..++. +++|++|+|++|.|+ .+|..|+++++|++|+|++|
T Consensus 205 ~~~~~~n~~~-~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~-l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N 280 (727)
T 4b8c_D 205 EDDDIENRMV-MPKDSKYDDQLWHALDLSNLQIF-NISANIFK-YDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHN 280 (727)
T ss_dssp ------------------CCCCCCEEECTTSCCS-CCCGGGGG-CCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTS
T ss_pred Ccccccccee-cChhhhccCCCCcEEECCCCCCC-CCChhhcC-CCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCC
Confidence 4455556655 56777788888888888888887 78877774 888888888888888 77888888888888888888
Q ss_pred cccccCCCccCCCcccCcccccCccccCCCCcccccccccCCCCceEEEeecCCCCccCCccccccccccceEEecCCcc
Q 045449 288 LFSGFIPNTIGNLRNLEFGNIADNYLTSSTPELSFLSSLTNCKKLKVLIVTGNPLDGILPKSIGNFSLSLETILMANCSI 367 (823)
Q Consensus 288 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l 367 (823)
+|+ .+|..|+.+++|++|+|++|.|+. +|..|.++++|+.|+|++|.|++.+|..+......+..++|++|.+
T Consensus 281 ~l~-~lp~~~~~l~~L~~L~L~~N~l~~------lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l 353 (727)
T 4b8c_D 281 RLT-SLPAELGSCFQLKYFYFFDNMVTT------LPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRP 353 (727)
T ss_dssp CCS-SCCSSGGGGTTCSEEECCSSCCCC------CCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCC
T ss_pred cCC-ccChhhcCCCCCCEEECCCCCCCc------cChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcc
Confidence 888 668888888888888888888764 3445777777888888888887777777665432333455666666
Q ss_pred eeccCc
Q 045449 368 SGNIPQ 373 (823)
Q Consensus 368 ~~~~p~ 373 (823)
++.+|.
T Consensus 354 ~~~~p~ 359 (727)
T 4b8c_D 354 EIPLPH 359 (727)
T ss_dssp CCCCCC
T ss_pred cCcCcc
Confidence 665554
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.75 E-value=3.7e-18 Score=169.75 Aligned_cols=152 Identities=17% Similarity=0.183 Sum_probs=68.4
Q ss_pred CCCCceEEEeecCCCCccCCccccccccccceEEecCCcceeccCccccCcccccEEEcccCcCCCCchhcccccCCCCE
Q 045449 328 NCKKLKVLIVTGNPLDGILPKSIGNFSLSLETILMANCSISGNIPQVVGNLSNLLVLELGGNNLTGPIPVTFSQLQTLQA 407 (823)
Q Consensus 328 ~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~ 407 (823)
.+++|+.|++++|.++ .+| .+..+ ++|++|++++|.++ .+..+..+++|++|++++|++++..|..+..+++|++
T Consensus 42 ~l~~L~~L~l~~n~i~-~l~-~l~~l-~~L~~L~l~~n~~~--~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~ 116 (197)
T 4ezg_A 42 QMNSLTYITLANINVT-DLT-GIEYA-HNIKDLTINNIHAT--NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTL 116 (197)
T ss_dssp HHHTCCEEEEESSCCS-CCT-TGGGC-TTCSEEEEESCCCS--CCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCE
T ss_pred hcCCccEEeccCCCcc-ChH-HHhcC-CCCCEEEccCCCCC--cchhhhcCCCCCEEEeECCccCcccChhhcCCCCCCE
Confidence 3444555555555554 223 33333 34444444444332 1224444555555555555555444444555555555
Q ss_pred EEccCCCCCCcchHhhhcCCCCCEEEcccCcCcccccccccCCCCCCeEeccCCccccccchhhhccCCCcEEecccccc
Q 045449 408 FDLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSVRVLYLGLNIFTSVLSSTIWNLKDILFIDVSSNFL 487 (823)
Q Consensus 408 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~LdLs~N~l 487 (823)
|+|++|++++..|..+..+++|++|+|++|.+.+.+| .+..+++|+.|++++|.+++.. .+..+++|+.|++++|++
T Consensus 117 L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~~~~-~l~~l~~L~~L~l~~n~i~~~~--~l~~l~~L~~L~l~~N~i 193 (197)
T 4ezg_A 117 LDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIM-PLKTLPELKSLNIQFDGVHDYR--GIEDFPKLNQLYAFSQTI 193 (197)
T ss_dssp EECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCCCCG-GGGGCSSCCEEECTTBCCCCCT--TGGGCSSCCEEEECBC--
T ss_pred EEecCCccCcHhHHHHhhCCCCCEEEccCCCCccccH-hhcCCCCCCEEECCCCCCcChH--HhccCCCCCEEEeeCccc
Confidence 5555555554444445555555555555554222333 3444444444444444444421 333444444444444443
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.75 E-value=1.6e-19 Score=190.84 Aligned_cols=123 Identities=15% Similarity=0.058 Sum_probs=105.3
Q ss_pred ccCCccceeeccC------------CeEEEEEEehHhh---HHHHHHHHHHHHHHhhcchhhHHH---------------
Q 045449 628 DRFSENNLIGIGN------------GMEVAVKVFHQQY---ERALKSFEDECEVRKRIRHRNLVK--------------- 677 (823)
Q Consensus 628 ~~f~~~~~lg~g~------------~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~--------------- 677 (823)
++|...+.||.|+ ++.||||++.... ....+.|.+|++++.+++||||++
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 110 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA 110 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence 5688888899885 6779999997543 445678999999999999999998
Q ss_pred -----------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccc
Q 045449 678 -----------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQ 734 (823)
Q Consensus 678 -----------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 734 (823)
++.|++++|+|+|+.||+||||||+|||++.++.+||+++|
T Consensus 111 e~~~g~~L~~~l~~~~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~---------------- 174 (286)
T 3uqc_A 111 EWIRGGSLQEVADTSPSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA---------------- 174 (286)
T ss_dssp ECCCEEEHHHHHTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC----------------
T ss_pred EecCCCCHHHHHhcCCChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc----------------
Confidence 46789999999999999999999999999999999988443
Q ss_pred cccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCCCc
Q 045449 735 TLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGETC 779 (823)
Q Consensus 735 ~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~~ 779 (823)
|++ .++.++|||||||++|++++|+.||.+..
T Consensus 175 ------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~ 206 (286)
T 3uqc_A 175 ------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAG 206 (286)
T ss_dssp ------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCS
T ss_pred ------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCC
Confidence 343 36889999999999999999999997643
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.75 E-value=1.5e-18 Score=180.94 Aligned_cols=171 Identities=20% Similarity=0.296 Sum_probs=121.4
Q ss_pred CcchhhhhccccccccCCccccccCCCCCcEEEccCCcccccCCcccccCCCCccEEEeeccccccccCccccCCCCCCe
Q 045449 202 NLPYLARLALATNNLVGVVPVTIFNMSALKEISLLNNSLSGSLPSRIDLSLPNVETLNLGINSFSGTIPSSITNSSKLSD 281 (823)
Q Consensus 202 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 281 (823)
++.++..++++.|.+++.. .+..+++|++|++++|.++ .+| .+. .+++|++|+|++|++++..+ +.++++|++
T Consensus 17 ~l~~l~~l~l~~~~i~~~~--~~~~l~~L~~L~l~~n~i~-~l~-~l~-~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~ 89 (263)
T 1xeu_A 17 GLANAVKQNLGKQSVTDLV--SQKELSGVQNFNGDNSNIQ-SLA-GMQ-FFTNLKELHLSHNQISDLSP--LKDLTKLEE 89 (263)
T ss_dssp HHHHHHHHHHTCSCTTSEE--CHHHHTTCSEEECTTSCCC-CCT-TGG-GCTTCCEEECCSSCCCCCGG--GTTCSSCCE
T ss_pred HHHHHHHHHhcCCCccccc--chhhcCcCcEEECcCCCcc-cch-HHh-hCCCCCEEECCCCccCCChh--hccCCCCCE
Confidence 4567788889999988654 5778889999999999988 666 444 38889999999998886544 888888888
Q ss_pred EEeecccccccCCCccCCCcccCcccccCccccCCCCcccccccccCCCCceEEEeecCCCCccCCccccccccccceEE
Q 045449 282 LELGENLFSGFIPNTIGNLRNLEFGNIADNYLTSSTPELSFLSSLTNCKKLKVLIVTGNPLDGILPKSIGNFSLSLETIL 361 (823)
Q Consensus 282 L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~ 361 (823)
|+|++|++++.. .. .. ++|+.|+|++|.+++. ..+..+++|+.|++++|++++. | .+..+ ++|++|+
T Consensus 90 L~L~~N~l~~l~-~~-~~-~~L~~L~L~~N~l~~~-------~~l~~l~~L~~L~Ls~N~i~~~-~-~l~~l-~~L~~L~ 156 (263)
T 1xeu_A 90 LSVNRNRLKNLN-GI-PS-ACLSRLFLDNNELRDT-------DSLIHLKNLEILSIRNNKLKSI-V-MLGFL-SKLEVLD 156 (263)
T ss_dssp EECCSSCCSCCT-TC-CC-SSCCEEECCSSCCSBS-------GGGTTCTTCCEEECTTSCCCBC-G-GGGGC-TTCCEEE
T ss_pred EECCCCccCCcC-cc-cc-CcccEEEccCCccCCC-------hhhcCcccccEEECCCCcCCCC-h-HHccC-CCCCEEE
Confidence 888888888643 22 22 7788888888877764 2466777777777777777654 2 45555 4666666
Q ss_pred ecCCcceeccCccccCcccccEEEcccCcCCCC
Q 045449 362 MANCSISGNIPQVVGNLSNLLVLELGGNNLTGP 394 (823)
Q Consensus 362 L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ 394 (823)
+++|++++. ..+..+++|+.|++++|.+++.
T Consensus 157 L~~N~i~~~--~~l~~l~~L~~L~l~~N~~~~~ 187 (263)
T 1xeu_A 157 LHGNEITNT--GGLTRLKKVNWIDLTGQKCVNE 187 (263)
T ss_dssp CTTSCCCBC--TTSTTCCCCCEEEEEEEEEECC
T ss_pred CCCCcCcch--HHhccCCCCCEEeCCCCcccCC
Confidence 666666654 4555666666666666666543
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.75 E-value=9.2e-18 Score=166.13 Aligned_cols=131 Identities=21% Similarity=0.239 Sum_probs=69.4
Q ss_pred ceEEecCCcceeccCccccCcccccEEEcccCcCCCCchh-cccccCCCCEEEccCCCCCCcchHhhhcCCCCCEEEccc
Q 045449 358 ETILMANCSISGNIPQVVGNLSNLLVLELGGNNLTGPIPV-TFSQLQTLQAFDLTRNKLAGPITDELCHLARLHSLVLQG 436 (823)
Q Consensus 358 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 436 (823)
+++++++|+++ .+|..+.. +|++|+|++|++++..+. .|..+++|++|+|++|+|++..|..|.++++|++|+|++
T Consensus 11 ~~l~~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 87 (192)
T 1w8a_A 11 TTVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp TEEECTTSCCS-SCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CEEEcCCCCcC-cCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence 45555555554 33433322 555555555555544332 255555555555555555555555555555555555555
Q ss_pred CcCcccccccccCCCCCCeEeccCCccccccchhhhccCCCcEEecccccccccc
Q 045449 437 NKFSGSIPSCLGNLTSVRVLYLGLNIFTSVLSSTIWNLKDILFIDVSSNFLDGPL 491 (823)
Q Consensus 437 N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~LdLs~N~l~g~~ 491 (823)
|+|++..|..|.++++|++|+|++|++++.+|..+..+++|++|+|++|.+++..
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c 142 (192)
T 1w8a_A 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNC 142 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSG
T ss_pred CcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcC
Confidence 5555555555555555555555555555555555555555555555555555443
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.74 E-value=6.4e-18 Score=168.06 Aligned_cols=155 Identities=16% Similarity=0.174 Sum_probs=134.2
Q ss_pred cccccccceEEecCCcceeccCccccCcccccEEEcccCcCCCCchhcccccCCCCEEEccCCCCCCcchHhhhcCCCCC
Q 045449 351 GNFSLSLETILMANCSISGNIPQVVGNLSNLLVLELGGNNLTGPIPVTFSQLQTLQAFDLTRNKLAGPITDELCHLARLH 430 (823)
Q Consensus 351 ~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 430 (823)
..+ .+|++|++++|.++ .+| .+..+++|++|++++|.++ .+..+..+++|++|++++|++++..+..+..+++|+
T Consensus 41 ~~l-~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~--~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~ 115 (197)
T 4ezg_A 41 AQM-NSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHAT--NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLT 115 (197)
T ss_dssp HHH-HTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCS--CCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCC
T ss_pred hhc-CCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCC--cchhhhcCCCCCEEEeECCccCcccChhhcCCCCCC
Confidence 455 68999999999999 555 6889999999999999776 334789999999999999999988888999999999
Q ss_pred EEEcccCcCcccccccccCCCCCCeEeccCCccccccchhhhccCCCcEEeccccccccccCccccCCCCCcEEEcccCC
Q 045449 431 SLVLQGNKFSGSIPSCLGNLTSVRVLYLGLNIFTSVLSSTIWNLKDILFIDVSSNFLDGPLSLDIGNLKVVIGLDFSRNN 510 (823)
Q Consensus 431 ~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~ls~N~ 510 (823)
+|+|++|.+++..|..++.+++|+.|+|++|.+.+.+| .+..+++|+.|++++|.+++. + .+..++.|+.|++++|+
T Consensus 116 ~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~~~~-~l~~l~~L~~L~l~~n~i~~~-~-~l~~l~~L~~L~l~~N~ 192 (197)
T 4ezg_A 116 LLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIM-PLKTLPELKSLNIQFDGVHDY-R-GIEDFPKLNQLYAFSQT 192 (197)
T ss_dssp EEECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCCCCG-GGGGCSSCCEEECTTBCCCCC-T-TGGGCSSCCEEEECBC-
T ss_pred EEEecCCccCcHhHHHHhhCCCCCEEEccCCCCccccH-hhcCCCCCCEEECCCCCCcCh-H-HhccCCCCCEEEeeCcc
Confidence 99999999999899999999999999999998334455 689999999999999999874 3 78899999999999999
Q ss_pred CCC
Q 045449 511 LSG 513 (823)
Q Consensus 511 l~g 513 (823)
+.+
T Consensus 193 i~~ 195 (197)
T 4ezg_A 193 IGG 195 (197)
T ss_dssp ---
T ss_pred cCC
Confidence 863
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.74 E-value=2.4e-18 Score=179.36 Aligned_cols=171 Identities=23% Similarity=0.276 Sum_probs=99.9
Q ss_pred CCcccCcccccCccccCCCCcccccccccCCCCceEEEeecCCCCccCCccccccccccceEEecCCcceeccCccccCc
Q 045449 299 NLRNLEFGNIADNYLTSSTPELSFLSSLTNCKKLKVLIVTGNPLDGILPKSIGNFSLSLETILMANCSISGNIPQVVGNL 378 (823)
Q Consensus 299 ~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l 378 (823)
.+.++..+++++|.++.. ..+..+++|+.|++++|.++. +| .+..+ .+|++|++++|++++..+ +..+
T Consensus 17 ~l~~l~~l~l~~~~i~~~-------~~~~~l~~L~~L~l~~n~i~~-l~-~l~~l-~~L~~L~L~~N~i~~~~~--l~~l 84 (263)
T 1xeu_A 17 GLANAVKQNLGKQSVTDL-------VSQKELSGVQNFNGDNSNIQS-LA-GMQFF-TNLKELHLSHNQISDLSP--LKDL 84 (263)
T ss_dssp HHHHHHHHHHTCSCTTSE-------ECHHHHTTCSEEECTTSCCCC-CT-TGGGC-TTCCEEECCSSCCCCCGG--GTTC
T ss_pred HHHHHHHHHhcCCCcccc-------cchhhcCcCcEEECcCCCccc-ch-HHhhC-CCCCEEECCCCccCCChh--hccC
Confidence 455566667777766653 145566666777777776663 23 45555 466666666666665443 6666
Q ss_pred ccccEEEcccCcCCCCchhcccccCCCCEEEccCCCCCCcchHhhhcCCCCCEEEcccCcCcccccccccCCCCCCeEec
Q 045449 379 SNLLVLELGGNNLTGPIPVTFSQLQTLQAFDLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSVRVLYL 458 (823)
Q Consensus 379 ~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L 458 (823)
++|++|+|++|++++ +|. +.. ++|++|+|++|++++. + .+..+++|+.|+|++|++++. | .+..+++|+.|+|
T Consensus 85 ~~L~~L~L~~N~l~~-l~~-~~~-~~L~~L~L~~N~l~~~-~-~l~~l~~L~~L~Ls~N~i~~~-~-~l~~l~~L~~L~L 157 (263)
T 1xeu_A 85 TKLEELSVNRNRLKN-LNG-IPS-ACLSRLFLDNNELRDT-D-SLIHLKNLEILSIRNNKLKSI-V-MLGFLSKLEVLDL 157 (263)
T ss_dssp SSCCEEECCSSCCSC-CTT-CCC-SSCCEEECCSSCCSBS-G-GGTTCTTCCEEECTTSCCCBC-G-GGGGCTTCCEEEC
T ss_pred CCCCEEECCCCccCC-cCc-ccc-CcccEEEccCCccCCC-h-hhcCcccccEEECCCCcCCCC-h-HHccCCCCCEEEC
Confidence 666666666666664 332 222 5666666666666643 2 355666666666666666643 2 4555666666666
Q ss_pred cCCccccccchhhhccCCCcEEeccccccccc
Q 045449 459 GLNIFTSVLSSTIWNLKDILFIDVSSNFLDGP 490 (823)
Q Consensus 459 s~N~l~~~~p~~~~~l~~L~~LdLs~N~l~g~ 490 (823)
++|++++. ..+..+++|+.|++++|.+++.
T Consensus 158 ~~N~i~~~--~~l~~l~~L~~L~l~~N~~~~~ 187 (263)
T 1xeu_A 158 HGNEITNT--GGLTRLKKVNWIDLTGQKCVNE 187 (263)
T ss_dssp TTSCCCBC--TTSTTCCCCCEEEEEEEEEECC
T ss_pred CCCcCcch--HHhccCCCCCEEeCCCCcccCC
Confidence 66666654 4455556666666666655543
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.72 E-value=1.4e-18 Score=184.99 Aligned_cols=122 Identities=25% Similarity=0.370 Sum_probs=100.0
Q ss_pred ccCCcc-ceeeccC------------CeEEEEEEehHhhHHHHHHHHHHHHHH-hhcchhhHHH----------------
Q 045449 628 DRFSEN-NLIGIGN------------GMEVAVKVFHQQYERALKSFEDECEVR-KRIRHRNLVK---------------- 677 (823)
Q Consensus 628 ~~f~~~-~~lg~g~------------~~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~h~niv~---------------- 677 (823)
++|... +.||.|+ +..||||++... ..+.+|++++ +..+||||++
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 91 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 91 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence 445554 6788875 567999999643 4567888887 5558999997
Q ss_pred ------------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCC---CCcEEEeecccccccC
Q 045449 678 ------------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDE---DMVAHISDFGIAKLLS 724 (823)
Q Consensus 678 ------------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~---~~~~kl~DfGla~~~~ 724 (823)
++.|++.+|+|+|+.+|+||||||+||+++. ++.+||+|||+++...
T Consensus 92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~ 171 (299)
T 3m2w_A 92 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT 171 (299)
T ss_dssp EEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECT
T ss_pred EEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEeccccccccc
Confidence 3678899999999999999999999999997 7899999999987532
Q ss_pred CCCccccccccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCCC
Q 045449 725 GEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 725 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
+..++.++||||+||++|++.+|..||...
T Consensus 172 ------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~ 201 (299)
T 3m2w_A 172 ------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSN 201 (299)
T ss_dssp ------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-
T ss_pred ------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence 245788999999999999999999999654
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.70 E-value=4.2e-17 Score=161.35 Aligned_cols=132 Identities=18% Similarity=0.284 Sum_probs=69.4
Q ss_pred cEEEcccCcCCCCchhcccccCCCCEEEccCCCCCCcchH-hhhcCCCCCEEEcccCcCcccccccccCCCCCCeEeccC
Q 045449 382 LVLELGGNNLTGPIPVTFSQLQTLQAFDLTRNKLAGPITD-ELCHLARLHSLVLQGNKFSGSIPSCLGNLTSVRVLYLGL 460 (823)
Q Consensus 382 ~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~ 460 (823)
+++++++|+++ .+|..+.. +|++|+|++|+|++..+. .|..+++|++|+|++|+|++..|..|.++++|++|+|++
T Consensus 11 ~~l~~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 87 (192)
T 1w8a_A 11 TTVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp TEEECTTSCCS-SCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CEEEcCCCCcC-cCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence 45555555553 34443322 455555555555544432 245555555555555555555555555555555555555
Q ss_pred CccccccchhhhccCCCcEEeccccccccccCccccCCCCCcEEEcccCCCCCCCC
Q 045449 461 NIFTSVLSSTIWNLKDILFIDVSSNFLDGPLSLDIGNLKVVIGLDFSRNNLSGDIP 516 (823)
Q Consensus 461 N~l~~~~p~~~~~l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~ip 516 (823)
|++++..+..+..+++|++|+|++|++++.+|..+..++.|++|++++|+++|.++
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~ 143 (192)
T 1w8a_A 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCH 143 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGG
T ss_pred CcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCc
Confidence 55555555555555555555555555555555555555555555555555554443
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.69 E-value=9.7e-18 Score=181.05 Aligned_cols=102 Identities=11% Similarity=0.045 Sum_probs=72.9
Q ss_pred cCCCCEEEccCCCCCCcchHhhhcCCCCCEEEcccCcCcccccccccCCCCCC-eEeccCCccccccchhhhccCCCcEE
Q 045449 402 LQTLQAFDLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSVR-VLYLGLNIFTSVLSSTIWNLKDILFI 480 (823)
Q Consensus 402 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~-~L~Ls~N~l~~~~p~~~~~l~~L~~L 480 (823)
+++|+.|+|++|+++...+..|.++.+|+.|+|++| ++...+.+|.++++|+ .+++.+ .++.+.+..|.++++|+.+
T Consensus 225 ~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l 302 (329)
T 3sb4_A 225 MPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYV 302 (329)
T ss_dssp CTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEE
T ss_pred cCCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEE
Confidence 567777777777777555556777777777777776 6655556677777777 777776 6666666777777777777
Q ss_pred eccccccccccCccccCCCCCcEEE
Q 045449 481 DVSSNFLDGPLSLDIGNLKVVIGLD 505 (823)
Q Consensus 481 dLs~N~l~g~~p~~~~~l~~L~~L~ 505 (823)
++++|.++..-+..|.++++|+.++
T Consensus 303 ~l~~n~i~~I~~~aF~~~~~L~~ly 327 (329)
T 3sb4_A 303 LATGDKITTLGDELFGNGVPSKLIY 327 (329)
T ss_dssp EECSSCCCEECTTTTCTTCCCCEEE
T ss_pred EeCCCccCccchhhhcCCcchhhhc
Confidence 7777777766666777777777765
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.69 E-value=1.4e-16 Score=153.94 Aligned_cols=132 Identities=22% Similarity=0.271 Sum_probs=91.2
Q ss_pred cccceEEecCCcce-eccCccccCcccccEEEcccCcCCCCchhcccccCCCCEEEccCCCCCCcchHhhhcCCCCCEEE
Q 045449 355 LSLETILMANCSIS-GNIPQVVGNLSNLLVLELGGNNLTGPIPVTFSQLQTLQAFDLTRNKLAGPITDELCHLARLHSLV 433 (823)
Q Consensus 355 ~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 433 (823)
.+|++|++++|.++ +.+|..+..+++|++|++++|.+++. ..+..+++|++|+|++|++++.+|..+..+++|++|+
T Consensus 24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 101 (168)
T 2ell_A 24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLN 101 (168)
T ss_dssp TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEE
T ss_pred ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEe
Confidence 45666667666666 56666667777777777777777754 5677777777777777777766676666677777777
Q ss_pred cccCcCcccc-cccccCCCCCCeEeccCCccccccc---hhhhccCCCcEEeccccccc
Q 045449 434 LQGNKFSGSI-PSCLGNLTSVRVLYLGLNIFTSVLS---STIWNLKDILFIDVSSNFLD 488 (823)
Q Consensus 434 Ls~N~l~g~~-p~~~~~l~~L~~L~Ls~N~l~~~~p---~~~~~l~~L~~LdLs~N~l~ 488 (823)
|++|.+++.. +..+..+++|+.|++++|.+++..+ ..+..+++|++||+++|.+.
T Consensus 102 Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~ 160 (168)
T 2ell_A 102 LSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ 160 (168)
T ss_dssp CBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC
T ss_pred ccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChh
Confidence 7777777532 2566677777777777777776554 45666667777777666654
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.68 E-value=3.8e-17 Score=176.38 Aligned_cols=266 Identities=14% Similarity=0.085 Sum_probs=185.1
Q ss_pred cchhhhhcccccccc--CCccccccCCCCCcEEEccCCcccccCCcccccC--------CCCccEEEeeccccccccCcc
Q 045449 203 LPYLARLALATNNLV--GVVPVTIFNMSALKEISLLNNSLSGSLPSRIDLS--------LPNVETLNLGINSFSGTIPSS 272 (823)
Q Consensus 203 l~~L~~L~Ls~N~l~--~~~p~~~~~l~~L~~L~Ls~N~l~g~lp~~~~~~--------l~~L~~L~Ls~N~l~~~~p~~ 272 (823)
+++|+.|||++|++. ...+..+ +.+..+.+..| .+|...|.+ +++|+.|+|.. +++.+-+.+
T Consensus 48 l~~L~~LdLs~n~i~~~~~~~~~~---~~~~~~~~~~~----~I~~~aF~~~~~~~~~g~~~L~~l~L~~-~i~~I~~~a 119 (329)
T 3sb4_A 48 FPSLKVLDISNAEIKMYSGKAGTY---PNGKFYIYMAN----FVPAYAFSNVVNGVTKGKQTLEKVILSE-KIKNIEDAA 119 (329)
T ss_dssp CTTCCEEEEEEEEECCEEESSSSS---GGGCCEEECTT----EECTTTTEEEETTEEEECTTCCC-CBCT-TCCEECTTT
T ss_pred hccCeEEecCcceeEEecCccccc---ccccccccccc----ccCHHHhcccccccccccCCCcEEECCc-cccchhHHH
Confidence 678999999999998 3332222 23556666666 456667777 99999999999 888777888
Q ss_pred ccCCCCCCeEEeecccccccCCCccCCCcccCcccccCccccCCCCcccccccccCCCCce-EEEeecCCCCccCCcccc
Q 045449 273 ITNSSKLSDLELGENLFSGFIPNTIGNLRNLEFGNIADNYLTSSTPELSFLSSLTNCKKLK-VLIVTGNPLDGILPKSIG 351 (823)
Q Consensus 273 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~-~L~Ls~N~l~~~~p~~~~ 351 (823)
|.++++|+.|++++|.+..+.+.+|..+.++..+.+..+........+ ....|.++..|+ .+.+.... .++..+.
T Consensus 120 F~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i-~~~~f~~~~~L~~~i~~~~~~---~l~~~~~ 195 (329)
T 3sb4_A 120 FKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRW-EHFAFIEGEPLETTIQVGAMG---KLEDEIM 195 (329)
T ss_dssp TTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTT-TTSCEEESCCCEEEEEECTTC---CHHHHHH
T ss_pred hhcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhccccc-cccccccccccceeEEecCCC---cHHHHHh
Confidence 999999999999999999888999999888888877664321100000 123466777777 45554321 2222221
Q ss_pred c---cccccceEEecCCcceeccCccccCcccccEEEcccCcCCCCchhcccccCCCCEEEccCCCCCCcchHhhhcCCC
Q 045449 352 N---FSLSLETILMANCSISGNIPQVVGNLSNLLVLELGGNNLTGPIPVTFSQLQTLQAFDLTRNKLAGPITDELCHLAR 428 (823)
Q Consensus 352 ~---~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 428 (823)
. .+.++..+.+.++-...........+++|+.|+|++|+++...+..|.++.+|+.|+|++| ++...+..|.++.+
T Consensus 196 ~~~~~~~~~~~l~~~~~l~~~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~ 274 (329)
T 3sb4_A 196 KAGLQPRDINFLTIEGKLDNADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGR 274 (329)
T ss_dssp HTTCCGGGCSEEEEEECCCHHHHHHHHHHCTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTT
T ss_pred hcccCccccceEEEeeeecHHHHHHHHHhcCCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChh
Confidence 1 1245555655544221111111123678888888888888555667888888888888887 77666677888888
Q ss_pred CC-EEEcccCcCcccccccccCCCCCCeEeccCCccccccchhhhccCCCcEEec
Q 045449 429 LH-SLVLQGNKFSGSIPSCLGNLTSVRVLYLGLNIFTSVLSSTIWNLKDILFIDV 482 (823)
Q Consensus 429 L~-~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~LdL 482 (823)
|+ .+++.+ .++...+.+|.++++|+.++++.|.++.+.+..|.++++|+.+..
T Consensus 275 L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~~~~L~~ly~ 328 (329)
T 3sb4_A 275 LAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLGDELFGNGVPSKLIYK 328 (329)
T ss_dssp CCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCCEECTTTTCTTCCCCEEEC
T ss_pred ccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccCccchhhhcCCcchhhhcc
Confidence 88 888887 777666788888888888888888888888888888888887753
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.68 E-value=1.3e-16 Score=150.79 Aligned_cols=127 Identities=19% Similarity=0.242 Sum_probs=95.0
Q ss_pred cccceEEecCCcce-eccCccccCcccccEEEcccCcCCCCchhcccccCCCCEEEccCCCCCCcchHhhhcCCCCCEEE
Q 045449 355 LSLETILMANCSIS-GNIPQVVGNLSNLLVLELGGNNLTGPIPVTFSQLQTLQAFDLTRNKLAGPITDELCHLARLHSLV 433 (823)
Q Consensus 355 ~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 433 (823)
.++++|++++|.++ +.+|..+..+++|++|++++|++++. ..+..+++|++|+|++|++++.+|..+..+++|++|+
T Consensus 17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ 94 (149)
T 2je0_A 17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLN 94 (149)
T ss_dssp GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEE
T ss_pred ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEE
Confidence 56777777777777 66777777778888888888888755 5677778888888888888876777777778888888
Q ss_pred cccCcCccc-ccccccCCCCCCeEeccCCccccccc---hhhhccCCCcEEecc
Q 045449 434 LQGNKFSGS-IPSCLGNLTSVRVLYLGLNIFTSVLS---STIWNLKDILFIDVS 483 (823)
Q Consensus 434 Ls~N~l~g~-~p~~~~~l~~L~~L~Ls~N~l~~~~p---~~~~~l~~L~~LdLs 483 (823)
+++|.+++. .|..+..+++|+.|++++|.+++..+ ..+..+++|+.||++
T Consensus 95 ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~ 148 (149)
T 2je0_A 95 LSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGY 148 (149)
T ss_dssp CTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTB
T ss_pred CCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCC
Confidence 888887763 34667777777777777777777655 467777777777765
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.68 E-value=8e-17 Score=155.65 Aligned_cols=134 Identities=17% Similarity=0.113 Sum_probs=123.2
Q ss_pred CcccccEEEcccCcCC-CCchhcccccCCCCEEEccCCCCCCcchHhhhcCCCCCEEEcccCcCcccccccccCCCCCCe
Q 045449 377 NLSNLLVLELGGNNLT-GPIPVTFSQLQTLQAFDLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSVRV 455 (823)
Q Consensus 377 ~l~~L~~L~Ls~N~l~-g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~ 455 (823)
..++|++|++++|+++ +.+|..+..+++|++|+|++|.+++. ..+..+++|++|+|++|.+++.+|..+..+++|++
T Consensus 22 ~~~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~ 99 (168)
T 2ell_A 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTH 99 (168)
T ss_dssp CTTSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCE
T ss_pred CcccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCE
Confidence 3478999999999998 78899899999999999999999976 77899999999999999999889999989999999
Q ss_pred EeccCCcccccc-chhhhccCCCcEEeccccccccccC---ccccCCCCCcEEEcccCCCC
Q 045449 456 LYLGLNIFTSVL-SSTIWNLKDILFIDVSSNFLDGPLS---LDIGNLKVVIGLDFSRNNLS 512 (823)
Q Consensus 456 L~Ls~N~l~~~~-p~~~~~l~~L~~LdLs~N~l~g~~p---~~~~~l~~L~~L~ls~N~l~ 512 (823)
|+|++|.+++.. +..+..+++|+.|++++|.+++..+ ..+..++.|++||+++|.+.
T Consensus 100 L~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~ 160 (168)
T 2ell_A 100 LNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ 160 (168)
T ss_dssp EECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC
T ss_pred EeccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChh
Confidence 999999999853 3789999999999999999997766 57899999999999999987
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.67 E-value=9.3e-17 Score=151.84 Aligned_cols=130 Identities=17% Similarity=0.133 Sum_probs=119.2
Q ss_pred CcccccEEEcccCcCC-CCchhcccccCCCCEEEccCCCCCCcchHhhhcCCCCCEEEcccCcCcccccccccCCCCCCe
Q 045449 377 NLSNLLVLELGGNNLT-GPIPVTFSQLQTLQAFDLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSVRV 455 (823)
Q Consensus 377 ~l~~L~~L~Ls~N~l~-g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~ 455 (823)
..++|+.|++++|+++ +.+|..+..+++|++|++++|++++. ..+..+++|++|+|++|.+++.+|..+..+++|++
T Consensus 15 ~~~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~ 92 (149)
T 2je0_A 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTH 92 (149)
T ss_dssp CGGGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCE
T ss_pred CCccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCE
Confidence 3578999999999998 78999999999999999999999976 77899999999999999999889999999999999
Q ss_pred EeccCCccccc-cchhhhccCCCcEEeccccccccccC---ccccCCCCCcEEEccc
Q 045449 456 LYLGLNIFTSV-LSSTIWNLKDILFIDVSSNFLDGPLS---LDIGNLKVVIGLDFSR 508 (823)
Q Consensus 456 L~Ls~N~l~~~-~p~~~~~l~~L~~LdLs~N~l~g~~p---~~~~~l~~L~~L~ls~ 508 (823)
|++++|.+++. .+..+..+++|++|++++|.+++..+ ..+..++.|+.||+++
T Consensus 93 L~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~d 149 (149)
T 2je0_A 93 LNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGYD 149 (149)
T ss_dssp EECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTBC
T ss_pred EECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCCC
Confidence 99999999985 45889999999999999999998776 5789999999999874
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.65 E-value=5.8e-16 Score=153.14 Aligned_cols=129 Identities=19% Similarity=0.253 Sum_probs=74.2
Q ss_pred cEEEcccCcCCCCchhcccccCCCCEEEccCCCCCCcchHhhhcCCCCCEEEcccCcCcccccccccCCCCCCeEeccCC
Q 045449 382 LVLELGGNNLTGPIPVTFSQLQTLQAFDLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSVRVLYLGLN 461 (823)
Q Consensus 382 ~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N 461 (823)
+++++++|+++ .+|..+. ++|++|+|++|+|+ .+|..|.++++|+.|+|++|.|++..|..|.++++|++|+|++|
T Consensus 13 ~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N 88 (193)
T 2wfh_A 13 TVVRCSNKGLK-VLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYN 88 (193)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEcCCCCCC-cCCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCC
Confidence 34555555555 3443332 35555566666555 44455555566666666666666555555666666666666666
Q ss_pred ccccccchhhhccCCCcEEeccccccccccCccccCCCCCcEEEcccCCCCCC
Q 045449 462 IFTSVLSSTIWNLKDILFIDVSSNFLDGPLSLDIGNLKVVIGLDFSRNNLSGD 514 (823)
Q Consensus 462 ~l~~~~p~~~~~l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~ 514 (823)
++++..|..|..+++|+.|+|++|.|++..+..+..++.|+.|++++|.+.+.
T Consensus 89 ~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~ 141 (193)
T 2wfh_A 89 RLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYCD 141 (193)
T ss_dssp CCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEECS
T ss_pred ccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeecC
Confidence 66665555566666666666666666654444566666666666666666543
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.65 E-value=5.4e-16 Score=151.23 Aligned_cols=133 Identities=19% Similarity=0.210 Sum_probs=80.6
Q ss_pred ccEEEcccCcCCCCchhcccccCCCCEEEccCCCCCCcchHhhhcCCCCCEEEcccCcCcccccccccCCCCCCeEeccC
Q 045449 381 LLVLELGGNNLTGPIPVTFSQLQTLQAFDLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSVRVLYLGL 460 (823)
Q Consensus 381 L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~ 460 (823)
.+.+++++|+++ .+|..+ .++|++|++++|++++..+..|..+++|++|+|++|++++..+..|..+++|+.|+|++
T Consensus 9 ~~~l~~~~~~l~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 85 (177)
T 2o6r_A 9 GTEIRCNSKGLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHE 85 (177)
T ss_dssp TTEEECCSSCCS-SCCTTC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEEEecCCCCc-cCCCCC--CCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCC
Confidence 345555555555 333322 24566666666666655555556666666666666666655555556666666666666
Q ss_pred CccccccchhhhccCCCcEEeccccccccccCccccCCCCCcEEEcccCCCCCCCC
Q 045449 461 NIFTSVLSSTIWNLKDILFIDVSSNFLDGPLSLDIGNLKVVIGLDFSRNNLSGDIP 516 (823)
Q Consensus 461 N~l~~~~p~~~~~l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~ip 516 (823)
|++++..+..+..+++|++|++++|.+++..+..+..++.|+.|++++|+++|.+|
T Consensus 86 N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 141 (177)
T 2o6r_A 86 NKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 141 (177)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred CCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence 66666555556666666666666666665544455666777777777777776554
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.64 E-value=7.8e-16 Score=152.22 Aligned_cols=129 Identities=22% Similarity=0.330 Sum_probs=87.5
Q ss_pred ceEEecCCcceeccCccccCcccccEEEcccCcCCCCchhcccccCCCCEEEccCCCCCCcchHhhhcCCCCCEEEcccC
Q 045449 358 ETILMANCSISGNIPQVVGNLSNLLVLELGGNNLTGPIPVTFSQLQTLQAFDLTRNKLAGPITDELCHLARLHSLVLQGN 437 (823)
Q Consensus 358 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 437 (823)
+++++++|.++ .+|..+. ++|++|+|++|+++ .+|..|..+++|++|+|++|+|++..+..|.++++|++|+|++|
T Consensus 13 ~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N 88 (193)
T 2wfh_A 13 TVVRCSNKGLK-VLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYN 88 (193)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEcCCCCCC-cCCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCC
Confidence 34455555554 2333322 45667777777776 55666777777777777777777666666777777777777777
Q ss_pred cCcccccccccCCCCCCeEeccCCccccccchhhhccCCCcEEeccccccccc
Q 045449 438 KFSGSIPSCLGNLTSVRVLYLGLNIFTSVLSSTIWNLKDILFIDVSSNFLDGP 490 (823)
Q Consensus 438 ~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~LdLs~N~l~g~ 490 (823)
+|++..|..|..+++|+.|+|++|++++..+..|..+++|+.|+|++|.+.+.
T Consensus 89 ~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~ 141 (193)
T 2wfh_A 89 RLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYCD 141 (193)
T ss_dssp CCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEECS
T ss_pred ccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeecC
Confidence 77766666777777777777777777776666677777777777777777653
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.63 E-value=1.2e-15 Score=148.61 Aligned_cols=114 Identities=25% Similarity=0.246 Sum_probs=66.9
Q ss_pred ccccEEEcccCcCCCCchhcccccCCCCEEEccCCCCCCcchHhhhcCCCCCEEEcccCcCcccccccccCCCCCCeEec
Q 045449 379 SNLLVLELGGNNLTGPIPVTFSQLQTLQAFDLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSVRVLYL 458 (823)
Q Consensus 379 ~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L 458 (823)
++|++|++++|++++..+..|..+++|++|+|++|++++..+..|..+++|++|+|++|++++..+..+..+++|+.|+|
T Consensus 28 ~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l 107 (177)
T 2o6r_A 28 SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELAL 107 (177)
T ss_dssp TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCCCccccCHHHhhCCcccCEEEC
Confidence 45555555555555444444555556666666666665554445555666666666666666555555566666666666
Q ss_pred cCCccccccchhhhccCCCcEEeccccccccccC
Q 045449 459 GLNIFTSVLSSTIWNLKDILFIDVSSNFLDGPLS 492 (823)
Q Consensus 459 s~N~l~~~~p~~~~~l~~L~~LdLs~N~l~g~~p 492 (823)
++|.+++..+..+..+++|+.|++++|.+++..|
T Consensus 108 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 141 (177)
T 2o6r_A 108 DTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 141 (177)
T ss_dssp CSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred cCCcceEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence 6666665555455566666666666666665444
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.63 E-value=5e-17 Score=186.63 Aligned_cols=136 Identities=19% Similarity=0.139 Sum_probs=100.1
Q ss_pred CccceeeccC----------CeEEEEEEehHh--------hHHHHHHHHHHHHHHhhcchhhHHH---------------
Q 045449 631 SENNLIGIGN----------GMEVAVKVFHQQ--------YERALKSFEDECEVRKRIRHRNLVK--------------- 677 (823)
Q Consensus 631 ~~~~~lg~g~----------~~~vavK~~~~~--------~~~~~~~~~~E~~~l~~l~h~niv~--------------- 677 (823)
...+.||+|+ +..+|+|+.... .....++|.+|++++++++||||++
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVm 418 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMM 418 (540)
T ss_dssp ---------CCEEEEEEECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEE
T ss_pred CCCCEEeeCCCEEEEEEEECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEE
Confidence 3456788876 455788875321 1223467999999999999999993
Q ss_pred -----------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccc-----ccccc
Q 045449 678 -----------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLS-----KQTQT 735 (823)
Q Consensus 678 -----------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~-----~~~~~ 735 (823)
++.|++++|+|+|+.+|+||||||+|||++. .+||+|||+|+......... .....
T Consensus 419 E~~~ggsL~~~l~~~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~~~~~~~~~~~ 496 (540)
T 3en9_A 419 SYINGKLAKDVIEDNLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKAVDLIVFKKAV 496 (540)
T ss_dssp ECCCSEEHHHHSTTCTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHHHHHHHHHHHH
T ss_pred ECCCCCCHHHHHHHHHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCccccccchhhhhhhh
Confidence 4688999999999999999999999999998 99999999999875432211 12356
Q ss_pred ccCCCcCcccccCC--Cccccccceehhhhhhccc
Q 045449 736 LATIGYMAPEYGTK--GRVSTRGDVCSFGIISGGK 768 (823)
Q Consensus 736 ~gt~~y~aPE~~~~--~~~~~~~Dv~S~Gvv~~~~ 768 (823)
+||+.|||||++.. ..|+..+|+||..+-..+.
T Consensus 497 ~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~ 531 (540)
T 3en9_A 497 LSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKD 531 (540)
T ss_dssp HHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHH
T ss_pred cCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHH
Confidence 89999999999876 6688899999987654433
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.60 E-value=1.1e-14 Score=160.71 Aligned_cols=252 Identities=12% Similarity=0.110 Sum_probs=144.5
Q ss_pred ccCCccccccCCCCCcEEEccCCcccccCCcccccCCCCccEEEeeccccccccCccccCCCCCCeEEeecccccccCCC
Q 045449 216 LVGVVPVTIFNMSALKEISLLNNSLSGSLPSRIDLSLPNVETLNLGINSFSGTIPSSITNSSKLSDLELGENLFSGFIPN 295 (823)
Q Consensus 216 l~~~~p~~~~~l~~L~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 295 (823)
++.+...+|.+. +|+.+.+..| ++ .++...|.+ .+|+.+++.. .++.+-+.+|.++++|+.++|++|+++.+...
T Consensus 124 i~~I~~~aF~~~-~L~~i~l~~~-i~-~I~~~aF~~-~~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l~~n~l~~I~~~ 198 (401)
T 4fdw_A 124 VKSIPKDAFRNS-QIAKVVLNEG-LK-SIGDMAFFN-STVQEIVFPS-TLEQLKEDIFYYCYNLKKADLSKTKITKLPAS 198 (401)
T ss_dssp CCEECTTTTTTC-CCSEEECCTT-CC-EECTTTTTT-CCCCEEECCT-TCCEECSSTTTTCTTCCEEECTTSCCSEECTT
T ss_pred cCEehHhhcccC-CccEEEeCCC-cc-EECHHhcCC-CCceEEEeCC-CccEehHHHhhCcccCCeeecCCCcceEechh
Confidence 343444555553 5667776655 44 555555553 3577777764 55555556677777777777777777666555
Q ss_pred ccCCCcccCcccccCccccCCCCcccccccccCCCCceEEEeecCCCCccCCccccccccccceEEecCCcceeccCccc
Q 045449 296 TIGNLRNLEFGNIADNYLTSSTPELSFLSSLTNCKKLKVLIVTGNPLDGILPKSIGNFSLSLETILMANCSISGNIPQVV 375 (823)
Q Consensus 296 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~p~~~ 375 (823)
+|. .++|+.+.|..+ ++.+ ...+|.+|++|+.+++..| ++.+-...|.+ .+|+.+.+ .+.++...+.+|
T Consensus 199 aF~-~~~L~~l~lp~~-l~~I-----~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~--~~L~~i~l-p~~i~~I~~~aF 267 (401)
T 4fdw_A 199 TFV-YAGIEEVLLPVT-LKEI-----GSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE--SGITTVKL-PNGVTNIASRAF 267 (401)
T ss_dssp TTT-TCCCSEEECCTT-CCEE-----CTTTTTTCTTCCCEECCTT-CCEECTTTTTT--CCCSEEEE-ETTCCEECTTTT
T ss_pred hEe-ecccCEEEeCCc-hhee-----hhhHhhCCCCCCEEecCCC-ccCcccccccc--CCccEEEe-CCCccEEChhHh
Confidence 565 466777666633 4433 2345666677777776654 44444445544 36777777 344555566677
Q ss_pred cCcccccEEEcccCcCC-----CCchhcccccCCCCEEEccCCCCCCcchHhhhcCCCCCEEEcccCcCcccccccccCC
Q 045449 376 GNLSNLLVLELGGNNLT-----GPIPVTFSQLQTLQAFDLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNL 450 (823)
Q Consensus 376 ~~l~~L~~L~Ls~N~l~-----g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l 450 (823)
.++++|+.+++.+|.+. ...+..|.++++|+.++|. |.++......|.++++|+.++|..| ++..-+.+|.++
T Consensus 268 ~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~~l~lp~~-l~~I~~~aF~~~ 345 (401)
T 4fdw_A 268 YYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKVTQLTIPAN-VTQINFSAFNNT 345 (401)
T ss_dssp TTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSCCEEEECTT-CCEECTTSSSSS
T ss_pred hCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCccEEEECcc-ccEEcHHhCCCC
Confidence 77777777777776654 2233456666666666666 3355444455666666666666433 444444555555
Q ss_pred CCCCeEeccCCccccccchhhhccC-CCcEEeccccc
Q 045449 451 TSVRVLYLGLNIFTSVLSSTIWNLK-DILFIDVSSNF 486 (823)
Q Consensus 451 ~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~LdLs~N~ 486 (823)
+|+.+++++|.+....+..|.+++ .++.|.+..|.
T Consensus 346 -~L~~l~l~~n~~~~l~~~~F~~~~~~l~~l~vp~~~ 381 (401)
T 4fdw_A 346 -GIKEVKVEGTTPPQVFEKVWYGFPDDITVIRVPAES 381 (401)
T ss_dssp -CCCEEEECCSSCCBCCCSSCCCSCTTCCEEEECGGG
T ss_pred -CCCEEEEcCCCCcccccccccCCCCCccEEEeCHHH
Confidence 566666666655554444444442 34444444443
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.58 E-value=2.8e-17 Score=163.56 Aligned_cols=135 Identities=20% Similarity=0.272 Sum_probs=64.3
Q ss_pred ccCCCCceEEEeecCCCCccCCc------cccccccccceEEecCCcceeccCccccCcccccEEEcccCcCCCCchhcc
Q 045449 326 LTNCKKLKVLIVTGNPLDGILPK------SIGNFSLSLETILMANCSISGNIPQVVGNLSNLLVLELGGNNLTGPIPVTF 399 (823)
Q Consensus 326 l~~l~~L~~L~Ls~N~l~~~~p~------~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~ 399 (823)
+.....++.++++.+.++|.+|. .+..+ ++|++|++++|.+++ +| .+..+++|++|++++|+++ .+|..+
T Consensus 14 ~~~~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l-~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~ 89 (198)
T 1ds9_A 14 FEERKSVVATEAEKVELHGMIPPIEKMDATLSTL-KACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLD 89 (198)
T ss_dssp HHHTTCCCCTTCSEEECCBCCTTCCCCHHHHHHT-TTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHH
T ss_pred HHhcccccCcchheeEeccccCcHhhhhHHHhcC-CCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchh
Confidence 33445555666666666665554 44444 345555555555544 33 4444555555555555554 344444
Q ss_pred cccCCCCEEEccCCCCCCcchHhhhcCCCCCEEEcccCcCccccc-ccccCCCCCCeEeccCCccccc
Q 045449 400 SQLQTLQAFDLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIP-SCLGNLTSVRVLYLGLNIFTSV 466 (823)
Q Consensus 400 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p-~~~~~l~~L~~L~Ls~N~l~~~ 466 (823)
..+++|++|+|++|++++ +| .+..+++|+.|+|++|++++..+ ..+..+++|+.|++++|.+++.
T Consensus 90 ~~~~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~ 155 (198)
T 1ds9_A 90 AVADTLEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYND 155 (198)
T ss_dssp HHHHHCSEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHH
T ss_pred hcCCcCCEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCccccc
Confidence 444445555555555543 22 34444444444444444443211 2344444444444444444443
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.58 E-value=5.5e-17 Score=161.43 Aligned_cols=142 Identities=18% Similarity=0.259 Sum_probs=83.0
Q ss_pred CCCcccCcccccCccccCCCCcc-cccccccCCCCceEEEeecCCCCccCCccccccccccceEEecCCcceeccCcccc
Q 045449 298 GNLRNLEFGNIADNYLTSSTPEL-SFLSSLTNCKKLKVLIVTGNPLDGILPKSIGNFSLSLETILMANCSISGNIPQVVG 376 (823)
Q Consensus 298 ~~l~~L~~L~L~~N~l~~~~~~~-~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~p~~~~ 376 (823)
.....++.++++.+.+++..+.+ .++..+..+++|++|++++|.+++ +| .+..+ ++|++|++++|.++ .+|..+.
T Consensus 15 ~~~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l-~~L~~L~l~~n~l~-~l~~~~~ 90 (198)
T 1ds9_A 15 EERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGM-ENLRILSLGRNLIK-KIENLDA 90 (198)
T ss_dssp HHTTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHH-TTCCEEEEEEEEEC-SCSSHHH
T ss_pred HhcccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccC-CCCCEEECCCCCcc-cccchhh
Confidence 33455666666666666553321 122255666666666666666665 44 55555 56666666666666 4555555
Q ss_pred CcccccEEEcccCcCCCCchhcccccCCCCEEEccCCCCCCcch-HhhhcCCCCCEEEcccCcCcccccc
Q 045449 377 NLSNLLVLELGGNNLTGPIPVTFSQLQTLQAFDLTRNKLAGPIT-DELCHLARLHSLVLQGNKFSGSIPS 445 (823)
Q Consensus 377 ~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~g~~p~ 445 (823)
.+++|++|+|++|++++ +| .+..+++|++|+|++|++++..+ ..+..+++|++|++++|.+++.+|.
T Consensus 91 ~~~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~ 158 (198)
T 1ds9_A 91 VADTLEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKE 158 (198)
T ss_dssp HHHHCSEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHT
T ss_pred cCCcCCEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCcccccccc
Confidence 56666666666666664 34 45666666666666666664322 3456666666666666666655543
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.56 E-value=7.6e-15 Score=142.86 Aligned_cols=105 Identities=18% Similarity=0.233 Sum_probs=51.3
Q ss_pred cccEEEcccCcCCCCchhcccccCCCCEEEccCCCCCCcchHhhhcCCCCCEEEcccCcCcccccc--cccCCCCCCeEe
Q 045449 380 NLLVLELGGNNLTGPIPVTFSQLQTLQAFDLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPS--CLGNLTSVRVLY 457 (823)
Q Consensus 380 ~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~--~~~~l~~L~~L~ 457 (823)
+|++|+|++|++++. ..|..+++|++|+|++|+|++..+..|..+++|++|+|++|+++ .+|. .+..+++|+.|+
T Consensus 43 ~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~ 119 (176)
T 1a9n_A 43 QFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV-ELGDLDPLASLKSLTYLC 119 (176)
T ss_dssp CCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECCSCCCC-CGGGGGGGGGCTTCCEEE
T ss_pred CCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCCCEEECCCCcCC-cchhhHhhhcCCCCCEEE
Confidence 444444444444432 33444455555555555554333333345555555555555553 2333 445555555555
Q ss_pred ccCCccccccch----hhhccCCCcEEeccccccc
Q 045449 458 LGLNIFTSVLSS----TIWNLKDILFIDVSSNFLD 488 (823)
Q Consensus 458 Ls~N~l~~~~p~----~~~~l~~L~~LdLs~N~l~ 488 (823)
+++|.++.. |. .++.+++|+.||+++|.+.
T Consensus 120 l~~N~i~~~-~~~~~~~~~~l~~L~~Ld~~~n~~~ 153 (176)
T 1a9n_A 120 ILRNPVTNK-KHYRLYVIYKVPQVRVLDFQKVKLK 153 (176)
T ss_dssp CCSSGGGGS-TTHHHHHHHHCTTCSEETTEECCHH
T ss_pred ecCCCCCCc-HhHHHHHHHHCCccceeCCCcCCHH
Confidence 555555432 32 2555555666666555544
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.56 E-value=5.5e-14 Score=155.09 Aligned_cols=263 Identities=14% Similarity=0.095 Sum_probs=160.2
Q ss_pred CCCcEEEccCCcccccCCcccccCCCCccEEEeeccccccccCccccCCCCCCeEEeecccccccCCCccCCCcccCccc
Q 045449 228 SALKEISLLNNSLSGSLPSRIDLSLPNVETLNLGINSFSGTIPSSITNSSKLSDLELGENLFSGFIPNTIGNLRNLEFGN 307 (823)
Q Consensus 228 ~~L~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 307 (823)
..++.+.+.+ .++ .|+...|.+ .+|+.++|..| ++.+-..+|.++ +|+.+++.. .++.+.+.+|.++++|+.++
T Consensus 113 ~~l~~i~ip~-~i~-~I~~~aF~~-~~L~~i~l~~~-i~~I~~~aF~~~-~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~ 186 (401)
T 4fdw_A 113 KGYNEIILPN-SVK-SIPKDAFRN-SQIAKVVLNEG-LKSIGDMAFFNS-TVQEIVFPS-TLEQLKEDIFYYCYNLKKAD 186 (401)
T ss_dssp SSCSEEECCT-TCC-EECTTTTTT-CCCSEEECCTT-CCEECTTTTTTC-CCCEEECCT-TCCEECSSTTTTCTTCCEEE
T ss_pred CCccEEEECC-ccC-EehHhhccc-CCccEEEeCCC-ccEECHHhcCCC-CceEEEeCC-CccEehHHHhhCcccCCeee
Confidence 4566666654 344 566666654 36888888765 665666667774 688888875 66666667777777777777
Q ss_pred ccCccccCCCCcccccccccCCCCceEEEeecCCCCccCCccccccccccceEEecCCcceeccCccccCcccccEEEcc
Q 045449 308 IADNYLTSSTPELSFLSSLTNCKKLKVLIVTGNPLDGILPKSIGNFSLSLETILMANCSISGNIPQVVGNLSNLLVLELG 387 (823)
Q Consensus 308 L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls 387 (823)
+++|.++.+.. ..|. +.+|+.+.+..+ ++.+-...|.++ .+|+.+.+..| ++.....+|.+ .+|+.+++
T Consensus 187 l~~n~l~~I~~-----~aF~-~~~L~~l~lp~~-l~~I~~~aF~~~-~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~l- 255 (401)
T 4fdw_A 187 LSKTKITKLPA-----STFV-YAGIEEVLLPVT-LKEIGSQAFLKT-SQLKTIEIPEN-VSTIGQEAFRE-SGITTVKL- 255 (401)
T ss_dssp CTTSCCSEECT-----TTTT-TCCCSEEECCTT-CCEECTTTTTTC-TTCCCEECCTT-CCEECTTTTTT-CCCSEEEE-
T ss_pred cCCCcceEech-----hhEe-ecccCEEEeCCc-hheehhhHhhCC-CCCCEEecCCC-ccCcccccccc-CCccEEEe-
Confidence 77777766532 2343 466777777633 555555566666 56777776653 45455556665 56676666
Q ss_pred cCcCCCCchhcccccCCCCEEEccCCCCC-----CcchHhhhcCCCCCEEEcccCcCcccccccccCCCCCCeEeccCCc
Q 045449 388 GNNLTGPIPVTFSQLQTLQAFDLTRNKLA-----GPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSVRVLYLGLNI 462 (823)
Q Consensus 388 ~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~-----~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~ 462 (823)
.|.++......|.++++|+.+++.+|.+. ...+..|.++++|+.++|. |.++..-..+|.++++|+.++|..|
T Consensus 256 p~~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~~l~lp~~- 333 (401)
T 4fdw_A 256 PNGVTNIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKVTQLTIPAN- 333 (401)
T ss_dssp ETTCCEECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSCCEEEECTT-
T ss_pred CCCccEEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCccEEEECcc-
Confidence 34455444556666667777776666554 2334456666666666666 3455444556666666666666443
Q ss_pred cccccchhhhccCCCcEEeccccccccccCccccCCC-CCcEEEcccCC
Q 045449 463 FTSVLSSTIWNLKDILFIDVSSNFLDGPLSLDIGNLK-VVIGLDFSRNN 510 (823)
Q Consensus 463 l~~~~p~~~~~l~~L~~LdLs~N~l~g~~p~~~~~l~-~L~~L~ls~N~ 510 (823)
++.+-...|.++ +|+.+++++|.+....+..|..++ .+..|.+..|.
T Consensus 334 l~~I~~~aF~~~-~L~~l~l~~n~~~~l~~~~F~~~~~~l~~l~vp~~~ 381 (401)
T 4fdw_A 334 VTQINFSAFNNT-GIKEVKVEGTTPPQVFEKVWYGFPDDITVIRVPAES 381 (401)
T ss_dssp CCEECTTSSSSS-CCCEEEECCSSCCBCCCSSCCCSCTTCCEEEECGGG
T ss_pred ccEEcHHhCCCC-CCCEEEEcCCCCcccccccccCCCCCccEEEeCHHH
Confidence 555555566666 666666666665544444455542 45555554443
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.55 E-value=8.6e-15 Score=142.49 Aligned_cols=135 Identities=21% Similarity=0.172 Sum_probs=110.3
Q ss_pred cccCCCCceEEEeecCCCCccCCccccccccccceEEecCCcceeccCccccCcccccEEEcccCcCCCCchhcccccCC
Q 045449 325 SLTNCKKLKVLIVTGNPLDGILPKSIGNFSLSLETILMANCSISGNIPQVVGNLSNLLVLELGGNNLTGPIPVTFSQLQT 404 (823)
Q Consensus 325 ~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~ 404 (823)
.+.++.+|+.|++++|.++.. |. +..+.++|++|++++|.+++. ..|..+++|++|+|++|++++..+..|..+++
T Consensus 14 ~~~~~~~L~~L~l~~n~l~~i-~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 89 (176)
T 1a9n_A 14 QYTNAVRDRELDLRGYKIPVI-EN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPD 89 (176)
T ss_dssp EEECTTSCEEEECTTSCCCSC-CC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTT
T ss_pred hcCCcCCceEEEeeCCCCchh-HH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCC
Confidence 456777888888888888854 43 555535899999999999876 67888999999999999999655555688999
Q ss_pred CCEEEccCCCCCCcchH--hhhcCCCCCEEEcccCcCccccccc----ccCCCCCCeEeccCCcccc
Q 045449 405 LQAFDLTRNKLAGPITD--ELCHLARLHSLVLQGNKFSGSIPSC----LGNLTSVRVLYLGLNIFTS 465 (823)
Q Consensus 405 L~~L~Ls~N~l~~~~p~--~~~~l~~L~~L~Ls~N~l~g~~p~~----~~~l~~L~~L~Ls~N~l~~ 465 (823)
|++|+|++|+++ .+|. .+..+++|+.|++++|.++ .+|.. +..+++|+.||++.|....
T Consensus 90 L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~-~~~~~~~~~~~~l~~L~~Ld~~~n~~~~ 154 (176)
T 1a9n_A 90 LTELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLDFQKVKLKE 154 (176)
T ss_dssp CCEEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEETTEECCHHH
T ss_pred CCEEECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCC-CcHhHHHHHHHHCCccceeCCCcCCHHH
Confidence 999999999996 4555 7889999999999999998 55664 8899999999999998765
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.50 E-value=6.4e-14 Score=135.39 Aligned_cols=107 Identities=22% Similarity=0.236 Sum_probs=59.9
Q ss_pred ccEEEcccCcCCCCchhcccccCCCCEEEccCCCCCCcchHhhhcCCCCCEEEcccCcCcccccccccCCCCCCeEeccC
Q 045449 381 LLVLELGGNNLTGPIPVTFSQLQTLQAFDLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSVRVLYLGL 460 (823)
Q Consensus 381 L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~ 460 (823)
.+++++++|+++ .+|..+. ++|++|+|++|+|++..|..|..+++|++|+|++|+|++..|..|..+++|++|+|++
T Consensus 11 ~~~l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~ 87 (170)
T 3g39_A 11 GTTVDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLND 87 (170)
T ss_dssp TTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEEEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCC
Confidence 345666666665 3444332 4556666666666655555555556666666666666555444555555555555555
Q ss_pred CccccccchhhhccCCCcEEeccccccccc
Q 045449 461 NIFTSVLSSTIWNLKDILFIDVSSNFLDGP 490 (823)
Q Consensus 461 N~l~~~~p~~~~~l~~L~~LdLs~N~l~g~ 490 (823)
|+|++..+..+..+++|+.|+|++|.+++.
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~ 117 (170)
T 3g39_A 88 NQLKSIPRGAFDNLKSLTHIWLLNNPWDCA 117 (170)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCBCTT
T ss_pred CccCEeCHHHhcCCCCCCEEEeCCCCCCCC
Confidence 555555444555555555555555555543
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=99.48 E-value=3e-13 Score=149.63 Aligned_cols=236 Identities=12% Similarity=0.080 Sum_probs=104.2
Q ss_pred ccCCcchhhhhccccccccCCccccccCCCCCcEEEccCCcccccCCcccccCCCCccEEEeeccccccccCccccCCCC
Q 045449 199 EIGNLPYLARLALATNNLVGVVPVTIFNMSALKEISLLNNSLSGSLPSRIDLSLPNVETLNLGINSFSGTIPSSITNSSK 278 (823)
Q Consensus 199 ~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 278 (823)
.|.++++|+.+.+.++ +.......|.++++|+.+++..| ++ .++...+..+..|+.+.+..+... +.+.+....+
T Consensus 157 aF~~c~~L~~i~l~~~-~~~I~~~~F~~c~~L~~i~l~~~-~~-~I~~~~F~~~~~L~~i~~~~~~~~--i~~~~~~~~~ 231 (394)
T 4fs7_A 157 AFATCESLEYVSLPDS-METLHNGLFSGCGKLKSIKLPRN-LK-IIRDYCFAECILLENMEFPNSLYY--LGDFALSKTG 231 (394)
T ss_dssp TTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCBCCCCTT-CC-EECTTTTTTCTTCCBCCCCTTCCE--ECTTTTTTCC
T ss_pred hhcccCCCcEEecCCc-cceeccccccCCCCceEEEcCCC-ce-EeCchhhccccccceeecCCCceE--eehhhcccCC
Confidence 3444455555555433 22233344555555555555444 22 344444444555555554443322 2222333344
Q ss_pred CCeEEeecccccccCCCccCCCcccCcccccCccccCCCCcccccccccCCCCceEEEeecCCCCccCCccccccccccc
Q 045449 279 LSDLELGENLFSGFIPNTIGNLRNLEFGNIADNYLTSSTPELSFLSSLTNCKKLKVLIVTGNPLDGILPKSIGNFSLSLE 358 (823)
Q Consensus 279 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~ 358 (823)
|+.+.+..+ ++.+....|..+..|+.+.+..+..+- ....|.++..+ +
T Consensus 232 l~~i~ip~~-~~~i~~~~f~~~~~l~~~~~~~~~~~i------~~~~F~~~~~l-------------------------~ 279 (394)
T 4fs7_A 232 VKNIIIPDS-FTELGKSVFYGCTDLESISIQNNKLRI------GGSLFYNCSGL-------------------------K 279 (394)
T ss_dssp CCEEEECTT-CCEECSSTTTTCSSCCEEEECCTTCEE------CSCTTTTCTTC-------------------------C
T ss_pred CceEEECCC-ceecccccccccccceeEEcCCCccee------ecccccccccc-------------------------c
Confidence 555544322 222333344444444444444332221 11233334444 4
Q ss_pred eEEecCCcceeccCccccCcccccEEEcccCcCCCCchhcccccCCCCEEEccCCCCCCcchHhhhcCCCCCEEEcccCc
Q 045449 359 TILMANCSISGNIPQVVGNLSNLLVLELGGNNLTGPIPVTFSQLQTLQAFDLTRNKLAGPITDELCHLARLHSLVLQGNK 438 (823)
Q Consensus 359 ~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 438 (823)
.+....+.+ ....|..+.+|+.+.+..+ ++..-...|.++.+|+.++|.++ ++..-...|.++.+|+.+++..|
T Consensus 280 ~~~~~~~~i---~~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~- 353 (394)
T 4fs7_A 280 KVIYGSVIV---PEKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS- 353 (394)
T ss_dssp EEEECSSEE---CTTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT-
T ss_pred eeccCceee---ccccccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc-
Confidence 444333221 1234445555555555433 33223344555555555555433 44333445555666666666544
Q ss_pred CcccccccccCCCCCCeEeccCCccccccchhhhccCCCcE
Q 045449 439 FSGSIPSCLGNLTSVRVLYLGLNIFTSVLSSTIWNLKDILF 479 (823)
Q Consensus 439 l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 479 (823)
++..-..+|.++++|+.+++..+ ++. +...|.++++|+.
T Consensus 354 l~~I~~~aF~~C~~L~~i~lp~~-~~~-~~~~F~~c~~L~~ 392 (394)
T 4fs7_A 354 LRKIGANAFQGCINLKKVELPKR-LEQ-YRYDFEDTTKFKW 392 (394)
T ss_dssp CCEECTTTBTTCTTCCEEEEEGG-GGG-GGGGBCTTCEEEE
T ss_pred ccEehHHHhhCCCCCCEEEECCC-CEE-hhheecCCCCCcE
Confidence 44344455666666666666543 111 2234444554443
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.48 E-value=9.9e-14 Score=134.04 Aligned_cols=110 Identities=18% Similarity=0.171 Sum_probs=100.7
Q ss_pred CCCEEEccCCCCCCcchHhhhcCCCCCEEEcccCcCcccccccccCCCCCCeEeccCCccccccchhhhccCCCcEEecc
Q 045449 404 TLQAFDLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSVRVLYLGLNIFTSVLSSTIWNLKDILFIDVS 483 (823)
Q Consensus 404 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~LdLs 483 (823)
+.+.+++++|.++. +|..+ .++|+.|+|++|+|++..|..|.++++|++|+|++|+|++..+..|..+++|++|+|+
T Consensus 10 ~~~~l~~s~n~l~~-ip~~~--~~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~ 86 (170)
T 3g39_A 10 SGTTVDCSGKSLAS-VPTGI--PTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLN 86 (170)
T ss_dssp ETTEEECTTSCCSS-CCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CCCEEEeCCCCcCc-cCccC--CCCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECC
Confidence 45799999999995 66555 3789999999999999999999999999999999999999888889999999999999
Q ss_pred ccccccccCccccCCCCCcEEEcccCCCCCCCC
Q 045449 484 SNFLDGPLSLDIGNLKVVIGLDFSRNNLSGDIP 516 (823)
Q Consensus 484 ~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~ip 516 (823)
+|+|++..+..+..++.|+.|+|++|.+++..+
T Consensus 87 ~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~ 119 (170)
T 3g39_A 87 DNQLKSIPRGAFDNLKSLTHIWLLNNPWDCACS 119 (170)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCBCTTBG
T ss_pred CCccCEeCHHHhcCCCCCCEEEeCCCCCCCCch
Confidence 999998888889999999999999999997765
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=99.47 E-value=7.5e-13 Score=146.39 Aligned_cols=330 Identities=10% Similarity=0.041 Sum_probs=206.1
Q ss_pred CcccCCCCCCcEEEccCCCCCCCCCCCCCCCCCCCEEECCCCcCcCCCchhhhcCCCCcEEecccccccCccCccccCCC
Q 045449 69 TPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLDFSDNQLFGSLSSFIFNMSSMTTIDLSINRLSGELPANICKIP 148 (823)
Q Consensus 69 ~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~p 148 (823)
..+|.++++|+.+.|.. .++.+-..+|.++++|+.++|..+ ++.....+|.++.+|+.+.+..+ ++..-.
T Consensus 64 ~~AF~~c~~L~~i~lp~-~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~-l~~i~~------- 133 (394)
T 4fs7_A 64 YAAFQGCRKVTEIKIPS-TVREIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLM-LKSIGV------- 133 (394)
T ss_dssp TTTTTTCTTEEEEECCT-TCCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECT-------
T ss_pred HHHhhCCCCceEEEeCC-CccCcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCc-eeeecc-------
Confidence 35688899999999974 477566788999999999999865 65566778889999998877654 221111
Q ss_pred CCCccccccceeeeccceeeccCccccccchhhHHHHHhhcCCCcccCCcccCCcchhhhhccccccccCCccccccCCC
Q 045449 149 STLSKCKQLEELNLGFNNLSGAIPKEIGNLTKLKEIISTITNSTVCEIPREIGNLPYLARLALATNNLVGVVPVTIFNMS 228 (823)
Q Consensus 149 ~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~~l~~n~~~~~ip~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 228 (823)
.+|.++..++......... .-..+|.++++|+.+. ..+.....-...|.++.+|+.+++..| ++......|.+..
T Consensus 134 ~aF~~~~~~~~~~~~~~~~--i~~~aF~~c~~L~~i~--l~~~~~~I~~~~F~~c~~L~~i~l~~~-~~~I~~~~F~~~~ 208 (394)
T 4fs7_A 134 EAFKGCDFKEITIPEGVTV--IGDEAFATCESLEYVS--LPDSMETLHNGLFSGCGKLKSIKLPRN-LKIIRDYCFAECI 208 (394)
T ss_dssp TTTTTCCCSEEECCTTCCE--ECTTTTTTCTTCCEEE--CCTTCCEECTTTTTTCTTCCBCCCCTT-CCEECTTTTTTCT
T ss_pred eeeecccccccccCccccc--cchhhhcccCCCcEEe--cCCccceeccccccCCCCceEEEcCCC-ceEeCchhhcccc
Confidence 1233433333322222221 1223455555555441 222222222456777788888888766 5555667788888
Q ss_pred CCcEEEccCCcccccCCcccccCCCCccEEEeeccccccccCccccCCCCCCeEEeecccccccCCCccCCCcccCcccc
Q 045449 229 ALKEISLLNNSLSGSLPSRIDLSLPNVETLNLGINSFSGTIPSSITNSSKLSDLELGENLFSGFIPNTIGNLRNLEFGNI 308 (823)
Q Consensus 229 ~L~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 308 (823)
.|+.+.+..+... +....+. ..+|+.+.+..+ ++..-...+.++..|+.+.+..+... +....|..+..++.+..
T Consensus 209 ~L~~i~~~~~~~~--i~~~~~~-~~~l~~i~ip~~-~~~i~~~~f~~~~~l~~~~~~~~~~~-i~~~~F~~~~~l~~~~~ 283 (394)
T 4fs7_A 209 LLENMEFPNSLYY--LGDFALS-KTGVKNIIIPDS-FTELGKSVFYGCTDLESISIQNNKLR-IGGSLFYNCSGLKKVIY 283 (394)
T ss_dssp TCCBCCCCTTCCE--ECTTTTT-TCCCCEEEECTT-CCEECSSTTTTCSSCCEEEECCTTCE-ECSCTTTTCTTCCEEEE
T ss_pred ccceeecCCCceE--eehhhcc-cCCCceEEECCC-ceecccccccccccceeEEcCCCcce-eeccccccccccceecc
Confidence 8888888776543 3333333 678888888643 44455667888899999999887554 66778888888888777
Q ss_pred cCccccCCCCcccccccccCCCCceEEEeecCCCCccCCccccccccccceEEecCCcceeccCccccCcccccEEEccc
Q 045449 309 ADNYLTSSTPELSFLSSLTNCKKLKVLIVTGNPLDGILPKSIGNFSLSLETILMANCSISGNIPQVVGNLSNLLVLELGG 388 (823)
Q Consensus 309 ~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~ 388 (823)
..+.+.. ..|..+.+|+.+.+..+ ++ ..-..+|.++.+|+.++|.+
T Consensus 284 ~~~~i~~--------~~F~~~~~L~~i~l~~~-i~-------------------------~I~~~aF~~c~~L~~i~lp~ 329 (394)
T 4fs7_A 284 GSVIVPE--------KTFYGCSSLTEVKLLDS-VK-------------------------FIGEEAFESCTSLVSIDLPY 329 (394)
T ss_dssp CSSEECT--------TTTTTCTTCCEEEECTT-CC-------------------------EECTTTTTTCTTCCEECCCT
T ss_pred Cceeecc--------ccccccccccccccccc-cc-------------------------eechhhhcCCCCCCEEEeCC
Confidence 6654432 24556666666665432 32 23344566666666666653
Q ss_pred CcCCCCchhcccccCCCCEEEccCCCCCCcchHhhhcCCCCCEEEcccCcCcccccccccCCCCCCeE
Q 045449 389 NNLTGPIPVTFSQLQTLQAFDLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSVRVL 456 (823)
Q Consensus 389 N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L 456 (823)
+ ++..-..+|.++.+|+.+++..| ++..-...|.++.+|+.+++..+ +. .+..+|.++++|+.+
T Consensus 330 ~-v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~lp~~-~~-~~~~~F~~c~~L~~I 393 (394)
T 4fs7_A 330 L-VEEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGCINLKKVELPKR-LE-QYRYDFEDTTKFKWI 393 (394)
T ss_dssp T-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTBTTCTTCCEEEEEGG-GG-GGGGGBCTTCEEEEE
T ss_pred c-ccEEhHHhccCCCCCCEEEECcc-ccEehHHHhhCCCCCCEEEECCC-CE-EhhheecCCCCCcEE
Confidence 3 44333455666667777776655 55444556777777777777654 22 334567777766653
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.46 E-value=2.5e-13 Score=131.69 Aligned_cols=105 Identities=20% Similarity=0.235 Sum_probs=93.2
Q ss_pred EEEEcCCCCCccccCcccCCCCCCcEEEccCCCCCCCCCCCCCCCCCCCEEECCCCcCcCCCchhhhcCCCCcEEecccc
Q 045449 55 IGLNISSFNLQGTITPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLDFSDNQLFGSLSSFIFNMSSMTTIDLSIN 134 (823)
Q Consensus 55 ~~L~L~~~~l~g~~~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 134 (823)
+.+++++++++ .+|..+. ++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|.++++|++|+|++|
T Consensus 15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N 91 (174)
T 2r9u_A 15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN 91 (174)
T ss_dssp SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence 47899999996 6777665 89999999999999999999999999999999999999888888899999999999999
Q ss_pred cccCccCccccCCCCCCccccccceeeeccceeec
Q 045449 135 RLSGELPANICKIPSTLSKCKQLEELNLGFNNLSG 169 (823)
Q Consensus 135 ~l~~~~p~~~~~~p~~~~~l~~L~~L~Ls~N~l~~ 169 (823)
+|++..+.. |..+++|++|+|++|.+..
T Consensus 92 ~l~~l~~~~-------~~~l~~L~~L~L~~N~~~c 119 (174)
T 2r9u_A 92 HLKSIPRGA-------FDNLKSLTHIYLYNNPWDC 119 (174)
T ss_dssp CCCCCCTTT-------TTTCTTCSEEECCSSCBCT
T ss_pred ccceeCHHH-------hccccCCCEEEeCCCCccc
Confidence 998543332 4889999999999999984
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.46 E-value=1.8e-13 Score=132.65 Aligned_cols=104 Identities=22% Similarity=0.253 Sum_probs=55.1
Q ss_pred cEEEcccCcCCCCchhcccccCCCCEEEccCCCCCCcchHhhhcCCCCCEEEcccCcCcccccccccCCCCCCeEeccCC
Q 045449 382 LVLELGGNNLTGPIPVTFSQLQTLQAFDLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSVRVLYLGLN 461 (823)
Q Consensus 382 ~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N 461 (823)
+.+++++|+++ .+|..+. ++|++|+|++|+|++..|..|.++++|+.|+|++|+|++..+..|.++++|+.|+|++|
T Consensus 15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N 91 (174)
T 2r9u_A 15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN 91 (174)
T ss_dssp SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence 45555555554 4444332 45555555555555555555555555555555555555444444455555555555555
Q ss_pred ccccccchhhhccCCCcEEeccccccc
Q 045449 462 IFTSVLSSTIWNLKDILFIDVSSNFLD 488 (823)
Q Consensus 462 ~l~~~~p~~~~~l~~L~~LdLs~N~l~ 488 (823)
+|++..+..+..+++|+.|+|++|.+.
T Consensus 92 ~l~~l~~~~~~~l~~L~~L~L~~N~~~ 118 (174)
T 2r9u_A 92 HLKSIPRGAFDNLKSLTHIYLYNNPWD 118 (174)
T ss_dssp CCCCCCTTTTTTCTTCSEEECCSSCBC
T ss_pred ccceeCHHHhccccCCCEEEeCCCCcc
Confidence 555544444555555555555555554
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.45 E-value=2.5e-14 Score=150.25 Aligned_cols=125 Identities=23% Similarity=0.172 Sum_probs=93.8
Q ss_pred HHHHHHHhccCCccceeeccC-----------CeEEEEEEehHhhH------------------HHHHHHHHHHHHHhhc
Q 045449 620 YHELLRATDRFSENNLIGIGN-----------GMEVAVKVFHQQYE------------------RALKSFEDECEVRKRI 670 (823)
Q Consensus 620 ~~~l~~at~~f~~~~~lg~g~-----------~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l 670 (823)
...+......|...+.||.|+ |..||||+++.... .....|.+|+++++++
T Consensus 82 l~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l 161 (282)
T 1zar_A 82 LHRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL 161 (282)
T ss_dssp HHHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhc
Confidence 334444555666678899885 67899999964321 2456799999999998
Q ss_pred chhhHHH-----------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeeccccc
Q 045449 671 RHRNLVK-----------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAK 721 (823)
Q Consensus 671 ~h~niv~-----------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~ 721 (823)
+|+++.. ++.|++.+|+++|+.||+||||||+|||++ ++.+||+|||+|+
T Consensus 162 ~~~~v~~~~~~~~~~lvmE~~~g~~L~~l~~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~DFG~a~ 240 (282)
T 1zar_A 162 QGLAVPKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFPQSV 240 (282)
T ss_dssp TTSSSCCEEEEETTEEEEECCCCEEGGGCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECCCTTCE
T ss_pred cCCCcCeEEeccceEEEEEecCCCcHHHcchhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEECCCCe
Confidence 8433222 578899999999999999999999999999 9999999999987
Q ss_pred ccCCCCccccccccccCCCcCcccccCC----------Cccccccceeh
Q 045449 722 LLSGEDQLSKQTQTLATIGYMAPEYGTK----------GRVSTRGDVCS 760 (823)
Q Consensus 722 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~----------~~~~~~~Dv~S 760 (823)
. +..|+|||++.+ ..|+..+|+|.
T Consensus 241 ~---------------~~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~ 274 (282)
T 1zar_A 241 E---------------VGEEGWREILERDVRNIITYFSRTYRTEKDINS 274 (282)
T ss_dssp E---------------TTSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHH
T ss_pred E---------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCChHH
Confidence 3 345789998754 34566666664
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.36 E-value=1.2e-12 Score=142.09 Aligned_cols=108 Identities=19% Similarity=0.147 Sum_probs=93.0
Q ss_pred ccceeeeeCCCCCcEEEEEcCCC-CCccccCcccCCCCCCcEEEccC-CCCCCCCCCCCCCCCCCCEEECCCCcCcCCCc
Q 045449 40 CIWIGITCDVNSHRVIGLNISSF-NLQGTITPQLGNLSSLQTLDLSH-NKLSGNIPSSIFNMHTLKLLDFSDNQLFGSLS 117 (823)
Q Consensus 40 c~w~gv~c~~~~~~v~~L~L~~~-~l~g~~~~~l~~l~~L~~L~Ls~-N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p 117 (823)
|.|..|.|+. + +|++ +|. +..+++|++|+|++ |+|++..+..|++|++|++|+|++|+|++..|
T Consensus 8 C~~~~v~~~~------------~n~l~~-ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 73 (347)
T 2ifg_A 8 HGSSGLRCTR------------DGALDS-LHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAP 73 (347)
T ss_dssp SSSSCEECCS------------SCCCTT-TTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECT
T ss_pred ccCCEEEcCC------------CCCCCc-cCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCH
Confidence 8888777753 3 5664 777 99999999999996 99998888999999999999999999999999
Q ss_pred hhhhcCCCCcEEecccccccCccCccccCCCCCCccccccceeeeccceeec
Q 045449 118 SFIFNMSSMTTIDLSINRLSGELPANICKIPSTLSKCKQLEELNLGFNNLSG 169 (823)
Q Consensus 118 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~p~~~~~l~~L~~L~Ls~N~l~~ 169 (823)
..|.++++|++|||++|+|++..+..+ ..++ |++|+|++|.|..
T Consensus 74 ~~~~~l~~L~~L~l~~N~l~~~~~~~~-------~~~~-L~~l~l~~N~~~c 117 (347)
T 2ifg_A 74 DAFHFTPRLSRLNLSFNALESLSWKTV-------QGLS-LQELVLSGNPLHC 117 (347)
T ss_dssp TGGGSCSCCCEEECCSSCCSCCCSTTT-------CSCC-CCEEECCSSCCCC
T ss_pred HHhcCCcCCCEEeCCCCccceeCHHHc-------ccCC-ceEEEeeCCCccC
Confidence 999999999999999999995433323 4444 9999999999984
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.35 E-value=6.2e-14 Score=153.17 Aligned_cols=135 Identities=13% Similarity=0.078 Sum_probs=73.9
Q ss_pred cccccEEEcccCcCCCCchhcc-----cccCCCCEEEccCCCCCCc----chHhhhcCCCCCEEEcccCcCccc----cc
Q 045449 378 LSNLLVLELGGNNLTGPIPVTF-----SQLQTLQAFDLTRNKLAGP----ITDELCHLARLHSLVLQGNKFSGS----IP 444 (823)
Q Consensus 378 l~~L~~L~Ls~N~l~g~~p~~~-----~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~g~----~p 444 (823)
+++|+.|+|++|+++......+ ...++|++|+|++|.|+.. ++..+..+++|++|+|++|.|+.. ++
T Consensus 125 L~~L~~L~Ls~n~l~~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~ 204 (372)
T 3un9_A 125 FLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLA 204 (372)
T ss_dssp HHTEEEEECCSSCCCHHHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHH
T ss_pred HHhccHhhcCCCCCCHHHHHHHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHH
Confidence 3455566666666553322222 2345566666666666532 233345566677777777766542 24
Q ss_pred ccccCCCCCCeEeccCCccccc----cchhhhccCCCcEEeccccccccccCccccCCC-----CCcEEE--cccCCCC
Q 045449 445 SCLGNLTSVRVLYLGLNIFTSV----LSSTIWNLKDILFIDVSSNFLDGPLSLDIGNLK-----VVIGLD--FSRNNLS 512 (823)
Q Consensus 445 ~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~LdLs~N~l~g~~p~~~~~l~-----~L~~L~--ls~N~l~ 512 (823)
..+...++|+.|+|++|.+++. ++..+...+.|++|||++|.|+..-...+..+. .|+.+. +..|.++
T Consensus 205 ~~L~~~~~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i~~~g~~~L~~~~~~~~~~L~~l~~ll~~~~~~ 283 (372)
T 3un9_A 205 AQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSSEGRQVLRDLGGAAEGGARVVVSLTEGTAVS 283 (372)
T ss_dssp HHGGGCSCCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSCCHHHHHHHHHCC------CEEECCCC----CH
T ss_pred HHHhcCCCcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCCCHHHHHHHHHHhcCCCccchhhHhhhcCCccC
Confidence 4555666777777777777653 333445567777888888877765444443331 155555 5555554
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.34 E-value=1.5e-13 Score=150.04 Aligned_cols=158 Identities=18% Similarity=0.115 Sum_probs=118.6
Q ss_pred ccceEEecCCcceeccCcccc-----CcccccEEEcccCcCCCCchhcc-cccCCCCEEEccCCCCCCcchHhhh-----
Q 045449 356 SLETILMANCSISGNIPQVVG-----NLSNLLVLELGGNNLTGPIPVTF-SQLQTLQAFDLTRNKLAGPITDELC----- 424 (823)
Q Consensus 356 ~L~~L~L~~N~l~~~~p~~~~-----~l~~L~~L~Ls~N~l~g~~p~~~-~~l~~L~~L~Ls~N~l~~~~p~~~~----- 424 (823)
.|++|+|++|.++......+. ..++|++|+|++|.++......+ ..+++|+.|+|++|.|+......++
T Consensus 73 ~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~~ 152 (372)
T 3un9_A 73 SLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLLH 152 (372)
T ss_dssp TCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHHS
T ss_pred hCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHHh
Confidence 455555555555433222222 23689999999999975444333 4567899999999999866555553
Q ss_pred cCCCCCEEEcccCcCccc----ccccccCCCCCCeEeccCCcccccc----chhhhccCCCcEEeccccccccc----cC
Q 045449 425 HLARLHSLVLQGNKFSGS----IPSCLGNLTSVRVLYLGLNIFTSVL----SSTIWNLKDILFIDVSSNFLDGP----LS 492 (823)
Q Consensus 425 ~l~~L~~L~Ls~N~l~g~----~p~~~~~l~~L~~L~Ls~N~l~~~~----p~~~~~l~~L~~LdLs~N~l~g~----~p 492 (823)
..++|++|+|++|.|+.. ++..+..+++|++|+|++|.+++.. +..+...+.|+.|||++|.|+.. ++
T Consensus 153 ~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l~ 232 (372)
T 3un9_A 153 DQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALA 232 (372)
T ss_dssp TTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHHH
T ss_pred cCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHHH
Confidence 468899999999999753 4555678899999999999998643 56677888999999999999863 44
Q ss_pred ccccCCCCCcEEEcccCCCCC
Q 045449 493 LDIGNLKVVIGLDFSRNNLSG 513 (823)
Q Consensus 493 ~~~~~l~~L~~L~ls~N~l~g 513 (823)
..+...+.|++|||++|.++.
T Consensus 233 ~~L~~~~~L~~L~Ls~N~i~~ 253 (372)
T 3un9_A 233 RAAREHPSLELLHLYFNELSS 253 (372)
T ss_dssp HHHHHCSSCCEEECTTSSCCH
T ss_pred HHHHhCCCCCEEeccCCCCCH
Confidence 556677999999999999873
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.30 E-value=3.9e-12 Score=138.03 Aligned_cols=102 Identities=17% Similarity=0.137 Sum_probs=54.2
Q ss_pred EecCC-cceeccCccccCcccccEEEccc-CcCCCCchhcccccCCCCEEEccCCCCCCcchHhhhcCCCCCEEEcccCc
Q 045449 361 LMANC-SISGNIPQVVGNLSNLLVLELGG-NNLTGPIPVTFSQLQTLQAFDLTRNKLAGPITDELCHLARLHSLVLQGNK 438 (823)
Q Consensus 361 ~L~~N-~l~~~~p~~~~~l~~L~~L~Ls~-N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 438 (823)
+++++ ++++ +|. +..+++|+.|+|++ |+|++..+..|.++++|++|+|++|+|++..|..|.++++|+.|+|++|+
T Consensus 14 ~~~~~n~l~~-ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~ 91 (347)
T 2ifg_A 14 RCTRDGALDS-LHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNA 91 (347)
T ss_dssp ECCSSCCCTT-TTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSC
T ss_pred EcCCCCCCCc-cCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCCCc
Confidence 44444 4442 344 55555555555553 55555444555555555555555555555555555555555555555555
Q ss_pred CcccccccccCCCCCCeEeccCCcccc
Q 045449 439 FSGSIPSCLGNLTSVRVLYLGLNIFTS 465 (823)
Q Consensus 439 l~g~~p~~~~~l~~L~~L~Ls~N~l~~ 465 (823)
|++..+..|..++ |+.|+|++|.|+.
T Consensus 92 l~~~~~~~~~~~~-L~~l~l~~N~~~c 117 (347)
T 2ifg_A 92 LESLSWKTVQGLS-LQELVLSGNPLHC 117 (347)
T ss_dssp CSCCCSTTTCSCC-CCEEECCSSCCCC
T ss_pred cceeCHHHcccCC-ceEEEeeCCCccC
Confidence 5544444444433 5555555555543
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=99.17 E-value=5.9e-10 Score=123.05 Aligned_cols=139 Identities=9% Similarity=0.085 Sum_probs=96.2
Q ss_pred cceeccCccccCcccccEEEcccCcCCCCchhcccccCCCCEEEccCCCCCCcchHhhhcCCCCCEEEcccCcCcccccc
Q 045449 366 SISGNIPQVVGNLSNLLVLELGGNNLTGPIPVTFSQLQTLQAFDLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPS 445 (823)
Q Consensus 366 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~ 445 (823)
.++..-..+|.++.+|+.+.+.++..+ .....|.++..|+.+.+. +.++......|.++.+|+.++|..+ ++..-..
T Consensus 252 ~v~~i~~~aF~~c~~L~~i~lp~~~~~-I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~ 328 (394)
T 4gt6_A 252 GVARIETHAFDSCAYLASVKMPDSVVS-IGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDD 328 (394)
T ss_dssp TEEEECTTTTTTCSSCCEEECCTTCCE-ECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTT
T ss_pred cceEcccceeeecccccEEecccccce-ecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHh
Confidence 445555678888899999988766543 445668888899999886 4566555667888899999999754 6645567
Q ss_pred cccCCCCCCeEeccCCccccccchhhhccCCCcEEeccccccccccCccccCCCCCcEEEcccCCC
Q 045449 446 CLGNLTSVRVLYLGLNIFTSVLSSTIWNLKDILFIDVSSNFLDGPLSLDIGNLKVVIGLDFSRNNL 511 (823)
Q Consensus 446 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~ls~N~l 511 (823)
+|.++++|+.+.|..+ ++.+-...|.++++|+.+++++|.... ..+.....|+.+.+..|.+
T Consensus 329 aF~~C~~L~~i~ip~s-v~~I~~~aF~~C~~L~~i~~~~~~~~~---~~~~~~~~L~~i~i~~~~~ 390 (394)
T 4gt6_A 329 AFAGCEQLERIAIPSS-VTKIPESAFSNCTALNNIEYSGSRSQW---NAISTDSGLQNLPVAPGSI 390 (394)
T ss_dssp TTTTCTTCCEEEECTT-CCBCCGGGGTTCTTCCEEEESSCHHHH---HTCBCCCCC----------
T ss_pred HhhCCCCCCEEEECcc-cCEEhHhHhhCCCCCCEEEECCceeeh---hhhhccCCCCEEEeCCCCE
Confidence 8889999999998654 676667788899999999998886542 3456667788777766554
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=99.15 E-value=1.1e-09 Score=120.95 Aligned_cols=335 Identities=12% Similarity=0.135 Sum_probs=172.1
Q ss_pred CCCCCCCCCC-CCCEEECCCCcCcCCCchhhhcCCCCcEEecccccccCccCccccCCC-CCCccccccceeeeccceee
Q 045449 91 NIPSSIFNMH-TLKLLDFSDNQLFGSLSSFIFNMSSMTTIDLSINRLSGELPANICKIP-STLSKCKQLEELNLGFNNLS 168 (823)
Q Consensus 91 ~~p~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~p-~~~~~l~~L~~L~Ls~N~l~ 168 (823)
+-..+|.+.. .|+.+.+..+ ++..-..+|.++++|+.+.++.|. |..+..+. .+|..+.+|+.+.+..+ ++
T Consensus 54 Ig~~aF~~~~~~L~sI~iP~s-vt~Ig~~AF~~C~~L~~i~~~~n~-----p~~l~~Ig~~aF~~c~~L~~i~~~~~-~~ 126 (394)
T 4gt6_A 54 IGDRVFCNYKYVLTSVQIPDT-VTEIGSNAFYNCTSLKRVTIQDNK-----PSCVKKIGRQAFMFCSELTDIPILDS-VT 126 (394)
T ss_dssp ECTTTTTTCCSCCCEEEECTT-CCEECTTTTTTCTTCCEEEEGGGC-----CCCCCEECTTTTTTCTTCCBCGGGTT-CS
T ss_pred cCHhhccCCCCcCEEEEECCC-eeEEhHHHhhCCccCceEeecCCC-----CCeeeEechhhchhcccceeeccCCc-cc
Confidence 4456777774 5888888754 665667788888888888887663 22222221 24566667766655433 21
Q ss_pred ccCccccccchhhHHHHHhhcCCCcccCCcccCCcchhhhhccccccccCCccccccCCCCCcEEEccCCcccccCCccc
Q 045449 169 GAIPKEIGNLTKLKEIISTITNSTVCEIPREIGNLPYLARLALATNNLVGVVPVTIFNMSALKEISLLNNSLSGSLPSRI 248 (823)
Q Consensus 169 ~~~p~~l~~l~~L~~L~~l~~n~~~~~ip~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~lp~~~ 248 (823)
..- ...|.++.+|+.+.+..+ +.......|.+..+|+.+.+..+ ++ .+....
T Consensus 127 ~I~-------------------------~~aF~~c~~L~~i~lp~~-~~~I~~~~F~~c~~L~~i~~~~~-~~-~I~~~a 178 (394)
T 4gt6_A 127 EID-------------------------SEAFHHCEELDTVTIPEG-VTSVADGMFSYCYSLHTVTLPDS-VT-AIEERA 178 (394)
T ss_dssp EEC-------------------------TTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEECCTT-CC-EECTTT
T ss_pred eeh-------------------------hhhhhhhcccccccccce-eeeecccceecccccccccccce-ee-Eecccc
Confidence 111 123444455555555432 33344455666677777776654 33 344444
Q ss_pred ccCCCCccEEEeeccccccccCccccCCCCCCeEEeecccccccCCCccCCCcccCcccccCccccCCCCcccccccccC
Q 045449 249 DLSLPNVETLNLGINSFSGTIPSSITNSSKLSDLELGENLFSGFIPNTIGNLRNLEFGNIADNYLTSSTPELSFLSSLTN 328 (823)
Q Consensus 249 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~ 328 (823)
+. ..+|+.+.+..+-. .....+|.++.+++......+......-..+........ ....+..
T Consensus 179 F~-~~~l~~i~ip~~~~-~i~~~af~~c~~l~~~~~~~~~~~~~~~~~~~~~~~~~~----------------~~~~~~~ 240 (394)
T 4gt6_A 179 FT-GTALTQIHIPAKVT-RIGTNAFSECFALSTITSDSESYPAIDNVLYEKSANGDY----------------ALIRYPS 240 (394)
T ss_dssp TT-TCCCSEEEECTTCC-EECTTTTTTCTTCCEEEECCSSSCBSSSCEEEECTTSCE----------------EEEECCT
T ss_pred cc-ccceeEEEECCccc-ccccchhhhccccceecccccccccccceeecccccccc----------------ccccccc
Confidence 44 45666666654432 244555666666666665554433211111100000000 0000111
Q ss_pred CCCceEEEeecCCCCccCCccccccccccceEEecCCcceeccCccccCcccccEEEcccCcCCCCchhcccccCCCCEE
Q 045449 329 CKKLKVLIVTGNPLDGILPKSIGNFSLSLETILMANCSISGNIPQVVGNLSNLLVLELGGNNLTGPIPVTFSQLQTLQAF 408 (823)
Q Consensus 329 l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L 408 (823)
...+..+.+. +.+...-...|.++ ..|+.+.+..+.. .....+|.++++|+.+.+. +.++......|.++.+|+.+
T Consensus 241 ~~~~~~~~ip-~~v~~i~~~aF~~c-~~L~~i~lp~~~~-~I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i 316 (394)
T 4gt6_A 241 QREDPAFKIP-NGVARIETHAFDSC-AYLASVKMPDSVV-SIGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSI 316 (394)
T ss_dssp TCCCSEEECC-TTEEEECTTTTTTC-SSCCEEECCTTCC-EECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEE
T ss_pred ccccceEEcC-CcceEcccceeeec-ccccEEecccccc-eecCcccccccccccccCC-CcccccCceeecCCCCcCEE
Confidence 1122222221 11222223334444 4566666654332 2445667777777777775 44553444567777777777
Q ss_pred EccCCCCCCcchHhhhcCCCCCEEEcccCcCcccccccccCCCCCCeEeccCCccccccchhhhccCCCcEEecccccc
Q 045449 409 DLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSVRVLYLGLNIFTSVLSSTIWNLKDILFIDVSSNFL 487 (823)
Q Consensus 409 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~LdLs~N~l 487 (823)
+|..+ ++..-...|.++.+|+.+.|..+ ++..-..+|.++++|+.+++.+|.... ..+.....|+.+.+..|.+
T Consensus 317 ~lp~~-v~~I~~~aF~~C~~L~~i~ip~s-v~~I~~~aF~~C~~L~~i~~~~~~~~~---~~~~~~~~L~~i~i~~~~~ 390 (394)
T 4gt6_A 317 DIPEG-ITQILDDAFAGCEQLERIAIPSS-VTKIPESAFSNCTALNNIEYSGSRSQW---NAISTDSGLQNLPVAPGSI 390 (394)
T ss_dssp ECCTT-CCEECTTTTTTCTTCCEEEECTT-CCBCCGGGGTTCTTCCEEEESSCHHHH---HTCBCCCCC----------
T ss_pred EeCCc-ccEehHhHhhCCCCCCEEEECcc-cCEEhHhHhhCCCCCCEEEECCceeeh---hhhhccCCCCEEEeCCCCE
Confidence 77654 55444556777777877777544 554445677778888888877765432 3455667777777766654
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.07 E-value=9.6e-11 Score=121.24 Aligned_cols=92 Identities=22% Similarity=0.299 Sum_probs=71.6
Q ss_pred CCccceeeccC------------CeE--EEEEEehHhh------------------------HHHHHHHHHHHHHHhhcc
Q 045449 630 FSENNLIGIGN------------GME--VAVKVFHQQY------------------------ERALKSFEDECEVRKRIR 671 (823)
Q Consensus 630 f~~~~~lg~g~------------~~~--vavK~~~~~~------------------------~~~~~~~~~E~~~l~~l~ 671 (823)
|...+.||.|+ |.. ||||+++... ......+.+|++++.++.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 44567788875 667 9999864321 112246889999999887
Q ss_pred hhhHH----------------------------------------HHHHHHHHHhhhcC-CCCEEeccCCCCCEEeCCCC
Q 045449 672 HRNLV----------------------------------------KIISSSLEYLHFGH-SIPIIHCDLKPSNVLLDEDM 710 (823)
Q Consensus 672 h~niv----------------------------------------~~~~~~l~~L~~~h-~~~ivHrdlk~~NiLl~~~~ 710 (823)
|+++. .++.|++.+|.++| +.||+||||||+|||++.
T Consensus 129 ~~~i~~p~~~~~~~~~lVmE~~g~~g~~~~~L~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~NILl~~-- 206 (258)
T 1zth_A 129 EAGVSVPQPYTYMKNVLLMEFIGEDELPAPTLVELGRELKELDVEGIFNDVVENVKRLYQEAELVHADLSEYNIMYID-- 206 (258)
T ss_dssp HTTCCCCCEEEEETTEEEEECCEETTEECCBHHHHGGGGGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTTSEEESS--
T ss_pred hCCCCCCeEEEcCCCEEEEEecCCCCCccccHHHHhhccChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEEcC--
Confidence 76431 14678899999999 999999999999999998
Q ss_pred cEEEeeccccccc
Q 045449 711 VAHISDFGIAKLL 723 (823)
Q Consensus 711 ~~kl~DfGla~~~ 723 (823)
.++|+|||+|...
T Consensus 207 ~~~liDFG~a~~~ 219 (258)
T 1zth_A 207 KVYFIDMGQAVTL 219 (258)
T ss_dssp SEEECCCTTCEET
T ss_pred cEEEEECcccccC
Confidence 8999999999764
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.86 E-value=2.2e-09 Score=116.04 Aligned_cols=83 Identities=16% Similarity=0.274 Sum_probs=43.5
Q ss_pred CCCCCEEEcccCcCccccccccc---CCCCCCeEeccCCccccc----cchhhhccCCCcEEeccccccccccCccccC-
Q 045449 426 LARLHSLVLQGNKFSGSIPSCLG---NLTSVRVLYLGLNIFTSV----LSSTIWNLKDILFIDVSSNFLDGPLSLDIGN- 497 (823)
Q Consensus 426 l~~L~~L~Ls~N~l~g~~p~~~~---~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~LdLs~N~l~g~~p~~~~~- 497 (823)
+++|+.|+|++|.+.+..+..+. .+++|++|+|+.|.+++. ++..+..+++|+.|+|++|.++...-..+..
T Consensus 251 ~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~d~~~~~l~~a 330 (362)
T 2ra8_A 251 FPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQKS 330 (362)
T ss_dssp CTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCCHHHHHHHHHH
T ss_pred CCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCCHHHHHHHHHH
Confidence 34555555555555433222221 345566666666666553 2333345667777777777666543333332
Q ss_pred CCCCcEEEcccCC
Q 045449 498 LKVVIGLDFSRNN 510 (823)
Q Consensus 498 l~~L~~L~ls~N~ 510 (823)
+ ...++++.|+
T Consensus 331 l--g~~~~~~~~~ 341 (362)
T 2ra8_A 331 L--PMKIDVSDSQ 341 (362)
T ss_dssp C--CSEEECCSBC
T ss_pred c--CCEEEecCCc
Confidence 2 3557777765
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.85 E-value=1.4e-09 Score=117.71 Aligned_cols=64 Identities=6% Similarity=0.236 Sum_probs=29.6
Q ss_pred cCCCCEEEccCCCCCCcchHhhh---cCCCCCEEEcccCcCccc----ccccccCCCCCCeEeccCCcccc
Q 045449 402 LQTLQAFDLTRNKLAGPITDELC---HLARLHSLVLQGNKFSGS----IPSCLGNLTSVRVLYLGLNIFTS 465 (823)
Q Consensus 402 l~~L~~L~Ls~N~l~~~~p~~~~---~l~~L~~L~Ls~N~l~g~----~p~~~~~l~~L~~L~Ls~N~l~~ 465 (823)
+++|++|+|++|.+.+..+..+. .+++|++|+|+.|.+.+. ++..+..+++|+.|+|++|.++.
T Consensus 251 ~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~d 321 (362)
T 2ra8_A 251 FPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSD 321 (362)
T ss_dssp CTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCCH
T ss_pred CCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCCH
Confidence 44555555555555433322222 244555555555555442 22222334555555555555444
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=98.80 E-value=1.1e-07 Score=104.06 Aligned_cols=271 Identities=9% Similarity=0.053 Sum_probs=121.7
Q ss_pred ccCCcchhhhhccccccccCCccccccCCCCCcEEEccCCcccccCCcccccCCCCccEEEeeccccccccCccccCCCC
Q 045449 199 EIGNLPYLARLALATNNLVGVVPVTIFNMSALKEISLLNNSLSGSLPSRIDLSLPNVETLNLGINSFSGTIPSSITNSSK 278 (823)
Q Consensus 199 ~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 278 (823)
+|.++.+|+.++|..+ ++.+-..+|.+. +|+.+.+..+ ++ .+....+. ..+|+.+++..+ +...-...|.+. +
T Consensus 64 aF~~C~~L~~I~lp~~-v~~Ig~~aF~~c-~l~~i~~~~~-l~-~I~~~aF~-~~~L~~i~lp~~-~~~i~~~~F~~~-~ 136 (379)
T 4h09_A 64 NFNSCYNMTKVTVAST-VTSIGDGAFADT-KLQSYTGMER-VK-KFGDYVFQ-GTDLDDFEFPGA-TTEIGNYIFYNS-S 136 (379)
T ss_dssp TTTTCTTCCEEEECTT-CCEECTTTTTTC-CCCEEEECTT-CC-EECTTTTT-TCCCSEEECCTT-CCEECTTTTTTC-C
T ss_pred HhhCCCCCCEEEeCCc-ceEechhhhcCC-CCceEECCce-ee-Eeccceec-cCCcccccCCCc-cccccccccccc-e
Confidence 4555555666666432 444444555554 5666655543 33 44555554 346676666544 222333334333 4
Q ss_pred CCeEEeecccccccCCCccCCCcccCcccccCccccCCCCc-------ccccccccCCCCceEEEeecCCCCccCCcccc
Q 045449 279 LSDLELGENLFSGFIPNTIGNLRNLEFGNIADNYLTSSTPE-------LSFLSSLTNCKKLKVLIVTGNPLDGILPKSIG 351 (823)
Q Consensus 279 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~-------~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~ 351 (823)
|+.+.+..+ ++.+....|..+.+++.+.+..+........ ......+..+..+..+.+..+. .......+.
T Consensus 137 l~~~~~~~~-v~~i~~~~f~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~i~~~~f~ 214 (379)
T 4h09_A 137 VKRIVIPKS-VTTIKDGIGYKAENLEKIEVSSNNKNYVAENYVLYNKNKTILESYPAAKTGTEFTIPSTV-KTVTAYGFS 214 (379)
T ss_dssp CCEEEECTT-CCEECSCTTTTCTTCCEEEECTTCSSEEEETTEEEETTSSEEEECCTTCCCSEEECCTTC-CEECTTTTT
T ss_pred eeeeeccce-eeccccchhcccccccccccccccceeecccceecccccceeccccccccccccccccce-eEEeecccc
Confidence 555554433 3334445566666666555544332211000 0011122223333333322211 111122222
Q ss_pred ccccccceEEecCCcceeccCccccCcccccEEEcccCcCCCCchhcccccCCCCEEEccCCCCCCcchHhhhcCCCCCE
Q 045449 352 NFSLSLETILMANCSISGNIPQVVGNLSNLLVLELGGNNLTGPIPVTFSQLQTLQAFDLTRNKLAGPITDELCHLARLHS 431 (823)
Q Consensus 352 ~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 431 (823)
.. .+|+.+.+..+ ++.....+|.++..|+.+.+..+ ++..-...|.++.+|+.+.+..+ ++......|.++.+|+.
T Consensus 215 ~~-~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~~ 290 (379)
T 4h09_A 215 YG-KNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNLTK 290 (379)
T ss_dssp TC-SSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTTCCE
T ss_pred cc-cccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-ceecccccccccccccc
Confidence 22 34444444332 33333445555555555555443 33233344555555555555432 33233334555555555
Q ss_pred EEcccCcCcccccccccCCCCCCeEeccCCccccccchhhhccCCCcEEecc
Q 045449 432 LVLQGNKFSGSIPSCLGNLTSVRVLYLGLNIFTSVLSSTIWNLKDILFIDVS 483 (823)
Q Consensus 432 L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~LdLs 483 (823)
+++.++.++..-..+|.++++|+.++|..+ ++.+-..+|.++.+|+.+.+.
T Consensus 291 i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip 341 (379)
T 4h09_A 291 VVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTISYP 341 (379)
T ss_dssp EEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCCCCCC
T ss_pred ccccccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEEEEC
Confidence 555555555444445555555555555433 444334455555555555554
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=98.79 E-value=3.7e-09 Score=113.97 Aligned_cols=46 Identities=17% Similarity=0.213 Sum_probs=40.7
Q ss_pred HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCC----------cEEEeeccccccc
Q 045449 678 IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDM----------VAHISDFGIAKLL 723 (823)
Q Consensus 678 ~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~----------~~kl~DfGla~~~ 723 (823)
++.|++.+|+++|+.|||||||||.|||+++++ .+.|+||+.+...
T Consensus 210 l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 210 LYADLIALILRLAKHGLIHGDFNEFNILIREEKDAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp HHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSSCTTSEEEEEEECCCTTCEET
T ss_pred HHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCcccccccccceEEEEeCCcccC
Confidence 568999999999999999999999999998766 4899999987654
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=98.78 E-value=8.5e-08 Score=105.01 Aligned_cols=148 Identities=16% Similarity=0.147 Sum_probs=91.0
Q ss_pred cCccccCCCCCCeEEeecccccccCCCccCCCcccCcccccCccccCCCCcccccccccCCCCceEEEeecCCCCccCCc
Q 045449 269 IPSSITNSSKLSDLELGENLFSGFIPNTIGNLRNLEFGNIADNYLTSSTPELSFLSSLTNCKKLKVLIVTGNPLDGILPK 348 (823)
Q Consensus 269 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~ 348 (823)
....+....+|+.+.+..+ +..+...+|.++..|+.+.+..+ ++.+ ...+|.++.+|+.+.+..+ +...-..
T Consensus 209 ~~~~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I-----~~~aF~~~~~l~~i~l~~~-i~~i~~~ 280 (379)
T 4h09_A 209 TAYGFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSI-----GSFLLQNCTALKTLNFYAK-VKTVPYL 280 (379)
T ss_dssp CTTTTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEE-----CTTTTTTCTTCCEEEECCC-CSEECTT
T ss_pred eecccccccccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEe-----Cccccceeehhcccccccc-ceecccc
Confidence 3444555556666665543 33344555666666666666544 3322 1235666667777766543 4444445
Q ss_pred cccccccccceEEecCCcceeccCccccCcccccEEEcccCcCCCCchhcccccCCCCEEEccCCCCCCcchHhhhcCC
Q 045449 349 SIGNFSLSLETILMANCSISGNIPQVVGNLSNLLVLELGGNNLTGPIPVTFSQLQTLQAFDLTRNKLAGPITDELCHLA 427 (823)
Q Consensus 349 ~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 427 (823)
.|.++ .+|+.+.+.++.++.....+|.++.+|+.++|..+ ++..-..+|.++.+|+.+.+..+ ++..-...|.++.
T Consensus 281 aF~~c-~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip~~-v~~I~~~aF~~c~ 356 (379)
T 4h09_A 281 LCSGC-SNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTISYPKS-ITLIESGAFEGSS 356 (379)
T ss_dssp TTTTC-TTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTTTTTTSS
T ss_pred ccccc-cccccccccccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEEEECCc-cCEEchhHhhCCC
Confidence 56666 57777777777777667778888888888888654 55344557888888888888654 5544455566654
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.58 E-value=3.7e-08 Score=96.08 Aligned_cols=116 Identities=17% Similarity=0.181 Sum_probs=69.7
Q ss_pred ccccCcccccEEEcccC-cCCCC----chhcccccCCCCEEEccCCCCCCc----chHhhhcCCCCCEEEcccCcCccc-
Q 045449 373 QVVGNLSNLLVLELGGN-NLTGP----IPVTFSQLQTLQAFDLTRNKLAGP----ITDELCHLARLHSLVLQGNKFSGS- 442 (823)
Q Consensus 373 ~~~~~l~~L~~L~Ls~N-~l~g~----~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~g~- 442 (823)
..+...++|++|+|++| .+... +...+...++|++|+|++|+|... +...+...+.|++|+|++|.|...
T Consensus 30 ~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g 109 (185)
T 1io0_A 30 RIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSG 109 (185)
T ss_dssp HHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHH
T ss_pred HHHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHH
Confidence 34555667777777777 66532 233455566777777777777643 223344456677777777777643
Q ss_pred ---ccccccCCCCCCeEec--cCCcccccc----chhhhccCCCcEEeccccccc
Q 045449 443 ---IPSCLGNLTSVRVLYL--GLNIFTSVL----SSTIWNLKDILFIDVSSNFLD 488 (823)
Q Consensus 443 ---~p~~~~~l~~L~~L~L--s~N~l~~~~----p~~~~~l~~L~~LdLs~N~l~ 488 (823)
+...+...++|++|+| ++|.++... ...+...+.|+.|+|++|.+.
T Consensus 110 ~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 110 ILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp HHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence 3445555666777777 667666542 233344466666666666654
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.58 E-value=7.3e-09 Score=106.29 Aligned_cols=79 Identities=19% Similarity=0.199 Sum_probs=38.7
Q ss_pred cCCCCCEEEcccCcCcc--cccccccCCCCCCeEeccCCccccccchhhhccC--CCcEEeccccccccccCc-------
Q 045449 425 HLARLHSLVLQGNKFSG--SIPSCLGNLTSVRVLYLGLNIFTSVLSSTIWNLK--DILFIDVSSNFLDGPLSL------- 493 (823)
Q Consensus 425 ~l~~L~~L~Ls~N~l~g--~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~--~L~~LdLs~N~l~g~~p~------- 493 (823)
++++|+.|+|++|+|++ .+|..+..+++|+.|+|++|+|++. ..+..+. .|+.|+|++|.+++.+|.
T Consensus 168 ~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~~ 245 (267)
T 3rw6_A 168 NIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTFRDQSTYISA 245 (267)
T ss_dssp HCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCSSHHHHHHH
T ss_pred hCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCccccCcchhHHHH
Confidence 34444444444444444 2334444445555555555555443 2222233 556666666666655441
Q ss_pred cccCCCCCcEEE
Q 045449 494 DIGNLKVVIGLD 505 (823)
Q Consensus 494 ~~~~l~~L~~L~ 505 (823)
.+..++.|+.||
T Consensus 246 il~~~P~L~~LD 257 (267)
T 3rw6_A 246 IRERFPKLLRLD 257 (267)
T ss_dssp HHHHCTTCCEES
T ss_pred HHHHCcccCeEC
Confidence 245566666665
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.55 E-value=2.2e-08 Score=102.74 Aligned_cols=80 Identities=19% Similarity=0.293 Sum_probs=45.3
Q ss_pred ccCCCCEEEccCCCCCC--cchHhhhcCCCCCEEEcccCcCcccccccccCCC--CCCeEeccCCccccccc-------h
Q 045449 401 QLQTLQAFDLTRNKLAG--PITDELCHLARLHSLVLQGNKFSGSIPSCLGNLT--SVRVLYLGLNIFTSVLS-------S 469 (823)
Q Consensus 401 ~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~--~L~~L~Ls~N~l~~~~p-------~ 469 (823)
++++|+.|+|++|+|++ .+|..+..+++|+.|+|++|+|++. ..+..+. +|++|+|++|.+++.+| .
T Consensus 168 ~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~~ 245 (267)
T 3rw6_A 168 NIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTFRDQSTYISA 245 (267)
T ss_dssp HCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCSSHHHHHHH
T ss_pred hCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCccccCcchhHHHH
Confidence 45555555555555555 3334455556666666666666543 2233333 66666666666665444 3
Q ss_pred hhhccCCCcEEec
Q 045449 470 TIWNLKDILFIDV 482 (823)
Q Consensus 470 ~~~~l~~L~~LdL 482 (823)
.+..+++|+.||-
T Consensus 246 il~~~P~L~~LDg 258 (267)
T 3rw6_A 246 IRERFPKLLRLDG 258 (267)
T ss_dssp HHHHCTTCCEESS
T ss_pred HHHHCcccCeECC
Confidence 4667777877773
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.52 E-value=4.8e-08 Score=95.25 Aligned_cols=118 Identities=9% Similarity=0.161 Sum_probs=94.2
Q ss_pred chhcccccCCCCEEEccCC-CCCCc----chHhhhcCCCCCEEEcccCcCccc----ccccccCCCCCCeEeccCCcccc
Q 045449 395 IPVTFSQLQTLQAFDLTRN-KLAGP----ITDELCHLARLHSLVLQGNKFSGS----IPSCLGNLTSVRVLYLGLNIFTS 465 (823)
Q Consensus 395 ~p~~~~~l~~L~~L~Ls~N-~l~~~----~p~~~~~l~~L~~L~Ls~N~l~g~----~p~~~~~l~~L~~L~Ls~N~l~~ 465 (823)
+...+...++|++|+|++| .+... +...+...++|++|+|++|.|... +...+...++|++|+|++|.++.
T Consensus 28 l~~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~ 107 (185)
T 1io0_A 28 LKRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISG 107 (185)
T ss_dssp HHHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCH
T ss_pred HHHHHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCH
Confidence 4455677899999999999 98753 344456678999999999999753 34556667899999999999987
Q ss_pred c----cchhhhccCCCcEEec--cccccccc----cCccccCCCCCcEEEcccCCCC
Q 045449 466 V----LSSTIWNLKDILFIDV--SSNFLDGP----LSLDIGNLKVVIGLDFSRNNLS 512 (823)
Q Consensus 466 ~----~p~~~~~l~~L~~LdL--s~N~l~g~----~p~~~~~l~~L~~L~ls~N~l~ 512 (823)
. +...+...+.|++|+| ++|.++.. +...+...+.|+.|+|++|.+.
T Consensus 108 ~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 108 SGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp HHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHHHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence 5 4566777889999999 88999875 3445666689999999999876
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.41 E-value=9.8e-05 Score=70.09 Aligned_cols=82 Identities=10% Similarity=0.117 Sum_probs=38.5
Q ss_pred cccEEEcccCcCCCCchhcccccCCCCEEEccCCC-CCCcchHhhhcC----CCCCEEEcccCc-CcccccccccCCCCC
Q 045449 380 NLLVLELGGNNLTGPIPVTFSQLQTLQAFDLTRNK-LAGPITDELCHL----ARLHSLVLQGNK-FSGSIPSCLGNLTSV 453 (823)
Q Consensus 380 ~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l----~~L~~L~Ls~N~-l~g~~p~~~~~l~~L 453 (823)
+|+.||++++.++..--..+.++++|+.|+|+++. ++..--..++.+ ++|++|+|+++. ++..--..+..+++|
T Consensus 62 ~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~L 141 (176)
T 3e4g_A 62 KIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRNL 141 (176)
T ss_dssp CEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTTC
T ss_pred eEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCCC
Confidence 45555555555543333334455555555555553 443322233332 245555555543 443333334445555
Q ss_pred CeEeccCC
Q 045449 454 RVLYLGLN 461 (823)
Q Consensus 454 ~~L~Ls~N 461 (823)
+.|+|+++
T Consensus 142 ~~L~L~~c 149 (176)
T 3e4g_A 142 KYLFLSDL 149 (176)
T ss_dssp CEEEEESC
T ss_pred CEEECCCC
Confidence 55555554
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.31 E-value=0.00011 Score=69.75 Aligned_cols=83 Identities=14% Similarity=0.078 Sum_probs=48.8
Q ss_pred CCCCEEEccCCCCCCcchHhhhcCCCCCEEEcccCc-CcccccccccCC----CCCCeEeccCC-ccccccchhhhccCC
Q 045449 403 QTLQAFDLTRNKLAGPITDELCHLARLHSLVLQGNK-FSGSIPSCLGNL----TSVRVLYLGLN-IFTSVLSSTIWNLKD 476 (823)
Q Consensus 403 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~-l~g~~p~~~~~l----~~L~~L~Ls~N-~l~~~~p~~~~~l~~ 476 (823)
..|+.|||+++.++..--..+.++++|+.|+|+++. ++..--..+..+ ++|+.|+|+++ ++|..--..+..+++
T Consensus 61 ~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~ 140 (176)
T 3e4g_A 61 YKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRN 140 (176)
T ss_dssp CCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTT
T ss_pred ceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCC
Confidence 457777777777765544555667777777777764 554333334443 25666666665 355544444555566
Q ss_pred CcEEecccc
Q 045449 477 ILFIDVSSN 485 (823)
Q Consensus 477 L~~LdLs~N 485 (823)
|+.|++++.
T Consensus 141 L~~L~L~~c 149 (176)
T 3e4g_A 141 LKYLFLSDL 149 (176)
T ss_dssp CCEEEEESC
T ss_pred CCEEECCCC
Confidence 666666655
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.29 E-value=0.00024 Score=68.70 Aligned_cols=86 Identities=8% Similarity=0.100 Sum_probs=44.6
Q ss_pred cCcccccEEEcccC-cCCCC----chhcccccCCCCEEEccCCCCCCc----chHhhhcCCCCCEEEcccCcCcccc---
Q 045449 376 GNLSNLLVLELGGN-NLTGP----IPVTFSQLQTLQAFDLTRNKLAGP----ITDELCHLARLHSLVLQGNKFSGSI--- 443 (823)
Q Consensus 376 ~~l~~L~~L~Ls~N-~l~g~----~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~g~~--- 443 (823)
.+-+.|++|+|++| ++... +-..+..-+.|+.|+|++|+|... +...+..-+.|+.|+|++|.|...-
T Consensus 38 ~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~a 117 (197)
T 1pgv_A 38 EDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLAR 117 (197)
T ss_dssp TTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHH
T ss_pred hcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHH
Confidence 34455666666664 55421 233444556666666666666532 2222334456666666666665332
Q ss_pred -cccccCCCCCCeEeccCC
Q 045449 444 -PSCLGNLTSVRVLYLGLN 461 (823)
Q Consensus 444 -p~~~~~l~~L~~L~Ls~N 461 (823)
-..+..-+.|+.|+|++|
T Consensus 118 la~aL~~N~tL~~L~L~n~ 136 (197)
T 1pgv_A 118 LLRSTLVTQSIVEFKADNQ 136 (197)
T ss_dssp HHHHTTTTCCCSEEECCCC
T ss_pred HHHHHhhCCceeEEECCCC
Confidence 223344455666666543
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=97.15 E-value=0.00013 Score=74.87 Aligned_cols=31 Identities=26% Similarity=0.398 Sum_probs=26.6
Q ss_pred CCEEeccCCCCCEEeCCCCcEEEeecccccc
Q 045449 692 IPIIHCDLKPSNVLLDEDMVAHISDFGIAKL 722 (823)
Q Consensus 692 ~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~ 722 (823)
..++|+|++|.||+++++..+.|+||+.+..
T Consensus 183 ~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 183 LVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp EEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred ceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 5599999999999998766678999997764
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.02 E-value=0.00051 Score=66.42 Aligned_cols=113 Identities=14% Similarity=0.215 Sum_probs=79.5
Q ss_pred cccccCCCCEEEccCC-CCCCc----chHhhhcCCCCCEEEcccCcCcccc----cccccCCCCCCeEeccCCccccccc
Q 045449 398 TFSQLQTLQAFDLTRN-KLAGP----ITDELCHLARLHSLVLQGNKFSGSI----PSCLGNLTSVRVLYLGLNIFTSVLS 468 (823)
Q Consensus 398 ~~~~l~~L~~L~Ls~N-~l~~~----~p~~~~~l~~L~~L~Ls~N~l~g~~----p~~~~~l~~L~~L~Ls~N~l~~~~p 468 (823)
.+.+-+.|+.|+|++| +|... +...+..-+.|+.|+|++|.|...- ...+..-+.|+.|+|++|.|+..--
T Consensus 36 ll~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga 115 (197)
T 1pgv_A 36 LREDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELL 115 (197)
T ss_dssp HHTTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHH
T ss_pred HHhcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHH
Confidence 3455678999999986 77642 3344566688999999999997543 3345566889999999999986533
Q ss_pred h----hhhccCCCcEEecccc---cccc----ccCccccCCCCCcEEEcccCC
Q 045449 469 S----TIWNLKDILFIDVSSN---FLDG----PLSLDIGNLKVVIGLDFSRNN 510 (823)
Q Consensus 469 ~----~~~~l~~L~~LdLs~N---~l~g----~~p~~~~~l~~L~~L~ls~N~ 510 (823)
. .+..-+.|+.|+|++| .+.. .+...+..-+.|..|+++.|.
T Consensus 116 ~ala~aL~~N~tL~~L~L~n~~~~~ig~~g~~~ia~aL~~N~tL~~L~l~~~~ 168 (197)
T 1pgv_A 116 ARLLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFAS 168 (197)
T ss_dssp HHHHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCC
T ss_pred HHHHHHHhhCCceeEEECCCCcCcCcCHHHHHHHHHHHHhCCCcCeEeccCCC
Confidence 3 4445567999999865 3343 234455566788888887654
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.00 E-value=0.00023 Score=72.70 Aligned_cols=31 Identities=16% Similarity=0.286 Sum_probs=27.0
Q ss_pred CCEEeccCCCCCEEeCCCCcEEEeecccccc
Q 045449 692 IPIIHCDLKPSNVLLDEDMVAHISDFGIAKL 722 (823)
Q Consensus 692 ~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~ 722 (823)
..++|+|++|.||+++++..++|+|||.+..
T Consensus 184 ~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 184 LVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp EEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred eEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 3499999999999998877778999998765
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.69 E-value=0.0031 Score=56.80 Aligned_cols=55 Identities=15% Similarity=0.179 Sum_probs=24.6
Q ss_pred EEEcCCCCCc-cccCcccCCCCCCcEEEccCCCCCCCCCCCCCCCCCCCEEECCCCcC
Q 045449 56 GLNISSFNLQ-GTITPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLDFSDNQL 112 (823)
Q Consensus 56 ~L~L~~~~l~-g~~~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l 112 (823)
.++.++++++ ..+|..+- .+|++|||++|+|+...+..|..+++|++|+|++|.+
T Consensus 12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~ 67 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPW 67 (130)
T ss_dssp EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCC
T ss_pred EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCe
Confidence 4555555554 23333221 2345555555555433334444444444444444443
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.46 E-value=0.0041 Score=56.06 Aligned_cols=56 Identities=14% Similarity=0.107 Sum_probs=28.1
Q ss_pred EEEcccCcCc-ccccccccCCCCCCeEeccCCccccccchhhhccCCCcEEeccccccc
Q 045449 431 SLVLQGNKFS-GSIPSCLGNLTSVRVLYLGLNIFTSVLSSTIWNLKDILFIDVSSNFLD 488 (823)
Q Consensus 431 ~L~Ls~N~l~-g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~LdLs~N~l~ 488 (823)
.++.+++.|+ ..+|..+. ++|+.|+|++|+|+.+.+..|..+++|+.|+|++|.+.
T Consensus 12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence 4455555554 23343221 23555555555555555555555555555555555554
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=96.11 E-value=0.00038 Score=73.17 Aligned_cols=83 Identities=23% Similarity=0.271 Sum_probs=50.4
Q ss_pred CCEEeccCCCCCEEeCC--CCcEEEeecccccccCCCCcccccccc------------ccCCCcCc-ccccCCCcccccc
Q 045449 692 IPIIHCDLKPSNVLLDE--DMVAHISDFGIAKLLSGEDQLSKQTQT------------LATIGYMA-PEYGTKGRVSTRG 756 (823)
Q Consensus 692 ~~ivHrdlk~~NiLl~~--~~~~kl~DfGla~~~~~~~~~~~~~~~------------~gt~~y~a-PE~~~~~~~~~~~ 756 (823)
..++|+|++|.||++++ ...+.|+||+.+..-............ ....++.. |+... ......
T Consensus 191 ~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~~~~~~~~~--r~~~~~ 268 (304)
T 3sg8_A 191 PCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKHKDIPTVLE--KYRMKE 268 (304)
T ss_dssp CEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTCSCHHHHHH--HHHHHH
T ss_pred ceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCCCCcHHHHH--HHHHHH
Confidence 56899999999999997 567889999998764322111000000 00001111 22111 112225
Q ss_pred ceehhhhhhccccCCCCCcC
Q 045449 757 DVCSFGIISGGKETRSMTVG 776 (823)
Q Consensus 757 Dv~S~Gvv~~~~~~~~~~~~ 776 (823)
+.|++|++++.+.+|+.++.
T Consensus 269 ~~~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 269 KYWSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp HHHHHHHHHHHHHTTCHHHH
T ss_pred HHHHHHHHHHHHHcCCHHHH
Confidence 88999999999999987763
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=92.59 E-value=0.11 Score=55.57 Aligned_cols=32 Identities=22% Similarity=0.424 Sum_probs=27.4
Q ss_pred CCCEEeccCCCCCEEeCCCC--cEEEeecccccc
Q 045449 691 SIPIIHCDLKPSNVLLDEDM--VAHISDFGIAKL 722 (823)
Q Consensus 691 ~~~ivHrdlk~~NiLl~~~~--~~kl~DfGla~~ 722 (823)
...++|+|+++.||+++.++ .+.|+||+.+..
T Consensus 215 ~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 215 LTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp CCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred CceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 36799999999999998765 368999999875
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=89.95 E-value=0.23 Score=52.32 Aligned_cols=33 Identities=24% Similarity=0.315 Sum_probs=29.3
Q ss_pred CCCCEEeccCCCCCEEeCCCCcEEEeecccccc
Q 045449 690 HSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKL 722 (823)
Q Consensus 690 h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~ 722 (823)
....++|+|+++.||+++.++.+.|+||+.+..
T Consensus 220 ~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 220 KSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp HSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred ccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 357899999999999998788899999998864
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=89.43 E-value=0.26 Score=53.91 Aligned_cols=33 Identities=21% Similarity=0.327 Sum_probs=29.3
Q ss_pred CCCCEEeccCCCCCEEeCCCCcEEEeeccccccc
Q 045449 690 HSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLL 723 (823)
Q Consensus 690 h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~ 723 (823)
+...++|+|+++.|||++.++ ++++||+.+..-
T Consensus 230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G 262 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYG 262 (420)
T ss_dssp BCCEEECSCCSGGGEEECSSC-EEECCCTTCEEE
T ss_pred CCCeEEecCCCCCcEEEeCCC-CEEEeCcccccC
Confidence 678899999999999998776 999999988763
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=84.16 E-value=0.49 Score=47.93 Aligned_cols=34 Identities=21% Similarity=0.305 Sum_probs=28.6
Q ss_pred CCCCEEeccCCCCCEEeCCCCcEEEeeccccccc
Q 045449 690 HSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLL 723 (823)
Q Consensus 690 h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~ 723 (823)
+...++|+|+.+.|||+++++.+-|+||+.+..-
T Consensus 191 ~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~g 224 (272)
T 4gkh_A 191 PDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGIA 224 (272)
T ss_dssp CCEEEECSCCCTTSEEEETTEEEEECCCTTCEEE
T ss_pred CCcEEEcCCCCCCeEEEECCeEEEEEECcccccC
Confidence 3456899999999999998877889999988653
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=83.46 E-value=0.58 Score=48.78 Aligned_cols=32 Identities=31% Similarity=0.358 Sum_probs=27.7
Q ss_pred CCCEEeccCCCCCEEeCCCCcEEEeecccccc
Q 045449 691 SIPIIHCDLKPSNVLLDEDMVAHISDFGIAKL 722 (823)
Q Consensus 691 ~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~ 722 (823)
..+++|+|+.+.||+++++..+.|+||+.+..
T Consensus 186 ~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 186 PAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp CEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred CcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 46799999999999999876678999998764
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=82.84 E-value=0.95 Score=47.44 Aligned_cols=34 Identities=26% Similarity=0.315 Sum_probs=29.3
Q ss_pred CCCCEEeccCCCCCEEeCCC----CcEEEeeccccccc
Q 045449 690 HSIPIIHCDLKPSNVLLDED----MVAHISDFGIAKLL 723 (823)
Q Consensus 690 h~~~ivHrdlk~~NiLl~~~----~~~kl~DfGla~~~ 723 (823)
+...++|+|+.+.||+++.+ ..+.|+||+.+..-
T Consensus 181 ~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 181 GDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp SCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred CCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 45689999999999999874 68999999988764
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=82.41 E-value=0.46 Score=48.78 Aligned_cols=25 Identities=40% Similarity=0.403 Sum_probs=21.0
Q ss_pred CCCEEeccCCCCCEEeCCCCcEEEee
Q 045449 691 SIPIIHCDLKPSNVLLDEDMVAHISD 716 (823)
Q Consensus 691 ~~~ivHrdlk~~NiLl~~~~~~kl~D 716 (823)
.+.+||+|+.+.||+++.++ +.+.|
T Consensus 187 ~p~LvHGDlw~gNvl~~~~g-~~~iD 211 (288)
T 3f7w_A 187 PPARIHGDLWNGNVLWQDDG-AVVID 211 (288)
T ss_dssp CCEEECSCCSGGGEEEETTE-EEECS
T ss_pred CCeeeecCCCCCcEEEcCCC-eEEEe
Confidence 46799999999999999887 45666
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=82.12 E-value=0.78 Score=31.81 Aligned_cols=6 Identities=0% Similarity=-0.097 Sum_probs=2.3
Q ss_pred HHhhhh
Q 045449 589 TLKWKL 594 (823)
Q Consensus 589 ~~~~~~ 594 (823)
+++|++
T Consensus 31 ~~~~RR 36 (44)
T 2l2t_A 31 AVYVRR 36 (44)
T ss_dssp HHHHHT
T ss_pred HHHhhh
Confidence 333443
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=81.23 E-value=1 Score=46.67 Aligned_cols=34 Identities=32% Similarity=0.432 Sum_probs=28.2
Q ss_pred CCCCEEeccCCCCCEEeCC---CCc-EEEeeccccccc
Q 045449 690 HSIPIIHCDLKPSNVLLDE---DMV-AHISDFGIAKLL 723 (823)
Q Consensus 690 h~~~ivHrdlk~~NiLl~~---~~~-~kl~DfGla~~~ 723 (823)
....++|+|+++.||+++. ++. +.|+||+.+..-
T Consensus 188 ~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 188 YTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp CCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred CCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence 5678999999999999987 355 589999988764
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=80.03 E-value=0.74 Score=48.83 Aligned_cols=32 Identities=19% Similarity=0.249 Sum_probs=27.8
Q ss_pred CCCEEeccCCCCCEEeCCCCcEEEeecccccc
Q 045449 691 SIPIIHCDLKPSNVLLDEDMVAHISDFGIAKL 722 (823)
Q Consensus 691 ~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~ 722 (823)
...++|+|+.+.||+++++..+.|+||+.+..
T Consensus 221 ~~~l~HgDl~~~Nil~~~~~~~~vIDwe~a~~ 252 (357)
T 3ats_A 221 EPVLLWGDARVGNVLYRDFQPVAVLDWEMVAL 252 (357)
T ss_dssp CCEEECSSCSGGGEEEETTEEEEECCGGGCEE
T ss_pred CceEEeCCCCCCeEEEeCCcEEEEEccccccc
Confidence 56899999999999999655679999998875
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| 823 | ||||
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 3e-27 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 5e-27 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 1e-26 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 7e-16 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 1e-13 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 1e-08 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 7e-26 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-25 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 8e-24 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-23 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-23 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 3e-23 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 3e-23 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 7e-23 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-22 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 3e-22 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 4e-22 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 5e-22 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 5e-22 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 8e-22 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-21 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-21 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-21 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-21 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 4e-21 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 5e-21 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 8e-21 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-20 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 5e-20 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 9e-20 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 9e-20 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 4e-18 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 7e-13 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 7e-12 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-10 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 7e-09 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-08 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-19 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-19 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-19 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 4e-19 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 4e-19 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 8e-18 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-17 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-17 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 3e-17 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 3e-17 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 7e-17 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 7e-17 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 8e-17 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 3e-16 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 6e-16 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 6e-16 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 6e-16 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 6e-16 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 7e-16 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 8e-16 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 9e-16 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-15 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-13 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 4e-09 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 4e-07 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 4e-07 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-15 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 5e-15 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 6e-15 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 7e-15 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 9e-14 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-13 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-13 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-13 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-12 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 5e-12 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 6e-12 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 7e-12 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 9e-12 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 3e-11 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 3e-11 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 7e-07 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 2e-10 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 2e-06 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 3e-10 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 6e-10 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 1e-09 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 0.001 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 0.001 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 6e-09 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 7e-08 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 6e-07 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 3e-05 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 6e-05 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 5e-08 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 6e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 8e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 5e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.001 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.002 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.002 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.003 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 9e-07 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 3e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 4e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 0.001 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 0.001 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 0.003 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 0.003 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 6e-06 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 0.003 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 3e-05 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 5e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.002 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.003 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 4e-05 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 3e-04 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 5e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 1e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.003 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 2e-04 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 4e-04 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 2e-04 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 0.003 | |
| d1m9la_ | 198 | c.10.3.1 (A:) Outer arm dynein light chain 1 {Gree | 0.001 |
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 110 bits (275), Expect = 3e-27
Identities = 38/219 (17%), Positives = 74/219 (33%), Gaps = 69/219 (31%)
Query: 615 IRRFSYHELLRATDRFSEN---------NLIGIG---------------NGMEVAVKVFH 650
I F++ + A F++ +IG G + VA+K
Sbjct: 4 IDPFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLK 63
Query: 651 QQY-ERALKSFEDECEVRKRIRHRNLVK-------------------------------- 677
Y E+ + F E + + H N++
Sbjct: 64 SGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDG 123
Query: 678 ---------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQ 728
++ + + + +H DL N+L++ ++V +SDFG+++ L +
Sbjct: 124 QFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS 183
Query: 729 LSKQTQTL---ATIGYMAPEYGTKGRVSTRGDVCSFGII 764
T L I + APE + ++ DV S+GI+
Sbjct: 184 DPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIV 222
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (273), Expect = 5e-27
Identities = 45/191 (23%), Positives = 77/191 (40%), Gaps = 54/191 (28%)
Query: 628 DRFSENNLIGIGN---------GMEVAVKVFHQQY--ERALKSFEDECEVRKRIRHRNLV 676
+ + IG G+ +VAVK+ + + L++F++E V ++ RH N++
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67
Query: 677 KIISSS--------LEY--------------------------------LHFGHSIPIIH 696
+ S ++ + + H+ IIH
Sbjct: 68 LFMGYSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIH 127
Query: 697 CDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEY---GTKGRVS 753
DLK +N+ L ED+ I DFG+A + S + Q +I +MAPE K S
Sbjct: 128 RDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYS 187
Query: 754 TRGDVCSFGII 764
+ DV +FGI+
Sbjct: 188 FQSDVYAFGIV 198
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 109 bits (271), Expect = 1e-26
Identities = 76/314 (24%), Positives = 124/314 (39%), Gaps = 21/314 (6%)
Query: 12 QALLALKAHISYDHTNLFARNWTSSTSVC--IWIGITCDVNS--HRVIGLNISSFNLQGT 67
QALL +K + T +W +T C W+G+ CD ++ +RV L++S NL
Sbjct: 9 QALLQIKKDLGNPTT---LSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKP 65
Query: 68 IT--PQLGNLSSLQTLDLSHN-KLSGNIPSSIFNMHTLKLLDFSDNQLFGSLSSFIFNMS 124
L NL L L + L G IP +I + L L + + G++ F+ +
Sbjct: 66 YPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIK 125
Query: 125 SMTTIDLSINRLSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKEIGNLTKLKEI 184
++ T+D S N +P ++S L + N +SGAIP G+ +KL
Sbjct: 126 TLVTLDFSYNA-------LSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTS 178
Query: 185 ISTITNSTVCEIPREIGNLPYLARLALATNNLVGVVPVTIFNMSALKEISLLNNSLSGSL 244
++ N +IP NL + + ++ S + S +
Sbjct: 179 MTISRNRLTGKIPPTFANLNLAFVD---LSRNMLEGDASVLFGSDKNTQKIHLAKNSLAF 235
Query: 245 PSRIDLSLPNVETLNLGINSFSGTIPSSITNSSKLSDLELGENLFSGFIPNTIGNLRNLE 304
N+ L+L N GT+P +T L L + N G IP GNL+ +
Sbjct: 236 DLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFD 294
Query: 305 FGNIADNYLTSSTP 318
A+N +P
Sbjct: 295 VSAYANNKCLCGSP 308
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 77.1 bits (188), Expect = 7e-16
Identities = 68/269 (25%), Positives = 100/269 (37%), Gaps = 11/269 (4%)
Query: 149 STLSKCKQLEELNLGFNNLSGA--IPKEIGNLTKLKEIISTITNSTVCEIPREIGNLPYL 206
T ++ ++ L+L NL IP + NL L + N+ V IP I L L
Sbjct: 44 DTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQL 103
Query: 207 ARLALATNNLVGVVPVTIFNMSALKEISLLNNSLSGSLPSRIDLSLPNVETLNLGINSFS 266
L + N+ G +P + + L + N+LSG+LP I SLPN+ + N S
Sbjct: 104 HYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSIS-SLPNLVGITFDGNRIS 162
Query: 267 GTIPSSITNSSKLSDLELGENLFSGFIPNTIGNLRNLEFGNIADNYLTSSTPELSFLSSL 326
G IP S + SKL N + F N+ ++ S L +S+
Sbjct: 163 GAIPDSYGSFSKLFTSMTISR-------NRLTGKIPPTFANLNLAFVDLSRNMLEGDASV 215
Query: 327 TNCKKLKVLIVTGNPLDGILPKSIGNFSLSLETILMANCSISGNIPQVVGNLSNLLVLEL 386
+ S +L + + N I G +PQ + L L L +
Sbjct: 216 LFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNV 275
Query: 387 GGNNLTGPIPVTFSQLQTLQAFDLTRNKL 415
NNL G IP LQ NK
Sbjct: 276 SFNNLCGEIP-QGGNLQRFDVSAYANNKC 303
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 70.6 bits (171), Expect = 1e-13
Identities = 61/296 (20%), Positives = 115/296 (38%), Gaps = 22/296 (7%)
Query: 263 NSFSGTIPSSITNSSKLSDLELGENLFSGF--IPNTIGNLRNLEFGNIADNYLTSSTPEL 320
++ G + + T + ++++L+L IP+++ NL L F I
Sbjct: 36 RTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGP--- 92
Query: 321 SFLSSLTNCKKLKVLIVTGNPLDGILPKSIGNFSLSLETILMANCSISGNIPQVVGNLSN 380
++ +L L +T + G + +L T+ + ++SG +P + +L N
Sbjct: 93 -IPPAIAKLTQLHYLYITHTNVSGA-IPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPN 150
Query: 381 LLVLELGGNNLTGPIPVTFSQLQTLQA-FDLTRNKLAGPITDELCHLARLHSLVLQGNKF 439
L+ + GN ++G IP ++ L ++RN+L G I + + V
Sbjct: 151 LVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFAN--LNLAFVDLSRNM 208
Query: 440 SGSIPSCLGNLTSVRVLYLGLNIFTSVLSSTIWNLKDILFIDVSSNFLDGPLSLDIGNLK 499
S L + + K++ +D+ +N + G L + LK
Sbjct: 209 LEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLK 268
Query: 500 VVIGLDFSRNNLSGDIPITIGEGEIPRGGPFANLTAKSFMGNELLCGLPDLQVSPC 555
+ L+ S NNL G EIP+GG ++ N+ LCG P + C
Sbjct: 269 FLHSLNVSFNNLCG---------EIPQGGNLQRFDVSAYANNKCLCGSP---LPAC 312
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 55.5 bits (132), Expect = 1e-08
Identities = 17/70 (24%), Positives = 29/70 (41%), Gaps = 1/70 (1%)
Query: 76 SSLQTLDLSHNKLSGNIPSSIFNMHTLKLLDFSDNQLFGSLSSFIFNMSSMTTIDLSINR 135
+L LDL +N++ G +P + + L L+ S N L G + N+ + N+
Sbjct: 244 KNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG-GNLQRFDVSAYANNK 302
Query: 136 LSGELPANIC 145
P C
Sbjct: 303 CLCGSPLPAC 312
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (264), Expect = 7e-26
Identities = 37/189 (19%), Positives = 73/189 (38%), Gaps = 54/189 (28%)
Query: 628 DRFSENNLIGIG-----------NGMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLV 676
+ +G G VA+K + ++F E +V K++RH LV
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLV 75
Query: 677 K-----------------------------------------IISSSLEYLHFGHSIPII 695
+ + + + + + +
Sbjct: 76 QLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYV 135
Query: 696 HCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTR 755
H DL+ +N+L+ E++V ++DFG+A+L+ +++ + + I + APE GR + +
Sbjct: 136 HRDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPEAALYGRFTIK 194
Query: 756 GDVCSFGII 764
DV SFGI+
Sbjct: 195 SDVWSFGIL 203
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (264), Expect = 2e-25
Identities = 36/195 (18%), Positives = 60/195 (30%), Gaps = 62/195 (31%)
Query: 626 ATDRFSENNLIGIG------------NGMEVAVKVFHQQY-ERALKSFEDECEVRKRIRH 672
D F + + +G G +G+ +A K+ H + E +V
Sbjct: 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63
Query: 673 RNLVKI-------------------------------------------ISSSLEYLHFG 689
+V + L YL
Sbjct: 64 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR-- 121
Query: 690 HSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTK 749
I+H D+KPSN+L++ + DFG++ L S + T YM+PE
Sbjct: 122 EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMANSFVGTRSYMSPERLQG 177
Query: 750 GRVSTRGDVCSFGII 764
S + D+ S G+
Sbjct: 178 THYSVQSDIWSMGLS 192
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (249), Expect = 8e-24
Identities = 36/168 (21%), Positives = 62/168 (36%), Gaps = 42/168 (25%)
Query: 639 GNGMEVAVKVFHQQYERA-LKSFEDECEVRKRIRHRNLVKIISSS--------LEY---- 685
++VA+KV Q E+A + E ++ ++ + +V++I +E
Sbjct: 34 KKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALMLVMEMAGGG 93
Query: 686 ----------------------------LHFGHSIPIIHCDLKPSNVLLDEDMVAHISDF 717
+ + +H DL NVLL A ISDF
Sbjct: 94 PLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDF 153
Query: 718 GIAKLLSGEDQLSKQTQTLA-TIGYMAPEYGTKGRVSTRGDVCSFGII 764
G++K L +D + + APE + S+R DV S+G+
Sbjct: 154 GLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVT 201
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 99.0 bits (246), Expect = 1e-23
Identities = 39/189 (20%), Positives = 72/189 (38%), Gaps = 54/189 (28%)
Query: 628 DRFSENNLIGIG-----------NGMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLV 676
+ +G G +VAVK Q + +F E + K+++H+ LV
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLV 71
Query: 677 KIISSS--------LEYLHFG---------------------------------HSIPII 695
++ + EY+ G I
Sbjct: 72 RLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYI 131
Query: 696 HCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTR 755
H DL+ +N+L+ + + I+DFG+A+L+ +++ + + I + APE G + +
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLIE-DNEYTAREGAKFPIKWTAPEAINYGTFTIK 190
Query: 756 GDVCSFGII 764
DV SFGI+
Sbjct: 191 SDVWSFGIL 199
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.9 bits (246), Expect = 2e-23
Identities = 45/195 (23%), Positives = 74/195 (37%), Gaps = 55/195 (28%)
Query: 625 RATDRFSENNLIGIG------------NGMEVAVKVFHQQY---ERALKSFEDECEVRKR 669
+ + F ++G G E A+K+ +++ E + E +V R
Sbjct: 5 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR 64
Query: 670 IRHRNLVKIISSS----------------------------------------LEYLHFG 689
+ H VK+ + + L +
Sbjct: 65 LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYL 124
Query: 690 HSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTK 749
H IIH DLKP N+LL+EDM I+DFG AK+LS E + ++ + T Y++PE T+
Sbjct: 125 HGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE 184
Query: 750 GRVSTRGDVCSFGII 764
D+ + G I
Sbjct: 185 KSACKSSDLWALGCI 199
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 98.6 bits (245), Expect = 3e-23
Identities = 40/203 (19%), Positives = 73/203 (35%), Gaps = 56/203 (27%)
Query: 616 RRFSYHELLRATDRFSENNLIGIG------------NGMEVAVKVFHQQYERALKSFEDE 663
+Y + + + +G G + VAVK + ++ F E
Sbjct: 5 SSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKE 63
Query: 664 CEVRKRIRHRNLVKIISS---------SLEYLHFG------------------------- 689
V K I+H NLV+++ E++ +G
Sbjct: 64 AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQ 123
Query: 690 --------HSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGY 741
IH DL N L+ E+ + ++DFG+++L++G D + I +
Sbjct: 124 ISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKW 182
Query: 742 MAPEYGTKGRVSTRGDVCSFGII 764
APE + S + DV +FG++
Sbjct: 183 TAPESLAYNKFSIKSDVWAFGVL 205
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.4 bits (244), Expect = 3e-23
Identities = 34/196 (17%), Positives = 70/196 (35%), Gaps = 59/196 (30%)
Query: 628 DRFSENNLIGIGN----------------GMEVAVKVFHQQY-ERALKSFEDECEVRKRI 670
+ +IG G + VA+K Y E+ F E + +
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66
Query: 671 RHRNLVK-----------------------------------------IISSSLEYLHFG 689
H N+++ ++ + +
Sbjct: 67 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYL 126
Query: 690 HSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLA-TIGYMAPEYGT 748
++ +H DL N+L++ ++V +SDFG++++L + + + T I + APE +
Sbjct: 127 ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAIS 186
Query: 749 KGRVSTRGDVCSFGII 764
+ ++ DV SFGI+
Sbjct: 187 YRKFTSASDVWSFGIV 202
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 96.7 bits (240), Expect = 7e-23
Identities = 40/189 (21%), Positives = 70/189 (37%), Gaps = 54/189 (28%)
Query: 628 DRFSENNLIGIG-----------NGMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLV 676
+ IG G N +VA+K + + + F +E EV ++ H LV
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLV 63
Query: 677 KIISSS-----------------------------------------LEYLHFGHSIPII 695
++ E + + +I
Sbjct: 64 QLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVI 123
Query: 696 HCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTR 755
H DL N L+ E+ V +SDFG+ + + +DQ + T T + + +PE + R S++
Sbjct: 124 HRDLAARNCLVGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWASPEVFSFSRYSSK 182
Query: 756 GDVCSFGII 764
DV SFG++
Sbjct: 183 SDVWSFGVL 191
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 96.2 bits (239), Expect = 1e-22
Identities = 45/171 (26%), Positives = 66/171 (38%), Gaps = 50/171 (29%)
Query: 637 GIGNGMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVKIISSS----------LEY- 685
G G +VAVK + ++F E V ++RH NLV+++ EY
Sbjct: 26 GDYRGNKVAVKCIKN--DATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 83
Query: 686 --------------------------------LHFGHSIPIIHCDLKPSNVLLDEDMVAH 713
+ + +H DL NVL+ ED VA
Sbjct: 84 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAK 143
Query: 714 ISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGII 764
+SDFG+ K S S Q + + APE + + ST+ DV SFGI+
Sbjct: 144 VSDFGLTKEAS-----STQDTGKLPVKWTAPEALREKKFSTKSDVWSFGIL 189
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 95.8 bits (238), Expect = 3e-22
Identities = 36/172 (20%), Positives = 61/172 (35%), Gaps = 48/172 (27%)
Query: 639 GNGMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVKIISSS---------LEY---- 685
+ A KV + E L+ + E ++ H N+VK++ + +E+
Sbjct: 35 ETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGG 94
Query: 686 ----------------------------LHFGHSIPIIHCDLKPSNVLLDEDMVAHISDF 717
L++ H IIH DLK N+L D ++DF
Sbjct: 95 AVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADF 154
Query: 718 GIAKLLSGEDQLSKQTQTLATIGYMAPEY-----GTKGRVSTRGDVCSFGII 764
G++ + Q ++ + T +MAPE + DV S GI
Sbjct: 155 GVSAKNTRTIQ--RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGIT 204
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 95.2 bits (236), Expect = 4e-22
Identities = 36/189 (19%), Positives = 62/189 (32%), Gaps = 56/189 (29%)
Query: 632 ENNLIGIGN--------------GMEVAVKVFHQQY--ERALKSFEDECEVRKRIRHRNL 675
E+ +G GN VAVK+ + E V +++ + +
Sbjct: 11 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70
Query: 676 VK---------------------------------------IISSSLEYLHFGHSIPIIH 696
V+ ++ + + +H
Sbjct: 71 VRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVH 130
Query: 697 CDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLA-TIGYMAPEYGTKGRVSTR 755
DL NVLL A ISDFG++K L ++ K + + APE + S++
Sbjct: 131 RDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSK 190
Query: 756 GDVCSFGII 764
DV SFG++
Sbjct: 191 SDVWSFGVL 199
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 94.0 bits (233), Expect = 5e-22
Identities = 30/166 (18%), Positives = 63/166 (37%), Gaps = 43/166 (25%)
Query: 640 NGMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVKIISSS---------LEYLHFG- 689
+VA+K+ + + F +E +V + H LV++ EY+ G
Sbjct: 27 GQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGC 85
Query: 690 -------------------------------HSIPIIHCDLKPSNVLLDEDMVAHISDFG 718
S +H DL N L+++ V +SDFG
Sbjct: 86 LLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFG 145
Query: 719 IAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGII 764
+++ + +D+ + + + + PE + S++ D+ +FG++
Sbjct: 146 LSRYVL-DDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVL 190
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 94.3 bits (234), Expect = 5e-22
Identities = 43/191 (22%), Positives = 67/191 (35%), Gaps = 54/191 (28%)
Query: 628 DRFSENNLIGIG------------NGMEVAVKVFHQQY-ERALKSFEDECEVRKRIRHRN 674
+ + +G G VAVK+ + ++ + E + K + H N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 675 LVKIISSS---------LEY-------------------------------LHFGHSIPI 694
+VK LEY + + H I I
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGI 124
Query: 695 IHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVST 754
H D+KP N+LLDE ISDFG+A + ++ + T+ Y+APE +
Sbjct: 125 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 184
Query: 755 RG-DVCSFGII 764
DV S GI+
Sbjct: 185 EPVDVWSCGIV 195
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 94.3 bits (234), Expect = 8e-22
Identities = 41/189 (21%), Positives = 71/189 (37%), Gaps = 53/189 (28%)
Query: 627 TDRFSENNLIGIG------------NGMEVAVKVFHQQYERALKSFEDECEVRKRIRHRN 674
+++ IG G G EVA++ + Q + + +E V + ++ N
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 675 LVK---------------------------------------IISSSLEYLHFGHSIPII 695
+V + L+ L F HS +I
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVI 138
Query: 696 HCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTR 755
H D+K N+LL D ++DFG ++ E SK++ + T +MAPE T+ +
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--SKRSTMVGTPYWMAPEVVTRKAYGPK 196
Query: 756 GDVCSFGII 764
D+ S GI+
Sbjct: 197 VDIWSLGIM 205
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 94.5 bits (234), Expect = 1e-21
Identities = 36/200 (18%), Positives = 69/200 (34%), Gaps = 58/200 (29%)
Query: 622 ELLRATDRFSENNLIGIGN----------------GMEVAVKVFHQ-QYERALKSFEDEC 664
+L+ T+ F + ++G G + VA+K + +A K DE
Sbjct: 4 RILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEA 62
Query: 665 EVRKRIRHRNLVKIISSS----------------------------------------LE 684
V + + ++ +++ +
Sbjct: 63 YVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 122
Query: 685 YLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAP 744
+++ ++H DL NVL+ I+DFG+AKLL E++ I +MA
Sbjct: 123 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 182
Query: 745 EYGTKGRVSTRGDVCSFGII 764
E + + DV S+G+
Sbjct: 183 ESILHRIYTHQSDVWSYGVT 202
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 93.9 bits (233), Expect = 1e-21
Identities = 42/196 (21%), Positives = 65/196 (33%), Gaps = 64/196 (32%)
Query: 627 TDRFSENNLIGIG------------NGMEVAVKVFHQ---QYERALKSFEDECEVRKRIR 671
FS+ IG G N VA+K Q + E +++R
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 672 HRNLVKIISSS---------LEY-------------------------------LHFGHS 691
H N ++ +EY L + HS
Sbjct: 74 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHS 133
Query: 692 IPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEY---GT 748
+IH D+K N+LL E + + DFG A + ++ + T +MAPE
Sbjct: 134 HNMIHRDVKAGNILLSEPGLVKLGDFGSASI------MAPANSFVGTPYWMAPEVILAMD 187
Query: 749 KGRVSTRGDVCSFGII 764
+G+ + DV S GI
Sbjct: 188 EGQYDGKVDVWSLGIT 203
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 92.7 bits (230), Expect = 2e-21
Identities = 36/195 (18%), Positives = 66/195 (33%), Gaps = 65/195 (33%)
Query: 628 DRFSENNLIGIG------------NGMEVAVKVFHQQY---ERALKSFEDECEVRKRIRH 672
+ F +G G + +A+KV + E E++ +RH
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 673 RNLVKI-------------------------------------------ISSSLEYLHFG 689
N++++ ++++L Y H
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH-- 123
Query: 690 HSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTK 749
S +IH D+KP N+LL I+DFG + S++T T+ Y+ PE
Sbjct: 124 -SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS----SRRTTLCGTLDYLPPEMIEG 178
Query: 750 GRVSTRGDVCSFGII 764
+ D+ S G++
Sbjct: 179 RMHDEKVDLWSLGVL 193
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 92.7 bits (230), Expect = 2e-21
Identities = 32/178 (17%), Positives = 61/178 (34%), Gaps = 55/178 (30%)
Query: 640 NGMEVAVKVFHQQY--ERALKSFEDECEVRKRIRHRNLVKI------------------- 678
+G + K E + E + + ++H N+V+
Sbjct: 28 DGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYC 87
Query: 679 ------------------------------ISSSLEYLHFGH--SIPIIHCDLKPSNVLL 706
++ +L+ H ++H DLKP+NV L
Sbjct: 88 EGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFL 147
Query: 707 DEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGII 764
D + DFG+A++L+ + +K T YM+PE + + + D+ S G +
Sbjct: 148 DGKQNVKLGDFGLARILNHDTSFAKAFVG--TPYYMSPEQMNRMSYNEKSDIWSLGCL 203
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 91.6 bits (227), Expect = 4e-21
Identities = 37/176 (21%), Positives = 60/176 (34%), Gaps = 56/176 (31%)
Query: 639 GNGMEVAVKVFHQQY--ERALKSFEDECEVRKRIRHRNLVKI------------------ 678
+EVA + + + F++E E+ K ++H N+V+
Sbjct: 32 ETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91
Query: 679 -----------------------------ISSSLEYLHFGHSIPIIHCDLKPSNVLL-DE 708
I L++LH + PIIH DLK N+ +
Sbjct: 92 ELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHT-RTPPIIHRDLKCDNIFITGP 150
Query: 709 DMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGII 764
I D G+A L S + T +MAPE + + DV +FG+
Sbjct: 151 TGSVKIGDLGLATLKRA----SFAKAVIGTPEFMAPEM-YEEKYDESVDVYAFGMC 201
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 92.8 bits (230), Expect = 5e-21
Identities = 37/168 (22%), Positives = 61/168 (36%), Gaps = 48/168 (28%)
Query: 640 NGMEVAVKVFHQQY---ERALKSFEDECEVRKRIRHRNLVKIISSS-------------- 682
NG A+KV ++ + ++ DE + + H ++++ +
Sbjct: 28 NGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIE 87
Query: 683 --------------------------LEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISD 716
L + HS II+ DLKP N+LLD++ I+D
Sbjct: 88 GGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITD 147
Query: 717 FGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGII 764
FG AK + T Y+APE + + D SFGI+
Sbjct: 148 FGFAKYVP-----DVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGIL 190
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 91.8 bits (227), Expect = 8e-21
Identities = 33/171 (19%), Positives = 61/171 (35%), Gaps = 45/171 (26%)
Query: 639 GNGMEVAVKVFHQQY-ERALKSFEDECEVRKRIRHRNLVKIISSSLE------------- 684
G + AVK ++ + F E + K H N++ ++ L
Sbjct: 53 GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMK 112
Query: 685 -----------------------------YLHFGHSIPIIHCDLKPSNVLLDEDMVAHIS 715
+ F S +H DL N +LDE ++
Sbjct: 113 HGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVA 172
Query: 716 DFGIAKLLSGED--QLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGII 764
DFG+A+ + ++ + +T + +MA E + +T+ DV SFG++
Sbjct: 173 DFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVL 223
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 90.6 bits (224), Expect = 2e-20
Identities = 28/118 (23%), Positives = 50/118 (42%)
Query: 647 KVFHQQYERALKSFEDECEVRKRIRHRNLVKIISSSLEYLHFGHSIPIIHCDLKPSNVLL 706
K + E + +E E + +L+ + + F +H DL NVL+
Sbjct: 138 KFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLV 197
Query: 707 DEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGII 764
V I DFG+A+ + + + + +MAPE +G + + DV S+GI+
Sbjct: 198 THGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGIL 255
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 89.5 bits (221), Expect = 5e-20
Identities = 23/90 (25%), Positives = 40/90 (44%)
Query: 675 LVKIISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQ 734
+ I + + +H DL N L+ E+MV I+DFG+++ + D
Sbjct: 142 QLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGN 201
Query: 735 TLATIGYMAPEYGTKGRVSTRGDVCSFGII 764
I +M PE R +T DV ++G++
Sbjct: 202 DAIPIRWMPPESIFYNRYTTESDVWAYGVV 231
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 89.5 bits (221), Expect = 9e-20
Identities = 44/196 (22%), Positives = 71/196 (36%), Gaps = 58/196 (29%)
Query: 627 TDRFSENNLIGIG------------NGMEVAVKVFHQ-QYERALKSFEDECEVRKRIRHR 673
R++ + IG G N + VA+K +++ + E ++ R RH
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 674 NLVK-------------------------------------------IISSSLEYLHFGH 690
N++ + L L + H
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH 126
Query: 691 SIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLL-SGEDQLSKQTQTLATIGYMAPEYGTK 749
S ++H DLKPSN+LL+ I DFG+A++ D T+ +AT Y APE
Sbjct: 127 SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 186
Query: 750 GRVSTR-GDVCSFGII 764
+ T+ D+ S G I
Sbjct: 187 SKGYTKSIDIWSVGCI 202
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 90.1 bits (222), Expect = 9e-20
Identities = 74/399 (18%), Positives = 137/399 (34%), Gaps = 46/399 (11%)
Query: 74 NLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLDFSDNQLFGSLSSFIFNMSSMTTIDLSI 133
L+ L ++ + + ++ + L + S+ + ++++T I+ S
Sbjct: 20 ALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGI-KSIDG-VEYLNNLTQINFSN 75
Query: 134 NRLSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKEIGNLTKLKEIISTITNSTV 193
N+L+ P L +L ++ + N ++ P + +
Sbjct: 76 NQLTDITP---------LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDID 126
Query: 194 CEIPR-----------EIGNLPYLARLALATNNLVGVVPVTIFNMSALKEISLLNNSLSG 242
I ++ L+ L G + ++ L + L+ S +
Sbjct: 127 PLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNK 186
Query: 243 SLPSRIDLSLPNVETLNLGINSFSGTIPSSITNSSKLSDLELGENLFSGFIPNTIGNLRN 302
+ L N+E+L N S P I + L +L L N T+ +L N
Sbjct: 187 VSDISVLAKLTNLESLIATNNQISDITPLGILTN--LDELSLNGNQLKD--IGTLASLTN 242
Query: 303 LEFGNIADNYLTSSTPELSFLSSLTNCKKLKVLIVTGNPLDGILPKSIGNFSLSLETILM 362
L ++A+N +++ P L+ KL L + N + I P + +
Sbjct: 243 LTDLDLANNQISNLAP-------LSGLTKLTELKLGANQISNISP-----LAGLTALTNL 290
Query: 363 ANCSISGNIPQVVGNLSNLLVLELGGNNLTGPIPVTFSQLQTLQAFDLTRNKLAGPITDE 422
+ NL NL L L NN++ P S L LQ NK++
Sbjct: 291 ELNENQLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSDV--SS 346
Query: 423 LCHLARLHSLVLQGNKFSGSIPSCLGNLTSVRVLYLGLN 461
L +L ++ L N+ S P L NLT + L L
Sbjct: 347 LANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 85.1 bits (209), Expect = 4e-18
Identities = 71/347 (20%), Positives = 129/347 (37%), Gaps = 30/347 (8%)
Query: 72 LGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLDFSDNQLFGSLS-----SFIFNMSSM 126
+ L++L ++ S+N+L+ P + N+ L + ++NQ+ +
Sbjct: 62 VEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFN 119
Query: 127 TTIDLSINRLSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKEIGNLTKLKEIIS 186
I + + +T+S L L G ++ L L +
Sbjct: 120 NQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLER 179
Query: 187 TITNSTVCEIPREIGNLPYLARLALATNNLVGVVPVTIFNMSALKEISLLNNSLSGSLPS 246
+S + L L L N + + P + ++ L E+SL N L
Sbjct: 180 LDISSNKVSDISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDIGTL 237
Query: 247 RIDLSLPNVETLNLGINSFSGTIPSSITNSSKLSDLELGENLFSGFIPNTIGNLRNLEFG 306
SL N+ L+L N S P ++ +KL++L+LG N S P + L L
Sbjct: 238 A---SLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNL 290
Query: 307 NIADNYLTSSTPELSFLSSLTNCKKLKVLIVTGNPLDGILPKSIGNFSLSLETILMANCS 366
+ +N L +P +N K L L + N + I P + + + L+ + AN
Sbjct: 291 ELNENQLEDISPI-------SNLKNLTYLTLYFNNISDISP--VSSLT-KLQRLFFANNK 340
Query: 367 ISGNIPQVVGNLSNLLVLELGGNNLTGPIPVTFSQLQTLQAFDLTRN 413
+S + NL+N+ L G N ++ P + L + L
Sbjct: 341 VSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 68.9 bits (167), Expect = 7e-13
Identities = 42/195 (21%), Positives = 81/195 (41%), Gaps = 22/195 (11%)
Query: 44 GITCDVNSHRVIGLNISSFNLQGTITPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLK 103
IT + L+++ L+ L +L++L LDL++N++S P + + L
Sbjct: 211 DITPLGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLTKLT 266
Query: 104 LLDFSDNQLFGSLSSFIFNMSSMTTIDLSINRLSGELPANICKIPSTLSKCKQLEELNLG 163
L NQ+ + + N + S +S K L L L
Sbjct: 267 ELKLGANQISNISPLAGLTALTNLEL-----------NENQLEDISPISNLKNLTYLTLY 315
Query: 164 FNNLSGAIPKEIGNLTKLKEIISTITNSTVCEIPREIGNLPYLARLALATNNLVGVVPVT 223
FNN+S P + +LTKL+ + N+ V ++ + NL + L+ N + + P
Sbjct: 316 FNNISDISP--VSSLTKLQRLF--FANNKVSDVS-SLANLTNINWLSAGHNQISDLTP-- 368
Query: 224 IFNMSALKEISLLNN 238
+ N++ + ++ L +
Sbjct: 369 LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 65.8 bits (159), Expect = 7e-12
Identities = 69/383 (18%), Positives = 134/383 (34%), Gaps = 49/383 (12%)
Query: 155 KQLEELNLGFNNLSGAIPK-EIGNLTKLKEIISTITNSTVCEIPREIGNLPYLARLALAT 213
+ + LG N++ + + ++ +T L + I + L L ++ +
Sbjct: 22 AEKMKTVLGKTNVTDTVSQTDLDQVTTL-----QADRLGIKSID-GVEYLNNLTQINFSN 75
Query: 214 NNLVGVVPVTIFNMSALKEISLLNNSLSGSLPSRIDLSLPNVETLNLGINSFSGTIPSSI 273
N L + P + N++ L +I + NN ++ P +L + N I +
Sbjct: 76 NQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTN 133
Query: 274 TNSSKLSDLEL------GENLFSGFIPNTIGNLRNLEFGNIADNYLTSSTP-ELSFLSSL 326
N +LS + + N+ + ++S +S L
Sbjct: 134 LNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVL 193
Query: 327 TNCKKLKVLIVTGNPLDGILPKSIGNFSLSLETILMANCSISGNIPQVVGNLSNLLVLEL 386
L+ LI T N + I P I +L+ + + + + +L+NL L+L
Sbjct: 194 AKLTNLESLIATNNQISDITPLGILT---NLDELSLNGNQLKD--IGTLASLTNLTDLDL 248
Query: 387 GGNNLTGPIPVTFSQLQTLQAFDLTRNKLAGPI--------------------TDELCHL 426
N ++ P S L L L N+++ + +L
Sbjct: 249 ANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNL 306
Query: 427 ARLHSLVLQGNKFSGSIPSCLGNLTSVRVLYLGLNIFTSVLSSTIWNLKDILFIDVSSNF 486
L L L N S P + +LT ++ L+ N + V S++ NL +I ++ N
Sbjct: 307 KNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSDV--SSLANLTNINWLSAGHNQ 362
Query: 487 LDGPLSLDIGNLKVVIGLDFSRN 509
+ L NL + L +
Sbjct: 363 ISDLTPL--ANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 61.6 bits (148), Expect = 2e-10
Identities = 67/363 (18%), Positives = 120/363 (33%), Gaps = 39/363 (10%)
Query: 202 NLPYLARLALATNNLVGVVPVTIFNMSALKEISLLNNSLSGSLPSRIDLSLPNVETLNLG 261
L + L N+ V T ++ + + + S+ ++ L N+ +N
Sbjct: 20 ALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIK-SIDG-VE-YLNNLTQINFS 74
Query: 262 INSFSGTIPSSITNSSKLSDLELGENLFSGFIPNTIGNLRNLE-------FGNIADNYLT 314
N + P + N +KL D+ + N + P LT
Sbjct: 75 NNQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLT 132
Query: 315 SSTPELSFLSSLTNCKKLKVLIVTGNPLDGILPKSIGNFSLSLETILMANCSISGNIPQV 374
+ +++++ L L G + + + S + V
Sbjct: 133 NLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISV 192
Query: 375 VGNLSNLLVLELGGNNLTGPIPVTFSQLQTLQAFDLTRNKLAGPITDELCHLARLHSLVL 434
+ L+NL L N ++ P+ L L N+L L L L L L
Sbjct: 193 LAKLTNLESLIATNNQISDITPLGILT--NLDELSLNGNQLKDI--GTLASLTNLTDLDL 248
Query: 435 QGNKFSGSIPSCLGNLTSVRVLYLGLNIFTSVLSSTIWNLKDILFIDVSSNFLDGPLSLD 494
N+ S P L LT + L LG N +++ S + L + ++++ N L+
Sbjct: 249 ANNQISNLAP--LSGLTKLTELKLGANQISNI--SPLAGLTALTNLELNENQLEDIS--P 302
Query: 495 IGNLKVVIGLDFSRNNLSGDIPITIGEGEIPRGGPFANLTAKSFMGNEL-----LCGLPD 549
I NLK + L NN+S P+ L F N++ L L +
Sbjct: 303 ISNLKNLTYLTLYFNNISDISPV----------SSLTKLQRLFFANNKVSDVSSLANLTN 352
Query: 550 LQV 552
+
Sbjct: 353 INW 355
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 56.2 bits (134), Expect = 7e-09
Identities = 20/95 (21%), Positives = 40/95 (42%), Gaps = 6/95 (6%)
Query: 40 CIWIGITCDVNSHRVIGLNISSFNLQGTITPQLGNLSSLQTLDLSHNKLSGNIPSSIFNM 99
I+ N + L + N+ + +L+ LQ L ++NK+S SS+ N+
Sbjct: 295 NQLEDISPISNLKNLTYLTLYFNNISDIS--PVSSLTKLQRLFFANNKVSD--VSSLANL 350
Query: 100 HTLKLLDFSDNQLFGSLSSFIFNMSSMTTIDLSIN 134
+ L NQ+ + N++ +T + L+
Sbjct: 351 TNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 55.8 bits (133), Expect = 1e-08
Identities = 78/384 (20%), Positives = 135/384 (35%), Gaps = 43/384 (11%)
Query: 162 LGFNNLSGAIP-KEIGNLTKLKEIISTITNSTVCEIPREIGNLPYLARLALATNNLVGVV 220
LG ++ P +I T L E + T+ T +L + L + +
Sbjct: 1 LGSATITQDTPINQIFTDTALAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIKSID 60
Query: 221 PVTIFNMSALKEISLLNNSLSGSLPSRIDLSLPNVETLNLGINSFSGTIPSSITNSSKLS 280
+ ++ L +I+ NN L+ P + +L + + + N + P + +
Sbjct: 61 G--VEYLNNLTQINFSNNQLTDITPLK---NLTKLVDILMNNNQIADITPLANLTNLTGL 115
Query: 281 DLELGENLFSGFIPNTIGNLRNLEFGN----IADNYLTSSTPELSFLSSLTNCKKLKVLI 336
L + + N R N I+ +S +LSF + +T+ K L L
Sbjct: 116 TLFNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLT 175
Query: 337 VTGNPLDGILPKSIGNFSLSLE---TILMANCSISGNIPQVVGNLSNLLVLELGGNNLTG 393
S + L +++ N IS P L+NL L L GN L
Sbjct: 176 TLERLDISSNKVSDISVLAKLTNLESLIATNNQISDITPLG--ILTNLDELSLNGNQLKD 233
Query: 394 PIPVTFSQLQTLQAFDLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIP--------- 444
T + L L DL N+++ L L +L L L N+ S P
Sbjct: 234 IG--TLASLTNLTDLDLANNQISNLA--PLSGLTKLTELKLGANQISNISPLAGLTALTN 289
Query: 445 -----------SCLGNLTSVRVLYLGLNIFTSVLSSTIWNLKDILFIDVSSNFLDGPLSL 493
S + NL ++ L L N + + S + +L + + ++N + SL
Sbjct: 290 LELNENQLEDISPISNLKNLTYLTLYFNNISDI--SPVSSLTKLQRLFFANNKVSDVSSL 347
Query: 494 DIGNLKVVIGLDFSRNNLSGDIPI 517
NL + L N +S P+
Sbjct: 348 --ANLTNINWLSAGHNQISDLTPL 369
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 87.9 bits (217), Expect = 1e-19
Identities = 36/170 (21%), Positives = 49/170 (28%), Gaps = 44/170 (25%)
Query: 639 GNGMEVAVKVFHQQY---ERALKSFEDECEVRKRIRHRNLVKIISSS--------LEYLH 687
G + VAVK A+ F E + HRNL+++ E
Sbjct: 34 GKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKMVTELAP 93
Query: 688 FG--------------------------------HSIPIIHCDLKPSNVLLDEDMVAHIS 715
G S IH DL N+LL + I
Sbjct: 94 LGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIG 153
Query: 716 DFGIAKLL-SGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGII 764
DFG+ + L +D Q + APE S D FG+
Sbjct: 154 DFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVT 203
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 88.4 bits (218), Expect = 1e-19
Identities = 39/187 (20%), Positives = 58/187 (31%), Gaps = 60/187 (32%)
Query: 637 GIGNGMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVKI------------------ 678
G G EVAVK+F + ER+ E E +RH N++
Sbjct: 22 GKWRGEEVAVKIFSSREERSWF-REAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80
Query: 679 ----------------------------ISSSLEYLH-----FGHSIPIIHCDLKPSNVL 705
+S L +LH I H DLK N+L
Sbjct: 81 DYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNIL 140
Query: 706 LDEDMVAHISDFGIAKLLSGEDQLS--KQTQTLATIGYMAPEY------GTKGRVSTRGD 757
+ ++ I+D G+A + T YMAPE R D
Sbjct: 141 VKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRAD 200
Query: 758 VCSFGII 764
+ + G++
Sbjct: 201 IYAMGLV 207
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 89.0 bits (220), Expect = 1e-19
Identities = 34/192 (17%), Positives = 56/192 (29%), Gaps = 58/192 (30%)
Query: 628 DRFSENNLIGIG------------NGMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNL 675
D + + +G G G A K +E ++ E + +RH L
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85
Query: 676 VKIISSS---------LEY--------------------------------LHFGHSIPI 694
V + + E+ L H
Sbjct: 86 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNY 145
Query: 695 IHCDLKPSNVLL--DEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRV 752
+H DLKP N++ + DFG+ L + + T T + APE V
Sbjct: 146 VHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTA---EFAAPEVAEGKPV 202
Query: 753 STRGDVCSFGII 764
D+ S G++
Sbjct: 203 GYYTDMWSVGVL 214
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 86.0 bits (212), Expect = 4e-19
Identities = 41/198 (20%), Positives = 67/198 (33%), Gaps = 60/198 (30%)
Query: 627 TDRFSENNLIGIG------------NGMEVAVKVFHQQY---ERALKSFEDECEVRKRIR 671
+DR+ ++G G +VAVKV F E + +
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 672 HRNLVK--------------------------------------------IISSSLEYLH 687
H +V +I+ + + L+
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALN 125
Query: 688 FGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLA-TIGYMAPEY 746
F H IIH D+KP+N+++ + DFGIA+ ++ QT + T Y++PE
Sbjct: 126 FSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQ 185
Query: 747 GTKGRVSTRGDVCSFGII 764
V R DV S G +
Sbjct: 186 ARGDSVDARSDVYSLGCV 203
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 86.0 bits (212), Expect = 4e-19
Identities = 31/167 (18%), Positives = 57/167 (34%), Gaps = 42/167 (25%)
Query: 639 GNGMEVAVKVFHQQY-ERALKSFEDECEVRKRIRHRNLVKIISSSLEY------------ 685
+ VA+K + + F E ++ H ++VK+I E
Sbjct: 33 NPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWIIMELCTLG 92
Query: 686 ----------------------------LHFGHSIPIIHCDLKPSNVLLDEDMVAHISDF 717
L + S +H D+ NVL+ + + DF
Sbjct: 93 ELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDF 152
Query: 718 GIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGII 764
G+++ + + K ++ I +MAPE R ++ DV FG+
Sbjct: 153 GLSRYME-DSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVC 198
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 83.6 bits (206), Expect = 8e-18
Identities = 34/192 (17%), Positives = 64/192 (33%), Gaps = 58/192 (30%)
Query: 628 DRFSENNLIGIG------------NGMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNL 675
D + +G G G K + Y + ++E + ++ H L
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88
Query: 676 VKIISSS---------LEY--------------------------------LHFGHSIPI 694
+ + + LE+ L H I
Sbjct: 89 INLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSI 148
Query: 695 IHCDLKPSNVLLD--EDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRV 752
+H D+KP N++ + + I DFG+A L+ ++ + T AT + APE + V
Sbjct: 149 VHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT---ATAEFAAPEIVDREPV 205
Query: 753 STRGDVCSFGII 764
D+ + G++
Sbjct: 206 GFYTDMWAIGVL 217
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 81.8 bits (201), Expect = 2e-17
Identities = 33/152 (21%), Positives = 67/152 (44%), Gaps = 2/152 (1%)
Query: 613 QAIRRFSYHELLRATDRFSENNLIGIGNGMEVAVKVFHQQYERALKSFEDECEVRKRIRH 672
++ F+ H ++R S+ + ME+ + + Y R+L+ V
Sbjct: 75 SVMKEFNCHHVVRLLGVVSQGQPTLVI--MELMTRGDLKSYLRSLRPAMANNPVLAPPSL 132
Query: 673 RNLVKIISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQ 732
++++ + + + ++ +H DL N ++ ED I DFG+ + + D K
Sbjct: 133 SKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKG 192
Query: 733 TQTLATIGYMAPEYGTKGRVSTRGDVCSFGII 764
+ L + +M+PE G +T DV SFG++
Sbjct: 193 GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVV 224
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 81.8 bits (201), Expect = 2e-17
Identities = 27/157 (17%), Positives = 61/157 (38%), Gaps = 8/157 (5%)
Query: 613 QAIRRFSYHE-LLRATDRFSENNLIGIG----NGMEVAVKVFHQQYERALKSFEDECEVR 667
+ + + +H ++ + + + + + +F
Sbjct: 62 EVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTA 121
Query: 668 KRIRHRNLVKIISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGED 727
+ + L+ + + + IH DL N+L+ E+ VA I+DFG+++ G++
Sbjct: 122 STLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR---GQE 178
Query: 728 QLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGII 764
K+T + +MA E +T DV S+G++
Sbjct: 179 VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVL 215
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 81.1 bits (199), Expect = 3e-17
Identities = 43/193 (22%), Positives = 67/193 (34%), Gaps = 58/193 (30%)
Query: 628 DRFSENNLIGIG------------NGMEVAVKVFH--QQYERALKSFEDECEVRKRIRHR 673
+ F + IG G G VA+K + E + E + K + H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 674 NLVK-----------------------------------------IISSSLEYLHFGHSI 692
N+VK + L+ L F HS
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 693 PIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPE-YGTKGR 751
++H DLKP N+L++ + ++DFG+A+ + T + T+ Y APE
Sbjct: 122 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYRAPEILLGCKY 179
Query: 752 VSTRGDVCSFGII 764
ST D+ S G I
Sbjct: 180 YSTAVDIWSLGCI 192
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 81.1 bits (199), Expect = 3e-17
Identities = 28/125 (22%), Positives = 52/125 (41%)
Query: 640 NGMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVKIISSSLEYLHFGHSIPIIHCDL 699
++ + ++ E E + + +L+ + + F S IH DL
Sbjct: 101 KFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDL 160
Query: 700 KPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVC 759
N+LL E V I DFG+A+ + + ++ + +MAPE + + DV
Sbjct: 161 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVW 220
Query: 760 SFGII 764
SFG++
Sbjct: 221 SFGVL 225
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 80.6 bits (198), Expect = 7e-17
Identities = 33/192 (17%), Positives = 59/192 (30%), Gaps = 57/192 (29%)
Query: 628 DRFSENNLIGIG------------NGMEVAVKVFHQQY---ERALKSFEDECEVRKRIRH 672
+ F L+G G G A+K+ ++ + + E V + RH
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 673 RNLVK----------------------------------------IISSSLEYLHFGHSI 692
L + + L + HS
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR 124
Query: 693 PIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRV 752
+++ D+K N++LD+D I+DFG+ K + + T Y+APE
Sbjct: 125 DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--ATMKTFCGTPEYLAPEVLEDNDY 182
Query: 753 STRGDVCSFGII 764
D G++
Sbjct: 183 GRAVDWWGLGVV 194
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 79.9 bits (196), Expect = 7e-17
Identities = 32/157 (20%), Positives = 67/157 (42%), Gaps = 5/157 (3%)
Query: 613 QAIRRFSYHE-LLRATDRFSENNLIGI----GNGMEVAVKVFHQQYERALKSFEDECEVR 667
+ ++ H+ ++ +++ + + + + + ++ S+
Sbjct: 70 EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPE 129
Query: 668 KRIRHRNLVKIISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGED 727
+++ ++LV + + S IH DL NVL+ ED V I+DFG+A+ + D
Sbjct: 130 EQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189
Query: 728 QLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGII 764
K T + +MAPE + + DV SFG++
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVL 226
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 79.5 bits (195), Expect = 8e-17
Identities = 39/191 (20%), Positives = 68/191 (35%), Gaps = 56/191 (29%)
Query: 628 DRFSENNLIGIG-----------NGMEVAVKVFH--QQYERALKSFEDECEVRKRIRHRN 674
+++ IG G G A+K ++ E + E + K ++H N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 675 LVKIISSS----------------------------------------LEYLHFGHSIPI 694
+VK+ L + + H +
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRV 121
Query: 695 IHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPE-YGTKGRVS 753
+H DLKP N+L++ + I+DFG+A+ + K T + T+ Y AP+ + S
Sbjct: 122 LHRDLKPQNLLINREGELKIADFGLARAFGIPVR--KYTHEIVTLWYRAPDVLMGSKKYS 179
Query: 754 TRGDVCSFGII 764
T D+ S G I
Sbjct: 180 TTIDIWSVGCI 190
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 79.4 bits (195), Expect = 3e-16
Identities = 41/196 (20%), Positives = 62/196 (31%), Gaps = 63/196 (32%)
Query: 628 DRFSENNLIGIG------------NGMEVAVKVFH------QQYERALKSFEDECEVRKR 669
+ FS + +IG G G A+K +Q E + +
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 670 IRHRNLVK----------------------------------------IISSSLEYLHFG 689
+V + + L
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHM 123
Query: 690 HSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTK 749
H+ +++ DLKP+N+LLDE ISD G+A S K ++ T GYMAPE K
Sbjct: 124 HNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK----KKPHASVGTHGYMAPEVLQK 179
Query: 750 GR-VSTRGDVCSFGII 764
G + D S G +
Sbjct: 180 GVAYDSSADWFSLGCM 195
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 77.5 bits (190), Expect = 6e-16
Identities = 40/193 (20%), Positives = 64/193 (33%), Gaps = 58/193 (30%)
Query: 628 DRFSENNLIGIG------------NGMEVAVKVFHQQY---ERALKSFEDECEV-RKRIR 671
+ F + ++G G A+K + + ++ E V
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 672 HRNLVKIISS---------SLEY-------------------------------LHFGHS 691
H L + + +EY L F HS
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHS 121
Query: 692 IPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGR 751
I++ DLK N+LLD+D I+DFG+ K D +K T Y+APE +
Sbjct: 122 KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD--AKTNTFCGTPDYIAPEILLGQK 179
Query: 752 VSTRGDVCSFGII 764
+ D SFG++
Sbjct: 180 YNHSVDWWSFGVL 192
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 76.9 bits (188), Expect = 6e-16
Identities = 37/192 (19%), Positives = 66/192 (34%), Gaps = 57/192 (29%)
Query: 628 DRFSENNLIGIG------------NGMEVAVKVFH--QQYERALKSFEDECEVRKRIRHR 673
++ + IG G VA+K E S E + K ++H+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 674 NLVK----------------------------------------IISSSLEYLHFGHSIP 693
N+V+ + L+ L F HS
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN 121
Query: 694 IIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPE-YGTKGRV 752
++H DLKP N+L++ + +++FG+A+ + + + T+ Y P+
Sbjct: 122 VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR--CYSAEVVTLWYRPPDVLFGAKLY 179
Query: 753 STRGDVCSFGII 764
ST D+ S G I
Sbjct: 180 STSIDMWSAGCI 191
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 77.2 bits (189), Expect = 6e-16
Identities = 36/202 (17%), Positives = 59/202 (29%), Gaps = 63/202 (31%)
Query: 624 LRATDRFSENNLIGIG------------NGMEVAVKVFHQQYERALKSFEDECEVRKRIR 671
LR +R+ IG G G EVA+K+ + + E ++ K ++
Sbjct: 3 LRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQ 60
Query: 672 HRNLVKIISSS-----------------------------------------LEYLHFGH 690
+ I + + + H
Sbjct: 61 GGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 120
Query: 691 SIPIIHCDLKPSNVL---LDEDMVAHISDFGIAKLLSGED-----QLSKQTQTLATIGYM 742
S IH D+KP N L + + +I DFG+AK + T Y
Sbjct: 121 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 180
Query: 743 APEYGTKGRVSTRGDVCSFGII 764
+ S R D+ S G +
Sbjct: 181 SINTHLGIEQSRRDDLESLGYV 202
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 77.2 bits (189), Expect = 6e-16
Identities = 26/159 (16%), Positives = 54/159 (33%), Gaps = 7/159 (4%)
Query: 613 QAIRRFSYHE-LLRATDRFSENNLIGI------GNGMEVAVKVFHQQYERALKSFEDECE 665
+ + H ++ + + + ++ + + S +
Sbjct: 78 KVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMED 137
Query: 666 VRKRIRHRNLVKIISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSG 725
+ +L+ + + F S IH DL N+LL + I DFG+A+ +
Sbjct: 138 DELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKN 197
Query: 726 EDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGII 764
+ + + +MAPE + DV S+GI
Sbjct: 198 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIF 236
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 76.8 bits (188), Expect = 7e-16
Identities = 25/176 (14%), Positives = 47/176 (26%), Gaps = 53/176 (30%)
Query: 640 NGMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLV----------------------- 676
N +VA+K ++ + DE K + +
Sbjct: 29 NNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLLGPS 86
Query: 677 ------------------KIISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAH----- 713
L + H +++ D+KP N L+ +
Sbjct: 87 LEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIY 146
Query: 714 ISDFGIAKLLSGED-----QLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGII 764
+ DFG+ K ++ T YM+ S R D+ + G +
Sbjct: 147 VVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHV 202
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 77.5 bits (190), Expect = 8e-16
Identities = 33/192 (17%), Positives = 63/192 (32%), Gaps = 60/192 (31%)
Query: 628 DRFSENNLIGIG------------NGMEVAVKVFHQQY---ERALKSFEDECEVRKRIRH 672
D+F +G G +G A+K+ +Q + ++ +E + + +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 673 RNLVK----------------------------------------IISSSLEYLHFGHSI 692
LVK + + + HS+
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 160
Query: 693 PIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRV 752
+I+ DLKP N+L+D+ ++DFG AK + T +APE
Sbjct: 161 DLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWTLCGTPEALAPEIILSKGY 215
Query: 753 STRGDVCSFGII 764
+ D + G++
Sbjct: 216 NKAVDWWALGVL 227
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 76.3 bits (187), Expect = 9e-16
Identities = 38/199 (19%), Positives = 66/199 (33%), Gaps = 65/199 (32%)
Query: 628 DRFSENNLIGIG------------NGMEVAVKVFH------QQYERALKSFEDECEVRKR 669
D + +G G G++ A K + + + E E + K
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 670 IRHRNLVK----------------------------------------IISSSLEYLHFG 689
I+H N++ + L +++
Sbjct: 70 IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYL 129
Query: 690 HSIPIIHCDLKPSNVLLDEDMVA----HISDFGIAKLLSGEDQLSKQTQTLATIGYMAPE 745
HS+ I H DLKP N++L + V I DFG+A + D ++ T ++APE
Sbjct: 130 HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI---DFGNEFKNIFGTPEFVAPE 186
Query: 746 YGTKGRVSTRGDVCSFGII 764
+ D+ S G+I
Sbjct: 187 IVNYEPLGLEADMWSIGVI 205
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 76.2 bits (186), Expect = 1e-15
Identities = 44/268 (16%), Positives = 96/268 (35%), Gaps = 15/268 (5%)
Query: 76 SSLQTLDLSHNKLSGNIPSSIFNMHTLKLLDFSDNQLFGSLSSFIFNMSSMTTIDLSINR 135
LDL +NK++ N+ L L +N++ + + + LS N+
Sbjct: 31 PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQ 90
Query: 136 LSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKEIGNLTKLKEIISTITNSTVCE 195
L ELP + K ++L + ++ + + + + T +
Sbjct: 91 LK-ELPEKMPKT------LQELRVHENEITKVRKSVFNGLNQMIVV--ELGTNPLKSSGI 141
Query: 196 IPREIGNLPYLARLALATNNLVGVVPVTIFNMSALKEISLLNNSLSGSLPSRIDLSLPNV 255
+ L+ + +A N+ + +L E+ L N ++ + + L N+
Sbjct: 142 ENGAFQGMKKLSYIRIADTNITTIPQ---GLPPSLTELHLDGNKITKVDAASLK-GLNNL 197
Query: 256 ETLNLGINSFSGTIPSSITNSSKLSDLELGENLFSGFIPNTIGNLRNLEFGNIADNYLTS 315
L L NS S S+ N+ L +L L N +P + + + ++ + +N +++
Sbjct: 198 AKLGLSFNSISAVDNGSLANTPHLRELHLN-NNKLVKVPGGLADHKYIQVVYLHNNNISA 256
Query: 316 STPE-LSFLSSLTNCKKLKVLIVTGNPL 342
T + + NP+
Sbjct: 257 IGSNDFCPPGYNTKKASYSGVSLFSNPV 284
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 69.7 bits (169), Expect = 2e-13
Identities = 56/264 (21%), Positives = 91/264 (34%), Gaps = 18/264 (6%)
Query: 230 LKEISLLNNSLSGSLPSRIDLSLPNVETLNLGINSFSGTIPSSITNSSKLSDLELGENLF 289
+ L NN ++ +L N+ TL L N S P + KL L L +N
Sbjct: 33 TALLDLQNNKITEIKDGDFK-NLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQL 91
Query: 290 SGFIPNTIGNLRNLEFGNIADNYLTSSTPELSFLSSLTNCKKLKVLIVTGNPLDGILPKS 349
L+ L + S + N + L GI +
Sbjct: 92 KELPEKMPKTLQELRVHENEITKVRKSVF------NGLNQMIVVELGTNPLKSSGIENGA 145
Query: 350 IGNFSLSLETILMANCSISGNIPQVVGNLSNLLVLELGGNNLTGPIPVTFSQLQTLQAFD 409
L I +A+ +I+ IPQ G +L L L GN +T + L L
Sbjct: 146 FQGMK-KLSYIRIADTNIT-TIPQ--GLPPSLTELHLDGNKITKVDAASLKGLNNLAKLG 201
Query: 410 LTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSVRVLYLGLNIFTSVLSS 469
L+ N ++ L + L L L NK +P L + ++V+YL N +++ S+
Sbjct: 202 LSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSN 260
Query: 470 T------IWNLKDILFIDVSSNFL 487
+ + SN +
Sbjct: 261 DFCPPGYNTKKASYSGVSLFSNPV 284
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 56.2 bits (134), Expect = 4e-09
Identities = 28/168 (16%), Positives = 59/168 (35%), Gaps = 4/168 (2%)
Query: 352 NFSLSLETILMANCSISGNIPQVVGNLSNLLVLELGGNNLTGPIPVTFSQLQTLQAFDLT 411
+ + + N I+ NL NL L L N ++ P F+ L L+ L+
Sbjct: 28 DLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLS 87
Query: 412 RNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSVRVLYLGLNIFTSVLSSTI 471
+N+L L L + K S+ + L + V L + + +
Sbjct: 88 KNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVE-LGTNPLKSSGIENGAF 146
Query: 472 WNLKDILFIDVSSNFLDGPLSLDIGNLKVVIGLDFSRNNLSGDIPITI 519
+K + +I ++ + ++ G + L N ++ ++
Sbjct: 147 QGMKKLSYIRIADTNIT---TIPQGLPPSLTELHLDGNKITKVDAASL 191
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 50.4 bits (119), Expect = 4e-07
Identities = 35/186 (18%), Positives = 70/186 (37%), Gaps = 22/186 (11%)
Query: 366 SISGNIPQVVGNLSNLLVLELGGNNLTGPIPVTFSQLQTLQAFDLTRNKLAGPITDELCH 425
+ ++P + +L+L N +T F L+ L L NK++
Sbjct: 24 KVPKDLP------PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAP 77
Query: 426 LARLHSLVLQGNKFSGSIPSCLGNLTSVRVLYLGLNIFTSVLSSTIWNLKDILFIDVSSN 485
L +L L L N+ +P + +++ L + N T V S L ++ +++ +N
Sbjct: 78 LVKLERLYLSKNQLK-ELPEKMPK--TLQELRVHENEITKVRKSVFNGLNQMIVVELGTN 134
Query: 486 FLD--GPLSLDIGNLKVVIGLDFSRNNLSGDIPITIGEGEIPRGGPFANLTAKSFMGNEL 543
L G + +K + + + N++ IP+G +LT GN++
Sbjct: 135 PLKSSGIENGAFQGMKKLSYIRIADTNIT----------TIPQGL-PPSLTELHLDGNKI 183
Query: 544 LCGLPD 549
Sbjct: 184 TKVDAA 189
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 50.0 bits (118), Expect = 4e-07
Identities = 20/119 (16%), Positives = 39/119 (32%), Gaps = 24/119 (20%)
Query: 73 GNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLDFSDNQLFGSLSSFI------------ 120
G SL L L NK++ +S+ ++ L L S N + + +
Sbjct: 168 GLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLN 227
Query: 121 -----------FNMSSMTTIDLSINRLSGELPANICKIPSTLSKCKQLEELNLGFNNLS 168
+ + + L N +S + +N P +K ++L N +
Sbjct: 228 NNKLVKVPGGLADHKYIQVVYLHNNNIS-AIGSNDFCPPGYNTKKASYSGVSLFSNPVQ 285
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 76.0 bits (186), Expect = 1e-15
Identities = 35/171 (20%), Positives = 62/171 (36%), Gaps = 48/171 (28%)
Query: 640 NGMEVAVKVFHQQY-----ERALKSFEDECEVRKRIRHRNLVK----------------- 677
VA+K + + ++ E ++ + + H N++
Sbjct: 22 TNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81
Query: 678 -----------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHI 714
+ +L+ L + H I+H DLKP+N+LLDE+ V +
Sbjct: 82 METDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKL 141
Query: 715 SDFGIAKLLSGEDQLSKQTQTLATIGYMAPE-YGTKGRVSTRGDVCSFGII 764
+DFG+AK ++ T + T Y APE D+ + G I
Sbjct: 142 ADFGLAKSFGSPNR--AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCI 190
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 74.5 bits (182), Expect = 5e-15
Identities = 45/204 (22%), Positives = 69/204 (33%), Gaps = 67/204 (32%)
Query: 625 RATDRFSENNLIGIG-------------NGMEVAVKVFHQQY--ERALKSFEDECEVRKR 669
RA ++ IG G G VA+K Q E S E V +
Sbjct: 4 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH 63
Query: 670 I---RHRNLVK----------------------------------------------IIS 680
+ H N+V+ ++
Sbjct: 64 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMF 123
Query: 681 SSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIG 740
L L F HS ++H DLKP N+L+ ++DFG+A++ S + T + T+
Sbjct: 124 QLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM---ALTSVVVTLW 180
Query: 741 YMAPEYGTKGRVSTRGDVCSFGII 764
Y APE + +T D+ S G I
Sbjct: 181 YRAPEVLLQSSYATPVDLWSVGCI 204
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 74.5 bits (182), Expect = 6e-15
Identities = 40/206 (19%), Positives = 69/206 (33%), Gaps = 65/206 (31%)
Query: 625 RATDRFSENNLIGIG------------NGMEVAVKVFH--QQYERALKSFEDECEVRKRI 670
++ + IG G G +VA+K + E + E ++ + +
Sbjct: 7 DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLL 66
Query: 671 RHRNLVKIISSS------------------------------------------------ 682
+H N+V +I
Sbjct: 67 KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQML 126
Query: 683 LEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLS--GEDQLSKQTQTLATIG 740
L L++ H I+H D+K +NVL+ D V ++DFG+A+ S Q ++ T + T+
Sbjct: 127 LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLW 186
Query: 741 YMAPEYGTKGR-VSTRGDVCSFGIIS 765
Y PE R D+ G I
Sbjct: 187 YRPPELLLGERDYGPPIDLWGAGCIM 212
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 73.9 bits (181), Expect = 7e-15
Identities = 42/194 (21%), Positives = 66/194 (34%), Gaps = 59/194 (30%)
Query: 627 TDRFSENNLIGIG------------NGMEVAVKVFHQQY-ERALKSFEDECEVRKRIRHR 673
D + +++G G VA+K ++ E S E+E V +I+H
Sbjct: 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHP 67
Query: 674 NLVKI-------------------------------------------ISSSLEYLHFGH 690
N+V + + +++YLH
Sbjct: 68 NIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLG 127
Query: 691 SIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKG 750
+ LDED ISDFG++K+ ED S + T GY+APE +
Sbjct: 128 IVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTACGTPGYVAPEVLAQK 184
Query: 751 RVSTRGDVCSFGII 764
S D S G+I
Sbjct: 185 PYSKAVDCWSIGVI 198
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 70.8 bits (173), Expect = 9e-14
Identities = 34/192 (17%), Positives = 54/192 (28%), Gaps = 59/192 (30%)
Query: 628 DRFSENNLIGIG------------NGMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNL 675
+++ +G G + K + + E + RHRN+
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNI 63
Query: 676 VK-----------------------------------------IISSSLEYLHFGHSIPI 694
+ + E L F HS I
Sbjct: 64 LHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNI 123
Query: 695 IHCDLKPSNVLLDEDMVAH--ISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRV 752
H D++P N++ + I +FG A+ L D Y APE V
Sbjct: 124 GHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF---RLLFTAPEYYAPEVHQHDVV 180
Query: 753 STRGDVCSFGII 764
ST D+ S G +
Sbjct: 181 STATDMWSLGTL 192
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 70.9 bits (173), Expect = 1e-13
Identities = 33/175 (18%), Positives = 57/175 (32%), Gaps = 58/175 (33%)
Query: 640 NGMEVAVKVFHQQYERALKSFEDECEVRKRI-RHRNLVKIISSS-------------LEY 685
+ A+K+ E E+ R + ++V+I+ +E
Sbjct: 36 TQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMEC 90
Query: 686 ---------------------------------LHFGHSIPIIHCDLKPSNVLLD---ED 709
+ + HSI I H D+KP N+L +
Sbjct: 91 LDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPN 150
Query: 710 MVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGII 764
+ ++DFG AK + + T T Y+APE + D+ S G+I
Sbjct: 151 AILKLTDFGFAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVI 202
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 70.6 bits (172), Expect = 2e-13
Identities = 45/210 (21%), Positives = 73/210 (34%), Gaps = 68/210 (32%)
Query: 618 FSYHELLRAT----DRFSENNLIGIG------------NGMEVAVKVFHQQY--ERALKS 659
F E+ + + + +G G G +VA+K ++ + E K
Sbjct: 4 FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 63
Query: 660 FEDECEVRKRIRHRNLVK------------------------------------------ 677
E + K +RH N++
Sbjct: 64 AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRI 123
Query: 678 --IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQT 735
++ L+ L + H+ IIH DLKP N+ ++ED I DFG+A+ S+ T
Sbjct: 124 QFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD-----SEMTGY 178
Query: 736 LATIGYMAPE-YGTKGRVSTRGDVCSFGII 764
+ T Y APE R + D+ S G I
Sbjct: 179 VVTRWYRAPEVILNWMRYTQTVDIWSVGCI 208
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 69.3 bits (169), Expect = 2e-13
Identities = 34/202 (16%), Positives = 68/202 (33%), Gaps = 65/202 (32%)
Query: 628 DRFSENNLIGIG------------NGMEVAVKVFH---------QQYERALKSFEDECEV 666
+ + ++G G E AVK+ ++ + ++ E ++
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 667 RKRIR-HRNLVKIISSS---------LEY------------------------------- 685
+++ H N++++ + +
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEV 122
Query: 686 LHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQT---LATIGYM 742
+ H + I+H DLKP N+LLD+DM ++DFG + L ++L + T LA
Sbjct: 123 ICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIE 182
Query: 743 APEYGTKGRVSTRGDVCSFGII 764
D+ S G+I
Sbjct: 183 CSMNDNHPGYGKEVDMWSTGVI 204
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 66.3 bits (161), Expect = 2e-12
Identities = 26/100 (26%), Positives = 40/100 (40%), Gaps = 6/100 (6%)
Query: 667 RKRIRHRNLVKIISSSLEYLHFGHSIPIIHCDLKPSNVLLDED-MVAHISDFGIAKLLSG 725
R ++ LE + H+ ++H D+K N+L+D + + DFG LL
Sbjct: 104 RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD 163
Query: 726 EDQLSKQTQTLATIGYMAPEYGTKGRVSTRG-DVCSFGII 764
+ T T Y PE+ R R V S GI+
Sbjct: 164 ----TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGIL 199
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 65.7 bits (159), Expect = 5e-12
Identities = 40/194 (20%), Positives = 61/194 (31%), Gaps = 60/194 (30%)
Query: 628 DRFSENNLIGIG------------NGMEVAVKVFHQQY--ERALKSFEDECEVRKRIRHR 673
R+ IG G VA+K + + + K E + K + H+
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 674 NLVK-------------------------------------------IISSSLEYLHFGH 690
N++ ++ L + H
Sbjct: 77 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 136
Query: 691 SIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKG 750
S IIH DLKPSN+++ D I DFG+A+ + T + T Y APE
Sbjct: 137 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM---TPYVVTRYYRAPEVILGM 193
Query: 751 RVSTRGDVCSFGII 764
D+ S G I
Sbjct: 194 GYKENVDIWSVGCI 207
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 65.2 bits (158), Expect = 6e-12
Identities = 34/178 (19%), Positives = 59/178 (33%), Gaps = 48/178 (26%)
Query: 634 NLIGIGNGMEVAVKVFHQ----QYERALKSFEDECEVRKRIRHRNLV------------- 676
+ G G A+KV + Q + + E +V + IR +
Sbjct: 45 KISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKL 104
Query: 677 ----------------------------KIISSSLEYLHFGHSIPIIHCDLKPSNVLLDE 708
+ + L H + II+ D+K N+LLD
Sbjct: 105 HLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDS 164
Query: 709 DMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPE--YGTKGRVSTRGDVCSFGII 764
+ ++DFG++K ++ + TI YMAP+ G D S G++
Sbjct: 165 NGHVVLTDFGLSKEFVADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVL 221
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 65.4 bits (158), Expect = 7e-12
Identities = 29/178 (16%), Positives = 62/178 (34%), Gaps = 10/178 (5%)
Query: 595 IKCWKSRTGPSNDGINSPQAIRRFSYHELLRATDRFSENNLIGIGNGMEVAVKVFHQQYE 654
+K + + + + ++R + + + + + L + + H
Sbjct: 43 MKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMV 102
Query: 655 RALKSFEDECEVRKRIRH-------RNLVKIISSSLEYLHFGHSIPIIHCDLKPSNVLLD 707
+ ++K + + K + L+Y+H I IH D+KP NVL++
Sbjct: 103 FEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGI--IHTDIKPENVLME 160
Query: 708 -EDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGII 764
D ++ IA L + T ++ T Y +PE D+ S +
Sbjct: 161 IVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACL 218
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 65.2 bits (158), Expect = 9e-12
Identities = 36/199 (18%), Positives = 60/199 (30%), Gaps = 68/199 (34%)
Query: 628 DRFSENNLIGIG------------NGMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNL 675
+++ +IG G +G VA+K Q E ++ +++ H N+
Sbjct: 20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNI 75
Query: 676 VK-------------------------------------------------IISSSLEYL 686
V+ + L
Sbjct: 76 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 687 HFGHSIPIIHCDLKPSNVLLDED-MVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPE 745
+ HS I H D+KP N+LLD D V + DFG AK L + + +
Sbjct: 136 AYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP--NVSYICSRYYRAPEL 193
Query: 746 YGTKGRVSTRGDVCSFGII 764
++ DV S G +
Sbjct: 194 IFGATDYTSSIDVWSAGCV 212
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 62.9 bits (151), Expect = 3e-11
Identities = 54/257 (21%), Positives = 82/257 (31%), Gaps = 16/257 (6%)
Query: 293 IPNTIGNLRNLEFGNIADNYLTSSTPELSFLSSLTNCKKLKVLIVTGNPLDGILPKSIGN 352
+P I + + N ++ S C+ L +L + N L I +
Sbjct: 26 VPVGIP--AASQRIFLHGNRISHVPAA-----SFRACRNLTILWLHSNVLARIDAAAFTG 78
Query: 353 FSLSLETILMANCSISGNIPQVVGNLSNLLVLELGGNNLTGPIPVTFSQLQTLQAFDLTR 412
+L + L N + P L L L L L P F L LQ L
Sbjct: 79 LALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQD 138
Query: 413 NKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSVRVLYLGLNIFTSVLSSTIW 472
N L D L L L L GN+ S L S+ L L N V
Sbjct: 139 NALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFR 198
Query: 473 NLKDILFIDVSSNFLDGPLSLDIGNLKVVIGLDFSRNNLSGDIPITIGEGEIPRGGPFAN 532
+L ++ + + +N L + + L+ + L + N D +A
Sbjct: 199 DLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRAR---------PLWAW 249
Query: 533 LTAKSFMGNELLCGLPD 549
L +E+ C LP
Sbjct: 250 LQKFRGSSSEVPCSLPQ 266
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 62.9 bits (151), Expect = 3e-11
Identities = 46/244 (18%), Positives = 84/244 (34%), Gaps = 9/244 (3%)
Query: 76 SSLQTLDLSHNKLSGNIPSSIFNMHTLKLLDFSDNQLFGSLSSFIFNMSSMTTIDLSINR 135
++ Q + L N++S +S L +L N L ++ ++ + +DLS N
Sbjct: 32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNA 91
Query: 136 LSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKEIGNLTKLKEIISTITNSTVCE 195
+ P+T +L L+L L P L L+ + N+
Sbjct: 92 QLRSVD------PATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLY-LQDNALQAL 144
Query: 196 IPREIGNLPYLARLALATNNLVGVVPVTIFNMSALKEISLLNNSLSGSLPSRIDLSLPNV 255
+L L L L N + V + +L + L N ++ P L +
Sbjct: 145 PDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFR-DLGRL 203
Query: 256 ETLNLGINSFSGTIPSSITNSSKLSDLELGENLFSGFIPNTIGNLRNLEFGNIADNYLTS 315
TL L N+ S ++ L L L +N + L+ + + +
Sbjct: 204 MTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVC-DCRARPLWAWLQKFRGSSSEVPC 262
Query: 316 STPE 319
S P+
Sbjct: 263 SLPQ 266
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.4 bits (116), Expect = 7e-07
Identities = 31/179 (17%), Positives = 58/179 (32%), Gaps = 22/179 (12%)
Query: 57 LNISSFNLQGTITPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLDFSDNQLFGSL 116
L++ LQ L++LQ L L N L + ++ L L N++
Sbjct: 110 LHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVP 169
Query: 117 SSFIFNMSSMTTIDLSINRLSGELPANICKIPST-----------------LSKCKQLEE 159
+ S+ + L NR++ P + L+ + L+
Sbjct: 170 ERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQY 229
Query: 160 LNLGFNNLSGAIPKEIGNLTKLKEIISTITNSTVCEIPREIGNLPYLARLALATNNLVG 218
L L N L++ + ++ C +P+ + LA N+L G
Sbjct: 230 LRLNDNPWVCDCR-ARPLWAWLQKFRGS-SSEVPCSLPQRLAGRDL---KRLAANDLQG 283
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 60.1 bits (144), Expect = 2e-10
Identities = 38/282 (13%), Positives = 80/282 (28%), Gaps = 24/282 (8%)
Query: 79 QTLDLSHNKLSGNIPSSIFNMHTLKLLDFSDNQLFGSLSSFIFNMSSMTTIDLSINRLSG 138
QTLDL+ L ++ + + + + + L+ F+ + +DLS + +
Sbjct: 3 QTLDLTGKNLHPDVTGRLLS-QGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEV 60
Query: 139 ELPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKEIGNLTKLKEIISTITNSTVCEIPR 198
+ LS+C +L+ L+L LS I + + L + + + +
Sbjct: 61 ST------LHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQ 114
Query: 199 E-------IGNLPYLARLALATNNLVGVVPVTIFNMSALKEISLLNNSLSGSLPSRIDLS 251
+ L ++ V ++ L N L + +
Sbjct: 115 TLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRC 174
Query: 252 LPNVETLNLGINSFSGTIPSSITNSSKLSDLEL-GENLFSGFIPNTIGNLRNLEFGNIAD 310
V + L L L +G + L+ +
Sbjct: 175 PNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFG 234
Query: 311 NYLTSSTPELSFLSSLTNCKKLKVLIVTGNPLDGILPKSIGN 352
+ L L++ + I +IGN
Sbjct: 235 IVPDGTLQLL-----KEALPHLQIN---CSHFTTIARPTIGN 268
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.8 bits (112), Expect = 2e-06
Identities = 41/267 (15%), Positives = 86/267 (32%), Gaps = 6/267 (2%)
Query: 44 GITCDVNSHRVIGLNISSFNLQGTITPQLGNLSSLQTLDLSHNKLSGNIPSSIF-NMHTL 102
+T + S VI + + + + +Q +DLS++ + + I L
Sbjct: 15 DVTGRLLSQGVIAFRCPRSFMDQPL-AEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKL 73
Query: 103 KLLDFSDNQLFGSLSSFIFNMSSMTTIDLSINR-LSGELPANICKIPSTLSKCKQLEELN 161
+ L +L + + + S++ ++LS S + S L + +
Sbjct: 74 QNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFD 133
Query: 162 LGFNNLSGAIPKEIGNLTKLKEIISTITNSTVCEIPREIGNLPYLARLALATNNLVGVVP 221
++ A+ +T+L + + L
Sbjct: 134 FTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCF 193
Query: 222 VTIFNMSALKEISLLNNSLSGSLPSRIDLSLPNVETLNLGINSFSGTIPSSITNSSKLSD 281
F ++ L+ +SL +P ++TL + GT+ L
Sbjct: 194 QEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLKEA---LPH 250
Query: 282 LELGENLFSGFIPNTIGNLRNLEFGNI 308
L++ + F+ TIGN +N E I
Sbjct: 251 LQINCSHFTTIARPTIGNKKNQEIWGI 277
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 60.3 bits (145), Expect = 3e-10
Identities = 38/196 (19%), Positives = 60/196 (30%), Gaps = 62/196 (31%)
Query: 627 TDRFSENNLIGIG------------NGMEVAVKVFHQQY--ERALKSFEDECEVRKRIRH 672
+R+ + +G G G+ VAVK + + K E + K ++H
Sbjct: 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76
Query: 673 RNLVKIISSS--------------------------------------------LEYLHF 688
N++ ++ L L +
Sbjct: 77 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 136
Query: 689 GHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGT 748
HS IIH DLKPSN+ ++ED I DFG+A+ E
Sbjct: 137 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM----TGYVATRWYRAPEIMLN 192
Query: 749 KGRVSTRGDVCSFGII 764
+ D+ S G I
Sbjct: 193 WMHYNQTVDIWSVGCI 208
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 59.1 bits (142), Expect = 6e-10
Identities = 33/191 (17%), Positives = 64/191 (33%), Gaps = 60/191 (31%)
Query: 628 DRFSENNLIGIG------------NGMEVAVKVFHQQYERALKSFEDECEVRKRIR-HRN 674
D + +G G N +V VK+ + K + E ++ + +R N
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK---KKIKREIKILENLRGGPN 91
Query: 675 LVK---------------------------------------IISSSLEYLHFGHSIPII 695
++ + L+ L + HS+ I+
Sbjct: 92 IITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIM 151
Query: 696 HCDLKPSNVLLD-EDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGR-VS 753
H D+KP NV++D E + D+G+A+ + +A+ + PE +
Sbjct: 152 HRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ---EYNVRVASRYFKGPELLVDYQMYD 208
Query: 754 TRGDVCSFGII 764
D+ S G +
Sbjct: 209 YSLDMWSLGCM 219
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 54.7 bits (131), Expect = 1e-09
Identities = 32/125 (25%), Positives = 50/125 (40%), Gaps = 12/125 (9%)
Query: 57 LNISSFNLQGTITPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLDFSDNQLFGSL 116
L+++ +L T+ L L + LDLSHN+L P ++ + L++L SDN L
Sbjct: 3 LHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALENVD 59
Query: 117 SSFIFNMSSMTTIDLSINRLSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKEIG 176
+ + L NRL L C +L LNL N+L
Sbjct: 60 GVANLPR--LQELLLCNNRLQQ------SAAIQPLVSCPRLVLLNLQGNSLCQ-EEGIQE 110
Query: 177 NLTKL 181
L ++
Sbjct: 111 RLAEM 115
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 37.4 bits (86), Expect = 0.001
Identities = 20/112 (17%), Positives = 38/112 (33%), Gaps = 10/112 (8%)
Query: 282 LELGENLFSGFIPNTIGNLRNLEFGNIADNYLTSSTPELSFLSSLTNCKKLKVLIVTGNP 341
L L + + + L + +++ N L + P L+ L L + +
Sbjct: 3 LHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQ--------ASD 52
Query: 342 LDGILPKSIGNFSLSLETILMANCSISGNIPQVVGNLSNLLVLELGGNNLTG 393
+ N E +L N Q + + L++L L GN+L
Sbjct: 53 NALENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 37.0 bits (85), Expect = 0.001
Identities = 23/111 (20%), Positives = 42/111 (37%), Gaps = 10/111 (9%)
Query: 375 VGNLSNLLVLELGGNNLTGPIPVTFSQLQTLQAFDLTRNKLAGPITDELCHLARLHSLVL 434
+ L + L+L N L P + L+ L+ + N D + +L RL L+L
Sbjct: 16 LEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNA--LENVDGVANLPRLQELLL 72
Query: 435 QGNKF-SGSIPSCLGNLTSVRVLYLGLNIFTSV------LSSTIWNLKDIL 478
N+ + L + + +L L N L+ + ++ IL
Sbjct: 73 CNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSIL 123
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 55.5 bits (132), Expect = 6e-09
Identities = 35/208 (16%), Positives = 58/208 (27%), Gaps = 18/208 (8%)
Query: 47 CDV-NSHRVIGLNISSFNLQGTITPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLL 105
C+V + +N NL + P L L LS N L +++ L L
Sbjct: 4 CEVSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQL 60
Query: 106 DFSDNQLFGSLSSFIFNMSSMTTIDLSINRLSGELPANICKIPSTLSKCKQLEEL----- 160
+ +L + + + + L + + +L L
Sbjct: 61 NLDRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGAL 120
Query: 161 --------NLGFNNLSGAIPKEIGNLTKLKEIISTITNSTVCEIPREIGNLPYLARLALA 212
N +P + T E +S N+ + L L L L
Sbjct: 121 RGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQ 180
Query: 213 TNNLVGVVPVTIFNMSALKEISLLNNSL 240
N+L +P F L L N
Sbjct: 181 ENSLY-TIPKGFFGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 52.4 bits (124), Expect = 7e-08
Identities = 39/222 (17%), Positives = 68/222 (30%), Gaps = 21/222 (9%)
Query: 122 NMSSMTTIDLSINRLSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKEIGNLTKL 181
++S ++ L+ LP ++ K L+L N L + T+L
Sbjct: 8 KVASHLEVNCDKRNLT-ALPPDLPK---------DTTILHLSENLLYTFSLATLMPYTRL 57
Query: 182 KEIISTITNSTVCEIPREIGNLPYLARLALATNNLVGVVPVTIFNMSALKEISLLNNSLS 241
++ T ++ + L L +L + + L
Sbjct: 58 TQLNLDRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLT---- 113
Query: 242 GSLPSRIDLSLPNVETLNLGINSFSGTIPSSITNSSKLSDLELGENLFSGFIPNTIGNLR 301
SLP L ++ L L N P +T + KL L L N + + L
Sbjct: 114 -SLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLE 172
Query: 302 NLEFGNIADNYLTSSTPELSFLSSLTNCKKLKVLIVTGNPLD 343
NL+ + +N L + L + GNP
Sbjct: 173 NLDTLLLQENSLYTIPKGFF------GSHLLPFAFLHGNPWL 208
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.3 bits (116), Expect = 6e-07
Identities = 42/217 (19%), Positives = 70/217 (32%), Gaps = 14/217 (6%)
Query: 223 TIFNMSALKEISLLNNSLSGSLPSRIDLSLPNVETLNLGINSFSGTIPSSITNSSKLSDL 282
+ +++ E++ +L+ +LP + + L+L N +++ ++L+ L
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDLP---KDTTILHLSENLLYTFSLATLMPYTRLTQL 60
Query: 283 ELGENLFSGFIPNTIGNLRNLEFGNIADNYLTSSTPELSFLSSLTNCKKLKVLIVTGNPL 342
L G L L S S L VL V+ N L
Sbjct: 61 NLDR--AELTKLQVDGTLPVL------GTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRL 112
Query: 343 DGILPKSIGNFSLSLETILMANCSISGNIPQVVGNLSNLLVLELGGNNLTGPIPVTFSQL 402
+ ++ E L N + P ++ L L L NNLT + L
Sbjct: 113 TSLPLGALRGLGELQELYLKGNE-LKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGL 171
Query: 403 QTLQAFDLTRNKLAGPITDELCHLARLHSLVLQGNKF 439
+ L L N L I L L GN +
Sbjct: 172 ENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.3 bits (103), Expect = 3e-05
Identities = 20/104 (19%), Positives = 30/104 (28%), Gaps = 3/104 (2%)
Query: 9 QHQQALLALKAHISYDHTNLFARNWTSSTSVCIWIGITCDVNSHRVIGLNISSFNLQGTI 68
L +L L + + G+ + ++++ NL
Sbjct: 107 VSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKL--SLANNNLTELP 164
Query: 69 TPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLDFSDNQL 112
L L +L TL L N L IP F H L N
Sbjct: 165 AGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.2 bits (100), Expect = 6e-05
Identities = 42/213 (19%), Positives = 63/213 (29%), Gaps = 16/213 (7%)
Query: 251 SLPNVETLNLGINSFSGTIPSSITNSSKLSDLELGENLFSGFIPNTIGNLRNLEFGNIAD 310
S V + + +P T L L ENL F T+ L N+ D
Sbjct: 11 SHLEVNCDKRNLTALPPDLPKDTTI------LHLSENLLYTFSLATLMPYTRLTQLNL-D 63
Query: 311 NYLTSSTPELSFLSSLTNCKKLKVLIVTGNPLDGILPKSIGNFSLSLETILMANCSISGN 370
+ L L + + L LP ++ ++
Sbjct: 64 RAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLD--------VSFNRLTSL 115
Query: 371 IPQVVGNLSNLLVLELGGNNLTGPIPVTFSQLQTLQAFDLTRNKLAGPITDELCHLARLH 430
+ L L L L GN L P + L+ L N L L L L
Sbjct: 116 PLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLD 175
Query: 431 SLVLQGNKFSGSIPSCLGNLTSVRVLYLGLNIF 463
+L+LQ N +IP + +L N +
Sbjct: 176 TLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 51.7 bits (123), Expect = 5e-08
Identities = 22/135 (16%), Positives = 35/135 (25%), Gaps = 48/135 (35%)
Query: 640 NGMEVAVKVFH----------QQYERALKSFEDECEVRKRIRHRNLVK------------ 677
E VK ++ + F R R L K
Sbjct: 23 KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82
Query: 678 -------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVA 712
++ LE + + I+H DL NVL+ E+ +
Sbjct: 83 EGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEEGI- 141
Query: 713 HISDFGIAKLLSGED 727
I DF + + E
Sbjct: 142 WIIDFPQSVEVGEEG 156
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 52.7 bits (124), Expect = 1e-07
Identities = 21/96 (21%), Positives = 37/96 (38%), Gaps = 6/96 (6%)
Query: 98 NMHTLKLLDFSDNQL----FGSLSSFIFNMSSMTTIDLSINRLSGELPANICKIPSTLSK 153
L++L +D + SL++ + S+ +DLS N L + + S
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVE--SVRQP 424
Query: 154 CKQLEELNLGFNNLSGAIPKEIGNLTKLKEIISTIT 189
LE+L L S + + L K K + I+
Sbjct: 425 GCLLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVIS 460
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.4 bits (118), Expect = 6e-07
Identities = 15/80 (18%), Positives = 26/80 (32%), Gaps = 4/80 (5%)
Query: 102 LKLLDFSDNQL-FGSLSSFIFNMSSMTTIDLSINRLSGELPANICKIPSTLSKCKQLEEL 160
++ LD +L + + + + L L+ +I S L L EL
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDIS---SALRVNPALAEL 60
Query: 161 NLGFNNLSGAIPKEIGNLTK 180
NL N L + +
Sbjct: 61 NLRSNELGDVGVHCVLQGLQ 80
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.1 bits (107), Expect = 1e-05
Identities = 16/92 (17%), Positives = 29/92 (31%), Gaps = 10/92 (10%)
Query: 57 LNISSFNLQGT------ITPQLGNLSSLQTLDLSHNKLSG----NIPSSIFNMHTLKLLD 106
L+I S ++Q L L Q + L L+ +I S++ L L+
Sbjct: 2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 61
Query: 107 FSDNQLFGSLSSFIFNMSSMTTIDLSINRLSG 138
N+L + + + L
Sbjct: 62 LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.6 bits (103), Expect = 3e-05
Identities = 13/73 (17%), Positives = 26/73 (35%), Gaps = 8/73 (10%)
Query: 117 SSFIFNMSSMTTIDLSINRLSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKEIG 176
S + + L+ +S + + +TL L EL+L N L A ++
Sbjct: 362 QGLGQPGSVLRVLWLADCDVSDS---SCSSLAATLLANHSLRELDLSNNCLGDAGILQLV 418
Query: 177 -----NLTKLKEI 184
L+++
Sbjct: 419 ESVRQPGCLLEQL 431
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.4 bits (100), Expect = 8e-05
Identities = 15/87 (17%), Positives = 30/87 (34%), Gaps = 5/87 (5%)
Query: 354 SLSLETILMANCSISGN-IPQVVGNLSNLLVLELGGNNLTG----PIPVTFSQLQTLQAF 408
SL ++++ + +S +++ L V+ L LT I L
Sbjct: 1 SLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAEL 60
Query: 409 DLTRNKLAGPITDELCHLARLHSLVLQ 435
+L N+L + + S +Q
Sbjct: 61 NLRSNELGDVGVHCVLQGLQTPSCKIQ 87
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.7 bits (93), Expect = 5e-04
Identities = 15/102 (14%), Positives = 29/102 (28%), Gaps = 9/102 (8%)
Query: 20 HISYDHTNLFARNWTSSTSVCIWIGITCDVNSHRVIGLNISSFNLQGT----ITPQLGNL 75
+ L N + + + L ++ ++ + + L
Sbjct: 337 AQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLAN 396
Query: 76 SSLQTLDLSHNKLSGNIPSSIF-----NMHTLKLLDFSDNQL 112
SL+ LDLS+N L + L+ L D
Sbjct: 397 HSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYW 438
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.0 bits (91), Expect = 0.001
Identities = 16/84 (19%), Positives = 33/84 (39%), Gaps = 5/84 (5%)
Query: 299 NLRNLEFGNIADNYLTSSTPELSFLSSLTNCKKLKVLIVTGNPLDGI----LPKSIGNFS 354
L +AD ++ S+ S ++L L+ L ++ N L L +S+
Sbjct: 367 PGSVLRVLWLADCDVSDSSCS-SLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPG 425
Query: 355 LSLETILMANCSISGNIPQVVGNL 378
LE +++ + S + + L
Sbjct: 426 CLLEQLVLYDIYWSEEMEDRLQAL 449
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.2 bits (89), Expect = 0.002
Identities = 10/75 (13%), Positives = 27/75 (36%), Gaps = 4/75 (5%)
Query: 230 LKEISLLNNSLSGSLPSRIDLSLPNVETLNLGINSFSG----TIPSSITNSSKLSDLELG 285
++ + + LS + + + L + + L + I S++ + L++L L
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 286 ENLFSGFIPNTIGNL 300
N + +
Sbjct: 64 SNELGDVGVHCVLQG 78
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.2 bits (89), Expect = 0.002
Identities = 15/84 (17%), Positives = 30/84 (35%), Gaps = 8/84 (9%)
Query: 226 NMSALKEISLLNNSLSGSLPSRIDLSL---PNVETLNLGINSFSGTIPSSI-----TNSS 277
S L+ + L + +S S S + +L ++ L+L N +
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426
Query: 278 KLSDLELGENLFSGFIPNTIGNLR 301
L L L + +S + + + L
Sbjct: 427 LLEQLVLYDIYWSEEMEDRLQALE 450
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.4 bits (87), Expect = 0.003
Identities = 20/118 (16%), Positives = 35/118 (29%), Gaps = 27/118 (22%)
Query: 125 SMTTIDLSINRLSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKEIGNLTKLKEI 184
+ ++D+ LS + L +Q + + L L+ A K+I +
Sbjct: 3 DIQSLDIQCEELSDA------RWAELLPLLQQCQVVRLDDCGLTEARCKDISSA------ 50
Query: 185 ISTITNSTVCEIPREIGNLPYLARLALATNNLVGVVPVTIFNMSALKEISLLNNSLSG 242
+ P LA L L +N L V + + SL
Sbjct: 51 ---------------LRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 49.4 bits (116), Expect = 9e-07
Identities = 18/110 (16%), Positives = 34/110 (30%), Gaps = 9/110 (8%)
Query: 40 CIWIGITCDVNSHRVIGLNISSFNLQGTITPQLGNLSSLQTLDLSHNKLSGNIPSSIFNM 99
+ + + I SL+ L++S+NKL +P+
Sbjct: 248 FLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPR- 305
Query: 100 HTLKLLDFSDNQLFGSLSSFIFNMSSMTTIDLSINRLSGELPANICKIPS 149
L+ L S N L+ ++ + + N L E P +
Sbjct: 306 --LERLIASFNH----LAEVPELPQNLKQLHVEYNPLR-EFPDIPESVED 348
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 47.9 bits (112), Expect = 3e-06
Identities = 19/94 (20%), Positives = 35/94 (37%), Gaps = 10/94 (10%)
Query: 214 NNLVGVVPVTIFNMSALKEISLLNNSLSGSLPSRIDLSLPNVETLNLGINSFSGTIPSSI 273
N + +L+E+++ NN L LP+ P +E L N + +P
Sbjct: 270 NASSNEIRSLCDLPPSLEELNVSNNKLI-ELPA----LPPRLERLIASFNHLA-EVPELP 323
Query: 274 TNSSKLSDLELGENLFSGFIPNTIGNLRNLEFGN 307
N L L + N P+ ++ +L +
Sbjct: 324 QN---LKQLHVEYNPLRE-FPDIPESVEDLRMNS 353
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 47.1 bits (110), Expect = 4e-06
Identities = 24/112 (21%), Positives = 43/112 (38%), Gaps = 17/112 (15%)
Query: 95 SIFNMHTLKLLDFSDNQLFGSLSSFIFNMSSMTTIDLSINRLSGELPANICKIPSTLSKC 154
+ L + N + S S+ +++S N+L ELPA +
Sbjct: 255 IFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPR-------- 305
Query: 155 KQLEELNLGFNNLSGAIPKEIGNLTKLKEIISTITNSTVCEIPREIGNLPYL 206
LE L FN+L+ +P+ NL +L + + + E P ++ L
Sbjct: 306 --LERLIASFNHLA-EVPELPQNLKQLH-----VEYNPLREFPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 39.8 bits (91), Expect = 0.001
Identities = 16/94 (17%), Positives = 31/94 (32%), Gaps = 5/94 (5%)
Query: 20 HISYDHTNLFARNWTSSTSVCIWIGITCDVNSHRVIGLNISSFNLQGT-ITPQLGNLSSL 78
N+F+ ++ + ++ S + ++ N+ + L
Sbjct: 247 TFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLIELPALPPRL 306
Query: 79 QTLDLSHNKLSGNIPSSIFNMHTLKLLDFSDNQL 112
+ L S N L+ +P N LK L N L
Sbjct: 307 ERLIASFNHLA-EVPELPQN---LKQLHVEYNPL 336
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 39.4 bits (90), Expect = 0.001
Identities = 16/79 (20%), Positives = 30/79 (37%), Gaps = 10/79 (12%)
Query: 328 NCKKLKVLIVTGNPLDGILPKSIGNFSLSLETILMANCSISGNIPQVVGNLSNLLVLELG 387
L+ L V+ N L + P LE ++ + ++ +P+ NL L +
Sbjct: 282 LPPSLEELNVSNNKLIEL-PALPPR----LERLIASFNHLA-EVPE---LPQNLKQLHVE 332
Query: 388 GNNLTGPIPVTFSQLQTLQ 406
N L P ++ L+
Sbjct: 333 YNPLRE-FPDIPESVEDLR 350
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 38.3 bits (87), Expect = 0.003
Identities = 13/61 (21%), Positives = 26/61 (42%), Gaps = 5/61 (8%)
Query: 76 SSLQTLDLSHNKLSGNIPSSIFNMHTLKLLDFSDNQLFGSLSSFIFNMSSMTTIDLSINR 135
L+L++ LS ++P + L+ L S N L L ++ S+ + ++
Sbjct: 38 RQAHELELNNLGLS-SLPELPPH---LESLVASCNSL-TELPELPQSLKSLLVDNNNLKA 92
Query: 136 L 136
L
Sbjct: 93 L 93
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 38.3 bits (87), Expect = 0.003
Identities = 19/87 (21%), Positives = 34/87 (39%), Gaps = 6/87 (6%)
Query: 389 NNLTGPIPVTFSQLQTLQAFDLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLG 448
N + I +L+ +++ NKL + RL L+ N + +P
Sbjct: 270 NASSNEIRSLCDLPPSLEELNVSNNKL----IELPALPPRLERLIASFNHLA-EVPELPQ 324
Query: 449 NLTSVRVLYLGLNIFTSVLSSTIWNLK 475
NL + V Y L F + S + +L+
Sbjct: 325 NLKQLHVEYNPLREFPDIPES-VEDLR 350
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.9 bits (105), Expect = 6e-06
Identities = 23/140 (16%), Positives = 41/140 (29%), Gaps = 7/140 (5%)
Query: 70 PQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLDFSDNQLFGSLSSFIFNMSSMTTI 129
Q N + LDL K+ I + + +DFSDN++ + + T+
Sbjct: 12 AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRK--LDGFPLLRRLKTL 68
Query: 130 DLSINRLSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKEIGNLTKLKEIISTIT 189
++ NR+ +P L L P I+
Sbjct: 69 LVNNNRICRIGEGLDQALPDLTELILTNNSL----VELGDLDPLASLKSLTYLCILRNPV 124
Query: 190 NSTVCEIPREIGNLPYLARL 209
+ I +P + L
Sbjct: 125 TNKKHYRLYVIYKVPQVRVL 144
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.2 bits (85), Expect = 0.003
Identities = 25/145 (17%), Positives = 48/145 (33%), Gaps = 11/145 (7%)
Query: 271 SSITNSSKLSDLELGENLFSGFIPNTIGNLRNLEFGNIADNYLTSSTPELSFLSSLTNCK 330
+ TN+ + +L+L I N L + + +DN + L +
Sbjct: 12 AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-------KLDGFPLLR 63
Query: 331 KLKVLIVTGNPLDGILPKSIGNFSLSLETILMANCSISGNIPQVVGNLSNLLVLELGGNN 390
+LK L+V N + I E IL N + + +L +L L + N
Sbjct: 64 RLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNP 123
Query: 391 ---LTGPIPVTFSQLQTLQAFDLTR 412
++ ++ D +
Sbjct: 124 VTNKKHYRLYVIYKVPQVRVLDFQK 148
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 44.9 bits (104), Expect = 3e-05
Identities = 43/321 (13%), Positives = 102/321 (31%), Gaps = 20/321 (6%)
Query: 102 LKLLDFSDNQLFGSLSSFIFNMSSMTTIDLSINRLSGELPANICKIPSTLSKCKQLEELN 161
LKL + S+ + + S+ I LS N + E + + ++ + E +
Sbjct: 10 LKLDAITTEDE-KSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSD 68
Query: 162 LGFNNLSGAIP-------KEIGNLTKLKEIISTITNSTVCEIPREIGNLPYLARLALATN 214
+ + IP + + KL + + I L L
Sbjct: 69 IFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYL 128
Query: 215 NLVGVVPVTIFNMSALKEISLLNNSLSGSLPSRIDLSLPNVETLNLGINSFSGTIPSSIT 274
+ G+ P ++ + +N + P R + N +
Sbjct: 129 HNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLL 188
Query: 275 NSSKLSDLELGENLFSGFIPNTIGNLRNLEFGNIADNYLTSSTPELSFLSSLTNCKKLKV 334
++ K+ + + + + L+ ++ DN T +L + L+
Sbjct: 189 HTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALA-IALKSWPNLRE 247
Query: 335 LIVTGNPLDGILPKSIGNF-----SLSLETILMANCSISGNIPQ-----VVGNLSNLLVL 384
L + L ++ + ++ L+T+ + I + + + + +LL L
Sbjct: 248 LGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFL 307
Query: 385 ELGGNNLTGPIPVTFSQLQTL 405
EL GN + +++ +
Sbjct: 308 ELNGNRFSE-EDDVVDEIREV 327
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 40.6 bits (93), Expect = 5e-04
Identities = 41/304 (13%), Positives = 81/304 (26%), Gaps = 17/304 (5%)
Query: 57 LNISSFNLQGTITPQLGNLSSLQTLDLSHNKLSGN----IPSSIFNMHTLKLLDFSDNQL 112
L+ + + ++ L S++ + LS N + + +I + L++ +FSD
Sbjct: 12 LDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFT 71
Query: 113 FGSLSSFIFNMSSMTTIDLSINRL-------SGELPANICKIPSTLSKCKQLEELNLGFN 165
+ + L +L + P + LSK LE L L N
Sbjct: 72 GRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNN 131
Query: 166 NLSGAIPKEIGNLTKLKEIISTITNSTVCEIPREIGNLPYLARLALATNNLVGVVPVTIF 225
L +I + + N+ N + +
Sbjct: 132 GLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTV 191
Query: 226 NMSALKEISLLNNSLSGSLPSRIDLSLPNVETLNLGINSFSGTIPSSITNSSKLSDLELG 285
M L + N + S + ++ + L +L L
Sbjct: 192 KMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLN 251
Query: 286 ENLFSGFIPNTIGN------LRNLEFGNIADNYLTSSTPELSFLSSLTNCKKLKVLIVTG 339
+ L S + + L+ + N + L L + G
Sbjct: 252 DCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNG 311
Query: 340 NPLD 343
N
Sbjct: 312 NRFS 315
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 39.1 bits (89), Expect = 0.002
Identities = 47/351 (13%), Positives = 96/351 (27%), Gaps = 44/351 (12%)
Query: 125 SMTTIDLSINRLSGELPANICKIPSTLSKCKQLEELNLGFNNLSG----AIPKEIGNLTK 180
S+ L ++ ++ E + + + L + ++E+ L N + + + I +
Sbjct: 4 SIEGKSLKLDAITTE---DEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKD 60
Query: 181 LKEI---------ISTITNSTVCEIPREIGNLPYLARLALATNNLVGVVPVTIFNMSALK 231
L+ + + + + + P L + L+ N K
Sbjct: 61 LEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQ-EPLIDFLSK 119
Query: 232 EISLLNNSLSGSLPSRIDLSLPNVETLNLGINSFSGTIPSSITNSSKLSDLELGENLFSG 291
L + L + + L +N + P + + LE G
Sbjct: 120 HTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWA 179
Query: 292 FIPNTIGNLRNLEFGNIADNYLTSSTPELSFLSSLTNCKKLKVLIVTGNPLDGILPKSIG 351
+ L ++ L L+ K L + T L
Sbjct: 180 KTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIAL 239
Query: 352 NFSLSLETILMANCSISGNIPQVVGN------LSNLLVLELGGNNLTGPIPVTFSQLQTL 405
+L + + +C +S V + L L L N + T +
Sbjct: 240 KSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTV--- 296
Query: 406 QAFDLTRNKLAGPITDELCHLARLHSLVLQGNKFS--GSIPSCLGNLTSVR 454
+ L L L GN+FS + + + S R
Sbjct: 297 ----------------IDEKMPDLLFLELNGNRFSEEDDVVDEIREVFSTR 331
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 38.3 bits (87), Expect = 0.003
Identities = 16/93 (17%), Positives = 32/93 (34%), Gaps = 22/93 (23%)
Query: 71 QLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLDFSDNQLFGSLSSFIFNMSSMTTID 130
LQTL L +N++ + ++ + M + ++
Sbjct: 268 SKLENIGLQTLRLQYNEIELDAVRTL-------------------KTVIDEKMPDLLFLE 308
Query: 131 LSINRLSGELPANICKIPSTLSKCK--QLEELN 161
L+ NR E + +I S +L+EL+
Sbjct: 309 LNGNRF-SEEDDVVDEIREVFSTRGRGELDELD 340
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 43.5 bits (101), Expect = 4e-05
Identities = 32/222 (14%), Positives = 71/222 (31%), Gaps = 15/222 (6%)
Query: 45 ITCDVNSHRVIGLNISSFNLQGTITPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKL 104
I D I + N+ T+T +L + TL ++ + ++ L
Sbjct: 12 IFPDPALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTT--IEGVQYLNNLIG 67
Query: 105 LDFSDNQLFGSLSSFIFNMSSMTTIDLSINRLSGELPANICKIPSTLSKCKQLEELNLGF 164
L+ DNQ+ + + + + + L+ + + L
Sbjct: 68 LELKDNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAG 127
Query: 165 NNLSGAIPKEIGNLTKLKEIISTITNSTV------CEIPREIGNLPYLARLALATNNLVG 218
+ + ++ +T + + + + NL L L N +
Sbjct: 128 LSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISD 187
Query: 219 VVPVTIFNMSALKEISLLNNSLSGSLPSRIDLSLPNVETLNL 260
+ P + ++ L E+ L NN +S P + N+ + L
Sbjct: 188 ISP--LASLPNLIEVHLKNNQISDVSPLA---NTSNLFIVTL 224
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 40.8 bits (94), Expect = 3e-04
Identities = 11/42 (26%), Positives = 21/42 (50%), Gaps = 3/42 (7%)
Query: 70 PQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLDFSDNQ 111
L +L +L + L +N++S P + N L ++ + NQ
Sbjct: 189 SPLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT-NQ 227
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 40.0 bits (92), Expect = 5e-04
Identities = 32/215 (14%), Positives = 70/215 (32%), Gaps = 11/215 (5%)
Query: 202 NLPYLARLALATNNLVGVVPVTIFNMSALKEISLLNNSLS-----GSLPSRIDLSLPNVE 256
L ++A +N+ V ++ + +S ++ L + I L L + +
Sbjct: 17 ALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTTIEGVQYLNNLIGLELKDNQ 74
Query: 257 TLNLGINSFSGTIPSSITNSSKLSDLELGENLFSGFIPNTIGNLRNLEFGNIADNYLTSS 316
+L I + + L ++ L S + + L
Sbjct: 75 ITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVL 134
Query: 317 TPELSFLSSLTNCKKLKVLIVTGNPLDGILPKSIGNFSLSLETILMANCSISGNIPQVVG 376
+L+ +++++ L L + + L T+ + IS P +
Sbjct: 135 YLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP--LA 192
Query: 377 NLSNLLVLELGGNNLTGPIPVTFSQLQTLQAFDLT 411
+L NL+ + L N ++ P + L LT
Sbjct: 193 SLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.8 bits (96), Expect = 1e-04
Identities = 10/77 (12%), Positives = 22/77 (28%)
Query: 40 CIWIGITCDVNSHRVIGLNISSFNLQGTITPQLGNLSSLQTLDLSHNKLSGNIPSSIFNM 99
I + + NL+ S LD+S ++ + N+
Sbjct: 165 IQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENL 224
Query: 100 HTLKLLDFSDNQLFGSL 116
L+ + + +L
Sbjct: 225 KKLRARSTYNLKKLPTL 241
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.6 bits (85), Expect = 0.003
Identities = 10/58 (17%), Positives = 19/58 (32%)
Query: 357 LETILMANCSISGNIPQVVGNLSNLLVLELGGNNLTGPIPVTFSQLQTLQAFDLTRNK 414
E L N ++ V S ++L++ + L+ L+A K
Sbjct: 179 DELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK 236
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.0 bits (95), Expect = 2e-04
Identities = 25/107 (23%), Positives = 45/107 (42%), Gaps = 3/107 (2%)
Query: 57 LNISSFNLQGTITPQLGNLSSLQTLDLSHNKLSG--NIPSSIFNMHTLKLLDFSDNQLFG 114
LN S ++ T+ N+ L +L+LS+N+L ++ S + LK+L+ S N+L
Sbjct: 47 LNRRS-SMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKS 105
Query: 115 SLSSFIFNMSSMTTIDLSINRLSGELPANICKIPSTLSKCKQLEELN 161
+ + L N LS I + + +L L+
Sbjct: 106 ERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRERFPKLLRLD 152
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.8 bits (92), Expect = 4e-04
Identities = 24/127 (18%), Positives = 45/127 (35%), Gaps = 8/127 (6%)
Query: 140 LPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKEIGNLTKLKEI-ISTITNSTVCEIPR 198
L + L LN ++++ + N+ +L + +S + ++
Sbjct: 27 LDLKGLRSDPDLVAQNIDVVLNRR-SSMAATLRIIEENIPELLSLNLSNNRLYRLDDMSS 85
Query: 199 EIGNLPYLARLALATNNLVGVVPVTIFNMSALKEISLLNNSLSGSLP------SRIDLSL 252
+ P L L L+ N L + L+E+ L NSLS + S I
Sbjct: 86 IVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRERF 145
Query: 253 PNVETLN 259
P + L+
Sbjct: 146 PKLLRLD 152
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 41.1 bits (95), Expect = 2e-04
Identities = 26/199 (13%), Positives = 67/199 (33%), Gaps = 12/199 (6%)
Query: 45 ITCDVNSHRVIGLNISSFNLQGTITPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKL 104
I D I N+ ++ +T L+S+ + +++ + I + +
Sbjct: 17 IFSDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSVQG--IQYLPNVTK 72
Query: 105 LDFSDNQL-----FGSLSSFIFNMSSMTTIDLSINRLSGELPANICKIPSTLSKCKQLEE 159
L + N+L +L + + + + + ++ + +S L
Sbjct: 73 LFLNGNKLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVH 132
Query: 160 LNLGFNNLSGA-IPKEIGNLTKLKEIISTITNSTVCEIPREIGNLPYLARLALATNNLVG 218
L + G +I L++L ++ + + L L L L+ N++
Sbjct: 133 LPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKNHISD 192
Query: 219 VVPVTIFNMSALKEISLLN 237
+ + + L + L +
Sbjct: 193 LRA--LAGLKNLDVLELFS 209
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 37.7 bits (86), Expect = 0.003
Identities = 19/92 (20%), Positives = 32/92 (34%), Gaps = 3/92 (3%)
Query: 20 HISYDHTNLFARNWTSSTSVCIWIGITCDVNSHRVIGLNISSFNLQGTITPQLGNLSSLQ 79
+ D L S + V S +S + Q + L L+ LQ
Sbjct: 122 NGISDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQ 181
Query: 80 TLDLSHNKLSGNIPSSIFNMHTLKLLDFSDNQ 111
L LS N +S ++ + L +L+ +Q
Sbjct: 182 NLYLSKNHISD--LRALAGLKNLDVLELF-SQ 210
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} Length = 198 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Score = 38.5 bits (88), Expect = 0.001
Identities = 16/62 (25%), Positives = 27/62 (43%), Gaps = 3/62 (4%)
Query: 123 MSSMTTIDLSINRLSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKEIGNLTKLK 182
S+ + L G +P I K+ +TLS K + L L NN+ I + + L+
Sbjct: 17 RKSVVATEAEKVELHGMIP-PIEKMDATLSTLKACKHLALSTNNIE-KIS-SLSGMENLR 73
Query: 183 EI 184
+
Sbjct: 74 IL 75
|
Homologous Domains Detected by HHsearch 
Original result of HHsearch against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 823 | |||
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 100.0 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.97 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 99.96 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.96 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 99.96 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 99.96 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 99.96 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 99.96 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 99.96 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 99.96 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 99.96 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 99.96 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 99.96 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 99.96 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 99.96 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 99.96 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 99.96 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 99.95 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 99.95 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 99.95 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 99.95 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 99.95 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 99.95 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 99.95 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 99.95 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 99.95 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 99.95 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 99.95 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 99.95 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 99.94 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 99.94 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.94 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 99.94 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 99.94 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 99.94 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 99.94 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 99.94 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 99.94 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.94 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 99.94 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.94 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 99.94 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 99.93 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 99.93 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 99.93 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 99.93 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 99.93 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 99.93 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.93 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 99.93 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 99.93 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 99.93 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 99.93 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 99.93 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 99.92 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 99.92 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 99.92 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 99.92 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 99.92 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 99.92 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 99.92 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 99.91 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 99.91 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 99.91 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 99.91 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 99.9 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 99.9 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 99.89 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.89 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.89 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 99.85 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.84 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.84 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.8 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.79 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.79 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.77 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.77 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.76 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.75 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.74 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.73 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.71 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.71 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.71 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.56 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.54 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.51 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.5 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.5 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.49 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.48 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.48 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.47 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.32 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.3 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.27 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.25 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.52 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.45 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.76 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.58 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 97.09 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 96.84 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 92.73 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 88.55 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 81.64 |
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=100.00 E-value=1.2e-45 Score=395.17 Aligned_cols=297 Identities=31% Similarity=0.484 Sum_probs=259.5
Q ss_pred chHHHHHHHHHHHHhccCCCccccccccCCCCCCcc--ceeeeeCCCC--CcEEEEEcCCCCCcc--ccCcccCCCCCCc
Q 045449 6 IISQHQQALLALKAHISYDHTNLFARNWTSSTSVCI--WIGITCDVNS--HRVIGLNISSFNLQG--TITPQLGNLSSLQ 79 (823)
Q Consensus 6 ~~~~~~~aLl~~k~~~~~~~~~~~~~~W~~~~~~c~--w~gv~c~~~~--~~v~~L~L~~~~l~g--~~~~~l~~l~~L~ 79 (823)
|+++||+|||+||+++.+ | ..++ +|..++|||. |.||+|+..+ +||++|||+++++.| .+|+++++|++|+
T Consensus 3 c~~~e~~aLl~~k~~~~~-~-~~l~-sW~~~~d~C~~~w~gv~C~~~~~~~~v~~L~L~~~~l~g~~~lp~~l~~L~~L~ 79 (313)
T d1ogqa_ 3 CNPQDKQALLQIKKDLGN-P-TTLS-SWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLN 79 (313)
T ss_dssp SCHHHHHHHHHHHHHTTC-C-GGGT-TCCTTSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCS
T ss_pred CCHHHHHHHHHHHHHCCC-C-CcCC-CCCCCCCCCCCcCCCeEEeCCCCcEEEEEEECCCCCCCCCCCCChHHhcCcccc
Confidence 899999999999999864 4 3566 9999999994 9999998754 489999999999998 5889999999999
Q ss_pred EEEccC-CCCCCCCCCCCCCCCCCCEEECCCCcCcCCCchhhhcCCCCcEEecccccccCccCccccCCCCCCccccccc
Q 045449 80 TLDLSH-NKLSGNIPSSIFNMHTLKLLDFSDNQLFGSLSSFIFNMSSMTTIDLSINRLSGELPANICKIPSTLSKCKQLE 158 (823)
Q Consensus 80 ~L~Ls~-N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~p~~~~~l~~L~ 158 (823)
+|||++ |+++|.+|.+|+++++|++|||++|+|.+..+..+..+.+|+++++++|++.+.+|..+ .++++|+
T Consensus 80 ~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l-------~~l~~L~ 152 (313)
T d1ogqa_ 80 FLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSI-------SSLPNLV 152 (313)
T ss_dssp EEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGG-------GGCTTCC
T ss_pred ccccccccccccccccccccccccchhhhccccccccccccccchhhhcccccccccccccCchhh-------ccCcccc
Confidence 999996 89999999999999999999999999999999999999999999999999998887776 8899999
Q ss_pred eeeeccceeeccCccccccchhhHHHHHhhcCCCcccCCcccCCcchhhhhccccccccCCccccccCCCCCcEEEccCC
Q 045449 159 ELNLGFNNLSGAIPKEIGNLTKLKEIISTITNSTVCEIPREIGNLPYLARLALATNNLVGVVPVTIFNMSALKEISLLNN 238 (823)
Q Consensus 159 ~L~Ls~N~l~~~~p~~l~~l~~L~~L~~l~~n~~~~~ip~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 238 (823)
++++++|.++|.+|..+..+.++........|.+.+..|..+.++..+ .++++.+.+.+.+|..+..+++++.+++++|
T Consensus 153 ~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~-~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~ 231 (313)
T d1ogqa_ 153 GITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLA-FVDLSRNMLEGDASVLFGSDKNTQKIHLAKN 231 (313)
T ss_dssp EEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCS-EEECCSSEEEECCGGGCCTTSCCSEEECCSS
T ss_pred eeeccccccccccccccccccccccccccccccccccccccccccccc-ccccccccccccccccccccccccccccccc
Confidence 999999999999999998888764333367788888888888877655 6888888888888888888899999999999
Q ss_pred cccccCCcccccCCCCccEEEeeccccccccCccccCCCCCCeEEeecccccccCCCccCCCcccCcccccCcc-ccCC
Q 045449 239 SLSGSLPSRIDLSLPNVETLNLGINSFSGTIPSSITNSSKLSDLELGENLFSGFIPNTIGNLRNLEFGNIADNY-LTSS 316 (823)
Q Consensus 239 ~l~g~lp~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~-l~~~ 316 (823)
.+++.+|. +. .+++|++|+|++|+|+|.+|..|+++++|++|+|++|+|+|.+|. ++++++|+.+++++|+ +.|.
T Consensus 232 ~l~~~~~~-~~-~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~-~~~L~~L~~l~l~~N~~l~g~ 307 (313)
T d1ogqa_ 232 SLAFDLGK-VG-LSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANNKCLCGS 307 (313)
T ss_dssp EECCBGGG-CC-CCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCC-STTGGGSCGGGTCSSSEEEST
T ss_pred cccccccc-cc-cccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCC-cccCCCCCHHHhCCCccccCC
Confidence 98876653 43 378899999999999988999999999999999999999988874 6788889989888887 4553
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=100.00 E-value=8.7e-33 Score=294.76 Aligned_cols=255 Identities=27% Similarity=0.461 Sum_probs=194.3
Q ss_pred CccEEEeecccccc--ccCccccCCCCCCeEEeec-ccccccCCCccCCCcccCcccccCccccCCCCcccccccccCCC
Q 045449 254 NVETLNLGINSFSG--TIPSSITNSSKLSDLELGE-NLFSGFIPNTIGNLRNLEFGNIADNYLTSSTPELSFLSSLTNCK 330 (823)
Q Consensus 254 ~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~ 330 (823)
.++.|||++|.++| .+|..++++++|++|+|++ |+++|.+|..|+++++|++|+|+
T Consensus 51 ~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls--------------------- 109 (313)
T d1ogqa_ 51 RVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYIT--------------------- 109 (313)
T ss_dssp CEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEE---------------------
T ss_pred EEEEEECCCCCCCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhc---------------------
Confidence 57777777777776 4667777777777777775 67777766666555555555554
Q ss_pred CceEEEeecCCCCccCCccccccccccceEEecCCcceeccCccccCcccccEEEcccCcCCCCchhcccccCCC-CEEE
Q 045449 331 KLKVLIVTGNPLDGILPKSIGNFSLSLETILMANCSISGNIPQVVGNLSNLLVLELGGNNLTGPIPVTFSQLQTL-QAFD 409 (823)
Q Consensus 331 ~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L-~~L~ 409 (823)
+|++.+..|..+..+ ..|+++++++|.+.+.+|..+.+++.|+++++++|.++|.+|..+..+..+ +.++
T Consensus 110 --------~N~l~~~~~~~~~~~-~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~ 180 (313)
T d1ogqa_ 110 --------HTNVSGAIPDFLSQI-KTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMT 180 (313)
T ss_dssp --------EECCEEECCGGGGGC-TTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEE
T ss_pred --------cccccccccccccch-hhhcccccccccccccCchhhccCcccceeeccccccccccccccccccccccccc
Confidence 455555555555555 567777777777777777777777888888888888887788777777665 7788
Q ss_pred ccCCCCCCcchHhhhcCCCCCEEEcccCcCcccccccccCCCCCCeEeccCCccccccchhhhccCCCcEEecccccccc
Q 045449 410 LTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSVRVLYLGLNIFTSVLSSTIWNLKDILFIDVSSNFLDG 489 (823)
Q Consensus 410 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~LdLs~N~l~g 489 (823)
+++|+++|..|..+..+..+ .+++++|.+.|.+|..+..+++++.+++++|.+++.+| .++.+++|+.|||++|+++|
T Consensus 181 ~~~n~l~~~~~~~~~~l~~~-~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g 258 (313)
T d1ogqa_ 181 ISRNRLTGKIPPTFANLNLA-FVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYG 258 (313)
T ss_dssp CCSSEEEEECCGGGGGCCCS-EEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEE
T ss_pred cccccccccccccccccccc-cccccccccccccccccccccccccccccccccccccc-ccccccccccccCccCeecc
Confidence 88888888888777776544 68888888888888888888888888888888888655 57788888999999999998
Q ss_pred ccCccccCCCCCcEEEcccCCCCCCCCCcccCccCCCCCCCCCCCcccccCCcccCCCCC
Q 045449 490 PLSLDIGNLKVVIGLDFSRNNLSGDIPITIGEGEIPRGGPFANLTAKSFMGNELLCGLPD 549 (823)
Q Consensus 490 ~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~~~g~ip~~~~~~~~~~~~~~~n~~~c~~~~ 549 (823)
.+|..+++++.|++|||++|+|+|.| |..+.+..+...++.||+.+||.|.
T Consensus 259 ~iP~~l~~L~~L~~L~Ls~N~l~g~i---------P~~~~L~~L~~l~l~~N~~l~g~pl 309 (313)
T d1ogqa_ 259 TLPQGLTQLKFLHSLNVSFNNLCGEI---------PQGGNLQRFDVSAYANNKCLCGSPL 309 (313)
T ss_dssp CCCGGGGGCTTCCEEECCSSEEEEEC---------CCSTTGGGSCGGGTCSSSEEESTTS
T ss_pred cCChHHhCCCCCCEEECcCCcccccC---------CCcccCCCCCHHHhCCCccccCCCC
Confidence 89988999999999999999998544 4445677888888999999999875
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.97 E-value=1.6e-29 Score=277.04 Aligned_cols=123 Identities=26% Similarity=0.417 Sum_probs=56.1
Q ss_pred CcccccEEEcccCcCCCCchhcccccCCCCEEEccCCCCCCcchHhhhcCCCCCEEEcccCcCcccccccccCCCCCCeE
Q 045449 377 NLSNLLVLELGGNNLTGPIPVTFSQLQTLQAFDLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSVRVL 456 (823)
Q Consensus 377 ~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L 456 (823)
.+++|++|++++|++++..+ +..+..++.+++++|++++. ..+..+++++.|++++|++++..| +..+++|++|
T Consensus 261 ~~~~L~~L~l~~~~l~~~~~--~~~~~~l~~l~~~~n~l~~~--~~~~~~~~l~~L~ls~n~l~~l~~--l~~l~~L~~L 334 (384)
T d2omza2 261 GLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDI--SPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRL 334 (384)
T ss_dssp TCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCC--GGGGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEE
T ss_pred ccccCCEeeccCcccCCCCc--cccccccccccccccccccc--cccchhcccCeEECCCCCCCCCcc--cccCCCCCEE
Confidence 33444444444444443221 33444444444444444432 123444444455555554443321 4444455555
Q ss_pred eccCCccccccchhhhccCCCcEEeccccccccccCccccCCCCCcEEEcccC
Q 045449 457 YLGLNIFTSVLSSTIWNLKDILFIDVSSNFLDGPLSLDIGNLKVVIGLDFSRN 509 (823)
Q Consensus 457 ~Ls~N~l~~~~p~~~~~l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~ls~N 509 (823)
++++|++++. + .+.++++|++||+++|++++..| +.+++.|+.|+|++|
T Consensus 335 ~L~~n~l~~l-~-~l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~L~~N 383 (384)
T d2omza2 335 FFANNKVSDV-S-SLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383 (384)
T ss_dssp ECCSSCCCCC-G-GGGGCTTCCEEECCSSCCCBCGG--GTTCTTCSEEECCCE
T ss_pred ECCCCCCCCC-h-hHcCCCCCCEEECCCCcCCCChh--hccCCCCCEeeCCCC
Confidence 5555554442 1 34455555555555555554433 445555555555554
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=2.4e-32 Score=283.09 Aligned_cols=152 Identities=26% Similarity=0.371 Sum_probs=128.0
Q ss_pred ccCCccceeeccC------------CeEEEEEEehHhh-HHHHHHHHHHHHHHhhcchhhHHH-----------------
Q 045449 628 DRFSENNLIGIGN------------GMEVAVKVFHQQY-ERALKSFEDECEVRKRIRHRNLVK----------------- 677 (823)
Q Consensus 628 ~~f~~~~~lg~g~------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~----------------- 677 (823)
++|+..+.||+|+ |+.||||++.... ....+.|.+|++++++++|||||+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy 84 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 84 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence 5688888999886 6779999986543 334567999999999999999999
Q ss_pred -----------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccc
Q 045449 678 -----------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQ 734 (823)
Q Consensus 678 -----------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 734 (823)
++.|++.+|+|+|+.+|+||||||+|||++.++.+||+|||+|+.............
T Consensus 85 ~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~~~~ 164 (271)
T d1nvra_ 85 CSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 164 (271)
T ss_dssp CTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECCBCC
T ss_pred cCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCccccccc
Confidence 578999999999999999999999999999999999999999998754443334456
Q ss_pred cccCCCcCcccccCCCcc-ccccceehhhhhhccccCCCCCcCCCc
Q 045449 735 TLATIGYMAPEYGTKGRV-STRGDVCSFGIISGGKETRSMTVGETC 779 (823)
Q Consensus 735 ~~gt~~y~aPE~~~~~~~-~~~~Dv~S~Gvv~~~~~~~~~~~~~~~ 779 (823)
.+||+.|||||++.+..+ +.++||||+||++|+|++|..||....
T Consensus 165 ~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~ 210 (271)
T d1nvra_ 165 MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS 210 (271)
T ss_dssp CCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSS
T ss_pred eeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCC
Confidence 789999999999988776 678999999999999999999996643
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.96 E-value=7.9e-29 Score=271.49 Aligned_cols=340 Identities=23% Similarity=0.301 Sum_probs=210.1
Q ss_pred cEEEEEcCCCCCccccCcccCCCCCCcEEEccCCCCCCCCCCCCCCCCCCCEEECCCCcCcCCCchhhhcCCCCcEEecc
Q 045449 53 RVIGLNISSFNLQGTITPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLDFSDNQLFGSLSSFIFNMSSMTTIDLS 132 (823)
Q Consensus 53 ~v~~L~L~~~~l~g~~~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 132 (823)
.+++|++++++++. + +.+..|++|++|||++|+|++.. .|+++++|++|+|++|.|.+..+ ++++++|+.|+++
T Consensus 45 ~l~~L~l~~~~I~~-l-~gl~~L~nL~~L~Ls~N~l~~l~--~l~~L~~L~~L~L~~n~i~~i~~--l~~l~~L~~L~~~ 118 (384)
T d2omza2 45 QVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLTDIT--PLKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLF 118 (384)
T ss_dssp TCCEEECCSSCCCC-C-TTGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECC
T ss_pred CCCEEECCCCCCCC-c-cccccCCCCCEEeCcCCcCCCCc--cccCCcccccccccccccccccc--ccccccccccccc
Confidence 57888888888774 3 35777888888888888888543 38888888888888888876543 7788888888888
Q ss_pred cccccCccCccccCCCCCCccccccceeeeccceeeccCccccccchhhHHHHHhhcCCCcccCCcccCCcchhhhhccc
Q 045449 133 INRLSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKEIGNLTKLKEIISTITNSTVCEIPREIGNLPYLARLALA 212 (823)
Q Consensus 133 ~N~l~~~~p~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~~l~~n~~~~~ip~~l~~l~~L~~L~Ls 212 (823)
+|.+++..+. .....+..+....|.+....+.......... ....
T Consensus 119 ~~~~~~~~~~---------~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~-------------------------~~~~- 163 (384)
T d2omza2 119 NNQITDIDPL---------KNLTNLNRLELSSNTISDISALSGLTSLQQL-------------------------SFGN- 163 (384)
T ss_dssp SSCCCCCGGG---------TTCTTCSEEEEEEEEECCCGGGTTCTTCSEE-------------------------EEEE-
T ss_pred cccccccccc---------ccccccccccccccccccccccccccccccc-------------------------cccc-
Confidence 8887754332 3345667777777776533222111111000 0000
Q ss_pred cccccCCccccccCCCCCcEEEccCCcccccCCcccccCCCCccEEEeeccccccccCccccCCCCCCeEEeeccccccc
Q 045449 213 TNNLVGVVPVTIFNMSALKEISLLNNSLSGSLPSRIDLSLPNVETLNLGINSFSGTIPSSITNSSKLSDLELGENLFSGF 292 (823)
Q Consensus 213 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 292 (823)
.......+...+.........|... ...... .+++++.+++++|.+++..| +...++|+.|++++|+++..
T Consensus 164 ----~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~-~l~~~~~l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~~~ 234 (384)
T d2omza2 164 ----QVTDLKPLANLTTLERLDISSNKVS--DISVLA-KLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI 234 (384)
T ss_dssp ----SCCCCGGGTTCTTCCEEECCSSCCC--CCGGGG-GCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC
T ss_pred ----ccchhhhhccccccccccccccccc--cccccc-cccccceeeccCCccCCCCc--ccccCCCCEEECCCCCCCCc
Confidence 0001112222333333333333332 111111 24555555555555554433 23445555666666655532
Q ss_pred CCCccCCCcccCcccccCccccCCCCcccccccccCCCCceEEEeecCCCCccCCccccccccccceEEecCCcceeccC
Q 045449 293 IPNTIGNLRNLEFGNIADNYLTSSTPELSFLSSLTNCKKLKVLIVTGNPLDGILPKSIGNFSLSLETILMANCSISGNIP 372 (823)
Q Consensus 293 ~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~p 372 (823)
+.+..+++|+.|++++|.+++. ..+..+++|+.|++++|.+++..+ +..+ ..++.+.++.|.+++.
T Consensus 235 --~~l~~l~~L~~L~l~~n~l~~~-------~~~~~~~~L~~L~l~~~~l~~~~~--~~~~-~~l~~l~~~~n~l~~~-- 300 (384)
T d2omza2 235 --GTLASLTNLTDLDLANNQISNL-------APLSGLTKLTELKLGANQISNISP--LAGL-TALTNLELNENQLEDI-- 300 (384)
T ss_dssp --GGGGGCTTCSEEECCSSCCCCC-------GGGTTCTTCSEEECCSSCCCCCGG--GTTC-TTCSEEECCSSCCSCC--
T ss_pred --chhhcccccchhccccCccCCC-------CcccccccCCEeeccCcccCCCCc--cccc-cccccccccccccccc--
Confidence 2455555666666666665553 125556666666666666664422 3344 4667777777777652
Q ss_pred ccccCcccccEEEcccCcCCCCchhcccccCCCCEEEccCCCCCCcchHhhhcCCCCCEEEcccCcCcccccccccCCCC
Q 045449 373 QVVGNLSNLLVLELGGNNLTGPIPVTFSQLQTLQAFDLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTS 452 (823)
Q Consensus 373 ~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~ 452 (823)
..+..+++++.|++++|++++..+ +..+++|++|++++|+|++ ++ .+.++++|++|++++|++++..| +.++++
T Consensus 301 ~~~~~~~~l~~L~ls~n~l~~l~~--l~~l~~L~~L~L~~n~l~~-l~-~l~~l~~L~~L~l~~N~l~~l~~--l~~l~~ 374 (384)
T d2omza2 301 SPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD-VS-SLANLTNINWLSAGHNQISDLTP--LANLTR 374 (384)
T ss_dssp GGGGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECCSSCCCBCGG--GTTCTT
T ss_pred cccchhcccCeEECCCCCCCCCcc--cccCCCCCEEECCCCCCCC-Ch-hHcCCCCCCEEECCCCcCCCChh--hccCCC
Confidence 346777888888888888886543 7778888888888888885 33 57888888888888888887655 788888
Q ss_pred CCeEeccCCc
Q 045449 453 VRVLYLGLNI 462 (823)
Q Consensus 453 L~~L~Ls~N~ 462 (823)
|+.|+|++|.
T Consensus 375 L~~L~L~~Na 384 (384)
T d2omza2 375 ITQLGLNDQA 384 (384)
T ss_dssp CSEEECCCEE
T ss_pred CCEeeCCCCc
Confidence 8888888873
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=6.7e-32 Score=280.95 Aligned_cols=152 Identities=30% Similarity=0.415 Sum_probs=123.0
Q ss_pred ccCCccceeeccC---------CeEEEEEEehHh--hHHHHHHHHHHHHHHhhcchhhHHH-------------------
Q 045449 628 DRFSENNLIGIGN---------GMEVAVKVFHQQ--YERALKSFEDECEVRKRIRHRNLVK------------------- 677 (823)
Q Consensus 628 ~~f~~~~~lg~g~---------~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~------------------- 677 (823)
++|...+.||+|+ +..||||+++.. .....+.|.+|++++++++|||||+
T Consensus 8 ~~~~~~~~lG~G~fg~Vy~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~lv~Ey~~~ 87 (276)
T d1uwha_ 8 GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQLAIVTQWCEG 87 (276)
T ss_dssp TCCCCCSEEEECSSCEEEEEESSSEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEEEECCCE
T ss_pred ccEEEEEEEeeCCCcEEEEEEECCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEeccEEEEEEecCCC
Confidence 5677788999986 335999998643 2445678999999999999999998
Q ss_pred ---------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccc
Q 045449 678 ---------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTL 736 (823)
Q Consensus 678 ---------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~ 736 (823)
++.|++.+|+|+|+++||||||||+|||++.++.+||+|||+|+...............
T Consensus 88 g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~ 167 (276)
T d1uwha_ 88 SSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLS 167 (276)
T ss_dssp EEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC------------CC
T ss_pred CCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeeccccCCcccccccc
Confidence 46789999999999999999999999999999999999999998765444333445668
Q ss_pred cCCCcCcccccCC---CccccccceehhhhhhccccCCCCCcCCCc
Q 045449 737 ATIGYMAPEYGTK---GRVSTRGDVCSFGIISGGKETRSMTVGETC 779 (823)
Q Consensus 737 gt~~y~aPE~~~~---~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~~ 779 (823)
||+.|||||++.+ ..|+.++|||||||++||+++|+.||.+..
T Consensus 168 gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~ 213 (276)
T d1uwha_ 168 GSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN 213 (276)
T ss_dssp CCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred cCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCC
Confidence 9999999999864 358999999999999999999999997653
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=8e-32 Score=281.76 Aligned_cols=151 Identities=30% Similarity=0.435 Sum_probs=127.4
Q ss_pred ccCCccceeeccC------------CeEEEEEEehHhh---HHHHHHHHHHHHHHhhcchhhHHH---------------
Q 045449 628 DRFSENNLIGIGN------------GMEVAVKVFHQQY---ERALKSFEDECEVRKRIRHRNLVK--------------- 677 (823)
Q Consensus 628 ~~f~~~~~lg~g~------------~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~--------------- 677 (823)
++|+..+.||+|+ |+.||||++.... ....+.+.+|++++++++|||||+
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 5688889999986 6679999997543 233467999999999999999999
Q ss_pred -------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccc
Q 045449 678 -------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQ 732 (823)
Q Consensus 678 -------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~ 732 (823)
+++|++.+|+|+|+.+|+||||||+|||+++++.+||+|||+|+.+.........
T Consensus 88 Ey~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~ 167 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARA 167 (288)
T ss_dssp CCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC--------
T ss_pred EccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCCccccc
Confidence 4679999999999999999999999999999999999999999987654433344
Q ss_pred cccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCCC
Q 045449 733 TQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 733 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
...+||+.|||||++.+..|+.++||||+||++|+|++|..||.+.
T Consensus 168 ~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~ 213 (288)
T d1uu3a_ 168 NSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG 213 (288)
T ss_dssp --CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCc
Confidence 5568999999999999999999999999999999999999999764
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=1.3e-31 Score=280.69 Aligned_cols=149 Identities=27% Similarity=0.384 Sum_probs=131.2
Q ss_pred ccCCccceeeccC------------CeEEEEEEehHhhHHHHHHHHHHHHHHhhcchhhHHH------------------
Q 045449 628 DRFSENNLIGIGN------------GMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVK------------------ 677 (823)
Q Consensus 628 ~~f~~~~~lg~g~------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------------ 677 (823)
++|...+.||+|+ |+.||||++........+.+.+|++++++++|||||+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 4688888899986 6779999997655445578999999999999999998
Q ss_pred ---------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccc
Q 045449 678 ---------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTL 736 (823)
Q Consensus 678 ---------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~ 736 (823)
++.|++.+|+|+|++||+||||||+|||++.++.+||+|||+|+....... .....+
T Consensus 100 ~gg~L~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~--~~~~~~ 177 (293)
T d1yhwa1 100 AGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KRSTMV 177 (293)
T ss_dssp TTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC--CBCCCC
T ss_pred CCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeeccccc--cccccc
Confidence 468999999999999999999999999999999999999999998654332 234568
Q ss_pred cCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCCC
Q 045449 737 ATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 737 gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
||+.|+|||++.+..|+.++||||+||++|+|++|..||.+.
T Consensus 178 gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~ 219 (293)
T d1yhwa1 178 GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNE 219 (293)
T ss_dssp SCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred cCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCC
Confidence 999999999999999999999999999999999999999764
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=1.5e-31 Score=276.04 Aligned_cols=147 Identities=24% Similarity=0.368 Sum_probs=128.9
Q ss_pred ccCCccceeeccC------------CeEEEEEEehHhh---HHHHHHHHHHHHHHhhcchhhHHH---------------
Q 045449 628 DRFSENNLIGIGN------------GMEVAVKVFHQQY---ERALKSFEDECEVRKRIRHRNLVK--------------- 677 (823)
Q Consensus 628 ~~f~~~~~lg~g~------------~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~--------------- 677 (823)
++|...+.||+|+ ++.||||++.... ....+.+.+|++++++++|||||+
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 5688888999986 6679999997543 223467899999999999999999
Q ss_pred -------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccc
Q 045449 678 -------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQ 732 (823)
Q Consensus 678 -------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~ 732 (823)
++.|++++|+|+|+.+|+||||||+|||++.++.+||+|||+|+...... .
T Consensus 86 Ey~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~----~ 161 (263)
T d2j4za1 86 EYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----R 161 (263)
T ss_dssp ECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC----C
T ss_pred eecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCCCc----c
Confidence 47899999999999999999999999999999999999999998764332 2
Q ss_pred cccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCCC
Q 045449 733 TQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 733 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
...+||+.|||||++.+..|+.++||||+||++|+|++|+.||.+.
T Consensus 162 ~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~ 207 (263)
T d2j4za1 162 TTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 207 (263)
T ss_dssp EETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred cccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCC
Confidence 3467999999999999999999999999999999999999999764
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.96 E-value=7.9e-31 Score=278.17 Aligned_cols=146 Identities=27% Similarity=0.330 Sum_probs=128.5
Q ss_pred ccCCccceeeccC------------CeEEEEEEehHhh---HHHHHHHHHHHHHHhhcchhhHHH---------------
Q 045449 628 DRFSENNLIGIGN------------GMEVAVKVFHQQY---ERALKSFEDECEVRKRIRHRNLVK--------------- 677 (823)
Q Consensus 628 ~~f~~~~~lg~g~------------~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~--------------- 677 (823)
++|+..+.||+|+ |+.||||+++... ....+.+.+|+.++++++|||||+
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 5678888899886 6779999997543 223568999999999999999998
Q ss_pred -------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccc
Q 045449 678 -------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQ 732 (823)
Q Consensus 678 -------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~ 732 (823)
++.|++.+|+|+|+++|+||||||+|||++.++.+||+|||+|+..... .
T Consensus 84 E~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~-----~ 158 (316)
T d1fota_ 84 DYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-----T 158 (316)
T ss_dssp CCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC-----B
T ss_pred eecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEeccc-----c
Confidence 4679999999999999999999999999999999999999999986432 2
Q ss_pred cccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCCC
Q 045449 733 TQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 733 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
...+||+.|||||++.+..|+.++||||+||++|+|++|..||.+.
T Consensus 159 ~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~ 204 (316)
T d1fota_ 159 YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDS 204 (316)
T ss_dssp CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred ccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCc
Confidence 3468999999999999999999999999999999999999999764
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.96 E-value=3.5e-31 Score=278.99 Aligned_cols=164 Identities=21% Similarity=0.384 Sum_probs=124.7
Q ss_pred cccCHHHHHHHhccCCc---------cceeeccC---------------CeEEEEEEehHh-hHHHHHHHHHHHHHHhhc
Q 045449 616 RRFSYHELLRATDRFSE---------NNLIGIGN---------------GMEVAVKVFHQQ-YERALKSFEDECEVRKRI 670 (823)
Q Consensus 616 ~~~~~~~l~~at~~f~~---------~~~lg~g~---------------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l 670 (823)
..++|++..+|+.+|.. .+.||+|+ ...||||++... .....++|.+|+++++++
T Consensus 5 d~~t~~d~~~a~~~f~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l 84 (299)
T d1jpaa_ 5 DPFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQF 84 (299)
T ss_dssp CGGGSSSHHHHHHHHSCBCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTC
T ss_pred CCCCHHHHHHHHhhhchhhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhC
Confidence 45788888888876653 46899987 124899988643 345567899999999999
Q ss_pred chhhHHH-----------------------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCC
Q 045449 671 RHRNLVK-----------------------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDED 709 (823)
Q Consensus 671 ~h~niv~-----------------------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~ 709 (823)
+|||||+ ++.|++++|+|+|+++|+||||||+|||++.+
T Consensus 85 ~HpnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~ 164 (299)
T d1jpaa_ 85 DHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSN 164 (299)
T ss_dssp CCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT
T ss_pred CCCCCccEEEEEeeCCEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCC
Confidence 9999998 46789999999999999999999999999999
Q ss_pred CcEEEeecccccccCCCCccc---cccccccCCCcCcccccCCCccccccceehhhhhhccccC-CCCCcCCCc
Q 045449 710 MVAHISDFGIAKLLSGEDQLS---KQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKET-RSMTVGETC 779 (823)
Q Consensus 710 ~~~kl~DfGla~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~-~~~~~~~~~ 779 (823)
+.+||+|||+|+......... ......||+.|||||++.++.|+.++|||||||++||+++ |+.||.+..
T Consensus 165 ~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~ 238 (299)
T d1jpaa_ 165 LVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMT 238 (299)
T ss_dssp CCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred CcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCC
Confidence 999999999999765433211 1223467999999999999999999999999999999997 889987653
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=3.9e-31 Score=274.06 Aligned_cols=150 Identities=23% Similarity=0.332 Sum_probs=119.2
Q ss_pred ccCCccceeeccC------------CeEEEEEEehHhh--HHHHHHHHHHHHHHhhcchhhHHH----------------
Q 045449 628 DRFSENNLIGIGN------------GMEVAVKVFHQQY--ERALKSFEDECEVRKRIRHRNLVK---------------- 677 (823)
Q Consensus 628 ~~f~~~~~lg~g~------------~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~---------------- 677 (823)
++|+..+.||+|+ |+.||||++.... +...+.|.+|++++++++|||||+
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 6788889999986 6779999986442 445678999999999999999998
Q ss_pred ------------------------------HHHHHHHHhhhcCCCC-----EEeccCCCCCEEeCCCCcEEEeecccccc
Q 045449 678 ------------------------------IISSSLEYLHFGHSIP-----IIHCDLKPSNVLLDEDMVAHISDFGIAKL 722 (823)
Q Consensus 678 ------------------------------~~~~~l~~L~~~h~~~-----ivHrdlk~~NiLl~~~~~~kl~DfGla~~ 722 (823)
++.|++.+|+|+|+.+ |+||||||+|||++.++.+||+|||+|+.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 3578888999999765 99999999999999999999999999998
Q ss_pred cCCCCccccccccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCCCc
Q 045449 723 LSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGETC 779 (823)
Q Consensus 723 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~~ 779 (823)
...... .....+||+.|||||++.+..|+.++|||||||++|+|++|..||.+..
T Consensus 164 ~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~ 218 (269)
T d2java1 164 LNHDTS--FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS 218 (269)
T ss_dssp C-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cccCCC--ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCC
Confidence 754322 2345689999999999999999999999999999999999999997643
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=7e-31 Score=273.06 Aligned_cols=148 Identities=26% Similarity=0.404 Sum_probs=125.4
Q ss_pred ccCCccceeeccC-----------CeEEEEEEehHhhHHHHHHHHHHHHHHhhcchhhHHH-------------------
Q 045449 628 DRFSENNLIGIGN-----------GMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVK------------------- 677 (823)
Q Consensus 628 ~~f~~~~~lg~g~-----------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------------- 677 (823)
++|...+.||+|+ +..||||+++... ...++|.+|++++++++|||||+
T Consensus 13 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~iv~Ey~~~ 91 (272)
T d1qpca_ 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYMEN 91 (272)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEEECCTT
T ss_pred HHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeeccCCeEEEEEeCCC
Confidence 4677778888886 5679999997543 23467999999999999999999
Q ss_pred ----------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCcccccccc
Q 045449 678 ----------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQT 735 (823)
Q Consensus 678 ----------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 735 (823)
++.|++++|+|+|+++|+||||||+|||+++++.+||+|||+|+....... ......
T Consensus 92 g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~-~~~~~~ 170 (272)
T d1qpca_ 92 GSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY-TAREGA 170 (272)
T ss_dssp CBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE-ECCTTC
T ss_pred CcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEccCCcc-cccccc
Confidence 467889999999999999999999999999999999999999998754332 233456
Q ss_pred ccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCC
Q 045449 736 LATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGE 777 (823)
Q Consensus 736 ~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~ 777 (823)
.||+.|||||++.++.|+.++|||||||++||++++..|+..
T Consensus 171 ~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~ 212 (272)
T d1qpca_ 171 KFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYP 212 (272)
T ss_dssp CCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred CCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCC
Confidence 799999999999988999999999999999999997665543
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=3.1e-31 Score=277.50 Aligned_cols=149 Identities=26% Similarity=0.322 Sum_probs=127.2
Q ss_pred ccCCccceeeccC------------CeEEEEEEehHhhHHHHHHHHHHHHHHhhcchhhHHH------------------
Q 045449 628 DRFSENNLIGIGN------------GMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVK------------------ 677 (823)
Q Consensus 628 ~~f~~~~~lg~g~------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------------ 677 (823)
+.|+..+.||+|+ +..||||++........+.|.+|++++++++|||||+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 4577778899886 6679999997655555678999999999999999999
Q ss_pred -----------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccc
Q 045449 678 -----------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQ 734 (823)
Q Consensus 678 -----------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 734 (823)
++.|++.+|+|+|+++|+||||||+|||++.++.+||+|||+|+...... .....
T Consensus 92 ~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~--~~~~~ 169 (288)
T d2jfla1 92 AGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--QRRDS 169 (288)
T ss_dssp TTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH--HHHTC
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCCc--ccccc
Confidence 46899999999999999999999999999999999999999998653221 12345
Q ss_pred cccCCCcCcccccC-----CCccccccceehhhhhhccccCCCCCcCCC
Q 045449 735 TLATIGYMAPEYGT-----KGRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 735 ~~gt~~y~aPE~~~-----~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
.+||+.|+|||++. ...|+.++||||+||++|+|++|..||.+.
T Consensus 170 ~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~ 218 (288)
T d2jfla1 170 FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHEL 218 (288)
T ss_dssp CCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred cccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCC
Confidence 68999999999874 456899999999999999999999999764
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=8.6e-31 Score=274.18 Aligned_cols=150 Identities=23% Similarity=0.413 Sum_probs=117.3
Q ss_pred ccCCccceeeccC-C---------------eEEEEEEehHhh-HHHHHHHHHHHHHHhhcchhhHHH-------------
Q 045449 628 DRFSENNLIGIGN-G---------------MEVAVKVFHQQY-ERALKSFEDECEVRKRIRHRNLVK------------- 677 (823)
Q Consensus 628 ~~f~~~~~lg~g~-~---------------~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~------------- 677 (823)
+.|...++||+|+ | ..||||++.... ....++|.+|++++++++|||||+
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 4577788899986 1 358999986543 444568999999999999999998
Q ss_pred ----------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCcc
Q 045449 678 ----------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQL 729 (823)
Q Consensus 678 ----------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~ 729 (823)
++.|++.+|+|+|+.+|+||||||+|||++.++.+||+|||+|+........
T Consensus 87 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~ 166 (283)
T d1mqba_ 87 ITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA 166 (283)
T ss_dssp EEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC----------
T ss_pred EEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhcccCCCcc
Confidence 3578899999999999999999999999999999999999999976543322
Q ss_pred -ccccccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCC
Q 045449 730 -SKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGE 777 (823)
Q Consensus 730 -~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~ 777 (823)
.......||+.|||||++.++.|+.++|||||||++||+.++..|+..
T Consensus 167 ~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~ 215 (283)
T d1mqba_ 167 TYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYW 215 (283)
T ss_dssp -------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred ceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccc
Confidence 122345689999999999999999999999999999999997666543
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=1.3e-30 Score=278.49 Aligned_cols=149 Identities=22% Similarity=0.280 Sum_probs=130.7
Q ss_pred ccCCccceeeccC------------CeEEEEEEehHhh---HHHHHHHHHHHHHHhhcchhhHHH---------------
Q 045449 628 DRFSENNLIGIGN------------GMEVAVKVFHQQY---ERALKSFEDECEVRKRIRHRNLVK--------------- 677 (823)
Q Consensus 628 ~~f~~~~~lg~g~------------~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~--------------- 677 (823)
++|...+.||+|+ |+.||||++++.. ....+.+.+|+.++++++|||||+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence 5788889999996 6779999997653 223467899999999999999998
Q ss_pred -------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccc
Q 045449 678 -------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQ 732 (823)
Q Consensus 678 -------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~ 732 (823)
+++|++.+|+|+|+++|+||||||+|||++.++.+||+|||+|+....... ..
T Consensus 85 ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~--~~ 162 (337)
T d1o6la_ 85 EYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TM 162 (337)
T ss_dssp ECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC--CB
T ss_pred eccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccCCc--cc
Confidence 478999999999999999999999999999999999999999997643322 23
Q ss_pred cccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCCC
Q 045449 733 TQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 733 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
...+||+.|+|||++.+..|+.++||||+||++|+|++|..||.+.
T Consensus 163 ~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~ 208 (337)
T d1o6la_ 163 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 208 (337)
T ss_dssp CCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCc
Confidence 4578999999999999999999999999999999999999999765
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.96 E-value=4.8e-31 Score=276.22 Aligned_cols=148 Identities=26% Similarity=0.421 Sum_probs=125.6
Q ss_pred ccCCccceeeccC------------CeEEEEEEehHhhHHHHHHHHHHHHHHhhcchhhHHH------------------
Q 045449 628 DRFSENNLIGIGN------------GMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVK------------------ 677 (823)
Q Consensus 628 ~~f~~~~~lg~g~------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------------ 677 (823)
++|...+.||+|+ ++.||||+++.... ..++|.+|++++++++|||||+
T Consensus 17 ~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~ 95 (287)
T d1opja_ 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 95 (287)
T ss_dssp GGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc-hHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeecc
Confidence 4677778888886 67799999975532 3467999999999999999998
Q ss_pred ------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCcccccc
Q 045449 678 ------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQT 733 (823)
Q Consensus 678 ------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~ 733 (823)
++.|++.+|+|+|+++|+||||||+|||++.++.+||+|||+|+....... ....
T Consensus 96 ~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~-~~~~ 174 (287)
T d1opja_ 96 TYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY-TAHA 174 (287)
T ss_dssp TTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSS-EEET
T ss_pred cCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecCCCCc-eeec
Confidence 356899999999999999999999999999999999999999997654332 2334
Q ss_pred ccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCC
Q 045449 734 QTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGE 777 (823)
Q Consensus 734 ~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~ 777 (823)
...||+.|+|||++.++.|+.++|||||||++||++++..|+..
T Consensus 175 ~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~ 218 (287)
T d1opja_ 175 GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYP 218 (287)
T ss_dssp TEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred cccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCC
Confidence 45689999999999999999999999999999999997766543
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.96 E-value=9.7e-31 Score=276.33 Aligned_cols=145 Identities=28% Similarity=0.375 Sum_probs=125.7
Q ss_pred ccCCccceeeccC------------CeEEEEEEehHh---hHHHHHHHHHHHHHHhhcchhhHHH---------------
Q 045449 628 DRFSENNLIGIGN------------GMEVAVKVFHQQ---YERALKSFEDECEVRKRIRHRNLVK--------------- 677 (823)
Q Consensus 628 ~~f~~~~~lg~g~------------~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~--------------- 677 (823)
+.|+..+.||+|+ ++.||||++... .....+.|.+|++++++++|||||+
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 4577788899986 677999998643 2445578999999999999999999
Q ss_pred -------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccc
Q 045449 678 -------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQ 732 (823)
Q Consensus 678 -------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~ 732 (823)
++.|++.+|+|+|+.+|+||||||+|||++.++.+||+|||+|+.... .
T Consensus 95 E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~------~ 168 (309)
T d1u5ra_ 95 EYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------A 168 (309)
T ss_dssp ECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS------B
T ss_pred EecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCC------C
Confidence 478999999999999999999999999999999999999999987542 2
Q ss_pred cccccCCCcCcccccCC---CccccccceehhhhhhccccCCCCCcCCC
Q 045449 733 TQTLATIGYMAPEYGTK---GRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 733 ~~~~gt~~y~aPE~~~~---~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
...+||+.|||||++.+ +.|+.++|||||||++|++++|..||.+.
T Consensus 169 ~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~ 217 (309)
T d1u5ra_ 169 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 217 (309)
T ss_dssp CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCC
Confidence 34579999999999854 46899999999999999999999999764
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=5.5e-30 Score=265.30 Aligned_cols=143 Identities=28% Similarity=0.370 Sum_probs=120.9
Q ss_pred CccceeeccC------------CeEEEEEEehHhh--HHHHHHHHHHHHHHhhcchhhHHH-------------------
Q 045449 631 SENNLIGIGN------------GMEVAVKVFHQQY--ERALKSFEDECEVRKRIRHRNLVK------------------- 677 (823)
Q Consensus 631 ~~~~~lg~g~------------~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~------------------- 677 (823)
...+.||+|+ +..||||++.... ....+.|.+|++++++++|||||+
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 3445788886 5679999986543 445678999999999999999998
Q ss_pred -------------------------HHHHHHHHhhhcCCCC--EEeccCCCCCEEeC-CCCcEEEeecccccccCCCCcc
Q 045449 678 -------------------------IISSSLEYLHFGHSIP--IIHCDLKPSNVLLD-EDMVAHISDFGIAKLLSGEDQL 729 (823)
Q Consensus 678 -------------------------~~~~~l~~L~~~h~~~--ivHrdlk~~NiLl~-~~~~~kl~DfGla~~~~~~~~~ 729 (823)
++.|++.+|+|+|+++ |+||||||+|||++ .++.+||+|||+|+.....
T Consensus 92 E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~--- 168 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS--- 168 (270)
T ss_dssp ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT---
T ss_pred eCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccCC---
Confidence 3679999999999988 99999999999997 5789999999999864332
Q ss_pred ccccccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCCC
Q 045449 730 SKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 730 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
.....+||+.|||||++.+ .|+.++||||+||++|+|++|+.||.+.
T Consensus 169 -~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~ 215 (270)
T d1t4ha_ 169 -FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSEC 215 (270)
T ss_dssp -SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred -ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCc
Confidence 2235689999999998865 6999999999999999999999999764
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.95 E-value=2.4e-30 Score=278.29 Aligned_cols=146 Identities=23% Similarity=0.313 Sum_probs=128.9
Q ss_pred ccCCccceeeccC------------CeEEEEEEehHhhH---HHHHHHHHHHHHHhhcchhhHHH---------------
Q 045449 628 DRFSENNLIGIGN------------GMEVAVKVFHQQYE---RALKSFEDECEVRKRIRHRNLVK--------------- 677 (823)
Q Consensus 628 ~~f~~~~~lg~g~------------~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~--------------- 677 (823)
++|...+.||+|+ |+.||||++..... ...+.+.+|++++++++|||||+
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 5788888999986 67799999975432 23467899999999999999998
Q ss_pred -------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccc
Q 045449 678 -------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQ 732 (823)
Q Consensus 678 -------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~ 732 (823)
++.|++.+|+|+|+.+||||||||+|||++.++.+||+|||+|+..... .
T Consensus 121 e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~-----~ 195 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----T 195 (350)
T ss_dssp ECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-----B
T ss_pred ccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeecccc-----c
Confidence 4789999999999999999999999999999999999999999986532 2
Q ss_pred cccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCCC
Q 045449 733 TQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 733 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
....||+.|||||++.+..|+.++||||+||++|+|++|..||.+.
T Consensus 196 ~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~ 241 (350)
T d1rdqe_ 196 WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD 241 (350)
T ss_dssp CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCc
Confidence 3467999999999999999999999999999999999999999764
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=1.5e-30 Score=269.16 Aligned_cols=147 Identities=25% Similarity=0.352 Sum_probs=113.0
Q ss_pred ccCCccceeeccC-----------CeEEEEEEehHhhHHHHHHHHHHHHHHhhcchhhHHH-------------------
Q 045449 628 DRFSENNLIGIGN-----------GMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVK------------------- 677 (823)
Q Consensus 628 ~~f~~~~~lg~g~-----------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------------- 677 (823)
++|...+.||+|+ +..||||+++... ...++|.+|++++++++|||||+
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence 3566677888885 5679999997543 23367999999999999999999
Q ss_pred ----------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCcccccccc
Q 045449 678 ----------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQT 735 (823)
Q Consensus 678 ----------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 735 (823)
++.|++++|+|+|+.+|+||||||+|||++.++.+||+|||+|+....... ......
T Consensus 84 ~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~-~~~~~~ 162 (263)
T d1sm2a_ 84 HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TSSTGT 162 (263)
T ss_dssp TCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC-----------------
T ss_pred CCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCCc-eeecce
Confidence 367889999999999999999999999999999999999999987654332 223346
Q ss_pred ccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcC
Q 045449 736 LATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVG 776 (823)
Q Consensus 736 ~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~ 776 (823)
.||+.|+|||++.+..|+.++|||||||++||++++..|+.
T Consensus 163 ~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~ 203 (263)
T d1sm2a_ 163 KFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPY 203 (263)
T ss_dssp --CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred ecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCC
Confidence 79999999999999999999999999999999999654443
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=1.4e-30 Score=277.62 Aligned_cols=148 Identities=23% Similarity=0.332 Sum_probs=126.8
Q ss_pred hccCCccceeeccC------------CeEEEEEEehHhh-HHHHHHHHHHHHHHhhcchhhHHH----------------
Q 045449 627 TDRFSENNLIGIGN------------GMEVAVKVFHQQY-ERALKSFEDECEVRKRIRHRNLVK---------------- 677 (823)
Q Consensus 627 t~~f~~~~~lg~g~------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~---------------- 677 (823)
.++|+..+.||+|+ |+.||||+++... ....+++.+|++++++++|||||+
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE 84 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 46788889999986 6779999986432 334578999999999999999999
Q ss_pred ------------------------HHHHHHHHhhhcCC-CCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccc
Q 045449 678 ------------------------IISSSLEYLHFGHS-IPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQ 732 (823)
Q Consensus 678 ------------------------~~~~~l~~L~~~h~-~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~ 732 (823)
++.|++.+|+|+|+ .+|+||||||+|||++.++.+||+|||+|+..... ..
T Consensus 85 y~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~----~~ 160 (322)
T d1s9ja_ 85 HMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MA 160 (322)
T ss_dssp CCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH----TC
T ss_pred cCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCC----cc
Confidence 46789999999997 59999999999999999999999999999976422 23
Q ss_pred cccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCCC
Q 045449 733 TQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 733 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
...+||+.|||||++.+..|+.++||||+||++|||++|+.||...
T Consensus 161 ~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~ 206 (322)
T d1s9ja_ 161 NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP 206 (322)
T ss_dssp ---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCC
T ss_pred ccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 4568999999999999999999999999999999999999999653
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=4.5e-30 Score=268.17 Aligned_cols=139 Identities=23% Similarity=0.339 Sum_probs=119.3
Q ss_pred CeEEEEEEehHhh-HHHHHHHHHHHHHHhhcchhhHHH----------------------------------------HH
Q 045449 641 GMEVAVKVFHQQY-ERALKSFEDECEVRKRIRHRNLVK----------------------------------------II 679 (823)
Q Consensus 641 ~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~----------------------------------------~~ 679 (823)
+..||||+++... ....++|.+|++++++++|||||+ ++
T Consensus 36 ~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~ 115 (285)
T d1u59a_ 36 QIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELL 115 (285)
T ss_dssp CEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHH
T ss_pred cEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccCeEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHH
Confidence 3469999996543 445678999999999999999998 46
Q ss_pred HHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCcc-ccccccccCCCcCcccccCCCccccccce
Q 045449 680 SSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQL-SKQTQTLATIGYMAPEYGTKGRVSTRGDV 758 (823)
Q Consensus 680 ~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv 758 (823)
.|++++|+|+|+++|+||||||+|||++.++.+||+|||+|+.+...... .......||+.|+|||++..+.++.++||
T Consensus 116 ~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV 195 (285)
T d1u59a_ 116 HQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDV 195 (285)
T ss_dssp HHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHH
T ss_pred HHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhcccccccccccccccccCccccChHHHhCCCCCccchh
Confidence 78999999999999999999999999999999999999999987554332 22334568999999999998999999999
Q ss_pred ehhhhhhccccC-CCCCcCCCc
Q 045449 759 CSFGIISGGKET-RSMTVGETC 779 (823)
Q Consensus 759 ~S~Gvv~~~~~~-~~~~~~~~~ 779 (823)
|||||++||+++ |..||.+..
T Consensus 196 wS~Gv~l~E~lt~G~~Pf~~~~ 217 (285)
T d1u59a_ 196 WSYGVTMWEALSYGQKPYKKMK 217 (285)
T ss_dssp HHHHHHHHHHHTTSCCTTTTCC
T ss_pred hcchHHHHHHHhCCCCCCCCCC
Confidence 999999999987 899997753
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.95 E-value=2e-30 Score=273.96 Aligned_cols=194 Identities=20% Similarity=0.211 Sum_probs=142.9
Q ss_pred HhccCCccceeeccC-----------------CeEEEEEEehHhh-HHHHHHHHHHHHHHhhcchhhHHH----------
Q 045449 626 ATDRFSENNLIGIGN-----------------GMEVAVKVFHQQY-ERALKSFEDECEVRKRIRHRNLVK---------- 677 (823)
Q Consensus 626 at~~f~~~~~lg~g~-----------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~---------- 677 (823)
..++|+..+.||+|+ ++.||||+++... ....++|.+|++++++++||||++
T Consensus 11 p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~ 90 (301)
T d1lufa_ 11 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP 90 (301)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred CHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCc
Confidence 456788889999986 2469999997543 445678999999999999999998
Q ss_pred ------------------------------------------------------HHHHHHHHhhhcCCCCEEeccCCCCC
Q 045449 678 ------------------------------------------------------IISSSLEYLHFGHSIPIIHCDLKPSN 703 (823)
Q Consensus 678 ------------------------------------------------------~~~~~l~~L~~~h~~~ivHrdlk~~N 703 (823)
++.|++.+|+|+|+.+||||||||+|
T Consensus 91 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~N 170 (301)
T d1lufa_ 91 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRN 170 (301)
T ss_dssp CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred eEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEcccc
Confidence 25688899999999999999999999
Q ss_pred EEeCCCCcEEEeecccccccCCCCccccccccccCCCcCcccccCCCccccccceehhhhhhccccCCCC-CcCCCcccc
Q 045449 704 VLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSM-TVGETCTPV 782 (823)
Q Consensus 704 iLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~-~~~~~~~~~ 782 (823)
||+|.++.+||+|||+|+...............||+.|+|||++.+..|+.++|||||||++||++++.. ||.+.....
T Consensus 171 ILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~e 250 (301)
T d1lufa_ 171 CLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEE 250 (301)
T ss_dssp EEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH
T ss_pred eEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCCHHH
Confidence 9999999999999999987755444334445678999999999999999999999999999999999864 565543221
Q ss_pred cccccccCCcccccccCCCcccccccccccccccccCC
Q 045449 783 RESKYEVHPATTTIMEHPLPRVGEVMDVDRGKARIQGK 820 (823)
Q Consensus 783 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 820 (823)
...... .......+....+.+.+++..+....+-+||
T Consensus 251 ~~~~v~-~~~~~~~p~~~~~~~~~li~~cl~~~P~~RP 287 (301)
T d1lufa_ 251 VIYYVR-DGNILACPENCPLELYNLMRLCWSKLPADRP 287 (301)
T ss_dssp HHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSC
T ss_pred HHHHHH-cCCCCCCCccchHHHHHHHHHHcCCChhHCc
Confidence 111110 1111222334445555655555555444444
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=3.9e-30 Score=274.63 Aligned_cols=152 Identities=22% Similarity=0.326 Sum_probs=126.1
Q ss_pred ccCCccceeeccC-----------------CeEEEEEEehHhh-HHHHHHHHHHHHHHhhc-chhhHHH-----------
Q 045449 628 DRFSENNLIGIGN-----------------GMEVAVKVFHQQY-ERALKSFEDECEVRKRI-RHRNLVK----------- 677 (823)
Q Consensus 628 ~~f~~~~~lg~g~-----------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~----------- 677 (823)
++|...+.||+|+ ...||||++.... ....+.|.+|++++.++ +|||||+
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~ 116 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI 116 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeE
Confidence 5677888999986 1248999886443 34456899999999998 8999998
Q ss_pred ----------------------------------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEE
Q 045449 678 ----------------------------------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVL 705 (823)
Q Consensus 678 ----------------------------------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiL 705 (823)
++.|++.+|+|+|+++||||||||+|||
T Consensus 117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~Nil 196 (325)
T d1rjba_ 117 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVL 196 (325)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEE
T ss_pred EEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchhccc
Confidence 2358889999999999999999999999
Q ss_pred eCCCCcEEEeecccccccCCCCccccccccccCCCcCcccccCCCccccccceehhhhhhccccC-CCCCcCCCc
Q 045449 706 LDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKET-RSMTVGETC 779 (823)
Q Consensus 706 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~-~~~~~~~~~ 779 (823)
++.++.+||+|||+|+...............||+.|||||++.++.|+.++|||||||++|||++ |..||.+..
T Consensus 197 l~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~ 271 (325)
T d1rjba_ 197 VTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 271 (325)
T ss_dssp EETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred cccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCC
Confidence 99999999999999987655444334455678999999999999999999999999999999997 899997653
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=5.2e-30 Score=266.87 Aligned_cols=138 Identities=24% Similarity=0.318 Sum_probs=115.1
Q ss_pred eEEEEEEehHhh--HHHHHHHHHHHHHHhhcchhhHHH---------------------------------------HHH
Q 045449 642 MEVAVKVFHQQY--ERALKSFEDECEVRKRIRHRNLVK---------------------------------------IIS 680 (823)
Q Consensus 642 ~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~---------------------------------------~~~ 680 (823)
+.||||+++... ....++|.+|++++++++|||||+ ++.
T Consensus 35 ~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~~~~lvmE~~~~g~L~~~l~~~~~l~~~~~~~i~~ 114 (277)
T d1xbba_ 35 KTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVH 114 (277)
T ss_dssp EEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESSSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHH
T ss_pred eEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccCCEEEEEEcCCCCcHHHHHhhccCCCHHHHHHHHH
Confidence 569999996443 334578999999999999999998 467
Q ss_pred HHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCcc-ccccccccCCCcCcccccCCCcccccccee
Q 045449 681 SSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQL-SKQTQTLATIGYMAPEYGTKGRVSTRGDVC 759 (823)
Q Consensus 681 ~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~ 759 (823)
|++.+|+|+|+.+|+||||||+|||++.++.+||+|||+|+........ .......||+.|||||++.+..|+.++|||
T Consensus 115 qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiw 194 (277)
T d1xbba_ 115 QVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVW 194 (277)
T ss_dssp HHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHH
T ss_pred HHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhccccccccccccccCCCceecCchhhcCCCCCchhhhc
Confidence 8999999999999999999999999999999999999999976544332 223345789999999999999999999999
Q ss_pred hhhhhhccccC-CCCCcCCCc
Q 045449 760 SFGIISGGKET-RSMTVGETC 779 (823)
Q Consensus 760 S~Gvv~~~~~~-~~~~~~~~~ 779 (823)
||||++||+++ |+.||.+..
T Consensus 195 S~Gv~l~ellt~g~~Pf~~~~ 215 (277)
T d1xbba_ 195 SFGVLMWEAFSYGQKPYRGMK 215 (277)
T ss_dssp HHHHHHHHHHTTTCCSSTTCC
T ss_pred cchhhhhHHhhCCCCCCCCCC
Confidence 99999999987 899997753
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=99.95 E-value=1.2e-29 Score=272.87 Aligned_cols=149 Identities=22% Similarity=0.333 Sum_probs=131.2
Q ss_pred hccCCccceeeccC------------CeEEEEEEehHhhHHHHHHHHHHHHHHhhcchhhHHH-----------------
Q 045449 627 TDRFSENNLIGIGN------------GMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVK----------------- 677 (823)
Q Consensus 627 t~~f~~~~~lg~g~------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~----------------- 677 (823)
.++|+..+.||+|+ |+.||||++........+.+.+|++++++++|||||+
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 107 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 107 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 35788889999986 6779999997665555678999999999999999998
Q ss_pred ------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeC--CCCcEEEeecccccccCCCCcccc
Q 045449 678 ------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLD--EDMVAHISDFGIAKLLSGEDQLSK 731 (823)
Q Consensus 678 ------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~--~~~~~kl~DfGla~~~~~~~~~~~ 731 (823)
++.|++.+|+|+|+.||+||||||+|||++ .++.+||+|||+|+.......
T Consensus 108 ~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~--- 184 (352)
T d1koba_ 108 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI--- 184 (352)
T ss_dssp CCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC---
T ss_pred CCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCCCc---
Confidence 478999999999999999999999999998 568999999999998754432
Q ss_pred ccccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCCC
Q 045449 732 QTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 732 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
.....||+.|+|||++.+..|+.++||||+||++|+|++|..||.+.
T Consensus 185 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~ 231 (352)
T d1koba_ 185 VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGE 231 (352)
T ss_dssp EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCS
T ss_pred eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCC
Confidence 34467999999999999999999999999999999999999999764
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.95 E-value=4.4e-30 Score=271.23 Aligned_cols=149 Identities=30% Similarity=0.397 Sum_probs=111.5
Q ss_pred hccCCccceeeccC------------CeEEEEEEehHhh-HHHHHHHHHHHHHHhhcchhhHHH----------------
Q 045449 627 TDRFSENNLIGIGN------------GMEVAVKVFHQQY-ERALKSFEDECEVRKRIRHRNLVK---------------- 677 (823)
Q Consensus 627 t~~f~~~~~lg~g~------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~---------------- 677 (823)
.+.|...+.||+|+ ++.||||++.... ....+.+.+|++++++++|||||+
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 35677788888885 6779999997543 334467889999999999999999
Q ss_pred ------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeC---CCCcEEEeecccccccCCCCccc
Q 045449 678 ------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLD---EDMVAHISDFGIAKLLSGEDQLS 730 (823)
Q Consensus 678 ------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~---~~~~~kl~DfGla~~~~~~~~~~ 730 (823)
++.|++.+|+|+|+.+|+||||||+|||+. +++.+||+|||+|+......
T Consensus 88 ~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~--- 164 (307)
T d1a06a_ 88 LVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS--- 164 (307)
T ss_dssp CCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC-------------
T ss_pred ccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCCC---
Confidence 478999999999999999999999999994 57899999999998764332
Q ss_pred cccccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCCC
Q 045449 731 KQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 731 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
.....+||+.|||||++.+..|+.++||||+||++|+|++|..||.+.
T Consensus 165 ~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~ 212 (307)
T d1a06a_ 165 VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDE 212 (307)
T ss_dssp --------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCC
Confidence 233467999999999999999999999999999999999999999764
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=5e-30 Score=272.88 Aligned_cols=152 Identities=24% Similarity=0.312 Sum_probs=123.6
Q ss_pred ccCCccceeeccC------------C----eEEEEEEehHhh-HHHHHHHHHHHHHHhhcchhhHHH-------------
Q 045449 628 DRFSENNLIGIGN------------G----MEVAVKVFHQQY-ERALKSFEDECEVRKRIRHRNLVK------------- 677 (823)
Q Consensus 628 ~~f~~~~~lg~g~------------~----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~------------- 677 (823)
.+|+..+.||+|+ | ..||||+++... .+..++|.+|++++++++|||||+
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~v 88 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLI 88 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeeEE
Confidence 3578888999986 1 248999886433 345678999999999999999999
Q ss_pred ---------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccc
Q 045449 678 ---------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLS 730 (823)
Q Consensus 678 ---------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~ 730 (823)
++.|++.+|+|+|+++|+||||||+|||++.++.+||+|||+|+.........
T Consensus 89 ~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 168 (317)
T d1xkka_ 89 TQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY 168 (317)
T ss_dssp EECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTCC--
T ss_pred EEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceecccccccc
Confidence 36789999999999999999999999999999999999999999876554433
Q ss_pred cccccccCCCcCcccccCCCccccccceehhhhhhccccC-CCCCcCCCc
Q 045449 731 KQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKET-RSMTVGETC 779 (823)
Q Consensus 731 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~-~~~~~~~~~ 779 (823)
......||+.|+|||++.++.|+.++|||||||++||+++ |..||.+..
T Consensus 169 ~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~ 218 (317)
T d1xkka_ 169 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP 218 (317)
T ss_dssp ------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC
T ss_pred cccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCC
Confidence 3445678999999999999999999999999999999998 788887643
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=99.95 E-value=2.2e-29 Score=270.49 Aligned_cols=149 Identities=23% Similarity=0.311 Sum_probs=131.1
Q ss_pred hccCCccceeeccC------------CeEEEEEEehHhhHHHHHHHHHHHHHHhhcchhhHHH-----------------
Q 045449 627 TDRFSENNLIGIGN------------GMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVK----------------- 677 (823)
Q Consensus 627 t~~f~~~~~lg~g~------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~----------------- 677 (823)
.++|...+.||+|+ |..||||++........+.+.+|++++++++|||||+
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 35788889999997 6779999997766666688999999999999999998
Q ss_pred ------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeC--CCCcEEEeecccccccCCCCcccc
Q 045449 678 ------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLD--EDMVAHISDFGIAKLLSGEDQLSK 731 (823)
Q Consensus 678 ------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~--~~~~~kl~DfGla~~~~~~~~~~~ 731 (823)
++.|++.+|+|+|+.+||||||||+|||++ .++.+||+|||+|+.+.....
T Consensus 105 ~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~--- 181 (350)
T d1koaa2 105 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS--- 181 (350)
T ss_dssp CCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSC---
T ss_pred CCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheecccccc---
Confidence 468999999999999999999999999996 457999999999998654332
Q ss_pred ccccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCCC
Q 045449 732 QTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 732 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
.....||+.|||||++.+..|+.++||||+||++|+|++|..||.+.
T Consensus 182 ~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~ 228 (350)
T d1koaa2 182 VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGE 228 (350)
T ss_dssp EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCC
Confidence 34467999999999999999999999999999999999999999754
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=99.94 E-value=4.8e-29 Score=260.25 Aligned_cols=152 Identities=26% Similarity=0.470 Sum_probs=123.5
Q ss_pred hccCCccceeeccC------------CeEEEEEEehHhh---HHHHHHHHHHHHHHhhcchhhHHH--------------
Q 045449 627 TDRFSENNLIGIGN------------GMEVAVKVFHQQY---ERALKSFEDECEVRKRIRHRNLVK-------------- 677 (823)
Q Consensus 627 t~~f~~~~~lg~g~------------~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~-------------- 677 (823)
.++|...+.||+|+ |+.||||+++... ....+.|.+|++++++++|||||+
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 36788889999986 6789999996432 455678999999999999999998
Q ss_pred ------------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCC
Q 045449 678 ------------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGED 727 (823)
Q Consensus 678 ------------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~ 727 (823)
++.|++.+|+|+|+.+|+||||||+|||++.++..+++|||.++......
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~ 165 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSG 165 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC---
T ss_pred EEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhcccc
Confidence 46899999999999999999999999999999999999999987654332
Q ss_pred c-cccccccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCCC
Q 045449 728 Q-LSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 728 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
. .......+||+.|||||++.+..|+.++||||+||++|+|++|..||.+.
T Consensus 166 ~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~ 217 (277)
T d1o6ya_ 166 NSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGD 217 (277)
T ss_dssp -------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCc
Confidence 2 12234568999999999999999999999999999999999999999764
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=3.1e-29 Score=257.88 Aligned_cols=190 Identities=17% Similarity=0.243 Sum_probs=141.7
Q ss_pred ccCCccceeeccC-----------CeEEEEEEehHhhHHHHHHHHHHHHHHhhcchhhHHH-------------------
Q 045449 628 DRFSENNLIGIGN-----------GMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVK------------------- 677 (823)
Q Consensus 628 ~~f~~~~~lg~g~-----------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------------- 677 (823)
++|...+.||+|+ +..||||+++.... ..++|.+|++++++++|||||+
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence 4667777788775 56799999975432 2368999999999999999999
Q ss_pred ----------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCcccccccc
Q 045449 678 ----------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQT 735 (823)
Q Consensus 678 ----------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 735 (823)
++.|++++|.|+|+.+|+||||||+||+++.++.+||+|||+|+....... ......
T Consensus 83 ~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~-~~~~~~ 161 (258)
T d1k2pa_ 83 NGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-TSSVGS 161 (258)
T ss_dssp TEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSC-CCCCCS
T ss_pred CCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCCc-eeeccc
Confidence 356888999999999999999999999999999999999999987654433 233456
Q ss_pred ccCCCcCcccccCCCccccccceehhhhhhccccC-CCCCcCCCcccccccccccCCcccccccCCCccccccccccccc
Q 045449 736 LATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKET-RSMTVGETCTPVRESKYEVHPATTTIMEHPLPRVGEVMDVDRGK 814 (823)
Q Consensus 736 ~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 814 (823)
.||+.|+|||++.+..|+.++|||||||++||+++ |+.||++............ ......+....+.+.+++..+...
T Consensus 162 ~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~-~~~~~~p~~~~~~l~~li~~cl~~ 240 (258)
T d1k2pa_ 162 KFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ-GLRLYRPHLASEKVYTIMYSCWHE 240 (258)
T ss_dssp CCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHT-TCCCCCCTTCCHHHHHHHHHTTCS
T ss_pred CCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHh-CCCCCCcccccHHHHHHHHHHccC
Confidence 79999999999999999999999999999999997 7889877543321111111 011112233444555666555555
Q ss_pred ccccCC
Q 045449 815 ARIQGK 820 (823)
Q Consensus 815 ~~~~~~ 820 (823)
.+-+||
T Consensus 241 dP~~RP 246 (258)
T d1k2pa_ 241 KADERP 246 (258)
T ss_dssp SGGGSC
T ss_pred CHhHCc
Confidence 444444
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.94 E-value=1.5e-26 Score=245.18 Aligned_cols=246 Identities=22% Similarity=0.314 Sum_probs=181.4
Q ss_pred ccceeeeeCCCCCcEEEEEcCCCCCccccCcccCCCCCCcEEEccCCCCCCCCCCCCCCCCCCCEEECCCCcCcCCCchh
Q 045449 40 CIWIGITCDVNSHRVIGLNISSFNLQGTITPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLDFSDNQLFGSLSSF 119 (823)
Q Consensus 40 c~w~gv~c~~~~~~v~~L~L~~~~l~g~~~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~ 119 (823)
|.|.+|.|+. ++++ .+|+.+. +++++|||++|+|+...+.+|.++++|++|++++|.+....|..
T Consensus 10 c~~~~~~C~~------------~~L~-~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~ 74 (305)
T d1xkua_ 10 CHLRVVQCSD------------LGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGA 74 (305)
T ss_dssp EETTEEECTT------------SCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTT
T ss_pred ecCCEEEecC------------CCCC-ccCCCCC--CCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhh
Confidence 7888999974 3355 5676663 68999999999999766778999999999999999999888999
Q ss_pred hhcCCCCcEEecccccccCccCccccCCCCCCccccccceeeeccceeeccCccccccchhhHHHHHhhcCCCcccCCcc
Q 045449 120 IFNMSSMTTIDLSINRLSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKEIGNLTKLKEIISTITNSTVCEIPRE 199 (823)
Q Consensus 120 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~~l~~n~~~~~ip~~ 199 (823)
|.++++|++|++++|+++ .+|..+ ...|+.|+++.|.+.+..+..+..
T Consensus 75 f~~l~~L~~L~l~~n~l~-~l~~~~---------~~~l~~L~~~~n~l~~l~~~~~~~---------------------- 122 (305)
T d1xkua_ 75 FAPLVKLERLYLSKNQLK-ELPEKM---------PKTLQELRVHENEITKVRKSVFNG---------------------- 122 (305)
T ss_dssp TTTCTTCCEEECCSSCCS-BCCSSC---------CTTCCEEECCSSCCCBBCHHHHTT----------------------
T ss_pred hhCCCccCEecccCCccC-cCccch---------hhhhhhhhccccchhhhhhhhhhc----------------------
Confidence 999999999999999998 445433 357899999999887543322222
Q ss_pred cCCcchhhhhccccccc--cCCccccccCCCCCcEEEccCCcccccCCcccccCCCCccEEEeeccccccccCccccCCC
Q 045449 200 IGNLPYLARLALATNNL--VGVVPVTIFNMSALKEISLLNNSLSGSLPSRIDLSLPNVETLNLGINSFSGTIPSSITNSS 277 (823)
Q Consensus 200 l~~l~~L~~L~Ls~N~l--~~~~p~~~~~l~~L~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 277 (823)
...+..++...|.. ....+..+..+++|+.+++++|.++ .+|..+ +++|+.|++++|.+.+..+..+.+++
T Consensus 123 ---~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~-~l~~~~---~~~L~~L~l~~n~~~~~~~~~~~~~~ 195 (305)
T d1xkua_ 123 ---LNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL---PPSLTELHLDGNKITKVDAASLKGLN 195 (305)
T ss_dssp ---CTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC-SCCSSC---CTTCSEEECTTSCCCEECTGGGTTCT
T ss_pred ---cccccccccccccccccCCCccccccccccCccccccCCcc-ccCccc---CCccCEEECCCCcCCCCChhHhhccc
Confidence 12233344444432 2334556777788888888888887 566543 56788888888888888888888888
Q ss_pred CCCeEEeecccccccCCCccCCCcccCcccccCccccCCCCcccccccccCCCCceEEEeecCCCCcc
Q 045449 278 KLSDLELGENLFSGFIPNTIGNLRNLEFGNIADNYLTSSTPELSFLSSLTNCKKLKVLIVTGNPLDGI 345 (823)
Q Consensus 278 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~ 345 (823)
.+++|++++|.+++..+..|.++++|++|+|++|.++.. +.++.++++|++|+|++|+|+..
T Consensus 196 ~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~~l------p~~l~~l~~L~~L~Ls~N~i~~i 257 (305)
T d1xkua_ 196 NLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKV------PGGLADHKYIQVVYLHNNNISAI 257 (305)
T ss_dssp TCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCSSC------CTTTTTCSSCCEEECCSSCCCCC
T ss_pred cccccccccccccccccccccccccceeeeccccccccc------ccccccccCCCEEECCCCccCcc
Confidence 888888888888877777777777777777777777653 33456666666666666666643
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.94 E-value=9.3e-29 Score=267.25 Aligned_cols=147 Identities=25% Similarity=0.240 Sum_probs=122.2
Q ss_pred ccCCccceeeccC------------CeEEEEEEehHhhH---HHHHHHH---HHHHHHhhcchhhHHH------------
Q 045449 628 DRFSENNLIGIGN------------GMEVAVKVFHQQYE---RALKSFE---DECEVRKRIRHRNLVK------------ 677 (823)
Q Consensus 628 ~~f~~~~~lg~g~------------~~~vavK~~~~~~~---~~~~~~~---~E~~~l~~l~h~niv~------------ 677 (823)
++|...+.||+|+ |+.||||++..... .....+. +|+++++.++|||||+
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 5788889999996 67799999864431 1122333 4567777889999998
Q ss_pred ----------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCcc
Q 045449 678 ----------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQL 729 (823)
Q Consensus 678 ----------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~ 729 (823)
++.|++.+|+|+|+.+|+||||||+|||++.++.+||+|||+|+......
T Consensus 84 ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~~-- 161 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-- 161 (364)
T ss_dssp EEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSSSC--
T ss_pred EEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCCCc--
Confidence 46799999999999999999999999999999999999999999765432
Q ss_pred ccccccccCCCcCcccccCC-CccccccceehhhhhhccccCCCCCcCCC
Q 045449 730 SKQTQTLATIGYMAPEYGTK-GRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 730 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
....+||+.|+|||++.. ..|+.++||||+||++|+|++|..||.+.
T Consensus 162 --~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~ 209 (364)
T d1omwa3 162 --PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH 209 (364)
T ss_dssp --CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSS
T ss_pred --ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCC
Confidence 234679999999999875 46899999999999999999999999764
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=2.8e-29 Score=265.24 Aligned_cols=151 Identities=25% Similarity=0.312 Sum_probs=117.6
Q ss_pred ccCCccceeeccC-----------------CeEEEEEEehHhh-HHHHHHHHHHHHHHhhc-chhhHHH-----------
Q 045449 628 DRFSENNLIGIGN-----------------GMEVAVKVFHQQY-ERALKSFEDECEVRKRI-RHRNLVK----------- 677 (823)
Q Consensus 628 ~~f~~~~~lg~g~-----------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~----------- 677 (823)
++|...+.||+|+ ++.||||+++... ....+.|.+|++++.++ +|+|||.
T Consensus 13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~ 92 (299)
T d1ywna1 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 92 (299)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSC
T ss_pred HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCe
Confidence 5677788899886 2469999997543 44457788899888887 6888887
Q ss_pred ----------------------------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCc
Q 045449 678 ----------------------------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMV 711 (823)
Q Consensus 678 ----------------------------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~ 711 (823)
++.|++.+|+|+|+++||||||||+|||++.++.
T Consensus 93 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~~~~ 172 (299)
T d1ywna1 93 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV 172 (299)
T ss_dssp CEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGC
T ss_pred EEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeECCCCc
Confidence 2458899999999999999999999999999999
Q ss_pred EEEeecccccccCCCCccccccccccCCCcCcccccCCCccccccceehhhhhhccccCCC-CCcCCC
Q 045449 712 AHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRS-MTVGET 778 (823)
Q Consensus 712 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~-~~~~~~ 778 (823)
+||+|||+|+..............+||+.|+|||++.++.|+.++|||||||++||++++. .||.+.
T Consensus 173 ~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~ 240 (299)
T d1ywna1 173 VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 240 (299)
T ss_dssp EEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred EEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCC
Confidence 9999999999765544444445678999999999999999999999999999999999865 566554
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=2.5e-29 Score=261.13 Aligned_cols=152 Identities=24% Similarity=0.288 Sum_probs=118.6
Q ss_pred ccCCccceeeccC---------------CeEEEEEEehHhh---HHHHHHHHHHHHHHhhcchhhHHH------------
Q 045449 628 DRFSENNLIGIGN---------------GMEVAVKVFHQQY---ERALKSFEDECEVRKRIRHRNLVK------------ 677 (823)
Q Consensus 628 ~~f~~~~~lg~g~---------------~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~------------ 677 (823)
++|+..+.||+|+ ...||||++.... ....++|.+|++++++++|||||+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~~~~l 87 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKM 87 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeecchhe
Confidence 3466666777765 2358999987543 344578999999999999999998
Q ss_pred ----------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCcc
Q 045449 678 ----------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQL 729 (823)
Q Consensus 678 ----------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~ 729 (823)
++.|++++|+|+|+++|+||||||+||+++.++.+||+|||+++........
T Consensus 88 v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~~~ 167 (273)
T d1u46a_ 88 VTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDH 167 (273)
T ss_dssp EEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-CCE
T ss_pred eeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhcccCCCc
Confidence 4678999999999999999999999999999999999999999987544332
Q ss_pred c-cccccccCCCcCcccccCCCccccccceehhhhhhccccC-CCCCcCCCc
Q 045449 730 S-KQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKET-RSMTVGETC 779 (823)
Q Consensus 730 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~-~~~~~~~~~ 779 (823)
. ......||..|+|||++.+..++.++|||||||++||+++ |..||.+..
T Consensus 168 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~ 219 (273)
T d1u46a_ 168 YVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN 219 (273)
T ss_dssp EEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred ceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcC
Confidence 2 2234567889999999999999999999999999999997 899997653
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=2.5e-29 Score=262.25 Aligned_cols=148 Identities=26% Similarity=0.445 Sum_probs=119.4
Q ss_pred ccCCccceeeccC-----------CeEEEEEEehHhhHHHHHHHHHHHHHHhhcchhhHHH-------------------
Q 045449 628 DRFSENNLIGIGN-----------GMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVK------------------- 677 (823)
Q Consensus 628 ~~f~~~~~lg~g~-----------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------------- 677 (823)
++|+..+.||+|+ +..||||++..... ..+.|.+|++++++++|||||+
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~lv~Ey~~~ 95 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSK 95 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEECCCTT
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccC-CHHHHHHHHHHHHhcccCCEeEEEEEEecCCeEEEEEecCC
Confidence 5788889999996 45699999975532 3367999999999999999999
Q ss_pred ----------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCcccccccc
Q 045449 678 ----------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQT 735 (823)
Q Consensus 678 ----------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 735 (823)
++.|++.+|+|+|+.+|+||||||+|||+|.++.+||+|||+|+....... ......
T Consensus 96 g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~-~~~~~~ 174 (285)
T d1fmka3 96 GSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-TARQGA 174 (285)
T ss_dssp CBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC--------------
T ss_pred CchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhccCCCc-eeeccc
Confidence 467888999999999999999999999999999999999999987643332 223446
Q ss_pred ccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCC
Q 045449 736 LATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGE 777 (823)
Q Consensus 736 ~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~ 777 (823)
.||+.|+|||++..+.++.++|||||||++||++++..|+..
T Consensus 175 ~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~ 216 (285)
T d1fmka3 175 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYP 216 (285)
T ss_dssp -CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred cccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCC
Confidence 799999999999999999999999999999999997666543
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=6e-29 Score=258.85 Aligned_cols=151 Identities=22% Similarity=0.299 Sum_probs=115.8
Q ss_pred ccCCccceeeccC---------------CeEEEEEEehHhh-HHHHHHHHHHHHHHhhcchhhHHH--------------
Q 045449 628 DRFSENNLIGIGN---------------GMEVAVKVFHQQY-ERALKSFEDECEVRKRIRHRNLVK-------------- 677 (823)
Q Consensus 628 ~~f~~~~~lg~g~---------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~-------------- 677 (823)
++|...+.||+|+ +..||||+++... ....+.|.+|++++++++|||||+
T Consensus 7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~iv~ 86 (273)
T d1mp8a_ 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWIIM 86 (273)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSCEEEE
T ss_pred HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCeEEEEE
Confidence 4677778888886 2358899886433 445678999999999999999998
Q ss_pred --------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCcccc
Q 045449 678 --------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSK 731 (823)
Q Consensus 678 --------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~ 731 (823)
++.|++++|+|+|+++|+||||||+||+++.++.+||+|||+|+....... ..
T Consensus 87 E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~~-~~ 165 (273)
T d1mp8a_ 87 ELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY-YK 165 (273)
T ss_dssp ECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC---------------
T ss_pred EeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheeccCCcc-ee
Confidence 367899999999999999999999999999999999999999987654322 22
Q ss_pred ccccccCCCcCcccccCCCccccccceehhhhhhccccC-CCCCcCCCc
Q 045449 732 QTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKET-RSMTVGETC 779 (823)
Q Consensus 732 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~-~~~~~~~~~ 779 (823)
.....||+.|+|||++.++.|+.++|||||||++||+++ |..||.+..
T Consensus 166 ~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~ 214 (273)
T d1mp8a_ 166 ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK 214 (273)
T ss_dssp -----CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred ccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCC
Confidence 344678999999999999999999999999999999987 788887653
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=8.5e-29 Score=260.37 Aligned_cols=149 Identities=24% Similarity=0.371 Sum_probs=128.0
Q ss_pred hccCCccceeeccC------------CeEEEEEEehHhh------HHHHHHHHHHHHHHhhcchhhHHH-----------
Q 045449 627 TDRFSENNLIGIGN------------GMEVAVKVFHQQY------ERALKSFEDECEVRKRIRHRNLVK----------- 677 (823)
Q Consensus 627 t~~f~~~~~lg~g~------------~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~----------- 677 (823)
.++|...+.||+|+ |+.||||++.... ....+.|.+|++++++++|||||+
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 36788889999986 6779999986432 123478999999999999999999
Q ss_pred -----------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCC----cEEEeecccccccC
Q 045449 678 -----------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDM----VAHISDFGIAKLLS 724 (823)
Q Consensus 678 -----------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~----~~kl~DfGla~~~~ 724 (823)
++.|++.+|+|+|+.+|+||||||+|||++.++ .+|++|||+|+...
T Consensus 89 ~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~ 168 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID 168 (293)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECT
T ss_pred EEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhcC
Confidence 468999999999999999999999999998766 59999999998865
Q ss_pred CCCccccccccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCCC
Q 045449 725 GEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 725 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
.... .....||+.|+|||++.+..|+.++||||+||++|+|++|..||.+.
T Consensus 169 ~~~~---~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~ 219 (293)
T d1jksa_ 169 FGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD 219 (293)
T ss_dssp TSCB---CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CCcc---ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCC
Confidence 4332 34467999999999999999999999999999999999999999764
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=9.6e-27 Score=243.87 Aligned_cols=267 Identities=19% Similarity=0.171 Sum_probs=163.2
Q ss_pred EEEccCCcccccCCcccccCCCCccEEEeeccccccccCccccCCCCCCeEEeecccccccCCCccCCCcccCccccc-C
Q 045449 232 EISLLNNSLSGSLPSRIDLSLPNVETLNLGINSFSGTIPSSITNSSKLSDLELGENLFSGFIPNTIGNLRNLEFGNIA-D 310 (823)
Q Consensus 232 ~L~Ls~N~l~g~lp~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~-~ 310 (823)
.++.++++++ .+|..+. +++++|+|++|+|+...+.+|.++++|++|++++|++.++.+..+..++.++.++.. .
T Consensus 15 ~v~c~~~~L~-~iP~~ip---~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~ 90 (284)
T d1ozna_ 15 TTSCPQQGLQ-AVPVGIP---AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDN 90 (284)
T ss_dssp EEECCSSCCS-SCCTTCC---TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSC
T ss_pred EEEcCCCCCC-ccCCCCC---CCCCEEECcCCcCCCCCHHHhhccccccccccccccccccccccccccccccccccccc
Confidence 4566666676 6776553 457778888888876666677778888888888888877777777777777766543 4
Q ss_pred ccccCCCCcccccccccCCCCceEEEeecCCCCccCCccccccccccceEEecCCcceeccCccccCcccccEEEcccCc
Q 045449 311 NYLTSSTPELSFLSSLTNCKKLKVLIVTGNPLDGILPKSIGNFSLSLETILMANCSISGNIPQVVGNLSNLLVLELGGNN 390 (823)
Q Consensus 311 N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 390 (823)
|.++.. .+..|.++++|++|++++|.+.+..+..+... .+|+.+++++|+|++..+..|..+++|+.|++++|+
T Consensus 91 ~~~~~l-----~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~-~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~ 164 (284)
T d1ozna_ 91 AQLRSV-----DPATFHGLGRLHTLHLDRCGLQELGPGLFRGL-AALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNR 164 (284)
T ss_dssp TTCCCC-----CTTTTTTCTTCCEEECTTSCCCCCCTTTTTTC-TTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred cccccc-----cchhhcccccCCEEecCCcccccccccccchh-cccchhhhccccccccChhHhccccchhhcccccCc
Confidence 444444 23456666666666666666665555545444 456666666666665555666666666666666666
Q ss_pred CCCCchhcccccCCCCEEEccCCCCCCcchHhhhcCCCCCEEEcccCcCcccccccccCCCCCCeEeccCCccccccchh
Q 045449 391 LTGPIPVTFSQLQTLQAFDLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSVRVLYLGLNIFTSVLSST 470 (823)
Q Consensus 391 l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~ 470 (823)
+++..+..|.++++|+++++++|++++..|..|.++++|++||+++|++++..|..|+++++|++|+|++|.+...-+.
T Consensus 165 l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~~- 243 (284)
T d1ozna_ 165 ISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA- 243 (284)
T ss_dssp CCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGG-
T ss_pred ccccchhhhccccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCCCccc-
Confidence 6655556666666666666666666666666666666666666666666666666666666666666666666553321
Q ss_pred hhccCCCcEEeccccccccccCccccCCCCCcEEEcccCCCC
Q 045449 471 IWNLKDILFIDVSSNFLDGPLSLDIGNLKVVIGLDFSRNNLS 512 (823)
Q Consensus 471 ~~~l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~ls~N~l~ 512 (823)
.+-...++.+....+.+.+..|..+.. ....+++.+.|+
T Consensus 244 ~~l~~~l~~~~~~~~~~~C~~p~~l~g---~~l~~l~~~~l~ 282 (284)
T d1ozna_ 244 RPLWAWLQKFRGSSSEVPCSLPQRLAG---RDLKRLAANDLQ 282 (284)
T ss_dssp HHHHHHHHHCCSEECCCBEEESGGGTT---CBGGGSCGGGSC
T ss_pred hHHHHHHHhCcCCCCceEeCCchHHcC---CccccCCHHHCC
Confidence 111222344455555555555554432 233344444444
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=1.8e-28 Score=260.25 Aligned_cols=149 Identities=26% Similarity=0.270 Sum_probs=126.8
Q ss_pred ccCCccceeeccC------------CeEEEEEEehHhh---HHHHHHHHHHHHHHh-hcchhhHHH--------------
Q 045449 628 DRFSENNLIGIGN------------GMEVAVKVFHQQY---ERALKSFEDECEVRK-RIRHRNLVK-------------- 677 (823)
Q Consensus 628 ~~f~~~~~lg~g~------------~~~vavK~~~~~~---~~~~~~~~~E~~~l~-~l~h~niv~-------------- 677 (823)
++|...+.||+|+ |+.||||+++... ....+.+.+|+.++. .++|||||+
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 5678888999886 6779999997543 223456778887765 689999998
Q ss_pred --------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCcccc
Q 045449 678 --------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSK 731 (823)
Q Consensus 678 --------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~ 731 (823)
+++|++.+|+|+|+.+|+||||||+|||++.++.+||+|||+|+....... .
T Consensus 82 mEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~--~ 159 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA--K 159 (320)
T ss_dssp EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC--C
T ss_pred EeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhcccccc--c
Confidence 468999999999999999999999999999999999999999987543322 2
Q ss_pred ccccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCCC
Q 045449 732 QTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 732 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
.....||+.|+|||++.+..|+.++||||+||++|+|++|+.||.+.
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~ 206 (320)
T d1xjda_ 160 TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQ 206 (320)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCC
Confidence 34568999999999999999999999999999999999999999764
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.94 E-value=1.5e-25 Score=237.33 Aligned_cols=266 Identities=20% Similarity=0.212 Sum_probs=184.9
Q ss_pred CcEEEccCCcccccCCcccccCCCCccEEEeeccccccccCccccCCCCCCeEEeecccccccCCCccCCCcccCccccc
Q 045449 230 LKEISLLNNSLSGSLPSRIDLSLPNVETLNLGINSFSGTIPSSITNSSKLSDLELGENLFSGFIPNTIGNLRNLEFGNIA 309 (823)
Q Consensus 230 L~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 309 (823)
.+.++-+++.++ ++|..+. +++++|+|++|+|+...+.+|.++++|++|++++|.+....|..|.++++|++|+++
T Consensus 12 ~~~~~C~~~~L~-~lP~~l~---~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~ 87 (305)
T d1xkua_ 12 LRVVQCSDLGLE-KVPKDLP---PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLS 87 (305)
T ss_dssp TTEEECTTSCCC-SCCCSCC---TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred CCEEEecCCCCC-ccCCCCC---CCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEeccc
Confidence 455666666676 6666553 467777777777775555567777777777777777777777777777777777777
Q ss_pred CccccCCCCcccccccccCCCCceEEEeecCCCCccCCccccccccccceEEecCCcce--eccCccccCcccccEEEcc
Q 045449 310 DNYLTSSTPELSFLSSLTNCKKLKVLIVTGNPLDGILPKSIGNFSLSLETILMANCSIS--GNIPQVVGNLSNLLVLELG 387 (823)
Q Consensus 310 ~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~--~~~p~~~~~l~~L~~L~Ls 387 (823)
+|+++..+. .....++.|++..|.+.+..+..+... ..+..+....|... ...+..+..+++|+.++++
T Consensus 88 ~n~l~~l~~--------~~~~~l~~L~~~~n~l~~l~~~~~~~~-~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~ 158 (305)
T d1xkua_ 88 KNQLKELPE--------KMPKTLQELRVHENEITKVRKSVFNGL-NQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIA 158 (305)
T ss_dssp SSCCSBCCS--------SCCTTCCEEECCSSCCCBBCHHHHTTC-TTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECC
T ss_pred CCccCcCcc--------chhhhhhhhhccccchhhhhhhhhhcc-ccccccccccccccccCCCccccccccccCccccc
Confidence 777776532 123466777777777776555545444 45666666666433 3445567777788888888
Q ss_pred cCcCCCCchhcccccCCCCEEEccCCCCCCcchHhhhcCCCCCEEEcccCcCcccccccccCCCCCCeEeccCCcccccc
Q 045449 388 GNNLTGPIPVTFSQLQTLQAFDLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSVRVLYLGLNIFTSVL 467 (823)
Q Consensus 388 ~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~ 467 (823)
+|+++ .+|..+ .++|+.|++++|.+++..+..|.+++.+++|++++|.+++..+.++.++++|++|+|++|.|+. +
T Consensus 159 ~n~l~-~l~~~~--~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~~-l 234 (305)
T d1xkua_ 159 DTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVK-V 234 (305)
T ss_dssp SSCCC-SCCSSC--CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCSS-C
T ss_pred cCCcc-ccCccc--CCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeecccccccc-c
Confidence 88776 344433 5677888888888877777777777888888888888877777777778888888888887775 4
Q ss_pred chhhhccCCCcEEeccccccccccCcc------ccCCCCCcEEEcccCCCC
Q 045449 468 SSTIWNLKDILFIDVSSNFLDGPLSLD------IGNLKVVIGLDFSRNNLS 512 (823)
Q Consensus 468 p~~~~~l~~L~~LdLs~N~l~g~~p~~------~~~l~~L~~L~ls~N~l~ 512 (823)
|..+..+++|++|+|++|+|+..-... ...+..|+.|++++|.++
T Consensus 235 p~~l~~l~~L~~L~Ls~N~i~~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~ 285 (305)
T d1xkua_ 235 PGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ 285 (305)
T ss_dssp CTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSC
T ss_pred ccccccccCCCEEECCCCccCccChhhccCcchhcccCCCCEEECCCCcCc
Confidence 667777888888888888777532222 344567778888887765
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=3.3e-28 Score=257.38 Aligned_cols=146 Identities=25% Similarity=0.336 Sum_probs=122.5
Q ss_pred cceeeccC---------------CeEEEEEEehH-hhHHHHHHHHHHHHHHhhcchhhHHH-------------------
Q 045449 633 NNLIGIGN---------------GMEVAVKVFHQ-QYERALKSFEDECEVRKRIRHRNLVK------------------- 677 (823)
Q Consensus 633 ~~~lg~g~---------------~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~------------------- 677 (823)
.++||+|+ ...||||+++. ......++|.+|++++++++|||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 36788886 12489999864 33555688999999999999999998
Q ss_pred -----------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCcc--ccc
Q 045449 678 -----------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQL--SKQ 732 (823)
Q Consensus 678 -----------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~--~~~ 732 (823)
++.|++.+|+|+|+.+|+||||||+|||+++++.+||+|||+++........ ...
T Consensus 112 ~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~~~~ 191 (311)
T d1r0pa_ 112 KHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNK 191 (311)
T ss_dssp TTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCTTCT
T ss_pred ecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhccccccccceec
Confidence 3568899999999999999999999999999999999999999976543322 223
Q ss_pred cccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCCC
Q 045449 733 TQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 733 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
....||+.|+|||++..+.++.++|||||||++||++++..||...
T Consensus 192 ~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~ 237 (311)
T d1r0pa_ 192 TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD 237 (311)
T ss_dssp TCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-
T ss_pred ccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCC
Confidence 3457899999999999999999999999999999999988887654
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.93 E-value=5.4e-28 Score=255.25 Aligned_cols=136 Identities=26% Similarity=0.311 Sum_probs=113.1
Q ss_pred CeEEEEEEehHhhHH-----HHHHHHHHHHHHhhcchhhHHH--------------------------------------
Q 045449 641 GMEVAVKVFHQQYER-----ALKSFEDECEVRKRIRHRNLVK-------------------------------------- 677 (823)
Q Consensus 641 ~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~-------------------------------------- 677 (823)
|+.||||+++..... ..+.+.+|++++++++|||||+
T Consensus 23 ~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~~~~~~~~~~~~~~~l~~~~~ 102 (299)
T d1ua2a_ 23 NQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHI 102 (299)
T ss_dssp CSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCSEEHHHHHTTCCSSCCSSHH
T ss_pred CcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhhcchHHhhhhhcccCCCHHHH
Confidence 678999999654321 2357899999999999999998
Q ss_pred --HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCcccccCCC-cccc
Q 045449 678 --IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKG-RVST 754 (823)
Q Consensus 678 --~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ 754 (823)
++.|++.+|+|+|+.+|+||||||+|||++.++.+||+|||+|+....... .....+||+.|+|||++... .|+.
T Consensus 103 ~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~ 180 (299)
T d1ua2a_ 103 KAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR--AYTHQVVTRWYRAPELLFGARMYGV 180 (299)
T ss_dssp HHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC--CCCCSCCCCTTCCHHHHTTCSCCCH
T ss_pred HHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCcc--cccceecChhhccHHHHccCCCCCh
Confidence 468999999999999999999999999999999999999999987654322 23346799999999988654 5799
Q ss_pred ccceehhhhhhccccCCCCCcCCC
Q 045449 755 RGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 755 ~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
++||||+||++|+|++|..||.+.
T Consensus 181 ~~DiwSlGvil~el~~g~~pf~~~ 204 (299)
T d1ua2a_ 181 GVDMWAVGCILAELLLRVPFLPGD 204 (299)
T ss_dssp HHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred hhhhhhcchHHHHHHhCcCCCCCC
Confidence 999999999999999999998653
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.93 E-value=2.5e-28 Score=258.48 Aligned_cols=151 Identities=24% Similarity=0.377 Sum_probs=127.4
Q ss_pred ccCCccceeeccC-C----------------eEEEEEEehHh-hHHHHHHHHHHHHHHhhcchhhHHH------------
Q 045449 628 DRFSENNLIGIGN-G----------------MEVAVKVFHQQ-YERALKSFEDECEVRKRIRHRNLVK------------ 677 (823)
Q Consensus 628 ~~f~~~~~lg~g~-~----------------~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~------------ 677 (823)
++|...+.||+|+ | ..||||+++.. .......|.+|++++++++|||||+
T Consensus 20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~ 99 (308)
T d1p4oa_ 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL 99 (308)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCE
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCcee
Confidence 5677778899986 2 35899999754 3455568999999999999999998
Q ss_pred --------------------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeeccc
Q 045449 678 --------------------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGI 719 (823)
Q Consensus 678 --------------------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGl 719 (823)
++.+++.+|+|+|+.+|+||||||+|||+++++++||+|||+
T Consensus 100 lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~Kl~DFGl 179 (308)
T d1p4oa_ 100 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGM 179 (308)
T ss_dssp EEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEECCTTC
T ss_pred EEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceEEEeeccc
Confidence 356788899999999999999999999999999999999999
Q ss_pred ccccCCCCccccccccccCCCcCcccccCCCccccccceehhhhhhccccCCC-CCcCCC
Q 045449 720 AKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRS-MTVGET 778 (823)
Q Consensus 720 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~-~~~~~~ 778 (823)
|+...............||+.|+|||.+.++.++.++|||||||++||++++. .|+.+.
T Consensus 180 a~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~ 239 (308)
T d1p4oa_ 180 TRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL 239 (308)
T ss_dssp CCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS
T ss_pred ceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCC
Confidence 99775544444445567999999999999999999999999999999999985 566554
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.93 E-value=5.3e-28 Score=254.96 Aligned_cols=149 Identities=30% Similarity=0.390 Sum_probs=125.8
Q ss_pred ccCCccceeeccC------------CeEEEEEEehHhh--HHHHHHHHHHHHHHhhcchhhHHH----------------
Q 045449 628 DRFSENNLIGIGN------------GMEVAVKVFHQQY--ERALKSFEDECEVRKRIRHRNLVK---------------- 677 (823)
Q Consensus 628 ~~f~~~~~lg~g~------------~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~---------------- 677 (823)
++|...+.||+|+ |+.||||+++... +...+++.+|++++++++|||||+
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 5788888999986 6779999996543 223578999999999999999999
Q ss_pred -------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccc
Q 045449 678 -------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQ 732 (823)
Q Consensus 678 -------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~ 732 (823)
++.|++.+|+|+|+.+||||||||+|||++.++.+||+|||+|+....... ..
T Consensus 82 ~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~--~~ 159 (298)
T d1gz8a_ 82 FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TY 159 (298)
T ss_dssp CCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSB--CT
T ss_pred ecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCCcc--cc
Confidence 478999999999999999999999999999999999999999987654332 23
Q ss_pred cccccCCCcCcccccCCCc-cccccceehhhhhhccccCCCCCcCCC
Q 045449 733 TQTLATIGYMAPEYGTKGR-VSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 733 ~~~~gt~~y~aPE~~~~~~-~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
....||+.|+|||+..... ++.++||||+||++|+|++|+.||.+.
T Consensus 160 ~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~ 206 (298)
T d1gz8a_ 160 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 206 (298)
T ss_dssp TCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred eeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCC
Confidence 4567999999999877665 588999999999999999999999654
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=99.93 E-value=1.1e-27 Score=248.70 Aligned_cols=149 Identities=26% Similarity=0.387 Sum_probs=127.2
Q ss_pred ccCCccceeeccC------------CeEEEEEEehHh---------hHHHHHHHHHHHHHHhhcc-hhhHHH--------
Q 045449 628 DRFSENNLIGIGN------------GMEVAVKVFHQQ---------YERALKSFEDECEVRKRIR-HRNLVK-------- 677 (823)
Q Consensus 628 ~~f~~~~~lg~g~------------~~~vavK~~~~~---------~~~~~~~~~~E~~~l~~l~-h~niv~-------- 677 (823)
++|...+.||+|+ |+.||||+++.. .+...+.+.+|+.++++++ |||||+
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 5788889999986 678999998542 1344567999999999997 999998
Q ss_pred --------------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCC
Q 045449 678 --------------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSG 725 (823)
Q Consensus 678 --------------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~ 725 (823)
+++|++.+|+|+|+.+|+||||||+|||++.++.+||+|||+|+....
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~ 162 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDP 162 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred cceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeEccC
Confidence 478999999999999999999999999999999999999999998754
Q ss_pred CCccccccccccCCCcCcccccCC------CccccccceehhhhhhccccCCCCCcCCCc
Q 045449 726 EDQLSKQTQTLATIGYMAPEYGTK------GRVSTRGDVCSFGIISGGKETRSMTVGETC 779 (823)
Q Consensus 726 ~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~~ 779 (823)
... ....+||+.|+|||++.+ ..++.++||||+||++|+|++|+.||.+..
T Consensus 163 ~~~---~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~ 219 (277)
T d1phka_ 163 GEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK 219 (277)
T ss_dssp TCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CCc---eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCC
Confidence 322 344679999999998753 346889999999999999999999998764
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.93 E-value=7.3e-28 Score=248.02 Aligned_cols=185 Identities=28% Similarity=0.293 Sum_probs=131.1
Q ss_pred ccCCccceeeccC----------CeEEEEEEehHhhHHHHHHHHHHHHHHhhcchhhHHH--------------------
Q 045449 628 DRFSENNLIGIGN----------GMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVK-------------------- 677 (823)
Q Consensus 628 ~~f~~~~~lg~g~----------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-------------------- 677 (823)
++|...+.||+|+ |..||||+++... ..++|.+|++++++++|||||+
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~i~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~ 84 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA 84 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCT
T ss_pred HHeEEeEEEecCCCeEEEEEEECCeEEEEEEECcHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccC
Confidence 4566677888886 6779999997553 3468999999999999999998
Q ss_pred -----------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccc
Q 045449 678 -----------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQ 734 (823)
Q Consensus 678 -----------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 734 (823)
++.|++++|+|+|+.+|+||||||+||+++.++.+|++|||+++..... ...
T Consensus 85 ~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~-----~~~ 159 (262)
T d1byga_ 85 KGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-----QDT 159 (262)
T ss_dssp TEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC---------------
T ss_pred CCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCCC-----Ccc
Confidence 3578899999999999999999999999999999999999999875432 223
Q ss_pred cccCCCcCcccccCCCccccccceehhhhhhccccC-CCCCcCCCcccccccccccCCcccccccCCCcccccccccccc
Q 045449 735 TLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKET-RSMTVGETCTPVRESKYEVHPATTTIMEHPLPRVGEVMDVDRG 813 (823)
Q Consensus 735 ~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 813 (823)
..+|..|+|||++.++.++.++|||||||++||+++ |+.|+.............. ....+.+....+.+.+++...-.
T Consensus 160 ~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~-~~~~~~~~~~~~~~~~li~~cl~ 238 (262)
T d1byga_ 160 GKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK-GYKMDAPDGCPPAVYEVMKNCWH 238 (262)
T ss_dssp --CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTT-TCCCCCCTTCCHHHHHHHHHHTC
T ss_pred ccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHc-CCCCCCCccCCHHHHHHHHHHcc
Confidence 468999999999999999999999999999999998 6777765432211111100 01112233344555555555544
Q ss_pred cccccCC
Q 045449 814 KARIQGK 820 (823)
Q Consensus 814 ~~~~~~~ 820 (823)
..+-+||
T Consensus 239 ~dP~~Rp 245 (262)
T d1byga_ 239 LDAAMRP 245 (262)
T ss_dssp SSGGGSC
T ss_pred cCHhHCc
Confidence 4444443
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.93 E-value=4.5e-28 Score=256.83 Aligned_cols=149 Identities=30% Similarity=0.344 Sum_probs=124.7
Q ss_pred hccCCccceeeccC-------------CeEEEEEEehHhh--HHHHHHHHHHHHHHhhc---chhhHHH-----------
Q 045449 627 TDRFSENNLIGIGN-------------GMEVAVKVFHQQY--ERALKSFEDECEVRKRI---RHRNLVK----------- 677 (823)
Q Consensus 627 t~~f~~~~~lg~g~-------------~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~----------- 677 (823)
.++|+..+.||+|+ ++.||||+++... +.....+.+|+++++.+ +||||++
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 46788888899886 4569999986432 12224567788887766 7999997
Q ss_pred -----------------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccc
Q 045449 678 -----------------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKL 722 (823)
Q Consensus 678 -----------------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~ 722 (823)
++.|++.+|+|+|+.+|+||||||+|||++.++.+||+|||+++.
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~~ 165 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI 165 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCC
T ss_pred cCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhhhh
Confidence 468999999999999999999999999999999999999999986
Q ss_pred cCCCCccccccccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCCC
Q 045449 723 LSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 723 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
.... ......+||+.|+|||++.+..|+.++||||+||++|+|++|..||.+.
T Consensus 166 ~~~~---~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~ 218 (305)
T d1blxa_ 166 YSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGS 218 (305)
T ss_dssp CCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred hccc---ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCC
Confidence 5432 2234578999999999999999999999999999999999999999754
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.93 E-value=8e-26 Score=236.77 Aligned_cols=254 Identities=19% Similarity=0.214 Sum_probs=196.6
Q ss_pred cEEEeeccccccccCccccCCCCCCeEEeecccccccCCCccCCCcccCcccccCccccCCCCcccccccccCCCCceEE
Q 045449 256 ETLNLGINSFSGTIPSSITNSSKLSDLELGENLFSGFIPNTIGNLRNLEFGNIADNYLTSSTPELSFLSSLTNCKKLKVL 335 (823)
Q Consensus 256 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L 335 (823)
..++.++++++ .+|..+. +++++|+|++|+|+.+.+.+|.++++|++|++++|++.... ...+.++..++.+
T Consensus 14 ~~v~c~~~~L~-~iP~~ip--~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~-----~~~~~~~~~~~~l 85 (284)
T d1ozna_ 14 VTTSCPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARID-----AAAFTGLALLEQL 85 (284)
T ss_dssp CEEECCSSCCS-SCCTTCC--TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEEC-----TTTTTTCTTCCEE
T ss_pred eEEEcCCCCCC-ccCCCCC--CCCCEEECcCCcCCCCCHHHhhccccccccccccccccccc-----ccccccccccccc
Confidence 34577777787 6677664 46899999999999888888999999999999999988773 3456677778887
Q ss_pred Eee-cCCCCccCCccccccccccceEEecCCcceeccCccccCcccccEEEcccCcCCCCchhcccccCCCCEEEccCCC
Q 045449 336 IVT-GNPLDGILPKSIGNFSLSLETILMANCSISGNIPQVVGNLSNLLVLELGGNNLTGPIPVTFSQLQTLQAFDLTRNK 414 (823)
Q Consensus 336 ~Ls-~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~ 414 (823)
+.. .|.++...|..|.++ ++|++|++++|.+....+..+....+|+.+++++|++++..+..|..+++|+.|++++|+
T Consensus 86 ~~~~~~~~~~l~~~~~~~l-~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~ 164 (284)
T d1ozna_ 86 DLSDNAQLRSVDPATFHGL-GRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNR 164 (284)
T ss_dssp ECCSCTTCCCCCTTTTTTC-TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred ccccccccccccchhhccc-ccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCc
Confidence 754 566776667777777 678888888888887777778888888888888888887667778888888888888888
Q ss_pred CCCcchHhhhcCCCCCEEEcccCcCcccccccccCCCCCCeEeccCCccccccchhhhccCCCcEEeccccccccccCcc
Q 045449 415 LAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSVRVLYLGLNIFTSVLSSTIWNLKDILFIDVSSNFLDGPLSLD 494 (823)
Q Consensus 415 l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~LdLs~N~l~g~~p~~ 494 (823)
+++..+..|.++++|+.+++++|++++..|..|.++++|++|++++|.+++..+..|+.+++|++|++++|.+.+..+..
T Consensus 165 l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~~~ 244 (284)
T d1ozna_ 165 ISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRAR 244 (284)
T ss_dssp CCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGGH
T ss_pred ccccchhhhccccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCCCccch
Confidence 88777778888888888888888888888888888888888888888888888888888888888888888887654421
Q ss_pred ccCCCCCcEEEcccCCCCCCCCCcc
Q 045449 495 IGNLKVVIGLDFSRNNLSGDIPITI 519 (823)
Q Consensus 495 ~~~l~~L~~L~ls~N~l~g~ip~~~ 519 (823)
.-...++.+....+++.+..|..+
T Consensus 245 -~l~~~l~~~~~~~~~~~C~~p~~l 268 (284)
T d1ozna_ 245 -PLWAWLQKFRGSSSEVPCSLPQRL 268 (284)
T ss_dssp -HHHHHHHHCCSEECCCBEEESGGG
T ss_pred -HHHHHHHhCcCCCCceEeCCchHH
Confidence 112234455556666666555554
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.93 E-value=3.2e-28 Score=253.08 Aligned_cols=147 Identities=22% Similarity=0.289 Sum_probs=122.9
Q ss_pred ccCCccceeeccC------------CeEEEEEEehHhhH------HHHHHHHHHHHHHhhcc--hhhHHH----------
Q 045449 628 DRFSENNLIGIGN------------GMEVAVKVFHQQYE------RALKSFEDECEVRKRIR--HRNLVK---------- 677 (823)
Q Consensus 628 ~~f~~~~~lg~g~------------~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~--h~niv~---------- 677 (823)
++|...+.||+|+ |+.||||++..... ....++.+|++++++++ |||||+
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 5788888999986 67799999875431 11245778999999996 899998
Q ss_pred -------------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCC-CCcEEEeecccccccCC
Q 045449 678 -------------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDE-DMVAHISDFGIAKLLSG 725 (823)
Q Consensus 678 -------------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~-~~~~kl~DfGla~~~~~ 725 (823)
++.|++++|+|+|+++|+||||||+|||++. ++.+||+|||+|+....
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~~ 163 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD 163 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCS
T ss_pred EEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceeccc
Confidence 4689999999999999999999999999985 47999999999987543
Q ss_pred CCccccccccccCCCcCcccccCCCcc-ccccceehhhhhhccccCCCCCcCCC
Q 045449 726 EDQLSKQTQTLATIGYMAPEYGTKGRV-STRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 726 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
. ..+..+||+.|+|||++.+..+ +.++||||+||++|+|++|+.||...
T Consensus 164 ~----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~ 213 (273)
T d1xwsa_ 164 T----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 213 (273)
T ss_dssp S----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH
T ss_pred c----cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCc
Confidence 2 2345689999999999887765 67799999999999999999999764
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.93 E-value=3.5e-27 Score=251.97 Aligned_cols=144 Identities=26% Similarity=0.343 Sum_probs=121.9
Q ss_pred hccCCcc-ceeeccC------------CeEEEEEEehHhhHHHHHHHHHHHHHHhhc-chhhHHH---------------
Q 045449 627 TDRFSEN-NLIGIGN------------GMEVAVKVFHQQYERALKSFEDECEVRKRI-RHRNLVK--------------- 677 (823)
Q Consensus 627 t~~f~~~-~~lg~g~------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~--------------- 677 (823)
.++|... ++||.|+ ++.||||+++.. +.+.+|++++.++ +|||||+
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence 3567654 5689886 677999999654 4577899987665 8999997
Q ss_pred -------------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCC---CCcEEEeeccccccc
Q 045449 678 -------------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDE---DMVAHISDFGIAKLL 723 (823)
Q Consensus 678 -------------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~---~~~~kl~DfGla~~~ 723 (823)
++.|++.+|+|+|+.+|+||||||+|||++. ++.+||+|||+|+..
T Consensus 85 ~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~ 164 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET 164 (335)
T ss_dssp EEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred EEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccceeeec
Confidence 4789999999999999999999999999985 467999999999876
Q ss_pred CCCCccccccccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCCC
Q 045449 724 SGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 724 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
..... ....+||+.|||||++.+..|+.++||||+||++|+|++|..||.+.
T Consensus 165 ~~~~~---~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~ 216 (335)
T d2ozaa1 165 TSHNS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSN 216 (335)
T ss_dssp CCCCC---CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEET
T ss_pred cCCCc---cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCC
Confidence 54332 34567999999999999999999999999999999999999999654
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.93 E-value=1e-27 Score=252.76 Aligned_cols=138 Identities=30% Similarity=0.354 Sum_probs=118.6
Q ss_pred eEEEEEEehHhh-HHHHHHHHHHHHHHhhc-chhhHHH------------------------------------------
Q 045449 642 MEVAVKVFHQQY-ERALKSFEDECEVRKRI-RHRNLVK------------------------------------------ 677 (823)
Q Consensus 642 ~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~------------------------------------------ 677 (823)
..||||+++... .....++.+|+..+.++ +|||||+
T Consensus 46 ~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~ 125 (299)
T d1fgka_ 46 TKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPS 125 (299)
T ss_dssp EEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHTTSCC---------
T ss_pred eEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccc
Confidence 469999997654 45567899999999999 8999998
Q ss_pred --------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccccccCCCcCc
Q 045449 678 --------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQTLATIGYMA 743 (823)
Q Consensus 678 --------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a 743 (823)
++.|++.+|+|+|+.+||||||||+|||++.++.+||+|||+++...............||+.|+|
T Consensus 126 ~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~a 205 (299)
T d1fgka_ 126 HNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMA 205 (299)
T ss_dssp ---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSC
T ss_pred cCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceeecCCCCeEeccchhhccccccccccccccCCCChhhhh
Confidence 246889999999999999999999999999999999999999997765444444455679999999
Q ss_pred ccccCCCccccccceehhhhhhccccC-CCCCcCCCc
Q 045449 744 PEYGTKGRVSTRGDVCSFGIISGGKET-RSMTVGETC 779 (823)
Q Consensus 744 PE~~~~~~~~~~~Dv~S~Gvv~~~~~~-~~~~~~~~~ 779 (823)
||++.++.|+.++|||||||++|++++ |..||.+..
T Consensus 206 PE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~ 242 (299)
T d1fgka_ 206 PEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 242 (299)
T ss_dssp HHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred hhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCC
Confidence 999999999999999999999999997 677886654
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.93 E-value=2.3e-27 Score=252.01 Aligned_cols=148 Identities=23% Similarity=0.274 Sum_probs=127.2
Q ss_pred hccCCccceeeccC------------CeEEEEEEehHhhHHHHHHHHHHHHHHhhcchhhHHH-----------------
Q 045449 627 TDRFSENNLIGIGN------------GMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVK----------------- 677 (823)
Q Consensus 627 t~~f~~~~~lg~g~------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~----------------- 677 (823)
.++|...+.||+|+ ++.||||+++..... ...+.+|++++++++|||||+
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~-~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHH-HHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCccc-HHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence 36788888999986 677999999765432 356889999999999999999
Q ss_pred ------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCC--CcEEEeecccccccCCCCcccc
Q 045449 678 ------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDED--MVAHISDFGIAKLLSGEDQLSK 731 (823)
Q Consensus 678 ------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~--~~~kl~DfGla~~~~~~~~~~~ 731 (823)
++.|++++|+|+|+.+|+||||||+|||++.+ ..+||+|||+++.......
T Consensus 83 ~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~--- 159 (321)
T d1tkia_ 83 ISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN--- 159 (321)
T ss_dssp CCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE---
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccCCc---
Confidence 46899999999999999999999999999844 5899999999987654322
Q ss_pred ccccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCCC
Q 045449 732 QTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 732 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
.....||+.|+|||...+..|+.++||||+||++|+|++|..||...
T Consensus 160 ~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~ 206 (321)
T d1tkia_ 160 FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAE 206 (321)
T ss_dssp EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred ccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCC
Confidence 23467899999999999999999999999999999999999999764
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.93 E-value=4.7e-27 Score=252.98 Aligned_cols=152 Identities=27% Similarity=0.338 Sum_probs=125.9
Q ss_pred hccCCccceeeccC------------CeEEEEEEehHh-hHHHHHHHHHHHHHHhhcchhhHHH----------------
Q 045449 627 TDRFSENNLIGIGN------------GMEVAVKVFHQQ-YERALKSFEDECEVRKRIRHRNLVK---------------- 677 (823)
Q Consensus 627 t~~f~~~~~lg~g~------------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~---------------- 677 (823)
+++|...+.||+|+ |+.||||++... .....+++.+|++++++++||||++
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 45788888899886 677999999643 3455678999999999999999997
Q ss_pred ---------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCcc-
Q 045449 678 ---------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQL- 729 (823)
Q Consensus 678 ---------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~- 729 (823)
++.|++.+|+|+|+.||+||||||+|||++.++.+||+|||+|+........
T Consensus 87 ~l~~~~~~g~L~~~l~~~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~~~ 166 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHT 166 (345)
T ss_dssp EEEEECCCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBC
T ss_pred EEEEeecCCchhhhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccCCCccc
Confidence 4689999999999999999999999999999999999999999876433221
Q ss_pred ccccccccCCCcCcccccCC-CccccccceehhhhhhccccCCCCCcCCC
Q 045449 730 SKQTQTLATIGYMAPEYGTK-GRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 730 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
......+||+.|+|||++.. ..++.++||||+||++++|++|..||...
T Consensus 167 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~ 216 (345)
T d1pmea_ 167 GFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGK 216 (345)
T ss_dssp CTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred eeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCC
Confidence 22345679999999999854 45789999999999999999999998653
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.92 E-value=2.8e-27 Score=252.19 Aligned_cols=152 Identities=26% Similarity=0.335 Sum_probs=125.0
Q ss_pred hccCCccceeeccC------------CeEEEEEEehHhh--HHHHHHHHHHHHHHhhcchhhHHH---------------
Q 045449 627 TDRFSENNLIGIGN------------GMEVAVKVFHQQY--ERALKSFEDECEVRKRIRHRNLVK--------------- 677 (823)
Q Consensus 627 t~~f~~~~~lg~g~------------~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~--------------- 677 (823)
.++|+..+.||+|+ |+.||||++.... +...+++.+|++++++++||||++
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 36888888999986 6789999986442 334467899999999999999997
Q ss_pred ---------------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccC
Q 045449 678 ---------------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLS 724 (823)
Q Consensus 678 ---------------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~ 724 (823)
++.|++++|+|+|+.+|+||||||+|||++.++.+|++|||+|+...
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~ 168 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFS 168 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred CceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceeeecc
Confidence 46799999999999999999999999999999999999999998765
Q ss_pred CCCcc--ccccccccCCCcCcccccCCC-ccccccceehhhhhhccccCCCCCcCCC
Q 045449 725 GEDQL--SKQTQTLATIGYMAPEYGTKG-RVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 725 ~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
..... ......+||+.|+|||++.+. .|+.++||||+||+++++++|..||.+.
T Consensus 169 ~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~ 225 (318)
T d3blha1 169 LAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGN 225 (318)
T ss_dssp C-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCC
Confidence 33221 122345799999999998765 6899999999999999999999999753
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.92 E-value=2.1e-27 Score=251.69 Aligned_cols=148 Identities=25% Similarity=0.316 Sum_probs=125.6
Q ss_pred ccCCccceeeccC-----------------CeEEEEEEehHhh-HHHHHHHHHHHHHHhhc-chhhHHH-----------
Q 045449 628 DRFSENNLIGIGN-----------------GMEVAVKVFHQQY-ERALKSFEDECEVRKRI-RHRNLVK----------- 677 (823)
Q Consensus 628 ~~f~~~~~lg~g~-----------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~----------- 677 (823)
++|...+.||.|+ ++.||||+++... .....+|.+|+.+++++ +|||||+
T Consensus 23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~ 102 (311)
T d1t46a_ 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT 102 (311)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEE
Confidence 5677778888886 2458999997543 44456899999999999 6999998
Q ss_pred -----------------------------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCC
Q 045449 678 -----------------------------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDM 710 (823)
Q Consensus 678 -----------------------------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~ 710 (823)
++.|++.+|+|+|++++|||||||+||+++.++
T Consensus 103 ~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~~~~~ 182 (311)
T d1t46a_ 103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGR 182 (311)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEETTT
T ss_pred EEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccccccccccC
Confidence 257889999999999999999999999999999
Q ss_pred cEEEeecccccccCCCCccccccccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCc
Q 045449 711 VAHISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTV 775 (823)
Q Consensus 711 ~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~ 775 (823)
.+|++|||.++..............+||+.|+|||++.++.++.++|||||||++|||+++..|+
T Consensus 183 ~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~ 247 (311)
T d1t46a_ 183 ITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP 247 (311)
T ss_dssp EEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCS
T ss_pred cccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCC
Confidence 99999999999876554444455678999999999999999999999999999999999855443
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.92 E-value=2.1e-27 Score=250.71 Aligned_cols=150 Identities=23% Similarity=0.250 Sum_probs=124.7
Q ss_pred ccCCccceeeccC------------CeEEEEEEehHhhHHHHHHHHHHHHHHhhcchhhHHH------------------
Q 045449 628 DRFSENNLIGIGN------------GMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVK------------------ 677 (823)
Q Consensus 628 ~~f~~~~~lg~g~------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------------ 677 (823)
++|+..+.||+|+ |+.||||++..... .+++.+|++++++++|+++|.
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~ 84 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 84 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence 4688888999986 67899998865432 246889999999998887775
Q ss_pred -----------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCC---CCcEEEeecccccccCCCCcc--
Q 045449 678 -----------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDE---DMVAHISDFGIAKLLSGEDQL-- 729 (823)
Q Consensus 678 -----------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~---~~~~kl~DfGla~~~~~~~~~-- 729 (823)
++.|++.+|+|+|+.+|+||||||+|||++. +..+|++|||+|+........
T Consensus 85 ~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~~ 164 (299)
T d1ckia_ 85 LGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQH 164 (299)
T ss_dssp CCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCCB
T ss_pred cCCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceeccccccccc
Confidence 4679999999999999999999999999863 457999999999987543321
Q ss_pred ---ccccccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCCCc
Q 045449 730 ---SKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGETC 779 (823)
Q Consensus 730 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~~ 779 (823)
......+||+.|||||++.+..++.++|||||||+++++.+|+.||....
T Consensus 165 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~ 217 (299)
T d1ckia_ 165 IPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLK 217 (299)
T ss_dssp CCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC
T ss_pred eeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccc
Confidence 12345679999999999999999999999999999999999999997643
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.92 E-value=2.2e-27 Score=249.28 Aligned_cols=149 Identities=19% Similarity=0.220 Sum_probs=123.0
Q ss_pred ccCCccceeeccC------------CeEEEEEEehHhhHHHHHHHHHHHHHHhhcch-hhHHH-----------------
Q 045449 628 DRFSENNLIGIGN------------GMEVAVKVFHQQYERALKSFEDECEVRKRIRH-RNLVK----------------- 677 (823)
Q Consensus 628 ~~f~~~~~lg~g~------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~----------------- 677 (823)
++|...+.||+|+ |+.||||++..... ...+.+|++.+.++.| +|++.
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~ 82 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL 82 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEe
Confidence 5788888999986 67799999854422 2457788889998866 77765
Q ss_pred -----------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCC-----CCcEEEeecccccccCCCCc-
Q 045449 678 -----------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDE-----DMVAHISDFGIAKLLSGEDQ- 728 (823)
Q Consensus 678 -----------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~-----~~~~kl~DfGla~~~~~~~~- 728 (823)
++.|++.+|+|+|+.||+||||||+|||++. ++.+||+|||+|+.......
T Consensus 83 ~~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~~ 162 (293)
T d1csna_ 83 LGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTK 162 (293)
T ss_dssp CCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTC
T ss_pred cCCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcccCccc
Confidence 4678999999999999999999999999974 56899999999997653321
Q ss_pred ----cccccccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCCC
Q 045449 729 ----LSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 729 ----~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
.......+||+.|||||++.+..++.++||||+||++|++++|..||.+.
T Consensus 163 ~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~ 216 (293)
T d1csna_ 163 QHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGL 216 (293)
T ss_dssp CBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSC
T ss_pred cceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCc
Confidence 11233567999999999999999999999999999999999999999754
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=99.92 E-value=2e-27 Score=249.15 Aligned_cols=149 Identities=26% Similarity=0.368 Sum_probs=122.9
Q ss_pred ccCCccceeeccC-----------CeEEEEEEehHhh--HHHHHHHHHHHHHHhhcchhhHHH-----------------
Q 045449 628 DRFSENNLIGIGN-----------GMEVAVKVFHQQY--ERALKSFEDECEVRKRIRHRNLVK----------------- 677 (823)
Q Consensus 628 ~~f~~~~~lg~g~-----------~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~----------------- 677 (823)
++|..-+.||+|+ |+.||||++.... +...++|.+|+.++++++|||||+
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 5777788888886 6779999986432 233478999999999999999998
Q ss_pred -----------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccccccc
Q 045449 678 -----------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQTQ 734 (823)
Q Consensus 678 -----------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 734 (823)
++.|++.+|+|+|+.+||||||||+|||++.++.+|++|||.|........ ....
T Consensus 82 ~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~--~~~~ 159 (286)
T d1ob3a_ 82 LDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR--KYTH 159 (286)
T ss_dssp CSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---------
T ss_pred ehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCcc--ccce
Confidence 478999999999999999999999999999999999999999987654322 2334
Q ss_pred cccCCCcCcccccCCC-ccccccceehhhhhhccccCCCCCcCCC
Q 045449 735 TLATIGYMAPEYGTKG-RVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 735 ~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
..|++.|+|||.+.+. .++.++||||+||+++++.+|+.||.+.
T Consensus 160 ~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~ 204 (286)
T d1ob3a_ 160 EIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGV 204 (286)
T ss_dssp --CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCC
Confidence 5789999999988754 4699999999999999999999999754
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.92 E-value=2.8e-27 Score=250.54 Aligned_cols=148 Identities=25% Similarity=0.339 Sum_probs=118.2
Q ss_pred ccCCccceeeccC------------C--eEEEEEEehHh-hHHHHHHHHHHHHHHhhc-chhhHHH--------------
Q 045449 628 DRFSENNLIGIGN------------G--MEVAVKVFHQQ-YERALKSFEDECEVRKRI-RHRNLVK-------------- 677 (823)
Q Consensus 628 ~~f~~~~~lg~g~------------~--~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~-------------- 677 (823)
++|...+.||+|+ | ..||||++... .....++|.+|+++++++ +|||||+
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 5677788899886 2 24788887543 334557899999999999 7999998
Q ss_pred ------------------------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEe
Q 045449 678 ------------------------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHIS 715 (823)
Q Consensus 678 ------------------------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~ 715 (823)
++.|++.+|+|+|+.+|+||||||+|||++.++.+||+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~~~kl~ 169 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIA 169 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEEC
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCCceEEc
Confidence 24688999999999999999999999999999999999
Q ss_pred ecccccccCCCCccccccccccCCCcCcccccCCCccccccceehhhhhhccccCCCC-CcCCC
Q 045449 716 DFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSM-TVGET 778 (823)
Q Consensus 716 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~-~~~~~ 778 (823)
|||+|+...... ......||..|+|||.+.++.|+.++|||||||++|||+++.. ||.+.
T Consensus 170 DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~ 230 (309)
T d1fvra_ 170 DFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM 230 (309)
T ss_dssp CTTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred cccccccccccc---cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCC
Confidence 999998653222 1234568999999999999999999999999999999999765 56543
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.92 E-value=1.9e-26 Score=248.58 Aligned_cols=147 Identities=30% Similarity=0.370 Sum_probs=123.8
Q ss_pred hccCCccceeeccC------------CeEEEEEEehHh--hHHHHHHHHHHHHHHhhcchhhHHH---------------
Q 045449 627 TDRFSENNLIGIGN------------GMEVAVKVFHQQ--YERALKSFEDECEVRKRIRHRNLVK--------------- 677 (823)
Q Consensus 627 t~~f~~~~~lg~g~------------~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~--------------- 677 (823)
.++|...+.||+|+ |+.||||+++.. .+...+.+.+|++++++++|||||+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 46788888888886 677999999743 2455678999999999999999997
Q ss_pred -----------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCc
Q 045449 678 -----------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQ 728 (823)
Q Consensus 678 -----------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~ 728 (823)
++.|++.+|+|+|+.||+||||||+|||++.++.+|++|||+|+.....
T Consensus 97 ~~~lv~e~~~~~l~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~~-- 174 (346)
T d1cm8a_ 97 DFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE-- 174 (346)
T ss_dssp CCEEEEECCSEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSS--
T ss_pred eEEEEEecccccHHHHHHhccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceeccCCc--
Confidence 4679999999999999999999999999999999999999999876432
Q ss_pred cccccccccCCCcCcccccCCC-ccccccceehhhhhhccccCCCCCcCCC
Q 045449 729 LSKQTQTLATIGYMAPEYGTKG-RVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 729 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
.+..+||+.|+|||++.+. .++.++||||+||+++++++|..||.+.
T Consensus 175 ---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~ 222 (346)
T d1cm8a_ 175 ---MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGS 222 (346)
T ss_dssp ---CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ---cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCC
Confidence 2456799999999988764 5689999999999999999999999664
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.91 E-value=3.8e-26 Score=240.75 Aligned_cols=149 Identities=28% Similarity=0.332 Sum_probs=110.3
Q ss_pred ccCCccceeeccC----------CeEEEEEEehHhhHHHHHHHHHHHHHHhhcchhhHHH--------------------
Q 045449 628 DRFSENNLIGIGN----------GMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVK-------------------- 677 (823)
Q Consensus 628 ~~f~~~~~lg~g~----------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-------------------- 677 (823)
++|...+.||+|+ |..||||+++..... ...++.|+..+.+++|||||+
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~~g~~vAvK~~~~~~~~-~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~E 81 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD 81 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEETTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccchh-HHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEe
Confidence 3455567788886 677999999755432 123345566667889999999
Q ss_pred -----------------------HHHHHHHHhhhcC--------CCCEEeccCCCCCEEeCCCCcEEEeecccccccCCC
Q 045449 678 -----------------------IISSSLEYLHFGH--------SIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGE 726 (823)
Q Consensus 678 -----------------------~~~~~l~~L~~~h--------~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~ 726 (823)
++.+++.+|+|+| +++|+||||||+|||++.++.+||+|||+++.....
T Consensus 82 y~~~g~L~~~l~~~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~~ 161 (303)
T d1vjya_ 82 YHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSA 161 (303)
T ss_dssp CCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEETT
T ss_pred cccCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccccCC
Confidence 1234444444444 579999999999999999999999999999987544
Q ss_pred Cccc--cccccccCCCcCcccccCCC------ccccccceehhhhhhccccCCCCCcCC
Q 045449 727 DQLS--KQTQTLATIGYMAPEYGTKG------RVSTRGDVCSFGIISGGKETRSMTVGE 777 (823)
Q Consensus 727 ~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~S~Gvv~~~~~~~~~~~~~ 777 (823)
.... .....+||+.|+|||++.+. .++.++|||||||++||+++|..|+..
T Consensus 162 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~ 220 (303)
T d1vjya_ 162 TDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI 220 (303)
T ss_dssp TTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTB
T ss_pred CcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCc
Confidence 3221 23356799999999997654 368899999999999999999877643
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.91 E-value=2.3e-26 Score=248.07 Aligned_cols=143 Identities=28% Similarity=0.372 Sum_probs=121.0
Q ss_pred cCCccceeeccC------------CeEEEEEEehHhhHHHHHHHHHHHHHHhhcchhhHHH-------------------
Q 045449 629 RFSENNLIGIGN------------GMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLVK------------------- 677 (823)
Q Consensus 629 ~f~~~~~lg~g~------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------------- 677 (823)
+|...++||+|+ |+.||||++.... +.+.+|++++++++|||||+
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS----SSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccc----hHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 566778899986 6779999996543 23457999999999999998
Q ss_pred ------------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCC-cEEEeecccccccCCC
Q 045449 678 ------------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDM-VAHISDFGIAKLLSGE 726 (823)
Q Consensus 678 ------------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~-~~kl~DfGla~~~~~~ 726 (823)
++.|++.+|+|+|++||+||||||+|||++.++ .+||+|||+|+.....
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~ 176 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 176 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEECCTT
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhccCC
Confidence 367999999999999999999999999999775 8999999999876543
Q ss_pred CccccccccccCCCcCcccccCC-CccccccceehhhhhhccccCCCCCcCCC
Q 045449 727 DQLSKQTQTLATIGYMAPEYGTK-GRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 727 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
.. ....+||+.|+|||.+.+ ..|+.++||||+||++|++++|..||...
T Consensus 177 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~ 226 (350)
T d1q5ka_ 177 EP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD 226 (350)
T ss_dssp SC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCS
T ss_pred cc---cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCC
Confidence 32 234679999999998765 56899999999999999999999998654
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.91 E-value=9.9e-26 Score=237.12 Aligned_cols=147 Identities=25% Similarity=0.315 Sum_probs=125.1
Q ss_pred ccCCccceeeccC------------CeEEEEEEehHhh--HHHHHHHHHHHHHHhhcchhhHHH----------------
Q 045449 628 DRFSENNLIGIGN------------GMEVAVKVFHQQY--ERALKSFEDECEVRKRIRHRNLVK---------------- 677 (823)
Q Consensus 628 ~~f~~~~~lg~g~------------~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~---------------- 677 (823)
++|+..+.||+|+ ++.||||+++... +...+++.+|++++++++|||||+
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 5788888999886 6679999985432 345678999999999999999998
Q ss_pred ------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCcccccc
Q 045449 678 ------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQT 733 (823)
Q Consensus 678 ------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~ 733 (823)
++.|++++|+|+|+.+|+||||||+|||++.++.+|++|||.|+....... ...
T Consensus 82 ~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~--~~~ 159 (292)
T d1unla_ 82 FCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR--CYS 159 (292)
T ss_dssp CCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS--CCC
T ss_pred eccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCCc--cce
Confidence 478999999999999999999999999999999999999999998654332 223
Q ss_pred ccccCCCcCcccccCCCc-cccccceehhhhhhccccCCCCCcC
Q 045449 734 QTLATIGYMAPEYGTKGR-VSTRGDVCSFGIISGGKETRSMTVG 776 (823)
Q Consensus 734 ~~~gt~~y~aPE~~~~~~-~~~~~Dv~S~Gvv~~~~~~~~~~~~ 776 (823)
...+++.|+|||++.... ++.++||||+||++++|++|..||.
T Consensus 160 ~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 203 (292)
T d1unla_ 160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLF 203 (292)
T ss_dssp SCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSC
T ss_pred eeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCC
Confidence 456789999999887665 6899999999999999999999864
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.91 E-value=8.3e-27 Score=247.81 Aligned_cols=150 Identities=25% Similarity=0.338 Sum_probs=124.3
Q ss_pred ccCCccceeeccC---------------CeEEEEEEehHhh----HHHHHHHHHHHHHHhhcch-hhHHH----------
Q 045449 628 DRFSENNLIGIGN---------------GMEVAVKVFHQQY----ERALKSFEDECEVRKRIRH-RNLVK---------- 677 (823)
Q Consensus 628 ~~f~~~~~lg~g~---------------~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h-~niv~---------- 677 (823)
++|+..+.||+|+ |+.||||+++... ....+.+.+|++++++++| |||++
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 6688889999886 4669999986432 2234678899999999977 89998
Q ss_pred ------------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCC
Q 045449 678 ------------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGED 727 (823)
Q Consensus 678 ------------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~ 727 (823)
+++|++.+|+|+|+.+|+||||||+|||++.++.+||+|||+|+.+....
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~~~ 183 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADE 183 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCGGG
T ss_pred eeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhhhcccc
Confidence 46899999999999999999999999999999999999999998764333
Q ss_pred ccccccccccCCCcCcccccCCC--ccccccceehhhhhhccccCCCCCcCCC
Q 045449 728 QLSKQTQTLATIGYMAPEYGTKG--RVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 728 ~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
. .......|++.|+|||.+.+. .++.++||||+||++|+|++|..||...
T Consensus 184 ~-~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~ 235 (322)
T d1vzoa_ 184 T-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVD 235 (322)
T ss_dssp G-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCT
T ss_pred c-ccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence 2 223456799999999998764 4688999999999999999999999664
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=99.90 E-value=2.2e-25 Score=238.32 Aligned_cols=145 Identities=22% Similarity=0.328 Sum_probs=123.8
Q ss_pred ccCCccceeeccC------------CeEEEEEEehHhhHHHHHHHHHHHHHHhhcc-hhhHHH-----------------
Q 045449 628 DRFSENNLIGIGN------------GMEVAVKVFHQQYERALKSFEDECEVRKRIR-HRNLVK----------------- 677 (823)
Q Consensus 628 ~~f~~~~~lg~g~------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~----------------- 677 (823)
++|...+.||.|+ |+.||||+++... .+++.+|+++++++. ||||++
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 5788889999986 6779999997543 257889999999995 999998
Q ss_pred ----------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCC-cEEEeecccccccCCCCccccccc
Q 045449 678 ----------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDM-VAHISDFGIAKLLSGEDQLSKQTQ 734 (823)
Q Consensus 678 ----------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~-~~kl~DfGla~~~~~~~~~~~~~~ 734 (823)
++.|++.+|.|+|++||+||||||+|||++.++ .+||+|||+|+....... ...
T Consensus 112 e~~~~~~L~~~~~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~~---~~~ 188 (328)
T d3bqca1 112 EHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE---YNV 188 (328)
T ss_dssp ECCCSCBGGGTTTSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTCC---CCS
T ss_pred eecCCCcHHHHhcCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccCCCc---ccc
Confidence 478999999999999999999999999998654 699999999987654332 345
Q ss_pred cccCCCcCcccccCCC-ccccccceehhhhhhccccCCCCCcCCC
Q 045449 735 TLATIGYMAPEYGTKG-RVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 735 ~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
.+||+.|+|||.+.+. .++.++||||+||+++++.+|..||...
T Consensus 189 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~ 233 (328)
T d3bqca1 189 RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHG 233 (328)
T ss_dssp CCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred cccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCC
Confidence 6799999999997765 4799999999999999999999998654
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.90 E-value=2.7e-25 Score=240.10 Aligned_cols=148 Identities=28% Similarity=0.341 Sum_probs=119.9
Q ss_pred ccCCccceeeccC------------CeEEEEEEehHhh--HHHHHHHHHHHHHHhhcchhhHHH----------------
Q 045449 628 DRFSENNLIGIGN------------GMEVAVKVFHQQY--ERALKSFEDECEVRKRIRHRNLVK---------------- 677 (823)
Q Consensus 628 ~~f~~~~~lg~g~------------~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~---------------- 677 (823)
++|...+.||+|+ |+.||||++.... ....+++.+|+.++++++|||||+
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 5788888999986 6789999996442 445578999999999999999998
Q ss_pred ---------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCccc
Q 045449 678 ---------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLS 730 (823)
Q Consensus 678 ---------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~ 730 (823)
++.|++.+|+|+|+.||+||||||+|||++.++.+|++|||+++......
T Consensus 97 ~~iv~Ey~~~~l~~~~~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~~--- 173 (355)
T d2b1pa1 97 VYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF--- 173 (355)
T ss_dssp EEEEEECCSEEHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-----------
T ss_pred eEEEEeccchHHHHhhhcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhcccccc---
Confidence 46899999999999999999999999999999999999999988754432
Q ss_pred cccccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCCC
Q 045449 731 KQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 731 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
.....+||+.|+|||++.+..++.++||||+||+++++.+|..||.+.
T Consensus 174 ~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~ 221 (355)
T d2b1pa1 174 MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR 221 (355)
T ss_dssp -------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCC
Confidence 234567999999999999999999999999999999999999998643
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.89 E-value=3.1e-25 Score=239.40 Aligned_cols=147 Identities=32% Similarity=0.394 Sum_probs=122.6
Q ss_pred hccCCccceeeccC------------CeEEEEEEehHhh--HHHHHHHHHHHHHHhhcchhhHHH---------------
Q 045449 627 TDRFSENNLIGIGN------------GMEVAVKVFHQQY--ERALKSFEDECEVRKRIRHRNLVK--------------- 677 (823)
Q Consensus 627 t~~f~~~~~lg~g~------------~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~--------------- 677 (823)
+++|+..+.||+|+ |+.||||++.... ....+++.+|++++++++|||||+
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 56788888999986 6789999997443 344568999999999999999997
Q ss_pred -----------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCc
Q 045449 678 -----------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQ 728 (823)
Q Consensus 678 -----------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~ 728 (823)
++.|++.+|+|+|+.||+||||||+|||++.++.+|++|||+|.....
T Consensus 97 ~~~i~~~~~gg~L~~~~~~~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~--- 173 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD--- 173 (348)
T ss_dssp CCEEEEECCSEEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCTG---
T ss_pred eEEEEEeecCCchhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcccCc---
Confidence 468999999999999999999999999999999999999999976532
Q ss_pred cccccccccCCCcCcccccCCCc-cccccceehhhhhhccccCCCCCcCCC
Q 045449 729 LSKQTQTLATIGYMAPEYGTKGR-VSTRGDVCSFGIISGGKETRSMTVGET 778 (823)
Q Consensus 729 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~S~Gvv~~~~~~~~~~~~~~ 778 (823)
......||+.|+|||+..+.. ++.++||||+||++|++++|..||.+.
T Consensus 174 --~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~ 222 (348)
T d2gfsa1 174 --EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 222 (348)
T ss_dssp --GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred --ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCC
Confidence 234467999999999876654 689999999999999999999998653
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.89 E-value=4.1e-23 Score=213.57 Aligned_cols=202 Identities=20% Similarity=0.209 Sum_probs=136.3
Q ss_pred CCCCCcEEEccCCcccccCCcccccCCCCccEEEeeccccccccCccccCCCCCCeEEeecccccccCCCccCCCcccCc
Q 045449 226 NMSALKEISLLNNSLSGSLPSRIDLSLPNVETLNLGINSFSGTIPSSITNSSKLSDLELGENLFSGFIPNTIGNLRNLEF 305 (823)
Q Consensus 226 ~l~~L~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 305 (823)
+...+.+++.+++.|+ .+|..+. ++|++|+|++|+|++..+.+|.++++|++|+|++|+|+.. | .++.+++|++
T Consensus 8 ~~~~~~~v~C~~~~L~-~iP~~lp---~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~l-~-~~~~l~~L~~ 81 (266)
T d1p9ag_ 8 KVASHLEVNCDKRNLT-ALPPDLP---KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKL-Q-VDGTLPVLGT 81 (266)
T ss_dssp CSTTCCEEECTTSCCS-SCCSCCC---TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEE-E-CCSCCTTCCE
T ss_pred ccCCCeEEEccCCCCC-eeCcCcC---cCCCEEECcCCcCCCcCHHHhhcccccccccccccccccc-c-cccccccccc
Confidence 4556666777777777 6776553 4677777777777766666777777777777777777643 2 2455666666
Q ss_pred ccccCccccCCCCcccccccccCCCCceEEEeecCCCCccCCccccccccccceEEecCCcceeccCccccCcccccEEE
Q 045449 306 GNIADNYLTSSTPELSFLSSLTNCKKLKVLIVTGNPLDGILPKSIGNFSLSLETILMANCSISGNIPQVVGNLSNLLVLE 385 (823)
Q Consensus 306 L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 385 (823)
|+|++|+++.. +..+.+++ +|++|++++|.+.+..+..+..+.++++|+
T Consensus 82 L~Ls~N~l~~~------~~~~~~l~-------------------------~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~ 130 (266)
T d1p9ag_ 82 LDLSHNQLQSL------PLLGQTLP-------------------------ALTVLDVSFNRLTSLPLGALRGLGELQELY 130 (266)
T ss_dssp EECCSSCCSSC------CCCTTTCT-------------------------TCCEEECCSSCCCCCCSSTTTTCTTCCEEE
T ss_pred ccccccccccc------cccccccc-------------------------ccccccccccccceeecccccccccccccc
Confidence 66666665543 12333444 455555555555555555666667777777
Q ss_pred cccCcCCCCchhcccccCCCCEEEccCCCCCCcchHhhhcCCCCCEEEcccCcCcccccccccCCCCCCeEeccCCcccc
Q 045449 386 LGGNNLTGPIPVTFSQLQTLQAFDLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSVRVLYLGLNIFTS 465 (823)
Q Consensus 386 Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~ 465 (823)
+++|.+++..+..+..+++|+.|++++|+|++..+..|..+++|++|+|++|+|+ .+|..+..+++|+.|+|++|.+.-
T Consensus 131 l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~C 209 (266)
T d1p9ag_ 131 LKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLC 209 (266)
T ss_dssp CTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCC
T ss_pred ccccccceeccccccccccchhcccccccccccCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCCCC
Confidence 7777777666666677777777777777777776667777777777777777777 677777777788888888887653
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.89 E-value=5.8e-23 Score=212.46 Aligned_cols=202 Identities=20% Similarity=0.191 Sum_probs=163.8
Q ss_pred CCCccEEEeeccccccccCccccCCCCCCeEEeecccccccCCCccCCCcccCcccccCccccCCCCcccccccccCCCC
Q 045449 252 LPNVETLNLGINSFSGTIPSSITNSSKLSDLELGENLFSGFIPNTIGNLRNLEFGNIADNYLTSSTPELSFLSSLTNCKK 331 (823)
Q Consensus 252 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~ 331 (823)
...+.+.|.++++++ .+|..+. +++++|+|++|+|++..+.+|.++++|++|+|++|+|+.. ..++.++
T Consensus 9 ~~~~~~v~C~~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~l-------~~~~~l~- 77 (266)
T d1p9ag_ 9 VASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKL-------QVDGTLP- 77 (266)
T ss_dssp STTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEE-------ECCSCCT-
T ss_pred cCCCeEEEccCCCCC-eeCcCcC--cCCCEEECcCCcCCCcCHHHhhcccccccccccccccccc-------ccccccc-
Confidence 445566788888887 4676554 4678888888888777666777777777777777776543 1223334
Q ss_pred ceEEEeecCCCCccCCccccccccccceEEecCCcceeccCccccCcccccEEEcccCcCCCCchhcccccCCCCEEEcc
Q 045449 332 LKVLIVTGNPLDGILPKSIGNFSLSLETILMANCSISGNIPQVVGNLSNLLVLELGGNNLTGPIPVTFSQLQTLQAFDLT 411 (823)
Q Consensus 332 L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls 411 (823)
+|++|+|++|++++ .+..+.++++|+.|++++|.+.+..+..+..+.++++|+++
T Consensus 78 ------------------------~L~~L~Ls~N~l~~-~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~ 132 (266)
T d1p9ag_ 78 ------------------------VLGTLDLSHNQLQS-LPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLK 132 (266)
T ss_dssp ------------------------TCCEEECCSSCCSS-CCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECT
T ss_pred ------------------------cccccccccccccc-cccccccccccccccccccccceeecccccccccccccccc
Confidence 55555555555553 35677889999999999999998888889999999999999
Q ss_pred CCCCCCcchHhhhcCCCCCEEEcccCcCcccccccccCCCCCCeEeccCCccccccchhhhccCCCcEEeccccccccc
Q 045449 412 RNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSVRVLYLGLNIFTSVLSSTIWNLKDILFIDVSSNFLDGP 490 (823)
Q Consensus 412 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~LdLs~N~l~g~ 490 (823)
+|.++...+..+..+++|+.|++++|++++..+..|..+++|++|+|++|+|+ .+|..+..++.|+.|+|++|.+...
T Consensus 133 ~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~Cd 210 (266)
T d1p9ag_ 133 GNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCN 210 (266)
T ss_dssp TSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCCS
T ss_pred ccccceeccccccccccchhcccccccccccCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCCCCC
Confidence 99999888888999999999999999999988899999999999999999999 5888899999999999999998753
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.85 E-value=4.3e-23 Score=223.79 Aligned_cols=144 Identities=25% Similarity=0.269 Sum_probs=118.2
Q ss_pred ccCCccceeeccC------------CeEEEEEEehHhhHHHHHHHHHHHHHHhhcchhhHH-----------H-------
Q 045449 628 DRFSENNLIGIGN------------GMEVAVKVFHQQYERALKSFEDECEVRKRIRHRNLV-----------K------- 677 (823)
Q Consensus 628 ~~f~~~~~lg~g~------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-----------~------- 677 (823)
++|...+.||+|+ |+.||||+++... ...+.+.+|+.++++++|++++ +
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 3578889999996 6779999997653 3346788999999998776543 3
Q ss_pred --------------------------------------HHHHHHHHhhhcCC-CCEEeccCCCCCEEeCCCC------cE
Q 045449 678 --------------------------------------IISSSLEYLHFGHS-IPIIHCDLKPSNVLLDEDM------VA 712 (823)
Q Consensus 678 --------------------------------------~~~~~l~~L~~~h~-~~ivHrdlk~~NiLl~~~~------~~ 712 (823)
++.|++.+|+|+|+ .||+||||||+|||++.++ .+
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~~ 171 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQI 171 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEE
T ss_pred ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCccccccee
Confidence 36788899999986 8999999999999997554 48
Q ss_pred EEeecccccccCCCCccccccccccCCCcCcccccCCCccccccceehhhhhhccccCCCCCcCC
Q 045449 713 HISDFGIAKLLSGEDQLSKQTQTLATIGYMAPEYGTKGRVSTRGDVCSFGIISGGKETRSMTVGE 777 (823)
Q Consensus 713 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv~~~~~~~~~~~~~ 777 (823)
|++|||.|+..... ....+||+.|+|||++....|+.++||||+||+++++++|+.||..
T Consensus 172 kl~dfg~s~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~ 231 (362)
T d1q8ya_ 172 KIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEP 231 (362)
T ss_dssp EECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC--
T ss_pred eEeecccccccccc-----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCC
Confidence 99999999865322 2346799999999999999999999999999999999999999864
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.84 E-value=1.4e-19 Score=194.28 Aligned_cols=303 Identities=25% Similarity=0.316 Sum_probs=175.4
Q ss_pred cEEEEEcCCCCCccccCcccCCCCCCcEEEccCCCCCCCCCCCCCCCCCCCEEECCCCcCcCCCchhhhcCCCCcEEecc
Q 045449 53 RVIGLNISSFNLQGTITPQLGNLSSLQTLDLSHNKLSGNIPSSIFNMHTLKLLDFSDNQLFGSLSSFIFNMSSMTTIDLS 132 (823)
Q Consensus 53 ~v~~L~L~~~~l~g~~~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 132 (823)
+++.|||++++++ .+|+. +++|++|+|++|+|+ .+|..+ .+|+.|++++|+++. ++.. .++|++|||+
T Consensus 39 ~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~~-l~~l---p~~L~~L~L~ 106 (353)
T d1jl5a_ 39 QAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLKA-LSDL---PPLLEYLGVS 106 (353)
T ss_dssp TCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCSC-CCSC---CTTCCEEECC
T ss_pred CCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccch-hhhh---cccccccccc
Confidence 4678999999998 46754 468999999999998 678654 578999999999873 3321 2469999999
Q ss_pred cccccCccCccccCCCCCCccccccceeeeccceeeccCccccccchhhHHHHHhhcCCCcccCCcccCCcchhhhhccc
Q 045449 133 INRLSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKEIGNLTKLKEIISTITNSTVCEIPREIGNLPYLARLALA 212 (823)
Q Consensus 133 ~N~l~~~~p~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~~l~~n~~~~~ip~~l~~l~~L~~L~Ls 212 (823)
+|.++ .+|. ++.+++|++|++++|.++. .|.....+. .+++.
T Consensus 107 ~n~l~-~lp~--------~~~l~~L~~L~l~~~~~~~-~~~~~~~l~----------------------------~l~~~ 148 (353)
T d1jl5a_ 107 NNQLE-KLPE--------LQNSSFLKIIDVDNNSLKK-LPDLPPSLE----------------------------FIAAG 148 (353)
T ss_dssp SSCCS-SCCC--------CTTCTTCCEEECCSSCCSC-CCCCCTTCC----------------------------EEECC
T ss_pred ccccc-cccc--------hhhhccceeeccccccccc-ccccccccc----------------------------chhhc
Confidence 99987 3332 3678899999999998873 333322222 22333
Q ss_pred cccccCCccccccCCCCCcEEEccCCcccccCCcccccCCCCccEEEeeccccccccCccccCCCCCCeEEeeccccccc
Q 045449 213 TNNLVGVVPVTIFNMSALKEISLLNNSLSGSLPSRIDLSLPNVETLNLGINSFSGTIPSSITNSSKLSDLELGENLFSGF 292 (823)
Q Consensus 213 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 292 (823)
.+... .+..+..++.++.+++++|.+. .++.. ....+.+..+.+.+. .+| .+..++.|+.+++++|....
T Consensus 149 ~~~~~--~~~~l~~l~~l~~L~l~~n~~~-~~~~~----~~~~~~l~~~~~~~~-~~~-~~~~l~~L~~l~l~~n~~~~- 218 (353)
T d1jl5a_ 149 NNQLE--ELPELQNLPFLTAIYADNNSLK-KLPDL----PLSLESIVAGNNILE-ELP-ELQNLPFLTTIYADNNLLKT- 218 (353)
T ss_dssp SSCCS--SCCCCTTCTTCCEEECCSSCCS-SCCCC----CTTCCEEECCSSCCS-SCC-CCTTCTTCCEEECCSSCCSS-
T ss_pred ccccc--ccccccccccceeccccccccc-ccccc----ccccccccccccccc-ccc-cccccccccccccccccccc-
Confidence 22222 2234455666667777766665 23221 223345555555444 222 34566677777777776553
Q ss_pred CCCccCCCcccCcccccCccccCCCCcccccccccCCCCceEEEeecCCCCccCCccccccccccceEEecCCcceeccC
Q 045449 293 IPNTIGNLRNLEFGNIADNYLTSSTPELSFLSSLTNCKKLKVLIVTGNPLDGILPKSIGNFSLSLETILMANCSISGNIP 372 (823)
Q Consensus 293 ~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~p 372 (823)
++. ...++..+.+.+|.+..... ....+...++..|.+.+. ..++......++..+.+.+.
T Consensus 219 ~~~---~~~~l~~~~~~~~~~~~~~~---------~~~~l~~~~~~~~~~~~l-----~~l~~~~~~~~~~~~~~~~~-- 279 (353)
T d1jl5a_ 219 LPD---LPPSLEALNVRDNYLTDLPE---------LPQSLTFLDVSENIFSGL-----SELPPNLYYLNASSNEIRSL-- 279 (353)
T ss_dssp CCS---CCTTCCEEECCSSCCSCCCC---------CCTTCCEEECCSSCCSEE-----SCCCTTCCEEECCSSCCSEE--
T ss_pred ccc---cccccccccccccccccccc---------cccccccccccccccccc-----ccccchhcccccccCccccc--
Confidence 222 23345555566665554311 123444555555555432 11223344455555555432
Q ss_pred ccccCcccccEEEcccCcCCCCchhcccccCCCCEEEccCCCCCCcchHhhhcCCCCCEEEcccCcCcccccc
Q 045449 373 QVVGNLSNLLVLELGGNNLTGPIPVTFSQLQTLQAFDLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPS 445 (823)
Q Consensus 373 ~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~ 445 (823)
...+++|++|+|++|+|+ .+|.. +++|+.|+|++|+|+ .+|. .+++|+.|+|++|+++ .+|.
T Consensus 280 --~~~~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~L~~N~L~-~l~~---~~~~L~~L~L~~N~L~-~lp~ 341 (353)
T d1jl5a_ 280 --CDLPPSLEELNVSNNKLI-ELPAL---PPRLERLIASFNHLA-EVPE---LPQNLKQLHVEYNPLR-EFPD 341 (353)
T ss_dssp --CCCCTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCS-SCCC
T ss_pred --cccCCCCCEEECCCCccC-ccccc---cCCCCEEECCCCcCC-cccc---ccCCCCEEECcCCcCC-CCCc
Confidence 123456666777766666 44432 455666666666666 3442 2345666666666665 4443
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.84 E-value=3.7e-19 Score=191.01 Aligned_cols=304 Identities=21% Similarity=0.237 Sum_probs=154.0
Q ss_pred CCCcEEEccCCCCCCCCCCCCCCCCCCCEEECCCCcCcCCCchhhhcCCCCcEEecccccccCccCccccCCCCCCcccc
Q 045449 76 SSLQTLDLSHNKLSGNIPSSIFNMHTLKLLDFSDNQLFGSLSSFIFNMSSMTTIDLSINRLSGELPANICKIPSTLSKCK 155 (823)
Q Consensus 76 ~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~p~~~~~l~ 155 (823)
.++++|||++|.++ .+|+. .++|++|+|++|+|+ .+|+. +.+|+.|++++|+++ .++ .+| +
T Consensus 38 ~~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~l~~n~l~-~l~----~lp------~ 98 (353)
T d1jl5a_ 38 RQAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPEL---PQSLKSLLVDNNNLK-ALS----DLP------P 98 (353)
T ss_dssp HTCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCC---CTTCCEEECCSSCCS-CCC----SCC------T
T ss_pred cCCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCc-ccccc---hhhhhhhhhhhcccc-hhh----hhc------c
Confidence 36889999999987 56753 467888888888887 45654 356777788887776 222 111 3
Q ss_pred ccceeeeccceeeccCccccccchhhHHHHHhhcCCCcccCCcccCCcchhhhhccccccccCCccccccCCCCCcEEEc
Q 045449 156 QLEELNLGFNNLSGAIPKEIGNLTKLKEIISTITNSTVCEIPREIGNLPYLARLALATNNLVGVVPVTIFNMSALKEISL 235 (823)
Q Consensus 156 ~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~~l~~n~~~~~ip~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 235 (823)
+|++|++++|.++ .+|. ++.+++|++|++++|.+..... ....+..+.+
T Consensus 99 ~L~~L~L~~n~l~-~lp~--------------------------~~~l~~L~~L~l~~~~~~~~~~----~~~~l~~l~~ 147 (353)
T d1jl5a_ 99 LLEYLGVSNNQLE-KLPE--------------------------LQNSSFLKIIDVDNNSLKKLPD----LPPSLEFIAA 147 (353)
T ss_dssp TCCEEECCSSCCS-SCCC--------------------------CTTCTTCCEEECCSSCCSCCCC----CCTTCCEEEC
T ss_pred ccccccccccccc-cccc--------------------------hhhhccceeecccccccccccc----ccccccchhh
Confidence 4677777777665 2221 1223344455555555442211 1223334444
Q ss_pred cCCcccccCCcccccCCCCccEEEeeccccccccCccccCCCCCCeEEeecccccccCCCccCCCcccCcccccCccccC
Q 045449 236 LNNSLSGSLPSRIDLSLPNVETLNLGINSFSGTIPSSITNSSKLSDLELGENLFSGFIPNTIGNLRNLEFGNIADNYLTS 315 (823)
Q Consensus 236 s~N~l~g~lp~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 315 (823)
..+... .+..+..++.++.|++++|.+.... ... ...+.+..+++.+..
T Consensus 148 ~~~~~~---------------------------~~~~l~~l~~l~~L~l~~n~~~~~~-~~~---~~~~~l~~~~~~~~~ 196 (353)
T d1jl5a_ 148 GNNQLE---------------------------ELPELQNLPFLTAIYADNNSLKKLP-DLP---LSLESIVAGNNILEE 196 (353)
T ss_dssp CSSCCS---------------------------SCCCCTTCTTCCEEECCSSCCSSCC-CCC---TTCCEEECCSSCCSS
T ss_pred cccccc---------------------------ccccccccccceecccccccccccc-ccc---ccccccccccccccc
Confidence 333332 2233444445555555555444221 111 112233333333332
Q ss_pred CCCcccccccccCCCCceEEEeecCCCCccCCccccccccccceEEecCCcceeccCccccCcccccEEEcccCcCCCCc
Q 045449 316 STPELSFLSSLTNCKKLKVLIVTGNPLDGILPKSIGNFSLSLETILMANCSISGNIPQVVGNLSNLLVLELGGNNLTGPI 395 (823)
Q Consensus 316 ~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~ 395 (823)
. ..+..++.|+.+++++|.... +|.. ..++..+.+..|.+... + ....++...++..|.+.+.
T Consensus 197 ~-------~~~~~l~~L~~l~l~~n~~~~-~~~~----~~~l~~~~~~~~~~~~~-~---~~~~~l~~~~~~~~~~~~l- 259 (353)
T d1jl5a_ 197 L-------PELQNLPFLTTIYADNNLLKT-LPDL----PPSLEALNVRDNYLTDL-P---ELPQSLTFLDVSENIFSGL- 259 (353)
T ss_dssp C-------CCCTTCTTCCEEECCSSCCSS-CCSC----CTTCCEEECCSSCCSCC-C---CCCTTCCEEECCSSCCSEE-
T ss_pred c-------ccccccccccccccccccccc-cccc----ccccccccccccccccc-c---ccccccccccccccccccc-
Confidence 2 223445556666666655442 2221 13455555555555422 1 1233455555555555421
Q ss_pred hhcccccCCCCEEEccCCCCCCcchHhhhcCCCCCEEEcccCcCcccccccccCCCCCCeEeccCCccccccchhhhccC
Q 045449 396 PVTFSQLQTLQAFDLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSVRVLYLGLNIFTSVLSSTIWNLK 475 (823)
Q Consensus 396 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 475 (823)
+. -.......++..|.+.+. + ..+++|++|+|++|+|+ .+|.. +++|+.|+|++|+|+. +|.. ++
T Consensus 260 ~~---l~~~~~~~~~~~~~~~~~-~---~~~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~L~~N~L~~-l~~~---~~ 324 (353)
T d1jl5a_ 260 SE---LPPNLYYLNASSNEIRSL-C---DLPPSLEELNVSNNKLI-ELPAL---PPRLERLIASFNHLAE-VPEL---PQ 324 (353)
T ss_dssp SC---CCTTCCEEECCSSCCSEE-C---CCCTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCSC-CCCC---CT
T ss_pred cc---ccchhcccccccCccccc-c---ccCCCCCEEECCCCccC-ccccc---cCCCCEEECCCCcCCc-cccc---cC
Confidence 11 012344556666665532 1 23456677777777766 45543 3556667777776664 3432 34
Q ss_pred CCcEEeccccccccccCc
Q 045449 476 DILFIDVSSNFLDGPLSL 493 (823)
Q Consensus 476 ~L~~LdLs~N~l~g~~p~ 493 (823)
+|+.|++++|+|+ .+|.
T Consensus 325 ~L~~L~L~~N~L~-~lp~ 341 (353)
T d1jl5a_ 325 NLKQLHVEYNPLR-EFPD 341 (353)
T ss_dssp TCCEEECCSSCCS-SCCC
T ss_pred CCCEEECcCCcCC-CCCc
Confidence 5666777777665 4443
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.80 E-value=2.5e-22 Score=224.12 Aligned_cols=397 Identities=19% Similarity=0.150 Sum_probs=202.5
Q ss_pred CcEEEEEcCCCCCcccc-CcccCCCCCCcEEEccCCCCCC----CCCCCCCCCCCCCEEECCCCcCcCCC----chhhh-
Q 045449 52 HRVIGLNISSFNLQGTI-TPQLGNLSSLQTLDLSHNKLSG----NIPSSIFNMHTLKLLDFSDNQLFGSL----SSFIF- 121 (823)
Q Consensus 52 ~~v~~L~L~~~~l~g~~-~~~l~~l~~L~~L~Ls~N~l~g----~~p~~~~~l~~L~~L~Ls~N~l~~~~----p~~~~- 121 (823)
.++++||++++++++.- ..-+..++++++|+|++|.|+. .+...+..+++|++|||++|.|+... ...+.
T Consensus 2 ~~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~ 81 (460)
T d1z7xw1 2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQT 81 (460)
T ss_dssp EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCS
T ss_pred CCCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhc
Confidence 46899999999998632 3335667899999999999872 34456778999999999999986322 22222
Q ss_pred cCCCCcEEecccccccCccCccccCCCCCCccccccceeeeccceeeccCccccccchhhHHHHHhhcCCCcccCCcccC
Q 045449 122 NMSSMTTIDLSINRLSGELPANICKIPSTLSKCKQLEELNLGFNNLSGAIPKEIGNLTKLKEIISTITNSTVCEIPREIG 201 (823)
Q Consensus 122 ~l~~L~~L~Ls~N~l~~~~p~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~~l~~n~~~~~ip~~l~ 201 (823)
...+|++|+|++|+++... +..++..+..+++|++|+|++|.++..-... +... +.....
T Consensus 82 ~~~~L~~L~L~~n~it~~~---~~~l~~~l~~~~~L~~L~L~~N~i~~~~~~~------l~~~--l~~~~~--------- 141 (460)
T d1z7xw1 82 PSCKIQKLSLQNCCLTGAG---CGVLSSTLRTLPTLQELHLSDNLLGDAGLQL------LCEG--LLDPQC--------- 141 (460)
T ss_dssp TTCCCCEEECTTSCCBGGG---HHHHHHHTTSCTTCCEEECCSSBCHHHHHHH------HHHH--HTSTTC---------
T ss_pred CCCCCCEEECCCCCccccc---cccccchhhccccccccccccccchhhhhhh------hhhc--cccccc---------
Confidence 2357999999999987431 1123334578899999999999887321111 1110 000000
Q ss_pred CcchhhhhccccccccCC----ccccccCCCCCcEEEccCCccccc----CCcccccCCCCccEEEeeccccccc----c
Q 045449 202 NLPYLARLALATNNLVGV----VPVTIFNMSALKEISLLNNSLSGS----LPSRIDLSLPNVETLNLGINSFSGT----I 269 (823)
Q Consensus 202 ~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~g~----lp~~~~~~l~~L~~L~Ls~N~l~~~----~ 269 (823)
...........+... .-..+.....++.++++++.+... +...+.........+++..+.+... .
T Consensus 142 ---~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ls~~~~~~~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~~~~ 218 (460)
T d1z7xw1 142 ---RLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDL 218 (460)
T ss_dssp ---CCCEEECTTSCCBGGGHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHH
T ss_pred ---ccccccccccccchhhhcccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhcc
Confidence 000011111111100 001122345666777776655411 1111111233455666666654321 1
Q ss_pred CccccCCCCCCeEEeecccccc-----cCCCccCCCcccCcccccCccccCCCCcccccccccCCCCceEEEeecCCCCc
Q 045449 270 PSSITNSSKLSDLELGENLFSG-----FIPNTIGNLRNLEFGNIADNYLTSSTPELSFLSSLTNCKKLKVLIVTGNPLDG 344 (823)
Q Consensus 270 p~~~~~l~~L~~L~Ls~N~l~~-----~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~ 344 (823)
...+...+.++.+++++|++.. ..+..+.....++.+++++|.+...... .....+...+.++.+++++|.++.
T Consensus 219 ~~~l~~~~~~~~l~~~~n~~~~~~~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~-~~~~~l~~~~~l~~l~l~~n~i~~ 297 (460)
T d1z7xw1 219 CGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCG-DLCRVLRAKESLKELSLAGNELGD 297 (460)
T ss_dssp HHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHH-HHHHHHHHCTTCCEEECTTCCCHH
T ss_pred cccccccccccccchhhccccccccchhhcccccccccccccccccccccccccc-cccccccccccccccccccccccc
Confidence 1223445667777777776532 2223334455666666666665432110 022233445556666666666543
Q ss_pred cCCccccccccccceEEecCCcceeccCccccCcccccEEEcccCcCCCCchh----cccccCCCCEEEccCCCCCCc--
Q 045449 345 ILPKSIGNFSLSLETILMANCSISGNIPQVVGNLSNLLVLELGGNNLTGPIPV----TFSQLQTLQAFDLTRNKLAGP-- 418 (823)
Q Consensus 345 ~~p~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~----~~~~l~~L~~L~Ls~N~l~~~-- 418 (823)
.....+... .......|+.+++++|.++..... .+....+|++|+|++|++++.
T Consensus 298 ~~~~~l~~~--------------------l~~~~~~L~~l~l~~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~ 357 (460)
T d1z7xw1 298 EGARLLCET--------------------LLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGV 357 (460)
T ss_dssp HHHHHHHHH--------------------HTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHH
T ss_pred cccchhhcc--------------------ccccccccccccccccchhhhhhhhcccccccccchhhhheeeecccCccc
Confidence 211111000 001123455555555555433222 122334555566665555432
Q ss_pred --chHhhh-cCCCCCEEEcccCcCccc----ccccccCCCCCCeEeccCCccccccchhhh-----ccCCCcEEeccccc
Q 045449 419 --ITDELC-HLARLHSLVLQGNKFSGS----IPSCLGNLTSVRVLYLGLNIFTSVLSSTIW-----NLKDILFIDVSSNF 486 (823)
Q Consensus 419 --~p~~~~-~l~~L~~L~Ls~N~l~g~----~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-----~l~~L~~LdLs~N~ 486 (823)
++..+. ..+.|++|+|++|.|+.. ++..+..+++|++|+|++|+++......+. +...|+.|++++|.
T Consensus 358 ~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~l~l~~~~ 437 (460)
T d1z7xw1 358 RELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIY 437 (460)
T ss_dssp HHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCC
T ss_pred chhhhhhhcccCCCCEEECCCCCCChHHHHHHHHHHhcCCCCCEEECCCCcCCHHHHHHHHHHHHhCCCccCEEECCCCC
Confidence 112221 234456666666665432 333444455666666666666543332221 22356666666666
Q ss_pred cccccC
Q 045449 487 LDGPLS 492 (823)
Q Consensus 487 l~g~~p 492 (823)
+.....
T Consensus 438 ~~~~~~ 443 (460)
T d1z7xw1 438 WSEEME 443 (460)
T ss_dssp CCHHHH
T ss_pred CCHHHH
Confidence 665443
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.79 E-value=4.7e-19 Score=178.14 Aligned_cols=208 Identities=22% Similarity=0.372 Sum_probs=130.3
Q ss_pred cchhhhhccccccccCCccccccCCCCCcEEEccCCcccccCCcccccCCCCccEEEeeccccccccCccccCCCCCCeE
Q 045449 203 LPYLARLALATNNLVGVVPVTIFNMSALKEISLLNNSLSGSLPSRIDLSLPNVETLNLGINSFSGTIPSSITNSSKLSDL 282 (823)
Q Consensus 203 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 282 (823)
+.++..++++.+++++.. .+.++.+|++|++++|.|+ .++ .+. .+++|++|++++|++++..| +..+++|+++
T Consensus 18 l~~~~~~~l~~~~~~d~~--~~~~l~~L~~L~l~~~~i~-~l~-~l~-~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l 90 (227)
T d1h6ua2 18 LANAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVT-TIE-GVQ-YLNNLIGLELKDNQITDLAP--LKNLTKITEL 90 (227)
T ss_dssp HHHHHHHHTTCSSTTSEE--CHHHHHTCCEEECTTSCCC-CCT-TGG-GCTTCCEEECCSSCCCCCGG--GTTCCSCCEE
T ss_pred HHHHHHHHhCCCCcCCcC--CHHHcCCcCEEECCCCCCC-cch-hHh-cCCCCcEeecCCceeecccc--cccccccccc
Confidence 445566788888888653 4567788899999998887 554 344 38888888888888875443 7777888888
Q ss_pred EeecccccccCCCccCCCcccCcccccCccccCCCCcccccccccCCCCceEEEeecCCCCccCCccccccccccceEEe
Q 045449 283 ELGENLFSGFIPNTIGNLRNLEFGNIADNYLTSSTPELSFLSSLTNCKKLKVLIVTGNPLDGILPKSIGNFSLSLETILM 362 (823)
Q Consensus 283 ~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L 362 (823)
++++|.++.. ..+..+++|++++++++...+. ..+...+.++.+.++++.+...
T Consensus 91 ~~~~n~~~~i--~~l~~l~~L~~l~l~~~~~~~~-------~~~~~~~~~~~l~~~~~~~~~~----------------- 144 (227)
T d1h6ua2 91 ELSGNPLKNV--SAIAGLQSIKTLDLTSTQITDV-------TPLAGLSNLQVLYLDLNQITNI----------------- 144 (227)
T ss_dssp ECCSCCCSCC--GGGTTCTTCCEEECTTSCCCCC-------GGGTTCTTCCEEECCSSCCCCC-----------------
T ss_pred cccccccccc--cccccccccccccccccccccc-------chhccccchhhhhchhhhhchh-----------------
Confidence 8888877643 2466677777777776666553 2234445555555555544432
Q ss_pred cCCcceeccCccccCcccccEEEcccCcCCCCchhcccccCCCCEEEccCCCCCCcchHhhhcCCCCCEEEcccCcCccc
Q 045449 363 ANCSISGNIPQVVGNLSNLLVLELGGNNLTGPIPVTFSQLQTLQAFDLTRNKLAGPITDELCHLARLHSLVLQGNKFSGS 442 (823)
Q Consensus 363 ~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ 442 (823)
. .+.++++|+.|++++|.+++.. .+.++++|++|+|++|++++. + .+.++++|++|+|++|++++.
T Consensus 145 --------~--~~~~~~~L~~L~l~~n~~~~~~--~l~~l~~L~~L~Ls~n~l~~l-~-~l~~l~~L~~L~Ls~N~lt~i 210 (227)
T d1h6ua2 145 --------S--PLAGLTNLQYLSIGNAQVSDLT--PLANLSKLTTLKADDNKISDI-S-PLASLPNLIEVHLKNNQISDV 210 (227)
T ss_dssp --------G--GGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCCC-G-GGGGCTTCCEEECTTSCCCBC
T ss_pred --------h--hhccccccccccccccccccch--hhcccccceecccCCCccCCC-h-hhcCCCCCCEEECcCCcCCCC
Confidence 1 2344555666666666555322 255566666666666666543 2 255666666666666666643
Q ss_pred ccccccCCCCCCeEecc
Q 045449 443 IPSCLGNLTSVRVLYLG 459 (823)
Q Consensus 443 ~p~~~~~l~~L~~L~Ls 459 (823)
.| ++++++|+.|+++
T Consensus 211 ~~--l~~l~~L~~L~ls 225 (227)
T d1h6ua2 211 SP--LANTSNLFIVTLT 225 (227)
T ss_dssp GG--GTTCTTCCEEEEE
T ss_pred cc--cccCCCCCEEEee
Confidence 22 5666666666665
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.79 E-value=1.1e-21 Score=218.86 Aligned_cols=188 Identities=19% Similarity=0.188 Sum_probs=131.6
Q ss_pred cccCCCCceEEEeecCCCCcc-----CCccccccccccceEEecCCcceecc----CccccCcccccEEEcccCcCCCCc
Q 045449 325 SLTNCKKLKVLIVTGNPLDGI-----LPKSIGNFSLSLETILMANCSISGNI----PQVVGNLSNLLVLELGGNNLTGPI 395 (823)
Q Consensus 325 ~l~~l~~L~~L~Ls~N~l~~~-----~p~~~~~~~~~L~~L~L~~N~l~~~~----p~~~~~l~~L~~L~Ls~N~l~g~~ 395 (823)
.+...+.++.+++++|.+... .+...... ..++.+++++|.+.... ...+...+.++.+++++|.++...
T Consensus 221 ~l~~~~~~~~l~~~~n~~~~~~~~~~~~~~~~~~-~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~ 299 (460)
T d1z7xw1 221 IVASKASLRELALGSNKLGDVGMAELCPGLLHPS-SRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEG 299 (460)
T ss_dssp HHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTT-CCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHH
T ss_pred cccccccccccchhhccccccccchhhccccccc-ccccccccccccccccccccccccccccccccccccccccccccc
Confidence 344566777888877776432 11111222 57888888888776432 334556788999999999987432
Q ss_pred hhcc-----cccCCCCEEEccCCCCCCcchHhh----hcCCCCCEEEcccCcCccc----cccccc-CCCCCCeEeccCC
Q 045449 396 PVTF-----SQLQTLQAFDLTRNKLAGPITDEL----CHLARLHSLVLQGNKFSGS----IPSCLG-NLTSVRVLYLGLN 461 (823)
Q Consensus 396 p~~~-----~~l~~L~~L~Ls~N~l~~~~p~~~----~~l~~L~~L~Ls~N~l~g~----~p~~~~-~l~~L~~L~Ls~N 461 (823)
...+ .....|+.+++++|.++......+ ....+|++|+|++|+++.. ++..+. ..+.|++|+|++|
T Consensus 300 ~~~l~~~l~~~~~~L~~l~l~~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n 379 (460)
T d1z7xw1 300 ARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADC 379 (460)
T ss_dssp HHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTS
T ss_pred cchhhccccccccccccccccccchhhhhhhhcccccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCC
Confidence 2222 234689999999999986644433 4567899999999999753 333443 4677999999999
Q ss_pred ccccc----cchhhhccCCCcEEeccccccccccCccc----c-CCCCCcEEEcccCCCCC
Q 045449 462 IFTSV----LSSTIWNLKDILFIDVSSNFLDGPLSLDI----G-NLKVVIGLDFSRNNLSG 513 (823)
Q Consensus 462 ~l~~~----~p~~~~~l~~L~~LdLs~N~l~g~~p~~~----~-~l~~L~~L~ls~N~l~g 513 (823)
.++.. ++..+...++|++|||++|+++......+ . +...|+.|++++|++..
T Consensus 380 ~i~~~~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~l~l~~~~~~~ 440 (460)
T d1z7xw1 380 DVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSE 440 (460)
T ss_dssp CCCHHHHHHHHHHHHHCCCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCCH
T ss_pred CCChHHHHHHHHHHhcCCCCCEEECCCCcCCHHHHHHHHHHHHhCCCccCEEECCCCCCCH
Confidence 99864 45567778999999999999986543333 2 34579999999998874
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.77 E-value=7.4e-19 Score=178.48 Aligned_cols=199 Identities=16% Similarity=0.140 Sum_probs=91.7
Q ss_pred CCcEEEccCCcccccCCcccccCCCCccEEEeecccccccc-CccccCCCCCCeEEeec-ccccccCCCccCCCcccCcc
Q 045449 229 ALKEISLLNNSLSGSLPSRIDLSLPNVETLNLGINSFSGTI-PSSITNSSKLSDLELGE-NLFSGFIPNTIGNLRNLEFG 306 (823)
Q Consensus 229 ~L~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L 306 (823)
++++|+|++|.|+ .+|...+.++++|++|+|++|.+...+ +.+|.+++++++|++.. |++....+..|..+++|+.+
T Consensus 30 ~l~~L~Ls~n~i~-~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~n~l~~~~~~~~~~l~~L~~l 108 (242)
T d1xwdc1 30 NAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYL 108 (242)
T ss_dssp CCSEEEEESCCCC-EECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECCTTCCEECTTSEECCTTCCEE
T ss_pred CCCEEECcCCcCC-ccChhHhhccchhhhhhhccccccceeecccccccccccccccccccccccccccccccccccccc
Confidence 3444444444444 344333333444444444444444322 22344444444444432 34444444444444444444
Q ss_pred cccCccccCCCCcccccccccCCCCceEEEeecCCCCccCCccccccccccceEEecCCcceeccCccccCcc-cccEEE
Q 045449 307 NIADNYLTSSTPELSFLSSLTNCKKLKVLIVTGNPLDGILPKSIGNFSLSLETILMANCSISGNIPQVVGNLS-NLLVLE 385 (823)
Q Consensus 307 ~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~-~L~~L~ 385 (823)
++++|.++.... ...+..+. .+..+...++.+....+..|.+++ .++.|+
T Consensus 109 ~l~~~~l~~~~~----~~~~~~l~-------------------------~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~ 159 (242)
T d1xwdc1 109 LISNTGIKHLPD----VHKIHSLQ-------------------------KVLLDIQDNINIHTIERNSFVGLSFESVILW 159 (242)
T ss_dssp EEESCCCCSCCC----CTTTCBSS-------------------------CEEEEEESCTTCCEECTTSSTTSBSSCEEEE
T ss_pred ccchhhhccccc----cccccccc-------------------------ccccccccccccccccccccccccccceeee
Confidence 444444433211 11122223 333444444455444444444443 455566
Q ss_pred cccCcCCCCchhcccccCCCC-EEEccCCCCCCcchHhhhcCCCCCEEEcccCcCcccccccccCCCCCCeEec
Q 045449 386 LGGNNLTGPIPVTFSQLQTLQ-AFDLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSVRVLYL 458 (823)
Q Consensus 386 Ls~N~l~g~~p~~~~~l~~L~-~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L 458 (823)
+++|+++...+..|. ..+++ .+++++|+++...+..|.++++|++|+|++|+|+...+..|.+++.|+.+++
T Consensus 160 l~~n~l~~i~~~~~~-~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~l~~ 232 (242)
T d1xwdc1 160 LNKNGIQEIHNCAFN-GTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST 232 (242)
T ss_dssp CCSSCCCEECTTTTT-TCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTCCEEESSSE
T ss_pred ccccccccccccccc-chhhhccccccccccccccHHHhcCCCCCCEEECCCCcCCccCHHHHcCCcccccCcC
Confidence 666666533332232 23333 3345555666444444566666666666666666443444556555555544
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.77 E-value=1.1e-18 Score=177.08 Aligned_cols=220 Identities=17% Similarity=0.164 Sum_probs=149.3
Q ss_pred cEEEccCCcccccCCcccccCCCCccEEEeeccccccccCccccCCCCCCeEEeecccccccC-CCccCCCcccCccccc
Q 045449 231 KEISLLNNSLSGSLPSRIDLSLPNVETLNLGINSFSGTIPSSITNSSKLSDLELGENLFSGFI-PNTIGNLRNLEFGNIA 309 (823)
Q Consensus 231 ~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~L~ 309 (823)
+.++.+++.++ .+|..++ +++++|||++|+|+...+..|.++++|++|++++|.+...+ +..|.++++++++++.
T Consensus 11 ~~i~c~~~~l~-~iP~~l~---~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~ 86 (242)
T d1xwdc1 11 RVFLCQESKVT-EIPSDLP---RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIE 86 (242)
T ss_dssp SEEEEESCSCS-SCCSCSC---SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEE
T ss_pred CEEEEeCCCCC-CcCCCCC---CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeecccccccccccccccc
Confidence 46677777776 6776553 36777777777777555556777777777777777766543 3345555555554433
Q ss_pred CccccCCCCcccccccccCCCCceEEEeecCCCCccCCccccccccccceEEecCCcceeccC-ccccCcccccEEEccc
Q 045449 310 DNYLTSSTPELSFLSSLTNCKKLKVLIVTGNPLDGILPKSIGNFSLSLETILMANCSISGNIP-QVVGNLSNLLVLELGG 388 (823)
Q Consensus 310 ~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~Ls~ 388 (823)
. .|++....+..|.++ ++|+++++++|+++...+ ..+..++.+..+..++
T Consensus 87 ~----------------------------~n~l~~~~~~~~~~l-~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n 137 (242)
T d1xwdc1 87 K----------------------------ANNLLYINPEAFQNL-PNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDN 137 (242)
T ss_dssp C----------------------------CTTCCEECTTSEECC-TTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESC
T ss_pred c----------------------------ccccccccccccccc-ccccccccchhhhcccccccccccccccccccccc
Confidence 2 234444444455555 456666666665553322 2344567778888888
Q ss_pred CcCCCCchhcccccC-CCCEEEccCCCCCCcchHhhhcCCCCCEE-EcccCcCcccccccccCCCCCCeEeccCCccccc
Q 045449 389 NNLTGPIPVTFSQLQ-TLQAFDLTRNKLAGPITDELCHLARLHSL-VLQGNKFSGSIPSCLGNLTSVRVLYLGLNIFTSV 466 (823)
Q Consensus 389 N~l~g~~p~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L-~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~ 466 (823)
+++....+..|..++ .++.|++++|+++...+..| ...++..+ ++++|+++...+..|.++++|++|+|++|+++..
T Consensus 138 ~~l~~i~~~~~~~~~~~l~~L~l~~n~l~~i~~~~~-~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l 216 (242)
T d1xwdc1 138 INIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAF-NGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSL 216 (242)
T ss_dssp TTCCEECTTSSTTSBSSCEEEECCSSCCCEECTTTT-TTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCC
T ss_pred cccccccccccccccccceeeecccccccccccccc-cchhhhccccccccccccccHHHhcCCCCCCEEECCCCcCCcc
Confidence 888866667777665 78999999999996555444 44555544 6788889865566789999999999999999987
Q ss_pred cchhhhccCCCcEEeccc
Q 045449 467 LSSTIWNLKDILFIDVSS 484 (823)
Q Consensus 467 ~p~~~~~l~~L~~LdLs~ 484 (823)
.+..|.+++.|+++++.+
T Consensus 217 ~~~~~~~l~~L~~l~~~~ 234 (242)
T d1xwdc1 217 PSYGLENLKKLRARSTYN 234 (242)
T ss_dssp CSSSCTTCCEEESSSEES
T ss_pred CHHHHcCCcccccCcCCC
Confidence 777788888888877654
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.76 E-value=2e-18 Score=173.42 Aligned_cols=205 Identities=19% Similarity=0.272 Sum_probs=123.5
Q ss_pred ccEEEeeccccccccCccccCCCCCCeEEeecccccccCCCccCCCcccCcccccCccccCCCCcccccccccCCCCceE
Q 045449 255 VETLNLGINSFSGTIPSSITNSSKLSDLELGENLFSGFIPNTIGNLRNLEFGNIADNYLTSSTPELSFLSSLTNCKKLKV 334 (823)
Q Consensus 255 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~ 334 (823)
+..++++.+++++.+ .+.++.+|+.|++++|.++.. +.+..+++|++|++++|++++. ..+..+++|+.
T Consensus 21 ~~~~~l~~~~~~d~~--~~~~l~~L~~L~l~~~~i~~l--~~l~~l~~L~~L~ls~n~i~~~-------~~l~~l~~l~~ 89 (227)
T d1h6ua2 21 AIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDNQITDL-------APLKNLTKITE 89 (227)
T ss_dssp HHHHHTTCSSTTSEE--CHHHHHTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCC-------GGGTTCCSCCE
T ss_pred HHHHHhCCCCcCCcC--CHHHcCCcCEEECCCCCCCcc--hhHhcCCCCcEeecCCceeecc-------ccccccccccc
Confidence 344566666666543 345666777777777777754 2466677777777777766654 12555566666
Q ss_pred EEeecCCCCccCCccccccccccceEEecCCcceeccCccccCcccccEEEcccCcCCCCchhcccccCCCCEEEccCCC
Q 045449 335 LIVTGNPLDGILPKSIGNFSLSLETILMANCSISGNIPQVVGNLSNLLVLELGGNNLTGPIPVTFSQLQTLQAFDLTRNK 414 (823)
Q Consensus 335 L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~ 414 (823)
+++++|.++.. ..+..+++|+.++++++...+.. .+...+.++.+.++++.
T Consensus 90 l~~~~n~~~~i---------------------------~~l~~l~~L~~l~l~~~~~~~~~--~~~~~~~~~~l~~~~~~ 140 (227)
T d1h6ua2 90 LELSGNPLKNV---------------------------SAIAGLQSIKTLDLTSTQITDVT--PLAGLSNLQVLYLDLNQ 140 (227)
T ss_dssp EECCSCCCSCC---------------------------GGGTTCTTCCEEECTTSCCCCCG--GGTTCTTCCEEECCSSC
T ss_pred ccccccccccc---------------------------ccccccccccccccccccccccc--hhccccchhhhhchhhh
Confidence 66665555421 12445556666666666655332 24445566666666666
Q ss_pred CCCcchHhhhcCCCCCEEEcccCcCcccccccccCCCCCCeEeccCCccccccchhhhccCCCcEEeccccccccccCcc
Q 045449 415 LAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSVRVLYLGLNIFTSVLSSTIWNLKDILFIDVSSNFLDGPLSLD 494 (823)
Q Consensus 415 l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~LdLs~N~l~g~~p~~ 494 (823)
+....+ +.++++|+.|++++|.+++.. .++++++|+.|+|++|++++.. .+..+++|++|+|++|++++..|
T Consensus 141 ~~~~~~--~~~~~~L~~L~l~~n~~~~~~--~l~~l~~L~~L~Ls~n~l~~l~--~l~~l~~L~~L~Ls~N~lt~i~~-- 212 (227)
T d1h6ua2 141 ITNISP--LAGLTNLQYLSIGNAQVSDLT--PLANLSKLTTLKADDNKISDIS--PLASLPNLIEVHLKNNQISDVSP-- 212 (227)
T ss_dssp CCCCGG--GGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCCCG--GGGGCTTCCEEECTTSCCCBCGG--
T ss_pred hchhhh--hccccccccccccccccccch--hhcccccceecccCCCccCCCh--hhcCCCCCCEEECcCCcCCCCcc--
Confidence 654322 455666666666666665432 2566667777777777766532 26667777777777777765432
Q ss_pred ccCCCCCcEEEcc
Q 045449 495 IGNLKVVIGLDFS 507 (823)
Q Consensus 495 ~~~l~~L~~L~ls 507 (823)
+++++.|+.|+++
T Consensus 213 l~~l~~L~~L~ls 225 (227)
T d1h6ua2 213 LANTSNLFIVTLT 225 (227)
T ss_dssp GTTCTTCCEEEEE
T ss_pred cccCCCCCEEEee
Confidence 6677777777775
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.75 E-value=8.3e-19 Score=171.27 Aligned_cols=173 Identities=23% Similarity=0.292 Sum_probs=114.8
Q ss_pred eEEEeecCCCCccCCccccccccccceEEecCCcceec-cCccccCcccccEEEcccCcCCCCchhcccccCCCCEEEcc
Q 045449 333 KVLIVTGNPLDGILPKSIGNFSLSLETILMANCSISGN-IPQVVGNLSNLLVLELGGNNLTGPIPVTFSQLQTLQAFDLT 411 (823)
Q Consensus 333 ~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls 411 (823)
+.++.++|+++ .+|..+ +.++++|+|++|+|++. .+..|.++++|+.|+|++|++.+..+..|..+++|++|+|+
T Consensus 11 ~~v~Cs~~~L~-~iP~~l---p~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls 86 (192)
T d1w8aa_ 11 TTVDCTGRGLK-EIPRDI---PLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLG 86 (192)
T ss_dssp TEEECTTSCCS-SCCSCC---CTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred CEEEEeCCCcC-ccCCCC---CCCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeec
Confidence 35666777776 345543 25677777777777653 35566777777777777777777777777777777777777
Q ss_pred CCCCCCcchHhhhcCCCCCEEEcccCcCcccccccccCCCCCCeEeccCCccccccchhhhccCCCcEEecccccccccc
Q 045449 412 RNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSVRVLYLGLNIFTSVLSSTIWNLKDILFIDVSSNFLDGPL 491 (823)
Q Consensus 412 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~LdLs~N~l~g~~ 491 (823)
+|+|++..|..|.++++|++|+|++|+|++..|..|..+++|++|+|++|.+....... +-...++.+.+..|.+++..
T Consensus 87 ~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~~-~~~~~l~~~~l~~~~~~c~~ 165 (192)
T d1w8aa_ 87 ENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLA-WFAEWLRKKSLNGGAARCGA 165 (192)
T ss_dssp SCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGH-HHHHHHHHHCCSGGGCBBCS
T ss_pred cccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccchH-HHhhhhhhhcccCCCeEeCC
Confidence 77777766667777777777777777777777777777777777777777776543321 11223445556666666655
Q ss_pred CccccCCCCCcEEEcccCCCCC
Q 045449 492 SLDIGNLKVVIGLDFSRNNLSG 513 (823)
Q Consensus 492 p~~~~~l~~L~~L~ls~N~l~g 513 (823)
|..+ ..++.+||+.|.|..
T Consensus 166 p~~l---~~~~l~~L~~n~l~C 184 (192)
T d1w8aa_ 166 PSKV---RDVQIKDLPHSEFKC 184 (192)
T ss_dssp STTT---TTSBGGGSCTTTCCC
T ss_pred Chhh---cCCEeeecCHhhCcC
Confidence 5433 334455666666653
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.74 E-value=2.5e-18 Score=167.84 Aligned_cols=179 Identities=18% Similarity=0.204 Sum_probs=136.6
Q ss_pred ccceEEecCCcceeccCccccCcccccEEEcccCcCCCCc-hhcccccCCCCEEEccCCCCCCcchHhhhcCCCCCEEEc
Q 045449 356 SLETILMANCSISGNIPQVVGNLSNLLVLELGGNNLTGPI-PVTFSQLQTLQAFDLTRNKLAGPITDELCHLARLHSLVL 434 (823)
Q Consensus 356 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~-p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 434 (823)
+.++++.++++++ .+|..+. +++++|+|++|+|++.+ +..|.++++|+.|+|++|++++..+..|..+++|++|+|
T Consensus 9 ~~~~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~L 85 (192)
T d1w8aa_ 9 EGTTVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQL 85 (192)
T ss_dssp ETTEEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEEC
T ss_pred cCCEEEEeCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeee
Confidence 3567888888888 5666553 67889999999998644 556788999999999999999888888888999999999
Q ss_pred ccCcCcccccccccCCCCCCeEeccCCccccccchhhhccCCCcEEeccccccccccCccccCCCCCcEEEcccCCCCCC
Q 045449 435 QGNKFSGSIPSCLGNLTSVRVLYLGLNIFTSVLSSTIWNLKDILFIDVSSNFLDGPLSLDIGNLKVVIGLDFSRNNLSGD 514 (823)
Q Consensus 435 s~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~ 514 (823)
++|+|++..|..|.++++|++|+|++|+|+++.|..|..+++|++|+|++|.+.+..+... -...++.+.+..|.+++.
T Consensus 86 s~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~~~-~~~~l~~~~l~~~~~~c~ 164 (192)
T d1w8aa_ 86 GENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAW-FAEWLRKKSLNGGAARCG 164 (192)
T ss_dssp CSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHH-HHHHHHHHCCSGGGCBBC
T ss_pred ccccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccchHH-HhhhhhhhcccCCCeEeC
Confidence 9999998888889999999999999999999888888889999999999998876544221 112345556677777755
Q ss_pred CCCcccCccCCCCCCCCCCCcccccCCcccCCCCC
Q 045449 515 IPITIGEGEIPRGGPFANLTAKSFMGNELLCGLPD 549 (823)
Q Consensus 515 ip~~~~~g~ip~~~~~~~~~~~~~~~n~~~c~~~~ 549 (823)
.|..+ ......++..|...|..+.
T Consensus 165 ~p~~l-----------~~~~l~~L~~n~l~C~~~~ 188 (192)
T d1w8aa_ 165 APSKV-----------RDVQIKDLPHSEFKCSSEN 188 (192)
T ss_dssp SSTTT-----------TTSBGGGSCTTTCCCCCC-
T ss_pred CChhh-----------cCCEeeecCHhhCcCCCCC
Confidence 55433 3344556777777776543
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.73 E-value=1.1e-17 Score=165.76 Aligned_cols=185 Identities=23% Similarity=0.305 Sum_probs=117.4
Q ss_pred hhhhhccccccccCCccccccCCCCCcEEEccCCcccccCCcccccCCCCccEEEeeccccccccCccccCCCCCCeEEe
Q 045449 205 YLARLALATNNLVGVVPVTIFNMSALKEISLLNNSLSGSLPSRIDLSLPNVETLNLGINSFSGTIPSSITNSSKLSDLEL 284 (823)
Q Consensus 205 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 284 (823)
+....++..+.+++.++. ..+.+|++|++++|.++ .++ .+. .+++|++|+|++|+|++.. .++++++|++|++
T Consensus 25 ~~i~~~l~~~~~~~~~~~--~~L~~L~~L~l~~~~i~-~l~-~l~-~l~~L~~L~L~~n~i~~l~--~~~~l~~L~~L~l 97 (210)
T d1h6ta2 25 ETIKDNLKKKSVTDAVTQ--NELNSIDQIIANNSDIK-SVQ-GIQ-YLPNVTKLFLNGNKLTDIK--PLANLKNLGWLFL 97 (210)
T ss_dssp HHHHHHTTCSCTTSEECH--HHHHTCCEEECTTSCCC-CCT-TGG-GCTTCCEEECCSSCCCCCG--GGTTCTTCCEEEC
T ss_pred HHHHHHhCcCccCCccCH--HHhcCccEEECcCCCCC-Cch-hHh-hCCCCCEEeCCCccccCcc--ccccCcccccccc
Confidence 344556777777665543 34667888888888877 343 233 3777888888888777533 2567777777777
Q ss_pred ecccccccCCCccCCCcccCcccccCccccCCCCcccccccccCCCCceEEEeecCCCCccCCccccccccccceEEecC
Q 045449 285 GENLFSGFIPNTIGNLRNLEFGNIADNYLTSSTPELSFLSSLTNCKKLKVLIVTGNPLDGILPKSIGNFSLSLETILMAN 364 (823)
Q Consensus 285 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~ 364 (823)
++|++++. | .+..+++|+.|++++|.+... ..+..+++++.+++++|.+++
T Consensus 98 ~~n~i~~l-~-~l~~l~~L~~L~l~~~~~~~~-------~~l~~l~~l~~l~~~~n~l~~-------------------- 148 (210)
T d1h6ta2 98 DENKVKDL-S-SLKDLKKLKSLSLEHNGISDI-------NGLVHLPQLESLYLGNNKITD-------------------- 148 (210)
T ss_dssp CSSCCCCG-G-GGTTCTTCCEEECTTSCCCCC-------GGGGGCTTCCEEECCSSCCCC--------------------
T ss_pred cccccccc-c-ccccccccccccccccccccc-------ccccccccccccccccccccc--------------------
Confidence 77777753 2 466666666666666665543 234455555555555555442
Q ss_pred CcceeccCccccCcccccEEEcccCcCCCCchhcccccCCCCEEEccCCCCCCcchHhhhcCCCCCEEEccc
Q 045449 365 CSISGNIPQVVGNLSNLLVLELGGNNLTGPIPVTFSQLQTLQAFDLTRNKLAGPITDELCHLARLHSLVLQG 436 (823)
Q Consensus 365 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 436 (823)
+..+..+++|+++++++|++++. +. +.++++|+.|+|++|+++. ++ .+.++++|++|+|++
T Consensus 149 -------~~~~~~l~~L~~l~l~~n~l~~i-~~-l~~l~~L~~L~Ls~N~i~~-l~-~l~~l~~L~~L~Ls~ 209 (210)
T d1h6ta2 149 -------ITVLSRLTKLDTLSLEDNQISDI-VP-LAGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELFS 209 (210)
T ss_dssp -------CGGGGGCTTCSEEECCSSCCCCC-GG-GTTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEEEEE
T ss_pred -------ccccccccccccccccccccccc-cc-ccCCCCCCEEECCCCCCCC-Ch-hhcCCCCCCEEEccC
Confidence 12344566777777777777643 32 6677777777777777774 34 467777777777764
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.71 E-value=2.2e-17 Score=162.04 Aligned_cols=181 Identities=23% Similarity=0.310 Sum_probs=115.2
Q ss_pred ccCcccccCccccCCCCcccccccccCCCCceEEEeecCCCCccCCccccccccccceEEecCCcceeccCccccCcccc
Q 045449 302 NLEFGNIADNYLTSSTPELSFLSSLTNCKKLKVLIVTGNPLDGILPKSIGNFSLSLETILMANCSISGNIPQVVGNLSNL 381 (823)
Q Consensus 302 ~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L 381 (823)
+...+.++.+.+++.. ....+.+++.|++++|.++.. ..+..+ ++|++|++++|++++..| ++++++|
T Consensus 19 ~~i~~~l~~~~~~~~~-------~~~~l~~l~~L~l~~~~i~~l--~~l~~l-~nL~~L~Ls~N~l~~~~~--l~~l~~L 86 (199)
T d2omxa2 19 EKMKTVLGKTNVTDTV-------SQTDLDQVTTLQADRLGIKSI--DGVEYL-NNLTQINFSNNQLTDITP--LKNLTKL 86 (199)
T ss_dssp HHHHHHTTCSSTTSEE-------CHHHHTTCCEEECTTSCCCCC--TTGGGC-TTCCEEECCSSCCCCCGG--GTTCTTC
T ss_pred HHHHHHhCCCCCCCcc-------CHHHhcCCCEEECCCCCCCCc--cccccC-CCcCcCccccccccCccc--ccCCccc
Confidence 3334455555555431 223455666666666666542 234455 567777777777665433 6677777
Q ss_pred cEEEcccCcCCCCchhcccccCCCCEEEccCCCCCCcchHhhhcCCCCCEEEcccCcCcccccccccCCCCCCeEeccCC
Q 045449 382 LVLELGGNNLTGPIPVTFSQLQTLQAFDLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSVRVLYLGLN 461 (823)
Q Consensus 382 ~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N 461 (823)
++|++++|.+.. ++ .+.++++|+.|++++|.+.... .+..+++|+.|++++|++.. +| .+..+++|+.|++++|
T Consensus 87 ~~L~l~~n~~~~-~~-~l~~l~~L~~L~l~~~~~~~~~--~~~~l~~L~~L~l~~n~l~~-~~-~l~~~~~L~~L~l~~n 160 (199)
T d2omxa2 87 VDILMNNNQIAD-IT-PLANLTNLTGLTLFNNQITDID--PLKNLTNLNRLELSSNTISD-IS-ALSGLTSLQQLNFSSN 160 (199)
T ss_dssp CEEECCSSCCCC-CG-GGTTCTTCSEEECCSSCCCCCG--GGTTCTTCSEEECCSSCCCC-CG-GGTTCTTCSEEECCSS
T ss_pred cccccccccccc-cc-cccccccccccccccccccccc--ccchhhhhHHhhhhhhhhcc-cc-cccccccccccccccc
Confidence 777777777763 33 3667777777777777776432 35667777777777777763 22 4667777777777777
Q ss_pred ccccccchhhhccCCCcEEeccccccccccCccccCCCCCcEE
Q 045449 462 IFTSVLSSTIWNLKDILFIDVSSNFLDGPLSLDIGNLKVVIGL 504 (823)
Q Consensus 462 ~l~~~~p~~~~~l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L 504 (823)
++++.. .+.++++|+.|++++|+++. ++ .++.+++|+.|
T Consensus 161 ~l~~l~--~l~~l~~L~~L~ls~N~i~~-i~-~l~~L~~L~~L 199 (199)
T d2omxa2 161 QVTDLK--PLANLTTLERLDISSNKVSD-IS-VLAKLTNLESL 199 (199)
T ss_dssp CCCCCG--GGTTCTTCCEEECCSSCCCC-CG-GGGGCTTCSEE
T ss_pred cccCCc--cccCCCCCCEEECCCCCCCC-Cc-cccCCCCCCcC
Confidence 777643 36777777777777777765 33 46667776654
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.71 E-value=2.7e-17 Score=162.78 Aligned_cols=165 Identities=21% Similarity=0.331 Sum_probs=107.6
Q ss_pred CCCceEEEeecCCCCccCCccccccccccceEEecCCcceeccCccccCcccccEEEcccCcCCCCchhcccccCCCCEE
Q 045449 329 CKKLKVLIVTGNPLDGILPKSIGNFSLSLETILMANCSISGNIPQVVGNLSNLLVLELGGNNLTGPIPVTFSQLQTLQAF 408 (823)
Q Consensus 329 l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L 408 (823)
+.+|+.|++++|.++... .+..+ ++|++|++++|+|++.. .++.+++|++|++++|++++ +| .+..+++|+.|
T Consensus 45 L~~L~~L~l~~~~i~~l~--~l~~l-~~L~~L~L~~n~i~~l~--~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L 117 (210)
T d1h6ta2 45 LNSIDQIIANNSDIKSVQ--GIQYL-PNVTKLFLNGNKLTDIK--PLANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSL 117 (210)
T ss_dssp HHTCCEEECTTSCCCCCT--TGGGC-TTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEE
T ss_pred hcCccEEECcCCCCCCch--hHhhC-CCCCEEeCCCccccCcc--ccccCccccccccccccccc-cc-ccccccccccc
Confidence 344555555555555432 24444 46666666666666533 24567777777777777763 44 36677777777
Q ss_pred EccCCCCCCcchHhhhcCCCCCEEEcccCcCcccccccccCCCCCCeEeccCCccccccchhhhccCCCcEEeccccccc
Q 045449 409 DLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSVRVLYLGLNIFTSVLSSTIWNLKDILFIDVSSNFLD 488 (823)
Q Consensus 409 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~LdLs~N~l~ 488 (823)
++++|.+... ..+.+++.++.+++++|.+++ +..+..+++|+.+++++|++++.. .+.++++|+.|+|++|+++
T Consensus 118 ~l~~~~~~~~--~~l~~l~~l~~l~~~~n~l~~--~~~~~~l~~L~~l~l~~n~l~~i~--~l~~l~~L~~L~Ls~N~i~ 191 (210)
T d1h6ta2 118 SLEHNGISDI--NGLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISDIV--PLAGLTKLQNLYLSKNHIS 191 (210)
T ss_dssp ECTTSCCCCC--GGGGGCTTCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCC
T ss_pred cccccccccc--ccccccccccccccccccccc--cccccccccccccccccccccccc--cccCCCCCCEEECCCCCCC
Confidence 7777777632 246677777777777777764 234666777777777777777643 2677777888888888776
Q ss_pred cccCccccCCCCCcEEEccc
Q 045449 489 GPLSLDIGNLKVVIGLDFSR 508 (823)
Q Consensus 489 g~~p~~~~~l~~L~~L~ls~ 508 (823)
. +| .+..+++|++|+|++
T Consensus 192 ~-l~-~l~~l~~L~~L~Ls~ 209 (210)
T d1h6ta2 192 D-LR-ALAGLKNLDVLELFS 209 (210)
T ss_dssp B-CG-GGTTCTTCSEEEEEE
T ss_pred C-Ch-hhcCCCCCCEEEccC
Confidence 4 44 477778888888763
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.71 E-value=3.9e-17 Score=160.20 Aligned_cols=183 Identities=23% Similarity=0.369 Sum_probs=113.7
Q ss_pred cchhhhhccccccccCCccccccCCCCCcEEEccCCcccccCCcccccCCCCccEEEeeccccccccCccccCCCCCCeE
Q 045449 203 LPYLARLALATNNLVGVVPVTIFNMSALKEISLLNNSLSGSLPSRIDLSLPNVETLNLGINSFSGTIPSSITNSSKLSDL 282 (823)
Q Consensus 203 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 282 (823)
+.+...+.++.+.+++.++ ...+.++++|++++|.++ .++ .+. .+++|++|+|++|++++..| +.++++|++|
T Consensus 17 l~~~i~~~l~~~~~~~~~~--~~~l~~l~~L~l~~~~i~-~l~-~l~-~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L 89 (199)
T d2omxa2 17 LAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK-SID-GVE-YLNNLTQINFSNNQLTDITP--LKNLTKLVDI 89 (199)
T ss_dssp HHHHHHHHTTCSSTTSEEC--HHHHTTCCEEECTTSCCC-CCT-TGG-GCTTCCEEECCSSCCCCCGG--GTTCTTCCEE
T ss_pred HHHHHHHHhCCCCCCCccC--HHHhcCCCEEECCCCCCC-Ccc-ccc-cCCCcCcCccccccccCccc--ccCCcccccc
Confidence 4455566777887776543 345678888888888887 443 233 37777777777777775433 6777777777
Q ss_pred EeecccccccCCCccCCCcccCcccccCccccCCCCcccccccccCCCCceEEEeecCCCCccCCccccccccccceEEe
Q 045449 283 ELGENLFSGFIPNTIGNLRNLEFGNIADNYLTSSTPELSFLSSLTNCKKLKVLIVTGNPLDGILPKSIGNFSLSLETILM 362 (823)
Q Consensus 283 ~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L 362 (823)
++++|.+.... .+.++++|+.|++++|.+... ..+..+++|+.|++++|++.
T Consensus 90 ~l~~n~~~~~~--~l~~l~~L~~L~l~~~~~~~~-------~~~~~l~~L~~L~l~~n~l~------------------- 141 (199)
T d2omxa2 90 LMNNNQIADIT--PLANLTNLTGLTLFNNQITDI-------DPLKNLTNLNRLELSSNTIS------------------- 141 (199)
T ss_dssp ECCSSCCCCCG--GGTTCTTCSEEECCSSCCCCC-------GGGTTCTTCSEEECCSSCCC-------------------
T ss_pred ccccccccccc--ccccccccccccccccccccc-------cccchhhhhHHhhhhhhhhc-------------------
Confidence 77777766432 356666666666666665543 12444555555555555443
Q ss_pred cCCcceeccCccccCcccccEEEcccCcCCCCchhcccccCCCCEEEccCCCCCCcchHhhhcCCCCCEE
Q 045449 363 ANCSISGNIPQVVGNLSNLLVLELGGNNLTGPIPVTFSQLQTLQAFDLTRNKLAGPITDELCHLARLHSL 432 (823)
Q Consensus 363 ~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 432 (823)
. + ..+..+++|+.|++++|++++. + .++++++|++|++++|+++.. + .++++++|++|
T Consensus 142 ------~-~-~~l~~~~~L~~L~l~~n~l~~l-~-~l~~l~~L~~L~ls~N~i~~i-~-~l~~L~~L~~L 199 (199)
T d2omxa2 142 ------D-I-SALSGLTSLQQLNFSSNQVTDL-K-PLANLTTLERLDISSNKVSDI-S-VLAKLTNLESL 199 (199)
T ss_dssp ------C-C-GGGTTCTTCSEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCCCC-G-GGGGCTTCSEE
T ss_pred ------c-c-ccccccccccccccccccccCC-c-cccCCCCCCEEECCCCCCCCC-c-cccCCCCCCcC
Confidence 2 1 2345566667777777776643 2 266677777777777777642 3 35666666654
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.56 E-value=2.8e-16 Score=163.09 Aligned_cols=258 Identities=17% Similarity=0.184 Sum_probs=131.3
Q ss_pred hhccccccccCCccccccCCCCCcEEEccCCcccccCCcccccCCCCccEEEeeccccccc-cCccccCCCCCCeEEeec
Q 045449 208 RLALATNNLVGVVPVTIFNMSALKEISLLNNSLSGSLPSRIDLSLPNVETLNLGINSFSGT-IPSSITNSSKLSDLELGE 286 (823)
Q Consensus 208 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~Ls~ 286 (823)
++||+++.+.......+.. ..+..+.++...+...+.. .+ ...+|++|||+++.++.. ++..+..+++|++|+|++
T Consensus 4 ~lDLs~~~l~~~~l~~l~~-~~~~~lrl~~~~~~~~~~~-~~-~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~ 80 (284)
T d2astb2 4 TLDLTGKNLHPDVTGRLLS-QGVIAFRCPRSFMDQPLAE-HF-SPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEG 80 (284)
T ss_dssp EEECTTCBCCHHHHHHHHH-TTCSEEECTTCEECSCCCS-CC-CCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTT
T ss_pred EEECCCCCCCchHHHHHHh-ccceEeeccccccccchhh-hc-cCCCCCEEECCCCccCHHHHHHHHHhCCCcccccccc
Confidence 5677777664322222211 1344556665555422222 22 255778888887776543 344466777888888888
Q ss_pred ccccccCCCccCCCcccCcccccCc-cccCCCCcccccccccCCCCceEEEeecC-CCCcc-CCccccccccccceEEec
Q 045449 287 NLFSGFIPNTIGNLRNLEFGNIADN-YLTSSTPELSFLSSLTNCKKLKVLIVTGN-PLDGI-LPKSIGNFSLSLETILMA 363 (823)
Q Consensus 287 N~l~~~~p~~~~~l~~L~~L~L~~N-~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N-~l~~~-~p~~~~~~~~~L~~L~L~ 363 (823)
+.+++..+..++.+++|++|+++++ .++... +..-..++++|++|+++++ .++.. ++..+....+.|+.|+++
T Consensus 81 ~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~----l~~l~~~~~~L~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~ 156 (284)
T d2astb2 81 LRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFA----LQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLS 156 (284)
T ss_dssp CBCCHHHHHHHTTCTTCSEEECTTCBSCCHHH----HHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECC
T ss_pred cCCCcHHHHHHhcCCCCcCccccccccccccc----cchhhHHHHhccccccccccccccccchhhhcccccccchhhhc
Confidence 8777766677777777777777773 444220 1122345677777777764 33321 111222222344444444
Q ss_pred CCcceeccCccccCcccccEEEcccCcCCCC-chhcccccCCCCEEEccCC-CCCCcchHhhhcCCCCCEEEccc-CcCc
Q 045449 364 NCSISGNIPQVVGNLSNLLVLELGGNNLTGP-IPVTFSQLQTLQAFDLTRN-KLAGPITDELCHLARLHSLVLQG-NKFS 440 (823)
Q Consensus 364 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~-~p~~~~~l~~L~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~Ls~-N~l~ 440 (823)
++. +.++.. +...+..+++|++|++++| .+++.....+..+++|++|+|++ +.++
T Consensus 157 ~~~----------------------~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~ 214 (284)
T d2astb2 157 GYR----------------------KNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDII 214 (284)
T ss_dssp SCG----------------------GGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCC
T ss_pred ccc----------------------cccccccccccccccccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCC
Confidence 321 122211 1122234455555555553 34444444555555566666655 3455
Q ss_pred ccccccccCCCCCCeEeccCCccccccchhhhccCCCcEEeccccccccccCccccC
Q 045449 441 GSIPSCLGNLTSVRVLYLGLNIFTSVLSSTIWNLKDILFIDVSSNFLDGPLSLDIGN 497 (823)
Q Consensus 441 g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~LdLs~N~l~g~~p~~~~~ 497 (823)
+.....++++++|+.|+++++.-.+.++.....+++| ++..++++...++.+++
T Consensus 215 ~~~l~~L~~~~~L~~L~l~~~~~d~~l~~l~~~lp~L---~i~~~~ls~~~~~~~~~ 268 (284)
T d2astb2 215 PETLLELGEIPTLKTLQVFGIVPDGTLQLLKEALPHL---QINCSHFTTIARPTIGN 268 (284)
T ss_dssp GGGGGGGGGCTTCCEEECTTSSCTTCHHHHHHHSTTS---EESCCCSCCTTCSSCSS
T ss_pred hHHHHHHhcCCCCCEEeeeCCCCHHHHHHHHHhCccc---cccCccCCCCCCCccCc
Confidence 4444555556666666666552112222222334443 34566666655555544
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.54 E-value=1.1e-15 Score=163.52 Aligned_cols=249 Identities=17% Similarity=0.201 Sum_probs=143.3
Q ss_pred CCCccEEEeeccccccc----cCccccCCCCCCeEEeecccccccC----------CCccCCCcccCcccccCccccCCC
Q 045449 252 LPNVETLNLGINSFSGT----IPSSITNSSKLSDLELGENLFSGFI----------PNTIGNLRNLEFGNIADNYLTSST 317 (823)
Q Consensus 252 l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~----------p~~~~~l~~L~~L~L~~N~l~~~~ 317 (823)
..+|+.|+|++|.+... +-..+...++|+.|+++++...... ...+...++|+.|+|++|.++...
T Consensus 30 ~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~ 109 (344)
T d2ca6a1 30 DDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTA 109 (344)
T ss_dssp CSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCCTTT
T ss_pred CCCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCccccccccccccccc
Confidence 56677777777776432 2334555667777777766443111 112233445555555555544321
Q ss_pred CcccccccccCCCCceEEEeecCCCCccCCccccccccccceEEecCCcceeccCccccCcccccEEEcccCcCCCC---
Q 045449 318 PELSFLSSLTNCKKLKVLIVTGNPLDGILPKSIGNFSLSLETILMANCSISGNIPQVVGNLSNLLVLELGGNNLTGP--- 394 (823)
Q Consensus 318 ~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~--- 394 (823)
.. .+...+..+++|+.|++++|.+...-...+.. .+..+. ........+.|+.+++++|+++..
T Consensus 110 ~~-~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~---~l~~~~---------~~~~~~~~~~L~~l~l~~n~i~~~~~~ 176 (344)
T d2ca6a1 110 QE-PLIDFLSKHTPLEHLYLHNNGLGPQAGAKIAR---ALQELA---------VNKKAKNAPPLRSIICGRNRLENGSMK 176 (344)
T ss_dssp HH-HHHHHHHHCTTCCEEECCSSCCHHHHHHHHHH---HHHHHH---------HHHHHHTCCCCCEEECCSSCCTGGGHH
T ss_pred cc-chhhhhcccccchheecccccccccccccccc---cccccc---------cccccccCcccceeecccccccccccc
Confidence 10 12222334444555555554443110000100 000000 000112456788888888887632
Q ss_pred -chhcccccCCCCEEEccCCCCCCc-----chHhhhcCCCCCEEEcccCcCccc----ccccccCCCCCCeEeccCCccc
Q 045449 395 -IPVTFSQLQTLQAFDLTRNKLAGP-----ITDELCHLARLHSLVLQGNKFSGS----IPSCLGNLTSVRVLYLGLNIFT 464 (823)
Q Consensus 395 -~p~~~~~l~~L~~L~Ls~N~l~~~-----~p~~~~~l~~L~~L~Ls~N~l~g~----~p~~~~~l~~L~~L~Ls~N~l~ 464 (823)
+...+...+.|+.|+|++|+++.. +...+..+++|+.|+|++|.++.. +...+..+++|++|+|++|.++
T Consensus 177 ~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~ 256 (344)
T d2ca6a1 177 EWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLS 256 (344)
T ss_dssp HHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCC
T ss_pred cccchhhhhhhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhhhcCccC
Confidence 233455677888888888888742 223356678888999998888643 3455677888999999999887
Q ss_pred cccchhh----hc--cCCCcEEeccccccccc----cCcccc-CCCCCcEEEcccCCCCC
Q 045449 465 SVLSSTI----WN--LKDILFIDVSSNFLDGP----LSLDIG-NLKVVIGLDFSRNNLSG 513 (823)
Q Consensus 465 ~~~p~~~----~~--l~~L~~LdLs~N~l~g~----~p~~~~-~l~~L~~L~ls~N~l~g 513 (823)
+.-...+ .. ...|+.||+++|.++.. +...+. +++.|+.|++++|+++.
T Consensus 257 ~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~~ 316 (344)
T d2ca6a1 257 ARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSE 316 (344)
T ss_dssp HHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCT
T ss_pred chhhHHHHHHhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCCC
Confidence 7544333 22 35788999999988753 233342 56789999999998873
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.51 E-value=3.1e-14 Score=127.22 Aligned_cols=101 Identities=23% Similarity=0.325 Sum_probs=52.1
Q ss_pred EEEcccCcCCCCchhcccccCCCCEEEccCCCCCCcchHhhhcCCCCCEEEcccCcCcccccccccCCCCCCeEeccCCc
Q 045449 383 VLELGGNNLTGPIPVTFSQLQTLQAFDLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSVRVLYLGLNI 462 (823)
Q Consensus 383 ~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~ 462 (823)
+|||++|+++ .++ .+..+++|++|++++|+|+ .+|..++.+++|+.|++++|.|++ +| .++.+++|+.|++++|+
T Consensus 2 ~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N~ 76 (124)
T d1dcea3 2 VLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNR 76 (124)
T ss_dssp EEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSC
T ss_pred EEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhcccccccccccccc-cC-ccccccccCeEECCCCc
Confidence 4555555554 233 2455555555555555555 234445555555555555555553 22 25555555555555555
Q ss_pred cccccc-hhhhccCCCcEEeccccccc
Q 045449 463 FTSVLS-STIWNLKDILFIDVSSNFLD 488 (823)
Q Consensus 463 l~~~~p-~~~~~l~~L~~LdLs~N~l~ 488 (823)
++.... ..++.+++|+.|++++|+++
T Consensus 77 i~~~~~~~~l~~~~~L~~L~l~~N~i~ 103 (124)
T d1dcea3 77 LQQSAAIQPLVSCPRLVLLNLQGNSLC 103 (124)
T ss_dssp CCSSSTTGGGGGCTTCCEEECTTSGGG
T ss_pred cCCCCCchhhcCCCCCCEEECCCCcCC
Confidence 554322 34555555555555555554
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.50 E-value=6.6e-15 Score=152.52 Aligned_cols=191 Identities=18% Similarity=0.208 Sum_probs=128.4
Q ss_pred ccCCCCceEEEeecCCCCccCCccccccccccceEEecCC-cceec-cCccccCcccccEEEcccC-cCCCC-chhcccc
Q 045449 326 LTNCKKLKVLIVTGNPLDGILPKSIGNFSLSLETILMANC-SISGN-IPQVVGNLSNLLVLELGGN-NLTGP-IPVTFSQ 401 (823)
Q Consensus 326 l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N-~l~~~-~p~~~~~l~~L~~L~Ls~N-~l~g~-~p~~~~~ 401 (823)
+..+++|++|+|+++.+++..+..++.+ ++|++|+++++ .++.. +...+.++++|++|+++++ +++.. +...+..
T Consensus 67 ~~~c~~L~~L~L~~~~l~~~~~~~l~~~-~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L~ls~c~~~~~~~~~~~~~~ 145 (284)
T d2astb2 67 LSQCSKLQNLSLEGLRLSDPIVNTLAKN-SNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAH 145 (284)
T ss_dssp HTTBCCCSEEECTTCBCCHHHHHHHTTC-TTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHH
T ss_pred HHhCCCcccccccccCCCcHHHHHHhcC-CCCcCccccccccccccccchhhHHHHhccccccccccccccccchhhhcc
Confidence 4445555555555555555445555554 45666666663 44422 1223456789999999985 45432 2233333
Q ss_pred -cCCCCEEEccCC--CCCCc-chHhhhcCCCCCEEEcccC-cCcccccccccCCCCCCeEeccC-CccccccchhhhccC
Q 045449 402 -LQTLQAFDLTRN--KLAGP-ITDELCHLARLHSLVLQGN-KFSGSIPSCLGNLTSVRVLYLGL-NIFTSVLSSTIWNLK 475 (823)
Q Consensus 402 -l~~L~~L~Ls~N--~l~~~-~p~~~~~l~~L~~L~Ls~N-~l~g~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~ 475 (823)
.++|+.|++++. .++.. +...+.++++|++|++++| .+++..+..+.++++|++|+|++ +.+++.....+++++
T Consensus 146 ~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~ 225 (284)
T d2astb2 146 VSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIP 225 (284)
T ss_dssp SCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCT
T ss_pred cccccchhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCC
Confidence 478999999975 45533 3333467899999999986 58888888999999999999999 578888888899999
Q ss_pred CCcEEeccccccccccCccccCCCCCcEEEcccCCCCCCCCCccc
Q 045449 476 DILFIDVSSNFLDGPLSLDIGNLKVVIGLDFSRNNLSGDIPITIG 520 (823)
Q Consensus 476 ~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~~ 520 (823)
+|+.|+++++--.+.++.-...++. |++..+++++..+.+++
T Consensus 226 ~L~~L~l~~~~~d~~l~~l~~~lp~---L~i~~~~ls~~~~~~~~ 267 (284)
T d2astb2 226 TLKTLQVFGIVPDGTLQLLKEALPH---LQINCSHFTTIARPTIG 267 (284)
T ss_dssp TCCEEECTTSSCTTCHHHHHHHSTT---SEESCCCSCCTTCSSCS
T ss_pred CCCEEeeeCCCCHHHHHHHHHhCcc---ccccCccCCCCCCCccC
Confidence 9999999988322233322334555 55688899977666664
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.50 E-value=1.4e-14 Score=136.24 Aligned_cols=106 Identities=17% Similarity=0.168 Sum_probs=48.4
Q ss_pred ccceEEecCCcceeccCccccCcccccEEEcccCcCCCCchhcccccCCCCEEEccCCCCCCcchHhhhcCCCCCEEEcc
Q 045449 356 SLETILMANCSISGNIPQVVGNLSNLLVLELGGNNLTGPIPVTFSQLQTLQAFDLTRNKLAGPITDELCHLARLHSLVLQ 435 (823)
Q Consensus 356 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 435 (823)
.+++|+|++|+|+.. +..+..+++|++|||++|+++ .++ .|..+++|++|++++|+++...+..+..+++|+.|+++
T Consensus 19 ~lr~L~L~~n~I~~i-~~~~~~l~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L~L~ 95 (162)
T d1a9na_ 19 RDRELDLRGYKIPVI-ENLGATLDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILT 95 (162)
T ss_dssp SCEEEECTTSCCCSC-CCGGGGTTCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECC
T ss_pred cCcEEECCCCCCCcc-CccccccccCCEEECCCCCCC-ccC-CcccCcchhhhhcccccccCCCccccccccccccceec
Confidence 445555555555432 333444455555555555554 222 24445555555555555543333333444555555555
Q ss_pred cCcCccccc-ccccCCCCCCeEeccCCccc
Q 045449 436 GNKFSGSIP-SCLGNLTSVRVLYLGLNIFT 464 (823)
Q Consensus 436 ~N~l~g~~p-~~~~~l~~L~~L~Ls~N~l~ 464 (823)
+|+++.... ..+..+++|+.|++++|.++
T Consensus 96 ~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~ 125 (162)
T d1a9na_ 96 NNSLVELGDLDPLASLKSLTYLCILRNPVT 125 (162)
T ss_dssp SCCCCCGGGGGGGGGCTTCCEEECCSSGGG
T ss_pred cccccccccccccccccccchhhcCCCccc
Confidence 555442111 23444444444444444443
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.49 E-value=3.3e-15 Score=159.67 Aligned_cols=248 Identities=17% Similarity=0.178 Sum_probs=138.3
Q ss_pred cccccCCCCCcEEEccCCcccccCCccc---ccCCCCccEEEeeccccccc----------cCccccCCCCCCeEEeecc
Q 045449 221 PVTIFNMSALKEISLLNNSLSGSLPSRI---DLSLPNVETLNLGINSFSGT----------IPSSITNSSKLSDLELGEN 287 (823)
Q Consensus 221 p~~~~~l~~L~~L~Ls~N~l~g~lp~~~---~~~l~~L~~L~Ls~N~l~~~----------~p~~~~~l~~L~~L~Ls~N 287 (823)
...+.+...|++|+|++|.++..-...+ ....++|+.|+++.+.+... +...+...++|+.|+|++|
T Consensus 24 ~~~L~~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~~n 103 (344)
T d2ca6a1 24 FAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDN 103 (344)
T ss_dssp SHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSC
T ss_pred HHHHhhCCCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCccccccccc
Confidence 3456678899999999999864322222 12378999999998765421 2234566789999999999
Q ss_pred ccccc----CCCccCCCcccCcccccCccccCCCCcc--------cccccccCCCCceEEEeecCCCCccCCcccccccc
Q 045449 288 LFSGF----IPNTIGNLRNLEFGNIADNYLTSSTPEL--------SFLSSLTNCKKLKVLIVTGNPLDGILPKSIGNFSL 355 (823)
Q Consensus 288 ~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~~~~--------~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~ 355 (823)
.++.. +...+...++|+.|++++|.+....... .........+.|+.+++++|.+....-..
T Consensus 104 ~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~------ 177 (344)
T d2ca6a1 104 AFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKE------ 177 (344)
T ss_dssp CCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHH------
T ss_pred ccccccccchhhhhcccccchheecccccccccccccccccccccccccccccCcccceeeccccccccccccc------
Confidence 98764 3334556789999999999875321100 00011134566777777777665321111
Q ss_pred ccceEEecCCcceeccCccccCcccccEEEcccCcCCCC-----chhcccccCCCCEEEccCCCCCCc----chHhhhcC
Q 045449 356 SLETILMANCSISGNIPQVVGNLSNLLVLELGGNNLTGP-----IPVTFSQLQTLQAFDLTRNKLAGP----ITDELCHL 426 (823)
Q Consensus 356 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~-----~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l 426 (823)
+...+...+.|+.|+|++|+++.. +...+...++|+.|+|++|.++.. +...+..+
T Consensus 178 ---------------l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~ 242 (344)
T d2ca6a1 178 ---------------WAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSW 242 (344)
T ss_dssp ---------------HHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGC
T ss_pred ---------------ccchhhhhhhhcccccccccccccccccchhhhhcchhhhccccccccccccccccccccccccc
Confidence 111223334455555555554421 122234445555555555555422 22334455
Q ss_pred CCCCEEEcccCcCccccccc----cc--CCCCCCeEeccCCcccccc----chhhh-ccCCCcEEecccccccc
Q 045449 427 ARLHSLVLQGNKFSGSIPSC----LG--NLTSVRVLYLGLNIFTSVL----SSTIW-NLKDILFIDVSSNFLDG 489 (823)
Q Consensus 427 ~~L~~L~Ls~N~l~g~~p~~----~~--~l~~L~~L~Ls~N~l~~~~----p~~~~-~l~~L~~LdLs~N~l~g 489 (823)
++|++|+|++|.+++..... +. ..+.|++|++++|.++..- ...+. +.+.|+.|+|++|.+..
T Consensus 243 ~~L~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~~ 316 (344)
T d2ca6a1 243 PNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSE 316 (344)
T ss_dssp TTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCT
T ss_pred ccchhhhhhcCccCchhhHHHHHHhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCCC
Confidence 55555566555555332221 21 1245666666666665432 22232 45667777777777653
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.48 E-value=4.2e-14 Score=132.80 Aligned_cols=109 Identities=19% Similarity=0.227 Sum_probs=49.5
Q ss_pred CcccccEEEcccCcCCCCchhcccccCCCCEEEccCCCCCCcchHhhhcCCCCCEEEcccCcCcccccccccCCCCCCeE
Q 045449 377 NLSNLLVLELGGNNLTGPIPVTFSQLQTLQAFDLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSVRVL 456 (823)
Q Consensus 377 ~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L 456 (823)
++.+|++|||++|+++ .++..+..+++|++|+|++|+|+. ++ .|..+++|++|++++|+++...+..+..+++|+.|
T Consensus 16 n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~~-l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L 92 (162)
T d1a9na_ 16 NAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRK-LD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTEL 92 (162)
T ss_dssp CTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCCE-EC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEE
T ss_pred CcCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCCc-cC-CcccCcchhhhhcccccccCCCccccccccccccc
Confidence 3444455555555554 233333444455555555555442 21 24444455555555555543333333444455555
Q ss_pred eccCCccccccc-hhhhccCCCcEEeccccccc
Q 045449 457 YLGLNIFTSVLS-STIWNLKDILFIDVSSNFLD 488 (823)
Q Consensus 457 ~Ls~N~l~~~~p-~~~~~l~~L~~LdLs~N~l~ 488 (823)
++++|+++.... ..+..+++|++|++++|.++
T Consensus 93 ~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~ 125 (162)
T d1a9na_ 93 ILTNNSLVELGDLDPLASLKSLTYLCILRNPVT 125 (162)
T ss_dssp ECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGG
T ss_pred eeccccccccccccccccccccchhhcCCCccc
Confidence 555554443211 23444455555555555443
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.48 E-value=5.5e-15 Score=143.55 Aligned_cols=119 Identities=24% Similarity=0.192 Sum_probs=85.1
Q ss_pred ccceeeccC-----------CeEEEEEEehHhh------------------HHHHHHHHHHHHHHhhcchhhHHH-----
Q 045449 632 ENNLIGIGN-----------GMEVAVKVFHQQY------------------ERALKSFEDECEVRKRIRHRNLVK----- 677 (823)
Q Consensus 632 ~~~~lg~g~-----------~~~vavK~~~~~~------------------~~~~~~~~~E~~~l~~l~h~niv~----- 677 (823)
..+.||+|+ |..||||+++... ......+.+|...+.++.|.+++.
T Consensus 4 vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~ 83 (191)
T d1zara2 4 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWE 83 (191)
T ss_dssp EEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEE
T ss_pred hCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEec
Confidence 456777775 6789999875221 112345667888888888877765
Q ss_pred ------------------------HHHHHHHHhhhcCCCCEEeccCCCCCEEeCCCCcEEEeecccccccCCCCcccccc
Q 045449 678 ------------------------IISSSLEYLHFGHSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKLLSGEDQLSKQT 733 (823)
Q Consensus 678 ------------------------~~~~~l~~L~~~h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~ 733 (823)
++.|++++++++|+.||+||||||+|||+++++ ++++|||.|+....+...
T Consensus 84 ~~~lvme~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~~-~~liDFG~a~~~~~~~~~---- 158 (191)
T d1zara2 84 GNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEEG-IWIIDFPQSVEVGEEGWR---- 158 (191)
T ss_dssp TTEEEEECCCCEEGGGCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETTE-EEECCCTTCEETTSTTHH----
T ss_pred CCEEEEEeeccccccchhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCCC-EEEEECCCcccCCCCCcH----
Confidence 578999999999999999999999999999654 899999999765422110
Q ss_pred ccccCCCcCc------ccccCCCccccccceehhh
Q 045449 734 QTLATIGYMA------PEYGTKGRVSTRGDVCSFG 762 (823)
Q Consensus 734 ~~~gt~~y~a------PE~~~~~~~~~~~Dv~S~G 762 (823)
.|.. .|. ....|+.++|+||..
T Consensus 159 ------~~l~rd~~~~~~~-f~r~y~~~~d~~s~~ 186 (191)
T d1zara2 159 ------EILERDVRNIITY-FSRTYRTEKDINSAI 186 (191)
T ss_dssp ------HHHHHHHHHHHHH-HHHHHCCCCCHHHHH
T ss_pred ------HHHHHHHHHHHHH-HcCCCCCcccHHHHH
Confidence 0111 111 135688999999974
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.47 E-value=1.3e-13 Score=123.00 Aligned_cols=118 Identities=20% Similarity=0.233 Sum_probs=81.5
Q ss_pred ceEEecCCcceeccCccccCcccccEEEcccCcCCCCchhcccccCCCCEEEccCCCCCCcchHhhhcCCCCCEEEcccC
Q 045449 358 ETILMANCSISGNIPQVVGNLSNLLVLELGGNNLTGPIPVTFSQLQTLQAFDLTRNKLAGPITDELCHLARLHSLVLQGN 437 (823)
Q Consensus 358 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 437 (823)
++|+|++|+++. ++ .+..+++|++||+++|+|+ .+|..++.+++|++|++++|+|++. | .+..+++|+.|++++|
T Consensus 1 R~L~Ls~n~l~~-l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~l-~-~~~~l~~L~~L~l~~N 75 (124)
T d1dcea3 1 RVLHLAHKDLTV-LC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALENV-D-GVANLPRLQELLLCNN 75 (124)
T ss_dssp SEEECTTSCCSS-CC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCC-G-GGTTCSSCCEEECCSS
T ss_pred CEEEcCCCCCCC-Cc-ccccCCCCCEEECCCCccC-cchhhhhhhhccccccccccccccc-C-ccccccccCeEECCCC
Confidence 356666676663 33 3677778888888888887 4666677788888888888888743 3 3777888888888888
Q ss_pred cCcccc-cccccCCCCCCeEeccCCccccc---cchhhhccCCCcEE
Q 045449 438 KFSGSI-PSCLGNLTSVRVLYLGLNIFTSV---LSSTIWNLKDILFI 480 (823)
Q Consensus 438 ~l~g~~-p~~~~~l~~L~~L~Ls~N~l~~~---~p~~~~~l~~L~~L 480 (823)
+++... ...++.+++|+.|++++|.++.. .......+++|+.|
T Consensus 76 ~i~~~~~~~~l~~~~~L~~L~l~~N~i~~~~~~~~~l~~~lp~L~~L 122 (124)
T d1dcea3 76 RLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSI 122 (124)
T ss_dssp CCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHCTTCSEE
T ss_pred ccCCCCCchhhcCCCCCCEEECCCCcCCcCccHHHHHHHHCcCcceE
Confidence 887443 24577788888888888887653 22334455666554
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.32 E-value=2.4e-14 Score=139.36 Aligned_cols=126 Identities=23% Similarity=0.278 Sum_probs=55.0
Q ss_pred ccCcccccEEEcccCcCCCCchhcccccCCCCEEEccCCCCCCcchHhhhcCCCCCEEEcccCcCcccccccccCCCCCC
Q 045449 375 VGNLSNLLVLELGGNNLTGPIPVTFSQLQTLQAFDLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSVR 454 (823)
Q Consensus 375 ~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~ 454 (823)
+..+++|++|+|++|+++ .++ .+..+++|++|+|++|+|+ .+|..+..+++|+.|++++|+++. + +.+..+++|+
T Consensus 44 l~~L~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~-l-~~~~~l~~L~ 118 (198)
T d1m9la_ 44 LSTLKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-L-SGIEKLVNLR 118 (198)
T ss_dssp HHHTTTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCC-H-HHHHHHHHSS
T ss_pred HhcccccceeECcccCCC-Ccc-cccCCccccChhhcccccc-cccccccccccccccccccccccc-c-cccccccccc
Confidence 334444444444444444 222 2444444444444444444 223222333344444444444442 1 1234444444
Q ss_pred eEeccCCccccccc-hhhhccCCCcEEeccccccccccCcc----------ccCCCCCcEEE
Q 045449 455 VLYLGLNIFTSVLS-STIWNLKDILFIDVSSNFLDGPLSLD----------IGNLKVVIGLD 505 (823)
Q Consensus 455 ~L~Ls~N~l~~~~p-~~~~~l~~L~~LdLs~N~l~g~~p~~----------~~~l~~L~~L~ 505 (823)
.|++++|+++.... ..+..+++|+.|+|++|++....+.. +..+++|+.||
T Consensus 119 ~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~r~~vi~~lp~L~~LD 180 (198)
T d1m9la_ 119 VLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD 180 (198)
T ss_dssp EEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHHHHCTTTTHHHHHHHHHHHCSSCCEES
T ss_pred ccccccchhccccccccccCCCccceeecCCCccccCcccccchhhHHHHHHHHCCCcCEeC
Confidence 45554444444221 23444555555555555544333221 44566666665
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.30 E-value=8.4e-14 Score=135.46 Aligned_cols=128 Identities=20% Similarity=0.247 Sum_probs=75.5
Q ss_pred ccccccccccceEEecCCcceeccCccccCcccccEEEcccCcCCCCchhcccccCCCCEEEccCCCCCCcchHhhhcCC
Q 045449 348 KSIGNFSLSLETILMANCSISGNIPQVVGNLSNLLVLELGGNNLTGPIPVTFSQLQTLQAFDLTRNKLAGPITDELCHLA 427 (823)
Q Consensus 348 ~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 427 (823)
..+..+ .+|++|+|++|+|+. ++ .+.++++|++|+|++|+++ .+|..+..+++|++|++++|+++.. ..+..++
T Consensus 42 ~sl~~L-~~L~~L~Ls~n~I~~-i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~l--~~~~~l~ 115 (198)
T d1m9la_ 42 ATLSTL-KACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIASL--SGIEKLV 115 (198)
T ss_dssp HHHHHT-TTCCEEECSEEEESC-CC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCCH--HHHHHHH
T ss_pred hHHhcc-cccceeECcccCCCC-cc-cccCCccccChhhcccccc-ccccccccccccccccccccccccc--ccccccc
Confidence 344444 455556666555553 22 3556666666666666665 3444444455666666666666632 2355666
Q ss_pred CCCEEEcccCcCccccc-ccccCCCCCCeEeccCCccccccch----------hhhccCCCcEEe
Q 045449 428 RLHSLVLQGNKFSGSIP-SCLGNLTSVRVLYLGLNIFTSVLSS----------TIWNLKDILFID 481 (823)
Q Consensus 428 ~L~~L~Ls~N~l~g~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~----------~~~~l~~L~~Ld 481 (823)
+|+.|+|++|+++.... ..+..+++|+.|+|++|.++...+. .+..+++|+.||
T Consensus 116 ~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~r~~vi~~lp~L~~LD 180 (198)
T d1m9la_ 116 NLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD 180 (198)
T ss_dssp HSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHHHHCTTTTHHHHHHHHHHHCSSCCEES
T ss_pred cccccccccchhccccccccccCCCccceeecCCCccccCcccccchhhHHHHHHHHCCCcCEeC
Confidence 66667776666663221 3466666777777777766554332 256788888887
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.27 E-value=7.5e-12 Score=116.32 Aligned_cols=91 Identities=19% Similarity=0.118 Sum_probs=39.7
Q ss_pred CccccCcccccEEEcccC-cCCCCchhcccccCCCCEEEccCCCCCCcchHhhhcCCCCCEEEcccCcCcccccccccCC
Q 045449 372 PQVVGNLSNLLVLELGGN-NLTGPIPVTFSQLQTLQAFDLTRNKLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNL 450 (823)
Q Consensus 372 p~~~~~l~~L~~L~Ls~N-~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l 450 (823)
|..+..+++|++|++++| .++...+..|.++++|+.|+|++|+|+...+..|..+++|++|+|++|+|+...+..|..
T Consensus 24 p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~- 102 (156)
T d2ifga3 24 LHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQG- 102 (156)
T ss_dssp TTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCSCCCSTTTCS-
T ss_pred cccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccCCCCcccChhhhcc-
Confidence 333444444444444433 244333334444444555555555444444444444444444444444444222222222
Q ss_pred CCCCeEeccCCcc
Q 045449 451 TSVRVLYLGLNIF 463 (823)
Q Consensus 451 ~~L~~L~Ls~N~l 463 (823)
.+|+.|+|++|.+
T Consensus 103 ~~l~~L~L~~Np~ 115 (156)
T d2ifga3 103 LSLQELVLSGNPL 115 (156)
T ss_dssp CCCCEEECCSSCC
T ss_pred ccccccccCCCcc
Confidence 2344444444444
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.25 E-value=1.1e-11 Score=115.14 Aligned_cols=110 Identities=15% Similarity=0.078 Sum_probs=75.6
Q ss_pred CcccccEEEcccCcCCCCchhcccccCCCCEEEccCC-CCCCcchHhhhcCCCCCEEEcccCcCcccccccccCCCCCCe
Q 045449 377 NLSNLLVLELGGNNLTGPIPVTFSQLQTLQAFDLTRN-KLAGPITDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSVRV 455 (823)
Q Consensus 377 ~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~ 455 (823)
.+.....++.+++++. .+|..+..+++|+.|++++| .++...+..|.++++|+.|+|++|+|+...|..|..+++|++
T Consensus 6 ~c~~~~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~ 84 (156)
T d2ifga3 6 CPHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSR 84 (156)
T ss_dssp CCSSSSCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCE
T ss_pred CcCCCCeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccc
Confidence 3444566777877776 56667777778888888655 477665666777777777777777777666777777777777
Q ss_pred EeccCCccccccchhhhccCCCcEEeccccccc
Q 045449 456 LYLGLNIFTSVLSSTIWNLKDILFIDVSSNFLD 488 (823)
Q Consensus 456 L~Ls~N~l~~~~p~~~~~l~~L~~LdLs~N~l~ 488 (823)
|+|++|+|+...+..+.. ..|+.|+|++|.+.
T Consensus 85 L~Ls~N~l~~l~~~~~~~-~~l~~L~L~~Np~~ 116 (156)
T d2ifga3 85 LNLSFNALESLSWKTVQG-LSLQELVLSGNPLH 116 (156)
T ss_dssp EECCSSCCSCCCSTTTCS-CCCCEEECCSSCCC
T ss_pred eeccCCCCcccChhhhcc-ccccccccCCCccc
Confidence 777777777644444433 35666666666664
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.52 E-value=5.4e-09 Score=97.24 Aligned_cols=83 Identities=17% Similarity=0.099 Sum_probs=44.2
Q ss_pred hhcCCCCCEEEcccCcCccc--ccccccCCCCCCeEeccCCccccccchhhhccCCCcEEeccccccccccCc-------
Q 045449 423 LCHLARLHSLVLQGNKFSGS--IPSCLGNLTSVRVLYLGLNIFTSVLSSTIWNLKDILFIDVSSNFLDGPLSL------- 493 (823)
Q Consensus 423 ~~~l~~L~~L~Ls~N~l~g~--~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~LdLs~N~l~g~~p~------- 493 (823)
+..+++|++|+|++|+|+.. ++..+..+++|+.|+|++|.++...+-.......|+.|++++|.++.....
T Consensus 61 ~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y~~~ 140 (162)
T d1koha1 61 EENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISA 140 (162)
T ss_dssp HHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHHHHH
T ss_pred HHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccccceeecCCCCcCcCcccchhHHHH
Confidence 34455555555555555532 223345555666666666666554443333444566666666666554332
Q ss_pred cccCCCCCcEEE
Q 045449 494 DIGNLKVVIGLD 505 (823)
Q Consensus 494 ~~~~l~~L~~L~ 505 (823)
.+..+++|+.||
T Consensus 141 i~~~~P~L~~LD 152 (162)
T d1koha1 141 IRERFPKLLRLD 152 (162)
T ss_dssp HHTTSTTCCEET
T ss_pred HHHHCCCCCEEC
Confidence 144566666665
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.45 E-value=1.1e-08 Score=94.99 Aligned_cols=86 Identities=16% Similarity=0.161 Sum_probs=48.6
Q ss_pred hhcccccCCCCEEEccCCCCCCcc--hHhhhcCCCCCEEEcccCcCcccccccccCCCCCCeEeccCCccccccc-----
Q 045449 396 PVTFSQLQTLQAFDLTRNKLAGPI--TDELCHLARLHSLVLQGNKFSGSIPSCLGNLTSVRVLYLGLNIFTSVLS----- 468 (823)
Q Consensus 396 p~~~~~l~~L~~L~Ls~N~l~~~~--p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p----- 468 (823)
+..+..+++|++|+|++|+|+... +..+..+++|+.|+|++|.++...+-.+.....|+.|++++|.++....
T Consensus 58 ~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y 137 (162)
T d1koha1 58 RIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTY 137 (162)
T ss_dssp HHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHH
T ss_pred HHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccccceeecCCCCcCcCcccchhH
Confidence 333445566666666666665432 2335556666666666666664333233334456667777776665433
Q ss_pred --hhhhccCCCcEEe
Q 045449 469 --STIWNLKDILFID 481 (823)
Q Consensus 469 --~~~~~l~~L~~Ld 481 (823)
..+..+++|+.||
T Consensus 138 ~~~i~~~~P~L~~LD 152 (162)
T d1koha1 138 ISAIRERFPKLLRLD 152 (162)
T ss_dssp HHHHHTTSTTCCEET
T ss_pred HHHHHHHCCCCCEEC
Confidence 2355677777776
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.76 E-value=1.9e-05 Score=72.97 Aligned_cols=108 Identities=9% Similarity=0.095 Sum_probs=53.1
Q ss_pred cccccEEEcccC-cCCCC----chhcccccCCCCEEEccCCCCCCc----chHhhhcCCCCCEEEcccCcCcccc----c
Q 045449 378 LSNLLVLELGGN-NLTGP----IPVTFSQLQTLQAFDLTRNKLAGP----ITDELCHLARLHSLVLQGNKFSGSI----P 444 (823)
Q Consensus 378 l~~L~~L~Ls~N-~l~g~----~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~g~~----p 444 (823)
.++|++|+|+++ .++.. +-..+...++|++|+|++|.+... +...+...+.|+.|+|++|.++... -
T Consensus 14 ~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~ 93 (167)
T d1pgva_ 14 DTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLL 93 (167)
T ss_dssp CSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHH
T ss_pred CCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHH
Confidence 455666666653 34321 122344455666666666666522 2222334456666666666665321 1
Q ss_pred ccccCCCCCCeEeccCCccccc-------cchhhhccCCCcEEecccc
Q 045449 445 SCLGNLTSVRVLYLGLNIFTSV-------LSSTIWNLKDILFIDVSSN 485 (823)
Q Consensus 445 ~~~~~l~~L~~L~Ls~N~l~~~-------~p~~~~~l~~L~~LdLs~N 485 (823)
..+...++|++|+|++|.+... +...+..-+.|+.|+++.+
T Consensus 94 ~aL~~n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~ 141 (167)
T d1pgva_ 94 RSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFA 141 (167)
T ss_dssp HHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCC
T ss_pred HHHHhCCcCCEEECCCCcCCCccHHHHHHHHHHHHhCCCccEeeCcCC
Confidence 2344455666666666544321 2233334455555555544
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.58 E-value=3.1e-05 Score=71.43 Aligned_cols=111 Identities=14% Similarity=0.187 Sum_probs=78.2
Q ss_pred cccCCCCEEEccCC-CCCCc----chHhhhcCCCCCEEEcccCcCcccc----cccccCCCCCCeEeccCCccccccc--
Q 045449 400 SQLQTLQAFDLTRN-KLAGP----ITDELCHLARLHSLVLQGNKFSGSI----PSCLGNLTSVRVLYLGLNIFTSVLS-- 468 (823)
Q Consensus 400 ~~l~~L~~L~Ls~N-~l~~~----~p~~~~~l~~L~~L~Ls~N~l~g~~----p~~~~~l~~L~~L~Ls~N~l~~~~p-- 468 (823)
.+.++|+.|+|+++ .++.. +-..+...+.|++|+|++|.+.... ...+...+.|+.|+|++|.++..-.
T Consensus 12 ~n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~ 91 (167)
T d1pgva_ 12 EDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLAR 91 (167)
T ss_dssp TTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHH
T ss_pred hCCCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHH
Confidence 34688999999974 56533 2234566788999999999987432 2345567889999999999886433
Q ss_pred --hhhhccCCCcEEeccccccccc-------cCccccCCCCCcEEEcccCC
Q 045449 469 --STIWNLKDILFIDVSSNFLDGP-------LSLDIGNLKVVIGLDFSRNN 510 (823)
Q Consensus 469 --~~~~~l~~L~~LdLs~N~l~g~-------~p~~~~~l~~L~~L~ls~N~ 510 (823)
..+...+.|+.|++++|.+... +...+..-+.|+.|+++.+.
T Consensus 92 l~~aL~~n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~~ 142 (167)
T d1pgva_ 92 LLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFAS 142 (167)
T ss_dssp HHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCC
T ss_pred HHHHHHhCCcCCEEECCCCcCCCccHHHHHHHHHHHHhCCCccEeeCcCCC
Confidence 3455667899999998865531 34455566888888886653
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=97.09 E-value=0.00011 Score=67.49 Aligned_cols=111 Identities=18% Similarity=0.170 Sum_probs=55.5
Q ss_pred cCcccccEEEccc-CcCCCC----chhcccccCCCCEEEccCCCCCCcchH----hhhcCCCCCEEEcccCcCccc----
Q 045449 376 GNLSNLLVLELGG-NNLTGP----IPVTFSQLQTLQAFDLTRNKLAGPITD----ELCHLARLHSLVLQGNKFSGS---- 442 (823)
Q Consensus 376 ~~l~~L~~L~Ls~-N~l~g~----~p~~~~~l~~L~~L~Ls~N~l~~~~p~----~~~~l~~L~~L~Ls~N~l~g~---- 442 (823)
.+.++|++|+|++ +.++.. +-..+...++|+.|+|++|.++...-. .+...++++.+++++|.+...
T Consensus 14 ~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~ 93 (166)
T d1io0a_ 14 NNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILA 93 (166)
T ss_dssp TTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHH
T ss_pred hcCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHH
Confidence 3455666666665 345421 222344556666667776666543222 233456666666666666432
Q ss_pred ccccccCCCCCCeEec--cCCcccc----ccchhhhccCCCcEEeccccc
Q 045449 443 IPSCLGNLTSVRVLYL--GLNIFTS----VLSSTIWNLKDILFIDVSSNF 486 (823)
Q Consensus 443 ~p~~~~~l~~L~~L~L--s~N~l~~----~~p~~~~~l~~L~~LdLs~N~ 486 (823)
+-..+...++|+.++| +.|.+.. .+...+...+.|+.|+++.|.
T Consensus 94 l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~ 143 (166)
T d1io0a_ 94 LVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQ 143 (166)
T ss_dssp HHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSS
T ss_pred HHHHHHhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCCC
Confidence 1233445555655433 3445533 223334445555555555443
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.84 E-value=0.00034 Score=63.98 Aligned_cols=113 Identities=11% Similarity=0.151 Sum_probs=82.3
Q ss_pred ccccCCCCEEEccC-CCCCCcc----hHhhhcCCCCCEEEcccCcCcccc----cccccCCCCCCeEeccCCcccccc--
Q 045449 399 FSQLQTLQAFDLTR-NKLAGPI----TDELCHLARLHSLVLQGNKFSGSI----PSCLGNLTSVRVLYLGLNIFTSVL-- 467 (823)
Q Consensus 399 ~~~l~~L~~L~Ls~-N~l~~~~----p~~~~~l~~L~~L~Ls~N~l~g~~----p~~~~~l~~L~~L~Ls~N~l~~~~-- 467 (823)
..+.++|++|+|++ |.++... -..+...+.|++|+|++|.++... -..+...++++.+++++|.++...
T Consensus 13 ~~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~ 92 (166)
T d1io0a_ 13 QNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGIL 92 (166)
T ss_dssp HTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHH
T ss_pred HhcCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHH
Confidence 45678999999998 5676432 233457889999999999987542 234566789999999999987643
Q ss_pred --chhhhccCCCcE--Eecccccccc----ccCccccCCCCCcEEEcccCCC
Q 045449 468 --SSTIWNLKDILF--IDVSSNFLDG----PLSLDIGNLKVVIGLDFSRNNL 511 (823)
Q Consensus 468 --p~~~~~l~~L~~--LdLs~N~l~g----~~p~~~~~l~~L~~L~ls~N~l 511 (823)
-..+...+.|+. |++++|.+.. .+...+...+.|+.|+++.++.
T Consensus 93 ~l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~~ 144 (166)
T d1io0a_ 93 ALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQ 144 (166)
T ss_dssp HHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSH
T ss_pred HHHHHHHhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCCCC
Confidence 345667788886 4556788865 3445566788999999877653
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=92.73 E-value=0.029 Score=56.29 Aligned_cols=32 Identities=31% Similarity=0.358 Sum_probs=28.5
Q ss_pred CCCEEeccCCCCCEEeCCCCcEEEeecccccc
Q 045449 691 SIPIIHCDLKPSNVLLDEDMVAHISDFGIAKL 722 (823)
Q Consensus 691 ~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~ 722 (823)
..|+||+|+.+.||+++++...-|.||+.|..
T Consensus 182 ~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 182 PAGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp CEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred ccccccCCcchhhhhcccccceeEeccccccc
Confidence 46899999999999999988888999998764
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=88.55 E-value=0.11 Score=52.17 Aligned_cols=30 Identities=20% Similarity=0.313 Sum_probs=24.6
Q ss_pred CCCEEeccCCCCCEEeCCCCcEEEeecccccc
Q 045449 691 SIPIIHCDLKPSNVLLDEDMVAHISDFGIAKL 722 (823)
Q Consensus 691 ~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~ 722 (823)
..+++|+|+.+.|||++++ ..++||+-+..
T Consensus 191 p~~liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 191 TVLRLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CCEECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred CceeecCCCCcccEEEeCC--ceEEechhccc
Confidence 3578999999999999754 45899997764
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=81.64 E-value=0.32 Score=46.33 Aligned_cols=33 Identities=15% Similarity=0.277 Sum_probs=27.9
Q ss_pred CCCCEEeccCCCCCEEeCCCCcEEEeecccccc
Q 045449 690 HSIPIIHCDLKPSNVLLDEDMVAHISDFGIAKL 722 (823)
Q Consensus 690 h~~~ivHrdlk~~NiLl~~~~~~kl~DfGla~~ 722 (823)
....++|+|+.|.|||++++..+.|+||+.+..
T Consensus 173 ~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 173 EDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp CCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred CCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 345689999999999999877788999997764
|